PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Matsumoto, K; Ogino, T				Matsumoto, Kazuo; Ogino, Tatsuo			The Lead Structure Does Not Always Work as Designed - "Trick or Treat"?	CIRCULATION JOURNAL			English	Editorial Material							STIMULATION THRESHOLD		[Matsumoto, Kazuo] Saitama Med Univ, Int Med Ctr, Dept Cardiol, Saitama 3551298, Japan; [Ogino, Tatsuo] Higashi Matsuyama Med Assoc Hosp, Saitama, Japan	Matsumoto, K (reprint author), Saitama Med Univ, Int Med Ctr, Dept Cardiol, 1397-1 Hidaka, Saitama 3551298, Japan.	kazuom@saitama-med.ac.jp					Aubert AE, 1997, PACEMAKER LEADS; CROSSLEY GH, 1995, CIRCULATION, V92, P2935; Ellenbogen KA, 1996, PACING REFERENCE GUI; Elmqvist R, 1960, MED ELECT, P253; Hidden-Lucet F, 2000, PACE, V23, P1798; Hyman AS, 1930, ARCH INTERN MED, V46, P553; LAGERGREN H., 1963, ACTA CHIR SCAND, V125, P562; MOND H, 1988, PACE, V11, P214, DOI 10.1111/j.1540-8159.1988.tb04543.x; Mond HG, 1999, CARDIAC ELECTROPHYSI, V3, P5, DOI 10.1023/A:1009923410323; Nakazato Y, 1999, JPN CIRC J, V63, P514, DOI 10.1253/jcj.63.514; Oginosawa Y, 2014, CIRC J, V78, P2862, DOI 10.1253/circj.CJ-14-0736	11	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2834	2835		10.1253/circj.CJ-14-1172		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300005		
J	Matoba, S				Matoba, Satoaki			Triiodothyronine as a Therapeutic Candidate for Cardiac Metabolism in the Failing Heart	CIRCULATION JOURNAL			English	Editorial Material							EXTRACORPOREAL MEMBRANE-OXYGENATION; FAILURE; DISEASE		[Matoba, Satoaki] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kyoto 6028566, Japan	Matoba, S (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	matoba@koto.kpu-m.ac.jp					Klein I, 2007, CIRCULATION, V116, P1725, DOI 10.1161/CIRCULATIONAHA.106.678326; Harper ME, 2008, THYROID, V18, P145, DOI 10.1089/thy.2007.0250; Kinugasa Y, 2013, CIRC J, V77, P705, DOI 10.1253/circj.CJ-12-1091; Naqvi N, 2014, CELL, V157, P795, DOI 10.1016/j.cell.2014.03.035; Kajimoto M, 2013, J MOL CELL CARDIOL, V62, P144, DOI 10.1016/j.yjmcc.2013.05.014; Abrams D, 2014, J AM COLL CARDIOL, V63, P2769, DOI 10.1016/j.jacc.2014.03.046; Taegtmeyer H, 2004, CIRCULATION, V110, P894, DOI 10.1161/01.CIR.0000139340.88769.D5; Doehner W, 2014, J AM COLL CARDIOL, V64, P1388, DOI 10.1016/j.jacc.2014.04.083; Fernandez-Vizarra E, 2008, CURR GENET, V54, P13, DOI 10.1007/s00294-008-0194-x; Files MD, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000680; Kajimoto M, 2014, CIRC J, V78, P2867, DOI 10.1253/circj.CJ-14-0821; Kajimoto M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000106; Leigh-Brown S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-215; Masaki M, 2014, CIRC J, V78, P1494, DOI 10.1253/circj.CJ-13-1556; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2836	2837		10.1253/circj.CJ-14-1140		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300006		
J	Watanabe, H; Iino, K; Ito, H				Watanabe, Hiroyuki; Iino, Kenji; Ito, Hiroshi			Subclinical Microalbuminuria as a Predictor of Heart Failure Prognosis	CIRCULATION JOURNAL			English	Editorial Material							URINARY ALBUMIN EXCRETION; PREVALENCE; REDUCTION		[Watanabe, Hiroyuki; Iino, Kenji; Ito, Hiroshi] Akita Univ, Sch Med, Dept Cardiovasc & Resp Med, Akita 0108543, Japan	Watanabe, H (reprint author), Akita Univ, Sch Med, Dept Cardiovasc & Resp Med, 1-1-1 Hondo, Akita 0108543, Japan.	hirow@doc.med.akita-u.ac.jp					Jackson CE, 2009, LANCET, V374, P543, DOI 10.1016/S0140-6736(09)61378-7; Jackson CE, 2011, EUR J HEART FAIL, V13, P746, DOI 10.1093/eurjhf/hfr031; Masson S, 2010, CIRC-HEART FAIL, V3, P65, DOI 10.1161/CIRCHEARTFAILURE.109.881805; Savarese G, 2014, INT J CARDIOL, V172, P403, DOI 10.1016/j.ijcard.2014.01.065; Kai H, 2013, CIRC J, V77, P1551, DOI 10.1253/circj.CJ-12-1102; Miura M, 2014, CIRC J, V78, P2890, DOI 10.1253/circj.CJ-14-0787	6	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2838	2839		10.1253/circj.CJ-14-1120		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300007		
J	Sato, K				Sato, Kayoko			Helper T Cell Diversity and Plasticity - Possible Role in Cardiovascular Disease	CIRCULATION JOURNAL			English	Editorial Material							ACUTE CORONARY SYNDROMES; ATHEROSCLEROSIS; PLAQUE		[Sato, Kayoko] Tokyo Womens Med Univ, Dept Cardiol, Tokyo 1628666, Japan	Sato, K (reprint author), Tokyo Womens Med Univ, Dept Cardiol, Shinjyuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	msatok@hij.twmu.ac.jp					Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Nakajima T, 2002, CIRCULATION, V105, P570, DOI 10.1161/hc0502.103348; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Liuzzo G, 2000, CIRCULATION, V101, P2883; Ait-Oufella H, 2014, CIRC RES, V114, P1640, DOI 10.1161/CIRCRESAHA.114.302761; Han SF, 2007, CLIN IMMUNOL, V124, P90, DOI 10.1016/j.clim.2007.03.546; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Sato K, 2006, J EXP MED, V203, P239, DOI 10.1084/jem.20051062; Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; da Silva Martins Maria, 2012, Trends Mol Med, V18, P454, DOI 10.1016/j.molmed.2012.06.001; de Boer OJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000779; Emoto T, 2014, CIRC J, V78, P2935, DOI 10.1253/circj.CJ-14-0644; Nakajima T, 2003, CIRC RES, V93, P106, DOI 10.1161/01.RES.0000082333.58263.58; Shimada K, 2012, CIRC J, V76, P2331, DOI 10.1253/circj.CJ-12-1052; Zal B, 2008, J IMMUNOL, V181, P5233	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2843	2844		10.1253/circj.CJ-14-1164		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300009		
J	Kawashiri, M; Nomura, A; Konno, T; Hayashi, K				Kawashiri, Masa-aki; Nomura, Akihiro; Konno, Tetsuo; Hayashi, Kenshi			Can Next-Generation Sequencing Replace Sanger Sequencing for Screening Genetic Variants?	CIRCULATION JOURNAL			English	Editorial Material							HYPERTROPHIC CARDIOMYOPATHY; PERSPECTIVES; MUTATION		[Kawashiri, Masa-aki; Nomura, Akihiro; Konno, Tetsuo; Hayashi, Kenshi] Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, Kanazawa, Ishikawa 9208641, Japan; [Konno, Tetsuo] Kanazawa Univ, Res & Educ Ctr Innovat & Prevent Med, Kanazawa, Ishikawa 9208641, Japan; [Nomura, Akihiro] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	Kawashiri, M (reprint author), Kanazawa Univ, Grad Sch Med, Div Cardiovasc Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	mk@med.kanazawa-u.ac.jp					Sikkema-Raddatz B, 2013, HUM MUTAT, V34, P1035, DOI 10.1002/humu.22332; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Kubo T, 2011, CIRC J, V75, P2654, DOI 10.1253/circj.CJ-10-1314; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Maron BJ, 2012, J AM COLL CARDIOL, V60, P705, DOI 10.1016/j.jacc.2012.02.068; Bell C.J., 2011, SCI TRANSL MED, V3, pra4, DOI DOI 10.1126/SCITRANSL-MED.3001756; Fujita T, 2013, JACC-HEART FAIL, V1, P459, DOI 10.1016/j.jchf.2013.08.007; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Gomez J, 2014, CIRC J, V78, P2963, DOI 10.1253/circj.CJ-14-0628; Kawashiri M, 2014, HEART VESSELS, V29, P129, DOI 10.1007/s00380-013-0391-5; Konno T, 2010, CURR OPIN CARDIOL, V25, P205, DOI 10.1097/HCO.0b013e3283375698; Martinez DA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000906; Morita H, 2013, CIRC J, V77, P876, DOI 10.1253/circj.CJ-13-0126; Wetterstrand K., DNA SEQUENCING COSTS	15	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2845	2847		10.1253/circj.CJ-14-1144		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300010		
J	Suzuki, T; Nishigaki, K				Suzuki, Tsugutoshi; Nishigaki, Kyoichi			Pacing Therapy in Pediatric and Congenital Heart Disease Patients	CIRCULATION JOURNAL			English	Editorial Material							CARDIAC RESYNCHRONIZATION THERAPY; BIPOLAR EPICARDIAL LEADS; SINGLE-CENTER EXPERIENCE; TERM-FOLLOW-UP; STIMULATION; PERFORMANCE; PACEMAKER		[Suzuki, Tsugutoshi] Osaka City Gen Hosp, Pediat Med Care Ctr, Dept Pediat Electrophysiol, Osaka 5340021, Japan; [Nishigaki, Kyoichi] Osaka City Gen Hosp, Pediat Med Care Ctr, Dept Pediat Cardiovasc Surg, Osaka 5340021, Japan	Suzuki, T (reprint author), Osaka City Gen Hosp, Dept Pediat Electrophysiol, Miyakojima Ku, 2-13-22 Miyakojimahondori, Osaka 5340021, Japan.	tsugutoshi@me.com					van der Hulst AE, 2011, EUR HEART J, V32, P2236, DOI 10.1093/eurheartj/ehr093; Ranjan R, 1998, BIOPHYS J, V74, P1850; Cohen MI, 2001, CIRCULATION, V103, P2585; Burger H, 2012, THORAC CARDIOV SURG, V60, P70, DOI 10.1055/s-0031-1280066; Cua CL, 2012, CIRC J, V76, P22, DOI 10.1253/circj.CJ-11-1267; Matsuhisa H, 2014, CIRC J, V78, P2972, DOI 10.1253/circj.CJ-14-0534; Motonaga KS, 2014, CIRCULATION, V129, P1879, DOI 10.1161/CIRCULATIONAHA.113.001383; Paech C, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-84; Papadopoulos N, 2010, EUROPACE, V12, P540, DOI 10.1093/europace/euq037; Silvetti M S, 2007, Minerva Cardioangiol, V55, P803; Suzuki T, 2014, CIRC J, V78, P1710, DOI 10.1253/circj.CJ-13-1379	11	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2848	2850		10.1253/circj.CJ-14-1137		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300011		
J	Shimizu, A				Shimizu, Akihiko			How Should We Use the Wearable Cardioverter-Defibrillator in Japan?	CIRCULATION JOURNAL			English	Editorial Material							HIGH-RISK; EXPERIENCE; DEATH		Yamaguchi Grad Sch Med, Fac Hlth Sci, Ube, Yamaguchi 7558505, Japan	Shimizu, A (reprint author), Yamaguchi Grad Sch Med, Fac Hlth Sci, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	ashimizu@yamaguchi-u.ac.jp					Wilkoff BL, 2009, HEART RHYTHM, V6, P1085, DOI 10.1016/j.hrthm.2009.05.020; Chung MK, 2010, J AM COLL CARDIOL, V56, P194, DOI 10.1016/j.jacc.2010.04.016; Klein HU, 2013, EUR HEART J, V34, P2230, DOI 10.1093/eurheartj/eht167; Feldman AM, 2004, PACE, V27, P4, DOI 10.1111/j.1540-8159.2004.00378.x; Adler A, 2013, CIRCULATION, V127, P854, DOI 10.1161/CIRCULATIONAHA.112.146530; Klein HU, 2010, PACE, V33, P353, DOI 10.1111/j.1540-8159.2009.02590.x; Auricchio A, 1998, AM J CARDIOL, V81, P1253, DOI 10.1016/S0002-9149(98)00120-9; JCS Joint Working Group, 2013, CIRC J, V77, P249; Lapage MJ, 2008, PACE, V31, P912, DOI 10.1111/j.1540-8159.2008.01110.x; Niwano S, STATEMENTS CLIN USE; Sasaki S, 2014, CIRC J, V78, P2987, DOI 10.1253/circj.CJ-14-1098; Shimizu A, 2013, CIRC J, V77, P319, DOI 10.1253/circj.CJ-12-1542; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233	13	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2851	2853		10.1253/circj.CJ-14-1188		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300012		
J	Oginosawa, Y; Abe, H; Ohe, H; Hayashi, K; Kohno, R; Watabe, T; Takahashi, M; Fujino, Y; Tamura, M; Takeuchi, M; Otsuji, Y				Oginosawa, Yasushi; Abe, Haruhiko; Ohe, Hisaharu; Hayashi, Katsuhide; Kohno, Ritsuko; Watabe, Taichi; Takahashi, Masao; Fujino, Yoshihisa; Tamura, Masahito; Takeuchi, Masaaki; Otsuji, Yutaka			Pacing and Sensing Interference by Air Bubble Surrounding the Non-Extended Helix of Intact Active Fixation Lead - In Vivo Observation and In Vitro Experiment	CIRCULATION JOURNAL			English	Article						Active fixation lead; Air bubble interference; Impedance; Insulation; Pacing lead	ATRIAL LEAD; IMPLANTATION; PERFORATION	Background: Active fixation pacing leads with silicon cylinder tips have been used for their safety and flexibility. Measurement of baseline sensing/pacing characteristics before fixation of helix helps to identify the optimal pacing site, but we encountered difficulties in making these measurements despite multiple attempts with the model LPA 1200M lead. To identify the cause and overcome this complication, we compared 4 different retractable active fixation lead models, which enabled baseline sensing/pacing measurements before extension of helix. Methods and Results: We immersed 4 different lead tips and rings in a 0.18% saline solution, and measured the lead impedance before and after flushing of air bubble visible inside the lead tip. Before evacuation of the air bubble, the impedance of the model LPA 1200M lead was >4,000 Omega in 8 out of 10 measurements, although that of the other leads was within the measurable range. After evacuation of the air bubble, the lead impedance returned to within the measurable range. There was no prominent change in the impedance of the metal cylinder tip lead. Conclusions: Air bubbles may interfere with the measurement of baseline sensing/pacing characteristics before active fixation of pacing leads with cylindrical silicon tips. In the case of high impedance beyond the measurable range before extension of helix, the measurement should be repeated after fixation into the myocardium before suspecting lead dysfunction.	[Oginosawa, Yasushi; Ohe, Hisaharu; Hayashi, Katsuhide; Watabe, Taichi; Takahashi, Masao; Tamura, Masahito; Takeuchi, Masaaki; Otsuji, Yutaka] Univ Occupat & Environm Hlth, Dept Internal Med 2, Kitakyushu, Fukuoka 8078555, Japan; [Abe, Haruhiko; Kohno, Ritsuko] Univ Occupat & Environm Hlth, Dept Heart Rhythm Management, Kitakyushu, Fukuoka 8078555, Japan; [Fujino, Yoshihisa] Univ Occupat & Environm Hlth, Dept Prevent Med & Community Hlth, Kitakyushu, Fukuoka 8078555, Japan	Abe, H (reprint author), Univ Occupat & Environm Hlth, Dept Heart Rhythm Management, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	haru-abe@med.uoeh-u.ac.jp					Antonelli D, 2012, EUROPACE, V14, P453, DOI 10.1093/europace/eur294; Danik SB, 2008, HEART RHYTHM, V5, P1667, DOI 10.1016/j.hrthm.2008.09.017; Furman Seymour, 1993, P29; IRNICH W, 1984, PACE, V7, P1021, DOI 10.1111/j.1540-8159.1984.tb05655.x; Kashiwase K, 2012, INT HEART J, V53, P108; McGavigan AD, 2006, PACE, V29, P1063, DOI 10.1111/j.1540-8159.2006.00499.x; Minamiguchi H, 2012, CIRC J, V76, P598, DOI 10.1253/circj.CJ-11-0745; Oginosawa Y, 2002, PACE, V25, P1278, DOI 10.1046/j.1460-9592.2002.01278.x; Ohlow MA, 2013, CIRC J, V77, P975, DOI 10.1253/circj.CJ-12-0707	9	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2862	2866		10.1253/circj.CJ-14-0736		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300014		
J	Hiraoka, A; Totsugawa, T; Kuinose, M; Nakajima, K; Chikazawa, G; Tamura, K; Yoshitaka, H; Sakaguchi, T				Hiraoka, Arudo; Totsugawa, Toshinori; Kuinose, Masahiko; Nakajima, Kosuke; Chikazawa, Genta; Tamura, Kentaro; Yoshitaka, Hidenori; Sakaguchi, Taichi			Propensity Score-Matched Analysis of Minimally Invasive Aortic Valve Replacement	CIRCULATION JOURNAL			English	Article						Aortic stenosis; Cardiovascular disease; Surgery; Valvular disease	RIGHT ANTERIOR MINITHORACOTOMY; STANDARD APPROACH; PORT-ACCESS; HEART-VALVE; SURGERY; MINISTERNOTOMY; STERNOTOMY; OUTCOMES; IMPLANTATION; OPERATIONS	Background: Right mini-thoracotomy and partial sternotomy are widely recognized as effective approaches in minimally invasive aortic valve replacement (AVR). The aim of this study was to evaluate the objective benefits of the respective approaches compared to the conventional approach. Methods and Results: A retrospective analysis was performed in 282 consecutive patients who underwent isolated and initial AVR at a single cardiovascular institute between May 2007 and December 2012. Mini-thoracotomy and partial sternotomy were performed in 62 (22%) and in 26 patients (9%), respectively. Propensity score matching produced 36 (mini-thoracotomy vs. full sternotomy) and 24 (partial sternotomy vs. full sternotomy) well-matched pairs. Compared to the conventional approach, mini-thoracotomy was associated with significantly shorter operative time (235 +/- 35 min vs. 272 +/- 73 min; P=0.009), lower prevalence of blood transfusion (42%, 15/36 vs. 67%, 24/36; P=0.025), and significantly shorter intensive care unit and postoperative hospital stay (1.4 +/- 0.8 days vs. 2.2 +/- 1.1 days, P=0.001; and 13.3 +/- 6.5 days vs. 21.5 +/- 10.3 days, P=0.001; respectively). There were no significant differences in operative and postoperative data between the partial sternotomy and full sternotomy groups. Conclusions: The objective benefits of right mini-thoracotomy included early rehabilitation and lower prevalence of blood transfusion. Significant advantages of partial sternotomy were not found.	[Hiraoka, Arudo; Totsugawa, Toshinori; Nakajima, Kosuke; Chikazawa, Genta; Tamura, Kentaro; Yoshitaka, Hidenori; Sakaguchi, Taichi] Sakakibara Heart Inst Okayama, Dept Cardiovasc Surg, Okayama 7000804, Japan; [Kuinose, Masahiko] Tokyo Med Univ Hosp, Dept Cardiovasc Surg, Tokyo, Japan	Hiraoka, A (reprint author), Sakakibara Heart Inst Okayama, Dept Cardiovasc Surg, Kita Ku, 2-5-1 Nakaicho, Okayama 7000804, Japan.	bassbord1028@yahoo.co.jp					Brown ML, 2009, J THORAC CARDIOV SUR, V137, P670, DOI 10.1016/j.jtcvs.2008.08.010; Brinkman WT, 2010, ANN THORAC SURG, V90, P131, DOI 10.1016/j.athoracsur.2010.03.055; Cerillo AG, 2012, J HEART VALVE DIS, V21, P168; Austin PC, 2007, J THORAC CARDIOV SUR, V134, P1128, DOI 10.1016/j.jtcvs.2007.07.021; D'Onofrio A, 2012, J THORAC CARDIOV SUR, V144, P1010, DOI 10.1016/j.jtcvs.2012.07.040; Kobayashi J, 2013, CIRC J, V77, P309, DOI 10.1253/circj.CJ-12-1546; Santarpino G, 2013, ANN THORAC SURG, V96, P77, DOI 10.1016/j.athoracsur.2013.03.083; Sawa Y, 2014, CIRC J, V78, P1083, DOI 10.1253/circj.CJ-14-0162; Aris A, 1999, ANN THORAC SURG, V67, P1583, DOI 10.1016/S0003-4975(99)00362-8; Bakir I, 2006, ANN THORAC SURG, V81, P1599, DOI 10.1016/j.athoracsur.2005.12.011; Bonacchi M, 2002, ANN THORAC SURG, V73, P460, DOI 10.1016/S0003-4975(01)03402-6; Glauber M, 2013, J THORAC CARDIOV SUR, V145, P1222, DOI 10.1016/j.jtcvs.2012.03.064; Glauber M, 2011, J THORAC CARDIOV SUR, V142, P1577, DOI 10.1016/j.jtcvs.2011.05.011; Glower Donald D, 2010, Innovations (Phila), V5, P326, DOI 10.1097/IMI.0b013e3181f64e54; Hiraoka A, 2011, CIRC J, V75, P1656, DOI 10.1253/circj.CJ-10-1257; Lorusso R, 2013, CURR OPIN CARDIOL, V28, P158, DOI 10.1097/HCO.0b013e32835da4b2; Machler HE, 1999, ANN THORAC SURG, V67, P1001, DOI 10.1016/S0003-4975(99)00072-7; Mihaljevic T, 2004, ANN SURG, V240, P529, DOI 10.1097/01.sla.0000137141.55267.47; Plass A, 2009, ANN THORAC SURG, V88, P1851, DOI 10.1016/j.athoracsur.2009.08.015; Tabata M, 2013, CIRC J, V77, P2232, DOI 10.1253/circj.C7-13-0827	20	3	3	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2876	2881		10.1253/circj.CJ-14-0861		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300016		
J	Fujino, T; Kinugawa, K; Hatano, M; Imamura, T; Muraoka, H; Minatsuki, S; Inaba, T; Maki, H; Kinoshita, O; Nawata, K; Yao, A; Ono, M; Komuro, I				Fujino, Takeo; Kinugawa, Koichiro; Hatano, Masaru; Imamura, Teruhiko; Muraoka, Hironori; Minatsuki, Shun; Inaba, Toshiro; Maki, Hisataka; Kinoshita, Osamu; Nawata, Kan; Yao, Atsushi; Ono, Minoru; Komuro, Issei			Low Blood Pressure, Low Serum Cholesterol and Anemia Predict Early Necessity of Ventricular Assist Device Implantation in Patients With Advanced Heart Failure at the Time of Referral From Non-Ventricular Assist Device Institutes	CIRCULATION JOURNAL			English	Article						INTERMACS profile; Seattle Heart Failure Model; Stage D heart failure	REDUCED EJECTION FRACTION; CIRCULATORY SUPPORT; MORTALITY; OUTCOMES; RISK; SURVIVAL; INSIGHTS; DATABASE; THERAPY; MODEL	Background: The timing of ventricular assist device (VAD) implantation is always a matter of debate, especially when a patient is referred from a non-VAD institute. We focused on objective noninvasive parameters at the time of admission to a VAD implant center and analyzed the factors predicting the necessity of early VAD. Methods and Results: We retrospectively analyzed advanced heart failure (HF) patients referred since January 2011, including patients less than 65 years old. They all had a history of hospitalization for HF management in non-VAD institutes within 1 month before referral. We excluded patients transferred with mechanical circulatory support. We enrolled 46 patients (40 males, 39.8 +/- 13.4 years old). Among them, 26 patients had a VAD implanted or died within 120 days. By multivariable logistic analysis using admission parameters, systolic blood pressure (BP) <93 mmHg [odds ratio (OR) 13.335], hemoglobin <12.7 g/dl (OR 12.175) and serum total cholesterol < 144 mg/dl (OR 8.096) were significant predictors of early VAD requirement. We constructed a scoring system according to the ORs, and the area under the receiver-operating characteristic curve was 0.913. Conclusions: Low BP, low serum cholesterol and anemia on admission predict early VAD in advanced HF patients who have been treated in non-VAD institutes. Such patients should be promptly referred to a VAD implant center.	[Fujino, Takeo; Hatano, Masaru; Muraoka, Hironori; Minatsuki, Shun; Inaba, Toshiro; Maki, Hisataka; Komuro, Issei] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Tokyo 1138655, Japan; [Kinugawa, Koichiro; Imamura, Teruhiko] Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Tokyo 1138655, Japan; [Kinoshita, Osamu; Nawata, Kan; Ono, Minoru] Univ Tokyo, Grad Sch Med, Dept Cardiothorac Surg, Tokyo 1138655, Japan; [Yao, Atsushi] Univ Tokyo, Div Hlth Serv Promot, Tokyo 1138655, Japan	Kinugawa, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Therapeut Strategy Heart Failure, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kinugawa-tky@umin.ac.jp					Afsarmanesh N, 2006, AM HEART J, V152, P1077, DOI 10.1016/j.ahj.2006.06.015; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Levy WC, 2009, J HEART LUNG TRANSPL, V28, P231, DOI 10.1016/j.healun.2008.12.015; Horwich TB, 2002, J CARD FAIL, V8, P216, DOI 10.1054/jcaf.2002.126519; Imamura T, 2014, CIRC J, V78, P1396, DOI 10.1253/circj.CJ-14-0077; Gheorghiade M, 2006, JAMA-J AM MED ASSOC, V296, P2217, DOI 10.1001/jama.296.18.2217; Groenveld HF, 2008, J AM COLL CARDIOL, V52, P818, DOI 10.1016/j.jacc.2008.04.061; Rao V, 2003, J THORAC CARDIOV SUR, V125, P855, DOI 10.1067/mtc.2003.111; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Kirklin JK, 2008, J HEART LUNG TRANSPL, V27, P1065, DOI 10.1016/j.healun.2008.07.021; Ambrosy AP, 2013, AM HEART J, V165, P216, DOI 10.1016/j.ahj.2012.11.004; Gheorghiade M, 2005, CIRCULATION, V112, P3958, DOI 10.1161/CIRCULATIONAHA.105.590091; Ezekowitz JA, 2003, CIRCULATION, V107, P223, DOI 10.1161/01.CIR.0000052622.51963.FC; Lietz K, 2007, CIRCULATION, V116, P497, DOI 10.1161/CIRCULATIONAHA.107.691972; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776; Maggioni AP, 2005, J CARD FAIL, V11, P91, DOI 10.1016/j.cardfail.2004.05.004; Kinugawa K, 2011, CIRC J, V75, P2038, DOI 10.1253/circj.CJ-11-0621; Rauchhaus M, 2000, LANCET, V356, P930, DOI 10.1016/S0140-6736(00)02690-8; Imamura T, 2012, CIRC J, V76, P1895, DOI 10.1253/circj.CJ-12-0182; Kirklin JK, 2014, J HEART LUNG TRANSPL, V33, P555, DOI 10.1016/j.healun.2014.04.010; Swedberg K, 2013, NEW ENGL J MED, V368, P1210, DOI 10.1056/NEJMoa1214865; Kato N, 2013, CIRC J, V77, P1001, DOI 10.1253/circj.CJ-12-1241; Silverberg DS, 2002, EUR J HEART FAIL, V4, P681, DOI 10.1016/S1388-9842(02)00115-0; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938	24	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2882	U130		10.1253/circj.CJ-14-0749		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300017		
J	Miura, M; Sakata, Y; Miyata, S; Nochioka, K; Takada, T; Tadaki, S; Ushigome, R; Yamauchi, T; Takahashi, J; Shimokawa, H				Miura, Masanobu; Sakata, Yasuhiko; Miyata, Satoshi; Nochioka, Kotaro; Takada, Tsuyoshi; Tadaki, Soichiro; Ushigome, Ryoichi; Yamauchi, Takeshi; Takahashi, Jun; Shimokawa, Hiroaki		CHART-2 Investigators	Prognostic Impact of Subclinical Microalbuminuria in Patients With Chronic Heart Failure - Report From the CHART-2 Study	CIRCULATION JOURNAL			English	Article						Chronic heart failure; Chronic kidney disease; Prognosis; Subclinical microalbuminuria	URINARY ALBUMIN EXCRETION; CHRONIC KIDNEY-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; NORD-TRONDELAG HEALTH; LOW-GRADE ALBUMINURIA; ALL-CAUSE MORTALITY; GENERAL-POPULATION; CLINICAL CHARACTERISTICS; NONDIABETIC INDIVIDUALS; CARDIOVASCULAR RISK	Background: Microalbuminuria, traditionally defined as urinary albumin/creatinine ratio (UACR) >= 30 mg/g, is a risk factor for mortality even in patients with preserved glomerular filtration rate (GFR). The prognostic impact of subclinical microalbuminuria, however, remains unknown in patients with chronic heart failure (CHF). Methods and Results: In the Chronic Heart Failure Analysis and Registry in the Tohoku District 2 Study, we enrolled 2,039 consecutive symptomatic CHF patients (median age, 67.4 years; 68.9% male) after excluding those on hemodialysis. On classification and regression tree analysis, UACR=10.2 mg/g and 27.4 mg/g were identified as the first and second discriminating points to stratify the risk for composite of death, acute myocardial infarction, HF admission and stroke, therefore subclinical microalbuminuria was defined as UACR >= 10.2 and <27.4 mg/g. There were 506 composite endpoints (24.8%) during the median follow-up of 2.69 years. On Kaplan-Meier analysis and multi-variate Cox modeling, subclinical microalbuminuria was significantly associated with increased composite endpoints with hazard ratios of 1.90 (P<0.001) and 2.29 (P<0.001) in patients with preserved (>60 ml . min(-1) . 1.73 m(-2), n=1,129) or mildly reduced eGFR (30-59.9 ml . min(-1) . 1.73 m(-2), n=789), respectively. In patients with severely reduced GFR (eGFR <30 ml . min(-1) . 1.73 m(-2), n=121), > 80% had microalbuminuria or macroalbuminuria, and only 9.1% were free from any composite endpoints. Conclusions: Subclinical microalbuminuria was associated with increased risk of cardiovascular events in CHF patients with mildly reduced or preserved renal function.	[Miura, Masanobu; Sakata, Yasuhiko; Nochioka, Kotaro; Takada, Tsuyoshi; Tadaki, Soichiro; Ushigome, Ryoichi; Yamauchi, Takeshi; Takahashi, Jun; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan; [Miyata, Satoshi] Tohoku Univ, Grad Sch Med, Dept Evidence Based Cardiovasc Med, Sendai, Miyagi 9808574, Japan	Sakata, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	sakatayk@cardio.med.tohoku.ac.jp			Ministry of Health, Labour, and Welfare; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Daiichi Sankyo (Tokyo, Japan); Bayer Yakuhin (Osaka, Japan); Kyowa Hakko Kirin (Tokyo, Japan); Kowa Pharmaceutical (Tokyo, Japan); Novartis Pharma (Tokyo, Japan); Dainippon Sumitomo Pharma (Osaka, Japan); Nippon Boehringer Ingelheim (Tokyo, Japan)	We thank all members of the Tohoku Heart Failure Society and the staff of the Departments of Cardiovascular Medicine and Evidence-Based Cardiovascular Medicine for their kind contributions (Appendix S1). This study was supported in part by Grants-in-Aid from the Ministry of Health, Labour, and Welfare and the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The Department of Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine, is supported in part by unrestricted research grants from Daiichi Sankyo (Tokyo, Japan), Bayer Yakuhin (Osaka, Japan), Kyowa Hakko Kirin (Tokyo, Japan), Kowa Pharmaceutical (Tokyo, Japan), Novartis Pharma (Tokyo, Japan), Dainippon Sumitomo Pharma (Osaka, Japan), and Nippon Boehringer Ingelheim (Tokyo, Japan). H.S. has received lecture fees from Bayer Yakuhin (Osaka, Japan), Daiichi Sankyo (Tokyo, Japan) and Novartis Pharma (Tokyo, Japan).	Sakata Y, 2014, CIRC J, V78, P428, DOI 10.1253/circj.CJ-13-1009; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Nochioka K, 2013, CIRC J, V77, P2318, DOI 10.1253/circj.CJ-13-0127; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Waheed S, 2012, AM J KIDNEY DIS, V60, P207, DOI 10.1053/j.ajkd.2012.03.011; Lieb W, 2006, NEPHROL DIAL TRANSPL, V21, P2780, DOI 10.1093/ndt/gfl364; Romundstad S, 2003, AM J KIDNEY DIS, V42, P466, DOI 10.1016/S0272-6386(03)00742-X; Shiba N, 2011, CIRC J, V75, P823, DOI 10.1253/circj.CJ-11-0135; Wang HE, 2011, AM J NEPHROL, V34, P330, DOI 10.1159/000330673; Jackson CE, 2009, LANCET, V374, P543, DOI 10.1016/S0140-6736(09)61378-7; Jackson CE, 2011, EUR J HEART FAIL, V13, P746, DOI 10.1093/eurjhf/hfr031; Masson S, 2010, CIRC-HEART FAIL, V3, P65, DOI 10.1161/CIRCHEARTFAILURE.109.881805; Blecker S, 2011, AM J KIDNEY DIS, V58, P47, DOI 10.1053/j.ajkd.2011.02.391; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Wachtell K, 2003, ANN INTERN MED, V139, P901; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Danziger J, 2008, MAYO CLIN PROC, V83, P806, DOI 10.4065/83.7.806; Anand IS, 2009, CIRCULATION, V120, P1577, DOI 10.1161/CIRCULATIONAHA.109.853648; Rachmani R, 2000, DIABETES RES CLIN PR, V49, P187, DOI 10.1016/S0168-8227(00)00155-8; Miura M, 2012, EUR J HEART FAIL, V14, P367, DOI 10.1093/eurjhf/hfs001; Breiman L., 1984, CLASSIFICATION REGRE; Furtner M, 2005, EUR HEART J, V26, P279, DOI 10.1093/eurheartj/ehi014; Imai Enyu, 2007, Clin Exp Nephrol, V11, P41, DOI 10.1007/s10157-006-0453-4; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Miura M, 2013, CIRC J, V77, P2954, DOI 10.1253/circj.CJ-13-0725; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; Pedersen LM, 2000, MED ONCOL, V17, P117, DOI 10.1007/BF02796206; R Core Team, 2012, R LANG ENV STAT COMP; Romundstad S, 2003, CIRCULATION, V108, P2783, DOI 10.1161/01.CIR.0000103667.27493.32; Scrutinio D, 2011, EUR J HEART FAIL, V13, P61, DOI 10.1093/eurjhf/hfq167; Van De Wal RMA, 2005, J CARD FAIL, V11, P602, DOI 10.1016/j.cardfail.2005.05.007; Yuyun MF, 2004, EUR J CARDIOV PREV R, V11, P207, DOI 10.1097/01.hjr.0000133070.75016.1d	35	2	2	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2890	U141		10.1253/circj.CJ-14-0787		11	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300018		
J	Obayashi, K; Saeki, K; Kurumatani, N				Obayashi, Kenji; Saeki, Keigo; Kurumatani, Norio			Asymmetric Dimethylarginine Attenuates the Association of Melatonin Secretion With Night-Time Blood Pressure and Dipping in Elderly Individuals - The HEIJO-KYO Cohort -	CIRCULATION JOURNAL			English	Article						Asymmetric dimethylarginine; Blood pressure; Melatonin; Nocturnal hypertension; Non-dipper	CARDIOVASCULAR EVENTS; HYPERTENSIVE PATIENTS; RISK-FACTOR; ADMA; DIMETHYLAMINOHYDROLASE; POPULATION; GUIDELINES; EXCRETION; RECEPTOR; PATTERN	Background: Melatonin decreases night-time blood pressure (BP) by increasing nitric oxide (NO) in endothelial cells. Whether serum asymmetric dimethylarginine (ADMA), a major endogenous competitive inhibitor of endothelial NO synthase, attenuates the association of melatonin with night-time BP and dipping in humans is unclear. Methods and Results: In this cross-sectional study of 852 community-based elderly individuals, serum ADMA, overnight urinary 6-sulfatoxymelatonin excretion (UME), and ambulatory BP were measured. Mean ADMA was 0.46+/-0.06 mu mol/L. In the low-ADMA group (n=451), crude OR for nocturnal hypertension (NH) and non-dipper significantly decreased with a quartile increase in UME (P=0.023 and 0.001, respectively), but these associations were not observed in the high-ADMA group (n=401). Higher UME was significantly and inversely associated with adjusted OR for NH and non-dipper in the low-ADMA group (Q1, 1.00 and 1.00; Q2, 0.92 and 0.74; Q3, 0.57 and 0.51; Q4, 0.48 and 0.40; P=0.004 and 0.002, respectively) but not in the high-ADMA group (P=0.75 and 0.12, respectively). These association trends were also observed on continuous variable analysis (low ADMA, P=0.031 and 0.003; high ADMA, P=0.52 and 0.13; respectively). Conclusions: ADMA attenuates the association of endogenous melatonin with night-time BP and dipping in the general elderly population.	[Obayashi, Kenji; Saeki, Keigo; Kurumatani, Norio] Nara Med Univ, Sch Med, Dept Community Hlth & Epidemiol, Kashihara, Nara 6348521, Japan	Obayashi, K (reprint author), Nara Med Univ, Sch Med, Dept Community Hlth & Epidemiol, 840 Shijocho, Kashihara, Nara 6348521, Japan.	obayashi@naramed-u.ac.jp			Department of Indoor Environmental Medicine, Nara Medical University; Ministry of Education, Culture, Sports, Science and Technology; Mitsui Sumitomo Insurance Welfare Foundation; Meiji Yasuda Life Foundation of Health and Welfare; Osaka Gas Group Welfare Foundation; Japan Diabetes Foundation; Daiwa Securities Health Foundation; Japan Science and Technology Agency; YKK AP	This work was supported by Grants from the Department of Indoor Environmental Medicine, Nara Medical University; Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology; Mitsui Sumitomo Insurance Welfare Foundation; Meiji Yasuda Life Foundation of Health and Welfare; Osaka Gas Group Welfare Foundation; Japan Diabetes Foundation; Daiwa Securities Health Foundation; Japan Science and Technology Agency; and YKK AP.	Wolf J, 2010, HYPERTENS RES, V33, P867, DOI 10.1038/hr.2010.153; Cooke JP, 2004, CIRCULATION, V109, P1813, DOI 10.1161/01.CIR.0000126823.07732.D5; Scheer FAJL, 2004, HYPERTENSION, V43, P192, DOI 10.1161/01.HYP.0000113293.15186.3b; Ekmekcioglu C, 2003, J PINEAL RES, V35, P40, DOI 10.1034/j.1600-079X.2003.00051.x; Zoccali C, 2006, J HYPERTENS, V24, P611, DOI 10.1097/01.hjh.0000217839.26971.8d; Grossman E, 2006, AM J MED, V119, P898, DOI 10.1016/j.amjmed.2006.02.002; Jonas M, 2003, BLOOD PRESSURE, V12, P19, DOI 10.1080/08037050310000418; Kielstein JT, 2003, CIRCULATION, V107, P1891, DOI 10.1161/01.CIR.0000060496.23144.A7; Obayashi K, 2013, HYPERTENS RES, V36, P736, DOI 10.1038/hr.2013.20; Obayashi K, 2014, J CLIN ENDOCR METAB, V99, P3233, DOI 10.1210/jc.2014-1262; Fagard RH, 2008, HYPERTENSION, V51, P55, DOI 10.1161/HYPERTENSIONAHA.107.100727; Kario K, 2001, HYPERTENSION, V38, P852, DOI 10.1161/hy1001.092640; Kobayashi S, 2008, CLIN J AM SOC NEPHRO, V3, P1289, DOI 10.2215/CJN.00010108; Tain YL, 2010, J PINEAL RES, V49, P390, DOI 10.1111/j.1600-079X.2010.00806.x; Reriani MK, 2012, CIRC J, V76, P778, DOI 10.1253/circj.CJ-12-0248; Boggia J, 2007, LANCET, V370, P1219, DOI 10.1016/S0140-6736(07)61538-4; Lin KY, 2002, CIRCULATION, V106, P987, DOI 10.1161/01.CIR.0000027109.14149.67; Boger RH, 1998, CIRCULATION, V98, P1842; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Sega R, 2005, CIRCULATION, V111, P1777, DOI 10.1161/01.CIR.0000160923.04524.5B; Arangino S, 1999, AM J CARDIOL, V83, P1417, DOI 10.1016/S0002-9149(99)00112-5; Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186; Drew JE, 2001, J NEUROENDOCRINOL, V13, P453, DOI 10.1046/j.1365-2826.2001.00651.x; European Medicines Agency, CIRC EPA REP; Holden DP, 2003, CIRCULATION, V108, P1575, DOI 10.1161/01.CIR.0000091083.61609.DF; Shimada K, 2012, CIRC J, V76, P508, DOI 10.1253/circj.CJ-88-0020; Jung CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052346; Mehra R, 2008, SLEEP, V31, P1569; Ministry of Health Labour and Welfare, 2010, NAT HLTH NUTR SURV J; Obayashi K, 2014, HYPERTENS RES, V37, P908, DOI 10.1038/hr.2014.99; Pogan L, 2002, J PINEAL RES, V33, P37, DOI 10.1034/j.1600-079X.2002.01890.x; Pullamsetti SS, 2010, CIRCULATION, V123, P1194; VERDECCHIA P, 1990, AM J CARDIOL, V66, P583, DOI 10.1016/0002-9149(90)90485-J; Zeman M, 2005, LIFE SCI, V76, P1795, DOI 10.1016/j.lfs.2004.08.034	34	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2908	2914		10.1253/circj.CJ-14-0613		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300020		
J	Abe, Y; Ito, K; Hao, K; Shindo, T; Ogata, T; Kagaya, Y; Kurosawa, R; Nishimiya, K; Satoh, K; Miyata, S; Kawakami, K; Shimokawa, H				Abe, Yuzuru; Ito, Kenta; Hao, Kiyotaka; Shindo, Tomohiko; Ogata, Tsuyoshi; Kagaya, Yuta; Kurosawa, Ryo; Nishimiya, Kensuke; Satoh, Kimio; Miyata, Satoshi; Kawakami, Kazuyoshi; Shimokawa, Hiroaki			Extracorporeal Low-Energy Shock-Wave Therapy Exerts Anti-Inflammatory Effects in a Rat Model of Acute Myocardial Infarction	CIRCULATION JOURNAL			English	Article						Inflammation; Left ventricular remodeling; Macrophages; Myocardial infarction; Shock-wave therapy	ENDOTHELIAL GROWTH-FACTOR; CORONARY-ARTERY-DISEASE; REGULATORY T-CELLS; PIGS IN-VIVO; NITRIC-OXIDE; ANGINA-PECTORIS; STEM-CELLS; ISCHEMIA; MANAGEMENT; IMPROVES	Background: It has been previously demonstrated that extracorporeal low-energy shock-wave (SW) therapy ameliorates left ventricular (LV) remodeling through enhanced angiogenesis after acute myocardial infarction (AMI) in pigs in vivo. However, it remains to be examined whether SW therapy also exerts anti-inflammatory effects on AMI. Methods and Results: AMI was created by ligating the proximal left anterior descending coronary artery in rats. They were randomly assigned to 2 groups: with (SW group) or without (control group) SW therapy (0.1 mJ/mm(2), 200 shots, 1 Hz to the whole heart at 1, 3 and 5 days after AMI). Four weeks after AMI, SW therapy significantly ameliorated LV remodeling and fibrosis. Histological examinations showed that SW therapy significantly suppressed the infiltration of neutrophils and macrophages at days 3 and 6, in addition to enhanced capillary density in the border area. Molecular examinations demonstrated that SW therapy enhanced the expression of endothelial nitric oxide synthase and suppressed the infiltration of transforming growth factor-beta 1-positive cells early after AMI. SW therapy also upregulated anti-inflammatory cytokines and downregulated pro-inflammatory cytokines in general. Conclusions: These results suggest that low-energy SW therapy suppressed post-MI LV remodeling in rats in vivo, which was associated with anti-inflammatory effects in addition to its angiogenic effects, and demonstrated a novel aspect of the therapy for AMI.	[Abe, Yuzuru; Ito, Kenta; Hao, Kiyotaka; Shindo, Tomohiko; Ogata, Tsuyoshi; Kagaya, Yuta; Kurosawa, Ryo; Nishimiya, Kensuke; Satoh, Kimio; Miyata, Satoshi; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan; [Abe, Yuzuru; Kawakami, Kazuyoshi] Tohoku Univ, Grad Sch Med, Dept Med Microbiol Mycol & Immunol, Sendai, Miyagi 9808574, Japan	Ito, K (reprint author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan.	ito-kenta@cardio.med.tohoku.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan; Japanese Ministry of Health, Labor and Welfare, Tokyo, Japan	This study was supported, in part, by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Tokyo, Japan and from the Japanese Ministry of Health, Labor and Welfare, Tokyo, Japan.	Stojadinovic A, 2008, ANGIOGENESIS, V11, P369, DOI 10.1007/s10456-008-9120-6; Wakao S, 2011, P NATL ACAD SCI USA, V108, P9875, DOI 10.1073/pnas.1100816108; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI 10.1016/j.jacc.2012.11.019; Kikuchi Y, 2010, CIRC J, V74, P589, DOI 10.1253/circj.CJ-09-1028; Sobirin MA, 2012, CIRC RES, V111, P1037, DOI 10.1161/CIRCRESAHA.112.270132; Uwatoku T, 2007, CORONARY ARTERY DIS, V18, P397, DOI 10.1097/MCA.0b013e328089f19b; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Yan XY, 2008, ANN PLAS SURG, V61, P646, DOI 10.1097/SAP.0b013e318172ba1f; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Oi K, 2008, TOHOKU J EXP MED, V214, P151, DOI 10.1620/tjem.214.151; Serizawa F, 2012, CIRC J, V76, P1486, DOI 10.1253/circj.CJ-11-1216; Fukumoto Y, 2006, CORONARY ARTERY DIS, V17, P63, DOI 10.1097/00019501-200602000-00011; Ciampa AR, 2005, FEBS LETT, V579, P6839, DOI 10.1016/j.febslet.2005.11.023; Wang Y, 2010, CLIN CARDIOL, V33, P693, DOI 10.1002/clc.20811; Dobaczewski M, 2010, AM J PATHOL, V176, P2177, DOI 10.2353/ajpath.2010.090759; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Khattab AA, 2007, INT J CARDIOL, V121, P84, DOI 10.1016/j.ijcard.2006.08.030; Yasuda S, 2009, CIRC J, V73, P2000; Penn MS, 2012, GENE THER, V19, P583, DOI 10.1038/gt.2012.32; Aicher A, 2006, CIRCULATION, V114, P2823, DOI 10.1161/CIRCULATIONAHA.106.628623; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Leri A, 2011, CIRC RES, V109, P941, DOI 10.1161/CIRCRESAHA.111.243154; Nishida T, 2004, CIRCULATION, V110, P3055, DOI 10.1161/01.CIR.0000148849.51177.97; Ito K, 2011, AM J CARDIOVASC DRUG, V11, P295, DOI 10.2165/11592760-000000000-00000; Takii T, 2010, CIRC J, V74, P93, DOI 10.1253/circj.CJ-09-0619; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Anzai T, 2013, CIRC J, V773, P580; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Freytes D.O., 2012, J CELL BIOCHEM, V114, P220, DOI DOI 10.1002/JCB.24357; Hayashi D, 2012, WOUND REPAIR REGEN, V20, P887, DOI 10.1111/j.1524-475X.2012.00851.x; Ito Y, 2010, CORONARY ARTERY DIS, V21, P304, DOI 10.1097/MCA.0b013e32833aec62; Kempf T, 2012, J MOL MED, V90, P361, DOI 10.1007/s00109-011-0847-y; Mariotto S, 2009, CURR MED CHEM, V16, P2366; Moretti B, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-54; Nahrendorf M, 2014, CIRC RES, V115, P7, DOI 10.1161/CIRCRESAHA.114.304295; Prinz C, 2009, CASE REP MED, V2009, DOI DOI 10.1155/2009/639594; Saggini R, 2008, ULTRASOUND MED BIOL, V34, P1261, DOI 10.1016/j.ultrasmedbio.2008.01.010; Satoh K, 2009, CARDIOVASC RES, V81, P226, DOI 10.1093/cvr/cvn244; Serizawa F, 2011, EUR J VASC ENDOVASC, V42, P254, DOI 10.1016/j.ejvs.2011.02.029; Sheu JJ, 2010, ANN VASC SURG, V24, P809, DOI 10.1016/j.avsg.2010.03.027; Springeling T, 2013, CIRC J, V77, P81, DOI 10.1253/circj.CJ-12-0043; Task FM, 2012, EUR HEART J, V33, P2569, DOI DOI 10.1093/EURHEARTJ/EHS215; van Nieuwenhoven FA, 2012, VASC PHARMACOL, V58, P182; Vasyuk Yury A, 2010, Congest Heart Fail, V16, P226, DOI 10.1111/j.1751-7133.2010.00182.x; Wang CJ, 2003, J ORTHOP RES, V21, P84; Yip HK, 2008, CIRC J, V72, P150, DOI 10.1253/circj.72.150	47	2	3	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2915	U170		10.1253/circj.CJ-14-0230		13	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300021		
J	Isshiki, T; Kimura, T; Ogawa, H; Yokoi, H; Nanto, S; Takayama, M; Kitagawa, K; Nishikawa, M; Miyazaki, S; Ikeda, Y; Nakamura, M; Saito, S				Isshiki, Takaaki; Kimura, Takeshi; Ogawa, Hisao; Yokoi, Hiroyoshi; Nanto, Shinsuke; Takayama, Morimasa; Kitagawa, Kazuo; Nishikawa, Masakatsu; Miyazaki, Shunichi; Ikeda, Yasuo; Nakamura, Masato; Saito, Shigeru		PRASFIT-Elective Investigators	Prasugrel, a Third-Generation P2Y12 Receptor Antagonist, in Patients With Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention - Phase III, Randomized, Double-Blind Study -	CIRCULATION JOURNAL			English	Article						Clopidogrel; Coronary artery disease; Elective percutaneous coronary intervention; Japanese; Prasugrel	PACLITAXEL-ELUTING STENT; OF-FUNCTION POLYMORPHISM; JAPANESE PATIENTS; ANTIPLATELET THERAPY; CLOPIDOGREL; TRIAL; IMPLANTATION; THROMBOSIS; EFFICACY; CYP2C19	Background: Prasugrel is being developed in Japan as an antiplatelet therapy for use during percutaneous coronary intervention (PCI). Up to 70% of Japanese patients with coronary artery disease undergo elective PCI. The PRASugrel For Japanese PatIenTs with Coronary Artery Diseases Undergoing Elective PCI (PRASFIT-Elective) study investigated the efficacy and safety of different prasugrel dosing regimens in Japanese patients undergoing elective PCI. Methods and Results: A total of 742 patients scheduled for elective coronary artery stenting were enrolled. Patients were randomized to receive either prasugrel (20/3.75 mg, loading/maintenance dose) or clopidogrel (300/75 mg) in a double-blind manner. Endpoints, including cardiovascular events and bleeding, were assessed at weeks 24-48. The incidence rate of major cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal ischemic stroke) up to week 24 was 4.1% (15/370) and 6.7% (25/372) in the prasugrel and clopidogrel groups, respectively. Other incidence rates were: non-coronary artery bypass graft-related major bleeding, 0% and 2.2%; major/minor bleeding, 1.6% and 3.0%; and all bleeding events, 38.1% and 34.4% in the prasugrel and clopidogrel groups, respectively. The incidence rate of bleeding-related adverse events was similar in both groups, being 40.8% and 35.8% in the prasugrel and clopidogrel groups, respectively. Conclusions: These results support the risk-benefit profile of an adjusted dosing regimen of prasugrel in Japanese patients undergoing PCI. Larger studies are required to confirm these findings.	[Isshiki, Takaaki] Teikyo Univ Hosp, Div Cardiol, Tokyo 117003, Japan; [Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Kyoto, Japan; [Ogawa, Hisao] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan; [Yokoi, Hiroyoshi] Fukuoka Sanno Hosp, Fukuoka, Japan; [Yokoi, Hiroyoshi] Int Univ Hlth & Welf, Ohtawara, Japan; [Nanto, Shinsuke] Osaka Univ, Grad Sch Med, Dept Adv Cardiovasc Therapeut, Osaka, Japan; [Takayama, Morimasa] Sakakibara Heart Inst, Tokyo, Japan; [Kitagawa, Kazuo] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka, Japan; [Nishikawa, Masakatsu] Mie Univ, Fac Med, Inst Human Res Promot & Drug Dev, Tsu, Mie 514, Japan; [Miyazaki, Shunichi] Kinki Univ, Fac Med, Dept Med, Div Cardiol, Osakasayama, Japan; [Ikeda, Yasuo] Waseda Univ, Fac Sci & Engn, Tokyo, Japan; [Nakamura, Masato] Toho Univ, Ohashi Med Ctr, Div Cardiovasc Med, Tokyo, Japan; [Saito, Shigeru] Shonan Kamakura Gen Hosp, Div Cardiol, Kamakura, Kanagawa, Japan	Isshiki, T (reprint author), Teikyo Univ Hosp, Div Cardiol, Itabashi Ku, 2-11-1 Kaga, Tokyo 117003, Japan.	isshiki@med.teikyo-u.ac.jp			Daiichi Sankyo (Tokyo, Japan)	This study was sponsored by Daiichi Sankyo (Tokyo, Japan).	Kushner FG, 2009, CIRCULATION, V120, P2271, DOI 10.1161/CIRCULATIONAHA.109.192663; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Sakurai R, 2007, AM J CARDIOL, V100, P818, DOI 10.1016/j.amjcard.2007.04.016; Price MJ, 2009, CIRCULATION, V119, P2625, DOI 10.1161/CIRCULATIONAHA.107.696732; Giusti B, 2009, AM J CARDIOL, V103, P806, DOI 10.1016/j.amjcard.2008.11.048; Kimura T, 2009, CIRCULATION, V119, P987, DOI 10.1161/CIRCULATIONAHA.108.808311; Stone GW, 2008, JAMA-J AM MED ASSOC, V299, P1903, DOI 10.1001/jama.299.16.1903; Saito S, 2014, CIRC J, V78, P1684, DOI 10.1253/circj.CJ-13-1482; Nakata T, 2013, CIRC J, V77, P1436, DOI 10.1253/circj.CJ-12-1095; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Wallentin L, 2010, LANCET, V376, P1320, DOI 10.1016/S0140-6736(10)61274-3; Jneid H, 2012, J AM COLL CARDIOL, V60, P645, DOI 10.1016/j.jacc.2012.06.004; Collet JP, 2009, LANCET, V373, P309, DOI 10.1016/S0140-6736(08)61845-0; Isshiki T, 2012, INT HEART J, V53, P91; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Turco MA, 2007, J AM COLL CARDIOL, V49, P1676, DOI 10.1016/j.jacc.2007.01.069	16	10	10	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2926	U181		10.1253/circj.CJ-14-0266		11	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300022		
J	Emoto, T; Sasaki, N; Yamashita, T; Kasahara, K; Yodoi, K; Sasaki, Y; Matsumoto, T; Mizoguchi, T; Hirata, K				Emoto, Takuo; Sasaki, Naoto; Yamashita, Tomoya; Kasahara, Kazuyuki; Yodoi, Keiko; Sasaki, Yoshihiro; Matsumoto, Takuya; Mizoguchi, Taiji; Hirata, Ken-ichi			Regulatory/Effector T-Cell Ratio Is Reduced in Coronary Artery Disease	CIRCULATION JOURNAL			English	Article						Coronary artery disease; Immune system; Regulatory T cell	DENDRITIC CELLS; ATHEROSCLEROSIS; MECHANISMS; MICE; HYPERCHOLESTEROLEMIA; INFLAMMATION; LYMPHOCYTES; SEVERITY; RISK	Background: The protective function of regulatory T cells (T-reg) has been identified in experimental atherosclerosis, but the contribution of T-reg to the pathogenesis of human coronary artery disease (CAD) remains poorly understood. We investigated T-reg and regulatory T-cell/effector T-cell (T-reg/T-eff) ratio in peripheral blood samples from CAD patients using a new strategy for precise identification of T-reg. Methods and Results: Peripheral blood samples were collected from 73 stable CAD patients (55 middle-aged CAD patients and 18 old CAD patients) and 64 controls (47 middle-aged controls and 17 young controls). CD3(+)CD4(+)FoxP3(+) T cells were divided into 3 fractions: CD45RA(+)FoxP3(low) resting T-reg (Fr1), CD45RA(-)FoxP3(high) activated T-reg (Fr2), and CD45RA(-)FoxP3(low) non-T-reg (Fr3). CAD patients had lower percentages of Fr1 and Fr2 and higher percentages of Fr3 and CD45RA(-)Foxp3(-) T-eff (Fr4+5) within the CD3(+)CD4(+) T-cell population compared to age-matched controls. T-reg/T-eff ratio (Fr1+2/Fr3+4+5) in CAD patients was also markedly lower than in controls (middle-aged control, 0.17+/-0.09 vs. middle-aged CAD, 0.10+/-0.05; P<0.001). The percentage of CD4(+)CD28(null) T cells within the CD4(+) T-cell population was negatively correlated with T-reg/T-eff ratio, excluding CD4(+)CD28(null) T cells <0.3% (r=-0.27, P<0.05). High-sensitivity C-reactive protein was also negatively correlated with T-reg/T-eff ratio (r=-0.22, P<0.05). Conclusions: CAD patients had reduced T-reg and T-reg/T-eff ratio compared to healthy controls. The present findings may be helpful when developing immunotherapy for the prevention of CAD.	[Emoto, Takuo; Sasaki, Naoto; Yamashita, Tomoya; Kasahara, Kazuyuki; Yodoi, Keiko; Sasaki, Yoshihiro; Matsumoto, Takuya; Mizoguchi, Taiji; Hirata, Ken-ichi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 6500017, Japan	Sasaki, N (reprint author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	sasakin@med.kobe-u.ac.jp			JSPS KAKENHI [25860601, 24591114]; Japan Heart Foundation; Astellas/Pfizer Grant for Research on Atherosclerosis Update; Kimura Memorial Heart Foundation; Japan Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology; Japan Circulation Society; Banyu Life Science Foundation International; Suzuken Memorial Foundation; ONO Medical Research Foundation; Takeda Science Foundation; Uehara Medical Foundation; Mochida Memorial Foundation; Mitsui Life Social Welfare Foundation; Kanae Medical Foundation; Senshin Medical Research Foundation; Yakult Bioscience Research Foundation	This work was supported by JSPS KAKENHI Grant Numbers 25860601 (N.S.) and 24591114 (T.Y.), a Japan Heart Foundation and Astellas/Pfizer Grant for Research on Atherosclerosis Update (N.S.), Kimura Memorial Heart Foundation Research Grant for 2011 (N.S.), Japan Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology 2012 (N.S.), a Translational Research Grant from Japan Circulation Society (K.H.), and research grants from Banyu Life Science Foundation International (N.S.), Suzuken Memorial Foundation (N.S. and T.Y.), ONO Medical Research Foundation (N.S.), Takeda Science Foundation (N.S. and T.Y.), Uehara Medical Foundation (T.Y., K.H.), Mochida Memorial Foundation (T.Y.), Mitsui Life Social Welfare Foundation (T.Y.), Kanae Medical Foundation (N.S., T.Y.), Senshin Medical Research Foundation (T.Y.), and Yakult Bioscience Research Foundation (T.Y.).	Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Giubilato S, 2011, EUR HEART J, V32, P1214, DOI 10.1093/eurheartj/ehq499; Wigren M, 2012, ARTERIOSCL THROM VAS, V32, P2000, DOI 10.1161/ATVBAHA.112.251579; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Maganto-Garcia E, 2011, CIRCULATION, V124, P185, DOI 10.1161/CIRCULATIONAHA.110.006411; Sasaki N, 2009, CIRCULATION, V120, P1996, DOI 10.1161/CIRCULATIONAHA.109.863431; Sasaki N, 2012, J ATHEROSCLER THROMB, V19, P503; Dietel B, 2013, ATHEROSCLEROSIS, V230, P92, DOI 10.1016/j.atherosclerosis.2013.06.014; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Takeda M, 2010, ARTERIOSCL THROM VAS, V30, P2495, DOI 10.1161/ATVBAHA.110.215459; Simon DI, 2012, CIRC J, V76, P1811, DOI 10.1253/circj.CJ-12-0801; Ammirati E, 2010, ARTERIOSCL THROM VAS, V30, P1832, DOI 10.1161/ATVBAHA.110.206813; Klingenberg R, 2013, J CLIN INVEST, V123, P1323, DOI 10.1172/JCI63891; Liuzzo G, 2007, J AM COLL CARDIOL, V50, P1450, DOI 10.1016/j.jacc.2007.06.040; Mor A, 2006, EUR HEART J, V27, P2530, DOI 10.1093/eurheartj/ehl222; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Kasahara K, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000719; Kita T, 2014, CARDIOVASC RES, V102, P107, DOI 10.1093/cvr/cvu002; Ozaki Y, 2012, CIRC J, V76, P2412, DOI 10.1253/circj.CJ-12-0412; Ross R, 1999, NEW ENGL J MED, V340, P115	22	4	4	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2935	2941		10.1253/circj.CJ-14-0644		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300023		
J	Fujii, T; Suzuki, T; Torii, S; Murakami, T; Nakano, M; Nakazawa, G; Masuda, N; Shinozaki, N; Matsukage, T; Ogata, N; Yoshimachi, F; Ikari, Y				Fujii, Toshiharu; Suzuki, Toshihiko; Torii, Sho; Murakami, Tsutomu; Nakano, Masataka; Nakazawa, Gaku; Masuda, Naoki; Shinozaki, Norihiko; Matsukage, Takashi; Ogata, Nobuhiko; Yoshimachi, Fuminobu; Ikari, Yuji			Diagnostic Accuracy of Global Registry of Acute Coronary Events (GRACE) Risk Score in ST-Elevation Myocardial Infarction for In-Hospital and 360-Day Mortality in Japanese Patients	CIRCULATION JOURNAL			English	Article						GRACE risk score; Mortality; ST-elevation myocardial infarction	TIMI; PREDICTION	Background: The purpose of the present study was to confirm the diagnostic accuracy of Global Registry of Acute Coronary Events (GRACE) risk score 1.0 (GRACE 1.0) and updated GRACE 1.0 (GRACE 2.0) for in-hospital and 360-day mortality in ST-elevation myocardial infarction (STEMI) in Japanese patients. GRACE 1.0 and GRACE 2.0 are the established predictive models in acute coronary syndrome, but their application to Japanese patients has not been fully verified. Methods and Results: The present study retrospectively analyzed 412 consecutive STEMI patients who had undergone primary percutaneous coronary intervention from January 2006 to September 2011. All causes of death during hospitalization were examined to confirm the diagnostic accuracy of GRACE 1.0 on receiver operating characteristic (ROC) analysis. Similarly, all causes of death during the 360 days after hospitalization were analyzed to confirm the diagnostic accuracy of GRACE 2.0. The average GRACE 1.0 score was 175.8+/-50.9. In-hospital and 360-day mortality were 13.1% and 15.5%, respectively. Area under the ROC curve, which describes the diagnostic accuracy of the GRACE 1.0 predicted in-hospital mortality and the GRACE 2.0 predicted 360-day mortality, was as high as 0.95 and 0.92, respectively. Conclusions: Both GRACE 1.0 and GRACE 2.0 had a high diagnostic accuracy for prediction of in-hospital and 360-day mortality in Japanese STEMI patients.	[Fujii, Toshiharu; Suzuki, Toshihiko; Torii, Sho; Murakami, Tsutomu; Nakano, Masataka; Nakazawa, Gaku; Masuda, Naoki; Shinozaki, Norihiko; Matsukage, Takashi; Ogata, Nobuhiko; Yoshimachi, Fuminobu; Ikari, Yuji] Tokai Univ, Sch Med, Dept Cardiol, Isehara, Kanagawa 2591193, Japan	Ikari, Y (reprint author), Tokai Univ, Sch Med, Dept Cardiol, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	ikari@is.icc.u-tokai.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Chan MY, 2011, AM HEART J, V162, P291, DOI 10.1016/j.ahj.2011.05.016; Hsieh MJ, 2013, CIRC J, V77, P217, DOI 10.1253/circj.CJ-12-0539; Tang EW, 2007, AM HEART J, V153, P29, DOI 10.1016/j.ahj.2006.10.004; Kojima S, 2013, CIRC J, V77, P2841, DOI 10.1253/circj.CJ-13-1011; Hao K, 2012, CIRC J, V76, P1136, DOI 10.1253/circj.CJ-11-1233; Daida H, 2013, CIRC J, V77, P934, DOI 10.1253/circj.CJ-13-0174; D'Ascenzo F, 2012, CONTEMP CLIN TRIALS, V33, P507, DOI 10.1016/j.cct.2012.01.001; Aragam KG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007947; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Correia LCL, 2010, ARQ BRAS CARDIOL, V94, P613, DOI 10.1590/S0066-782X2010005000036; Filipiak KJ, 2014, KARDIOL POL, V72, P155, DOI 10.5603/KP.a2013.0216; Fox KAA, 2006, BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; Fox KAA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004425; Investigators G, 2001, AM HEART, V141, P190; Kimura Kazuo, 2010, Cardiovasc Interv Ther, V25, P53, DOI 10.1007/s12928-010-0024-1; Nakamura Masato, 2013, Cardiovasc Interv Ther, V28, P162, DOI 10.1007/s12928-012-0146-8; Nakayama N, 2009, CIRC J, V73, P484	19	2	2	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2950	2954		10.1253/circj.CJ-14-0808		5	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300025		
J	Takata, K; Imaizumi, S; Kawachi, E; Suematsu, Y; Shimizu, T; Abe, S; Matsuo, Y; Tsukahara, H; Noda, K; Yahiro, E; Zhang, B; Uehara, Y; Miura, S; Saku, K				Takata, Kohei; Imaizumi, Satoshi; Kawachi, Emi; Suematsu, Yasunori; Shimizu, Tomohiko; Abe, Satomi; Matsuo, Yoshino; Tsukahara, Hitomi; Noda, Keita; Yahiro, Eiji; Zhang, Bo; Uehara, Yoshinari; Miura, Shin-ichiro; Saku, Keijiro			Impact of Cigarette Smoking Cessation on High-Density Lipoprotein Functionality - VN-SEESAW-HDL -	CIRCULATION JOURNAL			English	Article						Cholesterol efflux capacity; High-density lipoprotein (HDL); HDL inflammatory index; Malondialdehyde; Oxidative stress	ACTIVATING-FACTOR-ACETYLHYDROLASE; CORONARY-ARTERY-DISEASE; CHOLESTEROL EFFLUX; HEART-DISEASE; CARDIOVASCULAR-DISEASE; ANTIOXIDATIVE CAPACITY; PHOSPHOLIPASE A(2); JAPANESE MEN; HUMAN PLASMA; RISK	Background: Smoking cessation reduces the risk of cardiovascular disease (CVD) and improves clinical outcomes in public health. We studied the effect of smoking cessation on high-density lipoprotein (HDL) functionality. Methods and Results: We randomly treated 32 smokers with varenicline or a transdermal nicotine patch as part of a 12-week smoking cessation program (The VN-SEESAW Study). The plasma lipid profiles, plasma and HDL malondialdehyde (MDA) levels, HDL subfractions as analyzed by capillary isotachophoresis, cholesterol efflux capacity, and antiinflammatory activity of HDL were measured before and after the anti-smoking intervention. After smoking cessation, HDL-C, apoA-I levels and HDL subfractions were not significantly different from the respective baseline values. However, cholesterol efflux capacity and the HDL inflammatory index (HII) were significantly improved after smoking cessation. The changes in both parameters (%Delta cholesterol efflux capacity and Delta HII) were also significantly improved in the successful smoking cessation group compared with the unsuccessful group. The changes in cholesterol efflux capacity and HII also correlated with those in end-expiratory CO concentration and MDA in HDL, respectively. Conclusions: Our findings indicate that smoking cessation leads to improved HDL functionality, increased cholesterol efflux capacity and decreased HII, without changing HDL-C or apoA-I levels or HDL subfractions. This may be one of the mechanisms by which smoking cessation improves the risk of CVD.	[Takata, Kohei; Imaizumi, Satoshi; Kawachi, Emi; Suematsu, Yasunori; Shimizu, Tomohiko; Abe, Satomi; Matsuo, Yoshino; Noda, Keita; Yahiro, Eiji; Uehara, Yoshinari; Miura, Shin-ichiro; Saku, Keijiro] Fukuoka Univ, Sch Med, Dept Cardiol, Fukuoka 8140180, Japan; [Zhang, Bo] Fukuoka Univ, Sch Med, Dept Biochem, Fukuoka 8140180, Japan; [Tsukahara, Hitomi] Int Univ Hlth & Welf Fukuoka, Fukuoka, Japan	Imaizumi, S (reprint author), Fukuoka Univ, Sch Med, Dept Cardiol, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	simaizumi@fukuoka-u.ac.jp; saku-k@fukuoka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24591123, 24790789, 25461141]; Central Research Institute of Fukuoka University; FU-Global program; AIG Collaborative Research Institute of Cardiovascular Medicine, Fukuoka University; Endowed Department of Molecular Cardiovascular Therapeutics, Fukuoka University	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 24591123, No. 24790789, and No. 25461141), the Central Research Institute of Fukuoka University (2008-2012), the FU-Global program (2008-2010), the AIG Collaborative Research Institute of Cardiovascular Medicine, Fukuoka University (2011-2013), and the Endowed Department of Molecular Cardiovascular Therapeutics, Fukuoka University.	von Eckardstein A, 2001, ARTERIOSCL THROM VAS, V21, P13; WATSON AD, 1995, J CLIN INVEST, V95, P774, DOI 10.1172/JCI117726; MJOS OD, 1988, AM HEART J, V115, P272, DOI 10.1016/0002-8703(88)90649-7; Kane JP, 2012, CURR OPIN LIPIDOL, V23, P367, DOI 10.1097/MOL.0b013e328353eef1; Cunnington AJ, 2002, POSTGRAD MED J, V78, P233, DOI 10.1136/pmj.78.918.233; Annema W, 2013, CIRC J, V77, P2432, DOI 10.1253/circj.CJ-13-1025; Mannami T, 2004, STROKE, V35, P1248, DOI 10.1161/01.STR.0000128794.30660.e8; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Imaizumi S, 2011, CIRC J, V75, P1533, DOI 10.1253/circj.CJ-11-0460; Sanada S, 2012, CIRC J, V76, P2884, DOI 10.1253/circj.CJ-11-1506; Yagi K, 1998, Methods Mol Biol, V108, P101; Iso H, 2005, AM J EPIDEMIOL, V161, P170, DOI 10.1093/aje/kwi027; Tsukahara H, 2010, CIRC J, V74, P771, DOI 10.1253/circj.CJ-09-0803; Garner B, 1998, J BIOL CHEM, V273, P6088, DOI 10.1074/jbc.273.11.6088; Navab M, 2001, J LIPID RES, V42, P1308; Toth PP, 2013, J CLIN LIPIDOL, V7, P484, DOI 10.1016/j.jacl.2013.08.001; Zhang B, 2013, CIRC J, V77, P2651, DOI 10.1253/circj.CJ-12-1584; Rosenson RS, 2011, CLIN CHEM, V57, P392, DOI 10.1373/clinchem.2010.155333; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Kontush A, 2003, ARTERIOSCL THROM VAS, V23, P1881, DOI 10.1161/01.ATV.0000091338.93223.E8; Yamamoto S, 2012, J AM COLL CARDIOL, V60, P2372, DOI 10.1016/j.jacc.2012.09.013; Shao BH, 2010, J BIOL CHEM, V285, P18473, DOI 10.1074/jbc.M110.118182; Guey LT, 2011, AM J CARDIOL, V108, P360, DOI 10.1016/j.amjcard.2011.03.054; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Morgantini C, 2011, DIABETES, V60, P2617, DOI 10.2337/db11-0378; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Bottcher A, 2000, J LIPID RES, V41, P905; Criqui MH, CIRCULATION; Freeman DJ, 1998, EUR J CLIN INVEST, V28, P584; Gielen S, 2011, HEART, V97, P1899, DOI 10.1136/heartjnl-2011-300612; KAWANO M, 1993, BIOCHEMISTRY-US, V32, P5025, DOI 10.1021/bi00070a008; Maeda K, 2003, PREV MED, V37, P283, DOI 10.1016/S0091-7435(03)00110-5; Moffatt RJ, 2004, PREV MED, V38, P637, DOI 10.1016/j.ypmed.2003.12.002; Mulder DJ, 2011, ATHEROSCLEROSIS, V218, P102, DOI 10.1016/j.atherosclerosis.2011.05.011; MULLIGAN JJ, 1983, BIOCHEM BIOPH RES CO, V112, P843, DOI 10.1016/0006-291X(83)91694-7; NAGANO Y, 1991, P NATL ACAD SCI USA, V88, P6457, DOI 10.1073/pnas.88.15.6457; Okamura K, 2007, CIRC J, V71, P214, DOI 10.1253/circj.71.214; Patel PJ, 2011, J AM COLL CARDIOL, V58, P2068, DOI 10.1016/j.jacc.2011.08.030; SAKU K, 1985, THROMB RES, V39, P1, DOI 10.1016/0049-3848(85)90116-1; Sethi AA, 2010, CLIN CHEM, V56, P1128, DOI 10.1373/clinchem.2009.139931; Tellis CC, 2009, BBA-MOL CELL BIOL L, V1791, P327, DOI 10.1016/j.bbalip.2009.02.015; Tselepis AD, 2009, ATHEROSCLEROSIS, V206, P303, DOI 10.1016/j.atherosclerosis.2009.02.016; Ueshima H, 2004, STROKE, V35, P1836, DOI 10.1161/01.STR.0000131747.84423.74; Ueyama K, 1998, FREE RADICAL BIO MED, V24, P182, DOI 10.1016/S0891-5849(97)00214-1; Yamagishi K, 2003, HYPERTENS RES, V26, P209, DOI 10.1291/hypres.26.209; Zhang B, 2005, J LIPID RES, V46, P2265, DOI 10.1194/jlr.M500192-JLR200	47	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2955	2962		10.1253/circj.CJ-14-0638		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300026		
J	Matsuhisa, H; Oshima, Y; Maruo, A; Hasegawa, T; Tanaka, A; Noda, R; Iwaki, R; Matsushima, S; Tanaka, T; Kido, S				Matsuhisa, Hironori; Oshima, Yoshihiro; Maruo, Ayako; Hasegawa, Tomomi; Tanaka, Akiko; Noda, Rei; Iwaki, Ryuma; Matsushima, Shunsuke; Tanaka, Toshikatsu; Kido, Sachiko			Pacing Therapy in Children - Repeat Left Ventricular Pacing for Preservation of Ventricular Function	CIRCULATION JOURNAL			English	Article						Cardiac function; Pacemaker; Pediatrics	CARDIAC RESYNCHRONIZATION THERAPY; COMPLETE HEART-BLOCK; PEDIATRIC-PATIENTS; 12-YEAR EXPERIENCE; FOLLOW-UP; LEADS; PACEMAKER; DISEASE; MULTICENTER; PREDICTORS	Background: The importance of ventricular pacing site in pediatric pacemaker therapy has gradually become recognized. We reviewed our experience with a left ventricular (LV)-prioritized pacing strategy. Methods and Results: Between 2000 and 2012, 60 patients underwent 76 permanent pacemaker implantations. Eight of the 29 reoperations involved ventricular lead repositioning for pacing-induced ventricular dysfunction. Freedom from ventricular lead failure was 96.3%, 86.8%, and 81.0% at 1, 3, and 5 years, respectively. The independent predictors of ventricular lead failure were age (P=0.026) and peak minimal energy threshold within 6 months (P=0.035). At the measured points, redo bipolar, steroid-eluting leads had significantly better pacing properties than did redo non-steroid-eluting, screw-in leads (P=0.0009-0.03). Ventricular lead repositioning was effective in the 5 patients with systemic LV pacing, whereas its efficacy was inconsistent in patients with single-ventricle or systemic right ventricular (RV) pacing. At a median follow-up of 59 months, the 28 patients with LV pacing had preserved ventricular function (LV fraction shortening, 0.34+/-0.09). Conclusions: The outcome of this LV-prioritized pacing strategy in pediatric patients was excellent, demonstrating preserved ventricular function. Bipolar, steroid-eluting, epicardial pacing leads achieved good pacing properties, even in reoperation patients. In children with systemic LV and RV pacing-induced ventricular dysfunction, a conversion to LV apex pacing was an attractive alternative to cardiac resynchronization therapy.	[Matsuhisa, Hironori; Oshima, Yoshihiro; Maruo, Ayako; Hasegawa, Tomomi; Tanaka, Akiko; Noda, Rei; Iwaki, Ryuma; Matsushima, Shunsuke] Kobe Childrens Hosp, Dept Cardiovasc Surg, Kobe, Hyogo 6540081, Japan; [Tanaka, Toshikatsu; Kido, Sachiko] Kobe Childrens Hosp, Dept Cardiol, Kobe, Hyogo 6540081, Japan	Matsuhisa, H (reprint author), Kobe Childrens Hosp, Dept Cardiovasc Surg, Suma Ku, 1-1-1 Takakura Dai, Kobe, Hyogo 6540081, Japan.	matsuhisa_kch@hp.pref.hyogo.jp					Aellig NC, 2007, ANN THORAC SURG, V83, P1420, DOI 10.1016/j.athoracsur.2006.11.042; Kwak JG, 2012, ANN THORAC SURG, V93, P634, DOI 10.1016/j.athoracsur.2011.09.072; van Geldorp IE, 2011, HEART FAIL REV, V16, P305, DOI 10.1007/s10741-010-9207-1; Kurosaki KI, 2008, CIRC J, V72, P81, DOI 10.1253/circj.72.81; Janousek J, 2013, CIRCULATION, V127, P613, DOI 10.1161/CIRCULATIONAHA.112.115428; Gebauer RA, 2009, EUR HEART J, V30, P1097, DOI 10.1093/eurheartj/ehp060; Mills RW, 2009, CIRC-ARRHYTHMIA ELEC, V2, P571, DOI 10.1161/CIRCEP.109.882910; Tomaske M, 2009, EUROPACE, V11, P1168, DOI 10.1093/europace/eup178; Thambo JB, 2004, CIRCULATION, V110, P3766, DOI 10.1161/01.CIR.0000150336.86033.8D; Delgado V, 2009, CIRC-ARRHYTHMIA ELEC, V2, P135, DOI 10.1161/CIRCEP.108.814608; Vanagt WY, 2007, NEW ENGL J MED, V357, P2637, DOI 10.1056/NEJMc072317; van Geldorp IE, 2009, PEDIATR CARDIOL, V30, P125, DOI 10.1007/s00246-008-9284-2; Janousek J, 2009, HEART, V95, P1165, DOI 10.1136/hrt.2008.160465; Silvetti MS, 2006, EUROPACE, V8, P530, DOI 10.1093/europace/eul062; Mah DY, 2013, ANN THORAC SURG, V96, P904, DOI 10.1016/j.athoracsur.2013.05.082; Cohen MI, 2001, CIRCULATION, V103, P2585; Dubin AM, 2005, J AM COLL CARDIOL, V46, P2277, DOI 10.1016/j.jacc.2005.05.096; FANQ F, 2013, CIRC J, V77, P1364; HAMILTON R, 1991, PACE, V14, P2066, DOI 10.1111/j.1540-8159.1991.tb02817.x; JCS Joint Working Group, 2013, CIRC J, V77, P249; Kubus P, 2012, EUROPACE, V14, P509, DOI 10.1093/europace/eur327; Murayama H, 2008, J THORAC CARDIOV SUR, V135, P361, DOI 10.1016/j.jtcvs.2007.09.002; Suzuki T, 2014, CIRC J, V78, P1710, DOI 10.1253/circj.CJ-13-1379; Thomson JDR, 2004, ANN THORAC SURG, V77, P1366, DOI 10.1016/j.athoracsur.2003.08.057; Tomaske M, 2008, ANN THORAC SURG, V85, P1704, DOI 10.1016/j.athoracsur.2008.02.016	25	2	2	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2972	2978		10.1253/circj.CJ-14-0534		7	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300028		
J	Sasaki, S; Tomita, H; Shibutani, S; Izumiyama, K; Higuma, T; Itoh, T; Sasaki, K; Horiuchi, D; Kimura, M; Okumura, K				Sasaki, Shingo; Tomita, Hirofumi; Shibutani, Shuji; Izumiyama, Kei; Higuma, Takumi; Itoh, Taihei; Sasaki, Kenichi; Horiuchi, Daisuke; Kimura, Masaomi; Okumura, Ken			Usefulness of the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death - A Single-Center Primary Experience	CIRCULATION JOURNAL			English	Article						Implantable cardioverter-defibrillator; Sudden cardiac death; Wearable cardioverter-defibrillator		Background: Wearable cardioverter-defibrillators (WCD) have been available in Japan since April 2014, but their application is still limited. Methods and Results: We report 9 patients with a WCD applied between April and September 2014. All patients were at high risk of life-threatening ventricular arrhythmias. During WCD use, 1 patient had sustained ventricular tachycardia and successful shock delivery; 6 (67%) subsequently underwent implantable cardioverter-defibrillator (ICD) therapy, while 2 had no requirement because of reduced risk, and 1 died of heart failure during WCD use. Conclusions: WCD is useful during acute-phase care of high-risk patients, and may help to avoid unnecessary ICD implantation.	[Sasaki, Shingo; Horiuchi, Daisuke] Hirosaki Univ, Grad Sch Med, Dept Adv Management Cardiac Arrhythmias, Hirosaki, Aomori 0368562, Japan; [Tomita, Hirofumi; Shibutani, Shuji; Izumiyama, Kei; Higuma, Takumi; Itoh, Taihei; Sasaki, Kenichi; Kimura, Masaomi; Okumura, Ken] Hirosaki Univ, Grad Sch Med, Dept Cardiol, Hirosaki, Aomori 0368562, Japan	Okumura, K (reprint author), Hirosaki Univ, Grad Sch Med, Dept Cardiol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	okumura@cc.hirosaki-u.ac.jp					Chung MK, 2010, J AM COLL CARDIOL, V56, P194, DOI 10.1016/j.jacc.2010.04.016; Epstein AE, 2013, J AM COLL CARDIOL, V62, P2000, DOI 10.1016/j.jacc.2013.05.086; Klein HU, 2013, EUR HEART J, V34, P2230, DOI 10.1093/eurheartj/eht167; Feldman AM, 2004, PACE, V27, P4, DOI 10.1111/j.1540-8159.2004.00378.x; Klein HU, 2010, PACE, V33, P353, DOI 10.1111/j.1540-8159.2009.02590.x; Murakoshi N, 2013, CIRC J, V77, P2419, DOI 10.1253/circj.CJ-13-1129; Zishiri ET, 2013, CIRC-ARRHYTHMIA ELEC, V6, P117, DOI 10.1161/CIRCEP.112.973552; JCS Joint Working Group, 2013, CIRC J, V77, P249	8	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2987	2989		10.1253/circj.CJ-14-1098		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300030		
J	Wakabayashi, Y; Hayashi, T; Mitsuhashi, T; Momomura, S				Wakabayashi, Yasushi; Hayashi, Takekuni; Mitsuhashi, Takeshi; Momomura, Shin-ichi			Localized Reentrant Atrial Tachycardia Without a History of Catheter Ablation in a Patient With Apical Hypertrophic Cardiomyopathy	CIRCULATION JOURNAL			English	Editorial Material							ELECTROPHYSIOLOGICAL CHARACTERISTICS; FIBRILLATION ABLATION		[Wakabayashi, Yasushi; Hayashi, Takekuni; Mitsuhashi, Takeshi; Momomura, Shin-ichi] Jichi Med Univ, Saitama Med Ctr, Div Cardiovasc Med, Saitama 3308503, Japan	Wakabayashi, Y (reprint author), Jichi Med Univ, Saitama Med Ctr, Div Cardiovasc Med, Omiya Ku, 1-847 Amanuma, Saitama 3308503, Japan.	99098yw@jichi.ac.jp					Fukamizu S, 2013, J CARDIOVASC ELECTR, V24, P404, DOI 10.1111/jce.12059; Pak HN, 2011, HEART RHYTHM, V8, P199, DOI 10.1016/j.hrthm.2010.10.015; Sanders P, 2005, J AM COLL CARDIOL, V46, P2088, DOI 10.1016/j.jacc.2005.08.044; Ejima K, 2013, HEART VESSELS, V28, P546, DOI 10.1007/s00380-012-0294-x; Hirai Y, 2013, CIRC J, V77, P345, DOI 10.1253/circj.CJ-12-0698; Jais P, 2009, J CARDIOVASC ELECTR, V20, P480, DOI 10.1111/j.1540-8167.2008.01373.x; Maeda S, 2013, CIRC J, V77, P3054, DOI 10.1253/circj.CJ-13-0437; Takahashi Y, 2009, J CARDIOVASC ELECTR, V20, P623, DOI 10.1111/j.1540-8167.2008.01410.x	8	1	1	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2990	2992		10.1253/circj.CJ-14-0553		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300031		
J	Kiuchi, K; Okajima, K; Shimane, A; Shigenaga, Y				Kiuchi, Kunihiko; Okajima, Katsunori; Shimane, Akira; Shigenaga, Yutaka			Visualization of Pulmonary Vein-Left Atrium Reconduction Site on Delayed-Enhancement Magnetic Resonance Imaging in the Second Atrial Fibrillation Catheter Ablation	CIRCULATION JOURNAL			English	Editorial Material							ELECTRICAL ISOLATION; RECOVERY; GAPS		[Kiuchi, Kunihiko; Okajima, Katsunori; Shimane, Akira] Himeji Cardiovasc Ctr, Dept Cardiol, Himeji, Hyogo 6700981, Japan; [Shigenaga, Yutaka] Himeji Cardiovasc Ctr, Dept Lab & Radiol, Himeji, Hyogo 6700981, Japan	Kiuchi, K (reprint author), Himeji Cardiovasc Ctr, Dept Cardiol, 520 Kou, Himeji, Hyogo 6700981, Japan.	kunihikokiuchi@yahoo.co.jp					Bisbal F, 2014, JACC-CARDIOVASC IMAG, V7, P653, DOI 10.1016/j.jcmg.2014.01.014; Ranjan R, 2011, CIRC-ARRHYTHMIA ELEC, V4, P279, DOI 10.1161/CIRCEP.110.960567; McGann CJ, 2008, J AM COLL CARDIOL, V52, P1263, DOI 10.1016/j.jacc.2008.05.062; Miyazaki S, 2013, CIRC J, V77, P352, DOI 10.1253/circj.CJ-12-0951; Jadidi AS, 2013, J AM COLL CARDIOL, V62, P802, DOI 10.1016/j.jacc.2013.03.081; Kiuchi K, 2014, J CARDIOVASC ELECTR, V25, P1032, DOI 10.1111/jce.12434; Kiuchi Kunihiko, 2015, J Arrhythm, V31, P71, DOI 10.1016/j.joa.2014.06.005; Miyazaki S, 2013, CIRC J, V78, P78	8	0	0	JAPANESE CIRCULATION SOC	TOYKO	18TH FLOOR IMPERIAL HOTEL TOWER, 1-1-1 UCHISAIWAI-CHO CHIYODA-KU, TOYKO, 100-0011, JAPAN	1346-9843	1347-4820		CIRC J	Circ. J.	DEC	2014	78	12					2993	2995		10.1253/circj.CJ-14-0754		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HL	WOS:000346698300032		
J	Sporkova, A; Jichova, S; Huskova, Z; Kopkan, L; Nishiyama, A; Hwang, SH; Hammock, BD; Imig, JD; Kompanowska-Jezierska, E; Sadowski, J; Kramer, HJ; Cervenka, L				Sporkova, Alexandra; Jichova, Sarka; Huskova, Zuzana; Kopkan, Libor; Nishiyama, Akira; Hwang, Sung H.; Hammock, Bruce D.; Imig, John D.; Kompanowska-Jezierska, Elzbieta; Sadowski, Janusz; Kramer, Herbert J.; Cervenka, Ludek			Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: Studies in Cyp1a1-Ren-2 transgenic rats	CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY			English	Article						angiotensin-II; cytochrome P-450 epoxygenase; eicosanoids; epoxyeicosatrienoic acids; hypertension; soluble epoxide hydrolase	SPONTANEOUSLY HYPERTENSIVE-RATS; RENIN-ANGIOTENSIN SYSTEM; BLOOD-PRESSURE RESEARCH; END-ORGAN DAMAGE; II LEVELS; CYTOCHROME-P-450 METABOLITES; ARACHIDONIC-ACID; RENAL-FUNCTION; NITRIC-OXIDE; NATRIURESIS	Recent studies have shown that the long-term antihypertensive action of soluble epoxide hydrolase inhibition (sEH) in angiotensin-II (AngII)-dependent hypertension might be mediated by the suppression of intrarenal AngII levels. To test this hypothesis, we examined the effects of acute (2 days) and chronic (14 days) sEH inhibition on blood pressure (BP) in transgenic rats with inducible AngII-dependent hypertension. AngII-dependent malignant hypertension was induced by 10 days' dietary administration of indole-3-carbinol (I3C), a natural xenobiotic that activates the mouse renin gene in Cyp1a1-Ren-2 transgenic rats. BP was monitored by radiotelemetry. Acute and chronic sEH inhibition was achieved using cis-4-(4-(3-adamantan-1-yl-ureido)cyclohexyloxy) benzoic acid, given at doses of 0.3, 3, 13, 26, 60 and 130 mg/L in drinking water. At the end of experiments, renal concentrations of epoxyeicosatrienoic acids, their inactive metabolites dihydroxyeicosatrienoic acids and AngII were measured. Acute BP-lowering effects of sEH inhibition in I3C-induced rats was associated with a marked increase in renal epoxyeicosatrienoic acids to dihydroxyeicosatrienoic acids ratio and acute natriuresis. Chronic treatment with cis-4-(4-(3-adamantan-1-yl-ureido)cyclohexyloxy) benzoic acid in I3C-induced rats elicited dose-dependent persistent BP lowering associated with a significant reduction of plasma and kidney AngII levels. Our findings show that the acute BP-lowering effect of sEH inhibition in I3C-induced Cyp1a1-Ren-2 transgenic rats is mediated by a substantial increase in intrarenal epoxyeicosatrienoic acids and their natriuretic action without altering intrarenal renin-angiotensin system activity. Long-term antihypertensive action of cis-4-(4-(3-adamantan-1-yl-ureido)cyclohexyloxy) benzoic acid in I3C-induced Cyp1a1-Ren-2 transgenic rats is mediated mostly by suppression of intrarenal AngII concentration.	[Sporkova, Alexandra; Jichova, Sarka; Huskova, Zuzana; Kopkan, Libor; Cervenka, Ludek] Ctr Med Expt, Inst Clin & Expt Med, CZ-14000 Prague 4, Czech Republic; [Jichova, Sarka] Kagawa Univ, Dept Physiol, Kagawa, Japan; [Nishiyama, Akira] Kagawa Univ, Dept Pharmacol, Kagawa, Japan; [Hwang, Sung H.; Hammock, Bruce D.] Univ Calif Davis, UCD Comprehens Canc Ctr, Dept Entomol, Davis, CA 95616 USA; [Imig, John D.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Kompanowska-Jezierska, Elzbieta; Sadowski, Janusz] Polish Acad Sci, M Mossakowski Med Res Ctr, Dept Renal & Body Fluid Physiol, Warsaw, Poland; [Kramer, Herbert J.] Univ Bonn, Dept Med, Med Policlin, Nephrol Sect, Bonn, Germany; [Cervenka, Ludek] Charles Univ Prague, Fac Med 2, Prague, Czech Republic	Cervenka, L (reprint author), Ctr Med Expt, Inst Clin & Expt Med, 1958-9 Videnska, CZ-14000 Prague 4, Czech Republic.	luce@medicon.cz			Internal Grant Agency of the Ministry of Health [NT/12171-5]; European Commission [IRG 247847, CZ.2.16/3.1.00/28025]; Ministry of Health of the Czech Republic [00023001]; Grant Agency of Charles University [266213]; NIH [HL59699, DK38226]; NIEHS [R01 ES02710, R01 ES013933, P42 ES013933]; West Coast Center [U24 DK097154]; EicOsis	This study was principally supported by grant No. NT/12171-5 awarded by the Internal Grant Agency of the Ministry of Health to ZH. AS was supported by a Marie Curie Fellowship from the European Commission Program PEOPLE (IRG 247847). The Institute for Clinical and Experimental Medicine (IKEM) is a recipient of the project of the Ministry of Health of the Czech Republic for the development of research organization 00023001 (institutional support). SJ is supported the Grant Agency of Charles University No. 266213. The Center for Experimental Medicine (IKEM) received financial support from the European Commission within the Operational Program Prague-Competitiveness; project "Rozvoj infraskruktury PEM" (#CZ.2.16/3.1.00/28025). JDI was supported by NIH grants HL59699 and DK38226. SHH was supported by a fellowship from the NIEHS Supported Basic Research Program. Partial support was provided by NIEHS Grant R01 ES02710, R01 ES013933 and P42 ES013933, and by West Coast Center U24 DK097154 awarded to BDH. BDH is a George and Judy Marcus Senior Fellow of the American Asthma Foundation. BDH was funded by EicOsis to develop soluble epoxide hydrolase inhibitors for treating inflammatory and neuropathic pain. The other authors declare no potential conflict of interest.	Peters B, 2008, J HYPERTENS, V26, P102; Vaneckova I, 2012, KIDNEY BLOOD PRESS R, V35, P382, DOI 10.1159/000336823; Campbell WB, 2010, PFLUG ARCH EUR J PHY, V459, P881, DOI 10.1007/s00424-010-0804-6; Castrop H, 2010, PHYSIOL REV, V90, P607, DOI 10.1152/physrev.00011.2009; Reckelhoff JF, 2003, AM J PHYSIOL-REG I, V284, pR893, DOI 10.1152/ajpregu.00491.2002; Kurtz TW, 2005, HYPERTENSION, V45, P299, DOI 10.1161/01.HYP.0000150857.39919.cb; Hwang SH, 2007, J MED CHEM, V50, P3825, DOI 10.1021/jm070270t; Roman RJ, 2002, PHYSIOL REV, V82, P131; Kopkan L, 2012, KIDNEY BLOOD PRESS R, V35, P595, DOI 10.1159/000339883; Kantachuvesiri S, 2001, J BIOL CHEM, V276, P36727, DOI 10.1074/jbc.M103296200; Varcabova S, 2013, CLIN EXP PHARMACOL P, V40, P273, DOI 10.1111/1440-1681.12018; Elmarakby AA, 2012, AM J PHYSIOL-REG I, V302, pR321, DOI 10.1152/ajpregu.00606.2011; Sporkova A, 2011, AM J PHYSIOL-REG I, V300, pR1468, DOI 10.1152/ajpregu.00215.2010; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Pinto YM, 1998, CARDIOVASC RES, V39, P77, DOI 10.1016/S0008-6363(98)00077-7; Neckar J, 2012, CLIN SCI, V122, P513, DOI 10.1042/CS20110622; Imig JD, 2012, PHYSIOL REV, V92, P101, DOI 10.1152/physrev.00021.2011; Jiang HL, 2011, AM J PHYSIOL-HEART C, V300, pH1990, DOI 10.1152/ajpheart.01267.2010; HALL JE, 1992, AM J PHYSIOL, V262, pR61; Nogueira EF, 2007, J MOL ENDOCRINOL, V39, P365, DOI 10.1677/JME-07-0094; Kujal P, 2014, CLIN EXP PHARMACOL P, V41, P227, DOI 10.1111/1440-1681.12204; Lee CR, 2010, FASEB J, V24, P3770, DOI 10.1096/fj.10-160119; Capdevila J, 2013, CURR OPIN NEPHROL HY, V22, P163, DOI 10.1097/MNH.0b013e32835d911e; Erbanova M, 2009, J HYPERTENS, V27, P575, DOI 10.1097/HJH.0b013e32831cbd5a; Gonzalez-Villalobos RA, 2013, J CLIN INVEST, V125, P2011; Guyton AC, 1990, HYPERTENSION PATHOPH, P1029; Hall JE, 2000, THE KIDNEY PHYSIOLOG, P1009; Honetschlagerova Z, 2011, J HYPERTENS, V29, P1590, DOI 10.1097/HJH.0b013e328349062f; Honetschlagerova Z, 2013, J HYPERTENS, V31, P321, DOI 10.1097/HJH.0b013e32835b50aa; Honetschlagerova Z, 2011, J PHYSIOL-LONDON, V589, P207, DOI 10.1113/jphysiol.2010.199505; Huang H, 2007, AM J PHYSIOL-RENAL, V293, pF342, DOI 10.1152/ajprenal.00004.2007; Huskova Z, 2010, J HYPERTENS, V28, P495, DOI 10.1097/HJH.0b013e3283345d69; Kompanowska-Jezierska E, 2008, J PHYSIOL PHARMACOL, V59, P137; Kujal P, 2010, CLIN EXP PHARMACOL P, V37, P1159, DOI 10.1111/j.1440-1681.2010.05453.x; Li J, 2008, FRONT BIOSCI, V13, P3480, DOI 10.2741/2942; MADHUN ZT, 1991, J CLIN INVEST, V88, P456, DOI 10.1172/JCI115325; Miao CY, 2005, J HYPERTENS, V23, P1225, DOI 10.1097/01.hjh.0000170386.84450.e3; Mitchell KD, 2006, J RENIN-ANGIO-ALDO S, V7, P74, DOI 10.3317/jraas.2006.013; Mullins LJ, 2003, PFLUG ARCH EUR J PHY, V445, P491, DOI 10.1007/s00424-002-0968-9; Navar LG, 1998, NEWS PHYSIOL SCI, V13, P170; Navar LG, 2011, CURR OPIN PHARMACOL, V11, P180, DOI 10.1016/j.coph.2011.01.009; Peters BS, 2012, J MAGN RESON IMAGING, V36, P373, DOI 10.1002/jmri.23661; ROMAN RJ, 1985, AM J PHYSIOL, V248, pF199; SAKAIRI Y, 1995, AM J PHYSIOL-RENAL, V268, pF931; Van der Mark J, 1994, AM J PHYSIOL, V266, pF739; Vanourkova Z, 2006, J HYPERTENS, V24, P2465; VONTHUN AM, 1994, AM J PHYSIOL, V266, pF120	47	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1440-1681			CLIN EXP PHARMACOL P	Clin. Exp. Pharmacol. Physiol.	DEC	2014	41	12					1003	1013		10.1111/1440-1681.12310		11	Pharmacology & Pharmacy; Physiology	Pharmacology & Pharmacy; Physiology	AX1SR	WOS:000346726900008		
J	Kono, Y; Sengoku, R; Mitsumura, H; Bono, K; Sakuta, K; Yamasaki, M; Mochio, S; Iguchi, Y				Kono, Yu; Sengoku, Renpei; Mitsumura, Hidetaka; Bono, Keiko; Sakuta, Kenichi; Yamasaki, Mikihito; Mochio, Soichiro; Iguchi, Yasuyuki			Clinical characteristics associated with corticospinal tract hyperintensity on magnetic resonance imaging in patients with amyotrophic lateral sclerosis	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Amyotrophic lateral sclerosis; Biomarker; Conventional magnetic resonance imaging; Corticospinal tract; Diagnosis	MRI; DIAGNOSIS; ALS	Objective: The usefulness of conventional magnetic resonance imaging (C-MRI) for diagnosing amyotrophic lateral sclerosis (ALS) remains controversial. The aim of this study was to investigate the utility of C-MRI in identifying ALS, specifically the association between corticospinal tract (CST) hyperintensity on C-MRI and clinical characteristics in patients with ALS. Methods: Between June 2008 and April 2012, we retrospectively enrolled consecutive patients diagnosed with sporadic ALS who underwent C-MRI. Patients with ALS were classified as definite-phase ALS (D-ALS) and indefinite-phase ALS (ID-ALS). We focused on the hyperintensity of T2-weighted images in the CST in patients with ALS. Based on the MRI results, we divided patients into two groups: a positive CST group showing CST hyperintensity; and a negative CST group with no such findings. Clinical characteristics of the two groups were compared. Results: Seventeen patients (median age, 62 years; 8 women, 9 men) were enrolled in this study, with D-ALS in eight (47%) and ID-ALS in nine (53%). Eight patients (47%) showed CST positivity. The rate of CST positivity was higher in patients with D-ALS (75%) than in patients with ID-ALS (22%, p = 0.03). Conclusions: CST positivity appears significantly increased in D-ALS patients. C-MRI can play an important role in diagnosing ALS. (C) 2014 Elsevier B.V. All rights reserved.	[Kono, Yu; Sengoku, Renpei; Mitsumura, Hidetaka; Bono, Keiko; Sakuta, Kenichi; Yamasaki, Mikihito; Mochio, Soichiro; Iguchi, Yasuyuki] Jikei Univ, Sch Med, Dept Neurol, Tokyo 1058461, Japan	Kono, Y (reprint author), Jikei Univ, Sch Med, Dept Neurol, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	yu1028@jikei.ac.jp					Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Waragai M, 1997, NEURORADIOLOGY, V39, P847; Agosta F, 2010, AM J NEURORADIOL, V31, P1769, DOI 10.3174/ajnr.A2043; Ding XQ, 2011, AMYOTROPH LATERAL SC, V12, P406, DOI 10.3109/17482968.2011.597402; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Agosta F, 2010, EUR J NEUROSCI, V32, P1490, DOI 10.1111/j.1460-9568.2010.07445.x; Kassubek J, 2005, J CLIN NEUROSCI, V12, P588, DOI 10.1016/j.jocn.2004.07.020; Charil A, 2009, AMYOTROPH LATERAL SC, V10, P269, DOI 10.3109/17482960902777339; CHEUNG G, 1995, RADIOLOGY, V194, P263; Filippi M, 2010, EUR J NEUROL, V17, P526, DOI 10.1111/j.1468-1331.2010.02951.x; Hecht MJ, 2001, J NEUROL SCI, V186, P37, DOI 10.1016/S0022-510X(01)00503-2; MIROWITZ S, 1989, RADIOLOGY, V172, P535; Pradhan S, 2006, MAGN RESON IMAGING, V24, P173, DOI 10.1016/j.mri.2005.10.003; Rocha Antonio José da, 2012, Arq Neuropsiquiatr, V70, P532	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	DEC	2014	127						1	4		10.1016/j.clineuro.2014.09.011		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX5FS	WOS:000346952800001		
J	Yabe, I; Tanino, M; Yaguchi, H; Takiyama, A; Cai, H; Kanno, H; Takahashi, I; Hayashi, YK; Watanabe, M; Takahashi, H; Hatakeyama, S; Tanak, S; Sasaki, H				Yabe, Ichiro; Tanino, Mishie; Yaguchi, Hiroaki; Takiyama, Akihiro; Cai, Huaying; Kanno, Hiromi; Takahashi, Ikuko; Hayashi, Yukiko K.; Watanabe, Masashi; Takahashi, Hidehisa; Hatakeyama, Shigetsugu; Tanak, Shinya; Sasaki, Hidenao			Pathology of frontotemporal dementia with limb girdle muscular dystrophy caused by a DNAJB6 mutation	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Frontotemporal dementia; DNAJB6; Brain pathology; LC-3; Autophagy	MYOPATHY		[Yabe, Ichiro; Yaguchi, Hiroaki; Cai, Huaying; Takahashi, Ikuko; Sasaki, Hidenao] Hokkaido Univ, Grad Sch Med, Dept Neurol, Sapporo, Hokkaido, Japan; [Tanino, Mishie; Takiyama, Akihiro; Kanno, Hiromi; Tanak, Shinya] Hokkaido Univ, Grad Sch Med, Dept Canc Pathol, Sapporo, Hokkaido, Japan; [Yaguchi, Hiroaki; Watanabe, Masashi; Takahashi, Hidehisa; Hatakeyama, Shigetsugu] Hokkaido Univ, Grad Sch Med, Dept Biochem, Sapporo, Hokkaido, Japan; [Hayashi, Yukiko K.] NCNP, Dept Neuromuscular Res, Kodaira, Tokyo, Japan	Yabe, I (reprint author), Hokkaido Univ, Grad Sch Med, Dept Neurol, Sapporo, Hokkaido, Japan.	yabe@med.hokudai.ac.jp	Hatakeyama, Shigetsugu/C-8333-2012	Hatakeyama, Shigetsugu/0000-0002-2150-9979	Research Committee of CNS Degenerative Diseases; Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Science, Sports, and Culture, Japan	This work was supported in part by a Grant-in-Aid from the Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour and Welfare of Japan, and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture, Japan.	Josephs KA, 2011, ACTA NEUROPATHOL, V122, P137, DOI 10.1007/s00401-011-0839-6; Sieben A, 2012, ACTA NEUROPATHOL, V124, P353, DOI 10.1007/s00401-012-1029-x; Kragh CL, 2012, BRAIN PATHOL, V22, P99, DOI 10.1111/j.1750-3639.2011.00545.x; Durrenberger PF, 2009, J NEUROSCI RES, V87, P238, DOI 10.1002/jnr.21819; Sato T, 2013, NEUROMUSCULAR DISORD, V23, P269, DOI 10.1016/j.nmd.2012.12.010; Harms MB, 2012, ANN NEUROL, V71, P407, DOI 10.1002/ana.22683; Kakkar V, 2012, CURR TOP MED CHEM, V12, P2479	7	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	DEC	2014	127						10	12		10.1016/j.clineuro.2014.09.013		3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX5FS	WOS:000346952800003		
J	Shibazaki, K; Kimura, K; Aoki, J; Sakai, K; Saji, N; Uemura, J				Shibazaki, Kensaku; Kimura, Kazumi; Aoki, Junya; Sakai, Kenichiro; Saji, Naoki; Uemura, Junichi			Brain natriuretic peptide level on admission predicts recurrent stroke after discharge in stroke survivors with atrial fibrillation	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Brain natriuretic peptide; Predictive marker; Stroke recurrence; Ischemic stroke survivors; Atrial fibrillation	ACUTE ISCHEMIC-STROKE; TAKO-TSUBO CARDIOMYOPATHY; HEART-FAILURE; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; VENTRICULAR DYSFUNCTION; RISK; ATTACK; BIOMARKERS; JAPANESE	Objective: We investigated whether brain natriuretic peptide (BNP) levels could be used as a marker to predict recurrent stroke in ischemic stroke survivors. Methods: From April 2007 to March 2011, consecutive patients within 24 h of onset of ischemic stroke were prospectively enrolled, and admission plasma BNP levels were measured. Survivors were followed up to 12 months after stroke onset. Patients were divided into two groups: the recurrence group and the non-recurrence group. Factors associated with stroke recurrence were investigated by multiple logistic regression analysis. Results: A total of 793 patients who were alive at hospital discharge were included; 42(5%) patients had recurrent stroke. There were no differences in BNP levels between groups. With respect to 257 patients with atrial fibrillation (AF), BNP levels were significantly higher in the recurrence group than in the non-recurrence group (426.0 vs. 192.0 pg/mL, P = 0.0007). The optimal cutoff level, sensitivity, and specificity of BNP levels to distinguish the recurrence group from the non-recurrence group were 300.0 pg/mL, 80%, and 73%, respectively. After adjustment for age and sex, plasma BNP >= 300.0 pg/mL (OR, 9.2; 95% Cl, 1.87-45.01, P = 0.0062) was found to be independently associated with recurrent stroke in stroke survivors with AF. Conclusion: Admission BNP levels can predict recurrent stroke in stroke survivors with AF. (C) 2014 Elsevier B.V. All rights reserved.	[Shibazaki, Kensaku; Kimura, Kazumi; Aoki, Junya; Sakai, Kenichiro; Saji, Naoki; Uemura, Junichi] Kawasaki Med Univ, Dept Stroke Med, Kurashiki, Okayama 7010192, Japan	Shibazaki, K (reprint author), Kawasaki Med Univ, Dept Stroke Med, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	shibaken@med.kawasaki-m.ac.jp					Longstreth WT, 2013, STROKE, V44, P714, DOI 10.1161/STROKEAHA.112.675942; Lee VH, 2006, J NEUROSURG, V105, P264, DOI 10.3171/jns.2006.105.2.264; Nakagawa K, 2005, CEREBROVASC DIS, V19, P157, DOI 10.1159/000083249; Deininger MH, 2006, J NEUROSURG, V105, P465, DOI 10.3171/jns.2006.105.3.465; Tsutamoto T, 1997, CIRCULATION, V96, P509; VANSWIETEN JC, 1988, STROKE, V19, P604; Campbell DJ, 2006, ARCH NEUROL-CHICAGO, V63, P60, DOI 10.1001/archneur.63.1.noc50221; Makikallio AM, 2005, STROKE, V36, P1016, DOI 10.1161/01.STR.0000162751.54349.ae; Porapakkham P, 2010, ARCH INTERN MED, V170, P507, DOI 10.1001/archinternmed.2010.35; Hankey GJ, 2003, CEREBROVASC DIS, V16, P14, DOI 10.1159/000069936; Tung PP, 2005, STROKE, V36, P1567, DOI 10.1161/01.STR.0000170699.59783.d6; Rost NS, 2012, STROKE, V43, P441, DOI 10.1161/STROKEAHA.111.629212; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0; Shibazaki K, 2011, EUR J NEUROL, V18, P165, DOI 10.1111/j.1468-1331.2010.03101.x; Logeart D, 2004, J AM COLL CARDIOL, V43, P635, DOI 10.1016/j.jacc.2003.09.044; Hussein AA, 2011, CIRCULATION, V123, P2077, DOI 10.1161/CIRCULATIONAHA.110.007252; Kang DW, 2009, STROKE, V40, P1653, DOI 10.1161/STROKEAHA.108.539429; Montaner J, 2008, STROKE, V39, P2280, DOI 10.1161/STROKEAHA.107.505354; Shibazaki K, 2009, INTERNAL MED, V48, P259, DOI 10.2169/internalmedicine.48.1475; Di Angelantonlo E, 2007, J NEUROL SCI, V260, P139, DOI 10.1016/j.jns.2007.04.018; Garcia-Berrocoso T, 2013, NEUROLOGY, V82, P1976; Hata J, 2005, J NEUROL NEUROSUR PS, V76, P368, DOI 10.1136/jnnp.2004.038166; Kamouchi M, 2012, CEREBROVASC DIS, V34, P351, DOI 10.1159/000343503; Kimura K, 2010, J NEUROL SCI, V290, P37, DOI 10.1016/j.jns.2009.11.014; Okada Y, 2011, J NEUROL SCI, V301, P86, DOI 10.1016/j.jns.2010.10.017; Rodriguez-Yanez M, 2013, NEUROLOGY, V81, P444, DOI 10.1212/WNL.0b013e31829d8773; Rothwell PM, 2004, STROKE, V35, P2300, DOI 10.1161/01.STR.0000141701.36371.d1; Shibazaki K, 2014, J CLIN NEUROSCI, V21, P221, DOI 10.1016/j.jocn.2013.02.035; Shibazaki K, 2009, J NEUROL SCI, V281, P55, DOI 10.1016/j.jns.2009.02.374; Takase H, 2004, EUR J CLIN INVEST, V34, P79, DOI 10.1111/j.1365-2362.2004.01301.x; Woodward M, 2005, STROKE, V36, P2143, DOI 10.1161/01.STR.0000181754.38408.4c	33	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	DEC	2014	127						25	29		10.1016/j.clineuro.2014.09.028		5	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX5FS	WOS:000346952800007		
J	Hiraga, A; Takatsuna, Y; Sakakibara, R; Kamitsukasa, I; Minamide, M; Kuwabara, S				Hiraga, Akiyuki; Takatsuna, Yoko; Sakakibara, Ryuji; Kamitsukasa, Ikuo; Minamide, Masahiro; Kuwabara, Satoshi			Vogt-Koyanagi-Harada disease with meningitis-retention syndrome and increased CSF adenosine deaminase levels	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Vogt-Koyanagi-Harada disease; Urinary retention; Meningitis; Adenosine deaminase			[Hiraga, Akiyuki; Kamitsukasa, Ikuo] Chiba Rosai Hosp, Dept Neurol, Ichihara, Chiba 2900003, Japan; [Takatsuna, Yoko] Chiba Rosai Hosp, Dept Ophthalmol, Ichihara, Chiba 2900003, Japan; [Sakakibara, Ryuji] Toho Univ, Sakura Med Ctr, Dept Neurol, Sakura, Chiba, Japan; [Minamide, Masahiro] Chiba Rosai Hosp, Dept Urol, Ichihara, Chiba 2900003, Japan; [Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan	Hiraga, A (reprint author), Chiba Rosai Hosp, Dept Neurol, 2-16 Tatsumidai Higashi, Ichihara, Chiba 2900003, Japan.	hiragaa@yahoo.co.jp					Pan D, 2011, SEMIN OPHTHALMOL, V26, P312, DOI 10.3109/08820538.2011.588654; Andreoli Christopher M., 2006, International Ophthalmology Clinics, V46, P111, DOI 10.1097/00004397-200604620-00011; Sun Q, 2012, AM J MED SCI, V344, P116, DOI 10.1097/MAJ.0b013e318238fee3; Sakakibara R, 2013, NEUROUROL URODYNAM, V32, P19, DOI 10.1002/nau.22279; Kiyomoto Chihiro, 2007, International Ophthalmology, V27, P149, DOI 10.1007/s10792-007-9067-4	5	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	DEC	2014	127						42	43		10.1016/j.clineuro.2014.09.021		2	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX5FS	WOS:000346952800010		
J	Suehiro, E; Koizumi, H; Fujiyama, Y; Yoneda, H; Suzuki, M				Suehiro, Eiichi; Koizumi, Hiroyasu; Fujiyama, Yuichi; Yoneda, Hiroshi; Suzuki, Michiyasu			Predictors of deterioration indicating a requirement for surgery in mild to moderate traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Mild traumatic brain injury; Moderate traumatic brain injury; Exacerbation; Coagulopathy; Talk and deteriorate	HEAD-INJURY; COAGULOPATHY; THROMBELASTOGRAPHY; TRANSFUSION; DISORDERS	Objectives: Careful course observation is necessary for cases of mild to moderate traumatic brain injury even when disturbed consciousness is mild on admission. This is because delayed enlargement of hematoma and progression of cerebral swelling may occur and result in an emergency craniotomy. Here, we investigated coagulopathy and abnormal fibrinolysis as a predictive factor of "deterioration requiring surgery" in mild to moderate traumatic brain injury. Patients and methods: Sixty-one patients with mild to moderate (Glasgow Coma Scale (GCS) score 9-15) traumatic brain injury were admitted betweenJune 2009 and October 2010. There were 54 subjects in the study, excluding those treated with oral antiplatelet agents and anticoagulants. Patients were classified into those with deterioration requiring surgery [op(+)] or those without deterioration requiring surgery [01)H]. This was based on whether surgical treatment was performed for hematoma expansion, and exacerbated consciousness level within 3 days after admission. Age, GCS score on admission and blood test findings (platelet count, PT-INR, APTT, fibrinogen, FDP, and n-dimer) on admission were compared. Results: The op(+) and op(-) groups comprised 7 (13.0%) and 47 patients (87.0%), respectively. Platelet counts (24.8 vs 18.5 x 10(4)/mu l) were decreased, and PT-INR (1.0 vs 1.2) was higher in the op(+) group. Specially, APTT (28.6 vs 39.1 s), FDP (28.9 vs 112.9 mu g/ml), and n-dimer (17.3 vs 69.6 mu g/ml) values were significantly higher in the op(+) group. Conclusions: Coagulopathy and abnormal fibrinolysis, which are measurable in routine medical practice, is associated with deterioration requiring surgery in mild to moderate traumatic brain injury, indicating that careful course observation is necessary. (C) 2014 Elsevier B.V. All rights reserved.	[Suehiro, Eiichi; Koizumi, Hiroyasu; Fujiyama, Yuichi; Yoneda, Hiroshi; Suzuki, Michiyasu] Yamaguchi Univ, Sch Med, Dept Neurosurg, Ube, Yamaguchi 7558505, Japan	Suehiro, E (reprint author), Yamaguchi Univ, Sch Med, Dept Neurosurg, 1-1-1 Minamikogushi, Ube, Yamaguchi 7558505, Japan.	suehiro-nsu@umin.ac.jp					Windelov NA, 2011, BLOOD COAGUL FIBRIN, V22, P416, DOI 10.1097/MBC.0b013e3283464f53; Parr MJ, 2008, J TRAUMA, V65, P766, DOI 10.1097/TA.0b013e31818606d2; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; [Anonymous], 2012, NEUROL MED CHIR TOKY, V52, P1; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; Theusinger OM, 2009, CURR OPIN ANESTHESIO, V22, P305, DOI 10.1097/ACO.0b013e3283212c7c; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Cohen Mitchell Jay, 2007, J Trauma, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; Greuters S, 2011, CRIT CARE, V15; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Kushimoto S, 2001, NEUROSURGERY, V49, P1084, DOI 10.1097/00006123-200111000-00011; Kushimoto S, 2003, J NEUROTRAUM, V20, P357, DOI 10.1089/089771503765172318; Kushimoto S, 2010, JPN J THROMB HEMOST, V21, P578, DOI 10.2491/jjsth.21.578; Salehpour F, 2011, J CRIT CARE, V26, P352, DOI 10.1016/j.jcrc.2010.12.005; Tan JE, 2004, ANN ACAD MED SINGAP, V33, P489	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	DEC	2014	127						97	100		10.1016/j.clineuro.2014.10.007		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX5FS	WOS:000346952800020		
J	Ichikawa, T; Kurozumi, K; Michiue, H; Ishida, J; Maeda, Y; Kondo, E; Kawasaki, A; Date, I				Ichikawa, Tomotsugu; Kurozumi, Kazuhiko; Michiue, Hiroyuki; Ishida, Joji; Maeda, Yoshinobu; Kondo, Eisei; Kawasaki, Akihiro; Date, Isao			Reduced neurotoxicity with combined treatment of high-dose methotrexate, cyclophosphamide, doxorubicin, vincristine and prednisolone (M-CHOP) and deferred radiotherapy for primary central nervous system lymphoma	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Primary central nervous system lymphoma; Methotrexate; CHOP; Response rate	PRIMARY CNS LYMPHOMA; STEM-CELL TRANSPLANTATION; WHOLE-BRAIN RADIOTHERAPY; NON-HODGKINS-LYMPHOMA; PHASE-II; CONSOLIDATING RADIOTHERAPY; 1ST-LINE TREATMENT; FOLLOW-UP; CHEMOTHERAPY; THERAPY	Objective: Although high-dose methotrexate and whole-brain radiation therapy (WBRT) is the current standard for primary central nervous system lymphoma (PCNSL), it has a limited response rate and produces radiation-induced neurotoxicity. We report the effect of a combined treatment of high-dose methotrexate, cyclophosphamide, doxorubicin, vincristine and prednisolone (M-CHOP) for immunocompetent patients with PCNSL. Methods: We analyzed 24 patients who had received M-CHOP administered in 28-day cycles with or without WBRT. The response rate to M-CHOP, overall survival (OS), and recurrence-free survival (RFS) were analyzed. Results: Nine patients were treated with M-CHOP plus WBRT and 15 patients were treated with M-CHOP alone. Twenty-one patients achieved a complete response and three patients achieved a partial response to M-CHOP, for a 100% response rate. With a median follow-up of 70 months, the median OS and RFS were 33 and 13 months, respectively. The median OS for patients treated with M-CHOP plus WBRT and M-CHOP alone was 33 and 32 months, respectively. Of the 13 patients whose age was above 65 years, the median OS for the M-CHOP plus WBRT group (two patients) and the M-CHOP alone group (11 patients) was 14 and 32 months, respectively. Toxicities related to M-CHOP were mostly hematologic and generally mild to moderate. Two patients whose age was above 65 years in the M-CHOP plus WBRT group developed neurotoxicity. Conclusion: Combined treatment with M-CHOP was well tolerated and produced a high response rate. Deferring WBRT was associated with reduced neurotoxicity without worsening the prognosis, especially in elderly patients. (C) 2014 Elsevier B.V. All rights reserved.	[Ichikawa, Tomotsugu; Kurozumi, Kazuhiko; Ishida, Joji; Kawasaki, Akihiro; Date, Isao] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, Kita Ku, Okayama 7008558, Japan; [Michiue, Hiroyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Physiol, Kita Ku, Okayama 7008558, Japan; [Maeda, Yoshinobu; Kondo, Eisei] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Hematol & Oncol, Kita Ku, Okayama 7008558, Japan; [Kawasaki, Akihiro] Toyama Univ, Fac Human Dev, Toyama 9308555, Japan	Ichikawa, T (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Neurol Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	tomoichi@cc.okayama-u.ac.jp					Batchelor T, 2003, J CLIN ONCOL, V21, P1044, DOI 10.1200/JCO.2003.03.036; Olson JE, 2002, CANCER, V95, P1504, DOI 10.1002/cncr.10851; Gavrilovic IT, 2006, J CLIN ONCOL, V24, P4570, DOI 10.1200/JCO.2006.06.6910; Abrey LE, 2000, J CLIN ONCOL, V18, P3144; Poortmans PMP, 2003, J CLIN ONCOL, V21, P4483, DOI 10.1200/JCO.2003.03.108; Ferreri AJM, 2009, LANCET, V374, P1512, DOI 10.1016/S0140-6736(09)61416-1; Cheson BD, 1999, J CLIN ONCOL, V17, P1244; Schultz C, 1996, J CLIN ONCOL, V14, P556; Blay JY, 1998, J CLIN ONCOL, V16, P864; LACHANCE DH, 1994, NEUROLOGY, V44, P1721; DeAngelis LM, 2002, J CLIN ONCOL, V20, P4643, DOI 10.1200/JCO.2002.11.013; Colombat P, 2006, BONE MARROW TRANSPL, V38, P417, DOI 10.1038/sj.bmt.1705452; GLASS J, 1994, J NEUROSURG, V81, P188, DOI 10.3171/jns.1994.81.2.0188; Omuro AMP, 2005, NEUROLOGY, V64, P69; Pels H, 2003, J CLIN ONCOL, V21, P4489, DOI 10.1200/JCO.2003.04.056; Ferreri AJM, 2002, NEUROLOGY, V58, P1513; Illerhaus G, 2008, HAEMATOL-HEMATOL J, V93, P147, DOI 10.3324/haematol.11771; Thiel E, 2010, LANCET ONCOL, V11, P1036, DOI 10.1016/S1470-2045(10)70229-1; Abrey LE, 1998, J CLIN ONCOL, V16, P859; Shah GD, 2007, J CLIN ONCOL, V25, P4730, DOI 10.1200/JCO.2007.12.5062; Illerhaus G, 2006, J CLIN ONCOL, V24, P3865, DOI 10.1200/JCO.2006.06.2117; Alimohamed N, 2012, LEUKEMIA LYMPHOMA, V53, P862, DOI 10.3109/10428194.2011.633250; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; GABBAI AA, 1989, J NEUROSURG, V70, P190, DOI 10.3171/jns.1989.70.2.0190; Glass J, 1996, J NEURO-ONCOL, V30, P257; Guha-Thakurta N, 1999, J NEURO-ONCOL, V43, P259, DOI 10.1023/A:1006210703827; HAYAKAWA T, 1994, J NEURO-ONCOL, V19, P197, DOI 10.1007/BF01053274; Herrlinger U, 2002, ANN NEUROL, V51, P247, DOI 10.1002/ana.10102; Hiraga S, 1999, J NEUROSURG, V91, P221, DOI 10.3171/jns.1999.91.2.0221; Makino K, 2006, SURG NEUROL, V66, P503, DOI 10.1016/j.surneu.2006.05.055; Matsumoto K, 1998, NEUROL SURG TOKYO, V26, P889; Montemurro M, 2007, ANN ONCOL, V18, P665, DOI 10.1093/annonc/mdl458; O'Neill BP, 1999, INT J RADIAT ONCOL, V43, P559, DOI 10.1016/S0360-3016(98)00450-7; POLLACK IF, 1989, CANCER, V63, P939, DOI 10.1002/1097-0142(19890301)63:5<939::AID-CNCR2820630526>3.0.CO;2-V; Sandor V, 1998, J CLIN ONCOL, V16, P3000; Shah GD, J CLIN ONCOL, V26, P340	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	DEC	2014	127						106	111		10.1016/j.clineuro.2014.10.011		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX5FS	WOS:000346952800022		
J	Miyamoto, M; Kinoshita, M; Tanaka, K; Tanaka, M				Miyamoto, Masakazu; Kinoshita, Masako; Tanaka, Keiko; Tanaka, Masami			Recurrent myelitis in localized scleroderma	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Recurrent myelitis; Localized scleroderma; Multiple sclerosis; Neuromyelitis optica	COUP-DE-SABRE; MORPHEA		[Miyamoto, Masakazu; Tanaka, Masami] Natl Utano Hosp, Natl Hosp Org, MS Ctr, Kyoto 6168255, Japan; [Kinoshita, Masako] Natl Utano Hosp, Natl Hosp Org, Dept Neurol, Kyoto 6168255, Japan; [Tanaka, Keiko] Kanazawa Med Univ, Dept Neurol, Uchinada, Ishikawa 92002, Japan	Kinoshita, M (reprint author), Natl Utano Hosp, Natl Hosp Org, Dept Neurol, Ukyo Ku, 8 Ondoyama Cho, Kyoto 6168255, Japan.	machak@kuhp.kyoto-u.ac.jp			Health and Labor Sciences Research Grants for research on intractable diseases from the Ministry of Health, Labor and Welfare of Japan	This study was supported in part by Health and Labor Sciences Research Grants for research on intractable diseases from the Ministry of Health, Labor and Welfare of Japan.	Tollefson MM, 2007, J AM ACAD DERMATOL, V56, P257, DOI 10.1016/j.jaad.2006.10.959; Peterson LS, 1997, J RHEUMATOL, V24, P73; Kister I, 2008, NEUROLOGY, V71, P1538, DOI 10.1212/01.wnl.0000334474.88923.e3; Appenzeller S, 2004, NEUROLOGY, V62, P1585; LITTMAN BH, 1989, J RHEUMATOL, V16, P1135	5	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	DEC	2014	127						140	142		10.1016/j.clineuro.2014.10.005		3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX5FS	WOS:000346952800030		
J	Youn, JH; Hayashida, K; Koizumi, N; Ohnishi, M; Sugimoto, C				Youn, Jung-Ho; Hayashida, Kyoko; Koizumi, Nobuo; Ohnishi, Makoto; Sugimoto, Chihiro			Comparative genomic analysis of eight Leptospira strains from Japan and the Philippines revealing the existence of four putative novel genomic islands/islets in L-interrogans serovar Lai strain 56601	COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES			English	Article						Genomic island; Leptospira; Leptospirosis; Next-generation sequencer	PATHOGENIC LEPTOSPIRA; MEMBRANE-PROTEINS; GENETIC DIVERSITY; OUTER-MEMBRANE; REGULATORS; INSIGHTS; ANTIGEN; GROWTH; CHINA	Leptospirosis is one of the most widespread zoonotic diseases worldwide and can be considered an emerging health problem to both human and animal. Despite the importance of the disease, complete genome sequences are currently available for only three Leptospira interrogans strains: 56601, Fiocruz L1-130, and IPAV. Therefore, intra- and inter-species comparative genomic analyses of Leptospira are limited. Here, to advance current knowledge of the genomic differences within Leptospira species, next-generation sequencing technology was used to examine the genomes of eight L. interrogans strains belonging to six different serogroups isolated from humans and dogs in Japan and the Philippines. The genomic sequences were mapped to that of the reference strain, L. interrogans serovar Lai strain 56601. The results revealed the presence of four novel genomic islands/islets (GIs) in strain 56601. This study provides a deeper insight into the molecular basis and evolutionary perspective of the virulence of leptospires. (C) 2014 Elsevier Ltd. All rights reserved.	[Youn, Jung-Ho; Sugimoto, Chihiro] Hokkaido Univ, Res Ctr Zoonosis Control, Div Collaborat & Educ, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Hayashida, Kyoko] Obihiro Univ, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan; [Koizumi, Nobuo; Ohnishi, Makoto] Natl Inst Infect Dis, Dept Bacteriol, Shinjuku Ku, Tokyo 1628640, Japan	Sugimoto, C (reprint author), Hokkaido Univ, Res Ctr Zoonosis Control, Div Collaborat & Educ, Kita Ku, Kita 20,Nishi 10, Sapporo, Hokkaido 0010020, Japan.	youn@czc.hokudai.ac.jp; sugimoto@czc.hokudai.ac.jp	Sugimoto, Chihiro/F-6583-2012	Sugimoto, Chihiro/0000-0002-8708-0140	Global COE Program "Establishment of International Collaboration Centers for Zoonosis Control" of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	This study was supported by the Global COE Program "Establishment of International Collaboration Centers for Zoonosis Control" of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Ali A, 2012, GENE, V508, P145, DOI 10.1016/j.gene.2012.07.070; Abdelhaleem M, 2005, CLIN BIOCHEM, V38, P499, DOI 10.1016/j.clinbiochem.2005.01.010; Koizumi N, 2009, J MED MICROBIOL, V58, P1227, DOI 10.1099/jmm.0.011528-0; Sexton JA, 2004, J BACTERIOL, V186, P1658, DOI 10.1128/JB.186.6.1658-1666.2004; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Koizumi N, 2003, J MED MICROBIOL, V52, P585, DOI 10.1099/jmm.0.05148-0; Vinetz JM, 1996, ANN INTERN MED, V125, P794; Stern EJ, 2010, CLIN INFECT DIS, V50, P843, DOI 10.1086/650578; Koizumi N, 2004, VACCINE, V22, P1545, DOI 10.1016/j.vaccine.2003.10.007; McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Ko AI, 2009, NAT REV MICROBIOL, V7, P736, DOI 10.1038/nrmicro2208; Picardeau M, 2014, DIAGN MICR INFEC DIS, V78, P1, DOI 10.1016/j.diagmicrobio.2013.09.012; Lau CL, 2010, T ROY SOC TROP MED H, V104, P631, DOI 10.1016/j.trstmh.2010.07.002; Zhong Y, 2011, CELL RES, V21, P1210, DOI 10.1038/cr.2011.46; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Bourhy P, 2007, INFECT IMMUN, V75, P677, DOI 10.1128/IAI.01067-06; Cai CS, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-67; Eribo B, 2012, APPL ENVIRON MICROB, V78, P3045, DOI 10.1128/AEM.07465-11; Faine S., 1999, LEPTOSPIRA LEPTOSPIR; Haake DA, 2002, INFECT IMMUN, V70, P4936, DOI 10.1128/IAI.70.9.4936-4945.2002; He P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-204; Kaper J.B., 1999, PATHOGENICITY ISLAND; Koizumi N, 2012, J MED MICROBIOL, V62, P630, DOI DOI 10.1099/JMM.0; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; PULLINGER GD, 1992, MOL MICROBIOL, V6, P1631, DOI 10.1111/j.1365-2958.1992.tb00888.x; Saito M, 2013, INT J SYST EVOL MICR, V63, P2457, DOI 10.1099/ijs.0.047233-0; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Victoriano AFB, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-147; Yanagihara Y, 2007, COMP IMMUNOL MICROB, V30, P399, DOI 10.1016/j.cimid.2007.05.003	32	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0147-9571	1878-1667		COMP IMMUNOL MICROB	Comp. Immunol. Microbiol. Infect. Dis.	DEC	2014	37	5-6					289	297		10.1016/j.cimid.2014.09.001		9	Immunology; Microbiology; Veterinary Sciences	Immunology; Microbiology; Veterinary Sciences	AX8AX	WOS:000347133900003		
J	Nagashima, LA; Akagi, CY; Sano, A; Silva, PLAE; Murata, Y; Itano, EN				Nagashima, Luciene Airy; Akagi, Claudia Yuri; Sano, Ayako; Alvares e Silva, Paula Leonello; Murata, Yoshiteru; Itano, Eiko Nakagawa			Arthrographis kalrae soluble antigens present hemolytic and cytotoxic activities	COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES			English	Article						Hemolysis; Cytotoxicity; Fungus; Chromatography; Antibodies	OIDIODENDRON-KALRAI; PATIENT; ONYCHOMYCOSIS; SINUSITIS; AGENT	Arthrographis kalrae is a dimorphic, cosmopolitan and neurotropic fungus that has been described as a rare human pathogen. This study investigated the hemolytic and cytotoxic activities of A. kalrae cell-free antigens (CFAs). Total CFAs and their Sephadex chromatography fractions were tested on mouse erythrocytes for hemolysis and on the P3U1 cell line for cytotoxicity. Hemolytic and cytotoxic activities were detected in distinct molecular mass (MM) fractions. Additionally, antibodies against isogenic erythrocytes sensitized with CFAs (anti-E-CFAs) inhibited hemolysis but not cytotoxicity. Hemolysis was not affected by heating, and a higher reactivity was detected in the carbohydrate-rich fractions, which decreased after reduction by periodate treatment. The pioneering nature of this work is due to the demonstration of the cytotoxic activity in A. kalrae and the suggestion that this activity may be due to molecules distinct from the hemolytic factor, with the latter potentially being a component with a high MM. Published by Elsevier Ltd.	[Nagashima, Luciene Airy; Akagi, Claudia Yuri; Alvares e Silva, Paula Leonello; Itano, Eiko Nakagawa] Univ Estadual Londrina, BR-86057970 Londrina, PR, Brazil; [Sano, Ayako] Univ Ryukyus, Nishihara, Okinawa 90301, Japan; [Murata, Yoshiteru] Murata Anim Hosp, Mobara, Chiba, Japan	Itano, EN (reprint author), Univ Estadual Londrina, Rod Celso Garcia Cid,Km 380, BR-86057970 Londrina, PR, Brazil.	itanoeiko@hotmail.com			CAPES; Fundacao Araucaria; FAEP/PROPPG; Japan International Cooperating Agency (JICA)	This work was supported by CAPES, Fundacao Araucaria, FAEP/PROPPG, and by the Japan International Cooperating Agency (JICA). We are also particularly grateful to Nilson de Jesus Carlos for his technical collaboration on this work.	Abbas A.K., 2012, CELLULAR MOL IMMUNOL; LEUNK RD, 1988, J MED MICROBIOL, V26, P93; CAMARGO ZP, 1991, J MED VET MYCOL, V29, P31; Watanabe T, 1999, MICROBIOL-UK, V145, P689; ANSEL HC, 1964, J PHARM SCI, V53, P169, DOI 10.1002/jps.2600530213; Banger J, 2004, TOXICOLOGY, V202, P199; Biser SA, 2004, CORNEA, V23, P314, DOI 10.1097/00003226-200404000-00018; Boan Peter, 2012, Med Mycol Case Rep, V1, P112, DOI 10.1016/j.mmcr.2012.10.005; Chin-Hong PV, 2001, J CLIN MICROBIOL, V39, P804, DOI 10.1128/JCM.39.2.804-807.2001; CINO PM, 1976, CAN J MICROBIOL, V22, P327; CINO PM, 1975, CAN J MICROBIOL, V21, P1362; Candela JD, 2010, ANN THORAC SURG, V90, pE4, DOI 10.1016/j.athoracsur.2010.04.021; Degavre B, 1997, J AM ACAD DERMATOL, V37, P318; Fernandes-Vivan RH, 2010, MYCOPATHOLOGY, V169, P151; Nagashima LA, 2007, 13TH INTERNATIONAL CONGRESS OF IMMUNOLOGY, P557; Nyilasi Ildiko, 2005, Acta Microbiologica et Immunologica Hungarica, V52, P185, DOI 10.1556/AMicr.52.2005.2.4; Ong DC-G, 2013, J ORTHOPAED; Perlman EM, 1997, AM J OPHTHALMOL, V123, P547; Pichon N, 2008, J CLIN MICROBIOL, V46, P3152, DOI 10.1128/JCM.00800-08; Ramli SR, 2013, CASE REP INFECT DIS, V2013; Sugiura Y, 2010, MED MYCOL, V48, P384, DOI 10.3109/13693780903219014; SWENBERG JA, 1969, ACTA NEUROPATHOL, V13, P75; TEWARI RP, 1968, J BACTERIOL, V95, P1130; Thomas BC, 2011, CORNEA, V30, P364, DOI 10.1097/ICO.0b013e3181eadeb9; Vollekova A., 2008, Epidemiologie Mikrobiologie Imunologie, V57, P53; Vos CG, 2012, J MED MICROBIOL, V61, P593, DOI 10.1099/jmm.0.037531-0; Xi LY, 2004, J CLIN MICROBIOL, V42, P4828, DOI 10.1128/JCM.42.10.4828-4831.2004	27	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0147-9571	1878-1667		COMP IMMUNOL MICROB	Comp. Immunol. Microbiol. Infect. Dis.	DEC	2014	37	5-6					305	311		10.1016/j.cimid.2014.09.002		7	Immunology; Microbiology; Veterinary Sciences	Immunology; Microbiology; Veterinary Sciences	AX8AX	WOS:000347133900005		
J	Matsumoto, S; Shimodozono, M; Etoh, S; Noma, T; Uema, T; Ikeda, K; Miyara, K; Tanaka, N; Kawahira, K				Matsumoto, Shuji; Shimodozono, Megumi; Etoh, Seiji; Noma, Tomokazu; Uema, Tomohiro; Ikeda, Keiko; Miyara, Kodai; Tanaka, Nobuyuki; Kawahira, Kazumi			Anti-spastic effects of footbaths in post-stroke patients: A proof-of-principle study	COMPLEMENTARY THERAPIES IN MEDICINE			English	Article						Footbath; Spasticity; Stroke; F-wave; Temperature	RANDOMIZED CLINICAL-TRIAL; STROKE PATIENTS; THERMAL INTERVENTION; VIBRATORY STIMULI; HEMIPLEGIC LIMBS; F-RESPONSES; H-REFLEXES; FACILITATION; MUSCLES; MANAGEMENT	Objectives: To investigate whether a footbath inhibits spasticity in the hemiplegic lower limbs of post-stroke patients. Design: Randomized, controlled study. Setting: Rehabilitation education and research hospital. Interventions: Twenty-two post-stroke patients were randomly allocated to control or experimental groups. After relaxing in a supine posture for 30 min, the experimental group subject's legs were immersed in 41 degrees C water below the knee joint for 15 min, while the control group remained in a resting posture. Main outcome measures: Modified Ashworth Scale (MAS) scores of the affected triceps surae muscle and F-wave parameters (i.e., F-wave amplitude, F/M ratio, and F-wave persistence) were recorded before, immediately after, and 30 min after each intervention. Physiological parameters were simultaneously monitored to determine the thermo-therapeutic mechanisms and side effects of footbath usage. Results: At the time immediately after the intervention, F-wave amplitudes decreased significantly in the experimental group, compared to the control group (p < 0.01, difference: -106.8; 95% Cl; -181.58 to -32.09). F-wave amplitudes decreased significantly after 30-min intervention in the experimental group, with a total reduction of 161.2 mu V being recorded compared to 8.8 mu V Vincrease in the control group (p < 0.01, difference: -170.0; 95% Cl; -252.73 to -87.33). There were also significant differences between the experimental and control group for both F/M ratio and F-wave persistence, immediately after and 30 min after the intervention. Further, there were significant differences between the experimental and control group for the MAS scores immediately after the intervention (p < 0.05, difference: -0.72; 95% Cl; -1.262 to -0.193), and 30 min after the intervention (p < 0.05, difference: -0.73; 95% Cl; -1.162 to -0.293). Conclusion: These findings demonstrate that the use of footbaths is an effective non-pharmacological anti-spastic treatment for use in stroke rehabilitation. (C) 2014 Elsevier Ltd. All rights reserved.	[Matsumoto, Shuji; Shimodozono, Megumi; Etoh, Seiji; Tanaka, Nobuyuki; Kawahira, Kazumi] Kagoshima Univ, Dept Rehabil & Phys Med, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Noma, Tomokazu; Uema, Tomohiro; Ikeda, Keiko; Miyara, Kodai] Kagoshima Univ Hosp, Kirishima Rehabil Ctr, Dept Rehabil, Kagoshima, Japan	Matsumoto, S (reprint author), Kagoshima Univ, Dept Rehabil & Phys Med, Grad Sch Med & Dent Sci, Kagoshima 890, Japan.	shushusa71@yahoo.co.jp					Agishi Y, 1985, Int J Biometeorol, V29 Suppl 2, P89; Matsumoto S, 2006, INT J BIOMETEOROL, V50, P243, DOI 10.1007/s00484-005-0009-4; Biering-Sorensen F, 2006, SPINAL CORD, V44, P708, DOI 10.1038/sj.sc.3101928; MAGLADERY JW, 1950, B JOHNS HOPKINS HOSP, V86, P265; BELL KR, 1987, ARCH PHYS MED REHAB, V68, P490; Sommerfeld DK, 2012, AM J PHYS MED REHAB, V91, P814, DOI 10.1097/PHM.0b013e31825f13a3; Pisano F, 2000, CLIN NEUROPHYSIOL, V111, P1015, DOI 10.1016/S1388-2457(00)00289-3; Milanov I, 1999, FUNCT NEUROL, V14, P193; Matsumoto S, 2010, INT J BIOMETEOROL, V54, P465, DOI 10.1007/s00484-009-0300-x; Chen JC, 2005, STROKE, V36, P2665, DOI 10.1161/01.STR.0000189992.06654.ab; MILANOV I, 1994, ACTA NEUROL SCAND, V89, P274; Chen JC, 2011, CLIN REHABIL, V25, P823, DOI 10.1177/0269215511399591; Smania N, 2010, EUR J PHYS REHAB MED, V46, P423; Bogey Ross A, 2004, ARCH PHYS MED REHAB, V85, pS15; Bohannon R. W., 1987, PHYS THER, V67, P206; Brunnstrom S., 1970, MOVEMENT THERAPY HEM; Caty GD, 2008, STROKE, V39, P2803, DOI 10.1161/STROKEAHA.108.516153; Chua K. S. G., 2000, SMJ, V41, P209; Ducros J, 1972, Therapeutique, V48, P255; EISEN A, 1977, CAN J NEUROL SCI, V4, P117; EISEN A, 1979, NEUROLOGY, V29, P1306; Etoh S, 2013, J REHABIL MED, V45, P843, DOI 10.2340/16501977-1175; FISHER MA, 1994, MUSCLE NERVE, V17, P1185, DOI 10.1002/mus.880171009; Gracies J M, 2001, Phys Med Rehabil Clin N Am, V12, P769; Graham LA, 2013, AGE AGEING, V42, P435, DOI 10.1093/ageing/aft064; Hawamdeh Z M, 2007, Eura Medicophys, V43, P311; HULTBORN H, 1995, MUSCLE NERVE, V18, P1471, DOI 10.1002/mus.880181219; Kimura J., 2001, ELECTRODIAGNOSIS DIS, P439; Lance J., 1980, SPASTICITY DISORDERE, P485; Lehmann J F, 1970, Arch Phys Med Rehabil, V51, P481; Lundstrom E, 2008, EUR J NEUROL, V15, P529; MACHIDA M, 1983, Electromyography and Clinical Neurophysiology, V23, P353; Milanov GI, 1992, CAN J NEUROL SCI, V19, P64; MILANOV I G, 1992, Electromyography and Clinical Neurophysiology, V32, P11; Miwa C, 1993, ENV MED, V37, P207; Noma T, 2009, BRAIN INJURY, V23, P623, DOI 10.1080/02699050902997896; Noma T, 2012, J REHABIL MED, V44, P325, DOI 10.2340/16501977-0946; OHTSUKA Y, 1994, EUR J APPL PHYSIOL O, V68, P87, DOI 10.1007/BF00599247; SCHILLER HH, 1978, J NEUROL NEUROSUR PS, V41, P45, DOI 10.1136/jnnp.41.1.45; Skeil DA, 1994, CLIN REHABIL, V8, P240, DOI 10.1177/026921559400800309; Tei Chuwa, 2007, J Cardiol, V49, P301; Tsai Kuen-Horng, 2001, Proceedings of the National Science Council Republic of China Part B Life Sciences, V25, P76; van Kuijk AA, 2002, J REHABIL MED, V34, P51; Yamamoto K, 2008, Complement Ther Clin Pract, V14, P195, DOI 10.1016/j.ctcp.2008.04.001; Yorizumi K, 1998, RIGAKU RYOHO, V15, P693	45	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0965-2299	1873-6963		COMPLEMENT THER MED	Complement. Ther. Med.	DEC	2014	22	6					1001	1009		10.1016/j.ctim.2014.09.006		9	Integrative & Complementary Medicine	Integrative & Complementary Medicine	AX7YT	WOS:000347128300006		
J	Ueki, S; Niinomi, K; Takashima, Y; Kinnura, R; Komai, K; Murakanni, K; Fujiwara, C				Ueki, Shingo; Niinomi, Kazuteru; Takashima, Yuko; Kinnura, Ryoko; Komai, Kazuyo; Murakanni, Kiyotaka; Fujiwara, Chieko			Effectiveness of aromatherapy in decreasing maternal anxiety for a sick child undergoing infusion in a paediatric clinic	COMPLEMENTARY THERAPIES IN MEDICINE			English	Article						Aromatherapy; Anxiety; Mother; Analysis of variance UMIN000010984	LAVENDER OIL; MOTHERS	Objectives: We examined whether aromatherapy involving inhalation of yuzu (Citrus ichangensis x Citrus reticulata) oil was effective in decreasing mothers' anxiety for her sick child receiving an infusion at a paediatric clinic. Design: Controlled clinical trial. Setting: Mothers of sick children who arrived at the hospital were asked to complete an anonymous questionnaire. After a doctor examined the child and confirmed the necessity for infusion, the mothers who agreed to participate in our study were allocated to an aromatherapy or a control group. Interventions: A diffuser was filled with yuzu oil before the subjects entered the aromatherapy room. The mother was shown how to use the aromatherapy diffuser while the child was receiving an infusion in the same room. Fifteen minutes after entering the room, the mothers were asked to complete an another questionnaire. \Main outcome measures: We measured the mother's anxiety with the state anxiety score from the State-Trait Anxiety Inventory. Results: There were 60 subjects in the aromatherapy group and 61 in the control group. Both groups were well balanced in terms of demographic characteristics. Using analysis of variance, we demonstrated a significant difference in two-factor interactions between the control and aromatherapy groups. Maternal state anxiety was significantly lower in the aromatherapy than in the control group. Conclusions: Inhalation of yuzu oil was shown to decrease maternal anxiety for a sick child. A multicentre randomized controlled trial or double-blind study is necessary to obtain objective evidence of this benefit of aromatherapy. (C) 2014 Elsevier Ltd. All rights reserved.	[Ueki, Shingo; Niinomi, Kazuteru; Takashima, Yuko; Kinnura, Ryoko; Fujiwara, Chieko] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Komai, Kazuyo; Murakanni, Kiyotaka] Nakano Childrens Hosp, Asahi Ku, Osaka 5350022, Japan	Ueki, S (reprint author), Osaka Univ, Grad Sch Med, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan.	uekin0327@hotmail.com			Osaka University Faculty Research Fund	This study was supported in part by Osaka University Faculty Research Fund.	Akazawa K, 1999, ACTA PAEDIATR, V88, P428, DOI 10.1080/08035259950169828; Kim Y, 2009, J ETHNOPHARMACOL, V125, P31, DOI 10.1016/j.jep.2009.06.017; Holm L, 2008, PEDIATR EMERG CARE, V24, P836, DOI 10.1097/PEC.0b013e31818ea04c; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Tomiyama K, 2012, FLAVOUR FRAG J, V27, P341, DOI 10.1002/ffj.3104; Posadzki Paul, 2012, Int J Risk Saf Med, V24, P147, DOI 10.3233/JRS-2012-0568; Ju HO, 2011, J CLIN NURS, V20, P1490, DOI 10.1111/j.1365-2702.2010.03496.x; Lee YL, 2011, J ALTERN COMPLEM MED, V17, P101, DOI 10.1089/acm.2009.0277; Fitzgerald M, 2007, EXPLORE-NY, V3, P378, DOI 10.1016/j.explore.2007.04.009; Herz RS, 2009, INT J NEUROSCI, V119, P263, DOI 10.1080/00207450802333953; Hidano N, 2000, STAI MANUAL; Horita N, 2005, JAPANESE SOC CHILD H, V64, P3; Iimura N, 2011, JAPANESE J CLIN NURS, V34, P1693; Ishihara A, 1997, JAPANESE SOC CHILD H, V6, P56; Kawakami Chifumi, 2004, Fukuoka Acta Medica, V95, P73; Lv XN, 2013, CURR DRUG TARGETS, V14, P872; Mishina H, 2012, PEDIATR INT, V54, P504, DOI 10.1111/j.1442-200X.2012.03577.x; National Cancer Institute, 2013, AR ESS OILS PDQ; Shin ES, 2012, COCHRANE DB SYST REV, V6, DOI 10.1002/14651858.CD009873; Tanida K, 2003, JAPANESE J CLIN NURS, V13, P2044; Tsang HWH, 2013, FLAVOUR FRAG J, V28, P168, DOI 10.1002/ffj.3148; Tsitsi T, 2014, EUR J INTEGR MED, V6, P112, DOI 10.1016/j.eujim.2013.09.004; Zelkowitz Phyllis, 2012, Womens Health (Lond Engl), V8, P205, DOI 10.2217/whe.11.96	23	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0965-2299	1873-6963		COMPLEMENT THER MED	Complement. Ther. Med.	DEC	2014	22	6					1019	1026		10.1016/j.ctim.2014.09.004		8	Integrative & Complementary Medicine	Integrative & Complementary Medicine	AX7YT	WOS:000347128300008		
J	Igarashi, M; Ikei, H; Song, CR; Miyazaki, Y				Igarashi, Miho; Ikei, Harumi; Song, Chorong; Miyazaki, Yoshifumi			Effects of olfactory stimulation with rose and orange oil on prefrontal cortex activity	COMPLEMENTARY THERAPIES IN MEDICINE			English	Article						Rose; Orange; Physiological relaxation; Near-infrared spectroscopy; Semantic differential method	SHINRIN-YOKU; CHILDRENS ATTITUDES; FOREST LANDSCAPES; ATMOSPHERE; JAPAN; SPECTROSCOPY; PREFERENCES; INHALATION; ETHNICITY; CORTISOL	Objectives: People have been aware of essential oils, which are derived from plants, for a long time. Recently, we have become interested in physiological and subjective effects of daily exposure to essential oils. The primary aim of the present study was to clarify effects of olfactory stimulation with rose or orange oil on prefrontal cortex activity; subjective evaluations of relaxation were also determined. Setting and interventions: Subjects were exposed for 90s to air impregnated with either rose or orange essential oil. As a control, subjects wore the same device but inhaled only unimpregnated air. The three stimuli were randomly presented to each subject. Main outcome measures: Physiological effects were determined by near-infrared time-resolved spectroscopy and a modified semantic differential approach was used to determine subjective evaluations. Results: The study participants were 20 female university students (mean age 22.5 +/- 1.6 years). Olfactory stimulation by rose or orange oil induced: (1) a significant decrease in oxyhemoglobin concentration in the right prefrontal cortex and (2) an increase in "comfortable," "relaxed," and "natural" feelings. Conclusion: These findings indicate that olfactory stimulation by rose or orange oil induces physiological and psychological relaxation. (C) 2014 Elsevier Ltd. All rights reserved.	[Igarashi, Miho; Ikei, Harumi; Song, Chorong; Miyazaki, Yoshifumi] Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa, Chiba 2770882, Japan	Miyazaki, Y (reprint author), Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwanoha 6-2-1, Kashiwa, Chiba 2770882, Japan.	ymiyazaki@faculty.chiba-u.jp			Policy Research Institute, Ministry of Agriculture, Forestry and Fisheries in Japan; Extramural Research Program for Agricultural Forestry and Fishery Policy Research	This study was supported by a grant from the Policy Research Institute, Ministry of Agriculture, Forestry and Fisheries in Japan, Extramural Research Program for Agricultural Forestry and Fishery Policy Research.	Lee J, 2011, PUBLIC HEALTH, V125, P93, DOI 10.1016/j.puhe.2010.09.005; Haze S, 2002, JPN J PHARMACOL, V90, P247, DOI 10.1254/jjp.90.247; Tsunetsugu Yuko, 2007, Journal of Physiological Anthropology, V26, P135, DOI 10.2114/jpa2.26.135; Matsunaga K, 2011, J AM GERIATR SOC, V59, P2162, DOI 10.1111/j.1532-5415.2011.03651.x; Ohmae E, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804931; Park Bum-Jin, 2007, Journal of Physiological Anthropology, V26, P123, DOI 10.2114/jpa2.26.123; Park BJ, 2008, SCAND J FOREST RES, V23, P278, DOI 10.1080/02827580802055978; Park BJ, 2011, LANDSCAPE URBAN PLAN, V102, P24, DOI 10.1016/j.landurbplan.2011.03.005; Ayan M, 2013, J ALTERN COMPLEM MED, V19, P329, DOI 10.1089/acm.2011.0941; Lee J, 2009, SCAND J FOREST RES, V24, P227, DOI 10.1080/02827580902903341; Tsunetsugu Y, 2013, LANDSCAPE URBAN PLAN, V113, P90, DOI 10.1016/j.landurbplan.2013.01.014; Park Bum Jin, 2010, Environmental Health and Preventive Medicine, V15, P18, DOI 10.1007/s12199-009-0086-9; Lehrner J, 2005, PHYSIOL BEHAV, V86, P92, DOI 10.1016/j.physbeh.2005.06.031; Park BJ, 2009, SILVA FENN, V43, P291, DOI 10.14214/sf.213; Ohmae E, 2006, NEUROIMAGE, V29, P697, DOI 10.1016/j.neuroimage.2005.08.008; Fitzgerald M, 2007, EXPLORE-NY, V3, P378, DOI 10.1016/j.explore.2007.04.009; Fitzgerald M, 2010, EXPLORE-NY, V6, P172, DOI 10.1016/j.explore.2010.02.002; Fukada M, 2012, CHEM SENSES, V37, P347, DOI 10.1093/chemse/bjr108; Fuku H, 2007, NEUROENDOCRINOL LETT, V28, P433; Homae F, 2014, NEUROIMAGE, V85, P354, DOI 10.1016/j.neuroimage.2013.06.023; Komatsu M., 2013, JPN J PHYSL ANTHROPO, V18, P1; Lee J., 2012, NATURE THERAPY PREVE; Masago Ryoko, 2001, Journal of Physiological Anthropology and Applied Human Science, V20, P7, DOI 10.2114/jpa.20.7; Osgood C.E., 1957, MEASUREMENT MEANING; Song CR, 2013, J PHYSIOL ANTHROPOL, V32, DOI 10.1186/1880-6805-32-18; Torricelli A, 2014, NEUROIMAGE, V85, P28, DOI 10.1016/j.neuroimage.2013.05.106	26	3	3	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0965-2299	1873-6963		COMPLEMENT THER MED	Complement. Ther. Med.	DEC	2014	22	6					1027	1031		10.1016/j.ctim.2014.09.003		5	Integrative & Complementary Medicine	Integrative & Complementary Medicine	AX7YT	WOS:000347128300009		
J	Hata, T; Imanishi, D; Miyazaki, Y				Hata, Tomoko; Imanishi, Daisuke; Miyazaki, Yasushi			Lessons from the Atomic Bomb About Secondary MDS	CURRENT HEMATOLOGIC MALIGNANCY REPORTS			English	Article						Myelodysplastic syndromes; Hematopoiesis; Hematopoietic cells; Atomic bomb survivors	ACUTE MYELOID-LEUKEMIA; NON-HODGKINS-LYMPHOMA; MYELODYSPLASTIC SYNDROMES; MULTIPLE-MYELOMA; CANCER INCIDENCE; SURVIVORS; RADIATION; THERAPY; SERIES	Myelodysplastic syndromes (MDSs) is a hemato-logical neoplasm defined by ineffective hematopoiesis, dysplasia of hematopoietic cells, and risk of progression to acute leukemia. MDS occurs as de novo or secondary, and chemo-radiotherapy for cancers is thought to increase the risk of MDS among patients. Recently, an epidemiological study for MDS among A-bomb survivors was performed, and it clearly demonstrated that the exposure to external radiation significantly increased the risk of MDS. Precise epidemiological data among survivors have revealed important clinical factors related to the risk of leukemias. In this review, by comparing data for secondary MDS and leukemia/MDS among survivors, several factors which would affect the risk of MDS, especially secondary MDS, are discussed.	[Hata, Tomoko; Imanishi, Daisuke; Miyazaki, Yasushi] Nagasaki Univ, Atom Bomb Dis Inst, Dept Hematol, Nagasaki 8528523, Japan	Miyazaki, Y (reprint author), Nagasaki Univ, Atom Bomb Dis Inst, Dept Hematol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	y-miyaza@nagasaki-u.ac.jp					Mauritzson N, 2002, LEUKEMIA, V16, P2366, DOI 10.1038/sj.leu.2402713; Ozasa K, 2012, RADIAT RES, V177, P229, DOI 10.1667/RR2629.1; STONE RM, 1994, J CLIN ONCOL, V12, P2535; Smith SM, 2003, BLOOD, V102, P43, DOI 10.1182/blood-2002-11-3343; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Armitage JO, 2003, J CLIN ONCOL, V21, P897, DOI 10.1200/JCO.2003.07.113; Bejar R, 2014, J CLIN ONCOL, V32, P2691, DOI 10.1200/JCO.2013.52.3381; Iwanaga M, 2011, J CLIN ONCOL, V29, P428, DOI 10.1200/JCO.2010.31.3080; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Nardi V, 2012, J CLIN ONCOL, V30, P2340, DOI 10.1200/JCO.2011.38.7340; BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x; Ades L, 2014, LANCET, V383, P2239, DOI 10.1016/S0140-6736(13)61901-7; Finch SC, 2004, RADIAT RES, V161, P603, DOI 10.1667/RR3161; Hsu WL, 2013, RADIAT RES, V179, P361, DOI 10.1667/RR2892.1; Kaplan HG, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-260; Mukherjee S, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt462; Ojha RP, 2010, CANCER EPIDEMIOL, V34, P274, DOI 10.1016/j.canep.2010.04.003; PRESTON DL, 1994, RADIAT RES, V137, pS68, DOI 10.2307/3578893	18	1	1	CURRENT MEDICINE GROUP	PHILADELPHIA	400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA	1558-8211	1558-822X		CURR HEMATOL MALIG R	Curr. Hematol. Malig. Rep.	DEC	2014	9	4					407	411		10.1007/s11899-014-0235-0		5	Oncology; Hematology	Oncology; Hematology	AX5KH	WOS:000346964200013		
J	Karasuyama, H; Yamanishi, Y				Karasuyama, Hajime; Yamanishi, Yoshinori			Basophils have emerged as a key player in immunity	CURRENT OPINION IN IMMUNOLOGY			English	Review							THYMIC STROMAL LYMPHOPOIETIN; ANTIGEN-PRESENTING CELLS; HELPER TYPE-2 RESPONSE; ALLERGIC INFLAMMATION; SYSTEMIC-ANAPHYLAXIS; IN-VIVO; HELMINTH INFECTION; IL-4 PRODUCTION; TH2 RESPONSES; C/EBP-ALPHA	Basophils had long been neglected in immunological studies, because of their paucity and phenotypic similarity with tissue-resident mast cells. However, recent development of analytical tools has cast new light on this neglected minority, and revealed previously unappreciated roles of basophils, distinct from those of mast cells, in various immune responses. Primary function of basophils appears to be the protection against infections with parasites, including ticks and helminths. This is why basophils are evolutionally conserved well in many animal species, albeit a small number. Nevertheless, basophils sometimes exert host-deleterious functions in immunological disorders such as allergy. Here we summarize recent advance in our understanding of basophil ontogeny and their in vivo roles under physiological and pathological conditions.	[Karasuyama, Hajime; Yamanishi, Yoshinori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Immune Regulat, Tokyo 1138519, Japan; [Karasuyama, Hajime] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, JST, CREST, Tokyo 1138519, Japan	Karasuyama, H (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Immune Regulat, Tokyo 1138519, Japan.	karasuyama.mbch@tmd.ac.jp	Karasuyama, Hajime/A-7966-2011		Japan Science and Technology Agency (Core Research for Evolutional Science and Technology); Japanese Ministry of Education, Culture, Sports, Science and Technology	This work is supported by research grants from Japan Science and Technology Agency (Core Research for Evolutional Science and Technology), and the Japanese Ministry of Education, Culture, Sports, Science and Technology. The authors apologize for not citing all relevant publications due to space limitations.	Siracusa MC, 2013, J ALLERGY CLIN IMMUN, V132, P789, DOI 10.1016/j.jaci.2013.07.046; Maurer M, 2013, NEW ENGL J MED, V368, P924, DOI 10.1056/NEJMoa1215372; Murphy JT, 2014, BLOOD, V123, P2172, DOI 10.1182/blood-2013-12-544742; Sawaguchi M, 2012, J IMMUNOL, V188, P1809, DOI 10.4049/jimmunol.1101746; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Ito Y, 2011, ALLERGY, V66, P1107, DOI 10.1111/j.1398-9995.2011.02570.x; Campbell IK, 2014, J IMMUNOL, V192, P5031, DOI 10.4049/jimmunol.1301611; Mukai K, 2005, IMMUNITY, V23, P191, DOI 10.1016/j.immuni.2005.06.011; Charles N, 2010, NAT MED, V16, P701, DOI 10.1038/nm.2159; Anthony RM, 2011, NATURE, V475, P110, DOI 10.1038/nature10134; Jonsson F, 2011, J CLIN INVEST, V121, P1484, DOI 10.1172/JCI45232; Kim S, 2010, J IMMUNOL, V184, P1143, DOI 10.4049/jimmunol.0902447; Nei Y, 2013, P NATL ACAD SCI USA, V110, P18620, DOI 10.1073/pnas.1311668110; Suurmond J, 2014, EUR J IMMUNOL, V44, P386, DOI 10.1002/eji.201343617; Hida S, 2009, NAT IMMUNOL, V10, P214, DOI 10.1038/ni.1686; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Noti M, 2013, NAT MED, V19, P1005, DOI 10.1038/nm.3281; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; Karasuyama H, 2011, ANNU REV IMMUNOL, V29, P45, DOI 10.1146/annurev-immunol-031210-101257; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Moniaga CS, 2013, AM J PATHOL, V182, P841, DOI 10.1016/j.ajpath.2012.11.039; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Torrero MN, 2013, VACCINE, V31, P3675, DOI 10.1016/j.vaccine.2013.06.010; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Motomura Y, 2014, IMMUNITY, V40, P758, DOI 10.1016/j.immuni.2014.04.013; Giacomin PR, 2012, J IMMUNOL, V189, P4371, DOI 10.4049/jimmunol.1200691; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Hill DA, 2012, NAT MED, V18, P538, DOI 10.1038/nm.2657; Strait RT, 2002, J ALLERGY CLIN IMMUN, V109, P658, DOI 10.1067/mai.2002.123302; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Rao KN, 2013, BLOOD, V122, P2572, DOI 10.1182/blood-2013-04-494625; Lubben W, 2013, EUR J IMMUNOL, V43, P1231, DOI 10.1002/eji.201242675; Anyan WK, 2013, PARASITOL INT, V62, P508, DOI 10.1016/j.parint.2013.07.003; Dijkstra D, 2014, CYTOMETRY A; Dijkstra D, 2012, NAT MED, V18, P489; Dijkstra Dorothea, 2012, Nat Med, V18, P488, DOI 10.1038/nm.2663; Eckl-Dorna J, 2012, ALLERGY, V67, P601, DOI 10.1111/j.1398-9995.2012.02792.x; Egawa M, 2013, IMMUNITY, V38, P570, DOI 10.1016/j.immuni.2012.11.014; Grundstrom J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048308; Ito R, 2013, J IMMUNOL, V191, P2890, DOI 10.4049/jimmunol.1203543; Jiao DL, 2014, CELL IMMUNOL, V289, P97, DOI 10.1016/j.cellimm.2014.03.018; Khodoun MV, 2013, J ALLERGY CLIN IMMUN, V132, P1375, DOI 10.1016/j.jaci.2013.09.008; Kitzmuller C, 2012, ALLERGY, V67, P593, DOI 10.1111/j.1398-9995.2011.02764.x; Leyva-Castillo JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3847; Matsuda A, 2010, BRIT J OPHTHALMOL, V94, P513, DOI 10.1136/bjo.2009.165316; Metcalf D, 2013, P NATL ACAD SCI USA, V110, P9031, DOI 10.1073/pnas.1307711110; Mukai K, 2012, BLOOD, V120, P76, DOI 10.1182/blood-2011-12-399113; Muto T, 2014, INT IMMUNOL; Nakashima C, 2014, J ALLERGY CLIN IMMUN; Noti M, 2014, J ALLERGY CLIN IMMUN, V133, p[1390, 1391]; Obata-Ninomiya K, 2013, J EXP MED, V210, P2583, DOI 10.1084/jem.20130761; Otsuka A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2740; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Qi XP, 2013, IMMUNITY, V39, P97, DOI 10.1016/j.immuni.2013.06.012; Quelen C, 2011, BLOOD, V117, P5719, DOI 10.1182/blood-2011-01-333013; Reber LL, 2013, J ALLERGY CLIN IMMUN, V132, p[881, e881]; Gomez MR, 2014, MUCOSAL IMMUNOL, V7, P188, DOI 10.1038/mi.2013.38; Sharma M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01188; Tawara I, 2011, BIOL BLOOD MARROW TR, V17, P1747, DOI 10.1016/j.bbmt.2011.08.013; Voskamp AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081777; Wakahara K, 2013, ALLERGY, V68, P180, DOI 10.1111/all.12072; Yang Y, 2014, EUR J IMMUNOL; Ying S, 2002, J ALLERGY CLIN IMMUN, V109, P694, DOI 10.1067/mai.2002.123236; Zhong WW, 2014, IMMUNOLOGY, V142, P202, DOI 10.1111/imm.12240	71	8	8	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0952-7915	1879-0372		CURR OPIN IMMUNOL	Curr. Opin. Immunol.	DEC	2014	31						1	7		10.1016/j.coi.2014.07.004		7	Immunology	Immunology	AX8BS	WOS:000347136200003		
J	Ohno-Shosaku, T; Kano, M				Ohno-Shosaku, Takako; Kano, Masanobu			Endocannabinoid-mediated retrograde modulation of synaptic transmission	CURRENT OPINION IN NEUROBIOLOGY			English	Article							LONG-TERM DEPRESSION; DIACYLGLYCEROL LIPASE-ALPHA; CANNABINOID TYPE-1 RECEPTOR; FRAGILE-X-SYNDROME; INHIBITORY SYNAPSES; DEPENDENT PLASTICITY; PREFRONTAL CORTEX; CELL SYNAPSES; DENTATE GYRUS; ACTIVATION	One of the two major endocannabinoids, 2-arachidonoylglycerol (2-AG), serves as a retrograde messenger at various types of synapses throughout the brain. Upon postsynaptic activation, 2-AG is released immediately after de novo synthesis, activates presynaptic CB1 cannabinoid receptors, and transiently suppresses neurotransmitter release. When CB1, receptor activation is combined with some other factors such as presynaptic activity, the suppression is converted to a long-lasting form. Whereas 2-AG primarily transmits a rapid, transient, point-to-point retrograde signal, the other major endocannabinoid, anandamide, may function as a relatively slow retrograde or non-retrograde signal or as an agonist of the vanilloid receptor. The endocannabinoid system can be up-or down-regulated by a variety of physiological and environmental factors including stress, which might be clinically important.	[Ohno-Shosaku, Takako] Kanazawa Univ, Grad Sch Med Sci, Dept Impairment Study, Kanazawa, Ishikawa 9200942, Japan; [Kano, Masanobu] Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Bunkyo Ku, Tokyo 1130033, Japan	Kano, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Neurophysiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mkano-tky@m.u-tokyo.ac.jp	Ohno-Shosaku, Takako/C-3250-2015		Ministry of Education, Culture, Sports, Science and Technology of Japan;  [23500466];  [21220006];  [25000015]	We thank Y. Hashimotodani for comments on the manuscript. This work was supported by Grants-in-Aid for Scientific Research (23500466 to T.O-S., 21220006 and 25000015 to M.K.) and the Strategic Research Program for Brain Sciences (Development of Biomarker Candidates for Social Behavior) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Morozov YM, 2013, EUR J NEUROSCI, V38, P2341, DOI 10.1111/ejn.12237; Schlosburg JE, 2010, NAT NEUROSCI, V13, P1113, DOI 10.1038/nn.2616; Uchigashima M, 2011, J NEUROSCI, V31, P7700, DOI 10.1523/JNEUROSCI.5665-10.2011; Yoshino H, 2011, J PHYSIOL-LONDON, V589, P4857, DOI 10.1113/jphysiol.2011.212225; Puente N, 2011, NAT NEUROSCI, V14, P1542, DOI 10.1038/nn.2974; Kim J, 2010, NAT NEUROSCI, V13, P592, DOI 10.1038/nn.2517; Hillard CJ, 2012, NEUROSCIENCE, V204, P207, DOI 10.1016/j.neuroscience.2011.11.020; Glangetas C, 2013, J NEUROSCI, V33, P19657, DOI 10.1523/JNEUROSCI.3175-13.2013; Iremonger KJ, 2013, TRENDS NEUROSCI, V36, P471, DOI 10.1016/j.tins.2013.04.007; Wang DJ, 2014, J NEUROSCI, V34, P2355, DOI 10.1523/JNEUROSCI.4064-13.2014; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Hill MN, 2010, J NEUROSCI, V30, P14980, DOI 10.1523/JNEUROSCI.4283-10.2010; Alger BE, 2011, TRENDS NEUROSCI, V34, P304, DOI 10.1016/j.tins.2011.03.003; Castillo PE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005728; Lerner TN, 2012, NEURON, V73, P347, DOI 10.1016/j.neuron.2011.11.015; Katona I, 2012, ANNU REV NEUROSCI, V35, P529, DOI 10.1146/annurev-neuro-062111-150420; Foldy C, 2013, NEURON, V78, P498, DOI 10.1016/j.neuron.2013.02.036; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Ahumada J, 2013, HIPPOCAMPUS, V23, P1439, DOI 10.1002/hipo.22196; Pan B, 2008, J NEUROSCI, V28, P14018, DOI 10.1523/JNEUROSCI.4035-08.2008; Wamsteeker JI, 2010, J NEUROSCI, V30, P11188, DOI 10.1523/JNEUROSCI.1046-10.2010; Chavez AE, 2010, NAT NEUROSCI, V13, P1511, DOI 10.1038/nn.2684; Ohno-Shosaku T, 2012, NEUROSCIENTIST, V18, P119, DOI 10.1177/1073858410397377; Patel S, 2009, NEUROPSYCHOPHARMACOL, V34, P2699, DOI 10.1038/npp.2009.101; Tanimura A, 2012, P NATL ACAD SCI USA, V109, P12195, DOI 10.1073/pnas.1204404109; Gao Y, 2010, J NEUROSCI, V30, P2017, DOI 10.1523/JNEUROSCI.5693-09.2010; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; Zhang LH, 2010, J NEUROSCI, V30, P5724, DOI 10.1523/JNEUROSCI.0795-10.2010; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Hoffman AF, 2010, J NEUROSCI, V30, P545, DOI 10.1523/JNEUROSCI.4920-09.2010; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; Younts TJ, 2013, J NEUROSCI, V33, P13743, DOI 10.1523/JNEUROSCI.0817-13.2013; Hashimotodani Y, 2007, J NEUROSCI, V27, P1211, DOI 10.1523/JNEUROSCI.4159-06.2007; Navarrete M, 2010, NEURON, V68, P113, DOI 10.1016/j.neuron.2010.08.043; Shonesy BC, 2013, NAT NEUROSCI, V16, P456, DOI 10.1038/nn.3353; Piomelli D, 2014, NEUROPHARMACOLOGY, V76, P228, DOI 10.1016/j.neuropharm.2013.07.026; Senst L, 2014, J EXP BIOL, V217, P102, DOI 10.1242/jeb.089730; Han J, 2012, CELL, V148, P1039, DOI 10.1016/j.cell.2012.01.037; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Chiu CQ, 2010, J NEUROSCI, V30, P7236, DOI 10.1523/JNEUROSCI.0736-10.2010; Maccarrone M, 2010, NEUROPSYCHOPHARMACOL, V35, P1500, DOI 10.1038/npp.2010.19; Min R, 2012, NAT NEUROSCI, V15, P746, DOI 10.1038/nn.3075; Tanimura A, 2010, NEURON, V65, P320, DOI 10.1016/j.neuron.2010.01.021; Grueter BA, 2010, NAT NEUROSCI, V13, P1519, DOI 10.1038/nn.2685; Castillo PE, 2012, NEURON, V76, P70, DOI 10.1016/j.neuron.2012.09.020; Du HZ, 2013, J NEUROSCI, V33, P15022, DOI 10.1523/JNEUROSCI.5833-12.2013; Freestone PS, 2013, NEUROPHARMACOLOGY C, V79C, P467; Fu J, 2012, NAT NEUROSCI, V15, P64, DOI 10.1038/nn.2986; Hashimotodani Y, 2013, J PHYSIOL-LONDON, V591, P4765, DOI 10.1113/jphysiol.2013.254474; Heifets BD, 2008, P NATL ACAD SCI USA, V105, P10250, DOI 10.1073/pnas.0711880105; Jung KM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2045; Khlaifia A, 2013, J NEUROSCI, V33, P12627, DOI 10.1523/JNEUROSCI.1028-13.2013; Leung K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079355; Min R, 2010, J NEUROSCI, V30, P2710, DOI 10.1523/JNEUROSCI.BC-3622-09.2010; Min R, 2010, NEUROSCIENTIST, V16, P608, DOI 10.1177/1073858410373281; Singla S, 2007, J NEUROSCI, V27, P5260, DOI 10.1523/JNEUROSCI.0018-07.2007; Sugawara Y, 2013, BRAIN RES, V1512, P9, DOI 10.1016/j.brainres.2013.03.040; Wang DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041499; Zhang LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016305; Zhong P, 2011, J PHYSIOL-LONDON, V589, P4847, DOI 10.1113/jphysiol.2011.215509	60	28	29	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0959-4388	1873-6882		CURR OPIN NEUROBIOL	Curr. Opin. Neurobiol.	DEC	2014	29						1	8		10.1016/j.conb.2014.03.017		8	Neurosciences	Neurosciences & Neurology	AX7YS	WOS:000347128200002		
J	Ishibashi, K; Ishikawa, M				Ishibashi, Kazuhiro; Ishikawa, Masayuki			Mechanisms of tomato mosaic virus RNA replication and its inhibition by the host resistance factor Tm-1	CURRENT OPINION IN VIROLOGY			English	Article							CAP-INDEPENDENT TRANSLATION; ARABIDOPSIS-THALIANA; UNTRANSLATED REGION; PLANT-VIRUS; LYCOPERSICON-HIRSUTUM; VIRAL REPLICATION; PROTEIN TM-1; CELL-FREE; IN-VITRO; GENE	In the plant immune system, sensor proteins encoded by dominant resistance genes activate a defense response upon pathogen infection. The tomato mosaic virus (ToMV) resistance gene Tm-1 is exceptional in that it inhibits ToMV multiplication without inducing a defense response. Several lines of evidence had suggested that Tm-1 encodes a direct inhibitor of ToMV RNA replication. The Tm-1 gene product was identified by purification of an inhibitor protein using a cell-free translation and replication system for ToMV RNA. Further analyses using the system showed that Tm-1 bound ToMV replication proteins, and that the Tm-1-bound ToMV replication proteins retained the ability to bind membranes, while Tm-1 inhibited replication complex formation on the membranes.	[Ishibashi, Kazuhiro; Ishikawa, Masayuki] Natl Inst Agrobiol Sci, Div Plant Sci, Plant Microbe Interact Res Unit, Tsukuba, Ibaraki 3058602, Japan	Ishibashi, K (reprint author), Natl Inst Agrobiol Sci, Div Plant Sci, Plant Microbe Interact Res Unit, Tsukuba, Ibaraki 3058602, Japan.	bashi@affre.go.jp			JSPS KAKENHI Grants [25850032, 24380029]	We thank all of our colleagues for many helpful discussions and for their comments on the study since we began our effort to identify the Tm-1 gene product in 2001. KI and MI are supported in part by JSPS KAKENHI Grants (25850032 and 24380029, respectively).	An MN, 2010, VIROLOGY, V405, P100, DOI 10.1016/j.virol.2010.05.022; Ye RQ, 2012, MOL CELL, V46, P859, DOI 10.1016/j.molcel.2012.04.013; Yoshikawa M, 2013, P NATL ACAD SCI USA, V110, P4117, DOI 10.1073/pnas.1217050110; den Boon JA, 2010, CELL HOST MICROBE, V8, P77, DOI 10.1016/j.chom.2010.06.010; Iwakawa H, 2013, MOL CELL, V52, P591, DOI 10.1016/j.molcel.2013.10.033; MOLLA A, 1991, SCIENCE, V254, P1647, DOI 10.1126/science.1661029; TANKSLEY SD, 1992, GENETICS, V132, P1141; Iki T, 2010, MOL CELL, V39, P282, DOI 10.1016/j.molcel.2010.05.014; Schuck J, 2013, NUCLEIC ACIDS RES, V41, P5090, DOI 10.1093/nar/gkt193; Moncorge O, 2010, J VIROL, V84, P9978, DOI 10.1128/JVI.01134-10; Schwartz M, 2002, MOL CELL, V9, P505, DOI 10.1016/S1097-2765(02)00474-4; Endo Y, 2013, EMBO REP, V14, P652, DOI 10.1038/embor.2013.73; Laliberte JF, 2010, ANNU REV PHYTOPATHOL, V48, P69, DOI 10.1146/annurev-phyto-073009-114239; den Boon JA, 2010, ANNU REV MICROBIOL, V64, P241, DOI 10.1146/annurev.micro.112408.134012; Kraft JJ, 2013, NUCLEIC ACIDS RES, V41, P3398, DOI 10.1093/nar/gkt026; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; FRASER RSS, 1980, J GEN VIROL, V48, P87, DOI 10.1099/0022-1317-48-1-87; Fujisaki K, 2006, J GEN VIROL, V87, P2397, DOI 10.1099/vir.0.81942-0; GALLIE DR, 1987, NUCLEIC ACIDS RES, V15, P3257, DOI 10.1093/nar/15.8.3257; Gursinsky T, 2009, VIROLOGY, V390, P250, DOI 10.1016/j.virol.2009.05.009; Ishibashi K, 2014, P NATL ACAD SCI USA, V111, pE3486, DOI 10.1073/pnas.1407888111; Ishibashi K., 2012, CURR OPIN VIROL, V2, P693, DOI 10.1016/j.coviro.2012.09.011; Ishibashi K, 2007, P NATL ACAD SCI USA, V104, P13833, DOI 10.1073/pnas.0703203104; Ishibashi K, 2013, J VIROL, V87, P7933, DOI 10.1128/JVI.00743-13; Ishibashi K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002975; ISHIKAWA M, 1993, J VIROL, V67, P5328; ISHIKAWA M, 1991, MOL GEN GENET, V230, P33, DOI 10.1007/BF00290647; Iwakawa H, 2011, J VIROL, V85, P497, DOI 10.1128/JVI.01754-10; Iwakawa HO, 2012, J VIROL, V86, P7836, DOI 10.1128/JVI.00538-12; Iwakawa HO, 2007, VIROLOGY, V369, P168, DOI 10.1016/j.virol.2007.07.016; Kato M, 2013, PROTEIN EXPRES PURIF, V89, P1, DOI 10.1016/j.pep.2013.02.001; Kawamura-Nagaya K, 2014, P NATL ACAD SCI USA, V111, pE1620, DOI 10.1073/pnas.1321660111; KEITH J, 1975, FEBS LETT, V57, P31, DOI 10.1016/0014-5793(75)80145-1; Komoda K, 2007, J VIROL, V81, P2584, DOI 10.1128/JVI.01921-06; Komoda K, 2004, P NATL ACAD SCI USA, V101, P1863, DOI 10.1073/pnas.0307131101; LEVESQUE H, 1990, THEOR APPL GENET, V80, P602, DOI 10.1007/BF00224218; Lewandowski DJ, 2000, VIROLOGY, V271, P90, DOI 10.1006/viro.2000.0313; MANDELES S, 1968, J BIOL CHEM, V243, P3671; MESHI T, 1988, EMBO J, V7, P1575; Mizumoto H, 2006, J VIROL, V80, P3781, DOI 10.1128/JVI.80.8.3781-3791.2006; MOTOYOSHI F, 1977, J GEN VIROL, V34, P499, DOI 10.1099/0022-1317-34-3-499; Nishikiori M, 2012, J VIROL, V86, P7565, DOI 10.1128/JVI.00118-12; Nishikiori M, 2012, VIROLOGY, V434, P118, DOI 10.1016/j.virol.2012.09.011; Nishikiori M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002409; Nishikiori M, 2006, J VIROL, V80, P8459, DOI 10.1128/JVI.00545-06; Ohmori T, 1996, THEOR APPL GENET, V92, P151, DOI 10.1007/BF00223369; Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32; PELHAM J, 1966, EUPHYTICA, V15, P258, DOI 10.1007/BF00022331; PELHAM J, 1970, ANN APPL BIOL, V65, P293, DOI 10.1111/j.1744-7348.1970.tb04590.x; Porte WS, 1939, PHYTOPATHOLOGY, V29, P757; SLEAT DE, 1987, GENE, V60, P217, DOI 10.1016/0378-1119(87)90230-7; Strasser M, 2007, ARCH VIROL, V152, P903, DOI 10.1007/s00705-006-0915-8; Sugawara K, 2013, MOL PLANT MICROBE IN, V26, P1106, DOI 10.1094/MPMI-04-13-0094-R; Tajima Y, 2011, VIROLOGY, V417, P169, DOI 10.1016/j.virol.2011.05.012; WATANABE Y, 1987, VIROLOGY, V161, P527, DOI 10.1016/0042-6822(87)90147-4; YAMAFUJI R, 1991, VIROLOGY, V183, P99, DOI 10.1016/0042-6822(91)90122-R; Yamaji Y, 2012, PLANT CELL, V24, P778, DOI 10.1105/tpc.111.093658; Yamanaka T, 2000, P NATL ACAD SCI USA, V97, P10107, DOI 10.1073/pnas.170295097; ZIMMERN D, 1975, NUCLEIC ACIDS RES, V2, P1189, DOI 10.1093/nar/2.7.1189	59	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1879-6257			CURR OPIN VIROL	Curr. Opin. Virol.	DEC	2014	9						8	13		10.1016/j.coviro.2014.08.005		6	Virology	Virology	AX5IC	WOS:000346958700004		
J	Kato, H; Fujita, T				Kato, Hiroki; Fujita, Takashi			Autoimmunity caused by constitutive activation of cytoplasmic viral RNA sensors	CYTOKINE & GROWTH FACTOR REVIEWS			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; AICARDI-GOUTIERES-SYNDROME; INNATE IMMUNE-RESPONSES; I INTERFERON PATHWAY; DOUBLE-STRANDED-RNA; RIG-I; ANTIVIRAL RESPONSES; 5'-TRIPHOSPHATE RNA; EXONUCLEASE TREX1; ADAPTER PROTEIN	RIG-I-like receptors (RLRs) are well-known viral sensors that trigger the antiviral interferon (IFN) response by recognizing the non-self signatures of viral RNAs. The proper induction of the IFN response is known to play a crucial role in protecting against viral infections, whereas aberrant activation can lead to autoimmune disorders. We herein provided an overview of the antiviral IFN response and autoimmunity, with a focus on recent studies describing autoimmunity caused by mutations in the cytoplasmic viral RNA sensor, melanoma differentiation-associated gene 5 (MDA5). (C) 2014 Elsevier Ltd. All rights reserved.	[Kato, Hiroki; Fujita, Takashi] Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 606, Japan; [Kato, Hiroki] PRESTO, Tokyo, Japan	Fujita, T (reprint author), Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 606, Japan.	tfujita@virus.kyoto-u.ac.jp					Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Venkataraman T, 2007, J IMMUNOL, V178, P6444; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Oda H, 2014, AM J HUM GENET, V95, P121, DOI 10.1016/j.ajhg.2014.06.007; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Xiao TS, 2013, MOL CELL, V51, P135, DOI 10.1016/j.molcel.2013.07.004; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Napirei M, 2000, NAT GENET, V25, P177; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Hemmi H, 2000, NATURE, V408, P740; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Crow MK, 2014, CURR OPIN RHEUMATOL, V26, P467, DOI 10.1097/BOR.0000000000000087; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Miner JJ, 2014, NAT GENET, V46, P418, DOI 10.1038/ng.2959; Jaidane H, 2008, DIABETES METAB, V34, P537, DOI 10.1016/j.diabet.2008.05.008; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Patel JR, 2013, EMBO REP, V14, P780, DOI 10.1038/embor.2013.102; Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344; Robinson T, 2011, J IMMUNOL, V187, P1298, DOI 10.4049/jimmunol.1100857; Crampton SP, 2012, J IMMUNOL, V188, P1451, DOI 10.4049/jimmunol.1102705; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Yoneyama M, 2005, J IMMUNOL, V175, P2851; Yoo JS, 2014, CURR OPIN MICROBIOL, V20, P131, DOI 10.1016/j.mib.2014.05.011; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Higgs BW, 2011, ANN RHEUM DIS, V70, P2029, DOI 10.1136/ard.2011.150326; Hooks J J, 1980, Ann N Y Acad Sci, V350, P21, DOI 10.1111/j.1749-6632.1980.tb20603.x; Kageyama M, 2011, BIOCHEM BIOPH RES CO, V415, P75, DOI 10.1016/j.bbrc.2011.10.015; Onoguchi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001012; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; Yoo JS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004012	53	6	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1359-6101	1879-0305		CYTOKINE GROWTH F R	Cytokine Growth Factor Rev.	DEC	2014	25	6			SI		739	743		10.1016/j.cytogfr.2014.08.003		5	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AX7YO	WOS:000347127800012		
J	Baek, JY; Park, IH; So, TMK; Lalitha, MK; Shimono, N; Yasin, RM; Carlos, CC; Perera, J; Thamlikitkul, V; Hsueh, PR; Van, PH; Shibl, AM; Song, JH; Ko, KS				Baek, Jin Yang; Park, In Ho; So, Thomas Man-Kit; Lalitha, M. K.; Shimono, Nobuyuki; Yasin, Rohani Md.; Carlos, Celia C.; Perera, Jennifer; Thamlikitkul, Visanu; Hsueh, Po-Ren; Van, Pham Hung; Shibl, Atef M.; Song, Jae-Hoon; Ko, Kwan Soo			Prevalence and characteristics of Streptococcus pneumoniae "putative serotype 6E" isolates from Asian countries	DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE			English	Article						Pneumococci; Serogroup 6; CC90	19A	The prevalence, antimicrobial susceptibility, and genotypes of Streptococcus pneumoniae "putative serotype 6E" isolates from Asian countries were investigated. A total of 244 S. pneumoniae serogroup 6 isolates obtained from 11 Asian countries were included in this study. Of the 244 serogroup 6 isolates, 101 (41.4%) were typed as "putative serotype 6E," followed by serotypes 6A, 6B, 6C, and 6D (27.0, 20.1, 5.7, and 5.7%, respectively). Multilocus sequence typing revealed that clonal complex (CC) 90, including ST90 and its variants, was the most prevalent clonal group of "putative serotype 6E" isolates (n = 63; 62.4%). CC146 and CC315 were also found frequently in some of the countries. Most of the "putative serotype 6E" isolates showed very high resistance rates against cefuroxime, erythromycin, azithromycin, clarithromycin, clindamycin, and trimethoprim/sulfamethoxazole, probably due to their highly resistant to antimicrobials clone, CC90. Our results indicate that "putative serotype 6E" is prevalent in Asian countries. The clonal dissemination of "putative serotype 6E" isolates was also identified. (C) 2014 Elsevier Inc. All rights reserved.	[Baek, Jin Yang; Song, Jae-Hoon; Ko, Kwan Soo] APFID, Seoul, South Korea; [Park, In Ho] Ewha Womans Univ, Sch Med, Med Res Inst, Seoul, South Korea; [So, Thomas Man-Kit] SureCare Med Ctr, Kowloon, Hong Kong, Peoples R China; [Lalitha, M. K.] Madras Med Miss, Dept Microbiol, Madras, Tamil Nadu, India; [Shimono, Nobuyuki] Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan; [Yasin, Rohani Md.] Inst Med Res, Kuala Lumpur 50588, Malaysia; [Carlos, Celia C.] Res Inst Trop Med, Antimicrobial Resistance Surveillance Reference L, Manila, Philippines; [Perera, Jennifer] Univ Colombo, Colombo, Sri Lanka; [Thamlikitkul, Visanu] Mahidol Univ, Siriraj Hosp, Bangkok 10700, Thailand; [Hsueh, Po-Ren] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Coll Med, Taipei, Taiwan; [Van, Pham Hung] Univ Med & Pharm, Fac Med, Ho Chi Minh City, Vietnam; [Shibl, Atef M.] King Saud Univ, Riyadh, Saudi Arabia; [Song, Jae-Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Infect Dis, Seoul, South Korea; [Ko, Kwan Soo] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Seoul, South Korea	Song, JH (reprint author), APFID, Seoul, South Korea.	songjh@skku.edu; ksko@skku.edu		Hsueh, Po-Ren/0000-0002-7502-9225; Ko, Kwan Soo/0000-0002-0978-1937	Korea Healthcare Technology R&D Project, Ministry of Health, Welfare, and Family Affairs, Seoul, Republic of Korea [A111251]	The S. pneumoniae isolates used in this study were obtained from the Asian Bacterial Bank of the Asia Pacific Foundation for Infectious Diseases (Seoul, South Korea). This study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry of Health, Welfare, and Family Affairs, Seoul, Republic of Korea (A111251).	Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; Shin J, 2011, J ANTIMICROB CHEMOTH, V66, P1001, DOI 10.1093/jac/dkr048; Park IH, 2007, J CLIN MICROBIOL, V45, P1225, DOI 10.1128/JCM.02199-06; Kim SH, 2012, ANTIMICROB AGENTS CH, V56, P1418, DOI 10.1128/AAC.05658-11; Jin P, 2009, J INFECT DIS, V200, P1375, DOI 10.1086/606118; Baek JY, 2014, J CLIN MICROBIOL, V52, P2096, DOI 10.1128/JCM.00228-14; Clinical and Laboratory Standards Institute (CLSI), 2013, M100S23 CLSI; Henriques-Normark B, 2008, NAT REV MICROBIOL, V6, P827, DOI 10.1038/nrmicro2011; Jacobs MR, 2009, J CLIN MICROBIOL, V47, P64, DOI 10.1128/JCM.01524-08; Ko KS, 2013, J CLIN MICROBIOL, V51, P3395, DOI 10.1128/JCM.01645-13	10	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0732-8893	1879-0070		DIAGN MICR INFEC DIS	Diagn. Microbiol. Infect. Dis.	DEC	2014	80	4					334	337		10.1016/j.diagmicrobio.2014.08.017		4	Infectious Diseases; Microbiology	Infectious Diseases; Microbiology	AX4FW	WOS:000346890000021		
J	Takeiri, A; Wada, NA; Motoyama, S; Matsuzaki, K; Tateishi, H; Matsumoto, K; Niimi, N; Sassa, A; Gruz, P; Masumura, K; Yamada, M; Mishima, M; Jishage, K; Nohmi, T				Takeiri, Akira; Wada, Naoko A.; Motoyama, Shigeki; Matsuzaki, Kaori; Tateishi, Hiromi; Matsumoto, Kaoru; Niimi, Naoko; Sassa, Akira; Gruz, Petr; Masumura, Kenichi; Yamada, Masami; Mishima, Masayuki; Jishage, Kou-ichi; Nohmi, Takehiko			In vivo evidence that DNA polymerase kappa is responsible for error-free bypass across DNA cross-links induced by mitomycin C	DNA REPAIR			English	Article						DNA polymerase kappa; Knock-in mice; Gpt delta mice; Cross-links; Mitomycin C	S-PHASE CHECKPOINT; TRANSLESION SYNTHESIS; Y-FAMILY; POL-KAPPA; BASE SUBSTITUTIONS; INDUCED DELETIONS; PHENYLALANINE 171; TRANSGENIC MOUSE; MOLECULAR NATURE; STRAND BREAKS	Translesion DNA synthesis (TLS) is an important pathway that avoids genotoxicity induced by endogenous and exogenous agents. DNA polymerase kappa (Polk) is a specialized DNA polymerase involved in TLS but its protective roles against DNA damage in vivo are still unclear. To better understand these roles, we have established knock-in mice that express catalytically-inactive Polk and crossbred them with gpt delta mice, which possess reporter genes for mutations. The resulting mice (inactivated Polk KI mice) were exposed to mitomycin C (MMC), and the frequency of point mutations, micronucleus formation in peripheral erythrocytes, and gamma H2AX induction in the bone marrow was determined. The inactivated Polk KI mice exhibited significantly higher frequency of mutations at CpG and GpG sites, micronucleated cells, and gamma H2AX foci-positive cells than did the Polk wild-type (Polk(+)) mice. Recovery from MMC-induced DNA damage, which was evaluated by gamma H2AX induction, was retarded in embryonic fibroblasts from the knock-in mice when compared to those from the Polk(+) mice. These results suggest that Polk mediates TLS, which suppresses point mutations and DNA double-strand breaks caused by intra- and interstrand cross-links induced by MMC treatment. The established knock-in mice are extremely useful to elucidate the in vivo roles of the catalytic activity of Polk in suppressing DNA damage that was induced by a variety of genotoxic stresses. (C) 2014 Elsevier B.V. All rights reserved.	[Takeiri, Akira; Wada, Naoko A.; Motoyama, Shigeki; Matsuzaki, Kaori; Mishima, Masayuki; Jishage, Kou-ichi] Chugai Pharmaceut Co Ltd, Div Res, Gotemba, Shizuoka 4128513, Japan; [Tateishi, Hiromi; Matsumoto, Kaoru] Chugai Res Inst Med Sci Inc, Gotemba Branch, Gotemba, Shizuoka 4128513, Japan; [Niimi, Naoko; Sassa, Akira; Gruz, Petr; Masumura, Kenichi; Yamada, Masami; Nohmi, Takehiko] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Setagaya Ku, Tokyo 1588501, Japan	Takeiri, A (reprint author), Chugai Pharmaceut Co Ltd, Fuji Gotemba Res Labs, 1-135 Komakado, Gotemba, Shizuoka 4128513, Japan.	takeiriakr@chugai-pharm.co.jp; nohmi@nihs.go.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [18201010, 22241016]; Ministry of Health, Labour and Welfare, Japan (MHLW) [H21-Food-General-009]; Japan Health Science Foundation [KHB1007, KHB1006, KHB1209]; MHLW [20 designated-8]; Food Safety Commission	The authors thank Otoya Ueda for technical support; Yosuke Kawase and Toshio Hani for manipulation of mouse embryos; Takanori Tachibe, and Mami Kakefuda for breeding the transgenic mice; and Satomi Uchida, Yumiko Nakajima, Mariko Yano, Asako Harada, and, Kenji Tanaka for excellent technical assistance. The technical help of many contributors to this work is acknowledged. The authors thank Dr. Shuichi Chiba for critically reading the manuscript. This work was supported by grants in aid of scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT, 18201010; MEXT, 22241016), the Ministry of Health, Labour and Welfare, Japan (MHLW, H21-Food-General-009), and the Japan Health Science Foundation (KHB1007, KHB1006, KHB1209), and by grants in aid of cancer research from MHLW (20 designated-8) and the Food Safety Commission.	Jaloszynski P, 2005, GENES CELLS, V10, P543, DOI 10.1111/j.1365-2443.2005.000858.x; Schmitt MW, 2009, BIOCHIMIE, V91, P1163, DOI 10.1016/j.biochi.2009.06.007; Choi JY, 2006, J BIOL CHEM, V281, P21062, DOI 10.1074/jbc.M602246200; Sassa A, 2014, DNA REPAIR, V15, P21, DOI 10.1016/j.dnarep.2013.12.008; Fukuda H, 2009, J BIOL CHEM, V284, P25585, DOI 10.1074/jbc.M109.037259; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1365-2443.2004.00747.x; Wojtaszek J, 2012, J BIOL CHEM, V287, P33836, DOI 10.1074/jbc.M112.394841; Burgers PMJ, 2001, J BIOL CHEM, V276, P43487, DOI 10.1074/jbc.R100056200; Takeiri A, 2003, CHEM RES TOXICOL, V16, P171, DOI 10.1021/tx0255673; Bi XH, 2006, MOL CELL BIOL, V26, P3527, DOI 10.1128/MCB.26.9.3517-3540.2006; McCulloch SD, 2008, CELL RES, V18, P148, DOI 10.1038/cr.2008.4; Gruz P, 2001, J BIOL CHEM, V276, P47394, DOI 10.1074/jbc.M107213200; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; Bi XH, 2005, J BIOL CHEM, V280, P22343, DOI 10.1074/jbc.M501562200; Niimi N, 2009, BIOCHEMISTRY-US, V48, P4239, DOI 10.1021/bi900153t; Sharma S, 2012, ENVIRON MOL MUTAGEN, V53, P725, DOI 10.1002/em.21736; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Nohmi T, 2006, ANNU REV MICROBIOL, V60, P231, DOI 10.1146/annurev.micro.60.080805.142238; Zhang XL, 2013, DNA REPAIR, V12, P377, DOI 10.1016/j.dnarep.2013.02.008; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Horiguchi M, 2001, CANCER RES, V61, P3913; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Ulrich HD, 2013, CHROMOSOMA, V122, P259, DOI 10.1007/s00412-013-0410-4; Fischhaber PL, 2002, J BIOL CHEM, V277, P37604, DOI 10.1074/jbc.M206027200; Suzuki N, 2002, BIOCHEMISTRY-US, V41, P6100, DOI 10.1021/bi020049c; Ohashi E, 2009, GENES CELLS, V14, P101, DOI 10.1111/j.1365-2443.2008.01255.x; Yoon JH, 2010, P NATL ACAD SCI USA, V107, P14116, DOI 10.1073/pnas.1007795107; Betous R, 2013, EMBO J, V32, P2172, DOI 10.1038/emboj.2013.148; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Sassa A, 2011, MUTAT RES-GEN TOX EN, V718, P10, DOI 10.1016/j.mrgentox.2010.11.002; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Friedberg EC, 2002, SCIENCE, V296, P1627, DOI 10.1126/science.1070236; Tominaga T, 2011, J BIOL CHEM, V286, P20109, DOI 10.1074/jbc.M110.179382; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Ogi T, 2006, NAT CELL BIOL, V8, P640, DOI 10.1038/ncb1417; Baptiste BA, 2012, ENVIRON MOL MUTAGEN, V53, P787, DOI 10.1002/em.21721; Brondello JM, 2008, ONCOGENE, V27, P6093, DOI 10.1038/onc.2008.212; Carr GJ, 1996, ENVIRON MOL MUTAGEN, V28, P405, DOI 10.1002/(SICI)1098-2280(1996)28:4<405::AID-EM15>3.0.CO;2-J; Cleaver JE, 2011, CELL CYCLE, V10, P3223, DOI 10.4161/cc.10.19.17448; Friedberg E. C., 2006, DNA REPAIR MUTAGENES, V2nd, P9; Gerlach VL, 2000, COLD SPRING HARB SYM, V65, P41, DOI 10.1101/sqb.2000.65.41; Guo C, 2005, DNA REPAIR, V4, P397, DOI 10.1016/j.dnarep.2004.10.006; Ho The Vinh, 2010, Environ Mol Mutagen, V51, P552, DOI 10.1002/em.20573; Kunkel T A, 1999, Trends Genet, V15, P93, DOI 10.1016/S0168-9525(98)01664-3; Nohmi T., 2007, GENES ENV, V29, P75, DOI 10.3123/jemsge.29.75; Nohmi T, 2005, ENVIRON MOL MUTAGEN, V45, P150, DOI 10.1002/em.20110; Nohmi T, 2004, ADV BIOPHYS, V38, P97, DOI 10.1016/S0065-227X(04)80106-0; Nohmi T, 2000, MUTAT RES-FUND MOL M, V455, P191, DOI 10.1016/S0027-5107(00)00077-4; Nohmi T, 1999, ENVIRON MOL MUTAGEN, V34, P9, DOI 10.1002/(SICI)1098-2280(1999)34:1<9::AID-EM2>3.0.CO;2-E; Singer WD, 2013, DNA REPAIR, V12, P817, DOI 10.1016/j.dnarep.2013.07.010; Stancel JNK, 2009, DNA REPAIR, V8, P1355, DOI 10.1016/j.dnarep.2009.09.003; Swenberg JA, 2011, TOXICOL SCI, V120, pS130, DOI 10.1093/toxsci/kfq371; Takeiri A, 2006, MUTAT RES-GEN TOX EN, V609, P102, DOI 10.1016/j.mrgentox.2006.06.026; TOMASZ M, 1988, BIOCHEMISTRY-US, V27, P3182, DOI 10.1021/bi00409a009; Vasquez-Del Carpio Rodrigo, 2009, PLoS One, V4, pe5766, DOI 10.1371/journal.pone.0005766; Williams HL, 2012, MOL CELL, V47, P140, DOI 10.1016/j.molcel.2012.05.001	61	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1568-7864	1568-7856		DNA REPAIR	DNA Repair	DEC	2014	24						113	121		10.1016/j.dnarep.2014.09.002		9	Genetics & Heredity; Toxicology	Genetics & Heredity; Toxicology	AX6GA	WOS:000347019900014		
J	Yoshihara, M; Jiang, L; Akatsuka, S; Suyama, M; Toyokuni, S				Yoshihara, Minako; Jiang, Li; Akatsuka, Shinya; Suyama, Mikita; Toyokuni, Shinya			Genome-wide Profiling of 8-Oxoguanine Reveals Its Association with Spatial Positioning in Nucleus	DNA RESEARCH			English	Article						8-oxoguanine; lamina-associated domain; DNA modification; oxidative stress	ORDER CHROMATIN ARRANGEMENTS; RENAL-CELL CARCINOMA; BASE-EXCISION-REPAIR; FERRIC NITRILOTRIACETATE; DNA-DAMAGE; LAMINA INTERACTIONS; MITOCHONDRIAL-DNA; BROWSER DATABASE; MAMMALIAN-CELLS; LUNG-CANCER	8-Oxoguanine (8-oxoG) is one of the most common DNA lesions generated by reactive oxygen species. In this study, we analysed the genome-wide distribution profile of 8-oxoG by combining immunoprecipitation by antibodies specific for the DNA fragments containing 8-oxoG with a microarray that covers rat genome. Genome-wide mapping of 8-oxoG in normal rat kidney revealed that 8-oxoG is preferentially located at gene deserts. We did not observe differences in 8-oxoG levels between groups of genes with high and low expression, possibly because of the generally low 8-oxoG levels in genic regions compared with gene deserts. The distribution of 8-oxoG and lamina-associated domains (LADs) were strongly correlated, suggesting that the spatial location of genomic DNA in the nucleus determines the susceptibility to oxidative modifications. One possible explanation for high 8-oxoG levels in LADs is that the nuclear periphery is more susceptible to the oxidative damage caused by the extra-nuclear factors. Moreover, LADs have a rather compact conformation, which may limit the recruitment of repair components to the modified bases.	[Yoshihara, Minako; Suyama, Mikita] Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Fukuoka 8128582, Japan; [Yoshihara, Minako; Jiang, Li; Akatsuka, Shinya; Toyokuni, Shinya] Kyoto Univ, Grad Sch Med, Dept Pathol & Biol Dis, Kyoto 6068501, Japan; [Jiang, Li; Akatsuka, Shinya; Toyokuni, Shinya] Nagoya Univ, Grad Sch Med, Dept Pathologyand Biol Responses, Showa Ku, Nagoya, Aichi 4668550, Japan; [Suyama, Mikita] Japan Sci & Technol Agcy, CREST, Fukuoka 8128582, Japan	Suyama, M (reprint author), Kyushu Univ, Med Inst Bioregulat, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan.	mikita@bioreg.kyushu-u.ac.jp; toyokuni@med.nagoya-u.ac.jp	Toyokuni, Shinya/C-1358-2010	Toyokuni, Shinya/0000-0002-5757-1109	Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [20017017, 22132005, 221S0001-04]; Kyushu University	This work was supported in part by a grant-in-aid for research from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (20017017 and 22132005 to M.S.; 221S0001-04 to S.T.) and Kyushu University Interdisciplinary Program in Education and Projects in Research Development (P&P) to M.S. Funding to pay the Open Access publication charges for this article was provided by the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Akatsuka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043403; Akatsuka S, 2006, AM J PATHOL, V169, P1328, DOI 10.2353/ajpath.2006.051280; TOYOKUNI S, 1994, INT J CANCER, V57, P123, DOI 10.1002/ijc.2910570122; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Iida T, 2002, ACTA NEUROPATHOL, V103, P20; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Nomoto M, 1999, CARCINOGENESIS, V20, P837, DOI 10.1093/carcin/20.5.837; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Amouroux R, 2010, NUCLEIC ACIDS RES, V38, P2878, DOI 10.1093/nar/gkp1247; Guo J, 2013, NUCLEIC ACIDS RES, V41, P7700, DOI 10.1093/nar/gkt524; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Neeley WL, 2006, CHEM RES TOXICOL, V19, P491, DOI 10.1021/tx0600043; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Kobayashi T, 1999, CANCER RES, V59, P1206; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; Kikuchi H, 2002, ACTA NEUROPATHOL, V103, P408, DOI 10.1007/s00404-001-0480-x; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Li M, 2012, NAT REV MOL CELL BIO, V13, P524, DOI 10.1038/nrm3393; Akatsuka S, 2012, FREE RADICAL RES, V46, P523, DOI 10.3109/10715762.2011.633212; Hinrichs AS, 2006, NUCLEIC ACIDS RES, V34, pD590, DOI 10.1093/nar/gkj144; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Croteau DL, 1997, J BIOL CHEM, V272, P25409, DOI 10.1074/jbc.272.41.25409; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Bolzer A, 2005, PLOS BIOL, V3, P826, DOI 10.1371/journal.pbio.0030157; Cheung AF, 2010, ONCOGENE, V29, P1857, DOI 10.1038/onc.2009.457; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; EBINA Y, 1986, J NATL CANCER I, V76, P107; Gedik CM, 2005, FASEB J, V19, P82, DOI 10.1096/fj.04-1767fje; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; HSU TC, 1975, GENETICS, V79, P137; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Jiang L, 2006, CANCER SCI, V97, P1159, DOI 10.1111/j.1349-7006.2006.00301.x; LI JL, 1987, CANCER RES, V47, P1867; LIU YP, 2007, J JISHOU UNIV, V28, P1; Mayer R, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-44; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Neusser M, 2007, CHROMOSOMA, V116, P307, DOI 10.1007/s00412-007-0099-3; Nomoto M, 2002, ONCOGENE, V21, P1649, DOI 10.1038/sj/onc/1205237; Ohno M, 2006, GENOME RES, V16, P567, DOI 10.1101/gr.4769606; Smith AJ, 2008, DNA REPAIR, V7, P1670, DOI 10.1016/j.dnarep.2008.06.020; Taylor EM, 1998, INT J RADIAT BIOL, V74, P277; Yamaguchi R, 1996, CARCINOGENESIS, V17, P2419, DOI 10.1093/carcin/17.11.2419	48	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1340-2838	1756-1663		DNA RES	DNA Res.	DEC	2014	21	6					603	612		10.1093/dnares/dsu023		10	Genetics & Heredity	Genetics & Heredity	AX7MY	WOS:000347101100003		
J	Hirakawa, H; Shirasawa, K; Miyatake, K; Nunome, T; Negoro, S; Ohyama, A; Yamaguchi, H; Sato, S; Isobe, S; Tabata, S; Fukuoka, H				Hirakawa, Hideki; Shirasawa, Kenta; Miyatake, Koji; Nunome, Tsukasa; Negoro, Satomi; Ohyama, Akio; Yamaguchi, Hirotaka; Sato, Shusei; Isobe, Sachiko; Tabata, Satoshi; Fukuoka, Hiroyuki			Draft Genome Sequence of Eggplant (Solanum melongena L.): the Representative Solanum Species Indigenous to the Old World	DNA RESEARCH			English	Article						Solanum melongena L.; eggplant; genome sequencing; gene prediction; comparative analysis	LINKAGE MAP; CHROMOSOMAL EVOLUTION; BACTERIAL WILT; TOMATO; MARKERS; POTATO; GENES; IDENTIFICATION; SOLANACEAE; DATABASE	Unlike other important Solanaceae crops such as tomato, potato, chili pepper, and tobacco, all of which originated in South America and are cultivated worldwide, eggplant (Solanum melongena L.) is indigenous to the Old World and in this respect it is phylogenetically unique. To broaden our knowledge of the genomic nature of solanaceous plants further, we dissected the eggplant genome and built a draft genome dataset with 33,873 scaffolds termed SME_r2.5.1 that covers 833.1 Mb, ca. 74% of the eggplant genome. Approximately 90% of the gene space was estimated to be covered by SME_r2.5.1 and 85,446 genes were predicted in the genome. Clustering analysis of the predicted genes of eggplant along with the genes of three other solanaceous plants as well as Arabidopsis thaliana revealed that, of the 35,000 clusters generated, 4,018 were exclusively composed of eggplant genes that would perhaps confer eggplant-specific traits. Between eggplant and tomato, 16,573 pairs of genes were deduced to be orthologous, and 9,489 eggplant scaffolds could be mapped onto the tomato genome. Furthermore, 56 conserved synteny blocks were identified between the two species. The detailed comparative analysis of the eggplant and tomato genomes will facilitate our understanding of the genomic architecture of solanaceous plants, which will contribute to cultivation and further utilization of these crops.	[Hirakawa, Hideki; Shirasawa, Kenta; Sato, Shusei; Isobe, Sachiko; Tabata, Satoshi] Kazusa DNA Res Inst, Kisarazu, Chiba 2920818, Japan; [Miyatake, Koji; Nunome, Tsukasa; Negoro, Satomi; Ohyama, Akio; Yamaguchi, Hirotaka; Fukuoka, Hiroyuki] NARO Inst Vegetable & Tea Sci NIVTS, Tsu, Mie 5142392, Japan	Fukuoka, H (reprint author), NARO Inst Vegetable & Tea Sci NIVTS, 360 Kusawa, Tsu, Mie 5142392, Japan.	h.fukuoka@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan [SGE-1001]; Kazusa DNA Research Institute Foundation; National Agriculture and Food Research Organization (NARO)	This work was supported by grants from the Ministry of Agriculture, Forestry, and Fisheries of Japan('Program for the Promotion of Basic Research Activities for Innovative Biosciences [PROBRAIN]' and 'Genomics for Agricultural Innovation', SGE-1001) and the Kazusa DNA Research Institute Foundation. Funding to pay the Open Access publication charges for this article was provided by the National Agriculture and Food Research Organization (NARO).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Azuma K, 2008, J AGR FOOD CHEM, V56, P10154, DOI 10.1021/jf801322m; Nunome T, 2009, THEOR APPL GENET, V119, P1143, DOI 10.1007/s00122-009-1116-0; Lepelley M, 2007, PLANT SCI, V172, P978, DOI 10.1016/j.plantsci.2007.02.004; Huang XQ, 2006, NUCLEIC ACIDS RES, V34, P201, DOI 10.1093/nar/gkj419; Llorens C, 2011, NUCLEIC ACIDS RES, V39, pD70, DOI 10.1093/nar/gkq1061; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; TANKSLEY SD, 1992, GENETICS, V132, P1141; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Barchi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043740; BONIERBALE MW, 1988, GENETICS, V120, P1095; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Matsuno M, 2009, SCIENCE, V325, P1688, DOI 10.1126/science.1174095; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Kofler R, 2007, BIOINFORMATICS, V23, P1683, DOI 10.1093/bioinformatics/btm157; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Cao GH, 1996, J AGR FOOD CHEM, V44, P3426, DOI 10.1021/jf9602535; PAZARES J, 1987, EMBO J, V6, P3553; Fukuoka H, 2010, GENE, V450, P76, DOI 10.1016/j.gene.2009.10.006; Ashburner M, 2000, NAT GENET, V25, P25; Shirasawa K, 2010, THEOR APPL GENET, V121, P731, DOI 10.1007/s00122-010-1344-3; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Schoch G, 2001, J BIOL CHEM, V276, P36566, DOI 10.1074/jbc.M104047200; Ariizumi T, 2013, BREEDING SCI, V63, P3, DOI 10.1270/jsbbs.63.3; Flinn B, 2005, PLANT MOL BIOL, V59, P407, DOI 10.1007/s11103-005-0185-y; Doganlar S, 2002, GENETICS, V161, P1697; Li Ruiqiang, 2010, Genome Res, V20, P265, DOI 10.1101/gr.097261.109; Aoki K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-210; Bak Søren, 2011, Arabidopsis Book, V9, pe0144, DOI 10.1199/tab.0144; Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; D'Arcy WG, 1991, SOLANACEAE, P75; Daunay M.C., 1988, CAPSICUM NEWSLETT, V7, P70; Eddy Sean R, 2009, Genome Inform, V23, P205; Fukuoka H, 2012, THEOR APPL GENET, V125, P47, DOI 10.1007/s00122-012-1815-9; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jurka J, 1998, CURR OPIN STRUC BIOL, V8, P333, DOI 10.1016/S0959-440X(98)80067-5; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lebeau A., 2010, PHYTOPATHOLOGY, V101, P154; Lin CH, 2008, PLANT DIS, V92, P909, DOI 10.1094/PDIS-92-6-0909; Nunome T, 2003, BREEDING SCI, V53, P77, DOI 10.1270/jsbbs.53.77; Nunome T, 2003, PLANT BREEDING, V122, P256, DOI 10.1046/j.1439-0523.2003.00816.x; Nunome T, 2001, BREEDING SCI, V51, P19, DOI 10.1270/jsbbs.51.19; Peterson DG, 1997, PLANT MOL BIOL REP, V15, P148, DOI 10.1007/BF02812265; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Saito T, 2009, JARQ-JPN AGR RES Q, V43, P123; Sakata Y, 1996, J JPN SOC HORTIC SCI, V65, P81; Stanke M, 2003, BIOINFORMATICS S2, V19, pii215, DOI DOI 10.1093/BI0; Stommell JR, 2003, J AM SOC HORTIC SCI, V128, P704; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Wu FN, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-182; Wu FN, 2009, THEOR APPL GENET, V118, P927, DOI 10.1007/s00122-008-0950-9	58	8	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1340-2838	1756-1663		DNA RES	DNA Res.	DEC	2014	21	6					649	660		10.1093/dnares/dsu027		12	Genetics & Heredity	Genetics & Heredity	AX7MY	WOS:000347101100007		
J	Osada, N; Kohara, A; Yamaji, T; Hirayama, N; Kasai, F; Sekizuka, T; Kuroda, M; Hanada, K				Osada, Naoki; Kohara, Arihiro; Yamaji, Toshiyuki; Hirayama, Noriko; Kasai, Fumio; Sekizuka, Tsuyoshi; Kuroda, Makoto; Hanada, Kentaro			The Genome Landscape of the African Green Monkey Kidney-Derived Vero Cell Line	DNA RESEARCH			English	Article						Vero cell; whole genome; infectious diseases; vaccine; animal cell substrate	ESCHERICHIA-COLI; RUBELLA-VIRUS; INTERFERON-PRODUCTION; VACCINE PRODUCTION; SEQUENCING DATA; PLAQUE-ASSAY; DIVERSITY; NUMBER; CANCER	Continuous cell lines that originate from mammalian tissues serve as not only invaluable tools for life sciences, but also important animal cell substrates for the production of various types of biological pharmaceuticals. Verocells are susceptible to various types of microbes and toxins and have widely contributed to not only microbiology, but also the production of vaccines for human use. We here showed the genome landscape of a Vero cell line, in which 25,877 putative protein-coding genes were identified in the 2.97-Gb genome sequence. A homozygous similar to 9-Mb deletion on chromosome 12 caused the loss of the type I interferon gene cluster and cyclin-dependent kinase inhibitor genes in Vero cells. In addition, an similar to 59-Mb loss of heterozygosity around this deleted region suggested that the homozygosity of the deletion was established by a large-scale conversion. Moreover, a genomic analysis of Vero cells revealed a female Chlorocebus sabaeus origin and proviral variations of the endogenous simian type D retrovirus. These results revealed the genomic basis for the non-tumourigenic permanent Vero cell lineage susceptible to various pathogens and will be useful for generating new sub-lines and developing new tools in the quality control of Vero cells.	[Osada, Naoki] Natl Inst Genet, Dept Populat Genet, Div Evolutionary Genet, Mishima, Shizuoka 4118540, Japan; [Kohara, Arihiro; Hirayama, Noriko; Kasai, Fumio] Natl Inst Biomed Innovat, Lab Cell Cultures, Osaka 5670085, Japan; [Yamaji, Toshiyuki; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo 1628640, Japan; [Sekizuka, Tsuyoshi; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo 1628640, Japan	Hanada, K (reprint author), Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo 1628640, Japan.	hanak@nih.go.jp			Japan Society for the Promotion of Science KAKENHI [22370054, 25670065]; Takeda Science Foundation	This work was supported by the Japan Society for the Promotion of Science KAKENHI Grant numbers 22370054 and 25670065 (to K.H.) and also by Takeda Science Foundation (to K.H.). Funding to pay the Open Access publication charges for this article was provided by a Grant-in-Aid of Takeda Science Foundation (to K.H.).	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Finelli P, 1999, MAMM GENOME, V10, P713, DOI 10.1007/s003359901077; EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247; KONOWALCHUK J, 1977, INFECT IMMUN, V18, P775; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Yang LX, 2013, CELL, V153, P919, DOI 10.1016/j.cell.2013.04.010; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Grubb P, 2003, INT J PRIMATOL, V24, P1301, DOI 10.1023/B:IJOP.0000005994.86792.b9; Popov N, 2010, EPIGENETICS-US, V5, P685, DOI 10.4161/epi.5.8.12996; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Montomoli E, 2012, EXPERT REV VACCINES, V11, P587, DOI [10.1586/erv.12.24, 10.1586/ERV.12.24]; Victoria JG, 2010, J VIROL, V84, P6033, DOI 10.1128/JVI.02690-09; DESMYTER J, 1968, J VIROL, V2, P955; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Haus T, 2013, AM J PRIMATOL, V75, P350, DOI 10.1002/ajp.22113; Knezevic I, 2010, BIOLOGICALS, V38, P162, DOI 10.1016/j.biologicals.2009.08.019; Vincent-Falquet J C, 1989, Dev Biol Stand, V70, P153; Osada N, 2012, MOL BIOL EVOL, V29, P337, DOI 10.1093/molbev/msr211; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; DIAZ MO, 1988, P NATL ACAD SCI USA, V85, P5259, DOI 10.1073/pnas.85.14.5259; Barrett PN, 2009, EXPERT REV VACCINES, V8, P607, DOI [10.1586/erv.09.19, 10.1586/ERV.09.19]; Earley E.M., 1988, VERO CELLS ORIGIN PR, P26; ELLIS DS, 1979, J MED VIROL, V4, P213, DOI 10.1002/jmv.1890040307; HORAUD F, 1992, DEV BIOLOGICALS, V76, P43; Horimoto T, 2006, TRENDS MOL MED, V12, P506, DOI 10.1016/j.molmed.2006.09.003; LEVENBOOK IS, 1984, J BIOL STAND, V12, P391, DOI 10.1016/S0092-1157(84)80063-3; LIEBHABE.H, 1967, P SOC EXP BIOL MED, V125, P636; Ma HL, 2011, J VIROL, V85, P6579, DOI 10.1128/JVI.00147-11; MIYAMURA K, 1974, J BIOL STAND, V2, P189, DOI 10.1016/0092-1157(74)90015-8; Ohara H., 1988, VERO CELLS ORIGIN PR, P36; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; REMIS RS, 1984, ANN INTERN MED, V101, P624; RHIM JS, 1969, P SOC EXP BIOL MED, V132, P670; RHIM JS, 1967, P SOC EXP BIOL MED, V125, P602; SASAKI K, 1964, Kitasato Archives of Experimental Medicine, V37, P27; Seabright M, 1973, Lancet, V1, P1249; SIMIZU B, 1967, P SOC EXP BIOL MED, V125, P119; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; SPEIRS JI, 1977, INFECT IMMUN, V16, P617; STOCK AD, 1973, CHROMOSOMA, V43, P211, DOI 10.1007/BF00483380; Terasima T., 1988, VERO CELLS ORIGIN PR, P22; Wertheim JO, 2007, PLOS PATHOG, V3, P866, DOI 10.1371/journal.ppat.0030095; Yasumura V., 1963, NIPPON RINSHO, V21, P1201; Yasumura Y., 1988, VERO CELLS ORIGIN PR, P1	52	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1340-2838	1756-1663		DNA RES	DNA Res.	DEC	2014	21	6					673	683		10.1093/dnares/dsu029		11	Genetics & Heredity	Genetics & Heredity	AX7MY	WOS:000347101100009		
J	Li, W; Jin, Q; Li, XN; Nishimura, O				Li, Wei; Jin, Qiu; Li, Xianning; Nishimura, Osamu			Elimination of cyanobacteria and cyanobacterial microcystin with increase in heterogeneity	ECOLOGICAL ENGINEERING			English	Article						Water source; Cyanobacterial bloom; Eutrophication; Ecological restoration; Bioremediation; Microcystin	FRESH-WATER ECOSYSTEMS; SUBMERGED MACROPHYTES; PHYTOPLANKTON; IMPACT; BIODEGRADATION; BIODIVERSITY; REMOVAL; SYSTEM; GROWTH; STREAM	Cyanobacterial blooms and their corresponding toxins have resulted in the reduction of heterogeneity within aquatic ecosystems, and vice versa. Yet much remain to be known whether high heterogeneity can lead to effective elimination of cyanobacteria and microcystin (MC). In this work, by introducing biota (macrophyte and bivalve) and abiota (artificial substrate) to increase heterogeneity, cyanobacterial and MC elimination were enhanced. With increasing heterogeneity, the mean removal efficiencies of cyanobacteria increased from 58.86% to 79.11%. Correspondingly, the mean MC removal efficiencies enhanced from 42.38% to 74.16%. The biofilm was shown to be the most efficient for removing cyanobacteria and MC, whereas the bivalve was less efficient for cyanobacterial removal than the macrophyte and had no effect on MC removal. Furthermore, crustaceans were significantly enriched in all the heterogeneous systems; the introduced bivalve increased respiratory activity in the substrate biofilm. Conclusively, increasing heterogeneity appears to be a not only viable solution for improving the quality of water in protected sources but also potential criterion for restoring and managing aquatic ecosystems. Crown Copyright (C) 2014 Published by Elsevier B.V. All rights reserved.	[Li, Wei; Jin, Qiu; Li, Xianning] Southeast Univ, Sch Energy & Environm, Nanjing 210096, Jiangsu, Peoples R China; [Li, Wei; Nishimura, Osamu] Tohoku Univ, Dept Civil & Environm Engn, Sendai, Miyagi 9808579, Japan; [Jin, Qiu] Nanjing Hydraul Res Inst, Nanjing 210029, Jiangsu, Peoples R China	Li, XN (reprint author), Southeast Univ, Sch Energy & Environm, Sipailou 2, Nanjing 210096, Jiangsu, Peoples R China.	liwei@eco.civil.tohoku.ac.jp			National Science Foundation of China [20877018]	We gratefully acknowledge Dr. Feizhou Chen and Dr. Xiaolan Song of Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences for identifying zooplankton and algae. We also thank Dr. Yunhui Li and Mr. Guang Yu of The School of Public Health, Southeast University for the assistance of MCs analysis. This work was supported with funds from Grant No. 20877018 by the National Science Foundation of China.	Sommer U, 2001, ECOL LETT, V4, P545, DOI 10.1046/j.1461-0248.2001.00263.x; Nimptsch J, 2008, ENVIRON SCI TECHNOL, V42, P8552, DOI 10.1021/es8010404; Nakai S, 2000, WATER RES, V34, P3026, DOI 10.1016/S0043-1354(00)00039-7; Wang HX, 2007, WATER RES, V41, P4262, DOI 10.1016/j.watres.2007.05.057; Ji RP, 2009, ECOL ENG, V35, P1584, DOI 10.1016/j.ecoleng.2008.12.031; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; BLENKINSOPP SA, 1990, WATER RES, V24, P441, DOI 10.1016/0043-1354(90)90226-V; Ramanan S, 2000, J CHROMATOGR A, V883, P103, DOI 10.1016/S0021-9673(00)00378-2; Ozawa K, 2003, LIMNOLOGY, V4, P131, DOI 10.1007/s10201-003-0106-1; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Higgins SN, 2010, ECOL MONOGR, V80, P179, DOI 10.1890/09-1249.1; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Falconer IR, 2005, ACTA HYDROCH HYDROB, V33, P64, DOI 10.1002/aheh.200300551; Brookes JD, 2011, SCIENCE, V334, P46, DOI 10.1126/science.1207349; Rahel FJ, 2000, SCIENCE, V288, P854, DOI 10.1126/science.288.5467.854; Bourne DG, 2006, WATER RES, V40, P1294, DOI 10.1016/j.watres.2006.01.022; Wu YH, 2010, BIORESOURCE TECHNOL, V101, P3903, DOI 10.1016/j.biortech.2009.12.144; Hakenkamp CC, 1999, OECOLOGIA, V119, P445, DOI 10.1007/s004420050806; Cardinale BJ, 2002, ECOLOGY, V83, P412, DOI 10.2307/2680024; Cazzanelli M, 2008, HYDROBIOLOGIA, V605, P113, DOI 10.1007/s10750-008-9324-1; Chen J., 2005, TOXICON, V45; Daily G.C., NATURES SERVICES SOC; Declerck S, 2007, ECOLOGY, V88, P2199, DOI 10.1890/07-0048.1; Gao Q., 2000, ECOL MODEL, V45, P247; Huisman J., HARMFUL CYANOBACTERI; Ibelings B.W., 2007, ECOSYSTEMS, V10; Jang M.H., 2006, TOXICON, V49; Jones Gary J., 1994, Natural Toxins, V2, P228, DOI 10.1002/nt.2620020412; Jose M.R.B., 2009, SCIENCE, V325, P1121; Korner S, 2002, J PHYCOL, V38, P862, DOI 10.1046/j.1529-8817.2002.t01-1-02001.x; Pu P., 1998, ECOL ENG, V10, P79; Rohrlack T., 2003, J CHEM ECOL, V29; Sommer U, 2003, OECOLOGIA, V135, P639, DOI 10.1007/s00442-003-1214-7; Stansfield JH, 1997, HYDROBIOLOGIA, V342, P229, DOI 10.1023/A:1017091407556; Vaughn C.C., 2004, HYDROBIOLOGIA, V527; WHO, 1998, GUID DRINK WAT QUAL	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-8574	1872-6992		ECOL ENG	Ecol. Eng.	DEC	2014	73						487	493		10.1016/j.ecoleng.2014.09.083		7	Ecology; Engineering, Environmental; Environmental Sciences	Environmental Sciences & Ecology; Engineering	AX6FK	WOS:000347018400064		
J	Senavirathna, MDHJ; Takashi, A; Kimura, Y				Senavirathna, Mudalige Don Hiranya Jayasanka; Takashi, Asaeda; Kimura, Yuichi			Short-duration exposure to radiofrequency electromagnetic radiation alters the chlorophyll fluorescence of duckweeds (Lemna minor)	ELECTROMAGNETIC BIOLOGY AND MEDICINE			English	Article						Chlorophyll fluorescence; communication networks; non-thermal; photosystem; radiation; radiofrequency; stress	MOBILE-PHONE; IN-VITRO; 900 MHZ; DIURNAL-VARIATION; OXIDATIVE STRESS; REACTION CENTERS; REGULATED RIVER; CELLULAR PHONE; WATER-STRESS; FIELD	Plants growing in natural environments are exposed to radiofrequency electromagnetic radiation (EMR) emitted by various communication network base stations. The environmental concentration of this radiation is increasing rapidly with the congested deployment of base stations. Although numerous scientific studies have been conducted to investigate the effects of EMR on the physiology of humans and animals, there have been few attempts to investigate the effects of EMR on plants. In this study, we attempted to evaluate the effects of EMR on photosynthesis by investigating the chlorophyll fluorescence (ChF) parameters of duckweed fronds. During the experiment, the fronds were tested with 2, 2.5, 3.5, 5.5 and 8 GHz EMR frequencies, which are not widely studied even though there is a potentially large concentration of these frequencies in the environment. The duckweed fronds were exposed to EMR for 30 min, 1 h and 24 h durations with electric field strength of 45-50 V/m for each frequency. The results indicated that exposure to EMR causes a change in the non-photochemical quenching of the duckweeds. The changes varied with the frequency of the EMR and were time-varying within a particular frequency. The temperature remained unchanged in the duckweed fronds upon exposure to EMR, which confirms that the effect is non-thermal.	[Senavirathna, Mudalige Don Hiranya Jayasanka; Takashi, Asaeda] Saitama Univ, Dept Environm Sci & Technol, Saitama 3388570, Japan; [Kimura, Yuichi] Saitama Univ, Dept Elect & Elect Syst, Saitama 3388570, Japan	Takashi, A (reprint author), Saitama Univ, Dept Environm Sci & Technol, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	asaeda@mail.saitama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	The authors thank Prof. Takeshi Fujino, Prof. Hirofumi Kadono and Dr. Makoto Miwa for their valuable support during this study and Mr. Sakuyoshi Saito for his support in the preparation of the EMR exposure system. This work was financially supported by Ministry of Education, Culture, Sports, Science and Technology, Japan.	Willits DH, 2001, J AM SOC HORTIC SCI, V126, P188; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Dalu JM, 2003, PHYS CHEM EARTH, V28, P1147, DOI 10.1016/j.pce.2003.08.036; Heraud P, 2000, PHOTOSYNTH RES, V63, P123, DOI 10.1023/A:1006319802047; Erogul O, 2006, ARCH MED RES, V37, P840, DOI 10.1016/j.arcmed.2006.05.003; Challis L J, 2005, Bioelectromagnetics, VSuppl 7, pS98; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Gomes PIA, 2009, ANN LIMNOL-INT J LIM, V45, P181, DOI 10.1051/limn/2009015; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Niyogi KK, 2001, PHOTOSYNTH RES, V67, P139, DOI 10.1023/A:1010661102365; La Vignera S, 2012, J ANDROL, V33, P350, DOI 10.2164/jandrol.111.014373; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Krieger-Liszkay A, 2005, J EXP BOT, V56, P337, DOI 10.1093/jxb/erh237; Herde O, 1999, PLANT PHYSIOL, V119, P213, DOI 10.1104/pp.119.1.213; Cedergreen N, 2009, FIELD CROP RES, V114, P54, DOI 10.1016/j.fcr.2009.07.003; Diem E, 2005, MUTAT RES-GEN TOX EN, V583, P178, DOI 10.1016/j.mrgentox.2005.03.006; BOXER SG, 1983, ANNU REV PHYS CHEM, V34, P389, DOI 10.1146/annurev.pc.34.100183.002133; Dai F, 2007, PLANT PHYSIOL BIOCH, V45, P915, DOI 10.1016/j.plaphy.2007.09.006; COLLEN J, 1995, PLANTA, V196, P225; Meral I, 2007, BRAIN RES, V1169, P120, DOI 10.1016/j.brainres.2007.07.015; Fai PB, 2007, ENVIRON TOXICOL CHEM, V26, P1520, DOI 10.1897/06-394R1.1; Asaeda T, 2009, RIVER RES APPL, V25, P874, DOI 10.1002/rra.1191; d'Ambrosio G, 2002, BIOELECTROMAGNETICS, V23, P7, DOI 10.1002/bem.93; Daniells C, 1998, MUTAT RES-FUND MOL M, V399, P55, DOI 10.1016/S0027-5107(97)00266-2; Eliyahu I, 2006, BIOELECTROMAGNETICS, V27, P119, DOI 10.1002/bem.20187; Faraloni C, 2011, ENVIRON EXP BOT, V73, P49, DOI 10.1016/j.envexpbot.2010.10.011; Frankart C, 2003, ENVIRON EXP BOT, V49, P159, DOI 10.1016/S0098-8472(02)00067-9; GEACINTO.NE, 1971, BIOCHIM BIOPHYS ACTA, V226, P486, DOI 10.1016/0005-2728(71)90118-6; Haggerty K., 2010, International Journal of Forestry Research, V2010, P836278, DOI 10.1155/2010/836278; HUCK MG, 1962, PLANT PHYSIOL, V37, P371, DOI 10.1104/pp.37.3.371; Hyland G., 2005, EXPOSURE MOBILE PHON; Hyland G., 2001, PHSYL ENV EFFECTS NO; Khalafallah A. A., 2009, Romanian Journal of Biophysics, V19, P49; Kositsky N. N., 2001, NO PLACE HIDE NEWSLE, V3, P1; Lai H., 2005, ENCY BIOMATERIALS BI, P1, DOI DOI 10.1081/E-EBBE-120041846; Lai PY, 2008, MICROW OPT TECHN LET, V50, P2689, DOI 10.1002/mop.23777; Lauchli A., 2007, ADV MOL BREEDING DRO, P1, DOI 10.1007/978-1-4020-5578-2_1; Lazar D, 1998, PHOTOSYNTHETICA, V35, P121, DOI 10.1023/A:1006886202444; Lu CM, 1999, J EXP BOT, V50, P1199; Marinelli F, 2004, J CELL PHYSIOL, V198, P479, DOI 10.1002/jcp.10483; McNamee JP, 2009, RADIAT RES, V172, P265, DOI 10.1667/RR1726.1; Nylund R, 2006, PROTEOMICS, V6, P4769, DOI 10.1002/pmic.200600076; Penafiel LM, 1997, BIOELECTROMAGNETICS, V18, P132, DOI 10.1002/(SICI)1521-186X(1997)18:2<132::AID-BEM6>3.0.CO;2-3; Pologea-Moraru R, 2002, BIOELECTROCHEMISTRY, V56, P223, DOI 10.1016/S1567-5394(02)00037-3; POPOVIC ZD, 1986, BIOCHIM BIOPHYS ACTA, V851, P38, DOI 10.1016/0005-2728(86)90246-X; Prasad P. V. V., 2008, ADV AGR MODELING SER, V1, P301; REDDY KR, 1985, ECON BOT, V39, P200, DOI 10.1007/BF02907846; Roux D, 2008, PLANTA, V227, P883, DOI 10.1007/s00425-007-0664-2; Roux D, 2006, PHYSIOL PLANTARUM, V128, P283, DOI 10.1111/j.1399-3054.2006.00740.x; Sharma VP, 2009, SCI TOTAL ENVIRON, V407, P5543, DOI 10.1016/j.scitotenv.2009.07.006; SIECIECHOWICZ K, 1985, PLANT PHYSIOL, V77, P506, DOI 10.1104/pp.77.2.506; Tkalec M, 2007, SCI TOTAL ENVIRON, V388, P78, DOI 10.1016/j.scitotenv.2007.07.052; Tkalec M, 2005, BIOELECTROMAGNETICS, V26, P185, DOI 10.1002/bem.20104; Ursache M., 2007, ROM J PHYS, V54, P133; WHO, 2013, WHAT ARE ELECTROMAGN; Yamasaki H, 1997, PLANT PHYSIOL, V115, P1405; Ye LH, 2010, MICROW OPT TECHN LET, V52, P1228, DOI 10.1002/mop.25156; Yoo SD, 2003, PLANT PHYSIOL BIOCH, V41, P887, DOI 10.1016/S0981-9428(03)00138-4	59	1	1	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	1536-8378	1536-8386		ELECTROMAGN BIOL MED	Electromagn. Biol. Med.	DEC	2014	33	4					327	334		10.3109/15368378.2013.844705		8	Biology; Biophysics	Life Sciences & Biomedicine - Other Topics; Biophysics	AX1HP	WOS:000346698700011		
J	Fukuyama, M; Wang, Q; Kato, K; Ohno, S; Ding, WG; Toyoda, F; Itoh, H; Kimura, H; Makiyama, T; Ito, M; Matsuura, H; Horie, M				Fukuyama, Megumi; Wang, Qi; Kato, Koichi; Ohno, Seiko; Ding, Wei-Guang; Toyoda, Futoshi; Itoh, Hideki; Kimura, Hiromi; Makiyama, Takeru; Ito, Makoto; Matsuura, Hiroshi; Horie, Minoru			Long QT syndrome type 8: novel CACNA1C mutations causing QT prolongation and variant phenotypes	EUROPACE			English	Article						Long QT syndrome; L-type calcium channels; L-type calcium current; Genetics; Arrhythmia	CALCIUM-CHANNEL MUTATIONS; ARRHYTHMIA; MANAGEMENT; SPECTRUM; IMPACT	Aims CACNA1C mutations have been reported to cause LQTS type 8 (LQT8; Timothy syndrome), which exhibits severe phenotypes, although the frequency of patients with LQT8 exhibiting only QT prolongation is unknown. This study aimed to elucidate the frequency of CACNA1C mutations in patients with long QT syndrome (LQTS), except those with Timothy syndrome and investigate phenotypic variants. Methods and results CACNA1C gene screening was performed in 278 probands negative for LQTS-related gene mutations. Functional analysis of mutant channels using a whole-cell patch-clamp technique was also performed. Using genetic screening, we identified five novel CACNA1C mutations: P381S, M456I, A582D, R858H, and G1783C in seven (2.5%) unrelated probands. Seven mutation carriers showed alternative clinical phenotypes. Biophysical assay of CACNA1C mutations revealed that the peak calcium currents were significantly larger in R858H mutant channels than those of wild-type (WT). In contrast, A582D mutant channels displayed significantly slower inactivation compared with WT. The two mutant channels exerted different gain-of-function effects on calcium currents. Conclusion In patients with LQTS, the frequency of CACNA1C mutations was higher than reported. Even without typical phenotypes of Timothy syndrome, CACNA1C mutations may cause QT prolongation and/or fatal arrhythmia attacks.	[Fukuyama, Megumi; Wang, Qi; Kato, Koichi; Ohno, Seiko; Itoh, Hideki; Kimura, Hiromi; Ito, Makoto; Horie, Minoru] Shiga Univ Med Sci, Dept Cardiovasc & Resp Med, Otsu, Shiga 5202192, Japan; [Ohno, Seiko; Makiyama, Takeru] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan; [Ding, Wei-Guang; Toyoda, Futoshi; Matsuura, Hiroshi] Shiga Univ Med Sci, Dept Physiol, Otsu, Shiga 5202192, Japan	Horie, M (reprint author), Shiga Univ Med Sci, Dept Cardiovasc & Resp Med, Otsu, Shiga 5202192, Japan.	horie@belle.shiga-med.ac.jp			Ministry of Education, Culture, Science, and Technology of Japan; Ministry of Health, Labour and Welfare of Japan for Clinical Research on Measures for Intractable Diseases; Japan Circulation Society	This work was supported by research grants from the Ministry of Education, Culture, Science, and Technology of Japan; health science research grants from the Ministry of Health, Labour and Welfare of Japan for Clinical Research on Measures for Intractable Diseases; and Translational Research Funds from the Japan Circulation Society (to M.H.).	SCHWARTZ PJ, 1993, CIRCULATION, V88, P782; Schwartz PJ, 2009, CIRCULATION, V120, P1761, DOI 10.1161/CIRCULATIONAHA.109.863209; Tsuchiya T, 2002, J CARDIOVASC ELECTR, V13, P698, DOI 10.1046/j.1540-8167.2002.00698.x; Fressart V, 2010, EUROPACE, V12, P861, DOI 10.1093/europace/euq104; Antzelevitch C, 2007, CIRCULATION, V115, P442, DOI 10.1161/CIRCULATIONAHA.106.668392; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Boczek NJ, 2013, CIRC-CARDIOVASC GENE, V6, P279, DOI 10.1161/CIRCGENETICS.113.000138; Schwartz PJ, 2013, J AM COLL CARDIOL, V62, P169, DOI 10.1016/j.jacc.2013.04.044; MOSS AJ, 1991, CIRCULATION, V84, P1136; Stallmeyer B, 2012, HUM MUTAT, V33, P109, DOI 10.1002/humu.21599; Priori SG, 2013, EUROPACE, V15, P1389, DOI 10.1093/europace/eut272; Napolitano C, 2011, CIRC RES, V108, P607, DOI 10.1161/CIRCRESAHA.110.224279; Horner JM, 2011, HEART RHYTHM, V8, P1698, DOI 10.1016/j.hrthm.2011.05.018; Catterall W A, 1991, Curr Opin Neurobiol, V1, P5, DOI 10.1016/0959-4388(91)90004-Q; Fukuyama M, 2013, CIRC J, V77, P1799, DOI 10.1253/circj.CJ-12-1457; Millat G, 2011, CLIN CHIM ACTA, V412, P203, DOI 10.1016/j.cca.2010.09.013; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; SCHWARTZ PJ, 1985, AM HEART J, V109, P399, DOI 10.1016/0002-8703(85)90626-X; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Splawski I, 2005, P NATL ACAD SCI USA, V102, P6	20	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1099-5129	1532-2092		EUROPACE	Europace	DEC	2014	16	12					1828	1837		10.1093/europace/euu063		10	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX7OL	WOS:000347104900025		
J	Ohno, S; Horie, M				Ohno, Seiko; Horie, Minoru			Are RYR2 exon-3 deletions truly causative for non-compaction? Reply	EUROPACE			English	Letter									[Ohno, Seiko; Horie, Minoru] Shiga Univ Med Sci, Dept Cardiovasc, Otsu, Shiga, Japan	Horie, M (reprint author), Shiga Univ Med Sci, Dept Cardiovasc, Otsu, Shiga, Japan.	horie@belle.shiga-med.ac.jp					Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; Finsterer J, 2014, EUROPACE, V16, P1864, DOI 10.1093/europace/euu027; Ohno S, 2014, EUROPACE, V16, P1646, DOI 10.1093/europace/eut382; Osmonov D, 2013, CARDIOVASC J AFR, V24, P1	5	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1099-5129	1532-2092		EUROPACE	Europace	DEC	2014	16	12					1864	1865		10.1093/europace/euu061		3	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX7OL	WOS:000347104900032		
J	Tsuchiya, K; Hara, H; Fang, RD; Hernandez-Cuellar, E; Sakai, S; Daim, S; Chen, X; Dewamitta, SR; Qu, HX; Mitsuyama, M; Kawamura, I				Tsuchiya, Kohsuke; Hara, Hideki; Fang, Rendong; Hernandez-Cuellar, Eduardo; Sakai, Shunsuke; Daim, Sylvia; Chen, Xi; Dewamitta, Sita R.; Qu, Huixin; Mitsuyama, Masao; Kawamura, Ikuo			The adaptor ASC exacerbates lethal Listeria monocytogenes infection by mediating IL-18 production in an inflammasome-dependent and -independent manner	EUROPEAN JOURNAL OF IMMUNOLOGY			English	Article						ASC; Caspase-1; IL-18; Inflammasome; Listeria monocytogenes	NATURAL-KILLER-CELLS; CASPASE-1 ACTIVATION; PROTECTIVE IMMUNITY; AIM2 INFLAMMASOME; DEFICIENT MICE; CRITICAL ROLES; I RECEPTOR; INDUCTION; NLRP3; INVOLVEMENT	Listeria monocytogenes induces the formation of inflammasomes and subsequent caspase-1 activation, and the adaptor apoptosis-associated speck-like protein containing a CARD (ASC) is crucial for this response. However, the role of ASC in L. monocytogenes infection in vivo is unclear. In this study, we demonstrate that ASC has a detrimental effect on host defense against L. monocytogenes infection at a lethal dose (10(6) CFU), but not at a sublethal dose (10(3) CFU). During lethal L. monocytogenes infection, serum levels of IL-18 and IL-10 were markedly elevated in WT mice, but not in ASC KO mice. IL-18 KO mice were more resistant to lethal L. monocytogenes infection than WT mice and had lower levels of serum IL-10. Furthermore, blockade of IL-10 receptor resulted in a reduction in bacterial counts, suggesting that ASC and IL-18 might exacerbate L. monocytogenes infection through induction of IL-10. We noticed that maturation of IL-18 during lethal infection was partially independent of caspase-1, but was critically dependent on ASC. ASC was required for the elevation of serum neutrophil serine protease activity, which correlated with caspase-1-independent IL-18 maturation and IL-10 production. Collectively, these results suggest that ASC plays a detrimental role in lethal L. monocytogenes infection through IL-18 production in an inflammasome-dependent and -independent manner.	[Tsuchiya, Kohsuke; Hara, Hideki; Fang, Rendong; Hernandez-Cuellar, Eduardo; Sakai, Shunsuke; Daim, Sylvia; Chen, Xi; Dewamitta, Sita R.; Qu, Huixin; Mitsuyama, Masao; Kawamura, Ikuo] Kyoto Univ, Grad Sch Med, Dept Microbiol, Kyoto 6068501, Japan; [Mitsuyama, Masao] Kyoto Univ, Grad Sch Adv Integrated Study Human Survivabil, Kyoto 6068501, Japan	Tsuchiya, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Microbiol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	tsuchiya.kohsuke.5w@kyoto-u.ac.jp			JSPS KAKENHI [23590504, 22390082, 24649196]	We thank Professor Shun-ichiro Taniguchi, Shinshu University, for permission to use the ASC<SUP>-/-</SUP> mice; and Dr. Keisuke Kuida, Millennium Pharmaceuticals, for permission to use the caspase-1<SUP>-/-</SUP> mice. We thank Professor Haruki Okamura, Hyogo College of Medicine, for providing the IL-18<SUP>-/-</SUP> mice; Professor Hiroko Tsutsui, Hyogo College of Medicine, for providing the ASC<SUP>-/-</SUP> mice and caspase-1<SUP>-/-</SUP> mice. This work was supported by JSPS KAKENHI (Grant numbers 23590504, 22390082, and 24649196).	Abe R, 2008, J SURG RES, V147, P1, DOI 10.1016/j.jss.2007.07.009; Grobmyer SR, 2000, J CLIN IMMUNOL, V20, P212, DOI 10.1023/A:1006641630904; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Stavru F, 2011, IMMUNOL REV, V240, P160, DOI 10.1111/j.1600-065X.2010.00993.x; Menu P, 2011, CLIN EXP IMMUNOL, V166, P1, DOI 10.1111/j.1365-2249.2011.04440.x; Glaccum MB, 1997, J IMMUNOL, V159, P3364; Hara H, 2007, INFECT IMMUN, V75, P3791, DOI 10.1128/IAI.01779-06; Labow M, 1997, J IMMUNOL, V159, P2452; Wu JH, 2010, J CLIN IMMUNOL, V30, P693, DOI 10.1007/s10875-010-9425-2; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; SCHUCHAT A, 1991, CLIN MICROBIOL REV, V4, P169; Seki E, 2002, J IMMUNOL, V169, P3863; Sauer JD, 2011, P NATL ACAD SCI USA, V108, P12419, DOI 10.1073/pnas.1019041108; Tsuchiya K, 2014, CRIT REV IMMUNOL, V34, P41; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Zwijnenburg PJG, 2003, J NEUROIMMUNOL, V138, P31, DOI 10.1016/S0165-5728(03)00088-2; Grant LR, 2008, GENES IMMUN, V9, P316, DOI 10.1038/gene.2008.20; FREI K, 1993, J EXP MED, V178, P1255, DOI 10.1084/jem.178.4.1255; Lee CC, 2012, J IMMUNOL, V189, P3319, DOI 10.4049/jimmunol.1201247; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Perona-Wright G, 2009, CELL HOST MICROBE, V6, P503, DOI 10.1016/j.chom.2009.11.003; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Stevenson HL, 2010, AM J PATHOL, V177, P766, DOI [10.2353/ajpath.2010.091110, 10.2353/ajparh.2010.091110]; Fang RD, 2011, J IMMUNOL, V187, P4890, DOI 10.4049/jimmunol.1100381; Sugawara S, 2001, J IMMUNOL, V167, P6568; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; COSSART P, 1989, INFECT IMMUN, V57, P3629; Ikawa K, 2005, J LEUKOCYTE BIOL, V78, P1118, DOI 10.1189/jlb.0305151; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Warren SE, 2008, J IMMUNOL, V180, P7558; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakane A, 1999, FEMS MICROBIOL LETT, V175, P133, DOI 10.1111/j.1574-6968.1999.tb13612.x; Kessenbrock K, 2011, J MOL MED-JMM, V89, P23, DOI 10.1007/s00109-010-0677-3; Taxman DJ, 2011, J BIOL CHEM, V286, P19605, DOI 10.1074/jbc.M111.221077; Tsuji NM, 2004, INT IMMUNOL, V16, P335, DOI 10.1093/intimm/dxh041; Byrne A, 2002, J IMMUNOL, V168, P1968; Chakir H, 2001, CELL IMMUNOL, V212, P71, DOI 10.1006/cimm.2001.1844; Dai WJ, 1997, J IMMUNOL, V158, P2259; Deckert M, 2007, AM J PATHOL, V170, P990, DOI 10.2353/ajpath.2007.060507; Ghose P, 2011, J IMMUNOL, V187, P1333, DOI 10.4049/jimmunol.1100092; Hara H, 2008, J IMMUNOL, V180, P7859; Horng T, 2011, NAT MED, V17, P164, DOI 10.1038/nm0211-164; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Lochner M, 2008, INFECT IMMUN, V76, P3881, DOI 10.1128/IAI.01651-07; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Oberholzer A, 2002, CRIT CARE MED, V30, pS58, DOI 10.1097/00003246-200201001-00008; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Tsuchiya K, 2010, J IMMUNOL, V185, P1186, DOI 10.4049/jimmunol.1001058; Tsutsui H, 1996, J IMMUNOL, V157, P3967; ZHENG H, 1995, IMMUNITY, V3, P9, DOI 10.1016/1074-7613(95)90154-X	53	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2980	1521-4141		EUR J IMMUNOL	Eur. J. Immunol.	DEC	2014	44	12					3696	3707		10.1002/eji.201444673		12	Immunology	Immunology	AX1IO	WOS:000346701200022		
J	Czaplewska, JA; Theil, F; Altuntas, E; Niksch, T; Freesmeyer, M; Happ, B; Pretzel, D; Schafer, H; Obata, M; Yano, S; Schubert, US; Gottschaldt, M				Czaplewska, Justyna A.; Theil, Frank; Altuntas, Esra; Niksch, Tobias; Freesmeyer, Martin; Happ, Bobby; Pretzel, David; Schaefer, Hendrik; Obata, Makoto; Yano, Shigenobu; Schubert, Ulrich S.; Gottschaldt, Michael			Glycoconjugated Rhenium(I) and 99m-Technetium(I) Carbonyl Complexes from Pyridyltriazole Ligands Obtained by "Click Chemistry"	EUROPEAN JOURNAL OF INORGANIC CHEMISTRY			English	Article						Click chemistry; Rhenium; Technetium; Glycoconjugates; Ligand design	IN-VIVO EVALUATION; NUCLEAR-MEDICINE; METAL-COMPLEXES; CARBOHYDRATE; VITRO; AGENTS; FUNCTIONALIZATION; BIOMOLECULES; TC-99M(I); RE-186(I)	A series of pyridyltriazole ligands containing sugar moieties have been prepared by copper(I)-mediated 1,3-dipolar cycloaddition (click reaction) of azides functionalized with D-glucose, D-galactose, D-mannose, D-xylose as well as D-maltose residues, and 2-ethynylpyridine as alkyne. The peracetylated saccharide residues as well as their water-soluble deprotected derivatives were treated with Re(CO)(5)Cl to obtain the corresponding mononuclear rhenium(I) carbonyl complexes [LRe(CO)(3)Cl]. For comparison, one Re-I complex bearing a tert-butylbenzyl residue instead of a sugar moiety as well as two dinuclear rhenium complexes derived from a branched ligand containing two pyridyltriazole units were prepared. The structure and integrity of the ligands and complexes was established by NMR, IR, UV/Vis and fluorescence spectroscopy, mass spectrometry, and by elemental analysis. Coordination of the metal ion occurred by both the pyridyl nitrogen atoms and one of the triazole nitrogen atoms. Upon treatment with an excess of histidine, the Re-I complexes were stable for only 2.5 h. After a longer period (24 h) ligand exchange was detected by HPLC measurements. In contrast, a complex labeled with Tc-99m was found to be stable for up to 24 h against an excess of histidine. Cytotoxicity was screened for all Re-I complexes against HepG2 cells using a concentration of 100 M. All sugar-functionalized complexes were found to be nontoxic, except for the complex derived from the pyridyl (tert-butylbenzyl)-triazole, which exhibited remarkable toxicity.	[Czaplewska, Justyna A.; Theil, Frank; Altuntas, Esra; Happ, Bobby; Pretzel, David; Schaefer, Hendrik; Schubert, Ulrich S.; Gottschaldt, Michael] Univ Jena, Lab Organ & Macromol Chem IOMC, D-07743 Jena, Germany; [Czaplewska, Justyna A.; Altuntas, Esra; Happ, Bobby; Pretzel, David; Schubert, Ulrich S.; Gottschaldt, Michael] Univ Jena, JCSM, D-07743 Jena, Germany; [Niksch, Tobias; Freesmeyer, Martin] Univ Hosp Jena, Clin Nucl Med, D-07743 Jena, Germany; [Obata, Makoto] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Kofu, Yamanashi 4008510, Japan; [Yano, Shigenobu] Nara Inst Sci & Technol NAIST, Grad Sch Mat Sci, Nara 6300192, Japan	Gottschaldt, M (reprint author), Univ Jena, Lab Organ & Macromol Chem IOMC, Humboldtstr 10, D-07743 Jena, Germany.	michael.gottschaldt@uni-jena.de	Schubert, Ulrich/B-5777-2009	Schubert, Ulrich/0000-0003-4978-4670			Schibli R, 2000, BIOCONJUGATE CHEM, V11, P345, DOI 10.1021/bc990127h; Machura B, 2005, POLYHEDRON, V24, P701, DOI 10.1016/j.poly.2005.02.001; Mikata Y, 2001, J ORG CHEM, V66, P3783, DOI 10.1021/jo001702+; Mindt TL, 2006, J AM CHEM SOC, V128, P15096, DOI 10.1021/ja066779f; Gottschaldt M, 2009, EUR J INORG CHEM, P4298, DOI 10.1002/ejic.200900561; Comba P, 2006, J ORGANOMET CHEM, V691, P2495, DOI 10.1016/j.jorganchem.2006.01.068; Gottschaldt M, 2009, CHEM-EUR J, V15, P1548, DOI 10.1002/chem.200802013; Bayly SR, 2004, BIOCONJUGATE CHEM, V15, P923, DOI 10.1021/bc0499681; Gottschaldt M, 2007, CHEM-EUR J, V13, P10273, DOI 10.1002/chem.200700296; Ferreira CL, 2006, BIOCONJUGATE CHEM, V17, P1321, DOI 10.1021/bc060085e; Mikata Y, 2012, EUR J INORG CHEM, P217, DOI 10.1002/ejic.201100953; von Guggenberg E, 2004, BIOCONJUGATE CHEM, V15, P864, DOI 10.1021/bc0300807; Kolb HC, 2003, DRUG DISCOV TODAY, V8, P1128, DOI 10.1016/S1359-6446(03)02933-7; Gottschaldt M, 2009, DALTON T, P5148, DOI 10.1039/b901186b; Martin JN, 2005, J AM CHEM SOC, V127, P9518, DOI 10.1021/ja050794n; Yang DJ, 2003, RADIOLOGY, V226, P465, DOI 10.1148/radiol.2262011811; Chen XJ, 2006, BIOORG MED CHEM LETT, V16, P5503, DOI 10.1016/j.bmcl.2006.08.050; Struthers H, 2010, DALTON T, V39, P675, DOI 10.1039/b912608b; Dilworth JR, 2012, INORG CHIM ACTA, V389, P3, DOI 10.1016/j.ica.2012.02.019; Werz DB, 2005, CHEM-EUR J, V11, P3194, DOI 10.1002/chem.200500025; Pereira MA, 2008, EUR J PHARM SCI, V33, P42, DOI 10.1016/j.ejps.2007.09.007; Barandov A, 2014, CHEMBIOCHEM, V15, P986, DOI 10.1002/cbic.201400001; Barros A. L. B. sde, 2010, BIOORG MED CHEM LETT, V20, P2478; Barros A. L. B. sde, 2009, BIOORG MED CHEM LETT, V19, P2497; Barros A. L. B. sde, 2010, BIOORG MED CHEM LETT, V20, P315; Bowen ML, 2008, CHEM COMMUN, P5077, DOI 10.1039/b809365b; El-Mabhouh A, 2005, APPL RADIAT ISOTOPES, V62, P541, DOI 10.1016/j.apradiso.2004.10.004; Ferro-Flores G, 2008, ADV DRUG DELIVER REV, V60, P1389, DOI 10.1016/j.addr.2008.04.008; Giglio J, 2006, EUR J MED CHEM, V41, P1144, DOI 10.1016/j.ejmech.2006.05.006; HADFIELD AF, 1979, CARBOHYD RES, V77, P51, DOI 10.1016/S0008-6215(00)83792-1; Happ B, 2009, CHEM-ASIAN J, V4, P154, DOI 10.1002/asia.200800297; Howe J, 2008, CHEM PHYS LIPIDS, V155, P31, DOI 10.1016/j.chemphyslip.2008.07.002; Kothari KK, 2003, APPL RADIAT ISOTOPES, V58, P543, DOI 10.1016/S0969-8043(03)00030-7; La Bella R, 2002, NUCL MED BIOL, V29, P553, DOI 10.1016/S0969-8051(02)00314-1; Mikata Y, 2014, LIGAND DESIGN IN MEDICINAL INORGANIC CHEMISTRY, P145; Obata M, 2008, DALTON T, P3292, DOI 10.1039/b718538c; Papagiannopoulou D, 2010, POLYHEDRON, V29, P876, DOI 10.1016/j.poly.2009.10.009; Petrescu AJ, 2006, CURR OPIN STRUC BIOL, V16, P600, DOI 10.1016/j.sbi.2006.08.007; Pocci M, 2009, TETRAHEDRON, V65, P5684, DOI 10.1016/j.tet.2009.05.033; Morais GR, 2013, EUR J ORG CHEM, P1401, DOI 10.1002/ejoc.201201457; Savio E, 2004, BMC NUCL MED, V4, P1, DOI 10.1186/1471-2385-4-1; Seridi A, 2011, INORG CHEM COMMUN, V14, P238, DOI 10.1016/j.inoche.2010.11.002; Sharon N, 2006, BBA-GEN SUBJECTS, V1760, P527, DOI 10.1016/j.bbagen.2005.12.008; Storr T, 2005, DALTON T, P654, DOI 10.1039/b416040a; Storr T, 2005, CHEM-EUR J, V11, P195, DOI 10.1002/chem.200400719; Syed R, 2006, J NUCL MED, V47, P1927; Tamiaki H, 2009, J PHOTOCH PHOTOBIO A, V207, P115, DOI 10.1016/j.jphotochem.2009.01.008; Ures M., 2002, BMC NUCL MED, V2, P1, DOI 10.1186/1471-2385-2-1; Yano S, 2012, CHEM BIODIVERS, V9, P1903, DOI 10.1002/cbdv.201100426; Ye SF, 2004, INORG CHIM ACTA, V357, P3325, DOI 10.1016/j.ica.2004.03.040; Zhao YY, 2009, CARBOHYD RES, V344, P2137, DOI 10.1016/j.carres.2009.08.033	51	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1434-1948	1099-0682		EUR J INORG CHEM	Eur. J. Inorg. Chem.	DEC	2014		36					6290	6297		10.1002/ejic.201402881		8	Chemistry, Inorganic & Nuclear	Chemistry	AX1KG	WOS:000346705400019		
J	Rapanelli, M; Frick, LR; Pogorelov, V; Ota, KT; Abbasi, E; Ohtsu, H; Pittenger, C				Rapanelli, Maximiliano; Frick, Luciana R.; Pogorelov, Vladimir; Ota, Kristie T.; Abbasi, Eeman; Ohtsu, Hiroshi; Pittenger, Christopher			Dysregulated intracellular signaling in the striatum in a pathophysiologically grounded model of burette syndrome	EUROPEAN NEUROPSYCHOPHARMACOLOGY			English	Article						burette syndrome; Histamine; Dopamine; Basal ganglia; Striatum	HISTAMINE H-3 RECEPTOR; TOURETTE-SYNDROME; HISTIDINE-DECARBOXYLASE; DOPAMINE D-1; MAMMALIAN TARGET; IN-VIVO; KINASE; MICE; PHOSPHORYLATION; MODULATION	Tic disorders produce substantial morbidity, but their pathophysiology remains poorly understood. Convergent evidence suggests that dysregulation of the cortico-basal ganglia circuitry is central to the pathogenesis of tics. Tourette syndrome (TS), the most severe end of the continuum of tic disorders, is substantially genetic, but causative mutations have been elusive. We recently described a mouse model, the histidine decarboxylase (Hdc) knockout mouse, that recapitulates a rare, highly penetrant mutation found in a single family; these mice exhibit TS-like phenomenology. These animals have a global deficit in brain histamine and a consequent dysregulation of DA in the basal ganglia. Histamine modulation of DA effects is increasingly appreciated, but the mechanisms underlying this modulation remain unclear; the consequences of modest DA elevation in the context of profound HA deficiency are difficult to predict, but understanding them in the Hdc knockout mouse may provide generalizable insights into the pathophysiology of TS. Here we characterized signaling pathways in striatal cells in this model system, at baseline and after amphetamine challenge. In vivo microdialysis confirms elevated DA in Hdc-KO mice. We find dephosphorylation of Akt and its target GSK3 beta and activation of the MARK signaling cascade and its target rpS6; these are characteristic of the effects of DA on D2- and D1-expressing striatal neurons, respectively. Strikingly, there is no alteration in mTOR signaling, which can be regulated by DA in both cell types. These cellular effects help elucidate striatal signaling abnormalities in a uniquely validated mouse model of TS and move towards the identification of new potential therapeutic targets for tic disorders. (C) 2014 Elsevier B.V. and ECNP. All rights reserved.	[Rapanelli, Maximiliano; Frick, Luciana R.; Pogorelov, Vladimir; Ota, Kristie T.; Abbasi, Eeman; Pittenger, Christopher] Yale Univ, Dept Psychiat, New Haven, CT 06519 USA; [Pittenger, Christopher] Yale Univ, Dept Psychol, New Haven, CT 06519 USA; [Pittenger, Christopher] Yale Univ, Child Study Ctr, New Haven, CT 06519 USA; [Pittenger, Christopher] Yale Univ, Interdept Neurosci Program, New Haven, CT 06519 USA; [Rapanelli, Maximiliano; Frick, Luciana R.; Pogorelov, Vladimir; Ota, Kristie T.; Abbasi, Eeman; Pittenger, Christopher] Yale Univ, Ribicoff Res Facil, New Haven, CT 06519 USA; [Ohtsu, Hiroshi] Tohoku Univ, Grad Sch Engn, Sendai, Miyagi 980, Japan	Pittenger, C (reprint author), Yale Univ, Dept Psychiat, 34 Pk St,W315, New Haven, CT 06519 USA.	Christopher.pittenger@yale.edu			Allison Family Foundation; NIH [F32MH098513]; State of Connecticut	This work was funded by The Allison Family Foundation, NIH grant F32MH098513, and the State of Connecticut. The funders played no role in the design, execution, or interpretation of these experiments or in preparing the manuscript.	Prickaerts J, 2006, J NEUROSCI, V26, P9022, DOI 10.1523/JNEUROSCI.5216-05.2006; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Ellender TJ, 2011, J NEUROSCI, V31, P15340, DOI 10.1523/JNEUROSCI.3144-11.2011; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Bateup HS, 2008, NAT NEUROSCI, V11, P932, DOI 10.1038/nn.2153; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Urs NM, 2012, P NATL ACAD SCI USA, V109, P20732, DOI 10.1073/pnas.1215489109; Sutton LP, 2011, NEUROSCIENCE, V199, P116, DOI 10.1016/j.neuroscience.2011.09.056; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Ercan-Sencicek AG, 2010, NEW ENGL J MED, V362, P1901, DOI 10.1056/NEJMoa0907006; Beaulieu JM, 2007, J NEUROSCI, V27, P881, DOI 10.1523/JNEUROSCI.5074-06.2007; Bertran-Gonzalez J, 2008, J NEUROSCI, V28, P5671, DOI 10.1523/JNEUROSCI.1039-08.2008; Baym CL, 2008, BRAIN, V131, P165, DOI 10.1093/brain/awm278; Panula P, 2013, NAT REV NEUROSCI, V14, P472, DOI 10.1038/nrn3526; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Krusong K, 2011, NEUROSCI LETT, V495, P110, DOI 10.1016/j.neulet.2011.03.050; Wong DF, 2008, NEUROPSYCHOPHARMACOL, V33, P1239, DOI 10.1038/sj.npp.1301528; Moreno E, 2014, J NEUROSCI, V34, P3545, DOI 10.1523/JNEUROSCI.4147-13.2014; Albin RL, 2006, TRENDS NEUROSCI, V29, P175, DOI 10.1016/j.tins.2006.01.001; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Pillot C, 2002, NEUROSCIENCE, V114, P173, DOI 10.1016/S0306-4522(02)00135-5; Gerfen CR, 2002, J NEUROSCI, V22, P5042; Valjent E, 2005, P NATL ACAD SCI USA, V102, P491, DOI 10.1073/pnas.0408305102; Robertson MM, 2009, J PSYCHOSOM RES, V67, P475, DOI 10.1016/j.jpsychores.2009.07.010; Beaulieu JM, 2009, ANNU REV PHARMACOL, V49, P327, DOI 10.1146/annurev.pharmtox.011008.145634; Girault JA, 2007, CURR OPIN PHARMACOL, V7, P77, DOI 10.1016/j.coph.2006.08.012; Greengard P, 2001, BIOSCIENCE REP, V21, P247, DOI 10.1023/A:1013205230142; Ohtsu H, 2001, FEBS LETT, V502, P53, DOI 10.1016/S0014-5793(01)02663-1; Moreno E, 2011, J BIOL CHEM, V286, P5846, DOI 10.1074/jbc.M110.161489; Brami-Cherrier K, 2005, J NEUROSCI, V25, P11444, DOI 10.1523/JNEUROSCI.1711-05.2005; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Dere E, 2003, LEARN MEMORY, V10, P510, DOI 10.1101/lm.67603; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Bloch Michael H, 2008, Curr Psychiatry Rep, V10, P323, DOI 10.1007/s11920-008-0052-z; Baldan LC, 2014, NEURON, V81, P77, DOI 10.1016/j.neuron.2013.10.052; Davis LK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003864; Fernandez TV, 2012, BIOL PSYCHIAT, V71, P392, DOI 10.1016/j.biopsych.2011.09.034; Gerfen CR, 2008, J NEUROSCI, V28, P7113, DOI 10.1523/JNEUROSCI.3952-07.2008; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Karagiannidis I, 2012, MOL PSYCHIATR, V17, P665, DOI 10.1038/mp.2011.151; State MW, 2011, CURR OPIN GENET DEV, V21, P302, DOI 10.1016/j.gde.2011.01.007; Nishi A, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00043; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Pittenger C., 2014, ANIMAL MODELS MOVEME; Singer HS, 2002, AM J PSYCHIAT, V159, P1329, DOI 10.1176/appi.ajp.159.8.1329; Williams K., 2013, NEUROBIOLOGY MENTAL, Vfourth	50	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0924-977X	1873-7862		EUR NEUROPSYCHOPHARM	Eur. Neuropsychopharmacol.	DEC	2014	24	12					1896	1906		10.1016/j.euroneuro.2014.10.007		11	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	AX7LJ	WOS:000347097200004		
J	Kaseda, K; Goto, T; Emoto, K; Hayashi, Y				Kaseda, Kaoru; Goto, Taichiro; Emoto, Katsura; Hayashi, Yuichiro			Surgery for secondary pneumothorax caused by Hermansky-Pudlak syndrome	EUROPEAN RESPIRATORY JOURNAL			English	Letter							PULMONARY-FIBROSIS		[Kaseda, Kaoru; Goto, Taichiro] Keio Univ, Sch Med, Dept Surg, Div Gen Thorac Surg, Tokyo 1608582, Japan; [Emoto, Katsura; Hayashi, Yuichiro] Keio Univ, Sch Med, Dept Pathol, Tokyo 1608582, Japan	Goto, T (reprint author), Keio Univ, Sch Med, Dept Surg, Div Gen Thorac Surg,Shinjuku Ku, Tokyo 1608582, Japan.	taichiro@l997.jukuin.keio.ac.jp	Emoto, Katsura/D-5543-2014				Pierson DM, 2006, RESPIRATION, V73, P382, DOI 10.1159/000091609; Nakatani Y, 2000, VIRCHOWS ARCH, V437, P304, DOI 10.1007/s004280000241; Huizing M, 2002, PIGM CELL RES, V15, P405, DOI 10.1034/j.1600-0749.2002.02074.x; Lederer DJ, 2005, J HEART LUNG TRANSPL, V24, P1697, DOI 10.1016/j.healun.2004.11.015	4	0	0	EUROPEAN RESPIRATORY SOC JOURNALS LTD	SHEFFIELD	442 GLOSSOP RD, SHEFFIELD S10 2PX, ENGLAND	0903-1936	1399-3003		EUR RESPIR J	Eur. Resp. J.	DEC	2014	44	6					1715	1717				3	Respiratory System	Respiratory System	AY0DH	WOS:000347267500038		
J	Kondo, H; Kawana, Y; Suzuki, Y; Hirono, I				Kondo, Hidehiro; Kawana, Yuriko; Suzuki, Yoshiaki; Hirono, Ikuo			Comprehensive gene expression profiling in Japanese flounder kidney after injection with two different formalin-killed pathogenic bacteria	FISH & SHELLFISH IMMUNOLOGY			English	Article						Japanese flounder; Edwardsiella tarda; Microarray; Streptococcus iniae	GRAM-NEGATIVE BACTERIA; PARALICHTHYS-OLIVACEUS; ANTIBODY-PRODUCTION; FISH; RECOGNITION; BIOACTIVITY; INFECTION; ENDOTOXIN; VACCINES; MEDIATOR	Pathogenic bacteria possess some components, that are recognized by the host immune receptors. Different components are recognized by distinct receptors, and thus it is speculated that these components may regulate different gene sets. To investigate the gene expression profiles regulated by different bacterial components in Japanese flounder Paralichthys olivaceus, Japanese flounder were intraperitoneally injected with formalin-killed bacterial cells (FKC) of Edwardsiella tarda and Streptococcus iniae. The numbers of differentially regulated genes were much larger in the fish injected with E. tarda than those with S. iniae. Comprehensive gene expression profiling showed that almost all of the genes differentially regulated by injections of E. tarda FKC were also differentially regulated by injections of S. iniae FKC. mRNA levels of inflammatory cytokines, including interleukin (IL)-1 beta, IL-8, interferon gamma and tumor necrosis factor were upregulated in both of the injected groups. Each of these mRNAs except for IL-8 mRNA were also much higher in the E. tarda FKC injected group than in the S. iniae FKC injected group. Furthermore, mRNA levels of IL-6 were strongly up-regulated in the E. tarda FKC injected group. The E. tarda FKC might induce higher inflammatory responses than S. iniae FKC. (C) 2014 Elsevier Ltd. All rights reserved.	[Kondo, Hidehiro; Kawana, Yuriko; Suzuki, Yoshiaki; Hirono, Ikuo] Tokyo Univ Marine Sci & Technol, Lab Genome Sci, Grad Sch, Minato Ku, Tokyo 1088477, Japan	Kondo, H (reprint author), Tokyo Univ Marine Sci & Technol, Lab Genome Sci, Minato Ku, Konan 4-5-7, Tokyo 1088477, Japan.	h-kondo@kaiyodai.ac.jp	KONDO, Hidehiro/O-1954-2014; HIRONO, Ikuo/O-1940-2014	KONDO, Hidehiro/0000-0001-5102-6831; 	JSPS	This work was supported in part by grants from JSPS Grant-inAid for Young Scientists (B).	MacKenzie SA, 2010, MOL IMMUNOL, V47, P1450, DOI 10.1016/j.molimm.2010.02.009; Dumrongphol Y, 2009, FISH SHELLFISH IMMUN, V26, P197, DOI 10.1016/j.fsi.2008.03.014; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Taechavasonyoo A, 2013, FISH SHELLFISH IMMUN, V34, P393, DOI 10.1016/j.fsi.2012.10.001; Swain P, 2008, FISH SHELLFISH IMMUN, V25, P191, DOI 10.1016/j.fsi.2008.04.009; Lin B, 2007, MOL IMMUNOL, V44, P295, DOI 10.1016/j.molimm.2006.03.001; Sommerset I, 2005, EXPERT REV VACCINES, V4, P89, DOI 10.1586/14760584.4.1.89; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Matsuyama T, 2007, FISH SHELLFISH IMMUN, V22, P598, DOI 10.1016/j.fsi.2006.08.006; Aoki Takashi, 2008, P263; Chen HH, 2012, DEV COMP IMMUNOL, V38, P285, DOI 10.1016/j.dci.2012.06.013; Costa MM, 2011, MOL IMMUNOL, V48, P1903, DOI 10.1016/j.molimm.2011.05.027; DeClue AE, 2012, VET J, V192, P455, DOI 10.1016/j.tvjl.2011.09.001; Hastein T., 2005, V121, P55; Kaneda M, 2012, DEV COMP IMMUNOL, V38, P224, DOI 10.1016/j.dci.2012.02.002; Nakatsugawa T., 1983, Fish Pathology, V18, P99; Nguyen HT, 1999, J APPL MICROBIOL, V86, P769, DOI 10.1046/j.1365-2672.1999.00724.x; Tietze K, 2006, J PERIODONTAL RES, V41, P447, DOI 10.1111/j.1600-0765.2006.00890.x	19	3	3	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1050-4648	1095-9947		FISH SHELLFISH IMMUN	Fish Shellfish Immunol.	DEC	2014	41	2					437	440		10.1016/j.fsi.2014.09.038		4	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	AX6FB	WOS:000347017500039		
J	Zou, Y; Sun, QR; Li, J; Yang, C; Yang, JW; Zhang, LF				Zou, Ying; Sun, Qingrui; Li, Jing; Yang, Cheng; Yang, Jinwe; Zhang, Lianfu			Effects of E/Z isomers of lycopene on experimental prostatic hyperplasia in mice	FITOTERAPIA			English	Article						Benign prostatic hyperplasia (BPH); Z-isomers; All-E lycopene	CANCER; RATS; CAROTENOIDS; TRANS; RISK	Aim: Lycopene is a member of the carotenoid family and has strong anti-oxidant properties. Lycopene occurs in tomato-based food products primarily as an all-E isomer (80-97%),but its Z-isomers accounts for 79 to 88% of total lycopene in benign or malignant prostate tissues, while the specific biological functions of Z-isomers are still not clarified at present. This study was to examine the bioactive potency of Z-isomers on benign prostatic hyperplasia (BPH) in mice and to make a comparison of effective inhibition between Z-isomers and all-E isomer. Method: Mice were divided into the Saline group, Vehicle control group and testosterone propionate induced BPH mice group (BPH model group, vehicle BPH model group, lycopene treated (5 mg/kg and 2.5 mg/kg), Z-isomers (57%) treated, Z-isomers (86%) treated, finasteride treated). The drugs were orally administered once a day consecutively for 30 days. The inhibitory effects on BPH of all-E lycopene and Z-isomers were evaluated by prostatic index, prostatic acid phosphatase (PAP), estradiol, testosterone and dihydrotestosterone (DHT) levels in serum and histopathology examination. Results: Compared with the BPH model group, E/Z isomers exhibited significant differences in prostatic index, PAP, estradiol, testosterone and DHT levels in serum and similar histological aspects observed in the mice of the control group. The present research also shows that Z-isomers may be more potent inhibitors than all-E isomers in BPH treatment. (C) 2014 Elsevier B.V. All rights reserved.	[Zou, Ying; Zhang, Lianfu] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Peoples R China; [Zou, Ying; Sun, Qingrui; Li, Jing; Yang, Cheng; Zhang, Lianfu] Jiangnan Univ, Sch Food Sci & Technol, Wuxi 214122, Peoples R China; [Sun, Qingrui; Li, Jing; Yang, Cheng; Zhang, Lianfu] Jiangnan Univ, Natl Engn Res Ctr Funct Food, Wuxi 214122, Peoples R China; [Yang, Jinwe] Tokiwa Phytochem Co Ltd, Sakura, Chiba 2850801, Japan	Zhang, LF (reprint author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi 214122, Peoples R China.	lianfu@jiangnan.edu.cn			National Natural Science Foundation of China [31171724]; National Key Technology R&D Program for the 12th five-year plan [2012BAD33B05]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20130093110008]	This work was supported by grants from the National Natural Science Foundation of China (31171724), National Key Technology R&D Program for the 12th five-year plan (2012BAD33B05) and Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP 20130093110008).	Agrawal M, 2012, EUR J INTEGR MED, V4, pE177, DOI 10.1016/j.eujim.2012.01.004; Boileau TWM, 2002, EXP BIOL MED, V227, P914; Honest KN, 2011, FOOD REV INT, V27, P248, DOI 10.1080/87559129.2011.563392; Guo QL, 2004, BIOL PHARM BULL, V27, P333, DOI 10.1248/bpb.27.333; Shin IS, 2012, FOOD CHEM TOXICOL, V50, P884, DOI 10.1016/j.fct.2012.01.007; Clinton SK, 1996, CANCER EPIDEM BIOMAR, V5, P823; Mohanty NK, 2005, UROL ONCOL-SEMIN ORI, V23, P383, DOI 10.1016/j.urolonc.2005.05.012; Ilic D, 2012, MATURITAS, V72, P269, DOI 10.1016/j.maturitas.2012.04.014; Britton G, 1995, FASEB J, V9, P1551; Rittmaster RS, 2008, BEST PRACT RES CL EN, V22, P389, DOI 10.1016/j.beem.2008.01.016; Wertz K, 2004, ARCH BIOCHEM BIOPHYS, V430, P127, DOI 10.1016/j.abb.2004.04.023; van Breemen RB, 2011, CANCER PREV RES, V4, P711, DOI 10.1158/1940-6207.CAPR-10-0288; Huawei Z., 2013, International Food Research Journal, V20, P3229; Mirone V, 2006, EUR UROL SUPPL, V5, P410, DOI 10.1016/j.eursup.2006.02.004; Obermuiller-Jevic Ute C, 2003, J NUTR, V133, P3356; Obermuller Jevic UC, 2003, BIOCH MOL ACTIONS NU, P3356; Parsons JK, 2012, EUR UROL, V62, P234, DOI 10.1016/j.eururo.2012.03.007; Silke Schwarz UCO-J, 2008, J NUTR, V138, P49; Sun H, 2008, J ETHNOPHARMACOL, V115, P203, DOI 10.1016/j.jep.2007.09.026; Xu DH, 2014, ENVIRON TOXICOL PHAR, V37, P1; Zhang HJ, 2013, J ETHNOPHARMACOL, V145, P667, DOI 10.1016/j.jep.2012.11.027; Zu K, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt430	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0367-326X	1873-6971		FITOTERAPIA	Fitoterapia	DEC	2014	99						211	217		10.1016/j.fitote.2014.09.013		7	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX6FQ	WOS:000347019000027		
J	Wahyuni, TS; Widyawaruyanti, A; Lusida, MI; Fuad, A; Soetjipto; Fuchino, H; Kawahara, N; Hayashi, Y; Aoki, C; Hotta, H				Wahyuni, Tutik Sri; Widyawaruyanti, Aty; Lusida, Maria Inge; Fuad, Achmad; Soetjipto; Fuchino, Hiroyuki; Kawahara, Nobuo; Hayashi, Yoshitake; Aoki, Chie; Hotta, Hak			Inhibition of hepatitis C virus replication by chalepin and pseudane IX isolated from Ruta angustifolia leaves	FITOTERAPIA			English	Article						Hepatitis C virus; Ruta angustifolia; Rutaceae; Post-entry inhibition; Alkaloid; Coumarin	MEDICINAL-PLANTS; CELL-CULTURE; GRAVEOLENS; ALKALOIDS; CONSTITUENTS; DERIVATIVES; COUMARINS; EXTRACT; STEM; HCV	Hepatitis C virus (HCV) infection is highly prevalent among global populations, with an estimated number of infected patients being 170 million. Approximately 70-80% of patients acutely infected with HCV will progress to chronic liver disease, such as liver cirrhosis and hepatocellular carcinoma, which is a substantial cause of morbidity and mortality worldwide. New therapies for HCV infection have been developed, however, the therapeutic efficacies still need to be improved. Medicinal plants are promising sources for antivirals against HCV. A variety of plants have been tested and proven to be beneficial as antiviral drug candidates against HCV. In this study, we examined extracts, their subfractions and isolated compounds of Ruta angustifolia leaves for antiviral activities against HCV in cell culture. We isolated six compounds, chalepin, scopoletin, gamma-fagarine, arborinine, kokusaginine and pseudane IX. Among them, chalepin and pseudane IX showed strong anti-HCV activities with 50% inhibitory concentration (IC50) of 1.7 +/- 0.5 and 1.4 +/- 0.2 mu g/ml, respectively, without apparent cytotoxicity. Their anti-HCV activities were stronger than that of ribavirin (2.8 +/- 0.4 mu g/ml), which has been widely used for the treatment of HCV infection. Mode-of-action analyses revealed that chalepin and pseudane IX inhibited HCV at the post-entry step and decreased the levels of HCV RNA replication and viral protein synthesis. We also observed that arborinine, kokusaginine and gamma-fagarine possessed moderate levels of anti-HCV activities with IC50 values being 6.4 +/- 0.7, 6.4 +/- 1.6 and 20.4 +/- 0.4 mu g/ml, respectively, whereas scopoletin did not exert significant anti-HCV activities at 30 mu g/ml. (C) 2014 Elsevier B.V. All rights reserved.	[Wahyuni, Tutik Sri; Hotta, Hak] Kobe Univ, Grad Sch Med, Div Microbiol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Wahyuni, Tutik Sri; Widyawaruyanti, Aty; Fuad, Achmad] Airlangga Univ, Fac Pharm, Dept Pharmacognocy & Phytochem, Surabaya, Surabaya, Indonesia; [Lusida, Maria Inge; Soetjipto] Airlangga Univ, Inst Trop Dis, Jl Mulyorejo 60115, Surabaya, Indonesia; [Fuchino, Hiroyuki; Kawahara, Nobuo] Natl Inst Biomed Innovat, Res Ctr Med Plant Resources, Tsukuba, Ibaraki 3050843, Japan; [Hayashi, Yoshitake] Kobe Univ, Grad Sch Med, Div Infect Dis Pathol, Chuo Ku, Kobe, Hyogo 6500017, Japan	Hotta, H (reprint author), Kobe Univ, Grad Sch Med, Div Microbiol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hotta@kobe-u.ac.jp			Science and Technology Research Partnerships for Sustainable Development (SATREPS); Japan Science and Technology Agency; Japan International Cooperation Agency [55]	The authors are grateful to Dr. C. M. Rice (The Rockefeller University, New York, NY) for providing Huh-7.5 cells and pFL-J6/JFH1. This work was supported in part by Science and Technology Research Partnerships for Sustainable Development (SATREPS) supported by the Japan Science and Technology Agency, and the Japan International Cooperation Agency (55)	Anaya AL, 2005, PHYTOCHEMISTRY, V66, P487, DOI 10.1016/j.phytochem.2004.12.028; Lange CM, 2014, EMBO MOL MED, V6, P4, DOI 10.1002/emmm.201303131; Milesi S, 2001, PLANT SCI, V161, P189, DOI 10.1016/S0168-9452(01)00413-7; Kumar DV, 2011, BIOORG MED CHEM LETT, V21, P82, DOI 10.1016/j.bmcl.2010.11.068; Adianti M, 2014, MICROBIOL IMMUNOL, V58, P180, DOI 10.1111/1348-0421.12127; Neyts J, 2009, J MED CHEM, V52, P1486, DOI 10.1021/jm801240d; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Rupp D, 2014, SEMIN LIVER DIS, V34, P9, DOI 10.1055/s-0034-1371006; Calland N, 2012, VIRUSES-BASEL, V4, P2197, DOI 10.3390/v4102197; Ploss A, 2012, GUT, V61, P25, DOI 10.1136/gutjnl-2012-302048; Pollio A, 2008, J ETHNOPHARMACOL, V116, P469, DOI 10.1016/j.jep.2007.12.013; Veiga TM, 2013, J PHOTOCH PHOTOBIO B, V120, P36, DOI 10.1016/j.jphotobiol.2013.01.006; Bungyoku Y, 2009, J GEN VIROL, V90, P1681, DOI 10.1099/vir.0.010983-0; Adebajo AC, 2009, J ETHNOPHARMACOL, V122, P10, DOI 10.1016/j.jep.2008.11.015; Bodendiek SB, 2009, EUR J MED CHEM, V44, P1838, DOI 10.1016/j.ejmech.2008.10.033; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; Min YD, 2007, ARCH PHARM RES, V30, P58, DOI 10.1007/BF02977779; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Rollinger JM, 2009, PLANTA MED, V75, P195, DOI 10.1055/s-0028-1088397; Wu TS, 2003, J CHIN CHEM SOC-TAIP, V50, P171; Peng XM, 2013, CURR PHARM DESIGN, V19, P3884, DOI 10.2174/1381612811319210013; Heeb S, 2011, FEMS MICROBIOL REV, V35, P247, DOI 10.1111/j.1574-6976.2010.00247.x; Nichols DB, 2013, CHEM BIOL DRUG DES, V81, P607, DOI 10.1111/cbdd.12105; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Ashfaq UA, 2014, WORLD J GASTROENTERO, V20, P2941, DOI 10.3748/wjg.v20.i11.2941; Cuca Suarez LE, 2009, NAT PROD RES, V23, P370; DELCASTILLO JB, 1986, PHYTOCHEMISTRY, V25, P2209, DOI 10.1016/0031-9422(86)80093-0; DELCASTILLO JB, 1984, PHYTOCHEMISTRY, V23, P2095, DOI 10.1016/S0031-9422(00)84991-2; EMEROLE G, 1981, TOXICOLOGY, V20, P71, DOI 10.1016/0300-483X(81)90107-4; Fuchino H, 2008, CHEM PHARM BULL, V56, P93, DOI 10.1248/cpb.56.93; Fuchino H, 2013, CHEM PHARM BULL, V61, P497, DOI 10.1248/cpb.c12-00670; GRAY AI, 1978, PHYTOCHEMISTRY, V17, P845, DOI 10.1016/S0031-9422(00)88634-3; Haque MM, 2013, PHARMACOGN MAG, V9, P76, DOI 10.4103/0973-1296.108147; Ireton RC, 2014, ANTIVIR RES, V108, P156, DOI 10.1016/j.antiviral.2014.05.012; Kannan R, 2012, Anc Sci Life, V32, P16, DOI 10.4103/0257-7941.113792; Khan IA, 2012, ANTIVIR THER, V17, P467, DOI 10.3851/IMP1937; Liu WK, 2012, BIOORG MED CHEM LETT, V22, P5008, DOI 10.1016/j.bmcl.2012.06.014; MOHAN PS, 1985, J NAT PROD, V48, P501, DOI 10.1021/np50039a034; MOHR N, 1982, PHYTOCHEMISTRY, V21, P1838; NICOLETTI M, 1982, PLANTA MED, V45, P250, DOI 10.1055/s-2007-971386; OLORUNSOGO OO, 1983, TOXICOL LETT, V15, P323, DOI 10.1016/0378-4274(83)90151-0; Ratnoglik SL, 2014, MICROBIOL IMMUNOL, V58, P188, DOI 10.1111/1348-0421.12133; Ravikumar YS, 2011, VIRUS RES, V158, P89, DOI 10.1016/j.virusres.2011.03.014; Rethy B, 2007, PLANTA MED, V73, P41, DOI 10.1055/s-2006-951747; Richter Sara, 2004, Current Drug Targets - Infectious Disorders, V4, P111, DOI 10.2174/1568005043340920; Shoji Ikuo, 2011, Front Microbiol, V2, P278, DOI 10.3389/fmicb.2011.00278; SOMANATHAN R, 1981, J HETEROCYCLIC CHEM, V18, P1077; Wahyuni TS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-259; WIJERATNE EMK, 1992, J NAT PROD, V55, P1261, DOI 10.1021/np50087a013	49	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0367-326X	1873-6971		FITOTERAPIA	Fitoterapia	DEC	2014	99						276	283		10.1016/j.fitote.2014.10.011		8	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	AX6FQ	WOS:000347019000035		
J	Toyoda, T; Cho, YM; Mizuta, Y; Akagi, J; Ogawa, K				Toyoda, Takeshi; Cho, Young-Man; Mizuta, Yasuko; Akagi, Jun-ichi; Ogawa, Kumiko			A 13-week subchronic toxicity study of ferric citrate in F344 rats	FOOD AND CHEMICAL TOXICOLOGY			English	Article						Ferric citrate; Food additive; Subchronic toxicity; F344 rats; Eosinophilic enteritis	HEMODIALYSIS-PATIENTS; DIETARY IRON; HYPERPHOSPHATEMIA; TRIAL	Ferric citrate has been used as a food additive for supplementation of iron. We performed a 13-week subchronic toxicity study of ferric citrate in F344 rats with oral administration in the diet at concentrations of 0%, 0.25%, 1.0%, and 4.0%. Reduction of body weight gain was noted in 4.0% males and females. On hematology assessment, decreases of red blood cells and lymphocytes and increases of platelets and eosinophils were noted in 4.0% males and females. Serum biochemistry demonstrated increased iron and decreased total protein and transferrin in both sexes treated with 4.0% ferric citrate. In addition, an increase of serum inorganic phosphorus levels was noted in 4.0% females. Regarding organ weights, an increase of relative spleen weights was detected in 4.0% males and females and a decrease of absolute and relative heart weights in 4.0% females. On histopathological assessment, colitis with infiltration of eosinophils and hyperplasia of mucosal epithelium, eosinophilic infiltration in mesenteric lymph nodes, and increased hemosiderosis in spleen were observed as treatment-related toxicological changes in 4.0% males and females. Based on the results, the no-observed-adverse-effect level (NOAEL) of ferric citrate was estimated to be 1.0% (596 mg/kg bw/day for males and 601 mg/kg bw/day for females). (C) 2014 Elsevier Ltd. All rights reserved.	[Toyoda, Takeshi; Cho, Young-Man; Mizuta, Yasuko; Akagi, Jun-ichi; Ogawa, Kumiko] Natl Inst Hlth Sci, Div Pathol, Tokyo 1588501, Japan; [Akagi, Jun-ichi] Natl Inst Hlth Sci, Div Pharmacol, Tokyo 1588501, Japan	Toyoda, T (reprint author), Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	t-toyoda@nihs.go.jp			Research on Food Sanitation from the Ministry of Health, Labour and Welfare of Japan	We thank Ayako Saikawa and Yoshimi Komatsu for expert technical assistance in processing histological materials. This study was supported by a grant for Research on Food Sanitation from the Ministry of Health, Labour and Welfare of Japan.	Yang WC, 2002, NEPHROL DIAL TRANSPL, V17, P265, DOI 10.1093/ndt/17.2.265; Rothenberg ME, 2004, J ALLERGY CLIN IMMUN, V113, P11, DOI 10.1016/j.jaci.2003.10.047; Dwyer JP, 2013, AM J KIDNEY DIS, V61, P759, DOI 10.1053/j.ajkd.2012.11.041; Gkouvatsos K, 2012, BBA-GEN SUBJECTS, V1820, P188, DOI 10.1016/j.bbagen.2011.10.013; Onami S, 2014, ARCH TOXICOL, V88, P871, DOI 10.1007/s00204-013-1190-6; Yokoyama K, 2012, AM J NEPHROL, V36, P478, DOI 10.1159/000344008; Greaves P, 2012, HISTOPATHOLOGY OF PRECLINICAL TOXICITY STUDIES: INTERPRETATION AND RELEVANCE IN DRUG SAFETY EVALUATION, 4TH EDITION, P263, DOI 10.1016/B978-0-444-53856-7.00007-5; HONG CB, 1988, EXP MOL PATHOL, V48, P182, DOI 10.1016/0014-4800(88)90055-X; INAI K, 1994, FOOD CHEM TOXICOL, V32, P493, DOI 10.1016/0278-6915(94)90104-X; ISHIDATE M, 1984, FOOD CHEM TOXICOL, V22, P623, DOI 10.1016/0278-6915(84)90271-0; lida A., 2013, AM J NEPHROL, V37, P346; MacKenzie WF, 1990, PATHOLOGY FISCHER RA, P461; Ministry of Health Labour and Welfare of Japan, 2009, JAP SPEC STAND FOOD; Ministry of Health Labour and Welfare of Japan, 1996, GUID DES FOOD ADD RE; Montgomery C. A., 1990, PATHOLOGY FISCHER RA, P127; Narama I, 1999, TOXICOL PATHOL, V27, P318, DOI 10.1177/019262339902700307; Nastou D, 2014, DRUGS, V74, P863, DOI 10.1007/s40265-014-0224-6; Shirase T, 2010, AM J PATHOL, V177, P677, DOI 10.2353/ajpath.2010.090823; Sinsakul M, 2012, NEPHRON CLIN PRACT, V121, pC25, DOI 10.1159/000341922; Toyoda T, 2014, J TOXICOL SCI, V39, P109; Toyoda T., 2013, JPN J FOOD CHEM SAFE, V20, P52; Wyllie S, 1998, CARCINOGENESIS, V19, P1285, DOI 10.1093/carcin/19.7.1285	22	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-6915	1873-6351		FOOD CHEM TOXICOL	Food Chem. Toxicol.	DEC	2014	74						68	75		10.1016/j.fct.2014.09.005		8	Food Science & Technology; Toxicology	Food Science & Technology; Toxicology	AY0GD	WOS:000347274600010		
J	Lennon, W; Hecht-Nielsen, R; Yamazaki, T				Lennon, William; Hecht-Nielsen, Robert; Yamazaki, Tadashi			A spiking network model of cerebellar Purkinje cells and molecular layer interneurons exhibiting irregular firing	FRONTIERS IN COMPUTATIONAL NEUROSCIENCE			English	Article						molecular layer interneurons; Purkinje cells; cerebellum; irregular firing; inter-spike interval	ACTIVE MEMBRANE MODEL; STELLATE CELLS; BIDIRECTIONAL PLASTICITY; SYNAPTIC INHIBITION; RAT CEREBELLUM; NEURAL MODEL; MEMORY TRACE; CORTEX; NEURONS; NUCLEI	While the anatomy of the cerebellar microcircuit is well-studied, how it implements cerebellar function is not understood. A number of models have been proposed to describe this mechanism but few emphasize the role of the vast network Purkinje cells (PKJs) form with the molecular layer interneurons (MLIs)-the stellate and basket cells. We propose a model of the MLI-PKJ network composed of simple spiking neurons incorporating the major anatomical and physiological features. In computer simulations, the model reproduces the irregular firing patterns observed in PKJs and MLIs in vitro and a shift toward faster, more regular firing patterns when inhibitory synaptic currents are blocked. In the model, the time between PKJ spikes is shown to be proportional to the amount of feedforward inhibition from an MLI on average. The two key elements of the model are: (1) spontaneously active PKJs and MLIs due to an endogenous depolarizing current, and (2) adherence to known anatomical connectivity along a parasagittal strip of cerebellar cortex. We propose this model to extend previous spiking network models of the cerebellum and for further computational investigation into the role of irregular firing and MLIs in cerebellar learning and function.	[Lennon, William; Hecht-Nielsen, Robert] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Yamazaki, Tadashi] Univ Electrocommun, Grad Sch Informat & Engn, Chofu, Tokyo 182, Japan	Lennon, W (reprint author), Univ Calif San Diego, Dept Elect & Comp Engn, 9500 Gilman Dr, La Jolla, CA 92093 USA.	wlennon@ucsd.edu			U.S. Office of Naval Research [N00014-12-1-0588]	The authors would like to thank Professor Nobito Yamamoto, the Japan Society for the Promotion of Science (#SP13031) and the U.S. National Science Foundation (#OISE-1308822) for making this collaboration possible. WL and RH-N gratefully acknowledge funding from the U.S. Office of Naval Research (#N00014-12-1-0588). WL would like to acknowledge Soichi Nagao, Mehrdad Yazdani and Geoffrey Gamble for useful discussions.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P401; Medina JF, 2000, J NEUROSCI, V20, P5516; Jorntell H, 2010, TRENDS NEUROSCI, V33, P524, DOI 10.1016/j.tins.2010.08.004; Sultan F, 1998, J COMP NEUROL, V393, P353; Person AL, 2012, NATURE, V481, P502, DOI 10.1038/nature10732; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P375; Jirenhed DA, 2007, J NEUROSCI, V27, P2493, DOI 10.1523/JNEUROSCI.4202-06.2007; Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697; KORBO L, 1993, BRAIN RES, V609, P262, DOI 10.1016/0006-8993(93)90881-M; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Liu SQJ, 2000, NATURE, V405, P454; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; Raman IM, 1997, J NEUROSCI, V17, P4517; Smith SL, 2005, P NATL ACAD SCI USA, V102, P14901, DOI 10.1073/pnas.0505028102; Cerminara NL, 2004, J NEUROSCI, V24, P4510, DOI 10.1523/JNEUROSCI.4530-03.2004; Lachamp PM, 2009, J NEUROSCI, V29, P381, DOI 10.1523/JNEUROSCI.2354-08.2009; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; PUIA G, 1994, NEURON, V12, P117, DOI 10.1016/0896-6273(94)90157-0; Santamaria F, 2007, J NEUROPHYSIOL, V97, P248, DOI 10.1152/jn.01098.2005; FUJITA M, 1982, BIOL CYBERN, V45, P195, DOI 10.1007/BF00336192; Jorntell H, 2003, J NEUROSCI, V23, P9620; Watt AJ, 2009, NAT NEUROSCI, V12, P463, DOI 10.1038/nn.2285; Wulff P, 2009, NAT NEUROSCI, V12, P1042, DOI 10.1038/nn.2348; Schweighofer N, 1998, EUR J NEUROSCI, V10, P95, DOI 10.1046/j.1460-9568.1998.00007.x; Maex R, 2003, J NEUROSCI, V23, P10503; Raman IM, 1999, J NEUROSCI, V19, P1663; Pugh JR, 2008, J NEUROSCI, V28, P10549, DOI 10.1523/JNEUROSCI.2061-08.2008; Gao ZY, 2012, NAT REV NEUROSCI, V13, P619, DOI 10.1038/nrn3312; Apps R, 2009, NAT REV NEUROSCI, V10, P670, DOI 10.1038/nrn2698; Ruigrok TJH, 2011, J NEUROSCI, V31, P712, DOI 10.1523/JNEUROSCI.1959-10.2011; Heiney SA, 2014, J NEUROSCI, V34, P2321, DOI 10.1523/JNEUROSCI.4547-13.2014; Dean P, 2010, NAT REV NEUROSCI, V11, P30, DOI 10.1038/nrn2756; Rancillac A, 2004, J PHYSIOL-LONDON, V554, P707, DOI 10.1113/jphysiol.2003.055871; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/S0896-6273(04)00528-8; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Bower JM, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00027; CHANPALA.V, 1971, Z ANAT ENTWICKLUNGS, V134, P200, DOI 10.1007/BF00519300; Chu CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037031; Clopath C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002448; ContrerasVidal JL, 1997, LEARN MEMORY, V3, P475, DOI 10.1101/lm.3.6.475; Eccles J, 1967, CEREBELLUM NEURONAL; Gerstner W., 2002, SPIKING NEURON MODEL; Goodman Dan F M, 2009, Front Neurosci, V3, P192, DOI 10.3389/neuro.01.026.2009; Grossberg S., 1969, STUD APPL MATH, P105; HAWKES R, 1989, BRAIN RES, V476, P279, DOI 10.1016/0006-8993(89)91248-1; Ito M, 1984, CEREBELLUM NEURAL CO; Kassardjian CD, 2005, J NEUROSCI, V25, P7979, DOI 10.1523/JNEUROSCI.2215-05.2005; Kondo S, 1998, J PHYSIOL-LONDON, V509, P221, DOI 10.1111/j.1469-7793.1998.221bo.x; Maex R, 2013, EUR J NEUROSCI, V38, P2917, DOI 10.1111/ejn.12272; MARR D, 1969, J PHYSIOL-LONDON, V202, P437; McElvain LE, 2010, NEURON, V68, P763, DOI 10.1016/j.neuron.2010.09.025; MIDTGAARD J, 1992, J PHYSIOL-LONDON, V457, P329; ODONOGHUE DL, 1989, J NEUROSCI, V9, P2141; Palay S. L., 1974, CERBELLAR CORTEX CYT; PALKOVIT.M, 1971, BRAIN RES, V32, P1, DOI 10.1016/0006-8993(71)90151-X; Person AL, 2010, NEURON, V66, P550, DOI 10.1016/j.neuron.2010.04.024; Phoka E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000768; Yamazaki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033319	60	0	0	FRONTIERS RESEARCH FOUNDATION	LAUSANNE	PO BOX 110, LAUSANNE, 1015, SWITZERLAND	1662-5188			FRONT COMPUT NEUROSC	Front. Comput. Neurosci.	DEC 1	2014	8						1	10		10.3389/fncom.2014.00157		10	Mathematical & Computational Biology; Neurosciences	Mathematical & Computational Biology; Neurosciences & Neurology	AY1SX	WOS:000347373300001		
J	Hirooka, Y; Zhou, H; Ono, M				Hirooka, Yoshi; Zhou, Haishan; Ono, Masa			Hydrogen and helium recycling from stirred liquid lithium under steady state plasma bombardment	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	3rd International Symposium on Lithium Application for Fusion Devices (ISLA)	OCT, 2013	ENEA Frascati Ctr, Frascati, ITALY		ENEA Frascati Ctr	Plasma-surface interactions; Liquid metal divertor; Lithium; Hydrogen recycling; Helium recycling; Oxygen-containing impurity		For improved core performance via edge plasma-wall boundary control, solid and liquid lithium has been used as a plasma-facing material in a number of confinement experiments over the past several decades. Unfortunately, it is unavoidable that lithium is saturated in the surface region with implanted hydrogenic species as well as oxygen-containing impurities. For steady state operation, a flowing liquid lithium divertor with forced convection would probably be required. In the present work, the effects of liquid stirring to simulate forced convection have been investigated on the behavior of hydrogen and helium recycling from molten lithium at temperatures up to 350 C. Data indicate that liquid stirring reactivates hydrogen pumping via surface de-saturation and/or uncovering impurity films, but can also induce helium release via surface temperature change. (C) 2014 Elsevier B.V. All rights reserved.	[Hirooka, Yoshi] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Hirooka, Yoshi; Zhou, Haishan] Grad Sch Adv Studies, Toki, Gifu 5095292, Japan; [Ono, Masa] Princeton Plasma Phys Lab, Princeton, NJ 08543 USA	Hirooka, Y (reprint author), Natl Inst Fus Sci, 322-6 Oroshi, Toki, Gifu 5095292, Japan.	hirooka.yoshihiko@nifs.ac.jp					ADAMS PF, 1975, J LESS-COMMON MET, V42, P325, DOI 10.1016/0022-5088(75)90052-1; Kugel HW, 2012, FUSION ENG DES, V87, P1724, DOI 10.1016/j.fusengdes.2011.07.010; Hirooka Y, 2006, NUCL FUSION, V46, pS56, DOI 10.1088/0029-5515/46/3/S08; Doerner RP, 2003, J NUCL MATER, V313, P383, DOI 10.1016/S0022-3115(02)01359-4; Hirooka Y, 2010, FUSION ENG DES, V85, P838, DOI 10.1016/j.fusengdes.2010.04.025; Hirooka Y, 2005, J NUCL MATER, V337, P585, DOI [10.1016/j.jnucmat.2004.09.065, 10.1016/j.jnucmat.2004.03.065]; Janev R.K., 1987, SPRINGER SERIES ATOM, V4; Larsen E.M., 1981, UWFDM415; Majeski R., 2013, PHYS PLASMAS, V20, P1; Slotnick H., 1965, PWAC380; VELECKIS E, 1977, J LESS-COMMON MET, V55, P85, DOI 10.1016/0022-5088(77)90263-6	11	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	DEC	2014	89	12					2833	2837		10.1016/j.fusengdes.2014.04.014		5	Nuclear Science & Technology	Nuclear Science & Technology	AX6HI	WOS:000347023200005		
J	Ono, M; Jaworski, MA; Kaita, R; Hirooka, Y; Andruczyk, D; Gray, TK				Ono, M.; Jaworski, M. A.; Kaita, R.; Hirooka, Y.; Andruczyk, D.; Gray, T. K.		NSTX-U Res Team	Active radiative liquid lithium divertor concept	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	3rd International Symposium on Lithium Application for Fusion Devices (ISLA)	OCT, 2013	ENEA Frascati Ctr, Frascati, ITALY		ENEA Frascati Ctr	International lithium symposium; Lithium; Divertor; Plasma-wall interactions	TRANSPORT	Developing a reactor compatible divertor has been identified as a particularly challenging technology problem for magnetic confinement fusion. Application of lithium (Li) in NSTX resulted in improved Hmode confinement, H-mode power threshold reduction, and reduction in the divertor peak heat flux while maintaining essentially Li-free core plasma operation even during H-modes. These promising Li results in NSTX and related modeling calculations motivated the radiative liquid lithium divertor (RLLD) concept [1]. In the RLLD, Li is evaporated from the liquid lithium (LL) coated divertor strike point surface due to the intense heat flux. The evaporated Li is readily ionized by the plasma due to its low ionization energy, and the poor Li particle confinement near the divertor plate enables ionized Li ions to radiate strongly, resulting in a significant reduction in the divertor heat flux. This radiative process has the desired effect of spreading the localized divertor heat load to the rest of the divertor chamber wall surfaces, facilitating divertor heat removal. The modeling results indicated that the Li radiation can be quite strong, so that only a small amount of Li (a few malls) is needed to significantly reduce the divertor peak heat flux for typical reactor parameters. In this paper, we examine an active version of the RLLD, which we term ARLLD, where LL is injected in the upstream region of divertor. We find that the ARLLD has similar effectiveness in reducing the divertor heat flux as the RLLD, again requiring only a few mol/s of LL to significantly reduce the divertor peak heat flux for a reactor. An advantage of the ARLLD is that one can inject LL proactively even in a feedback mode to insure the divertor peak heat flux remains below an acceptable level, providing the first line of defense against excessive divertor heat loads which could result in damage to divertor PFCs. Moreover, the low confinement property of the divertor (i.e., <1 ms for Li particle confinement time) makes the ARLLD response fast enough to mitigate the effects of possible transient events such as large ELMs. (C) 2014 Elsevier B.V. All rights reserved.	[Ono, M.; Jaworski, M. A.; Kaita, R.] Princeton Plasma Phys Lab, Princeton, NJ 08543 USA; [Hirooka, Y.] Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Andruczyk, D.] Univ Illinois, Ctr Plasma Mat Interact, Urbana, IL 61801 USA; [Gray, T. K.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA	Ono, M (reprint author), Princeton Plasma Phys Lab, POB 451, Princeton, NJ 08543 USA.	mono@pppl.gov					Abrams T., 2014, FUSION ENG IN PRESS; Andruczyk D, FUSION ENG DES UNPUB; Menard JE, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/8/083015; Soukhanovskii VA, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/1/012001; Doerner RP, 2001, J NUCL MATER, V290, P166, DOI 10.1016/S0022-3115(00)00568-7; Mansfield DK, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113023; Scotti F, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/8/083001; Peng YKM, 2009, FUSION SCI TECHNOL, V56, P957; Nygren RE, 2011, J NUCL MATER, V417, P451, DOI 10.1016/j.jnucmat.2010.12.289; Bell MG, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/12/124054; Valanju PM, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3110984; Maingi R, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.135004; Kugel HW, 2012, FUSION ENG DES, V87, P1724, DOI 10.1016/j.fusengdes.2011.07.010; Kotschenreuther M, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2739422; Evtikhin VA, 2002, PLASMA PHYS CONTR F, V44, P955, DOI 10.1088/0741-3335/44/6/322; Ono M, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/113030; Kaye SM, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/6/063005; Maingi R, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/8/083001; Goldston RJ, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/1/013009; Gray TK, 2014, NUCL FUSION, V54, DOI 10.1088/0029-5515/54/2/023001; [Anonymous], 2009, MAGNETIC FUSION ENER; Ono M, 2000, NUCL FUSION, V40, P557, DOI 10.1088/0029-5515/40/3Y/316; Wakatani M, 1999, NUCL FUSION, V39, P2175, DOI 10.1088/0029-5515/39/12/302; Wang XR, 2012, FUSION ENG DES, V87, P732, DOI 10.1016/j.fusengdes.2012.02.012; Kugel HW, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2906260; Maingi R, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.075001; Gray TK, 2011, J NUCL MATER, V415, pS360, DOI 10.1016/j.jnucmat.2011.01.029; Hirooka Y., 2010, NUCL FUSION, V50; Jaworski M.A., 2013, PLASMA PHYS IN PRESS; Kaye S.M., 2011, NUCL FUSION, V52, P1823; Kondo H, 2011, FUSION ENG DES, V86, P2437, DOI 10.1016/j.fusengdes.2010.12.021; Mansfield DK, 2010, FUSION ENG DES, V85, P890, DOI 10.1016/j.fusengdes.2010.08.033; Mirnov S.V., 2013, J NUCL MATER, V438, P224; Nagayama Y., FUSION ENG DES, V84, P1380; Nieto M, 2006, J NUCL MATER, V350, P101, DOI 10.1016/j.jnucmat.2005.09.028; Ono M, 2010, FUSION ENG DES, V85, P882, DOI 10.1016/j.fusengdes.2010.03.045; Ono M, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/3/037001; Ono M., 2011, FUSION ENG DES, V87, P1770; Podesta M, 2012, NUCL FUSION, V52, DOI 10.1088/0029-5515/52/3/033008; Rognlien TD, 2002, PHYS PLASMAS, V9, P2120, DOI 10.1063/1.1461384; Scotti F., 2012, B AM PHYS SOC, V75, P109; Skinner CH, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3464465; Stangeby P.C., 2002, PLASMA BOUNDARY MAGN; Tobita K, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/7/075029; Visca E, 2012, FUSION ENG DES, V87, P941, DOI 10.1016/j.fusengdes.2012.02.070	45	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	DEC	2014	89	12					2838	2844		10.1016/j.fusengdes.2014.05.008		7	Nuclear Science & Technology	Nuclear Science & Technology	AX6HI	WOS:000347023200006		
J	Furukawa, T; Hirakawa, Y; Kato, S; Iijima, M; Ohtaka, M; Kondo, H; Kanemura, T; Wakai, E				Furukawa, Tomohiro; Hirakawa, Yasushi; Kato, Shoichi; Iijima, Minoru; Ohtaka, Masahiko; Kondo, Hiroo; Kanemura, Takuji; Wakai, Eiichi			Current status of the technology development on lithium safety handling under IFMIF/EVEDA	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	3rd International Symposium on Lithium Application for Fusion Devices (ISLA)	OCT, 2013	ENEA Frascati Ctr, Frascati, ITALY		ENEA Frascati Ctr	IFMIF; EVEDA; Lithium; Safety; Leak		Studies for establishing technology for the safe handling of lithium was performed in the Engineering Validation and Engineering Design Activities (EVEDA) for the International Fusion Material Irradiation Facility (IFMIF). This research comprises four tasks: (a) extinguishing lithium files, (b) chemical reactions of lithium on the event of a leak, (c) lithium removal from the components, and (d) chemical analysis of impurities in lithium. Tasks (a) and (b), related to functions on the event of a lithium leak, involve selection of the material suitable for extinguishing lithium fires and assessment of corrosive effects of leaked lithium on materials at high temperature, respectively. Task (c) involves evaluation of methods for the replacement and/or decommissioning of the lithium components. Task (d) constitutes the development of high-precision techniques for the determination of impurities in lithium, particularly the dominating corrosive impurity dissolved nitrogen. Experimental results addressing the objectives of each of the tasks are described in this communication. (C) 2014 Elsevier B.V. All rights reserved.	[Furukawa, Tomohiro; Hirakawa, Yasushi; Kato, Shoichi; Iijima, Minoru; Ohtaka, Masahiko; Kondo, Hiroo; Kanemura, Takuji; Wakai, Eiichi] Japan Atom Energy Agcy, Oarai, Ibaraki 3111393, Japan	Furukawa, T (reprint author), Japan Atom Energy Agcy, O Arai Res & Dev Ctr, 4002 Narita, Oarai, Ibaraki 3111393, Japan.	furukawa.tomohiro@jaea.go.jp					CHOPRA OK, 1986, J NUCL MATER, V141, P584, DOI 10.1016/0022-3115(86)90058-9; Knaster J, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/11/116001; Kondo H, 2011, NUCL FUSION, V51, DOI 10.1088/0029-5515/51/12/123008; Furukawa T, 2013, FUSION ENG DES, V88, P2502, DOI 10.1016/j.fusengdes.2013.04.036; [Anonymous], SPEC PROD EXT LIQ ME; [Anonymous], French pat, Patent No. [75 36225, 7536225]; Furukawa T, 2011, FUSION ENG DES, V86, P2433, DOI 10.1016/j.fusengdes.2010.12.037; Kondo H, 2012, FUSION ENG DES, V87, P418, DOI 10.1016/j.fusengdes.2011.11.011; [Anonymous], SPEC PROD EXT LITH F, VProduced by Miyata Industry Co Ltd.; Furukawa T., 2012, P 2012 20 INT C NUCL; Furukawa T., 2010, P 18 INT C NUCL ENG; Matsumoto T., 1992, NETSUSOKUTEI, V19, P170; Moeslang A., 2002, P 19 FUS EN C FRANC	13	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	DEC	2014	89	12					2902	2909		10.1016/j.fusengdes.2014.07.010		8	Nuclear Science & Technology	Nuclear Science & Technology	AX6HI	WOS:000347023200015		
J	Kamiya, K; Itami, K; Takeuchi, M; Enokuchi, A				Kamiya, K.; Itami, K.; Takeuchi, M.; Enokuchi, A.			Design study of a wide-angle infrared thermography and visible observation diagnostic on JT-60SA	FUSION ENGINEERING AND DESIGN			English	Article; Proceedings Paper	3rd International Symposium on Lithium Application for Fusion Devices (ISLA)	OCT, 2013	ENEA Frascati Ctr, Frascati, ITALY		ENEA Frascati Ctr	JT-60SA; Diagnostic; IR camera; Visible camera; Optics; Wide angle view	ITER	Design study of a wide-angle infrared (IR) thermography (surface temperature measurement) and visible observation diagnostics for JT-60SA are reported. The new design offers an optical solution without a "blind spot" which is one of the advantages. In order to image a large section inside the vacuum vessel (both in poloidal and toroidal directions), the optical system of endoscope is to provide a wide-angle view in the IR and visible wavelength ranges. The estimated IR optical spatial resolution is approximately 2 cm at a distance of 7.6 m from the front optics with a pupil diameter of 4mm. For a surface temperature measurement it would be larger (similar to 4 cm for a surface temperature error less than 5%). The optics of this system can be divided into three parts: (1) a mirror based optical head (two set of spherical mirrors plus two flat mirrors) that produces an intermediate image, (2) a Cassegrain telescope system, and (3) a relay group of lenses, being adapted to the two kinds of detectors for IR and visible observations. (C) 2014 Elsevier B.V. All rights reserved.	[Kamiya, K.; Itami, K.; Takeuchi, M.] Japan Atom Energy Agcy JAEA, Naka, Ibaraki 3110193, Japan; [Enokuchi, A.] Genesia Co, Mitaka, Tokyo 1810013, Japan	Kamiya, K (reprint author), Japan Atom Energy Agcy JAEA, Naka, Ibaraki 3110193, Japan.	kamiya.kensaku@jaea.go.jp					Janeschitz G, 2001, J NUCL MATER, V290, P1, DOI 10.1016/S0022-3115(00)00623-1; Eich T, 2005, PLASMA PHYS CONTR F, V47, P815, DOI 10.1088/0741-3335/47/6/007; Guilhem D, 2005, FUSION ENG DES, V74, P879, DOI 10.1016/j.fusengdes.2005.08.021; Ishida S, 2010, FUSION ENG DES, V85, P2070, DOI 10.1016/j.fusengdes.2010.07.027; Salasca S, 2009, FUSION ENG DES, V84, P1689, DOI 10.1016/j.fusengdes.2008.12.088; Gauthier E, 2007, FUSION ENG DES, V82, P1335, DOI 10.1016/j.fusengdes.2007.06.026; Arnoux G, 2009, NUCL FUSION, V49, DOI 10.1088/0029-5515/49/8/085038; Cantarini J, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2979880; Guilhem D, 1999, REV SCI INSTRUM, V70, P427, DOI 10.1063/1.1149388; Takeuchi M., 2013, PLASMA FUSION RES, V8	10	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0920-3796	1873-7196		FUSION ENG DES	Fusion Eng. Des.	DEC	2014	89	12					3089	3094		10.1016/j.fusengdes.2014.09.011		6	Nuclear Science & Technology	Nuclear Science & Technology	AX6HI	WOS:000347023200042		
J	Kaiya, H; Konno, N; Kangawa, K; Uchiyama, M; Miyazato, M				Kaiya, Hiroyuki; Konno, Norifumi; Kangawa, Kenji; Uchiyama, Minoru; Miyazato, Mikiya			Identification, tissue distribution and functional characterization of the ghrelin receptor in West African lungfish, Protopterus annectens	GENERAL AND COMPARATIVE ENDOCRINOLOGY			English	Article						cDNA cloning; Functional characterization; Ghrelin receptor; GHS-R1a; GHS-R1b; Lungfish	HORMONE SECRETAGOGUE RECEPTOR; 2ND EXTRACELLULAR LOOP; COMPLEMENTARY DEOXYRIBONUCLEIC-ACID; TROUT ONCORHYNCHUS-MYKISS; MESSENGER-RNA EXPRESSION; RAY-FINNED FISH; GROWTH-HORMONE; RAINBOW-TROUT; OREOCHROMIS-MOSSAMBICUS; FOOD-INTAKE	We identified two ghrelin receptor isoforms, the ghrelin receptor type-la (GHS-R1a) and its alternative splice form (GHS-R1b) for West African lungfish, Protopterus annectens. Lungfish GHS-R1a and 1b comprised 361 and 281 amino acids, respectively. Lungfish GHS-R1a showed the highest identity to coelacanth GHS-R1a (80.4%). The highest expression of GHS-R1a mRNAs was seen in the brain, liver, ovary, heart, intestine, and gills. GHS-R1b mRNAs were also detected in the same tissues with GHS-R1a, but their expression level was 1/20 that of GHS-R1a. In human embryonic kidney 293 cells transiently expressing lungfish GHS-R1a, rat and bullfrog ghrelin, and two GHS-R1a agonists, GHRP-6 and hexarelin, increased intracellular Ca2+ concentrations. The intensity of the Ca2+ increases induced by GHS-R1a agonists was twice when compared to that induced by ghrelin, although the median effective doses (ED50) were similar, suggesting a long-lasting effect of GHS-R1 a agonists with similar affinity. We also examined changes in the GHS-R gene expression during an eight-week estivation. Body weight was slightly lowered, but plasma sodium and glucose concentrations decreased; plasma urea concentration increased significantly 4 weeks after the start of estivation. Overall, expression of GHS-Rla mRNA decreased, but changes in GHS-Rlb mRNA expression were inconsistent with those of GHS-R1a during estivation, suggesting an involvement of GHS-R in energy homeostasis, as seen in mammals. Our results suggest that the ghrelinGHS-Rla system is present in this lungfish although ghrelin has not yet been found. The structure of GHSRla is closer to that of tetrapods than Actinopterygian fish, indicating a process of evolution that follows the Crossopterygii such as coelacanth. (C) 2014 Elsevier Inc. All rights reserved.	[Kaiya, Hiroyuki; Kangawa, Kenji; Miyazato, Mikiya] Natl Cardiovasc Ctr, Res Inst, Dept Biochem, Suita, Osaka 5658565, Japan; [Konno, Norifumi; Uchiyama, Minoru] Toyama Univ, Grad Sch Sci & Engn, Lab Regulatory Biol, Gofuku 3190, Toyama 9308555, Japan	Kaiya, H (reprint author), Natl Cardiovasc Ctr, Res Inst, Dept Biochem, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	kaiya@ncvc.go.jp			Japan Society for the Promotion of Science (JSPS); Takeda Science Foundation; Suntory Institute for Bioorganic Research (SUNBOR); Ocean Research Institute, The University of Tokyo [06J01325]	We thank Mrs. Azumi Ooyama for her skilful technical assistance. This work was supported, in part, by a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS) for H. Kaiya, M. Miyazato, and K. Kangawa, and for S. Hyodo, a Grant from the Takeda Science Foundation for M. Miyazato and K. Kangawa, a Grant from the Suntory Institute for Bioorganic Research (SUNBOR) for H. Kaiya, a Research Fellowship (06J01325) for N. Konno, and a Fund (No. 115) from the cooperative program of the Ocean Research Institute, The University of Tokyo for N. Konno.	Rediger A, 2011, J BIOL CHEM, V286, P39623, DOI 10.1074/jbc.M111.287607; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Kaiya H, 2010, MOL CELL ENDOCRINOL, V327, P25, DOI 10.1016/j.mce.2010.06.004; Kaiya H, 2003, ENDOCRINOLOGY, V144, P5215, DOI 10.1210/en.2003-1085; Shiiya T, 2002, J CLIN ENDOCR METAB, V87, P240, DOI 10.1210/jc.87.1.240; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Riley LG, 2005, GEN COMP ENDOCR, V142, P234, DOI 10.1016/j.ygcen.2005.01.009; Soares JB, 2008, PEPTIDES, V29, P1255, DOI 10.1016/j.peptides.2008.02.018; Liu G, 2007, J PHARMACOL EXP THER, V322, P1036, DOI 10.1124/jpet.107.123141; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; DELANEY RG, 1974, J EXP BIOL, V61, P111; Matsuda K, 2006, PEPTIDES, V27, P1335, DOI 10.1016/j.peptides.2005.10.011; Fox BK, 2009, DOMEST ANIM ENDOCRIN, V37, P1, DOI 10.1016/j.domaniend.2009.01.001; Shepherd BS, 2007, COMP BIOCHEM PHYS A, V146, P390, DOI 10.1016/j.cbpa.2006.11.004; Tanaka M, 2003, GEN COMP ENDOCR, V134, P198, DOI 10.1016/S0016-6480(03)00247-8; Takaya K, 2000, J CLIN ENDOCR METAB, V85, P4908, DOI 10.1210/jc.85.12.4908; Hosoda H, 2006, J PHARMACOL SCI, V100, P398, DOI 10.1254/jphs.CRJ06002X; Farmer C, 1997, PALEOBIOLOGY, V23, P358; Matsuda K, 2006, PEPTIDES, V27, P2321, DOI 10.1016/j.peptides.2006.03.028; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Kitazawa T, 2009, REGUL PEPTIDES, V158, P132, DOI 10.1016/j.regpep.2009.07.005; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Kitazawa T, 2011, PEPTIDES, V32, P1876, DOI 10.1016/j.peptides.2011.07.026; Shi L, 2004, P NATL ACAD SCI USA, V101, P440, DOI 10.1073/pnas.2237265100; Sun YX, 2004, P NATL ACAD SCI USA, V101, P4679, DOI 10.1073/pnas.0305930101; Unniappan S, 2002, ENDOCRINOLOGY, V143, P4143, DOI 10.1210/en.2002-220644; Small BC, 2009, COMP BIOCHEM PHYS A, V154, P451, DOI 10.1016/j.cbpa.2009.07.027; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Ferrini F, 2009, CURR NEUROPHARMACOL, V7, P37, DOI 10.2174/157015909787602779; Unniappan S, 2004, AM J PHYSIOL-REG I, V286, pR1093, DOI 10.1152/ajpregu.00669.2003; Unniappan S, 2005, COMP BIOCHEM PHYS A, V140, P396, DOI 10.1016/j.cbpb.2005.02.011; Kaiya H, 2009, ZOOL SCI, V26, P330, DOI 10.2108/zsj.26.330; Palyha OC, 2000, MOL ENDOCRINOL, V14, P160, DOI 10.1210/me.14.1.160; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Leung PK, 2007, CELL SIGNAL, V19, P1011, DOI 10.1016/j.cellsig.2006.11.011; Mary S, 2013, J BIOL CHEM, V288, P24656, DOI 10.1074/jbc.M113.453423; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Jonsson E, 2007, COMP BIOCHEM PHYS A, V147, P1116, DOI 10.1016/j.cbpa.2007.03.024; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Geelissen SME, 2003, GEN COMP ENDOCR, V134, P167, DOI 10.1016/S0016-6480(03)00250-8; Kaiya H, 2009, COMP BIOCHEM PHYS A, V153, P438, DOI 10.1016/j.cbpa.2009.04.612; Kaiya H, 2003, COMP BIOCHEM PHYS B, V135, P421, DOI 10.1016/S1096-4959(03)00109-X; Olsson C, 2008, GEN COMP ENDOCR, V155, P217, DOI 10.1016/j.ygcen.2007.05.016; Kitazawa T, 2007, PEPTIDES, V28, P617, DOI 10.1016/j.peptides.2006.10.012; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Kaiya H, 2008, COMP BIOCHEM PHYS A, V149, P109, DOI 10.1016/j.cbpa.2007.12.004; Kitazawa T, 2012, GEN COMP ENDOCR, V178, P539, DOI 10.1016/j.ygcen.2012.06.025; Takezaki N, 2004, MOL BIOL EVOL, V21, P1512, DOI 10.1093/molbev/msh150; Kaiya H, 2001, J BIOL CHEM, V276, P40441, DOI 10.1074/jbc.M105212200; Kaiya H, 2014, J MOL ENDOCRINOL, V52, pT87, DOI 10.1530/JME-13-0175; Buyse J, 2009, PEPTIDES, V30, P1342, DOI 10.1016/j.peptides.2009.04.015; Chan CB, 2004, MOL CELL ENDOCRINOL, V214, P81, DOI 10.1016/j.mce.2003.11.020; Chen LL, 2007, COMP BIOCHEM PHYS A, V147, P893, DOI 10.1016/j.cbpa.2007.02.017; Chen T, 2008, J ENDOCRINOL, V199, P253, DOI 10.1677/JOE-08-0325; Chiu CH, 2004, GENOME RES, V14, P11, DOI 10.1101/gr.1712904; Conner M, 2007, J BIOL CHEM, V282, P17405, DOI 10.1074/jbc.M702151200; Ding LY, 2008, CELL BIOL INT, V32, P1310, DOI 10.1016/j.cellbi.2008.07.019; Feighner SD, 1998, MOL ENDOCRINOL, V12, P137; George D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022136; Granado M, 2008, AM J PHYSIOL-ENDOC M, V294, pE131, DOI 10.1152/ajpendo.00308.2007; Hoist B., 2004, J BIOL CHEM, V279, P53806; Jonsson E, 2010, GEN COMP ENDOCR, V166, P39, DOI 10.1016/j.ygcen.2009.11.001; Kaiya H., 2002, ENDOCRINOLOGY, V143, P3445; Kaiya Hiroyuki, 2013, Front Endocrinol (Lausanne), V4, P81, DOI 10.3389/fendo.2013.00081; Kaiya Hiroyuki, 2011, Front Endocrinol (Lausanne), V2, P31, DOI 10.3389/fendo.2011.00031; Lai YYY, 2012, GENE, V504, P253, DOI 10.1016/j.gene.2012.04.089; Ledderose Carola, 2011, Recent Pat Endocr Metab Immune Drug Discov, V5, P1, DOI 10.2174/187221411794351897; Ma Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035265; Malaga-Trillo E, 2002, J MOL EVOL, V54, P235, DOI 10.1007/s00239-001-0005-1; Mao YJ, 2013, ENDOCRINOLOGY, V154, P3847, DOI 10.1210/en.2013-1291; Matsuura B, 2006, J BIOL CHEM, V281, P12390, DOI 10.1074/jbc.M511921200; Richards M.P., 2010, INT J PEPT; Riley LG, 2009, COMP BIOCHEM PHYS A, V154, P541, DOI 10.1016/j.cbpa.2009.08.018; Sato Y, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-204; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Shimizu S., 2013, PEPTIDES C, V51C, P74; Xu XB, 2012, AM J PHYSIOL-HEART C, V303, pH703, DOI 10.1152/ajpheart.00257.2011; Yokote R, 1998, PEPTIDES, V19, P15, DOI 10.1016/S0196-9781(97)00263-5; Zaccone D, 2012, ACTA HISTOCHEM, V114, P763, DOI 10.1016/j.acthis.2012.01.003	84	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0016-6480	1095-6840		GEN COMP ENDOCR	Gen. Comp. Endocrinol.	DEC 1	2014	209				SI		106	117		10.1016/j.ygcen.2014.07.021		12	Endocrinology & Metabolism	Endocrinology & Metabolism	AX4GB	WOS:000346890500011		
J	Ubuka, T; Tsutsui, K				Ubuka, Takayoshi; Tsutsui, Kazuyoshi			Evolution of gonadotropin-inhibitory hormone receptor and its ligand	GENERAL AND COMPARATIVE ENDOCRINOLOGY			English	Article						Gonadotropin-inhibitory hormone; Neuropeptide FF; SIFamide; Famide peptides; GPR147; GPR74	PROTEIN-COUPLED RECEPTORS; RFAMIDE-RELATED PEPTIDE-3; QUAIL COTURNIX-JAPONICA; PRECURSOR MESSENGER-RNA; LPXRF-AMIDE PEPTIDES; HYPOTHALAMIC NEUROPEPTIDE; GROWTH-HORMONE; LUTEINIZING-HORMONE; GENOME DUPLICATION; DOMESTIC CHICKEN	Gonadotropin-inhibitory hormone (GnIH) is a neuropeptide inhibitor of gonadotropin secretion, which was first identified in the Japanese quail hypothalamus. GnIH peptides share a C-terminal LPXRFamide (X = L or Q) motif in most vertebrates. The receptor for GnIH (GnIHR) is the seven-transmembrane G protein-coupled receptor 147 (GPR147) that inhibits cAMP production. GPR147 is also named neuropeptide FF (NPFF) receptor 1 (NPFER1), because it also binds NPFF that has a C-terminal PQRFamide motif. To understand the evolutionary history of the GnIH system in the animal kingdom, we searched for receptors structurally similar to GnIHR in the genome of six mammals (human, mouse, rat, cattle, cat, and rabbit), five birds (pigeon, chicken, turkey, budgerigar, and zebra finch), one reptile (green anole), one amphibian (Western clawed flog), six fishes (zebrafish, Nile tilapia, Fugu, coelacanth, spotted gar, and lamprey), one hemichordate (acorn worm), one echinoderm (purple sea urchin), one mollusk (California sea hare), seven insects (pea aphid, African malaria mosquito, honey bee, buff-tailed bumblebee, fruit fly, jewel wasp, and red flour beetle), one cnidarian (hydra), and constructed phylogenetic trees by neighbor joining (NJ) and maximum likelihood (ML) methods. A multiple sequence alignment of the receptors showed highly conserved seven-transmembrane domains as well as disulfide bridge sites between the first and second extracellular loops, including the receptor of hydra. Both NJ and ML analyses grouped the receptors of vertebrates into NPFFR1 and NPFFR2 (GPR74), and the receptors of insects into the receptor for SIFamide peptides that share a C-terminal YRKPPFNGSIFamide motif. Although human, quail and zebrafish GnIHR (NPFFR1) were most structurally similar to SIFamide receptor of fruit fly in the Famide peptide (FMRFamide, neuropeptide F, short neuropeptide F, drosulfakinin, myosuppressin, SIFamide) receptor families, the amino acid sequences and the peptide coding regions of GnIH precursors were most similar to FMRFamide precursor of fruit fly in the precursors of Famide peptide families. Chromosome synteny analysis of the precursor genes of human, quail and zebrafish GnIH and fruit fly Famide peptides further identified conserved synteny in vertebrate GnIH and fruit fly FMRFa precursor genes as well as other Famide peptide precursor genes. These results suggest that GnIH and its receptor pair and SIFamide and its receptor pair may have diverged and co-evolved independently in vertebrates and insects, respectively, from their ancestral Famide peptide and its receptor pair, during diversification and evolution of deuterostomian and protostomian species. (C) 2014 Elsevier Inc. All rights reserved.	[Ubuka, Takayoshi; Tsutsui, Kazuyoshi] Waseda Univ, Dept Biol, Tokyo 1628480, Japan	Tsutsui, K (reprint author), Waseda Univ, Ctr Med Life Sci, Dept Biol, Lab Integrat Brain Sci,Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	k-tsutsui@waseda.jp			Ministry of Education, Science and Culture, Japan [22132004, 22227002]	This work was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science and Culture, Japan (22132004 and 22227002 to K.T.).	Tsutsui K, 2000, BIOCHEM BIOPH RES CO, V275, P661, DOI 10.1006/bbrc.2000.3350; Braasch I, 2014, COMP BIOCHEM PHYS C, V163, P24, DOI 10.1016/j.cbpc.2014.01.005; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Tsutsui K, 2012, GEN COMP ENDOCR, V177, P305, DOI 10.1016/j.ygcen.2012.02.013; Amano M, 2006, J ENDOCRINOL, V188, P417, DOI 10.1677/joe.1.06494; Ubuka T, 2003, J ENDOCRINOL, V178, P311, DOI 10.1677/joe.0.1780311; Ubuka T, 2013, GEN COMP ENDOCR, V181, P179, DOI 10.1016/j.ygcen.2012.09.010; Roumy M, 1998, EUR J PHARMACOL, V345, P1, DOI 10.1016/S0014-2999(97)01604-X; Barnett DK, 2006, ENDOCRINOLOGY, V147, P615, DOI 10.1210/en.2005-0662; Osugi T, 2012, ENDOCRINOLOGY, V153, P2362, DOI 10.1210/en.2011-2046; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; DOCKRAY GJ, 1983, NATURE, V305, P328, DOI 10.1038/305328a0; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; Ciccone NA, 2004, J NEUROENDOCRINOL, V16, P999, DOI 10.1111/j.1365-2826.2005.01260.x; Ubuka T, 2012, ENDOCRINOLOGY, V153, P373, DOI 10.1210/en.2011-1110; Koda A, 2002, ENDOCRINOLOGY, V143, P411, DOI 10.1210/en.143.2.411; PRICE DA, 1977, SCIENCE, V197, P670, DOI 10.1126/science.877582; Amores A, 2011, GENETICS, V188, P799, DOI 10.1534/genetics.111.127324; Shahjahan M, 2011, J NEUROENDOCRINOL, V23, P39, DOI 10.1111/j.1365-2826.2010.02081.x; Maney DL, 1997, HORM BEHAV, V32, P11, DOI 10.1006/hbeh.1997.1399; Ubuka T, 2006, ENDOCRINOLOGY, V147, P1187, DOI 10.1210/en.2005-1178; Tsutsui K, 2010, FRONT NEUROENDOCRIN, V31, P284, DOI 10.1016/j.yfrne.2010.03.001; Tsutsui K, 2009, PROG NEUROBIOL, V88, P76, DOI 10.1016/j.pneurobio.2009.02.003; Ukena K, 2005, MASS SPECTROM REV, V24, P469, DOI 10.1002/mas.20031; Yasuda A, 2004, GEN COMP ENDOCR, V135, P391, DOI 10.1016/j.ygcen.2003.10.001; Ubuka T, 2009, J ENDOCRINOL, V201, P81, DOI 10.1677/JOE-08-0508; SHARP PJ, 1990, J ENDOCRINOL, V124, P291, DOI 10.1677/joe.0.1240291; Clarke IJ, 2008, ENDOCRINOLOGY, V149, P5811, DOI 10.1210/en.2008-0575; Liu QY, 2001, J BIOL CHEM, V276, P36961, DOI 10.1074/jbc.M105308200; Tobari Y, 2010, PEPTIDES, V31, P816, DOI 10.1016/j.peptides.2010.01.015; Ubuka T, 2005, P NATL ACAD SCI USA, V102, P3052, DOI 10.1073/pnas.0403840102; Chowdhury VS, 2011, J ENDOCRINOL, V209, P211, DOI 10.1530/JOE-10-0494; Walker RJ, 2009, INVERTEBR NEUROSCI, V9, P111, DOI 10.1007/s10158-010-0097-7; Tsutsui K, 2006, PEPTIDES, V27, P1121, DOI 10.1016/j.peptides.2005.06.036; Kirby ED, 2009, P NATL ACAD SCI USA, V106, P11324, DOI 10.1073/pnas.0901176106; Ubuka T, 2008, ENDOCRINOLOGY, V149, P268, DOI 10.1210/en.2007-0983; Ubuka T, 2009, GEN COMP ENDOCR, V162, P301, DOI 10.1016/j.ygcen.2009.04.001; Moussavi M, 2012, MOL CELL ENDOCRINOL, V350, P53, DOI 10.1016/j.mce.2011.11.020; Verleyen P, 2009, GEN COMP ENDOCR, V162, P27, DOI 10.1016/j.ygcen.2008.10.020; Ukena K, 2003, ENDOCRINOLOGY, V144, P3879, DOI 10.1210/en.2003-0359; Ubuka T, 2008, INTEGR COMP BIOL, V48, P560, DOI 10.1093/icb/icn019; Temple JL, 2003, ENDOCRINOLOGY, V144, P13, DOI 10.1210/en.2002-220883; Kriegsfeld LJ, 2006, P NATL ACAD SCI USA, V103, P2410, DOI 10.1073/pnas.0511003103; Terhzaz S, 2007, BIOCHEM BIOPH RES CO, V352, P305, DOI 10.1016/j.bbrc.2006.11.030; Ubuka T, 2009, J COMP NEUROL, V517, P841, DOI 10.1002/cne.22191; Ubuka T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4061; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Mallo M, 2013, DEVELOPMENT, V140, P3951, DOI 10.1242/dev.068346; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Mirabeau O, 2013, P NATL ACAD SCI USA, V110, pE2028, DOI 10.1073/pnas.1219956110; Bonini JA, 2000, J BIOL CHEM, V275, P39324, DOI 10.1074/jbc.M004385200; Fukusumi S, 2001, BBA-MOL CELL RES, V1540, P221, DOI 10.1016/S0167-4889(01)00135-5; Ikemoto T, 2005, J REPROD DEVELOP, V51, P359, DOI 10.1262/jrd.16087; Qi X, 2013, MOL CELL ENDOCRINOL, V366, P9, DOI 10.1016/j.mce.2012.11.001; Horn F, 1998, NUCLEIC ACIDS RES, V26, P275, DOI 10.1093/nar/26.1.275; Bentley GE, 2003, J NEUROENDOCRINOL, V15, P794; Tsutsui K, 2010, J NEUROENDOCRINOL, V22, P716, DOI 10.1111/j.1365-2826.2010.02018.x; Chartrel N, 2002, J COMP NEUROL, V448, P111, DOI 10.1002/cne.10253; Vazquez-Acevedo N, 2009, BIOL BULL-US, V217, P313; Sawada K, 2002, EUR J BIOCHEM, V269, P6000, DOI 10.1046/j.1432-1033.2002.03351.x; Satake H, 2001, BIOCHEM J, V354, P379, DOI 10.1042/0264-6021:3540379; Zhang Y, 2010, PEPTIDES, V31, P1034, DOI 10.1016/j.peptides.2010.03.003; Ukena K, 2003, CELL TISSUE RES, V312, P73, DOI 10.1007/s00441-003-0700-x; Bentley G.E., 2006, HORM BEHAV, V49, P560; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Janssen I, 1996, MOL CELL ENDOCRINOL, V117, P157, DOI 10.1016/0303-7207(95)03746-2; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Jorgensen LM, 2006, BIOCHEM BIOPH RES CO, V340, P696, DOI 10.1016/j.bbrc.2005.12.062; Sawada K, 2002, J ENDOCRINOL, V174, P395, DOI 10.1677/joe.0.1740395; Son YL, 2014, ENDOCRINOLOGY, V155, P1817, DOI 10.1210/en.2013-2076; Son YL, 2012, ENDOCRINOLOGY, V153, P2332, DOI 10.1210/en.2011-1904; Tessmar-Raible K, 2007, SEMIN CELL DEV BIOL, V18, P492, DOI 10.1016/j.semcdb.2007.04.007; Tobari Y, 2014, J NEUROSCI, V34, P9803, DOI 10.1523/JNEUROSCI.3706-13.2014; Tsutsui K, 2012, HDB BIOL ACTIVE PEPT, P802; Tsutsui K, 2007, GEN COMP ENDOCR, V153, P365, DOI 10.1016/j.gcen.2006.10.005; Tsutsui K, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00060; Ubuka T., 2010, HORMONES REPROD VERT, V4, P1; Ubuka T, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00038; Ubuka T, 2013, GEN COMP ENDOCR, V190, P10, DOI 10.1016/j.ygcen.2013.02.030; Ubuka Takayoshi, 2012, Front Endocrinol (Lausanne), V3, P148, DOI 10.3389/fendo.2012.00148; Ubuka T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030202; Ubuka T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008400; Ukena K., 2002, FEBS LETT, V512, P256; Verleyen P, 2004, BIOCHEM BIOPH RES CO, V320, P334, DOI 10.1016/j.bbrc.2004.05.173; Yin H, 2005, J ENDOCRINOL, V184, P257, DOI 10.1677/joe.1.05926; Yoshida H, 2003, BBA-MOL CELL RES, V1593, P151, DOI 10.1016/S0167-4889(02)00389-0	86	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0016-6480	1095-6840		GEN COMP ENDOCR	Gen. Comp. Endocrinol.	DEC 1	2014	209				SI		148	161		10.1016/j.ygcen.2014.09.002		14	Endocrinology & Metabolism	Endocrinology & Metabolism	AX4GB	WOS:000346890500014		
J	Satoh, N; Tagawa, K; Lowe, CJ; Yu, JK; Kawashima, T; Takahashi, H; Ogasawara, M; Kirschner, M; Hisata, K; Su, YH; Gerhart, J				Satoh, Noriyuki; Tagawa, Kunifumi; Lowe, Christopher J.; Yu, Jr-Kai; Kawashima, Takeshi; Takahashi, Hiroki; Ogasawara, Michio; Kirschner, Marc; Hisata, Kanako; Su, Yi-Hsien; Gerhart, John			On a Possible Evolutionary Link of the Stomochord of Hemichordates to Pharyngeal Organs of Chordates	GENESIS			English	Review						hemichordates; stomochord; chordates; notochord; pharyngeal organs	SACCOGLOSSUS-KOWALEVSKII; PTYCHODERA-FLAVA; GENE-EXPRESSION; CIONA-INTESTINALIS; AMPHIOXUS GENOME; PARAHOX GENES; HOX CLUSTER; BODY PLAN; 18S RDNA; NOTOCHORD	As a group closely related to chordates, hemichordate acorn worms are in a key phylogenic position for addressing hypotheses of chordate origins. The stomochord of acorn worms is an anterior outgrowth of the pharynx endoderm into the proboscis. In 1886 Bateson proposed homology of this organ to the chordate notochord, crowning this animal group hemichordates. Although this proposal has been debated for over a century, the question still remains unresolved. Here we review recent progress related to this question. First, the developmental mode of the stomochord completely differs from that of the notochord. Second, comparison of expression profiles of genes including Brachyury, a key regulator of notochord formation in chordates, does not support the stomochord/notochord homology. Third, FoxE that is expressed in the stomochord-forming region in acorn worm juveniles is expressed in the club-shaped gland and in the endostyle of amphioxus, in the endostyle of ascidians, and in the thyroid gland of vertebrates. Based on these findings, together with the anterior endodermal location of the stomochord, we propose that the stomochord has evolutionary relatedness to chordate organs deriving from the anterior pharynx rather than to the notochord. genesis 52:925-934, 2014. (c) 2014 Wiley Periodicals, Inc.	[Satoh, Noriyuki; Kawashima, Takeshi; Hisata, Kanako] Okinawa Inst Sci & Technol Grad Univ, Marine Genom Unit, Onna, Okinawa 9040495, Japan; [Tagawa, Kunifumi] Hiroshima Univ, Grad Sch Sci, Marine Biol Lab, Onomichi, Hiroshima, Japan; [Lowe, Christopher J.] Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA; [Yu, Jr-Kai; Su, Yi-Hsien] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Takahashi, Hiroki] Natl Inst Basic Biol, Div Dev Biol, Okazaki, Aichi 444, Japan; [Ogasawara, Michio] Chiba Univ, Dept Nanobiol, Grad Sch Adv Integrat Sci, Chiba, Japan; [Kirschner, Marc] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Gerhart, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Satoh, N (reprint author), Okinawa Inst Sci & Technol Grad Univ, Marine Genom Unit, Onna, Okinawa 9040495, Japan.	norisky@oist.jp	Su, Yi-Hsien/F-2910-2014; Kawashima, Takeshi/M-4510-2015; 	Lowe, Christopher/0000-0002-7789-8643			Amemiya CT, 2008, J EXP ZOOL PART B, V310B, P465, DOI 10.1002/jez.b.21213; Annunziata R, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-68; Satoh N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1729; Peterson KJ, 1999, DEVELOPMENT, V126, P85; Luttrell S, 2012, INTEGR COMP BIOL, V52, P829, DOI 10.1093/icb/ics117; Hiruta J, 2005, DEV DYNAM, V233, P1031, DOI 10.1002/dvdy.20401; Pani AM, 2012, NATURE, V483, P289, DOI 10.1038/nature10838; Damante G, 2001, PROG NUCLEIC ACID RE, V66, P307; Telford MJ, 2008, GENESIS, V46, P580, DOI 10.1002/dvg.20414; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Satoh N, 2012, EVOL DEV, V14, P56, DOI 10.1111/j.1525-142X.2011.00522.x; Gillis JA, 2012, P ROY SOC B-BIOL SCI, V279, P237, DOI 10.1098/rspb.2011.0599; Ruppert EE, 2005, CAN J ZOOL, V83, P8, DOI 10.1139/Z04-158; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Tagawa K, 2014, ZOOL SCI, V31, P414, DOI 10.2108/zs130262; Freeman R, 2012, CURR BIOL, V22, P2053, DOI 10.1016/j.cub.2012.08.052; Gerhart J, 2005, CURR OPIN GENET DEV, V15, P461, DOI 10.1016/j.gde.2005.06.004; Yu JK, 2007, NATURE, V445, P613, DOI 10.1038/nature05472; Conklin EG, 1932, J MORPHOL, V54, P69, DOI 10.1002/jmor.1050540103; Cameron RA, 2006, J EXP ZOOL PART B, V306B, P45, DOI 10.1002/jez.b.21070; Tagawa K, 1998, MECH DEVELOP, V75, P139, DOI 10.1016/S0925-4773(98)00078-1; Ogasawara M, 1999, DEVELOPMENT, V126, P2539; Brown FD, 2008, GENESIS, V46, P605, DOI 10.1002/dvg.20471; Satoh N, 2008, GENESIS, V46, P614, DOI 10.1002/dvg.20416; Tagawa K, 2001, EVOL DEV, V3, P443, DOI 10.1046/j.1525-142X.2001.01050.x; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Nomaksteinsky M, 2009, CURR BIOL, V19, P1264, DOI 10.1016/j.cub.2009.05.063; Holland LZ, 2008, GENOME RES, V18, P1100, DOI 10.1101/gr.073676.107; Jiang D, 2007, DEV DYNAM, V236, P1748, DOI 10.1002/dvdy.21184; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Ozair MZ, 2013, WIRES DEV BIOL, V2, P479, DOI 10.1002/wdev.90; Halanych KM, 1995, MOL PHYLOGENET EVOL, V4, P72, DOI 10.1006/mpev.1995.1007; Arnone MI, 2006, DEV BIOL, V300, P63, DOI 10.1016/j.ydbio.2006.07.037; Takahashi H, 1999, GENE DEV, V13, P1519, DOI 10.1101/gad.13.12.1519; Lauri A, 2014, SCIENCE, V345, P1365, DOI 10.1126/science.1253396; Chen SH, 2014, MAR GENOM, V15, P35, DOI 10.1016/j.margen.2014.04.010; WADA H, 1994, P NATL ACAD SCI USA, V91, P1801, DOI 10.1073/pnas.91.5.1801; Kaul S, 2010, J MORPHOL, V271, P1240, DOI 10.1002/jmor.10868; BALSER EJ, 1990, ACTA ZOOL-STOCKHOLM, V71, P235; Bateson W., 1885, Q J MICR SCI S, V25, P81; Bateson W., 1886, Q J MICROSC SCI, V2, P535; Capellini TD, 2008, GENESIS, V46, P683, DOI 10.1002/dvg.20406; Fritzenwanker JH, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-17; Harrison FW, 1997, MICROSCOPIC ANATOMY; Hatschek B., 1893, AMPHIOXUS ITS DEV; Hirakow R, 1994, Kaibogaku Zasshi, V69, P1; Holland PWH, 1995, DEVELOPMENT, V121, P4283; Hotta K, 2000, DEV BIOL, V224, P69, DOI 10.1006/dbio.2000.9765; Hotta K, 2008, EVOL DEV, V10, P37, DOI 10.1111/j.1525-142X.2007.00212.x; Ikuta T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-129; Katikala L, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001697; Kaul-Strehlow S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-53; KOMAI T, 1951, AM NAT, V85, P270, DOI 10.1086/281678; Lacalli TC, 2005, CAN J ZOOL, V83, P216, DOI 10.1139/Z04-162; Lowe CJ, 2006, PLOS BIOL, V9, pe291; Miyamoto N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3713; MOOKERJEE H K, 1955, Anat Anz, V102, P155; NEWELL GE, 1952, P ZOOL SOC LOND, V121, P741; Rychel AL, 2007, J EXP ZOOL PART B, V308B, P325, DOI 10.1002/jez.b.21157; Satoh N, 2014, DEV GENOMICS ASCIDIA; Suzuki MM, 2000, DEV BIOL, V224, P168, DOI 10.1006/dbio.2000.9796; TERAZAWA K, 1995, DEV GROWTH DIFFER, V37, P395; Urano A, 2003, EVOL DEV, V5, P447, DOI 10.1046/j.1525-142X.2003.03051.x; Yu JK, 2002, EVOL DEV, V4, P9, DOI 10.1046/j.1525-142x.2002.01057.x	66	5	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1526-954X	1526-968X		GENESIS	Genesis	DEC	2014	52	12					925	934		10.1002/dvg.22831		10	Developmental Biology; Genetics & Heredity	Developmental Biology; Genetics & Heredity	AX1IY	WOS:000346702100001		
J	Baughman, KW; McDougall, C; Cummins, SF; Hall, M; Degnan, BM; Satoh, N; Shoguchi, E				Baughman, Kenneth W.; McDougall, Carmel; Cummins, Scott F.; Hall, Mike; Degnan, Bernard M.; Satoh, Nori; Shoguchi, Eiichi			Genomic Organization of Hox and ParaHox Clusters in the Echinoderm, Acanthaster planci	GENESIS			English	Article						Hox cluster; ParaHox cluster; starfish genome; Acanthaster planci; echinoderm development	GENE-CLUSTER; SEA-URCHIN; EXPRESSION; OUTBREAKS; REVEALS; STAR	The organization of echinoderm Hox clusters is of interest due to the role that Hox genes play in deuterostome development and body plan organization, and the unique gene order of the Hox complex in the sea urchin Strongylocentrotus purpuratus, which has been linked to the unique development of the axial region. Here, it has been reported that the Hox and ParaHox clusters of Acanthaster planci, a corallivorous starfish found in the Pacific and Indian oceans, generally resembles the chordate and hemichordate clusters. The A. planci Hox cluster shared with sea urchins the loss of one of the medial Hox genes, even-skipped (Evx) at the anterior of the cluster, as well as organization of the posterior Hox genes. genesis 52:952-958, 2014. (c) 2014 Wiley Periodicals, Inc.	[Baughman, Kenneth W.; Satoh, Nori; Shoguchi, Eiichi] Okinawa Inst Sci & Technol Grad Univ, Marine Genom Unit, Onna, Okinawa 9040495, Japan; [McDougall, Carmel; Degnan, Bernard M.] Univ Queensland, Sch Biol Sci, Ctr Marine Sci, Brisbane, Qld 4072, Australia; [Cummins, Scott F.] Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Qld 4558, Australia; [Hall, Mike] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	Baughman, KW (reprint author), OIST Marine Genom Unit, 1919-1 Tancha, Onna Son, Okinawa 9040495, Japan.	kbaughman@oist.jp	McDougall, Carmel/G-3512-2010; Baughman, Kenneth/G-4599-2015	Baughman, Kenneth/0000-0001-6404-5206			Annunziata R, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-68; Ikuta T, 2004, P NATL ACAD SCI USA, V101, P15118, DOI 10.1073/pnas.0401389101; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Kielbasa SM, 2011, GENOME RES, V21, P487, DOI 10.1101/gr.113985.110; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Freeman R, 2012, CURR BIOL, V22, P2053, DOI 10.1016/j.cub.2012.08.052; Brooke NM, 1998, NATURE, V392, P920; Shoguchi E, 2013, CURR BIOL, V23, P1399, DOI 10.1016/j.cub.2013.05.062; Fabricius KE, 2010, CORAL REEFS, V29, P593, DOI 10.1007/s00338-010-0628-z; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Cameron RA, 2006, J EXP ZOOL PART B, V306B, P45, DOI 10.1002/jez.b.21070; Brodie J, 2005, MAR POLLUT BULL, V51, P266, DOI 10.1016/j.marpolbul.2004.10.035; Pisani D, 2012, MOL PHYLOGENET EVOL, V62, P27, DOI 10.1016/j.ympev.2011.08.028; Arenas-Mena C, 2000, DEVELOPMENT, V127, P4631; Cameron RA, 2009, NUCLEIC ACIDS RES, V37, pD750, DOI 10.1093/nar/gkn887; CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0; Ben Khadra Y, 2013, BIOCH GENET, V52, P166; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CHESHER RH, 1969, SCIENCE, V165, P280, DOI 10.1126/science.165.3890.280; Cisternas P, 2009, DEV GENES EVOL, V219, P613, DOI 10.1007/s00427-010-0318-4; Garstang M, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-72; Gyoja F, 2014, GENE, V542, P29, DOI 10.1016/j.gene.2014.03.024; HENDERSO.JA, 1971, NATURE, V232, P655, DOI 10.1038/232655a0; Hui JHL, 2011, MOL BIOL EVOL, V29, P157; Martinez P, 1999, P NATL ACAD SCI USA, V96, P1469, DOI 10.1073/pnas.96.4.1469; Mooi R, 2008, ANNU REV ECOL EVOL S, V39, P43, DOI 10.1146/annurev.ecolsys.39.110707.173521; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; WADA H, 1994, J MOL EVOL, V38, P41	30	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1526-954X	1526-968X		GENESIS	Genesis	DEC	2014	52	12					952	958		10.1002/dvg.22840		7	Developmental Biology; Genetics & Heredity	Developmental Biology; Genetics & Heredity	AX1IY	WOS:000346702100004		
J	Li, J; Wong, CF; Wong, MT; Huang, H; Leung, FC				Li, Jun; Wong, Chi-Fat; Wong, Mabel Ting; Huang, He; Leung, Frederick C.			Modularized Evolution in Archaeal Methanogens Phylogenetic Forest	GENOME BIOLOGY AND EVOLUTION			English	Article						network analysis; co-evolution network; HGT; LGT; phylogenetic forest; modularized evolution	HORIZONTAL GENE-TRANSFER; METHANOPYRUS-KANDLERI; TRANSLATION MACHINERIES; ECOLOGICAL DIVERSITY; EUKARYOTIC GENOMES; TREE SELECTION; CONGRUENCE; NETWORKS; ORIGIN; CORE	Methanogens are methane-producing archaea that plays a key role in the global carbon cycle. To date, the evolutionary history of methanogens and closely related nonmethanogen species remains unresolved among studies conducted upon different genetic markers, attributing to horizontal gene transfers (HGTs). With an effort to decipher both congruent and conflicting evolutionary events, reconstruction of coevolved gene clusters and hierarchical structure in the archaeal methanogen phylogenetic forest, comprehensive evolution, and network analyses were performed upon 3,694 gene families from 41 methanogens and 33 closely related archaea. Our results show that 1) greater than 50% of genes are in topological dissonance with others; 2) the prevalent interorder HGTs, even for core genes, in methanogen genomes led to their scrambled phylogenetic relationships; 3) most methanogenesis-related genes have experienced at least one HGT; 4) greater than 20% of the genes in methanogen genomes were transferred horizontally from other archaea, with genes involved in cell-wall synthesis and defense system having been transferred most frequently; 5) the coevolution network contains seven statistically robust modules, wherein the central module has the highest average node strength and comprises a majority of the core genes; 6) different coevolutionary module genes boomed in different time and evolutionary lineage, constructing diversified pan-genome structures; 7) the modularized evolution is also closely related to the vertical evolution signals and the HGT rate of the genes. Overall, this study presented a modularized phylogenetic forest that describes a combination of complicated vertical and nonvertical evolutionary processes for methanogenic archaeal species.	[Li, Jun; Wong, Chi-Fat; Wong, Mabel Ting; Leung, Frederick C.] Univ Hong Kong, Sch Biol Sci, Fac Sci, Hong Kong, Hong Kong, Peoples R China; [Huang, He] Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime 790, Japan; [Leung, Frederick C.] Nanjing Agr Univ, Bioinformat Ctr, Nanjing, Jiangsu, Peoples R China	Leung, FC (reprint author), Univ Hong Kong, Sch Biol Sci, Fac Sci, Hong Kong, Hong Kong, Peoples R China.	fcleung@hkucc.hku.hk			Initiative on Clean Energy and Environment, The University of Hong Kong (HKU-ICEE)	The authors appreciate the help from Dr Ivan Tasovski in editing the language. The authors also thank three anonymous reviewers for helping us improving the manuscripts. This work was partially supported by Initiative on Clean Energy and Environment, The University of Hong Kong (HKU-ICEE).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Castresana J, 2000, MOL BIOL EVOL, V17, P540; Schliep K, 2011, MOL BIOL EVOL, V28, P1393, DOI 10.1093/molbev/msq323; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Deppenmeier U, 2002, J MOL MICROB BIOTECH, V4, P453; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Brochier-Armanet C, 2011, CURR OPIN MICROBIOL, V14, P274, DOI 10.1016/j.mib.2011.04.015; Kelly S, 2011, P ROY SOC B-BIOL SCI, V278, P1009, DOI 10.1098/rspb.2010.1427; Norman A, 2009, PHILOS T R SOC B, V364, P2275, DOI 10.1098/rstb.2009.0037; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Leigh JW, 2011, GENOME BIOL EVOL, V3, P571, DOI 10.1093/gbe/evr050; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; Redner S, 2005, PHYS TODAY, V58, P49, DOI 10.1063/1.1996475; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101; PENNY D, 1985, SYST ZOOL, V34, P75, DOI 10.2307/2413347; Jain R, 1999, P NATL ACAD SCI USA, V96, P3801, DOI 10.1073/pnas.96.7.3801; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Barabasi AL, 1999, PHYSICA A, V272, P173, DOI 10.1016/S0378-4371(99)00291-5; Reeve JN, 1997, J BACTERIOL, V179, P5975; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Creevey CJ, 2005, BIOINFORMATICS, V21, P390, DOI 10.1093/bioinformatics/bti020; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Leigh JW, 2008, SYSTEMATIC BIOL, V57, P104, DOI 10.1080/10635150801910436; Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Dagan T, 2008, P NATL ACAD SCI USA, V105, P10039, DOI 10.1073/pnas.0800679105; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Lapointe FJ, 2010, TRENDS MICROBIOL, V18, P341, DOI 10.1016/j.tim.2010.03.009; David LA, 2011, NATURE, V469, P93, DOI 10.1038/nature09649; Nelson-Sathi S, 2012, P NATL ACAD SCI USA, V109, P20537, DOI 10.1073/pnas.1209119109; Droge J, 2012, BRIEF BIOINFORM, V13, P646, DOI 10.1093/bib/bbs031; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Deppenmeier U, 2002, PROG NUCLEIC ACID RE, V71, P223, DOI 10.1016/S0079-6603(02)71045-3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Kloesges T, 2011, MOL BIOL EVOL, V28, P1057, DOI 10.1093/molbev/msq297; Liu YC, 2008, ANN NY ACAD SCI, V1125, P171, DOI 10.1196/annals.1419.019; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Doyon JP, 2010, LECT N BIOINFORMAT, V6398, P93, DOI 10.1007/978-3-642-16181-0_9; Bapteste E, 2008, MOL BIOL EVOL, V25, P83, DOI 10.1093/mlbev/msm229; Bapteste Eric, 2005, Archaea, V1, P353, DOI 10.1155/2005/859728; Bhattacharya K, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/02/P02002; Boone DR, 2001, BERGEYS MANUAL SYSTE; Boone DR, 1993, METHANOGENESIS; Boucher Y, 2009, BIOESSAYS, V31, P526, DOI 10.1002/bies.200800216; Brilli M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-551; Brochier C, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r17; Brochier C, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-36; BURGGRAF S, 1991, SYST APPL MICROBIOL, V14, P346; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Elizabeth AS, 2006, ENERGY J, V27, P33; Ferry J. G., 1994, METHANOGENESIS ECOLO; Gao B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-86; Ge F, 2005, PLOS BIOL, V3, P1709, DOI 10.1371/journal.pbio.0030316; Hedderich R., 2006, PROKARYOTES, V2, P1050; Lawrence JG, 2005, CURR OPIN MICROBIOL, V8, P572, DOI 10.1016/j.mib.2005.08.005; Luo HW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006069; Morrison DA, 2011, INTRO PHYLOGENETIC N; Nolling J, 1996, INT J SYST BACTERIOL, V46, P1170; Garcia JL, 2000, ANAEROBE, V6, P205, DOI 10.1006/anae.2000.0345; Opsahl T, 2009, STRUCTURE EVOLUTION; Puigbo Pere, 2009, Journal of Biology (London), V8, P59, DOI 10.1186/jbiol159; Puigbo P, 2012, METHODS MOL BIOL, V856, P53, DOI 10.1007/978-1-61779-585-5_3; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Ripley BD, 2002, MODERN APPL STAT S; Rivera MC, 1996, INT J SYST BACTERIOL, V46, P348; Sakai S, 2008, INT J SYST EVOL MICR, V58, P929, DOI 10.1099/ijs.0.65571-0; Salichos L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018755; Schlesinger W. H., 1997, BIOGEOCHEMISTRY ANAL; Segata N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024704; Slesarev AI, 2002, P NATL ACAD SCI USA, V99, P4644, DOI 10.1073/pnas.032671499; Susko E, 2006, MOL BIOL EVOL, V23, P1019, DOI 10.1093/molbev/msj113; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; Wright ADG, 2006, INT J SYST EVOL MICR, V56, P1223, DOI 10.1099/ijs.0.63776-0; Yip Andy M, 2007, BMC Bioinformatics, V8, P22, DOI 10.1186/1471-2105-8-22	82	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1759-6653			GENOME BIOL EVOL	Genome Biol. Evol.	DEC	2014	6	12					3344	3359		10.1093/gbe/evu259		16	Evolutionary Biology; Genetics & Heredity	Evolutionary Biology; Genetics & Heredity	AX5YO	WOS:000347000800016		
J	Konuma, T; Ooi, J; Uchida, N; Ogawa, H; Ohashi, K; Kanamori, H; Aotsuka, N; Onishi, Y; Yamaguchi, H; Kozai, Y; Nagamura-Inoue, T; Kato, K; Suzuki, R; Atsuta, Y; Kato, S; Asano, S; Takahashi, S				Konuma, Takaaki; Ooi, Jun; Uchida, Naoyuki; Ogawa, Hiroyasu; Ohashi, Kazuteru; Kanamori, Heiwa; Aotsuka, Nobuyuki; Onishi, Yasushi; Yamaguchi, Hiroki; Kozai, Yasuji; Nagamura-Inoue, Tokiko; Kato, Koji; Suzuki, Ritsuro; Atsuta, Yoshiko; Kato, Seiko; Asano, Shigetaka; Takahashi, Satoshi			Granulocyte colony-stimulating factor combined regimen in cord blood transplantation for acute myeloid leukemia: a nationwide retrospective analysis in Japan	HAEMATOLOGICA			English	Letter						cord blood transplantation; conditioning regimen; granulocyte colony-stimulating factor; acute myeloid leukemia	BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; HEMATOLOGIC MALIGNANCIES; ADULT PATIENTS; CONDITIONING REGIMEN; UNRELATED DONOR; IRRADIATION; CYTARABINE; INDUCTION; REMISSION		[Konuma, Takaaki; Kato, Seiko] Univ Tokyo, Inst Med, Dept Hematol & Oncol, Tokyo 1138654, Japan; [Ooi, Jun] Teikyo Univ, Sch Med, Dept Hematol & Oncol, Tokyo 173, Japan; [Uchida, Naoyuki] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Ogawa, Hiroyasu] Hyogo Coll Med, Dept Internal Med, Div Hematol, Nishinomiya, Hyogo 6638501, Japan; [Ohashi, Kazuteru] Komagome Hosp, Metropolitan Canc & Infect Dis Ctr, Div Hematol, Tokyo, Japan; [Kanamori, Heiwa] Kanagawa Univ, Ctr Canc, Dept Hematol, Yokohama, Kanagawa, Japan; [Aotsuka, Nobuyuki] Japanese Red Cross Soc Narita Hosp, Div Hematol & Oncol, Narita, Japan; [Onishi, Yasushi] Tohoku Univ Hosp, Dept Hematol & Rheumatol, Sendai, Miyagi, Japan; [Yamaguchi, Hiroki] Nippon Med Sch, Dept Hematol, Tokyo 113, Japan; [Kozai, Yasuji] Tokyo Metropolitan Tama Med Ctr, Dept Transfus Med, Tokyo 158, Japan; [Nagamura-Inoue, Tokiko] Univ Tokyo, Res Hosp, Inst Med Sci, Dept Cell Proc & Transfus, Tokyo 1138654, Japan; [Kato, Koji] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Suzuki, Ritsuro] Nagoya Univ, Grad Sch Med, Dept HSCT Data Management & Biostat, Nagoya, Aichi 4648601, Japan; [Atsuta, Yoshiko] Japanese Data Ctr Hematopoiet Cell Transplantat, Nagoya, Aichi, Japan; [Atsuta, Yoshiko] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Asano, Shigetaka] Waseda Univ, Sch Adv Sci & Engn, Syst Med Biol Lab, Tokyo, Japan; [Takahashi, Satoshi] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Div Mol Therapy, Tokyo 1138654, Japan	Konuma, T (reprint author), Univ Tokyo, Inst Med, Dept Hematol & Oncol, Tokyo 1138654, Japan.	tkonuma@ims.u-tokyo.ac.jp					Pabst T, 2012, BLOOD, V119, P5367, DOI 10.1182/blood-2011-11-389841; Eapen M, 2010, LANCET ONCOL, V11, P653, DOI 10.1016/S1470-2045(10)70127-3; Atsuta Y, 2009, BLOOD, V113, P1631, DOI 10.1182/blood-2008-03-147041; Lowenberg B, 2003, NEW ENGL J MED, V349, P743, DOI 10.1056/NEJMoa025406; RIDDELL S, 1988, J CLIN ONCOL, V6, P576; Kanda Y, 2005, BIOL BLOOD MARROW TR, V11, P881, DOI 10.1016/j.bbmt.2005.07.005; Mori T, 2013, BIOL BLOOD MARROW TR, V19, P486, DOI 10.1016/j.bbmt.2012.12.007; Takahashi S, 2007, BLOOD, V109, P1322, DOI 10.1182/blood-2006-04-020172; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Mengarelli A, 2002, HAEMATOLOGICA, V87, P52; Takahashi S, 2004, BLOOD, V104, P3813, DOI 10.1182/blood-2004-03-1001; Konuma T, 2014, BIOL BLOOD MARROW TR, V20, P396, DOI 10.1016/j.bbmt.2013.12.555; Mardiney M, 1996, BLOOD, V87, P4049; MIYAUCHI J, 1989, BLOOD, V73, P1272; TAKAHASHI S, 1994, BONE MARROW TRANSPL, V13, P239	15	2	2	FERRATA STORTI FOUNDATION	PAVIA	VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY	0390-6078			HAEMATOLOGICA	Haematologica	DEC	2014	99	12								10.3324/haematol.2014.114504		5	Hematology	Hematology	AX6EP	WOS:000347016400021		
J	Yoshida, N; Kobayashi, R; Yabe, H; Kosaka, Y; Yagasaki, H; Watanabe, K; Kudo, K; Morimoto, A; Ohga, S; Muramatsu, H; Takahashi, Y; Kato, K; Suzuki, R; Ohara, A; Kojima, S				Yoshida, Nao; Kobayashi, Ryoji; Yabe, Hiromasa; Kosaka, Yoshiyuki; Yagasaki, Hiroshi; Watanabe, Ken-Ichiro; Kudo, Kazuko; Morimoto, Akira; Ohga, Shouichi; Muramatsu, Hideki; Takahashi, Yoshiyuki; Kato, Koji; Suzuki, Ritsuro; Ohara, Akira; Kojima, Seiji			First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy	HAEMATOLOGICA			English	Article							SAA-WORKING-PARTY; STEM-CELL TRANSPLANTATION; COLONY-STIMULATING FACTOR; ANTI-THYMOCYTE GLOBULIN; ANTITHYMOCYTE GLOBULIN; ALTERNATIVE DONOR; EUROPEAN GROUP; HOST DISEASE; CYCLOSPORINE; SURVIVAL	The current treatment approach for severe aplastic anemia in children is based on studies performed in the 1980s, and updated evidence is required. We retrospectively compared the outcomes of children with acquired severe aplastic anemia who received immunosuppressive therapy within prospective trials conducted by the Japanese Childhood Aplastic Anemia Study Group or who underwent bone marrow transplantation from an HLA-matched family donor registered in the Japanese Society for Hematopoietic Cell Transplantation Registry. Between 1992 and 2009, 599 children (younger than 17 years) with severe aplastic anemia received a bone marrow transplant from an HLA-matched family donor (n=213) or immunosuppressive therapy (n=386) as first-line treatment. While the overall survival did not differ between patients treated with immunosuppressive therapy or bone marrow transplantation [88% (95% confidence interval: 86-90) versus 92% (90-94)], failure-free survival was significantly inferior in patients receiving immunosuppressive therapy than in those undergoing bone marrow transplantation [56% (54-59) versus 87% (85-90); P<0.0001]. There was no significant improvement in outcomes over the two time periods (1992-1999 versus 2000-2009). In multivariate analysis, age <10 years was identified as a favorable factor for overall survival (P=0.007), and choice of first-line immunosuppressive therapy was the only unfavorable factor for failure-free survival (P<0.0001). These support the current algorithm for treatment decisions, which recommends bone marrow transplantation when an HLA-matched family donor is available in pediatric severe aplastic anemia.	[Yoshida, Nao; Kato, Koji] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Kobayashi, Ryoji] Sapporo Hokuyu Hosp, Dept Pediat, Isehara, Kanagawa, Japan; [Yabe, Hiromasa] Tokai Univ, Sch Med, Dept Cell Transplantat & Regenerat Med, Isehara, Kanagawa 25911, Japan; [Kosaka, Yoshiyuki] Hyogo Childrens Hosp, Dept Pediat, Kobe, Hyogo, Japan; [Yagasaki, Hiroshi] Nihon Univ, Sch Med, Dept Pediat, Tokyo, Japan; [Watanabe, Ken-Ichiro] Shizuoka Childrens Hosp, Div Hematol & Oncol, Toyoake, Aichi, Japan; [Kudo, Kazuko] Fujita Hlth Univ, Sch Med, Dept Pediat, Toyoake, Aichi 47011, Japan; [Morimoto, Akira] Jichi Med Univ, Sch Med, Dept Pediat, Shimotsuke, Tochigi, Japan; [Ohga, Shouichi] Kyushu Univ, Grad Sch Med Sci, Dept Perinatal & Pediat Med, Fukuoka 812, Japan; [Muramatsu, Hideki; Takahashi, Yoshiyuki; Kojima, Seiji] Nagoya Univ, Grad Sch Med, Dept Pediat, Tokyo, Japan; [Suzuki, Ritsuro] Nagoya Univ, Grad Sch Med, Dept HSCT Data Management & Biostat, Tokyo, Japan; [Ohara, Akira] Toho Univ, Sch Med, Dept Pediat, Tokyo, Japan	Kojima, S (reprint author), Nagoya Univ, Grad Sch Med, Dept Pediat, Tokyo, Japan.	kojimas@med.nagoya-u.ac.jp	Muramatsu, Hideki/I-3763-2012				Alsultan A, 2009, PEDIATR BLOOD CANCER, V52, P626, DOI 10.1002/pbc.21926; Scheinberg P, 2012, BLOOD, V119, P345, DOI 10.1182/blood-2011-05-352328; Bacigalupo A, 2010, HAEMATOL-HEMATOL J, V95, P976, DOI 10.3324/haematol.2009.018267; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Kojima S, 2000, BLOOD, V96, P2049; Scheinberg P, 2012, HEMATOL-AM SOC HEMAT, P292, DOI 10.1182/asheducation-2012.1.292; Tichelli A, 2011, BLOOD, V117, P4434, DOI 10.1182/blood-2010-08-304071; Yoshida N, 2008, BRIT J HAEMATOL, V142, P427, DOI 10.1111/j.1365-2141.2008.07182.x; Bacigalupo A, 2000, SEMIN HEMATOL, V37, P69, DOI 10.1016/S0037-1963(00)90031-3; Bacigalupo A, 2012, HAEMATOL-HEMATOL J, V97, P1142, DOI 10.3324/haematol.2011.054841; Afable MG, 2011, HAEMATOL-HEMATOL J, V96, P1269, DOI 10.3324/haematol.2011.042622; Fuhrer M, 2005, BLOOD, V106, P2102, DOI 10.1182/blood-2005-03-0874; Yoshida N, 2011, HAEMATOL-HEMATOL J, V96, P771, DOI 10.3324/haematol.2010.032805; Locasciulli A, 2007, HAEMATOL-HEMATOL J, V92, P11, DOI 10.3324/haematol.10075; Marsh JC, 2012, BLOOD, V119, P5391, DOI 10.1182/blood-2012-02-407684; Scheinberg P, 2008, J PEDIATR, V153, P814, DOI 10.1016/j.jpeds.2008.06.004; Passweg JR, 2010, HEMATOL-AM SOC HEMAT, P36, DOI 10.1182/asheducation-2010.1.36; BACIGALUPO A, 1988, BRIT J HAEMATOL, V70, P177, DOI 10.1111/j.1365-2141.1988.tb02460.x; Kosaka Y, 2008, BLOOD, V111, P1054, DOI 10.1182/blood-2007-08-099168; Marsh JCW, 2009, BRIT J HAEMATOL, V147, P43, DOI 10.1111/j.1365-2141.2009.07842.x; Kennedy-Nasser AA, 2006, BIOL BLOOD MARROW TR, V12, P1277, DOI 10.1016/j.bbmt.2006.07.011; BACIGALUPO A, 1995, BLOOD, V85, P1348; BAYEVER E, 1984, J PEDIATR-US, V105, P920, DOI 10.1016/S0022-3476(84)80078-5; Chang MH, 2009, EUR J HAEMATOL, V84, P154; DEEG HJ, 1994, BONE MARROW TRANSPL, V14, pS56; Doney K, 1997, ANN INTERN MED, V126, P107; GLUCKSBE.H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; Jeong D-C, 2011, ASH ANN M, V118, P1346; Kikuchi A, 2012, BONE MARROW TRANSPL, V48, P657; Kojima S, 2000, BRIT J HAEMATOL, V111, P321, DOI 10.1046/j.1365-2141.2000.02289.x; LOCASCIULLI A, 1990, BONE MARROW TRANSPL, V6, P211; MATHE G, 1971, TRANSPLANT P, V3, P325; Nair V, 2012, INDIAN PEDIATR, V49, P371; Peinemann F, 2013, COCHRANE DB SYST REV, V7; Scheinberg P, N ENGL J MED, V365, P430; Scheinberg P, 2009, HAEMATOL-HEMATOL J, V94, P348, DOI 10.3324/haematol.13829; Scheinberg P, 2006, BRIT J HAEMATOL, V133, P606, DOI 10.1111/j.1365-2141.2006.06085.x; Valdez JM, 2011, CLIN INFECT DIS, V52, P726, DOI 10.1093/cid/ciq245; Yagasaki H, 2010, BONE MARROW TRANSPL, V45, P1508, DOI 10.1038/bmt.2009.378; Young NS, 1999, JAMA-J AM MED ASSOC, V282, P271, DOI 10.1001/jama.282.3.271	40	3	3	FERRATA STORTI FOUNDATION	PAVIA	VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY	0390-6078			HAEMATOLOGICA	Haematologica	DEC	2014	99	12					1784	1791		10.3324/haematol.2014.109355		8	Hematology	Hematology	AX6EP	WOS:000347016400003		
J	Aoki, T; Izutsu, K; Suzuki, R; Nakaseko, C; Arima, H; Shimada, K; Tomita, A; Sasaki, M; Takizawa, J; Mitani, K; Igarashi, T; Maeda, Y; Fukuhara, N; Ishida, F; Niitsu, N; Ohmachi, K; Takasaki, H; Nakamura, N; Kinoshita, T; Nakamura, S; Ogura, M				Aoki, Tomohiro; Izutsu, Koji; Suzuki, Ritsuro; Nakaseko, Chiaki; Arima, Hiroshi; Shimada, Kazuyuki; Tomita, Akihiro; Sasaki, Makoto; Takizawa, Jun; Mitani, Kinuko; Igarashi, Tadahiko; Maeda, Yoshinobu; Fukuhara, Noriko; Ishida, Fumihiro; Niitsu, Nozomi; Ohmachi, Ken; Takasaki, Hirotaka; Nakamura, Naoya; Kinoshita, Tomohiro; Nakamura, Shigeo; Ogura, Michinori			Prognostic significance of pleural or pericardial effusion and the implication of optimal treatment in primary mediastinal large B-cell lymphoma: a multicenter retrospective study in Japan	HAEMATOLOGICA			English	Article							RADIATION-THERAPY; MACOP-B; HODGKIN LYMPHOMA; CONTAINING CHEMOTHERAPY; ELDERLY-PATIENTS; RITUXIMAB; SCLEROSIS; RADIOTHERAPY; CHOP; TRANSPLANTATION	The prognosis of patients with primary mediastinal large B-cell lymphoma has improved over recent years. However, the optimal treatment strategy including the role of radiotherapy remains unknown. We retrospectively analyzed the clinical outcomes of 345 patients with newly diagnosed primary mediastinal large B-cell lymphoma in Japan. With a median follow up of 48 months, the overall survival at four years for patients treated with R-CHOP (n=187), CHOP (n=44), DA-EPOCH-R (n=9), 2nd- or 3rd-generation regimens, and chemotherapy followed by autologous stem cell transplantation were 90%, 67%, 100%, 91% and 92%, respectively. Focusing on patients treated with R-CHOP, a higher International Prognostic Index score and the presence of pleural or pericardial effusion were identified as adverse prognostic factors for overall survival in patients treated with R-CHOP without consolidative radiotherapy (IPI: hazard ratio 4.23, 95% confidence interval 1.48-12.13, P=0.007; effusion: hazard ratio 4.93, 95% confidence interval 1.37-17.69, P=0.015). Combined with the International Prognostic Index score and the presence of pleural or pericardial effusion for the stratification of patients treated with R-CHOP without radiotherapy, patients with lower International Prognostic Index score and the absence of effusion comprised approximately one-half of these patients and could be identified as curable patients (95% overall survival at 4 years). The DA-EPOCH-R regimen might overcome the effect of these adverse prognostic factors. Our simple indicators of International Prognostic Index score and the presence of pleural or pericardial effusion could stratify patients with primary mediastinal large B-cell lymphoma and help guide selection of treatment.	[Aoki, Tomohiro; Ogura, Michinori] Nagoya Daini Red Cross Hosp, Dept Hematol & Oncol, Nagoya, Aichi, Japan; [Aoki, Tomohiro; Shimada, Kazuyuki; Tomita, Akihiro] Nagoya Univ, Grad Sch Med, Dept Hematol & Oncol, Nagoya, Aichi 4648601, Japan; [Izutsu, Koji] Toranomon Gen Hosp, Dept Hematol, Tokyo, Japan; [Suzuki, Ritsuro] Nagoya Univ, Grad Sch Med, Dept HSCT Data Management & Biostat, Nagoya, Aichi 4648601, Japan; [Nakaseko, Chiaki] Chiba Univ Hosp, Dept Hematol, Chiba, Japan; [Arima, Hiroshi] Kyoto Univ, Grad Sch Med, Dept Hematol & Oncol, Kyoto, Japan; [Sasaki, Makoto] Juntendo Univ, Sch Med, Dept Internal Med, Div Hematol, Tokyo 113, Japan; [Takizawa, Jun] Niigata Univ, Fac Med, Dept Hematol Endocrinol & Metab, Niigata 95021, Japan; [Mitani, Kinuko] Dokkyo Med Univ Med, Dept Hematol & Oncol, Mibu, Tochigi, Japan; [Igarashi, Tadahiko] Gunma Canc Ctr, Dept Hematol & Oncol, Ota, Japan; [Maeda, Yoshinobu] Okayama Univ Hosp, Dept Hematol & Oncol, Okayama, Japan; [Fukuhara, Noriko] Tohoku Univ Hosp, Dept Hematol & Rheumatol, Sendai, Miyagi, Japan; [Ishida, Fumihiro] Shinshu Univ, Sch Med, Dept Hematol, Dept Biomed Lab Sci, Matsumoto, Nagano 390, Japan; [Niitsu, Nozomi] Saitama Med Univ, Int Med Ctr, Dept Hematol, Hidaka, Japan; [Ohmachi, Ken] Tokai Univ, Dept Hematol, Isehara, Kanagawa, Japan; [Takasaki, Hirotaka] Kanagawa Canc Ctr, Dept Med Oncol, Yokohama, Kanagawa 2410815, Japan; [Nakamura, Naoya] Tokai Univ, Dept Pathol, Isehara, Kanagawa, Japan; [Kinoshita, Tomohiro] Aichi Canc Ctr, Dept Hematol & Cell Therapy, Nagoya, Aichi 464, Japan; [Nakamura, Shigeo] Nagoya Univ Hosp, Dept Pathol & Lab Med, Nagoya, Aichi, Japan; [Ogura, Michinori] Suzuka Natl Hosp, Natl Hosp Org, Dept Internal Med & Lab Med, Suzuka, Japan	Aoki, T (reprint author), Nagoya Daini Red Cross Hosp, Dept Hematol & Oncol, Nagoya, Aichi, Japan.	iwbamasbytryf0305@yahoo.co.jp	Nakamura, Shigeo/I-1571-2012		Hematological Malignancy Clinical Study Group; National Cancer Center Research and Development Fund [23-A-17]	This work was supported by the Hematological Malignancy Clinical Study Group and the National Cancer Center Research and Development Fund (23-A-17).	Galper SL, 2011, BLOOD, V117, P412, DOI 10.1182/blood-2010-06-291328; Barth TFE, 2002, LANCET ONCOL, V3, P229, DOI 10.1016/S1470-2045(02)00714-3; Martelli M, 2014, J CLIN ONCOL, V32, P1769, DOI 10.1200/JCO.2013.51.7524; Meyer RM, 2012, NEW ENGL J MED, V366, P399, DOI 10.1056/NEJMoa1111961; Lazzarino M, 1997, J CLIN ONCOL, V15, P1646; Yamada Y, 2001, BRIT J HAEMATOL, V113, P375, DOI 10.1046/j.1365-2141.2001.02737.x; Rieger M, 2011, ANN ONCOL, V22, P664, DOI 10.1093/annonc/mdq418; Zinzani PL, 2009, CLIN LYMPHOMA MYELOM, V9, P381, DOI 10.3816/CLM.2009.n.074; Vassilakopoulos TP, 2012, ONCOLOGIST, V17, P239, DOI 10.1634/theoncologist.2011-0275; Zinzani PL, 2002, HAEMATOLOGICA, V87, P1258; Henderson TO, 2010, ANN INTERN MED, V152, P444, DOI 10.7326/0003-4819-152-7-201004060-00009; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Dunleavy K, 2013, NEW ENGL J MED, V368, P1408, DOI 10.1056/NEJMoa1214561; Shimada K, 2008, J CLIN ONCOL, V26, P3189, DOI 10.1200/JCO.2007.15.4278; Filippi AR, 2013, INT J RADIAT ONCOL, V87, P311, DOI 10.1016/j.ijrobp.2013.05.053; Cheson BD, 1999, J CLIN ONCOL, V17, P1244; Yamamoto W, 2013, LEUKEMIA LYMPHOMA, V54, P967, DOI 10.3109/10428194.2012.733881; Hu SM, 2013, BLOOD, V121, P2715, DOI 10.1182/blood-2012-10-461848; Martelli MP, 1998, ANN ONCOL, V9, P1027, DOI 10.1023/A:1008412009667; CazalsHatem D, 1996, AM J SURG PATHOL, V20, P877, DOI 10.1097/00000478-199607000-00012; Savage KJ, 2006, ANN ONCOL, V17, P123, DOI 10.1093/annonc/mdj030; van Besien K, 2001, J CLIN ONCOL, V19, P1855; Pfreundschuh M, 2008, LANCET ONCOL, V9, P105, DOI 10.1016/S1470-2045(08)70002-0; Cairoli R, 2002, BONE MARROW TRANSPL, V29, P473, DOI 10.1038/sj/bmt/1703401; Hamlin PA, 2005, BRIT J HAEMATOL, V130, P691, DOI 10.1111/j.1365-2141.2005.05661.x; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Henderson TO, 2010, ANN INTERN MED, V152, pW144; Hunter BD, 2014, LEUKEMIA LYMPHOMA, V55, P1822, DOI 10.3109/10428194.2013.836599; Nieder C, 2007, RADIOTHER ONCOL, V82, P301, DOI 10.1016/j.radonc.2006.10.015; Niitsu N, 2006, ANN HEMATOL, V85, P374, DOI 10.1007/s00277-006-0080-x; Rodriguez J, 2006, ASH ANN M, V108, P3056; Savage KJ, 2012, ASH ANN M, V120, P303; Sehn LH, 1998, BLOOD, V91, P717; Swerdlow S, 2008, WHO CLASSIFICATION T; Tai WM, 2011, LEUKEMIA LYMPHOMA, V52, P604, DOI 10.3109/10428194.2010.550073; TODESCHINI G, 1990, J CLIN ONCOL, V8, P804; Witzens-Harig M, 2012, ASH ANN M, V120, P1612; Woessmann Wilhelm, 2013, N Engl J Med, V369, P282, DOI 10.1056/NEJMc1305983#SA1; Xu LM, 2013, LEUKEMIA LYMPHOMA, V54, P1684, DOI 10.3109/10428194.2012.746684; Zinzani PL, 1999, BLOOD, V94, P3289; Zinzani PL, 2001, HAEMATOLOGICA, V86, P187	41	1	1	FERRATA STORTI FOUNDATION	PAVIA	VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY	0390-6078			HAEMATOLOGICA	Haematologica	DEC	2014	99	12					1817	1825		10.3324/haematol.2014.111203		9	Hematology	Hematology	AX6EP	WOS:000347016400007		
J	Nagao, Y; Kawahigashi, Y; Sata, M				Nagao, Yumiko; Kawahigashi, Yuji; Sata, Michio			Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection	HEPATITIS MONTHLY			English	Article						Periodontal Disease; Hepatitis C virus; Hepatitis B Virus; Interferon; Fibrosis; Porphyromonas gingivalis; Fimbrillin	GINGIVAL CREVICULAR FLUID; CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; PORPHYROMONAS-GINGIVALIS; INTERFERON THERAPY; INSULIN-RESISTANCE; VIRUS-INFECTION; FIMA GENOTYPES; SALIVA; JAPAN	Background: Periodontal disease and systemic health are closely associated. However, there is no data supporting the association between periodontal disease and patients with liver diseases associated with hepatitis C virus (HCV) and/or hepatitis B virus (HBV) infection. Objectives: The aim of this study was to evaluate the association between periodontitis and progression of liver diseases in patients with HCV and/or HBV infection. Patients and Methods: In this retrospective study, 351 patients with HCV- and/or HBV-related liver diseases underwent screening for periodontal disease using the Salivaster (R) salivary occult blood test from February 2010 to June 2014. Furthermore, we examined the prevalence of fimbrillin (fimA) genotype of Porphyromonas gingivalis (P. gingivalis) in 28 HCV- infected patients visited at our hospital between January 2013 and June 2014. P. gingivalis with fimA genotype with types I to V was further detected using a PCR method. Results: Of 351 patients, 76 patients (group 1) had a strong positive result for salivary occult blood test and 275 patients (group 2) had weak positive or negative test results. Significant factors between the groups were obesity, level of AST, ALT, LDH, ALP, Alb, D. Bil, T. cho, AFP, platelets (Plt), IRI, HOMA-IR, current interferon (IFN) treatment and the daily frequency of tooth brushing. Between-groups analysis indicated that total protein (T. pro) level and liver fibrosis were significant factors. According to multivariate analysis, five factors were associated with periodontal disease as Plt count below 80000, brushing teeth only once a day, current IFN treatment, aged 65 years or older and obesity. The adjusted odds ratios for these five factors were 5.80, 3.46, 2.87, 2.50 and 2.33, respectively, and each was statistically significant. Twenty-eight saliva specimens had positive results for P. gingivalis with fimA genotype types I to V. The prevalence of fimA genotype II was higher in 14 patients with liver cirrhosis or a history of hepatocellular carcinoma treatment (group B, 50.00%) than 14 patients with only hepatitis C (group A, 21.43%). Conclusions: Periodontitis might be associated with progression of viral liver disease; hence, controlling oral disease is essential for the prevention and management of liver fibrosis.	[Nagao, Yumiko; Kawahigashi, Yuji] Kurume Univ, Sch Med, Dept Digest Dis Informat & Res, Kurume, Fukuoka 8300011, Japan; [Sata, Michio] Kurume Univ, Sch Med, Res Ctr Innovat Canc Therapy, Kurume, Fukuoka 8300011, Japan	Nagao, Y (reprint author), Kurume Univ, Sch Med, Dept Digest Dis Informat & Res, Kurume, Fukuoka 8300011, Japan.	nagao@med.kurume-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25463274]	This study was supported in part by a Grant-in-Aid for Scientific Research (C) (No. 25463274) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; Yoshida H, 2002, GASTROENTEROLOGY, V123, P483, DOI 10.1053/gast.2002.34785; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Kaufman E, 2000, J CLIN PERIODONTOL, V27, P453, DOI 10.1034/j.1600-051x.2000.027007453.x; Maticic M, 2001, J PERIODONTOL, V72, P11, DOI 10.1902/jop.2001.72.1.11; Missailidis CG, 2004, ORAL MICROBIOL IMMUN, V19, P224, DOI 10.1111/j.1399-302X.2004.00140.x; Amano A, 1999, J CLIN MICROBIOL, V37, P1426; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; Serfaty L, 2009, LIVER INT, V29, P13, DOI 10.1111/j.1478-3231.2008.01952.x; Lopez NJ, 2002, J DENT RES, V81, P58; Mealey BL, 2006, J PERIODONTOL, V77, P1289, DOI 10.1902/jop.2006.050459; DUSHEIKO G, 1994, HEPATOLOGY, V19, P13, DOI 10.1016/0270-9139(94)90046-9; Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Lee SC, 2000, J CLIN MICROBIOL, V38, P4171; Ishihara K, 2004, J CLIN MICROBIOL, V42, P1313, DOI 10.1128/JCM.42.3.1313-1315.2004; Nakagawa I, 2002, INFECT IMMUN, V70, P277, DOI 10.1128/IAI.70.1.277-285.2002; Kiyosawa K, 2004, GASTROENTEROLOGY, V127, pS17, DOI 10.1053/j.gastro.2004.09.012; Umemura T, 2009, J GASTROENTEROL, V44, P102, DOI 10.1007/s00535-008-2251-0; Yoshida H, 1999, ANN INTERN MED, V131, P174; Bascones-Martínez Antonio, 2004, Med Oral Patol Oral Cir Bucal, V9 Suppl, P101; BENARYEH H, 1985, ARCH ORAL BIOL, V30, P97, DOI 10.1016/0003-9969(85)90032-9; El-Serag HB, 2014, HEPATOLOGY, V60, P779, DOI 10.1002/hep.27172; Embery G, 1994, Adv Dent Res, V8, P329; Hashimoto Masanori, 2006, Bull Tokyo Dent Coll, V47, P37, DOI 10.2209/tdcpublication.47.37; Henderson L, 2001, ORAL DIS, V7, P271, DOI 10.1034/j.1601-0825.2001.00695.x; Montebugnoli L, 2000, Minerva Stomatol, V49, P1; Moura-Grec Patrícia Garcia de, 2014, Cien Saude Colet, V19, P1763; Nagao Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-192; Nagao Y, 2000, Kansenshogaku Zasshi, V74, P961; Nagao Y, 2008, J GASTROEN HEPATOL, V23, P580, DOI 10.1111/j.1440-1746.2007.04835.x; Nishimura F, 2001, J DENT RES, V80, P1690; Niwa M, 1989, Shigaku, V77, P598; PERSSON GR, 1990, J PERIODONTAL RES, V25, P81, DOI 10.1111/j.1600-0765.1990.tb00896.x; Sizmann D, 2007, J CLIN VIROL, V38, P326, DOI 10.1016/j.jcv.2006.12.021; Tadokoro K, 2010, MICROBIOL RES, V165, P43, DOI 10.1016/j.micres.2008.06.001; Yamasaki K, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-139; Yoneda M, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-16	37	1	1	KOWSAR PUBL	HOENSBROEK	PATERSWEG 22,, HOENSBROEK, LIMBURG 6431 GC, NETHERLANDS	1735-143X	1735-3408		HEPAT MON	Hepat. Mon.	DEC	2014	14	12							e23264	10.5812/hepatmon.23264		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AX8LY	WOS:000347162100004		
J	Matsumoto, K; Hosoya, T; Ishikawa, E; Tashima, K; Amagase, K; Kato, S; Murayama, T; Horie, S				Matsumoto, Kenjiro; Hosoya, Takuji; Ishikawa, Eriko; Tashima, Kimihito; Amagase, Kikuko; Kato, Shinichi; Murayama, Toshihiko; Horie, Syunji			Distribution of transient receptor potential cation channel subfamily V member 1-expressing nerve fibers in mouse esophagus	HISTOCHEMISTRY AND CELL BIOLOGY			English	Article						TRPV1; Mouse; Esophagus; Spinal afferent; Vagal afferent	INTRAGANGLIONIC LAMINAR ENDINGS; NONEROSIVE REFLUX DISEASE; INFLAMED HUMAN ESOPHAGUS; CAPSAICIN RECEPTOR; VISCERAL HYPERSENSITIVITY; EPITHELIAL-CELLS; RAT ESOPHAGUS; TRPV1; EXPRESSION; NEURONS	Transient receptor potential cation channel subfamily V member 1 (TRPV1) plays a role in esophageal function. However, the distribution of TRPV1 nerve fibers in the esophagus is currently not well understood. In the present study, we investigated the distribution of TRPV1 and neurotransmitters released from TRPV1 nerve fibers in the mouse lower esophagus. Furthermore, we investigated changes in the presence of TRPV1 in the mouse model of esophagitis. Numerous TRPV1-immunoreactive nerve fibers were seen in both the submucosal layer and myenteric plexus of the lower esophagus and colocalized with calcitonin gene-related peptide (CGRP). TRPV1 colocalized with substance P in axons in the submucosal layer and myenteric plexus. TRPV1 colocalized with neuronal nitric oxide synthase in the myenteric plexus. We observed some colocalization of CGRP with the vesicular acetylcholine (ACh) transporter, packaging of ACh into synaptic vesicles after its synthesis in terminal cytoplasm, in the submucosal layer and myenteric plexus. In the esophagitis model, the number of the TRPV1 nerve fibers did not change, but their immunoreactive intensity increased compared with sham-operated mice. Inhibitory effect of exogenous capsaicin on electrically stimulated twitch contraction significantly increased in esophagitis model compared with the effect in sham-operated mice. Overall, these results suggest that TRPV1 nerve fibers projecting to both the submucosal and muscle layer of the esophagus are extrinsic spinal and vagal afferent neurons. Furthermore, TRPV1 nerve fibers contain CGRP, substance P, nitric oxide, and ACh. Therefore, acid influx-mediated TRPV1 activation may play a role in regulating esophageal relaxation.	[Matsumoto, Kenjiro; Ishikawa, Eriko; Tashima, Kimihito; Horie, Syunji] Josai Int Univ, Fac Pharmaceut Sci, Pharmacol Lab, Togane, Chiba 2838555, Japan; [Matsumoto, Kenjiro; Amagase, Kikuko; Kato, Shinichi] Kyoto Pharmaceut Univ, Dept Pharmacol & Expt Therapeut, Div Pathol Sci, Kyoto 6078414, Japan; [Hosoya, Takuji; Murayama, Toshihiko] Chiba Univ, Grad Sch Pharmaceut Sci, Dept Chem Pharmacol, Chuo Ku, Chiba 2608675, Japan	Matsumoto, K (reprint author), Josai Int Univ, Fac Pharmaceut Sci, Pharmacol Lab, 1 Gumyo, Togane, Chiba 2838555, Japan.	kenjiro@mb.kyoto-phu.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Taiho Pharmaceutical Co. Ltd, Tokyo, JAPAN	This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and by Taiho Pharmaceutical Co. Ltd, Tokyo, JAPAN.	Omura N, 1999, SCAND J GASTROENTERO, V34, P948; Akiba Y, 2008, GUT, V57, P1654, DOI 10.1136/gut.2007.144378; Shieh KR, 2010, NEUROGASTROENT MOTIL, V22, P971, DOI 10.1111/j.1365-2982.2010.01530.x; Ma J, 2012, AM J PHYSIOL-GASTR L, V303, pG635, DOI 10.1152/ajpgi.00097.2012; Harrington AM, 2013, NEUROGASTROENT MOTIL, V25, pE660, DOI 10.1111/nmo.12180; Matthews PJ, 2004, EUR J GASTROEN HEPAT, V16, P897, DOI 10.1097/00042737-200409000-00014; Furness JB, 2000, J AUTONOM NERV SYST, V81, P87, DOI 10.1016/S0165-1838(00)00127-2; Bielefeldt K, 2008, AM J PHYSIOL-GASTR L, V294, pG130, DOI 10.1152/ajpgi.00388.2007; Caterina MJ, 1997, NATURE, V389, P816; Kishimoto E, 2011, AM J PHYSIOL-GASTR L, V301, pG230, DOI 10.1152/ajpgi.00436.2009; Russo D, 2013, J COMP NEUROL, V521, P342, DOI 10.1002/cne.23177; Surdenikova L, 2012, NEUROGASTROENT MOTIL, V24, pe517, DOI 10.1111/nmo.12002; Banerjee B, 2007, NEUROGASTROENT MOTIL, V19, P681, DOI 10.1111/j.1365-2982.2007.00946.x; Matsumoto K, 2011, NEUROSCIENCE, V172, P518, DOI 10.1016/j.neuroscience.2010.10.024; Yoshida N, 2013, DIGEST DIS SCI, V58, P2237, DOI 10.1007/s10620-012-2337-7; Bhat YM, 2006, EUR J GASTROEN HEPAT, V18, P263, DOI 10.1097/00042737-200603000-00006; Boudaka A, 2007, J VET MED SCI, V69, P365, DOI 10.1292/jvms.69.365; Boudaka A, 2007, EUR J PHARMACOL, V556, P157, DOI 10.1016/j.ejphar.2006.11.005; Cheng L, 2009, AM J PHYSIOL-GASTR L, V297, pG135, DOI 10.1152/ajpgi.90386.2008; Horling L, 2014, HISTOCHEM CELL BIOL, V141, P321, DOI 10.1007/s00418-013-1162-1; Matsumoto K, 2009, AM J PHYSIOL-GASTR L, V297, pG348, DOI 10.1152/ajpgi.90578.2008; Matsumoto K, 2012, LAB INVEST, V92, P769, DOI 10.1038/labinvest.2012.14; Miwa Hiroto, 2010, J Neurogastroenterol Motil, V16, P353, DOI 10.5056/jnm.2010.16.4.353; Peles S, 2009, NEUROSCIENCE, V161, P515, DOI 10.1016/j.neuroscience.2009.03.040; Qin C, 2008, AM J PHYSIOL-GASTR L, V294, pG708, DOI 10.1152/ajpgi.00477.2007; Raab M, 2004, HISTOCHEM CELL BIOL, V122, P445, DOI 10.1007/s00418-004-0703-z; Sang Q, 1997, J COMP NEUROL, V386, P119, DOI 10.1002/(SICI)1096-9861(19970915)386:1<119::AID-CNE11>3.0.CO;2-F; Shiina T, 2006, NEUROSCIENCE, V139, P495, DOI 10.1016/j.neuroscience.2005.12.027; Sivarao DV, 2001, GASTROENTEROLOGY, V121, P34, DOI 10.1053/gast.2001.25541; Worl J, 2002, ANAT EMBRYOL, V205, P141, DOI 10.1007/s00429-002-0239-8	30	2	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0948-6143	1432-119X		HISTOCHEM CELL BIOL	Histochem. Cell Biol.	DEC	2014	142	6					635	644		10.1007/s00418-014-1246-6		10	Cell Biology; Microscopy	Cell Biology; Microscopy	AX4WT	WOS:000346930200003		
J	Yu, QQ; Sasaki, K				Yu, Qianqian; Sasaki, Keiko			In situ X-ray diffraction investigation of the evolution of a nanocrystalline lithium-ion sieve from biogenic manganese oxide	HYDROMETALLURGY			English	Article						Biogenic birnessite; Li-ion sieve; In situ X-ray diffraction; Mn-oxidizing fungus; Bio-templated microtubes	STRUCTURE REFINEMENT; THERMAL-STABILITY; LI4MN5O12; BIRNESSITE; FUNGUS; STRAIN	Microbial catalysis, a primary pathway for the generation of Mn oxides in most natural environments, provides potential to fabricate new materials. A microtube-type lithium manganese oxide (LMO-MT) was synthesized through a solid-state transformation using Mn-oxidizing fungus, Paraconiothyrium sp. WL-2. Compared with abiotic precursors, the lithium-ion sieve microtube (HMO-MT) showed better performance for Li+ recovery. In order to clarify the formation process of LMO-MTs, in situ high-temperature X-ray diffraction was used to compare with three synthetic references. The effects of calcination temperature on crystal phase, composition, particle size and lattice parameters of the LMO-MTs were systematically discussed. It was found that the poorly crystalline structure of biogenic precursor as well as high content of organic matter facilitated the formation of highly crystalline LMO-MTs at low temperature. The unique structural properties of LMO-MTs, including high crystallinity and small lattice constant, are attributed to the high Li+ sorption capacity of HMO-MTs. (c) 2014 Elsevier B.V. All rights reserved.	[Yu, Qianqian; Sasaki, Keiko] Kyushu Univ, Dept Earth Resources Engn, Fukuoka 8190395, Japan	Sasaki, K (reprint author), Kyushu Univ, Dept Earth Resources Engn, 744 Motooka, Fukuoka 8190395, Japan.	qianqianyu09@gmail.com; keikos@mine.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [GR078]	This work was financially supported by the funding program Next Generation of World-Leading Researchers "Creation of Eco-Materials from Geomimetics" (GR078) from the Japan Society for the Promotion of Science (JSPS). The authors express their appreciation to Mr. Taichi Momoki at Kyushu University for assisting in the sorption experiments.	FENG Q, 1992, LANGMUIR, V8, P1861, DOI 10.1021/la00043a029; Drits VA, 1997, AM MINERAL, V82, P946; TAKADA T, 1995, J SOLID STATE CHEM, V115, P420, DOI 10.1006/jssc.1995.1154; Ivanova S, 2011, J MATER SCI, V46, P7098, DOI 10.1007/s10853-011-5409-8; Takada T, 1997, J SOLID STATE CHEM, V130, P74, DOI 10.1006/jssc.1997.7282; WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6; Thackeray MM, 1996, MATER RES BULL, V31, P133, DOI 10.1016/0025-5408(95)00190-5; Li GS, 2005, J AM CHEM SOC, V127, P8659, DOI 10.1021/ja050517g; Paolone A., 2006, ELECTROCHEM COMMUN, V8, P5; Sasaki K, 2006, MATER TRANS, V47, P2457, DOI 10.2320/matertrans.47.2457; Takada T, 1996, J SOLID STATE CHEM, V121, P79, DOI 10.1006/jssc.1996.0012; Takano K, 2006, LIMNOLOGY, V7, P219, DOI 10.1007/s10201-006-0177; Vainshtein B. K., 1995, STRUCTURE CRYSTAL, P71; Yu QQ, 2013, J HAZARD MATER, V262, P38, DOI 10.1016/j.jhazmat.2013.08.027; Yu QQ, 2013, MICROPOR MESOPOR MAT, V179, P122, DOI 10.1016/j.micromeso.2013.05.026; Yu QQ, 2012, CHEM GEOL, V310, P106, DOI 10.1016/j.chemgeo.2012.03.029	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0304-386X	1879-1158		HYDROMETALLURGY	Hydrometallurgy	DEC	2014	150						253	258		10.1016/j.hydromet.2014.07.002		6	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	AX6GH	WOS:000347020600032		
J	Tamura, K; Ohki, K; Kobayashi, R; Uneda, K; Azushima, K; Ohsawa, M; Wakui, H; Sakai, M; Tokita, Y; Umemura, S				Tamura, Kouichi; Ohki, Koji; Kobayashi, Ryu; Uneda, Kazushi; Azushima, Kengo; Ohsawa, Masato; Wakui, Hiromichi; Sakai, Masashi; Tokita, Yasuo; Umemura, Satoshi			Therapeutic impact of the single fixed-dose combination with a high-dose angiotensin-receptor blocker and a low-dose thiazide diuretic in the management of hypertension: awaiting further accumulation of clinical evidence	HYPERTENSION RESEARCH			English	Editorial Material							CHRONIC KIDNEY-DISEASE; METAANALYSIS; GUIDELINES; RISK; PROTEINURIA; PREVENTION; SOCIETY; TRIALS		[Tamura, Kouichi; Ohki, Koji; Kobayashi, Ryu; Uneda, Kazushi; Azushima, Kengo; Ohsawa, Masato; Wakui, Hiromichi; Umemura, Satoshi] Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 232, Japan; [Sakai, Masashi] Int Goodwill Hosp, Dept Hypertens & Nephrol, Yokohama, Kanagawa, Japan; [Tokita, Yasuo] Fujisawa Municipal Hosp, Dept Med, Div Renal, Fujisawa, Kanagawa, Japan	Tamura, K (reprint author), Yokohama City Univ, Grad Sch Med, Dept Med Sci & Cardiorenal Med, Yokohama, Kanagawa 232, Japan.	tamukou@med.yokohama-cu.ac.jp					Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Rahman M, 2012, CLIN J AM SOC NEPHRO, V7, P989, DOI 10.2215/CJN.07800811; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Hackam DG, 2013, CAN J CARDIOL, V29, P528, DOI 10.1016/j.cjca.2013.01.005; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Wald DS, 2009, AM J MED, V122, P290, DOI 10.1016/j.amjmed.2008.09.038; Weber MA, 2014, J CLIN HYPERTENS, V16, P14, DOI 10.1111/jch.12237; Gupta AK, 2010, HYPERTENSION, V55, P399, DOI 10.1161/HYPERTENSIONAHA.109.139816; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Go AS, 2014, HYPERTENSION, V63, P878, DOI 10.1161/HYP.0000000000000003; Bakris GL, 2010, LANCET, V375, P1173; CKD JCfE-BCPGf, 2014, CLIN EXP NEPHROL, V18, P346; Fujisaki K, 2014, HYPERTENS RES, V37, P993, DOI 10.1038/hr.2014.110; Hasegawa H, 2013, HYPERTENS RES, V36, P776, DOI 10.1038/hr.2013.41; Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group, 2012, KIDNEY INT S, V2, P337; Krause T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4891; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Ninomiya T, 2013, BMJ-BRIT MED J, V347, pf5680, DOI DOI 10.1136/BMJ.F5680.A; Rakugi H, 2013, HYPERTENS RES, V36, P947, DOI 10.1038/hr.2013.63; Rakugi H, 2014, HYPERTENS RES, V37, P1042, DOI 10.1038/hr.2014.114; Shimamoto Kazuaki, 2014, Hypertens Res, V37, P253, DOI 10.1038/hr.2014.20; Yanagi M, 2013, HYPERTENS RES, V36, P262, DOI 10.1038/hr.2012.184	22	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	DEC	2014	37	12					1032	1034		10.1038/hr.2014.130		3	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AX7OQ	WOS:000347105400002		
J	Oyama, J; Node, K				Oyama, Jun-ichi; Node, Koichi			Sympathetic nerve activity and endothelial function	HYPERTENSION RESEARCH			English	Editorial Material							FLOW-MEDIATED VASODILATATION; BRACHIAL-ARTERY; DYSFUNCTION; HYPERTENSION; AMPLITUDE		[Oyama, Jun-ichi] Saga Univ, Dept Adv Cardiol, Saga 840, Japan; [Node, Koichi] Saga Univ, Dept Cardiovasc Med, Saga 840, Japan	Oyama, J (reprint author), Saga Univ, Dept Adv Cardiol, Saga 840, Japan.	junoyama@cc.saga-u.ac.jp					Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Higashi Y, 2012, HYPERTENS RES, V35, P1039, DOI 10.1038/hr.2012.138; Nohria A, 2006, J APPL PHYSIOL, V101, P545, DOI 10.1152/japplphysiol.01285.2005; Kuvin JT, 2003, AM HEART J, V146, P168, DOI 10.1016/S0002-8703(03)00094-2; Inaba Y, 2010, INT J CARDIOVAS IMAG, V26, P631, DOI 10.1007/s10554-010-9616-1; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Schachinger V, 2000, CIRCULATION, V101, P1899; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P1468; Iguchi T, 2013, HYPERTENS RES, V36, P691, DOI 10.1038/hr.2013.35; Tomiyama H, 2014, HYPERTENS RES, V37, P914, DOI 10.1038/hr.2014.103	10	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	DEC	2014	37	12					1035	1036		10.1038/hr.2014.142		2	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AX7OQ	WOS:000347105400003		
J	Rakugi, H; Tsuchihashi, T; Shimada, K; Numaguchi, H; Nishida, C; Yamaguchi, H; Fujimoto, G; Azuma, K; Shirakawa, M; Hanson, ME; Fujita, KP				Rakugi, Hiromi; Tsuchihashi, Takuya; Shimada, Kazuyuki; Numaguchi, Hirotaka; Nishida, Chisato; Yamaguchi, Hiroya; Fujimoto, Go; Azuma, Kyoichi; Shirakawa, Masayoshi; Hanson, Mary E.; Fujita, Kenji P.			Efficacy and safety of losartan 100 mg/hydrochlorothiazide 12.5mg in Japanese subjects with essential hypertension: two randomized, controlled trials	HYPERTENSION RESEARCH			English	Article						hydrochlorothiazide; Japanese; losartan; randomized; uric acid		Two randomized studies were designed to assess the safety, tolerability and efficacy of losartan 100 mg (L100) plus hydrochlorothiazide 12.5mg (H12.5) in a single fixed-dose combination. In one study, subjects received losartan 50 mg (L50) plus H12.5 during an 8-week filter period. They were then randomized to either L100/H12.5 or L50/H12.5 for another 8 weeks, followed by L100/H12.5 for 44 weeks. The primary end point was safety of L100/H12.5 for 52 weeks. In the second study, subjects received L100 during an 8-week filter period. Subjects were then randomized to receive either L100/H12.5 or L100 for a further 8 weeks. The primary end point was change from baseline in sitting diastolic blood pressure (SiDBP) at week 8. Safety was assessed throughout both studies. L100/H12.5 reduced SiDBP and sitting systolic blood pressure (SiSBP) at 8 weeks, and when compared with L100, the differences were statistically significant for both measures (P<0.001). L100/H12.5 reductions SiDBP for 8 weeks were comparable to L50/H12.5. The efficacy of L100/H12.5 was maintained to week 52. Drug-related adverse events with an incidence >= 2% in the L100/H12.5 group during the 52-week extension period were an increase in aspartate aminotransferase and in blood uric acid. Additionally, mean uric acid levels were reduced by 0.57 mgd l(-1) from baseline with long-term treatment with L100/H12.5 in subjects whose baseline uric acid level was >7.0 mgd l(-1). In conclusion, L100/H12.5 was shown to be more effective than L100 at reducing SiDBP and SiSBP and showed good tolerability in Japanese patients with essential hypertension.	[Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan; [Tsuchihashi, Takuya] Steel Mem Yawata Hosp, Fukuoka, Japan; [Shimada, Kazuyuki] Shin Oyama City Hosp, Dept Internal Med, Oyama, Tochigi, Japan; [Numaguchi, Hirotaka; Nishida, Chisato; Yamaguchi, Hiroya; Fujimoto, Go; Azuma, Kyoichi; Shirakawa, Masayoshi] MSD KK, Tokyo, Japan; [Hanson, Mary E.; Fujita, Kenji P.] Merck, Whitehouse Stn, NJ USA	Rakugi, H (reprint author), Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, 2-2 Yamadaoka,B6, Suita, Osaka 5650871, Japan.	rakugi@geriat.med.osaka-u.ac.jp			MSD KK, Tokyo, Japan	L100 Filter Study Investigators: S Inoue (Heishinkai Medical Group Incorporated OCROM Clinic), O Matsuoka (Heishinkai Medical Group Incorporated ToCROM Clinic), Y Shimizu (Shimizu Clinic), R Yoshimura (Yoshimura Internal Medicine), A Nagumo (Nagumo Hospital), K Mabuchi (Kanda Clinic), M Ueno (Cosmo Clinic), T Yokoyama (Medical Corporation Hakuyukai Yotsuya Naika), M Yamamoto (Adachi Kyosai Hospital), M Hirata (Hirata Clinic), K Yoshii (Izumino Hospital), F Takeda (Riverside Clinic), M Owa (Suwa Red Cross Hospital), K Ono (Hachiouji Junkanki Clinic), I Kawa (Ootsuka Kitaguchi Clinic), H Nakamura (Medical Corporation HSR Nakamura Clinic), K Miyakoshi (Minamiosaka General Hospital), H Kawakami (Azumi General Hospital), M Fujioka (Fujioka Clinic), A Takeuchi (Shinkoukai Takeuchi Hospital), S Hotta (Hitachi. Ltd, Taga General Hospital), H Yamamoto (Gakkentoshi Clinic), T Koseki (Minamikoen-Clinic), H Futamatsu (Social Insurance Kamata General Hospital), Y Wakasa (Medical Corporation Wakasa Medical Clinic), M Koshiji (Gifu Central Hospital), H Tanahashi (Matsunami General Hospital), J Ogawa (Medical corporation Handa Medical Clinic), S Nakada (Social Medical Corporation Keiaikai Chibana Clinic). Medical writing and editorial assistance was provided by Liz Anfield and Kerren Davenport of Prime Healthcare, Knutsford, Cheshire, UK. We thank: William Malbecq, PhD, Kristel Vandormael, PhD and Rachid Massaad, PhD, of MSD Belgium for providing statistical expertise; Emanuela Santoro, MS, of Merck, for assistance with study design and conduct; Hiroomi Iwata, of MSD KK, and Yoichi Inoue, MD, of MSD KK, for assistance with conduct of the study; Sachiko Yoshimoto, MD, of MSD KK, for assistance with study design and conduct. Martha Carroll Vollmer of Merck provided editorial assistance. The study was funded by MSD KK, Tokyo, Japan.	[Anonymous], 2014, HYPERTENS RES, V37, P253; Chowdhury EK, 2013, J HUM HYPERTENS, V27, P545, DOI 10.1038/jhh.2013.11; Liang KY, 2000, SANKHYA INDIAN J S B, V62, P134; Lu K, 2009, STAT MED, V28, P678; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Nakamura K, 2013, J HYPERTENS, V31, P1032, DOI 10.1097/HJH.0b013e32835f5747; Sakima A, 2011, CLIN EXP HYPERTENS, V33, P309, DOI 10.3109/10641963.2010.549260	7	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	DEC	2014	37	12					1042	1049		10.1038/hr.2014.114		8	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AX7OQ	WOS:000347105400005		
J	Yoshitomi, R; Nakayama, M; Ura, Y; Kuma, K; Nishimoto, H; Fukui, A; Ikeda, H; Tsuchihashi, T; Tsuruya, K; Kitazono, T				Yoshitomi, Ryota; Nakayama, Masaru; Ura, Yoriko; Kuma, Kazuyoshi; Nishimoto, Hitomi; Fukui, Akiko; Ikeda, Hirofumi; Tsuchihashi, Takuya; Tsuruya, Kazuhiko; Kitazono, Takanari			Ankle-brachial blood pressure index predicts cardiovascular events and mortality in Japanese patients with chronic kidney disease not on dialysis	HYPERTENSION RESEARCH			English	Article						ankle-brachial blood pressure index; cardiovascular events; chronic kidney disease; mortality	PERIPHERAL ARTERIAL-DISEASE; PULSE-WAVE VELOCITY; ALL-CAUSE MORTALITY; CORONARY HEART-DISEASE; HEMODIALYSIS-PATIENTS; ELDERLY CHINESE; RISK-FACTORS; ARM INDEX; ASSOCIATION; STIFFNESS	The ankle-brachial blood pressure index (ABPI) has been recognized to have a predictive value for cardiovascular (CV) events and mortality in general or dialysis populations. However, the associations between ABPI and those outcomes have not been fully investigated in predialysis patients. The present study aimed to clarify the relationships between ABPI and both CV events and mortality in Japanese chronic kidney disease (CKD) patients not on dialysis. In this prospective observational study, we enrolled 320 patients with CKD stages 3-5 who were not on dialysis. At baseline, ABPI was examined and a low ABPI was defined as <0.9. CV events and all-cause deaths were examined in each patient. A Cox proportional hazards model was applied to determine the risk factors for CV events, as well as for mortality from CV and all causes. The median follow-up period was 30 months. CV events occurred in 56 patients and all-cause deaths occurred in 48, including 20 CV deaths. Multivariate analysis showed that age and low ABPI were risk factors for CV events. It was demonstrated that age, a history of cerebrovascular disease and low ABPI were determined as independent risk factors for CV mortality. In addition, age, body mass index and low ABPI were independently associated with all-cause mortality. In patients with CKD, low ABPI during the predialysis period is independently associated with poor survival and CV events, suggesting the usefulness of measuring ABPI for predicting CV events and patient survival in CKD.	[Yoshitomi, Ryota; Tsuruya, Kazuhiko; Kitazono, Takanari] Kyushu Univ, Dept Med & Clin Sci, Grad Sch Med Sci, Fukuoka 812, Japan; [Nakayama, Masaru; Ura, Yoriko; Kuma, Kazuyoshi; Nishimoto, Hitomi; Fukui, Akiko; Ikeda, Hirofumi] Natl Kyushu Med Ctr Hosp, Div Nephrol, Fukuoka 8108563, Japan; [Nakayama, Masaru; Ura, Yoriko; Kuma, Kazuyoshi; Nishimoto, Hitomi; Fukui, Akiko; Ikeda, Hirofumi; Tsuchihashi, Takuya] Natl Kyushu Med Ctr Hosp, Clin Res Inst, Dept Internal Med, Fukuoka 8108563, Japan; [Tsuchihashi, Takuya] Natl Kyushu Med Ctr Hosp, Div Hypertens, Fukuoka 8108563, Japan	Nakayama, M (reprint author), Natl Kyushu Med Ctr Hosp, Div Nephrol, Chuo Ku, 1-8-1 Jigyohama, Fukuoka 8108563, Japan.	mnaka@kyumed.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Zheng ZJ, 1997, ATHEROSCLEROSIS, V131, P115, DOI 10.1016/S0021-9150(97)06089-9; Ono K, 2003, J AM SOC NEPHROL, V14, P1591, DOI 10.1097/01.ASN.0000065547.98258.3D; Fishbane S, 1996, AM J KIDNEY DIS, V27, P668, DOI 10.1016/S0272-6386(96)90101-8; Kitahara T, 2005, AM J KIDNEY DIS, V46, P688, DOI 10.1053/j.ajkd.2005.06.016; Cheung AK, 2000, KIDNEY INT, V58, P353, DOI 10.1046/j.1523-1755.2000.00173.x; Murakami Y, 2008, HYPERTENSION, V51, P1483, DOI 10.1161/HYPERTENSIONAHA.107.102459; van Popele NM, 2001, STROKE, V32, P454; Wei M, 1998, DIABETES CARE, V21, P1167, DOI 10.2337/diacare.21.7.1167; Tanaka M, 2011, ATHEROSCLEROSIS, V219, P643, DOI 10.1016/j.atherosclerosis.2011.09.037; Resnick HE, 2004, CIRCULATION, V109, P733, DOI 10.1161/01.CIR.0000112642.63927.54; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Shinohara K, 2004, KIDNEY INT, V65, P936, DOI 10.1111/j.1523-1755.2004.00468.x; DeLoach SS, 2007, CLIN J AM SOC NEPHRO, V2, P839, DOI 10.2215/CJN.04101206; MADHAVAN S, 1994, HYPERTENSION, V23, P395; Leng GC, 1996, BRIT MED J, V313, P1440; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197; Herzog CA, 2011, KIDNEY INT, V80, P572, DOI 10.1038/ki.2011.223; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538; LONDON GM, 1990, KIDNEY INT, V37, P137, DOI 10.1038/ki.1990.19; Tozawa M, 2002, KIDNEY INT, V61, P717, DOI 10.1046/j.1523-1755.2002.00173.x; Pilote L, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.051455; Banerjee D, 2006, NEPHROL DIAL TRANSPL, V21, P975, DOI 10.1093/ndt/gfi345; BARENBROCK M, 1994, KIDNEY INT, V45, P1397, DOI 10.1038/ki.1994.182; CARTER SA, 1969, J AMER MED ASSOC, V207, P1869, DOI 10.1001/jama.207.10.1869; Chae CU, 1999, JAMA-J AM MED ASSOC, V281, P634, DOI 10.1001/jama.281.7.634; Chen J, 2012, AM J CARDIOL, V110, P136, DOI 10.1016/j.amjcard.2012.02.061; Chen SC, 2010, NEPHROLOGY, V15, P294, DOI 10.1111/j.1440-1797.2010.01187.x; Chen SC, 2009, AM J NEPHROL, V29, DOI 10.1159/000168485; DEVINUESA SG, 2005, KIDNEY INT S, V93, pS44; Fang W, 2009, PERITON DIALYSIS INT, V29, P163; Franklin SS, 1997, J HYPERTENS, V15, P1143, DOI 10.1097/00004872-199715100-00012; GIRERD X, 1991, AM HEART J, V122, P1210, DOI 10.1016/0002-8703(91)90941-A; Hara M, 2002, JPN J CANCER RES, V93, P6; Itaya H, 2010, NEPHROLOGY, V15, P230, DOI 10.1111/j.1440-1797.2009.01188.x; Kato A, 2010, NEPHRON CLIN PRACT, V114, pC29, DOI 10.1159/000245067; Korhonen P, 2013, J HUM HYPERTENS, V28, P242; Lawlor DA, 2001, BRIT MED J, V323, P541, DOI 10.1136/bmj.323.7312.541; Lee MLT, 1999, ANN EPIDEMIOL, V9, P101, DOI 10.1016/S1047-2797(98)00034-9; Nakagawa N, 2008, HYPERTENS RES, V31, P193, DOI 10.1291/hypres.31.193; NEWMAN AB, 1993, JAMA-J AM MED ASSOC, V270, P487, DOI 10.1001/jama.270.4.487; Newman AB, 1997, J AM GERIATR SOC, V45, P1472; Wang Y, 2012, VASA, V41, P205, DOI 10.1024/0301-1526/a000187; Weatherley Beth D, 2007, BMC Cardiovasc Disord, V7, P3, DOI 10.1186/1471-2261-7-3; Xu YX, 2007, HYPERTENS RES, V30, P613, DOI 10.1291/hypres.30.613; YAO ST, 1969, BRIT J SURG, V56, P676, DOI 10.1002/bjs.1800560910; Zhan YQ, 2012, J EPIDEMIOL, V22, P454, DOI 10.2188/jea.JE20110140	47	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	DEC	2014	37	12					1050	1055		10.1038/hr.2014.120		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AX7OQ	WOS:000347105400006		
J	Nakama, C; Kamide, K; Kawai, T; Hongyo, K; Ito, N; Onishi, M; Takeya, Y; Yamamoto, K; Sugimoto, K; Rakugi, H				Nakama, Chikako; Kamide, Kei; Kawai, Tatsuo; Hongyo, Kazuhiro; Ito, Norihisa; Onishi, Miyuki; Takeya, Yasushi; Yamamoto, Koichi; Sugimoto, Ken; Rakugi, Hiromi			The influence of aging on the diagnosis of primary aldosteronism	HYPERTENSION RESEARCH			English	Article						confirmatory test; diagnosis; elderly; primary aldosteronism; screening test	HYPERTENSIVE PATIENTS; PRIMARY HYPERALDOSTERONISM; PLASMA-ALDOSTERONE; CONFIRMATORY TESTS; HIGH PREVALENCE; SCREENING-TEST; RENIN RATIO; SOCIETY; SPIRONOLACTONE; GUIDELINES	Primary aldosteronism (PA) is common in young or middle-aged hypertensive patients, but PA among the elderly has recently become more common. As salt sensitivity increases with age, plasma renin activity (PRA) tends to decrease, whereas the aldosterone-to-renin ratio (ARR) tends to increase in the elderly. The aim of this study was to clarify the influence of aging on the diagnosis of PA. We retrospectively evaluated 155 consecutively admitted patients who were not taking antihypertensive medications or calcium channel blockers and alpha blockers that underwent PRA and plasma aldosterone concentration (PAC) measurements. The study subjects included 13 PA and 69 essential hypertensive (EHT) patients aged over 65 years, and 32 PA and 41 EHT patients under aged 65 years. Our study clarified the influence of aging through screening and confirmatory tests for the diagnosis of PA. Our results showed the ARR cutoff value for a screening test to be 556 (area under the curve: AUC = 0.906), its sensitivity and specificity to be 84.6% and 89.9%, respectively, and the likelihood ratio to be 8.34 in the elderly, whereas the ARR cutoff value was 272 in the non-elderly. In the saline infusion test, the mean PAC was 86.6 +/- 41.8 pg ml(-1) in the elderly and 158.1 +/- 116.5 pg ml(-1) in the non-elderly (P = 0.04). There was no influence from age in both the captopril challenge test and the furosemide upright test. Aging may influence PA screening and saline infusion tests; thus, we should consider the influence of aging in the diagnosis of elderly subjects with PA.	[Nakama, Chikako; Kamide, Kei; Kawai, Tatsuo; Hongyo, Kazuhiro; Ito, Norihisa; Onishi, Miyuki; Takeya, Yasushi; Yamamoto, Koichi; Sugimoto, Ken; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan; [Kamide, Kei] Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Hlth Promot Sci, Suita, Osaka 5650871, Japan	Kamide, K (reprint author), Osaka Univ, Grad Sch Med, Div Hlth Sci, Dept Hlth Promot Sci, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan.	kamide@sahs.med.osaka-u.ac.jp			Program for Promotion of Fundamental Studies through Japanese Ministry of Health, Labor, and Welfare	This study was supported by the Program for Promotion of Fundamental Studies through a research grant from the Japanese Ministry of Health, Labor, and Welfare.	Agharazii M, 2001, HYPERTENSION, V37, P1440; Giacchetti G, 2006, J HYPERTENS, V24, P737, DOI 10.1097/01.hjh.0000217857.20241.0f; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Olivieri O, 2004, J CLIN ENDOCR METAB, V89, P4221, DOI 10.1210/jc.2003-032179; BRILLA CG, 1992, J LAB CLIN MED, V120, P893; BROWN JJ, 1972, BRIT MED J, V2, P729; Omura M, 2004, HYPERTENS RES, V27, P193, DOI 10.1291/hypres.27.193; Williams JS, 2006, J HUM HYPERTENS, V20, P129, DOI 10.1038/sj.jhh.1001948; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; GORDON RD, 1994, CLIN EXP PHARMACOL P, V21, P315, DOI 10.1111/j.1440-1681.1994.tb02519.x; Fujii H, 2005, CIRC J, V69, P1425, DOI 10.1253/circj.69.1425; Rossi E, 2002, AM J HYPERTENS, V15, P896, DOI 10.1016/S0895-7061(02)02969-2; Loh KC, 2000, J CLIN ENDOCR METAB, V85, P2854, DOI 10.1210/jc.85.8.2854; Blasi ER, 2003, KIDNEY INT, V63, P1791, DOI 10.1046/j.1523-1755.2003.00929.x; Rossi GP, 2011, NAT REV ENDOCRINOL, V7, P485, DOI 10.1038/nrendo.2011.76; Savard S, 2013, HYPERTENSION, V62, P331, DOI 10.1161/HYPERTENSIONAHA.113.01060; Mulatero P, 2013, J CLIN ENDOCR METAB, V98, P4826, DOI 10.1210/jc.2013-2805; Seifarth C, 2002, CLIN ENDOCRINOL, V57, P457, DOI 10.1046/j.1365-2265.2002.01613.x; Lim PO, 2000, J HUM HYPERTENS, V14, P311, DOI 10.1038/sj.jhh.1001013; HIRAMATSU K, 1981, ARCH INTERN MED, V141, P1589, DOI 10.1001/archinte.141.12.1589; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; Catena C, 2007, HYPERTENSION, V50, P911, DOI 10.1161/HYPERTENSIONAHA.107.095448; Strauch B, 2003, J HUM HYPERTENS, V17, P349, DOI 10.1038/sj.jhh.1001554; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Nishikawa T, 2011, ENDOCR J, V58, P711; Castro OL, 2002, HYPERTENSION, V39, P935, DOI 10.1161/01.HYP.0000014324.68506.CA; Conn JW, 1955, J LAB CLIN MED, V45, P6; Hannemann A, 2011, EUR J ENDOCRINOL, V164, P751, DOI 10.1530/EJE-10-1074; HOLLAND OB, 1984, HYPERTENSION, V6, P717; Mulatero P, 2006, J CLIN ENDOCR METAB, V91, P2618, DOI 10.1210/jc.2006-0078; Nanba K, 2012, J CLIN ENDOCR METAB, V97, P1688, DOI 10.1210/jc.2011-2504; Omura Masao, 2006, Rinsho Byori, V54, P1157; Tanabe A, 2003, J CLIN ENDOCR METAB, V88, P2489, DOI 10.1210/jc.2002-021476; Yin GS, 2012, ENDOCRINE, V42, P182, DOI 10.1007/s12020-012-9609-z	34	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	DEC	2014	37	12					1062	1067		10.1038/hr.2014.129		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AX7OQ	WOS:000347105400008		
J	Kaneko, H; Suzuki, S; Uejima, T; Kano, H; Matsuno, S; Takai, H; Oikawa, Y; Yajima, J; Aizawa, T; Yamashita, T				Kaneko, Hidehiro; Suzuki, Shinya; Uejima, Tokuhisa; Kano, Hiroto; Matsuno, Shunsuke; Takai, Hideaki; Oikawa, Yuji; Yajima, Junji; Aizawa, Tadanori; Yamashita, Takeshi			Functional mitral regurgitation and left ventricular systolic dysfunction in the recent era of cardiovascular clinical practice, an observational cohort study	HYPERTENSION RESEARCH			English	Article						functional mitral regurgitation; left ventricular dysfunction; prognosis	CARDIAC RESYNCHRONIZATION THERAPY; CORONARY-ARTERY-DISEASE; HEART-FAILURE; VALVE ANNULOPLASTY; EJECTION FRACTION; JAPANESE PATIENTS; SEVERITY; IMPACT; CARDIOMYOPATHY; INTERVENTION	Functional mitral regurgitation (MR) is frequently associated with left ventricular systolic dysfunction (LVSD). Ventricular volume overload that occurs in patients with MR may lead to a progression of myocardial dysfunction. However, the prevalence and clinical outcomes of functional MR in Japanese patients with LVSD remain unclear. The aim of the present study is to clarify the prevalence and prognosis of functional MR in Japanese LVSD patients in the contemporary era. We followed patients with LVSD (LV ejection fraction (LVEF) <= 40%) who were listed within a single, hospital-based cohort in the Shinken Database from 2004 to 2011, which was composed of all new patients (n = 17 517) who visited the Cardiovascular Institute. A total of 506 patients were included: 86 FMR (moderate-to-severe functional MR) patients and 420 non-FMR (none or mild functional MR) patients. FMR patients were older, had lower rates of hypertension and ischemic heart disease but had higher rates of chronic kidney disease, dilated cardiomyopathy and New York Heart Association III/IV classification. FMR patients had higher brain natriuretic peptide levels and lower LVEF. The Kaplan-Meier curves revealed that the incidence of all-cause death, cardiovascular death and heart failure (HF) admission was significantly higher in FMR patients. The presence of FMR was independently associated with a significantly higher risk of composite end point, including all-cause death and/or HF admission (hazard ratio 1.551, 95% confidence interval 1.045-2.303, P = 0.029). FMR was common in Japanese patients with LVSD and was associated with adverse long-term outcomes. Future study is warranted to establish the optimal therapeutic strategy for FMR and LVSD.	[Kaneko, Hidehiro; Suzuki, Shinya; Uejima, Tokuhisa; Kano, Hiroto; Matsuno, Shunsuke; Takai, Hideaki; Oikawa, Yuji; Yajima, Junji; Aizawa, Tadanori; Yamashita, Takeshi] Cardiovasc Inst, Dept Cardiovasc Med, Tokyo 1060031, Japan	Kaneko, H (reprint author), Cardiovasc Inst, Dept Cardiovasc Med, Minato Ku, 3-2-19 Nishiazabu, Tokyo 1060031, Japan.	kanekohidehiro@gmail.com			Japanese society for the promotion of science	We thank Shiro Ueda and Nobuko Ueda at the Medical Edge for assembling the database using the Clinical Study Support System (CliSSS) and Ineko Hayakawa, Hiroaki Arai and Hiroshi Aoki for data management and system administration. This work was supported by the Japanese society for the promotion of science (to HK).	Felker GM, 2002, J AM COLL CARDIOL, V39, P210, DOI 10.1016/S0735-1097(01)01738-7; Feldman T, 2009, J AM COLL CARDIOL, V54, P686, DOI 10.1016/j.jacc.2009.03.077; ENRIQUEZSARANO M, 1993, J AM COLL CARDIOL, V21, P1211; Mihaljevic T, 2007, J AM COLL CARDIOL, V49, P2191, DOI 10.1016/j.jacc.2007.02.043; van Bommel RJ, 2011, CIRCULATION, V124, P912, DOI 10.1161/CIRCULATIONAHA.110.009803; Feldman T, 2005, J AM COLL CARDIOL, V46, P2134, DOI 10.1016/j.jacc.2005.07.065; Trichon BH, 2003, AM J CARDIOL, V91, P538, DOI 10.1016/S0002-9149(02)03301-5; Breithardt OA, 2003, J AM COLL CARDIOL, V41, P765, DOI 10.1016/S0735-1097(02)02937-6; Grayburn PA, 2013, CIRCULATION, V128, P1667, DOI 10.1161/CIRCULATIONAHA.112.001039; Kaneko H, 2013, J CARDIOL, V62, P18, DOI 10.1016/j.jjcc.2013.02.009; Suzuki S, 2008, CIRC J, V72, P914, DOI 10.1253/circj.72.914; Wu AH, 2005, J AM COLL CARDIOL, V45, P381, DOI 10.1016/j.jacc.2004.09.073; Bart BA, 1997, J AM COLL CARDIOL, V30, P1002, DOI 10.1016/S0735-1097(97)00235-0; Kaneko H, 2014, HEART VESSELS, V29, P156, DOI 10.1007/s00380-013-0339-9; Auricchio A, 2011, J AM COLL CARDIOL, V58, P2183, DOI 10.1016/j.jacc.2011.06.061; Neuss M, 2013, EUR J HEART FAIL, V15, P786, DOI 10.1093/eurjhf/hfs214; Koelling TM, 2002, AM HEART J, V144, P524, DOI 10.1067/mhj.2002.123575; Feldman I, 2011, NEW ENGL J MED, V364, P1395; Harris Kevin M, 2005, Am Heart J, V150, P1106; HARRIS PJ, 1979, CIRCULATION, V60, P1259; Ionelli M, 2006, BMJ-BRIT MED J, V332, P1426; Kaneko H, 2013, J CARDIOL, V62, P102, DOI 10.1016/j.jjcc.2013.03.013; Kaneko H, 2012, J CARDIOL, V59, P359, DOI 10.1016/j.jjcc.2012.01.004; Kaneko H, 2014, HEART VESSELS, V29, P21, DOI 10.1007/s00380-013-0325-2; SHEEHAN FH, 1986, CIRCULATION, V74, P293; SMITH LR, 1991, CIRCULATION, V84, P245; STRAUSS RH, 1987, AM J CARDIOL, V59, P892, DOI 10.1016/0002-9149(87)91114-3; VanDantzig JM, 1996, AM HEART J, V131, P865, DOI 10.1016/S0002-8703(96)90166-0; Varadarajan P, 2008, J AM COLL CARDIOL, V102, P611	29	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	DEC	2014	37	12					1082	1087		10.1038/hr.2014.122		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	AX7OQ	WOS:000347105400011		
J	Murakami, M; Ikeda, H				Murakami, Masayuki; Ikeda, Hiroyasu			Study of Charged Frame ESD Immunity Testing Specified in ISO 7176-21	IEEE TRANSACTIONS ON ELECTROMAGNETIC COMPATIBILITY			English	Article						Charged frame ESD; ISO 7176-21; electromagnetic immunity; personal care robot	DISCHARGE	The EMC product standard for electrically powered wheelchairs is ISO 7176-21, which requires charged frame electrostatic discharge (ESD) immunity testing. When a moving wheelchair carrying a buildup of electrostatic charge due to triboelectrification of the wheels and floor comes into contact with a grounded metal object, the resulting air-gap discharge may cause the wheelchair to malfunction. Since the IEC 61000-4 series does not cover immunity testing that simulates such ESD events, ISO 7176-21 independently provides the test method. Currently, many companies are developing personal care robots to assist human in daily activities. Considering the risk presented by such robots that involve physical contact with humans, the charged frame ESD test will be a test item for the safety validation of personal care robots that are mobile and battery powered. In practice, however, when charged frame ESD tests are conducted according to the test procedure specified in ISO 7176-21, some issues and questions arise in regard to such matters as the means of charging the robot under test, the material of the insulating support on which to place the robot, and simulation of discharge from a robot rider or wearer. This paper investigates the test procedure of ISO 7176-21 and proposes modifications for enabling charged frame ESD testing to be properly carried out for personal care robots.	[Murakami, Masayuki] Tokyo Metropolitan Ind Technol Res Inst, Tokyo 1350064, Japan; [Ikeda, Hiroyasu] Natl Inst Occupat Safety & Hlth, Tokyo 2040024, Japan	Murakami, M (reprint author), Tokyo Metropolitan Ind Technol Res Inst, Tokyo 1350064, Japan.	murakami@ieee.org; ikeda@s.jniosh.go.jp			New Energy and Industrial Technology Development Organization Project: Practical Applications of Service Robot	This work was supported by the New Energy and Industrial Technology Development Organization Project: Practical Applications of Service Robot.	[Anonymous], 2010, 12100 ISO; Chundru R, 2004, IEEE T ELECTROMAGN C, V46, P498, DOI 10.1109/TEMC.2004.837700; Mertz L, 2012, IEEE PULSE, V3, P56, DOI 10.1109/MPUL.2012.2196836; [Anonymous], 2008, 6100042 IEC; Kawamoto H, 2003, IEEE SYS MAN CYBERN, P1648; [Anonymous], 1993, C6316 ANSI; [Anonymous], 2009, 717621 ISO; [Anonymous], 2010, 6100043 IEC; [Anonymous], 2014, 13482 ISO; [Anonymous], 2012, WEATHER DATA TATENO; Yuan QY, 2010, IEEE T ELECTROMAGN C, V52, P985, DOI 10.1109/TEMC.2010.2060489; Armstrong K, 2000, IEE REVIEW, V46, P34, DOI 10.1049/ir:20000610; Brown S., 1994, IEE REV, V40, P11; Frei S., 1999, P 13 INT ZUR S EMC F, P105; Harper C, 2010, INT J SOC ROBOT, V2, P229, DOI 10.1007/s12369-010-0051-1; Maas J., 2012, P EMC EUROPE INT S E; Mori I., 2005, IEEJ T FUNDAM MAT, V125, P598, DOI 10.1541/ieejfms.125.598; Rhoades W., 1991, P IEEE INT S EL COMP, P337; Yamazaki K, 2012, P IEEE, V100, P2429, DOI 10.1109/JPROC.2012.2200563	19	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9375	1558-187X		IEEE T ELECTROMAGN C	IEEE Trans. Electromagn. Compat.	DEC	2014	56	6					1276	1286		10.1109/TEMC.2014.2325868		11	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	AX1OS	WOS:000346716800004		
J	Tian, Y; Tatematsu, A; Tanabe, K; Miyajima, K				Tian, Ye; Tatematsu, Akiyoshi; Tanabe, Kazuo; Miyajima, Kiyotomi			Development of Locating System of Pulsed Electromagnetic Interference Source Based on Advanced TDOA Estimation Method	IEEE TRANSACTIONS ON ELECTROMAGNETIC COMPATIBILITY			English	Article						Direction of arrival (DOA); localization; pulsed electromagnetic (EM) interference (PEMI); spark discharge; time difference of arrival (TDOA)	PARTIAL DISCHARGE LOCATION; TIME-DELAY; EM WAVES; ARRIVAL; DOA	A locating system based on an advanced time difference of arrival (TDOA) estimation method is developed to locate the position of a discharge source to avoid pulsed electromagnetic interference (PEMI) with the surrounding radio communication environment. In general, from the waveforms of PEMI waves received by an antenna array, the source position can be located or the direction of arrival (DOA) of the EM waves can be estimated by applying TDOA-based methods. However, owing to noises and multipath waves that occur at the metal surfaces of electric power equipment, the estimation accuracy of the TDOA may decrease, and the location accuracy will be degraded. To improve the accuracy of TDOA estimation, we propose a new TDOA estimation technique. In our developed locating system, PEMI waves are received by a four-antenna-square array and the DOA is estimated from the TDOA, which is estimated using the generalized cross-correlation phase transform method in combination with the proposed technique. A PEMI source is ultimately located by aiming a charge-coupled device camera, installed at the center of the antenna array, at the estimated DOA. The estimation accuracy of the locating system is evaluated through experimental measurements. The results show that the developed locating system can locate the position of a PEMI source existing within about 30 m from the system with high accuracy.	[Tian, Ye; Tatematsu, Akiyoshi; Tanabe, Kazuo; Miyajima, Kiyotomi] Cent Res Inst Elect Power Ind, Elect Power Engn Res Lab, Yokosuka, Kanagawa 2400196, Japan	Tian, Y (reprint author), Cent Res Inst Elect Power Ind, Elect Power Engn Res Lab, Yokosuka, Kanagawa 2400196, Japan.	ye.tian@ieee.org; akiyoshi@criepi.denken.or.jp; tanabe@criepi.denken.or.jp; miyajima@criepi.denken.or.jp					Hirata A, 2003, IEEE ANTENN WIREL PR, V2, P190, DOI 10.1109/LAWP.2003.819668; Moore PJ, 2005, IEEE T POWER DELIVER, V20, P2264, DOI 10.1109/TPWRD.2004.843397; Portugues IE, 2009, IEEE T POWER DELIVER, V24, P20, DOI 10.1109/TPWRD.2008.2005464; KNAPP CH, 1976, IEEE T ACOUST SPEECH, V24, P320, DOI 10.1109/TASSP.1976.1162830; Boggs S. A., 1990, IEEE Electrical Insulation Magazine, V6, DOI 10.1109/57.63057; Brandstein MS, 1997, INT CONF ACOUST SPEE, P375, DOI 10.1109/ICASSP.1997.599651; Hirata A., 2003, P IEEE INT S EL COMP, P896; Hyvarinen A., 2001, INDEPENDENT COMPONEN; Ishimaru H., 2006, IEEJ T PE, V126, P1247, DOI 10.1541/ieejpes.126.1247; Kawada M., 2002, P IEEE POW ENG SOC W, V2, P1482; Kawada M, 2003, ELECTR ENG JPN, V144, P32, DOI 10.1002/eej.10145; Okubo H., 2002, IEEE J T POWER ENERG, V122, P481; Pearl J., 1988, PROBABILISTIC REASON; Peck CH, 2001, IEEE T ELECTROMAGN C, V43, P149; SCHMIDT RO, 1986, IEEE T ANTENN PROPAG, V34, P276, DOI 10.1109/TAP.1986.1143830; Tang J, 2011, IET ELECTR POWER APP, V5, P175, DOI 10.1049/iet-epa.2010.0029; Tang ZG, 2006, IEEE T DIELECT EL IN, V13, P1193, DOI 10.1109/TDEI.2006.258190; Tantisattayakul T, 2005, J ATMOS SOL-TERR PHY, V67, P1031, DOI 10.1016/j.jastp.2005.04.002; Tatematsu A., 2010, IEEJ T POWER ENERGY, V130, P802; Tian Y, 2012, IEEJ T ELECTR ELECTR, V7, pS6, DOI 10.1002/tee.21799; Tian Y., 2012, CIGRE SC C4 HAK C, P223; Tian Y., 2009, IEEJ T FUNDAMENTALS, V129, P89; Tungkanawanich A, 2000, P IEEE POW ENG SOC W, P2453; Tungkanawanich A., 2000, IEEJ T POWER ENERGY, V120, P1431; WANG H, 1985, IEEE T ACOUST SPEECH, V33, P823, DOI 10.1109/TASSP.1985.1164667	25	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9375	1558-187X		IEEE T ELECTROMAGN C	IEEE Trans. Electromagn. Compat.	DEC	2014	56	6					1326	1334		10.1109/TEMC.2014.2315438		9	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	AX1OS	WOS:000346716800010		
J	Tanaka, Y; Baba, Y; Nagaoka, N; Ametani, A				Tanaka, Yohei; Baba, Yoshihiro; Nagaoka, Naoto; Ametani, Akihiro			Computation of Lightning Electromagnetic Pulses With the Constrained Interpolation Profile Method in the 2-D Cylindrical Coordinate System	IEEE TRANSACTIONS ON ELECTROMAGNETIC COMPATIBILITY			English	Article						Constrained interpolation profile (CIP) method; electromagnetic field; finite-difference time-domain (FDTD) method; lightning; transmission-line modeling (TLM) method; two-dimensional (2-D) cylindrical coordinate system	NUMERICAL SOLUTION; RETURN STROKE; MODEL; REPRESENTATION; SIMULATION; EQUATIONS; BOUNDARY; WIRE	In this paper, a procedure for computing transient electromagnetic fields with the constrained interpolation profile (CIP) method in the two-dimensional (2-D) cylindrical coordinate system has been derived. Then, it has been applied to analyzing electromagnetic pulses produced by a current wave propagating upward along a vertical lightning return-stroke channel. CIP-computed waveforms agree well with corresponding waveforms computed using analytical expression of Uman et al. or the finite-difference time-domain method.	[Tanaka, Yohei; Baba, Yoshihiro; Nagaoka, Naoto; Ametani, Akihiro] Doshisha Univ, Dept Elect Engn, Kyoto 6100321, Japan	Tanaka, Y (reprint author), Doshisha Univ, Dept Elect Engn, Kyoto 6100321, Japan.	dun0361@mail4.doshisha.ac.jp; ybaba@mail.doshisha.ac.jp; nnagaoka@mail.doshisha.ac.jp; aametani@mail.doshisha.ac.jp					Baba Y, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD009811; Silveira FH, 2010, IEEE T ELECTROMAGN C, V52, P929, DOI 10.1109/TEMC.2010.2044042; JOHNS PB, 1971, P I ELECTR ENG, V118, P1203; Yang CS, 2004, IEEE T ELECTROMAGN C, V46, P133, DOI 10.1109/TEMC.2004.823626; Ren HM, 2008, IEEE T ELECTROMAGN C, V50, P651, DOI 10.1109/TEMC.2008.926910; Baba Y, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016341; Visacro S, 2011, IEEE T ELECTROMAGN C, V53, P401, DOI 10.1109/TEMC.2011.2106790; RUEHLI AE, 1974, IEEE T MICROW THEORY, VTT22, P216, DOI 10.1109/TMTT.1974.1128204; Visacro S, 2005, IEEE T POWER DELIVER, V20, P1206, DOI 10.1109/TPWRD.2004.839743; Okubo K, 2007, IEEE T ANTENN PROPAG, V55, P111, DOI 10.1109/TAP.2006.888392; Baba Y, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018407; Yutthagowith P, 2011, IEEE T ELECTROMAGN C, V53, P726, DOI 10.1109/TEMC.2010.2077676; TAKEWAKI H, 1985, J COMPUT PHYS, V61, P261, DOI 10.1016/0021-9991(85)90085-3; UMAN MA, 1975, AM J PHYS, V43, P33, DOI 10.1119/1.10027; Baba Y, 2008, IEEE T POWER DELIVER, V23, P800, DOI 10.1109/TPWRD.2007.916169; Baba Y, 2009, IEEE T ELECTROMAGN C, V51, P479, DOI 10.1109/TEMC.2009.2019122; Brans H.-D., 2007, IEEE T ELECTROMAGN C, V49, P253; Du Y, 2012, IEEE T ELECTROMAGN C, V54, P871, DOI 10.1109/TEMC.2011.2174240; Harrington R. F., 1968, FIELD COMPUTATION MO; Heidler F., 1985, 6TH P S EL COMP ZUR, P157; Kajita K, 2014, ELECTR POW SYST RES, V115, P94, DOI 10.1016/j.epsr.2014.02.017; LIAO ZP, 1984, SCI SIN A-MATH P A T, V27, P1063; SADIKU MNO, 1989, IEEE T EDUC, V32, P85, DOI 10.1109/13.28037; Smajic J, 2011, IEEE T MAGN, V47, P1514, DOI 10.1109/TMAG.2010.2090653; Tanaka Y, 2014, IEEE T ELECTROMAGN C, V56, P949, DOI 10.1109/TEMC.2013.2293760; Taniguchi Y, 2008, IEEE T ELECTROMAGN C, V50, P1014, DOI 10.1109/TEMC.2008.2004466; Wang SC, 2010, IEEE T ELECTROMAGN C, V52, P128, DOI 10.1109/TEMC.2009.2035815; Yang B, 2011, IEEE T ELECTROMAGN C, V53, P256, DOI 10.1109/TEMC.2010.2087413; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302; Yuda S, 2013, IEEE T ELECTROMAGN C, V55, P175, DOI 10.1109/TEMC.2012.2205152	30	0	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9375	1558-187X		IEEE T ELECTROMAGN C	IEEE Trans. Electromagn. Compat.	DEC	2014	56	6					1497	1505		10.1109/TEMC.2014.2354359		9	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	AX1OS	WOS:000346716800030		
J	Baba, Y; Rakov, VA				Baba, Y.; Rakov, Vladimir A.			Applications of the FDTD Method to Lightning Electromagnetic Pulse and Surge Simulations	IEEE TRANSACTIONS ON ELECTROMAGNETIC COMPATIBILITY			English	Article						Electromagnetic field; FDTD method; lightning; lightning return stroke; surge	TIME-DOMAIN SIMULATION; INDUCED VOLTAGES; RETURN STROKE; TRANSMISSION TOWER; NUMERICAL-SIMULATION; 3-DIMENSIONAL FDTD; EQUIVALENT-CIRCUIT; DISTRIBUTION LINE; CORONA DISCHARGE; SOIL IONIZATION	Electromagnetic computation methods (ECMs) have been widely used in analyzing lightning electromagnetic pulses (LEMPs) and lightning-caused surges in various systems. One of the advantages of ECMs, in comparison with circuit simulation methods, is that they allow a self-consistent full-wave solution for both the transient current distribution in a 3-D conductor system and resultant electromagnetic fields, although they are computationally expensive. Among ECMs, the finite-difference time-domain (FDTD) method for solving Maxwell's equations has been most frequently used in LEMP and surge simulations. In this paper, we review applications of the FDTD method to LEMP and surge simulations, including 1) lightning electromagnetic fields at close and far distances, 2) lightning surges on overhead power transmission line conductors and towers, 3) lightning surges on overhead distribution and telecommunication lines, 4) lightning electromagnetic environment in power substations, 5) lightning surges in wind-turbine-generator towers, 6) lightning surges in photovoltaic (PV) arrays, 7) lightning electromagnetic environment in electric vehicles (EVs), 8) lightning electromagnetic environment in airborne vehicles, 9) lightning surges and electromagnetic environment in buildings, and 10) surges on grounding electrodes.	[Baba, Y.] Doshisha Univ, Dept Elect Engn, Kyoto 6100321, Japan; [Rakov, Vladimir A.] Univ Florida, Dept Elect & Comp Engn, Gainesville, FL 32611 USA	Baba, Y (reprint author), Doshisha Univ, Dept Elect Engn, Kyoto 6100321, Japan.	ybaba@mail.doshisha.ac.jp; rakov@ece.ufl.edu					Rakov VA, 1998, J GEOPHYS RES-ATMOS, V103, P1879, DOI 10.1029/97JD03116; Thang TH, 2013, IEEE T POWER DELIVER, V28, P1635, DOI 10.1109/TPWRD.2013.2261324; Yamamoto K, 2010, IEEE T POWER DELIVER, V25, P3035, DOI 10.1109/TPWRD.2010.2043748; Yamamoto K, 2009, ELECTR POW SYST RES, V79, P436, DOI 10.1016/j.epsr.2008.09.002; Baba Y, 2005, IEEE T ELECTROMAGN C, V47, P533, DOI 10.1109/TEMC.2005.852220; JOHNS PB, 1971, P I ELECTR ENG, V118, P1203; Thang TH, 2012, IEEE T ELECTROMAGN C, V54, P1234, DOI 10.1109/TEMC.2012.2198919; Mimouni A, 2014, IEEE T ELECTROMAGN C, V56, P413, DOI 10.1109/TEMC.2013.2282995; [Anonymous], 2013, 543 CIGRE WORK GROUP; Zhang QL, 2014, IEEE T ELECTROMAGN C, V56, P435, DOI 10.1109/TEMC.2013.2284929; Bonyadi-Ram S, 2008, IEEE T ELECTROMAGN C, V50, P118, DOI [10.1109/TEMC.2007.913221, 10.1109/TEMC.2007.013221]; AGRAWAL AK, 1980, IEEE T ELECTROMAGN C, V22, P119, DOI 10.1109/TEMC.1980.303824; Yang CS, 2004, IEEE T ELECTROMAGN C, V46, P133, DOI 10.1109/TEMC.2004.823626; BERENGER JP, 1994, J COMPUT PHYS, V114, P185, DOI 10.1006/jcph.1994.1159; Hu WY, 2006, IEEE T ANTENN PROPAG, V54, P1513, DOI 10.1109/TAP.2006.874336; Baba Y, 2006, IEEE T ELECTROMAGN C, V48, P212, DOI 10.1109/TEMC.2006.870807; Apra M, 2008, IEEE T ELECTROMAGN C, V50, P513, DOI 10.1109/TEMC.2008.927738; Ren HM, 2008, IEEE T ELECTROMAGN C, V50, P651, DOI 10.1109/TEMC.2008.926910; Nucci CA, 2000, IEEE T POWER DELIVER, V15, P1265, DOI 10.1109/61.891513; Ala G, 2008, IET SCI MEAS TECHNOL, V2, P134, DOI 10.1049/iet-smt:20070001; Baba Y, 2005, IEEE T ELECTROMAGN C, V47, P521, DOI 10.1109/TEMC.2005.850690; Li DS, 2014, IEEE T ELECTROMAGN C, V56, P143, DOI 10.1109/TEMC.2013.2266479; Li DS, 2013, J GEOPHYS RES-ATMOS, V118, P12749, DOI 10.1002/2013JD020078; Berenger JP, 2005, IEEE T ELECTROMAGN C, V47, P1008, DOI 10.1109/TEMC.2005.858747; RUEHLI AE, 1974, IEEE T MICROW THEORY, VTT22, P216, DOI 10.1109/TMTT.1974.1128204; CHISHOLM WA, 1989, IEEE T POWER DELIVER, V4, P1329, DOI 10.1109/61.25620; Visacro S, 2005, IEEE T POWER DELIVER, V20, P1206, DOI 10.1109/TPWRD.2004.839743; Sumitani H, 2012, IEEE T ELECTROMAGN C, V54, P1161, DOI 10.1109/TEMC.2012.2191558; Shoory A, 2010, IEEE T ELECTROMAGN C, V52, P657, DOI 10.1109/TEMC.2010.2045229; Rachidi F, 1999, IEEE T POWER DELIVER, V14, P294, DOI 10.1109/61.736741; Baba Y, 2005, IEEE T ELECTROMAGN C, V47, P54, DOI 10.1109/TEMC.2004.842115; Rubinstein M, 1996, IEEE T ELECTROMAGN C, V38, P531, DOI 10.1109/15.536087; Tsumura M, 2006, IEEE T ELECTROMAGN C, V48, P817, DOI 10.1109/TEMC.2006.884448; Mimouni A, 2008, J ELECTROSTAT, V66, P504, DOI 10.1016/j.elstat.2008.05.002; LIEW AC, 1974, P I ELECTR ENG, V121, P123; Baba Y, 2007, IEEE T ELECTROMAGN C, V49, P632, DOI 10.1109/TEMC.2007.902402; UMAN MA, 1975, AM J PHYS, V43, P33, DOI 10.1119/1.10027; Baba Y., 2003, GEOPHYS RES LETT, V30; Baba Y., 2012, IET LIGHTNING EL JUN, P263; Baba Y, 2008, IEEE T POWER DELIVER, V23, P800, DOI 10.1109/TPWRD.2007.916169; Baba Y., 2005, J GEOPHYS RES, V110; Baba Y., 2011, J GEOPHYS RES, V116; Baba Y, 2009, IEEE T ELECTROMAGN C, V51, P479, DOI 10.1109/TEMC.2009.2019122; Baba Y, 2007, IEEE T ELECTROMAGN C, V49, P886, DOI 10.1109/TEMC.2007.908260; Baba Y., 2008, J GEOPHYS RES, V113; Baba Y., 2007, J GEOPHYS RES, V112; Biagi C. J., 2011, J GEOPHYS RES, V116; Bonyadi-ram S., 2005, 16 INT ZUR S EL COMP, P213; Chen JQ, 2010, IEEE T ELECTROMAGN C, V52, P914, DOI 10.1109/TEMC.2010.2043437; de Oliveira RMES, 2009, IEEE T ELECTROMAGN C, V51, P995, DOI 10.1109/TEMC.2009.2028879; Filho R. H. T. C., 2013, APPL MATH MODEL, V37, P6530; Gorin B.N., 1984, ELECTR TECHNOL RUSS+, V8, P64; Haddad M., 2012, J GEOPHYS RES, V117; Harrington R. F., 1968, FIELD COMPUTATION MO; Heidler F., 1985, 6TH P S EL COMP ZUR, P157; IDONE VP, 1982, J GEOPHYS RES-OC ATM, V87, P4903, DOI 10.1029/JC087iC07p04903; Inoue A., 1983, 114 CRIEPI, V114; Ishii M, 2012, ELECTR POW SYST RES, V85, P2, DOI 10.1016/j.epsr.2011.07.001; Kato S., 1999, 11 INT S HIGH VOLT E; Kato S., 2001, IEEJ NAT CONV NAG JA; Khosravi-Farsani M, 2013, IEEE T ELECTROMAGN C, V55, P362, DOI 10.1109/TEMC.2012.2211364; LIAO ZP, 1984, SCI SIN A-MATH P A T, V27, P1063; Lloyd B. L., 1954, AIEE T POWER APPARAT, V73, P196; Matsuura S., 2009, IEEJ T POWER ENERGY, V129, P1225; Miyazaki S., 2004, IEEJ NAT CONV KAN JA, P98; Moini R, 1998, IEEE T ELECTROMAGN C, V40, P154, DOI 10.1109/15.673621; Moini R, 2000, J GEOPHYS RES-ATMOS, V105, P29693, DOI 10.1029/2000JD900541; Nag A, 2011, IEEE T ELECTROMAGN C, V53, P407, DOI 10.1109/TEMC.2010.2073470; Nagao M., 2009, IEEJ T POWER ENERGY, V129, P1181; Nagao M., 2008, IEEJ T POWER ENERGY, V128, P1393, DOI 10.1541/ieejpes.128.1393; Nagaoka N., 2008, IEEJ T POWER ENERGY, V128, P473, DOI 10.1541/ieejpes.128.473; Noda T, 2007, ELECTR POW SYST RES, V77, P1495, DOI 10.1016/j.epsr.2006.08.021; Noda T., 2007, IEEJ T PE, V127, P379, DOI DOI 10.1541/IEEJPES.127.379; Noda T, 2008, IEEE T POWER DELIVER, V23, P1262, DOI 10.1109/TPWRD.2008.917944; Oikawa T., 2012, IEEJ T FUNDAMENTALS, V132, P44; Oshiro R., 2010, IEEJ T POWER ENERGY, V130, P687; Otani K, 2014, ELECTR POW SYST RES, V113, P171, DOI 10.1016/j.epsr.2014.02.032; Perrin E, 2013, IEEE T ELECTROMAGN C, V55, P747, DOI 10.1109/TEMC.2012.2232296; PODGORSKI AS, 1987, IEEE T POWER DELIVER, V2, P931, DOI 10.1109/TPWRD.1987.4308198; Rakov V. A., 2007, J LIGHTNING RES, V1, P80; Rakov V. A., 1987, Tekhnicheskaya Elektrodinamika; SADIKU MNO, 1989, IEEE T EDUC, V32, P85, DOI 10.1109/13.28037; Sarto MS, 2001, IEEE T ELECTROMAGN C, V43, P368, DOI 10.1109/15.942608; Sartori CAF, 2000, IEEE T MAGN, V36, P1631, DOI 10.1109/20.877754; Takami J, 2010, IEEE T ELECTROMAGN C, V52, P753, DOI 10.1109/TEMC.2010.2041458; Takami J, 2014, IEEE T DIELECT EL IN, V21, P96, DOI [10.1109/TDEI.2014.6740730, 10.1109/TDEI.2013.004059]; Tanabe K., 2001, IEEE Power Engineering Review, V21, DOI 10.1109/39.948615; Tatematsu A., 2010, IEEJ TRANS PE, V130, P373; Tatematsu A, 2014, IEEE T ELECTROMAGN C, V56, P159, DOI 10.1109/TEMC.2013.2272652; Thang TH, 2014, IEEE T ELECTROMAGN C, V56, P168, DOI 10.1109/TEMC.2013.2278384; Thang TH, 2012, IEEE T ELECTROMAGN C, V54, P585, DOI 10.1109/TEMC.2011.2172688; Tu YP, 2013, ELECTR POW SYST RES, V94, P10, DOI 10.1016/j.epsr.2012.06.012; Xiong R., IEEE T POWE IN PRESS; Xiong R, 2012, IEEE ANTENN WIREL PR, V11, P957, DOI 10.1109/LAWP.2012.2213569; Xiong R, 2014, IEEE T ANTENN PROPAG, V62, P345, DOI 10.1109/TAP.2013.2287889; Yamamoto K., 2012, IEEJ T POWER ENERGY, V132, P667; Yamamoto K., 2012, IEEJ T POWER ENERGY, V132, P903; Yang B, 2011, IEEE T ELECTROMAGN C, V53, P256, DOI 10.1109/TEMC.2010.2087413; Yao CG, 2013, IEEE T DIELECT EL IN, V20, P1239; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302; Zhang Q., 2012, J GEOPHYS RES, V117; Zhang SQ, 2013, J ELECTROSTAT, V71, P703, DOI 10.1016/j.elstat.2013.03.014	102	3	4	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9375	1558-187X		IEEE T ELECTROMAGN C	IEEE Trans. Electromagn. Compat.	DEC	2014	56	6					1506	1521		10.1109/TEMC.2014.2331323		16	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	AX1OS	WOS:000346716800031		
J	Ametani, A; Miyamoto, Y; Baba, Y; Nagaoka, N				Ametani, Akihiro; Miyamoto, Yoshiko; Baba, Yoshihiro; Nagaoka, Naoto			Wave Propagation on an Overhead Multiconductor in a High-Frequency Region	IEEE TRANSACTIONS ON ELECTROMAGNETIC COMPATIBILITY			English	Article						Earth-return admittance; earth-return impedance; high frequency; overhead line; wave propagation	GROUND RETURN CIRCUITS; ADMITTANCE CORRECTION; STRATIFIED EARTH; LINES	Carson's, Pollaczek's, Wise's, and Sunde's earth-return impedances of an overhead line have been examined, and errors involved in the formulas are explained. Modified Pollaczek's and Carson's/Sunde's formulas are described. Wave propagation characteristics on a multiconductor in a high-frequency region are evaluated by adopting the modified earth-return impedance and Wise's earth-return admittance. Sommerfeld-Goubau propagation in a high-frequency region, which shows transition between transverse electromagnetic and transverse magnetic propagation, has been confirmed in the calculated results which agree with those predicted by Kikuchi for a single conductor. On a multiconductor system, it is found that the aerial mode also shows Sommerfeld-Goubau propagation when the separation between conductors is large and the earth resistivity is high.	[Ametani, Akihiro; Miyamoto, Yoshiko; Baba, Yoshihiro; Nagaoka, Naoto] Doshisha Univ, Dept Elect Engn, Kyoto 6100321, Japan	Ametani, A (reprint author), Doshisha Univ, Dept Elect Engn, Kyoto 6100321, Japan.	aametani@mail.doshisha.ac.jp; dun0334@mail4.doshisha.ac.jp; ybaba@mail.doshisha.ac.jp; nnagaoka@mail.doshisha.ac.jp					AMETANI A, 1979, P I ELECTR ENG, V126, P51; AMETANI A, 1974, IEEE T POWER AP SYST, VPA93, P1233, DOI 10.1109/TPAS.1974.293846; Ametani A., 1990, DISTRIBUTED PARAMETE; Rachidi F, 1996, IEEE T ELECTROMAGN C, V38, P250, DOI 10.1109/15.536054; GOUBAU G, 1950, J APPL PHYS, V21, P1119, DOI 10.1063/1.1699553; Rachidi F, 1999, IEEE T POWER DELIVER, V14, P294, DOI 10.1109/61.736741; Carson J.R., 1926, Bell System Technical Journal, V5; Deri A., 1981, POWER APPARATUS SYST, V8, P3686; Gary C., 1976, EDF B DIRECTION ET B, P5; GOUBAU G, 1951, P IRE, V39, P619, DOI 10.1109/JRPROC.1951.233782; Kikuchi H., 1955, J I ELEC ENG JAPAN, V75, P1176; Kikuchi H., 1957, J I ELEC JAPAN, V77, P721; NAKAGAWA M, 1981, IEEE T POWER AP SYST, V100, P3626, DOI 10.1109/TPAS.1981.316656; NAKAGAWA M, 1981, IEEE T POWER AP SYST, V100, P1154, DOI 10.1109/TPAS.1981.316582; NAKAGAWA M, 1973, P I ELECTR ENG, V120, P1521; Pollaczek F., 1926, Elektrische Nachrichten-Technik, V3; Sommerfeld A., 1899, ELECTROMAGNETIC THEO, V67, P233; Sunde E.D., 1968, EARTH CONDUCTION EFF; Tesche F.M., 1997, EMC ANAL METHODS COM; Wise WH, 1934, P IRE, V22, P522, DOI 10.1109/JRPROC.1934.225868; WISE WH, 1948, AT&T TECH J, V27, P365	21	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9375	1558-187X		IEEE T ELECTROMAGN C	IEEE Trans. Electromagn. Compat.	DEC	2014	56	6					1638	1648		10.1109/TEMC.2014.2314720		11	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	AX1OS	WOS:000346716800046		
J	Li, GH; Itou, K; Katou, Y; Mukai, N; Pommerenke, D; Fan, J				Li, Guanghua; Itou, Koichi; Katou, Yoshihiro; Mukai, Noriyuki; Pommerenke, David; Fan, Jun			A Resonant E-Field Probe for RFI Measurements	IEEE TRANSACTIONS ON ELECTROMAGNETIC COMPATIBILITY			English	Article						Electric field probe; enhanced sensitivity; impedance transformer; receiver desensitization; RF interference	SENSITIVITY	Near-field probes with high sensitivity facilitate the identification of the root causes of intrasystem radio frequency interference issues, where weak noise desensitizes the receiver. In the study presented in this paper, a high-sensitivity resonant electric field probe was designed, consisting of an LC resonator loaded by quarter-wave transformers for optimal power transfer at the resonant frequency. Based on the equivalent circuit model, analytical derivations and numerical simulations were performed to illustrate the design methodology. The simulation results agreed well with the measured values. At the resonant frequency of 1.577 GHz, the measured vertical bar S-21 vertical bar from a matched trace to the resonant probe was approximately 6.6 dB higher than that of an equivalently sized broadband probe.	[Li, Guanghua; Pommerenke, David; Fan, Jun] Missouri Univ Sci & Technol, EMC Lab, Rolla, MO 65409 USA; [Itou, Koichi; Mukai, Noriyuki] Sony EMCS Corp, Tokyo 1080075, Japan; [Katou, Yoshihiro] Sony Corp, Tokyo 1080075, Japan	Li, GH (reprint author), Missouri Univ Sci & Technol, EMC Lab, Rolla, MO 65409 USA.	glbm4@mst.edu; koichi.itou@jp.sony.com; Yoshihiro.Katou@jp.sony.com; NoriyukiA.Mukai@jp.sony.com; davidjp@mst.edu; jfan@mst.edu			National Science Foundation [0855878]	This work was supported in part by the National Science Foundation under Grant 0855878.	Baudry D, 2007, IEEE T ELECTROMAGN C, V49, P485, DOI 10.1109/TEMC.2007.902194; Pan JN, 2013, IEEE INT SYMP ELEC, P666; [Anonymous], 2011, HFSS VER 13; Baudry D, 2006, PROG ELECTROMAGN RES, V60, P311, DOI 10.2528/PIER05112501; Bouchelouk L, 2008, INT J RF MICROW C E, V18, P146, DOI 10.1002/mmce.20274; Chuang HH, 2013, IEEE T ELECTROMAGN C, V55, P991, DOI 10.1109/TEMC.2013.2248011; DAHELE JS, 1980, IEEE T MICROW THEORY, V28, P752, DOI 10.1109/TMTT.1980.1130162; Gao YJ, 1998, IEEE T MICROW THEORY, V46, P907; Hosoyama H, 1999, IEEE T ELECTROMAGN C, V41, P154, DOI 10.1109/15.765107; KANDA M, 1993, IEEE T ANTENN PROPAG, V41, P1349, DOI 10.1109/8.247775; Li GH, 2013, IEEE INT SYMP ELEC, P134; Reck JN, 2010, IEEE T DEVICE MAT RE, V10, P26, DOI 10.1109/TDMR.2009.2033382	12	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9375	1558-187X		IEEE T ELECTROMAGN C	IEEE Trans. Electromagn. Compat.	DEC	2014	56	6					1719	1722		10.1109/TEMC.2014.2354018		4	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	AX1OS	WOS:000346716800057		
J	Gu, XM; Huang, TZ; Li, L; Li, HB; Sogabe, T; Clemens, M				Gu, Xian-Ming; Huang, Ting-Zhu; Li, Liang; Li, Hou-Biao; Sogabe, Tomohiro; Clemens, Markus			Quasi-Minimal Residual Variants of the COCG and COCR Methods for Complex Symmetric Linear Systems in Electromagnetic Simulations	IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES			English	Article						Complex symmetric matrices; conjugate orthogonal conjugate gradient (COCG); electromagnetic simulations; Krylov subspace methods; quasi-minimal residual (QMR)	FINITE-ELEMENT-METHOD; GRADIENT-TYPE METHODS; SCATTERING PROBLEMS; INDEFINITE; ALGORITHM; EQUATION	The conjugate orthogonal conjugate gradient (COCG) method has been considered an attractive part of the Lanczos-type Krylov subspace method for solving complex symmetric linear systems. However, it is often faced with apparently irregular convergence behaviors in practical electromagnetic simulations. To avoid such a problem, the symmetric quasi-minimal residual (QMR) method has been developed. On the other hand, the conjugate A-orthogonal conjugate residual (COCR) method, which can be regarded as an extension of the conjugate residual method, also had been established. It shows that the COCR often gives smoother convergence behavior than the COCG method. The purpose of this paper is to apply the QMR approaches to the COCG and COCR to derive two new methods (including their preconditioned versions), and to report the benefits of the modified methods by some practical examples arising in electromagnetic simulations.	[Gu, Xian-Ming; Huang, Ting-Zhu; Li, Liang; Li, Hou-Biao] Univ Elect Sci & Technol China, Sch Math Sci, Chengdu 611731, Sichuan, Peoples R China; [Sogabe, Tomohiro] Aichi Prefectural Univ, Grad Sch Informat Sci & Technol, Nagakute, Aichi 4801198, Japan; [Clemens, Markus] Berg Univ Wuppertal, Chair Electromagnet Theory, D-42119 Wuppertal, Germany	Gu, XM (reprint author), Univ Elect Sci & Technol China, Sch Math Sci, Chengdu 611731, Sichuan, Peoples R China.	guxianming@live.cn; tingzhuhuang@126.com; clemens@uni-wuppertal.de	Li, Hou-biao/J-2458-2013	Li, Hou-biao/0000-0002-7268-307X	National Science Foundation of China (NSFC) [61370147, 61170311, 11101071, 11301057, 61170309]; 973 Program [2013CB329404]; Fundamental Research Funds for the Central Universities [ZYGX2013J106]	This work was supported by the National Science Foundation of China (NSFC) under Grant 61370147, Grant 61170311, Grant 11101071, Grant 11301057, and Grant 61170309, by the 973 Program (2013CB329404), and by Fundamental Research Funds for the Central Universities (ZYGX2013J106).	Li L, 2014, J COMPUT PHYS, V256, P563, DOI 10.1016/j.jcp.2013.09.003; FREUND RW, 1994, SIAM J SCI COMPUT, V15, P313, DOI 10.1137/0915022; HESTENES MR, 1952, J RES NAT BUR STAND, V49, P409, DOI 10.6028/jres.049.044; Axelsson O, 2000, NUMER LINEAR ALGEBR, V7, P197, DOI 10.1002/1099-1506(200005)7:4<197::AID-NLA194>3.0.CO;2-S; Bai ZZ, 2010, COMPUTING, V87, P93, DOI 10.1007/s00607-010-0077-0; Sogabe T, 2007, J COMPUT APPL MATH, V199, P297, DOI 10.1016/j.cam.2005.07.032; Alessandri F, 2004, IEEE T MICROW THEORY, V52, P1790, DOI 10.1109/TMTT.2004.831583; FREUND RW, 1993, SIAM J SCI COMPUT, V14, P470, DOI 10.1137/0914029; PAIGE CC, 1975, SIAM J NUMER ANAL, V12, P617, DOI 10.1137/0712047; Bunse-Gerstner A, 1999, LINEAR ALGEBRA APPL, V287, P105, DOI 10.1016/S0024-3795(98)10091-5; Choi S.-C., 2013, ANLMCSP30280812 U CH, P26; Clemens M., 1996, 11 COPP MOUNT IT M 2; Clemens M, 1998, IEEE T MAGN, V34, P3335, DOI 10.1109/20.717784; Davis TA, 2011, ACM T MATH SOFTWARE, V38, DOI 10.1145/2049662.2049663; Fletcher R., 1976, LECT NOTES MATH, V506, P73; FREUND RW, 1992, SIAM J SCI STAT COMP, V13, P425, DOI 10.1137/0913023; Freund R. W., 1992, P 2 COPP MOUNT IT ME; Gu X.-M., 2014, COMPUT PHYS COMMUN, P1; ISE K, 1991, IEEE T MICROW THEORY, V39, P1289, DOI 10.1109/22.85402; JACOBS DAH, 1986, IMA J NUMER ANAL, V6, P447, DOI 10.1093/imanum/6.4.447; Joly P., 1993, Numerical Algorithms, V4, DOI 10.1007/BF02145754; Li L, 2010, COMPUT PHYS COMMUN, V181, P271, DOI 10.1016/j.cpc.2009.09.019; Li L, 2008, J ELECTROMAGNET WAVE, V22, P2023, DOI 10.1163/156939308787537793; MARKHAM G, 1990, IMA J NUMER ANAL, V10, P155, DOI 10.1093/imanum/10.2.155; Minami Satsuki, 2007, Transactions of the Japan Society for Industrial and Applied Mathematics, V17; Saad Y., 2003, ITERATIVE METHODS SP; Shiode A, 2007, Systems Modeling and Simulation: Theory and Applications, Asia Simulation Conference 2006, P108, DOI 10.1007/978-4-431-49022-7_22; Sogabe T., 2006, THESIS U TOKYO TOKYO; van der Vorst H, 2003, ITERATIVE KRYLOV MET; Van Loan C. F., 1996, MATRIX COMPUTATIONS; VANDERVORST HA, 1990, IEEE T MAGN, V26, P706, DOI 10.1109/20.106415	31	4	4	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9480	1557-9670		IEEE T MICROW THEORY	IEEE Trans. Microw. Theory Tech.	DEC	2014	62	12	1				2859	2867		10.1109/TMTT.2014.2365472		9	Engineering, Electrical & Electronic	Engineering	AX6EK	WOS:000347015900002		
J	Hashimoto, J; Itoh, K; Shimozawa, M; Mizuno, K				Hashimoto, Jun; Itoh, Kenji; Shimozawa, Mitsuhiro; Mizuno, Koji			Fundamental Limitations on the Output Power of Balanced Mixers and Even Harmonic Mixers in Modulator Operation	IEEE TRANSACTIONS ON MICROWAVE THEORY AND TECHNIQUES			English	Article						Diodes; linearity; mixers; nonlinear circuits	MILLIMETER-WAVE; CONVERSION LOSS; DIODE; BAND	A theoretical comparison of fundamental limitations on the output power of balanced diode mixers and even harmonic mixers is presented in this paper. The modulator operation is employed for the formulation. Additionally, the maximum output power, the output power at the 1-dB gain compression point, and the conversion loss of both mixers are formulated. It is theoretically confirmed that even harmonic mixers exhibit output power saturation when there is a high local oscillator power, although balanced diode mixers exhibit no saturation. This saturation is caused by restrictions in the built-in voltage of diodes, and even harmonic mixers therefore have lower output power capability when compared to balanced diode mixers. Derived formulas are confirmed by performing experimental investigations at 100 MHz.	[Hashimoto, Jun] Kanazawa Inst Technol, Kanazawa, Ishikawa 9218501, Japan; [Itoh, Kenji] Kanazawa Inst Technol, Dept Elect, Kanazawa, Ishikawa 9218501, Japan; [Shimozawa, Mitsuhiro] Mitsubishi Electr Corp, Karnakura, Kanagawa 9218501, Japan; [Mizuno, Koji] Tohoku Univ, Sendai, Miyagi 9808577, Japan	Hashimoto, J (reprint author), Kanazawa Inst Technol, Kanazawa, Ishikawa 9218501, Japan.	itoh.kenji@ieee.org					Pfeiffer UR, 2008, IEEE T MICROW THEORY, V56, P364, DOI 10.1109/TMTT.2007.914656; Okazaki H, 1997, IEEE T MICROW THEORY, V45, P2375, DOI 10.1109/22.643847; Tokumitsu T, 2001, IEEE T MICROW THEORY, V49, P2066, DOI 10.1109/22.963138; BARBER MR, 1967, IEEE T MICROW THEORY, VMT15, P629, DOI 10.1109/TMTT.1967.1126552; COHN M, 1975, IEEE T MICROW THEORY, V23, P667, DOI 10.1109/TMTT.1975.1128646; Henderson B, 2013, ARTECH HSE MICROW LI, P1; Itoh K., 1991, IEEE MTT S INT MICR, V2, P879; Itoh K, 1996, IEEE MTT-S, P967, DOI 10.1109/MWSYM.1996.511189; Itoh K, 2002, IEEE MTT S INT MICR, P9, DOI 10.1109/MWSYM.2002.1011545; Kawakami K., 1998, IEEE MTT S INT MICR, P1443; KELLY AJ, 1977, IEEE T MICROW THEORY, V25, P867, DOI 10.1109/TMTT.1977.1129233; Maas S, 1993, MICROWAVE MIXERS; Mizoe J, 1997, 1997 IEEE RADIO FREQUENCY INTEGRATED CIRCUITS (RFIC) SYMPOSIUM, P207, DOI 10.1109/RFIC.1997.598786; Razavi B., 1998, RF MICROELECTRONICS; SALEH A. A. M., 1971, THEORY RESISTIVE MIX; SCHNEIDER MV, 1975, IEEE T MICROW THEORY, VMT23, P271, DOI 10.1109/TMTT.1975.1128547; Torrey H. C., 1948, CRYSTAL RECTIFIER; Tsai ZM, 2013, IEEE T MICROW THEORY, V61, P2670, DOI 10.1109/TMTT.2013.2261537; Tucker D. G., 1964, CIRCUITS PERIODICALL; Tucker D. G., 1953, MODULATORS FREQUENCY	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9480	1557-9670		IEEE T MICROW THEORY	IEEE Trans. Microw. Theory Tech.	DEC	2014	62	12	1				3085	3094		10.1109/TMTT.2014.2364583		10	Engineering, Electrical & Electronic	Engineering	AX6EK	WOS:000347015900024		
J	Asai, H; Nashiyama, I; Sugimoto, K; Shiba, K; Sakaide, Y; Ishimaru, Y; Okazaki, Y; Noguchi, K; Morimura, T				Asai, Hiroaki; Nashiyama, Isamu; Sugimoto, Kenji; Shiba, Kensuke; Sakaide, Yasuo; Ishimaru, Yasuo; Okazaki, Yuji; Noguchi, Kenta; Morimura, Tadaaki			Tolerance Against Terrestrial Neutron-Induced Single-Event Burnout in SiC MOSFETs	IEEE TRANSACTIONS ON NUCLEAR SCIENCE			English	Article						Insulated gate bipolar transistor (IGBT); power device; power MOSFET; Schottky barrier diode (SBD); silicon carbide (SiC); single-event burnout (SEB); spallation neutron; terrestrial neutron	INDUCED FAILURE; DEVICES; DIODES; SEB	SEB tolerance of SiC power MOSFETs against terrestrial neutrons is studied. It is shown that the failure probability increases exponentially with applied voltage and is several orders of magnitude lower than that of a Si MOSFET. The energetic secondary carbon atoms generated by the nuclear reactions and the collisions between the terrestrial neutrons and the lattice atoms of SiC devices may play important role in the SEB triggering mechanism in SiC power devices.	[Asai, Hiroaki; Nashiyama, Isamu; Sugimoto, Kenji; Shiba, Kensuke; Sakaide, Yasuo; Ishimaru, Yasuo; Okazaki, Yuji; Noguchi, Kenta; Morimura, Tadaaki] High Reliabil Engn & Components Corp HIREC, Tsukuba, Ibaraki 3050033, Japan	Asai, H (reprint author), High Reliabil Engn & Components Corp HIREC, Tsukuba, Ibaraki 3050033, Japan.	asai@hirec.co.jp; i-nashiyama@hirec.co.jp; sugimoto@hirec.co.jp; shiba@hirec.co.jp; y-sakaide@hirec.co.jp; y-ishimaru@hirec.co.jp; y-okazaki@hirec.co.jp; noguchi@hirec.co.jp; morimura@hirec.co.jp					Normand E, 1997, IEEE T NUCL SCI, V44, P2358, DOI 10.1109/23.659062; Normand E, 1996, IEEE T NUCL SCI, V43, P2742, DOI 10.1109/23.556861; Iwase H, 2002, J NUCL SCI TECHNOL, V39, P1142, DOI 10.3327/jnst.39.1142; Griffoni A, 2012, IEEE T NUCL SCI, V59, P866, DOI 10.1109/TNS.2011.2180924; Iwamoto Y, 2011, NUCL TECHNOL, V173, P210; Asai H, 2012, IEEE T NUCL SCI, V59, P880, DOI 10.1109/TNS.2012.2203145; [Anonymous], 2006, JESD89A; Hands A, 2011, IEEE T NUCL SCI, V58, P952, DOI 10.1109/TNS.2011.2106142; Findeisen C. H., 2000, P INT FDN HFSJG ACT; Hands A, 2011, IEEE T NUCL SCI, V58, P2687, DOI 10.1109/TNS.2011.2168540; Kobayashi H., 2004, P IEEE INT REL PHYS, P288; Kuboyama S, 2007, IEEE T NUCL SCI, V54, P2379, DOI 10.1109/TNS.2007.910877; Liu S, 2008, IEEE T NUCL SCI, V55, P3122, DOI 10.1109/TNS.2008.2006841; Luu A, 2010, IEEE T NUCL SCI, V57, P1900, DOI 10.1109/TNS.2010.2044808; Nishida S, 2010, PROC INT SYMP POWER, P129; Oberg DL, 1996, IEEE T NUCL SCI, V43, P2913, DOI 10.1109/23.556885; Scheick L., 2007, P IEEE RAD EFF DAT W, P58; Shoji T., 2011, IEEJ T IND APPL, V131, P992, DOI DOI 10.1541/IEEJIAS.131.992; Soelkner G, 2007, MATER SCI FORUM, V556-557, P851; Stiasny T. H., 2005, P INT FDN HFSJG ACT; Zeller HR, 1997, MICROELECTRON RELIAB, V37, P1711, DOI 10.1016/S0026-2714(97)00146-7	21	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9499	1558-1578		IEEE T NUCL SCI	IEEE Trans. Nucl. Sci.	DEC	2014	61	6	1				3109	3114		10.1109/TNS.2014.2371892		6	Engineering, Electrical & Electronic; Nuclear Science & Technology	Engineering; Nuclear Science & Technology	AX1RO	WOS:000346724100046		
J	Yao, J; Saito, M; Okada, S; Kobayashi, K; Nakashima, Y				Yao, Jun; Saito, Mitsutoshi; Okada, Shogo; Kobayashi, Kazutoshi; Nakashima, Yasuhiko			EReLA: A Low-Power Reliable Coarse-Grained Reconfigurable Architecture Processor and Its Irradiation Tests	IEEE TRANSACTIONS ON NUCLEAR SCIENCE			English	Article						Data flow computing; fault tolerance; reconfigurable architectures; redundancy	RADIATION STRESS TEST; SYSTEMS; DESIGN	In this work, facing pressure from both the increasing vulnerability to single event effects (SEEs) and design constraints of the power consumption, we have proposed a Coarse-Grained Reconfigurable Architecture (CGRA) processor. Our goal is to translate a user programmable redundancy to a guide for balancing energy consumption on the one hand and the reliability requirements on the other. We designed software (SW) and hardware (HW) approaches, coordinating them closely to achieve this purpose. The framework provides several user-assignable patterns of redundancy and the hardware modules to interpret well these patterns. A first version prototype processor, with the name EReLA (Explicit Redundancy Linear Array) has been implemented and manufactured with a 0.18 mu m CMOS technology. Stress tests based on alpha particle irradiation were conducted to verify the tradeoff between the robustness and the power efficiency of the proposed schemes.	[Yao, Jun; Saito, Mitsutoshi; Nakashima, Yasuhiko] Nara Inst Sci & Technol, Grad Sch Informat Sci, Ikoma 6300192, Japan; [Okada, Shogo; Kobayashi, Kazutoshi] Kyoto Inst Technol, Grad Sch Sci & Technol, Kyoto 6068585, Japan	Yao, J (reprint author), Nara Inst Sci & Technol, Grad Sch Informat Sci, Ikoma 6300192, Japan.	yaojun@is.naist.jp; m-saito@is.naist.jp; sokada@vlsi.es.kit.ac.jp; kobayasi@vlsi.es.kit.ac.jp; nakashim@is.naist.jp			VLSI Design and Education Center, University of Tokyo; Synopsys; Cadence; Mentor Graphics; KAKENHI Program; STARC Program	This work was supported in part by VLSI Design and Education Center, University of Tokyo, in part by Synopsys, in part by Cadence, in part by Mentor Graphics, and in part by KAKENHI and STARC Programs.	Aggarwal N, 2007, CONF PROC INT SYMP C, P470; Ahmed T, 2014, IEEE T NUCL SCI, V61, P1567, DOI 10.1109/TNS.2014.2314691; Esmaeilzadeh H, 2012, ASPLOS XVII: SEVENTEENTH INTERNATIONAL CONFERENCE ON ARCHITECTURAL SUPPORT FOR PROGRAMMING LANGUAGES AND OPERATING SYSTEMS, P301; Yao J, 2012, IEEE T NUCL SCI, V59, P2852, DOI 10.1109/TNS.2012.2223715; [Anonymous], 2002, FR550 SER INSTR SET; Meaney PJ, 2005, IEEE T DEVICE MAT RE, V5, P419, DOI 10.1109/TDMR.2005.859577; Yamamoto R, 2011, IEEE T NUCL SCI, V58, P3053, DOI 10.1109/TNS.2011.2169457; Rotenberg E, 1999, DIG PAP INT SYMP FAU, P84, DOI 10.1109/FTCS.1999.781037; Mitra S, 2005, COMPUTER, V38, P43, DOI 10.1109/MC.2005.70; Kan R, 2014, IEEE J SOLID-ST CIRC, V49, P32, DOI 10.1109/JSSC.2013.2284650; Arbelo C, 2007, DES AUT TEST EUROPE, P177; de Kruijf M., 2011, P 44 ANN IEEE ACM IN, P140; Keckler SW, 2003, ISSCC DIG TECH PAP I, V46, P168; Slegel TJ, 1999, IEEE MICRO, V19, P12, DOI 10.1109/40.755464; Yoshimura K, 2011, IEICE T INF SYST, VE94D, P286, DOI 10.1587/transinf.E94.D.286	15	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9499	1558-1578		IEEE T NUCL SCI	IEEE Trans. Nucl. Sci.	DEC	2014	61	6	1				3250	3257		10.1109/TNS.2014.2367541		8	Engineering, Electrical & Electronic; Nuclear Science & Technology	Engineering; Nuclear Science & Technology	AX1RO	WOS:000346724100064		
J	Uemura, T; Kato, T; Tanabe, R; Iwata, H; Ariyoshi, J; Matsuyama, H; Hashimoto, M				Uemura, Taiki; Kato, Takashi; Tanabe, Ryo; Iwata, Hiroshi; Ariyoshi, Junichi; Matsuyama, Hideya; Hashimoto, Masanori			Exploring Well-Configurations for Minimizing Single Event Latchup	IEEE TRANSACTIONS ON NUCLEAR SCIENCE			English	Article						Alpha; neutron; parasitic bipolar action; single event latchup; soft-error; SRAM; terrestrial environment	CMOS DEVICES; TECHNOLOGIES; SRAMS	This work experimentally studies single event latchup (SEL) prevention by altering well configurations. The well structures under consideration in this paper are ordinary twin-well structure, triple-well structure with deep N-well (DNW) and triple-well structure with deep P-well (DPW). Doping profiles are also varied in our experiments. Neutron irradiation tests for test chips fabricated in 55-nm and 90-nm bulk Si CMOS processes show that SEL can be suppressed with a DPW or a DNW well configuration and a high-dose implantation in the well. Among these, DPW was the most effective to eliminate SEL, and no SEL was observed throughout our irradiation tests in the SRAM with DPW in both 55-nm and 90-nm processes. In addition, DPW brings a desirable side effect of single event upset (SEU) reduction. A disadvantage is a cost to develop a DPW process. DNW is a common process option and hence it is easily adopted for SEL prevention, but we need to pay attention to the fact that DNW increases SEU rate. Increasing well doping in twin-well structure reduced SEL by 60%.	[Uemura, Taiki; Kato, Takashi; Tanabe, Ryo; Iwata, Hiroshi; Matsuyama, Hideya] Fujitsu Semicond Ltd, Tokyo 1970833, Japan; [Ariyoshi, Junichi] Fujitsu Semicond Ltd, Kuwana, Mie 5110192, Japan; [Hashimoto, Masanori] Osaka Univ, Dept Informat Syst Engn, Osaka 5650871, Japan	Uemura, T (reprint author), Fujitsu Semicond Ltd, Tokyo 1970833, Japan.	uemura.taiki@jp.fujitsu.com; kato_takashi@jp.fujitsu.com; tanabe.ryou@jp.fujitsu.com; iwata.hiroshi@jp.fujitsu.com; ariyoshi@jp.fujitsu.com; matsuyama.hidey@jp.fujitsu.com; hasimoto@ist.osaka-u.ac.jp					Schwank JR, 2003, IEEE T NUCL SCI, V50, P522, DOI 10.1109/TNS.2003.812930; Gasiot G, 2007, IEEE T NUCL SCI, V54, P2468, DOI 10.1109/TNS.2007.908147; Iwamoto Y, 2011, NUCL TECHNOL, V173, P210; AOKI T, 1988, IEEE T ELECTRON DEV, V35, P1885, DOI 10.1109/16.7401; Becker HN, 2002, IEEE T NUCL SCI, V49, P3009, DOI 10.1109/TNS.2002.805332; Bruguier G, 1996, IEEE T NUCL SCI, V43, P522, DOI 10.1109/23.490898; Dodd PE, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P333, DOI 10.1109/IEDM.2002.1175846; Dodd PE, 2003, INT REL PHY, P51; Dodd PE, 2001, IEEE T NUCL SCI, V48, P1865, DOI 10.1109/23.983144; Dodds NA, 2010, IEEE T NUCL SCI, V57, P3575, DOI 10.1109/TNS.2010.2082562; Ibe E, 2006, IEEE CUST INTEGR CIR, P437, DOI 10.1109/CICC.2006.321010; JEDEC, 2006, JEDEC STADARD JEDEC, P1; Johnston AH, 1996, IEEE T NUCL SCI, V43, P505, DOI 10.1109/23.490897; Layton P. J., 1997, P RADECS, P327; Nicolaidis M., 2006, P 12 IEEE INT ON LIN, P111; Prokofiev AV, 2009, 2009 IEEE INTERNATIONAL RELIABILITY PHYSICS SYMPOSIUM, VOLS 1 AND 2, P929, DOI 10.1109/IRPS.2009.5173383; Puchner H, 2006, INT REL PHY, P721, DOI 10.1109/RELPHY.2006.251342; SOLIMAN K, 1983, IEEE T NUCL SCI, V30, P4514, DOI 10.1109/TNS.1983.4333163; Spratt JP, 2003, IEEE T NUCL SCI, V50, P2219, DOI 10.1109/TNS.2003.821607; Uemura T., 2014, P IEEE IRPS; Useinc R. G., 2005, P 2005 8 EUR C RAD I; Voldman S, 2005, INT REL PHY, P129, DOI 10.1109/RELPHY.2005.1493074; Yeon J.-E., 2013, P 2013 15 EUR C POW, P1	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9499	1558-1578		IEEE T NUCL SCI	IEEE Trans. Nucl. Sci.	DEC	2014	61	6	1				3282	3289		10.1109/TNS.2014.2363666		8	Engineering, Electrical & Electronic; Nuclear Science & Technology	Engineering; Nuclear Science & Technology	AX1RO	WOS:000346724100068		
J	Kato, T; Akano, R; Uemura, T; Watanabe, Y; Matsuyama, H				Kato, Takashi; Akano, Ryoto; Uemura, Taiki; Watanabe, Yukinobu; Matsuyama, Hideya			Neutron Shielding Effect of Stacked Servers and Its Impact on Reduction of Soft Error Rate	IEEE TRANSACTIONS ON NUCLEAR SCIENCE			English	Article						Bonner sphere neutron spectrometer; neutron energy spectrum; neutron shielding; single event upset; soft error simulation; SRAM; stacked server; terrestrial neutron	SINGLE-EVENT UPSETS; SPECTROMETER; ATMOSPHERE; MODEL; CODE	The shielding effect of stacked servers on terrestrial neutrons and its impact on soft error rate of the device in the server are studied. Shielding simulation using the PHITS code is performed with the model of stacked servers and demonstrates its strong effect on neutron attenuation. The measurement of terrestrial neutrons by a Bonner sphere neutron spectrometer is carried out in open air and in a building in order to compare the shielding contributions from stacked servers and from the building. This comparison shows that the neutron attenuation is mainly due to stacked servers depending on its location in the building. Finally, the soft error rate of a 28 nm SRAM cell implemented in CPUs of stacked servers is simulated through PHYSERD with circuit simulation. Our study reveals that the soft error rate is significantly suppressed by the neutron flux attenuation and the distortion of the energy spectrum, both of which are caused by the shielding effect of stacked servers.	[Kato, Takashi; Uemura, Taiki; Matsuyama, Hideya] Fujitsu Semicond Ltd, Qual Assurance Div, Dept Reliabil Engn, Tokyo 1970833, Japan; [Akano, Ryoto; Watanabe, Yukinobu] Kyushu Univ, Dept Adv Energy Engn Sci, Fukuoka 8168580, Japan	Kato, T (reprint author), Fujitsu Semicond Ltd, Qual Assurance Div, Dept Reliabil Engn, Tokyo 1970833, Japan.	kato_takashi@jp.fujitsu.com					Abe S, 2014, IEEE T NUCL SCI, V61, P1806, DOI 10.1109/TNS.2014.2307298; Ando H, 2008, I C DEPEND SYS NETWO, P62, DOI 10.1109/DSN.2008.4630071; [Anonymous], 2006, JESD89A JEDEC; [Anonymous], 2011, HYENEXSS VER 5 5; Cugnon J, 2011, J KOREAN PHYS SOC, V59, P955, DOI 10.3938/jkps.59.955; Abe S, 2012, IEEE T NUCL SCI, V59, P965, DOI 10.1109/TNS.2012.2187215; Reginatto M, 1999, HEALTH PHYS, V77, P579; Shibata K, 2011, J NUCL SCI TECHNOL, V48, P1, DOI 10.3327/jnst.48.1; Heidel DF, 2009, IEEE T NUCL SCI, V56, P3499, DOI 10.1109/TNS.2009.2033796; Sato T, 2006, RADIAT RES, V166, P544, DOI 10.1667/RR0610.1; BRAMBLETT RL, 1960, NUCL INSTRUM METHODS, V9, P1, DOI 10.1016/0029-554X(60)90043-4; Baggio J, 2007, IEEE T NUCL SCI, V54, P2149, DOI 10.1109/TNS.2007.910039; Sato T, 2008, RADIAT RES, V170, P244, DOI 10.1667/RR1094.1; Ziegler JF, 1996, IBM J RES DEV, V40, P19; Dirk LT. J. D., 2003, IEEE T NUCL SCI, V50, P2060; Dixit A., 2011, P IEEE INT REL PHYS, p5B41; Harris K. W., 2005, IEEE T DEVICE MAT RE, V5, P1530; Kato T., 2014, P INT C SIM SEM PROC, P345; Niita K., 2010, PHITS PARTICLE HEAVY; Theis C, 2006, NUCL INSTRUM METH A, V562, P827, DOI 10.1016/j.nima.2006.02.125; ZIEGLER JF, 1981, IEEE T ELECTRON DEV, V28, P560, DOI 10.1109/T-ED.1981.20383	21	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9499	1558-1578		IEEE T NUCL SCI	IEEE Trans. Nucl. Sci.	DEC	2014	61	6	1				3408	3415		10.1109/TNS.2014.2369014		8	Engineering, Electrical & Electronic; Nuclear Science & Technology	Engineering; Nuclear Science & Technology	AX1RO	WOS:000346724100084		
J	Mori, H; Uemura, T; Matsuyama, H; Yamazaki, T; Soeda, T				Mori, Hiroko; Uemura, Taiki; Matsuyama, Hideya; Yamazaki, Takashi; Soeda, Takeshi			Detection Technique With Alpha-Tracking and Emissivity Comparison	IEEE TRANSACTIONS ON NUCLEAR SCIENCE			English	Article						Alpha-emissivity; alpha-tracking; Columbia resin 39 (CR-39); low background	CR-39	We achieved accurate alpha emissivity measurement with the alpha-tracking technique by decreasing the background effect. It is possible to lower the detection limit of this technique to 4.9 x 10(-2) alphas/kh-cm(2) using a normal detector. We measured various large-scale integration materials using this technique.	[Mori, Hiroko; Uemura, Taiki; Matsuyama, Hideya] Fujitsu Semicond Ltd, Tokyo 1970833, Japan; [Yamazaki, Takashi; Soeda, Takeshi] Fujitsu Labs Ltd, Atsugi, Kanagawa 2430197, Japan	Mori, H (reprint author), Fujitsu Semicond Ltd, Tokyo 1970833, Japan.	mori.hiroko@jp.fujitsu.com; uemura.taiki@jp.fujitsu.com; matsuyama.hidey@jp.fujitsu.com; yamazakit@jp.fujitsu.com; t-soeda@jp.fujitsu.com					Iwamoto Y, 2011, NUCL TECHNOL, V173, P210; CARTWRIGHT BG, 1978, NUCL INSTRUM METHODS, V153, P457, DOI 10.1016/0029-554X(78)90989-8; Baumann R., 2001, 01054118A XFR; Csige I., 1987, P 20 INT COSMIC RAY, V2, P414; Dorschel B, 2005, RADIAT MEAS, V40, P234, DOI 10.1016/j.radmeas.2004.11.008; Gordon MS, 2009, IEEE T NUCL SCI, V56, P3381, DOI 10.1109/TNS.2009.2034001; Gordon MS, 2012, IEEE T NUCL SCI, V59, P3101, DOI 10.1109/TNS.2012.2223234; JEDEC Standard, 2006, JESD89A; Kato T., 2014, NUCL SPAC RAD EFF C; Takasu R, 2005, INT REL PHY, P230, DOI 10.1109/RELPHY.2005.1493089; Tosaka Y, 2006, JPN J APPL PHYS 1, V45, P3185, DOI 10.1143/JJAP.45.3185; Warburton WK, 2007, NUCL INSTRUM METH B, V263, P221, DOI 10.1016/j.nimb.2007.04.089; YAMAUCHI T, 1992, NUCL TRACKS RAD MEAS, V20, P615	13	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9499	1558-1578		IEEE T NUCL SCI	IEEE Trans. Nucl. Sci.	DEC	2014	61	6	1				3438	3442		10.1109/TNS.2014.2359472		5	Engineering, Electrical & Electronic; Nuclear Science & Technology	Engineering; Nuclear Science & Technology	AX1RO	WOS:000346724100088		
J	Abe, S; Watanabe, Y				Abe, Shin-ichiro; Watanabe, Yukinobu			Analysis of Charge Deposition and Collection Caused by Low Energy Neutrons in a 25-nm Bulk CMOS Technology	IEEE TRANSACTIONS ON NUCLEAR SCIENCE			English	Article						Monte Carlo simulation; neutrons; PHYSERD; single event upset (SEU); terrestrial radiation effects	SOFT ERROR RATE; CROSS-SECTIONS; CODE SYSTEM; SILICON; SPECTROSCOPY; RADIATION; PHITS; SOI; N,P	Neutron-induced single event upsets (SEUs) in a 25-nm NMOSFET are analyzed using PHYSERD simulation. We confirm that the secondary H and He ions dominate SEUs above the threshold energies of (n, p) and (n,alpha) reactions although the production cross sections for H and He ions are smaller than the elastic scattering cross sections below 20 MeV. The SEUs induced by secondary H and He ions are influenced strongly by the size of the interaction volume considered in the simulation because the ranges of H and He ions are much longer than those of elastic recoils.	[Abe, Shin-ichiro; Watanabe, Yukinobu] Kyushu Univ, Dept Adv Energy Engn, Fukuoka 8168580, Japan	Abe, S (reprint author), Kyushu Univ, Dept Adv Energy Engn, Fukuoka 8168580, Japan.	watanabe@aees.kyushu-u.acjp			KAKENHI Grant [24-7673]	This work was supported by Grant-in Aid for JSPS Fellows, KAKENHI Grant Number 24-7673.	Abe S., 2012, P INT REL PHYS S; Abe S, 2014, IEEE T NUCL SCI, V61, P1806, DOI 10.1109/TNS.2014.2307298; PETERSEN EL, 1992, IEEE T NUCL SCI, V39, P1577, DOI 10.1109/23.211340; [Anonymous], 2006, JESD89A JEDEC; Shivakumar P, 2002, INTERNATIONAL CONFERENCE ON DEPENDABLE SYSTEMS AND NETWORKS, PROCEEDINGS, P389; Hanson S, 2008, IEEE T ELECTRON DEV, V55, P175, DOI 10.1109/TED.2007.911033; Abe S, 2012, IEEE T NUCL SCI, V59, P965, DOI 10.1109/TNS.2012.2187215; COHEN AV, 1956, NUCL PHYS, V1, P73, DOI 10.1016/S0029-5582(56)80009-6; Shibata K, 2011, J NUCL SCI TECHNOL, V48, P1, DOI 10.3327/jnst.48.1; Baggio J, 2007, IEEE T NUCL SCI, V54, P2149, DOI 10.1109/TNS.2007.910039; Reed RA, 2013, IEEE T NUCL SCI, V60, P1876, DOI 10.1109/TNS.2013.2262101; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; Bass R., 1966, P EANDC, V66, P64; Bateman FB, 1999, PHYS REV C, V60; BIRK M, 1963, NUCL INSTRUM METHODS, V21, P197, DOI 10.1016/0029-554X(63)90116-2; Boeuf F, 2008, IEEE T ELECTRON DEV, V55, P1433, DOI 10.1109/TED.2008.921274; Fessler A, 2000, NUCL SCI ENG, V134, P171; Furihata S, 2000, NUCL INSTRUM METH B, V171, P251, DOI 10.1016/S0168-583X(00)00332-3; Furuta M, 2008, ANN NUCL ENERGY, V35, P1652, DOI 10.1016/j.anucene.2008.02.010; Gasiot G, 2002, IEEE T NUCL SCI, V49, P3032, DOI 10.1109/TNS.2002.805395; Iwamoto Y, 2008, INTERNATIONAL CONFERENCE ON NUCLEAR DATA FOR SCIENCE AND TECHNOLOGY, VOL 2, PROCEEDINGS, P945, DOI 10.1051/ndata:07417; KERN BD, 1959, NUCL PHYS, V10, P226, DOI 10.1016/0029-5582(59)90211-1; MAINSBRIDGE B, 1963, NUCL PHYS, V48, P83, DOI 10.1016/0029-5582(63)90145-7; Mannhart W., 2007, 53 PTB NEUTR; Nakamura T., 2008, TERRESTRIAL NEUTRON; Ogawa T., 2014, COMMUNICATION; PETERSEN EL, 1993, IEEE T NUCL SCI, V40, P1888, DOI 10.1109/23.273465; Roche P, 2003, IEEE T NUCL SCI, V50, P2046, DOI 10.1109/TNS.2003.821588; Semiconductor Leading Edge Technologies Inc. Yokohama-shi Kanagawa Japan, 1996, 3 D TCAD SIM HYENEXS; SHANNON JA, 1966, NUCL INSTRUM METHODS, V41, P255, DOI 10.1016/0029-554X(66)90009-7; Shibano N., 2010, THESIS U TSUKUBA TSU; SHOCKLEY W, 1961, SOLID STATE ELECTRON, V2, P35, DOI 10.1016/0038-1101(61)90054-5; Sierawski B. D., 2010, P 48 IEEE INT REL PH, P395; Tosaka Y., 2004, P SISPAD, P219; Watanabe Y, 2008, INTERNATIONAL CONFERENCE ON NUCLEAR DATA FOR SCIENCE AND TECHNOLOGY, VOL 2, PROCEEDINGS, P1121, DOI 10.1051/ndata:07196; Yahagi Y., 2004, P IEEE INT REL PHYS, P669; Zhou HY, 2011, NUCL INSTRUM METH A, V648, P192, DOI 10.1016/j.nima.2011.04.014	37	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9499	1558-1578		IEEE T NUCL SCI	IEEE Trans. Nucl. Sci.	DEC	2014	61	6	1				3519	3526		10.1109/TNS.2014.2367513		8	Engineering, Electrical & Electronic; Nuclear Science & Technology	Engineering; Nuclear Science & Technology	AX1RO	WOS:000346724100100		
J	Shinaji, T; Tashima, H; Yoshida, E; Yamaya, T; Ohnishi, T; Haneishi, H				Shinaji, Tetsuya; Tashima, Hideaki; Yoshida, Eiji; Yamaya, Taiga; Ohnishi, Takashi; Haneishi, Hideaki			Time-Delay Correction Method for PET-Based Tumor Tracking	IEEE TRANSACTIONS ON NUCLEAR SCIENCE			English	Article						OpenPET; positron emission tomography; respiratory motion; tumor tracking	STANDARDIZED UPTAKE VALUES; SUPPORT VECTOR REGRESSION; MOTION; LUNG	The world's first open-type positron emission tomography (PET), named OpenPET, is being developed at the National Institute of Radiological Sciences, Japan. We are aiming to employ the OpenPET in radiotherapy and to track the respiratory motion of a tumor in the thoracoabdominal region of a patient. By using PET images, we expect that the tumor itself can be directly visualized without using radio-opaque markers. Our demonstration results using a small prototype OpenPET system showed that the system can output reconstructed images at about two frames per second with about a 2-s delay; this delay is mainly due to the reconstruction calculation time. In this paper, we developed a time-delay correction method for tumor tracking for the OpenPET. Since it is difficult to correct the time delay using only the tumor location at 2 s before, we assumed the introduction of another high-speed sensor to acquire the respiration phase for correction. In the proposed method, the relationship between the tumor motion and the additional sensor output signal is calculated by support vector regression and the time delay is corrected by using the obtained regression line. We simulated this time-delay correction method with computer-generated PET images which had actual respiration motions obtained from clinical magnetic resonance imaging. As a result, we could track the tumor with 1.20 +/- 0.91 mm mean error when we assumed the use of a belt-type respiratory motion sensor.	[Shinaji, Tetsuya] Chiba Univ, Grad Sch Engn, Chiba 2638522, Japan; [Tashima, Hideaki; Yoshida, Eiji; Yamaya, Taiga] Natl Inst Radiol Sci, Chiba 2638555, Japan; [Yamaya, Taiga; Ohnishi, Takashi; Haneishi, Hideaki] Chiba Univ, Ctr Frontier Med Engn, Chiba 2638522, Japan	Shinaji, T (reprint author), Chiba Univ, Grad Sch Engn, Chiba 2638522, Japan.	tetsuya.shinaji@gmail.com; tashima@nirs.go.jp; rush@nirs.go.jp; taiga@nirs.go.jp; t-ohnishi@chiba-u.jp; haneishi@faculty.chiba-u.jp			MEXT Kakenhi [22240065, 24103703]	This work was supported in part by MEXT Kakenhi under Grant 22240065, and Grant 24103703.	Smola AJ, 2004, STAT COMPUT, V14, P199, DOI 10.1023/B:STCO.0000035301.49549.88; Riaz N, 2009, PHYS MED BIOL, V54, P5735, DOI 10.1088/0031-9155/54/19/005; Yamaya T, 2008, PHYS MED BIOL, V53, P757, DOI 10.1088/0031-9155/53/3/015; Segars WP, 2008, MED PHYS, V35, P3800, DOI 10.1118/1.2955743; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Zincirkeser S, 2007, J INT MED RES, V35, P231; Hoisak JDP, 2004, INT J RADIAT ONCOL, V60, P1298, DOI 10.1016/j.ijrobp.2004.07.681; Seppenwoolde Y, 2002, INT J RADIAT ONCOL, V53, P822, DOI 10.1016/S0360-3016(02)02803-1; Bishop N. M., 2006, PATTERN RECOGNITION; Lin C., 2004, SIMPLE PROBABILISTIC; Ramos CD, 2001, EUR J NUCL MED, V28, P155, DOI 10.1007/s002590000421; Shinaji T., 2011, JAPANESE J MED PHYS, V31, P276; Tashima H, 2012, IEEE T NUCL SCI, V59, P40, DOI 10.1109/TNS.2011.2169988; Wang YB, 2007, MOL IMAGING BIOL, V9, P83, DOI 10.1007/s11307-006-0075-y	14	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9499	1558-1578		IEEE T NUCL SCI	IEEE Trans. Nucl. Sci.	DEC	2014	61	6	2				3711	3720		10.1109/TNS.2014.2364047		10	Engineering, Electrical & Electronic; Nuclear Science & Technology	Engineering; Nuclear Science & Technology	AX1SC	WOS:000346725400017		
J	Iwamoto, N; Makino, T; Kada, W; Skukan, N; Pomorski, M; Grilj, V; Jaksic, M; Onoda, S; Ohshima, T; Kamiya, T				Iwamoto, N.; Makino, T.; Kada, W.; Skukan, N.; Pomorski, M.; Grilj, V.; Jaksic, M.; Onoda, S.; Ohshima, T.; Kamiya, T.			Charge Collection Characteristics of A Super-Thin Diamond Membrane Detector Measured With High-Energy Heavy Ions	IEEE TRANSACTIONS ON NUCLEAR SCIENCE			English	Article						Charge collection efficiency; diamond; high-energy heavy ion; membrane; transmission detector	CVD-DIAMOND; SILICON; DEPOSITION; MICROBEAMS	A transmission particle detector based on a super-thin diamond membrane film which can also be used simultaneously as a vacuum window for ion beam extraction has been developed. Charge collection characteristics of a m-thick diamond membrane detector for high-energy heavy ions including 75 MeV Ne, 150 MeV Ar, 322 MeV Kr, and 454 MeV Xe have been investigated for the first time. Charge collection signals under single particle flux from the thin part are stable and are well distinguishable from background signals. This behavior suggests that the diamond membrane detector could be used for counting single ions. On the other hand, charge collection efficiency is found to decrease with increasing of charge generated in the diamond membrane detector. This suggests that the pulse height defect, which has been previously reported for Si and SiC detectors, also occurs in the diamond membrane detector.	[Iwamoto, N.; Makino, T.; Onoda, S.; Ohshima, T.; Kamiya, T.] Japan Atom Energy Agcy, Gunma 3701292, Japan; [Kada, W.] Gunma Univ, Fac Sci & Technol, Div Elect & Informat, Kiryu, Gunma 3768515, Japan; [Skukan, N.; Grilj, V.; Jaksic, M.] Rudjer Boskovic Inst, Div Expt Phys, Zagreb 10000, Croatia; [Pomorski, M.] CEA LIST, Diamond Sensors Lab, F-91191 Gif Sur Yvette, France	Iwamoto, N (reprint author), Univ Oslo, Ctr Mat Sci & Nanotechnol, N-0316 Oslo, Norway.	naoya.iwamoto@smn.uio.no; makino.takahiro@jaea.go.jp; kada.wataru@gunma-u.ac.jp; nskukan@irb.hr; michal.pomorski@cea.fr; veljko.grilj@irb.hr; milko.jaksic@irb.hr; onoda.shinobu@jaea.go.jp; ohshima.takeshi20@jaea.go.jp; kamiya.tomihiro@jaea.go.jp		Michal, Pomorski/0000-0003-1272-1764; Grilj, Veljko/0000-0001-6573-8063	Japan Science and Technology Agency; Ministry of Science, Education, and Sports of the Republic of Croatia	This work was supported in part by the project "Development of high-energy ion microbeam technology for novel applications of diamond" under the Strategic Japanese-Croatian Cooperative Program on Materials Science of the Japan Science and Technology Agency and the Ministry of Science, Education, and Sports of the Republic of Croatia.	Prise KM, 2009, NAT REV CANCER, V9, P351, DOI 10.1038/nrc2603; Kozak M, 2014, PHYS STATUS SOLIDI A, V211, P2244, DOI 10.1002/pssa.201431174; FAGEEHA O, 1994, J APPL PHYS, V75, P2317, DOI 10.1063/1.356274; Funayama T, 2008, J RADIAT RES, V49, P71, DOI 10.1269/jrr.07085; Kaneko JH, 2003, NUCL INSTRUM METH A, V505, P187, DOI 10.1016/S0168-9002(03)01048-9; Bergonzo P, 2003, SEMICOND SCI TECH, V18, pS105, DOI 10.1088/0268-1242/18/3/315; Pomorski M, 2007, DIAM RELAT MATER, V16, P1066, DOI 10.1016/j.diamond.2006.11.016; KOBETICH EJ, 1968, PHYS REV, V170, P391, DOI 10.1103/PhysRev.170.391; Berdermann E, 2010, DIAM RELAT MATER, V19, P358, DOI 10.1016/j.diamond.2009.11.019; Koizumi S, 2001, SCIENCE, V292, P1899, DOI 10.1126/science.1060258; FINCH EC, 1973, NUCL INSTRUM METHODS, V113, P29, DOI 10.1016/0029-554X(73)90474-6; Fischer BE, 2001, NUCL INSTRUM METH B, V181, P60, DOI 10.1016/S0168-583X(01)00555-9; Folkard M, 2002, NUCL INSTRUM METH B, V188, P49, DOI 10.1016/S0168-583X(01)01007-2; Fukuda M., 1999, Proceedings of the 1999 Particle Accelerator Conference (Cat. No.99CH36366), DOI 10.1109/PAC.1999.792652; Grilj V., 2013, APPL PHYS LETT, V103; Jansen H., 2013, THESIS RHEINISCHEN F; Kada W., 2013, T MAT RES SOC JPN, V38, P279; Kamiya T, 2011, NUCL INSTRUM METH B, V269, P2184, DOI 10.1016/j.nimb.2011.02.043; Kobayashi Y, 2003, NUCL INSTRUM METH B, V210, P308, DOI 10.1016/S0168-583X(03)01047-4; Lohstroh A., 2007, J APPL PHYS, V101; Moyal J. E., 1954, PHILOS MAG 7, V47, P263; Ohshima T, 2011, SURF COAT TECH, V206, P864, DOI 10.1016/j.surfcoat.2011.03.097; Onoda S, 2007, IEEE T NUCL SCI, V54, P2706, DOI 10.1109/TNS.2007.908459; Pomorski M., 2008, THESIS U FRANKFURT M; Pomorski M., 2013, APPL PHYS LETT, V103; STEINBER.EP, 1972, NUCL INSTRUM METHODS, V99, P309, DOI 10.1016/0029-554X(72)90791-4; WILKINS BD, 1971, NUCL INSTRUM METHODS, V92, P381, DOI 10.1016/0029-554X(71)90414-9; Ziegler J. F., 2011, STOPPING RANGE IONS	28	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9499	1558-1578		IEEE T NUCL SCI	IEEE Trans. Nucl. Sci.	DEC	2014	61	6	2				3732	3738		10.1109/TNS.2014.2360937		7	Engineering, Electrical & Electronic; Nuclear Science & Technology	Engineering; Nuclear Science & Technology	AX1SC	WOS:000346725400020		
J	Xia, F; Ahmed, AM; Yang, LT; Ma, JH; Rodrigues, JJPC				Xia, Feng; Ahmed, Ahmedin Mohammed; Yang, Laurence Tianruo; Ma, Jianhua; Rodrigues, Joel J. P. C.			Exploiting Social Relationship to Enable Efficient Replica Allocation in Ad-hoc Social Networks	IEEE TRANSACTIONS ON PARALLEL AND DISTRIBUTED SYSTEMS			English	Article						Replica allocation; social relationship; ad-hoc social networks; community; data distribution; middleware	INTERNET ARCHITECTURE; MOBILE; WIRELESS	Replication is an important mechanism in modern wireless networks and has attracted significant efforts to improve its performance with different metrics including read cost, consistency and relocation cost. Traditionally, different ideal approaches are widely used to facilitate data availability. However, the quality of wireless links would be affected by many factors like mobility and overhead. The accessibility and reliability of Ad-hoc Social Network (ASNET) services can be assured by replication approaches. It is used to increase data availability by replicating data items locally or nearby. In ASNETs, replication helps to avoid data losses in case of an unpredictable group mobility that causes community partition and also aids in reducing the number of hops when a data is transmitted from source to destination. A new data replication method called ComPAS (community-partition aware replica allocation method) is proposed in this paper. This method can significantly improve ASNETs performance by exploiting social relationship while replicating in the community to achieve better efficiency and consistency while keeping the replica relocation cost as low as possible. This type of replica allocation method will increase the availability of different data items in a partitioned social community. Evaluation results verify the effectiveness of the method.	[Xia, Feng; Ahmed, Ahmedin Mohammed] Dalian Univ Technol, Sch Software, Dalian 116620, Peoples R China; [Yang, Laurence Tianruo] St Francis Xavier Univ, Dept Comp Sci, Antigonish, NS B2G 1C0, Canada; [Ma, Jianhua] Hosei Univ, Fac Comp & Informat Sci, Dept Digital Media, Koganei, Tokyo 184, Japan; [Rodrigues, Joel J. P. C.] Univ Beira Interior, Inst Telecomunicacoes, Covilha, Portugal	Xia, F (reprint author), Dalian Univ Technol, Sch Software, Dalian 116620, Peoples R China.	f.xia@ieee.org			NSFC [60903153, 61203165]; Liaoning Provincial Natural Science Foundation of China [201202032]; Instituto de Telecomunicacoes, NetGNA research Group, Portugal; National Funding from the FCT [PEst-OE/EEI/LA0008/2013]	This work was partially supported by the NSFC under Grant No. 60903153 and No. 61203165, by Liaoning Provincial Natural Science Foundation of China under Grant No. 201202032, by Instituto de Telecomunicacoes, NetGNA research Group, Portugal, and by National Funding from the FCT through PEst-OE/EEI/LA0008/2013 Project.	Ahmed A. M., 2013, P IEEE INT C CYB PHY, P834; Tran DA, 2012, COMPUT NETW, V56, P2001, DOI 10.1016/j.comnet.2012.02.010; Xylomenos G, 2012, IEEE COMMUN MAG, V50, P52, DOI 10.1109/MCOM.2012.6231279; Pujol JM, 2010, ACM SIGCOMM COMP COM, V40, P375, DOI 10.1145/1851275.1851227; Cao GH, 2004, COMPUTER, V37, P32; Derhab A, 2009, IEEE COMMUN SURV TUT, V11, P33, DOI 10.1109/SURV.2009.090204; Bellavista P, 2013, PERVASIVE MOB COMPUT, V9, P437, DOI 10.1016/j.pmcj.2013.03.001; Hara T, 2009, IEEE T MOBILE COMPUT, V8, P950, DOI 10.1109/TMC.2008.150; Fife LD, 2003, SIGMOD RECORD, V32, P42; Raychaudhuri D, 2012, P IEEE, V100, P824, DOI 10.1109/JPROC.2011.2182095; Makris P, 2013, IEEE COMMUN SURV TUT, V15, P362, DOI 10.1109/SURV.2012.040912.00180; Li Y, 2011, IEEE T VEH TECHNOL, V60, P2224, DOI 10.1109/TVT.2011.2149552; Balasubramaniam S, 2011, IEEE COMMUN MAG, V49, P44, DOI 10.1109/MCOM.2011.5936154; Guo B, 2012, 2012 9TH INTERNATIONAL CONFERENCE ON UBIQUITOUS INTELLIGENCE & COMPUTING AND 9TH INTERNATIONAL CONFERENCE ON AUTONOMIC & TRUSTED COMPUTING (UIC/ATC), P188, DOI 10.1109/UIC-ATC.2012.29; Hara T, 2001, IEEE INFOCOM SER, P1568; Huang JL, 2006, IEEE T MOBILE COMPUT, V5, P492; Jain S., 2013, P INT C ADV COMM CON, P189; Lu W., 2010, P 2 IEEE INT C COMP, V7, P23; Mascolo C, 2010, IEEE INTERNET COMPUT, V14, P76, DOI 10.1109/MIC.2010.150; Peng W.-C., 2003, IEEE T KNOWL DATA EN, V15, P75; Sengul C, 2012, ACM COMPUT SURV, V44, DOI 10.1145/2333112.2333118; Serrat O., 2009, SOCIAL NETWORK ANAL; Shen HY, 2010, IEEE T PARALL DISTR, V21, P827, DOI 10.1109/TPDS.2009.127; Wei K., 2013, IEEE COMMUN SURV TUT, V16, P556; WU HK, 2001, IEEE INFOCOM SER, P21; ZHANG C, 2008, P 27 IEEE COMM SOC C, P825; Zhu Y., 2012, IEEE COMMUN SURV TUT, V15, P387	27	5	5	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1045-9219	1558-2183		IEEE T PARALL DISTR	IEEE Trans. Parallel Distrib. Syst.	DEC	2014	25	12					3167	3176		10.1109/TPDS.2013.2295805		10	Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	AX6EJ	WOS:000347015800012		
J	Luo, CQ; Guo, SY; Guo, S; Yang, LT; Min, GY; Xie, X				Luo, Changqing; Guo, Shengyong; Guo, Song; Yang, Laurence T.; Min, Geyong; Xie, Xia			Green Communication in Energy Renewable Wireless Mesh Networks: Routing, Rate Control, and Power Allocation	IEEE TRANSACTIONS ON PARALLEL AND DISTRIBUTED SYSTEMS			English	Article						Multi-hop wireless mesh networks; renewable energy; fairness; energy consumption minimization; routing	RATE ADAPTATION; CHANNEL	The increasing demand for wireless services has led to a severe energy consumption problem with the rising of greenhouse gas emission. While the renewable energy can somehow alleviate this problem, the routing, flow rate, and power still have to be well investigated with the objective of minimizing energy consumption in multi-hop energy renewable wireless mesh networks (ER-WMNs). This paper formulates the problem of network-wide energy consumption minimization under the network throughput constraint as a mixed-integer nonlinear programming problem by jointly optimizing routing, rate control, and power allocation. Moreover, the min-max fairness model is applied to address the fairness issue because the uneven routing problem may incur the sharp reduction of network performance in multi-hop ER-WMNs. Due to the high computational complexity of the formulated mathematical programming problem, an energy-aware multi-path routing algorithm (EARA) is also proposed to deal with the joint control of routing, flow rate, and power allocation in practical multi-hop WMNs. To search the optimal routing, it applies a weighted Dijkstra's shortest path algorithm, where the weight is defined as a function of the power consumption and residual energy of a node. Extensive simulation results are presented to show the performance of the proposed schemes and the effects of energy replenishment rate and network throughput on the network lifetime.	[Luo, Changqing; Guo, Shengyong; Yang, Laurence T.; Xie, Xia] Huazhong Univ Sci & Technol, Sch Comp Sci & Technol, Wuhan 430074, Hubei, Peoples R China; [Guo, Song] Univ Aizu, Sch Comp Sci & Engn, Fukushima, Japan; [Yang, Laurence T.] St Francis Xavier Univ, Dept Comp Sci, Antigonish, NS B2G 1C0, Canada; [Min, Geyong] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England	Luo, CQ (reprint author), Huazhong Univ Sci & Technol, Sch Comp Sci & Technol, Wuhan 430074, Hubei, Peoples R China.	chqluo2013@gmail.com; gshyong@gmail.com; sguo@u-aizu.ac.jp; ltyang@gmail.com; g.min@exeter.ac.uk; shelicy@hust.edu.cn			National Natural Science Foundation of China [61201219, 61173045]	This work was supported by the National Natural Science Foundation of China under Grant 61201219 and 61173045.	Akyildiz I. F., 2005, IEEE COMMUNICATIONS, V43, P23; Oyman O, 2007, IEEE COMMUN MAG, V45, P116, DOI 10.1109/MCOM.2007.4378330; Badawy GH, 2010, IEEE T VEH TECHNOL, V59, P3859, DOI 10.1109/TVT.2010.2064797; Al-Hazmi Y, 2011, IEEE NETWORK, V25, P32, DOI 10.1109/MNET.2011.5730526; Lin LB, 2007, IEEE ACM T NETWORK, V15, P1021, DOI 10.1109/TNET.2007.896173; Salinas S, 2013, IEEE T SMART GRID, V4, P2139, DOI 10.1109/TSG.2013.2265556; Subramanian AP, 2008, IEEE T MOBILE COMPUT, V7, P1459, DOI 10.1109/TMC.2008.70; Weeraddana PC, 2011, IEEE T SIGNAL PROCES, V59, P3977, DOI 10.1109/TSP.2011.2152397; FLETCHER R, 1994, MATH PROGRAM, V66, P327, DOI 10.1007/BF01581153; Song Y, 2008, IEEE J SEL AREA COMM, V26, P1149, DOI 10.1109/JSAC.2008.080912; Benyamina D, 2012, IEEE COMMUN SURV TUT, V14, P299, DOI 10.1109/SURV.2011.042711.00007; Sims REH, 2004, SOL ENERGY, V76, P9, DOI 10.1016/S0038-092X(03)00101-4; Capone A, 2010, AD HOC NETW, V8, P545, DOI 10.1016/j.adhoc.2009.11.003; Hou YT, 2005, IEEE T WIREL COMMUN, V4, P2579, DOI 10.1109/TWC.2005.853969; Passos D, 2012, IEEE ACM T NETWORK, V20, P999, DOI 10.1109/TNET.2011.2170585; Luo J, 2010, IEEE ACM T NETWORK, V18, P1387, DOI 10.1109/TNET.2010.2041788; Cai L., 2011, P IEEE GLOBECOM, P1; Garey M.R., 1979, WH FREEMAN COMPUTERS, P245; Heile B, 2010, IEEE WIREL COMMUN, V17, P4, DOI 10.1109/MWC.2010.5490972; Jiang CM, 2012, 2012 PROCEEDINGS IEEE INFOCOM, P1934; Jun J, 2003, IEEE VTS VEH TECHNOL, P2936; Lee KD, 2008, IEEE T VEH TECHNOL, V57, P1166, DOI 10.1109/TVT.2007.905606; Liu X, 2011, IEICE T COMMUN, VE94B, P2857, DOI 10.1587/transcom.E94.B.2857; Tang J., 2006, P IEEE INFOCOM, P1, DOI 10.1109/INFOCOM.2006.249; Vijayalayan KS, 2013, INT CON ADV INFO NET, P311, DOI 10.1109/AINA.2013.24; Wei YF, 2012, GREEN RADIO COMMUNICATION NETWORKS, P286; Zheng Z., 2011, POW EL APPL EPE 2011, P1	27	1	1	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1045-9219	1558-2183		IEEE T PARALL DISTR	IEEE Trans. Parallel Distrib. Syst.	DEC	2014	25	12					3211	3220		10.1109/TPDS.2013.2297922		10	Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	AX6EJ	WOS:000347015800016		
J	Li, P; Guo, S; Yu, S; Vasilakos, AV				Li, Peng; Guo, Song; Yu, Shui; Vasilakos, Athanasios V.			Reliable Multicast with Pipelined Network Coding Using Opportunistic Feeding and Routing	IEEE TRANSACTIONS ON PARALLEL AND DISTRIBUTED SYSTEMS			English	Article						Multicast; network coding; opportunistic feeding; optimization; protocol design	WIRELESS NETWORKS; INFORMATION; FLOW	Multicast is an important mechanism in modern wireless networks and has attracted significant efforts to improve its performance with different metrics including throughput, delay, energy efficiency, etc. Traditionally, an ideal loss-free channel model is widely used to facilitate routing protocol design. However, the quality of wireless links is affected or even jeopardized resulting in transmission failures by many factors like collisions, fading or the noise of environment. In this paper, we propose a reliable multicast protocol, called CodePipe, with energy-efficiency, high throughput and fairness in lossy wireless networks. Building upon opportunistic routing and random linear network coding, CodePipe can not only eliminate coordination between nodes, but also improve the multicast throughput significantly by exploiting both intra-batch and inter-batch coding opportunities. In particular, four key techniques, namely, LP-based opportunistic routing structure, opportunistic feeding, fast batch moving and inter-batch coding, are proposed to offer significant improvement in throughput, energy-efficiency and fairness. Moreover, we design an efficient online extension of CodePipe such that it can work in a dynamic network where nodes join and leave the network as time progresses. We evaluate CodePipe on ns2 simulator by comparing with other two state-of-art multicast protocols, MORE and Pacifier. Simulation results show that CodePipe significantly outperforms both of them.	[Li, Peng; Guo, Song] Univ Aizu, Sch Comp Sci & Engn, Aizu Wakamatsu, Fukushima, Japan; [Yu, Shui] Deakin Univ, Sch Informat Technol, Melbourne, Vic 3125, Australia; [Vasilakos, Athanasios V.] Univ Western Macedonia, Dept Comp Engn, Kozani, Greece	Li, P (reprint author), Univ Aizu, Sch Comp Sci & Engn, Aizu Wakamatsu, Fukushima, Japan.	pengli@u.aizu.ac.jp; sguo@u.aizu.ac.jp; syu@deakin.edu.au; vasilako@ath.forthnet.gr					Li P, 2012, 2012 PROCEEDINGS IEEE INFOCOM, P100; Punnoose RJ, 2000, IEEE VTS VEH TECHNOL, P764, DOI 10.1109/VETECF.2000.887108; Chachulski S, 2007, ACM SIGCOMM COMP COM, V37, P169, DOI 10.1145/1282427.1282400; Liu J, 2007, IEEE INFOCOM SER, P724, DOI 10.1109/INFCOM.2007.90; Biswas S, 2005, ACM SIGCOMM COMP COM, V35, P133, DOI 10.1145/1090191.1080108; Koutsonikolas D, 2009, IEEE INFOCOM SER, P2473, DOI 10.1109/INFCOM.2009.5062175; Katti S, 2008, IEEE ACM T NETWORK, V16, P497, DOI 10.1109/TNET.2008.923722; Aguayo D, 2004, ACM SIGCOMM COMP COM, V34, P121, DOI 10.1145/1030194.1015482; Ahlswede R, 2000, IEEE T INFORM THEORY, V46, P1204, DOI 10.1109/18.850663; Zhang J, 2009, IEEE INFOCOM SER, P181, DOI 10.1109/INFCOM.2009.5061920; Li SYR, 2003, IEEE T INFORM THEORY, V49, P371, DOI 10.1109/TIT.2002.807285; Chou Philip A., 2003, P ALL C COMM CONTR C; De Couto D.S.J., 2003, P 9 ANN INT C MOB CO, P134, DOI 10.1145/938985.939000; JAFFE JM, 1981, IEEE T COMMUN, V29, P954, DOI 10.1109/TCOM.1981.1095081; Mayer A, 1996, IEEE INFOCOM SER, P928, DOI 10.1109/INFCOM.1996.493393; Sengupta S., 2007, P IEEE INFOCOM, P1028, DOI DOI 10.1109/INFC0M.2007.124	16	8	8	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1045-9219	1558-2183		IEEE T PARALL DISTR	IEEE Trans. Parallel Distrib. Syst.	DEC	2014	25	12					3264	3273		10.1109/TPDS.2013.2297105		10	Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	AX6EJ	WOS:000347015800021		
J	Nomura, R; Otsugu, M; Naka, S; Teramoto, N; Kojima, A; Muranaka, Y; Matsumoto-Nakano, M; Ooshima, T; Nakano, K				Nomura, Ryota; Otsugu, Masatoshi; Naka, Shuhei; Teramoto, Noboru; Kojima, Ayuchi; Muranaka, Yoshinori; Matsumoto-Nakano, Michiyo; Ooshima, Takashi; Nakano, Kazuhiko			Contribution of the Interaction of Streptococcus mutans Serotype k Strains with Fibrinogen to the Pathogenicity of Infective Endocarditis	INFECTION AND IMMUNITY			English	Article							COLLAGEN-BINDING ADHESIN; COMPLETE GENOME SEQUENCE; VON-WILLEBRAND-FACTOR; PROTEIN ANTIGEN-C; PLATELET-AGGREGATION; ORAL STREPTOCOCCI; CLUMPING FACTOR; DENTAL-CARIES; HEART-VALVE; BACTEREMIA	Streptococcus mutans, a pathogen responsible for dental caries, is occasionally isolated from the blood of patients with bacteremia and infective endocarditis (IE). Our previous study demonstrated that serotype k-specific bacterial DNA is frequently detected in S. mutans-positive heart valve specimens extirpated from IE patients. However, the reason for this frequent detection remains unknown. In the present study, we analyzed the virulence of IE from S. mutans strains, focusing on the characterization of serotype k strains, most of which are positive for the 120-kDa cell surface collagen-binding protein Cbm and negative for the 190-kDa protein antigen (PA) known as SpaP, P1, antigen I/II, and other designations. Fibrinogen-binding assays were performed with 85 clinical strains classified by Cbm and PA expression levels. The Cbm(+)/PA(-) group strains had significantly higher fibrinogen-binding rates than the other groups. Analysis of platelet aggregation revealed that SA31, a Cbm(+)/PA(-) strain, induced an increased level of aggregation in the presence of fibrinogen, while negligible aggregation was induced by the Cbm-defective isogenic mutant SA31CBD. A rat IE model with an artificial impairment of the aortic valve created using a catheter showed that extirpated heart valves in the SA31 group displayed a prominent vegetation mass not seen in those in the SA31CBD group. These findings could explain why Cbm(+)/PA(-) strains are highly virulent and are related to the development of IE, and the findings could also explain the frequent detection of serotype k DNA in S. mutans-positive heart valve clinical specimens.	[Nomura, Ryota; Otsugu, Masatoshi; Naka, Shuhei; Kojima, Ayuchi; Ooshima, Takashi; Nakano, Kazuhiko] Osaka Univ, Grad Sch Dent, Dept Pediat Dent, Div Oral Infect & Dis Control, Suita, Osaka, Japan; [Teramoto, Noboru] Hamaguchi Lab Anim, Ibaraki, Osaka, Japan; [Muranaka, Yoshinori] Osaka Univ, Res Ctr Ultra High Voltage Elect Microscopy, Ibaraki, Osaka, Japan; [Matsumoto-Nakano, Michiyo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Pediat Dent, Okayama, Japan	Nakano, K (reprint author), Osaka Univ, Grad Sch Dent, Dept Pediat Dent, Div Oral Infect & Dis Control, Suita, Osaka, Japan.	nakano@dent.osaka-u.ac.jp			Japan Society for Promotion of Science [23390472, 24390461]	A portion of the present experiments were carried out by using a facility in the Research Center for Ultra-High Voltage Electron Microscopy, Osaka University. We thank Howard K. Kuramitsu, State University of New York at Buffalo, for editing the manuscript. This work was supported by a Grant-in-Aid for Scientific Research (B) 23390472 and (B) 24390461 from the Japan Society for Promotion of Science.	Aikawa C, 2012, J BACTERIOL, V194, P2754, DOI 10.1128/JB.00350-12; Nakano K, 2010, J PHARMACOL SCI, V113, P120, DOI 10.1254/jphs.09R24FM; MOREILLON P, 1995, INFECT IMMUN, V63, P4738; Nomura R, 2009, J MED MICROBIOL, V58, P469, DOI 10.1099/jmm.0.007559-0; Matsumoto-Nakano M, 2008, ORAL MICROBIOL IMMUN, V23, P265, DOI 10.1111/j.1399-302X.2007.00421.x; Nakano K, 2004, J CLIN MICROBIOL, V42, P4925, DOI 10.1128/JCM.42.11.4925-4930.2004; Shun CT, 2005, INFECT IMMUN, V73, P3261, DOI 10.1128/IAI.73.6.3261-3270.2005; Shivaprasad HV, 2009, J ETHNOPHARMACOL, V123, P106, DOI 10.1016/j.jep.2009.02.016; Kozarov E, 2006, MICROBES INFECT, V8, P687, DOI 10.1016/j.micinf.2005.09.004; Abranches J, 2011, INFECT IMMUN, V79, P2277, DOI 10.1128/IAI.00767-10; Nakano K, 2004, J CLIN MICROBIOL, V42, P198, DOI 10.1128/JCM.421.1.198-202.2004; Ruggeri ZM, 2003, J THROMB HAEMOST, V1, P1335, DOI 10.1046/j.1538-7836.2003.00260.x; Shibata Y, 2003, J CLIN MICROBIOL, V41, P4107, DOI 10.1128/JCM.41.9.4107-4112.2003; Sonbol H, 2009, ORAL MICROBIOL IMMUN, V24, P177, DOI 10.1111/j.1399-302X.2008.00492.x; Lapirattanakul J, 2011, J MED MICROBIOL, V60, P1677, DOI 10.1099/jmm.0.033415-0; Nakano K, 2010, ARCH ORAL BIOL, V55, P34, DOI 10.1016/j.archoralbio.2009.11.008; Sato Y, 2004, J DENT RES, V83, P534; Nallapareddy SR, 2003, MOL MICROBIOL, V47, P1733, DOI 10.1046/j.1365-2958.2003.03417.x; OOSHIMA T, 1983, JPN J MED SCI BIOL, V36, P219; Jung CJ, 2012, J INFECT DIS, V205, P1066, DOI 10.1093/infdis/jis021; Hendrickx APA, 2009, TRENDS MICROBIOL, V17, P423, DOI 10.1016/j.tim.2009.06.004; Nomura R, 2013, ARCH ORAL BIOL, V58, P1627, DOI 10.1016/j.archoralbio.2013.06.008; Nakano K, 2009, FUTURE MICROBIOL, V4, P891, DOI [10.2217/fmb.09.64, 10.2217/FMB.09.64]; KOGA T, 1990, INFECT IMMUN, V58, P289; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Lapirattanakul J, 2009, ORAL MICROBIOL IMMUN, V24, P431, DOI 10.1111/j.1399-302X.2009.00530.x; Beg AM, 2002, BIOCHEM BIOPH RES CO, V298, P75, DOI 10.1016/S0006-291X(02)02390-2; Nomura R, 2012, MOL ORAL MICROBIOL, V27, P308, DOI 10.1111/j.2041-1014.2012.00649.x; Nakano K, 2008, J DENT RES, V87, P964; HAMADA S, 1980, MICROBIOL REV, V44, P331; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Nakano K, 2006, J CLIN MICROBIOL, V44, P3313, DOI 10.1128/JCM.00377-06; Biswas S, 2012, J BACTERIOL, V194, P4787, DOI 10.1128/JB.01106-12; Chia JS, 2004, INFECT IMMUN, V72, P2605, DOI 10.1128/IAI.72.5.2605-2617.2004; DOUGLAS CWI, 1990, FEMS MICROBIOL LETT, V72, P63, DOI 10.1111/j.1574-6968.1990.tb03863.x; Fujiwara T, 2001, EUR J ORAL SCI, V109, P330, DOI 10.1034/j.1600-0722.2001.00119.x; Herzberg MC, 2005, J PERIODONTOL, V76, P2101, DOI 10.1902/jop.2005.76.11-S.2101; Hirasawa M, 2003, CARIES RES, V37, P212, DOI 10.1159/000070447; Ishii K, 2010, J BIOL CHEM, V285, P33338, DOI 10.1074/jbc.M110.112987; Jung CJ, 2009, MOL MICROBIOL, V74, P888, DOI 10.1111/j.1365-2958.2009.06903.x; Kojima A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00332; Mair RW, 2012, FEMS MICROBIOL LETT, V331, P44, DOI 10.1111/j.1574-6968.2012.02550.x; Maruyama F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-358; Matsumoto-Nakano M, 2009, ORAL MICROBIOL IMMUN, V24, P427, DOI 10.1111/j.1399-302X.2009.00521.x; Miajlovic H, 2007, INFECT IMMUN, V75, P3335, DOI 10.1128/IAI.01993-06; Murakami Y, 1997, INFECT IMMUN, V65, P794; Nakano K, 2006, MICROBES INFECT, V8, P114, DOI 10.1016/j.micinf.2005.06.005; Nakano K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1491; Nakano K, 2007, J MED MICROBIOL, V56, P1413, DOI 10.1099/jmm.0.47335-0; Nomura R, 2013, ORAL DIS, V19, P387, DOI 10.1111/odi.12016; Nomura R, 2004, ARCH ORAL BIOL, V49, P783, DOI 10.1016/j.archoralbio.2004.04.001; PROCTOR RA, 1984, J LAB CLIN MED, V104, P455; Sato Y, 2011, J ORAL MICROBIOL, V3, P5495; SAVAGE B, 1992, J BIOL CHEM, V267, P11300; TAKEI T, 1992, ARCH ORAL BIOL, V37, P99, DOI 10.1016/0003-9969(92)90004-R; Taniguchi N, 2010, ARCH ORAL BIOL, V55, P410, DOI 10.1016/j.archoralbio.2010.03.017; Walker JN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003819	57	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0019-9567	1098-5522		INFECT IMMUN	Infect. Immun.	DEC	2014	82	12					5223	5234		10.1128/IAI.02164-14		12	Immunology; Infectious Diseases	Immunology; Infectious Diseases	AX5HZ	WOS:000346958400031		
J	Honjo, K; Kubagawa, Y; Suzuki, Y; Takagi, M; Ohno, H; Bucy, RP; Izui, S; Kubagawa, H				Honjo, Kazuhito; Kubagawa, Yoshiki; Suzuki, Yusuke; Takagi, Miyuki; Ohno, Hiroshi; Bucy, R. Pat; Izui, Shozo; Kubagawa, Hiromi			Enhanced auto-antibody production and Mott cell formation in Fc mu R-deficient autoimmune mice	INTERNATIONAL IMMUNOLOGY			English	Article						auto-antibody; Fc mu R; IgM; marginal zone B cells; Mott cells	129-DERIVED CHROMOSOME-1 LOCI; SYSTEMIC-LUPUS-ERYTHEMATOSUS; HUMORAL IMMUNE-RESPONSES; GAMMA-RIIB DEFICIENCY; B-CELLS; IGG AUTOANTIBODIES; ANTIBODY-RESPONSES; MARGINAL ZONE; C57BL/6 MICE; SECRETED IGM	The IgM-Fc receptor (Fc mu R) is involved in IgM homeostasis as evidenced by increased pre-immune serum IgM and natural auto-antibodies of both IgM and IgG isotypes in Fcmr-deficient C57BL/6 (B6) mice. To determine the impact of Fcmr-ablation on autoimmunity, we introduced the Fcmr null mutation onto the Fas-deficient autoimmune-prone B6. MRL Fas(lpr/lpr) mouse background (B6/lpr). Both IgM and IgG auto-antibodies against dsDNA or chromatin appeared earlier in Fc mu R(-) B6/lpr than Fc mu R(+) B6/lpr mice, but this difference became less pronounced with age. Splenic B2 cells, which were 2-fold elevated in Fc mu R(+) B6/lpr mice, were reduced to normal B6 levels in Fc mu R(-) B6/lpr mice, whereas splenic B1 cells were comparable in both groups of B6/lpr mice. By contrast, marginal zone (MZ) B cells were markedly reduced in Fc mu R(-) B6/lpr mice compared with either Fc mu R(+) B6/lpr or wild type (WT) B6 mice. This reduction appeared to result from rapid differentiation of MZ B cells into plasma cells in the absence of Fc mu R, as IgM antibody to a Smith (Sm) antigen, to which MZ B cells are known to preferentially respond, was greatly increased in both groups (B6/lpr and B6) of Fc mu R(-) mice compared with Fc mu R(+) B6/lpr or B6 mice. Mott cells, aberrant plasma cells with intra-cytoplasmic inclusions, were also increased in the absence of Fc mu R. Despite these abnormalities, the severity of renal pathology and function and survival were all indistinguishable between Fc mu R(-) and Fc mu R(+) B6/lpr mice. Collectively, these findings suggest that Fc mu R plays important roles in the regulation of auto-antibody production, Mott cell formation and the differentiation of MZ B cells into plasma cells in B6. MRL Fas(lpr/lpr) mice.	[Honjo, Kazuhito; Kubagawa, Yoshiki; Bucy, R. Pat; Kubagawa, Hiromi] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Suzuki, Yusuke; Takagi, Miyuki] Juntendo Univ, Sch Med, Dept Internal Med, Div Nephrol, Tokyo 1138421, Japan; [Ohno, Hiroshi] RIKEN Ctr Integrat Med Sci, Lab Intestinal Ecosyst, Yokohama, Kanagawa 2300045, Japan; [Izui, Shozo] Univ Geneva, Dept Pathol & Immunol, CH-1211 Geneva 4, Switzerland	Kubagawa, H (reprint author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	hiromikubagawa@uab.edu	Ohno, Hiroshi/L-7899-2014	Ohno, Hiroshi/0000-0001-8776-9661	National Institute of Health/National Institute of Allergy and Infectious Diseases [R56 AI82249, R21 AI094625]	National Institute of Health/National Institute of Allergy and Infectious Diseases (R56 AI82249 and R21 AI094625 to H.K.).	Murakami Y, 2012, J IMMUNOL, V189, P587, DOI 10.4049/jimmunol.1200840; Hao Y, 2011, BLOOD, V118, P1294, DOI 10.1182/blood-2011-01-330530; Yajima K, 2003, EUR J IMMUNOL, V33, P1020, DOI 10.1002/eji.200323794; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Carlucci F, 2007, J IMMUNOL, V178, P2352; NAKAMURA T, 1993, J IMMUNOL, V151, P6933; Hitoshi Y, 1998, IMMUNITY, V8, P461, DOI 10.1016/S1074-7613(00)80551-8; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Vire B, 2011, J IMMUNOL, V187, P4040, DOI 10.4049/jimmunol.1100532; Honjo K, 2012, P NATL ACAD SCI USA, V109, P15882, DOI 10.1073/pnas.1206567109; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; OHNO T, 1990, J EXP MED, V172, P1165, DOI 10.1084/jem.172.4.1165; Ehrenstein MR, 2010, NAT REV IMMUNOL, V10, P778, DOI 10.1038/nri2849; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; Kubagawa H, 2009, J EXP MED, V206, P2779, DOI 10.1084/jem.20091107; Boes M, 1998, J IMMUNOL, V160, P4776; Honda S, 2009, P NATL ACAD SCI USA, V106, P11230, DOI 10.1073/pnas.0809917106; Nguyen XH, 2011, BLOOD, V118, P598, DOI 10.1182/blood-2010-10-313643; Fossati-Jimack L, 2008, ARTHRITIS RHEUM, V58, P2131, DOI 10.1002/art.23553; Shlomchik MJ, 2009, CURR OPIN IMMUNOL, V21, P626, DOI 10.1016/j.coi.2009.08.005; Jiang Y, 2000, IMMUNOGENETICS, V51, P429, DOI 10.1007/s002510050641; Boes M, 2000, P NATL ACAD SCI USA, V97, P1184, DOI 10.1073/pnas.97.3.1184; Boross P, 2011, J IMMUNOL, V187, P1304, DOI 10.4049/jimmunol.1101194; Czajkowsky DM, 2009, P NATL ACAD SCI USA, V106, P14960, DOI 10.1073/pnas.0903805106; VIEIRA P, 1988, EUR J IMMUNOL, V18, P313, DOI 10.1002/eji.1830180221; Ehrenstein MR, 2000, J EXP MED, V191, P1253, DOI 10.1084/jem.191.7.1253; IZUI S, 1984, J IMMUNOL, V133, P227; Ouchida R, 2012, P NATL ACAD SCI USA, V109, pE2699, DOI 10.1073/pnas.1210706109; Pritchard NR, 2000, CURR BIOL, V10, P227, DOI 10.1016/S0960-9822(00)00344-4; Shima H, 2010, INT IMMUNOL, V22, P149, DOI 10.1093/intimm/dxp121; Honjo K, 2012, BLOOD, V119, P1789, DOI 10.1182/blood-2011-09-380782; Choi SC, 2013, J IMMUNOL, V190, P987, DOI 10.4049/jimmunol.1202227; Alugupalli KR, 2008, CURR TOP MICROBIOL, V319, P105; Jiang CC, 2007, J IMMUNOL, V178, P7422; Clarke SH, 2008, IMMUNOL RES, V41, P203, DOI 10.1007/s12026-008-8023-3; Xiang Z, 2007, NAT IMMUNOL, V8, P419, DOI 10.1038/ni1440; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Su KH, 2007, J IMMUNOL, V178, P3272; Mackay M, 2006, J EXP MED, V203, P2157, DOI 10.1084/jem.20051503; Lang KS, 2013, P NATL ACAD SCI USA, V110, P2593, DOI 10.1073/pnas.1222264110; Baker N, 2002, J IMMUNOL, V169, P6686; Corcos D, 2010, BLOOD, V115, P282, DOI 10.1182/blood-2009-07-234864; Dal Porto JM, 2004, IMMUNITY, V21, P443, DOI 10.1016/j.immuni.2004.07.018; Hashimoto A, 2012, AM J PATHOL, V181, P1338, DOI 10.1016/j.ajpath.2012.06.038; Honjo K, 2013, P NATL ACAD SCI USA, V110, pE2540, DOI 10.1073/pnas.1304904110; JACK HM, 1992, P NATL ACAD SCI USA, V89, P11688, DOI 10.1073/pnas.89.24.11688; Jiang Y, 1997, J IMMUNOL, V158, P992; Khan SN, 2011, J IMMUNOL, V187, P3198, DOI 10.4049/jimmunol.1101336; Kishi Y, 2012, P NATL ACAD SCI USA, V109, P7811, DOI 10.1073/pnas.1204509109; Lang KS, 2013, P NATL ACAD SCI USA, V110, pE2542, DOI 10.1073/pnas.1306422110; McGaha TL, 2008, J IMMUNOL, V180, P5670; Oliver AM, 1999, HYBRIDOMA, V18, P113, DOI 10.1089/hyb.1999.18.113; Radic M, 2013, P NATL ACAD SCI USA, V110, P11958, DOI 10.1073/pnas.1308620110; Ravetch J.V., 2008, FUNDAMENTAL IMMUNOLO, P684; SANDERS SK, 1987, J IMMUNOL, V139, P188; Sato-Hayashizaki A., 2011, ARTHRITIS RHEUM, V63, P2930; Shimada S, 1999, J IMMUNOL, V163, P5367; SHULTZ LD, 1987, AM J PATHOL, V127, P38; Suda T, 1997, J ALLERGY CLIN IMMUN, V100, pS97, DOI 10.1016/S0091-6749(97)70013-7; TARLINTON D, 1992, EUR J IMMUNOL, V22, P531, DOI 10.1002/eji.1830220236	62	2	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178	1460-2377		INT IMMUNOL	Int. Immunol.	DEC	2014	26	12					659	672		10.1093/intimm/dxu070		14	Immunology	Immunology	AX7PD	WOS:000347106600002		
J	Kimura, T; Kobayashi, S; Hanihara-Tatsuzawa, F; Sayama, A; MaruYama, T; Muta, T				Kimura, Toshifumi; Kobayashi, Shuhei; Hanihara-Tatsuzawa, Fumito; Sayama, Aoi; MaruYama, Takashi; Muta, Tatsushi			Responses of macrophages to the danger signals released from necrotic cells	INTERNATIONAL IMMUNOLOGY			English	Article						chemokine; danger signal; inflammation; necrosis; P2Y6	INDUCIBLE NUCLEAR-PROTEIN; REGULATORY T-CELLS; FACTOR-KAPPA-B; APOPTOTIC CELLS; INNATE IMMUNITY; RECEPTORS; INFLAMMATION; IDENTIFICATION; CLEARANCE; CLONING	The immune system maintains homeostasis by recognizing and responding to cell death caused by various stresses. The immune response is considered to be elicited by 'danger signals' released from necrotic cells. However, the identity of the danger signals remains elusive. In this study, we focused on the expression of chemokines by macrophages stimulated with necrotic cells. In mouse bone-marrow-derived macrophages, the chemokine monocyte chemoattractant protein (MCP)-3 was induced at both the mRNA and protein levels in response to heat-killed murine cells. The induction of MCP-3 was also observed in MyD88-deficient macrophages, indicating that Toll-like receptors and the IL-1 receptor are not involved in this response. Consistent with this observation, the activation of NF-kappa B was not detected in RAW264.7 macrophages stimulated with necrotic cells. Treatments with proteinase K, DNaseI or RNaseA did not affect the 'stimulating activity' of necrotic cells. In contrast, treatment with apyrase, which removes phosphates from nucleoside tri- and di-phosphates, abolished the inducing activity. Purified UDP at 30 mu M concentration elicited similar induction of MCP-3 in RAW264.7 macrophages. Small interfering RNA-mediated knock-down of the UDP receptor P2Y6 in RAW264.7 cells significantly reduced the induction of MCP-3 in response to necrotic cells, but not its induction by lipopolysaccharide. Furthermore, ectopic expression of the P2Y6 receptor in HEK293 cells conferred responsiveness to necrotic cells. These results suggest that UDP released by necrotic cells plays a critical role as an endogenous danger signal and that P2Y6 is required for the induction of MCP-3 in response to necrotic cells.	[Kimura, Toshifumi; Kobayashi, Shuhei; Hanihara-Tatsuzawa, Fumito; Sayama, Aoi; MaruYama, Takashi; Muta, Tatsushi] Tohoku Univ, Grad Sch Life Sci, Lab Cell Recognit & Response, Sendai, Miyagi 9808578, Japan; [MaruYama, Takashi] Gifu Univ, Sch Med, Lab Cell Signaling, Gifu 5011194, Japan	MaruYama, T (reprint author), Tohoku Univ, Grad Sch Life Sci, Lab Cell Recognit & Response, Sendai, Miyagi 9808578, Japan.	ta-maru@umin.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21117004]; Japan Society for the Promotion of Science [24790458]; Uehara Memorial Foundation	Grant-in-Aid for Scientific Research on Priority Area from the Ministry of Education, Culture, Sports, Science and Technology of Japan (21117004 to T.M.); Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (24790458 to T.M.Y.); and the Uehara Memorial Foundation to T.M.Y.	Ma MH, 2002, J NEUROSCI RES, V68, P691, DOI 10.1002/jnr.10269; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Koizumi S, 2007, NATURE, V446, P1091, DOI 10.1038/nature05704; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Zhan YM, 2005, J CLIN INVEST, V115, P2508, DOI 10.1172/JCI24403; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Thompson WL, 2009, BRAIN RES, V1287, P47, DOI 10.1016/j.brainres.2009.06.081; Handa M, 1996, BIOCHEM BIOPH RES CO, V218, P916, DOI 10.1006/bbrc.1996.0162; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Potula HSK, 2009, J BIOL CHEM, V284, P31142, DOI 10.1074/jbc.M109.012526; Zhang Z, 2011, J IMMUNOL, V186, P5376, DOI 10.4049/jimmunol.1002946; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Kim B, 2011, J IMMUNOL, V186, P3701, DOI 10.4049/jimmunol.1000212; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Konkel JE, 2014, P NATL ACAD SCI USA, V111, pE465, DOI 10.1073/pnas.1320319111; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Shi Y, 2000, P NATL ACAD SCI USA, V97, P14590, DOI 10.1073/pnas.260497597; Kataoka K, 2002, J BIOL CHEM, V277, P36825, DOI 10.1074/jbc.M206756200; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066; Boeynaems JM, 2005, SEMIN THROMB HEMOST, V31, P139, DOI 10.1055/s-2005-869519; Communi D, 1996, BIOCHEM BIOPH RES CO, V222, P303, DOI 10.1006/bbrc.1996.0739; Gallo PM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00138; Ishii KJ, 2001, J IMMUNOL, V167, P2602; Lazarowski ER, 2001, J PHARMACOL EXP THER, V297, P43; MAJNO G, 1960, VIRCHOWS ARCH A, V333, P421, DOI 10.1007/BF00955327; Nicholas RA, 1996, MOL PHARMACOL, V50, P224; Piccinini AM, 2010, MEDIAT INFLAMM, DOI 10.1155/2010/672395	40	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178	1460-2377		INT IMMUNOL	Int. Immunol.	DEC	2014	26	12					697	704		10.1093/intimm/dxu080		8	Immunology	Immunology	AX7PD	WOS:000347106600005		
J	Tabata, R; Tabata, C				Tabata, Rie; Tabata, Chiharu			Distinct effect of cyclophosphamide and cyclosporine on pure red cell aplasia associated with T-cell large granular lymphocyte leukemia	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Large granular lymphocyte leukemia; Pure red cell aplasia; Hypoplastic myelodysplastic syndrome; Cyclophosphamide; Cyclosporine	MYELODYSPLASTIC SYNDROME; RESPONSES; ANEMIA	Large granular lymphocyte (LGL) leukemia is characterized by a clonal proliferation of large-sized lymphocytes with prominent large azurophilic cytoplasmic granules. Although most cases of T-LGL leukemia are indolent and asymptomatic during the course of the disease, some present with pure red cell aplasia (PRCA) and require therapy. We here reported a case of T-LGL leukemia complicated by PRCA in which anemia was resistant to cyclosporine and had been controlled for several years by cyclophosphamide; however, progressive anemia developed despite the administration of cyclophosphamide, but was ameliorated by the re-administration of cyclosporine. The present case demonstrated the 3 different phases of T-LGL proliferation associated with anemia (1st, T-LGL leukemia; 2nd, polyclonal T-LGL expansion; 3rd, myelodysplastic syndrome). We also showed that cyclophosphamide was effective when PRCA was caused by increased numbers of LGL, whereas cyclosporine was administered when hypoplastic myelodysplastic syndrome was suspected as the main cause of anemia. Repetitive bone marrow examinations should be performed throughout the course of T-LGL in order to monitor combined myelodysplastic syndrome. (C) 2014 Elsevier B.V. All rights reserved.	[Tabata, Rie] Hyogo Prefectural Tsukaguchi Hosp, Dept Hematol & Oncol, Amagasaki, Hyogo 6610012, Japan; [Tabata, Chiharu] Hyogo Coll Med, Ctr Canc, Nishinomiya, Hyogo, Japan	Tabata, R (reprint author), Hyogo Prefectural Tsukaguchi Hosp, Dept Hematol & Oncol, 6-8-17 Minamitsukaguchi, Amagasaki, Hyogo 6610012, Japan.	rtabata@hp.pref.hyogo.jp					Wlodarski MW, 2006, BLOOD, V108, P2632, DOI 10.1182/blood-2005-09-3902; LOUGHRAN TP, 1993, BLOOD, V82, P1; Sawada K, 2008, BRIT J HAEMATOL, V142, P505, DOI 10.1111/j.1365-2141.2008.07216.x; Go RS, 2001, BLOOD, V98, P483, DOI 10.1182/blood.V98.2.483; Huh YO, 2009, AM J CLIN PATHOL, V131, P347, DOI 10.1309/AJCP6YHI1JEXAWAP; Maciejewski JP, 2007, FOLIA HISTOCHEM CYTO, V45, P5; Rose MG, 2004, ONCOLOGIST, V9, P247, DOI 10.1634/theoncologist.9-3-247; Lamy T, 2011, BLOOD, V117, P2764, DOI 10.1182/blood-2010-07-296962; Fujishima N, 2008, HAEMATOL-HEMATOL J, V93, P1555, DOI 10.3324/haematol.12871; Sloand EM, 2010, J CLIN ONCOL, V28, P5166, DOI 10.1200/JCO.2010.29.7010; Nyland SB, 2012, LEUKEMIA RES, V36, P581, DOI 10.1016/j.leukres.2012.02.001; Selleri C, 2002, CANCER, V95, P1911, DOI 10.1002/cncr.10915; Serio B, 2014, Transl Med UniSa, V8, P31	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	DEC	2014	23	2					391	394		10.1016/j.intimp.2014.10.013		4	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	AX5GF	WOS:000346954000003		
J	Milki, K; Nagaoka, K; Harada, M; Hayashi, T; Jinguji, H; Kato, Y; Maekawa, R				Milki, Kenji; Nagaoka, Koji; Harada, Mitsunori; Hayashi, Tatsuyuki; Jinguji, Hidemasa; Kato, Yasuki; Maekawa, Ryuji			Combination therapy with dendritic cell vaccine and IL-2 encapsulating polymeric micelles enhances intra-tumoral accumulation of antigen-specific CTLs	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Immunotherapy; Dendritic cells; Interleukin-2; Drug delivery system; Cytotoxic T lymphocytes	IN-VIVO; INTERLEUKIN-2; EFFICACY; IMMUNOTHERAPY; ACTIVATION; MELANOMA; IMMUNITY; CANCER; ROUTE	Dendritic cell (DC) vaccine is a promising immunotherapy for cancer due to its ability to induce antigen-specific CTLs efficiently. However, a number of clinical studies have implied insufficient therapeutic benefits with the use of MHC class 1 restricted peptide-pulsed DC vaccine. To enhance the clinical efficacy, we examined combination therapy of DC vaccine pulsed with OVA peptide and intravenous low dose unmodified IL-2 (IL-2 solution) administration against EG7 tumor-bearing mice. Unexpectedly, no additional effects of IL-2 solution were observed on CTL induction and the therapeutic effects of DC vaccine, possibly because of the short half-life of IL-2 in plasma. Therefore, we generated IL-2-encapsulating polymeric micelles (IL-2 micelle), which showed prolonged IL-2 retention in the circulation after intravenous administration compared with IL-2 solution. When mice were treated with OVA peptide-pulsed DCs in combination with IL-2 micelle, OVA-specific CTLs were efficiently induced in the spleen in comparison with DC vaccine combined with IL-2 solution or DC vaccine alone. In addition, combination therapy of DC vaccine and IL-2 micelle against EG7 tumor-bearing mice induced the efficient accumulation of antigen-specific CTLs into the tumor and marked anti-tumor effects. Thus, the administration of IL-2 micelle can significantly enhance DC vaccine efficacy against tumors. (C) 2014 Elsevier B.V. All rights reserved.	[Milki, Kenji; Nagaoka, Koji; Jinguji, Hidemasa; Maekawa, Ryuji] MEDINET Co Ltd, Medinet Med Inst, Tokyo, Tokyo, Japan; [Harada, Mitsunori; Hayashi, Tatsuyuki; Kato, Yasuki] NanoCarrier Co Ltd, Div Res, Kashiwa, Chiba, Japan	Maekawa, R (reprint author), Ctr Res & Dev, Setagaya Ku, 2-2-8 Tamagawadai, Tokyo 1580096, Japan.	maekawa@medinet-inc.co.jp					Lukyanov AN, 2002, PHARMACEUT RES, V19, P1424, DOI 10.1023/A:1020488012264; Eggert AAO, 1999, CANCER RES, V59, P3340; Kamimura D, 2006, J IMMUNOL, V177, P306; Wei YZ, 2006, INT J ONCOL, V28, P585; DONOHUE JH, 1983, J IMMUNOL, V130, P2203; Park J, 2012, NAT MATER, V11, P895, DOI [10.1038/nmat3355, 10.1038/NMAT3355]; Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592; Moghimi SM, 2001, PHARMACOL REV, V53, P283; YOKOYAMA M, 1990, CANCER RES, V50, P1693; Takeshima T, 2010, CANCER RES, V70, P2697, DOI 10.1158/0008-5472.CAN-09-2982; Jin GH, 2008, INT IMMUNOL, V20, P783, DOI 10.1093/intimm/dxn036; Stift A, 2003, J CLIN ONCOL, V21, P135, DOI 10.1200/JCO.2003.02.135; Malek TR, 2010, IMMUNITY, V33, P153, DOI 10.1016/j.immuni.2010.08.004; Mullins DW, 2003, J EXP MED, V198, P1023, DOI 10.1084/jem.20021348; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Baluna R, 1997, IMMUNOPHARMACOLOGY, V37, P117, DOI 10.1016/S0162-3109(97)00041-6; Harada M, 2011, J CONTROL RELEASE, V156, P101, DOI 10.1016/j.jconrel.2011.06.024; Harada M, 2012, INT J NANOMED, V7, P2713, DOI 10.2147/IJN.S31247; Hersey P, 2008, CANCER IMMUNOL IMMUN, V57, P1039, DOI 10.1007/s00262-007-0435-8; Hosoi A, 2008, BIOCHEM BIOPH RES CO, V371, P242, DOI 10.1016/j.bbrc.2008.04.034; Porgador A, 1996, J IMMUNOL, V156, P2918; Shimizu K, 1999, P NATL ACAD SCI USA, V96, P2268, DOI 10.1073/pnas.96.5.2268; ZIMMERMAN RJ, 1989, CANCER RES, V49, P6521	23	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	DEC	2014	23	2					499	504		10.1016/j.intimp.2014.09.025		6	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	AX5GF	WOS:000346954000018		
J	Karuppagounder, V; Arumugam, S; Thandavarayan, RA; Pitchaimani, V; Sreedhar, R; Afrin, R; Harima, M; Suzuki, H; Nomoto, M; Miyashita, S; Suzuki, K; Watanabe, K				Karuppagounder, Vengadeshprabhu; Arumugam, Somasundaram; Thandavarayan, Rajarajan A.; Pitchaimani, Vigneshwaran; Sreedhar, Remya; Afrin, Rejina; Harima, Meilei; Suzuki, Hiroshi; Nomoto, Mayumi; Miyashita, Shizuka; Suzuki, Kenji; Watanabe, Kenichi			Resveratrol attenuates HMGB1 signaling and inflammation in house dust mite-induced atopic dermatitis in mice	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Resveratrol; Inflammation; High mobility group box protein 1; Nuclear factor kappa B; Cytokine; Receptor for advanced glycation end products	NF-KAPPA-B; GROUP BOX 1; LUPUS-ERYTHEMATOSUS; HUMAN KERATINOCYTES; ENDOTHELIAL-CELLS; IMMUNE-RESPONSE; NC/NGA MICE; MOUSE SKIN; PATHWAY; STRESS	Resveratrol is a polyphenol abundantly found in red grape skin and is effective against antiaging and anti-inflammation associated with immune responses. In this study, we have investigated the effect of resveratrol on skin lesion, high mobility group box (HMGB)1 and inflammation pathway in an atopic dermatitis (AD) mouse model. AD-like lesion was induced by the application of house dust mite extract to the dorsal skin of NC/Nga mouse. After AD induction, resveratrol (20 mg/kg, p.o.) was administered daily for 2 weeks. We evaluated dermatitis severity, histopathological changes, serum levels of T helper (Th) cytokines (interferon (IFN)gamma, interleukin (IL)-4) and changes in protein expression by Western blotting for HMGB1, receptor for advanced glycation end products (RAGE), toll like receptor (TLR)4, nuclear factor (NF)kappa B, phosphatidylinositide 3-kinase (PI3K), extracellular signal-regulated kinase (ERK)1/2, cyclooxygenase (COX)2, tumor necrosis factor (TNF)alpha, IL-1 beta IL-2R alpha and other inflammatory markers in the skin of AD mice. Treatment of resveratrol inhibited the development of the AD-like skin lesions. Histological analysis showed that resveratrol inhibited hypertrophy, intracellular edema, mast cells and infiltration of inflammatory cells. Furthermore, resveratrol treatment down-regulated HMGB1, RAGE, p-NF kappa B, p-PI3K, p-ERK1/2, COX2, TNF alpha, IL-1 beta, IL-2R alpha, IFN gamma and IL-4. Considering all these findings together, the HMGB1 pathway might be a potential therapeutic target in skin inflammation, and resveratrol treatment could have beneficial effects on AD by modulating the HMGB1 protein expression. (C) 2014 Elsevier B.V. All rights reserved.	[Karuppagounder, Vengadeshprabhu; Arumugam, Somasundaram; Thandavarayan, Rajarajan A.; Pitchaimani, Vigneshwaran; Sreedhar, Remya; Afrin, Rejina; Harima, Meilei; Suzuki, Hiroshi; Nomoto, Mayumi; Miyashita, Shizuka; Watanabe, Kenichi] Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Clin Pharmacol, Niigata 9568603, Japan; [Thandavarayan, Rajarajan A.] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX 77030 USA; [Suzuki, Kenji] Niigata Univ, Grad Sch Med & Dent Sci, Dept Gastroenterol, Niigata 9518510, Japan	Watanabe, K (reprint author), Niigata Univ Pharm & Appl Life Sci, Fac Pharmaceut Sci, Dept Clin Pharmacol, Akiha Ku, 265-1 Higashijima, Niigata 9568603, Japan.	watanabe@nupals.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23602012]; Promotion and Mutual Aid Corporation for Private Schools, Japan [26460239]	This research was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by a grant from the Promotion and Mutual Aid Corporation for Private Schools, Japan (23602012 and 26460239) respectively.	van Beijnum JR, 2008, ANGIOGENESIS, V11, P91, DOI 10.1007/s10456-008-9093-5; Minamino T, 2010, J MOL CELL CARDIOL, V48, P1105, DOI 10.1016/j.yjmcc.2009.10.026; Luo Y, 2013, BIOCHEM BIOPH RES CO, V438, P732, DOI 10.1016/j.bbrc.2013.07.098; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Kao CL, 2009, INT J RADIAT ONCOL, V74, P219, DOI 10.1016/j.ijrobp.2008.12.035; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82; Volz HC, 2010, SEMIN THROMB HEMOST, V36, P185, DOI 10.1055/s-0030-1251503; Kim JR, 2014, J ETHNOPHARMACOL, V151, P365, DOI 10.1016/j.jep.2013.10.058; Makarov SS, 2000, MOL MED TODAY, V6, P441, DOI 10.1016/S1357-4310(00)01814-1; Lee GR, 2004, INT IMMUNOL, V16, P1155, DOI 10.1093/intimm/dxh117; Barkauskaite V, 2007, LUPUS, V16, P794, DOI 10.1177/0961203307081895; Sanchez-Fidalgo S, 2010, EUR J PHARMACOL, V633, P78, DOI 10.1016/j.ejphar.2010.01.025; Kuo IH, 2013, J ALLERGY CLIN IMMUN, V131, P266, DOI 10.1016/j.jaci.2012.12.1563; Zhang Q, 2012, J SURG RES, V176, P343, DOI 10.1016/j.jss.2011.06.069; Wang GZ, 2013, J THORAC DIS, V5, P706, DOI 10.3978/j.issn.2072-1439.2013.08.69; Kundu JK, 2004, BIOFACTORS, V21, P33; Feng L, 2013, INT IMMUNOPHARMACOL, V15, P206, DOI 10.1016/j.intimp.2012.11.015; Afaq F, 2003, TOXICOL APPL PHARM, V186, P28, DOI 10.1016/S0041-008X(02)00014-5; Kundu JK, 2006, BIOCHEM PHARMACOL, V72, P1506, DOI 10.1016/j.bcp.2006.08.005; Ipaktchi K, 2006, SHOCK, V26, P201, DOI 10.1097/01.shk.0000225739.13796.f2; Afaq F, 2011, MINI-REV MED CHEM, V11, P1200; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Hashimoto Y, 2011, EXP DERMATOL, V20, P820, DOI 10.1111/j.1600-0625.2011.01337.x; Young CN, 2008, J INVEST DERMATOL, V128, P2606, DOI 10.1038/jid.2008.122; Arshad SH, 2010, CURR ALLERGY ASTHM R, V10, P49, DOI 10.1007/s11882-009-0082-6; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Adhami VM, 2003, NEOPLASIA, V5, P74; Chang YC, 2013, TOXICOL APPL PHARM, V268, P178, DOI 10.1016/j.taap.2013.01.014; Chen T, 2013, ARCH DERMATOL RES, V305, P263, DOI 10.1007/s00403-013-1330-0; Drew PD, 1995, J INTERF CYTOK RES, V15, P1037; Hanifin JM, 2001, EXP DERMATOL, V10, P11, DOI 10.1034/j.1600-0625.2001.100102.x; Hu QS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002946; PIKE MC, 1989, J INVEST DERMATOL, V92, P791, DOI 10.1111/1523-1747.ep12696808; Schaper F, 2014, MOL MED, V20, P72, DOI 10.2119/molmed.2014.00019; Sharma S, 2007, CLIN EXP IMMUNOL, V147, P155, DOI 10.1111/j.1365-2249.2006.03257.x; Udompataikul M, 2012, J DRUGS DERMATOL, V11, P366; Voll RE, 2008, ISR MED ASSOC J, V10, P26; Yamamoto Mina, 2007, Allergol Int, V56, P139, DOI 10.2332/allergolint.O-06-458	38	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	DEC	2014	23	2					617	623		10.1016/j.intimp.2014.10.014		7	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	AX5GF	WOS:000346954000034		
J	Kamiyama, K; Komuro, M; Endo, T; Aihara, K				Kamiyama, Kyohei; Komuro, Motomasa; Endo, Tetsuro; Aihara, Kazuyuki			Classification of Bifurcations of Quasi-Periodic Solutions Using Lyapunov Bundles	INTERNATIONAL JOURNAL OF BIFURCATION AND CHAOS			English	Article						Continuous-time dynamical system; discrete-time dynamical system; quasi-periodic solution; Invariant Closed Curve (ICC); local bifurcation; Dominant Lyapunov Exponent (DLE); Lyapunov Vector (LV); Dominant Lyapunov Bundle (DLB)	SADDLE-NODE BIFURCATION; FIXED-POINTS; 3D-DIFFEOMORPHISMS; OSCILLATIONS; SYSTEM; TORUS	In continuous-time dynamical systems, a periodic orbit becomes a fixed point on a certain Poincare section. The eigenvalues of the Jacobian matrix at this fixed point determine the local stability of the periodic orbit. Analogously, a quasi-periodic orbit (2-torus) becomes an invariant closed curve (ICC) on a Poincare section. From the Lyapunov exponents of an ICC, we can determine the time average of the exponential divergence rate of the orbit, which corresponds to the eigenvalues of a fixed point. We denote the Lyapunov exponent with the smallest nonzero absolute value as the Dominant Lyapunov Exponent (DLE). A local bifurcation manifests as a crossing or touch of the DLE locus with zero. However, the type of bifurcation cannot be determined from the DLE. To overcome this problem, we define the Dominant Lyapunov Bundle (DLB), which corresponds to the dominant eigenvectors of a fixed point. We prove that the DLB of a 1-torus in a map can be classified into four types: A(+) (annulus and orientation preserving), A(-) (annulus and orientation reversing), M (Mobius band), and F (focus). The DLB of a 2-torus in a flow can be classified into three types: A(+) x A(+), A(-) x M (equivalently M x Aand M x M), and F x F. From the results, we conjecture the possible local bifurcations in both cases. For the 1-torus in a map, we conjecture that type A(+) and A(-) DLBs correspond to a saddle-node and period-doubling bifurcations, respectively, whereas a type M DLB denotes a double-covering bifurcation, and type F relates to a Neimark-Sacker bifurcation. Similarly, for the 2-torus in a flow, we conjecture that type A(+) x A(+) DLBs correspond to saddle-node bifurcations, type A(-) x M DLBs to double-covering bifurcations, and type F x F DLBs to the Neimark-Sacker bifurcations. After introducing the mathematical concepts, we provide a DLB-calculating algorithm and illustrate all of the above bifurcations by examples.	[Kamiyama, Kyohei; Endo, Tetsuro] Meiji Univ, Dept Elect & Bioinformat, Tama Ku, Kawasaki, Kanagawa 2148571, Japan; [Komuro, Motomasa] Teikyo Univ Sci, Ctr Fundamental Educ, Uenohara, Yamanashi 4090193, Japan; [Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Kamiyama, K (reprint author), Meiji Univ, Dept Elect & Bioinformat, Tama Ku, 1-1-1 Higashi Mita, Kawasaki, Kanagawa 2148571, Japan.	kamiyama@meiji.ac.jp; komuro@ntu.ac.jp; endoh@isc.meiji.ac.jp; aihara@sat.t.u-tokyo.ac.jp			Aihara Project; FIRST program from JSPS; CSTP; KAKENHI [24560556]; Special Research Project by Institute of Science and Technology, Meiji University	The work of the second and last authors (M. Komuro and K. Aihara) was supported by the Aihara Project, the FIRST program from JSPS, which was initiated by CSTP. The work of the third author (T. Endo) was partially supported by Grant-in-Aid of Scientific Research (KAKENHI) (C) No. 24560556 and by Grant-in-Aid of Special Research Project by Institute of Science and Technology, Meiji University. The authors would like to thank these grants.	Broer H, 2008, PHYSICA D, V237, P1773, DOI 10.1016/j.physd.2008.01.026; CRAWFORD JD, 1991, REV MOD PHYS, V63, P991, DOI 10.1103/RevModPhys.63.991; KAWAKAMI H, 1984, IEEE T CIRCUITS SYST, V31, P248, DOI 10.1109/TCS.1984.1085495; GREBOGI C, 1984, PHYSICA D, V13, P261, DOI 10.1016/0167-2789(84)90282-3; Ginelli F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.130601; ASHWIN P, 1995, INT J BIFURCAT CHAOS, V5, P231, DOI 10.1142/S021812749500017X; Banerjee S., 2012, INT J BIFURCAT CHAOS, V22; Broer H, 2008, B BELG MATH SOC-SIM, V15, P769; DEWAN EM, 1972, IEEE T AUTOMAT CONTR, VAC17, P655, DOI 10.1109/TAC.1972.1100089; DEWAN EM, 1969, IEEE T AUTOMAT CONTR, VAC14, P212, DOI 10.1109/TAC.1969.1099140; Doedel E. J., 2012, CONTINUATION BIFURCA; ENDO T, 1980, IEEE T CIRCUITS SYST, V27, P277; Guckenheimer J., 1983, APPL MATH SCI, V42; Hayashi C, 1964, NONLINEAR OSCILLATIO; Hirsch M.W., 1976, GRADUATE TEXTS MATH, V33; Huska J., 2004, J DYN DIFFER EQU, V16, P347, DOI 10.1007/s10884-004-2784-8; Iooss G., 1979, BIFURCATIONS MAPS AP; Kamiyama K., 2013, INT J BIFURCAT CHAOS, V23; Kamiyama K., 2012, INT J BIFURCAT CHAOS, V22; Kamiyama K., 2013, P 2013 INT S NONL TH, V66; Kamiyama K., 2012, INT J BIFURCAT CHAOS, V22; KANEKO K, 1983, PROG THEOR PHYS, V69, P1806, DOI 10.1143/PTP.69.1806; Kawakami H., 1978, IEICE TECH REP, V78, P27; Kuznetsov Y., 2004, APPL MATH SCI, V112; Los JE, 1989, NONLINEARITY, V2, P149, DOI 10.1088/0951-7715/2/1/009; Oseledec VI, 1968, T MOSCOW MATH SOC, V19, P179; Ruelle D., 1979, I HAUTES ETUDES SCI, V50, P27; Van Loan C. F., 1996, MATRIX COMPUTATIONS	28	1	1	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-1274	1793-6551		INT J BIFURCAT CHAOS	Int. J. Bifurcation Chaos	DEC	2014	24	12							1430034	10.1142/S0218127414300341		30	Mathematics, Interdisciplinary Applications; Multidisciplinary Sciences	Mathematics; Science & Technology - Other Topics	AY1GI	WOS:000347341500002		
J	Ma, H; Zhou, T; Aihara, K; Chen, L				Ma, Huanfei; Zhou, Tianshou; Aihara, Kazuyuki; Chen, Luonan			Predicting Time Series from Short-Term High-Dimensional Data	INTERNATIONAL JOURNAL OF BIFURCATION AND CHAOS			English	Article						Prediction; short-term; high-dimensional data	SPACE RECONSTRUCTION; NEURAL-NETWORKS; SYSTEMS; CHAOS; NOISE	The prediction of future values of time series is a challenging task in many fields. In particular, making prediction based on short-term data is believed to be difficult. Here, we propose a method to predict systems' low-dimensional dynamics from high-dimensional but short-term data. Intuitively, it can be considered as a transformation from the inter-variable information of the observed high-dimensional data into the corresponding low-dimensional but long-term data, thereby equivalent to prediction of time series data. Technically, this method can be viewed as an inverse implementation of delayed embedding reconstruction. Both methods and algorithms are developed. To demonstrate the effectiveness of the theoretical result, benchmark examples and real-world problems from various fields are studied.	[Ma, Huanfei; Aihara, Kazuyuki] Univ Tokyo, Collaborat Res Ctr Innovat Math Modelling, Inst Ind Sci, Tokyo 1538505, Japan; [Ma, Huanfei] Soochow Univ, Sch Math Sci, Suzhou 215006, Peoples R China; [Zhou, Tianshou] Sun Yat Sen Univ, Sch Math & Computat Sci, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Luonan] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai 200031, Peoples R China	Aihara, K (reprint author), Univ Tokyo, Collaborat Res Ctr Innovat Math Modelling, Inst Ind Sci, Tokyo 1538505, Japan.	hfma@suda.edu.cn; mcszhtsh@mail.sysu.edu.cn; aihara@sat.t.u-tokyo.ac.jp; lnchen@sibs.ac.cn			FIRST program from JSPS; CSTP; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB13040700]; National Natural Science Foundation of China [61134013, 91029301, 11301366, 91230204]	This research is supported by the FIRST program from JSPS initiated by CSTP, the Strategic Priority Research Program of the Chinese Academy of Sciences (No. XDB13040700), and the National Natural Science Foundation of China (Nos. 61134013, 91029301, 11301366 and 91230204).	CASDAGLI M, 1991, PHYSICA D, V51, P52, DOI 10.1016/0167-2789(91)90222-U; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Crone SF, 2011, INT J FORECASTING, V27, P635, DOI 10.1016/j.ijforecast.2011.04.001; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; FARMER JD, 1987, PHYS REV LETT, V59, P845, DOI 10.1103/PhysRevLett.59.845; SAUER T, 1991, J STAT PHYS, V65, P579, DOI 10.1007/BF01053745; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; ABARBANEL HDI, 1994, PHYS REV E, V49, P1840, DOI 10.1103/PhysRevE.49.1840; Komalapriya C, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066217; Stark J, 2003, J NONLINEAR SCI, V13, P519, DOI 10.1007/s00332-003-0534-4; ROSSLER OE, 1976, PHYS LETT A, V57, P397, DOI 10.1016/0375-9601(76)90101-8; Moreno Y, 2004, EUROPHYS LETT, V68, P603, DOI 10.1209/epl/i2004-10238-x; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Pecora LM, 2007, CHAOS, V17, DOI 10.1063/1.2430294; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Menck PJ, 2013, NAT PHYS, V9, P89, DOI 10.1038/nphys2516; PACKARD NH, 1980, PHYS REV LETT, V45, P712, DOI 10.1103/PhysRevLett.45.712; Candes EJ, 2006, COMMUN PUR APPL MATH, V59, P1207, DOI 10.1002/cpa.20124; Stark J, 1997, NONLINEAR ANAL-THEOR, V30, P5303, DOI 10.1016/S0362-546X(96)00149-6; Binder PM, 2010, CHAOS, V20, DOI 10.1063/1.3298244; Box G.E., 2013, TIME SERIES ANAL FOR; ELSNER JB, 1992, B AM METEOROL SOC, V73, P49, DOI 10.1175/1520-0477(1992)073<0049:NPCAN>2.0.CO;2; Giebel G., 2011, STATE OF THE ART SHO; Greenwood G. W., 1997, IEEE Transactions on Evolutionary Computation, V1, DOI 10.1109/4235.687884; Hamilton J. D., 1994, TIME SERIES ANAL, V2; Haykin S, 1994, NEURAL NETWORKS COMP; Holton J.R., 2013, INTRO DYNAMIC METEOR; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Kantz H., 2004, NONLINEAR TIME SERIE, V7; Komalapriya C, 2010, CHAOS, V20, DOI 10.1063/1.3279680; KURAMOTO Y., 2003, CHEM OSCILLATIONS WA; Na YJ, 2009, EXP MOL MED, V41, P638, DOI 10.3858/emm.2009.41.9.070; Park J., 1991, Neural Computation, V3, DOI 10.1162/neco.1991.3.2.246; Simonoff JS, 1996, SMOOTHING METHODS ST; SUGIHARA G, 1990, NATURE, V344, P734, DOI 10.1038/344734a0; Takens F., 1981, DYNAMICAL SYSTEMS TU, P366, DOI DOI 10.1007/BFB0091924; Weigend A.S., 1994, TIME SERIES PREDICTI	38	3	4	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-1274	1793-6551		INT J BIFURCAT CHAOS	Int. J. Bifurcation Chaos	DEC	2014	24	12							1430033	10.1142/S021812741430033X		19	Mathematics, Interdisciplinary Applications; Multidisciplinary Sciences	Mathematics; Science & Technology - Other Topics	AY1GI	WOS:000347341500001		
J	Shimizu, K				Shimizu, Kuniyasu			Experimental Observations of Propagating Waves and Switching Phenomena in a Coupled Bistable Oscillator System	INTERNATIONAL JOURNAL OF BIFURCATION AND CHAOS			English	Article						Propagating wave; quasi-periodic oscillation; propagation failure; coupled oscillators	NON-LINEAR CHARACTERISTICS; MULTIMODE OSCILLATIONS; FAILURE	In this study, we construct a circuit composed of bistable oscillators and we report the experimental observations of quasi-periodic waves propagating in the circuit and compare them with the associated numerical results. Two different types of propagating quasi-periodic waves with identical parameter sets are experimentally verified. The associated numerical results are distinguished by comparing trajectories on the phase planes and by analyzing the one-parameter bifurcation diagrams. Furthermore, the experiments reveal five different types of switching oscillations. The associated numerical results are also presented, and the stability of the switching oscillations (when constrained to an invariant subspace) is numerically investigated. We also calculate spectral distribution for one type of the switching oscillation.	Chiba Inst Technol, Dept Elect Elect & Comp Engn, Narashino, Chiba 2750016, Japan	Shimizu, K (reprint author), Chiba Inst Technol, Dept Elect Elect & Comp Engn, 2-17-1 Tsudanuma, Narashino, Chiba 2750016, Japan.	kuniyasu.shimizu@it-chiba.ac.jp			MEXT-Supported Program for the Strategic Research Foundation at Private Universities [s1311004]	The author expresses his thanks to Professor T. Endo and Dr. N. Inaba of Meiji University, Japan for their invaluable assistance. This study was supported in part by the MEXT-Supported Program for the Strategic Research Foundation at Private Universities 2013-2017 (s1311004).	PLATT N, 1993, PHYS REV LETT, V70, P279, DOI 10.1103/PhysRevLett.70.279; Flach S, 2008, PHYS REP, V467, P1, DOI 10.1016/j.physrep.2008.05.002; Kimura M, 2009, CHAOS, V19, DOI 10.1063/1.3097068; Sato M, 2006, REV MOD PHYS, V78, P137, DOI 10.1103/RevModPhys.78.137; Binczak S, 2004, INT J BIFURCAT CHAOS, V14, P1819, DOI 10.1142/S0218127404010187; Comte JC, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.027102; DATARDINA SP, 1978, IEEE T CIRCUITS SYST, V25, P308, DOI 10.1109/TCS.1978.1084477; ENDO T, 1980, IEEE T CIRCUITS SYST, V27, P277; Kamiyama K., 2012, INT J BIFURCAT CHAOS, V22; KEENER JP, 1987, SIAM J APPL MATH, V47, P556, DOI 10.1137/0147038; Nishiura Y., 2005, SIAM J APPL DYN SYST, V4, P723; Ott E., 2002, CHAOS DYNAMICAL SYST; Shimizu K., 2011, IEICE NONLIN TH ITS, V2, P139; Yamauchi M, 1999, IEICE T FUND ELECTR, VE82A, P2592; Yoshinaga T., 1993, Electronics and Communications in Japan, Part 3 (Fundamental Electronic Science), V76, DOI 10.1002/ecjc.4430760511	15	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-1274	1793-6551		INT J BIFURCAT CHAOS	Int. J. Bifurcation Chaos	DEC	2014	24	12							1450157	10.1142/S0218127414501570		21	Mathematics, Interdisciplinary Applications; Multidisciplinary Sciences	Mathematics; Science & Technology - Other Topics	AY1GI	WOS:000347341500011		
J	Park, SK; Dodaran, AA; Han, CS; Shahmirzadi, MEM				Park, Sang Kil; Dodaran, Asgar Ahadpour; Han, Chong Soo; Shahmirzadi, Mohammad Ebrahim Meshkati			Effects of vertical wall and tetrapod weights on wave overtopping in rubble mound breakwaters under irregular wave conditions	INTERNATIONAL JOURNAL OF NAVAL ARCHITECTURE AND OCEAN ENGINEERING			English	Article								Rubble mound breakwaters protect the coastal line against severe erosion caused by wave action. This study examined the performance of different sizes and properties (i.e. height of vertical wall and tetrapod size) of rubble mound breakwaters on reducing the overtopping discharge. The physical model used in this study was derived based on an actual rubble mound in Busan Yacht Harbor. This research attempts to fill the gap in practical knowledge on the combined effect of the armor roughness and vertical wall on wave overtopping in rubble mound breakwaters. The main governing parameters used in this study were the vertical wall height, variation of the tetrapod weights, initial water level elevation, and the volume of overtopping under constant wave properties. The experimental results showed that the roughness factor differed according to the tetrapod size. Furthermore, the overtopping discharge with no vertical wall was similar to that with relatively short vertical walls (gamma(v) = 1). Therefore, the experimental results highlight the importance of the height of the vertical wall in reducing overtopping discharge. Moreover, a large tetrapod size may allow coastal engineers to choose a shorter vertical wall to save cost, while obtaining better performance.	[Park, Sang Kil; Dodaran, Asgar Ahadpour; Han, Chong Soo] Pusan Natl Univ, Dept Civil Engn, Pusan, South Korea; [Shahmirzadi, Mohammad Ebrahim Meshkati] Kyoto Univ, Disaster Prevent Res Inst, Kyoto, Japan	Dodaran, AA (reprint author), Pusan Natl Univ, Dept Civil Engn, Pusan, South Korea.	asgar.ahadpour2@pusan.ac.kr			BK21 PLUS Program for Leading Universities and Students of Pusan National University	This study was supported by BK21 PLUS Program for Leading Universities and Students of Pusan National University.	Aminti P.L., 1988, P INT C COASTAL ENG, P770; Bradbury A.P., 1988, P BREAKW 88 C I CIV, P385; Bruce T., 2009, SPECIAL ISSUE J COAS, V56, P166; Busan Port Authority, 2011, WORLD PORT SOURC POR; Franco L., 1993, P MAST2 MCS 1 PROJ W; Franco L, 2009, COAST ENG, V56, P154, DOI 10.1016/j.coastaleng.2008.03.009; Franco L., 1994, ASCE P 24 INT C COAS, P1030; Goda Y., 1985, RANDOM SEAS DESIGN M; Jensen O.J., 1987, P 2 INT C COAST PORT; Mansard E.P.D., 1980, NATL C PUBLICATION I, P154; Owen M.W, 1980, DESIGN SEAWALLS ALLO; Pullen T., 2007, EUROTOP WAVE OVERTOP; Saville T., 1953, P MINN INT HYDR CONV, P261; Van der Meer J.W., 1993, WATER MOVEMENT SLOPE; Van der Meer J.W., 2002, TECHNICAL ADVISORY C; Weggel R.J., 1976, 15 COAST ENG C AM SO, P2737	16	0	0	SOC NAVAL ARCHITECTS KOREA	SEOUL	SCI & TECHNOL BLDG, RM 508, 635-4, YEOKSAM-DONG, GANGNAM-GU, SEOUL, 135-703, SOUTH KOREA	2092-6782	2092-6790		INT J NAV ARCH OCEAN	Int. J. Nav. Archit. Ocean Eng.	DEC	2014	6	4					947	964		10.2478/IJNAOE-2013-0224		18	Engineering, Marine	Engineering	AY0GO	WOS:000347275700014		
J	Nishiura, D; Sakaguchi, H				Nishiura, Daisuke; Sakaguchi, Hide			Microscopic measurements of planar viscoelastic body eccentric impacts on a convex corner	INTERNATIONAL JOURNAL OF NON-LINEAR MECHANICS			English	Article						Impact motion; Impact ratio; Stiffness; Friction; Deformation; Bounce-off angle	DISCRETE ELEMENT METHOD; POLYHEDRAL BLOCKS; MODEL; FORMULATION; SIMULATION; COLLISIONS; PARTICLES; BEHAVIOR	This paper presents the effects of the target edge shape on eccentric impact motions, which were experimentally investigated by concurrently measuring the microscopic deformation of the target edge around a contact point and the global trajectory. This study is important for understanding the impact motions that occur between viscoelastic deformable polygonal objects with friction. The materials used in this experiment were four types of resin and one metal; four convex shapes and one circular shape were used for the impacted target plate. Interestingly, anomalous trajectories of the impact plate that varied with the target edge shape were found beyond the regime of rigid body dynamics, and were strongly dependent on the tangential deformation of the edge. In addition, it was found that the tangential deformation amount had a correlation with the bounce-off angle of the impact body for all materials used. That is, the target edge had a weaker tangential stiffness with sharpening of the edge shape, and thus, remarkably, absorbed the tangential impact energy as strain energy, due to a tangential deformation of the edge. Consequently, the bounce-off angle of the elastic body became smaller than that generally expected from rigid body dynamics, and sometimes even became negative because the direction of the contact force is significantly changed with increase in the tangential deformation of the edge. (C) 2014 Elsevier Ltd. All rights reserved.	[Nishiura, Daisuke; Sakaguchi, Hide] Japan Agcy Marine Earth Sci & Technol, Dept Math Sci & Adv Technol, Yokosuka, Kanagawa 2360001, Japan	Nishiura, D (reprint author), Japan Agcy Marine Earth Sci & Technol, Dept Math Sci & Adv Technol, Yokosuka, Kanagawa 2360001, Japan.	nishiura@jamstec.go.jp			JSPS KAKENHI [23740304]	This research was partially supported by JSPS KAKENHI Grant number 23740304 (Grant-in-Aid for Young Scientists (B) to D. N.).	Beyabanaki SAR, 2008, COMPUT GEOTECH, V35, P346, DOI 10.1016/j.compgeo.2007.08.006; SONDERGAARD R, 1990, J APPL MECH-T ASME, V57, P694, DOI 10.1115/1.2897079; Potyondy DO, 2004, INT J ROCK MECH MIN, V41, P1329, DOI 10.1016/j.ijrmms.2004.09.011; MAW N, 1981, J LUBRIC TECH-T ASME, V103, P74; Saussine G, 2006, COMPUT METHOD APPL M, V195, P2841, DOI 10.1016/j.cma.2005.07.006; WANG Y, 1992, J APPL MECH-T ASME, V59, P635, DOI 10.1115/1.2893771; Kuninaka H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.154301; Hosseininia ES, 2006, POWDER TECHNOL, V166, P100, DOI 10.1016/j.powtec.2006.05.006; Chatterjee A, 1998, J APPL MECH-T ASME, V65, P939, DOI 10.1115/1.2791938; Louge MY, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021303; Zhao DW, 2006, ENG COMPUTATION, V23, P749, DOI 10.1108/02644400610689884; Bobet A, 2009, J GEOTECH GEOENVIRON, V135, P1547, DOI 10.1061/(ASCE)GT.1943-5606.0000133; Calsamiglia J, 1999, J APPL MECH-T ASME, V66, P146, DOI 10.1115/1.2789141; Canny J., 1995, P 1995 S INT 3D GRAP, P181; CUNDALL PA, 1988, INT J ROCK MECH MIN, V25, P107, DOI 10.1016/0148-9062(88)92293-0; Ergenzinger C, 2012, J COMPUT NONLIN DYN, V7, DOI 10.1115/1.4006731; Fu PC, 2012, INT J NUMER METH ENG, V89, P599, DOI 10.1002/nme.3254; HART R, 1988, INT J ROCK MECH MIN, V25, P117, DOI 10.1016/0148-9062(88)92294-2; Matsushima T., 2005, POWDERS GRAINS 2005, V2, P1319; Muller P, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.041306; Munjiza A, 2010, PARTICUOLOGY, V8, P100, DOI 10.1016/j.partic.2009.04.008; Saitoh K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.238001; Sakaguchi Hide, 2010, Theoretical and Applied Mechanics Japan, V58; Shi GH, 1992, ENG COMPUT, V9, P157, DOI 10.1108/eb023855; SMITH CE, 1991, J APPL MECH-T ASME, V58, P754, DOI 10.1115/1.2897260; Strange W.J., 1991, J APPL MECH, V58, P1049	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7462	1878-5638		INT J NONLIN MECH	Int. J. Non-Linear Mech.	DEC	2014	67						133	143		10.1016/j.ijnonlinmec.2014.08.015		11	Mechanics	Mechanics	AX6GX	WOS:000347022100016		
J	Huang, H; Meller, W; Kishi, Y; Kathol, RG				Huang, Heather; Meller, William; Kishi, Yasuhiro; Kathol, Roger G.			What is integrated care?	INTERNATIONAL REVIEW OF PSYCHIATRY			English	Article							HOSPITALIZED OLDER PATIENTS; RANDOMIZED CONTROLLED-TRIAL; BEHAVIORAL HEALTH-SERVICES; LENGTH-OF-STAY; COLLABORATIVE CARE; PSYCHIATRIC-CONSULTATION; DEPRESSIVE-DISORDERS; PREVENT DELIRIUM; MENTAL-DISORDERS; MANAGEMENT	Increasing awareness of mental illness's impact on medical and psychiatric health has accelerated global efforts to integrate medical and behavioural health services. As the field of integration has advanced, numerous integrated programmes have been implemented. In examining the impact of these programmes, it is important to maintain a standardized vocabulary to describe the various components of their integration. Additionally important is examination of how these programmes impact elements of patient care and the healthcare system. Specifically, what value do they bring? This article will discuss the importance of carefully assessing the value integrated services bring to patients, and questioning whether they do so in ways in which today's segregated world of medical and behavioural health cannot. This article will also explore the various settings in which medical and behavioural integration can bring added value.	[Huang, Heather] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Huang, Heather] Univ Wisconsin, Dept Internal Med, Madison, WI USA; [Meller, William; Kathol, Roger G.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Kishi, Yasuhiro] Nippon Med Sch, Musashikosugi Hosp, Dept Psychiat, Kawasaki, Kanagawa, Japan; [Kathol, Roger G.] Univ Minnesota, Dept Internal Med, Minneapolis, MN USA	Huang, H (reprint author), 1102 South Pk St,Suite 400, Madison, WI 53715 USA.	heather.huang@uwmf.wisc.edu					Thomas MR, 2005, PSYCHIAT SERV, V56, P1394, DOI 10.1176/appi.ps.56.11.1394; Kathol R, 2006, MED CLIN N AM, V90, P549, DOI 10.1016/j.mcna.2006.04.002; Jacob V, 2012, AM J PREV MED, V42, P539, DOI 10.1016/j.amepre.2012.01.011; Wang PS, 2007, JAMA-J AM MED ASSOC, V298, P1401, DOI 10.1001/jama.298.12.1401; Druss BG, 2011, MED CARE, V49, P599, DOI 10.1097/MLR.0b013e31820bf86e; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Muntingh A, 2014, PSYCHOTHER PSYCHOSOM, V83, P37, DOI 10.1159/000353682; Marcantonio ER, 2001, J AM GERIATR SOC, V49, P516, DOI 10.1046/j.1532-5415.2001.49108.x; Katon W, 2006, PSYCHOL MED, V36, P353, DOI 10.1017/S0033291705006896; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Bower P, 2003, PSYCHOL MED, V33, P203, DOI 10.1017/S0033291702006979; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Inouye SK, 1999, NEW ENGL J MED, V340, P669, DOI 10.1056/NEJM199903043400901; Alford DP, 2011, ARCH INTERN MED, V171, P425, DOI 10.1001/archinternmed.2010.541; Manderscheid R, 2014, ANN INTERN MED, V160, P61, DOI 10.7326/M13-1693; Kathol RG, 2009, PSYCHOSOMATICS, V50, P93, DOI 10.1176/appi.psy.50.2.93; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Kishi Y, 1999, PSYCHOSOMATICS, V40, P345; Ansseau M, 2004, J AFFECT DISORDERS, V78, P49, DOI 10.1016/S0165-0327(02)00219-7; Huyse FJ, 2001, PSYCHOSOMATICS, V42, P222, DOI 10.1176/appi.psy.42.3.222; Huyse FJ, 2001, GEN HOSP PSYCHIAT, V23, P124, DOI 10.1016/S0163-8343(01)00139-6; Kathol RG, 2005, J GEN INTERN MED, V20, P160, DOI 10.1111/j.1525-1497.2005.40099.x; Unutzer J, 2008, AM J MANAG CARE, V14, P95; Thota AB, 2012, AM J PREV MED, V42, P525, DOI 10.1016/j.amepre.2012.01.019; Kathol RG, 2014, ANN FAM MED, V12, P172, DOI 10.1370/afm.1619; Larkin GL, 2005, PSYCHIAT SERV, V56, P671, DOI 10.1176/appi.ps.56.6.671; Bower P, 2011, COCHRANE DB SYST REV, V9; Bradford DW, 2008, PSYCHIAT SERV, V59, P847, DOI 10.1176/appi.ps.59.8.847; Brandt B., 2014, J INTERPROF CARE, P1; Chang C. K., 2011, PLOS ONE, V6; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Desan PH, 2011, PSYCHOSOMATICS, V52, P513, DOI 10.1016/j.psym.2011.06.002; Druss Benjamin G, 2011, Synth Proj Res Synth Rep, P1; Gater RA, 1998, J PSYCHOSOM RES, V45, P437, DOI 10.1016/S0022-3999(98)00058-0; Kathol R, 2010, INTEGRATED CASE MANA; Kathol R. G., 2014, CLIN INTEGRATION ACC; Katon WJ, 2008, J OCCUP ENVIRON MED, V50, P459, DOI 10.1097/JOM.0b013e318168efb7; Kishi Y, 2004, PSYCHOSOMATICS, V45, P470, DOI 10.1176/appi.psy.45.6.470; Little-Upah Pat, 2013, Perm J, V17, P45, DOI 10.7812/TPP/12-016; LEVENSON JL, 1992, AM J PSYCHIAT, V149, P631; Melek S. P., 2014, EC IMPACT INTEGRATED; Peek C., 2013, LEXICON BEHAV HLTH P; Rizzo JA, 2001, MED CARE, V39, P740, DOI 10.1097/00005650-200107000-00010; Seelig MD, 2008, J OCCUP ENVIRON MED, V50, P451, DOI 10.1097/JOM.0b013e318169cce4; Shirley K. G., 2014, INTEGRATED CARE PSYC	45	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0954-0261	1369-1627		INT REV PSYCHIATR	Int. Rev. Psych.	DEC	2014	26	6					620	628		10.3109/09540261.2014.964189		9	Psychiatry	Psychiatry	AX9OT	WOS:000347232500002		
J	Yokomizu, Y; Hayase, T; Meguro, Y; Matsumura, T				Yokomizu, Yasunobu; Hayase, Tetsuo; Meguro, Yoshikazu; Matsumura, Toshiro			A fundamental approach to applying an insulated-gate bipolar transistor to current interruption in a low-voltage direct current delivery system	INTERNATIONAL TRANSACTIONS ON ELECTRICAL ENERGY SYSTEMS			English	Article						direct current interruption; current limitation; circuit breaker; high-power semiconductor	CIRCUIT-BREAKER; DISTRIBUTION NETWORKS; DC DISTRIBUTION; POWER-SYSTEMS; FEASIBILITY	A fundamental approach to apply an insulated gate bipolar transistor to a current interruption technique in a low-voltage direct current (DC) power delivery system is described. By considering the dependence of collector-emitter resistance on the gate-emitter voltage, a circuit configuration of circuit-breaker components was contrived to operate a DC interruption. Based on this design, a model DC circuit breaker composed of an insulated gate bipolar transistor was constructed to verify the interrupting performance of various DCs I-DC under different source voltages E-DC. The experimental results demonstrate that the model circuit breaker successfully decreased the instantaneous current to zero over an elapsed time and then interrupted the current. In addition, the results show that the current-interrupting time was almost constant against higher I-DC and E-DC. The results also verify that by adjusting the time constant of the gate-emitter voltage, the current-interrupting time could be controlled. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Yokomizu, Yasunobu; Hayase, Tetsuo; Meguro, Yoshikazu; Matsumura, Toshiro] Nagoya Univ, Dept Elect Engn & Comp Sci, Nagoya, Aichi 4648601, Japan	Yokomizu, Y (reprint author), Nagoya Univ, Dept Elect Engn & Comp Sci, Nagoya, Aichi 4648601, Japan.	yokomizu@nuee.nagoya-u.ac.jp			Japan Society for the Promotion of Science (JSPS);  [20560266]	This work was supported by a Grant-in-Aid for Scientific Research (C) (20560266). We would like to express sincere thanks to the Japan Society for the Promotion of Science (JSPS) for supporting the present research.	Ahmed MMR, 2006, IEEE T POWER DELIVER, V21, P1997, DOI 10.1109/TPWRD.2006.874584; Vodyakho O, 2011, IET ELECTR POWER APP, V5, P521, DOI 10.1049/iet-epa.2010.0258; Corzine KA, 2012, IEEE T POWER ELECTR, V27, P2796, DOI 10.1109/TPEL.2011.2178125; Meyer JM, 2006, IEEE T POWER DELIVER, V21, P646, DOI 10.1109/TPWRD.2006.870981; Baran ME, 2003, IEEE T IND APPL, V39, P1596, DOI 10.1109/TIA.2003.818969; Meyer C, 2004, IEEE T POWER ELECTR, V19, P1333, DOI 10.1109/TPEL.2004.833454; [Anonymous], 8023AF IEEE; Abramovitz A, 2012, IEEE T POWER ELECTR, V27, P2770, DOI 10.1109/TPEL.2011.2174804; Sannino A, 2003, IEEE T IND APPL, V39, P1499, DOI 10.1109/TIA.2003.816517; Furuse M, 2005, IEEE T APPL SUPERCON, V15, P1759, DOI 10.1109/TASC.2005.849275; Novello L, 2011, IEEE T APPL SUPERCON, V21, P3621, DOI 10.1109/TASC.2011.2169411; Hammerstrom D. J., 2007, IEEE POW ENG SOC GEN, P1; KHALIFA M, 1979, P I ELECTR ENG, V126, P75; Kim D-H, 2011, 2011 IEEE 8 INT C PO, P2352; Magro MC, 2006, IEEE IMTC P, P1885, DOI 10.1109/IMTC.2006.328304; Mansoor A, 2006, DC POWER PRODUCTION; Meyer C, 2006, IEEE T POWER ELECTR, V21, P450, DOI 10.1109/TPEL.2005.869756; Salomonsson D, 2007, IEEE T POWER DELIVER, V22, P1620, DOI [10.1109/TPWRD.2006.883024, 10.1109/TPWRD.2007.883024]; SMITH RK, 1993, IEEE T POWER DELIVER, V8, P1155, DOI 10.1109/61.252640; Yokomizu Y, 2010, FRONTIER APPL PLASMA, V3, P5; Yokomizu Y, P 7 INT S APPL PLASM, P67	21	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2050-7038			INT T ELECTR ENERGY	Int. Trans. Electr. Energy Syst.	DEC	2014	24	12					1805	1817		10.1002/etep.1830		13	Engineering, Electrical & Electronic	Engineering	AX1IU	WOS:000346701800013		
J	Asaoka, R; Iwase, A; Hirasawa, K; Murata, H; Araie, M				Asaoka, Ryo; Iwase, Aiko; Hirasawa, Kazunori; Murata, Hiroshi; Araie, Makoto			Identifying "Preperimetric'' Glaucoma in Standard Automated Perimetry Visual Fields	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						glaucoma; preperimetric stage; Random Forests method; visual field	FREQUENCY-DOUBLING TECHNOLOGY; OPTICAL COHERENCE TOMOGRAPHY; SCANNING LASER POLARIMETRY; NERVE-FIBER LAYER; BLUE-ON-YELLOW; RANDOM FOREST; DEFECTS; CLASSIFICATION; PREDICT; EYES	PURPOSE. To compare the visual fields (VFs) of preperimetric open angle glaucoma (OAG) patients (preperimetric glaucoma VFs, PPGVFs) with the VFs of healthy eyes, and to discriminate these two groups by using the Random Forests machine-learning method. METHODS. All VFs before a first diagnosis of manifest glaucoma (Anderson-Patella's criteria) were classified as PPGVFs. Series of VFs were obtained with the Humphrey Field Analyzer 302 program from 171 PPGVFs from 53 eyes in 51 OAG or OAG suspect patients and 108 healthy eyes of 87 normal subjects. The area under the receiver operating characteristic curve (AROC) in discriminating between PPGVFs and healthy VFs was calculated by using the Random Forests method, with 52 total deviation (TD) values, mean deviation (MD), and pattern standard deviation (PSD) as predictors. RESULTS. There was a significant difference in MD between healthy VFs and PPGVFs (-0.03 +/- 1.11 and -0.91 +/- 1.56 dB [mean +/- standard deviation], respectively; P < 0.001, linear mixed model) and in PSD (1.56 +/- 0.33 and 1.97 +/- 0.43 dB, respectively; P < 0.001). A significant difference was observed in the TD values between healthy VFs and PPGVFs at 25 (P < 0.001) of 52 test points (linear mixed model). The AROC obtained by using the Random Forests method was 79.0% (95% confidence interval, 73.5%-84.5%). CONCLUSIONS. Differences exist between healthy VFs and VFs of preperimetric glaucoma eyes, which go on to develop manifest glaucoma; these two groups of VFs could be well distinguished by using the Random Forests classifier.	[Asaoka, Ryo; Hirasawa, Kazunori; Murata, Hiroshi] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Bunkyo Ku, Tokyo 1138655, Japan; [Iwase, Aiko] Tajimi Iwase Eye Clin, Tajimi, Japan; [Hirasawa, Kazunori] Kitasato Univ, Grad Sch Med Sci, Dept Ophthalmol, Sagamihara, Kanagawa, Japan; [Araie, Makoto] Mutual Aid Assoc Publ Sch Teachers, Kanto Cent Hosp, Tokyo, Japan	Asaoka, R (reprint author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	rasaoka-tky@umin.ac.jp			Technology Agency (JST) CREST; Ministry of Education, Culture, Sports, Science and Technology of Japan [25861618, 26462679]	Supported in part by Technology Agency (JST) CREST (RA and HM) and Grants 25861618 (HM) and 26462679 (RA) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Anderson D. R., 1999, AUTOMATED STATIC PER; DRANCE SM, 1969, INVEST OPHTH VISUAL, V8, P84; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Palmer DS, 2007, J CHEM INF MODEL, V47, P150, DOI 10.1021/ci060164k; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Medeiros FA, 2004, AM J OPHTHALMOL, V137, P863, DOI 10.1016/j.ajo.2003.12.009; Harwerth RS, 1999, INVEST OPHTH VIS SCI, V40, P2242; Landers JA, 2003, ARCH OPHTHALMOL-CHIC, V121, P1705, DOI 10.1001/archopht.121.12.1705; Choi JA, 2009, JPN J OPHTHALMOL, V53, P24, DOI 10.1007/s10384-008-0604-0; QUIGLEY HA, 1989, AM J OPHTHALMOL, V107, P453; JOHNSON CA, 1993, ARCH OPHTHALMOL-CHIC, V111, P645; Lisboa R, 2013, INVEST OPHTH VIS SCI, V54, P3417, DOI 10.1167/iovs.13-11676; Svetnik V, 2003, J CHEM INF COMP SCI, V43, P1947, DOI 10.1021/ci034160g; WILD JM, 1989, ACTA OPHTHALMOL, V67, P537; Baraibar B, 2007, J GLAUCOMA, V16, P659; Wu BL, 2003, BIOINFORMATICS, V19, P1636, DOI 10.1093/bioinformatics/btg210; Lisboa R, 2012, OPHTHALMOLOGY, V119, P2261, DOI 10.1016/j.ophtha.2012.06.009; Douglas PK, 2011, NEUROIMAGE, V56, P544, DOI 10.1016/j.neuroimage.2010.11.002; Aoyama Y, 2014, INVEST OPHTH VIS SCI, V55, P2584, DOI 10.1167/iovs.13-13616; Asaoka R, 2014, INVEST OPHTH VIS SCI, V55, P2482, DOI 10.1167/iovs.14-14009; Asaoka R, 2006, OPHTHAL RES, V38, P29, DOI 10.1159/000088549; Breiman L., 2004, RANDOM FORESTS; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Ferreras A, 2007, J GLAUCOMA, V16, P372, DOI 10.1097/IJG.0b013e31803bbb17; Hardin James William, 2007, GEN LINEAR MODELS EX; Heijl A, 1996, ARCH OPHTHALMOL-CHIC, V114, P19; HEIJL A, 1989, ARCH OPHTHALMOL-CHIC, V107, P204; Hirashima T, 2013, GRAEF ARCH CLIN EXP, V251, P129, DOI 10.1007/s00417-012-2076-7; Japkowicz N., 2011, EVALUATING LEARNING; Jeoung JW, 2013, J GLAUCOMA, V23, P299; JOHNSON CA, 1993, ARCH OPHTHALMOL-CHIC, V111, P651; Kamantigue MEG, 2006, J GLAUCOMA, V15, P35, DOI 10.1097/01.ijg.0000196621.41991.ff; Kim HG, 2011, OPTOMETRY VISION SCI, V88, P124, DOI 10.1097/OPX.0b013e3181fdef9c; Kogure S, 2006, BRIT J OPHTHALMOL, V90, P347, DOI 10.1136/bjo.2005.077065; Kouris I, 2012, TECHNOL HEALTH CARE, V20, P263, DOI 10.3233/THC-2012-0674; Leeprechanon N, 2007, OPHTHALMOLOGY, V114, P931, DOI 10.1016/j.ophtha.2007.01.006; Maddess T, 2011, INVEST OPHTH VIS SCI, V52, P1014, DOI 10.1167/iovs.10-6014; Maroco João, 2011, BMC Res Notes, V4, P299, DOI 10.1186/1756-0500-4-299; Marvasti Amir H, 2013, Case Rep Ophthalmol, V4, P144, DOI 10.1159/000355102; Nevalainen J, 2009, GRAEF ARCH CLIN EXP, V247, P1659, DOI 10.1007/s00417-009-1134-2; Nordmann J P, 1996, Curr Opin Ophthalmol, V7, P47, DOI 10.1097/00055735-199604000-00009; Gordon MO, 2008, OPHTHALMOLOGY, V115, P2030, DOI 10.1016/j.ophtha.2009.06.036; SAMPLE PA, 1993, AM J OPHTHALMOL, V115, P225; Shields MB, 1997, TXB GLAUCOMA; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Sugimoto K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003114; Sung MS, 2013, J GLAUCOMA, V23, pe144; Traynis I, 2014, JAMA OPHTHALMOL, V132, P291, DOI 10.1001/jamaophthalmol.2013.7656; WEBER J, 1986, OPHTHALMOLOGICA, V192, P88; Zimmerman TJ, 2001, CLIN PATHWAYS GLAUCO	50	0	0	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	DEC	2014	55	12					7814	7820		10.1167/iovs.14-15120		7	Ophthalmology	Ophthalmology	AX9KR	WOS:000347222300012		
J	Hata, M; Oishi, A; Tsujikawa, A; Yamashiro, K; Miyake, M; Ooto, S; Tamura, H; Nakanishi, H; Takahashi, A; Yoshikawa, M; Yoshimura, N				Hata, Masayuki; Oishi, Akio; Tsujikawa, Akitaka; Yamashiro, Kenji; Miyake, Masahiro; Ooto, Sotaro; Tamura, Hiroshi; Nakanishi, Hideo; Takahashi, Ayako; Yoshikawa, Munemitsu; Yoshimura, Nagahisa			Efficacy of Intravitreal Injection of Aflibercept in Neovascular Age-Related Macular Degeneration With or Without Choroidal Vascular Hyperpermeability	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						age-related macular degeneration; polypoidal choroidal vasculopathy; choroidal vascular hyperpermeability; optical coherence tomography	ENDOTHELIAL GROWTH-FACTOR; CENTRAL SEROUS CHORIORETINOPATHY; INDOCYANINE-GREEN ANGIOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY; VEGF-TRAP; PHOTODYNAMIC THERAPY; RANIBIZUMAB; VASCULOPATHY; THICKNESS; BEVACIZUMAB	PURPOSE. To compare therapeutic responses to intravitreal aflibercept and ranibizumab in neovascular age-related macular degeneration (AMD)-affected eyes with and without choroidal vascular hyperpermeability (CVH). METHODS. Medical records of 216 consecutive patients (216 eyes) with treatment-naive exudative AMD who had received three monthly intravitreal injections of aflibercept (2 mg) and ranibizumab (0.5 mg) at a single institution were analyzed. The associations of CVH with functional and morphologic changes were compared between the treatment groups. RESULTS. Although foveal thickness (P = 0.85) and visual acuity (P = 0.13) changes were not significantly different between the treatment groups, subfoveal choroidal thickness (CT) (P = 0.001) and pigment epithelial detachment (PED) height (P = 0.043) decreased more profoundly in the aflibercept-treated group. The incidence of dry macula after treatments was lower in the ranibizumab-treated eyes with CVH than in those without CVH (P = 0.043), but it showed no significant difference between the aflibercept-treated eyes with and without CVH (P = 0.74). The aflibercept-treated eyes with CVH showed a higher incidence of dry macula (P = 0.04) and greater decrease in subfoveal CT (P = 0.002) than the ranibizumab-treated eyes with CVH. CONCLUSIONS. Intravitreal aflibercept can achieve remission of exudative retinal changes in eyes with AMD even in the presence of CVH. In addition, it showed greater effects on the choroid and PED than intravitreal ranibizumab. The possible relationship between CVH suppression and decrease in CT warrants further study.	[Hata, Masayuki; Oishi, Akio; Tsujikawa, Akitaka; Yamashiro, Kenji; Miyake, Masahiro; Ooto, Sotaro; Tamura, Hiroshi; Nakanishi, Hideo; Takahashi, Ayako; Yoshikawa, Munemitsu; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto 6068507, Japan	Oishi, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyoto 6068507, Japan.	aquio@kuhp.kyoto-u.ac.jp					Schmidt-Erfurth U, 2002, INVEST OPHTH VIS SCI, V43, P830; Bakall B, 2013, AM J OPHTHALMOL, V156, P15, DOI 10.1016/j.ajo.2013.02.017; Koizumi H, 2013, AM J OPHTHALMOL, V155, P305, DOI 10.1016/j.ajo.2012.07.018; Branchini L, 2013, JAMA OPHTHALMOL, V131, P693, DOI 10.1001/jamaophthalmol.2013.692; Schmidt-Erfurth U, 2000, SURV OPHTHALMOL, V45, P195, DOI 10.1016/S0039-6257(00)00158-2; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Maruko I, 2013, AM J OPHTHALMOL, V156, P548, DOI 10.1016/j.ajo.2013.03.041; Ho VY, 2013, AM J OPHTHALMOL, V156, P23, DOI 10.1016/j.ajo.2013.02.009; Yonekawa Y, 2013, AM J OPHTHALMOL, V156, P29, DOI 10.1016/j.ajo.2013.03.030; Kumar N, 2013, RETINA-J RET VIT DIS, V33, P1605, DOI 10.1097/IAE.0b013e31828e8551; Michels S, 2003, INVEST OPHTH VIS SCI, V44, P2147, DOI 10.1167/iovs.02-0604; Julien S, 2014, BRIT J OPHTHALMOL, V98, P813, DOI 10.1136/bjophthalmol-2013-304019; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Sasahara M, 2006, AM J OPHTHALMOL, V142, P601, DOI 10.1016/j.ajo.2006.05.051; Jirarattanasopa P, 2012, INVEST OPHTH VIS SCI, V53, P3663, DOI 10.1167/iovs.12-9619; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Cho HJ, 2013, AM J OPHTHALMOL, V156, P1192, DOI 10.1016/j.ajo.2013.07.001; Lafaut BA, 1998, GRAEF ARCH CLIN EXP, V236, P513, DOI 10.1007/s004170050114; Stewart MW, 2008, BRIT J OPHTHALMOL, V92, P667, DOI 10.1136/bjo.2007.134874; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Dixon JA, 2009, EXPERT OPIN INV DRUG, V18, P1573, DOI 10.1517/13543780903201684; Cao XS, 2014, RETINA-J RET VIT DIS, V34, P1554, DOI 10.1097/IAE.0000000000000122; Fassnacht-Riederle H, 2014, GRAEF ARCH CLIN EXP, V252, P1705, DOI 10.1007/s00417-014-2589-3; GUYER DR, 1992, OPHTHALMOLOGY, V99, P287; Patel KH, 2013, EYE, V27, P664, DOI 10.1038/eye.2013.31; Spaide RF, 1996, RETINA-J RET VIT DIS, V16, P203, DOI 10.1097/00006982-199616030-00004	29	1	1	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	DEC	2014	55	12					7874	7880		10.1167/iovs.14-14610		7	Ophthalmology	Ophthalmology	AX9KR	WOS:000347222300018		
J	Aizawa, N; Nitta, F; Kunikata, H; Sugiyama, T; Ikeda, T; Araie, M; Nakazawa, T				Aizawa, Naoko; Nitta, Fumihiko; Kunikata, Hiroshi; Sugiyama, Tetsuya; Ikeda, Tsunehiko; Araie, Makoto; Nakazawa, Toru			Laser Speckle and Hydrogen Gas Clearance Measurements of Optic Nerve Circulation in Albino and Pigmented Rabbits With or Without Optic Disc Atrophy	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						mean blur rate; laser speckle flowgraphy; capillary blood flow; optic nerve head; endothelin-1	OCULAR BLOOD-FLOW; VISUAL IMPAIRMENT; HEAD; ENDOTHELIN-1; GLAUCOMA; FLOWGRAPHY; MICROCIRCULATION; HEMODYNAMICS; POPULATION; BLINDNESS	PURPOSE. The purpose of this study was to evaluate the correlation between laser speckle flowgraphy measurements of mean blur rate (MBR) and hydrogen gas clearance measurements of capillary blood flow (CBF) in the optic nerve head (ONH) of albino and pigmented rabbits, with or without chronic ischemia-induced ONH atrophy. METHODS. The ONH MBR and ONH CBF were measured at baseline, 30 and 60 minutes after the intravenous administration of endothelin-1 (ET-1) (10(-10) mol/kg) in six albino and six pigmented rabbit eyes. The ONH MBR and ONH CBF were also measured in nine pigmented rabbit eyes that underwent the intravitreal administration of ET-1 (20 pmol) twice per week for 4 weeks to provoke chronic ischemia-induced ONH atrophy. RESULTS. In the group that received intravenous ET-1, average measurements of ONH MBR and ONH CBF at all time points were correlated in both the albino (r = 0.88, P < 0.001, n = 18) and pigmented rabbits (r = 0.85, P < 0.001, n = 18), with no intrarabbit correlations (P = 0.524). The ONH MBR and ONH CBF were also correlated in the model of chronic ischemia-induced ONH atrophy (r = 0.78, P = 0.013, n = 9). Pooled ONH MBR and ONH CBF measurements in both the intravenous and intravitreal groups were also highly correlated (r = 0.87, P < 0.001, n = 45), with no significant intergroup differences in the relationship between ONH MBR and ONH CBF (P = 0.138). CONCLUSIONS. Regardless of the presence of fundus pigmentation or ONH atrophy, ONH MBR and ONH CBF were highly correlated, suggesting that MBR in the ONH tissue is usable for interindividual and intergroup comparisons.	[Aizawa, Naoko; Nitta, Fumihiko; Kunikata, Hiroshi; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 9808574, Japan; [Kunikata, Hiroshi; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Sendai, Miyagi 9808574, Japan; [Sugiyama, Tetsuya] Nakano Eye Clin Kyoto Med Cooperat, Kyoto, Japan; [Ikeda, Tsunehiko] Osaka Med Coll, Dept Ophthalmol, Osaka, Japan; [Araie, Makoto] Mutual Aid Assoc Publ Sch Teachers, Kanto Cent Hosp, Dept Ophthalmol, Tokyo, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi 9808574, Japan	Kunikata, H (reprint author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	kunikata@oph.med.tohoku.ac.jp			JST grant from Japan Society for the Promotion of Science KAKENHI (Tokyo, Japan) [26293372, 26462629, 26670751]	Supported in part by a JST grant from Japan Society for the Promotion of Science KAKENHI (Tokyo, Japan) Grants-in-Aid for Scientific Research (B) Grant 26293372 (TN), Scientific Research (C) Grant 26462629 (HK), and Exploratory Research Grant 26670751 (TN).	Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Lesk MR, 2008, CAN J OPHTHALMOL, V43, P351, DOI 10.3129/i08-057; Xu L, 2006, OPHTHALMOLOGY, V113, P1134, DOI 10.1016/j.ophtha.2006.01.035; TAMAKI Y, 1994, INVEST OPHTH VIS SCI, V35, P3825; Dallinger S, 2000, INVEST OPHTH VIS SCI, V41, P864; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P8303, DOI 10.1167/iovs.12-10911; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Sugiyama T, 1996, JPN J OPHTHALMOL, V40, P339; GRANSTAM E, 1992, CURR EYE RES, V11, P325, DOI 10.3109/02713689209001786; Takahashi H, 2013, EXP EYE RES, V108, P10, DOI 10.1016/j.exer.2012.12.003; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Sugiyama T, 2009, ARCH OPHTHALMOL-CHIC, V127, P454, DOI 10.1001/archophthalmol.2008.606; Konishi N, 2002, OPT REV, V9, P163, DOI 10.1007/s10043-002-0163-4; Nagahara M, 2011, INVEST OPHTH VIS SCI, V52, P87, DOI 10.1167/iovs.09-4422; GEERAETS WJ, 1962, INVEST OPHTH VISUAL, V1, P340; Harris A, 2008, AM J OPHTHALMOL, V145, P595, DOI 10.1016/j.ajo.2007.12.019; Oku H, 1999, SURV OPHTHALMOL, V44, pS74, DOI 10.1016/S0039-6257(99)00068-5; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Sasaoka M, 2006, EXP EYE RES, V83, P629, DOI 10.1016/j.exer.2006.03.007; Schmetterer L, 1997, CURR EYE RES, V16, P687, DOI 10.1076/ceyr.16.7.687.5065; Sugiyama T, 2014, PHOTONICS, V1, P220; Watanabe G, 2008, JPN J OPHTHALMOL, V52, P175, DOI 10.1007/s10384-007-0521-7	23	0	0	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	DEC	2014	55	12					7991	7996		10.1167/iovs.14-15373		6	Ophthalmology	Ophthalmology	AX9KR	WOS:000347222300031		
J	Inoue, T; Kobayashi, T; Nakao, S; Hara, Y; Suzuki, T; Hayashi, Y; Zheng, XD; Shiraishi, A; Ohashi, Y				Inoue, Tomoyuki; Kobayashi, Takeshi; Nakao, Saori; Hara, Yuko; Suzuki, Takashi; Hayashi, Yasuhito; Zheng, Xiaodong; Shiraishi, Atsushi; Ohashi, Yuichi			Horizontal Intracorneal Swirling Water Migration Indicative of Corneal Endothelial Function	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						water movement in cornea; corneal hydration; intracorneal water flow	SWELLING PRESSURE; TRANSPORT; HYDRATION; DYNAMICS; STROMA; PUMP	PURPOSE. To test our hypothesis about whether there is water migration in the horizontal corneal plane and investigate its developmental mechanism. METHODS. A fluorescein solution was intrastromally injected into normal and edematous corneas of rabbits, and the movement of the fluorescein solution was observed and recorded over time. RESULTS. In normal corneas, the water flow was characterized by a swirling movement from the center to the periphery in the stroma. The fluorescein solution ultimately spread and occupied the entire cornea, indicating horizontal intracorneal swirling of water. In contrast, when the corneal endothelia were injured by intracameral injection of a preservative to create corneal edema, no water migration occurred, suggesting that the integrity of the corneal endothelial function is essential for water migration. The water migration stopped with injection of a sodium-potassium pump inhibitor, indicating that the enzyme is necessary for physiologic water migration in the cornea. With recovery of corneal endothelial function, the water migration began, and focal edema remained in the periphery with no water migration in this edematous area. CONCLUSIONS. We report for the first time the presence of horizontal water migration in the cornea in a swirling pattern (i. e., intracorneal swirling migration of water, generated by the pump function in the corneal endothelial cells), which may supplement the conventional concept of development of corneal edema in the vertical plane. This dynamic water circulatory system may be involved in increasing the efficiency of the water transfer in the entire cornea.	[Inoue, Tomoyuki; Nakao, Saori; Hara, Yuko; Suzuki, Takashi; Hayashi, Yasuhito; Shiraishi, Atsushi; Ohashi, Yuichi] Ehime Univ, Sch Med, Dept Ophthalmol, Toon City, Ehime 7910295, Japan; [Kobayashi, Takeshi] Ehime Univ, Grad Sch Med, Dept Ophthalmol & Regenerat Med, Toon City, Ehime 7910295, Japan	Inoue, T (reprint author), Ehime Univ, Sch Med, Dept Ophthalmol, Toon City, Ehime 7910295, Japan.	tomonoue@m.ehime-u.ac.jp					MISHIMA S, 1967, EXP EYE RES, V6, P10, DOI 10.1016/S0014-4835(67)80049-6; Morishige N, 2012, INVEST OPHTH VIS SCI, V53, P4998, DOI 10.1167/iovs.12-10214; Nichols JJ, 2012, INVEST OPHTH VIS SCI, V53, P5426, DOI 10.1167/iovs.12-10033; Beebe DC, 2008, SEMIN CELL DEV BIOL, V19, P125, DOI 10.1016/j.semcdb.2007.08.014; CHEN RF, 1988, ANAL BIOCHEM, V172, P61, DOI 10.1016/0003-2697(88)90412-5; BORCHERDING MS, 1975, EXP EYE RES, V21, P59, DOI 10.1016/0014-4835(75)90057-3; DOHLMAN CH, 1962, INVEST OPHTH VISUAL, V1, P158; FATT I, 1965, J COLL SCI IMP U TOK, V20, P962, DOI 10.1016/0095-8522(65)90068-1; GOLDMAN JEROME N., 1967, INVEST OPHTHALMOL, V6, P574; GOTHARD TW, 1993, AM J OPHTHALMOL, V115, P729; HARRIS JE, 1955, AM J OPHTHALMOL, V40, P100; HEDBYS BO, 1963, EXP EYE RES, V2, P122, DOI 10.1016/S0014-4835(63)80003-2; HODSON S, 1976, J PHYSIOL-LONDON, V263, P563; Klyce SD, 2005, CORNEA; KLYCE SD, 1979, J PHYSIOL-LONDON, V292, P107; Manchester P T Jr, 1970, Trans Am Ophthalmol Soc, V68, P425; MAURICE D, 1977, INVEST OPHTH VIS SCI, V16, P646; MAURICE DM, 1951, J PHYSIOL-LONDON, V112, P367; MAURICE DM, 1972, J PHYSIOL-LONDON, V221, P43; Wilson G, 1995, J Am Optom Assoc, V66, P435; YTTEBORG J, 1965, ARCH OPHTHALMOL-CHIC, V74, P477	21	0	0	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	DEC	2014	55	12					8006	8014		10.1167/iovs.14-14762		9	Ophthalmology	Ophthalmology	AX9KR	WOS:000347222300033		
J	Ishiyama, Y; Murata, H; Mayama, C; Asaoka, R				Ishiyama, Yukako; Murata, Hiroshi; Mayama, Chihiro; Asaoka, Ryo			An Objective Evaluation of Gaze Tracking in Humphrey Perimetry and the Relation With the Reproducibility of Visual Fields: A Pilot Study in Glaucoma	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						gaze tracking; glaucoma; visual field	FALSE-NEGATIVE RESPONSES; AUTOMATED PERIMETRY; FULL THRESHOLD; SITA STANDARD; RELIABILITY; VARIABILITY; FIXATION	PURPOSE. To develop a novel method to evaluate gaze tracking (GT) results and to examine their relationship with test-retest reproducibility of visual field (VF) measurements. METHODS. Subjects comprised of 42 eyes of 42 glaucoma patients. Vision fixation during VF tests with the Humphrey Field Analyzer was evaluated using the gaze fixation line chart at the bottom of the VF printout. We defined some GT parameters as follows: average tracking failure frequency per stimulus (TFF), average frequency of eye movements between 1 degrees and 2 degrees, 3 degrees and 5 degrees, and more than 6 degrees. Humphrey VFs (24-2 and 10-2 Swedish Interactive Threshold Algorithm [SITA] standard) were prospectively examined twice within a period of 3 months in 42 glaucoma patients. Mean absolute variability of total deviation (TD) values in the test-retest VFs was measured and its relationship to fixation losses (FLs), false positives (FPs), false negatives (FNs), mean deviation (MD), and pattern standard deviation (PSD) was investigated using the corrected Akaike Information Criterion (AICc) from linear modeling. RESULTS. The best model to predict test-retest variability in the 24-2 VF included PSD, TFF, and FNs as dependent variables, while the best model for the 10-2 VF included PSD and average frequency of eye movements between 3 degrees and 5 degrees (P < 0.05 for all coefficients). CONCLUSIONS. Gaze tracking parameters are closely related to the reproducibility of VF results, and it would be beneficial to objectively use these parameters when estimating the reliability of VF tests.	[Ishiyama, Yukako; Murata, Hiroshi; Mayama, Chihiro; Asaoka, Ryo] Univ Tokyo, Dept Ophthalmol, Tokyo 1138655, Japan	Asaoka, R (reprint author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	rasaoka-tky@umin.ac.jp			Japan Science and Technology Agency (JST) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Tokyo, Japan) [25861618, 50570701, 26462679]	Supported in part by Japan Science and Technology Agency (JST) CREST (RA and HM) Grants, 25861618 (HM), 50570701 (CM), and 26462679 (RA) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Tokyo, Japan).	Anderson D. R., 1999, AUTOMATED STATIC PER; Bengtsson B, 2000, INVEST OPHTH VIS SCI, V41, P2201; Artes PH, 2002, INVEST OPHTH VIS SCI, V43, P2654; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Bengtsson B, 2000, ACTA OPHTHALMOL SCAN, V78, P519, DOI 10.1034/j.1600-0420.2000.078005519.x; MCMILLAN TA, 1992, ACTA OPHTHALMOL, V70, P665; Henson DB, 1996, INVEST OPHTH VIS SCI, V37, P444; SANABRIA O, 1991, OPHTHALMOLOGY, V98, P76; [Anonymous], 1994, HUMPHR FIELD AN SER; [Anonymous], 2010, HUMPHR FIELD AN 2 I; Newkirk MR, 2006, INVEST OPHTH VIS SCI, V47, P4632, DOI 10.1167/iovs.05-1598; Blumenthal EZ, 2003, OPHTHALMOLOGY, V110, P1895, DOI 10.1016/S0161-6420(03)00541-4; Demirel S, 1994, J Glaucoma, V3, P28; Demirel S, 1992, PERIMETRY UPDATE 199, P515; FANKHAUSER F, 1977, SURV OPHTHALMOL, V22, P131, DOI 10.1016/0039-6257(77)90094-7; Johnson CA, 2014, J GLAUCOMA, V23, P288, DOI 10.1097/IJG.0b013e31829463ab; KATZ J, 1990, OPHTHALMOLOGY, V97, P1032; Kunimatsu Shiho, 1999, Nippon Ganka Gakkai Zasshi, V103, P748; Reddy GR., 2006, VISUAL FIELD EVALUAT; Wall M, 2008, J GLAUCOMA, V17, P626, DOI 10.1097/IJG.0b013e318168f03e	20	1	1	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	DEC	2014	55	12					8149	8152		10.1167/iovs.14-15541		4	Ophthalmology	Ophthalmology	AX9KR	WOS:000347222300050		
J	Kamao, H; Mandai, M; Wakamiya, S; Ishida, J; Goto, K; Ono, T; Suda, T; Takahashi, M; Kiryu, J				Kamao, Hiroyuki; Mandai, Michiko; Wakamiya, Shunji; Ishida, Junko; Goto, Katsutoshi; Ono, Takaaki; Suda, Taiji; Takahashi, Masayo; Kiryu, Junichi			Objective Evaluation of the Degree of Pigmentation in Human Induced Pluripotent Stem Cell-Derived RPE	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						retinal pigment epithelium; degree of pigmentation; human induced pluripotent stem cell	MACULAR DEGENERATION; HUMAN FIBROBLASTS; EPITHELIUM; NEOVASCULARIZATION; TRANSPLANTATION; GENERATION; MELANIN; MODELS; MOUSE	PURPOSE. For the transplantation of human induced pluripotent stem cell-derived retinal pigment epithelium (hiPSC-RPE), determination of the maturation status of these cells is essential, and the degree of pigmentation (dPG) can serve as a good indicator of this status. The aim of this study was to establish a method of objectively and quantitatively evaluating the dPG of hiPSC-RPE. METHODS. Two observers determined the dPG subjectively by observing recorded images of hiPSC-RPE as follows: the dPG of a single cell was classified into three different pigmentation stages, and the overall dPG was compared between two cell groups to identify the group with the higher dPG. The kappa statistic was applied to assess interobserver reproducibility. Next, the dPG of single cells and cell groups was objectively determined by the lightness of the hue, saturation, and value (HSL) color space, and the correlation between the subjective evaluation and time-dependent change in the objective dPG of hiPSC-RPE was investigated. RESULTS. The kappa statistic was 0.88 and 0.81 in the single-cell and cell-group observations, respectively. The objective dPG of single cells and cell groups was highly correlated with the subjective dPG. However, the observers were occasionally unable to subjectively determine the group with the higher dPG. The objective dPG increased in a time-dependent manner. CONCLUSIONS. The lightness of the HSL color space can be used to objectively and quantitatively evaluate the dPG of hiPSC-RPE in culture. The objective evaluation was consistent and was able to better identify small differences than subjective evaluation.	[Kamao, Hiroyuki; Wakamiya, Shunji; Ishida, Junko; Goto, Katsutoshi; Ono, Takaaki; Kiryu, Junichi] Kawasaki Med Univ, Dept Ophthalmol, Kurashiki, Okayama, Japan; [Kamao, Hiroyuki; Mandai, Michiko; Takahashi, Masayo] RIKEN, Ctr Dev Biol, Lab Retinal Regenerat, Chuo Ku, Kobe, Hyogo, Japan; [Suda, Taiji] Kawasaki Med Univ, Tissue Biol & Electron Microscopy Res Ctr, Kurashiki, Okayama, Japan	Kamao, H (reprint author), 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	hironeri@med.kawasaki-m.ac.jp			Kawasaki Medical School [24GS-6]; KAWASAKI Foundation for Medical Science & Medical Welfare	Supported by Grant 24GS-6 from Kawasaki Medical School, the KAWASAKI Foundation for Medical Science & Medical Welfare, and an academic contribution from Pfizer Japan, Inc.	Rozanowska M, 1999, FREE RADICAL BIO MED, V26, P518, DOI 10.1016/S0891-5849(98)00234-2; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; MULLEN RJ, 1976, SCIENCE, V192, P799, DOI 10.1126/science.1265483; Jin ZB, 2012, STEM CELL TRANSL MED, V1, P503, DOI 10.5966/sctm.2012-0005; Lu B, 2009, STEM CELLS, V27, P2126, DOI 10.1002/stem.149; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/nmeth.1591, 10.1038/NMETH.1591]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Binder S, 2002, AM J OPHTHALMOL, V133, P215, DOI 10.1016/S0002-9394(01)01373-3; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Singh R, 2013, HUM MOL GENET, V22, P593, DOI 10.1093/hmg/dds469; Kamao H, 2014, STEM CELL REP, V2, P205, DOI 10.1016/j.stemcr.2013.12.007; ALGVERE PV, 1994, GRAEF ARCH CLIN EXP, V232, P707, DOI 10.1007/BF00184273; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Anthony V, 2008, EXP NEUROL, V214, P347; Boulton ME, 1998, RETINAL PIGMENT EPIT, P68; Joblove GH, 1978, COMPUT GRAPH, V12, P20, DOI [10.1145/965139.807362, DOI 10.1145/965139.807362]; Munshell AH, 1912, AM J PSYCHOL, V23, P236, DOI 10.2307/1412843; SARNA T, 1992, J PHOTOCH PHOTOBIO B, V12, P215, DOI 10.1016/1011-1344(92)85027-R; Schwartz DS, 2012, LANCET, V379, P713; Smith A.R., 1978, COMPUTER GRAPHICS, V12, P12, DOI DOI 10.1145/965139.807361; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755	23	0	0	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	DEC	2014	55	12					8309	8318		10.1167/iovs.14-14694		10	Ophthalmology	Ophthalmology	AX9KR	WOS:000347222300069		
J	Kaneko, H				Kaneko, Hiroki			Author Response: Interleukin-18 Bioactivity and Dose: Data Interpretation at a Crossroads	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Letter							MACULAR DEGENERATION; RHEUMATOID-ARTHRITIS; NLRP3 INFLAMMASOME; IL-18; ACTIVATION; APOPTOSIS; VEGF; RETINOPATHY; EXPRESSION; MICROGLIA		Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan	Kaneko, H (reprint author), Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan.	h-kaneko@med.nagoya-u.ac.jp					Ambati Jayakrishna, 2011, Invest Ophthalmol Vis Sci, V52, P2165, DOI 10.1167/iovs.11-7328; Haimovici R, 2002, OPHTHALMOLOGY, V109, P164, DOI 10.1016/S0161-6420(01)00947-2; Michaelides M, 2011, ARCH OPHTHALMOL-CHIC, V129, P30, DOI 10.1001/archophthalmol.2010.321; Jeon S, 2012, CYTOKINE, V60, P535, DOI 10.1016/j.cyto.2012.07.005; Wang GF, 2008, CELL MOL IMMUNOL, V5, P113, DOI 10.1038/cmi.2008.14; Park CC, 2001, J IMMUNOL, V167, P1644; Shen JK, 2014, J CELL PHYSIOL, V229, P974, DOI 10.1002/jcp.24575; Leung BP, 2001, J IMMUNOL, V167, P2879; Marneros AG, 2013, CELL REP, V4, P945, DOI 10.1016/j.celrep.2013.08.002; Dridi S, 2012, P NATL ACAD SCI USA, V109, P13781, DOI 10.1073/pnas.1206494109; Gracie JA, 1999, J CLIN INVEST, V104, P1393, DOI 10.1172/JCI7317; Amin MA, 2010, ANN RHEUM DIS, V69, P2204, DOI 10.1136/ard.2009.127241; Kim Y, 2014, P NATL ACAD SCI USA, V111, P16082, DOI 10.1073/pnas.1403814111; Doyle SL, 2012, NAT MED, V18, P791, DOI 10.1038/nm.2717; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Tarallo V, 2012, CELL, V149, P847, DOI 10.1016/j.cell.2012.03.036; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Wang XJ, 2005, MECH AGEING DEV, V126, P1241, DOI 10.1016/j.mad.2005.06.012; Chew EY, 2014, JAMA OPHTHALMOL, V132, P272, DOI 10.1001/jamaophthalmol.2013.6636; Cho ML, 2006, IMMUNOL LETT, V103, P159, DOI 10.1016/j.imlet.2005.10.020; Cressey D, 2013, NATURE, V502, P154, DOI 10.1038/502154a; Doyle SL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007616; Doyle SL, 2014, INVEST OPHTH VIS SCI, V55, P8349, DOI 10.1167/iovs.14-15786; Hirano Y, 2014, NAT MED, V20, P1372, DOI 10.1038/nm.3671; Hosohara K, 2002, CLIN DIAGN LAB IMMUN, V9, P777, DOI 10.1128/CDLI.9.4.777-783.2002; Jones N, 2013, NATURE NEWS; Kaestel CG, 2001, EXP CLIN IMMUNOGENET, V18, P34; Ohtsuki T, 1997, ANTICANCER RES, V17, P3253; Reddy P, 2001, J EXP MED, V194, P1433, DOI 10.1084/jem.194.10.1433; Whitman SC, 2002, CIRC RES, V90, pE34, DOI 10.1161/hh0202.105292; Wieseler B, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001526	32	0	0	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	DEC	2014	55	12					8350	8352		10.1167/iovs.14-15878		3	Ophthalmology	Ophthalmology	AX9KR	WOS:000347222300075		
J	Hirasawa, K; Shoji, N; Yoshii, Y; Haraguchi, S				Hirasawa, Kazunori; Shoji, Nobuyuki; Yoshii, Yukako; Haraguchi, Shota			Comparison of Kang's and Littmann's Methods of Correction for Ocular Magnification in Circumpapillary Retinal Nerve Fiber Layer Measurement	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						circumpapillary retinal nerve fiber layer; optical coherence tomography; magnification correction; Kang's method; Littmann's method	OPTICAL COHERENCE TOMOGRAPHY; TIME-DOMAIN OCT; CIRRUS HD-OCT; SPECTRAL-DOMAIN; THICKNESS MEASUREMENTS; AXIAL LENGTH; NORMAL EYES; FUNDUS OBJECTS; REAL SIZE; REPRODUCIBILITY	PURPOSE. To assess and compare the accuracy of Kang's method for ocular magnification correction in circumpapillary retinal nerve fiber layer (cpRNFL) thickness measurement with that of the currently used Littmann's method. METHODS. A total of 148 eyes of 148 healthy participants underwent cpRNFL measurement without correction and with correction by Littmann's method using spectral-domain optical coherence tomography. Correction of ocular magnification by Kang's method is based on the observed uncorrected cpRNFL thickness. The accuracy of Kang's method was compared with that of Littmann's method for magnification correction by using the Pearson product-moment correlation coefficient (r) and Bland-Altman analysis. RESULTS. A total of 132 eyes were assessed. The two methods used to correct the global cpRNFL thickness were strongly correlated (r = 0.940, P < 0.01), and the mean difference between the two methods was -0.4 mu m, with 95% limits of agreement (LoA) of +/- 6 mu m without systemic bias (P > 0.05). Although the cpRNFL thicknesses corrected with the two methods at quadrant and 12-o'clock sectors showed a strong correlation (r > 0.731, P < 0.01), high LoAs ranging from +/- 13.3 to +/- 27.9 and systemic biases were observed at nasal and inferior sectors. CONCLUSION. No difference was found between Kang's and Littmann's methods for correction of ocular magnification in global cpRNFL thickness measurement. However, with regard to magnification correction for sectoral cpRNFL thickness, further scrutiny of Kang's method is warranted, even in healthy participants, because of the high variability between Littmann's and Kang's methods.	[Hirasawa, Kazunori; Shoji, Nobuyuki; Yoshii, Yukako; Haraguchi, Shota] Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Sagamihara, Kanagawa 2520374, Japan	Hirasawa, K (reprint author), Kitasato Univ, Sch Allied Hlth Sci, Dept Rehabil, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	hirasawa@kitasato-u.ac.jp					Mwanza JC, 2010, INVEST OPHTH VIS SCI, V51, P5724, DOI 10.1167/iovs.10-5222; Savini G, 2012, BRIT J OPHTHALMOL, V96, P57, DOI 10.1136/bjo.2010.196782; Vizzeri G, 2009, BRIT J OPHTHALMOL, V93, P775, DOI 10.1136/bjo.2008.150698; Kang SH, 2010, INVEST OPHTH VIS SCI, V51, P4075, DOI 10.1167/iovs.09-4737; Wu HJ, 2011, J GLAUCOMA, V20, P470, DOI 10.1097/IJG.0b013e3181f3eb64; Toteberg-Harms M, 2012, GRAEF ARCH CLIN EXP, V250, P279, DOI 10.1007/s00417-011-1811-9; Yamashita T, 2013, INVEST OPHTH VIS SCI, V54, P5481, DOI 10.1167/iovs.12-11008; Gonzalez-Garcia AO, 2009, AM J OPHTHALMOL, V147, P1067, DOI 10.1016/j.ajo.2008.12.032; Garas A, 2010, OPHTHALMOLOGY, V117, P738, DOI 10.1016/j.ophtha.2009.08.039; Garway-Heath DF, 1998, BRIT J OPHTHALMOL, V82, P643, DOI 10.1136/bjo.82.6.643; Leung CKS, 2007, INVEST OPHTH VIS SCI, V48, P3178, DOI 10.1167/iovs.06-1315; Varma R, 1996, OPHTHALMOLOGY, V103, P2114; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Hong S, 2010, JPN J OPHTHALMOL, V54, P43, DOI 10.1007/s10384-009-0762-8; Tan BB, 2012, J GLAUCOMA, V21, P266, DOI 10.1097/IJG.0b013e3182071cdd; Seibold LK, 2010, AM J OPHTHALMOL, V150, P807, DOI 10.1016/j.ajo.2010.06.024; Aykut V, 2013, CURR EYE RES, V38, P1241, DOI 10.3109/02713683.2013.820328; BLAND JM, 1986, LANCET, V1, P307; Carpineto P, 2012, OPHTHALMOLOGICA, V227, P139, DOI 10.1159/000334967; Coleman AL, 1996, J GLAUCOMA, V5, P433; Dawczynski J, 2011, GRAEF ARCH CLIN EXP, V249, P381, DOI 10.1007/s00417-010-1498-3; Hirasawa H, 2010, ARCH OPHTHALMOL-CHIC, V128, P1420, DOI 10.1001/archophthalmol.2010.244; Hong Jung Taeck, 2012, Korean J Ophthalmol, V26, P32, DOI 10.3341/kjo.2012.26.1.32; Hsu SY, 2013, CLIN EXP OPTOM, V96, P373, DOI 10.1111/cxo.12052; Kanamori A, 2012, JPN J OPHTHALMOL, V56, P354, DOI 10.1007/s10384-012-0143-6; Kim MJ, 2010, BRIT J OPHTHALMOL, V94, P115, DOI 10.1136/bjo.2009.162206; Littmann H, 1992, Optom Vis Sci, V69, P717; LITTMANN H, 1982, KLIN MONATSBL AUGENH, V180, P286, DOI 10.1055/s-2008-1055068; Menke MN, 2008, INVEST OPHTH VIS SCI, V49, P5386, DOI 10.1167/iovs.07-1435; Moreno-Montanes J, 2013, J GLAUCOMA, V22, P243, DOI 10.1097/IJG.0b013e318237c878; Oner V, 2014, EUR J OPHTHALMOL, V24, P265, DOI 10.5301/ejo.5000345; Oner V, 2013, BRIT J OPHTHALMOL, V97, P75, DOI 10.1136/bjophthalmol-2012-301865; Oner V, 2013, CURR EYE RES, V38, P102, DOI 10.3109/02713683.2012.715714; Shpak AA, 2012, GRAEF ARCH CLIN EXP, V250, P271, DOI 10.1007/s00417-011-1808-4; Yoo YC, 2012, OPTOMETRY VISION SCI, V89, P4, DOI 10.1097/OPX.0b013e3182358008	35	0	0	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	DEC	2014	55	12					8353	8358		10.1167/iovs.14-15720		6	Ophthalmology	Ophthalmology	AX9KR	WOS:000347222300076		
J	Morishige, N; Shin-gyou-uchi, R; Azumi, H; Ohta, H; Morita, Y; Yamada, N; Kimura, K; Takahara, A; Sonoda, KH				Morishige, Naoyuki; Shin-gyou-uchi, Ryutaro; Azumi, Haruya; Ohta, Hiroaki; Morita, Yukiko; Yamada, Naoyuki; Kimura, Kazuhiro; Takahara, Atsushi; Sonoda, Koh-Hei			Quantitative Analysis of Collagen Lamellae in the Normal and Keratoconic Human Cornea by Second Harmonic Generation Imaging Microscopy	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						corneal stroma; collagen; normal cornea; second harmonic generation; keratoconus	OCULAR RESPONSE ANALYZER; ATOMIC-FORCE MICROSCOPY; BULLOUS KERATOPATHY; OXIDATIVE STRESS; EX-VIVO; BIOMECHANICAL PROPERTIES; BRILLOUIN MICROSCOPY; ANTERIOR STROMA; ORGANIZATION; FIBRILS	PURPOSE. To characterize the structural properties of collagen lamellae in the normal and keratoconic human corneal stroma, we measured their width and angle relative to Bowman's layer (BL). METHODS. Thirteen normal and four keratoconic corneas were examined. Collagen lamellae in tissue blocks from the central cornea were visualized by second harmonic generation imaging microscopy. Images obtained in 1-mu m steps from BL to Descemet's membrane (DM) were subjected to three- dimensional reconstruction. The reconstructed data sets were divided into 10 layers of equal depth ( L1-L10) for analysis. The width of lamellae adherent to BL (L0) was also determined. RESULTS. For the normal cornea, the width (mean 6 SD) of collagen lamellae was 6.5 +/- 1.7 mu m at L0, decreased to 4.3 +/- 1.3 mu m at L1, and then increased gradually with progression toward DM to 122.2 +/- 34.5 mu m at L10, whereas the angle of lamellae was 20.9 degrees +/- 5.4 degrees at L1 and decreased initially to 10.6 degrees +/- 3.2 degrees at L2 before declining gradually to 2.7 degrees +/- 2.2 degrees at L10. The width and angle of collagen lamellae in the keratoconic cornea were significantly larger and smaller, respectively, relative to those in the normal cornea. CONCLUSIONS. In the normal human cornea, collagen lamellae adjacent to BL are narrow and form a steep angle with BL, whereas they increase in width and their angle relative to BL flattens with progression toward DM. These properties of collagen lamellae are altered in keratoconus and are likely related to abnormalities of corneal shape.	[Morishige, Naoyuki; Shin-gyou-uchi, Ryutaro; Azumi, Haruya; Ohta, Hiroaki; Morita, Yukiko; Yamada, Naoyuki; Kimura, Kazuhiro; Sonoda, Koh-Hei] Yamaguchi Univ, Grad Sch Med, Dept Ophthalmol, Ube, Yamaguchi 7558505, Japan; [Takahara, Atsushi] Kyushu Univ, Inst Mat Chem & Engn, Fukuoka 812, Japan	Morishige, N (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Ophthalmol, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	morishig@yamaguchi-u.ac.jp					Meek KM, 2004, EXP EYE RES, V78, P503, DOI 10.1016/j.exer.2003.07.003; POLACK FM, 1961, AM J OPHTHALMOL, V51, P1051; Saghizadeh M, 2001, AM J PATHOL, V158, P723, DOI 10.1016/S0002-9440(10)64015-1; Morishige N, 2011, INVEST OPHTH VIS SCI, V52, P911, DOI 10.1167/iovs.10-5657; Saghizadeh M, 2001, EXP EYE RES, V73, P179, DOI 10.1006/exer.2001.1028; Teng SW, 2006, INVEST OPHTH VIS SCI, V47, P1216, DOI 10.1167/iovs.04-1520; Moreno-Montanes J, 2008, INVEST OPHTH VIS SCI, V49, P968, DOI 10.1167/iovs.07-0280; Morishige N, 2006, J CATARACT REFR SURG, V32, P1784, DOI 10.1016/j.jcrs.2006.08.027; Shah S, 2007, INVEST OPHTH VIS SCI, V48, P3026, DOI 10.1167/iovs.04-0694; Kenney MC, 2005, INVEST OPHTH VIS SCI, V46, P823, DOI 10.1167/iovs.04-0549; Scarcelli G, 2013, INVEST OPHTH VIS SCI, V54, P1418, DOI 10.1167/iovs.12-11387; Luce DA, 2005, J CATARACT REFR SURG, V31, P156, DOI 10.1016/j.jcrs.2004.10.044; Morishige N, 2009, INVEST OPHTH VIS SCI, V50, P3145, DOI 10.1167/iovs.08-3309; Morishige N, 2012, INVEST OPHTH VIS SCI, V53, P4998, DOI 10.1167/iovs.12-10214; Balasubramanian SA, 2010, CURR EYE RES, V35, P185, DOI 10.3109/02713680903477824; Meek KM, 2005, INVEST OPHTH VIS SCI, V46, P1948, DOI 10.1167/iovs.04-1253; Chwa M, 2008, INVEST OPHTH VIS SCI, V49, P4361, DOI 10.1167/iovs.08-1969; Morishige N, 2007, INVEST OPHTH VIS SCI, V48, P1087, DOI 10.1167/iovs.06-1177; Winkler M, 2013, INVEST OPHTH VIS SCI, V54, P7293, DOI 10.1167/iovs.13-13150; Radner W, 1998, OPHTHALMIC RES, V30, P327, DOI 10.1159/000055492; Akhtar S, 2008, ACTA OPHTHALMOL, V86, P764, DOI 10.1111/j.1755-3768.2007.01142.x; Radner W, 1998, CORNEA, V17, P537, DOI 10.1097/00003226-199809000-00012; Lo W, 2012, INVEST OPHTH VIS SCI, V53, P3501, DOI 10.1167/iovs.10-6697; Mohler W, 2003, METHODS, V29, P97, DOI 10.1016/S1046-2023(02)00292-X; Lombardo M, 2012, INVEST OPHTH VIS SCI, V53, P1050, DOI 10.1167/iovs.11-8720; Muller LJ, 2001, BRIT J OPHTHALMOL, V85, P437, DOI 10.1136/bjo.85.4.437; Arnal E, 2011, INVEST OPHTH VIS SCI, V52, P8592, DOI 10.1167/iovs.11-7732; Barishak YR, 2001, EMBRYOLOGY EYE ITS A, P7; Bron AJ, 1997, WOLFFS ANATOMY EYE O, P233; Dias JM, 2013, EXP EYE RES, V115, P41, DOI 10.1016/j.exer.2013.06.004; Drubaix I, 1996, EXP EYE RES, V62, P367, DOI 10.1006/exer.1996.0042; FULLWOOD NJ, 1992, INVEST OPHTH VIS SCI, V33, P1734; Hayes S, 2007, EXP EYE RES, V84, P423, DOI 10.1016/j.exer.2006.10.014; Hogan MJ, 1971, HISTOLOGY HUMAN EYE, P55; Jun AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016437; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; Last JA, 2012, MICRON, V43, P1293, DOI 10.1016/j.micron.2012.02.014; Tan HY, 2006, INVEST OPHTH VIS SCI, V47, P5251, DOI 10.1167/iovs.06-0386; Maurice D, 1969, EYE, P489; MAURICE DM, 1990, EXP EYE RES, V50, P59, DOI 10.1016/0014-4835(90)90011-I; McTigue J W, 1967, Trans Am Ophthalmol Soc, V65, P591; Morishige N, 2009, CORNEA, V28, pS46; Morishige N, 2013, CORNEA, V32, pS77, DOI 10.1097/ICO.0b013e3182a1bc65; Patey A, 1984, Cornea, V3, P119; Richoz O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105095; Sawaguchi S, 1998, ARCH OPHTHALMOL-CHIC, V116, P62; Scarcelli G, 2014, INVEST OPHTH VIS SCI, V55, P4490, DOI 10.1167/iovs.14-14450; Smith VA, 2000, EUR J OPHTHALMOL, V10, P215; TAKAHASHI A, 1990, Nippon Ganka Gakkai Zasshi, V94, P1068; TRIPATHI RC, 1975, BRIT J OPHTHALMOL, V59, P59, DOI 10.1136/bjo.59.1.59	50	1	1	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	DEC	2014	55	12					8377	8385		10.1167/iovs.14-15348		9	Ophthalmology	Ophthalmology	AX9KR	WOS:000347222300081		
J	Murata, H; Araie, M; Asaoka, R				Murata, Hiroshi; Araie, Makoto; Asaoka, Ryo			A New Approach to Measure Visual Field Progression in Glaucoma Patients Using Variational Bayes Linear Regression	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						visual field; glaucoma; progression; variational Bayes; E-M algorithm	STANDARD AUTOMATED PERIMETRY; NORMAL-TENSION GLAUCOMA; MEASURING RATES; RISK-FACTORS; OPEN-ANGLE; DEFECTS; ALGORITHM; SCOTOMAS; IMPROVE; DAMAGE	PURPOSE. We generated a variational Bayes model to predict visual field (VF) progression in glaucoma patients. METHODS. This retrospective study included VF series from 911 eyes of 547 glaucoma patients as test data, and VF series from 5049 eyes of 2858 glaucoma patients as training data. Using training data, variational Bayes linear regression (VBLR) was created to predict VF progression. The performance of VBLR was compared against ordinary least-squares linear regression (OLSLR) by predicting VFs in the test dataset. The total deviation (TD) values of test patients' 11th VFs were predicted using TD values from their second to 10th VFs (VF210), the root mean squared error (RMSE) associated with each approach then was calculated. Similarly, mean TD (mTD) of test patients' 11th VFs was predicted using VBLR and OLSLR, and the absolute prediction errors compared. RESULTS. The RMSE resulting from VBLR averaged 3.9 +/- 2.1 (SD) and 4.9 +/- 2.6 dB for prediction based on the second to 10th VFs (VF2-10) and the second to fourth VFs (VF2-4), respectively. The RMSE resulting from OLSLR was 4.1 +/- 2.0 (VF2-10) and 19.9 +/- 12.0 (VF2-4) dB. The absolute prediction error (SD) for mTD using VBLR was 1.2 +/- 1.3 (VF2-10) and 1.9 +/- 2.0 (VF2-4) dB, while the prediction error resulting from OLSLR was 1.2 +/- 1.3 (VF2-10) and 6.2 +/- 6.6 (VF2-4) dB. CONCLUSIONS. The VBLR more accurately predicts future VF progression in glaucoma patients compared to conventional OLSLR, especially in short VF series.	[Murata, Hiroshi; Araie, Makoto; Asaoka, Ryo] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo 1138655, Japan; [Araie, Makoto] Mutual Aid Assoc Publ Sch Teachers, Kanto Cent Hosp, Tokyo, Japan	Asaoka, R (reprint author), Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	rasaoka-tky@umin.ac.jp			Japan Science and Technology Agency (JST) CREST; Ministry of Education, Culture, Sports, Science and Technology of Japan [25861618, 26462679]	Supported in part by Japan Science and Technology Agency (JST) CREST (RA, HM), and Grants 25861618 (HM) and 26462679 (RA) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors alone are responsible for the content and writing of the paper. A patent application (PCT/JP2013/073426: Visual-field-test assistance device) has been filed and variational Bayes linear regression is part of analytical methods.	Altangerel Undraa, 2003, Curr Opin Ophthalmol, V14, P100, DOI 10.1097/00055735-200304000-00009; DRANCE SM, 1969, INVEST OPHTH VISUAL, V8, P84; Chauhan BC, 2008, BRIT J OPHTHALMOL, V92, P569, DOI 10.1136/bjo.2007.135012; LEVENE RZ, 1980, SURV OPHTHALMOL, V24, P621, DOI 10.1016/0039-6257(80)90123-X; Ueda N, 1998, NEURAL NETWORKS, V11, P271, DOI 10.1016/S0893-6080(97)00133-0; Fitzke FW, 1996, BRIT J OPHTHALMOL, V80, P40, DOI 10.1136/bjo.80.1.40; Suzuki Y, 2001, J GLAUCOMA, V10, P121, DOI 10.1097/00061198-200104000-00009; CAPRIOLI J, 1986, AM J OPHTHALMOL, V102, P402; Russell RA, 2012, INVEST OPHTH VIS SCI, V53, P2760, DOI 10.1167/iovs.11-7976; MIKELBERG FS, 1986, AM J OPHTHALMOL, V101, P1; Jansonius NM, 2010, BRIT J OPHTHALMOL, V94, P1404, DOI 10.1136/bjo.2009.164897; Park SC, 2011, OPHTHALMOLOGY, V118, P1782, DOI 10.1016/j.ophtha.2011.02.013; Bryan SR, 2013, INVEST OPHTH VIS SCI, V54, P6694, DOI 10.1167/iovs.12-11185; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Medeiros FA, 2012, AM J OPHTHALMOL, V153, P1197, DOI 10.1016/j.ajo.2011.11.015; MANDAVA S, 1993, AM J OPHTHALMOL, V116, P684; DRANCE SM, 1987, AM J OPHTHALMOL, V104, P577; Caprioli J, 2011, INVEST OPHTH VIS SCI, V52, P4765, DOI 10.1167/iovs.10-6414; O'Leary N, 2012, INVEST OPHTH VIS SCI, V53, P6776, DOI 10.1167/iovs.12-10049; Medeiros FA, 2012, INVEST OPHTH VIS SCI, V53, P2199, DOI 10.1167/iovs.11-8639; Nakagami T, 2006, JPN J OPHTHALMOL, V50, P38, DOI 10.1007/s10384-005-0273-1; Goldbaum MH, 2002, INVEST OPHTH VIS SCI, V43, P162; Betz-Stablein BD, 2013, INVEST OPHTH VIS SCI, V54, P1544, DOI 10.1167/iovs.12-11226; Spry PGD, 2000, INVEST OPHTH VIS SCI, V41, P2192; SUZUKI Y, 1993, OPHTHALMOLOGY, V100, P69; CHAUHAN BC, 1989, AM J OPHTHALMOL, V108, P636; Nouri-Mahdavi K, 2012, INVEST OPHTH VIS SCI, V53, P2390, DOI 10.1167/iovs.11-9021; Elhamifar E, 2013, IEEE T PATTERN ANAL, V35, P2765, DOI 10.1109/TPAMI.2013.57; CAPRIOLI J, 1984, AM J OPHTHALMOL, V97, P730; ARAIE M, 1995, GRAEF ARCH CLIN EXP, V233, P610, DOI 10.1007/BF00185280; HOLMIN C, 1982, ACTA OPHTHALMOL, V60, P267; MCNAUGHT AI, 1995, GRAEF ARCH CLIN EXP, V233, P750, DOI 10.1007/BF00184085; Bishop C. M., 2006, PATTERN RECOGNITION, V1; Gardiner SK, 2008, OPTOMETRY VISION SCI, V85, P1043, DOI 10.1097/OPX.0b013e31818b9b40; Heijl A, 1996, ARCH OPHTHALMOL-CHIC, V114, P19; Jacobs R. A., 1991, Neural Computation, V3, DOI 10.1162/neco.1991.3.1.79; Katahira K, 2008, J PHYS CONF SER, V95, pU159, DOI 10.1088/1742-6596/95/1/012015; Krakau C E, 1985, Acta Ophthalmol Suppl, V173, P19; Malik R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002067; McLachlan G., 2004, FINITE MIXTURE MODEL; Pathak M, 2013, INVEST OPHTH VIS SCI, V54, P5505, DOI 10.1167/iovs.13-12236; Russell RA, 2011, INVEST OPHTH VIS SCI, V52, P9539, DOI 10.1167/iovs.11-8948; Sanderson C, 2010, ARMADILLO OPEN SOURC; Viswanathan AC, 2003, BRIT J OPHTHALMOL, V87, P726, DOI 10.1136/bjo.87.6.726; Zhu HG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085654	45	2	2	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	DEC	2014	55	12					8386	8392		10.1167/iovs.14-14625		7	Ophthalmology	Ophthalmology	AX9KR	WOS:000347222300082		
J	Watanabe, K; Zhu, H; Willcox, M				Watanabe, Keizo; Zhu, Hua; Willcox, Mark			Susceptibility of Stenotrophomonas maltophilia Clinical Isolates to Antibiotics and Contact Lens Multipurpose Disinfecting Solutions	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						disinfection; Stenotrophomonas; antibiotics	OPPORTUNISTIC PATHOGEN; MICROBIAL KERATITIS; DAILY WEAR; ACANTHAMOEBA; INFECTIONS; ENDOPHTHALMITIS; RESISTANCE; BACTERIA	PURPOSE. To determine the susceptibility of Stenotrophomonas maltophilia to various antibiotics and contact lens multipurpose disinfecting solutions. METHODS. Forty S. maltophilia strains from contact lens cases, contact lenses, or eye swabs of contact lens wearers including 27 asymptomatic wearers and 13 keratitis patients were examined for their susceptibility to different antibiotics, using a disc diffusion assay, and to multipurpose disinfecting solutions using a broth microdilution method. RESULTS. Certain strains were resistant to aztreonum (15%), imipenem (93%), chroramphenicol (13%), and cefepime (8%). Two of those strains were multidrug resistant. All strains were sensitive to trimethoprim-sulfamethoxazole, tigecycline, ceftazidime, and fluoroquinolones. Overall, the minimum inhibitory concentration (MIC) for all strains was significantly higher (P < 0.05) for AQuify (50% dilution) and OPTI-FREE RepleniSH (25%) than all other multipurpose contact lens disinfecting solutions (MPDS) (3%-14%, except RepleniSH versus MeniCare Soft [14%]). AQuify, OPTI-FREE RepleniSH, and MeniCare Soft had significantly higher minimum bactericidal concentrations (undiluted MPDS) than other disinfecting solutions (P < 0.05). CONCLUSIONS. The Australian ocular isolates of S. maltophilia remain susceptible to trimethoprim-sulfamethozole, tigecycline, and most fluoroquinolones. However, the isolates showed resistance to certain multipurpose disinfecting solutions.	[Watanabe, Keizo] Kinki Univ, Dept Ophthalmol, Fac Med, Osaka, Japan; [Watanabe, Keizo; Zhu, Hua] Univ New S Wales, Brien Holden Vis Inst, Sydney, NSW 2052, Australia; [Zhu, Hua; Willcox, Mark] Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW 2052, Australia	Willcox, M (reprint author), Univ New S Wales, Sch Optometry & Vis Sci, Sydney, NSW 2052, Australia.	m.willcox@unsw.edu.au			Brien Holden Vision Institute	Supported by the Brien Holden Vision Institute. The authors alone are responsible for the content and writing of the paper.	Abbott Iain J, 2011, Expert Rev Anti Infect Ther, V9, P471, DOI 10.1586/eri.11.24; Akcakaya AA, 2011, BRIT J OPHTHALMOL, V95, P481, DOI 10.1136/bjo.2009.177709; Hansen CR, 2012, CURR OPIN PULM MED, V18, P628, DOI 10.1097/MCP.0b013e328358d4f8; Falagas ME, 2009, FUTURE MICROBIOL, V4, P1103, DOI [10.2217/fmb.09.84, 10.2217/FMB.09.84]; Stapleton F, 2012, OPHTHALMOLOGY, V119, P1516, DOI 10.1016/j.ophtha.2012.01.052; Holifield K, 2011, EYE CONTACT LENS, V37, P326, DOI 10.1097/ICL.0b013e3182146e26; Stapleton F, 2008, OPHTHALMOLOGY, V115, P1655, DOI 10.1016/j.ophtha.2008.04.002; Brooke JS, 2014, EXPERT REV ANTI-INFE, V12, P1, DOI 10.1586/14787210.2014.864553; PALLERONI NJ, 1993, INT J SYST BACTERIOL, V43, P606; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI [10.1128/​CMR.00019-11, 10.1128/CMR.00019-11]; Sanchez MB, 2009, FUTURE MICROBIOL, V4, P655, DOI [10.2217/fmb.09.45, 10.2217/FMB.09.45]; Falagas ME, 2009, EUR J CLIN MICROBIOL, V28, P719, DOI 10.1007/s10096-009-0709-5; Das T, 2009, J MED MICROBIOL, V58, P837, DOI 10.1099/jmm.0.009431-0; HUGH R, 1963, INT B BACT NOMENCL T, V13, P133; Farrell DJ, 2010, ANTIMICROB AGENTS CH, V54, P2735, DOI 10.1128/AAC.01774-09; Wiley L, 2012, INVEST OPHTH VIS SCI, V53, P3896, DOI 10.1167/iovs.11-8762; Szczotka-Flynn LB, 2009, CORNEA, V28, P918, DOI 10.1097/ICO.0b013e3181a81835; Willcox MDP, 2013, EYE CONTACT LENS, V39, P24, DOI 10.1097/ICL.0b013e318275e0d9; Kilvington S, 2013, CONTACT LENS ANTERIO, V36, P294, DOI 10.1016/j.clae.2013.02.001; Canton R, 2003, PEDIATR PULM, V35, P99, DOI 10.1002/ppul.10216; Chen KJ, 2010, OPHTHAL SURG LAS IM, V41, P555, DOI 10.3928/15428877-20100910-03; Chen Yeong-Fong, 2005, Chang Gung Med J, V28, P142; Clinical and Laboratory Standards Institute, 2007, M100S17 CLIN LAB STA, P104; Corsaro D, 2013, EXP PARASITOL, V133, P383, DOI 10.1016/j.exppara.2012.12.016; Kim JH, 2006, CORNEA, V25, P1234, DOI 10.1097/01.ico.0000226361.11431.5a; Mauger TF, 2006, CORNEA, V25, P631, DOI 10.1097/01.ico.0000214214.45070.b6; Mauger Thomas F, 2010, Clin Ophthalmol, V4, P1207, DOI 10.2147/OPTH.S14507; Nyc O, 2010, FOLIA MICROBIOL, V55, P286, DOI 10.1007/s12223-010-0043-4; Penland RL, 1996, ARCH OPHTHALMOL-CHIC, V114, P433; Penland RL, 1997, J CLIN MICROBIOL, V35, P915; Sood Smita, 2013, J Clin Diagn Res, V7, P1696, DOI 10.7860/JCDR/2013/5614.3248; Wang XH, 1997, CURR MICROBIOL, V34, P212, DOI 10.1007/s002849900170; Willcox MDP, 2010, OPTOMETRY VISION SCI, V87, P456, DOI 10.1097/OPX.0b013e3181e19eda	33	0	0	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	DEC	2014	55	12					8475	8479		10.1167/iovs.14-15667		5	Ophthalmology	Ophthalmology	AX9KR	WOS:000347222300092		
J	Arichika, S; Uji, A; Murakami, T; Unoki, N; Yoshitake, S; Dodo, Y; Ooto, S; Miyamoto, K; Yoshimura, N				Arichika, Shigeta; Uji, Akihito; Murakami, Tomoaki; Unoki, Noriyuki; Yoshitake, Shin; Dodo, Yoko; Ooto, Sotaro; Miyamoto, Kazuaki; Yoshimura, Nagahisa			Retinal Hemorheologic Characterization of Early-Stage Diabetic Retinopathy Using Adaptive Optics Scanning Laser Ophthalmoscopy	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						diabetic retinopathy; AO-SLO; hemorheology	PARAFOVEAL CAPILLARIES; BLOOD-FLOW; ERYTHROCYTE AGGREGATION; MELLITUS; COMPLICATIONS; VISUALIZATION; HEMODYNAMICS; PREVALENCE; LEUKOCYTES; MORTALITY	PURPOSE. Adaptive optics scanning laser ophthalmoscopy (AO-SLO) is a noninvasive technique that allows for the direct monitoring of erythrocyte aggregates in retinal capillaries. We analyzed the retinal hemorheologic characteristics in normal subjects, diabetic patients without diabetic retinopathy (NDR), and diabetic patients with nonproliferative diabetic retinopathy (NPDR), using spatiotemporal (ST) blood flow images to visualize blood corpuscle trajectory. METHODS. AO-SLO images of the parafoveal capillary network were acquired for three groups: 20 healthy volunteers, 17 diabetic patients with NDR (8 type 1 and 9 type 2 patients), and 10 diabetic patients with NPDR (4 type 1 and 6 type 2). The erythrocyte aggregate velocity assigned to a relative cardiac cycle and the elongation rate of the erythrocyte aggregate were calculated. RESULTS. Careful observation revealed that flow velocity fluctuations were found with higher frequency in diabetic patients than in normal subjects. The total average velocities were 1.26 +/- 0.22 mm/s in the normal group, 1.31 +/- 0.21 mm/s in the NDR group, and 1.63 +/- 0.35 mm/s in the NPDR group. The average velocities of the NPDR group were higher than those in the normal (P = 0.001) and NDR (P = 0.009) groups. The average elongation rates of the 3 groups were 0.67 +/- 0.20, 0.39 +/- 0.19, and 0.33 +/- 0.11, respectively. Elongation rate differed significantly between the normal and NDR (P = 0.003) groups as well as the normal and NPDR (P = 0.001) groups. CONCLUSIONS. AO-SLO can be used to detect retinal hemorheologic changes in the early stages of diabetic retinopathy.	[Arichika, Shigeta; Uji, Akihito; Murakami, Tomoaki; Unoki, Noriyuki; Yoshitake, Shin; Dodo, Yoko; Ooto, Sotaro; Miyamoto, Kazuaki; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto 6068507, Japan	Uji, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	akihito1@kuhp.kyoto-u.ac.jp		Murakami, Tomoaki/0000-0002-0314-8807	Innovative Techno-Hub for Integrated Medical Bio-Imaging of the Project for Developing Innovation Systems; Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan	Supported, in part, by the Innovative Techno-Hub for Integrated Medical Bio-Imaging of the Project for Developing Innovation Systems, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) in Japan. The authors alone are responsible for the content and writing of the paper.	Juutilainen A, 2007, DIABETES CARE, V30, P292, DOI 10.2337/dc06-1747; Mostany R, 2010, J NEUROSCI, V30, P14116, DOI 10.1523/JNEUROSCI.3908-10.2010; Curtis TM, 2009, EYE, V23, P1496, DOI 10.1038/eye.2009.108; Shichiri M, 2000, DIABETES CARE, V23, pB21; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Chui TYP, 2013, INVEST OPHTH VIS SCI, V54, P7115, DOI 10.1167/iovs.13-13027; Kramer CK, 2011, DIABETES CARE, V34, P1238, DOI 10.2337/dc11-0079; Tam J, 2010, INVEST OPHTH VIS SCI, V51, P1691, DOI 10.1167/iovs.09-4483; Vinik AI, 2001, DIABETES CARE, V24, P1476, DOI 10.2337/diacare.24.8.1476; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Clermont AC, 2007, MICROCIRCULATION, V14, P49, DOI 10.1080/10739680601072164; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; Kawasaki R, 2013, OPHTHALMOLOGY, V120, P574, DOI 10.1016/j.ophtha.2012.08.029; Singh M, 2009, INDIAN J EXP BIOL, V47, P7; Tam J, 2011, INVEST OPHTH VIS SCI, V52, P9257, DOI 10.1167/iovs.11-8481; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; Sato Y, 1997, IEEE T BIO-MED ENG, V44, P225, DOI 10.1109/10.563292; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Nicolela MT, 1996, AM J OPHTHALMOL, V122, P775; Nagaoka T, 2010, INVEST OPHTH VIS SCI, V51, P6729, DOI 10.1167/iovs.10-5364; Babu N, 2005, CLIN HEMORHEOL MICRO, V32, P269; Arichika S, 2013, INVEST OPHTH VIS SCI, V54, P4394, DOI 10.1167/iovs.12-11138; Arichika S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089679; Beutelspacher SC, 2011, GRAEF ARCH CLIN EXP, V249, P1855, DOI 10.1007/s00417-011-1757-y; Cho Young I, 2008, J Diabetes Sci Technol, V2, P1130; Demiroglu H, 1997, BLOOD, V89, P4236; Early Treatment Diabetic Retinopathy Study Research Group, 1991, OPHTHALMOLOGY, V98, P786; Hirose F, 2011, PROC SPIE, V7885, DOI 10.1117/12.873671; Lasers ANSftSUo, 2007, ANSIZ136; Le Devehat C, 2001, CLIN HEMORHEOL MICRO, V25, P43; Lorenzi M, 2008, DIABETOLOGIA, V51, P361, DOI 10.1007/s00125-007-0872-0; Martin JA, 2009, EXP EYE RES, V88, P356, DOI 10.1016/j.exer.2008.07.008; Miyamoto K, 1997, MICROVASC RES, V54, P43, DOI 10.1006/mvre.1997.2018; Nishiwaki H, 1996, INVEST OPHTH VIS SCI, V37, P1341; Ogura Y, 2000, JPN J OPHTHALMOL, V44, P322, DOI 10.1016/S0021-5155(00)00164-7; Takayama K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033158; Tam J, 2011, BIOMED OPT EXPRESS, V2, P781, DOI 10.1364/BOE.2.000781; The Diabetes Control and Complications Trial Research Group, 1993, N ENGL J MED, V329, P977; Uji A, 2012, INVEST OPHTH VIS SCI, V53, P171, DOI 10.1167/iovs.11-8192	40	2	2	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	DEC	2014	55	12					8513	8522		10.1167/iovs.14-15121		10	Ophthalmology	Ophthalmology	AX9KR	WOS:000347222300097		
J	Ishikawa, M; Yoshitomi, T; Zorumski, CF; Izumi, Y				Ishikawa, Makoto; Yoshitomi, Takeshi; Zorumski, Charles F.; Izumi, Yukitoshi			Neurosteroids Are Endogenous Neuroprotectants in an Ex Vivo Glaucoma Model	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article						transporter-knockout; Neurosteroid; allopregnanolone; glaucoma; GABA; neuroprotection	LONG-TERM POTENTIATION; ANGLE-CLOSURE GLAUCOMA; ISOLATED RAT RETINA; INTRAOCULAR-PRESSURE; GLUTAMATE TRANSPORTER; HYDROSTATIC-PRESSURE; DOWN-REGULATION; IN-VIVO; ALLOPREGNANOLONE; BRAIN	PURPOSE. Allopregnanolone is a neurosteroid and powerful modulator of neuronal excitability. The neuroprotective effects of allopregnanolone involve potentiation of c-aminobutyric acid (GABA) inhibitory responses. Although glutamate excitotoxicity contributes to ganglion cell death in glaucoma, the role of GABA in glaucoma remains uncertain. The aim of this study was to determine whether allopregnanolone synthesis is induced by high pressure in the retina and whether allopregnanolone modulates pressure-mediated toxicity. METHODS. Ex vivo rat retinas were exposed to hydrostatic pressure (10, 35, and 75 mm Hg) for 24 hours. Endogenous allopregnanolone production was determined by liquid chromatography and tandem mass spectrometry (LC-MS/MS) and immunochemistry. We also examined the effects of allopregnanolone, finasteride, and dutasteride (inhibitors of 5 beta-reductase), picrotoxin (a GABA(A) receptor antagonist), and D-2-amino-5-phosphonovalerate (APV, a broad-spectrum N-methyl-D-aspartate receptor [NMDAR] antagonist). RESULTS. Pressure loading at 75 mm Hg significantly increased allopregnanolone levels as measured by LC-MS/MS. Elevated hydrostatic pressure also increased neurosteroid immunofluorescence, especially in the ganglion cell layer and inner nuclear layers. Staining was negligible at lower pressures. Enhanced allopregnanolone levels and immunostaining were substantially blocked by finasteride, but more effectively inhibited by dutasteride and APV. Administration of exogenous allopregnanolone suppressed pressure-induced axonal swelling in a concentration-dependent manner, while picrotoxin overcame these neuroprotective effects. CONCLUSIONS. These results indicate that the synthesis of allopregnanolone is enhanced mainly via NMDARs in the pressure-loaded retina, and that allopregnanolone diminishes pressure-mediated retinal degeneration via GABAA receptors. Allopregnanolone and other related neurosteroids may serve as potential novel therapeutic targets for the prevention of pressure-induced retinal damage in glaucoma.	[Ishikawa, Makoto; Yoshitomi, Takeshi] Akita Grad Univ, Sch Med, Dept Ophthalmol, Akita, Japan; [Zorumski, Charles F.; Izumi, Yukitoshi] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Zorumski, Charles F.; Izumi, Yukitoshi] Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO 63110 USA	Ishikawa, M (reprint author), Akita Univ, Sch Med, Dept Ophthalmol, 1-1-1 Hondo, Akita 0108543, Japan.	mako@med.akita-u.ac.jp			JSPS KAKENHI Grant [24592666]; National Institutes of Health (NIH; Bethesda, MD, USA) [MH077791, MH101874, AA017413]; Bantly Foundation	Supported in part by JSPS KAKENHI Grant No. 24592666 (MI) and National Institutes of Health (NIH; Bethesda, MD, USA) Grants MH077791, MH101874, and AA017413 (CFZ) and the Bantly Foundation. The authors alone are responsible for the content and writing of the paper.	Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; Yawno T, 2009, NEUROSCIENCE, V163, P838, DOI 10.1016/j.neuroscience.2009.07.009; Brambilla P, 2003, MOL PSYCHIATR, V8, P721, DOI 10.1038/sj.mp.4001362; Luscher B, 2011, MOL PSYCHIATR, V16, P383, DOI 10.1038/mp.2010.120; Clark RV, 2004, J CLIN ENDOCR METAB, V89, P2179, DOI 10.1210/jc.2003-030330; Foster PJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P1105; Traish AM, 2011, J SEX MED, V8, P872, DOI 10.1111/j.1743-6109.2010.02157.x; Dandona L, 2000, OPHTHALMOLOGY, V107, P1710, DOI 10.1016/S0161-6420(00)00274-8; Guarneri P, 2003, ANN NY ACAD SCI, V1007, P117, DOI 10.1196/annals.1286.012; Ciriza I, 2004, J NEUROENDOCRINOL, V16, P58, DOI 10.1111/j.1365-2826.2004.01121.x; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Martin KRG, 2002, INVEST OPHTH VIS SCI, V43, P2236; Saalmann YB, 2007, J NEUROENDOCRINOL, V19, P272, DOI 10.1111/j.1365-2826.2006.01527.x; CRAWLEY JN, 1986, BRAIN RES, V398, P382, DOI 10.1016/0006-8993(86)91500-3; Tokuda K, 2010, J NEUROSCI, V30, P16788, DOI 10.1523/JNEUROSCI.4101-10.2010; He J, 2004, RESTOR NEUROL NEUROS, V22, P19; FERRARESE C, 1991, NEUROPHARMACOLOGY, V30, P1445; Ishihara Y, 2013, J STEROID BIOCHEM, V135, P1, DOI 10.1016/j.jsbmb.2012.12.013; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Pesaresi M, 2010, HORM BEHAV, V57, P46, DOI 10.1016/j.yhbeh.2009.04.008; Izumi Y, 1999, GLIA, V25, P379; Marx CE, 2011, NEUROSCIENCE, V191, P78, DOI 10.1016/j.neuroscience.2011.06.076; Naskar R, 2000, INVEST OPHTH VIS SCI, V41, P1940; Harada T, 2007, J CLIN INVEST, V117, P1763, DOI 10.1172/JCI30178; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002; Fourgeux C, 2014, BIOCHEM BIOPH RES CO, V446, P775, DOI 10.1016/j.bbrc.2014.01.118; Lam DY, 2003, INVEST OPHTH VIS SCI, V44, P2573, DOI 10.1167/iovs.02-0779; Foster PJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P1235; Irwig MS, 2012, J CLIN PSYCHIAT, V73, P1220, DOI 10.4088/JCP.12m07887; Frank C, 2000, PROG NEURO-PSYCHOPH, V24, P1117, DOI 10.1016/S0278-5846(00)00124-X; Reddy DS, 2010, PROG BRAIN RES, V186, P113, DOI 10.1016/B978-0-444-53630-3.00008-7; Kalloniatis M, 1999, PROG RETIN EYE RES, V18, P811, DOI 10.1016/S1350-9462(98)00036-6; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; LOUZADAJUNIOR P, 1992, J NEUROCHEM, V59, P358, DOI 10.1111/j.1471-4159.1992.tb08912.x; Iwata S, 2013, BRAIN RES BULL, V93, P39, DOI 10.1016/j.brainresbull.2012.11.002; Vallee M, 2000, ANAL BIOCHEM, V287, P153, DOI 10.1006/abio.2000.4841; Kajta M, 1999, POL J PHARMACOL, V51, P531; Ardeshiri A, 2006, EUR J NEUROSCI, V24, P2567, DOI 10.1111/j.1460-9568.2006.05142.x; Aung T, 2001, AM J OPHTHALMOL, V131, P7, DOI 10.1016/S0002-9394(00)00621-8; Bernardi F, 1998, EUR J ENDOCRINOL, V138, P316, DOI 10.1530/eje.0.1380316; CASPER DS, 1982, J COMP NEUROL, V209, P79, DOI 10.1002/cne.902090108; Cheng JW, 2014, PLOS ONE, V24; Chesnoy-Marchais D, 2009, EUR J NEUROSCI, V30, P2100, DOI 10.1111/j.1460-9568.2009.07013.x; Do Rego Jean Luc, 2012, Front Endocrinol (Lausanne), V3, P4, DOI 10.3389/fendo.2012.00004; Fourgeux C, 2012, ACTA OPHTHALMOL, V90, pE560, DOI 10.1111/j.1755-3768.2012.02490.x; Girdler SS, 2007, PHARMACOL THERAPEUT, V116, P125, DOI 10.1016/j.pharmthera.2007.05.006; Guarneri P, 1998, EUR J NEUROSCI, V10, P1752, DOI 10.1046/j.1460-9568.1998.00191.x; Guennoun R, 2014, J STEROID BIOCHEM, DOI [10.1016/j.jsbmp.2014.09.001, DOI 10.1016/J.JSBMP.2014.09.001]; Gunn BG, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00131; Ishikawa M, 2010, INVEST OPHTH VIS SCI, V51, P6414, DOI 10.1167/iovs.09-5127; Ishikawa M, 2011, INVEST OPHTH VIS SCI, V52, P6604, DOI 10.1167/iovs.11-7375; Izumi Y, 2013, NEUROSCIENCE, V233, P166, DOI 10.1016/j.neuroscience.2012.12.035; IZUMI Y, 1995, J NEUROSCI METH, V60, P219, DOI 10.1016/0165-0270(95)00015-M; Izumi Y, 1996, GLIA, V17, P285, DOI 10.1002/(SICI)1098-1136(199608)17:4<285::AID-GLIA3>3.0.CO;2-Z; Lowe R F, 1962, Br J Ophthalmol, V46, P641, DOI 10.1136/bjo.46.11.641; LOWE RF, 1973, BRIT J OPHTHALMOL, V57, P457, DOI 10.1136/bjo.57.7.457; Matsumoto K1, 2005, NIHON YAKURIGAKU ZAS, V126, P107; Moreno MC, 2005, FASEB J, V19, P1161, DOI 10.1096/fj.04-3313fje; Moreno MC, 2008, NEUROCHEM INT, V52, P675, DOI 10.1016/j.neuint.2007.08.014; Morrow AL, 2001, INT REV NEUROBIOL, V46, P349; Muller A, 1997, EXP EYE RES, V64, P291, DOI 10.1006/exer.1996.0173; NEAL MJ, 1994, J NEUROCHEM, V62, P1025; Nucci C, 2005, NEUROTOXICOLOGY, V26, P935, DOI 10.1016/j.neuro.2005.06.002; Pibiri F, 2008, P NATL ACAD SCI USA, V105, P5567, DOI 10.1073/pnas.0801853105; PURDY RH, 1991, P NATL ACAD SCI USA, V88, P4553, DOI 10.1073/pnas.88.10.4553; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Ritch R, 2000, VISION IMPAIRMENT VI, P53; Shahsuvaryan ML, 2013, MED HYPOTHESIS DISCO, V2, P41; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; TIAN GC, 1994, BIOCHEMISTRY-US, V33, P2291, DOI 10.1021/bi00174a041; Tokuda K., 2013, NEUROL CLIN NEUROSCI, V1, P138, DOI [10.1111/ncn3.39, DOI 10.1111/NCN3.39]; Tsai JC, 2013, CAN J OPHTHALMOL, V48, P141, DOI 10.1016/j.jcjo.2013.02.003; Weir CJ, 2004, BRIT J ANAESTH, V92, P704, DOI 10.1093/bja/aeh125; Zorumski C F, 2000, Curr Opin Investig Drugs, V1, P360	74	1	1	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	DEC	2014	55	12					8531	8541		10.1167/iovs.14-15624		11	Ophthalmology	Ophthalmology	AX9KR	WOS:000347222300099		
J	Kuroda, Y; Tsujikawa, A; Yoshimura, N				Kuroda, Yoshimasa; Tsujikawa, Akitaka; Yoshimura, Nagahisa			Author Response: Association of Focal Choroidal Excavation With Age-Related Macular Degeneration	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Letter									[Kuroda, Yoshimasa; Tsujikawa, Akitaka; Yoshimura, Nagahisa] Kyoto Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Kyoto, Japan	Kuroda, Y (reprint author), Kyoto Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Kyoto, Japan.	tujikawa@kuhp.kyoto-u.ac.jp					Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; BRESSLER NM, 1988, SURV OPHTHALMOL, V32, P375, DOI 10.1016/0039-6257(88)90052-5; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)000304; Bressler NM, 2006, RETINA, P1075; Kuroda Y, 2014, INVEST OPHTH VIS SCI, V55, P6046, DOI 10.1167/iovs.14-14723; Querques G, 2014, INVEST OPHTH VIS SCI, V55, P8542, DOI 10.1167/iovs.14-15804	7	0	0	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	ROCKVILLE	12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA	0146-0404	1552-5783		INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	DEC	2014	55	12					8543	8543		10.1167/iovs.14-15991		1	Ophthalmology	Ophthalmology	AX9KR	WOS:000347222300101		
J	Nagai, K; Matsumaru, K; Hirai, I; Takae, Y; Andoh, K				Nagai, Kazuki; Matsumaru, Katsuhiko; Hirai, Ikuko; Takae, Yujiro; Andoh, Kazuo			New Therapy Using Omega-3-Acid Ethyl Esters for Decubitus Ulcers and Stasis Dermatitis: A Case Report	IRANIAN RED CRESCENT MEDICAL JOURNAL			English	Article						Omega-3 Fatty Acids; Ethyl-Eicosapentaenoic Acid; Docosahexaenoic Acid Ethyl Ester; Pressure Ulcers	POLYUNSATURATED FATTY-ACIDS; PRESSURE ULCER; BLOOD-PRESSURE; EXPRESSION; DISEASE	Introduction: In daily practice, it is common to experience difficulty in treating decubitus ulcers ( pressure ulcers, also known as decubitus ulcers) and stasis dermatitis of the lower limbs. We hereby report that omega-3-acid ethyl esters were remarkably effective when administered to cases of refractory pressure ulcers and stasis dermatitis for the purpose of improving the blood flow and promoting blood circulation. Case Presentation: Case 1: A 21-year-old Japanese female with lower-body paralysis. Pressure ulcers appeared on the heel and first toe of her left lower extremity. Although the patient had been treated with various ointments such as dimethyl isopropylazulene and 0.9% iodine-containing ointment, the course showed no improvement, so omega-3-acid ethyl esters was administered orally, completely healing the ulcer of the first toe in 10 weeks. Case 2: A 76-year-old Japanese male. The patient had been treated on an outpatient basis for 15 years due to hypertension, heart failure, type 2 diabetes mellitus, and hyperlipidemia. Two years prior to this presentation, stasis dermatitis occurred in the lower limbs and at the end of last year, erosive ulcers appeared on the front part of the lower-right thigh and shin. Although treatment with various topical ointment and dressings was performed, the course showed no improvement. Oral administration of omega-3-acid ethyl esters was initiated. At 12 weeks, his condition entered the white phase and healed almost completely. Conclusions: This report is the first to document other treatment possibilities for pressure ulcer and/or stasis dermatitis in cases where the use of topical applied ointments and medications is difficult. This new therapy may therefore help physicians to treat pressure ulcers and stasis dermatitis.	[Nagai, Kazuki; Matsumaru, Katsuhiko] Nagai Clin, Dept Internal Med, Yokohama, Kanagawa, Japan; [Hirai, Ikuko; Takae, Yujiro] Saiseikai Yokohama Shi Nanbu Hosp, Dept Dermatol, Yokohama, Kanagawa, Japan; [Andoh, Kazuo] Saiseikai Yokohama Shi Nanbu Hosp, Dept Radiol, Yokohama, Kanagawa, Japan	Nagai, K (reprint author), Nagai Clin, Dept Internal Med, POB 2350045, Yokohama, Kanagawa, Japan.	k-nagai@mtj.biglobe.ne.jp					Schiano V, 2008, CLIN NUTR, V27, P241, DOI 10.1016/j.clnu.2007.11.007; MORRIS MC, 1993, CIRCULATION, V88, P523; Wang TM, 2011, J NUTR BIOCHEM, V22, P187, DOI 10.1016/j.jnutbio.2010.01.007; DECATERINA R, 1994, ARTERIOSCLER THROMB, V14, P1829; Mori TA, 1999, HYPERTENSION, V34, P253; Yates CM, 2014, PHARMACOL THERAPEUT, V141, P272, DOI 10.1016/j.pharmthera.2013.10.010; Bou Torra Joan-Enric, 2002, Rev Enferm, V25, P50; Jiang L, 2014, SPINAL CORD, V52, P145, DOI 10.1038/sc.2013.132; Koziolova NA, 2013, KARDIOLOGIYA, V53, P15; Matić M, 2000, Med Pregl, V53, P579; Mauckner P, 2004, ZBL CHIR, V129, pS104, DOI 10.1055/s-2004-822619; Piljac A, 2008, J CUTAN MED SURG, V12, P142, DOI 10.2310/7750.2008.07052; Seljeflot I, 1998, EUR J CLIN INVEST, V28, P629; Tull SP, 2009, PLOS BIOL, V7	14	0	0	KOWSAR PUBL	HOENSBROEK	PATERSWEG 22,, HOENSBROEK, LIMBURG 6431 GC, NETHERLANDS	2074-1804	2074-1812		IRAN RED CRESCENT ME	Iran. Red Crescent Med. J.	DEC	2014	16	12							e19500	10.5812/ircmj.19500		4	Medicine, General & Internal	General & Internal Medicine	AX8OE	WOS:000347167800013		
J	Setiawan, BI; Imansyah, A; Arif, C; Watanabe, T; Mizoguchi, M; Kato, H				Setiawan, Budi I.; Imansyah, Arief; Arif, Chusnul; Watanabe, Tsugihiro; Mizoguchi, Masaru; Kato, Hisaaki			SRI PADDY GROWTH AND GHG EMISSIONS AT VARIOUS GROUNDWATER LEVELS	IRRIGATION AND DRAINAGE			English	Article						SRI paddy; rice yield; water productivity; emission factor; artificial neural network	NITROUS-OXIDE EMISSIONS; WATER MANAGEMENT; RICE FIELDS; METHANE; EQUATION	The System of Rice Intensification (SRI) for improving rice production has been attracting worldwide attention for its relatively high yield and greater water productivity (WP). One distinctive characteristic of SRI paddy fields is maintaining groundwater level (GWL) close to the soil's surface as dynamic aerobic-anaerobic soil conditions enhance crop growth. We investigated the performance of SRI paddy rice when subjected to a gradual lowering of GWL to assess the consequences of this for yield, WP, and greenhouse gas (GHG) emissions. Intensive measurements of climate data, plant biomass, soil nutrients, and CH4 and N2O emissions were made in four plots with experimentally different GWLs. Statistical analysis was used to assess differences among the plots, and an artificial neural network (ANN) model was used to track and estimate CH4 and N2O based on measured GWL, soil pH, and soil temperature data. The results showed that a gradually decreasing GWL, as deep as 35 cm from the surface, was able to reduce GHG emissions, but it also produced lower yield and less WP, with correspondingly higher GHG per unit yield. In conclusion, maintaining GWL close to the soil surface would be the best practice for water management in the SRI paddy fields. Copyright (C) 2014 John Wiley & Sons, Ltd.	[Setiawan, Budi I.; Imansyah, Arief; Arif, Chusnul] Bogor Agr Univ, Bogor 16680, Indonesia; [Watanabe, Tsugihiro] Kyoto Univ, Kyoto, Japan; [Mizoguchi, Masaru] Univ Tokyo, Tokyo, Japan; [Kato, Hisaaki] Res Inst Humanity & Nat, Kyoto, Japan	Setiawan, BI (reprint author), Bogor Agr Univ, Bogor 16680, Indonesia.	budindra@ipb.ac.id		Arif, Chusnul/0000-0002-4760-9783	Ministry of Education of the Republic of Indonesia; Research Institute of Humanity and Nature (RIHN), Japan; Bogor Agricultural University (IPB)	This research was a part of the research project entitled 'Environmental Monitoring System on the Advancement of the System of Rice Intensification' (EMSA-SRI), funded by the Ministry of Education of the Republic of Indonesia (2010-2012). It was successively sponsored by the Research Institute of Humanity and Nature (RIHN), Japan, under collaboration with the Bogor Agricultural University (IPB) launched in 2011, and was entitled ` Designing Local Framework for Integrated Water Resources Management.'	Cai ZC, 1997, PLANT SOIL, V196, P7, DOI 10.1023/A:1004263405020; Hargreaves GH, 2003, J IRRIG DRAIN E-ASCE, V129, P53, DOI 10.1061/(ASCE)0733-9437(2003)129:1(53); Tyagi L, 2010, SCI TOTAL ENVIRON, V408, P1085, DOI 10.1016/j.scitotenv.2009.09.010; Kassam A, 2011, PADDY WATER ENVIRON, V9, P163, DOI 10.1007/s10333-011-0259-1; Mishra A, 2011, PADDY WATER ENVIRON, V9, P41, DOI 10.1007/s10333-010-0240-4; Towprayoon S, 2005, CHEMOSPHERE, V59, P1547, DOI 10.1016/j.chemosphere.2005.02.009; Anas I, 2011, PADDY WATER ENVIRON, V9, P53, DOI 10.1007/s10333-011-0260-8; Uphoff N, 2011, PADDY WATER ENVIRON, V9, P3, DOI 10.1007/s10333-010-0224-4; Lin XQ, 2011, PADDY WATER ENVIRON, V9, P33, DOI 10.1007/s10333-010-0238-y; Hadi A, 2010, PADDY WATER ENVIRON, V8, P319, DOI 10.1007/s10333-010-0210-x; Sato S, 2011, PADDY WATER ENVIRON, V9, P79, DOI 10.1007/s10333-010-0242-2; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892; Miyata A, 2000, AGR FOREST METEOROL, V102, P287, DOI 10.1016/S0168-1923(00)00092-7; Arif C., 2012, Rice Science, V19, P143, DOI 10.1016/S1672-6308(12)60033-X; Askari M., 2008, J JAPAN SOC HYDROLOG, V21, P215, DOI 10.3178/jjshwr.21.215; Babu YJ, 2005, CURR SCI INDIA, V89, P1; Dill J, 2013, PROMOTING SYSTEM RIC; Gathorne-Hardy A, 2013, TAIWAN WATER CONSERV, V61, P110; Govindarajan S, 2008, PADDY WATER ENVIRON, V6, P327, DOI 10.1007/s10333-008-0131-0; HUSIN YA, 1995, CHEMOSPHERE, V31, P3153, DOI 10.1016/0045-6535(95)00173-6; Lee KB, 2005, KOREAN J SOIL SCI FE, V38, P150; Nishimura S, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002207; Purkait N. N., 2007, Indian Journal of Radio & Space Physics, V36; Rajkishore SK, 2013, TAIWAN WATER CONSERV, V61, P126; Sato S, 2007, CAB REV, V2, P1; Setiawan BI, 2013, TAIWAN WATER CONSERV, V61, P135; Setyanto P., 2005, Indonesian Journal of Agricultural Science, V6, P1; Setyanto P., 2004, Indonesian Journal of Agricultural Science, V5, P20; Snyder CS, 2007, BETTER CROP, V19, P16; van Lier HN, 1999, CIGR HDB AGR ENG, VI; Wassmann R, 2000, NUTR CYCL AGROECOSYS, V58, P1, DOI 10.1023/A:1009848813994	31	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1531-0353	1531-0361		IRRIG DRAIN	Irrig. Drain.	DEC	2014	63	5					612	620		10.1002/ird.1866		9	Agronomy; Water Resources	Agriculture; Water Resources	AX8PJ	WOS:000347170800006		
J	Harafuji, K; Sato, H; Matsuura, T; Omoto, Y; Kaji, T; Hiramoto, M				Harafuji, Kenji; Sato, Hiroaki; Matsuura, Takahiro; Omoto, Yuta; Kaji, Toshihiko; Hiramoto, Masahiro			Degradation in organic solar cells under illumination and electrical stresses in air	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							EFFICIENCY; STABILITY; HETEROJUNCTIONS; INTERLAYER; PIGMENTS; DEVICES; DIODES; C-60	The degradation phenomenon in small molecular organic solar cells with an indium tin oxide (anode)/copper phthalocyanine (donor)/fullerene (acceptor)/bathocuproine (buffer)/Ag (cathode) structure is experimentally investigated. The effect of three kinds of stress, that is, air exposure, repetitive illumination, and repetitive electrical stress, on device performance is examined. Both air exposure and repetitive illumination deteriorate the device performance appreciably. The decrease in power conversion efficiency is dominated by the decrease in the fill factor. Repetitive electrical stress does not cause substantial device degradation. The degree of degradation under a combination of stresses from repetitive illumination and air exposure is lower than that under illumination stress alone. Furthermore, there is a possibility that this combination of stresses induces some passivation against further air exposure stress. (C) 2014 The Japan Society of Applied Physics	[Harafuji, Kenji; Sato, Hiroaki; Matsuura, Takahiro; Omoto, Yuta] Ritsumeikan Univ, Dept Elect & Elect Engn, Kusatsu, Shiga 5258577, Japan; [Kaji, Toshihiko; Hiramoto, Masahiro] Inst Mol Sci, Dept Mat Mol Sci, Okazaki, Aichi 4448787, Japan	Harafuji, K (reprint author), Ritsumeikan Univ, Dept Elect & Elect Engn, Kusatsu, Shiga 5258577, Japan.	harafuji@se.ritsumei.ac.jp	Kaji, Toshihiko/C-5510-2008	Kaji, Toshihiko/0000-0001-5045-2361			Song QL, 2005, CHEM PHYS LETT, V416, P42, DOI 10.1016/j.cplett.2005.09.052; Peumans P, 2000, APPL PHYS LETT, V76, P2650, DOI 10.1063/1.126433; SUSSMAN A, 1967, J APPL PHYS, V38, P2748, DOI 10.1063/1.1709999; TANG CW, 1986, APPL PHYS LETT, V48, P183, DOI 10.1063/1.96937; Vogel M, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2362624; Oida T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.011601; Kim I, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3177349; Wang JC, 2011, ORG ELECTRON, V12, P880, DOI 10.1016/j.orgel.2011.02.016; Fujishima D, 2009, SOL ENERG MAT SOL C, V93, P1029, DOI 10.1016/j.solmat.2008.11.034; Kumar A, 2009, J APPL PHYS, V105, DOI 10.1063/1.3117513; Oida T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.081601; Walzer K, 2007, CHEM REV, V107, P1233, DOI 10.1021/cr050156n; SARICIFTCI NS, 1993, APPL PHYS LETT, V62, P585, DOI 10.1063/1.108863; HIRAMOTO M, 1992, J APPL PHYS, V72, P3781, DOI 10.1063/1.352274; Yang HB, 2010, SOL ENERG MAT SOL C, V94, P846, DOI 10.1016/j.solmat.2010.01.006; Krebs FC, 2007, PROG PHOTOVOLTAICS, V15, P697, DOI 10.1002/pip.794; Kroon JM, 2002, THIN SOLID FILMS, V403, P223, DOI 10.1016/S0040-6090(01)01589-9; Cattin L, 2009, J APPL PHYS, V105, DOI 10.1063/1.3077160; Peumans P, 2003, J APPL PHYS, V93, P3693, DOI 10.1063/1.1534621; Sullivan P, 2008, ORG ELECTRON, V9, P656, DOI 10.1016/j.orgel.2008.04.008; Wagenpfahl A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.115306; Heutz S, 2004, SOL ENERG MAT SOL C, V83, P229, DOI 10.1016/j.solmat.2004.02.027; Song QL, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2422911; Norrman K, 2010, J AM CHEM SOC, V132, P16883, DOI 10.1021/ja106299g; Jorgensen M, 2008, SOL ENERG MAT SOL C, V92, P686, DOI 10.1016/j.solmat.2008.01.005; Schulze K, 2006, ADV MATER, V18, P2872, DOI 10.1002/adma.200600658; HIRAMOTO M, 1991, APPL PHYS LETT, V58, P1062, DOI 10.1063/1.104423; Glatthaar M, 2007, SOL ENERG MAT SOL C, V91, P390, DOI 10.1016/j.solmat.2006.10.020; MARTIN M, 1983, J APPL PHYS, V54, P2792, DOI 10.1063/1.332310; Uhrich C, 2008, J APPL PHYS, V104, DOI 10.1063/1.2973199; Vivo P, 2008, SOL ENERG MAT SOL C, V92, P1416, DOI 10.1016/j.solmat.2008.06.002	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2014	53	12							122303	10.7567/JJAP.53.122303		9	Physics, Applied	Physics	AX5HS	WOS:000346957800011		
J	Hosoda, M; Sakai, K				Hosoda, Maiko; Sakai, Keiji			Electromagnetically revolving sphere viscometer	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ROLLING-BALL VISCOMETER; PRESSURES	In this paper, we propose a new method of low viscosity measurement, in which the rolling of a probe sphere on the flat solid bottom of a sample cell is driven remotely and the revolution speed of the probe in a sample liquid gives the viscosity measurements. The principle of this method is based on the electromagnetically spinning technique that we developed, and the method is effective especially for viscosity measurements at levels below 100 mPa.s with an accuracy higher than 1%. The probe motion is similar to that in the well-known rolling sphere (ball) method. However, our system enables a steady and continuous measurement of viscosity, which is problematic using the conventional method. We also discuss the limits of the measurable viscosity range common to rolling-sphere-type viscometers by considering the accelerating motion of a probe sphere due to gravity, and we demonstrate the performance of our methods. (C) 2014 The Japan Society of Applied Physics	[Hosoda, Maiko] Tokyo Denki Univ, Hatoyama, Saitama 3500394, Japan; [Sakai, Keiji] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Hosoda, M (reprint author), Tokyo Denki Univ, Hatoyama, Saitama 3500394, Japan.				Ministry of Education, Science, Sports and Culture, Japan	This work was partially supported by a Grant-in-Aid from the Ministry of Education, Science, Sports and Culture, Japan.	BRISCOE BJ, 1992, COLLOID SURFACE, V62, P153, DOI 10.1016/0166-6622(92)80047-6; Flowers A. E., 1914, P AM SOC TEST MATER, V14, P565; HARRISON DE, 1965, REV SCI INSTRUM, V36, P1840, DOI 10.1063/1.1719476; Hersey M.D., 1916, Journal of the Washington Academy of Sciences, V6; Hirano T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011703; Hirano T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.096701; Hoepper F., 1933, Z TECH PHYS, V14, P165; Hosoda M, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.07HB03; Hosoda M, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.07GA05; Hubbard RM, 1943, IND ENG CHEM, V15, P212, DOI 10.1021/i560115a018; Ishiwata T., APPL PHYS E IN PRESS; IZUCHI M, 1986, JPN J APPL PHYS 1, V25, P1091, DOI 10.1143/JJAP.25.1091; LEWIS HW, 1953, ANAL CHEM, V25, P507, DOI 10.1021/ac60075a035; MATSUOKA T, 1993, PHYS REV LETT, V71, P1510, DOI 10.1103/PhysRevLett.71.1510; Sage BH, 1933, IND ENG CHEM, V5, P261, DOI 10.1021/ac50084a020; Sakai K, 2003, JPN J APPL PHYS 1, V42, P2935, DOI 10.1143/JJAP.42.2935; Sakai K, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.016602; Sakai K, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.036601; SAWAMURA S, 1990, REV SCI INSTRUM, V61, P871, DOI 10.1063/1.1141456; Viswanath D. S., 2007, VISCOSITY LIQUIDS TH, P61	20	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2014	53	12							126602	10.7567/JJAP.53.126602		4	Physics, Applied	Physics	AX5HS	WOS:000346957800026		
J	Ishikawa, T; Okada, JT; Paradis, PF; Watanabe, Y; Kumar, MV; Watanabe, M				Ishikawa, Takehiko; Okada, Junpei T.; Paradis, Paul-Francois; Watanabe, Yuki; Kumar, Malahalli Vijaya; Watanabe, Masahito			Surface tension measurement using sample rotation combined with electrostatic levitation	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ELECTRICAL-RESISTIVITY MEASUREMENT; NONCONTACT MEASUREMENT TECHNIQUE; HIGH-TEMPERATURE; SPECTRAL EMISSIVITY; LIQUID-DROPS; ALLOYS; METALS; VISCOSITY; APPARATUS; DENSITY	In order to measure the surface tension of high temperature melts with high viscosity, a sample rotation method was developed. An electrostatically levitated melt was spun with a rotating magnetic field, and the shape evolution of the sample was observed. Especially, the bifurcation behavior (shape transformation from axisymmetric to non-axisymmetric) was closely monitored by a high speed camera. The experiments confirmed that the rotation frequency at the bifurcation could be precisely measured by monitoring the fluctuation of the power of the beam of a He-Ne laser reflected at the sample surface, and thus, the surface tension could be calculated based on the theory by Brown and Scriven. The validity of this measurement technique was demonstrated with ZrCoAl bulk glass forming alloy. (C) 2014 The Japan Society of Applied Physics	[Ishikawa, Takehiko; Okada, Junpei T.] Japan Aerosp Explorat Agcy JAXA, Inst Space & Astronaut Sci, Tsukuba, Ibaraki 3058505, Japan; [Ishikawa, Takehiko] Grad Univ Adv Studies SOKENDAI, Sagamihara, Kanagawa 2525210, Japan; [Paradis, Paul-Francois] Remote Sensing Grp, INO, Quebec City, PQ G1P 4S4, Canada; [Watanabe, Yuki] Adv Engn Serv Co Ltd, Tsukuba, Ibaraki 3050032, Japan; [Kumar, Malahalli Vijaya] Tufts Univ, Medford, MA 02155 USA; [Watanabe, Masahito] Gakushuin Univ, Toshima Ku, Tokyo 1718588, Japan	Ishikawa, T (reprint author), Japan Aerosp Explorat Agcy JAXA, Inst Space & Astronaut Sci, Tsukuba, Ibaraki 3058505, Japan.	ishikawa.takehiko@jaxa.jp			Japan Society for the Promotion of Science	We wish to thank Professor E. S. Park and Ms. C. W. Ryu (Seoul National University) for providing the BMG alloy samples. We are also grateful to Mr. W. Imai and Mr. Y. Yamazaki (Gakushuin University) for help during levitation experiments and data analysis. This research was partially supported by a Grant-in-Aid for Science Research (B) from the Japan Society for the Promotion of Science.	Ishikawa T, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/2/025305; Chung SK, 1996, REV SCI INSTRUM, V67, P3175, DOI 10.1063/1.1147584; Amore S, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4817679; Mukherjee S, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1844596; RHIM WK, 1993, REV SCI INSTRUM, V64, P2961, DOI 10.1063/1.1144475; BUSSE FH, 1984, J FLUID MECH, V142, P1, DOI 10.1017/S0022112084000963; Brillo J, 2005, J MATER SCI, V40, P2213, DOI 10.1007/s10853-005-1935-6; Sarou-Kanian V, 2003, INT J THERMOPHYS, V24, P277, DOI 10.1023/A:1022466319501; BROWN RA, 1980, P ROY SOC LOND A MAT, V371, P331, DOI 10.1098/rspa.1980.0084; Paradis PF, 2014, MAT SCI ENG R, V76, P1, DOI 10.1016/j.mser.2013.12.001; Ishikawa T, 2005, MEAS SCI TECHNOL, V16, P443, DOI 10.1088/0957-0233/16/2/016; Elleman D. D., 1988, NASA TECH MEMO, V2, P557; Glorieux B, 2002, INT J THERMOPHYS, V23, P1249, DOI 10.1023/A:1019848405502; Holland-Moritz D, 2005, MEAS SCI TECHNOL, V16, P372, DOI 10.1088/0957-0233/16/2/007; Ishikawa T, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/12/125602; Ishikawa T, 2013, J CHEM THERMODYN, V65, P1, DOI 10.1016/j.jct.2013.05.036; Kawamura H, 2005, MEAS SCI TECHNOL, V16, P386, DOI 10.1088/0957-0233/16/2/009; Kobatake H, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/2/025901; KRISHNAN S, 1993, J NUCL MATER, V203, P112, DOI 10.1016/0022-3115(93)90047-3; Krishnan S, 1997, REV SCI INSTRUM, V68, P3512, DOI 10.1063/1.1148315; Lohofer G, 2005, MEAS SCI TECHNOL, V16, P417, DOI 10.1088/0957-0233/16/2/012; RHIM WK, 1989, ESA SP PUBL, V295, P629; Rhim WK, 2001, REV SCI INSTRUM, V72, P3572, DOI 10.1063/1.1388215; Rhim WK, 1999, REV SCI INSTRUM, V70, P2796, DOI 10.1063/1.1149797; Rhim WK, 1998, REV SCI INSTRUM, V69, P3628, DOI 10.1063/1.1149150; RULISON AJ, 1994, REV SCI INSTRUM, V65, P695, DOI 10.1063/1.1145087; Rustan GE, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4759021; Wang HP, 2009, J APPL PHYS, V106, DOI 10.1063/1.3187793; WANG TG, 1994, J FLUID MECH, V276, P389, DOI 10.1017/S0022112094002612; Wunderlich RK, 2001, INT J THERMOPHYS, V22, P579, DOI 10.1023/A:1010739318317	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2014	53	12							126601	10.7567/JJAP.53.126601		5	Physics, Applied	Physics	AX5HS	WOS:000346957800025		
J	Itoh, H; Sugiura, K				Itoh, Hideaki; Sugiura, Keisuke			Analysis of quality factor of quartz-crystal tuning forks using L-shaped bar model with torsion spring	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MICROMECHANICAL BEAM RESONATORS	We analyzed the quality factor of a quartz-crystal tuning fork using an L-shaped bar model that consisted of two bars depicting the right half of the tuning fork and a torsion spring at the joint of its arm and base bars. An analysis of the quality factor showed that the calculated quality factor is lower by approximately 10% of that calculated by a cantilever model and is closer to the measured quality factor. (C) 2014 The Japan Society of Applied Physics	[Itoh, Hideaki; Sugiura, Keisuke] Shinshu Univ, Fac Engn, Nagano 3808553, Japan	Itoh, H (reprint author), Shinshu Univ, Fac Engn, Nagano 3808553, Japan.	rokuro1@shinshu-u.ac.jp					Hao ZL, 2009, J SOUND VIB, V322, P870, DOI 10.1016/j.jsv.2008.12.005; Yasumura KY, 2000, J MICROELECTROMECH S, V9, P117, DOI 10.1109/84.825786; Duwel A, 2006, J MICROELECTROMECH S, V15, P1437, DOI 10.1109/JMEMS.2006.883573; Liu X, 2005, J APPL PHYS, V97, DOI 10.1063/1.1819980; Lifshitz R, 2000, PHYS REV B, V61, P5600, DOI 10.1103/PhysRevB.61.5600; Vengallatore S, 2005, J MICROMECH MICROENG, V15, P2398, DOI 10.1088/0960-1317/15/12/023; Zener C, 1937, PHYS REV, V52, P0230, DOI 10.1103/PhysRev.52.230; Prabhakar S, 2007, J MICROMECH MICROENG, V17, P532, DOI 10.1088/0960-1317/17/3/016; Candler RN, 2006, J MICROELECTROMECH S, V15, P927, DOI 10.1109/JMEMS.2006.879374; Houston BH, 2002, APPL PHYS LETT, V80, P1300, DOI 10.1063/1.1449534; Bishop JE, 1997, INT J SOLIDS STRUCT, V34, P1075, DOI 10.1016/S0020-7683(96)00085-6; Gerber E. A., 1985, PRECISION FREQUENCY, V1, P12; Ishikawa T., 2012, P 2012 IEEE ULTR S, P851; Itoh H, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.07GF03; Itoh H, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.046604; Itoh H, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.087203; Itoh H, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.126702; Itoh H, 2003, JPN J APPL PHYS 1, V42, P3110, DOI 10.1143/JJAP.42.3110; Landau L. D., 1986, THEORY ELASTICITY, P133; Metcalf TH, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3190509; Prabhakar S, 2008, J MICROELECTROMECH S, V17, P494, DOI 10.1109/JMEMS.2008.916316; Sezawa K., 1932, Bulletin of the Earthquake Research Institute, Tokyo Imperial University, V10; SHIEH RC, 1971, J APPL MECH, V38, P839; Zener C., 1938, PHYS REV, V53, P90	24	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2014	53	12							126702	10.7567/JJAP.53.126702		5	Physics, Applied	Physics	AX5HS	WOS:000346957800028		
J	Iwasaki, H				Iwasaki, Hideo			Thermal hysteresis behaviors of thermoelectric properties	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							FIGURE; MERIT; TELLURIDE; BI2S3; POWER	Thermoelectric behaviors for the thermal cycles between room and high temperatures are investigated in (Bi, Sb)(2)Te-3 and Bi2S3. Because the reliability and reproducibility of the data against repeated heating are required, the Harman method is adopted to evaluate the figure of merit, ZT, in which only electrical contacts are needed. The electrical contacts are made by the spot welding method using a simple and low-power machine made in our laboratory to avoid damage to the samples. Thermoelectric properties are changed by repeating thermal cycles, though their rate of change is not always very high and is material dependent. The carrier number dominantly contributes to the thermal hysteresis of the thermoelectric properties upon the repetition of the thermal cycles, which actually affects the sample as an annealing effect. It is pointed out that changes in thermoelectric properties upon the repetition of the thermal cycles should be examined beforehand in practical applications. (C) 2014 The Japan Society of Applied Physics	JAIST, Ctr Nano Mat Technol, Nomi, Ishikawa 9231292, Japan	Iwasaki, H (reprint author), JAIST, Ctr Nano Mat Technol, Nomi, Ishikawa 9231292, Japan.						BLACK J, 1957, J PHYS CHEM SOLIDS, V2, P240, DOI 10.1016/0022-3697(57)90090-2; Dughaish ZH, 2002, PHYSICA B, V322, P205, DOI 10.1016/S0921-4526(02)01187-0; Chen BX, 1997, CHEM MATER, V9, P1655, DOI 10.1021/cm970033m; Nolas GS, 1998, APPL PHYS LETT, V73, P178, DOI 10.1063/1.121747; MILLER GR, 1965, J PHYS CHEM SOLIDS, V26, P173, DOI 10.1016/0022-3697(65)90084-3; Caillat T, 1997, J PHYS CHEM SOLIDS, V58, P1119, DOI 10.1016/S0022-3697(96)00228-4; HARMAN TC, 1958, J APPL PHYS, V29, P1373, DOI 10.1063/1.1723445; Akasaka M, 2008, J APPL PHYS, V104, DOI 10.1063/1.2946722; Terasaki I, 1997, PHYS REV B, V56, P12685; Iwasaki H, 2002, JPN J APPL PHYS 1, V41, P6606, DOI 10.1143/JJAP.41.6606; WIESE JR, 1960, J PHYS CHEM SOLIDS, V15, P13, DOI 10.1016/0022-3697(60)90094-9; Caillat T., 1994, P 12 INT C THERM, P132; Ge ZH, 2011, J ELECTRON MATER, V40, P1087, DOI 10.1007/s11664-011-1548-6; Iwasaki H., 2005, P 24 INT C THERM, P498; Iwasaki H, 2003, JPN J APPL PHYS 1, V42, P5477, DOI 10.1143/JJAP.42.5477; Iwasaki H, 2013, J ELECTRON MATER, V42, P1840, DOI 10.1007/s11664-012-2448-0; IYE Y, 1988, JPN J APPL PHYS 2, V27, pL658, DOI 10.1143/JJAP.27.L658; KANISHCHEVA AS, 1981, INORG MATER+, V17, P1466; MIZOGUCHI H, 1995, J APPL PHYS, V78, P1376, DOI 10.1063/1.360315; Scherrer H., 1995, CRC HDB THERMOELECTR, P211; Zhao LD, 2008, J SOLID STATE CHEM, V181, P3278, DOI 10.1016/j.jssc.2008.08.022	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2014	53	12							125502	10.7567/JJAP.53.125502		6	Physics, Applied	Physics	AX5HS	WOS:000346957800021		
J	Jung, SM; Mizutani, T; Hiramoto, T				Jung, Seung-Min; Mizutani, Tomoko; Hiramoto, Toshiro			Effect of drain-induced barrier lowering on performance of ultralow-supply-voltage CMOS circuits operating in subthreshold region	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							LOW-POWER; IMPACT; LOGIC; MEMORY; SRAM	The effects of drain-induced barrier lowering (DIBL) on the performance characteristics of devices and circuits operating in the subthreshold region are evaluated by measurement and simulation. It is found that the measured drain current markedly decreases in the presence of a large DIBL at supply voltage (V-dd) in the subthreshold region such as 0.3 V. In addition, the simulated propagation delay of ring oscillators is more degraded in the subthreshold region as DIBL increases even though the on-current (I-on) is the same in all the devices, and the calculated energy consumption increases with DIBL in the subthreshold region. It is concluded that DIBL should be suppressed in the design of subthreshold CMOS circuits. (C) 2014 The Japan Society of Applied Physics	[Jung, Seung-Min; Mizutani, Tomoko; Hiramoto, Toshiro] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan	Jung, SM (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan.	smjung@nano.iis.u-tokyo.ac.jp			LEAP; METI; NEDO	Part of this work was carried out in "Ultra-Low Voltage Device Project" of LEAP funded and supported by METI and NEDO.	SWANSON RM, 1972, IEEE J SOLID-ST CIRC, VSC 7, P146, DOI 10.1109/JSSC.1972.1050260; Hanson S, 2008, IEEE T ELECTRON DEV, V55, P175, DOI 10.1109/TED.2007.911033; Deng J, 2006, IEEE T ELECTRON DEV, V53, P1317, DOI 10.1109/TED.2006.874159; Pillai V, 2007, IEEE T CIRCUITS-I, V54, P1500, DOI 10.1109/TCSI.2007.897768; Zhai B, 2005, IEEE T VLSI SYST, V13, P1239, DOI 10.1109/TVLSI.2005.859588; Kang M, 2011, IEEE T ELECTRON DEV, V58, P3626, DOI 10.1109/TED.2011.2161313; Yeh PC, 2007, IEEE T ELECTRON DEV, V54, P1760, DOI 10.1109/TED.2007.898043; Kim JJ, 2004, IEEE T ELECTRON DEV, V51, P1468, DOI 10.1109/ted.2004.833965; Park S, 2006, JPN J APPL PHYS 1, V45, P638, DOI 10.1143/JJAP.45.638; DAVARI B, 1995, P IEEE, V83, P595, DOI 10.1109/5.371968; Sakurai T, 2004, IEICE T ELECTRON, VE87C, P429; Sheng D, 2007, IEEE T CIRCUITS-II, V54, P954, DOI 10.1109/TCSII.2007.903782; Paul BC, 2005, IEEE T ELECTRON DEV, V52, P237, DOI 10.1109/TED.2004.842538; Dreslinski RG, 2010, P IEEE, V98, P253, DOI 10.1109/JPROC.2009.2034764; Hanson S, 2006, IBM J RES DEV, V50, P469; Buss D., 2011, IEDM, P239; Calhoun B. H., 2004, Proceedings of the 2004 International Symposium on Low Power Electronics and Design (IEEE Cat. No.04TH8758), DOI 10.1145/1013235.1013265; Chen JH, 2006, IEEE J SOLID-ST CIRC, V41, P2344, DOI 10.1109/JSSC.2006.881549; Fuketa H., 2011, IEDM, V559, DOI [10.1109/IEDM.2011.6131609, DOI 10.1109/IEDM.2011.6131609]; Hiramoto T., 2010, P IEEE INT SOI C, P170; Miyamura M, 2008, INT EL DEVICES MEET, P447; Na MH, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P121, DOI 10.1109/IEDM.2002.1175793; Ng K. K., 2001, IEDM, P693; Sakurai T., 2011, ISLPED INT S, P57; Skotnicki T., 2010, VLSI S, P153; Soeleman H, 2001, IEEE T VLSI SYST, V9, P90, DOI 10.1109/92.920822; Soeleman Hendrawan, 1999, INT S LOW POW EL DES, P94; Song X., 2010, IEDM, P62; Tachibana F, 2005, JPN J APPL PHYS 1, V44, P2147, DOI 10.1143/JJAP.44.2147; Vaddi R, 2010, IEEE T ELECTRON DEV, V57, P654, DOI 10.1109/TED.2009.2039529; Wang A, 2002, P IEEE COMP SOC ANN, P5; Wong ACW, 2008, IEEE J SOLID-ST CIRC, V43, P1511, DOI 10.1109/JSSC.2008.923717; Yoshida E., 2006, IEDM, P195	33	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2014	53	12							124301	10.7567/JJAP.53.124301		4	Physics, Applied	Physics	AX5HS	WOS:000346957800017		
J	Kajita, M				Kajita, Masatoshi			Suppression of AC Stark shift in Raman spectroscopy of optically trapped molecules	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ELECTRON MASS-RATIO; CONSTANTS; CLOCKS	The variation of proton-electron mass ratio can be tested through precise measurements of the ( v, N) = (0,0)-(1, 0) transition frequency of ultracold diatomic molecules confined in an optical trap. We propose to measure resonant frequency via the Raman transition induced by an intense trapping laser beam and a weak probe laser beam. By tuning the trap laser to a specific frequency at which the AC Stark shift is cancelled, the relative frequency shift on the Raman transition can be reduced to below 10(-16). (C) 2014 The Japan Society of Applied Physics	Natl Inst Informat & Communicat Technol, Koganei, Tokyo 1848795, Japan	Kajita, M (reprint author), Natl Inst Informat & Communicat Technol, Koganei, Tokyo 1848795, Japan.	kajita@nict.go.jp					Webb JK, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.191101; Kajita M, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.032509; van Weerdenburg F, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.180802; Calmet X, 2002, EUR PHYS J C, V24, P639, DOI 10.1007/s10052-002-0976-0; Bethlem HL, 2008, EUR PHYS J-SPEC TOP, V163, P55, DOI 10.1140/epjst/e2008-00809-5; DeMille D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.043202; Bagdonaite J, 2013, SCIENCE, V339, P46, DOI 10.1126/science.1224898; Berengut JC, 2012, EPL-EUROPHYS LETT, V97, DOI 10.1209/0295-5075/97/20006; Dirac P.A.M., 1937, Nature, V139, DOI 10.1038/139323a0; Flambaum VV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.150801; Germann M, 2014, NAT PHYS, V10, P820, DOI 10.1038/NPHYS3085; Kajita M, 2014, J MOL SPECTROSC, V300, P99, DOI 10.1016/j.jms.2014.03.009; Kajita M, 2012, J PHYS B-AT MOL OPT, V45, DOI 10.1088/0953-4075/45/18/185401; Kajita M, 2013, J PHYS B-AT MOL OPT, V46, DOI 10.1088/0953-4075/46/2/025001; Kajita M, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/15/154022; Kajita M, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.022507; Kajita M, 2011, J PHYS B-AT MOL OPT, V44, DOI 10.1088/0953-4075/44/2/025402; Rosenband T, 2008, SCIENCE, V319, P1808, DOI 10.1126/science.1154622	18	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2014	53	12							128001	10.7567/JJAP.53.128001		3	Physics, Applied	Physics	AX5HS	WOS:000346957800030		
J	Kawai, K; Kuzuwata, M; Sasaki, T; Noda, K; Kawatsuki, N; Ono, H				Kawai, Kotaro; Kuzuwata, Mitsuru; Sasaki, Tomoyuki; Noda, Kohei; Kawatsuki, Nobuhiro; Ono, Hiroshi			Blazed vector grating liquid crystal cells with photocrosslinkable polymeric alignment films fabricated by one-step polarizer rotation method	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							HOLOGRAPHY; LAYER	Blazed vector grating liquid crystal (LC) cells, in which the directors of low-molar-mass LCs are antisymmetrically distributed, were fabricated by one-step exposure of an empty glass cell inner-coated with a photocrosslinkable polymer LC (PCLC) to UV light. By adopting a LC cell structure, twisted nematic (TN) and homogeneous (HOMO) alignments were obtained in the blazed vector grating LC cells. Moreover, the diffraction efficiency of the blazed vector grating LC cells was greatly improved by increasing the thickness of the device in comparison with that of a blazed vector grating with a thin film structure obtained in our previous study. In addition, the diffraction efficiency and polarization states of +/- 1st-order diffracted beams from the resultant blazed vector grating LC cells were controlled by designing a blazed pattern in the alignment films, and these diffraction properties were well explained on the basis of Jones calculus and the elastic continuum theory of nematic LCs. (C) 2014 The Japan Society of Applied Physics	[Kawai, Kotaro; Kuzuwata, Mitsuru; Sasaki, Tomoyuki; Noda, Kohei; Ono, Hiroshi] Nagaoka Univ Technol, Dept Elect Engn, Nagaoka, Niigata 9402188, Japan; [Kawatsuki, Nobuhiro] Univ Hyogo, Dept Mat Sci & Chem, Himeji, Hyogo 6712280, Japan	Kawai, K (reprint author), Nagaoka Univ Technol, Dept Elect Engn, Nagaoka, Niigata 9402188, Japan.	s135016@stn.nagaokaut.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [25289097]	The research is partially supported by the Ministry of Education, Culture, Sports, Science and Technology, under Grant No. 25289097.	Kawatsuki N, 2002, MACROMOLECULES, V35, P706, DOI 10.1021/ma011439u; Crawford GP, 2005, J APPL PHYS, V98, DOI 10.1063/1.2146075; Kuzuwata M, 2012, OPT LETT, V37, P1115, DOI 10.1364/OL.37.001115; Sasaki T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.042503; Ono H, 2003, J APPL PHYS, V94, P1298, DOI 10.1063/1.1587269; Park JH, 2003, APPL PHYS LETT, V83, P1918, DOI 10.1063/1.1609042; Choi H, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2162672; Honma M, 2004, APPL OPTICS, V43, P5193, DOI 10.1364/AO.43.005193; Presnyakov V, 2006, OPT EXPRESS, V14, P10558, DOI 10.1364/OE.14.010558; Honma M, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4737945; Yu CJ, 2005, OPT LETT, V30, P1995, DOI 10.1364/OL.30.001995; Gorkhali SP, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2214176; CHEN AGS, 1992, OPT LETT, V17, P1231, DOI 10.1364/OL.17.001231; Emoto A, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.032502; Noda K, 2014, APPL OPTICS, V53, P2556, DOI 10.1364/AO.53.002556; Ono H, 2014, APPL PHYS A-MATER, V114, P1353, DOI 10.1007/s00339-013-7983-x; Sheremet N, 2013, APPL OPTICS, V52, pE40, DOI 10.1364/AO.52.000E40; Simoni F, 1997, OPT LETT, V22, P549, DOI 10.1364/OL.22.000549	18	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2014	53	12							122601	10.7567/JJAP.53.122601		6	Physics, Applied	Physics	AX5HS	WOS:000346957800014		
J	Kawatsuki, N; Hosoda, R; Kondo, M; Sasaki, T; Ono, H				Kawatsuki, Nobuhiro; Hosoda, Risa; Kondo, Mizuho; Sasaki, Tomoyuki; Ono, Hiroshi			Molecularly oriented surface relief formation in polymethacrylates comprising N-benzylideneaniline derivative side groups	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							POLYMER-FILMS; PHOTOINDUCED ORIENTATION; GRATING FORMATION	Molecularly oriented surface relief (SR) formation in polymethacrylates with N-benzylideneaniline (NBA) derivative side groups is investigated by holographic exposure using a 325nm He-Cd laser. Because the NBA moieties show a photoinduced orientation perpendicular to the polarization of light, polarization holography successfully forms a molecularly oriented SR structure in accordance with the polarization distribution that includes p-polarized components. Although intensity holography induces molecular orientation, it does not generate a satisfactory SR structure. In all the holographic modes, the SR depth depends on the direction of the C = N bonds in the NBA moieties and the photoproducts affect the SR formation ability. (C) 2014 The Japan Society of Applied Physics	[Kawatsuki, Nobuhiro; Hosoda, Risa; Kondo, Mizuho] Univ Hyogo, Dept Mat Sci & Chem, Himeji, Hyogo 6712280, Japan; [Sasaki, Tomoyuki; Ono, Hiroshi] Nagaoka Univ Technol, Dept Elect Engn, Nagaoka, Niigata 9402188, Japan	Kawatsuki, N (reprint author), Univ Hyogo, Dept Mat Sci & Chem, Himeji, Hyogo 6712280, Japan.						Pedersen TG, 1998, PHYS REV LETT, V80, P89, DOI 10.1103/PhysRevLett.80.89; Kawatsuki N, 2013, APL MATER, V1, DOI 10.1063/1.4818003; Isayama J, 2010, MACROMOLECULES, V43, P4105, DOI 10.1021/ma100328e; Kumar J, 1998, APPL PHYS LETT, V72, P2096, DOI 10.1063/1.121287; Nakano H, 2002, ADV MATER, V14, P1157, DOI 10.1002/1521-4095(20020816)14:16<1157::AID-ADMA1157>3.0.CO;2-Z; Kawatsuki N, 2014, MACROMOLECULES, V47, P324, DOI 10.1021/ma4023247; Viswanathan NK, 1999, JPN J APPL PHYS 1, V38, P5928, DOI 10.1143/JJAP.38.5928; KIM DY, 1995, APPL PHYS LETT, V66, P1166, DOI 10.1063/1.113845; ROCHON P, 1995, APPL PHYS LETT, V66, P136, DOI 10.1063/1.113541; FUREY RL, 1968, TETRAHEDRON, V24, P3085, DOI 10.1016/S0040-4020(01)98716-2; Goldenberg LM, 2009, J MATER CHEM, V19, P8068, DOI 10.1039/b918130j; Kawatsuki N, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.041601; Luo Y, 2011, CHEMPHYSCHEM, V12, P2311, DOI 10.1002/cphc.201100179; Nishioka E, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.021601; Seki T., 2009, SMART LIGHT RESPONSI, P273, DOI 10.1002/9780470439098.ch8; Ubukata T, 2012, POLYM J, V44, P966, DOI 10.1038/pj.2012.40; Ubukata T, 2012, J MATER CHEM, V22, P14410, DOI 10.1039/c2jm32149a; Uchida E, 2006, POLYM J, V38, P724, DOI 10.1295/polymj.PJ2005236	18	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2014	53	12								10.7567/JJAP.53.128002		3	Physics, Applied	Physics	AX5HS	WOS:000346957800031		
J	Kojiri, T; Matsuda, T; Kimura, M				Kojiri, Takashi; Matsuda, Tokiyoshi; Kimura, Mutsumi			Thermally enhanced threshold voltage shifts in amorphous In-Ga-Zn-O thin-film transistor	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							OXIDE SEMICONDUCTORS; STABILITY	We examined the stability of amorphous In-Ga-Zn-O (a-IGZO) thin-film transistors (TFTs) under positive bias temperature stress (PBTS) and negative bias temperature stress (NBTS). The threshold voltage of a-IGZO TFTs shifted in the negative direction under NBTS, while there was minimal threshold voltage shift under PBTS. We also measured the relaxation time of the threshold voltage shifts under NBTS and conducted device simulations. Our results suggest that the threshold voltage shifts under NBTS are caused by a mechanism similar to that under negative bias illumination stress (NBIS). Furthermore, we found that this threshold voltage shift can be reduced by proper back-channel passivation using SiO2. (C) 2014 The Japan Society of Applied Physics	[Kojiri, Takashi] Zeon Corp, R&D Ctr, Res Lab, Kawasaki, Kanagawa 2109507, Japan; [Matsuda, Tokiyoshi; Kimura, Mutsumi] Ryukoku Univ, Dept Elect & Informat, Otsu, Shiga 5202194, Japan	Kojiri, T (reprint author), Zeon Corp, R&D Ctr, Res Lab, Kawasaki, Kanagawa 2109507, Japan.						Mativenga M, 2011, IEEE ELECTR DEVICE L, V32, P170, DOI 10.1109/LED.2010.2093504; Lee KH, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3272015; Kimura M, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3455072; Yabuta H, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2353811; Suresh A, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2824758; Nomura K, 2012, THIN SOLID FILMS, V520, P3778, DOI 10.1016/j.tsf.2011.10.068; Nomura K, 2006, JPN J APPL PHYS 1, V45, P4303, DOI 10.1143/JJAP.45.4303; Kim DH, 2009, ELECTROCHEM SOLID ST, V12, pH296, DOI 10.1149/1.3142470; Migliorato P, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4752238; Sung SY, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3357431; Jeong JK, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2990657; Nomura K, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3622121; Arai T., 2012, SID INT S, V43, P756; Chowdhury MDH, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3580611; Gong N., 2012, 19 INT DISPL WORKSH, P421; Han C-W, 2012, SID S, V43, P279; Huh JY, 2011, CURR APPL PHYS, V11, pS49, DOI 10.1016/j.cap.2011.05.026; Hyung GW, 2012, SOLID STATE ELECTRON, V69, P27, DOI 10.1016/j.sse.2011.12.001; Kimura M, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.054302; Nakajima Y., 2012, SID S, V43, P271; Nakata M, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.044105; Nakata M, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.081607; Noda M., 2012, SID S, V43, P998; Nomura K, 2004, NATURE, V432, P488, DOI 10.1038/nature03090; Oh H, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3540500; Takeshita M., 2013, 20 INT DISPL WORKSH, P489; Tanabe A., 2012, 19 INT DISPL WORKSH, P969; Tanabe T., 2012, SID S, V43, P88; Teramoto K., 2012, 19 INT DISPL WORKSH, P855; Um JG, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4751849; Yamaguchi H., 2012, 19 INT DISPL WORKSH, P851; Yamazaki S., 2012, SID S, V43, P183; Yeh B.-L., 2012, 19 INT DISPL WORKSH, P425	33	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2014	53	12							125802	10.7567/JJAP.53.125802		5	Physics, Applied	Physics	AX5HS	WOS:000346957800023		
J	Matsumoto, R; Kubota, H; Yamaji, T; Arai, H; Yuasa, S; Imamura, H				Matsumoto, Rie; Kubota, Hitoshi; Yamaji, Toshiki; Arai, Hiroko; Yuasa, Shinji; Imamura, Hiroshi			Spin-torque diode spectrum of a spin valve with a synthetic antiferromagnetic reference layer	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MAGNETIC TUNNEL-JUNCTIONS; MAGNETORESISTANCE; MULTILAYER; DRIVEN; OSCILLATIONS; EXCITATION; EMISSION; DEVICES	The spin torque diode (STD) effect of a spin-valve with a synthetic antiferromagnetic reference layer is theoretically analyzed. Based on the macrospin model the analytical expression of the STD spectrum is derived. The obtained result enables us to analyze the spin transfer torque (STT) acting on the reference layer. The peak of the STD spectrum at the resonance frequencies of the reference layer changes its sign depending on the magnitude of the STT which is generated by the RF current injected from the pinned layer. (C) 2014 The Japan Society of Applied Physics	[Matsumoto, Rie; Kubota, Hitoshi; Yamaji, Toshiki; Arai, Hiroko; Yuasa, Shinji; Imamura, Hiroshi] Natl Inst Adv Ind Sci & Technol, Spintron Res Ctr, Tsukuba, Ibaraki 3058568, Japan	Matsumoto, R (reprint author), Natl Inst Adv Ind Sci & Technol, Spintron Res Ctr, Tsukuba, Ibaraki 3058568, Japan.	h-imamura@aist.go.jp			JSPS [25790045]	This work was supported by JSPS KAKENHI Grant Number 25790045.	Deac AM, 2008, NAT PHYS, V4, P803, DOI 10.1038/nphys1036; Tsoi M, 1998, PHYS REV LETT, V80, P4281, DOI 10.1103/PhysRevLett.80.4281; Myers EB, 1999, SCIENCE, V285, P867, DOI 10.1126/science.285.5429.867; Suzuki Y, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.031002; PARKIN SSP, 1990, PHYS REV LETT, V64, P2304, DOI 10.1103/PhysRevLett.64.2304; Sankey JC, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.227601; Taniguchi T, 2013, J APPL PHYS, V114, DOI 10.1063/1.4817281; Tulapurkar AA, 2005, NATURE, V438, P339, DOI 10.1038/nature04207; Kubota H, 2008, NAT PHYS, V4, P37, DOI 10.1038/nphys784; Theodonis I, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.237205; Ishibashi S, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.073001; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Yuasa S, 2007, J PHYS D APPL PHYS, V40, pR337, DOI 10.1088/0022-3727/40/21/R01; Kiselev SI, 2003, NATURE, V425, P380, DOI 10.1038/nature01967; Wang C, 2009, J APPL PHYS, V106, DOI 10.1063/1.3197137; Wang C, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.224416; Sankey JC, 2008, NAT PHYS, V4, P67, DOI 10.1038/nphys783; Miwa S, 2014, NAT MATER, V13, P50, DOI [10.1038/nmat3778, 10.1038/NMAT3778]; Ishibashi S, 2011, IEEE T MAGN, V47, P3373, DOI 10.1109/TMAG.2011.2159830; Konoto M, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.073002; Lacoste B, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.064408; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Tsunegi S, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.033004; Yakata S, 2009, J APPL PHYS, V105, DOI 10.1063/1.3057974	24	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2014	53	12							123001	10.7567/JJAP.53.123001		5	Physics, Applied	Physics	AX5HS	WOS:000346957800015		
J	Ogawa, J; Koumura, N; Hara, K; Mori, S				Ogawa, Junichi; Koumura, Nagatoshi; Hara, Kohjiro; Mori, Shogo			Deceleration of dye cation reduction kinetics by adding alkyl chains to the Pi-conjugated linker of dye molecules	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SENSITIZED SOLAR-CELLS; NANOCRYSTALLINE TIO2 FILMS; ELECTRON-TRANSFER KINETICS; ORGANIC-DYE; RECOMBINATION; PHOTOVOLTAICS; ENERGY	To retard charge recombination between the injected electrons in TiO2 and acceptor species in the electrolyte solution in dye-sensitized solar cells (DSSCs), alkyl chains have been introduced to dye molecules. To examine the effect of the alkyl chains on the dye cation reduction kinetics, we measured the transient absorption of the cationic state of dyes with and without alkyl chains in DSSCs and found that the reduction kinetics with alkyl chains slowed down for both injected electrons in TiO2 and I-. The slower back electron transfer was interpreted with the slower hopping rate of the holes among the dyes on the TiO2 surface, whereas the slower reduction by I- was probably a result of the blocking effect against the approach of I- to the dye molecules. (C) 2014 The Japan Society of Applied Physics	[Ogawa, Junichi; Mori, Shogo] Shinshu Univ, Div Chem & Mat, Fac Text Sci & Technol, Ueda, Nagano 3868567, Japan; [Koumura, Nagatoshi; Hara, Kohjiro] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan; [Mori, Shogo] Shinshu Univ, Ctr Energy & Environm Sci, Ueda, Nagano 3868567, Japan	Ogawa, J (reprint author), Shinshu Univ, Div Chem & Mat, Fac Text Sci & Technol, Ueda, Nagano 3868567, Japan.	shogmori@shinshu-u.ac.jp	Mori, Shogo/B-3817-2013		New Energy and Industrial Technology Development Organization (NEDO) of Japan	This work was supported by New Energy and Industrial Technology Development Organization (NEDO) of Japan.	Pastore M, 2012, J PHYS CHEM C, V116, P5965, DOI 10.1021/jp300095z; Johansson PG, 2013, J AM CHEM SOC, V135, P8331, DOI 10.1021/ja402193f; Miyashita M, 2008, J AM CHEM SOC, V130, P17874, DOI 10.1021/ja803534u; Wang ZS, 2008, CHEM MATER, V20, P3993, DOI 10.1021/cm8003276; Montanari I, 2002, J PHYS CHEM B, V106, P12203, DOI 10.1021/jp025824c; Nelson J, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.205321; Clifford JN, 2004, J AM CHEM SOC, V126, P5225, DOI 10.1021/ja039924n; Katoh R, 2009, ENERG ENVIRON SCI, V2, P542, DOI 10.1039/b900372j; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Hara K, 2005, J PHYS CHEM B, V109, P15476, DOI 10.1021/jp0518557; Moia D, 2014, CHEM SCI, V5, P281, DOI 10.1039/c3sc52359d; Murakami TN, 2014, LANGMUIR, V30, P2274, DOI 10.1021/la4047808; Koumura N, 2006, J AM CHEM SOC, V128, P14256, DOI 10.1021/ja0645640	13	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2014	53	12							127301	10.7567/JJAP.53.127301		5	Physics, Applied	Physics	AX5HS	WOS:000346957800029		
J	Ota, Y; Nishioka, K				Ota, Yasuyuki; Nishioka, Kensuke			Estimation of operating temperature and energy output of concentrator photovoltaic module under concentration conditions	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MULTIJUNCTION SOLAR-CELLS; HIGH-EFFICIENCY MULTIJUNCTION; V COMPOUND MULTIJUNCTION; SHAPED FRESNEL LENSES; SYSTEM; MODEL	The operating temperature of a concentrator photovoltaic (CPV) module is a dominant factor in its conversion efficiency. It is necessary to reduce the operating temperature to generate a high output of a CPV module under field operation. Therefore, we estimated the operating temperature and conversion efficiency of a cell or module under real concentrating operations. First, we developed a heat transfer model for the CPV module. The operating temperature in the CPV module was calculated as functions of the thermal resistance and the heat transfer coefficient. A low thermal resistance between the solar cell and the back-surface and a high heat transfer coefficient of the back-surface were effective for reducing operating temperature. Next, the conversion efficiency of a triple-junction solar cell was calculated using an equivalent circuit simulation. We can evaluate the cell performance under actual operating conditions using the calculated operating temperatures of the cell. (C) 2014 The Japan Society of Applied Physics	[Ota, Yasuyuki; Nishioka, Kensuke] Miyazaki Univ, Miyazaki 8892192, Japan	Ota, Y (reprint author), Miyazaki Univ, Miyazaki 8892192, Japan.	y-ota@cc.miyazaki-u.ac.jp			New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry, Japan (METI)	Part of this work was supported by the New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry, Japan (METI). The authors would like to thanks Professor Masafumi Yamaguchi and Dr. Kenji Araki for their helpful suggestions and discussions on the concentrator photovoltaic module.	Araki K, 2005, PROG PHOTOVOLTAICS, V13, P513, DOI 10.1002/pip.643; Geisz JF, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2753729; Segev G, 2012, SOL ENERG MAT SOL C, V98, P57, DOI 10.1016/j.solmat.2011.10.013; Nishioka K, 2005, SOL ENERG MAT SOL C, V85, P429, DOI 10.1016/j.solmat.2004.05.008; Nishioka K, 2012, SOL ENERGY, V86, P3021, DOI 10.1016/j.solener.2012.07.009; Sasaki K, 2013, AIP CONF PROC, V1556, P22, DOI 10.1063/1.4822190; Kinsey GS, 2009, PROG PHOTOVOLTAICS, V17, P279, DOI 10.1002/pip.875; Yamaguchi M, 2006, SOL ENERG MAT SOL C, V90, P3068, DOI 10.1016/j.solmat.2006.06.028; Nishioka K, 2006, SOL ENERG MAT SOL C, V90, P57, DOI 10.1016/j.solmat.2005.01.011; Anton I, 2012, AIP CONF PROC, V1477, P331, DOI 10.1063/1.4753898; Araki K, 2010, OPT EXPRESS, V18, pA53, DOI [10.1364/OE.18.000A53, 10.1364/OE.18.0000A53]; Dimroth F, 2014, PROG PHOTOVOLTAICS, V22, P277, DOI 10.1002/pip.2475; Nishioka K, 2010, J ELECTRON MATER, V39, P704, DOI 10.1007/s11664-010-1171-y; Yamaguchi M, 2003, SOL ENERG MAT SOL C, V75, P261, DOI 10.1016/S0927-0248(02)00168-X; Guter W, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3148341; Ota Y, 2010, IEEE PHOT SPEC CONF, P2093; Peharz G, 2011, PROG PHOTOVOLTAICS, V19, P54, DOI 10.1002/pip.987; Ouennoughi Z, 1999, SOLID STATE ELECTRON, V43, P1985, DOI 10.1016/S0038-1101(99)00174-4; Araki K, 2006, SOL ENERG MAT SOL C, V90, P3312, DOI 10.1016/j.solmat.2005.09.017; Benitez P, 2010, OPT EXPRESS, V18, pA25, DOI [10.1364/OE.18.000A25, 10.1364/OE.18.0000A25]; Bett A. W., 2014, 10 INT C CONC PHOT; Jaus J., 2009, IEEE PHOT SPEC C; Leutz R., 2001, NONIMAGING FRESNEL L; Nabemoto K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10ND11; Nishioka K, 2003, JPN J APPL PHYS 1, V42, P7175, DOI 10.1143/JJAP.42.7175; Ota Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BP03; Ota Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CR03; Sabnis V, 2012, AIP CONF PROC, V1477, P14, DOI 10.1063/1.4753823; Sakurada Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.04DP13; Sze S. M., 2007, PHYS SEMICONDUCTOR D; Yamaguchi M, 2012, ENRGY PROCED, V15, P265, DOI 10.1016/j.egypro.2012.02.031; Yandt MD, 2012, AIP CONF PROC, V1477, P172, DOI 10.1063/1.4753861	32	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2014	53	12							122301	10.7567/JJAP.53.122301		5	Physics, Applied	Physics	AX5HS	WOS:000346957800009		
J	Satoh, N; Kobayashi, K; Watanabe, S; Fujii, T; Matsushige, K; Yamada, H				Satoh, Nobuo; Kobayashi, Kei; Watanabe, Shunji; Fujii, Toru; Matsushige, Kazumi; Yamada, Hirofumi			Scanning near-feild optical microscopy system based on frequency-modulation atomic force microscopy using a piezoelectric cantilever	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TITANATE THIN-FILM; ELECTRICAL-PROPERTIES; SHEAR FORCE; FIELD; PROBE; REFLECTION; CONTRAST; NANO; PZT	We developed a scanning near-field optical microscopy (SNOM) system based on frequency-modulation atomic force microscopy (FM-AFM), using a microfabricated force-sensing cantilever with a lead zirconate titanate (PZT) thin film as an integrated deflection sensor. In the system, an evanescent field is generated on the sample surface by total internal reflection, and the light transmitted through the optically transparent tip is collected by a photomultiplier while the gap distance between the tip and the sample surface is regulated by the FM detection method. We obtained a SNOM image of a sample with the nanometer-scale resolution of polystyrene particles dispersed in a polyvinyl alcohol thin film deposited onto a glass substrate with the developed SNOM/AFM system, under a completely dark condition. (C) 2014 The Japan Society of Applied Physics	[Satoh, Nobuo; Matsushige, Kazumi; Yamada, Hirofumi] Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan; [Kobayashi, Kei] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto 6158520, Japan; [Watanabe, Shunji; Fujii, Toru] Nikon Inc, Sagamihara, Kanagawa 2280828, Japan	Satoh, N (reprint author), Chiba Inst Technol, Narashino, Chiba 2750016, Japan.	n-satoh@kuee.kyoto-u.ac.jp	Satoh, Nobuo/J-4288-2015		Global Center of Excellence program of Kyoto University [C09]; Ministry of Education, Culture, Sports, Science and Technology of Japan [20043018, 20760469]	This research was partially supported by the Global Center of Excellence program of Kyoto University (C09), a Grant-in-Aid for Scientific Research on Priority Areas (No. 20043018), and a Grant-in-Aid for Young Scientists (B) (Grant No. 20760469) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Adam PM, 1998, ULTRAMICROSCOPY, V71, P327, DOI 10.1016/S0304-3991(97)00091-0; ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; Fukuma T, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1896938; BETZIG E, 1992, APPL PHYS LETT, V60, P2484, DOI 10.1063/1.106940; Naber A, 1999, REV SCI INSTRUM, V70, P3955, DOI 10.1063/1.1150019; Gerber C, 2006, NAT NANOTECHNOL, V1, P3, DOI 10.1038/nnano.2006.70; FUJII T, 1995, J VAC SCI TECHNOL B, V13, P1119, DOI 10.1116/1.587914; Fujii T, 1996, APPL PHYS LETT, V68, P467, DOI 10.1063/1.116415; Gesuele F, 2009, PHYSICA E, V41, P1130, DOI 10.1016/j.physe.2008.08.042; HEINZELMANN H, 1994, APPL PHYS A-MATER, V59, P89, DOI 10.1007/BF00332200; Hillenbrand R, 2004, ULTRAMICROSCOPY, V100, P421, DOI 10.1016/j.ultramic.2003.11.017; Hosaka S, 1999, APPL SURF SCI, V140, P388, DOI 10.1016/S0169-4332(98)00560-1; INOUYE Y, 1994, OPT LETT, V19, P159, DOI 10.1364/OL.19.000159; Ito S, 2003, B CHEM SOC JPN, V76, P1693, DOI 10.1246/bcsj.76.1693; JALOCHA A, 1995, OPT COMMUN, V119, P17, DOI 10.1016/0030-4018(95)00276-E; Kalkbrenner T, 2000, APPL PHYS LETT, V76, P1206, DOI 10.1063/1.125984; Nakajima K, 1999, JPN J APPL PHYS 1, V38, P3949, DOI 10.1143/JJAP.38.3949; Kobayashi K, 2001, REV SCI INSTRUM, V72, P4383, DOI 10.1063/1.1416104; KREMPASKY J, 1991, SOLID STATE COMMUN, V78, P1039, DOI 10.1016/0038-1098(91)90125-F; Minh PN, 2000, REV SCI INSTRUM, V71, P3111, DOI 10.1063/1.1304867; Morita S., 2002, NONCONTACT ATOMIC FO; Ohtsu M, 2008, SER OPT OPTOELECTRON, P1; POHL DW, 1994, J VAC SCI TECHNOL B, V12, P1441, DOI 10.1116/1.587313; Ruiter AGT, 1996, J VAC SCI TECHNOL B, V14, P597, DOI 10.1116/1.589142; Saiki T, 1999, APPL PHYS LETT, V74, P2773, DOI 10.1063/1.123307; Satoh N, 2004, JPN J APPL PHYS 1, V43, P4651, DOI 10.1143/JJAP.43.4651; Satoh N, 2002, APPL SURF SCI, V188, P425, DOI 10.1016/S0169-4332(01)00969-2; Satoh N, 2002, IEICE T ELECTRON, VE85C, P2071; Satoh N, 2003, JPN J APPL PHYS 1, V42, P4878, DOI 10.1143/JJAP.42.4878; Schubert E.F., 2004, REFRACTIVE INDEX EXT; Shubeita GT, 2000, J APPL PHYS, V88, P2921, DOI 10.1063/1.1287234; Watanabe S, 1996, REV SCI INSTRUM, V67, P3898, DOI 10.1063/1.1147290; Wurtz G, 1998, REV SCI INSTRUM, V69, P1735, DOI 10.1063/1.1148834; Yamada H, 1999, SURF INTERFACE ANAL, V27, P503, DOI 10.1002/(SICI)1096-9918(199905/06)27:5/6<503::AID-SIA529>3.3.CO;2-C; Zvyagin AV, 1997, APPL PHYS LETT, V71, P2541, DOI 10.1063/1.120111	35	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2014	53	12							125201	10.7567/JJAP.53.125201		5	Physics, Applied	Physics	AX5HS	WOS:000346957800019		
J	Suzuki, Y; Takeuchi, A				Suzuki, Yoshio; Takeuchi, Akihisa			X-ray holographic microscopy with Fresnel zone plate objective lens and double-diamond-prism interferometer	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							FOURIER-TRANSFORM HOLOGRAPHY; GABOR HOLOGRAPHY; REFRACTIVE PRISM; RESOLUTION; OPTICS	A hard X-ray imaging holography system with a Fresnel zone plate objective lens and double-diamond-prism interferometer has been developed. The refractive prism made of single-crystal diamond is used for solving the radiation damage problem caused by high-flux-density X-ray beams. Uniform periodic interference fringes are observed, and a carrier fringe scan is carried out using a rotating thin glass plate as a phase shifter. Phase retrieval by the fringe scan method is also achieved with a suboptical spatial resolution. (C) 2014 The Japan Society of Applied Physics	[Suzuki, Yoshio; Takeuchi, Akihisa] SPring 8, Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan	Suzuki, Y (reprint author), SPring 8, Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan.	yoshio@spring8.or.jp					Leitenberger W, 2001, J APPL PHYS, V90, P538, DOI 10.1063/1.1378810; Harada K, 2004, APPL PHYS LETT, V84, P3229, DOI 10.1063/1.1715155; Takano H, 2003, JPN J APPL PHYS 2, V42, pL132, DOI 10.1143/JJAP.42.L132; Suzuki Y, 2004, AIP CONF PROC, V705, P344; LEITH EN, 1962, J OPT SOC AM, V52, P1123, DOI 10.1364/JOSA.52.001123; GABOR D, 1948, NATURE, V161, P777, DOI 10.1038/161777a0; MCNULTY I, 1992, SCIENCE, V256, P1009, DOI 10.1126/science.256.5059.1009; AOKI S, 1974, JPN J APPL PHYS, V13, P1385, DOI 10.1143/JJAP.13.1385; AOKI S, 1972, JPN J APPL PHYS, V11, P1857, DOI 10.1143/JJAP.11.1857; Aoki S, 2005, JPN J APPL PHYS 1, V44, P417, DOI 10.1143/JJAP.44.417; HOWELLS M, 1987, SCIENCE, V238, P514, DOI 10.1126/science.3659925; Koyama T, 2006, JPN J APPL PHYS 2, V45, pL1159, DOI 10.1143/JJAP.45.L1159; Koyama T, 2004, JPN J APPL PHYS 2, V43, pL421, DOI 10.1143/JJAP.43.L421; Lang AR, 1999, J SYNCHROTRON RADIAT, V6, P59, DOI 10.1107/S0909049599001041; Lim J, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.072504; Suzuki Y, 2002, JPN J APPL PHYS 2, V41, pL1019, DOI 10.1143/JJAP.41.L1019; Suzuki Y, 2008, JPN J APPL PHYS, V47, P8595, DOI 10.1143/JJAP.47.8595; Suzuki Y, 2010, AIP CONF PROC, V1234, P453, DOI 10.1063/1.3463238; Suzuki Y, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2018378; Suzuki Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.086701; Suzuki Y, 2009, J PHYS CONF SER, V186, DOI 10.1088/1742-6596/186/1/012048; Suzuki Y, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.016601; Suzuki Y, 2007, AIP CONF PROC, V879, P1305; Takeuchi A, 2005, JPN J APPL PHYS 1, V44, P3293, DOI 10.1143/JJAP.44.3293; Watanabe N, 2003, J PHYS IV, V104, P551, DOI 10.1051/jp4:20030142; Watanabe N, 1997, APPL OPTICS, V36, P7433, DOI 10.1364/AO.36.007433; Watanabe N, 2009, J PHYS CONF SER, V186, DOI 10.1088/1742-6596/186/1/012021; Watanabe N, 2004, AIP CONF PROC, V705, P1340; Watanabe N., 2006, IPAP C SER, V7, P372	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2014	53	12							122501	10.7567/JJAP.53.122501		5	Physics, Applied	Physics	AX5HS	WOS:000346957800013		
J	Tochikubo, F; Shimokawa, Y; Shirai, N; Uchida, S				Tochikubo, Fumiyoshi; Shimokawa, Yudai; Shirai, Naoki; Uchida, Satoshi			Chemical reactions in liquid induced by atmospheric-pressure dc glow discharge in contact with liquid	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ION BEAM MEASUREMENTS; CHARGE-TRANSFER; ELECTROLYTE CATHODE; HYDRATED ELECTRONS; TEMPERATURE-DEPENDENCE; AQUEOUS-SOLUTION; RATE CONSTANTS; WATER; MICROPLASMA; NANOPARTICLES	We experimentally investigated some of the initial reactions in a liquid induced by electron or positive-ion irradiation from an atmospheric-pressure dc glow discharge in contact with the liquid. Aqueous solutions of NaCl, AgNO3, and HAuCl4 are used as the electrolyte. We measured the pH and conductivity in the liquid at approximately 1 cm below the solution surfaces. OH radical generation in the liquid was observed by a chemical probe method. Experimental results showed that electron irradiation of the liquid surface generates OH- in water and that positive-ion irradiation of the liquid surface generates H+ in water even without the dissolution of gas-phase nitrogen oxide. A possible reaction process is qualitatively discussed. In particular, the contribution of charge transfer collision between impinging low-energy positive ions and water molecules to the ionic species in the liquid is used to explain the overall tendency of the experimental results. (C) 2014 The Japan Society of Applied Physics	[Tochikubo, Fumiyoshi; Shimokawa, Yudai; Shirai, Naoki; Uchida, Satoshi] Tokyo Metropolitan Univ, Dept Elect & Elect Engn, Hachioji, Tokyo 1920397, Japan	Tochikubo, F (reprint author), Tokyo Metropolitan Univ, Dept Elect & Elect Engn, Hachioji, Tokyo 1920397, Japan.	tochi@tmu.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21110007]	This work was supported financially by a Grant-in-Aid for Scientific Research on Innovative Areas (No. 21110007) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Chiang WH, 2010, PLASMA SOURCES SCI T, V19, DOI 10.1088/0963-0252/19/3/034011; CSERFALVI T, 1993, J PHYS D APPL PHYS, V26, P2184, DOI 10.1088/0022-3727/26/12/015; SCHMIDT KH, 1995, CHEM PHYS, V190, P145, DOI 10.1016/0301-0104(94)00332-5; Itikawa Y, 2005, J PHYS CHEM REF DATA, V34, P1, DOI 10.1063/1.1799251; Kanazawa S, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034010; Wang Q, 2006, J APPL PHYS, V100, DOI 10.1063/1.2214591; Kaneko T, 2009, PLASMA PROCESS POLYM, V6, P713, DOI 10.1002/ppap.200900029; Choi HS, 2006, J COLLOID INTERF SCI, V300, P640, DOI 10.1016/j.jcis.2006.04.001; HICKLING A, 1964, T FARADAY SOC, V60, P783, DOI 10.1039/tf9646000783; Bruggeman P, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/5/053001; Shirai N, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/3/034013; BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513; Richmonds C, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2988283; Mariotti D, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/32/323001; SHIRAISHI H, 1994, J PHYS CHEM-US, V98, P5164, DOI 10.1021/j100070a037; Chang FC, 2010, J VAC SCI TECHNOL A, V28, pL5, DOI 10.1116/1.3428708; Locke BR, 2006, IND ENG CHEM RES, V45, P882, DOI 10.1021/ie050981u; Fang XW, 1996, ULTRASON SONOCHEM, V3, P57, DOI 10.1016/1350-4177(95)00032-1; Rumbach P, 2013, J AM CHEM SOC, V135, P16264, DOI 10.1021/ja407149y; Shirai N, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.046202; Witzke M, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/44/442001; Cserfalvi T, 1996, FRESEN J ANAL CHEM, V355, P813; Marcus RK, 2001, ANAL CHEM, V73, P2903, DOI 10.1021/ac010158h; Choi J, 2007, IEEE T PLASMA SCI, V35, P1274, DOI 10.1109/TPS.2007.904827; Kanazawa S, 2013, J PHYS CONF SER, V418, DOI 10.1088/1742-6596/418/1/012102; ARNOLD ST, 1995, J CHEM PHYS, V102, P6110, DOI 10.1063/1.469345; CHRISTENSEN H, 1994, RADIAT PHYS CHEM, V43, P527, DOI 10.1016/0969-806X(94)90163-5; DAVIES RA, 1952, J CHEM SOC, P3595, DOI 10.1039/jr9520003595; DRESSLER RA, 1994, J CHEM PHYS, V100, P5656, DOI 10.1063/1.467275; DRESSLER RA, 1992, PLANET SPACE SCI, V40, P1695, DOI 10.1016/0032-0633(92)90126-9; DRESSLER RA, 1993, J CHEM PHYS, V99, P1159, DOI 10.1063/1.465413; ERSHOV BG, 1993, J PHYS CHEM-US, V97, P4589, DOI 10.1021/j100120a006; Ghosh-Mazumdar A S, 1968, ADV CHEM SER, V81, P193; Nishiyama S., 2013, MRS P, V1598; SCHWARZ HA, 1992, J PHYS CHEM-US, V96, P8937, DOI 10.1021/j100201a044; Shirai N, 2011, IEEE T PLASMA SCI, V39, P2652, DOI 10.1109/TPS.2011.2158324; Titov VA, 2005, SURF COAT TECH, V199, P231, DOI 10.1016/j.surfcoat.2005.01.037; Tochikubo F., 2012, P 4 INT S ADV PLASM	38	3	3	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2014	53	12							126201	10.7567/JJAP.53.126201		8	Physics, Applied	Physics	AX5HS	WOS:000346957800024		
J	Tsunoi, Y; Sato, S; Watanabe, R; Kawauchi, S; Ashida, H; Terakawa, M				Tsunoi, Yasuyuki; Sato, Shunichi; Watanabe, Ryota; Kawauchi, Satoko; Ashida, Hiroshi; Terakawa, Mitsuhiro			Compact acoustic-resolution photoacoustic imaging system with fiber-based illumination	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							HEMODYNAMIC-CHANGES; MICROSCOPY; TISSUES; SKIN	Acoustic-resolution photoacoustic imaging enables unique high-resolution visualization of chromophores in deep tissue. However, most current systems are bulky and use complex optical components for illumination. In this study, we developed a compact acoustic-resolution photoacoustic imaging system with simple fiber-based illumination. Around the ultrasound sensor attached to an acoustic lens, four optical fibers were placed in four directions 90 degrees apart, and the sensor plane was covered with an optically and acoustically transparent plastic spacer. The imaging head is compact (diameter, 32 mm; height, 27 mm) and lightweight (32 g) and is alignment-free, thus being suitable for in vivo applications. We assessed the uniformity and symmetry of photoacoustic excitation both by Monte Carlo simulation and experiments. A phantom study showed lateral and axial resolutions of the system to be 148 and 66 mu m, respectively. With the system, high-contrast visualization of blood vessels in rat skin was demonstrated in vivo. (C) 2014 The Japan Society of Applied Physics	[Tsunoi, Yasuyuki; Watanabe, Ryota; Terakawa, Mitsuhiro] Keio Univ, Sch Integrated Design Engn, Yokohama, Kanagawa 2238522, Japan; [Sato, Shunichi; Kawauchi, Satoko; Ashida, Hiroshi] Natl Def Med Coll, Res Inst, Div Biomed Informat Sci, Tokorozawa, Saitama 3598513, Japan	Tsunoi, Y (reprint author), Keio Univ, Sch Integrated Design Engn, Yokohama, Kanagawa 2238522, Japan.	shunsato@ndmc.ac.jp			Japan Society for the Promotion of Science (JSPS) [25460665]	The authors sincerely thank Mr. Kenichiro Yoshimi and Mr. Nori Kumai of Research Center of Computational Mechanics for supporting calculation for PA imaging. They also thank Toray Industries, Inc. for providing carbon fibers and Advantest Corporation for the use of the high-repetition-rate optical parametric oscillator. This work was partially supported by a Grant-in-Aid for Scientific Research (C), No. 25460665 from the Japan Society for the Promotion of Science (JSPS). Y. Tsunoi is grateful for a Grant-in-Aid for Research Fellow of JSPS.	American National Standard for Safety Use of Lasers, 2007, Z1361 ANSI; Zhang HF, 2007, NAT PROTOC, V2, P797, DOI 10.1038/nprot.2007.108; Li ML, 2006, OPT LETT, V31, P474, DOI 10.1364/OL.31.000474; Ding HF, 2006, PHYS MED BIOL, V51, P1479, DOI 10.1088/0031-9155/51/6/008; Liao LD, 2010, NEUROIMAGE, V52, P562, DOI 10.1016/j.neuroimage.2010.03.065; Maslov K, 2005, OPT LETT, V30, P625, DOI 10.1364/OL.30.6.000625; Zhang HF, 2006, OPT EXPRESS, V14, P9317, DOI 10.1364/OE.14.009317; Liao LD, 2012, J CEREBR BLOOD F MET, V32, P938, DOI 10.1038/jcbfm.2012.42; Wang PH, 2011, BIOMED OPT EXPRESS, V2, P1462, DOI 10.1364/BOE.2.001462; Yao M, 2010, LASER SURG MED, V42, P123, DOI 10.1002/lsm.20869; Ma R, 2012, BIOMED OPT EXPRESS, V3, P1724, DOI 10.1364/BOE.3.001724; Barton JK, 1998, OPT EXPRESS, V2, P391; Cai X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043999; Kikuchi Y., 1980, CHOONPA IGAKU, P48; Maslov K, 2007, P SOC PHOTO-OPT INS, V6437, P43727, DOI 10.1117/12.702227; Stein EW, 2009, J APPL PHYS, V105, DOI 10.1063/1.3116134; Tsunoi Y, 2013, PROC SPIE, V8581, DOI 10.1117/12.2003150; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; Wang PH, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.061222; Zerda A. D. L., 2010, OPT LETT, V35, P270; Zerda A. D. L., 2008, NAT NANOTECHNOL, V3, P557; Zhang HF, 2006, NAT BIOTECHNOL, V24, P848, DOI 10.1038/nbt1220	22	3	3	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2014	53	12							126701	10.7567/JJAP.53.126701		6	Physics, Applied	Physics	AX5HS	WOS:000346957800027		
J	Verma, S; Singh, M; Ahuja, D; Shimose, H; Nishino, S; Miyata, M; Mott, D; Koyano, M; Maenosono, S				Verma, Sandhya; Singh, Maninder; Ahuja, Dipali; Shimose, Hiroyuki; Nishino, Shunsuke; Miyata, Masanobu; Mott, Derrick; Koyano, Mikio; Maenosono, Shinya			Chalcopyrite nanocomposite material for sustainable thermoelectrics	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CU2S NANOCRYSTALS; ENHANCEMENT; PERFORMANCE	A chalcopyrite nanocomposite is explored as a low temperature and sustainable thermoelectric material. Chalcopyrite nanoparticles are created through a wet chemical synthetic method and display remarkable phase purity. These nanoparticle building blocks are processed into a large scale material by linking of nanoparticles by short chain ligands to enhance electrical conductivity, pressing into a pellet and subsequent thermal annealing to remove volatiles and enhance particle contacts through sintering. The resulting materials Seebeck characteristics are measured and found to be 23.6 mu V/K, a P-type material. (C) 2014 The Japan Society of Applied Physics	[Verma, Sandhya; Singh, Maninder; Ahuja, Dipali; Shimose, Hiroyuki; Nishino, Shunsuke; Miyata, Masanobu; Mott, Derrick; Koyano, Mikio; Maenosono, Shinya] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231211, Japan	Verma, S (reprint author), Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231211, Japan.	shinya@jaist.ac.jp	Maenosono, Shinya/E-9494-2011	Maenosono, Shinya/0000-0003-2669-8219			Anno H., 2014, 15 INT C AS INT UN M; WAGNER CD, 1981, SURF INTERFACE ANAL, V3, P211, DOI 10.1002/sia.740030506; Mott D, 2010, CHEM MATER, V22, P261, DOI 10.1021/cm903038w; Suekuni K, 2013, J APPL PHYS, V113, DOI 10.1063/1.4789389; Ge ZH, 2011, CHEM COMMUN, V47, P12697, DOI 10.1039/c1cc16368j; Poudel B, 2008, SCIENCE, V320, P634, DOI 10.1126/science.1156446; Heremans JP, 2008, SCIENCE, V321, P554, DOI 10.1126/science.1159725; Sigman MB, 2003, J AM CHEM SOC, V125, P16050, DOI 10.1021/ja037688a; Li S, 2009, J COLLOID INTERF SCI, V330, P483, DOI 10.1016/j.jcis.2008.10.062; Suekuni K, 2014, J APPL PHYS, V115, DOI 10.1063/1.4871265; Zhang YC, 2011, ACS NANO, V5, P3158, DOI 10.1021/nn2002294; Zhao LD, 2013, J AM CHEM SOC, V135, P7364, DOI 10.1021/ja403134b; Zhuang ZB, 2008, J AM CHEM SOC, V130, P10482, DOI 10.1021/ja803644g; Kanatzidis MG, 2010, CHEM MATER, V22, P648, DOI 10.1021/cm902195j; Tsujii N, 2013, J ELECTRON MATER, V42, P1974, DOI 10.1007/s11664-013-2485-3; Kovalenko MV, 2010, J AM CHEM SOC, V132, P6686, DOI 10.1021/ja909591x; Lyubutin IS, 2013, ACTA MATER, V61, P3956, DOI 10.1016/j.actamat.2013.03.009; Goncalves AP, 2014, EUR PHYS J B, V87, DOI 10.1140/epjb/e2014-40989-3; Mai NT, 2014, CHEM LETT, V43, P615, DOI 10.1246/cl.131186; Scherrer P., 1918, NACHR GES WISS GOTT, V2, P98	20	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2014	53	12							120301	10.7567/JJAP.53.120301		3	Physics, Applied	Physics	AX5HS	WOS:000346957800001		
J	Yoshiki, W; Tanabe, T				Yoshiki, Wataru; Tanabe, Takasumi			Performance of Kerr bistable memory in silicon nitride microring and silica microtoroid	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							PHOTONIC CRYSTAL MICROCAVITIES; FREQUENCY-CONVERSION; TOROID MICROCAVITY; FIBER TAPER; WAVE-GUIDE; CHIP; BISTABILITY; RESONATOR; NONLINEARITIES; DEVICES	We quantitatively analyze the performance of optical memories based on Kerr bistability in microcavites. We model a silicon nitride microring and a silica toroid microcavity, and examine the performances of these cavities in an actual situation where there is a thermo-optic effect. Numerical simulations based on coupled mode theory and the thermal diffusion equation reveal that an input power of 1.8W is necessary to achieve a Kerr bistable memory in a silicon nitride microring, while that of only 1.7mW is necessary in a silica toroid microcavity. This result shows that the use of silica toroid microcavity is advantageous when we want to demonstrate a Kerr bistable memory operation with a reasonably low input power. In addition, we quantitatively investigate the trade-off between the required input power and the response speed of the device. (C) 2014 The Japan Society of Applied Physics	[Yoshiki, Wataru; Tanabe, Takasumi] Keio Univ, Fac Sci & Technol, Dept Elect & Elect Engn, Yokohama, Kanagawa 2238522, Japan	Yoshiki, W (reprint author), Keio Univ, Fac Sci & Technol, Dept Elect & Elect Engn, Yokohama, Kanagawa 2238522, Japan.	takasumi@elec.keio.ac.jp	Tanabe, Takasumi/B-4230-2009	Tanabe, Takasumi/0000-0001-5984-4265	Strategic Information and Communications R&D Promotion Programme (SCOPE) of the Ministry of Internal Affairs and Communications of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan	This work is supported in part by the Strategic Information and Communications R&D Promotion Programme (SCOPE) of the Ministry of Internal Affairs and Communications of Japan and the Leading Graduate School program for "Science for Development of Super Mature Society" from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Agha I, 2013, OPT EXPRESS, V21, P21628, DOI 10.1364/OE.21.021628; Huang YP, 2013, OPT LETT, V38, P2119, DOI 10.1364/OL.38.002119; Barclay PE, 2005, OPT EXPRESS, V13, P801, DOI 10.1364/OPEX.13.000801; Matthews JCF, 2009, NAT PHOTONICS, V3, P346, DOI 10.1038/NPHOTON.2009.93; Oxborrow M, 2007, IEEE T MICROW THEORY, V55, P1209, DOI 10.1109/TMTT.2007.897850; Cai M, 2000, PHYS REV LETT, V85, P74, DOI 10.1103/PhysRevLett.85.74; Brunstein M, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.031803; Notomi M, 2011, IET CIRC DEVICE SYST, V5, P84, DOI 10.1049/iet-cds.2010.0159; Tanabe T, 2005, OPT LETT, V30, P2575, DOI 10.1364/OL.30.002575; Yanik MF, 2003, APPL PHYS LETT, V83, P2739, DOI 10.1063/1.1615835; Eckhouse V, 2012, OPT EXPRESS, V20, P8524, DOI 10.1364/OE.20.008524; Jager JB, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3658389; Gondarenko A, 2009, OPT EXPRESS, V17, P11366, DOI 10.1364/OE.17.011366; Rokhsari H, 2004, APPL PHYS LETT, V85, P3029, DOI 10.1063/1.1804240; Nozaki K, 2012, NAT PHOTONICS, V6, P248, DOI 10.1038/nphoton.2012.2; Armani DK, 2003, NATURE, V421, P925, DOI 10.1038/nature01371; Manolatou C, 1999, IEEE J QUANTUM ELECT, V35, P1322, DOI 10.1109/3.784592; Pollinger M, 2010, OPT EXPRESS, V18, P17764, DOI 10.1364/OE.18.017764; Barth M, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2958346; Kippenberg TJ, 2004, APPL PHYS LETT, V85, P6113, DOI [10.1063/1.1833556, 10.1063/1.1835556]; Yoshiki W, 2012, J OPT SOC AM B, V29, P3335, DOI 10.1364/JOSAB.29.003335; Gorodetsky ML, 1996, OPT LETT, V21, P453, DOI 10.1364/OL.21.000453; Almeida VR, 2004, OPT LETT, V29, P2387, DOI 10.1364/OL.29.002387; Barclay PE, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2356892; Ikeda K, 2007, SOLID STATE ELECTRON, V51, P1376, DOI 10.1016/j.sse.2007.06.012; Kawashima H, 2008, IEEE J QUANTUM ELECT, V44, P841, DOI 10.1109/JQE.2008.924818; Kim MK, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2724921; Kudo H, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4807924; MIYA T, 1979, ELECTRON LETT, V15, P106, DOI 10.1049/el:19790077; Pollinger M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.053901; Razdolskiy I, 2011, OPT EXPRESS, V19, P9523, DOI 10.1364/OE.19.009523; Shafiei M, 2010, OPT EXPRESS, V18, P25509, DOI 10.1364/OE.18.025509; Soljacic M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.055601; Uesugi T, 2006, OPT EXPRESS, V14, P377, DOI 10.1364/OPEX.14.000377	34	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	DEC	2014	53	12							122202	10.7567/JJAP.53.122202		7	Physics, Applied	Physics	AX5HS	WOS:000346957800008		
J	Woelfel, JB; Igarashi, T; Dong, JK				Woelfel, Julian B.; Igarashi, Takayoshi; Dong, Jin-Keun			Faculty-supervised measurements of the face and of mandibular movements on young adults	JOURNAL OF ADVANCED PROSTHODONTICS			English	Article						Measurements of the face; Anthropometry; Ala-tragus line; Occlusal plane; Maximum and normal mandibular openings and excursions	ARTIFICIAL TEETH; PROPORTIONS	PURPOSE. The purpose of this study was to determine the average facial proportions and mandibular movement capacity of 316 first-year dental students who carefully recorded them on each other. MATERIALS AND METHODS. This early exacting clinical experience was closely supervised by the authors in Columbus, Ohio during 1969-70. Five vertical and six horizontal distances were measured on each subject's face. An ala-tragus line and an occlusal line were drawn on the left side of the face to determine if these two lines were parallel. Measurements of mandibular movements involved maximum normal and hinge opening at the incisors and maximum amounts of right, left lateral and protrusive excursions of the mandible. RESULTS. The ala width and distance between the tips of upper right and left canine cusps averaged (35.2 mm and 34.8 mm) but with very large individual variations. The distance between ala to occlusal plane lines was 29.9 mm at the tragus and 31.3 mm near the ala. The angle between orbitale and ala-tragus averaged 13.6 degrees. CONCLUSION. The upper lip length was the most variable and the distance between the pupils was the most stable of the eleven facial measurements. The ala-tragus line and the occlusal plane lines were for all practical purposes parallel. Maximum jaw opening averaged 51.2 mm which was 3.0 times larger than maximal hinge opening of 17.2 mm. The maximum right plus left side jaw excursions (9.2 and 9.4 mm) totaled 18.6 mm, 2.3 times more than the 8.0 mm mean maximum forward protrusion.	[Woelfel, Julian B.] Ohio State Univ, Coll Dent, Columbus, OH 43210 USA; [Igarashi, Takayoshi] Nihon Univ, Sch Dent, Dept Fixed Prosthodont, Tokyo 101, Japan; [Dong, Jin-Keun] Wonkwang Univ, Dept Prosthodont, Coll Dent, Iksan 570749, South Korea	Dong, JK (reprint author), Wonkwang Univ, Dept Prosthodont, Coll Dent, 460 Iksandae Ro, Iksan 570749, South Korea.	dong@wku.ac.kr			Wonkwang University	This paper was supported by Wonkwang University in 2012.	PECK H, 1970, ANGLE ORTHOD, V40, P284; VISSER A, 1995, J ORAL REHABIL, V22, P387, DOI 10.1111/j.1365-2842.1995.tb00789.x; SOLBERG WK, 1979, J AM DENT ASSOC, V98, P25; FARKAS LG, 1987, CLIN PLAST SURG, V14, P599; BROADBENT T R, 1957, Plast Reconstr Surg (1946), V20, P1, DOI 10.1097/00006534-195707000-00001; da Vinci L, 1980, ORIGINS STUDY HUMAN, P167; FARKAS LG, 1985, PLAST RECONSTR SURG, V75, P328, DOI 10.1097/00006534-198503000-00005; FARKAS LG, 1984, AM J ORTHOD DENTOFAC, V86, P52, DOI 10.1016/0002-9416(84)90276-8; Farkas LG, 1994, ANTHROPOMETRY HEAD F; Ferrario VF, 1996, AM J ORTHOD DENTOFAC, V109, P86, DOI 10.1016/S0889-5406(96)70167-1; Francesca P, 1977, DRAWING HUMAN FORMS, P116; Gedrange T, 2005, J DENT RES, V84, P1026; Hickey JC, 1985, BOUCHERS PROSTHODONT, P292; House MM, 1939, FORM COLOR HARMONY D; Hutzen D, 2007, ANN ANAT, V189, P407, DOI 10.1016/j.aanat.2007.02.014; Ingervall B, 1970, Scand J Dent Res, V78, P311; ISMAIL YH, 1968, J PROSTHET DENT, V20, P407, DOI 10.1016/S0022-3913(68)80017-4; LEE L, 1979, EAR NOSE THROAT J, V58, P150; Lejoyeux J., 1967, PROTHESE COMPLETE, P15; Lenner PR, 1985, INTRO DENT ANATOMY E, P246; Nagle RJ, 1962, DENTURE PROSTHETICS, V2, P134; Posselt U., 1957, J PROSTHET DENT, V7, P375, DOI 10.1016/S0022-3913(57)80083-3; Posselt U., 1962, PHYSL OCCLUSION REHA, p[41, 56, 181]; POSSELT U, 1961, J PROSTHET DENT, V11, P43, DOI 10.1016/0022-3913(61)90108-1; Reicheneder C, 2008, ANN ANAT, V190, P344, DOI 10.1016/j.aanat.2008.04.005; Scheid RC, 2007, WOELFELS DENT ANATOM, V263, p[267, 277, 288]; Sforza C, 2010, FORENSIC SCI INT, V200; SHEPPARD I M, 1965, J Dent Med, V20, P13; THEUSNER J, 1993, J PROSTHET DENT, V69, P209, DOI 10.1016/0022-3913(93)90142-B; WEHNER PJ, 1967, J PROSTHET DENT, V18, P222, DOI 10.1016/0022-3913(67)90185-0; Yatabe M, 1995, J DENT RES, V74, P1644	31	0	0	KOREAN ACAD PROSTHODONTICS	SEOUL	#705 KOREA SCIENCE & TECHNOLOGY CENTER, 22 TAHRANNO 7 GIL, GANGNAMGU, SEOUL, 135-703, SOUTH KOREA	2005-7806	2005-7814		J ADV PROSTHODONT	J. Adv. Prosthodont.	DEC	2014	6	6					483	490		10.4047/jap.2014.6.6.483		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AY0EE	WOS:000347269700009		
J	Kusdianto, K; Gen, M; Lenggoro, IW				Kusdianto, K.; Gen, Masao; Lenggoro, I. Wuled			Area-selective deposition of charged particles derived from colloidal aerosol droplets on a surface with different hydrophilic levels	JOURNAL OF AEROSOL SCIENCE			English	Article						Substrate; Pattern; Chemical treatment; Electrostatic; Surface potential	ELECTROHYDRODYNAMIC ATOMIZATION; GAS-PHASE; ELECTROSPRAY; ADHESION; NANOPARTICLES; WATER; SPECTROSCOPY; ALUMINUM; DROPS; FILMS	The effect of chemical treatment of a metallic substrate on the deposition behavior of charged aerosol particles derived from spraying droplets was investigated. A single substrate with areas having different hydrophilic levels was prepared as target surface. The treated (i.e., higher hydrophilic level) area, measured using a surface potential meter, showed a higher negative potential. A numerical simulation predicted that positively charged aerosol particles tended to approach and were subsequently immobilized on the high hydrophilic area. The area with higher hydrophilicity could collect particles with higher number concentration (density) than the other areas. The relationships were demonstrated in (i) the electrostatic surface potential, (ii) the hydrophilicity of surface, and (iii) the enhancement of adhesive force between the deposited particles and the surface. (C) 2014 Published by Elsevier Ltd.	[Kusdianto, K.; Gen, Masao; Lenggoro, I. Wuled] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo 1848588, Japan; [Lenggoro, I. Wuled] Tokyo Univ Agr & Technol, Dept Chem Engn, Koganei, Tokyo 1848588, Japan; [Lenggoro, I. Wuled] Tokyo Univ Agr & Technol, Inst Engn, Koganei, Tokyo 1848588, Japan; [Kusdianto, K.] Jalan ITS Raya, Inst Teknol Sepuluh Nopember, Dept Chem Engn, Surabaya 60111, Indonesia	Lenggoro, IW (reprint author), Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Nakacho 2-24-16, Koganei, Tokyo 1848588, Japan.	wuled.@cc.tuat.ac.jp	Lenggoro, Wuled/B-8629-2009; Gen, Masao/P-9490-2015	Lenggoro, Wuled/0000-0002-0048-8486; 	Special Condition Funds for Promoting Science and Technology from the Japan Science and Technology Agency (JST); Japan Society for Promotion of Science (JSPS) [23560904, 23246132, 26420761]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [20120010]; Ministry of Education and Culture, Republic of Indonesia	The authors are grateful to Drs. H. Kamiya, M. Iijima, M. Tsukada and Mr. Y. Yamada, for their support and to Dr. K. Kuchitsu and Ms. M.P. Khairunnisa for English editing. The present study has been supported in part by the Special Condition Funds for Promoting Science and Technology from the Japan Science and Technology Agency (JST), a Grant-in-Aid for Scientific Research from the Japan Society for Promotion of Science (JSPS) Nos. 23560904, 23246132, and 26420761, and Grants-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) No. 20120010. The Doctoral Program Scholarship for K. Kusdianto has been awarded by the Ministry of Education and Culture, Republic of Indonesia.	ALLEN KW, 1993, INT J ADHES ADHES, V13, P67, DOI 10.1016/0143-7496(93)90015-2; Tammet H, 2001, ATMOS ENVIRON, V35, P3413, DOI 10.1016/S1352-2310(01)00119-4; VAZQUEZ G, 1995, J CHEM ENG DATA, V40, P611, DOI 10.1021/je00019a016; Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Barry CR, 2003, APPL PHYS LETT, V83, P5527, DOI 10.1063/1.1637143; Park J, 2006, LANGMUIR, V22, P3506, DOI 10.1021/la053450j; Hartman RPA, 2000, J AEROSOL SCI, V31, P65, DOI 10.1016/S0021-8502(99)00034-8; Lee SW, 2011, ADV FUNCT MATER, V21, P2155, DOI 10.1002/adfm.201100093; Ranganath SH, 2011, AICHE J, V57, P3052, DOI 10.1002/aic.12525; Kwok DY, 1999, ADV COLLOID INTERFAC, V81, P167, DOI 10.1016/S0001-8686(98)00087-6; Rotole JA, 2001, CHEM MATER, V13, P3933, DOI 10.1021/cm0009468; Krinke TJ, 2001, APPL PHYS LETT, V78, P3708, DOI 10.1063/1.1377625; Deegan RD, 2000, PHYS REV E, V62, P756, DOI 10.1103/PhysRevE.62.756; Jung JH, 2011, J AEROSOL SCI, V42, P725, DOI 10.1016/j.jaerosci.2011.06.007; BAIER RE, 1968, SCIENCE, V162, P1360, DOI 10.1126/science.162.3860.1360; Jaworek A, 2008, J ELECTROSTAT, V66, P197, DOI 10.1016/j.elstat.2007.10.001; Kim H, 2006, NAT NANOTECHNOL, V1, P117, DOI 10.1038/nnano.2006.94; Mogus-Milankovic A, 2001, J NON-CRYST SOLIDS, V289, P204, DOI 10.1016/S0022-3093(01)00701-3; Bhalwankar RV, 2004, P INDIAN AS-EARTH, V113, P129; CARRE A, 1983, J ADHESION, V15, P151, DOI 10.1080/00218468308073223; Cherepy NJ, 2005, J COLLOID INTERF SCI, V282, P80, DOI 10.1016/j.jcis.2004.08.064; Deng WW, 2011, INT J HEAT MASS TRAN, V54, P2270, DOI 10.1016/j.ijheatmasstransfer.2011.02.038; Eustathopolos N., 1999, WETTABILITY HIGH TEM, P22; Ganan-Calvo AM, 1999, J AEROSOL SCI, V30, P863, DOI 10.1016/S0021-8502(98)00780-0; HENNEMANN OD, 1981, J ADHESION, V12, P297, DOI 10.1080/00218468108071208; Hinds W.C., 1999, AEROSOL TECHNOLOGY P, P46; Jacobs HO, 1999, SURF INTERFACE ANAL, V27, P361, DOI 10.1002/(SICI)1096-9918(199905/06)27:5/6<361::AID-SIA482>3.0.CO;2-8; Kim K, 2008, J AEROSOL SCI, V39, P365, DOI 10.1016/j.jaerosci.2007.12.006; Lee H, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3077158; Lenggoro IW, 2000, J AEROSOL SCI, V31, P121, DOI 10.1016/S0021-8502(99)00534-0; Lenggoro IW, 2006, J COLLOID INTERF SCI, V303, P124, DOI 10.1016/j.jcis.2006.07.033; Lo AKF, 1999, ATMOS ENVIRON, V33, P4727; Naim MN, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.06GH17; Ozasa K, 2008, JPN J APPL PHYS, V47, P5630, DOI 10.1143/JJAP.47.5630; Rezvanpour A, 2012, AICHE J, V58, P3329, DOI 10.1002/aic.13727; Seinfeld J.H., 1998, ATMOSPHERIC CHEM PHY, P464; SMITH DPH, 1986, IEEE T IND APPL, V22, P527, DOI 10.1109/TIA.1986.4504754; Taylor G.I., 1965, J FLUID MECH, V2, P1; Xie JW, 2010, AICHE J, V56, P2607, DOI 10.1002/aic.12198	39	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-8502	1879-1964		J AEROSOL SCI	J. Aerosol. Sci.	DEC	2014	78						83	96		10.1016/j.jaerosci.2014.06.001		14	Engineering, Chemical; Engineering, Mechanical; Environmental Sciences; Meteorology & Atmospheric Sciences	Engineering; Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	AX6IC	WOS:000347025100007		
J	Ullah, MS; Gotoh, T; Lim, UT				Ullah, Mohammad Shaef; Gotoh, Tetsuo; Lim, Un Taek			Life history parameters of three phytophagous spider mites, Tetranychus piercei, T. truncatus and T. bambusae (Acari: Tetranychidae)	JOURNAL OF ASIA-PACIFIC ENTOMOLOGY			English	Article						Tetranychus piercei; T. truncatus; T. bambusae; Life history parameters; Bangladesh	TRAITS; TABLE; TEMPERATURE; PROJECTION; JACKKNIFE; BIOLOGY; LEAVES	Tetranychus piercei McGregor and Tetranychus truncatus Ehara are major pests of many crops in Bangladesh, while Tetranychus bambusae Wang and Ma is found only on plants in the family Bambusaceae. We compared the development, survivorship, and life table parameters of T. piercei and T. truncatus on bean leaves and of T. bambusae on bamboo leaves at 25 degrees C, 60-70% RH and a photoperiod of 16:8 h (light:dark). The development times of T. piercei and T. truncatus from eggs to adult females were 10.2 and 8.8 days, respectively, when fed on bean leaves, while it took 9.5 days for T bambusae feeding on Bambusa sp. leaves to develop from eggs to adult females. Mated T. piercei, T truncatus, and T. bambusae females laid 186.9, 132.5, and 46.3 eggs on average over oviposition periods averaging 22.3, 13.5, and 20.2 days, respectively. The intrinsic rate of increase (r(m)) was 0.275 for T. piercei, 0.301 for T. truncatus, and 0.182 for T. bambusae; meanwhile the net reproductive rate (R-0) was 114.5/female for T. piercei, 101.9/female for T. truncatus, and 25.4/female for T. bambusae. The doubling time (t(D)) was lowest in T. truncatus (2.3 days) compare to T. piercei (2.5 days) and T. bambusae (3.8 days). The two polyphagous Tetranychus mites collected in Bangladesh were found to share similar life table parameters with Tetranychus mites from various other regions irrespective of food sources. This is the first report of the life table parameters of T. bambusae reared on bamboo leaves. (C) 2014 Korean Society of Applied Entomology, Taiwan Entomological Society and Malaysian Plant Protection Society. Published by Elsevier B.V. All rights reserved.	[Ullah, Mohammad Shaef] Bangladesh Agr Univ, Dept Entomol, Mymensingh 2202, Bangladesh; [Ullah, Mohammad Shaef; Lim, Un Taek] Andong Natl Univ, Dept Bioresource Sci, Andong 760749, South Korea; [Gotoh, Tetsuo] Ibaraki Univ, Fac Agr, Lab Appl Entomol & Zool, Ami, Ibaraki 3000393, Japan	Lim, UT (reprint author), Andong Natl Univ, Dept Bioresource Sci, Andong 760749, South Korea.	ullahipm@gmail.com; gotoh@mx.ibaraki.ac.jp; utlim@andong.ac.kr			BK21 plus program of the Ministry of Education, Science and Technology, Republic of Korea	We would like to thank Professor Dr. Hsin Chi, from National Chung Hsing University of Taiwan, for giving permission in analyzing the data using "Age-stage, two-sex life table program" software. Dr. Ullah was supported by the BK21 plus program of the Ministry of Education, Science and Technology, Republic of Korea.	Ullah MS, 2012, EXP APPL ACAROL, V56, P327, DOI 10.1007/s10493-012-9523-3; SHIH CIT, 1976, ANN ENTOMOL SOC AM, V69, P362; Morse JG, 2006, ANNU REV ENTOMOL, V51, P67, DOI 10.1146/annurev.ento.51.110104.151044; Kavousi A, 2009, J ECON ENTOMOL, V102, P595; CHI H, 1988, ENVIRON ENTOMOL, V17, P26; Gotoh T, 2003, APPL ENTOMOL ZOOL, V38, P7, DOI 10.1303/aez.2003.7; Tuan SJ, 2014, PEST MANAG SCI, V70, P805, DOI 10.1002/ps.3618; Razmjou Jabraeil, 2009, Munis Entomology & Zoology, V4, P204; Bonato O, 1999, EXP APPL ACAROL, V23, P11, DOI 10.1023/A:1006144610009; Bolland H. R., 1998, WORLD CATALOGUE SPID, P392; Carey J. R., 1982, ACAROLOGIA, V23, P334; Chi H, 2012, TWOSEX MSCHART COMPU; CHI H, 1985, Bulletin of the Institute of Zoology Academia Sinica (Taipei), V24, P225; Efron B., 1993, INTRO BOOTSTRAP; [范丽清 Fan Liqing], 2003, [植物保护, Plant Protection], V29, P32; Fu YueGuan, 2002, Systematic and Applied Acarology, V7, P69; Gotoh T, 2004, APPL ENTOMOL ZOOL, V39, P675, DOI 10.1303/aez.2004.675; Gotoh T, 2010, EXP APPL ACAROL, V52, P239, DOI 10.1007/s10493-010-9362-z; Hazan A., 1973, ACAROLOGIA, V15, P414; Huang R. H., 1992, Acta Phytophylacica Sinica, V19, P17; Huang Y. B., 2012, J APPL ENTOMOL; KONDO A, 1985, RES POPUL ECOL, V27, P145, DOI 10.1007/BF02515487; Laing J. E., 1969, ACAROLOGIA, V11, P320; Maia AHN, 2000, J ECON ENTOMOL, V93, P511; Migeon A., 2014, SPIDER MITES WEB COM; Noronha ACD, 2006, REV BRAS ZOOL, V23, P404, DOI 10.1590/S0101-81752006000200014; Pang Bao-ping, 2004, Acta Entomologica Sinica, V47, P55; Pang B.-P., 2005, CHINESE J APPL ECOLO, V16, P1313; Sabelis M.W., 1991, P23; Sakunwarin Suthida, 2003, Systematic and Applied Acarology, V8, P13; SAS Institute, 2000, SAS US GUID STAT; Sokal R.R., 1995, BIOMETRY PRINCIPLES, P887; Southwood T. R. E., 2000, ECOLOGICAL METHODS; Ullah MS, 2011, EXP APPL ACAROL, V54, P1, DOI 10.1007/s10493-010-9420-6; WRENSCH DL, 1978, ENVIRON ENTOMOL, V7, P499; Yu LY, 2013, J ECON ENTOMOL, V106, P1, DOI 10.1603/EC12200	36	0	0	KOREAN SOC APPLIED ENTOMOLOGY	SUWON	NATL INST AGRICULTURAL SCIENCE & TECHNOLOGY, DIVISION ENTOMOLOGY, RDA, 249 SEODUN-DONG, SUWON, 441-707, SOUTH KOREA	1226-8615	1876-7990		J ASIA-PAC ENTOMOL	J. Asia-Pac. Entomol.	DEC	2014	17	4					767	773		10.1016/j.aspen.2014.07.008		7	Entomology	Entomology	AX4CT	WOS:000346882300018		
J	Shibuya, S; Kikvidze, Z; Toki, W; Kanazawa, Y; Suizu, T; Yajima, T; Fujimori, T; Mansournia, MR; Sule, Z; Kubota, K; Fukuda, K				Shibuya, Sonomi; Kikvidze, Zaal; Toki, Wataru; Kanazawa, Yasuto; Suizu, Tatsuya; Yajima, Tamio; Fujimori, Takahiro; Mansournia, Mohammad Reza; Sule, Zuhair; Kubota, Kohei; Fukuda, Kenji			Ground beetle community in suburban Satoyama - A case study on wing type and body size under small scale management	JOURNAL OF ASIA-PACIFIC ENTOMOLOGY			English	Article						Brachyptery; Carabidae; Environmental monitoring; Forest management; Macroptery	SUSTAINABLE FOREST MANAGEMENT; CARABID BEETLES; COLEOPTERA; ASSEMBLAGES; BIOINDICATORS; FLIGHTLESSNESS; INSECTS; NETWORK; PATTERN; JAPAN	A Satoyama landscape is an important reservoir of biodiversity; however, in post-industrial era traditional Satoyama management became economically unfeasible. To maintain Satoyama, labor-saving management styles have begun to be implemented. In contrast to the traditional styles based on labor-intensive practices such as rotational tree clear-cutting, the labor-saving styles consist mainly in tree thinning and ground vegetation cutting within a small spatial range. The consequences of this new approach are unclear, and our study aimed at filling this gap in our knowledge by analyzing the effects of small scale management on ground beetle community in suburban Satoyama (Kashiwa city, central Japan). We applied labor-saving management at limited spatial range, and sampled and analyzed ground beetles both before and after management. Cluster analysis revealed three groups of beetle assemblages, corresponding to three habitats: forest, bamboo stand and grassland. Comparison of wing traits showed that, before management, brachypterous beetles dominated forest plots and macropterous beetles were more prominent in the grassland plot, while in the bamboo stand both types of wing morphology were evenly represented. This trend can be linked to habitat structural stability driven by vegetation regeneration cycles which reflect dominant plant longevity. After management, macroptery increased in all three habitats. Probably, habitat disturbance created by vegetation management gave advantage to macropterous beetles over brachypterous beetles. These results suggest that wing type can be linked to vegetation structural stability. In some species, decline in abundance was accompanied with decline in body size. Our study shows that small scale Satoyama management can have pronounced effects on beetle assemblages. (C) 2014 Korean Society of Applied Entomology, Taiwan Entomological Society and Malaysian Plant Protection Society. Published by Elsevier B.V. All rights reserved.	[Shibuya, Sonomi; Kikvidze, Zaal; Yajima, Tamio; Fujimori, Takahiro; Mansournia, Mohammad Reza; Sule, Zuhair; Fukuda, Kenji] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778563, Japan; [Toki, Wataru; Kanazawa, Yasuto; Suizu, Tatsuya; Kubota, Kohei] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Kikvidze, Zaal] Ilia State Univ, Res Inst 4D, GE-0162 Tbilisi, Rep of Georgia; [Toki, Wataru] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan	Shibuya, S (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Kashiwanoha 5-1-5, Kashiwa, Chiba 2778563, Japan.	sshibuya@nenv.k.u-tokyo.ac.jp			MEXT, Japan	This study was supported by the project: Development Funds for Leading Creative Science and Technology, Promotion of Social System Reformation Integrated with Research and Development by MEXT, Japan. We thank M. Yokohari, our section leader in this project, for his support. We are also grateful to two anonymous reviewers for valuable comments.	ROFF DA, 1990, ECOL MONOGR, V60, P389, DOI 10.2307/1943013; Pearce JL, 2006, ECOL INDIC, V6, P780, DOI 10.1016/j.ecolind.2005.03.005; Niemela J, 2007, J INSECT CONSERV, V11, P5, DOI 10.1007/s10841-006-9014-0; Jimenez-Cortes JG, 2012, J INSECT PHYSIOL, V58, P318, DOI 10.1016/j.jinsphys.2011.11.004; Gobbi M, 2007, ECOL ENTOMOL, V32, P682, DOI 10.1111/j.1365-2311.2007.00912.x; Rainio J, 2003, BIODIVERS CONSERV, V12, P487, DOI 10.1023/A:1022412617568; Maleque MA, 2009, APPL ENTOMOL ZOOL, V44, P1, DOI 10.1303/aez.2009.1; Magura T, 2002, FOREST ECOL MANAG, V157, P23, DOI 10.1016/S0378-1127(00)00654-X; WAGNER DL, 1992, TRENDS ECOL EVOL, V7, P216, DOI 10.1016/0169-5347(92)90047-F; Ribera I, 2001, ECOLOGY, V82, P1112; BLAKE S, 1994, PEDOBIOLOGIA, V38, P502; Braun SD, 2004, ECOL ENTOMOL, V29, P543, DOI 10.1111/j.0307-6946.2004.00643.x; Rusch A, 2013, AGR ECOSYST ENVIRON, V176, P63, DOI 10.1016/j.agee.2013.05.014; Cole L.J., 2006, ENTOMOL FENNICA, V11, P229; Ikeda Hiroshi, 2006, Biogeography, V8, P11; Irmler U, 2003, AGR ECOSYST ENVIRON, V98, P141, DOI 10.1016/S0167-8809(03)00076-8; Ishitani Masahiro, 1996, Miscellaneous Reports of the Hiwa Museum for Natural History, V34, P1; Japanese Government, 2012, NAT BIOD STRAT JAP 2; Kashiwa City, 2009, MASTER PLAN PARKS OP; Mefford M. J., 2006, PC ORD MULTIVARIATE; Moriyama H., 1988, WHAT DOES IT MEAN PR; Niemela J, 2000, J INSECT CONSERV, V4, P3, DOI 10.1023/A:1009655127440; NIEMELA JK, 1994, ECOGRAPHY, V17, P166, DOI 10.1111/j.1600-0587.1994.tb00090.x; Scott WA, 2003, BIOL CONSERV, V110, P197, DOI 10.1016/S0006-3207(02)00189-1; Shibuya S, 2011, EUR J ENTOMOL, V108, P453; Shibuya Sonomi, 2008, Web Ecology, V8, P116; Shibuya S., 2008, THESIS U TOKYO; Shibuya S., 2008, Eurasian Journal of Forest Research, V11-2, P61; Shigematsu T., 1991, CONSERVATION SATOYAM; Sota T., 2000, CARABUS 4 SEASONS LI; Takeuchi K., 2003, P9; Takeuchi K., 2003, SATOYAMA TRADITIONAL; Terada T., 2010, Journal of Rural Planning, V29, P179; Thiele HU, 1977, CARABID BEETLES THEI; Ueno S, 1985, COLEOPTERA JAPAN COL, VII; Yamashita H, 2006, APPL ENTOMOL ZOOL, V41, P463, DOI 10.1303/aez.2006.463	36	0	0	KOREAN SOC APPLIED ENTOMOLOGY	SUWON	NATL INST AGRICULTURAL SCIENCE & TECHNOLOGY, DIVISION ENTOMOLOGY, RDA, 249 SEODUN-DONG, SUWON, 441-707, SOUTH KOREA	1226-8615	1876-7990		J ASIA-PAC ENTOMOL	J. Asia-Pac. Entomol.	DEC	2014	17	4					775	780		10.1016/j.aspen.2014.07.013		6	Entomology	Entomology	AX4CT	WOS:000346882300019		
J	Krishna, UVM; Reddy, KK; Mastanaiah, R; Shirooka, R; Pan, CJ				Krishna, U. V. Murali; Reddy, K. Krishna; Mastanaiah, R.; Shirooka, Ryuichi; Pan, Chen-Jeih			Observational study on melting layer characteristics over Palau in Pacific Ocean	JOURNAL OF ATMOSPHERIC AND SOLAR-TERRESTRIAL PHYSICS			English	Article						Bright band; Wind profiler radar; Radar reflectivity; TRMM PR Radar; Radiosonde	TRMM PRECIPITATION RADAR; BRIGHT BAND; STRATIFORM PRECIPITATION; SOUTHERN-OSCILLATION; RAIN ATTENUATION; ISOTHERM HEIGHT; CLOUD SYSTEMS; MODEL; COMMUNICATION; HYDROMETEORS	In this paper, four years (April, 2003-March, 2007) of wind profiler radar (WPR) observations, Tropical Rainfall Measuring Mission measurements, radiosonde and automatic weather station data are utilized to characterize melting layer/bright band (caused due to the melting of hydrometeors when the precipitation has a significant stratiform cloud contribution) variability during easterly and westerly monsoon periods over Palau in Western Pacific Ocean. Four years observational results show that presence of stratiform precipitation is more in Westerly monsoon compared to Easterly monsoon. However, bright band height (BBH) is lower in Westerly monsoon. It is also observed that the BBH during the year 2006 is higher than 2005 possibly due to El Nino effect. (C) 2014 Elsevier Ltd. All rights reserved.	[Krishna, U. V. Murali; Reddy, K. Krishna; Mastanaiah, R.] Yogi Vemana Univ, Dept Phys, Kadapa 516003, Andhra Pradesh, India; [Shirooka, Ryuichi] JAMSTEC, Res Inst Global Change, Yokosuka, Kanagawa, Japan; [Pan, Chen-Jeih] Natl Cent Univ, Inst Space Sci, Jhongli, Taiwan	Reddy, KK (reprint author), Yogi Vemana Univ, Dept Phys, Kadapa 516003, Andhra Pradesh, India.	krishna.kkreddy@gmail.com					Ajayi G.O., 1984, J CLIM APPL METEOROL, V5, P562; Allnutt J.E., 1989, SATELLITE TO GROUND; Atlas D, 1999, J GEOPHYS RES-ATMOS, V104, P6155, DOI 10.1029/1998JD200098; Iguchi T, 2000, J APPL METEOROL, V39, P2038, DOI 10.1175/1520-0450(2001)040<2038:RPAFTT>2.0.CO;2; Peters G, 2010, J ATMOS OCEAN TECH, V27, P829, DOI 10.1175/2009JTECHA1342.1; Smith CJ, 1986, J ATMOS OCEAN TECH, V3, P129, DOI 10.1175/1520-0426(1986)003<0129:TROECB>2.0.CO;2; Sharma S, 2009, J APPL METEOROL CLIM, V48, P1245, DOI 10.1175/2008JAMC1948.1; Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; CARTER DA, 1995, RADIO SCI, V30, P977, DOI 10.1029/95RS00649; LEARY CA, 1979, J ATMOS SCI, V36, P669, DOI 10.1175/1520-0469(1979)036<0669:MAEOHI>2.0.CO;2; Thurai M, 2003, RADIO SCI, V38, DOI 10.1029/2002RS002855; WILLIS PT, 1989, J ATMOS SCI, V46, P2008, DOI 10.1175/1520-0469(1989)046<2008:SOTMLI>2.0.CO;2; White AB, 2002, J ATMOS OCEAN TECH, V19, P687, DOI 10.1175/1520-0426(2002)019<0687:AABHDA>2.0.CO;2; Martner BE, 2008, J HYDROMETEOROL, V9, P408, DOI 10.1175/2007JHM924.1; Di Girolamo P, 2012, ATMOS CHEM PHYS, V12, P4143, DOI 10.5194/acp-12-4143-2012; STEWART RE, 1984, J ATMOS SCI, V41, P3227, DOI 10.1175/1520-0469(1984)041<3227:CTTMLO>2.0.CO;2; White AB, 2003, J HYDROMETEOROL, V4, P264, DOI 10.1175/1525-7541(2003)4<264:CORPOB>2.0.CO;2; Ropelewski CF, 1989, J CLIMATE, V2, P268, DOI 10.1175/1520-0442(1989)002<0268:PPAWTH>2.0.CO;2; FABRY F, 1995, J ATMOS SCI, V52, P838, DOI 10.1175/1520-0469(1995)052<0838:LTROOT>2.0.CO;2; MARSHALL JS, 1947, J METEOROL, V4, P186, DOI 10.1175/1520-0469(1947)004<0186:MORBR>2.0.CO;2; Chakravarty K, 2010, J ATMOS SOL-TERR PHY, V72, P135, DOI 10.1016/j.jastp.2009.10.018; AUSTIN PM, 1950, J METEOROL, V7, P145, DOI 10.1175/1520-0469(1950)007<0145:AQSOTB>2.0.CO;2; Houze RA, 1997, B AM METEOROL SOC, V78, P2179, DOI 10.1175/1520-0477(1997)078<2179:SPIROC>2.0.CO;2; Qi YC, 2013, Q J ROY METEOR SOC, V139, P2233, DOI 10.1002/qj.2095; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; ROPELEWSKI CF, 1987, MON WEATHER REV, V115, P1606, DOI 10.1175/1520-0493(1987)115<1606:GARSPP>2.0.CO;2; MURAKAMI T, 1994, J METEOROL SOC JPN, V72, P719; Dai A, 1997, J CLIMATE, V10, P2943, DOI 10.1175/1520-0442(1997)010<2943:SOGLPV>2.0.CO;2; GAGE KS, 1994, B AM METEOROL SOC, V75, P2289, DOI 10.1175/1520-0477(1994)075<2289:UWPANT>2.0.CO;2; Badron K, 2011, J ATMOS SOL-TERR PHY, V73, P601, DOI 10.1016/j.jastp.2010.12.006; Battan L.J., 1973, RADAR OBSERVATIONS A, P279; Bryant GH, 2001, INT J SATELL COMMUN, V19, P263, DOI 10.1002/sat.673; Chen YH, 2007, J CLIMATE, V20, P3580, DOI 10.1175/JCLI4208.1; Crane R., 1996, ELECTROMAGNETIC WAVE; CUNNINGHAM RM, 1947, J METEOROL, V4, P163, DOI 10.1175/1520-0469(1947)004<0163:ADEOTB>2.0.CO;2; Ecklund W. L., 1988, Journal of Atmospheric and Oceanic Technology, V5, DOI 10.1175/1520-0426(1988)005<0432:AUWPFT>2.0.CO;2; FABRY F, 1992, Q J ROY METEOR SOC, V118, P435, DOI 10.1256/smsqj.50502; Glickman T., 2000, GLOSSARY METEOROLOGY; Gray WR, 2001, METEOROL APPL, V8, P371, DOI 10.1017/S1350482701003139; Hall M.P.M, 1979, EFFECT TROPOSPHERE R; Harris GN, 2000, J CLIMATE, V13, P4137, DOI 10.1175/1520-0442(2000)013<4137:COFLAF>2.0.CO;2; Ippolito L.J., 1986, RADIO WAVE PROPAGATI; Joss J., 1990, RADAR METEOROLOGY, P577; Kawanishi T, 2000, ADV SPACE RES, V25, P969, DOI 10.1016/S0273-1177(99)00932-1; KLAASSEN W, 1988, J ATMOS SCI, V45, P3741, DOI 10.1175/1520-0469(1988)045<3741:ROASOT>2.0.CO;2; Kubota H, 2005, J HYDROMETEOROL, V6, P518, DOI 10.1175/JHM432.1; Lhermitte R.M., 1963, 10TH P RAD WEATH C, P297; Li Rui, 2012, J CLIMATOL, V24, P6373; Mandeep JS, 2009, ADV SPACE RES, V43, P984, DOI 10.1016/j.asr.2008.09.013; Meneghini R, 2000, J ATMOS OCEAN TECH, V17, P628, DOI 10.1175/1520-0426(2000)017<0628:EDCOMP>2.0.CO;2; Merritt D.A., 1995, J ATMOS OCEAN TECH, V12, P995; Minder JR, 2013, J ATMOS SCI, V70, P916, DOI 10.1175/JAS-D-12-0194.1; Mondal NC, 2001, INT J INFRARED MILLI, V22, P495, DOI 10.1023/A:1010710209795; Moteki Q, 2008, J GEOPHYS, V113, DOI [10.1029/Res.,D141262008JD009793, DOI 10.1029/RES.,D141262008JD009793]; Olson WS, 2001, J APPL METEOROL, V40, P1145, DOI 10.1175/1520-0450(2001)040<1145:AMLMFP>2.0.CO;2; Pan CJ, 2010, ANN GEOPHYS-GERMANY, V28, P11, DOI 10.5194/angeo-28-11-2010; Reddy K.K., 2002, RADIO SCI, V37; Romo JA, 2012, IEEE T ANTENN PROPAG, V60, P4884, DOI 10.1109/TAP.2012.2207356; Russchenberg HWJ, 1996, IEEE T GEOSCI REMOTE, V34, P3, DOI 10.1109/36.481885; Thurai M, 2003, INT J SATELL COMM N, V21, P533, DOI 10.1002/sat.768; Ushiyama T, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036242; White AB, 2010, J HYDROMETEOROL, V11, P739, DOI 10.1175/2009JHM1181.1; Zawadzki I, 2005, J ATMOS SCI, V62, P3705, DOI 10.1175/JAS3563.1	63	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1364-6826	1879-1824		J ATMOS SOL-TERR PHY	J. Atmos. Sol.-Terr. Phys.	DEC	2014	121		A				132	140		10.1016/j.jastp.2014.09.015		9	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	AX6GY	WOS:000347022200015		
J	Kumar, V; Dhaka, SK; Choudhary, RK; Ho, SP; Yoden, S; Reddy, KK				Kumar, V.; Dhaka, S. K.; Choudhary, R. K.; Ho, Shu-Peng; Yoden, S.; Reddy, K. K.			On the occurrence of the coldest region in the stratosphere and tropical tropopause stability: A study using COSMIC/FORMOSAT-3 satellite measurements	JOURNAL OF ATMOSPHERIC AND SOLAR-TERRESTRIAL PHYSICS			English	Article							GPS RADIO OCCULTATION; INTRASEASONAL VARIABILITY; INTERANNUAL VARIABILITY; GRAVITY-WAVES; SOUTH-POLE; TEMPERATURE; TROPOSPHERE; HEIGHT; ATMOSPHERE; CHAMP	The occurrence of coldest region in the lower and middle stratosphere has been investigated using COSMIC/FORMASAT-3 radio occultation measurements. Observations from January 2007 to December 2011, comprising of 2,871,811 numbers of occultations uniformly spread over land and sea, have been used in this study. Using vertical profiles of temperature upto 40 km altitude, zonally averaged at each 5 latitude band between 90 degrees N and 90 degrees S, it is shown that the coldest region in the upper atmosphere occurs during winter in high latitude stratosphere (latitudes >45 degrees) in both the hemispheres with southern hemisphere (temperature less than < -85 degrees C) cooler than northern hemisphere (temperature similar to-75 degrees C). The spatial extent of the region of low temperature region found between 10 km and 30 km altitude, indicating a 20 km vertical thick layer of cold temperature. In the southern hemisphere, such a region of coldest temperature remains for more than six months (April October), in the Northern hemispheric polar region (75 C) it is seen mostly during four winter months between October and January. Using NCEP-DOE reanalysis data, we show that cold temperature in the stratospheric region coexists with the jet streams prevalent in those regions. Strong wind jet is surmised to make stratosphere colder. The absence of sunlight in the coldest region is known to cause jet streams. Impact of stratospheric quasi-biennial oscillation (QBO) on the sharpness of tropical tropopause (stability) has also been investigated. Observations suggest that during westerly phase of QBO, the stability of the tropopause increases. (C) 2014 Elsevier Ltd. All rights reserved.	[Kumar, V.; Dhaka, S. K.] Univ Delhi, Rajdhani Coll, Radio & Atmospher Phys Lab, Delhi 110007, India; [Kumar, V.] Univ Delhi, Dept Phys & Astrophys, Delhi 110007, India; [Choudhary, R. K.] VSSC, Space Phys Lab, Trivanduram, India; [Ho, Shu-Peng] Univ Corp Atmospher Res, COSMIC Program Off, Boulder, CO USA; [Yoden, S.] Kyoto Univ, Dept Geophys, Kyoto, Japan; [Reddy, K. K.] Yogi Vemana Univ, Dept Phys, Kadapa, AP, India	Dhaka, SK (reprint author), Univ Delhi, Rajdhani Coll, Radio & Atmospher Phys Lab, Delhi 110007, India.	skdhaka@gmail.com			CAWSES-India program; JSPS KAKENSHI [24224011]; Kyoto University Foundation	Data are obtained from http://cdaac www.cosmic.ucar.edu/ cdaac/login/cosmic/leve12/wetPrf/and the authors would like to thank all the members of CDAAC team for providing the COSMIC data sets. One of authors Dr. Vinay Kumar is thankful to the Director, SPL, Trivandrum for providing the working facility at SPL during this work. The work mainly supported by CAWSES-India program. For partial support, we acknowledge JSPS KAKENSHI (S) grant number 24224011 and the Kyoto University Foundation. Authors are thankful to the anonymous reviewers for their comments and suggestions.	Ho SP, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017665; Tilmes S, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026925; Foelsche U, 2008, CLIM DYNAM, V31, P49, DOI 10.1007/s00382-007-0337-7; REID GC, 1981, J ATMOS SCI, V38, P1928, DOI 10.1175/1520-0469(1981)038<1928:OTAVIH>2.0.CO;2; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI [10.1175/Bams-83-11-1631, 10.1175/BAMS-83-11-1631]; Anthes RA, 2008, B AM METEOROL SOC, V89, P313, DOI 10.1175/BAMS-89-3-313; Forster PMD, 1999, GEOPHYS RES LETT, V26, P3309; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; HOLTON JR, 1995, REV GEOPHYS, V33, P403, DOI 10.1029/95RG02097; Wickert J, 2001, GEOPHYS RES LETT, V28, P3263, DOI 10.1029/2001GL013117; Ware R, 1996, B AM METEOROL SOC, V77, P19, DOI 10.1175/1520-0477(1996)077<0019:GSOTAF>2.0.CO;2; Dhaka SK, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014745; Kim J, 2012, J CLIMATE, V25, P5343, DOI 10.1175/JCLI-D-11-00554.1; Hajj GA, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003909; Ho SP, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD011969; Randel WJ, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007904; Highwood EJ, 1998, Q J ROY METEOR SOC, V124, P1579, DOI 10.1256/smsqj.54910; He WY, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038712; Birner T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026549; Zangl G, 2001, J CLIMATE, V14, P3117, DOI 10.1175/1520-0442(2001)014<3117:TTITPR>2.0.CO;2; ATTICKS MG, 1983, Q J ROY METEOR SOC, V109, P295, DOI 10.1002/qj.49710946004; Dhaka SK, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027026; Dhaka SK, 2010, EARTH PLANETS SPACE, V62, P319, DOI 10.5047/eps.2009.09.001; Dhaka SK, 2011, ANN GEOPHYS-GERMANY, V29, P2259, DOI 10.5194/angeo-29-2259-2011; Dhaka SK, 2003, J METEOROL SOC JPN, V81, P1185, DOI 10.2151/jmsj.81.1185; Ho SP, 2009, TERR ATMOS OCEAN SCI, V20, P87, DOI 10.3319/TAO.2007.12.06.01(F3C); Ho SP, 2007, J ATMOS OCEAN TECH, V24, P1726, DOI 10.1175/JTECH2071.1; Ho S.-P., 2010, REMOTE SENS, P1320; Ho SP, 2009, NEW HORIZONS IN OCCULTATION RESEARCH, P207, DOI 10.1007/978-3-642-00321-9_17; Ho SP, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030202; Hudson SR, 2005, J CLIMATE, V18, P1673, DOI 10.1175/JCLI3360.1; Kishore P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006827; Kishore P, 2009, ATMOS CHEM PHYS, V9, P897; Kumar V, 2014, ATMOS RES, V139, P62, DOI 10.1016/j.atmosres.2013.12.014; Kuo YH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021443; Kursinski E.R., 1997, J GEOPHYS RES, V102, P23; Lewis HW, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039231; Pan WL, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003217; Pfenninger M, 1999, J GEOPHYS RES-ATMOS, V104, P5963, DOI 10.1029/98JD02705; Randel WJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002595; Randel WJ, 2000, J GEOPHYS RES-ATMOS, V105, P15509, DOI 10.1029/2000JD900155; REID GC, 1985, J GEOPHYS RES-ATMOS, V90, P5629, DOI 10.1029/JD090iD03p05629; Reid GC, 1996, J GEOPHYS RES-ATMOS, V101, P21233, DOI 10.1029/96JD01622; Seidel J.D., 2001, J GEOPHYS RES, V106, P7857; SOLOMON S, 1990, NATURE, V347, P347, DOI 10.1038/347347a0; Son SW, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016030; Son SW, 2007, J ATMOS SCI, V64, P608, DOI 10.1175/JAS3855.1; Ratnam MV, 2005, SOLA, V1, P185, DOI 10.2151/sola.2005-048; Wang KY, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030159; Wirth V, 2000, Q J ROY METEOR SOC, V126, P299, DOI 10.1256/smsqj.56214; Zangl G, 2002, Q J ROY METEOR SOC, V128, P2301, DOI 10.1256/qj.01.76	51	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1364-6826	1879-1824		J ATMOS SOL-TERR PHY	J. Atmos. Sol.-Terr. Phys.	DEC	2014	121		B		SI		271	286		10.1016/j.jastp.2014.10.007		16	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	AX6GZ	WOS:000347022300014		
J	Fukunishi, Y; Kurosawa, T; Mikami, Y; Nakamura, H				Fukunishi, Yoshifumi; Kurosawa, Takashi; Mikami, Yoshiaki; Nakamura, Haruki			Prediction of Synthetic Accessibility Based on Commercially Available Compound Databases	JOURNAL OF CHEMICAL INFORMATION AND MODELING			English	Article							DRUG-LIKE MOLECULES; COMPLEXITY; CHEMISTRY; DESIGN; ZINC; SETS	A compounds synthetic accessibility (SA) is an important aspect of drug design, since in some cases computer-designed compounds cannot be synthesized. There have been several reports on SA prediction, most of which have focused on the difficulties of synthetic reactions based on retro-synthesis analyses, reaction databases and the availability of starting materials. We developed a new method of predicting SA using commercially available compound databases and molecular descriptors. SA was estimated from the probability of existence of substructures consisting of the compound in question, the number of symmetry atoms, the graph complexity, and the number of chiral centers of the compound. The probabilities of the existence of given substructures were estimated based on a compound library. The predicted SA results reproduced the expert manual assessments with a Pearson correlation coefficient of 0.56. Since our method required a compound database and not a reaction database, it should be easy to customize the prediction for compound vendors. The correlation between the sales price of approved drugs and the SA values was also examined and found to be weak. The price most likely depends on the total cost of development and other factors.	[Fukunishi, Yoshifumi] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery Molprof, Koto Ku, Tokyo 1350064, Japan; [Fukunishi, Yoshifumi; Kurosawa, Takashi; Mikami, Yoshiaki] Technol Res Assoc Next Generat Nat Prod Chem, Koto Ku, Tokyo 1350064, Japan; [Kurosawa, Takashi; Mikami, Yoshiaki] Hitachi Solut East Japan, Kawasaki Ku, Kawasaki, Kanagawa 2100007, Japan; [Nakamura, Haruki] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Fukunishi, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery Molprof, Koto Ku, 2-3-26 Aomi, Tokyo 1350064, Japan.	y-fukunishi@aist.go.jp			National Institute of Advanced Industrial Science and Technology (AIST); New Energy and Industrial Technology Development Organization of Japan (NEDO); Ministry of Economy, Trade, and Industry (METI), of Japan	This work was supported by grants from the National Institute of Advanced Industrial Science and Technology (AIST), the New Energy and Industrial Technology Development Organization of Japan (NEDO), and the Ministry of Economy, Trade, and Industry (METI), of Japan. Y.F. thanks Dr. Isao Yasumatsu for helpful suggestions.	Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; BERTZ SH, 1981, J AM CHEM SOC, V103, P3599, DOI 10.1021/ja00402a071; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Podolyan Y, 2010, J CHEM INF MODEL, V50, P979, DOI 10.1021/ci900301v; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Lewell XQ, 1998, J CHEM INF COMP SCI, V38, P511, DOI 10.1021/ci970429i; Schneider G, 2005, NAT REV DRUG DISCOV, V4, P649, DOI 10.1038/nrd1799; Fukunishi Y, 2003, J PHYS CHEM B, V107, P13201, DOI 10.1021/jp035478e; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Boda K, 2007, J COMPUT AID MOL DES, V21, P311, DOI 10.1007/s10822-006-9099-2; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Baber JC, 2004, MINI-REV MED CHEM, V4, P681; COREY EJ, 1969, SCIENCE, V166, P178, DOI 10.1126/science.166.3902.178; Ertl P, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-8; Fukunishi Y., 2008, SYNTHESIOLOGY, V2, P64; Funatsu K., 1988, TETRAHEDRON COMP MET, V1, P27, DOI 10.1016/0898-5529(88)90006-1; Gaulton A, 2011, NUCLEIC ACIDS RES, V40, pD1100; Gillet VJ, 1995, PERSPECT DRUG DISCOV, V3, P34, DOI 10.1007/BF02174466; Huang Q, 2011, J CHEM INF MODEL, V51, P2768, DOI 10.1021/ci100216g; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; JOHNSON AP, 1992, J CHEM INF COMP SCI, V32, P411, DOI 10.1021/ci00009a003; KAWABATA T, 2013, BIOPHYSICS-USSR, V9, P113; Lajiness MS, 2004, J MED CHEM, V47, P4891, DOI 10.1021/jm049740z; Pfortner M., 2003, HDB CHEMOINFORMATICS, P1457; Takaoka Y, 2003, J CHEM INF COMP SCI, V43, P1269, DOI 10.1021/ci0340431; Timothy D., 1980, J ORG CHEM, V45, P2043	26	0	0	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1549-9596	1549-960X		J CHEM INF MODEL	J. Chem Inf. Model.	DEC	2014	54	12					3259	3267		10.1021/ci500568d		9	Chemistry, Medicinal; Chemistry, Multidisciplinary; Computer Science, Information Systems; Computer Science, Interdisciplinary Applications	Pharmacology & Pharmacy; Chemistry; Computer Science	AX8CG	WOS:000347137500001		
J	Hagiwara, Y; Ohno, K; Watanabe, T; Orita, M				Hagiwara, Yohsuke; Ohno, Kazuki; Watanabe, Toshihiro; Orita, Masaya			Rating high-throughput screening results via h-index	JOURNAL OF CHEMOMETRICS			English	Article						h-index; HTS rating; maximum common substructure		The quantification of both the impact and quality of a scientist's publication record is an essential step in making decisions concerning hiring, promotion, and allocation of funding. In an attempt to resolve this problem, Hirsh proposed the h-index, a single-number criterion incorporating both the number of publications and the number of citations per publication. This value facilitates rating of a scientist's performance and is now one of the most commonly used matrices. Here, we would like to propose the rating of high-throughput screening (HTS) result by the h-index. Rating HTS result is to estimate how the HTS result is preferred by a medicinal chemist. In this study, we applied the h-index for rating HTS results and observed an enhanced rating of preferred starting points for drug development. In addition, we developed a new index, the maximum common structure (MCS) index, which is more effective than the h-index. Copyright (c) 2014 John Wiley & Sons, Ltd.	[Hagiwara, Yohsuke; Ohno, Kazuki; Watanabe, Toshihiro; Orita, Masaya] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan	Orita, M (reprint author), Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	masaya.orita@astellas.com					Akritopoulou-Zanze I, 2009, DRUG DISCOV TODAY, V14, P291, DOI 10.1016/j.drudis.2008.12.002; Bornmann L, 2013, EMBO REP, V14, P226, DOI 10.1038/embor.2013.9; Ball P, 2005, NATURE, V436, P900, DOI 10.1038/436900a; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; Bornmann L, 2009, EMBO REP, V10, P2, DOI 10.1038/embor.2008.233; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hertzberg RP, 2000, CURR OPIN CHEM BIOL, V4, P445, DOI 10.1016/S1367-5931(00)00110-1; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Banks MG, 2006, SCIENTOMETRICS, V69, P161, DOI 10.1007/s11192-006-0146-5; Romanovsky AA, 2012, CELL CYCLE, V11, P4118, DOI 10.4161/cc.22179; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Bornmann L, 2007, J AM SOC INF SCI TEC, V58, P1381, DOI 10.1002/asi.20609; Bender A, 2008, CURR OPIN DRUG DISC, V11, P327; Vempati UD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049198	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0886-9383	1099-128X		J CHEMOMETR	J. Chemometr.	DEC	2014	28	12					844	850		10.1002/cem.2658		7	Automation & Control Systems; Chemistry, Analytical; Computer Science, Artificial Intelligence; Instruments & Instrumentation; Mathematics, Interdisciplinary Applications; Statistics & Probability	Automation & Control Systems; Chemistry; Computer Science; Instruments & Instrumentation; Mathematics	AX9QJ	WOS:000347236700004		
J	Ishikawa, T; Komine, T; Aoki, SI; Okabe, T				Ishikawa, Toshinori; Komine, Tsutomu; Aoki, Shin Ichi; Okabe, Takumi			Characteristics of Rip Current Drowning on the Shores of Japan	JOURNAL OF COASTAL RESEARCH			English	Article						Rip current drowning; rescue reports; field observations; management problems; coastal structures		The characteristics of rip current drowning on the shores of Japan was investigated using the analysis of the lifesaver's rescue reports of 2013 and field observations of some beaches. Although the necessary rescue equipment and the water safety information such as signboards were mostly prepared, a large amount of rip current drowning occurred. On most re-occurring rip current drowning beaches, there are permanent rips and fixed rips associated with the characteristic of topography and the coastal structures at most beaches under the relatively high wave condition. Especially, in the case lifesavers cannot determine the swimming areas, swimming areas are generally determined by the local regulations from local governments and shop owners on most beaches. The most important outbreak factor regarding the rip current drowning is the human factor such as the management problems and coastal structures, which was concluded.	[Ishikawa, Toshinori; Komine, Tsutomu] Chuo Univ, Japan Lifesaving Assoc, Coastal Engn Lab Co Ltd, Hachioji, Tokyo, Japan; [Aoki, Shin Ichi] Osaka Univ, Suita, Osaka 565, Japan; [Okabe, Takumi] Toyohashi Univ Technol, Toyohashi, Aichi, Japan	Ishikawa, T (reprint author), Chuo Univ, Japan Lifesaving Assoc, Coastal Engn Lab Co Ltd, Hachioji, Tokyo, Japan.						Ishikawa T., 2013, P WORLD C DROWN PREV; Japan Meteorological Agency (JMA), TID INF 2013; Ports and Harbours Bureau Ministry of Land Infrastructure Transport and Tourism (MLIT), WAV INF 2013	3	0	0	COASTAL EDUCATION & RESEARCH FOUNDATION	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	0749-0208	1551-5036		J COASTAL RES	J. Coast. Res.	WIN	2014					72		44	49		10.2112/SI72-009.1		6	Environmental Sciences; Geography, Physical; Geosciences, Multidisciplinary	Environmental Sciences & Ecology; Physical Geography; Geology	AY0GI	WOS:000347275100009		
J	Choi, JJ; Hiraki, T; Landi, JA				Choi, Jongmoo Jay; Hiraki, Takato; Landi, James A.			The value of multinationality and business group for Japanese firms	JOURNAL OF CORPORATE FINANCE			English	Article						Multinationality; Corporate international diversification; Business group; Keiretsu; Japanese corporate finance	INTERNAL CAPITAL-MARKETS; CORPORATE DIVERSIFICATION; GLOBAL DIVERSIFICATION; INEFFICIENT INVESTMENT; OWNERSHIP STRUCTURE; CULTURAL DISTANCE; EMERGING MARKETS; KOREAN CHAEBOLS; ECONOMIC-CRISIS; UNITED-STATES	We provide evidence for the combined value impacts of corporate multinationality and business group affiliation, incorporating the effect of endogeneity of diversification decisions. The results for Japanese industrial firms indicate that multinational firms have a statistically significant 23% value premium during FY1995-2011 relative to comparable domestic firms; however, the multinationality premium is moderated by the nature of business group as well as the characteristics of the host country. Specifically, the multinationality premium is negatively associated with both keiretsu membership and main bank ownership of group firms. Main bank ownership as well as vertical keiretsu affiliation positively impact the value of multinationality for firms operating in developing countries. These results hold even during the later part of the sample period, when the keiretsu and main bank systems have been under pressure. The implication is that corporate multinationality is a substitute for business group and for inadequate indigenous institutional infrastructure. (C) 2014 Elsevier B.V. All rights reserved.	[Choi, Jongmoo Jay] Temple Univ, Dept Finance & Int Business, Fox Sch Business, Philadelphia, PA 19122 USA; [Hiraki, Takato] Tokyo Univ Sci, Sch Management, Kuki, Saitama 3468512, Japan; [Landi, James A.] ACAP Advisory Publ Co Ltd, Bangkok 10120, Thailand	Choi, JJ (reprint author), Temple Univ, Dept Finance & Int Business, Fox Sch Business, Philadelphia, PA 19122 USA.	jjchoi@temple.edu; hiraki@ms.kuki.tus.ac.jp; james_l@acap.co.th					Abegglen J. C., 1985, KAISHA JAPANESE CORP; Almeida H, 2006, J FINANC ECON, V79, P99, DOI 10.1016/j.jfineco.2005.02.001; Ang J., 2002, J MULTINATIONAL FINA, V12, P89, DOI 10.1016/S1042-444X(01)00046-9; Baek JS, 2006, J FINANC, V61, P2415, DOI 10.1111/j.1540-6261.2006.01062.x; Chakrabarti A, 2007, STRATEGIC MANAGE J, V28, P101, DOI 10.1002/smj.572; Chung CC, 2010, J INT BUS STUD, V41, P500, DOI 10.1057/jibs.2009.72; Dastidar P, 2009, J INT BUS STUD, V40, P71, DOI 10.1057/palgrave.jibs.2008.57; Allen L, 1996, J INT BUS STUD, V27, P633, DOI 10.1057/palgrave.jibs.8490147; Khanna T, 2000, J FINANC, V55, P867, DOI 10.1111/0022-1082.00229; Morck R, 2000, J BUS, V73, P539, DOI 10.1086/209654; Fauver L, 2003, J FINANC QUANT ANAL, V38, P135, DOI 10.2307/4126767; KOGUT B, 1988, J INT BUS STUD, V19, P411, DOI 10.1057/palgrave.jibs.8490394; Lins KV, 2003, J FINANC QUANT ANAL, V38, P159, DOI 10.2307/4126768; Xu D, 2002, ACAD MANAGE REV, V27, P608, DOI 10.2307/4134406; La Porta R, 1998, J POLIT ECON, V106, P1113; Ferris SP, 2003, J BANK FINANC, V27, P251, DOI 10.1016/S0378-4266(01)00248-5; La Porta R, 2002, J FINANC, V57, P1147, DOI 10.1111/1540-6261.00457; Almeida H, 2011, J FINANC ECON, V99, P447, DOI 10.1016/j.jfineco.2010.08.017; Rajan R, 2000, J FINANC, V55, P35, DOI 10.1111/0022-1082.00200; Villalonga B, 2004, FINANC MANAGE, V33, P5; MYERSON RB, 1982, J MATH ECON, V10, P67, DOI 10.1016/0304-4068(82)90006-4; Lins K, 1999, J FINANC, V54, P2215, DOI 10.1111/0022-1082.00186; Shenkar O, 2001, J INT BUS STUD, V32, P519, DOI 10.1057/palgrave.jibs.8490982; Pantzalis C, 2001, J INT BUS STUD, V32, P133, DOI 10.1057/palgrave.jibs.8490942; Gedajlovic E, 2002, ACAD MANAGE J, V45, P565, DOI 10.2307/3069381; MORCK R, 1991, J BUS, V64, P165, DOI 10.1086/296532; Lu JW, 2004, ACAD MANAGE J, V47, P598, DOI 10.2307/20159604; Doukas JA, 2003, J CORP FINANC, V9, P59, DOI 10.1016/S0929-1199(01)00056-6; Kang JK, 1997, J FINANC ECON, V46, P29, DOI 10.1016/S0304-405X(97)00024-X; Tseng CH, 2007, J INT BUS STUD, V38, P961, DOI 10.1057/palgrave.jibs.8400305; BERGER PG, 1995, J FINANC ECON, V37, P39, DOI 10.1016/0304-405X(94)00798-6; Lee SH, 2009, J INT BUS STUD, V40, P405, DOI 10.1057/jibs.2008.79; Joh SW, 2003, J FINANC ECON, V68, P287, DOI 10.1016/S0304-405X(03)00068-0; Tihanyi L, 2005, J INT BUS STUD, V36, P270, DOI 10.1057/palgrave.jibs.8400136; Tong TW, 2007, J INT BUS STUD, V38, P215, DOI 10.1057/palgrave.jibs.8400260; Denis DJ, 2002, J FINANC, V57, P1951, DOI 10.1111/0022-1082.00485; Campa JM, 2002, J FINANC, V57, P1731, DOI 10.1111/1540-6261.00476; Weinstein DE, 1998, J FINANC, V53, P635, DOI 10.1111/0022-1082.254893; Scharfstein DS, 2000, J FINANC, V55, P2537, DOI 10.1111/0022-1082.00299; KOGUT B, 1993, J INT BUS STUD, V24, P625, DOI 10.1057/palgrave.jibs.8490248; BARNEY J, 1991, J MANAGE, V17, P99, DOI 10.1177/014920639101700108; Aoki M., 1994, JAPANESE MAIN BANK S, P3; Belsley David A., 1980, REGRESSION DIAGNOSTI; Buckley P., 1976, FUTURE MULTINATIONAL, P32; Choi JJ, 2009, J BANK FINANC, V33, P1973, DOI 10.1016/j.jbankfin.2009.04.014; Click R., 2000, DOES MULTINATI UNPUB; Dehejia R., 2001, REV ECON STAT, V84, P151; Dewenter K, 2001, J BUS, V74, P79, DOI 10.1086/209664; Dewenter KL, 1998, J FINANC, V53, P879, DOI 10.1111/0022-1082.00038; DOUKAS J, 1988, J FINANC, V43, P1161, DOI 10.2307/2328212; Dow S, 2009, J BANK FINANC, V33, P1817, DOI 10.1016/j.jbankfin.2009.05.012; DUNNING JH, 1988, J INT BUS STUD, V19, P1, DOI 10.1057/palgrave.jibs.8490372; Fauver L, 2004, J CORP FINANC, V10, P729, DOI 10.1016/S0929-1199(03)00027-0; Ferris S., 1995, PACIFIC BASIN FINANC, V3, P319, DOI 10.1016/0927-538X(95)00005-6; Gande A, 2009, J INT BUS STUD, V40, P1515, DOI 10.1057/jibs.2009.59; Greenwood R., 2012, FINANC MANAG, V41, P885; Hackett SC, 1998, JPN WORLD ECON, V10, P13, DOI 10.1016/S0922-1425(96)00214-9; Harita M., 2010, DYNAMIC IMPACT UNPUB; HOFSTEDE G, 1983, J INT BUS STUD, V14, P75, DOI 10.1057/palgrave.jibs.8490867; Horiba Y., 2003, JAPANESE FINANCE COR, P59; JENSEN MC, 1986, AM ECON REV, V76, P323; JOHANSSON JK, 1994, STRATEGIC MANAGE J, V15, P579, DOI 10.1002/smj.4250150802; Kang JK, 2007, J FINANC ECON, V84, P142, DOI 10.1016/j.jfineco.2006.02.004; Kawai M., 2003, JAPANS BANKING UNPUB; KOGUT B, 1985, SLOAN MANAGE REV, V27, P27; LANG LHP, 1994, J POLIT ECON, V102, P1248, DOI 10.1086/261970; Lee PM, 2003, ACAD MANAGE J, V46, P212, DOI 10.2307/30040615; Li DD, 1996, J FINANC, V51, P691, DOI 10.2307/2329376; Lincoln J., 2009, WHITHER KEIRET UNPUB; Morck R, 1999, J FINANC, V54, P319, DOI 10.1111/0022-1082.00106; PROWSE SD, 1990, J FINANC ECON, V27, P43, DOI 10.1016/0304-405X(90)90020-Z; Sambharya R, 2006, MANAGE INT REV, V46, P7, DOI 10.1007/s11575-007-0047-8; Schaede U., 2006, STRATEGIE LOGI UNPUB; Stein JC, 1997, J FINANC, V52, P111, DOI 10.2307/2329558; Tabeta N., 1998, ASIA PACIFIC J MANAG, V15, P1, DOI 10.1023/A:1015428707475; Villalonga B, 2004, J FINANC, V59, P479, DOI 10.1111/j.1540-6261.2004.00640.x; Walker MD, 2005, J BUS, V78, P1973, DOI 10.1086/431449; WERNERFELT B, 1984, STRATEGIC MANAGE J, V5, P171, DOI 10.1002/smj.4250050207; Williamson O. E., 1996, MECH GOVERNANCE; Yafeh Y, 2000, OXFORD REV ECON POL, V16, P74, DOI 10.1093/oxrep/16.2.74	80	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0929-1199	1872-6313		J CORP FINANC	J. Corp. Financ.	DEC	2014	29						88	110		10.1016/j.jcorpfin.2014.08.002		23	Business, Finance	Business & Economics	AY0CM	WOS:000347265500006		
J	Hori, K; Osano, H				Hori, Keiichi; Osano, Hiroshi			Investment timing decisions of managers under endogenous contracts	JOURNAL OF CORPORATE FINANCE			English	Article						Agency conflicts; Investment timing; Real options; Restricted stock; Stock options	EXECUTIVE-COMPENSATION; ASYMMETRIC INFORMATION; OPTIONS; UNCERTAINTY; MARKET; RISK; FIRM; PAY; INCENTIVES; GOVERNANCE	This paper considers what kind of managerial compensation contract is optimal for mitigating the moral hazard decision regarding investment timing. We examine the situation where the personal objectives of managers do not align with those of shareholders and where there is the possibility of project liquidation but where managerial compensation is endogenously determined. Using a real options approach, we show that restricted stock is optimal relative to stock options under various circumstances. However, we also suggest that stock options are more likely to be used instead of, or in addition to, restricted stock in firms with new debt financing and more impatient managers, diversified firms involving more complicated business activities, and firms with weaker corporate governance. In addition, we find that project start-up is more likely to be deterred by the greater likelihood of project liquidation and larger managerial effort cost, whereas the amount of stock-based managerial compensation is independent of the probability of liquidation but is increasing in managerial effort cost. (C) 2013 Elsevier B.V. All rights reserved.	[Hori, Keiichi] Ritsumeikan Univ, Fac Econ, Kusatsu, Shiga 5258577, Japan; [Osano, Hiroshi] Kyoto Univ, Inst Econ Res, Kyoto 6068501, Japan	Osano, H (reprint author), Kyoto Univ, Inst Econ Res, Sakyo Ku, Kyoto 6068501, Japan.	osano@kier.kyoto-u.ac.jp					Frydman C, 2010, REV FINANC STUD, V23, P2099, DOI 10.1093/rfs/hhp120; Aggarwal RK, 1999, J POLIT ECON, V107, P65, DOI 10.1086/250051; Carruth A, 2000, J ECON SURV, V14, P119, DOI 10.1111/1467-6419.00107; Cyert RM, 2002, MANAGE SCI, V48, P453, DOI 10.1287/mnsc.48.4.453.205; Bebchuk L, 2005, OXFORD REV ECON POL, V21, P283, DOI 10.1093/oxrep/gri017; Murphy KJ, 2004, AM ECON REV, V94, P192, DOI 10.1257/0002828041302262; Czarnitzki D, 2011, REV ECON STAT, V93, P147, DOI 10.1162/REST_a_00069; Morellec E, 2011, J FINANC ECON, V99, P262, DOI 10.1016/j.jfineco.2010.09.003; Jin L, 2002, J FINANC ECON, V66, P29, DOI 10.1016/S0304-405X(02)00150-2; Lambrecht BM, 2007, J FINANC, V62, P809, DOI 10.1111/j.1540-6261.2007.01224.x; Lambrecht BM, 2008, J FINANC ECON, V89, P209, DOI 10.1016/j.jfineco.2007.07.007; Bloom N, 2007, REV ECON STUD, V74, P391, DOI 10.1111/j.1467-937X.2007.00426.x; Dittmann I, 2007, J FINANC, V62, P303, DOI 10.1111/j.1540-6261.2007.01208.x; Ross SA, 2004, J FINANC, V59, P207, DOI 10.1111/j.1540-6261.2004.00631.x; Habib MA, 2007, REV FINANC STUD, V20, P189, DOI 10.1093/rfs/hhl007; Hall BJ, 2002, J ACCOUNT ECON, V33, P3, DOI 10.1016/S0165-4101(01)00050-7; Berry TK, 2006, J CORP FINANC, V12, P797, DOI 10.1016/j.jcorpfin.2005.04.001; Dangl T, 2008, REV FINANC STUD, V21, P2307, DOI 10.1093/rfs/hhl031; Dee CC, 2005, J CORP FINANC, V12, P80, DOI 10.1016/j.jcorpfin.2004.12.002; de Meza D, 2007, J EUR ECON ASSOC, V5, P66; Drakos K, 2013, J APPL ECONOMET, V28, P151, DOI 10.1002/jae.2297; Frydman C., 2010, 16585 NBER; GAREN JE, 1994, J POLIT ECON, V102, P1175, DOI 10.1086/261967; Garvey G, 2003, J FINANC, V58, P1557, DOI 10.1111/1540-6261.00577; Grenadier SR, 2005, J FINANC ECON, V75, P493, DOI 10.1016/j.jfineco.2004.02.004; Hori K, 2009, J ECON DYN CONTROL, V33, P1962, DOI 10.1016/j.jedc.2009.06.001; Hugonnier J, 2007, J ECON DYN CONTROL, V31, P1781, DOI 10.1016/j.jedc.2006.09.001; Kadan O, 2008, REV FINANC STUD, V21, P451, DOI 10.1093/rfs/hhm077; Karatzas I., 1998, METHODS MATH FINANCE; Kraft K, 1999, J ECON BEHAV ORGAN, V40, P17, DOI 10.1016/S0167-2681(99)00040-2; Lyandres E, 2010, J BANK FINANC, V34, P2587, DOI 10.1016/j.jbankfin.2010.04.015; MCDONALD R, 1986, Q J ECON, V101, P707, DOI 10.2307/1884175; Mmland J., 2006, VALUATION IRRE UNPUB; Morellec E, 2004, REV FINANC STUD, V17, P257, DOI 10.1093/rfs/hhg036; Murphy K.J., 2013, HDB EC FINANCE A, V2, P211; Pindyck R. S., 1994, INVESTMENT UNCERTAIN; Shibata T, 2009, J ECON DYN CONTROL, V33, P903, DOI 10.1016/j.jedc.2008.10.005	37	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0929-1199	1872-6313		J CORP FINANC	J. Corp. Financ.	DEC	2014	29						607	627		10.1016/j.jcorpfin.2013.11.013		21	Business, Finance	Business & Economics	AY0CM	WOS:000347265500034		
J	Satoh, K; Mitsukawa, N; Abe, T				Satoh, Kaneshige; Mitsukawa, Nobuyuki; Abe, Takumi			Is prophylactic decompression of the optic canal necessary in surgical correction of fronto-orbital fibrous dysplasia?: A review of 11 consecutive cases	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Fibrous dysplasia; Optic canal decompression; Prophylactic; Visual impairment; Esthetic reconstruction	NERVE DECOMPRESSION; SAFETY	Fronto-orbital fibrous dysplasia is a disease characterized by frontal bossing and orbital dystopia. Simultaneous, prophylactic optic canal decompression remains controversial in the surgical correction of this condition. The authors review a series of 11 patients with fronto-orbital fibrous dysplasia. All patients underwent intracranial malformation excision. Concomitant optic canal decompression was carried out in 6 of 11 cases. Simultaneous reconstruction was carried out using autologous bone in all cases except for 1. Esthetic morphological satisfaction was obtained in all 11 cases. In 2 of 6 cases with optic canal decompression, 1 exhibited half-blindness, and the other exhibited quarter-blindness postoperatively. In 5 cases without decompression, there have been no changes in visual acuity through follow-up ranging from 5 to 22 years. Although therapeutic decompression is well accepted, prophylactic decompression is controversial and the efficacy of prophylactic decompression is questionable. Current strategies should focus on esthetic improvement, with careful observation carried out to assess for optic canal encroachment without prophylactic decompression. (C) 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Satoh, Kaneshige; Mitsukawa, Nobuyuki] Chiba Univ, Dept Plast & Reconstruct Surg, Grad Sch Med, Chiba 2608670, Japan	Mitsukawa, N (reprint author), Chiba Univ, Dept Plast & Reconstruct Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	nmitsu@air.linkclub.or.jp					Cutler CM, 2006, NEUROSURGERY, V59, P1011; Chen YR, 1997, PLAST RECONSTR SURG, V99, P22, DOI 10.1097/00006534-199701000-00004; Goisis M, 2006, OPHTHAL PLAST RECONS, V22, P383, DOI 10.1097/01.iop.0000229761.37416.3e; Lee JS, 2002, NEW ENGL J MED, V347, P1670, DOI 10.1056/NEJMoa020742; Michael CB, 2000, J NEUROSURG, V92, P350, DOI 10.3171/jns.2000.92.2.0350; Tan YC, 2007, PLAST RECONSTR SURG, V120, P1957, DOI 10.1097/01.prs.0000287338.28018.c7	6	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	DEC	2014	42	8					1614	1616		10.1016/j.jcms.2014.04.031		3	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	AX3IM	WOS:000346833200012		
J	Suga, H; Mishima, K; Nakano, H; Nakano, A; Matsumura, M; Mano, T; Yamasaki, Y; Ueyama, Y				Suga, Hokuto; Mishima, Katsuaki; Nakano, Hiroyuki; Nakano, Asuka; Matsumura, Mayumi; Mano, Takamitsu; Yamasaki, Youichi; Ueyama, Yoshiya			Different therapeutic mechanisms of rigid and semi-rigid mandibular repositioning devices in obstructive sleep apnea syndrome	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Computer-assisted image processing; Computed tomography; Mandibular repositioning device; Polysomnography; Sleep apnea syndromes; Temporomandibular joint disorders	POSITIVE AIRWAY PRESSURE; PRACTICE PARAMETERS; ORAL APPLIANCES; ADVANCEMENT SPLINTS; MANAGEMENT	To clarify the mechanisms of rigid and semi-rigid mandibular repositioning devices (MRDs) in obstructive sleep apnea syndrome (OSAS), seven and 13 patients received rigid and semi-rigid MRDs, respectively. Each patient underwent polysomnographic and computed tomographic examinations at the initial consultation and after symptom improvement. Three-dimensional models of the upper airway (hard palate level to epiglottic base) were reconstructed by image processing software (Mimics version 14.2) to measure airway morphology. The mean age and body mass index were 58.1 years and 24.8 kg/m(2), respectively, in the rigid MRD group and 57.9 years and 23.2 kg/m(2), respectively, in the semi-rigid MRD group. The apnea-hypopnea index significantly improved (P < 0.05, Wilcoxon signed-rank test) from 22.0 to 8.9 and 20.5 to 11.5 events per hour of sleep in the respective groups. The cross-sectional areas measured at the epiglottic tip (from 2.0 to 2.6 cm(2)) and hard palate (from 2.6 to 3.3 cm(2)) levels also increased in the respective groups (P < 0.05). However, airway volume, cross-sectional area measured at the uvular tip level, and anteroposterior and transverse diameters of the airway were not significantly different. In conclusion, both types of MRDs improve respiratory status, but they affect different parts of the airway. (C) 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Suga, Hokuto; Yamasaki, Youichi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Pediat Dent, Kagoshima 8908544, Japan; [Mishima, Katsuaki; Nakano, Asuka; Matsumura, Mayumi; Mano, Takamitsu; Ueyama, Yoshiya] Yamaguchi Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Ube, Yamaguchi 7558505, Japan; [Nakano, Hiroyuki] Kyushu Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 2, Higashi Ku, Fukuoka 8128585, Japan	Mishima, K (reprint author), Yamaguchi Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, 1-1-1 Minami Kogushi, Ube, Yamaguchi 7558505, Japan.	kmishima@yamaguchi-u.ac.jp					Lee SH, 2007, LARYNGOSCOPE, V117, P1102, DOI 10.1097/MLG.0b013e318042aef7; Hamilton GS, 2004, INTERN MED J, V34, P420, DOI 10.1111/j.1445-5994.2004.00596.x; Hoekema A, 2008, J DENT RES, V87, P882; Kushida CA, 2006, SLEEP, V29, P240; Ferguson KA, 2006, SLEEP, V29, P244; Liu YH, 2000, AM J ORTHOD DENTOFAC, V118, P248, DOI 10.1067/mod.2000.104831; Aurora RN, 2010, SLEEP, V33, P1408; Hoffstein V, 2007, SLEEP BREATH, V11, P1, DOI 10.1007/s11325-006-0084-8; Kushida CA, 2006, SLEEP, V29, P375; Lam B, 2007, THORAX, V62, P354, DOI 10.1136/thx.2006.063644; Aarab G, 2011, RESPIRATION, V81, P411, DOI 10.1159/000319595; Tan YK, 2002, EUR J ORTHODONT, V24, P239, DOI 10.1093/ejo/24.3.239; Doff MHJ, 2012, CLIN ORAL INVEST, V16, P689, DOI 10.1007/s00784-011-0555-6; Okushi T, 2011, J ORAL MAXIL SURG, V69, P877, DOI 10.1016/j.joms.2010.10.012; Barrera JE, 2007, CLIN PLAST SURG, V34, P565, DOI 10.1016/i.cps.2007.04.010; Blanco J, 2005, Sleep Breath, V9, P20, DOI 10.1007/s11325-005-0003-4; Chan ASL, 2007, CHEST, V132, P693, DOI 10.1378/chest.06-2038; Ellis SG, 2003, DENT UPDATE, V30, P24; Gerbino G, 2014, J CRANIO MAXILL SURG, V42, P66, DOI 10.1016/j.jcms.2013.02.004; Higurashi N, 2002, PSYCHIAT CLIN NEUROS, V56, P331, DOI 10.1046/j.1440-1819.2002.01003.x; Ihara Keisuke, 2011, J Prosthodont Res, V55, P184, DOI 10.1016/j.jpor.2010.05.001; Johal A, 2005, EUR J ORTHODONT, V27, P607, DOI 10.1093/ejo/cji063; Nakano Hiroyuki, 2013, Oral Maxillofac Surg, V17, P105, DOI 10.1007/s10006-012-0332-y; Rose EC, 2001, ANGLE ORTHOD, V71, P452; Schendel SA, 2007, J CRANIOFAC SURG, V18, P902, DOI 10.1097/scs.0b013e31806843b5	25	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	DEC	2014	42	8					1650	1654		10.1016/j.jcms.2014.05.007		5	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	AX3IM	WOS:000346833200019		
J	Sotobori, M; Ueki, K; Ishihara, Y; Moroi, A; Marukawa, K; Nakazawa, R; Higuchi, M; Iguchi, R; Ikawa, H; Kosaka, A				Sotobori, Megumi; Ueki, Koichiro; Ishihara, Yuri; Moroi, Akinori; Marukawa, Kohei; Nakazawa, Ryuichi; Higuchi, Masatoshi; Iguchi, Ran; Ikawa, Hiroumi; Kosaka, Akihiko			Bone regeneration by periosteal elevation using conventional orthodontic wire and uHA/PLLA mesh	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Periosteal elevation; Continuous force; Orthodontic wire; uHA/PLLA mesh	ALPHA-TRICALCIUM PHOSPHATE; DISTRACTION OSTEOGENESIS; ABSORBABLE PLATE; FIXATION; TISSUES; AUGMENTATION; COMPOSITES; STABILITY; DEVICES; SURGERY	This study evaluated bone regeneration by periosteal elevation using conventional orthodontic wire and an unsintered hydroxyapatite (u-HA)/poly-L-lactic acid (PLLA) mesh in rabbit frontal bone. Thirty two rabbits (12-16 weeks: 2.5-3.0 kg) were used in this study. In the experimental group, 1 week after the mesh was inserted under the periosteal membrane, it was elevated by traction using the mesh connected with wire and two anchor screws. In the control group, the mesh was kept inserted under the periosteal membrane. Four animals were killed in each period in both groups, at 2, 3, 5 and 9 weeks post-operatively. Operated parts in the frontal bone were removed and prepared for radiological and histological assessment. The distance between the mesh and pristine bone (elevation length), the bone area and the expression of BMP-2 were evaluated. The value in the experimental group was significantly higher when compared to the control group (length P < 0.0001, bone area P < 0.0010, BMP-2 P = 0.0015). The BMP-2 labelling index after 3 weeks tended to be the largest in both groups. This study suggests that bone regeneration can be induced by periosteal elevation using a conventional orthodontic wire and an uHA/PLLA mesh. (C) 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Sotobori, Megumi; Ueki, Koichiro; Ishihara, Yuri; Moroi, Akinori; Marukawa, Kohei; Nakazawa, Ryuichi; Higuchi, Masatoshi; Iguchi, Ran; Ikawa, Hiroumi; Kosaka, Akihiko] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Div Med, Dept Oral & Maxillofacial Surg, Chuo, Yamanashi 4093898, Japan	Sotobori, M (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Div Med, Dept Oral & Maxillofacial Surg, 1110 Shimokato Chuo, Chuo, Yamanashi 4093898, Japan.	msotobori@yamanashi.ac.jp					ALHO A, 1982, ACTA ORTHOP SCAND, V53, P29, DOI 10.3109/17453678208992175; Zakaria O, 2012, J BIOMED MATER RES B, V100B, P882, DOI 10.1002/jbm.b.31944; Rachmiel A, 2013, J CRANIO MAXILL SURG, V41, P728, DOI 10.1016/j.jcms.2012.12.008; Zakaria O, 2012, J ORAL MAXIL SURG, V70, pE225, DOI 10.1016/j.joms.2011.10.032; Shikinami Y, 2005, BIOMATERIALS, V26, P5542, DOI 10.1016/j.biomaterials.2005.02.016; Idelsohn S, 2004, J MATER SCI-MATER M, V15, P541, DOI 10.1023/B:JMSM.0000021135.72288.8f; Mukozawa A, 2011, CLIN ORAL IMPLAN RES, V22, P1327, DOI 10.1111/j.1600-0501.2010.02135.x; Ueki K, 2014, J CRANIO MAXILL SURG, V42, P351, DOI 10.1016/j.jcms.2013.06.001; BASSETT CA, 1961, NATURE, V190, P460, DOI 10.1038/190460a0; Burstein FD, 2004, CLIN PLAST SURG, V31, P407, DOI 10.1016/j.cps.2004.03.004; Fernandez DJ, UNDERSTANDING SHAPE; Furukawa T, 2000, J BIOMED MATER RES, V50, P410, DOI 10.1002/(SICI)1097-4636(20000605)50:3<410::AID-JBM16>3.0.CO;2-Y; ILIZAROV GA, 1989, CLIN ORTHOP RELAT R, P249; ILIZAROV GA, 1989, CLIN ORTHOP RELAT R, P263; Ishihara Y, 2013, J CRANIOMAXILLOFAC S, Vxxx, P1; KARP NS, 1990, ANN PLAS SURG, V24, P231, DOI 10.1097/00000637-199003000-00007; KARP NS, 1992, ANN PLAS SURG, V29, P2; KOSTOPOULOS L, 1995, J CLIN PERIODONTOL, V22, P247; Marukawa K, 2011, CLIN ORAL IMPLAN RES, V22, P606, DOI 10.1111/j.1600-0501.2010.02023.x; Matthews JL, 1980, BONE STRUCTURE ULTRA, P4; Mohammad Z, 2013, J CRANIOMAXILLOFAC S, Vxxx, P1; Okabe K, 2010, ORAL SURG ORAL MED O, V110, P560, DOI 10.1016/j.tripleo.2010.02.033; Poukens J, 2008, INT J MED ROBOT COMP, V4, P46, DOI 10.1002/rcs.171; Sato K, 2010, ORAL SURG ORAL MED O, V110, P32, DOI 10.1016/j.tripleo.2009.11.005; Saulacic N, 2012, J PERIODONTOL, V83, P757, DOI 10.1902/jop.2011.110418; Schmidt BL, 2002, J ORAL MAXIL SURG, V60, P1170, DOI 10.1053/joms.2002.34993; Tudor C, 2010, INT J ORAL MAX SURG, V39, P897, DOI 10.1016/j.ijom.2010.05.005; Ueki K, 2014, J CRANIO MAXILL SURG, V42, pE210, DOI 10.1016/j.jcms.2013.08.009; Ueki K, 2011, J ORAL MAXIL SURG, V69, P939, DOI 10.1016/j.joms.2010.07.045; Xie M, 2012, J ORAL MAXIL SURG, V70, P2876, DOI 10.1016/j.joms.2012.02.025; Yamauchi K, 2009, ORAL SURG ORAL MED O, V108, P861, DOI 10.1016/j.tripleo.2009.07.047; Yamauchi K, 2010, INT J ORAL MAX SURG, V39, P1000, DOI 10.1016/j.ijom.2010.05.008; Yasunaga T, 1999, J BIOMED MATER RES, V47, P412, DOI 10.1002/(SICI)1097-4636(19991205)47:3<412::AID-JBM17>3.0.CO;2-B	33	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	DEC	2014	42	8					1742	1747		10.1016/j.jcms.2014.06.009		6	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	AX3IM	WOS:000346833200035		
J	Ueki, K; Sotobori, M; Ishihara, Y; Iguchi, R; Kosaka, A; Ikawa, H; Moroi, A; Yoshizawa, K; Marukawa, K				Ueki, Koichiro; Sotobori, Megumi; Ishihara, Yuri; Iguchi, Ran; Kosaka, Akihiko; Ikawa, Hiroumi; Moroi, Akinori; Yoshizawa, Kunio; Marukawa, Kohei			Evaluation of factors affecting recovery period in lower lip hypoesthesia after sagittal split ramus osteotomy in mandibular prognathism patients	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Trigeminal somatosensory-evoked potential (TSEP); Recovery period; Lower lip hypoesthesia; Sagittal split ramus osteotomy (SSRO); Multivariate analysis	SOMATOSENSORY-EVOKED POTENTIALS; INFERIOR ALVEOLAR NERVE; FORT-I OSTEOTOMY; TERM-FOLLOW-UP; NEUROSENSORY DISTURBANCE; 3RD MOLARS; FUNCTIONAL IMPAIRMENT; TRIGEMINAL NERVE; PLATE FIXATION; REMOVAL	Purpose: The purpose of this study was to evaluate the factors affecting the recovery period of lower lip hypoesthesia after sagittal split ramus osteotomy (SSRO) in mandibular prognathism patients using multivariate analysis, retrospectively. Subjects and methods: The subjects were 222 patients (444 sides) who underwent bilateral SSRO setback surgery with and without Le Fort I osteotomy. Trigeminal nerve hypoesthesia at the region of the lower lip was assessed bilaterally by the trigeminal somatosensory-evoked potential (TSEP) method pre-and post-operatively. Recovery period was determined as the time when TSEP was first measurable post-operatively. Age, sex, presence or absence of third molars, setback amount and osteotomy type and fixation method were selected as covariates in the multivariate analysis. The factor affecting the recovery period in lower lip hypoesthesia was examined with Cox's proportional hazard regression. Results: Sex and osteotomy fixation method affected the recovery period in lower lip hypoesthesia significantly (P = 0.0132 and P = 0.0394). However, the other factors did not affect the recovery period. Conclusion: This study suggested that sex and osteotomy type and fixation method may affect the recovery period in lower lip hypoesthesia after SSRO setback surgery. (C) 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Ueki, Koichiro; Sotobori, Megumi; Ishihara, Yuri; Iguchi, Ran; Kosaka, Akihiko; Ikawa, Hiroumi; Moroi, Akinori; Yoshizawa, Kunio; Marukawa, Kohei] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Div Med, Dept Oral & Maxillofacial Surg,Chuo Ku, Yamanashi 4093893, Japan	Ueki, K (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Div Med, Dept Oral & Maxillofacial Surg,Chuo Ku, 1110 Shimokato, Yamanashi 4093893, Japan.	kueki@yamanashi.ac.jp					Al-Bishri A, 2005, INT J ORAL MAX SURG, V34, P247, DOI 10.1016/j.ijom.2004.06.009; Hashiba Y, 2007, ORAL SURG ORAL MED O, V104, P177, DOI 10.1016/j.tripleo.2006.11.038; Van Sickels JE, 2002, J ORAL MAXIL SURG, V60, P1012, DOI 10.1053/joms.2002.34411; Ueki K, 2013, J CRANIO MAXILL SURG, V41, P129, DOI 10.1016/j.jcms.2012.06.004; Al-Bishri A, 2004, J ORAL MAXIL SURG, V62, P1472, DOI 10.1016/j.joms.2004.04.021; Al-Bishri A, 2004, BRIT J ORAL MAX SURG, V42, P105, DOI 10.1016/j.bjoms.2003.12.002; Yoshioka I, 2011, BRIT J ORAL MAX SURG, V49, P552, DOI 10.1016/j.bjoms.2010.09.014; Ueki K, 2001, INT J ORAL MAX SURG, V30, P490, DOI 10.1054/ijom.2001.0171; Lemke RR, 2000, J ORAL MAXIL SURG, V58, P1354, DOI 10.1053/joms.2000.18261; Nakagawa K, 2003, J ORAL MAXIL SURG, V61, P898, DOI 10.1016/S0278-2391(03)00295-7; CODERRE TJ, 1993, PAIN, V52, P259, DOI 10.1016/0304-3959(93)90161-H; Ueki K, 2014, J CRANIO MAXILL SURG, V42, P351, DOI 10.1016/j.jcms.2013.06.001; Takazakura D, 2007, INT J ORAL MAX SURG, V36, P11, DOI 10.1016/j.ijom.2006.09.016; August M, 1998, J ORAL MAXIL SURG, V56, P1231, DOI 10.1016/S0278-2391(98)90595-X; Baas EM, 2012, J ORAL MAXIL SURG, V70, P910, DOI 10.1016/j.joms.2011.02.107; Becelli R, 2002, J CRANIOFAC SURG, V13, P315, DOI 10.1097/00001665-200203000-00027; Bruckmoser E, 2013, OR SURG OR MED OR PA, V115, P473, DOI 10.1016/j.oooo.2012.08.454; de Beukelaer JGP, 1998, ORAL SURG ORAL MED O, V85, P366, DOI 10.1016/S1079-2104(98)90058-0; Doucet JC, 2012, J ORAL MAXIL SURG, V70, P2153, DOI 10.1016/j.joms.2011.08.029; FRIDRICH KL, 1995, J ORAL MAXIL SURG, V53, P1300, DOI 10.1016/0278-2391(95)90588-X; Fujioka M, 1998, PLAST RECONSTR SURG, V102, P37, DOI 10.1097/00006534-199807000-00006; Hanzelka T, 2011, INT J ORAL MAX SURG, V40, P901, DOI 10.1016/j.ijom.2011.04.002; Hashiba Y, 2008, ORAL SURG ORAL MED O, V105, P11, DOI 10.1016/j.tripleo.2007.04.006; JONES D L, 1990, International Journal of Adult Orthodontics and Orthognathic Surgery, V5, P167; Joss CU, 2007, EUR J ORTHODONT, V29, P263, DOI 10.1093/ejo/cjm021; Kim YK, 2011, J ORAL MAXIL SURG, V69, P893, DOI 10.1016/j.joms.2010.10.025; MCQUAY HJ, 1994, PAIN, V59, P127, DOI 10.1016/0304-3959(94)90056-6; Nakagawa K, 1997, J CRANIO MAXILL SURG, V25, P97, DOI 10.1016/S1010-5182(97)80052-2; Nakagawa K, 2001, ORAL SURG ORAL MED O, V91, P146, DOI 10.1067/moe.2001.112331; Reyneke JP, 2002, J ORAL MAXIL SURG, V60, P654, DOI 10.1053/joms.2002.33114; Schultze-Mosgau S, 2001, J ORAL MAXIL SURG, V59, P128, DOI 10.1053/joms.2001.20480; Schwartz HC, 2004, J ORAL MAXIL SURG, V62, P1147, DOI 10.1016/j.joms.2004.04.015; TAKEUCHI T, 1994, BRIT J ORAL MAX SURG, V32, P105, DOI 10.1016/0266-4356(94)90139-2; Teerijoki-Oksa T, 2002, INT J ORAL MAX SURG, V31, P33, DOI 10.1054/ijom.2001.0157; Ueki K, 2012, J CRANIO MAXILL SURG, V40, pE119, DOI 10.1016/j.jcms.2011.07.002; Yikontiola L, 2000, J ORAL MAXILLOFAC SU, V58, P1234	36	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	DEC	2014	42	8					1748	1752		10.1016/j.jcms.2014.06.010		5	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	AX3IM	WOS:000346833200036		
J	Ueki, K; Moroi, A; Ishihara, Y; Sotobori, M; Iguchi, R; Kosaka, A; Ikawa, H; Yoshizawa, K; Marukawa, K				Ueki, Koichiro; Moroi, Akinori; Ishihara, Yuri; Sotobori, Megumi; Iguchi, Ran; Kosaka, Akihiko; Ikawa, Hiroumi; Yoshizawa, Kunio; Marukawa, Kohei			Comparison of lower lip hypoesthesia between hybrid fixation and conventional fixation following sagittal split ramus osteotomy	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Hybrid fixation; Trigeminal somatosensory-evoked potential (TSEP); Sagittal split ramus osteotomy (SSRO); Absorbable plate	SOMATOSENSORY-EVOKED POTENTIALS; INFERIOR ALVEOLAR NERVE; MANDIBULAR OSTEOTOMIES; TRIGEMINAL NERVE; SETBACK SURGERY; PLATE FIXATION; ADVANCEMENT; PARESTHESIA; DISTURBANCE; PAIN	Purpose: The purpose of this study was to compare the recovery period of lower lip hypoesthesia between hybrid fixation and conventional fixation using absorbable plates and screw systems following sagittal split ramus osteotomy (SSRO). Subjects and methods: The subjects were 66 patients (132 sides) who underwent bilateral SSRO setback surgery. They were divided into a hybrid fixation group (66 sides, 1 u-HA/PLLA plate and 4 mono-cortical screws and a bi-cortical screw in each side) and a conventional fixation group (66 sides, 1 u-HA/PLLA plate and 4 mono-cortical screws in each side). Trigeminal nerve hypoesthesia at the region of the lower lip was assessed bilaterally by the trigeminal somatosensory-evoked potential (TSEP) method. Results: The mean measurable periods were 8.1 +/- 10.4 weeks in the hybrid fixation group, 5.1 +/- 11.5 weeks in the conventional group with no significant difference. However, the maximum in the hybrid fixation group was 27 sides at 4 weeks postoperative and in the conventional fixation group was 37 sides at 1 week postoperative, and there was significant difference in the distribution of the measurable period (P < 0.0001). Conclusion: This study suggested that additional bi-cortical screws could affect the recovery of lower lip hypoesthesia after SSRO with bent absorbable plate fixation. (C) 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Ueki, Koichiro; Moroi, Akinori; Ishihara, Yuri; Sotobori, Megumi; Iguchi, Ran; Kosaka, Akihiko; Ikawa, Hiroumi; Yoshizawa, Kunio; Marukawa, Kohei] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Div Med, Dept Oral & Maxillofacial Surg,Chuo Ku, Yamanashi 4093893, Japan	Ueki, K (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Div Med, Dept Oral & Maxillofacial Surg,Chuo Ku, 1110 Shimokato, Yamanashi 4093893, Japan.	kueki@yamanashi.ac.jp					Hashiba Y, 2007, ORAL SURG ORAL MED O, V104, P177, DOI 10.1016/j.tripleo.2006.11.038; Brasileiro BF, 2012, J ORAL MAXIL SURG, V70, P941, DOI 10.1016/j.joms.2011.02.106; Van Sickels JE, 2002, J ORAL MAXIL SURG, V60, P1012, DOI 10.1053/joms.2002.34411; Ueki K, 2011, J ORAL MAXIL SURG, V69, P1464, DOI 10.1016/j.joms.2010.06.187; Westermark A, 1998, BRIT J ORAL MAX SURG, V36, P425, DOI 10.1016/S0266-4356(98)90457-0; Ueki K, 2001, INT J ORAL MAX SURG, V30, P490, DOI 10.1054/ijom.2001.0171; Lemke RR, 2000, J ORAL MAXIL SURG, V58, P1354, DOI 10.1053/joms.2000.18261; Nakagawa K, 2003, J ORAL MAXIL SURG, V61, P898, DOI 10.1016/S0278-2391(03)00295-7; CODERRE TJ, 1993, PAIN, V52, P259, DOI 10.1016/0304-3959(93)90161-H; Ueki K, 2014, J CRANIO MAXILL SURG, V42, P351, DOI 10.1016/j.jcms.2013.06.001; Schwartz HC, 1996, J ORAL MAXIL SURG, V54, P234, DOI 10.1016/S0278-2391(96)90457-7; Augaust M, 1998, J ORAL MAXILLOFAC SU, V56, P1231; BRUSATI R, 1981, J MAXILLOFAC SURG, V9, P123, DOI 10.1016/S0301-0503(81)80028-8; de Beukelaer JGP, 1998, ORAL SURG ORAL MED O, V85, P366, DOI 10.1016/S1079-2104(98)90058-0; Fujioka M, 1998, PLAST RECONSTR SURG, V102, P37, DOI 10.1097/00006534-199807000-00006; Hashiba Y, 2008, ORAL SURG ORAL MED O, V105, P11, DOI 10.1016/j.tripleo.2007.04.006; JONES D L, 1990, International Journal of Adult Orthodontics and Orthognathic Surgery, V5, P167; MCQUAY HJ, 1994, PAIN, V59, P127, DOI 10.1016/0304-3959(94)90056-6; Nakagawa K, 1997, J CRANIO MAXILL SURG, V25, P97, DOI 10.1016/S1010-5182(97)80052-2; Nakagawa K, 2001, ORAL SURG ORAL MED O, V91, P146, DOI 10.1067/moe.2001.112331; Pratt CA, 1996, BRIT J ORAL MAX SURG, V34, P75, DOI 10.1016/S0266-4356(96)90141-2; TAKEUCHI T, 1994, BRIT J ORAL MAX SURG, V32, P105, DOI 10.1016/0266-4356(94)90139-2; Tucker MR, 1988, INT J ADULT ORTHOD O, V2, P71; VANSICKELS JE, 1985, J ORAL MAXIL SURG, V43, P808, DOI 10.1016/0278-2391(85)90341-6; Yikontiola L, 2000, J ORAL MAXILLOFAC SU, V58, P1234	25	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	DEC	2014	42	8					1808	1812		10.1016/j.jcms.2014.06.019		5	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	AX3IM	WOS:000346833200045		
J	Maeda, T; Oyama, A; Okamoto, T; Funayama, E; Furukawa, H; Hayashi, T; Murao, N; Sato, Y; Yamamoto, Y				Maeda, Taku; Oyama, Akihiko; Okamoto, Toru; Funayama, Emi; Furukawa, Hiroshi; Hayashi, Toshihiko; Murao, Naoki; Sato, Yoshiaki; Yamamoto, Yuhei			Combination of Tessier clefts 3 and 4: Case report of a rare anomaly with 12 years' follow-up	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Facial cleft; Tessier cleft 3; Tessier cleft 4; Active appliance; Presurgical alveolar molding	PALATE; LIP	Tessier cleft types 3 and 4 are both rare craniofacial anomalies. Here we present the first case of a girl born with a combined anomaly of Tessier clefts 3 and 4 with severe bilateral cleft lip, a displaced premaxilla, and three-dimensional underdevelopment of the hard and soft tissues of the maxilla and zygoma. This type of rare facial cleft poses a major operative challenge. Over a period of years, presurgical alveolar molding with an active appliance was followed by seven operations. A satisfactory esthetic outcome was obtained. A multidisciplinary approach to treatment with a plastic surgeon in charge of the operations and an orthodontist in charge of the cleft deformity is essential. (C) 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Maeda, Taku; Oyama, Akihiko; Okamoto, Toru; Funayama, Emi; Furukawa, Hiroshi; Hayashi, Toshihiko; Murao, Naoki; Yamamoto, Yuhei] Hokkaido Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Sapporo, Hokkaido 060, Japan; [Sato, Yoshiaki] Hokkaido Univ, Grad Sch Med, Dept Orthodont, Div Oral Funct Sci, Sapporo, Hokkaido 060, Japan	Oyama, A (reprint author), 106 Nishi 7 Chome,Kita 15 Jo,Kita Ku, Sapporo, Hokkaido, Japan.	akihiko.oyama@mac.com					VANDERMEULEN JC, 1983, PLAST RECONSTR SURG, V71, P560, DOI 10.1097/00006534-198304000-00022; GEORGIADE NG, 1975, PLAST RECONSTR SURG, V56, P52, DOI 10.1097/00006534-197507000-00011; Chen PKT, 2012, PLAST RECONSTR SURG, V129, P1337, DOI 10.1097/PRS.0b013e31824ec310; Versnel SL, 2011, J PLAST RECONSTR AES, V64, P1334, DOI 10.1016/j.bjps.2011.04.021; BOO-CHAI K, 1970, British Journal of Plastic Surgery, V23, P352, DOI 10.1016/S0007-1226(70)80074-1; Gawrych E, 2010, INT J ORAL MAXILLOF, V21, P390; GEORGIAD.N, 1968, PLAST RECONSTR SURG, V41, P240, DOI 10.1097/00006534-196803000-00005; GRAYSON BH, 1993, PLAST RECONSTR SURG, V92, P1422; Kawamoto H K Jr, 1976, Clin Plast Surg, V3, P529; Longaker MT, 1997, PLAST RECONSTR SURG, V99, P1501, DOI 10.1097/00006534-199705000-00004; TESSIER P, 1976, Journal of Maxillofacial Surgery, V4, P69, DOI 10.1016/S0301-0503(76)80013-6; Wu DD, 2013, J CRANIO MAXILL SURG, V41, P598, DOI 10.1016/j.jcms.2012.11.040	12	1	1	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	DEC	2014	42	8					1985	1989		10.1016/j.jcms.2014.09.003		5	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	AX3IM	WOS:000346833200073		
J	Hattori-Hara, E; Mitsui, SN; Mori, H; Arafurue, K; Kawaoka, T; Ueda, K; Yasue, A; Kuroda, S; Koolstra, JH; Tanaka, E				Hattori-Hara, Erica; Mitsui, Silvia N.; Mori, Hiroyo; Arafurue, Keiji; Kawaoka, Takuji; Ueda, Kanji; Yasue, Akihiro; Kuroda, Shingo; Koolstra, Jan Harm; Tanaka, Eiji			The influence of unilateral disc displacement on stress in the contralateral joint with a normally positioned disc in a human temporomandibular joint: An analytic approach using the finite element method	JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY			English	Article						Unilateral disc displacement; Finite element method; Clenching; Temporomandibular joint; Stress analysis	3-DIMENSIONAL MATHEMATICAL-MODEL; DISORDERS; SYSTEM; COMPRESSION; RELAXATION; TISSUE	Objectives: To investigate the influence of unilateral disc displacement (DD) in the temporomandibular joint (TMJ) on the stress in the contralateral joint, with a normally-positioned disc, during clenching. Study design: A finite element model of the TMJ was constructed based on MRI and 3D-CT of a single patient with a unilateral DD. A second model with bilateral normally-positioned discs served as a reference. The differences in stress distribution in various TMJ components during clenching were predicted with these models. Results: In the unaffected joint of the unilateral DD model, the largest von Mises stress at the start of clenching was predicted in the inferior surface of the disc and increased by 30% during clenching. In the connective tissue the largest stress (1.16 MPa) did not reduce during clenching, in contrast to the (unaffected) joints of the reference model. In the affected joint, the largest stress was predicted in the temporal cartilage throughout clenching. In the surrounding connective tissue, the largest stress (1.42 MPa) hardly changed during clenching indicating no, or negligible, stress relaxation. Conclusions: This suggested that a unilateral DD could affect the stresses in the unaffected (contralateral) joint during clenching, where it may lead to weakening of the tissues that keep the disc on the top of the condyle. The results may be helpful in counseling worried patients, since they give insight into possible future developments of the disorder. (C) 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.	[Hattori-Hara, Erica; Mitsui, Silvia N.; Mori, Hiroyo; Yasue, Akihiro; Kuroda, Shingo; Tanaka, Eiji] Univ Tokushima, Grad Sch, Dept Orthodont & Dentofacial Orthoped, Inst Hlth Biosci, Tokushima, Tokushima 7708504, Japan; [Arafurue, Keiji; Kawaoka, Takuji; Ueda, Kanji] Digital Solut Co Ltd, Hiroshima, Japan; [Koolstra, Jan Harm] ACTA, Dept Funct Anat, Amsterdam, Netherlands	Tanaka, E (reprint author), Univ Tokushima, Grad Sch, Dept Orthodont & Dentofacial Orthoped, Inst Hlth Biosci, 3-18-15 Kuramoto Cho, Tokushima, Tokushima 7708504, Japan.	etanaka@tokushima-u.ac.jp	Tanaka, Eiji/E-7105-2015		Ministry of Education, Science and Culture, Japan [23659966]	A Grant (No. 23659966) for Science Research from the Ministry of Education, Science and Culture, Japan.	Abe S, 2013, J ORAL REHABIL, V40, P239, DOI 10.1111/joor.12036; del Palomar AP, 2006, J BIOMECH, V39, P2153, DOI 10.1016/j.jbiomech.2005.06.020; SOLBERG WK, 1985, J ORAL REHABIL, V12, P303, DOI 10.1111/j.1365-2842.1985.tb01285.x; Koolstra JH, 2005, J BIOMECH, V38, P2431, DOI 10.1016/j.jbiomech.2004.10.014; DIJKGRAAF LC, 1995, J ORAL MAXIL SURG, V53, P1182, DOI 10.1016/0278-2391(95)90632-0; KOOLSTRA JH, 1988, J BIOMECH, V21, P563, DOI 10.1016/0021-9290(88)90219-9; Breedveld PC, 2004, MATH COMPUT SIMULAT, V66, P99, DOI 10.1016/j.matcom.2003.11.002; Tanaka E, 2004, J DENT RES, V83, P404; Mori H, 2010, ARCH ORAL BIOL, V55, P879, DOI 10.1016/j.archoralbio.2010.07.011; Kuroda S, 2009, OSTEOARTHR CARTILAGE, V17, P1408, DOI 10.1016/j.joca.2009.04.025; Koolstra JH, 2012, OSTEOARTHR CARTILAGE, V20, P43, DOI 10.1016/j.joca.2011.10.009; Tanaka E, 2008, J DENT RES, V87, P296; Koolstra JH, 2009, J ANAT, V215, P411, DOI 10.1111/j.1469-7580.2009.01127.x; Allen KD, 2006, J BIOMECH, V39, P312, DOI 10.1016/j.jbiomech.2004.11.012; Detamore MS, 2003, J ORAL MAXIL SURG, V61, P494, DOI 10.1053/joms.2003.50096; Beek M, 2000, J BIOMECH, V33, P307, DOI 10.1016/S0021-9290(99)00168-2; Naeije M, 2013, J ORAL REHABIL, V40, P139, DOI 10.1111/joor.12016; HUISKES R, 1982, J BIOMECH, V15, P65, DOI 10.1016/0021-9290(82)90036-7; Tanaka E, 2003, CRIT REV ORAL BIOL M, V14, P138; De Leeuw Reny, 1994, Journal of Orofacial Pain, V8, P18; de Freitas RFCP, 2013, J ORAL REHABIL, V40, P864, DOI 10.1111/joor.12098; DELEEUW R, 1995, CRANIO, V13, P81; Fung YC, 1969, 1 COURSE CONTINUUM M, P174; Kawai N, 2004, J BIOMED MATER RES A, V70A, P149, DOI 10.1002/jbm.a.30078; KOOLSTRA JH, 1992, J BIOMECH, V25, P175, DOI 10.1016/0021-9290(92)90274-5; Koolstra JH, 2007, J BIOMECH, V40, P2330, DOI 10.1016/j.jbiomech.2006.10.019; Lamela MJ, 2013, J MECH BEHAV BIOMED, V23, P62, DOI 10.1016/j.jmbbm.2013.04.006; Nickerson JW, 1989, ORAL MAXILLOFAC SURG, V1, P27; Scapino RP, 2006, CELLS TISSUES ORGANS, V182, P201, DOI 10.1159/000093969; Singh M, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2838062; SUTTON DI, 1992, AM J ORTHOD DENTOFAC, V101, P70, DOI 10.1016/0889-5406(92)70084-N; Tanaka E, 2007, J BIOMECH ENG-T ASME, V129, P890, DOI 10.1115/1.2800825; Tanaka E, 1999, ARCH ORAL BIOL, V44, P1021, DOI 10.1016/S0003-9969(99)00097-7; Tanaka E, 2002, J ORAL MAXIL SURG, V60, P546, DOI 10.1053/joms.2002.31853; WESTESSON PL, 1989, ORAL SURG ORAL MED O, V68, P551, DOI 10.1016/0030-4220(89)90236-3	35	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	1010-5182	1878-4119		J CRANIO MAXILL SURG	J. Cranio-MaxilloFac. Surg.	DEC	2014	42	8					2018	2024		10.1016/j.jcms.2014.09.008		7	Dentistry, Oral Surgery & Medicine; Surgery	Dentistry, Oral Surgery & Medicine; Surgery	AX3IM	WOS:000346833200078		
J	Aksornmuang, J; Nakajima, M; Tagami, J				Aksornmuang, Juthatip; Nakajima, Masatoshi; Tagami, Junji			Effect of viscosity of dual-cure luting resin composite core materials on bond strength to fiber posts with various surface treatments	JOURNAL OF DENTAL SCIENCES			English	Article						bond strength; post-surface treatment; resin composites; viscosity	ROOT-CANAL DENTIN; MECHANICAL-PROPERTIES; ADHESION; AGENTS; GLASS	Background/purpose: The objective of this study was to evaluate the viscosity of two dual-cure resin composite core materials and their bond strength to fiber posts treated with various surface treatments. Materials and methods: Viscosity at 60-90 seconds after mixing two resin composite core materials, Clearfil DC Core (DC) and Build-It FR (BI), was tested by a rheometer. Eighteen fiber posts (FibreKor) were divided into three groups according to the following post surface treatments: (1) no surface treatment; (2) application of silane coupling agent (Silane); and (3) application of silane followed by Bond-1 adhesive resin (Silane Bond-1). Treated posts were cemented into artificial post spaces using DC or BI. After 24-hour storage, each specimen was serially sliced into 12 beams for a microtensile bond strength test. The data were divided into upper, middle, and bottom regions, and statistically analyzed (alpha = 0.05). Failure modes were observed using a scanning electron microscope. Results: The viscosity of BI at 60 seconds after mixing was lower than that of DC. Bond strengths were found to be affected by luting resin composites, surface treatment, and region. For DC, bond strength was significantly improved in the group of Silane + Bond-1 (P < 0.05). For BI, application of Si lane significantly improved bond strength (P <0.05), but application of Si lane + Bond-1 had no advantageous effect on it. Conclusion: Bond strengths between luting resin composites and fiber posts were affected by post surface treatments, depending on the resin composite used. Application of a low-viscosity adhesive resin to the post surface seemed to be beneficial for a high-viscosity luting resin composite. Copyright (C) 2014, Association for Dental Sciences of the Republic of China. Published by Elsevier Taiwan LLC. All rights reserved.	[Aksornmuang, Juthatip] Prince Songkla Univ, Fac Dent, Dept Prosthet Dent, Hat Yai 90112, Songkhla, Thailand; [Nakajima, Masatoshi; Tagami, Junji] Tokyo Med & Dent Univ, Dept Restorat Sci, Tokyo, Japan; [Tagami, Junji] Tokyo Med & Dent Univ, Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence Program, Tokyo, Japan	Aksornmuang, J (reprint author), Prince Songkla Univ, Fac Dent, Dept Prosthet Dent, Hat Yai 90112, Songkhla, Thailand.	juthatip.a@psu.ac.th			Thailand Research Fund (TRF); Commission on Higher Education, Thailand	The authors gratefully acknowledge the financial support received from the Thailand Research Fund (TRF) and the Commission on Higher Education, Thailand.	Aksornmuang J, 2006, AM J DENT, V19, P51; Aksornmuang J, 2007, DENT MATER, V23, P226, DOI 10.1016/j.dental.2006.01.014; Aksornmuang J, 2008, OPER DENT, V33, P636, DOI 10.2341/07-160; Aksornmuang J, 2004, J DENT, V32, P443, DOI 10.1016/j.jdent.2004.03.001; Monticelli F, 2008, OPER DENT, V33, P346, DOI 10.2341/07-86; Akkayan B, 2002, J PROSTHET DENT, V87, P431, DOI 10.1067/mpr.2002.123227; Debnath S, 2003, DENT MATER, V19, P441, DOI 10.1016/S0109-5641(02)00089-1; Monticelli F, 2006, DENT MATER, V22, P1024, DOI 10.1016/j.dental.2005.11.024; Boschian PL, 2002, DENT MATER, V18, P596; Choi Y, 2010, J PROSTHET DENT, V103, P362, DOI 10.1016/S0022-3913(10)60078-9; Cormier C J, 2001, J Prosthodont, V10, P26, DOI 10.1111/j.1532-849X.2001.00026.x; D'Arcangelo C, 2007, J ENDODONT, V33, P264, DOI 10.1016/j.joen.2006.10.015; de Rijk W G, 2000, Am J Dent, V13, p19B; de Sousa Menezes Murilo, 2011, J Endod, V37, P398, DOI 10.1016/j.joen.2010.11.037; Ferrari M, 2000, AM J DENT, V13, P9; Finger W J, 1994, Am J Dent, V7, P35; Rodig T, 2010, J ADHES DENT, V12, P197, DOI 10.3290/j.jad.a18441; Sahafi A, 2003, J ADHES DENT, V5, P153; Soares CJ, 2008, J PROSTHET DENT, V99, P444, DOI 10.1016/S0022-3913(08)60106-7; Takahashi H, 2004, J J DENT MAT, V23, P287; TENCATE JM, 1977, J ORAL REHABIL, V4, P149	21	0	0	ELSEVIER TAIWAN	TAIPEI	RM N-412, 4F, CHIA HSIN BUILDING 11, NO 96, ZHONG SHAN N ROAD SEC 2, TAIPEI, 10449, TAIWAN	1991-7902			J DENT SCI	J. Dental Sci.	DEC	2014	9	4					320	327		10.1016/j.jds.2014.04.001		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AX7ZZ	WOS:000347131400003		
J	Komatsu, S; Tsukamoto, T; Iwasaki, T; Toyokawa, A; Hasegawa, Y; Tsuchida, S; Takahashi, T; Takebe, A; Wakahara, T; Watanabe, A; Sugahara, A; Mukai, H				Komatsu, Shohei; Tsukamoto, Tadashi; Iwasaki, Takeshi; Toyokawa, Akihiro; Hasegawa, Yasuhisa; Tsuchida, Shinobu; Takahashi, Tsuyoshi; Takebe, Atsushi; Wakahara, Tomoyuki; Watanabe, Akihiko; Sugahara, Atsushi; Mukai, Hidekazu			Role of percutaneous transhepatic gallbladder aspiration in the early management of acute cholecystitis	JOURNAL OF DIGESTIVE DISEASES			English	Article						acute cholecystitis; cholecystectomy; percutaneous transhepatic gallbladder aspiration; percutaneous transhepatic gallbladder drainage; treatment outcome	DELAYED LAPAROSCOPIC CHOLECYSTECTOMY; CRITICALLY ILL PATIENTS; GANGRENOUS CHOLECYSTITIS; ELDERLY-PATIENTS; CHOLECYSTOSTOMY; DRAINAGE; TRIAL	ObjectiveEarly cholecystectomy is currently the gold standard treatment for acute cholecystitis (AC). However, the acceptability and safety of this strategy remain in dispute. The aim of this study was to clarify the role of percutaneous transhepatic gallbladder aspiration (PTGBA) in the early management of AC in a single center. MethodsA total of 147 consecutive patients who were treated with PTGBA for AC from 2008 to 2012 were included in the study. The therapeutic outcomes and adverse events were evaluated. ResultsA single PTGBA was adequate for 96 (65.3%) patients with AC. Of the remaining 51 patients, 43 (29.3%) showed an improvement after repeated PTGBA and/or percutaneous transhepatic gallbladder drainage (PTGBD), while semi-emergency cholecystectomy was needed in eight patients. Although five patients experienced adverse events (intra-abdominal hemorrhage in two, bile leakage in two and gallbladder hemorrhage in one), no patient died of treatment-related complications. Subsequently, 87 (59.2%) patients underwent cholecystectomy after PTGBA (a single PTGBA in 48 and repeated PTGBA and/or PTGBD in 39 patients). No significant differences were observed in the conversion rate from laparoscopic surgery to open cholecystectomy, operative time or intraoperative hemorrhage volume between the two groups. ConclusionsThe present study demonstrated the safety and acceptability of treatment with PTGBA for AC at our center. This elective treatment strategy may be a useful alternative option in the treatment of AC.	[Komatsu, Shohei; Toyokawa, Akihiro; Hasegawa, Yasuhisa; Tsuchida, Shinobu; Takahashi, Tsuyoshi; Takebe, Atsushi; Wakahara, Tomoyuki] Yodogawa Christians Hosp, Dept Surg, Osaka, Japan; [Watanabe, Akihiko; Sugahara, Atsushi; Mukai, Hidekazu] Yodogawa Christians Hosp, Dept Gastroenterol, Osaka, Japan; [Tsukamoto, Tadashi] Osaka City Gen Hosp, Dept Hepatobiliary Pancreat Surg, Osaka, Japan; [Iwasaki, Takeshi] Natl Hosp Org, Dept Surg, Kobe Med Ctr, Kobe, Hyogo, Japan	Komatsu, S (reprint author), Kobe Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	komasho8@gmail.com					Lo CM, 1998, ANN SURG, V227, P461, DOI 10.1097/00000658-199804000-00001; JARVINEN HJ, 1980, ANN SURG, V191, P501; Kortram K, 2011, SURG ENDOSC, V25, P3642, DOI 10.1007/s00464-011-1771-5; Eldar S, 1997, WORLD J SURG, V21, P540; Pessaux P, 2001, SURG LAPARO ENDO PER, V11, P252, DOI 10.1097/00019509-200108000-00005; Germanos S, 2007, LANCET, V369, P1774, DOI 10.1016/S0140-6736(07)60796-X; Chikamori F, 2002, SURG ENDOSC, V16, P1704, DOI 10.1007/s00464-002-9004-6; Borzellino G, 1999, BRIT J SURG, V86, P1521, DOI 10.1046/j.1365-2168.1999.01284.x; Spira RM, 2002, AM J SURG, V183, P62, DOI 10.1016/S0002-9610(01)00849-2; Kuster GGR, 1996, SURG ENDOSC-ULTRAS, V10, P426; Lai PBS, 1998, BRIT J SURG, V85, P764; Wu B, 2014, HPB, V16, P801, DOI 10.1111/hpb.12226; LEE MJ, 1991, AM J ROENTGENOL, V156, P1163; Hirota M, 2007, J HEPATO-BILIARY-PAN, V14, P78, DOI 10.1007/s00534-006-1159-4; Ito K, 2004, AM J ROENTGENOL, V183, P193; Chandler CF, 2000, AM SURGEON, V66, P896; Sugiyama M, 1998, WORLD J SURG, V22, P459; Bingener J, 2003, ARCH SURG-CHICAGO, V138, P531, DOI 10.1001/archsurg.138.5.531; CROLEY GG, 1992, AM SURGEON, V58, P284; Dabus Gde C, 2003, SAO PAULO MED J, V121, P260; Han IW, 2012, J HEPATO-BIL-PAN SCI, V19, P187, DOI 10.1007/s00534-011-0458-6; Kiviniemi H, 1998, INT SURG, V83, P299; Lee KT, 1998, DIGEST SURG, V15, P328, DOI 10.1159/000018647; MCGAHAN JP, 1988, RADIOLOGY, V167, P669; Nikfarjam M, 2011, HPB, V13, P551, DOI 10.1111/j.1477-2574.2011.00327.x; Shibasaki S, 2014, J HEPATO-BIL-PAN SCI, V21, P335, DOI 10.1002/jhbp.28; TEEFEY SA, 1991, J ULTRAS MED, V10, P603; Tsutsui K, 2007, J GASTROENTEROL, V42, P583, DOI 10.1007/s00535-007-2061-9; VERBANCK JJ, 1993, LANCET, V341, P1132, DOI 10.1016/0140-6736(93)93138-Q	29	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1751-2972	1751-2980		J DIGEST DIS	J. Dig. Dis.	DEC	2014	15	12					669	675		10.1111/1751-2980.12198		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AX6WE	WOS:000347058200005		
J	Liu, H; Xie, XY; Cui, J; Takahashi, K; Sato, M				Liu, Hai; Xie, Xiongyao; Cui, Jie; Takahashi, Kazunori; Sato, Motoyuki			Groundwater Level Monitoring for Hydraulic Characterization of an Unconfined Aquifer by Common Mid-point Measurements using GPR	JOURNAL OF ENVIRONMENTAL AND ENGINEERING GEOPHYSICS			English	Article							PENETRATING RADAR; DIELECTRIC PERMITTIVITY; ANTENNA-ARRAY; WATER-CONTENT; TIME-LAPSE; REFLECTION; SEMBLANCE; THICKNESS; VELOCITY; TABLE	Because of its limited bandwidth, ground penetrating radar (GPR) signal has an oscillating character that degrades the ability to distinguish reflection events and introduces an error in the velocity analysis. In this paper, we use the analytic signal to calculate the envelope velocity spectrum, which is void of the oscillating nature of a GPR wavelet. A comparison study on a synthetic common mid-point (CMP) gather demonstrates that the envelope velocity spectrum gives a more robust velocity estimation. We applied this technique to explore the potential of GPR for monitoring the pumping-induced groundwater level change, then estimating the hydraulic properties of an aquifer in Ulaanbaatar, the capital of Mongolia. A field survey was conducted along three different directions when a production well was under pumping and static conditions. In addition, a simple velocity picking scheme was suggested based on the maximum coherency curve. From the velocity picks, the vertical profiles of interval electromagnetic velocity and water content were estimated. The groundwater table was easily identified in these profiles. The groundwater level changes under the CMP sounding locations along the northeast and north survey lines were estimated to be 27 and 23 cm, respectively, whereas it failed to detect the groundwater level change on the northwest survey line because of the effect of strong scatterers near the groundwater table. The estimated groundwater level change was input into the unconfined aquifer model for estimating the hydraulic conductivity, which yields comparable results with a previous study. We conclude that the hydraulic parameter estimation using GPR is much easier and effective than the conventional hydraulic test methods.	[Liu, Hai] Xiamen Univ, Dept Elect Sci, Xiamen 361005, Peoples R China; [Xie, Xiongyao] Tongji Univ, Dept Geotech Engn, Shanghai 200092, Peoples R China; [Cui, Jie] Guangzhou Univ, Sch Civil Engn, Guangzhou 510006, Peoples R China; [Takahashi, Kazunori; Sato, Motoyuki] Tohoku Univ, Ctr Northeast Asian Studies, Sendai, Miyagi 9808576, Japan	Liu, H (reprint author), Xiamen Univ, Dept Elect Sci, Xiamen 361005, Peoples R China.	liuhai8619@xmu.edu.cn; xiexiongyao@tongji.edu.cn; jcui2009@hotmail.com; sato@cneas.tohoku.ac.jp			JSPS [23246076, 24612001]; National Basic Research Program of China (973 Programs) [2011CB013803, 2011CB013606]; Ministry of Education of China [20124410110004]	This work was supported by JSPS Grant-in-Aid for Scientific Research (A) 23246076 and (C) 24612001, the National Basic Research Program of China (973 Programs: 2011CB013803, 2011CB013606), and the Doctoral Fund of Ministry of Education of China (20124410110004). We acknowledge Dr. Lu Qi for field data acquisition.	Annan A.P., 1991, 61 ANN INT M SOC EXP, P494; Tsoflias GP, 2001, WATER RESOUR RES, V37, P1221, DOI 10.1029/2000WR900297; NEIDELL NS, 1971, GEOPHYSICS, V36, P482, DOI 10.1190/1.1440186; TANER MT, 1979, GEOPHYSICS, V44, P1041, DOI 10.1190/1.1440994; Looms MC, 2008, VADOSE ZONE J, V7, P227, DOI 10.2136/vzj2006.0129; Booth AD, 2010, NEAR SURF GEOPHYS, V8, P235, DOI 10.3997/1873-0604.2010008; Lambot S, 2009, VADOSE ZONE J, V8, P743, DOI 10.2136/vzj2008.0058; Saintenoy A, 2008, VADOSE ZONE J, V7, P208, DOI 10.2136/vzj2007.0132; Bradford JH, 2008, VADOSE ZONE J, V7, P184, DOI 10.2136/vzj2006.0160; TOPP GC, 1980, WATER RESOUR RES, V16, P574, DOI 10.1029/WR016i003p00574; Bano M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026158; Blias E., 2006, CSEG RECORDER, V6, P24; Dix C. H., 1955, GEOPHYSICS, V20, P68, DOI DOI 10.1190/1.1438126; Feng X, 2009, IEEE GEOSCI REMOTE S, V6, P23, DOI 10.1109/LGRS.2008.2006634; Fetter C, 2001, APPL HYDROGEOLOGY; Fitts C.R, 2002, GROUNDWATER SCI; Gloaguen E, 2001, J APPL GEOPHYS, V47, P135, DOI 10.1016/S0926-9851(01)00057-X; Hudak P.F., 2004, PRINCIPLES HYDROGEOL; Idi B. Y., 2011, Asian Journal of Earth Sciences, V4, P193, DOI 10.3923/ajes.2011.193.202; Jacob RW, 2004, J ENVIRON ENG GEOPH, V9, P143; JICA (Japan International Cooperation Agency), 1995, STUD WAT SUPPL SYST; Kuroda S, 2009, J APPL GEOPHYS, V67, P361, DOI 10.1016/j.jappgeo.2008.07.005; Liu H, 2014, IEEE J-STARS, V7, P820, DOI 10.1109/JSTARS.2013.2266792; Liu H, 2014, NDT&E INT, V64, P65, DOI 10.1016/j.ndteint.2014.03.001; Lu Q, 2005, THESIS TOHOKU U SEND; Lu Q., 2007, INT J, V8, P83; Lu Q., 2002, THESIS TOHOKU U SEND; PNIIIS (Production & Research Institute for Engineering Construction Survey), 1977, INV WAT SUPPL NEAR U; Pyke K, 2008, J ENVIRON ENG GEOPH, V13, P335, DOI 10.2113/JEEG13.4.335; Rubin Y., 2005, HYDROGEOPHYSICS; SCHMUGGE TJ, 1980, IEEE T GEOSCI REMOTE, V18, P353, DOI 10.1109/TGRS.1980.350313; Seger M.A., 2011, ENG TECH J, V29, P554; Sheriff R. E., 1983, EXPLORATION SEISMOLO, V2; Steelman CM, 2012, J HYDROL, V436, P51, DOI 10.1016/j.jhydrol.2012.02.041; Theim G., 1906, HYDROLOGICAL METHODS; Ulaby F. T., 2001, FUNDAMENTALS APPL EL; Vacher H.L., 2004, GEOLOGY HYDROGEOLOGY; Yilmaz O, 2001, SEISMIC DATA ANAL PR; Zaki H., 1996, J APPL GEOPHYS, V36, P43	39	0	0	ENVIRONMENTAL ENGINEERING GEOPHYSICAL SOC	DENVER	1720 SOUTH BELLAIRE, STE 110, DENVER, CO 80222-433 USA	1083-1363			J ENVIRON ENG GEOPH	J. Environ. Eng. Geophys.	DEC	2014	19	4			SI		259	268		10.2113/JEEG19.4.259		10	Geochemistry & Geophysics; Engineering, Geological	Geochemistry & Geophysics; Engineering	AX5DG	WOS:000346946600006		
J	Skinner, JP; Mitani, Y; Burkanov, VN; Andrews, RD				Skinner, John P.; Mitani, Yoko; Burkanov, Vladimir N.; Andrews, Russel D.			Proxies of food intake and energy expenditure for estimating the time-energy budgets of lactating northern fur seals Callorhinus ursinus	JOURNAL OF EXPERIMENTAL MARINE BIOLOGY AND ECOLOGY			English	Article						Behavior; Biologging; Energetics; Marine mammals; Population trends; Telemetry	DOUBLY LABELED WATER; LIONS EUMETOPIAS-JUBATUS; FREE-LIVING ANIMALS; HEART-RATE; STOMACH TEMPERATURE; METABOLIC-RATE; FORAGING BEHAVIOR; OXYGEN-CONSUMPTION; PRIBILOF ISLANDS; PREY CONSUMPTION	Northern fur seal Callorhinus ursinus numbers on the Pribilof Islands have been in decline over the past two decades while numbers have increased at other sites, such as in the Kuril Islands in Russia and at Bogoslof Island in the Aleutian Islands. Although these divergent abundance trends remain unexplained, the potential influence of food limitations could be studied by examining the time-energy budgets of individual lactating fur seals. Our goal was to find suitable proxies for food intake and energy expenditure of lactating seals so that we might provide time and energy budgets of an increasing population on Lovushki Island, Russia that could be compared with the declining Pribilof fur seal population. Between 2005 and 2008, we outfitted 13 lactating fur seals with instruments that collected data on depth, external temperature, stomach temperature, GPS location, and acceleration. With these data we investigated proxies for 1) food intake, including time spent at sea, time spent diving, vertical travel distance (VTD), wiggle behavior, and changes in stomach temperature; 2) involuntary costs, including indices of basal metabolism (BMCI), thermal exposure, and instrument hydrodynamic drag (TAG); and 3) locomotive costs, including overall dynamic body acceleration (ODBA), horizontal travel distance, and flipper strokes. We also considered an index of work (WORK) calculated using horizontal distance, ODBA, and seal mass. Multimodel inference was used to determine which proxies best described changes in seal mass at sea when considering two sets of candidate models that differed by excluding or including locomotive costs (n = 13 and n = 7, respectively). Seal mass changes were positively associated with VTD and TAG and negatively associated with BMCI (p < 0.001, adjusted R-2 = 0.84) when locomotive proxies were excluded. With locomotive proxies considered, models were improved and mass changes were best described by being positively related to VTD and negatively associated with WORK (p < 0.001, adjusted R-2 = 0.95). We suggest that relative energy budgets for individual lactating northern fur seals could be compared using proxies for energetics that are easily monitored with standard data logging instruments. (C) 2014 Elsevier B.V. All rights reserved.	[Skinner, John P.; Andrews, Russel D.] Alaska SeaLife Ctr, Seward, AK 99664 USA; [Mitani, Yoko] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Hakodate, Hokkaido 0418611, Japan; [Burkanov, Vladimir N.] Natl Marine Mammal Lab, Seattle, WA 98115 USA; [Burkanov, Vladimir N.] RAS, Pacific Geog Inst, Kamchatka Branch, Petropavlovsk Kamchatski 683000, Russia; [Andrews, Russel D.] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK 99775 USA	Skinner, JP (reprint author), Alaska SeaLife Ctr, 301 Railway Ave,POB 1329, Seward, AK 99664 USA.	john.skinner@alaska.gov			National Oceanic and Atmospheric Administration; National Marine Mammal Laboratory; North Pacific Wildlife Consulting	We would like to thank our Russia field crew including V. Aderholt, A.V. Altukhov, R.V. Belobrov, V.A. Burkanova, N.N. Kutrukhin, D. Calkins, D. Holley, E.G. Mamaev, S.N. Norberg, D.S. Pasenyuk, P.A. Permyakov, S.Y. Purtov, O.V. Savenko, S.N. Sergeev, T.S. Shulezhko, A.A. Sychenko, A.V. Tret'yakov, and J.N. Waite. Funding was provided by the National Oceanic and Atmospheric Administration via grants to the Alaska SeaLife Center and the National Marine Mammal Laboratory, with additional funding and logistical support from North Pacific Wildlife Consulting. This work was authorized by the Alaska SeaLife Center Institutional Animal Care and Use Committee and conducted under permits from Russian permitting agencies: the Sakhalin Department of the Federal Fisheries Agency of Russia (Sakhalinrybvod), the Federal Veterinary and Agricultural Control Service (Rosselkhoznadzor, Sakhalin Region) and Sakhalin-Kuril Territorial Department of the Federal Committee of Fisheries of Russia (Goskomrybolovstvo). [SS]	Ancel A, 1997, J EXP BIOL, V200, P149; Williams TM, 2004, J EXP BIOL, V207, P973, DOI 10.1242/jeb.00822; Young BL, 2011, J EXP BIOL, V214, P2267, DOI 10.1242/jeb.047340; GOEBEL ME, 1991, FISH B-NOAA, V89, P171; Kuhn CE, 2009, J ANIM ECOL, V78, P513, DOI 10.1111/j.1365-2656.2008.01509.x; LIFSON N, 1955, J APPL PHYSIOL, V7, P704; Simeone A, 2003, MAR BIOL, V143, P825, DOI 10.1007/s00227-003-1114-8; Kuzin AE, 2010, RUSS J MAR BIOL+, V36, P507, DOI 10.1134/S1063074010070047; Halsey LG, 2009, COMP BIOCHEM PHYS A, V152, P197, DOI 10.1016/j.cbpa.2008.09.021; Kuhn CE, 2006, J EXP BIOL, V209, P4524, DOI 10.1242/jeb.02530; Boyd IL, 1997, BEHAV ECOL SOCIOBIOL, V40, P135, DOI 10.1007/s002650050326; Andrews RD, 1998, MAR ECOL PROG SER, V175, P289, DOI 10.3354/meps175289; Hedd A, 1996, POLAR BIOL, V16, P261, DOI 10.1007/s003000050053; Insley S. J., 2008, Endangered Species Research, V4, P147, DOI 10.3354/esr00050; Williams TM, 2000, SCIENCE, V288, P133, DOI 10.1126/science.288.5463.133; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Wilson RP, 2002, MAR BIOL, V140, P17, DOI 10.1007/s002270100659; Iwata T, 2012, MAR MAMMAL SCI, V28, P345, DOI 10.1111/j.1748-7692.2011.00482.x; Sterling JT, 2004, CAN J ZOOL, V82, P1621, DOI 10.1139/Z04-136; Bekkby T, 1998, MAR MAMMAL SCI, V14, P627, DOI 10.1111/j.1748-7692.1998.tb00750.x; Humphries MM, 2011, INTEGR COMP BIOL, V51, P419, DOI 10.1093/icb/icr059; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Hanuise N, 2010, J EXP BIOL, V213, P3874, DOI 10.1242/jeb.044057; COSTA DP, 1988, CAN J ZOOL, V66, P45; Elliott KH, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0919; Aoki K, 2011, J EXP BIOL, V214, P2973, DOI 10.1242/jeb.055137; Towell RG, 2006, MAR MAMMAL SCI, V22, P486, DOI 10.1111/j.1748-7692.2006.00026.x; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Heath RB, 1996, J ZOO WILDLIFE MED, V27, P35; Call KA, 2008, DEEP-SEA RES PT II, V55, P1883, DOI 10.1016/j.dsr2.2008.04-022; WILSON RP, 1992, J EXP BIOL, V167, P267; Suzuki I, 2009, POLAR BIOL, V32, P667, DOI 10.1007/s00300-009-0596-3; Bost CA, 2007, DEEP-SEA RES PT II, V54, P248, DOI 10.1016/j.dsr2.2006.11.007; BUTLER PJ, 1992, J EXP BIOL, V170, P35; Arnould JPY, 1996, J ZOOL, V239, P769; Baechler J, 2002, CAN J ZOOL, V80, P1569, DOI 10.1139/Z02-150; BOYD IL, 1995, FUNCT ECOL, V9, P151, DOI 10.2307/2390559; Boyd IL, 1999, AM J PHYSIOL-HEART C, V276, pH844; BURKANOV V, 2007, 17TH BIENNIAL CONFER; Burnham K. P., 2002, MODEL SELECTION AND; BUTLER PJ, 1984, J EXP BIOL, V108, P419; Core Team R, 2012, R LANG ENV STAT COMP; Costa Daniel P., 1999, P176; COSTA DP, 1984, PHYSIOL ZOOL, V57, P199; Costa D.P., 1986, P79; Dalton AJM, 2014, MAR MAMMAL SCI, V30, P994, DOI 10.1111/mms.12103; FADELY BS, 1990, J WILDLIFE MANAGE, V54, P246, DOI 10.2307/3809037; Fahlman A, 2013, AQUAT BIOL, V18, P175, DOI 10.3354/ab00500; Fahlman A, 2008, AQUAT BIOL, V2, P75, DOI 10.3354/ab00039; Green JA, 2009, J EXP BIOL, V212, P471, DOI 10.1242/jeb.026377; GREMILLET DJH, 1994, J EXP BIOL, V189, P105; Halsey LG, 2011, PHYSIOL BIOCHEM ZOOL, V84, P230, DOI 10.1086/658636; HAMPTON IFG, 1976, COMP BIOCHEM PHYS A, V55, P195, DOI 10.1016/0300-9629(76)90092-X; KLEIBER M, 1975, THE FIRE OF LIFE AN; Kuhn CE, 2011, MAR BIOL, V158, P649, DOI 10.1007/s00227-010-1589-z; Liwanag HEM, 2009, J EXP BIOL, V212, P3977, DOI 10.1242/jeb.033282; Liwanag HEM, 2010, PHYSIOL BIOCHEM ZOOL, V83, P898, DOI 10.1086/656426; Mazerolle M.J., 2013, ALCCMODAVG MODEL SEL; McPhee JM, 2003, J EXP BIOL, V206, P1941, DOI 10.1242/jeb.00369; MILLER LK, 1978, FINAL REPORT TO THE; NAGY KA, 1980, AM J PHYSIOL, V238, pR466; NAGY KA, 1984, ECOLOGY, V65, P1648, DOI 10.2307/1939143; Naito Yasuhiko, 2007, Polar Science, V1, P101, DOI 10.1016/j.polar.2007.10.001; *NAT MAR FISH SERV, 2007, CONSERVATION PLAN FO; REAM RR, 1999, FUR SEAL INVESTIGATI, P81; ROSEN DAS, 2013, MAR MAMMAL SCI, V30, P1014; Rosen DAS, 1997, COMP BIOCHEM PHYS A, V118, P877, DOI 10.1016/S0300-9629(97)00039-X; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Sala JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051487; Skinner John P., 2010, Endangered Species Research, V10, P61, DOI 10.3354/esr00236; Skinner JP, 2012, MAR ECOL PROG SER, V471, P293, DOI 10.3354/meps10038; Sparling CE, 2008, FUNCT ECOL, V22, P245, DOI 10.1111/j.1365-2435.2007.01368.x; Towell Rodney G., 2012, NOAA Technical Memorandum NMFS-AFSC, V241, P8; Venables W. N., 2002, MODEM APPLIED STATIS; WEISBERG S, 2005, APPLIED LINEAR REGRE; WILSON RP, 1995, J EXP BIOL, V198, P1115; YORK AE, 1981, CAN J FISH AQUAT SCI, V38, P84	77	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-0981	1879-1697		J EXP MAR BIOL ECOL	J. Exp. Mar. Biol. Ecol.	DEC	2014	461						107	115		10.1016/j.jembe.2014.08.002		9	Ecology; Marine & Freshwater Biology	Environmental Sciences & Ecology; Marine & Freshwater Biology	AX4HU	WOS:000346894900013		
J	Pfaller, JB; Alfaro-Shigueto, J; Giffoni, B; Ishihara, T; Mangel, JC; Peckham, SH; Bjomdal, KA; Baeza, JA				Pfaller, Joseph B.; Alfaro-Shigueto, Joanna; Giffoni, Bruno; Ishihara, Takashi; Mangel, Jeffrey C.; Peckham, S. Hoyt; Bjomdal, Karen A.; Baeza, J. Antonio			Social monogamy in the crab Planes major, a facultative symbiont of loggerhead sea turtles	JOURNAL OF EXPERIMENTAL MARINE BIOLOGY AND ECOLOGY			English	Article						Mating system evolution; Monogamy; Planes; Sea turtle; Symbiosis	CENTRAL NORTH PACIFIC; CARETTA-CARETTA; LEPIDOCHELYS-OLIVACEA; HOST CHARACTERISTICS; INACHUS-PHALANGIUM; INANIMATE FLOTSAM; SEXUAL SELECTION; SNAPPING SHRIMP; COLUMBUS CRABS; MATING SYSTEM	Studying how host characteristics and ecology affect the mating systems of symbiotic crustaceans offers an opportunity to understand how ecological factors contribute to the evolution of different animal mating systems. In theory, symbiotic crustaceans should display social monogamy with long-term heterosexual pairing when hosts are relatively small in body size and structurally simple, and when hosts have relatively low abundance in habitats where the risk of mortality for symbionts (e.g., predation) away from hosts is high. We test this prediction in the mating system of the flotsam crab (Planes major) and its facultative association with loggerhead sea turtles (Caretta caretta). First, we found that the overall population and sex distributions were non-random and crabs inhabited host turtles as heterosexual pairs more frequently than expected by chance, which supports the hypothesis that P. major is socially monogamous on C. caretta. Second, we found that male crabs pair with females regardless of their reproductive state, male-female pairs do not display size-assortative pairing, crab body size and host turtle body size are not correlated, and crabs display reverse sexual dimorphism in body size and conventional sexual dimorphism in weaponry. These results do not support the hypothesis that social monogamy in P. major is always long term. Instead, our results suggest that the duration of social monogamy in P. major is likely variable and may involve some degree of host switching and intra-sexual (mostly male-male) competition. Our results were only partially consistent with theoretical considerations for how host characteristics and ecology affect the mating systems of symbiotic crustaceans, and future studies should focus on quantifying the degree and direction of host switching to better understand the factors that affect the duration of monogamous pairing when P. major associates with C. caretta. (C) 2014 Elsevier B.V. All rights reserved.	[Pfaller, Joseph B.; Bjomdal, Karen A.] Univ Florida, Archie Carr Ctr Sea Turtle Res, Gainesville, FL 32611 USA; [Pfaller, Joseph B.; Bjomdal, Karen A.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Pfaller, Joseph B.] Caretta Res Project, Savannah, GA 31412 USA; [Alfaro-Shigueto, Joanna; Mangel, Jeffrey C.] ProDelphinus, Lima 18, Peru; [Alfaro-Shigueto, Joanna; Mangel, Jeffrey C.] Univ Exeter, Ctr Ecol & Conservat, Pentyn TR10 9EZ, Cornwall, England; [Giffoni, Bruno] Fdn ProTAMAR, BR-11680000 Ubatuba, SP, Brazil; Sea Turtle Assoc Japan, Osaka, Japan; [Peckham, S. Hoyt] Stanford Univ, Ctr Ocean Solut, Stanford, CA 94305 USA; [Baeza, J. Antonio] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Baeza, J. Antonio] Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL 34949 USA; [Baeza, J. Antonio] Univ Catalica Norte, Fac Ciencias Mar, Dept Marine Biol, Larrondo 1281, Coquimbo, Chile	Pfaller, JB (reprint author), Univ Florida, Archie Carr Ctr Sea Turtle Res, 220 Bartram Hall, Gainesville, FL 32611 USA.	jpfaller@ufl.edu; jas_26@yahoo.com; bruno@tamar.org.br; ishihara@umigame.org; jeffrey_mangel@yahoo.com; hoyt@propeninsula.org; bjorndal@ufl.edu; baeza.antonio@gmail.com					ADAMS J, 1985, CRUSTACEANA, V48, P188, DOI 10.1163/156854085X00882; Thiel M, 2003, J ZOOL, V261, P353, DOI 10.1017/S0952836903004333; Thiel M, 2001, SYMBIOSIS, V30, P163; Flores AAV, 2002, J MAR BIOL ASSOC UK, V82, P229, DOI 10.1017/S0025315402005404; Polovina JJ, 2000, FISH OCEANOGR, V9, P71, DOI 10.1046/j.1365-2419.2000.00123.x; Mathews LM, 2002, ANIM BEHAV, V63, P767, DOI 10.1006/anbe.2001.1976; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; De Bruyn C, 2009, MAR ECOL PROG SER, V375, P173, DOI 10.3354/meps07733; DIESEL R, 1986, ETHOLOGY, V72, P311; Baeza JA, 2011, J EXP MAR BIOL ECOL, V407, P41, DOI 10.1016/j.jembe.2011.07.011; Polovina JJ, 2004, FISH OCEANOGR, V13, P36, DOI 10.1046/j.1365-2419.2003.00270.x; Seminoff Jeffrey A., 2014, Endangered Species Research, V24, P207, DOI 10.3354/esr00601; Bjorndal KA, 2003, ECOLOGY, V84, P1237, DOI 10.1890/0012-9658(2003)084[1237:CGIOLS]2.0.CO;2; Baeza JA, 2013, J ZOOL, V289, P172, DOI 10.1111/j.1469-7998.2012.00974.x; HARTNOLL RG, 1978, CRUSTACEANA, V34, P281, DOI 10.1163/156854078X00844; Aucoin S, 2010, SYMBIOSIS, V50, P135, DOI 10.1007/s13199-010-0050-x; Baeza JA, 2008, MAR BIOL, V153, P387, DOI 10.1007/s00227-007-0815-9; Asakura A, 2009, DECAPOD CRUSTACEAN P, P121; Baeza Juan A., 1999, Revista de Biologia Marina y Oceanografia, V34, P303; Baeza JA, 2003, MAR BIOL, V142, P93, DOI 10.1007/s00227-002-0927-1; Baeza JA, 2007, REPROD SOCIAL BEHAV, P245; Baeza JA, 2010, NATURWISSENSCHAFTEN, V97, P729, DOI 10.1007/s00114-010-0689-4; Baeza JA, 2000, J MAR BIOL ASSOC UK, V80, P39; Carranza Alvar, 2003, Marine Turtle Newsletter, V102, P5; DAVENPORT J, 1992, J MAR BIOL ASSOC UK, V72, P611; Dellinger T, 1997, J MAR BIOL ASSOC UK, V77, P185; DIESEL R, 1988, J CRUSTACEAN BIOL, V8, P63, DOI 10.2307/1548431; Dodd Jr CK, 1988, 88 US FISH WILDL SER; Frick MG, 2004, J CRUSTACEAN BIOL, V24, P350, DOI 10.1651/C-2440; Frick MG, 2011, MAR BIOL, V158, P1699, DOI 10.1007/s00227-011-1684-9; Hamner WM, 1995, MAR FRESHW BEHAV PHY, V26, P71; Hartnoll R.G., 1982, P111; HARTNOLL R. G., 1963, PROC ZOOL SOC LONDON, V141, P423; KNOWLTON N, 1980, EVOLUTION, V34, P161; Peiro D.F., 2012, J MAR BIOL ASSOC UK, V93, P715; Pfaller J.B., 2014, MAR BIOL; PLACKETT RL, 1953, BIOMETRICS, V9, P485, DOI 10.2307/3001439; Pons M, 2011, CRUSTACEANA, V84, P425, DOI 10.1163/001121611X557064; Rodgers PJ, 2011, MAR BIOL, V158, P1733, DOI 10.1007/s00227-011-1687-6; Sakai T., 1969, Proceedings of the Biological Society of Washington, V82, P243; SHANKS AL, 1983, MAR ECOL PROG SER, V13, P311, DOI 10.3354/meps013311; Sokal RR, 1995, BIOMETRY; VANDERMEEREN GI, 1994, J ANIM ECOL, V63, P307; Wade M, 2003, MATING SYSTEMS STRAT	44	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-0981	1879-1697		J EXP MAR BIOL ECOL	J. Exp. Mar. Biol. Ecol.	DEC	2014	461						124	132		10.1016/j.jembe.2014.08.011		9	Ecology; Marine & Freshwater Biology	Environmental Sciences & Ecology; Marine & Freshwater Biology	AX4HU	WOS:000346894900015		
J	Nanjo, K; Kohno, H; Nakamura, Y; Horinouchi, M; Sano, M				Nanjo, Kusuto; Kohno, Hiroyoshi; Nakamura, Yohei; Horinouchi, Masahiro; Sano, Mitsuhiko			Effects of mangrove structure on fish distribution patterns and predation risks	JOURNAL OF EXPERIMENTAL MARINE BIOLOGY AND ECOLOGY			English	Article						Field experiment; Fish assemblage; Mangrove estuary; Predation risk; Root structure	CORAL-REEF FISH; COD GADUS-MORHUA; HABITAT COMPLEXITY; FIELD EXPERIMENT; UNVEGETATED MICROHABITATS; SEAGRASS HABITATS; JUVENILE FISH; FOOD; ASSEMBLAGES; ESTUARY	This study examined the effects of mangrove structure on fish distribution patterns and predation risks in southern Japan, utilizing field experiments in which artificial units mimicked mangrove root structure and canopy shade in a mangrove estuary. Fishes responded strongly to the different levels of root structure complexity but not to canopy shade, fish species richness and abundance being consistently higher in the units with roots than in those without roots, regardless of shade presence/absence. With increasing root density, fish abundance increased considerably, although with decreasing fish body size. A tethering experiment, employing the above units and the most abundant local fish Apogon amboinensis as representative of small fishes, revealed that the predation mortality rates of small fishes decrease with increasing root density. The results suggested that the sheltering effects provided by root structure against predators may be one of the most important factors determining the distribution patterns of mangrove-associated fishes, and at least partly explain the greater abundance of small-sized fishes in microhabitats with greater root densities. (C) 2014 Elsevier B.V. All rights reserved.	[Nanjo, Kusuto] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Kohno, Hiroyoshi] Tokai Univ, Okinawa Reg Res Ctr, Taketomi, Okinawa 9071541, Japan; [Nakamura, Yohei] Kochi Univ, Grad Sch Kuroshio Sci, Nanko Ku, Kochi 7838502, Japan; [Horinouchi, Masahiro] Shimane Univ, Res Ctr Coastal Lagoon Environm, Matsue, Shimane 6908504, Japan; [Sano, Mitsuhiko] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Nanjo, K (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan.	knanjo@aori.u-tokyo.ac.jp			Japan Society for the Promotion of Science [21380121]	We are grateful to Ken Sakihara, Akira Mizutani, Morito Toma, Masaki Jinno and the Okinawa Regional Research Center, Tokai University, for assistance in the fieldwork. Constructive comments on the manuscript from Graham Hardy and two anonymous reviewers were much appreciated. This study was funded by a Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (No. 21380121). [ST]	Nakamura Y, 2012, MAR BIOL, V159, P1305, DOI 10.1007/s00227-012-1911-z; Ellis WL, 2004, ESTUARIES, V27, P966, DOI 10.1007/BF02803423; SAVINO JF, 1982, T AM FISH SOC, V111, P255, DOI 10.1577/1548-8659(1982)111<255:PIBLBA>2.0.CO;2; Dahlgren CP, 2000, ECOLOGY, V81, P2227; Almany GR, 2004, OIKOS, V106, P275, DOI 10.1111/j.0030-1299.2004.13193.x; Tupper M, 1997, MAR ECOL PROG SER, V151, P225, DOI 10.3354/meps151225; Horinouchi M, 2009, MAR ECOL PROG SER, V377, P43, DOI 10.3354/meps07869; Dorenbosch M, 2009, MAR ECOL PROG SER, V379, P181, DOI 10.3354/meps07896; Horinouchi M, 2007, J EXP MAR BIOL ECOL, V350, P111, DOI 10.1016/j.jembe.2007.06.015; Sogard SM, 1997, B MAR SCI, V60, P1129; Kathiresan K, 2001, ADV MAR BIOL, V40, P81, DOI 10.1016/S0065-2881(01)40003-4; Laegdsgaard P, 2001, J EXP MAR BIOL ECOL, V257, P229, DOI 10.1016/S0022-0981(00)00331-2; Laurel BJ, 2003, MAR ECOL PROG SER, V251, P245, DOI 10.3354/meps251245; de la Moriniere EC, 2004, MAR BIOL, V144, P139, DOI 10.1007/s00227-003-1167-8; Manson FJ, 2005, OCEANOGR MAR BIOL, V43, P483; PETERSON CH, 1994, MAR ECOL PROG SER, V111, P289, DOI 10.3354/meps111289; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Wen CKC, 2013, J EXP MAR BIOL ECOL, V443, P39, DOI 10.1016/j.jembe.2013.02.027; Verweij MC, 2006, MAR ECOL PROG SER, V306, P257, DOI 10.3354/meps306257; Bartholomew A, 2002, ESTUARIES, V25, P1045, DOI 10.1007/BF02691351; Beukera JS, 1997, OECOLOGIA, V114, P50, DOI DOI 10.1007/S004420050419); BLABER S.J.M., 2000, TROPICAL ESTUARINE F; Curran MC, 1998, MAR ECOL PROG SER, V163, P45, DOI 10.3354/meps163045; FAO, 2007, 153 FAO; Gotceitas V, 1997, CAN J FISH AQUAT SCI, V54, P1306, DOI 10.1139/cjfas-54-6-1306; Horinouchi M, 2013, MAR ECOL PROG SER, V488, P255, DOI 10.3354/meps10396; Horinouchi M, 2007, ESTUAR COAST SHELF S, V72, P657, DOI 10.1016/j.ecss.2006.11.025; Horinouchi M, 2009, ICHTHYOL RES, V56, P109, DOI 10.1007/s10228-008-0070-1; Lindholm JB, 1999, MAR ECOL PROG SER, V180, P247, DOI 10.3354/meps180247; MacDonald JA, 2008, ESTUAR COAST, V31, P981, DOI 10.1007/s12237-008-9083-2; Nagelkerken I, 2010, J EXP MAR BIOL ECOL, V396, P27, DOI 10.1016/j.jembe.2010.10.002; Nanjo K, 2014, FISHERIES SCI, V80, P21, DOI 10.1007/s12562-013-0682-x; Nanjo K, 2008, FISHERIES SCI, V74, P1024, DOI 10.1111/j.1444-2906.2008.01620.x; Nanjo K, 2011, J EXP MAR BIOL ECOL, V405, P53, DOI 10.1016/j.jembe.2011.05.016; Robertson A.I., 1992, TROPICAL MANGROVE EC, P173; Rosenfeld JS, 2001, CAN J FISH AQUAT SCI, V58, P585, DOI 10.1139/cjfas-58-3-585; Shinnaka T, 2007, FISHERIES SCI, V73, P862, DOI 10.1111/j.1444-2906.2007.01407.x; Underwood A.J., 1981, Oceanography and Marine Biology an Annual Review, V19, P513; ZWEIMULLER I, 1995, HYDROBIOLOGIA, V303, P125, DOI 10.1007/BF00034050	39	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-0981	1879-1697		J EXP MAR BIOL ECOL	J. Exp. Mar. Biol. Ecol.	DEC	2014	461						216	225		10.1016/j.jembe.2014.08.014		10	Ecology; Marine & Freshwater Biology	Environmental Sciences & Ecology; Marine & Freshwater Biology	AX4HU	WOS:000346894900026		
J	Taniguchi, A; Yoshida, T; Eguchi, M				Taniguchi, Akito; Yoshida, Takashi; Eguchi, Mitsuru			Bacterial production is enhanced by coral mucus in reef systems	JOURNAL OF EXPERIMENTAL MARINE BIOLOGY AND ECOLOGY			English	Article						H-3-thymidine; H-3-leucine; Bacterial production; Coral mucus; Growth enhancement	DISSOLVED ORGANIC-CARBON; RELEASE; GROWTH; ENVIRONMENTS; PARTICULATE; POPULATIONS; ENRICHMENT; NITROGEN	Coral mucus influences the abundance and composition of microbes in the surrounding seawater. Here, the hypothesis that the mucus of the coral genera Acropora, Favia, Favites, and Goniastrea would influence bacterial growth (production) in seawater (measured using 3H-thymidine and 3H-leucine incorporation methods) was tested. The bacterial production in mucus-supplemented seawater was significantly greater than that in unsupplemented seawater: production in the mucus-supplemented seawater ranged from 108.2 to 4111 mu g C.L-1.d(-1) when measured by thymidine incorporation and from 72.9 to 115.9 mu g C.L-1.d(-1) when measured by leucine incorporation. This study showed that the enhanced production may be due to bacteria originating from seawater and not from coral mucus. Nonetheless, the effect of mucus on bacterial production was different among the coral genera: the mucus of Favia did not always enhance bacterial production. Additionally, even a very small amount of coral mucus, only similar to 300 mu L. of mucus per liter of seawater, was sufficient to enhance bacterial production by approximately 2-fold compared to unsupplemented seawater. These results suggest that coral mucus has a significant impact on the marine biogeochemical cycle around coral reefs. (C) 2014 Elsevier B.V. All rights reserved.	[Taniguchi, Akito; Eguchi, Mitsuru] Kinki Univ, Fac Agr, Nara 6318505, Japan; [Yoshida, Takashi] Kinki Univ, Grad Sch Agr, Nara 6318505, Japan	Eguchi, M (reprint author), Kinki Univ, Fac Agr, 3327-204 Naka Machi, Nara 6318505, Japan.	eguchi@nara.kindai.ac.jp			Global COE program "International education and research center for aquaculture science of bluefin tuna and other cultured fish", JSPS KAKENHI [23658168]; "The Strategic Project to Support the Formation of Research Infrastructure at Private Universities: A Matching Fund Subsidy" from MEXT [S1412003]	The authors would like to thank Shogo Takii, Tatsuya Kasai, and Ken Nakanishi for their assistance during sampling and radioisotope analysis. This work was supported by the Global COE program "International education and research center for aquaculture science of bluefin tuna and other cultured fish", JSPS KAKENHI grant number 23658168, and in part by "The Strategic Project to Support the Formation of Research Infrastructure at Private Universities: A Matching Fund Subsidy" from MEXT (S1412003).[SS]	Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Fukuda R, 1998, APPL ENVIRON MICROB, V64, P3352; Kirchman D, 2001, METHOD MICROBIOL, V30, P227, DOI 10.1016/S0580-9517(01)30047-8; Bythell JC, 2011, J EXP MAR BIOL ECOL, V408, P88, DOI 10.1016/j.jembe.2011.07.028; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; Wild C, 2005, MAR ECOL PROG SER, V287, P87, DOI 10.3354/meps287087; DUCKLOW HW, 1979, LIMNOL OCEANOGR, V24, P715; Allers E, 2008, APPL ENVIRON MICROB, V74, P3274, DOI 10.1128/AEM.01870-07; HERNDL GJ, 1986, MAR BIOL, V90, P363, DOI 10.1007/BF00428560; Tanaka Y, 2008, B MAR SCI, V82, P237; Shiah FK, 1997, AQUAT MICROB ECOL, V13, P151, DOI 10.3354/ame013151; Nakajima R, 2010, B MAR SCI, V86, P861, DOI 10.5343/bms.2009.1069; Wild C, 2004, NATURE, V428, P66, DOI 10.1038/nature02344; Brown BE, 2005, MAR ECOL PROG SER, V296, P291, DOI 10.3354/meps296291; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943; Wegley L, 2007, ENVIRON MICROBIOL, V9, P2707, DOI 10.1111/j.1462-2920.2007.01383.x; Naumann MS, 2010, CORAL REEFS, V29, P649, DOI 10.1007/s00338-010-0612-7; MEIKLE P, 1988, MAR BIOL, V99, P187, DOI 10.1007/BF00391980; Shnit-Orland M, 2009, FEMS MICROBIOL ECOL, V67, P371, DOI 10.1111/j.1574-6941.2008.00644.x; Garren M, 2010, APPL ENVIRON MICROB, V76, P6128, DOI 10.1128/AEM.01100-10; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Nakajima R, 2009, AQUAT ECOL, V43, P815, DOI 10.1007/s10452-008-9210-y; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Ferrier-Pages C, 2000, AQUAT MICROB ECOL, V21, P203, DOI 10.3354/ame021203; Krediet CJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2328; MORIARTY DJW, 1985, MAR BIOL, V85, P285, DOI 10.1007/BF00393249; Nakajima R, 2013, MAR ECOL PROG SER, V490, P11, DOI 10.3354/meps10481; RUBLEE PA, 1980, B MAR SCI, V30, P888; Tanaka Y, 2011, CORAL REEFS, V30, P443, DOI 10.1007/s00338-011-0729-3; Tanaka Y, 2010, CORAL REEFS, V29, P675, DOI 10.1007/s00338-010-0639-9; Tanaka Y., 2008, 11 INT COR REEF S FT, P945	31	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-0981	1879-1697		J EXP MAR BIOL ECOL	J. Exp. Mar. Biol. Ecol.	DEC	2014	461						331	336		10.1016/j.jembe.2014.09.004		6	Ecology; Marine & Freshwater Biology	Environmental Sciences & Ecology; Marine & Freshwater Biology	AX4HU	WOS:000346894900039		
J	Shishimi, T; Hara, S				Shishimi, Toru; Hara, Shoji			BrF3-KHF2: An air-stable fluorinating reagent	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Stable fluorinating reagent; KHF2; BrF3; Desulfurizing fluorination	GLYCOSYL FLUORIDES; ORGANIC-MOLECULES; SYNTHETIC METHODS; CHEMISTRY; DIFLUOROMETHYLATION; THIOGLYCOSIDES; TRIFLUORIDE; ALDEHYDES; IODIDES; LIQUID	BrF3-KHF2, an air-stable solid prepared from BrF3 and KHF2, was used in the various fluorination reactions, including desulfurizing fluorination reactions of benzylic sulfides, ketone and aldehyde dithioacetals, (phenylthio)glycosides, and trimethyl trithioorthocarboxylates. As the results, one to three fluorine atoms were selectively introduced to the substrates. (C) 2014 Elsevier B.V. All rights reserved.	[Shishimi, Toru; Hara, Shoji] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan	Hara, S (reprint author), Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan.	shara@eng.hokudai.ac.jp					Anderson R.F., 1979, ORGANOFLUORINE CHEM, P123; Lopez JC, 2007, J ORG CHEM, V72, P10268, DOI 10.1021/jo7018653; Suzuki K, 2012, CARBOHYD RES, V359, P81, DOI 10.1016/j.carres.2012.07.003; Prakash GKS, 2012, ANGEW CHEM INT EDIT, V51, P12090, DOI 10.1002/anie.201205850; Singh RP, 2004, ACCOUNTS CHEM RES, V37, P31, DOI 10.1021/ar030043v; Fujikawa K, 2011, ORG LETT, V13, P5560, DOI 10.1021/ol202289z; Fuchigami T, 2011, CHEM COMMUN, V47, P10211, DOI 10.1039/c1cc12414e; Kirk KL, 2008, ORG PROCESS RES DEV, V12, P305, DOI 10.1021/op700134j; Hara S, 2012, TETRAHEDRON, V68, P10145, DOI 10.1016/j.tet.2012.09.104; Rozen S, 2010, ADV SYNTH CATAL, V352, P2691, DOI 10.1002/adsc.201000482; Al-Maharik N, 2011, ALDRICHIM ACTA, V44, P65; Kuroboshi M, 2001, ADV SYNTH CATAL, V343, P235, DOI 10.1002/1615-4169(20010330)343:3<235::AID-ADSC235>3.0.CO;2-0; Rapp M, 2009, J FLUORINE CHEM, V130, P321, DOI 10.1016/j.jfluchem.2008.12.004; Toshima K, 2000, CARBOHYD RES, V327, P15, DOI 10.1016/S0008-6215(99)00325-0; Tsegay S, 2012, CARBOHYD RES, V357, P16, DOI 10.1016/j.carres.2012.04.016; Shimizu M, 2005, ANGEW CHEM INT EDIT, V44, P214, DOI 10.1002/anie.200460441; Sawamura T, 2010, ADV SYNTH CATAL, V352, P2757, DOI 10.1002/adsc.201000501; Mugunthan G, 2012, TETRAHEDRON LETT, V53, P5631, DOI 10.1016/j.tetlet.2012.08.024; BARBERO M, 1988, SYNTHESIS-STUTTGART, P22; Bastos MM, 2008, J HETEROCYCLIC CHEM, V45, P969; CHRISTE KO, 1970, INORG CHEM, V9, P1852, DOI 10.1021/ic50090a015; Furuya T, 2005, J FLUORINE CHEM, V126, P721, DOI 10.1016/j.jfluchem.2005.02.004; Hara S, 2006, ADV ORGANIC SYNTHESI, P49; Hiyama T., 2000, ORGANOFLUORINE COMPO, P183; Hugenberg V, 2012, J FLUORINE CHEM, V143, P238, DOI 10.1016/j.jfluchem.2012.06.015; Kirsch P., 2004, MODERN FLUOROORGANIC, P203; Kunigami M., 2014, J FLUORINE CHEM; Mukaiyama T, 2004, ANGEW CHEM INT EDIT, V43, P5590, DOI 10.1002/anie.200300641; NICOLAOU KC, 1984, J AM CHEM SOC, V106, P4189, DOI 10.1021/ja00327a021; Nyffeler PT, 2005, ANGEW CHEM INT EDIT, V44, P192, DOI 10.1002/anie.200400648; OLAH GA, 1974, J AM CHEM SOC, V96, P925, DOI 10.1021/ja00810a052; RAY FE, 1948, J AM CHEM SOC, V70, P1954, DOI 10.1021/ja01185a091; Reddy V.P., 2006, ADV ORGANIC SYNTHESI, P183; Rozen S, 2005, ACCOUNTS CHEM RES, V38, P803, DOI 10.1021/ar040270c; Shimizu M, 1998, SYNTHESIS-STUTTGART, P799; SIEGEL S, 1956, ACTA CRYSTALLOGR, V9, P493, DOI 10.1107/S0365110X56001340; Singh RP, 2002, SYNTHESIS-STUTTGART, P2561; SZAREK WA, 1984, CHEM LETT, P1751, DOI 10.1246/cl.1984.1751; Uneyama K., 2006, ORGANOFLUORINE CHEM; WILSON WW, 1989, INORG CHEM, V28, P4172, DOI 10.1021/ic00321a027	40	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	DEC	2014	168						55	60		10.1016/j.jfluchem.2014.08.019		6	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	AX6FT	WOS:000347019300009		
J	Iida, N; Tokunaga, E; Saito, N; Shibata, N				Iida, Norihito; Tokunaga, Etsuko; Saito, Norimichi; Shibata, Norio			Synthesis and property of novel phthalocyanine having a 3,5-bis-pentafluorosulfanylphenyl group on the alpha-peripheral position	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Fluorine; Pentafluorosulfanyl; Phthalocyanine; Aggregation; Trifluoromethyl	HYPERVALENT SULFUR FLUORIDES; ZINC PHTHALOCYANINES; PHENYL DERIVATIVES; METAL-FREE; OXIDATION; PHTHALONITRILES; PENTAFLUOROSULFANYL; ALCOHOLS	The pentafluorosulfanyl (SF5) group is bulky, highly lipophilic, highly electronegative, and highly stable. Despite the potential use of SF5-containing phthalocyanines, no example exists. We herein report the synthesis of 3,5-bis-pentafluorosulfanylphenyl ((SF5)(2)Ph)-Substituted phthalocyanine onto the alpha-peripheral position for the first time. Regioselective synthesis was possible by the effect of the SF5 moiety via macrocyclization. The synthesis of phthalocyanines with CF3 and H instead of SF5 was also carried out in order to investigate the effect of SF5. Phthalocyanines were compared using UV/Vis spectra. Phthalocyanine with SF5 exists free from aggregation and protonation in dichloromethane solution. The two planes of 3,5-(SF5)(2)Ph and parent Pc ring in space are nearly perpendicular at which they meet is a right angle, while the two planes of CF3 analogue in space are not. (C) 2014 Elsevier B.V. All rights reserved.	[Iida, Norihito; Shibata, Norio] Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan; [Tokunaga, Etsuko; Shibata, Norio] Nagoya Inst Technol, Dept Nanopharmaceut Sci, Showa Ku, Nagoya, Aichi 4668555, Japan; [Saito, Norimichi] Ube Ind Ltd, Div Pharmaceut, Minato Ku, Tokyo 1058449, Japan	Shibata, N (reprint author), Nagoya Inst Technol, Dept Frontier Mat, Showa Ku, Nagoya, Aichi 4668555, Japan.	nozshiba@nitech.ac.jp			MEXT Japan; JSPS [25288045, 25670055]	This research was financially supported in part by the Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT Japan, JSPS Grand-in-Aid Scientific Research (B) (25288045) and JSPS Grand-in-Aid for Exploratory Research (25670055).	Geraskin IM, 2008, TETRAHEDRON LETT, V49, P7410, DOI 10.1016/j.tetlet.2008.10.060; SHEPPARD WA, 1962, J AM CHEM SOC, V84, P3072, DOI 10.1021/ja00875a007; Paradine SM, 2012, J AM CHEM SOC, V134, P2036, DOI 10.1021/ja211600g; Yoshiyama H, 2009, ORG BIOMOL CHEM, V7, P2265, DOI 10.1039/b902905b; Kobayashi N, 2001, J AM CHEM SOC, V123, P10740, DOI 10.1021/ja0113753; Reddy MR, 2006, ANGEW CHEM INT EDIT, V45, P8163, DOI 10.1002/anie.200603590; Ranta J, 2010, J ORG CHEM, V75, P5178, DOI 10.1021/jo100766h; Allen CM, 2001, J PORPHYR PHTHALOCYA, V5, P161, DOI 10.1002/jpp.324; Altomonte S, 2012, J FLUORINE CHEM, V143, P57, DOI 10.1016/j.jfluchem.2012.06.030; Wipf P, 2009, ORG BIOMOL CHEM, V7, P4163, DOI 10.1039/b911483a; Pozzi G, 2011, J PHYS CHEM C, V115, P3777, DOI 10.1021/jp109846k; Kobayashi N, 2003, CHEM-EUR J, V9, P5123, DOI 10.1002/chem.200304834; Sharma U, 2012, GREEN CHEM, V14, P2289, DOI 10.1039/c2gc35452g; Lim DS, 2007, J PESTIC SCI, V32, P255, DOI 10.1584/jpestics.G06-50; Stump B, 2009, CHEMBIOCHEM, V10, P79, DOI 10.1002/cbic.200800565; Sharma VB, 2003, TETRAHEDRON LETT, V44, P383, DOI 10.1016/S0040-4039(02)02453-X; Aranyos V, 1999, ACTA CHEM SCAND, V53, P714, DOI 10.3891/acta.chem.scand.53-0714; Banks R.E., 1979, ORGANOFLUORINE CHEM; Bench BA, 2002, ANGEW CHEM INT EDIT, V41, P750, DOI 10.1002/1521-3773(20020301)41:5<750::AID-ANIE750>3.0.CO;2-6; Bench Barbara A, 2002, Angew Chem Int Ed Engl, V41, P747, DOI 10.1002/1521-3773(20020301)41:5<747::AID-ANIE747>3.0.CO;2-J; BERNSTEIN PA, 1992, INORG CHIM ACTA, V198, P543, DOI 10.1016/S0020-1693(00)92398-3; Colonna S, 2001, EUR J ORG CHEM, P181; Derkacheva V.M., 1981, J GEN CHEM USSR, V51, P1998; Fukuda T, 2005, CHEM-EUR J, V11, P5205, DOI 10.1002/chem.200500176; Gerdes R., 2009, DALTON T, V38, P1098; Gorlach B, 2001, CHEM-EUR J, V7, P2459, DOI 10.1002/1521-3765(20010601)7:11<2459::AID-CHEM24590>3.0.CO;2-4; Gorun SM, 1998, J FLUORINE CHEM, V91, P37, DOI 10.1016/S0022-1139(98)00206-1; Gregory P., 2000, J PORPHYR PHTHALOCYA, V4, P43; Kadish K.M., 2010, HDB PORPHYRIN SCI, P1; Kadish K.M., 1999, PORPHYRIN HDB, V1-20, P2003; Kirsch P, 2006, EUR J ORG CHEM, P1125, DOI 10.1002/ejoc.200500715; Kirsch P, 1999, ANGEW CHEM INT EDIT, V38, P1989, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1989::AID-ANIE1989>3.0.CO;2-K; Lee HJ, 2003, CHEM COMMUN, P1576, DOI 10.1039/b303035k; Levedev O.L., 1971, OPT SPECTROSC, V30, P347; Nixon PG, 2000, CHEM MATER, V12, P3108, DOI 10.1021/cm000339k; Selivanova GA, 2011, RUSS J ORG CHEM+, V47, P1240, DOI 10.1134/S1070428011080215; Shibata N, 2014, CHEM COMMUN, V50, P3040, DOI 10.1039/c3cc49831j; Shinu VS, 2011, TETRAHEDRON LETT, V52, P3110, DOI 10.1016/j.tetlet.2011.04.016; Stuzhin PA, 1999, J PORPHYR PHTHALOCYA, V3, P500; Sugimori T, 2000, CHEM LETT, P1200, DOI 10.1246/cl.2000.1200; Sugimori T, 2002, INORG CHEM COMMUN, V5, P1031, DOI 10.1016/S1387-7003(02)00636-6; Thayer AM, 2006, CHEM ENG NEWS, V84, P27; Torre G., 2007, CHEM COMMUN, V43, P2000; Yoshiyama H, 2008, CHEM COMMUN, P1977, DOI 10.1039/b800918j	44	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	DEC	2014	168						93	98		10.1016/j.jfluchem.2014.09.012		6	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	AX6FT	WOS:000347019300014		
J	Ozawa, TC; Naka, T; Matsushita, A; Kauzlarich, SM; Sasaki, T				Ozawa, Tadashi C.; Naka, Takashi; Matsushita, Akiyuki; Kauzlarich, Susan M.; Sasaki, Takayoshi			Chemical composition and magnetic property modifications of Na2Ti2Sb2O using PTFE as an alkali-metal ion extraction reagent	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Deintercalation; PTFE; AEP; Superconductivity; Ferromagnetism; Layered compound	PNICTIDE OXIDE; LAYERED SUPERCONDUCTOR; DENSITY-WAVE; FERROMAGNETISM; TRANSITION; COMPOUND; BEHAVIOR	Na+ extraction from Na2Ti2Sb2O has been attempted using polytetrafluoroethylene (PTFE; empirical formula CF2) as the extraction reagent. Systematic increase in both lattice parameters a along the intralayer direction and c along the interlayer direction was observed with respect to the reacted PTFE amounts, suggesting the successful deintercalation of the interlayer Na+. In addition, ferromagnet-like behavior, which is rare for systems consisting of ions with low magnetic moments, such as Ti3+(d(1)), was observed in the Ne-deintercalated Na2Ti2Sb2O. This result suggests that the method of alkali-metal ion extraction using polytetrafluoroethylene as an extraction reagent (AEP) can be utilized in order to induce interesting and important properties in compounds including highly air- and solvent-sensitive mixed-anion compounds such as Na2Ti2Sb2O. (C) 2014 Elsevier B.V. All rights reserved.	[Ozawa, Tadashi C.; Sasaki, Takayoshi] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050044, Japan; [Ozawa, Tadashi C.; Sasaki, Takayoshi] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan; [Naka, Takashi] Natl Inst Mat Sci, Mat Proc Unit, Tsukuba, Ibaraki 3050047, Japan; [Matsushita, Akiyuki] Natl Inst Mat Sci, Environm Remediat Mat Unit, Tsukuba, Ibaraki 3050047, Japan; [Kauzlarich, Susan M.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	Ozawa, TC (reprint author), Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	ozawa.tadashi@nims.go.jp			JSPS KAKENHI [24550087]; CREST of JST; World Premier International Research Center Initiative on Materials Nanoarchitectonics (WPI-MANA); MEXT, Japan	We thank H. Kitazawa for use of the SQUID magnetometer. This work was supported by JSPS KAKENHI Grant Number 24550087, CREST of JST, and World Premier International Research Center Initiative on Materials Nanoarchitectonics (WPI-MANA), MEXT, Japan.	Liu RH, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.144516; Ponhan W, 2014, J ALLOY COMPD, V606, P182, DOI 10.1016/j.jallcom.2014.03.113; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Yajima T, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.103706; TERHAAR LW, 1987, PHYS REV B, V35, P1932, DOI 10.1103/PhysRevB.35.1932; Takahashi H, 2008, NATURE, V453, P376, DOI 10.1038/nature06972; Ozawa TC, 2000, J SOLID STATE CHEM, V153, P275, DOI 10.1006/jssc.2000.8758; SUNSTROM JE, 1993, CHEM MATER, V5, P1539, DOI 10.1021/cm00034a026; Kamihara Y, 2006, J AM CHEM SOC, V128, P10012, DOI 10.1021/ja063355c; Ozawa TC, 2004, J CRYST GROWTH, V265, P571, DOI 10.1016/j.jcrysgro.2004.02.099; Ozawa TC, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/3/033003; ADAM A, 1990, Z ANORG ALLG CHEM, V584, P150, DOI 10.1002/zaac.19905840115; Xu K, 2013, ANGEW CHEM INT EDIT, V52, P10477, DOI 10.1002/anie.201304337; Appleman D.E., 1973, PB NATL TECHNICAL IN, P60; Axtell EA, 1997, J SOLID STATE CHEM, V134, P423, DOI 10.1006/jssc.1997.7715; Doan P, 2012, J AM CHEM SOC, V134, P16520, DOI 10.1021/ja3078889; KINOSHITA M, 1994, JPN J APPL PHYS 1, V33, P5718, DOI 10.1143/JJAP.33.5718; Maazaz A., 1983, J INCLUSION PHENOM, V1, P45, DOI 10.1007/BF00658014; Nakano K, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.074707; Ozawa TC, 2014, DALTON T, V43, P14902, DOI 10.1039/c4dt01869a; Ozawa TC, 2010, INORG CHEM, V49, P3044, DOI 10.1021/ic1000182; Ozawa TC, 2001, CHEM MATER, V13, P1804, DOI 10.1021/cm010009r; Ozawa TC, 2012, INORG CHEM, V51, P7317, DOI 10.1021/ic3006986; Yajima T, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.013703	24	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	DEC	2014	168						189	192		10.1016/j.jfluchem.2014.09.028		4	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	AX6FT	WOS:000347019300028		
J	Hori, A; Takeda, H; Premkumar, JR; Sastry, GN				Hori, Akiko; Takeda, Haruhi; Premkumar, J. Richard; Sastry, G. Narahari			1:1 and 2:1 cocrystallizations of alkoxy-substituted naphthalene derivatives with octafluoronaphthalene through arene-perfluoroarene interactions	JOURNAL OF FLUORINE CHEMISTRY			English	Article						Cocrystal; Computational study; Molecular recognitions	PHENYL-PERFLUOROPHENYL STACKING; PI-PI INTERACTIONS; PHASE-BEHAVIOR; BIOLOGICAL RECOGNITION; AROMATIC RINGS; CATION-PI; BENZENE; COMPLEX; MOLECULES; FLUORINE	Naphthalene derivatives with laterally orientated short side chains readily form cocrystals with octafluoronaphthalene in which the position and the length of the lateral chain can control the 1:1 and 2:1 cocrystallization stoichiometries and overlapped areas of the Pi-planes, showing that the systematic substitution patterns in the chains of molecules can be exploited to rationally designed cocrystals. (C) 2014 Elsevier B.V. All rights reserved.	[Hori, Akiko; Takeda, Haruhi] Kitasato Univ, Sch Sci, Dept Chem, Minami Ku, Sagamihara, Kanagawa 2520373, Japan; [Premkumar, J. Richard; Sastry, G. Narahari] CSIR, Indian Inst Chem Technol, Ctr Mol Modelling, Hyderabad 500607, Andhra Pradesh, India	Hori, A (reprint author), Kitasato Univ, Sch Sci, Dept Chem, Minami Ku, Kitasato 1-15-1, Sagamihara, Kanagawa 2520373, Japan.	hori@kitasato-u.ac.jp			INTELCOAT [CSC-0114]; DST, New Delhi [SR/S1/PC-58/2009]	A.H thank Prof. Hidetaka Yuge and Mr. Yuuki Akimoto of Kitasato University for valuable discussion and helpful supports. G.N.S and J.R.P thank CSIR, New Delhi for 12th five year project INTELCOAT (CSC-0114) and DST, New Delhi for funding the project (SR/S1/PC-58/2009).	Parthasarathi R, 2006, J PHYS CHEM A, V110, P3349, DOI 10.1021/jp060571z; Grabowski SJ, 2006, J PHYS CHEM B, V110, P6444, DOI 10.1021/jp0600817; Muller-Dethlefs K, 2000, CHEM REV, V100, P143, DOI 10.1021/cr9900331; Umadevi D, 2011, J PHYS CHEM LETT, V2, P1572, DOI 10.1021/jz200705w; Chourasia M, 2011, INT J BIOL MACROMOL, V48, P540, DOI 10.1016/j.ijbiomac.2011.01.008; Moulton B, 2001, CHEM REV, V101, P1629, DOI 10.1021/cr9900432; Sinnokrot MO, 2006, J PHYS CHEM A, V110, P10656, DOI 10.1021/jp0610416; Reichenbacher K, 2005, CHEM SOC REV, V34, P22, DOI 10.1039/b406892k; Watt SW, 2004, ANGEW CHEM INT EDIT, V43, P3061, DOI 10.1002/anie.200453828; Kilbinger AFM, 2002, ANGEW CHEM INT EDIT, V41, P1563, DOI 10.1002/1521-3773(20020503)41:9<1563::AID-ANIE1563>3.0.CO;2-7; Grimme S, 2008, ANGEW CHEM INT EDIT, V47, P3430, DOI 10.1002/anie.200705157; Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319; Vijay D, 2010, CHEM PHYS LETT, V485, P235, DOI 10.1016/j.cplett.2009.12.012; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Salonen LM, 2011, ANGEW CHEM INT EDIT, V50, P4808, DOI 10.1002/anie.201007560; Coates GW, 1997, ANGEW CHEM INT EDIT, V36, P248, DOI 10.1002/anie.199702481; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; Bader R F W, 1990, ATOMS MOL QUANTUM TH; Biegler-Konig F., 2002, AIM2000; Dai CY, 1999, CHEM COMMUN, P2493, DOI 10.1039/a906199a; Desiraju G.R., 2003, CRYSTAL DESIGN STRUC, V7; Durmus Z., 2009, SYNTHETIC MET, V159, P1563; Fasina TM, 2004, J MATER CHEM, V14, P2395, DOI 10.1039/b405128a; Frisch M. J., 2009, GAUSSIAN 09 REVISION; HOBZA P, 1994, CHEM REV, V94, P1767, DOI 10.1021/cr00031a002; Hori A., 2012, IMPORTANCE PI INTERA, P163; Hori A, 2007, CRYSTENGCOMM, V9, P215, DOI 10.1039/b617808a; Hori A, 2007, ANGEW CHEM INT EDIT, V46, P7617, DOI 10.1002/anie.200702662; Kim M, 2008, J AM CHEM SOC, V130, P6332, DOI 10.1021/ja801626c; Mahadevi A.S., 2010, J CHEM PHYS, V133; POTENZA J, 1975, ACTA CRYSTALLOGR B, V31, P1975, DOI 10.1107/S0567740875006619; Premkumar JR, 2012, DALTON T, V41, P4965, DOI 10.1039/c2dt30119a; PATRICK CR, 1960, NATURE, V187, P1021, DOI 10.1038/1871021a0; Sheldrick G. M., 1997, SHELXL 97 PROGRAM CR; Sheldrick G.M., 1996, SADABS EMPIRICAL ADS; Vangala VR, 2002, CHEM COMMUN, P1304, DOI 10.1039/b202181a; WILLIAMS JH, 1993, ACCOUNTS CHEM RES, V26, P593, DOI 10.1021/ar00035a005	37	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-1139	1873-3328		J FLUORINE CHEM	J. Fluor. Chem.	DEC	2014	168						193	197		10.1016/j.jfluchem.2014.09.025		5	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	AX6FT	WOS:000347019300029		
J	Tamashiro, H; Yoshino, M				Tamashiro, Hirotake; Yoshino, Masami			Signaling pathway underlying the octopaminergic modulation of myogenic contraction in the cricket lateral oviduct	JOURNAL OF INSECT PHYSIOLOGY			English	Article						IP3 receptor; Ryanodine receptor; Cricket; Lateral oviduct; Myogenic contraction	INSECT VISCERAL MUSCLE; LOCUST SCHISTOCERCA-GREGARIA; MIGRATORIA; RECEPTORS; MYOCYTES; CALCIUM; ADENOSINE-3',5'-MONOPHOSPHATE; NEUROMODULATOR; SEROTONIN; FOREGUT	Octopamine (OA), a biogenic monoamine, is a neurotransmitter and neuromodulator in invertebrates. Here, we report the effect of OA on the spontaneous rhythmic contractions (SRCs) of the lateral oviduct of the cricket Gryllus bimaculatus and the possible signaling pathway involved. Application of OA increased both the frequency and amplitude of SRCs in a dose-dependent manner. The effect of OA was inhibited by subsequent application of the OA receptor antagonist epinastine, indicating that the action of OA is mediated by OA receptor. To investigate the predominant signaling pathway underlying the action of OA, we first examined a possible involvement of the cAMP/cAMP-dependent protein kinase A (PKA) signaling pathway. Application of the membrane-permeable CAMP analog 8-Br-cAMP had little effect on SRCs and the effect of OA was not influenced by subsequent application of the PKA inhibitor H89, indicating that the cAMP/PKA signaling pathway is not the predominant pathway in the action of OA. Next, we examined a possible involvement of the second messenger inositol 1,4,5-trisphosphate in the action of OA. The effect of OA on SRCs was inhibited by subsequent application of the phosphoinositide-specific phospholipase C (PLC) inhibitor U73122, indicating that the PLC pathway is involved in the action of OA. The OA-induced increase in the frequency of SRCs was inhibited by pretreatment of the cell with the ryanodine receptor antagonist tetracaine but was not significantly affected by the IP3 receptor antagonist 2-aminoethoxydiphenyl borate (2-APB). On the other hand, the OA-induced increase in the amplitude of SRCs was inhibited by pretreatment of the cells with 2-APB but was not significantly affected by tetracaine. Taken together, these results suggest that the OA-induced excitatory effect on SRCs is mediated by the PLC signaling pathway: Ca2+ release from IP3 receptors may contribute to the modulation of the amplitude of SRCs, whereas Ca2+ release from ryanodine receptors may contribute to the modulation of the frequency of SRCs. (C) 2014 Elsevier Ltd. All rights reserved.	[Tamashiro, Hirotake; Yoshino, Masami] Tokyo Gakugei Univ, Dept Biol, Tokyo 1848501, Japan	Yoshino, M (reprint author), Tokyo Gakugei Univ, Dept Biol, Tokyo 1848501, Japan.	myoshi@u-gakugei.ac.jp			 [24570083]	The present experiments were performed under the Guiding Principles for the Care and Use Animals in the field of Physiological Sciences recommended by the Physiological Society of Japan. This work was supported by a Grant-in-Aid for Scientific Research (C) (No. 24570083).	ORCHARD I, 1985, J NEUROBIOL, V16, P171, DOI 10.1002/neu.480160303; ORCHARD I, 1982, CAN J ZOOL, V60, P659, DOI 10.1139/z82-095; Farooqui T, 2007, NEUROCHEM RES, V32, P1511, DOI 10.1007/s11064-007-9344-7; Farooqui Tahira, 2012, Open Access Insect Physiology, V4, P1; Braines D., 1992, ARCH INSECT BIOCH PH, V20, P215; Clark J, 2003, J COMP PHYSIOL A, V189, P105, DOI 10.1007/s00359-002-0375-x; DUDAI Y, 1986, ACTA BIOCHIM BIOPHYS, V21, P177; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Gordienko DV, 2002, J PHYSIOL-LONDON, V542, P743, DOI 10.1113/jphysiol.2001.015966; HINTON JM, 1995, J INSECT PHYSIOL, V41, P1027, DOI 10.1016/0022-1910(95)00074-5; Hinton JM, 1998, INSECT BIOCHEM MOLEC, V28, P331, DOI 10.1016/S0965-1748(98)00008-3; Lange AB, 2004, ARCH INSECT BIOCHEM, V56, P179, DOI 10.1002/arch.20010; Lange AB, 1996, ARCH INSECT BIOCHEM, V33, P183; LANGE AB, 1986, BRAIN RES, V363, P340, DOI 10.1016/0006-8993(86)91020-6; LANGE AB, 1984, J INSECT PHYSIOL, V30, P271, DOI 10.1016/0022-1910(84)90127-6; LANGE AB, 1993, J INSECT PHYSIOL, V39, P393, DOI 10.1016/0022-1910(93)90027-O; Menzel R., 1988, SYNAPTIC TRANSMISSIO, P335; MUSZYNSKAPYTEL M, 1978, COMP BIOCHEM PHYS C, V59, P13, DOI 10.1016/0306-4492(78)90005-9; Mutoh H, 2004, J COMP PHYSIOL B, V174, P21, DOI 10.1007/s00360-003-0385-1; NATHANSON JA, 1979, SCIENCE, V203, P65, DOI 10.1126/science.214856; Numata T, 2005, J INSECT PHYSIOL, V51, P481, DOI 10.1016/j.jinsphys.2004.10.001; Nykamp DA, 1998, BIOGENIC AMINES, V14, P177; SOMBATI S, 1984, J NEUROBIOL, V15, P481, DOI 10.1002/neu.480150607; Tamashiro H., 2014, J INSECT PH IN PRESS; WILCOX CL, 1995, REGUL PEPTIDES, V56, P49, DOI 10.1016/0167-0115(95)00006-W; Wong R, 2014, J INSECT PHYSIOL, V63, P1, DOI 10.1016/j.jinsphys.2014.02.002	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-1910	1879-1611		J INSECT PHYSIOL	J. Insect Physiol.	DEC	2014	71						30	36		10.1016/j.jinsphys.2014.09.010		7	Entomology; Physiology; Zoology	Entomology; Physiology; Zoology	AX8DR	WOS:000347141100005		
J	Tamashiro, H; Yoshino, M				Tamashiro, Hirotake; Yoshino, Masami			Involvement of plasma membrane Ca2+ channels, IP3 receptors, and ryanodine receptors in the generation of spontaneous rhythmic contractions of the cricket lateral oviduct	JOURNAL OF INSECT PHYSIOLOGY			English	Article						IP3 receptor; Ryanodine receptor; Cricket; Lateral oviduct; Myogenic contraction	PHOSPHOLIPASE-C ACTIVITY; INSECT VISCERAL MUSCLE; CRUSTACEAN CARDIOACTIVE PEPTIDE; LOCUST SCHISTOCERCA-GREGARIA; NONSELECTIVE CATION CHANNEL; RAT VENTRICULAR MYOCYTES; SMOOTH-MUSCLE; INTRACELLULAR CALCIUM; INOSITOL TRISPHOSPHATE; SARCOPLASMIC-RETICULUM	In the present study, the isolated cricket (Gryllus bimaculatus) lateral oviduct exhibited spontaneous rhythmic contractions (SRCs) with a frequency of 0.29 +/- 0.009 Hz (n = 43) and an amplitude of 14.6 +/- 1.25 mg (n = 29). SRCs completely disappeared following removal of extracellular Ca2+ using a solution containing 5 mM EGTA. Application of the non-specific Ca2+ channel blockers Co2+, Ni2+, and Cd2+ also decreased both the frequency and amplitude of SRCs in dose-dependent manners, suggesting that Ca2+ entry through plasma membrane Ca2+ channels is essential for the generation of SRCs. Application of ryanodine (30 mu M), which depletes intracellular Ca2+ by locking ryanodine receptor (RyR)-Ca2+ channels in an open state, gradually reduced the frequency and amplitude of SRCs. A RyR antagonist, tetracaine, reduced both the frequency and amplitude of SRCs, whereas a RyR activator, caffeine, increased the frequency of SRCs with a subsequent increase in basal tonus, indicating that RyRs are essential for generating SRCs. To further investigate the involvement of phospholipase C (PLC) and inositol 1,4,5-trisphosphate receptors (IP(3)Rs) in SRCs, we examined the effect of a PLC inhibitor, U73122, and an IP3R antagonist, 2-aminoethoxydiphenyl borate (2-APB), on SRCs. Separately, U73122 (10 mu M) and 2-APB (30-50 mu M) both significantly reduced the amplitude of SRCs with little effect on their frequency, further indicating that the PLC/IP3R signaling pathway is fundamental to the modulation of the amplitude of SRCs. A hypotonic-induced increase in the frequency and amplitude of SRCs and a hypertonic-induced decrease in the frequency and amplitude of SRCs indicated that mechanical stretch of the lateral oviduct is involved in the generation of SRCs. The sarcoplasmic reticulum Ca2+-pump ATPase inhibitors thapsigargin and cyclopiazonic acid impaired or suppressed the relaxation phase of SRCs. Taken together, the present results indicate that Ca2+ influx through plasma membrane Ca2+ channels and Ca2+ release from RyRs play an essential role in pacing SRCs and that Ca2+ release from IP3Rs may play a role in modulating the amplitude of SRCs, probably via activation of PLC. (C) 2014 Elsevier Ltd. All rights reserved.	[Tamashiro, Hirotake; Yoshino, Masami] Tokyo Gakugei Univ, Dept Biol, Tokyo 1848501, Japan	Yoshino, M (reprint author), Tokyo Gakugei Univ, Dept Biol, Tokyo 1848501, Japan.	myoshi@u-gakugei.ac.jp			 [24570083]	The present experiments were performed under the Guiding Principles for the Care and Use Animals in the field of Physiological Sciences recommended by the Physiological Society of Japan. This work was supported by a Grant-in-Aid for Scientific Research (C) (No. 24570083).	SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; ORCHARD I, 1985, J NEUROBIOL, V16, P171, DOI 10.1002/neu.480160303; Overend CL, 1997, J PHYSIOL-LONDON, V502, P471, DOI 10.1111/j.1469-7793.1997.471bj.x; Donini A, 2002, PEPTIDES, V23, P683, DOI 10.1016/S0196-9781(01)00662-3; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Gyorke S, 1997, J PHYSIOL-LONDON, V500, P297; Park SY, 2010, ARCH PHARM RES, V33, P159, DOI 10.1007/s12272-010-2238-2; Donini A, 2001, J INSECT PHYSIOL, V47, P277, DOI 10.1016/S0022-1910(00)00112-8; BROPHY CM, 1993, BIOCHEM BIOPH RES CO, V190, P576, DOI 10.1006/bbrc.1993.1087; DASSOULI A, 1993, J MOL CELL CARDIOL, V25, P973, DOI 10.1006/jmcc.1993.1109; Donini A, 2004, J INSECT PHYSIOL, V50, P351, DOI 10.1016/j.jinsphys.2004.02.005; GUERRERO A, 1994, J GEN PHYSIOL, V104, P375, DOI 10.1085/jgp.104.2.375; HANSEN M, 1995, J CELL SCI, V108, P2583; HINTON JM, 1995, J INSECT PHYSIOL, V41, P1027, DOI 10.1016/0022-1910(95)00074-5; Hinton JM, 1998, INSECT BIOCHEM MOLEC, V28, P331, DOI 10.1016/S0965-1748(98)00008-3; KALOGIANNI E, 1995, J EXP BIOL, V198, P507; Komari S. O., 2013, PHYSL REP, V1, P1; KULIK TJ, 1991, BIOCHEM BIOPH RES CO, V180, P982, DOI 10.1016/S0006-291X(05)81162-3; Lange A. B., 1988, ARCH INSECT BIOCH PH, V6, P201; Lange AB, 2004, ARCH INSECT BIOCHEM, V56, P179, DOI 10.1002/arch.20010; Lange AB, 1996, ARCH INSECT BIOCHEM, V33, P183; Lange AB, 2002, PEPTIDES, V23, P2063, DOI 10.1016/S0196-9781(02)00223-1; Lemonnier L, 2004, FEBS LETT, V556, P121, DOI 10.1016/S0014-5793(03)01387-5; IINO M, 1989, Journal of General Physiology, V94, P363, DOI 10.1085/jgp.94.2.363; Martin-Cano FE, 2009, J PHYSIOL PHARMACOL, V60, P93; MATSUMOTO H, 1995, AM J PHYSIOL-CELL PH, V268, pC458; McHale N, 2006, J PHYSIOL-LONDON, V570, P23, DOI 10.1113/jphysiol.2005.098376; Moore AL, 2002, J BIOL CHEM, V277, P34030, DOI 10.1074/jbc.M205945200; Mutoh H, 2004, J COMP PHYSIOL B, V174, P21, DOI 10.1007/s00360-003-0385-1; Noronha KF, 1997, J NEUROBIOL, V33, P139, DOI 10.1002/(SICI)1097-4695(199708)33:2<139::AID-NEU3>3.0.CO;2-3; Numata T, 2005, J COMP PHYSIOL B, V175, P257, DOI 10.1007/s00360-005-0480-6; Numata T, 2005, J INSECT PHYSIOL, V51, P481, DOI 10.1016/j.jinsphys.2004.10.001; Nykamp DA, 2000, J INSECT PHYSIOL, V46, P809, DOI 10.1016/S0022-1910(99)00170-5; Nykamp DA, 1998, BIOGENIC AMINES, V14, P177; ORCHARD I, 1986, J INSECT PHYSIOL, V32, P741, DOI 10.1016/0022-1910(86)90117-4; Ruwhof C, 2001, CELL CALCIUM, V29, P73, DOI 10.1054/ceca.2000.0158; Splettstoesser F, 2007, BRIT J PHARMACOL, V151, P1176, DOI 10.1038/sj.bjp.0707335; SUTKO JL, 1980, CIRC RES, V46, P332; Taylor CW, 1998, TRENDS PHARMACOL SCI, V19, P370, DOI 10.1016/S0165-6147(98)01243-7; Tsukamoto A, 2010, CELL CALCIUM, V47, P253, DOI 10.1016/j.ceca.2009.12.008; WANG Z, 1995, NEUROPEPTIDES, V28, P147, DOI 10.1016/0143-4179(95)90109-4; WILCOX CL, 1995, REGUL PEPTIDES, V56, P49, DOI 10.1016/0167-0115(95)00006-W; Xu H., 2010, ACTA PHYSL SIN, V62, P387; Zima AV, 2007, J PHYSIOL-LONDON, V584, P601, DOI 10.1113/jphysiol.2007.140731	44	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-1910	1879-1611		J INSECT PHYSIOL	J. Insect Physiol.	DEC	2014	71						97	104		10.1016/j.jinsphys.2014.10.004		8	Entomology; Physiology; Zoology	Entomology; Physiology; Zoology	AX8DR	WOS:000347141100013		
J	Matsumoto, Y; Suetsugu, Y; Nakamura, M; Hattori, M				Matsumoto, Yukiko; Suetsugu, Yoshitaka; Nakamura, Masatoshi; Hattori, Makoto			Transcriptome analysis of the salivary glands of Nephotettix cincticeps (Uhler)	JOURNAL OF INSECT PHYSIOLOGY			English	Article						Green rice leafhopper; Nephotettix cincticeps; Salivary glands; Transcriptome; Illumina HiSeq 2000	GREEN RICE LEAFHOPPER; HEMIPTERA CICADELLIDAE; ACYRTHOSIPHON-PISUM; HOST-PLANT; PEA APHID; BROWN PLANTHOPPER; POTATO LEAFHOPPER; FEEDING-BEHAVIOR; SECRETED SALIVA; PHOSPHOLIPASE-D	The green rice leafhopper (GRH), Nephotettix cincticeps, is one of the most important pests of rice in temperate Asian countries. GRH, a vascular feeder, secretes watery and gelling saliva in the process of feeding on phloem and xylem sap. It is known that GRH saliva contains several bioactive proteins, including enzymes such as laccase and beta-glucosidase. In this study, we performed transcriptome analysis of salivary glands of GRH using Illumina paired-end sequencing. Of 51,788 assembled contigs, 16,017 (30.9%) showed significant similarity to known proteins in the NCBI nr database, while 34,978 (67.5%) could not be annotated by similarity search, Pfam, or gene ontology (GO). Contigs (905) with predicted signal peptides and no putative transmembrane domains are suggested to represent secreted protein coding genes. Among the 76 most highly expressed putative secretory protein contigs, 68 transcripts were found to be salivary gland-specific or at least -dominant, but not expressed in stomach or Malpighian tubules. However, 45 of the 68 transcripts were unknown proteins. These findings suggest that most of the GRH transcripts encoding secreted proteins expressed in salivary glands are species and/or tissue specific. Our results provide a fundamental list of genes involved in GRH-Poaceae host plant interactions including successful feeding and plant pathogen transmission. (C) 2014 The Authors. Published by Elsevier Ltd.	[Matsumoto, Yukiko; Suetsugu, Yoshitaka; Hattori, Makoto] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058634, Japan; [Nakamura, Masatoshi] Natl Inst Agrobiol Sci, Hokuto, Yamanashi 4080044, Japan	Matsumoto, Y (reprint author), Natl Inst Agrobiol Sci, Owashi 1-2, Tsukuba, Ibaraki 3058634, Japan.	matsumt@affrc.go.jp; suetsugu@affrc.go.jo; nakamura@affrc.go.jp; hatto@affrc.go.jp					Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; McVean RIK, 2002, J APPL ENTOMOL, V126, P281, DOI 10.1046/j.1439-0418.2002.00671.x; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Petrova A, 2014, INSECT MOL BIOL, V23, P13, DOI 10.1111/imb.12058; Backus EA, 2005, ANNU REV ENTOMOL, V50, P125, DOI 10.1146/annurev.ento.49.061802.123310; JANSSEN JAM, 1989, ENTOMOL EXP APPL, V52, P69; Nicholson SJ, 2012, J PROTEOMICS, V75, P2252, DOI 10.1016/j.jprot.2012.01.031; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; SOGAWA K, 1982, ANNU REV ENTOMOL, V27, P49, DOI 10.1146/annurev.en.27.010182.000405; Aki T, 2008, PLANT CELL PHYSIOL, V49, P767, DOI 10.1093/pcp/pcn049; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Kerchev PI, 2012, PLANT CELL ENVIRON, V35, P441, DOI 10.1111/j.1365-3040.2011.02399.x; Hattori M, 2010, INSECT BIOCHEM MOLEC, V40, P331, DOI 10.1016/j.ibmb.2010.02.009; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munnik T, 1995, PLANT CELL, V7, P2197, DOI 10.1105/tpc.7.12.2197; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Ashburner M, 2000, NAT GENET, V25, P25; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Wang XM, 1999, PLANT PHYSIOL, V120, P645, DOI 10.1104/pp.120.3.645; Carolan JC, 2011, J PROTEOME RES, V10, P1505, DOI 10.1021/pr100881q; Tomizawa M, 2013, APPL ENTOMOL ZOOL, V48, P553, DOI 10.1007/s13355-013-0211-5; Brennan M, 2011, MOL PLANT, V4, P144, DOI 10.1093/mp/ssq067; Hattori M, 2005, J INSECT PHYSIOL, V51, P1359, DOI 10.1016/j.jinsphys.2005.08.010; Bonaventure G, 2012, PLANT BIOLOGY, V14, P872, DOI 10.1111/j.1438-8677.2012.00650.x; Vandermoten S, 2014, INSECT MOL BIOL, V23, P67, DOI 10.1111/imb.12061; Knoblauch M, 2001, PLANT CELL, V13, P1221, DOI 10.1105/tpc.13.5.1221; Liu XM, 2010, PLANT PHYSIOL, V152, P985, DOI 10.1104/pp.109.150656; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Havukainen H, 2013, J BIOL CHEM, V288, P28369, DOI 10.1074/jbc.M113.465021; Cristofoletti PT, 2006, FEBS J, V273, P5574, DOI 10.1111/j.1742-4658.2006.05547.x; Aronesty E, 2013, OPEN BIOINFORMATICS, V7, P1, DOI DOI 10.2174/1875036201307010001; Benning UF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00053; Bos JIB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001216; DeLay B, 2012, J INSECT PHYSIOL, V58, P1626, DOI 10.1016/j.jinsphys.2012.10.002; Feyereisen R, 2005, COMPREHENSIVE MOL IN, V4, P1; Hattori M, 1997, APPL ENTOMOL ZOOL, V32, P409; Hattori M, 2012, INSECT BIOCHEM MOLEC, V42, P1, DOI 10.1016/j.ibmb.2011.10.001; Hogenhout SA, 2011, CURR OPIN PLANT BIOL, V14, P1; Jackson CJ, 2013, P NATL ACAD SCI USA, V110, P10177, DOI 10.1073/pnas.1304097110; Ji R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079612; Jiang YX, 1999, J ECON ENTOMOL, V92, P357; KAWABE S, 1985, JARQ-JPN AGR RES Q, V19, P115; LAMP WO, 1994, J KANSAS ENTOMOL SOC, V67, P354; Mutti Navdeep S., 2006, Journal of Insect Science (Tucson), V6, P1, DOI 10.1673/031.006.3801; NAITO A, 1967, Japanese Journal of Applied Entomology and Zoology, V11, P50; Nakamura M, 2013, APPL ENTOMOL ZOOL, V48, P489, DOI 10.1007/s13355-013-0210-6; NAKASHIMA K, 1991, APPL ENVIRON MICROB, V57, P3570; NAULT LR, 1966, ANN ENTOMOL SOC AM, V59, P1185; OYA S, 1980, APPL ENTOMOL ZOOL, V15, P392; Powell S, 2011, NUCLEIC ACIDS RES, V40, pD284; Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065; SATOMI H, 1993, APPL ENTOMOL ZOOL, V28, P207; Shukle RH, 2009, J INSECT PHYSIOL, V55, P104, DOI 10.1016/j.jinsphys.2008.10.008; Silva AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036810; SOGAWA K, 1967, Applied Entomology and Zoology, V2, P195; SOGAWA K, 1973, Review of Plant Protection Research, V6, P31; Sogawa K., 1971, Japanese Journal of Applied Entomology and Zoology, V15, P132; Su YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039303; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; TJALLINGII WF, 1985, ENTOMOL EXP APPL, V38, P187; WALKER GP, 1994, ANN ENTOMOL SOC AM, V87, P363; Yokoyama R., 2014, BSJ REV, V5, P45	67	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-1910	1879-1611		J INSECT PHYSIOL	J. Insect Physiol.	DEC	2014	71						170	176		10.1016/j.jinsphys.2014.10.010		7	Entomology; Physiology; Zoology	Entomology; Physiology; Zoology	AX8DR	WOS:000347141100022		
J	Kitano, M; Yazaki, S; Abe, T; Osamu, Y				Kitano, Masataka; Yazaki, Satoshi; Abe, Tadaaki; Osamu, Yamada			Evaluation of Valsalva Sinus Wall Deformation Due to Compression by the Amplatzer Septal Occluder and the Potential for Erosion Development	JOURNAL OF INTERVENTIONAL CARDIOLOGY			English	Article							TRANSCATHETER CLOSURE; CARDIAC EROSION; DEVICE CLOSURE; ATRIAL; DEFECTS; RECOMMENDATIONS; MANUFACTURER; AORTA	Objectives: We studied whether the pressure exerted by the Amplatzer septal occluder (ASO) disk on the Valsalva sinus wall (VW) is a risk factor for erosion and attempted to determine the pressure that may trigger erosion. Background: The causes and mechanisms of erosion after ASO placement remain unclear. Methods: We reviewed 665 consecutive patients with atrial septal defects who underwent ASO closure at our hospital from 2005 to 2012. We used transesophageal echocardiography and other tests to evaluate disk-related VW deformation as a risk factor for erosion. Results: Immediately after ASO placement, intermittent VW deformation from either disk was determined in 54 of the 665 patients (8%). Of these 54 patients, only 1 exhibited late erosion (0.15%) during a follow-up of more than 4 years (0.035% a year). The maximum VW deformation depth relative to the standard curve, or dent, was 2.6mm in this patient, whereas that in the remaining patients ranged from 0.5 to 2.0 mm. The dent values were significantly deeper in patients with contact between the left atrial disk and posterior atrial wall than in those without contact (P = 0.03). There was a significant negative correlation between dent and the aortic side-maximum device thickness (DT)/middle part-DT ratio (P = 0.04). Conclusion: Although VW deformation, particularly deep VW deformation caused by pressure from either disk after ASO placement must be a recognized risk for erosion, which deformation level carries a stronger risk for erosion could not be concluded.	[Kitano, Masataka; Yazaki, Satoshi; Abe, Tadaaki; Osamu, Yamada] Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, Suita, Osaka 5658565, Japan	Kitano, M (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Pediat Cardiol, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	kitanom@ncvc.go.jp					Pascotto M, 2006, INT J CARDIOL, V112, P348, DOI 10.1016/j.ijcard.2005.10.008; Crawford GB, 2012, CATHETER CARDIO INTE, V80, P157, DOI 10.1002/ccd.24347; Kutty S, 2012, AM J CARDIOL, V109, P1348, DOI 10.1016/j.amjcard.2011.12.031; El-Said HG, 2009, CATHETER CARDIO INTE, V73, P925, DOI 10.1002/ccd.21931; Moore J, 2013, JACC-CARDIOVASC INTE, V6, P433, DOI 10.1016/j.jcin.2013.02.005; Diab K, 2012, CATHETER CARDIO INTE, V80, P168, DOI 10.1002/ccd.24517; Amin Z, 2004, CATHETER CARDIO INTE, V63, P496, DOI 10.1002/ccd.20211; Amin Z, 2014, CATHETER CARDIO INTE, V83, P84, DOI 10.1002/ccd.25175; DiBardino DJ, 2009, J THORAC CARDIOV SUR, V137, P1334, DOI 10.1016/j.jtcvs.2009.02.032; Chun DS, 2003, CATHETER CARDIO INTE, V58, P246, DOI 10.1002/ccd.10434; Du ZD, 2002, J AM COLL CARDIOL, V39, P1836; Jang GY, 2005, AM J CARDIOL, V96, P1605, DOI 10.1016/j.amjcard.2005.08.012; Kitano M, 2009, J INTERV CARDIOL, V22, P83, DOI 10.1111/j.1540-8183.2008.00421.x	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0896-4327	1540-8183		J INTERV CARDIOL	J. Interv. Cardiol.	DEC	2014	27	6					555	562		10.1111/joic.12158		8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AX1HF	WOS:000346697700005		
J	Hiruma-Shimizu, K; Kalverda, AP; Henderson, PJF; Homans, SW; Patching, SG				Hiruma-Shimizu, Kazumi; Kalverda, Arnout P.; Henderson, Peter J. F.; Homans, Steve W.; Patching, Simon G.			Synthesis of uniformly deuterated n-dodecyl-beta-D-maltoside (d(39)-DDM) for solubilization of membrane proteins in TROSY NMR experiments	JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS			English	Article						detergent; deuteration; n-dodecyl--d-maltoside; membrane proteins; NMR	NUCLEAR-MAGNETIC-RESONANCE; ALKYL GLYCOSIDE DETERGENTS; CYTOCHROME-C-OXIDASE; NEUTRON REFLECTION; SPECTROSCOPY; ALPHA; BACTERIORHODOPSIN; MICELLES; MODEL	This work reports the first synthesis of uniformly deuterated n-dodecyl--d-maltoside (d(39)-DDM). DDM is a mild non-ionic detergent often used in the extraction and purification of membrane proteins and for solubilizing them in experimental studies of their structure, dynamics and binding of ligands. We required d(39)-DDM for solubilizing large -helical membrane proteins in samples for [N-15-H-1]TROSY (transverse relaxation-optimized spectroscopy) NMR experiments to achieve the highest sensitivity and best resolved spectra possible. Our synthesis of d(39)-DDM used d(7)-d-glucose and d(25)-n-dodecanol to introduce deuterium labelling into both the maltoside and dodecyl moieties, respectively. Two glucose molecules, one converted to a glycosyl acceptor with a free C4 hydroxyl group and one converted to a glycosyl donor substituted at C1 with a bromine in the -configuration, were coupled together with an (14) glycosidic bond to give maltose, which was then coupled with n-dodecanol by its substitution of a C1 bromine in the -configuration to give DDM. H-1 NMR spectra were used to confirm a high level of deuteration in the synthesized d(39)-DDM and to demonstrate its use in eliminating interfering signals from TROSY NMR spectra of a 52-kDa sugar transport protein solubilized in DDM.	[Hiruma-Shimizu, Kazumi; Kalverda, Arnout P.; Homans, Steve W.] Univ Leeds, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Henderson, Peter J. F.] Univ Leeds, Sch Biomed Sci, Leeds, W Yorkshire, England; [Hiruma-Shimizu, Kazumi; Kalverda, Arnout P.; Henderson, Peter J. F.; Homans, Steve W.] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds, W Yorkshire, England; [Hiruma-Shimizu, Kazumi] Waseda Univ, Tokyo, Japan; [Homans, Steve W.] Newcastle Univ, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Patching, Simon G.] Univ Leeds, Leeds, W Yorkshire, England	Patching, SG (reprint author), 37 Dene House Court,Leicester Pl, Leicester LS2 9BS, Leics, England.	sgp_uk2000@yahoo.co.uk			EU EDICT consortium [201924]; EPSRC [EP/G035695/1]; BBSRC [BBG020043/1]; University of Leeds; Leverhulme Trust	This work was supported by the EU EDICT consortium (contract 201924), the EPSRC (EP/G035695/1), the BBSRC (BBG020043/1) and the University of Leeds. P. J. F. H. received personal funding from the Leverhulme Trust. The authors thank Tanya Marinko-Covell (University of Leeds) for performing mass spectrometry analysis and John O' Reilly, Ryan Hope and David Sharples (University of Leeds) for assistance with fermentor cultures.	Alvares R, 2014, J PHYS CHEM B, V118, P5698, DOI 10.1021/jp500139p; Nietlispach D, 2011, CURR OPIN STRUC BIOL, V21, P497, DOI 10.1016/j.sbi.2011.06.009; Sanders CR, 2006, MAGN RESON CHEM, V44, pS24, DOI 10.1002/mrc.1816; Page Richard C., 2006, Journal of Structural and Functional Genomics, V7, P51, DOI 10.1007/s10969-006-9009-9; Hines JD, 1997, J PHYS CHEM B, V101, P9215, DOI 10.1021/jp972099a; Wen H, 2008, EUR J MED CHEM, V43, P166, DOI 10.1016/j.ejmech.2007.03.018; Imai S, 2010, P NATL ACAD SCI USA, V107, P6216, DOI 10.1073/pnas.0911270107; USUI T, 1973, J CHEM SOC PERK T 1, P2425, DOI 10.1039/p19730002425; Koenigs W, 1901, BER DTSCH CHEM GES, V34, P957, DOI 10.1002/cber.190103401162; Rouse SL, 2013, BIOPHYS J, V105, P648, DOI 10.1016/j.bpj.2013.06.025; Vacklin HP, 2005, LANGMUIR, V21, P2827, DOI 10.1021/la047389e; Maslennikov I, 2013, CURR OPIN STRUC BIOL, V23, P555, DOI 10.1016/j.sbi.2013.05.002; ROSEVEAR P, 1980, BIOCHEMISTRY-US, V19, P4108, DOI 10.1021/bi00558a032; Michel O, 2008, LANGMUIR, V24, P12116, DOI 10.1021/la802304w; Koto S, 2004, CARBOHYD RES, V339, P2415, DOI 10.1016/j.carre.2004.07.016; Hwang PM, 2002, P NATL ACAD SCI USA, V99, P13560, DOI 10.1073/pnas.212344499; KOCHETKOV NK, 1991, CARBOHYD RES, V212, P77, DOI 10.1016/0008-6215(91)84047-I; Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028; Vacklin HP, 2005, BBA-BIOMEMBRANES, V1668, P17, DOI 10.1016/j.bbamem.2004.11.001; Ciaccafava A, 2012, ELECTROCHIM ACTA, V82, P115, DOI 10.1016/j.electacta.2012.03.034; Patzelt H, 2002, P NATL ACAD SCI USA, V99, P9765, DOI 10.1073/pnas.132253899; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Arnold T, 2008, CURR PROTOC PROTEIN; BREDERECK H, 1959, CHEM BER-RECL, V92, P2405, DOI 10.1002/cber.19590921004; Breyton C, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13071-6; BROWN LR, 1979, BIOCHIM BIOPHYS ACTA, V557, P135, DOI 10.1016/0005-2736(79)90096-8; Brunner H, 2005, Z ANORG ALLG CHEM, V631, P2555, DOI 10.1002/zaac.200500037; Chattopadhyay K, 2002, J INORG BIOCHEM, V91, P116, DOI 10.1016/S0162-0134(02)00427-0; Furniss B. S., 1989, VOGELS TXB PRACTICAL, P654; Hatanaka K, 2004, POLYM J, V36, P567, DOI 10.1295/polymj.36.567; HEYRAUD A, 1979, BIOPOLYMERS, V18, P167, DOI 10.1002/bip.1979.360180113; Hiller S, 2009, CURR OPIN STRUC BIOL, V19, P396, DOI 10.1016/j.sbi.2009.07.013; Kalverda AP, 2014, MOL MEMBR BIOL, V31, P131, DOI 10.3109/09687688.2014.911980; Klammt C, 2012, NAT METHODS, V9, P834, DOI [10.1038/nmeth.2033, 10.1038/NMETH.2033]; LEMIEUX RU, 1953, CAN J CHEM, V31, P949, DOI 10.1139/v53-125; Mahkam M., 2006, E-POLYMERS, V6, P58; Pagliano C, 2012, BBA-BIOENERGETICS, V1817, P1506, DOI 10.1016/j.bbabio.2011.11.001; Patching SG, 2011, MOL MEMBR BIOL, V28, P370, DOI 10.3109/09687688.2011.603100; Reckel S, 2013, MOL PHYS, V111, P843, DOI 10.1080/00268976.2013.783639; Schubert M, 2002, CHEMBIOCHEM, V3, P1019, DOI 10.1002/1439-7633(20021004)3:10<1019::AID-CBIC1019>3.0.CO;2-C; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; SHELLING JG, 1984, CARBOHYD RES, V132, P241, DOI 10.1016/0008-6215(84)85222-2; VANAKEN T, 1986, METHOD ENZYMOL, V125, P27; Ward A., 2000, AMPLIFIED EXPRESSION, P131; WEYGAND F, 1958, CHEM BER-RECL, V91, P2534, DOI 10.1002/cber.19580911143; Zhao H, 2008, BIOSCI BIOTECH BIOCH, V72, P3006, DOI 10.1271/bbb.80295	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0362-4803	1099-1344		J LABELLED COMPD RAD	J. Label. Compd. Radiopharm.	DEC	2014	57	14					737	743		10.1002/jlcr.3249		7	Biochemical Research Methods; Chemistry, Medicinal; Chemistry, Analytical	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	AX1TU	WOS:000346729700003		
J	Tamai, T				Tamai, Toshiki			Public capital, deficit financing, and economic growth in a stochastic economy	JOURNAL OF MACROECONOMICS			English	Article						Public capital; National debt; Stochastic growth	PRODUCTIVE GOVERNMENT EXPENDITURE; CROSS-COUNTRY EVIDENCE; ENDOGENOUS GROWTH; INFRASTRUCTURE INVESTMENT; DEBT; SUSTAINABILITY; POLICY; MODEL; ACCUMULATION; UNCERTAINTY	This paper examines the relationship among deficit-financing fiscal policy, risk and economic growth in a stochastic endogenous growth model with private and public capital. We show that there are positive balanced-growth rate and a debt-to-GDP ratio that depend on deep parameters such as the income tax rate and the standard deviation of the growth rate of private and public capital. Investment and fiscal shocks influence the mean and variance of the growth rate and the debt dependency rate through portfolio changes and capital accumulation. In particular, an increase in the risk of private investment destabilizes the economy and reduces the mean growth rate if the portfolio change is drastic, and this increase in risk increases the debt-to-GDP ratio. In contrast, an increase in the income tax rate stabilizes the economy, increases the mean growth rate, and has a positive or negative effect on the debt-to-GDP ratio according to the ratio of public to private capital if the income tax rate is sufficiently small. (C) 2014 Elsevier Inc. All rights reserved.	Kinki Univ, Fac Econ, Higashiosaka, Osaka 5778502, Japan	Tamai, T (reprint author), Kinki Univ, Fac Econ, 3-4-1 Kowakae, Higashiosaka, Osaka 5778502, Japan.	tamai@kindai.ac.jp					Adam CS, 2005, J PUBLIC ECON, V89, P571, DOI 10.1016/j.jpubeco.2004.02.006; Ramey G, 1995, AM ECON REV, V85, P1138; BARRO RJ, 1990, J POLIT ECON, V98, pS103, DOI 10.1086/261726; Romero-Avila D, 2008, EUR J POLIT ECON, V24, P172, DOI 10.1016/j.ejpoleco.2007.06.008; Irmen A, 2009, J ECON SURV, V23, P692, DOI 10.1111/j.1467-6419.2009.00576.x; Imbs J, 2007, J MONETARY ECON, V54, P1848, DOI 10.1016/j.jmoneco.2006.08.001; Greiner A, 2007, JPN ECON REV, V58, P345, DOI 10.1111/j.1468-5876.2007.00394.x; Bredin D, 2005, MANCH SCH, V73, P58, DOI 10.1111/j.1467-9957.2005.00461.x; GRIER KB, 1989, J MONETARY ECON, V24, P259, DOI 10.1016/0304-3932(89)90006-8; Futagami K, 2008, MACROECON DYN, V12, P445, DOI 10.1017/S1365100508070235; FUTAGAMI K, 1993, SCAND J ECON, V95, P607, DOI 10.2307/3440914; Bond S, 2010, J APPL ECONOMET, V25, P1073, DOI 10.1002/jae.1163; Kamiguchi A, 2012, METROECONOMICA, V63, P443, DOI 10.1111/j.1467-999X.2011.04150.x; Arrow K. J., 1970, PUBLIC INVESTMENT RA; ASCHAUER DA, 1989, J MONETARY ECON, V23, P177, DOI 10.1016/0304-3932(89)90047-0; Barro R. J., 1998, DETERMINANTS EC GROW; Bloom N, 2014, J ECON PERSPECT, V28, P153, DOI 10.1257/jep.28.2.153; Bohn H, 1998, Q J ECON, V113, P949, DOI 10.1162/003355398555793; Brauninger Michael, 2005, J PUBLIC ECON THEORY, V7, P827, DOI 10.1111/j.1467-9779.2005.00247.x; Chalk NA, 2000, J MONETARY ECON, V45, P293, DOI 10.1016/S0304-3932(99)00052-5; EATON J, 1981, REV ECON STUD, V48, P435, DOI 10.2307/2297156; Ghosh S., 2004, J MACROECON, V26, P624; GRAMLICH EM, 1994, J ECON LIT, V32, P1176; Greiner A, 2000, J MACROECON, V22, P363, DOI 10.1016/S0164-0704(00)00136-1; Haddow A., 2013, BANK ENGL Q B, V53, P100; KORMENDI RC, 1985, J MONETARY ECON, V16, P141, DOI 10.1016/0304-3932(85)90027-3; MUNNELL AH, 1992, J ECON PERSPECT, V6, P189; OECD, 2012, EC OUTL NO 92; Ott I., 2004, EMPIRICA, V31, P117, DOI 10.1007/s10663-004-1077-0; Pereira A., 2012, EC EFFECTS PUBLIC IN; Sturm JE., 1998, PUBLIC CAPITAL EXPEN; DELONG JB, 1991, Q J ECON, V106, P445; Turnovsky SJ, 1999, MACROECON DYN, V3, P544, DOI 10.1017/S136510059901305X; Wang HJ, 2007, J SYST SCI COMPLEX, V20, P95, DOI 10.1007/s11424-007-9008-3; Yakita A, 2008, J PUBLIC ECON, V92, P897, DOI 10.1016/j.jpubeco.2007.05.007	35	0	0	LOUISIANA STATE UNIV PR	BATON ROUGE	BATON ROUGE, LA 70893 USA	0164-0704			J MACROECON	J. Macroecon.	DEC	2014	42						14	26		10.1016/j.jmacro.2014.06.006		13	Economics	Business & Economics	AX6HN	WOS:000347023700002		
J	Furrer, F; Berta, M; Tomamichel, M; Scholz, VB; Christandl, M				Furrer, Fabian; Berta, Mario; Tomamichel, Marco; Scholz, Volkher B.; Christandl, Matthias			Position-momentum uncertainty relations in the presence of quantum memory	JOURNAL OF MATHEMATICAL PHYSICS			English	Article							TRANSITION-PROBABILITY; FOURIER-ANALYSIS; ENTROPY; PRINCIPLE; INEQUALITIES; INFORMATION; ALGEBRAS	A prominent formulation of the uncertainty principle identifies the fundamental quantum feature that no particle may be prepared with certain outcomes for both position and momentum measurements. Often the statistical uncertainties are thereby measured in terms of entropies providing a clear operational interpretation in information theory and cryptography. Recently, entropic uncertainty relations have been used to show that the uncertainty can be reduced in the presence of entanglement and to prove security of quantum cryptographic tasks. However, much of this recent progress has been focused on observables with only a finite number of outcomes not including Heisenberg's original setting of position and momentum observables. Here, we show entropic uncertainty relations for general observables with discrete but infinite or continuous spectrum that take into account the power of an entangled observer. As an illustration, we evaluate the uncertainty relations for position and momentum measurements, which is operationally significant in that it implies security of a quantum key distribution scheme based on homodyne detection of squeezed Gaussian states. (C) 2014 AIP Publishing LLC.	[Furrer, Fabian] Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Berta, Mario] CALTECH, Inst Quantum Informat & Matter, Pasadena, CA 91125 USA; [Berta, Mario; Scholz, Volkher B.; Christandl, Matthias] ETH, Inst Theoret Phys, CH-8093 Zurich, Switzerland; [Tomamichel, Marco] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Tomamichel, Marco] Natl Univ Singapore, Ctr Quantum Technol, Singapore 117543, Singapore; [Christandl, Matthias] Univ Copenhagen, Dept Math Sci, DK-2100 Copenhagen, Denmark	Furrer, F (reprint author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	furrer@eve.phys.s.u-tokyo.ac.jp	Tomamichel, Marco/D-5441-2013	Tomamichel, Marco/0000-0001-5410-3329	Swiss National Science Foundation [PP00P2-128455, 20CH21-138799]; Swiss National Center of Competence in Research "Quantum Science and Technology (QSIT)"; Swiss State Secretariat for Education and Research supporting COST action [MP1006]; European Research Council under the European Union / ERC [337603]; Danish Council for Independent Research; ETH Postdoctoral Fellowship; Japan Society for the Promotion of Science (JSPS) by KAKENHI [24-02793]; Ministry of Education (MOE); National Research Foundation Singapore; MOE [MOE2012-T3-1-009]	We gratefully acknowledge discussions with Renato Renner, Reinhard F. Werner, and Jukka Kiukkas and express special thanks to Michael Walter. MB, VBS, and MC acknowledge financial support by the Swiss National Science Foundation (Grant Nos. PP00P2-128455, 20CH21-138799 (CHIST-ERA project CQC)), the Swiss National Center of Competence in Research "Quantum Science and Technology (QSIT)," the Swiss State Secretariat for Education and Research supporting COST action MP1006, and the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement No. 337603. MC also acknowledges a Sapere Aude Grant from the Danish Council for Independent Research. VBS is in addition supported by an ETH Postdoctoral Fellowship. FF acknowledges support from Japan Society for the Promotion of Science (JSPS) by KAKENHI Grant No. 24-02793. MT is funded by the Ministry of Education (MOE) and National Research Foundation Singapore, as well as MOE Tier 3 Grant " Random numbers from quantum processes" (MOE2012-T3-1-009).	ALBERTI PM, 1983, LETT MATH PHYS, V7, P25, DOI 10.1007/BF00398708; Alberti PM, 2000, ACTA APPL MATH, V60, P1, DOI 10.1023/A:1006317508252; Robertson HP, 1929, PHYS REV, V34, P163, DOI 10.1103/PhysRev.34.163; Berta M, 2010, NAT PHYS, V6, P659, DOI 10.1038/NPHYS1734; BECKNER W, 1975, ANN MATH, V102, P159, DOI 10.2307/1970980; Schneeloch J, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.130407; PARTOVI MH, 1983, PHYS REV LETT, V50, P1883, DOI 10.1103/PhysRevLett.50.1883; Walborn SP, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.130402; DAVIES EB, 1970, COMMUN MATH PHYS, V17, P239, DOI 10.1007/BF01647093; BURES D, 1969, T AM MATH SOC, V135, P199, DOI 10.2307/1995012; SLEPIAN D, 1961, AT&T TECH J, V40, P43; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; HIRSCHMAN II, 1957, AM J MATH, V79, P152, DOI 10.2307/2372390; Terhal BM, 2004, IBM J RES DEV, V48, P71; Holevo AS, 1999, PHYS REV A, V59, P1820, DOI 10.1103/PhysRevA.59.1820; Furrer F, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.100502; Lodewyck J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042305; SHANNON CE, 1948, AT&T TECH J, V27, P623; Weedbrook C, 2012, REV MOD PHYS, V84, P621, DOI 10.1103/RevModPhys.84.621; Furrer F, 2011, COMMUN MATH PHYS, V306, P165, DOI 10.1007/s00220-011-1282-1; UHLMANN A, 1977, COMMUN MATH PHYS, V54, P21, DOI 10.1007/BF01609834; Tomamichel M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.110506; Araki H., 1976, RELATIVE ENTROPY STA, V9, P809; Berta M., 2011, ARXIV11075460V1; Bialynicki-Birula I, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.052101; BIALYNICKIBIRULA I, 1975, COMMUN MATH PHYS, V44, P129, DOI 10.1007/BF01608825; BIALYNICKIBIRULA I, 1984, PHYS LETT A, V103, P253, DOI 10.1016/0375-9601(84)90118-X; Bratteli O., 1979, OPERATOR ALGEBRAS QU, VI; Coles PJ, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.062338; Coles PJ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.210405; Frank RL, 2013, COMMUN MATH PHYS, V323, P487, DOI 10.1007/s00220-013-1775-1; Frank RL, 2012, ANN HENRI POINCARE, V13, P1711, DOI 10.1007/s00023-012-0175-y; Furrer F., 2014, ARXIV14055965; Furrer F., 2012, THESIS LEIBNIZ U HAN; Heisenberg W., 1927, Zeitschrift fur Physik, V43, DOI 10.1007/BF01397280; Kennard E.H., 1927, Zeitschrift fur Physik, V44, DOI 10.1007/BF01391200; Kiukas J, 2010, J MATH PHYS, V51, DOI 10.1063/1.3447736; Konig R., 2009, IEEE T INFORM THEORY, V55, P4337; [Кузнецова А.А. Kuznetsova A.A.], 2010, [Теория вероятностей и ее применения, Theory of Probability and its Applications, Teoriya veroyatnostei i ee primeneniya], V55, P782, DOI 10.4213/tvp4282; Murphy G. J., 1990, C ALGEBRAS OPERATOR; Ohya M., 1993, QUANTUM ENTROPY ITS; PAULSEN V., 2002, COMPLETELY BOUNDED M; Petz D, 2008, THEOR MATH PHYS SER, P1, DOI 10.1007/978-3-540-74636-2_1; Ray MR, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.042326; Renner R., 2005, THESIS ETH ZURICH; Rudnicki L, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.042115; Rudnicki L, 2011, J RUSS LASER RES, V32, P393; Rudnicki L., 2010, ARXIV10103269V1; Rumin M, 2011, DUKE MATH J, V160, P567, DOI 10.1215/00127094-1444305; Rumin M, 2012, LETT MATH PHYS, V100, P291, DOI 10.1007/s11005-011-0543-4; Takesaki M., 2002, THEORY OPERATOR ALGE, V2; Takesaki M., 2001, THEORY OPERATOR ALGE, V1; Tobias E., 2013, OPT EXPRESS, V21, P11546; Tomamichel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1631; Tomamichel M., 2013, THESIS ETH ZURICH; Uhlmann A., 1976, Reports on Mathematical Physics, V9, DOI 10.1016/0034-4877(76)90060-4; Umegaki H, 1962, KODAI MATH SEM REP, V14, P59, DOI DOI 10.2996/KMJ/1138844604; Walk N., 2004, PHYS REV A, V90	58	1	1	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0022-2488	1089-7658		J MATH PHYS	J. Math. Phys.	DEC	2014	55	12							122205	10.1063/1.4903989		30	Physics, Mathematical	Physics	AX8OG	WOS:000347168000020		
J	Hatano, N; Ordonez, G				Hatano, Naomichi; Ordonez, Gonzalo			Time-reversal symmetric resolution of unity without background integrals in open quantum systems	JOURNAL OF MATHEMATICAL PHYSICS			English	Article							RESONANT STATES; NUCLEAR-REACTIONS; WAVE-FUNCTIONS; S-MATRIX; PROBABILISTIC-INTERPRETATION; DECAYING STATES; UNIFIED THEORY; MECHANICS; EXPANSIONS; SCATTERING	We present a new complete set of states for a class of open quantum systems, to be used in expansion of the Green's function and the time-evolution operator. A remarkable feature of the complete set is that it observes time-reversal symmetry in the sense that it contains decaying states (resonant states) and growing states (anti-resonant states) parallelly. We can thereby pinpoint the occurrence of the breaking of time-reversal symmetry at the choice of whether we solve Schrodinger equation as an initial-condition problem or a terminal-condition problem. Another feature of the complete set is that in the subspace of the central scattering area of the system, it consists of contributions of all states with point spectra but does not contain any background integrals. In computing the time evolution, we can clearly see contribution of which point spectrum produces which time dependence. In the whole infinite state space, the complete set does contain an integral but it is over unperturbed eigenstates of the environmental area of the system and hence can be calculated analytically. We demonstrate the usefulness of the complete set by computing explicitly the survival probability and the escaping probability as well as the dynamics of wave packets. The origin of each term of matrix elements is clear in our formulation, particularly, the exponential decays due to the resonance poles. (C) 2014 AIP Publishing LLC.	[Hatano, Naomichi] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Hatano, Naomichi] Washington Univ, Dept Phys, St Louis, MO 63130 USA; [Ordonez, Gonzalo] Butler Univ, Dept Phys & Astron, Indianapolis, IN 46208 USA	Hatano, N (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	hatano@iis.u-tokyo.ac.jp; gordonez@butler.edu	Hatano, Naomichi/K-8176-2012	Hatano, Naomichi/0000-0003-0277-1856	JSPS [22340110]; Yamada Science Foundation; Mitsubishi foundation; Holcomb Awards Committee; Woods Lecture Series at Butler University	One of the authors (N.H.) is deeply indebted to Dr. S. Klaiman for introducing to him the concept of the quadratic eigenvalue problem and to Professor A. Leggett for introducing to him the articles by H. Price. He also greatly appreciates the Clark Way Harrison Visiting Professorship of Washington University in St. Louis. Both authors express sincere gratitude to Dr. T. Petrosky for helpful comments. The paper is partially supported by JSPS Grant-in-Aid for Scientific Research (B) Grant No. 22340110, a Research Grant from the Yamada Science Foundation, a Research Grant in the Natural Sciences from the Mitsubishi foundation, as well as the Holcomb Awards Committee and Woods Lecture Series at Butler University.	Albeverio S, 1996, J MATH PHYS, V37, P4888, DOI 10.1063/1.531668; Gamow G, 1928, Z PHYS, V51, P204, DOI 10.1007/BF01343196; ROTTER I, 1991, REP PROG PHYS, V54, P635, DOI 10.1088/0034-4885/54/4/003; NEWTON RG, 1960, J MATH PHYS, V1, P319, DOI 10.1063/1.1703665; Kunz H, 2006, J PHYS A-MATH GEN, V39, P10155, DOI 10.1088/0305-4470/39/32/S16; Siegert AJF, 1939, PHYS REV, V56, P750, DOI 10.1103/PhysRev.56.750; Sadreev AF, 2003, J PHYS A-MATH GEN, V36, P11413, DOI 10.1088/0305-4470/36/45/005; Petrosky T, 1996, CHAOS SOLITON FRACT, V7, P441, DOI 10.1016/0960-0779(95)00042-9; SUDARSHAN ECG, 1978, PHYS REV D, V18, P2914, DOI 10.1103/PhysRevD.18.2914; FISHER DS, 1981, PHYS REV B, V23, P6851, DOI 10.1103/PhysRevB.23.6851; Fyodorov YV, 1997, J MATH PHYS, V38, P1918, DOI 10.1063/1.531919; LANDAUER R, 1957, IBM J RES DEV, V1, P223; Okolowicz J, 2003, PHYS REP, V374, P271, DOI 10.1016/S0370-1573(02)00366-6; Hatano N, 2008, PROG THEOR PHYS, V119, P187, DOI 10.1143/PTP.119.187; Rotter I, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/15/153001; Tisseur F, 2001, SIAM REV, V43, P235, DOI 10.1137/S0036144500381988; BERGGREN T, 1982, NUCL PHYS A, V389, P261, DOI 10.1016/0375-9474(82)90519-X; Berggren T, 1996, PHYS LETT B, V373, P1, DOI 10.1016/0370-2693(96)00132-3; BERGGREN T, 1968, NUCL PHYS A, VA109, P265, DOI 10.1016/0375-9474(68)90593-9; BERGGREN T, 1970, PHYS LETT B, VB 33, P547, DOI 10.1016/0370-2693(70)90344-8; BOHM A, 1989, AM J PHYS, V57, P1103, DOI 10.1119/1.15797; Datta S., 1995, ELECT TRANSPORT MESO; De la Madrid R, 2005, CZECH J PHYS, V55, P1141, DOI 10.1007/s10582-005-0119-6; Dittes F.-M., 2000, Physics Reports, V339, DOI 10.1016/S0370-1573(00)00065-X; FESHBACH H, 1958, ANN PHYS-NEW YORK, V5, P357, DOI 10.1016/0003-4916(58)90007-1; FESHBACH H, 1962, ANN PHYS-NEW YORK, V19, P287, DOI 10.1016/0003-4916(62)90221-X; Garcia-Calderon G, 2010, ADV QUANTUM CHEM, V60, P407, DOI 10.1016/S0065-3276(10)60007-X; Garmon S, 2013, FORTSCHR PHYS, V61, P261, DOI 10.1002/prop.201200077; Garmon S., DYNAMICAL EVOL UNPUB; Goldzak T, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.052105; GYARMATI B, 1971, NUCL PHYS A, VA160, P523, DOI 10.1016/0375-9474(71)90095-9; Hatano N, 2009, PRAMANA-J PHYS, V73, P553, DOI 10.1007/s12043-009-0107-7; Hatano N, 2010, PROG THEOR PHYS SUPP, P497; Hatano N, 2013, FORTSCHR PHYS, V61, P238, DOI 10.1002/prop.201200064; HOKKYO N, 1965, PROG THEOR PHYS, V33, P1116, DOI 10.1143/PTP.33.1116; KATO T., 1982, SHORT INTRO PERTURBA; Khalfin L.A., 1957, Zhurnal Eksperimental'noi i Teoreticheskoi Fiziki, V33; Kim S., 2014, ARXIV12106714; Klaiman S, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3577997; Kunz H, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.054203; Landau L. D., 1977, QUANTUM MECH NONRELA; LECOUTEUR KJ, 1960, PROC R SOC LON SER-A, V256, P115; Livshits M.S., 1956, Zhurnal Eksperimental'noi i Teoreticheskoi Fiziki, V31; Moiseyev N, 2011, NONHERMITIAN QUANTUM; NAKANISHI N, 1958, PROG THEOR PHYS, V19, P607, DOI 10.1143/PTP.19.607; Nakano R, 2011, INT J THEOR PHYS, V50, P1134, DOI 10.1007/s10773-010-0606-9; Newton R. G., 1982, SCATTERING THEORY WA; Ordonez G, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.052106; Ordonez G., DYNAMICAL BREA UNPUB; Peierls R., 1979, SURPRISES THEORETICA; PEIERLS RE, 1959, PROC R SOC LON SER-A, V253, P16, DOI 10.1098/rspa.1959.0176; PETROSKY T, 1991, PHYSICA A, V173, P175, DOI 10.1016/0378-4371(91)90257-D; Petrosky T, 1997, ADV CHEM PHYS, V99, P1; Petrosky T, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.062101; Pichugin K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.056227; Price H, 2006, STUD HIST PHILOS M P, V37, P498, DOI 10.1016/j.shpsb.2006.03.004; PRIGOGIN.I, 1973, CHEM SCRIPTA, V4, P5; Romo W., 1968, NUCL PHYS          A, V116, P618; ROMO WJ, 1980, J MATH PHYS, V21, P311, DOI 10.1063/1.524417; Sasada K, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.025003; Sasada K, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.104707; Sasada K, 2005, PHYSICA E, V29, P609, DOI 10.1016/j.physe.2005.06.038; Zeldovich Ya.B., 1960, Zhurnal Eksperimental'noi i Teoreticheskoi Fiziki, V39	63	2	2	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0022-2488	1089-7658		J MATH PHYS	J. Math. Phys.	DEC	2014	55	12							122106	10.1063/1.4904200		40	Physics, Mathematical	Physics	AX8OG	WOS:000347168000015		
J	Kotani, M; Schulz-Baldes, H; Villegas-Blas, C				Kotani, Motoko; Schulz-Baldes, Hermann; Villegas-Blas, Carlos			Quantization of interface currents	JOURNAL OF MATHEMATICAL PHYSICS			English	Article							EDGE STATES; HALL; OPERATORS; BULK	At the interface of two two-dimensional quantum systems, there may exist interface currents similar to edge currents in quantum Hall systems. It is proved that these interface currents are macroscopically quantized by an integer that is given by the difference of the Chern numbers of the two systems. It is also argued that at the interface between two time-reversal invariant systems with half-integer spin, one of which is trivial and the other non-trivial, there are dissipationless spin-polarized interface currents. (C) 2014 AIP Publishing LLC.	[Kotani, Motoko] Tohoku Univ, AIMR, Sendai, Miyagi 980, Japan; [Schulz-Baldes, Hermann] Univ Erlangen Nurnberg, Dept Math, D-91054 Erlangen, Germany; [Villegas-Blas, Carlos] UNAM, Inst Matemat, Cuernavaca, Morelos, Mexico	Kotani, M (reprint author), Tohoku Univ, AIMR, Sendai, Miyagi 980, Japan.				AIMR; DFG; PAPIIT-UNAM [IN 106812]	We are thankful for financial support from AIMR, DFG and project PAPIIT-UNAM IN 106812.	HATSUGAI Y, 1993, PHYS REV LETT, V71, P3697, DOI 10.1103/PhysRevLett.71.3697; Schulz-Baldes H, 2013, COMMUN MATH PHYS, V324, P589, DOI 10.1007/s00220-013-1814-y; Reijniers J, 2000, J PHYS-CONDENS MAT, V12, P9771, DOI 10.1088/0953-8984/12/47/305; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Dombrowski N, 2011, ANN HENRI POINCARE, V12, P1169, DOI 10.1007/s00023-011-0093-4; IWATSUKA A, 1985, PUBL RES I MATH SCI, V21, P385, DOI 10.2977/prims/1195179628; Schulz-Baldes H, 2000, J PHYS A-MATH GEN, V33, pL27, DOI 10.1088/0305-4470/33/2/102; HALDANE FDM, 1988, PHYS REV LETT, V61, P2015, DOI 10.1103/PhysRevLett.61.2015; BELLISSARD J, 1994, J MATH PHYS, V35, P5373, DOI 10.1063/1.530758; Avila JC, 2013, MATH PHYS ANAL GEOM, V16, P136; CONNES A, 1985, PUBL MATH-PARIS, V62, P41, DOI 10.1007/BF02698807; De Bievre S., 1999, ELECT J MATH PHYS, V5; De Nittis G., MARKOV PROCESS RELAT; Elbau P, 2002, COMMUN MATH PHYS, V229, P415, DOI 10.1007/s00220-002-0698-z; Frohlich J, 2000, ANN HENRI POINCARE, V1, P405, DOI 10.1007/s000230050001; Kellendonk J, 2004, J FUNCT ANAL, V209, P388, DOI 10.1016/S0022-1236(03)00174-5; Kellendonk J, 2002, REV MATH PHYS, V14, P87, DOI 10.1142/S0129055X02001107; Schulz-Baldes H., ARXIV13110379V2	18	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0022-2488	1089-7658		J MATH PHYS	J. Math. Phys.	DEC	2014	55	12							121901	10.1063/1.4902377		9	Physics, Mathematical	Physics	AX8OG	WOS:000347168000009		
J	Mascaraque, N; Takebe, H; Tricot, G; Fierro, JLG; Duran, A; Munoz, F				Mascaraque, Nerea; Takebe, Hiromichi; Tricot, Gregory; Fierro, Jose Luis G.; Duran, Alicia; Munoz, Francisco			Structure and electrical properties of a new thio-phosphorus oxynitride glass electrolyte	JOURNAL OF NON-CRYSTALLINE SOLIDS			English	Article						Solid electrolytes; Ionic conductivity; Oxynitride glasses; Sulfur; NMR	RAY PHOTOELECTRON-SPECTROSCOPY; PHOSPHATE-GLASSES; NETWORK STRUCTURE; CONDUCTIVITY; NITROGEN; SUBSTITUTION; NMR	For the first time, a thio-phosphorus oxynitride glass containing nitrogen and sulfur, LiPOSN, has been prepared by a melting process in two steps and its manipulation is possible in air without any decomposition. The anionic substitution of oxygen by sulfur and nitrogen in the phosphate glass structure has been confirmed by 1D(31)P solid state NMR and XPS. The 2D(31)P DQ-SQ experiment indicates that S bearing phosphate groups are integrated into the global phosphate network and do not form clusters. Through the study of the properties of this glass, it was verified a decrease of the glass transition temperature, due to the depolymerization of the phosphate network when lithium sulfide is introduced into the oxynitride glass, along with a pronounced increase of the ionic conductivity, that suggest that this glass can be considered as a new highly conductive and corrosion resistant glass electrolyte. (C) 2014 Elsevier B.V. All rights reserved.	[Mascaraque, Nerea; Duran, Alicia; Munoz, Francisco] CSIC, Inst Ceram & Vidrio, Madrid 28049, Spain; [Takebe, Hiromichi] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Tricot, Gregory] Univ Lille 1, LASIR UMR CNRS 8516, F-59655 Villeneuve Dascq, France; [Fierro, Jose Luis G.] CSIC, Inst Catalisis & Petroquim, E-28049 Madrid, Spain	Munoz, F (reprint author), CSIC, Inst Ceram & Vidrio, Kelsen 5, Madrid 28049, Spain.	fmunoz@icv.csic.es		Munoz, Francisco/0000-0002-7322-6559	Ministry of Science [MAT2010-20459]; MEC Ministry	Financial support from the Ministry of Science through project MAT2010-20459 is greatly acknowledged. N. Mascaraque thanks MEC Ministry for providing a FPU-2009 grant. Maria Jose de la Mata (SIDI-UAM) is also greatly acknowledged for her assistance in the NMR characterization.	ALMEIDA RM, 1987, J MATER SCI LETT, V6, P701, DOI 10.1007/BF01770931; Minami T, 2000, SOLID STATE IONICS, V136, P1015, DOI 10.1016/S0167-2738(00)00555-5; WAGNER CD, 1981, SURF INTERFACE ANAL, V3, P211, DOI 10.1002/sia.740030506; LIPPMAA E, 1980, J AM CHEM SOC, V102, P4889, DOI 10.1021/ja00535a008; Minami K, 2011, SOLID STATE IONICS, V192, P122, DOI 10.1016/j.ssi.2010.06.018; Munoz F, 2008, SOLID STATE IONICS, V179, P574, DOI 10.1016/j.ssi.2008.04.004; Le Sauze A, 2000, J NON-CRYST SOLIDS, V263, P285, DOI 10.1016/S0022-3093(99)00673-0; MARCHAND R, 1988, J NON-CRYST SOLIDS, V103, P35, DOI 10.1016/0022-3093(88)90413-9; Brow RK, 2000, J NON-CRYST SOLIDS, V263, P1, DOI 10.1016/S0022-3093(99)00620-1; Sakuda A, 2011, J POWER SOURCES, V196, P6735, DOI 10.1016/j.jpowsour.2010.10.103; BRUCKNER R, 1980, J NON-CRYST SOLIDS, V42, P49, DOI 10.1016/0022-3093(80)90007-1; BUNKER BC, 1987, J AM CERAM SOC, V70, P675, DOI 10.1111/j.1151-2916.1987.tb05738.x; Yu XH, 1997, J ELECTROCHEM SOC, V144, P524, DOI 10.1149/1.1837443; Minami K, 2007, SOLID STATE IONICS, V178, P837, DOI 10.1016/j.ssi.2007.03.001; Ohtomo T, 2013, J NON-CRYST SOLIDS, V364, P57, DOI 10.1016/j.jnoncrysol.2012.12.044; Le Sauze A, 2000, J NON-CRYST SOLIDS, V263, P139, DOI 10.1016/S0022-3093(99)00630-4; WANG B, 1995, J NON-CRYST SOLIDS, V183, P297, DOI 10.1016/0022-3093(94)00665-2; Agostini M, 2013, SOLID STATE IONICS, V244, P48, DOI 10.1016/j.ssi.2013.04.024; REIDMEYER MR, 1995, J NON-CRYST SOLIDS, V181, P201, DOI 10.1016/S0022-3093(94)00511-7; Mascaraque N, 2013, SOLID STATE IONICS, V233, P73, DOI 10.1016/j.ssi.2012.12.017; Cho KI, 2006, ELECTROCHIM ACTA, V52, P1576, DOI 10.1016/j.electacta.2006.02.065; Feike M, 1996, J MAGN RESON SER A, V122, P214, DOI 10.1006/jmra.1996.0197; Larink D, 2012, SOLID STATE NUCL MAG, V45-46, P30, DOI 10.1016/j.ssnmr.2012.05.001; Lee S, 2007, SOLID STATE IONICS, V178, P375, DOI 10.1016/j.ssi.2007.01.011; MARCHAND R, 1983, J NON-CRYST SOLIDS, V56, P173, DOI 10.1016/0022-3093(83)90464-7; Mascaraque N, 2014, SOLID STATE IONICS, V254, P40, DOI 10.1016/j.ssi.2013.10.061; Takebe H., 2005, J MIN MAT PROC I JPN, V121, P260; Takebe H., 2003, REC RES DEV NONCRYST, V3, P159	28	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3093	1873-4812		J NON-CRYST SOLIDS	J. Non-Cryst. Solids	DEC 1	2014	405						159	162		10.1016/j.jnoncrysol.2014.09.011		4	Materials Science, Ceramics; Materials Science, Multidisciplinary	Materials Science	AY0CW	WOS:000347266400025		
J	Takitani, K; Inoue, K; Koh, M; Miyazaki, H; Kishi, K; Inoue, A; Tamai, H				Takitani, Kimitaka; Inoue, Keisuke; Koh, Maki; Miyazaki, Hiroshi; Kishi, Kanta; Inoue, Akiko; Tamai, Hiroshi			alpha-Tocopherol Status and Altered Expression of alpha-Tocopherol-Related Proteins in Streptozotocin-Induced Type 1 Diabetes in Rat Models	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						alpha-tocopherol; type 1 diabetes; oxidative stress; alpha-tocopherol transfer protein	IN-VITRO EXPRESSION; DIETARY VITAMIN-E; OXIDATIVE STRESS; ANTIOXIDANT STATUS; ABC TRANSPORTERS; MELLITUS; CHILDREN; CELLS; SERUM; BINDING	Vitamin E plays a critical role as an antioxidant in several pathological conditions, including diabetes, cancer, cardiovascular diseases, and neurodegenerative disorders. Diabetes is a metabolic disorder of glucose due to the lack of adequate insulin production (type 1) or peripheral insulin resistance (type 2). Oxidative stress plays a major role in the pathogenesis of diabetes and its complications. The purpose of the present study was to determine alpha-tocopherol status and the expression of alpha-tocopherol-related proteins, including binding proteins and metabolizing enzymes, under streptozotocin (STZ)-induced type 1 diabetes in rat models. In STZ rats, plasma alpha-tocopherol levels decreased compared to the control rats, whereas hepatic alpha-tocopherol levels in the STZ rats were significantly increased. CuZn-superoxide dismutase (SOD) gene expression in the liver of STZ rats was markedly decreased, whereas Mn-SOD gene expression remained unaltered. Accelerated lipid peroxidation in the liver of STZ rats was observed and the hepatic expression of alpha-tocopherol transfer protein (alpha-TTP) in STZ rats decreased compared to that in the controls. The hepatic expression of cytochrome P450 4F2 (CYP4F2) and CYP3A2 genes in STZ rats also decreased. The reduced expression of hepatic alpha-TTP and CYP4F2 genes probably leads to decreased plasma alpha-tocopherol levels and elevated alpha-tocopherol levels in the liver of STZ rats. The altered expression of hepatic alpha-tocopherol-related proteins might regulate alpha-tocopherol status in type 1 diabetes. Determining the mechanism of modulating alpha-tocopherol status may be helpful in promoting antioxidant therapy in diabetes.	[Takitani, Kimitaka; Koh, Maki; Kishi, Kanta; Inoue, Akiko; Tamai, Hiroshi] Osaka Med Coll, Dept Pediat, Takatsuki, Osaka 5698686, Japan; [Inoue, Keisuke] Hirakata City Hosp, Dept Pediat, Hirakata, Osaka 5731013, Japan; [Miyazaki, Hiroshi] Osaka Rosai Hosp, Dept Pediat, Sakai, Osaka 5918025, Japan	Takitani, K (reprint author), Osaka Med Coll, Dept Pediat, Takatsuki, Osaka 5698686, Japan.	ped016@poh.osaka-med.ac.jp			Japan Society for the Promotion of Science [17591122, 23591589]; Morinaga Foundation	We thank Yumiko Yoshimura and Kazumi Honda for their technical assistance, and Ryoichi Ban for helpful suggestions. We are grateful to Hiroyuki Arai for antirat alpha-TTP IgG, and Keiichiro Suzuki for antibodies of rat CuZn-SOD and Mn-SOD. This work was supported by Grants-in-Aid for Scientific Research (No. 17591122 and 23591589) from the Japan Society for the Promotion of Science, and a grant of Morinaga Foundation.	Zimmer S, 2000, J BIOL CHEM, V275, P25672, DOI 10.1074/jbc.M000851200; Yamauchi J, 2001, BIOCHEM BIOPH RES CO, V285, P295, DOI 10.1006/bbrc.2001.5162; Ulatowski L, 2012, FREE RADICAL BIO MED, V53, P2318, DOI 10.1016/j.freeradbiomed.2012.10.528; Hozumi M, 1998, J NUTR SCI VITAMINOL, V44, P1; Misaki K, 2003, FREE RADICAL RES, V37, P1037, DOI 10.1080/10715760310001600426; Sontag TJ, 2002, J BIOL CHEM, V277, P25290, DOI 10.1074/jbc.M201466200; Panagabko C, 2003, BIOCHEMISTRY-US, V42, P6467, DOI 10.1021/bi034086v; OOKAWARA T, 1992, J BIOL CHEM, V267, P18505; Seven A, 2004, YONSEI MED J, V45, P703; Kratzer I, 2009, J NEUROCHEM, V108, P707, DOI 10.1111/j.1471-4159.2008.05796.x; Jerkovic L, 2005, J PROTEOME RES, V4, P889, DOI 10.1021/pr0500105; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Mustacich DJ, 2006, FREE RADICAL BIO MED, V41, P1069, DOI 10.1016/j.freeadbiomed.2006.06.022; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; ASAYAMA K, 1994, HORM METAB RES, V26, P313, DOI 10.1055/s-2007-1001693; ASAYAMA K, 1993, FREE RADICAL BIO MED, V15, P597, DOI 10.1016/0891-5849(93)90162-N; Azzi A, 2000, OXIDAT STRESS DIS, V4, P219; Ban R, 2002, FREE RADICAL RES, V36, P933, DOI 10.1080/107156021000006644; Bella DL, 2006, LIPIDS, V41, P105, DOI 10.1007/s11745-006-5077-7; Etzl RP, 2012, J PERINAT MED, V40, P373, DOI 10.1515/jpm-2011-0307; FOLCH J, 1957, J BIOL CHEM, V226, P497; Granado F, 1998, CLIN SCI, V94, P189; Heiser M, 2002, J NEURAL TRANSM-SUPP, P337; Hernandez-Marco R, 2009, PEDIATR NEPHROL, V24, P121, DOI 10.1007/s00467-008-0961-4; HIGUCHI Y, 1982, ACTA MED OKAYAMA, V36, P165; Johnson Felicity, 2005, Molecular Aspects of Medicine, V26, P340, DOI 10.1016/j.mam.2005.07.006; Knekt P, 1999, J INTERN MED, V245, P99, DOI 10.1046/j.1365-2796.1999.00416.x; Leonhardt W, 2000, ANTIOXIDANTS DIABETE, P219; Manuel-y-Keenoy B, 2007, ENCY VITAMIN E, P381; Martin-Gallan P, 2005, FREE RADICAL RES, V39, P933, DOI 10.1080/10715760500156751; McArthur AG, 2003, J MOL EVOL, V57, P200, DOI 10.1007/s00239-003-2466-x; UCHIYAMA M, 1978, ANAL BIOCHEM, V86, P271, DOI 10.1016/0003-2697(78)90342-1; Miyazaki H, 2015, J CLIN BIOC IN PRESS; Packer RS, 2013, BIOCH PHYSL MOL ASPE, P670; Porter TD, 2003, J NUTR BIOCHEM, V14, P3, DOI 10.1016/S0955-2863(02)00262-0; Shaw HM, 1998, J NUTR, V128, P2348; Shibata N, 2001, P NATL ACAD SCI USA, V98, P2244, DOI 10.1073/pnas.041620398; Sun F, 1999, CLIN SCI, V96, P185, DOI 10.1042/CS19980189; Takai S, 2009, J PHARMACOL SCI, V110, P459, DOI 10.1254/jphs.09115FP; TAMAI H, 1988, INT J VITAM NUTR RES, V58, P202; TANIGUCHI N, 1992, ADV CLIN CHEM, V29, P1, DOI 10.1016/S0065-2423(08)60221-8; Traber MG, 2011, FREE RADICAL BIO MED, V51, P2031, DOI 10.1016/j.freeradbiomed.2011.08.033; Traber MG, 2012, MODERN NUTR HLTH DIS, P293; Uusitalo L, 2008, DIABETOLOGIA, V51, P773, DOI 10.1007/s00125-008-0959-2; Uusitalo L, 2005, J PEDIATR ENDOCR MET, V18, P1409	45	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	DEC	2014	60	6					380	386				7	Nutrition & Dietetics	Nutrition & Dietetics	AY1OB	WOS:000347361100002		
J	Asakura, K; Haga, M; Adachi, M; Sakai, H; Takahashi, C; Sasaki, S				Asakura, Keiko; Haga, Megumi; Adachi, Miyuki; Sakai, Haruko; Takahashi, Chieko; Sasaki, Satoshi			Estimation of Food Portion Sizes Frequently Consumed by Children 3-6 Years Old in Japan	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						food portion size; Japan; child; 3-6 y old; nutritional research	BODY-MASS INDEX; DIETARY PATTERNS; PROTEIN-INTAKE; OBESITY; ADULTHOOD; CHILDHOOD; AGE; QUESTIONNAIRE; BEHAVIORS; TRACKING	No study has documented Japanese children's food portion sizes. Since this information is essential to establish valid measurement tools and effective education methods for dietary intake, we measured them using one-day, semi-weighed diet records (DRs) for 489 Japanese children aged 3-6 y. Each food's frequency of appearance on the DRs was counted. If a child consumed a certain food more than once per day, an average weight for that food was calculated and used in the portion size calculation as that child's representative value. In total, 67 food items were consumed by twenty or more children. We calculated the mean, standard deviation, median, minimum, and maximum portion size values for these food items. In addition to these 67 items, Chinese noodles and water were included in the analysis. The most frequently consumed food was well-milled rice (mean portion size for rice = 79 g), which was consumed by 350 children, followed by soy sauce (4 g), eggs (26 g), and carrots (9 g). Among the five most frequently consumed foods, portion sizes of rice and pork but not milk, eggs, or carrots significantly increased with age, height, and weight. In multivariate linear regression analysis, however, the significant relationships between rice portion size and age were not observed. Regarding pork, only the relationship with height was significant. A sex difference was detected in the rice and milk portion sizes. Most of portion sizes observed here were apparently smaller than those reported among United Kingdom children. This study provides important basic information for the implementation of quantitative nutritional research and educational efforts for Japanese preschool children.	[Asakura, Keiko] Univ Tokyo, Interfac Initiat Informat Studies, Tokyo 1130033, Japan; [Asakura, Keiko; Sasaki, Satoshi] Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Tokyo 1130033, Japan; [Haga, Megumi] Ishinomaki Senshu Univ, Res Ctr Creat Partnerships, Ishinomaki, Miyagi 9868580, Japan; [Adachi, Miyuki] Nagoya Univ Arts & Sci, Inst Hlth & Nutr, Aichi 4700196, Japan; [Sakai, Haruko] Tokyo Kasei Gakuin Univ, Dept Hlth & Nutr, Tokyo 1028341, Japan; [Takahashi, Chieko] Nonprofit Corp Shokuseitaigaku Jissen Forum, Tokyo 1690075, Japan	Sasaki, S (reprint author), Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Tokyo 1130033, Japan.	stssasak@m.u-tokyo.ac.jp			Ministry of Health, Labour and Welfare	The collection of original data for this study was financially supported by a research grant from the former Ministry of Health and Welfare (currently the Ministry of Health, Labour and Welfare) in 1998-2000. None of the authors has a potential conflict of interest to disclose.	Hsiao PY, 2013, J NUTR HEALTH AGING, V17, P566, DOI 10.1007/s12603-013-0014-y; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; Koletzko B, 2009, AM J CLIN NUTR, V89, P1836, DOI 10.3945/ajcn.2008.27091; Piernas C, 2011, J NUTR, V141, P1159, DOI 10.3945/jn.111.138727; KELDER SH, 1994, AM J PUBLIC HEALTH, V84, P1121, DOI 10.2105/AJPH.84.7.1121; Gunther ALB, 2007, AM J CLIN NUTR, V86, P1765; Hoppe C, 2004, AM J CLIN NUTR, V79, P494; BELLISLE F, 1988, APPETITE, V11, P111, DOI 10.1016/S0195-6663(88)80010-2; Cercamondi CI, 2013, J NUTR; Council for Science and Technology, 2010, STAND TABL FOOD COMP; Dubois L, 2008, PUB HLTH NUTR, V12, P19; Food and Agriculture Organization of the United Nations, FAOSTAT FOOD BAL SHE; Hornell A, 2013, FOOD NUTR RES, V57, P1; Inokuchi M, 2006, ANN HUM BIOL, V33, P444, DOI 10.1080/03014460600802353; Kobayashi T, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-17; Lake AA, 2006, J PUBLIC HEALTH, V28, P10, DOI 10.1093/pubmed/fdi082; Mikkila V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418; Ministry of Health. Labour and welfare, 2009, DIET REF INT JAP 201; Reeves S, 2011, J NUTR EDUC BEHAV, V43, P543, DOI 10.1016/j.jneb.2010.12.006; Royal College of Paediatrics and Child Health, 2013, BOYS UK GROWTH CHART; Royal College of Paediatrics and Child Health, 2013, GIRLS UK GROWTH CHAR; Sahashi Y, 2011, J NUTR SCI VITAMINOL, V57, P372, DOI 10.3177/jnsv.57.372; Tsubono Y, 1997, NUTR CANCER, V29, P140; Wrieden WL, 2008, BRIT J NUTR, V99, P1344, DOI 10.1017/S0007114507868516	25	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	DEC	2014	60	6					387	396				10	Nutrition & Dietetics	Nutrition & Dietetics	AY1OB	WOS:000347361100003		
J	Tsuchiya, Y; Fujita, R; Saitou, A; Wajima, N; Aizawa, F; Iinuma, A				Tsuchiya, Yo; Fujita, Rina; Saitou, Akae; Wajima, Nanako; Aizawa, Fuyuka; Iinuma, Akane			[6]-Gingerol Induces Electrogenic Sodium Absorption in the Rat Colon via the Capsaicin Receptor TRPV1	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						[6]-gingerol; colon; electrogenic sodium absorption; TRPV1	GUINEA-PIG ILEUM; DISTAL COLON; NA+ ABSORPTION; ION-TRANSPORT; CONTRACTION; MECHANISMS; EXPRESSION; CHANNEL; ANALOGS; CELLS	[6]-Gingerol possesses a variety of beneficial pharmacological and therapeutic properties, including anti-carcinogenic, anti-inflammatory, and anti-emetic activities. Although [6]-gingerol is known to regulate the contraction of the intestine, its effect on intestinal ion transport is unclear. The aim of this study was to examine the role of [6]-gingerol in the regulation of electrogenic ion transport in the rat intestine by measuring the transmural potential difference (Delta PD). [6]-Gingerol induced significant positive Delta PD when administered to the serosal but not mucosal side of the colon, ileum, and jejunum; the highest effect was detected in the colon at a concentration of 10 mu M. [6]-Gingerol-induced increase in Delta PD was suppressed by ouabain, an inhibitor of Na+/K+-ATPase, whereas no effect was observed in response to bumetanide, an inhibitor of the Na+-K+-2Cl(-) co-transporter. In addition, Delta PD induction by [6]-gingerol was greatly diminished by capsazepine, an inhibitor of the capsaicin receptor TRPV1. These results suggest that [6]-gingerol induced the electrogenic absorption of sodium in the rat colon via TRPV1.	[Tsuchiya, Yo; Fujita, Rina; Saitou, Akae; Wajima, Nanako; Aizawa, Fuyuka; Iinuma, Akane] Tohoku Womens Coll, Fac Home Econ, Dept Living Sci, Hirosaki, Aomori 0368530, Japan	Tsuchiya, Y (reprint author), Tohoku Womens Coll, Fac Home Econ, Dept Living Sci, 1-1-16 Kiyohara, Hirosaki, Aomori 0368530, Japan.	ytsuchiya@tojo.ac.jp			Aomori Research, Art and Culture Foundation	This work was supported by Aomori Research, Art and Culture Foundation.	Li XH, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/146142; KAWAI T, 1994, PLANTA MED, V60, P17, DOI 10.1055/s-2006-959399; Lee SH, 2008, MOL CARCINOGEN, V47, P197, DOI 10.1002/mc.20374; Tripathi S, 2007, J SURG RES, V138, P209, DOI 10.1016/j.jss.2006.07.051; Cortright DN, 2007, BBA-MOL BASIS DIS, V1772, P978, DOI 10.1016/j.bbadis.2007.03.003; Kim SO, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/761852; Ahui MLB, 2008, INT IMMUNOPHARMACOL, V8, P1626, DOI 10.1016/j.intimp.2008.07.009; Tsuchiya Y, 2013, BIOSCI BIOTECH BIOCH, V77, P1955, DOI 10.1271/bbb.130140; Abdel-Aziz H, 2006, EUR J PHARMACOL, V530, P136, DOI 10.1016/j.ejphar.2005.10.049; WALPOLE CSJ, 1993, J MED CHEM, V36, P2362, DOI 10.1021/jm00068a014; Someya A, 2003, J PHARMACOL SCI, V92, P359; Binder Henry J., 1994, P2133; Fukuda K, 1998, PEPTIDES, V19, P1043, DOI 10.1016/S0196-9781(98)00043-6; Jiang SZ, 2008, BIOPHARM DRUG DISPOS, V29, P529, DOI 10.1002/bdd.638; Kaji I, 2012, AM J PHYSIOL, V302, P690; Khan K, 2012, MOL NUTR FOOD RES, V56, P1860, DOI 10.1002/mnfr.201200200; Kirschne LB, 1983, AM J PHYSIOL, V244, P429; Li XH, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/951758; Matsumoto K, 2009, AM J PHYSIOL-GASTR L, V297, P348; Md Shahidul I, 2011, ADV EXP MED BIOL, V704, P41; MOUMMI C, 1992, J PHARMACOL EXP THER, V262, P409; Niisato N, 1999, AM J PHYSIOL, V277, P727; Okumi H, 2012, PLANTA MED, V78, P1801, DOI 10.1055/s-0032-1315387; See NA, 1990, AM J PHYSIOL, V259, P593; Shang JJ, 2013, WORLD J GASTROENTERO, V19, P8071, DOI 10.3748/wjg.v19.i44.8071; Tokuda S, 2002, BIOCHEM BIOPH RES CO, V298, P619, DOI 10.1016/S0006-291X(02)02514-7; Tsuchiya Y, 2001, JPN J PHYSIOL, V51, P435, DOI 10.2170/jjphysiol.51.435; TSUJI Y, 1986, J NUTR SCI VITAMINOL, V32, P93; Yang Y, 2002, PHYTOMEDICINE, V9, P146, DOI 10.1078/0944-7113-00091	29	1	1	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	DEC	2014	60	6					403	407				5	Nutrition & Dietetics	Nutrition & Dietetics	AY1OB	WOS:000347361100005		
J	Osaki, A; Okazaki, Y; Kimoto, A; Izu, H; Kato, N				Osaki, Aimi; Okazaki, Yukako; Kimoto, Akiko; Izu, Hanae; Kato, Norihisa			Beneficial Effect of a Low Dose of Ethanol on Liver Function and Serum Urate in Rats Fed a High-Fat Diet	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						ethanol; liver function; urate; high-fat diet; rat	METABOLIC SYNDROME; ANIMAL-TISSUES; ALCOHOL; DISEASE; HYPERTENSION; CONSUMPTION; PROTEIN; HEALTH; GROWTH; ACID	This study investigated the effects of the consumption of 1% or 2% (v/v) ethanol in drinking water for 12 wk on rats fed a high-fat diet. Body weight gain, food intake, and fluid intake were unaffected by ethanol intake. Adipose tissue weight, and serum glucose and lipids were unaffected. Compared to the control (no ethanol), 1% ethanol intake significantly reduced serum levels of alanine aminotransferase (ALT), lactate dehydrogenase (LDH), and ammonia (p<0.05), whereas 2% ethanol intake did so to a lesser extent. Serum urate was significantly lower in both the 1% and 2% ethanol groups than that in the control group (p<0.05). The results suggest a low dose of ethanol has beneficial effects on liver function and serum urate in rats fed a high-fat diet.	[Osaki, Aimi; Kimoto, Akiko; Kato, Norihisa] Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan; [Okazaki, Yukako] Fuji Womens Univ, Fac Human Life Sci, Ishikari, Hokkaido 0613204, Japan; [Izu, Hanae] Natl Res Inst Brewing, Higashihiroshima 7390046, Japan	Kato, N (reprint author), Hiroshima Univ, Grad Sch Biosphere Sci, Higashihiroshima 7398528, Japan.	nkato@hiroshima-u.ac.jp			Brewers Association of Japan	This study was supported by a grant from the Brewers Association of Japan.	Aethur LK, 2007, PHARM RES, V55, P237; Leu JI, 2003, MOL CELL BIOL, V23, P1251, DOI 10.1128/MCB.23.4.1251-1259.2003; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; LIEBER CS, 1965, J CLIN INVEST, V44, P1009, DOI 10.1172/JCI105200; Poli A, 2013, NUTR METAB CARDIOVAS, V23, P487, DOI 10.1016/j.numecd.2013.02.007; Rajwani A, 2012, DIABETES, V61, P915, DOI 10.2337/db11-0963; Li CG, 2013, CURR OPIN RHEUMATOL, V25, P210, DOI 10.1097/BOR.0b013e32835d951e; Dunn W, 2012, J HEPATOL, V57, P384, DOI 10.1016/j.jhep.2012.03.024; Fekjaer HO, 2013, ADDICTION, V108, P2051, DOI 10.1111/add.12104; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Dobrian AD, 2001, HYPERTENSION, V37, P554; Damink SWMO, 2002, NEUROCHEM INT, V41, P177; Okazaki Y, 2011, J NUTR, V141, P1975, DOI 10.3945/jn.111.144246; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Tsugane S, 2012, J GASTROEN HEPATOL, V27, P121, DOI 10.1111/j.1440-1746.2011.07021.x; Botros Mona, 2013, Clin Biochem Rev, V34, P117; Chiarugi P, 2010, EXPERT OPIN THER TAR, V14, P193, DOI 10.1517/14728220903530712; Fini Mehdi A, 2012, Clin Transl Med, V1, P16, DOI 10.1186/2001-1326-1-16; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fromenty B, 2009, J PHARMACOL EXP THER, V331, P23, DOI 10.1124/jpet.109.155168; Magne L, 2007, J HEPATOL, V47, P691, DOI 10.1016/j.jhep.2007.05.018; MARMOT M, 1991, BRIT MED J, V303, P565; Martin CG, 2011, ALCOHOL, V45, P381, DOI 10.1016/j.alcohol.2010.08.003; MIKATA A, 1963, GASTROENTEROLOGY, V44, P159; VandenBerg CL, 1997, EUR J CANCER, V33, P1108, DOI 10.1016/S0959-8049(97)00071-3; Wartburg JP, 1967, BIOCH FACTORS ALCOHO, P3	26	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	DEC	2014	60	6					408	412				5	Nutrition & Dietetics	Nutrition & Dietetics	AY1OB	WOS:000347361100006		
J	Hoshino, D; Hanawa, T; Takahashi, Y; Masuda, H; Kato, M; Hatta, H				Hoshino, Daisuke; Hanawa, Tatsuya; Takahashi, Yumiko; Masuda, Hiroyuki; Kato, Mai; Hatta, Hideo			Chronic Post-Exercise Lactate Administration with Endurance Training Increases Glycogen Concentration and Monocarboxylate Transporter 1 Protein in Mouse White Muscle	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						skeletal muscle; glycogen; lactate supplementation; monocarboxylate transporter1	RAT SKELETAL-MUSCLE; GLUCONEOGENIC PATHWAY; GENE-EXPRESSION; PYRUVATE-KINASE; GLUCOSE-UPTAKE; EXERCISE; OXIDATION; PERFORMANCE; SUBSTRATE; INFUSION	Lactate is oxidized as an energy fuel during exercise, and it also plays a key role in the regulation of glycogen synthesis in the muscles and liver after exercise. Previous studies have suggested that lactate is converted to glycogen and stimulates glycogen synthesis. However, it remains unclear whether chronic post-exercise lactate administration can increase glycogen storage in skeletal muscle. We examined whether 3 wk of chronic post-exercise lactate administration with training can increase muscle glycogen storage and whether such changes are associated with monocarboxylate transporter 1 (MCT1) protein expression in mice. Mice were assigned to receive saline with training (SA+T group; n=6) or lactate with training (LA+T group; n=6). All mice performed 40 min of treadmill running at 25 m/min, following which they received saline or lactate (2.5 mg/g body weight), 6 d/wk for 3 wk. After 3 wk, glycogen concentration at rest was higher in the white tibialis anterior (TA; p<0.05, +34%), but not in the red TA, in the LA+T group. Protein expression of MCT1, the primary lactate transporter, was increased with chronic post-exercise lactate administration in the white TA (p<0.05, +32%), but not in the red TA. MCT1 protein expression was significantly correlated with muscle glycogen concentration in the red and white TA in both groups (p<0.05, r=0.9.69). These results suggest that chronic lactate administration after exercise increases MCT1 protein expression, which can be involved in the regulation of the observed increase in muscle glycogen storage after exercise training.	[Hoshino, Daisuke; Hanawa, Tatsuya; Takahashi, Yumiko; Masuda, Hiroyuki; Kato, Mai; Hatta, Hideo] Univ Tokyo, Grad Sch Arts & Sci, Dept Sports Sci, Tokyo 1538902, Japan	Hatta, H (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Sports Sci, Tokyo 1538902, Japan.	hatta@idaten.c.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [23800021]	This study was partially supported by a grant (Grant-in-Aid for Research Activity Start-up: 23800021) from Japan Society for the Promotion of Science (JSPS).	Dobson GP, 2002, J BIOL CHEM, V277, P27176, DOI 10.1074/jbc.M111422200; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; MCLANE JA, 1979, J BIOL CHEM, V254, P6548; Philp A, 2012, AM J PHYSIOL-ENDOC M, V302, pE1343, DOI 10.1152/ajpendo.00004.2012; JOHNSON JL, 1988, J APPL PHYSIOL, V64, P1591; Brooks GA, 2000, MED SCI SPORT EXER, V32, P790, DOI 10.1097/00005768-200004000-00011; De Bock K, 2008, J APPL PHYSIOL, V104, P1045, DOI 10.1152/japplphysiol.01195.2007; IVY JL, 1988, J APPL PHYSIOL, V64, P1480; Vettor R, 2002, INT J OBESITY, V26, P838, DOI 10.1038/sj.ijo.0802005; Burke LM, 2010, SCAND J MED SCI SPOR, V20, P48, DOI 10.1111/j.1600-0838.2010.01185.x; LO S, 1970, J APPL PHYSIOL, V28, P234; REN JM, 1994, J BIOL CHEM, V269, P14396; Hashimoto T, 2007, FASEB J, V21, P2602, DOI 10.1096/fj.07-8174com; Jin ES, 2009, AM J PHYSIOL-ENDOC M, V296, pE748, DOI 10.1152/ajpendo.90935.2008; Cox GR, 2010, J APPL PHYSIOL, V109, P126, DOI 10.1152/japplphysiol.00950.2009; Bonen A, 2000, AM J PHYSIOL-ENDOC M, V279, pE1131; Hashimoto T, 2013, J APPL PHYSIOL, V115, P260, DOI 10.1152/japplphysiol.00427.2013; Hoshino D, 2012, AM J PHYSIOL-REG I, V302, pR373, DOI 10.1152/ajpregu.00183.2011; ARMSTRON.RB, 1974, PFLUG ARCH EUR J PHY, V352, P243, DOI 10.1007/BF00590489; BERGSTRO.J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; DUFF DA, 1982, BIOCHEM J, V206, P147; Fogt DL, 2004, AM J PHYSIOL-ENDOC M, V286, pE363, DOI 10.1152/ajpendo.00115.2003; HATTA H, 1988, INT J SPORTS MED, V9, P429, DOI 10.1055/s-2007-1025045; Ishihara A, 2002, EXP PHYSIOL, V87, P113; Kitaoka Y, 2011, J PHYSIOL SCI, V61, P467, DOI 10.1007/s12576-011-0167-6; Kitaoka Y, 2010, COMP EXER PHYSL, V6, P171; Lombardi AM, 1999, AM J PHYSIOL-ENDOC M, V276, pE922; Minet AD, 2010, BIOCHEM BIOPH RES CO, V402, P196, DOI 10.1016/j.bbrc.2010.08.102; Nakatani A, 1997, J APPL PHYSIOL, V82, P711; NEWGARD CB, 1984, J BIOL CHEM, V259, P6958; Pagano C, 1997, AM J PHYSIOL-REG I, V273, pR2072; RYAN C, 1995, AM J PHYSIOL-ENDOC M, V269, pE538; SHIOTA M, 1984, BIOCHEM J, V222, P281; STEVENSON RW, 1987, J APPL PHYSIOL, V62, P2237; ZHANG Z, 1994, AM J PHYSIOL, V266, pE583	35	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	DEC	2014	60	6					413	419				7	Nutrition & Dietetics	Nutrition & Dietetics	AY1OB	WOS:000347361100007		
J	Shiraishi, M; Haruna, M; Matsuzaki, M; Murayama, R				Shiraishi, Mie; Haruna, Megumi; Matsuzaki, Masayo; Murayama, Ryoko			Demographic and Lifestyle Factors Associated with Vitamin D Status in Pregnant Japanese Women	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						dietary intake; pregnancy; sunlight exposure; supplement; vitamin D	25-HYDROXYVITAMIN D CONCENTRATIONS; PHYSICAL-ACTIVITY QUESTIONNAIRE; DIET HISTORY QUESTIONNAIRE; D DEFICIENCY; D INSUFFICIENCY; HIGH PREVALENCE; HEALTH; POPULATION; VALIDATION; PREDICTORS	Maternal vitamin D deficiency causes pregnancy complications and delayed skeletal development in offspring. This study aimed at identifying demographic and lifestyle factors associated with vitamin D status in pregnant Japanese women. A total of 284 healthy pregnant women in the second trimester were recruited at a university hospital in Tokyo, between June 2010 and July 2011. Serum 25-hydroxyvitamin D (25(OH)D) concentrations were measured using chemiluminescent immunoassay. We assessed vitamin D intake using a self-administered diet history questionnaire and asked participants about lifestyle variables, including daily duration of sunlight exposure and supplement use. The mean (SD) serum 25(OH)D concentration was 9.8 (4.7) ng/mL. Almost 60% of the participants had severe vitamin D deficiency (measured as 25(OH)D<10 ng/mL). Multiple regression analysis showed that multigravidity, pre-pregnancy non-underweight status, higher energy-adjusted vitamin D intake, and use of vitamin D supplements were correlated with higher serum 25(OH)D concentrations (beta=0.245, beta=-0.119, beta=0.226, and beta=0.197, respectively). In the summer investigation, women with longer durations of sunlight exposure had significantly higher serum 25(OH)D concentrations (beta=0.201) that were unrelated to the factors outlined previously. In the winter investigation, women with a high education level had higher serum 25(OH)D concentrations than others (beta=0.330). Our results would be useful for identifying pregnant women at a high risk of low vitamin D status, such as primigravidae and those with pre-pregnancy underweight status, low education level, low vitamin D intake, and short durations of sunlight exposure.	[Shiraishi, Mie; Haruna, Megumi; Matsuzaki, Masayo] Univ Tokyo, Grad Sch Med, Dept Midwifery & Womens Hlth, Div Hlth Sci & Nursing,Bunkyo Ku, Tokyo 1130033, Japan; [Murayama, Ryoko] Univ Tokyo, Grad Sch Med, Dept Adv Nursing Technol, Tokyo 1138655, Japan	Shiraishi, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Midwifery & Womens Hlth, Div Hlth Sci & Nursing,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	mi-shi@umin.ac.jp			Institute for Food and Health Science; Yazuya Co. Ltd.; Fumiko Yamaji Professional Nursing Education	This work was supported by Institute for Food and Health Science, Yazuya Co. Ltd., 2009, and Fumiko Yamaji Professional Nursing Education, 2011. We are deeply grateful to the participants and the hospital staff for their cooperation.	Ahmed WA, 2013, ECOL FOOD NUTR, V52, P191, DOI 10.1080/03670244.2012.706105; Moon HW, 2012, CLIN BIOCHEM, V45, P326, DOI 10.1016/j.clinbiochem.2011.12.025; Shibata M, 2011, J BONE MINER METAB, V29, P615, DOI 10.1007/s00774-011-0264-x; van den Berg G, 2013, EUR J NUTR, V52, P273, DOI 10.1007/s00394-012-0327-3; ARROYO P, 1978, BRIT J NUTR, V40, P485, DOI 10.1079/BJN19780150; Lips P, 2007, J STEROID BIOCHEM, V103, P620, DOI 10.1016/j.jsbmb.2006.12.076; Sasaki S, 2003, INT J OBESITY, V27, P1405, DOI 10.1038/sj.ijo.0802425; Jaaskelainen T, 2013, EUR J NUTR, V52, P513, DOI 10.1007/s00394-012-0354-0; van der Meer IM, 2006, AM J CLIN NUTR, V84, P350; Christesen HT, 2012, ACTA OBSTET GYN SCAN, V91, P1357, DOI 10.1111/aogs.12000; Earthman CP, 2012, INT J OBESITY, V36, P387, DOI 10.1038/ijo.2011.119; Bassir M, 2001, ACTA PAEDIATR, V90, P577, DOI 10.1080/080352501750197755; Nanri A, 2011, J EPIDEMIOL, V21, P346, DOI 10.2188/jea.JE20100161; Perez-Lopez FR, 2011, REPROD SCI, V18, P730, DOI 10.1177/1933719110396720; Millen AE, 2010, AM J CLIN NUTR, V91, P1324, DOI 10.3945/ajcn.2009.28908; Sasaki S, 2000, J NUTR SCI VITAMINOL, V46, P285; Holvik K, 2005, EUR J CLIN NUTR, V59, P57, DOI 10.1038/sj.ejcn.1602033; Calvo MS, 2005, J NUTR, V135, P310; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Chasan-Taber L, 2004, MED SCI SPORT EXER, V36, P1750, DOI 10.1249/01.MSS.0000142303.49306.0D; Nowson CA, 2002, MED J AUSTRALIA, V177, P149; Ohta H, 2009, J BONE MINER METAB, V27, P682, DOI 10.1007/s00774-009-0095-1; Sasaki S, 1998, JPN CIRC J, V62, P431, DOI 10.1253/jcj.62.431; Matsuzaki M, 2014, JOGNN-J OBST GYN NEO, V43, P107, DOI 10.1111/1552-6909.12267; Perampalam S, 2011, AUST NZ J OBSTET GYN, V51, P353, DOI 10.1111/j.1479-828X.2011.01313.x; Wortsman J, 2000, AM J CLIN NUTR, V72, P690; HADDAD JG, 1993, J CLIN INVEST, V91, P2552, DOI 10.1172/JCI116492; Viljakainen HT, 2010, J CLIN ENDOCR METAB, V95, P1749, DOI 10.1210/jc.2009-1391; Bener Abdulbari, 2013, Int J Womens Health, V5, P523, DOI 10.2147/IJWH.S51403; Christesen HT, 2012, ACTA OBSTET GYN SCAN, V91, P1368, DOI 10.1111/aogs.12006; Datt S, 2002, BJOG-INT J OBSTET GY, V109, P905, DOI 10.1016/S1470-0328(02)01171-0; Dror DK, 2011, J AM DIET ASSOC, V111, P111, DOI 10.1016/j.jada.2010.10.002; EMERSON K, 1975, OBSTET GYNECOL, V45, P505; Japan Meteorological Agency, 2013, MONTHL CUM UV B DOS; Kawada A, 2011, J JPN COSMETIC SCI S, V35, P89; Matsuzaki M, 2010, BIOSCI TRENDS, V4, P170; Ministry of Education Culture Sports Science and Technology, 2005, STAND TABL FOOD COMP; Ministry of Health. Labour and welfare, 2009, DIET REF INT JAP 201; Ministry of Health Labour and Welfare of Japan, 2010, POP SURV REP 2010; Ministry of the Environment, 2008, HLTH GUID MAN ULTR R; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Sasaki S, 1998, J Epidemiol, V8, P203; Shiraishi M, 2015, MATERN CHILD NUTR, V11, P525, DOI 10.1111/mcn.12063; Tsubyama-Kasaoka N, 2013, J NUTR SCI VITAMINOL, V59, P584; Vitamin D, 1997, DIET REF INT CALC PH, P250; Wei SQ, 2012, BJOG-INT J OBSTET GY, V119, P832, DOI 10.1111/j.1471-0528.2012.03307.x; Willett WC, 1997, AM J CLIN NUTR, V65, P1220; Wu BT, 2013, BRIT J NUTR, V109, P936, DOI 10.1017/S0007114512002103; Wuertz C, 2013, BRIT J NUTR, V110, P1895, DOI 10.1017/S0007114513001438	49	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	DEC	2014	60	6					420	428				9	Nutrition & Dietetics	Nutrition & Dietetics	AY1OB	WOS:000347361100008		
J	Tamaru, S; Kurayama, T; Sakono, M; Fukuda, N; Nakamori, T; Furuta, H; Nagata, Y; Tanaka, K				Tamaru, Shizuka; Kurayama, Takayuki; Sakono, Masanobu; Fukuda, Nobuhiro; Nakamori, Toshihiro; Furuta, Hitoshi; Nagata, Yasuo; Tanaka, Kazunari			Dietary Soybean Peptides Containing a Low-Molecular Fraction Can Lower Serum and Liver Triglyceride Levels in Rats	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						low-molecular-weight soybean peptides; hypotriglyceridemic effect; rats	SOY PROTEIN; LIPID-METABOLISM; GENE-EXPRESSION; CHOLESTEROL ABSORPTION; BETA-CONGLYCININ; DOWN-REGULATION; CACO-2 CELLS; DECREASES; MICE; TRIACYLGLYCEROL	We investigated the effects of dietary soybean peptides, particularly low-molecular-weight peptides, on serum and hepatic concentrations of lipids in rats. Soybean protein isolate (SPI) was digested with protease to produce low-molecular-weight peptides (LD) or a mixture of high- and low-molecular-weight peptides (HLD). Rats were fed diets containing 20% casein, SPI, LD or HLD as a nitrogen source, with or without 0.5% cholesterol, for 2 wk. Next, rats were fed cholesterol-free diets containing 0%, 5%, 10%, or 20% LD at the expense of casein for 2 wk. Serum triglyceride levels were the lowest in the LD group, and liver triglyceride levels were significantly lower in rats fed SPI and LD/HLD diets than in those fed casein diets, both in the presence and absence of dietary cholesterol. In addition, dietary LD significantly lowered serum and liver triglyceride levels in a dose-dependent manner. These results suggest that low-molecular-weight soybean peptides have a potent hypotriglyceridemic effect and may be beneficial for improving lipid metabolism.	[Tamaru, Shizuka; Kurayama, Takayuki; Sakono, Masanobu; Fukuda, Nobuhiro] Miyazaki Univ, Fac Agr, Dept Biochem & Appl Biosci, Miyazaki 8892192, Japan; [Tamaru, Shizuka; Nagata, Yasuo; Tanaka, Kazunari] Nagasaki Univ, Fac Nursing & Nutr, Dept Nutr, Nagasaki 8512195, Japan; [Fukuda, Nobuhiro] Miyazaki Int Coll, Sch Educ, Dept Childhood Educ, Miyazaki 8891605, Japan; [Nakamori, Toshihiro; Furuta, Hitoshi] Fuji Oil Co Ltd, Inst Res & Dev, Osaka 5988540, Japan; [Nagata, Yasuo] Nagasaki Univ, Univ & Govt Cooperat, Ctr Ind, Nagasaki 8528131, Japan	Tamaru, S (reprint author), Miyazaki Univ, Fac Agr, Dept Biochem & Appl Biosci, Miyazaki 8892192, Japan.	tamaru@sun.ac.jp			Fuji Foundation	This work was supported by a research grant from the Fuji Foundation for soybean protein and peptides research.	American Institute of Nutrition, 1977, J NUTR, V107, P1340; Shukla A, 2007, J NUTR BIOCHEM, V18, P313, DOI 10.1016/j.jnutbio.2006.05.007; Zhan SY, 2005, AM J CLIN NUTR, V81, P397; Lovati MR, 2000, J NUTR, V130, P2543; Hashidume T, 2011, BIOSCI BIOTECH BIOCH, V75, P1702, DOI 10.1271/bbb.110224; Torres N, 2006, J NUTR BIOCHEM, V17, P365, DOI 10.1016/j.jnutbio.2005.11.005; Mochizuki Y, 2009, J AGR FOOD CHEM, V57, P1473, DOI 10.1021/jf8031793; FLETCHER MJ, 1968, CLIN CHIM ACTA, V22, P393, DOI 10.1016/0009-8981(68)90041-7; Tovar AR, 2002, J NUTR, V132, P2562; Kohno M, 2006, J ATHEROSCLER THROMB, V13, P247; Nagaoka S, 1999, J NUTR, V129, P1725; Moriyama T, 2004, BIOSCI BIOTECH BIOCH, V68, P352, DOI 10.1271/bbb.68.352; ROUSER G, 1966, LIPIDS, V1, P85, DOI 10.1007/BF02668129; Junghans P, 2004, J NUTR, V134, P43; SPERRY WM, 1950, J BIOL CHEM, V187, P97; Anderson JW, 2011, J AM COLL NUTR, V30, P79; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gomez KA, 1984, STAT PROCEDURES AGR, P13; IDE T, 1992, ANN NUTR METAB, V36, P87, DOI 10.1159/000177703; Inoue N, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-85; Lee IT, 2012, NUTR RES, V32, P85, DOI 10.1016/j.nutres.2011.12.011; Lin CY, 2005, WORLD J GASTROENTERO, V11, P5549; Nagaoka S, 1997, BIOSCI BIOTECH BIOCH, V61, P354; SUGANO M, 1990, J NUTR, V120, P977; Sugano M, 1990, Monogr Atheroscler, V16, P85; SUGANO M, 1990, J NUTR SCI VITAMINOL, V36, pS147; SUGANO M, 1988, ATHEROSCLEROSIS, V72, P115, DOI 10.1016/0021-9150(88)90071-8; SUGANO M, 1982, J NUTR, V112, P855; Takahashi Y, 2011, J AGR FOOD CHEM, V59, P8976, DOI 10.1021/jf201403u; Tamaru S, 2007, BIOSCI BIOTECH BIOCH, V71, P2451, DOI 10.1271/bbb.70221; Xie SL, 2012, BRIT J NUTR, V108, P603, DOI 10.1017/S0007114511006015; Yamada Y, 2012, AM J PHYSIOL-ENDOC M, V302, pE433, DOI 10.1152/ajpendo.00161.2011	32	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	DEC	2014	60	6					436	442				7	Nutrition & Dietetics	Nutrition & Dietetics	AY1OB	WOS:000347361100010		
J	Fukuzawa, K; Ouchi, A; Nagaoka, S; Shibata, A; Mukai, K				Fukuzawa, Kenji; Ouchi, Aya; Nagaoka, Shin-ichi; Shibata, Akira; Mukai, Kazuo			A Kinetic Study of the Radical-Scavenging Action of Tocotrienols in the Membranes of Egg Yolk Phosphatidylcholine Vesicles	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						vitamin E; tocopherol; tocotrienol; antioxidant; membrane	ALPHA-TOCOPHEROL; ANTIOXIDANT ACTIVITY; VITAMIN-E; DYNAMICS; PEROXIDATION	Vitamin E is localized in membranes and functions as an efficient inhibitor of lipid peroxidation in biological systems. In this study, we measured the second-order rate constants (k(s)) for the reaction of tocotrienol homologues (alpha-, beta-, gamma-, and delta-Toc-3Hs) with the aroxyl radical (ArO.) used as a model for lipid peroxyl radicals (LOO.) in the membranes of egg yolk phosphatidylcholine (EYPC) vesicles by stopped-flow spectrophotometry, and compared them to those of tocopherol homologues (alpha-, beta-, gamma-, and delta-TocHs). The relative rate constants of Toc-3H homologues to alpha-Toc-3H in membranes (alpha//beta/gamma/ delta=100183.7/63.2120.2) were not much different to those of TocH homologues to alpha-TocH (alpha/beta/gamma/delta=100188.4/83.8/17.3). Each k(s) value of Toc-3H homologues in membranes was 60-80% of that of the corresponding TocH homologues except for the almost identical ks values of delta-homologues, but there was no difference in EtOH solution between each k(s) value of the corresponding homologues of Toc-3H and TocH. These results indicate that the difference of the alkyl-side chain structure of vitamin E causes a change in the mobility of vitamin E molecules and/or the location of their antioxidant OH-groups in membranes, resulting in lowered radical-trapping rates of Toc-3Hs. By use of the ratio of the k(inh) value of alpha-TocH with LOO. (3.20 x 10(6) m(-1)s(-1)) to the k(s) value of alpha-TocH with ArO. (8.05 x 10(4) M(-1)a(-1)) in chlorobenzene (that is, 39.8), the kinh value for the reaction of a-TocH with LOO. in membrane was estimated to be 1.03X10(5) M(-1)s(-1).	[Fukuzawa, Kenji; Shibata, Akira] Yasuda Womens Univ, Fac Pharm, Hiroshima 7310153, Japan; [Ouchi, Aya; Nagaoka, Shin-ichi; Mukai, Kazuo] Ehime Univ, Fac Sci, Matsuyama, Ehime 7908577, Japan	Fukuzawa, K (reprint author), Yasuda Womens Univ, Fac Pharm, Hiroshima 7310153, Japan.	fukuzawaknj@gmail.com					SUZUKI Y, 1993, BIOCHEMISTRY-US, V32, P10692, DOI 10.1021/bi00091a020; Fukuzawa K, 2008, J NUTR SCI VITAMINOL, V54, P273, DOI 10.3177/jnsv.54.273; Ouchi A, 2014, J AGR FOOD CHEM, V62, P8101, DOI 10.1021/jf502049k; Yoshida Y, 2003, CHEM PHYS LIPIDS, V123, P63, DOI 10.1016/S0009-3084(02)00164-0; BURTON GW, 1985, J AM CHEM SOC, V107, P7053, DOI 10.1021/ja00310a049; Niki E, 2010, FREE RADICAL BIO MED, V49, P503, DOI 10.1016/j.freeradbiomed.2010.04.016; Atkinson J, 2008, FREE RADICAL BIO MED, V44, P739, DOI 10.1016/j.freeradbiomed.2007.11.010; BARCLAY LRC, 1993, CAN J CHEM, V71, P1, DOI 10.1139/v93-001; Barclay LRC, 1997, J AM CHEM SOC, V119, P5764, DOI 10.1021/ja9705856; Fukuzawa K, 1997, FREE RADICAL BIO MED, V22, P923, DOI 10.1016/S0891-5849(96)00485-6; Fukuzawa K, 2011, CHEM PHYS LIPIDS, V164, P205, DOI 10.1016/j.chemphyslip.2011.01.001; GRUGER EH, 1971, LIPIDS, V6, P147, DOI 10.1007/BF02531333; Mukai K, 2009, B CHEM SOC JPN, V82, P494, DOI 10.1246/bcsj.82.494; RIEKER A, 1965, LIEBIGS ANN CHEM, V689, P78; Servinova E, 1991, FREE RADICAL BIO MED, V10, P263; Yoshida Y, 2007, J BIOSCI BIOENG, V104, P439, DOI 10.1263/jbb.104.439	16	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	DEC	2014	60	6					443	446				4	Nutrition & Dietetics	Nutrition & Dietetics	AY1OB	WOS:000347361100011		
J	Yoshida, M; Mukama, A; Hosomi, R; Fukunaga, K; Nishiyama, T				Yoshida, Munehiro; Mukama, Ayumi; Hosomi, Ryota; Fukunaga, Kenji; Nishiyama, Toshimasa			Serum and Tissue Iodine Concentrations in Rats Fed Diets Supplemented with Kombu Powder or Potassium Iodide	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						iodine; kombu; thyroid function; absorption	SEAWEED	Serum and tissue iodine concentration was measured in rats fed a diet supplemented with powdered kombu (Saccharina sculpera) or potassium iodide to evaluate the absorption of iodine from kombu. Eighteen male 5-wk-old Wistar rats were divided into three groups and fed a basal AIN93G diet (iodine content, 0.2 mg/kg) or the basal diet supplemented with iodine (183 mg/kg) either in the form of kombu powder or potassium iodine (KI) for 4 wk. There were no differences in weight gain or serum biochemistry tests (alanine aminotransferase and aspartate aminotransferase activity, and total serum cholesterol and triglyceride concentration) after iodine supplementation. In addition, serum levels of the thyroid hormones thyroxine and triiodothyronine, as well as thyroid-stimulating hormone, were not affected. On the other hand, serum and tissue (thyroid, liver and kidney) iodine concentrations were markedly elevated after iodine supplementation. There was no difference in thyroid iodine concentration between KI and kombu supplementation. However, there was a significant difference observed in the iodine concentrations of serum, liver and kidney between the two iodine sources; rats fed KI had iodine concentrations in these tissues 1.8 to 1.9 times higher than those in rats fed kombu powder. These results suggest that the absorption of iodine from kombu is reduced compared to that from potassium iodide.	[Yoshida, Munehiro; Mukama, Ayumi; Hosomi, Ryota; Fukunaga, Kenji] Kansai Univ, Fac Chem Mat & Bioengn, Lab Food & Nutr Sci, Suita, Osaka 5648680, Japan; [Nishiyama, Toshimasa] Kansai Med Univ, Dept Publ Hlth, Hirakata, Osaka 5731010, Japan	Yoshida, M (reprint author), Kansai Univ, Fac Chem Mat & Bioengn, Lab Food & Nutr Sci, 3-3-35 Yamate, Suita, Osaka 5648680, Japan.	hanmyou4@kansai-u.ac.jp					REEVES PG, 1993, J NUTR, V123, P1939; Romaris-Hortas V, 2013, J CHROMATOGR A, V1309, P33, DOI 10.1016/j.chroma.2013.08.022; European Food Safety Authority, 2006, TOL UPP INT LEV VIT, P135; Food and Nutrition Board Institute of Medicine, 2001, DIET REF INT VIT A V, P258; Gao J, 2013, BIOL TRACE ELEM RES, V155, P416, DOI 10.1007/s12011-013-9811-8; Kikuchi Yuriko, 2008, Nihon Eiseigaku Zasshi, V63, P724, DOI 10.1265/jjh.63.724; Miyai K, 2008, ENDOCR J, V55, P1103; NAMBA H, 1993, J CLIN ENDOCR METAB, V76, P605, DOI 10.1210/jc.76.3.605; The Council for Science and Technology, 2010, STAND TABL FOOD COMP, P134; Yoshida M, 2013, J NUTR SCI VITAMINOL, V59, pS91; Yoshida M., 2013, FFI J FOODS FOOD ING, V218, P12; Zava Theodore T, 2011, Thyroid Res, V4, P14, DOI 10.1186/1756-6614-4-14; Zimmermann M. B., 2012, Present knowledge in nutrition, P554	13	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	DEC	2014	60	6					447	449				3	Nutrition & Dietetics	Nutrition & Dietetics	AY1OB	WOS:000347361100012		
J	Shimizu, H; Hagio, M; Iwaya, H; Tsuneki, I; Lee, JY; Fukiya, S; Yokota, A; Miyazaki, H; Hara, H; Ishizuka, S				Shimizu, Hidehisa; Hagio, Masahito; Iwaya, Hitoshi; Tsuneki, Ikuya; Lee, Ja-Young; Fukiya, Satoru; Yokota, Atsushi; Miyazaki, Hitoshi; Hara, Hiroshi; Ishizuka, Satoshi			Deoxycholic Acid Is Involved in the Proliferation and Migration of Vascular Smooth Muscle Cells	JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY			English	Article						high-fat diet; enterobacterium; bile acid; atherosclerosis	CHRONIC-RENAL-FAILURE; NF-KAPPA-B; BILE-ACIDS; GENE-EXPRESSION; INSULIN-RESISTANCE; BETA-RECEPTORS; GLOBAL BURDEN; ATHEROSCLEROSIS; LIGANDS; RATS	Obesity is increasingly becoming associated with increased risk of atherosclerosis. Serum levels of the bile acid deoxycholic acid (DCA) are elevated in mice with obesity induced by a high-fat (HF) diet. Therefore, we investigated the influence of DCA on the functions of vascular smooth muscle cells (VSMCs) because the initiation and progression of atherosclerosis are associated with VSMC proliferation and migration. DCA induced c-jun N-terminal kinase (JNK) activation whereas a JNK inhibitor prevented DCA-induced VSMC proliferation and migration. Based on these findings, we examined whether DCA promotes the expression of platelet-derived growth factor beta-receptor (PDGFR beta) that has a c-Jun binding site in its promoter region. The mRNA and protein expression levels of PDGFR beta were upregulated in VSMCs after a 24- and 48-h incubation with DCA, respectively. The effects of PDGF such as proliferation and migration of VSMCs were promoted after a 48-h incubation with DCA despite the absence of DCA during PDGF stimulation. These findings suggest that elevated serum concentrations of DCA are involved in the pathogenesis of atherosclerosis in HF-induced obesity.	[Shimizu, Hidehisa; Iwaya, Hitoshi; Tsuneki, Ikuya; Lee, Ja-Young; Fukiya, Satoru; Yokota, Atsushi; Hara, Hiroshi; Ishizuka, Satoshi] Hokkaido Univ, Res Fac Agr, Div Appl Biosci, Sapporo, Hokkaido 0608589, Japan; [Hagio, Masahito] Toyo Univ, Fac Life Sci, Gunma 3740193, Japan; [Miyazaki, Hitoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Shimizu, H (reprint author), Hokkaido Univ, Res Fac Agr, Div Appl Biosci, Sapporo, Hokkaido 0608589, Japan.	hideshmz@chem.agr.hokudai.ac.jp	Fukiya, Satoru/C-8346-2012	Fukiya, Satoru/0000-0002-3147-1070	Regional Innovation Strategy Support Program of the MEXT (Ministry of Education, Culture, Sports, Science and Technology) from the Japanese government; Ministry of Education, Culture, Sports, Science and Technology of Japan [25750356]	We thank Norma Foster for help with preparing the manuscript. This study was supported by the Regional Innovation Strategy Support Program of the MEXT (Ministry of Education, Culture, Sports, Science and Technology) from the Japanese government and a Grant-in-Aid for Young Scientists (B) 25750356 (to H.S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Lew JL, 2004, J BIOL CHEM, V279, P8856, DOI 10.1074/jbc.M306422200; Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046; Izumi Y, 2001, CIRC RES, V88, P1120, DOI 10.1161/hh1101.091267; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Chen AP, 2003, J BIOL CHEM, V278, P23381, DOI 10.1074/jbc.M212042200; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Li YTY, 2007, ARTERIOSCL THROM VAS, V27, P2606, DOI 10.1161/ATVBAHA.107.152694; Hagio M, 2009, J LIPID RES, V50, P173, DOI 10.1194/jlr.D800041-JLR200; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; Bornfeldt KE, 2011, CELL METAB, V14, P575, DOI 10.1016/j.cmet.2011.07.015; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; London GM, 1997, KIDNEY INT, V51, P1678, DOI 10.1038/ki.1997.233; Jimenez F, 2002, DIGEST DIS SCI, V47, P2398, DOI 10.1023/A:1020575001944; Rault-Nania MH, 2006, BRIT J NUTR, V96, P840, DOI 10.1017/BJN20061913; Zhang QH, 2008, CARDIOVASC RES, V77, P560, DOI 10.1093/cvr/cvm068; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; NORDIN AA, 1968, P SOC EXP BIOL MED, V129, P57; Qin P, 2006, AM J PHYSIOL-HEART C, V291, pH741, DOI 10.1152/ajpheart.01182.2005; REDDY BS, 1981, CANCER RES, V41, P3766; ROSS R, 1995, ANNU REV PHYSIOL, V57, P791, DOI 10.1146/annurev.ph.57.030195.004043; Shimizu H, 2009, AM J PHYSIOL-CELL PH, V297, pC389, DOI 10.1152/ajpcell.00206.2009; Shimizu H, 2013, AM J PHYSIOL-CELL PH, V304, pC685, DOI 10.1152/ajpcell.00236.2012; Tamura K, 2000, ATHEROSCLEROSIS, V149, P351, DOI 10.1016/S0021-9150(99)00349-4; Yamakado M, 1999, Kidney Int Suppl, V71, pS190	27	0	0	CENTER ACADEMIC PUBL JAPAN	TOKYO	2-4-16 YAYOI, BUNKYO-KU, TOKYO, 113-0032, JAPAN	0301-4800	1881-7742		J NUTR SCI VITAMINOL	J. Nutr. Sci. Vitaminol.	DEC	2014	60	6					450	454				5	Nutrition & Dietetics	Nutrition & Dietetics	AY1OB	WOS:000347361100013		
J	Sasaki, S; Yoshioka, E; Saijo, Y; Kita, T; Tamakoshi, A; Kishi, R				Sasaki, Sachiko; Yoshioka, Eiji; Saijo, Yasuaki; Kita, Toshiko; Tamakoshi, Akiko; Kishi, Reiko			Short Sleep Duration Increases the Risk of Chronic Kidney Disease in Shift Workers	JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							GLOMERULAR-FILTRATION-RATE; CORONARY-HEART-DISEASE; JAPANESE MALE WORKERS; CARDIOVASCULAR-DISEASE; EPIDEMIOLOGIC EVIDENCE; FOLLOW-UP; HEALTH; ASSOCIATION; POPULATION; COHORT	Objective: To investigate the association of sleep duration and shift work with development of chronic kidney disease (CKD) in Japanese workers. Methods: A total of 3600 participants without CKD were observed for an average of 4.4 years. The Cox proportional-hazards regression model was used to estimate hazard ratios and 95% confidence intervals of the risk of CKD associated with sleep duration and shift work. Results: Sleep duration and shift work showed no significant association with the risk of CKD. Nevertheless, when the results were stratified by shift work status, short sleep duration was associated with a significantly higher risk of CKD among shift workers (hazard ratio = 3.60; 95% confidence interval: 1.52 to 10.68). Conclusions: Short sleep duration was a risk factor for early CKD but only among shift workers.	[Sasaki, Sachiko; Tamakoshi, Akiko] Hokkaido Univ, Grad Sch Med, Dept Publ Hlth Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Sasaki, Sachiko] Hokkaido Bunkyo Univ, Fac Human Sci, Dept Phys Therapy, Kogane, Eniwa, Japan; [Yoshioka, Eiji; Saijo, Yasuaki] Asahikawa Med Univ, Dept Hlth Sci, Asahikawa, Hokkaido, Japan; [Kita, Toshiko] Hokkaido Informat Univ, Dept Med Management & Informat, Ebetsu, Hokkaido, Japan; [Kishi, Reiko] Hokkaido Univ, Ctr Environm & Hlth Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Kishi, R (reprint author), Hokkaido Univ, Ctr Environm & Hlth Sci, Kita Ku, Kita 12,Nishi 7, Sapporo, Hokkaido 0600812, Japan.	rkishi@med.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan	This work was supported in part by a Grant-in-Aid for Young Scientists from the Ministry of Education, Culture, Sports, Science and Technology of Japan and a Grant-in-Aid for Scientific Research from the Ministry of Health, Labor and Welfare of Japan.	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Harma M, 2006, SCAND J WORK ENV HEA, V32, P502; Iseki K, 2012, CLIN EXP NEPHROL, V16, P244, DOI 10.1007/s10157-011-0551-9; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; Rajaratnam SMW, 2013, MED J AUSTRALIA, V199, pS11, DOI 10.5694/mja13.10561; Frost P, 2009, SCAND J WORK ENV HEA, V35, P163; Tsutsumi A, 2001, OCCUP ENVIRON MED, V58, P367, DOI 10.1136/oem.58.6.367; Puttonen S, 2010, SCAND J WORK ENV HEA, V36, P96; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; Fried LF, 2003, J AM COLL CARDIOL, V41, P1364, DOI 10.1016/S0735-1097(03)00163-3; Drey N, 2003, AM J KIDNEY DIS, V42, P677, DOI 10.1053/S0272-6386(03)00916-8; Mullington JM, 2009, PROG CARDIOVASC DIS, V51, P294, DOI 10.1016/j.pcad.2008.10.003; Tsatsoulis A, 2006, ANN NY ACAD SCI, V1083, P196, DOI 10.1196/annals.1367.020; Kinebuchi SI, 2004, CLIN SCI, V107, P317, DOI 10.1042/CS20040074; Drake CL, 2004, SLEEP, V27, P1453; Chandola T, 2010, SLEEP, V33, P739; Ikehara S, 2009, SLEEP, V32, P295; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Mallon L, 2005, DIABETES CARE, V28, P2762, DOI 10.2337/diacare.28.11.2762; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Nickolas TL, 2008, CURR OPIN NEPHROL HY, V17, P127, DOI 10.1097/MNH.0b013e3282f4e525; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Spiegel K, 2005, J APPL PHYSIOL, V99, P2008, DOI 10.1152/japplphysiol.00660.2005; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Gangwisch JE, 2013, AM J HYPERTENS, V26, P903, DOI 10.1093/ajh/hpt044; Brown DL, 2009, AM J EPIDEMIOL, V169, P1370, DOI 10.1093/aje/kwp056; Turek NF, 2012, AM J KIDNEY DIS, V60, P823, DOI 10.1053/j.ajkd.2012.04.027; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Itani O, 2011, SLEEP MED, V12, P341, DOI 10.1016/j.sleep.2010.09.007; Tamakoshi A, 2004, SLEEP, V27, P51; Bansil P, 2011, J CLIN HYPERTENS, V13, P739, DOI 10.1111/j.1751-7176.2011.00500.x; De Bacquer D, 2009, INT J EPIDEMIOL, V38, P848, DOI 10.1093/ije/dyn360; Gottlieb DJ, 2006, SLEEP, V29, P1009; Chou YT, 2011, NEPHROL DIAL TRANSPL, V26, P2244, DOI 10.1093/ndt/gfq821; Beihl DA, 2009, ANN EPIDEMIOL, V19, P351, DOI 10.1016/j.annepidem.2008.12.001; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Ohayon MM, 2010, CHRONOBIOL INT, V27, P575, DOI 10.3109/07420521003749956; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Davidson MB, 2006, ARCH INTERN MED, V166, P846, DOI 10.1001/archinte.166.8.846; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Leproult R, 1997, SLEEP, V20, P865; Basta M, 2007, SLEEP MED CLIN, V2, P279, DOI 10.1016/j.jsmc.2007.04.002; Charles LE, 2013, J OCCUP ENVIRON MED, V55, P1323, DOI 10.1097/JOM.0b013e3182a299c9; Collins Allan J, 2013, Am J Kidney Dis, V61, pe1, DOI 10.1053/j.ajkd.2012.11.031; Collins AJ, 2013, AM J KIDNEY DIS, V61, pE1; Doi Y, 2000, J Epidemiol, V10, P79; Fujibayashi K, 2012, J ATHEROSCLER THROMB, V19, P932; Fujino Y, 2006, AM J EPIDEMIOL, V164, P128, DOI 10.1093/aje.kwj185; Heslop Pauline, 2002, Sleep Med, V3, P305, DOI 10.1016/S1389-9457(02)00016-3; Kawashima M, 2012, J OCCUP HEALTH, V54, P176; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; NHK Broadcasting Culture Research Institute, 2006, NAT TIM US SURV 2005; Sugisawa A, 1993, Sangyo Igaku, V35, P7; Tenkanen L, 1998, SCAND J WORK ENV HEA, V24, P351; US-Sleep-Foundation, 2005, SLEEP AM POLL SUMM F; Vyas MV, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4800; Yamamoto R, 2012, AM J KIDNEY DIS, V59, P343, DOI 10.1053/j.ajkd.2011.08.032; Zandi-Nejad K, 2004, KIDNEY INT S, V92, pS76	59	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1076-2752	1536-5948		J OCCUP ENVIRON MED	J. Occup. Environ. Med.	DEC	2014	56	12					1243	1248		10.1097/JOM.0000000000000322		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AX1GR	WOS:000346696400004		
J	Kashima, S; Yorifuji, T; Suzuki, E				Kashima, Saori; Yorifuji, Takashi; Suzuki, Etsuji			Asian Dust and Daily Emergency Ambulance Calls Among Elderly People in Japan An Analysis of Its Double Role as a Direct Cause and as an Effect Modifier	JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE			English	Article							STRATIFIED CASE-CROSSOVER; PARTICULATE MATTER; AIR-POLLUTION; SAHARAN DUST; DAILY MORTALITY; DESERT DUST; HOSPITAL ADMISSIONS; COARSE PARTICLES; WESTERN JAPAN; MADRID SPAIN	Objective: To evaluate the direct health effects of Asian dust on ambulance calls and its role as an effect modifier on the effects of anthropogenic air pollution in Japan. Methods: The subjects were 51,945 elderly residents who visited hospital emergency departments from 2006 to 2010. We evaluated the impact of Asian dust by time-series analyses and the excess risk from suspended particulate matter (SPM) stratified by Asian-dust exposure. Results: Asian dust was associated with daily ambulance calls due to all-cause, cardiovascular, and respiratory disease independently of SPM, for example, the relative risk per interquartile increase in Asian dust (3-day lag) was 1.021 (1.002 to 1.039) for cardiovascular disease. Furthermore, Asian dust modified the effects of SPM on cardiovascular and respiratory diseases. Conclusions: Asian dust had adverse effects and modified the effect of SPM.	[Kashima, Saori] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Minami Ku, Hiroshima 7348551, Japan; [Yorifuji, Takashi] Okayama Univ, Grad Sch Environm & Life Sci, Dept Human Ecol, Kita Ku, Okayama 7008530, Japan; [Suzuki, Etsuji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Epidemiol, Kita Ku, Okayama 7008530, Japan	Kashima, S (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	saori.ksm@gmail.com			Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan [25860462, 24510033, 22390124]; Graduate School of Environmental and Life Science, Okayama University [20802C4302]	This research was supported by a Grant-in-Aid for Young Scientists (B) (No. 25860462), in addition to Grants-in-Aid for Scientific Research (C) (No. 24510033 and 22390124) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan and a further grant from the Discretionary Research Fund of the Dean of the Graduate School of Environmental and Life Science, Okayama University (No. 20802C4302).	Perez L, 2008, EPIDEMIOLOGY, V19, P800, DOI 10.1097/EDE.0b013e31818131cf; Sajani SZ, 2011, OCCUP ENVIRON MED, V68, P446, DOI 10.1136/oem.2010.058156; Kashima S, 2012, OCCUP ENVIRON MED, V69, P908, DOI 10.1136/oemed-2012-100797; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Uno I, 2009, NAT GEOSCI, V2, P557, DOI 10.1038/NGEO583; Reyes M, 2014, INT J ENVIRON HEAL R, V24, P63, DOI 10.1080/09603123.2013.782604; Sandstrom T, 2008, EPIDEMIOLOGY, V19, P808, DOI 10.1097/EDE.0b013e31818809e0; Chan CC, 2011, SCI TOTAL ENVIRON, V410, P47, DOI 10.1016/j.scitotenv.2011.09.031; Samoli E, 2011, SCI TOTAL ENVIRON, V409, P2049, DOI 10.1016/j.scitotenv.2011.02.031; Karanasiou A, 2012, ENVIRON INT, V47, P107, DOI 10.1016/j.envint.2012.06.012; Mallone S, 2011, ENVIRON HEALTH PERSP, V119, P1409, DOI [10.12989/ehp.1003026, 10.1289/ehp.1003026]; Armstrong BG, 1998, OCCUP ENVIRON MED, V55, P651; Yorifuji T, 2013, J OCCUP ENVIRON MED, V55, P768, DOI 10.1097/JOM.0b013e3182973092; Lipsett MJ, 2006, ENVIRON HEALTH PERSP, V114, P1215, DOI 10.1289/ehp.8856; Johnston F, 2011, ENVIRON RES, V111, P811, DOI 10.1016/j.envres.2011.05.007; Yang CY, 2005, ENVIRON RES, V99, P79, DOI 10.1016/j.envres.2004.12.009; Sugimoto N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016349; Tao Y, 2012, SCI TOTAL ENVIRON, V423, P8, DOI 10.1016/j.scitotenv.2012.01.064; Jimenez E, 2010, SCI TOTAL ENVIRON, V408, P5729, DOI 10.1016/j.scitotenv.2010.08.049; Wang QZ, 2011, SCI TOTAL ENVIRON, V409, P573, DOI 10.1016/j.scitotenv.2010.10.032; Alessandrini ER, 2013, OCCUP ENVIRON MED, V70, P432, DOI 10.1136/oemed-2012-101182; Kamouchi M, 2012, STROKE, V43, P3085, DOI 10.1161/STROKEAHA.112.672501; Kanatani KT, 2010, AM J RESP CRIT CARE, V182, P1475, DOI 10.1164/rccm.201002-0296OC; Ueda K, 2012, INHAL TOXICOL, V24, P858, DOI 10.3109/08958378.2012.724729; Chan CC, 2008, ENVIRON RES, V106, P393, DOI 10.1016/j.envres.2007.09.006; Yorifuji T, 2014, STROKE, V45, P1264, DOI 10.1161/STROKEAHA.114.005227; Bell ML, 2008, OCCUP ENVIRON MED, V65, P104, DOI 10.1136/oem.2006.031500; Yorifuji T, 2011, SCI TOTAL ENVIRON, V409, P3620, DOI 10.1016/j.scitotenv.2011.06.002; Daniels MJ, 2000, AM J EPIDEMIOL, V152, P397, DOI 10.1093/aje/152.5.397; Kang JH, 2012, ANN EPIDEMIOL, V22, P257, DOI 10.1016/j.annepidem.2012.02.008; Lee H, 2014, ATMOS ENVIRON, V89, P309, DOI 10.1016/j.atmosenv.2014.02.048; Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805; Gerlofs-Nijland ME, 2007, INHAL TOXICOL, V19, P1055, DOI 10.1080/08958370701626261; Zanobetti A, 2009, ENVIRON HEALTH PERSP, V117, P898, DOI 10.1289/ehp.0800108; Mori I, 2003, ATMOS ENVIRON, V37, P4253, DOI 10.1016/S1352-2310(03)00535-1; Hashizume Masahiro, 2010, Nihon Eiseigaku Zasshi, V65, P413; Hwang Seung-Sik, 2005, J Prev Med Public Health, V38, P197; Matsukawa R, 2014, CIRC-CARDIOVASC QUAL, V7, P743, DOI 10.1161/CIRCOUTCOMES.114.000921; Middleton N, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-39; Nishikawa M, 2011, SOLA, V7A, P9, DOI 10.2151/sola.7A-003; Okayama City, 2013, INFL SURV; Working Group on Health Effects Assessment for Fine Particulate Matter, 2008, REP WORK GROUP M HLT; Yorifuji T, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-67	43	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1076-2752	1536-5948		J OCCUP ENVIRON MED	J. Occup. Environ. Med.	DEC	2014	56	12					1277	1283		10.1097/JOM.0000000000000334		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	AX1GR	WOS:000346696400008		
J	Battino, R; Rettich, TR; Tominaga, T				Battino, Rubin; Rettich, Timothy R.; Tominaga, Toshihiro			The Solubility of Nitrogen and Air in Liquids (vol 13, pg 563, 1984)	JOURNAL OF PHYSICAL AND CHEMICAL REFERENCE DATA			English	Correction									[Battino, Rubin] Wright State Univ, Dept Chem, Dayton, OH 45435 USA; [Rettich, Timothy R.] Illinois Wesleyan Univ, Dept Chem, Bloomington, IL 61701 USA; [Tominaga, Toshihiro] Okayama Univ Sci, Dept Fundamental Nat Sci, Okayama 700, Japan	Battino, R (reprint author), Wright State Univ, Dept Chem, Dayton, OH 45435 USA.	rubin.battino@wright.edu					BATTINO R, 1984, J PHYS CHEM REF DATA, V13, P563	1	0	0	AMER INST PHYSICS	MELVILLE	1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA	0047-2689	1529-7845		J PHYS CHEM REF DATA	J. Phys. Chem. Ref. Data	DEC	2014	43	4							049901	10.1063/1.4901082		1	Chemistry, Multidisciplinary; Chemistry, Physical; Physics, Multidisciplinary	Chemistry; Physics	AX8HW	WOS:000347151700006		
J	Hoshi, T; Imanishi, N; Higa, Y; Chaves, LF				Hoshi, Tomonori; Imanishi, Nozomi; Higa, Yukiko; Fernando Chaves, Luis			MOSQUITO BIODIVERSITY PATTERNS AROUND URBAN ENVIRONMENTS IN SOUTH-CENTRAL OKINAWA ISLAND, JAPAN	JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION			English	Article						Mosquito biodiversity; mosquito fauna; Ryukyu Archipelago; Okinawa Island	ANOPHELES HYRCANUS GROUP; RYUKYU ARCHIPELAGO; SIMILARITY INDEXES; DIPTERA-CULICIDAE; IDENTIFICATION; ABUNDANCE; HABITATS; DYNAMICS; WEATHER; RECORDS	Okinawa is the largest, most urbanized, and densely populated island in the Ryukyus Archipelago, where mosquito species diversity has been thoroughly studied. However, the south-central Okinawa mosquito fauna has been relatively poorly studied. Here, we present results from a mosquito faunal survey in urban environments of Nishihara city, south-central Okinawa. Mosquitoes were sampled biweekly, from April 2007 to March 2008, at 3 different environments: a forest preserve, an animal farm, and a water reservoir. We employed 4 mosquito collection methods: 1) oviposition traps; 2) light traps; 3) sweep nets; and 4) larval surveys of tree holes, leaf axils, and artificial water containers. We collected a total of 568 adults and 10,270 larvae belonging to 6 genera and 13 species, including 6 species of medical importance: Aedes albopictus, Armigeres subalbatus, Anopheles Hyrcanus group, Culex bitaeniorhynchus, Cx. quinquefasciatus, and Cx. tritaeniorhynchus. Mosquito species composition was similar to data from previous studies in Okinawa Island. The flattening of the species accumulation curve suggests that our diversity sampling was exhaustive with light and oviposition traps, as well as the coincidence between the species richness we found in the field and estimates from the Chao2 index, a theoretical estimator of species richness based on species abundance. This study highlights the importance of combining several sampling techniques to properly characterize regional mosquito fauna and to monitor changes in the presence of mosquito species.	[Hoshi, Tomonori] Univ Ryukyus, Fac Agr, Entomol Lab, Nishihara, Okinawa 9030213, Japan; [Hoshi, Tomonori; Imanishi, Nozomi; Higa, Yukiko; Fernando Chaves, Luis] Nagasaki Univ, Inst Trop Med NEKKEN, Nagasaki 8528523, Japan; [Fernando Chaves, Luis] Univ Nacl, Escuela Med Vet, PIET, Heredia 3043000, Costa Rica	Chaves, LF (reprint author), Nagasaki Univ, Inst Trop Med NEKKEN, Nagasaki 8528523, Japan.		Chaves, Luis Fernando/F-3448-2010	Hoshi, Tomonori/0000-0003-4569-4600; Chaves, Luis Fernando/0000-0002-5301-2764	Nagasaki University	We thank Ichiro Miyagi (University of Ryukyus) and Takako Toma (University of Ryukyus), who supported study design and implementation, including technical and financial support, and Masako Yafuso (University of Ryukyus) for encouragement throughout the study. Two anonymous reviewers provided valuable comments to improve the manuscript presentation. Junko Sakemoto provided administrative support at Nagasaki University. This study was partially supported by the Nagasaki University Program for Nurturing Global Leaders in Tropical and Emerging Communicable Diseases.	Nguyen AT, 2012, J MED ENTOMOL, V49, P1328, DOI 10.1603/ME12090; Li C, 2005, ZOOTAXA, P1; Foley DH, 2007, J MED ENTOMOL, V44, P554, DOI 10.1603/0022-2585(2007)44[554:IIGMBF]2.0.CO;2; Hoshi T, 2014, ANN ENTOMOL SOC AM, V107, P136, DOI 10.1603/AN13071; Brown HE, 2008, J MED ENTOMOL, V45, P517, DOI 10.1603/0022-2585(2008)45[517:EOMTIM]2.0.CO;2; Rueda LM, 2007, ZOOTAXA, P43; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Ota H, 1998, RES POPUL ECOL, V40, P189, DOI 10.1007/BF02763404; Bram RA, 1967, CONTRIBUTIONS AM ENT, V2, P1; Chaves L. F., 2011, ECOSPHERE, V2, DOI DOI 10.1890/ES11-00088.1; Chaves LF, 2011, B ENTOMOL RES, V101, P633, DOI 10.1017/S0007485310000519; Doi Hideyuki, 2011, Japanese Journal of Ecology (Otsu), V61, P3; Goma LKH, 1966, THE MOSQUITO; GOTELLI N. J., 2010, BIOL DIVERSITY FRONT, P39; Intermill RW, 1967, DISTRIBUTION ABUNDAN; Kasai S, 2007, J MED ENTOMOL, V44, P822, DOI 10.1603/0022-2585(2007)44[822:IRIPVM]2.0.CO;2; Makiya K., 1974, Japanese Journal of Sanitary Zoology, V25, P41; MCDONALD JL, 1972, MOSQ NEWS, V32, P466; MIYAGI I, 1976, Tropical Medicine, V17, P201; Miyagi Ichiro, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P498; MIYAGI I, 1992, MED VET ENTOMOL, V6, P290, DOI 10.1111/j.1365-2915.1992.tb00620.x; Miyagi I, 1980, JPN J SANIT ZOOL, V31, P81; MIYAGI I, 1990, Mosquito Systematics, V22, P185; Mizuno Y, 2011, J INFECT CHEMOTHER, V17, P419, DOI 10.1007/s10156-010-0124-y; NIID [National Institute of Infectious Diseases-Japan], 2010, NESID ANN SURV DAT N; Okudo H, 2004, J AM MOSQUITO CONTR, V20, P134; REISEN WK, 1972, MOSQ NEWS, V32, P107; Rueda LM, 2005, J AM MOSQUITO CONTR, V21, P458, DOI 10.2987/8756-971X(2006)21[458:HADOAS]2.0.CO;2; Silver J, 2008, MOSQUITO ECOLOGY FIE; Taira Katsuya, 2012, Medical Entomology and Zoology, V63, P289, DOI 10.7601/mez.63.289; Takasaki Tomohiko, 2011, Trop Med Health, V39, P13, DOI 10.2149/tmh.2011-S07; TANAKA K, 1979, Contributions of the American Entomological Institute, V16, P1; Tanaka Kazuo, 2003, Japanese Journal of Systematic Entomology, V9, P159; Thongsripong P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002507; TOMA T, 1986, Mosquito Systematics, V18, P1; Toma Takako, 2002, Medical Entomology and Zoology, V53, P7; Toma Takako, 2003, Medical Entomology and Zoology, V54, P267; WHO, 1975, MAN PRACT ENT MAL 2; WHO [World Health Organization], 1975, MANUAL PRACTICAL E 1	39	3	3	AMER MOSQUITO CONTROL ASSOC	MOUNT LAUREL	15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA	8756-971X	1943-6270		J AM MOSQUITO CONTR	J. Am. Mosq. Control Assoc.	DEC	2014	30	4					260	267		10.2987/14-6432R.1		8	Entomology	Entomology	AX7GQ	WOS:000347085200002		
J	Lin, YJ; Ikeya, T; Kirchner, DK; Guntert, P				Lin, Yi-Jan; Ikeya, Teppei; Kirchner, Donata K.; Guentert, Peter			Influence of NMR Data Completeness on Structure Determinations of Homodimeric Proteins	JOURNAL OF THE CHINESE CHEMICAL SOCIETY			English	Article						Homodimeric protein; NMR structure determination; NOESY; Resonance assignment; CYANA	CHEMICAL-SHIFT ASSIGNMENTS; TORSION ANGLE DYNAMICS; AUTOMATED ASSIGNMENT; NOESY SPECTRA; DOMAIN; ALGORITHM; DYANA; ARIA	The structure determination of homodimeric proteins by NMR using conventional NOESYexperiments is still challenging due to the degeneracy of the chemical shifts in the identical monomers, which causes ambiguity in the NOE assignments. Residues involved in the interface between two monomers provide essential intermolecular NOEs for the structure determinations of homodimeric proteins. Hence NMR data, such as NOE peak lists and chemical shift assignments of these interface residues, play a crucial role for the successful structure determination of homodimeric proteins. This paper extends our previous report (Lin, Y.-J.; Kirchner, D.K.; Guntert, P. J. Magn. Reson. 2012, 222, 96) and investigates the influence of incomplete NOESY peak lists combined with incomplete H-1 chemical shift assignments of the interface residues on the structure determination of homodimeric proteins using the program CYANA. Data incompleteness was simulated by random omission of both NOESY cross peaks and interface H-1 chemical shifts. Our results for three proteins with different percentages of interface residues reveal that the algorithm can tolerate about 40-50% NOESY peak omission with complete interface chemical shift assignments, which indicates that partial NOESY peak omission does not cause severe problems when the interface chemical shifts are completely assigned. Combining NOESY peak omission with incomplete interface chemical shift assignments, the tolerance for interface chemical shift omission decreases with the extent of omitted NOESY peaks. The tolerance for unassigned interface side chain, methyl and aromatic chemical shifts is affected more strongly by NOESY peak omission than that for the omission of general interface H-1 chemical shifts including the backbone. In general about 10-30% peaks omission is tolerated in conjunction with missing chemical shift assignments. If more NOESY peaks are omitted calculations gradually become unstable and tend not to tolerate any missing interface chemical shifts. A large amount of omitted NOESY peaks, for instance 30% omission in our calculations, could decrease the tolerance for missing aromatic or methyl interface H-1 chemical shifts to as few as 2-4 missing chemical shifts, suggesting that complete aromatic and methyl H-1 chemical shift assignments are important when the NOESY peak data is significantly incomplete. Finally, for homodimeric proteins with a low percentage of interface residues, our results reveal that the omission of NOESYpeaks, even at an extent of only 10%, can result in no tolerance against the omission of interface H-1 chemical shifts, suggesting that the completeness of both interface H-1 chemical shift assignments and NOESY peaks are important for the successful structure determination of proteins with a small homodimer interface.	[Lin, Yi-Jan] Kaohsiung Med Univ, Grad Inst Nat Prod, Ctr Res Resources & Dev, Ctr Excellence Environm Med,Ctr Infect Dis & Canc, Kaohsiung 807, Taiwan; [Ikeya, Teppei; Guentert, Peter] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Chem, Hachioji, Tokyo 1920397, Japan; [Kirchner, Donata K.; Guentert, Peter] Goethe Univ Frankfurt, Inst Biophys Chem, Ctr Biomol Magnet Resonance, D-60438 Frankfurt, Germany; [Kirchner, Donata K.; Guentert, Peter] Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, D-60438 Frankfurt, Germany	Lin, YJ (reprint author), Kaohsiung Med Univ, Grad Inst Nat Prod, Ctr Res Resources & Dev, Ctr Excellence Environm Med,Ctr Infect Dis & Canc, 100 Shi Chuan 1st Rd, Kaohsiung 807, Taiwan.	yjlin@kmu.edu.tw	Fachbereich14, Dekanat/C-8553-2015		National Science Council of Taiwan; Lichtenberg program of the Volkswagen Foundation; Japanese Society for the Promotion of Science (JSPS) [25440032, 24770101, 24113720, 26102538, 25120003]	We gratefully acknowledge financial support by the National Science Council of Taiwan, the Lichtenberg program of the Volkswagen Foundation, and the Japanese Society for the Promotion of Science (JSPS) through Grants-in-Aid for Scientific Research C (25440032), Young Scientists B (24770101), and Scientific Research on Innovative Areas (24113720, 26102538 and 25120003).	Guerry P, 2011, Q REV BIOPHYS, V44, P257, DOI 10.1017/S0033583510000326; NILGES M, 1993, PROTEINS, V17, P297, DOI 10.1002/prot.340170307; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Huang YJ, 2006, PROTEINS, V62, P587, DOI 10.1002/prot.20820; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Greenfield NJ, 2001, J MOL BIOL, V312, P833, DOI 10.1006/jmbi.2001.4982; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Linge JP, 2001, METHOD ENZYMOL, V339, P71; Mumenthaler C, 1997, J BIOMOL NMR, V10, P351, DOI 10.1023/A:1018383106236; MUMENTHALER C, 1995, J MOL BIOL, V254, P465, DOI 10.1006/jmbi.1995.0631; Bardiaux B, 2009, PROTEINS, V75, P569, DOI 10.1002/prot.22268; EPP O, 1975, BIOCHEMISTRY-US, V14, P4943, DOI 10.1021/bi00693a025; FURUYA N, 1995, J BACTERIOL, V177, P46; Gronwald W, 2002, J BIOMOL NMR, V23, P271, DOI 10.1023/A:1020279503261; Kuszewski J, 2004, J AM CHEM SOC, V126, P6258, DOI 10.1021/ja049786h; Lin YJ, 2012, J MAGN RESON, V222, P96, DOI 10.1016/j.jmr.2012.07.001; O'Donoghue S. I., 1999, STRUCTURE COMPUTATIO, V17, P131; Ohnishi S, 2007, FEBS LETT, V581, P462, DOI 10.1016/j.febslet.2007.01.008; Rosato A., 2012, STRUCTURE, V8, P227; Savarin P, 2001, J BIOMOL NMR, V19, P49, DOI 10.1023/A:1008311110174; Williamson M., 2012, HOW PROTEINS WORK, P99; Yoshida H, 2008, J MOL BIOL, V384, P690, DOI 10.1016/j.jmb.2008.09.067	23	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	0009-4536	2192-6549		J CHIN CHEM SOC-TAIP	J. Chin. Chem. Soc.	DEC	2014	61	12					1297	1306		10.1002/jccs.201400095		10	Chemistry, Multidisciplinary	Chemistry	AX8UP	WOS:000347184200004		
J	Nemoto, O; Kitada, A; Naitou, S; Tsuchihara, T; Ito, Y; Tachibana, A				Nemoto, Osamu; Kitada, A.; Naitou, S.; Tsuchihara, T.; Ito, Y.; Tachibana, A.			Comparative clinical and radiographic study of the lumbar spine between parachute infantry soldiers and non-parachute infantry soldiers in Japanese Ground Self-Defense forces	JOURNAL OF THE ROYAL ARMY MEDICAL CORPS			English	Article						Neurosurgery	INTERVERTEBRAL DISC DEGENERATION; MILITARY PARACHUTISTS; INJURIES; JUMPS	Background The long-term effect of repetitive trauma by military parachuting on the lumbar spine is not well investigated. Therefore, the purpose of this study was to examine the development of lumbar degenerative changes during a 30-year follow-up in Japanese Ground Self Defense Forces (JGSDF) parachute infantry soldiers with normal lumbar radiographs at entry by comparison with those with non-parachute infantry soldiers. Methods 79 non-parachutists and 65 parachutists were included for radiological examination and questionnaires for low back pain (LBP). All subjects were non-commissioned officers with similar socioeconomic status and life styles. The number of parachuting descent during the 30-year in the parachute group ranged from 208 to 630, with an average of 322. Results The mean age of the subjects was 18.3 0.5 years at entry and 48.5 +/- 0.3 years at follow-up. LBP had been experienced by 37% in the non-parachute group and 25% in the parachute group with no significant difference. The nature of their LBP was judged as mild. The prevalence rate of degenerative changes was similar in both groups. Disc space narrowing was detected 37 subjects (47%) in non-parachute group an 23 subjects (35%) in parachute group without significant difference. Vertebral osteophytes were detected in 52 subjects (67%) in non-parachute group and 47 subjects (72%) in parachute group without significant difference. Conclusions This study did not identify any significant differences in the development of lumbar degenerative changes between the parachutists and non-parachutists over a 30-year follow-up, suggesting that military parachuting itself does not accelerate the development of intervertebral disc degeneration. Further studies are needed using large cohorts assessed by MRI as well as plain X-ray.	[Nemoto, Osamu; Kitada, A.; Naitou, S.; Tsuchihara, T.; Ito, Y.; Tachibana, A.] Japanese Self Def Forces Cent Hosp, Dept Orthopaed Surg, Tokyo 1548532, Japan	Nemoto, O (reprint author), Japanese Self Def Forces Cent Hosp, Dept Orthopaed Surg, Setagaya Ku, 1-2-24 Ikejiri, Tokyo 1548532, Japan.	drsamusio@world.ocn.ne.jp					Battie MC, 2009, SPINE J, V9, P47, DOI 10.1016/j.spinee.2008.11.011; Grunhagen T, 2006, J BONE JOINT SURG AM, V88A, P30, DOI 10.2106/JBJS.E.01290; Hassett G, 2003, ARTHRITIS RHEUM, V48, P3112, DOI 10.1002/art.11321; HALLEL T, 1975, J TRAUMA, V15, P14; Kauppila LI, 2009, EUR J VASC ENDOVASC, V37, P661, DOI 10.1016/j.ejvs.2009.02.006; MACNAB I, 1971, J BONE JOINT SURG AM, VA 53, P663; Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Stokes IAF, 2004, SPINE, V29, P2724, DOI 10.1097/01.brs.0000146049.52152.da; Cheung KMC, 2009, SPINE, V34, P934, DOI 10.1097/BRS.0b013e3181a01b3f; Bar-Dayan Y, 2003, J R Army Med Corps, V149, P260; CICCONE R, 1948, J BONE JOINT SURG AM, V30-A, P77; Craig SC, 1997, MIL MED, V162, P162; Ellitsgaard N, 1987, Br J Sports Med, V21, P13; ESSEXLOPRESTI P, 1946, BRIT J SURG, V34, P1, DOI 10.1002/bjs.18003413302; FARROW GB, 1992, AUST NZ J SURG, V62, P209, DOI 10.1111/j.1445-2197.1992.tb05465.x; Kirby NG, 1966, J H MED J, V118, P2; KIRKPATRICK AW, 1991, MIL MED, V156, P687; LAURELL L, 1963, AEROSPACE MED, V34, P726; Lillywhite L P, 1991, J R Army Med Corps, V137, P115; Lord CD, 1944, J AMER MED ASSOC, V125, P1182; LOWDON IMR, 1989, INJURY, V20, P257, DOI 10.1016/0020-1383(89)90161-7; MURRAYLESLIE CF, 1977, ANN RHEUM DIS, V36, P332, DOI 10.1136/ard.36.4.332; MUSTAJOKI P, 1978, AVIAT SPACE ENVIR MD, V49, P823; NEEL S H Jr, 1951, Mil Surg, V108, P91; REID DH, 1971, AEROSPACE MED, V42, P1207	25	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0035-8665	2052-0468		J ROY ARMY MED CORPS	J. R. Army Med. Corps	DEC	2014	160	4					286	288		10.1136/jramc-2013-000149		3	Medicine, General & Internal	General & Internal Medicine	AX9NQ	WOS:000347229700005		
J	Mitsudomi, T				Mitsudomi, Tetsuya			Dacomitinib: another option for EGFR-mutant lung cancer?	LANCET ONCOLOGY			English	Editorial Material							MUTATIONS; AFATINIB		Kinki Univ, Fac Med, Dept Thorac Surg, Osaka, Japan	Mitsudomi, T (reprint author), Kinki Univ, Fac Med, Dept Thorac Surg, Osaka, Japan.	mitsudom@surg.med.kindai.ac.jp					Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Janne PA, 2014, LANCET ONCOL, P70461; Janne PA, 2014, P SOC AM CLIN ONCO S, V32; Sequist LV, 2014, P SOC AM CLIN ONCO S, V32; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yang JC-H, 2014, P SOC AM CLIN ONCO S, V32	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	DEC	2014	15	13					1408	1409		10.1016/S1470-2045(14)70487-5		2	Oncology	Oncology	AX4OT	WOS:000346912300029		
J	Boku, N				Boku, Narikazu			How can we improve adjuvant chemotherapy for colon cancer?	LANCET ONCOLOGY			English	Editorial Material							METASTATIC COLORECTAL-CANCER; 5-FLUOROURACIL; FLUOROURACIL; CAPECITABINE; OXALIPLATIN; SENSITIVITY; EXPRESSION; SURVIVAL; THERAPY; ENZYMES		St Marianna Univ, Sch Med, Dept Clin Oncol, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan	Boku, N (reprint author), St Marianna Univ, Sch Med, Dept Clin Oncol, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	n.boku@marianna-u.ac.jp					Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Cassidy J, 2011, BRIT J CANCER, V105, P58, DOI 10.1038/bjc.2011.201; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Grothey A, 2005, J CLIN ONCOL, V23, P9441, DOI 10.1200/JCO.2005.04.4792; Miwa M, 1998, EUR J CANCER, V34, P1274, DOI 10.1016/S0959-8049(98)00058-6; Chibaudel B, 2013, EUR J CANCER, V49, P3813, DOI 10.1016/j.ejca.2013.07.150; Kawahara S, 2013, ANTI-CANCER DRUG, V24, P473, DOI 10.1097/CAD.0b013e32835f705f; Schmoll H- J, 2014, LANCET ONCOL; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; Yasui H, 2015, J CANCER RES CLIN, V141, P153, DOI 10.1007/s00432-014-1783-3; Yasuno H, 2013, ONCOL REP, V29, P451, DOI 10.3892/or.2012.2149; Yothers GA, 2010, AM SOC CLIN ONC GAST	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	DEC	2014	15	13					1413	1415		10.1016/S1470-2045(14)71034-4		4	Oncology	Oncology	AX4OT	WOS:000346912300033		
J	Janne, PA; Ou, SHI; Kim, DW; Oxnard, GR; Martins, R; Kris, MG; Dunphy, F; Nishio, M; O'Connell, J; Paweletz, C; Taylor, I; Zhang, H; Goldberg, Z; Mok, T				Jaenne, Pasi A.; Ou, Sai-Hong I.; Kim, Dong-Wan; Oxnard, Geoffrey R.; Martins, Renato; Kris, Mark G.; Dunphy, Frank; Nishio, Makoto; O'Connell, Joseph; Paweletz, Cloud; Taylor, Ian; Zhang, Hui; Goldberg, Zelanna; Mok, Tony			Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial	LANCET ONCOLOGY			English	Article							QUALITY-OF-LIFE; EGFR MUTATIONS; GEFITINIB; ERLOTINIB; AFATINIB; ADENOCARCINOMA; CHEMOTHERAPY; RESISTANCE; INHIBITOR; THERAPY	Background Patients with EGFR-mutant non-small-cell lung cancer generally have a progression-free survival of 9-13 months while being treated with the EGFR tyrosine-kinase inhibitors gefitinib or erlotinib. However, resistance inevitably develops, and more effective EGFR inhibitors are needed. Dacomitinib is a covalent pan-HER inhibitor that has shown clinical activity in patients previously treated with gefitinib or erlotinib. We did a trial of dacomitinib as initial systemic therapy in clinically and molecularly selected patients with advanced non-small-cell lung cancer. Methods In this open-label, multicentre, phase 2 trial, we enrolled treatment-naive patients with advanced lung cancer who had clinical (never-smokers [<100 cigarettes per lifetime] or former light smokers [<10 pack-years per lifetime] and >= 15 years since last cigarette) or molecular (EGFR mutation, regardless of smoking status) characteristics associated with response to EGFR inhibitors. We gave dacomitinib orally once daily (45 mg or 30 mg) until progressive disease, unacceptable toxicity, or patient withdrawal. We used Response Evaluation Criteria in Solid Tumors criteria (version 1.0) to investigate the activity of dacomitinib in all patients with a baseline scan and at least one post-treatment scan, with investigator assessment of response and progression. The primary endpoint was progression-free survival at 4 months in the as-enrolled population, with a null hypothesis of progression-free survival at 4 months of 50% or less. The study is registered with ClinicalTrials. gov, number NCT00818441, and is no longer accruing patients. Findings Between March 11, 2009, and April 1, 2011, we enrolled 89 patients from 25 centres, including 45 (51%) with EGFR-activating mutations in exon 19 (n=25) or exon 21 (n=20). Progression-free survival at 4 months was 76.8% (95% CI 66.4-84.4) in the as-enrolled population, and was 95.5% (95% CI 83.2-98.9) in the EGFR-mutant population. The most common all-grade treatment-related adverse events were diarrhoea in 83 (93%) patients, dermatitis acneiform in 69 (78%) patients, dry skin in 39 (44%) patients, and stomatitis in 36 (40%) patients. Two patients (2%) had grade 4 treatment-related events (one with hypokalaemia and one with dyspnoea). No grade 5 toxicities were recorded. Interpretation Dacomitinib had encouraging clinical activity as initial systemic treatment in clinically or molecularly selected patients with advanced non-small-cell lung cancer.	[Jaenne, Pasi A.; Oxnard, Geoffrey R.] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA; [Jaenne, Pasi A.; Paweletz, Cloud] Dana Farber Canc Inst, Belfer Inst Appl Canc, Boston, MA 02115 USA; [Ou, Sai-Hong I.] Univ Calif Irvine, Sch Med, Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA; [Kim, Dong-Wan] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Martins, Renato] Univ Washington, Dept Med, Div Oncol, Seattle, WA 98195 USA; [Kris, Mark G.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Dunphy, Frank] Duke Univ, Med Ctr, Durham, NC USA; [Nishio, Makoto] Hosp JFCR, Inst Canc, Dept Thorac Med Oncol, Tokyo, Japan; [O'Connell, Joseph] Pfizer Oncol, New York, NY USA; [Taylor, Ian] Pfizer Oncol, Groton, CT USA; [Zhang, Hui] Pfizer China Res & Dev Co Ltd, Shanghai, Peoples R China; [Goldberg, Zelanna] Pfizer Oncol, San Diego, CA USA; [Mok, Tony] Chinese Univ Hong Kong, Prince Wales Hosp, Hong Kong Canc Inst, Dept Clin Oncol,State Key Lab Oncol South China, Shatin, Hong Kong, Peoples R China	Janne, PA (reprint author), Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, HIM 223, Boston, MA 02115 USA.	pasi_janne@dfci.harvard.edu			Pfizer	We thank all of the patients, their families, the investigators, research nurses, study coordinators, and operations staff who participated in this trial. The study was sponsored by Pfizer. Medical writing support was provided by Rachel Mason at ACUMED (Tytherington, UK) and Joanne Fitz-Gerald, a freelance medical writer, and was funded by Pfizer.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; BERGMAN B, 1994, EUR J CANCER, V30A, P635, DOI 10.1016/0959-8049(94)90535-5; Osoba D, 1998, J CLIN ONCOL, V16, P139; Ramalingam SS, 2014, LANCET ONCOL, V15, P1369, DOI 10.1016/S1470-2045(14)70452-8; Janne PA, 2011, CLIN CANCER RES, V17, P1131, DOI 10.1158/1078-0432.CCR-10-1220; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Yang JCH, 2012, LANCET ONCOL, V13, P539, DOI 10.1016/S1470-2045(12)70086-4; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Claassens L, 2011, J CLIN ONCOL, V29, P2104, DOI 10.1200/JCO.2010.32.3683; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Ramalingam SS, 2012, J CLIN ONCOL, V30, P3337, DOI 10.1200/JCO.2011.40.9433; Oxnard GR, 2014, CLIN CANCER RES, V20, P1698, DOI 10.1158/1078-0432.CCR-13-2482; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Miller VA, 2012, LANCET ONCOL, V13, P528, DOI 10.1016/S1470-2045(12)70087-6; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yang JCH, 2013, J CLIN ONCOL, V31, P3342, DOI 10.1200/JCO.2012.46.1764	24	12	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	DEC	2014	15	13					1433	1441		10.1016/S1470-2045(14)70461-9		9	Oncology	Oncology	AX4OT	WOS:000346912300042		
J	Hassan, WA; Yoshida, R; Kudoh, S; Hasegawa, K; Niimori-Kita, K; Ito, T				Hassan, Wael Abdo; Yoshida, Ryoji; Kudoh, Shinji; Hasegawa, Koki; Niimori-Kita, Kanako; Ito, Takaaki			Notch1 controls cell invasion and metastasis in small cell lung carcinoma cell lines	LUNG CANCER			English	Article						Small cell lung carcinoma (SCLC); Notch1 signaling; Epithelial mesenchymal transition (EMT); Cell motility; Cell metastatic potential; Tail vein xenograft mouse model	CANCER CELLS; DOWN-REGULATION; GROWTH; INHIBITION; DIFFERENTIATION; APOPTOSIS; ARREST	Introduction: Notch signaling plays a key role in a wide variety of human neoplasms, and it can be either oncogenic or anti-proliferative. Moreover, Notch function in regulating cancer is unpredictable, and its outcome is strictly context-dependent. Aim: To study the role of Notch1 signaling in human small cell lung carcinoma (SCLC) and its effect on cell invasion and metastasis. Materials and methods: We used small interfering RNA (siRNA) technology, to down-regulate the expression of Notch1 in H69AR and SBC3 SCLC cells. On the other hand, we up-regulated Notch1 in H69 and H1688 SCLC cells through transfection with venus Notch1 intracellular domain (v.NICD) plasmid. In addition, H69 cells with v.NICD were xenotransplanted into immune-compromised Rag2(-/-) Jak3(-/-) mice, for analysis of ex vivo tumor epithelial mesenchymal transition (EMT) phenotype and for detection of metastatic cancer cells in the lung tissues. Moreover, we examined the metastatic ability for H69AR and SBC3 cells transfected with siRNA against Notch1, compared to their subsequent controls, by use of tail vein xenograft mouse models. Results: Notch1 controls cell adhesion and EMT. Overexpression of Notch1 in SCLC switched off EMT, cell motility and cell metastatic potential. Conclusion: Our results demonstrate that activation of Notch1 signaling pathway may represent a new strategy for treating human SCLC. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Hassan, Wael Abdo; Kudoh, Shinji; Hasegawa, Koki; Niimori-Kita, Kanako; Ito, Takaaki] Kumamoto Univ, Grad Sch Med Sci, Dept Pathol & Expt Med, Kumamoto 8608556, Japan; [Hassan, Wael Abdo] Suez Canal Univ, Dept Pathol, Fac Med, Ismailia, Egypt; [Yoshida, Ryoji] Kumamoto Univ, Grad Sch Med Sci, Dept Oral & Maxillofacial Surg, Kumamoto 8608556, Japan	Ito, T (reprint author), Kumamoto Univ, Grad Sch Med Sci, Dept Pathol & Expt Med, Chuo Ku, Honjo 1-1-1, Kumamoto 8608556, Japan.	takaito@kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23220010]; MEXT	We thank Dr. Mitsuru Morimoto (Laboratory of Lung Development and Regeneration, RIKEN Center for Development Biology, Kobe, Japan) for his contribution. We also would like to thank Mrs. Motoko Kagayama and Mrs. Takako Maeda for their skillful technical assistance. This study was partially supported by a Grant-in-Aid for Scientific Research (C; No. 23220010) from Ministry of Education, Culture, Sports, Science and Technology of Japan. Wael Abdo Hassan is a MEXT fellowship recipient.	Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Wael H, 2014, LUNG CANCER, V85, P131, DOI 10.1016/j.lungcan.2014.05.001; Ji XM, 2011, J CELL BIOCHEM, V112, P2773, DOI 10.1002/jcb.23184; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Zheng QJ, 2007, ONCOL REP, V17, P847; Kuramoto T, 2012, MOL CANCER THER, V11, P2578, DOI 10.1158/1535-7163.MCT-12-0640; Wang L, 2007, INT J GYNECOL CANCER, V17, P1283, DOI 10.1111/j.1525-1438.2007.00927.x; Sriuranpong V, 2001, CANCER RES, V61, P3200; Xie M, 2012, J CELL BIOCHEM, V113, P1501, DOI 10.1002/jcb.24019; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; Bunn PA, 2012, ARCH PATHOL LAB MED, V136, P1478, DOI 10.5858/arpa.2012-0295-SA; Ito T, 2003, ENDOCR PATHOL, V14, P133, DOI 10.1385/EP:14:2:133; Yoshida R, 2013, LAB INVEST, V93, P1068, DOI 10.1038/labinvest.2013.95; Yu H, 2007, INT J GYNECOL CANCER, V17, P511, DOI 10.1111/j.1525-1438.2007.00813.x; Kunnimalaiyaan M, 2007, ONCOLOGIST, V12, P535, DOI 10.1634/theoncologist.12-5-535; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Hintermann E, 2004, MATRIX BIOL, V23, P75, DOI 10.1016/j.matbio.2004.03.001; Travis WD, 2004, WHO CLASSIFICATION T; Watanabe M, 1996, CANCER, V77, P1676, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1676::AID-CNCR14>3.0.CO;2-V	20	3	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	DEC	2014	86	3					304	310		10.1016/j.lungcan.2014.10.007		7	Oncology; Respiratory System	Oncology; Respiratory System	AX8BU	WOS:000347136400002		
J	Masai, K; Nakagawa, K; Yoshida, A; Sakurai, H; Watanabe, S; Asamura, H; Tsuta, K				Masai, Kyohei; Nakagawa, Kazuo; Yoshida, Akihiko; Sakurai, Hiroyuki; Watanabe, Shun-ichi; Asamura, Hisao; Tsuta, Koji			Cytokeratin 19 expression in primary thoracic tumors and lymph node metastases	LUNG CANCER			English	Article						CK19; Lung; OSNA; Immunohistochemistry; TMA; LN	NUCLEIC-ACID AMPLIFICATION; EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER PATIENTS; CELL LUNG-CANCER; TOUCH IMPRINT CYTOLOGY; INTRAOPERATIVE DETECTION; PROGNOSTIC-SIGNIFICANCE; DIFFERENTIAL-DIAGNOSIS; MOLECULAR-DETECTION; FROZEN-SECTION	Background: The use of one-step nucleic acid amplification (OSNA), which allows for the rapid intraoperative detection of lymph node (LN) metastasis, is becoming more widely accepted in breast cancer. To provide basic data for the development of this method for lung tumors, we conducted a large-scale investigation of cytokeratin (CK) 19 expression in thoracic tumors. Patients and methods: We examined CK19 expression in specimens from a total of 801 surgically resected samples of primary lung adenocarcinoma (ADC), squamous cell carcinoma (SQC), large-cell carcinoma (LCC), pleomorphic carcinoma (PC), large cell neuroendocrine carcinoma (LCNEC), small cell carcinoma (SCC), and carcinoid tumor (CT) as well as pleural malignant mesothelioma and lung metastatic deposits from breast cancer using tissue microarrays (TMAs) and whole sections. We also compared the CK19 expression status between primary sites and LN metastatic deposits. Results: The overall rate of CK19 expression as observed on TMAs and whole sections in the 801 analyzed cases was 88.0%. CK19 expression was detected in 94.6% of ADCs, 93.6% of SQCs, 54.5% of LCCs, 54.8% of PCs, 77.4% of LCNECs, 31.8% of SCCs, 34.0% of CTs, and 92.9% of malignant mesotheliomas. Expression of CK19 was also detected in 90.9% of lung metastatic deposits from breast carcinomas. CK19 expression was maintained between CK19-positive primary sites and the corresponding LN metastatic deposits. Of note, a portion of CK19-negative primary tumors showed upregulation of CK19 protein expression in LN metastases. Conclusions: Most thoracic tumors, except for PCs, CTs, and SCCs, were positive for CK19. We also found that CK19 expression was maintained between CK19-positive primary tumors and the corresponding LN metastatic deposits. These results may be useful in the development of the OSNA method for the intraoperative detection of LN metastasis in non-small cell lung cancer (NSCLC). (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Masai, Kyohei; Yoshida, Akihiko; Tsuta, Koji] Natl Canc Ctr, Div Pathol & Clin Labs, Tokyo 1040045, Japan; [Masai, Kyohei; Nakagawa, Kazuo; Sakurai, Hiroyuki; Watanabe, Shun-ichi; Asamura, Hisao] Natl Canc Ctr, Div Thorac Surg, Tokyo 1040045, Japan	Tsuta, K (reprint author), Natl Canc Ctr, Div Pathol, Chuo Ku, 1-1 Tsukiji 5 Chome, Tokyo 1040045, Japan.	ktsuta@ncc.go.jp			Sysmex Corporation (Kobe, Japan)	Division of Pathology and Clinical Laboratory, National Cancer Center Hospital (Tokyo, Japan) received research fund during study period from Sysmex Corporation (Kobe, Japan). The sponsor of the study had no role in the conduct of the study, data collection, data interpretation or preparation of the report.	MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Tsujimoto M, 2007, CLIN CANCER RES, V13, P4807, DOI 10.1158/1078-0432.CCR-06-2512; Giancotti FG, 2013, CELL, V155, P750, DOI 10.1016/j.cell.2013.10.029; Eccles SA, 2007, LANCET, V369, P1742, DOI 10.1016/S0140-6736(07)60781-8; BROERS JLV, 1988, CANCER RES, V48, P3221; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Tsuta K, 2011, J THORAC ONCOL, V6, P1190, DOI 10.1097/JTO.0b013e318219ac78; Schem C, 2009, VIRCHOWS ARCH, V454, P203, DOI 10.1007/s00428-008-0703-9; Tanis PJ, 2001, ANN SURG ONCOL, V8, P222, DOI 10.1245/aso.2001.8.3.222; Guller U, 2012, CANCER-AM CANCER SOC, V118, P6039, DOI 10.1002/cncr.27667; Tamaki Y, 2009, CLIN CANCER RES, V15, P2879, DOI 10.1158/1078-0432.CCR-08-1881; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Tarin D, 2005, CANCER RES, V65, P5996, DOI 10.1158/0008-5472.CAN-05-0699; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Inoue M, 2012, LUNG CANCER, V78, P212, DOI 10.1016/j.lungcan.2012.08.018; Demir A, 2009, ANN THORAC SURG, V87, P1014, DOI 10.1016/j.athoracsur.2008.12.053; Pegolo E, 2013, VIRCHOWS ARCH, V463, P7, DOI 10.1007/s00428-013-1440-2; Godey F, 2012, BREAST CANCER RES TR, V131, P509, DOI 10.1007/s10549-011-1808-4; Broers JL, 1998, CANCER RES, V48, P3221; Carella R, 2001, AM J SURG PATHOL, V25, P43, DOI 10.1097/00000478-200101000-00004; Cates JMM, 2008, APPL IMMUNOHISTO M M, V16, P251, DOI 10.1097/PAI.0b013e318156e9b4; Chen YZ, 2011, ONCOL LETT, V2, P277, DOI 10.3892/ol.2011.233; Fujisue M, 2013, CANCER, V5, P1; Kumagai K, 2014, GASTRIC CANCER, V17, P273, DOI 10.1007/s10120-013-0271-9; Menes TS, 2003, ANN SURG ONCOL, V10, P1166, DOI 10.1245/ASO.2003.04.023; Passlick B., 2001, LUNG CANCER S3, V34, P25, DOI 10.1016/S0169-5002(01)00375-0; Rena O, 2007, EUR J CARDIO-THORAC, V32, P863, DOI 10.1016/j.ejcts.2007.09.014; SAID JW, 1983, AM J PATHOL, V113, P27; Salla C, 2009, CANCER CYTOPATHOL, V117, P516, DOI 10.1002/cncy.20048; Van Eetvelde E, 2011, ACTA CHIR BELG, V111, P130; Yamamoto H, 2011, ANN SURG ONCOL, V18, P1891, DOI 10.1245/s10434-010-1539-5	31	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	DEC	2014	86	3					318	323		10.1016/j.lungcan.2014.09.018		6	Oncology; Respiratory System	Oncology; Respiratory System	AX8BU	WOS:000347136400004		
J	Naito, T; Seto, T; Takeda, K; Goto, K; Okamoto, I; Nakagawa, K; Ohba, T; Murakami, H; Takahashi, T; Yamanaka, T; Yamamoto, N				Naito, T.; Seto, T.; Takeda, K.; Goto, K.; Okamoto, I.; Nakagawa, K.; Ohba, T.; Murakami, H.; Takahashi, T.; Yamanaka, T.; Yamamoto, N.			Phase II clinical trial of S-1 plus oral leucovorin in previously treated patients with non-small-cell lung cancer	LUNG CANCER			English	Article						Non-small-cell lung cancer; S-1; Leucovorin; Fluoropyrimidine; Chemotherapy; Phase II clinical trial	METASTATIC COLORECTAL-CANCER; 5-FLUOROURACIL; CHEMOTHERAPY; MONOTHERAPY; CISPLATIN; MICE	Background: S-1, a novel oral fluoropyrimidine, has potent antitumor activity against non-small-cell lung cancer (NSCLC). Meanwhile, leucovorin enhances the efficacy of 5-fluorouracil by inhibiting thymidylate synthase. Therefore, this phase II clinical trial evaluated the safety and efficacy of S-1 plus leucovorin combination therapy for previously treated patients with NSCLC. Patients and methods: Patients with stage IIIB or IV NSCLC were prospectively enrolled if they received 1 or 2 prior chemotherapy regimens. S-1 (40-60 mg) and leucovorin (25 mg) were administered together orally twice per day for 7 consecutive days followed by 7 days of rest. This 2-week cycle was repeated for a maximum of 25 cycles until the onset of disease progression or unacceptable adverse events. Endpoints included objective tumor response, progression-free survival, overall survival, and safety. Results: Among 33 patients, 6 (18.2%), 14 (42.4%), and 11 (33.3%) had partial response, stable disease, and progressive disease, respectively. Median progression-free and overall survival times were 3.5 and 11.7 months, respectively. The common grade 3 toxicities included stomatitis (18.2%), anorexia (12.1%), and neutropenia (9.1%). One patient had pneumatosis cystoides intestinalis, and another experienced paralytic ileus. There were no treatment-related deaths. Conclusions: 5-1 plus leucovorin combination therapy demonstrated promising efficacy and an acceptable toxicity profile in previously treated patients with NSCLC. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Naito, T.; Murakami, H.; Takahashi, T.] Shizuoka Canc Ctr, Div Thorac Oncol, Nagaizumi, Shizuoka, Japan; [Seto, T.; Ohba, T.] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Fukuoka, Japan; [Takeda, K.] Osaka City Gen Hosp, Dept Clin Oncol, Osaka, Japan; [Goto, K.] Natl Canc Ctr Hosp East, Div Thorac Oncol, Kashiwa, Chiba, Japan; [Okamoto, I.] Kyushu Univ Hosp, Ctr Clin & Translat Res, Fukuoka, Japan; [Nakagawa, K.] Kinki Univ, Sch Med, Dept Med Oncol, Higashiosaka, Osaka 577, Japan; [Yamanaka, T.] Yokohama City Univ, Dept Biostat, Yokohama, Kanagawa, Japan; [Yamamoto, N.] Wakayama Med Univ, Dept Internal Med 3, Wakayama, Japan	Naito, T (reprint author), Shizuoka Canc Ctr, Div Thorac Oncol, 1007 Shimonagakubo, Nagaizumi, Shizuoka, Japan.	t.naito@scchr.jp			Fuji pharma valley center	This work was supported by the Fuji pharma valley center.	Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Sasaki T, 2013, CANCER CHEMOTH PHARM, V71, P973, DOI 10.1007/s00280-013-2090-4; HOUGHTON JA, 1981, CANCER RES, V41, P144; Haller DG, 2008, J CLIN ONCOL, V26, P2118, DOI 10.1200/JCO.2007.15.2090; SHIRASAKA T, 1993, CANCER RES, V53, P4004; Okamoto I, 2010, J CLIN ONCOL, V28, P5240, DOI 10.1200/JCO.2010.31.0326; EVANS RM, 1981, CANCER RES, V41, P3288; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Sudo K, 2014, CANCER CHEMOTH PHARM, V73, P389, DOI 10.1007/s00280-013-2368-6; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Koizumi W, 2010, ANN ONCOL, V21, P766, DOI 10.1093/annonc/mdp371; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Goldberg RM, 2004, J CLIN ONCOL, V22, P23, DOI 10.1200/JCO.2004.09.046; Cohen SJ, 2002, CLIN CANCER RES, V8, P2116; Denda T, 2012, J CLIN ONCOL S34; Govindan R, 2011, J THORAC ONCOL, V6, P790, DOI 10.1097/JTO.0b013e3182103b51; Ichinose Y, 2011, J THORAC ONCOL, V6, P2069, DOI 10.1097/JTO.0b013e3182307e5a; Katakami N, 2012, J CLIN ONCOL S; Ohyanagi F, 2009, BRIT J CANCER, V101, P225, DOI 10.1038/sj.bjc.6605152; Shiroyama T, 2011, LUNG CANCER, V74, P85, DOI 10.1016/j.lungcan.2011.01.017; Taguchi T, 1997, Gan To Kagaku Ryoho, V24, P2253; Thirion P, 2004, J Clin Oncol, V22, P3766; Totani Y, 2009, CANCER CHEMOTH PHARM, V64, P1181, DOI 10.1007/s00280-009-0981-1; Tsukioka S, 2009, MOL MED REP, V2, P393, DOI 10.3892/mmr_00000111; van Groeningen CJ, 2000, J CLIN ONCOL, V18, P2772; Wada M, 2012, CANCER CHEMOTH PHARM, V69, P1005, DOI 10.1007/s00280-011-1795-5	27	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0169-5002	1872-8332		LUNG CANCER	Lung Cancer	DEC	2014	86	3					339	343		10.1016/j.lungcan.2014.10.010		5	Oncology; Respiratory System	Oncology; Respiratory System	AX8BU	WOS:000347136400008		
J	Tanaka, S; Kawahara, T; Okada, H				Tanaka, Satoyuki; Kawahara, Takahiro; Okada, Hiroshi			Study on crack propagation simulation of surface crack in welded joint structure	MARINE STRUCTURES			English	Article						Finite element method; Extended finite element method; Welded joints; Surface crack; Crack propagation analysis	STRESS INTENSITY FACTORS; FINITE-ELEMENT-METHOD; CLOSURE-INTEGRAL-METHOD; TOE MAGNIFICATION FACTORS; WAVELET GALERKIN METHOD; FREE MESH METHOD; T-BUTT JOINTS; SEMIELLIPTIC CRACKS; TUBULAR JOINTS; METHOD VCCM	Recently developed computational techniques are applied to the simulation of the crack propagation of a surface crack in a welded joint. The results are compared with those obtained by the conventional techniques. Three approaches are adopted: three-dimensional finite element analysis using quadratic tetrahedral finite elements; the two-dimensional extended finite element method using the Mk factor; and the use of three-dimensional Mk factor formulae. In the numerical examples, stress intensity factors, Mk factors, crack paths and fatigue cycles are evaluated for a surface crack in a T-shaped welded joint. The accuracy and effectiveness of the approaches are discussed. (C) 2014 Elsevier Ltd. All rights reserved.	[Tanaka, Satoyuki; Kawahara, Takahiro] Hiroshima Univ, Grad Sch Engn, Higashihiroshima 7398527, Japan; [Okada, Hiroshi] Tokyo Univ Sci, Fac Sci & Technol, Dept Mech Engn, Noda, Chiba 2788510, Japan	Tanaka, S (reprint author), Hiroshima Univ, Grad Sch Engn, 4-1 Kagamiyama 1 Chome, Higashihiroshima 7398527, Japan.	satoyuki@hiroshima-u.ac.jp; hokada@rs.noda.tus.ac.p					Anderson TL, 2005, FRACTURE MECH FUNDAM; [Anonymous], 1991, SR202; Belytschko T, 1999, INT J NUMER METH ENG, V45, P601, DOI 10.1002/(SICI)1097-0207(19990620)45:5<601::AID-NME598>3.0.CO;2-S; Nagai M, 2013, COMPUT MECH, V51, P603, DOI 10.1007/s00466-012-0740-8; Ritchie RO, 1999, INT J FRACTURE, V100, P55, DOI 10.1023/A:1018655917051; Yagawa G, 1996, COMPUT MECH, V18, P383; BELYTSCHKO T, 1994, INT J NUMER METH ENG, V37, P229, DOI 10.1002/nme.1620370205; Bowness D, 1996, FATIGUE FRACT ENG M, V19, P787, DOI 10.1111/j.1460-2695.1996.tb01323.x; Tanaka S, 2013, INT J NUMER METH ENG, V93, P1082, DOI 10.1002/nme.4433; Moes N, 1999, INT J NUMER METH ENG, V46, P131, DOI 10.1002/(SICI)1097-0207(19990910)46:1<131::AID-NME726>3.0.CO;2-J; Mahmoud HN, 2005, MAR STRUCT, V18, P265, DOI 10.1016/j.marstruc.2005.09.001; [Anonymous], 2007, BS7910; NEWMAN JC, 1981, ENG FRACT MECH, V15, P185, DOI 10.1016/0013-7944(81)90116-8; [Anonymous], 2007, WES2805; Bowness D, 2000, INT J FATIGUE, V22, P389, DOI 10.1016/S0142-1123(00)00013-X; Okada H, 2013, INT J FATIGUE, V50, P33, DOI 10.1016/j.ijfatigue.2012.04.009; Seifi R, 2013, MAR STRUCT, V34, P1, DOI 10.1016/j.marstruc.2013.07.001; AMARATUNGA K, 1994, INT J NUMER METH ENG, V37, P2703, DOI 10.1002/nme.1620371602; Okada H, 2005, ENG FRACT MECH, V72, P1717, DOI 10.1016/j.engfracmech.2004.12.005; RICE JR, 1968, J APPL MECH, V35, P379; Okada H, 2008, ENG FRACT MECH, V75, P4466, DOI 10.1016/j.engfracmech.2008.04.014; Fleming M, 1997, INT J NUMER METH ENG, V40, P1483, DOI 10.1002/(SICI)1097-0207(19970430)40:8<1483::AID-NME123>3.0.CO;2-6; Fricke W, 2003, MAR STRUCT, V16, P185, DOI 10.1016/S0951-8339(02)00075-8; HOBBACHER A, 1993, ENG FRACT MECH, V46, P173, DOI 10.1016/0013-7944(93)90278-Z; Bowness D, 2000, INT J FATIGUE, V22, P369, DOI 10.1016/S0142-1123(00)00012-8; Bowness D, 1995, INT J FRACTURE, V73, P129, DOI 10.1007/BF00055725; Chen T, 2013, ENG FRACT MECH, V98, P44, DOI 10.1016/j.engfracmech.2012.12.010; Chui C.K., 1992, INTRO WAVELETS; Cisilino AP, 1999, ENG FRACT MECH, V63, P713, DOI 10.1016/S0013-7944(99)00047-8; Cisilino AP, 1997, INT J PRES VES PIP, V70, P135, DOI 10.1016/S0308-0161(96)00031-2; Daubechies I., 1992, 10 LECT WAVELETS; Diaz AR, 1999, INT J NUMER METH ENG, V44, P1599, DOI 10.1002/(SICI)1097-0207(19990420)44:11<1599::AID-NME556>3.0.CO;2-P; Erdogan F, 1963, T ASME D, P528; FU B, 1993, INT J FRACTURE, V63, P155, DOI 10.1007/BF00017283; He WT, 2014, MAR STRUCT, V35, P45, DOI 10.1016/j.marstruc.2013.12.001; Hellen T. K., 1975, International Journal for Numerical Methods in Engineering, V9, DOI 10.1002/nme.1620090114; Higuchi M, 1974, J JPN SOC NAV ARCHIT, V135, P327; HOBBACHER A, 1992, ENG FRACT MECH, V41, P897, DOI 10.1016/0013-7944(92)90238-A; HOLLISTER SJ, 1994, BIOTECHNOL BIOENG, V43, P586, DOI 10.1002/bit.260430708; Kam JCP, 1995, MAR STRUCT, V8, P37, DOI 10.1016/0951-8339(95)90664-G; Lee MMK, 2002, INT J FATIGUE, V24, P861, DOI 10.1016/S0142-1123(01)00209-2; Li Y, 2012, 2012 ASME PRESS VESS; MADDOX SJ, 1975, INT J FRACTURE, V11, P221, DOI 10.1007/BF00038890; Maddox SJ, 2002, FATIGUE STRENGTH WEL; Murakami Y, 1986, STRESS INTENSITY FAC; Nishioka T, 2001, INT J SOLIDS STRUCT, V38, P5273, DOI 10.1016/S0020-7683(00)00345-0; NIU X, 1987, INT J FRACTURE, V35, P3; Okawa T, 2006, MAR STRUCT, V19, P217, DOI 10.1016/j.marstruc.2007.01.002; Rajaram H, 2000, ENG FRACT MECH, V66, P455, DOI 10.1016/S0013-7944(00)00025-4; Sumi Y., 1998, J MAR SCI TECHNOL, V3, P102, DOI DOI 10.1007/BF02492565; Suresh S, 2002, FATIGUE MAT; Tanaka S, 2012, COMPUT MECH, V50, P35, DOI 10.1007/s00466-011-0671-9; Yagawa G, 2000, INT J NUMER METH ENG, V47, P1419, DOI 10.1002/(SICI)1097-0207(20000320)47:8<1419::AID-NME837>3.3.CO;2-5	53	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0951-8339	1873-4170		MAR STRUCT	Mar. Struct.	DEC	2014	39						315	334		10.1016/j.marstruc.2014.08.001		20	Engineering, Marine; Engineering, Civil	Engineering	AX6HZ	WOS:000347024800014		
J	Park, JU; An, G; Woo, WC; Choi, JH; Ma, N				Park, Jeong-Ung; An, GyuBaek; Woo, Wan Chuck; Choi, Jae-Hyouk; Ma, Ninshu			Residual stress measurement in an extra thick multi-pass weld using initial stress integrated inherent strain method	MARINE STRUCTURES			English	Article						Welding residual stress; Initial stress; Measurement; Inherent strain method; Neutron diffraction	NEUTRON-DIFFRACTION	Residual stresses existing in a multi-pass butt joint with a thickness of 70 mm, using a flux-cored arc welding process, were measured by an inherent strain method (ISM). Since such a thick plate before welding contains a large amount of initial residual stresses (-300 to +100 MPa), the initial stresses were integrated with conventional ISM in order to determine the total residual stresses in a welded joint. Two methods named as initial stress integrated ISM and initial inherent strain integrated ISM were suggested for the consideration of the initial stress distributions through the thickness of base plates. The results show that there is a significant difference between the integrated ISM with initial stresses or initial inherent strain and the conventional ISM without initial stresses. The residual stresses measured by any of the initial Mess integrated ISM and initial inherent strain integrated ISM agreed well with the neutron diffraction measurement. Thus, the proposed initial stress integrated ISM is a proper destructive measurement method in the case of thick weld joints. (C) 2014 Elsevier Ltd. All rights reserved.	[Park, Jeong-Ung] Chosun Univ, Dept Civil Engn, Kwangju 501759, South Korea; [An, GyuBaek] POSCO Tech Res Labs, Pohang 790785, South Korea; [Woo, Wan Chuck] Korea Atom Energy Res Inst, Div Neutron Sci, Taejon 305353, South Korea; [Choi, Jae-Hyouk] Chosun Univ, Sch Architecture, Gwangu 501759, South Korea; [Ma, Ninshu] Osaka Univ, Joining & Welding Res Inst, Osaka, Japan	An, G (reprint author), POSCO Tech Res Labs, Pohang 790785, South Korea.	gyubaekan@posco.coms			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013-056169]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 2013-056169). Neutron diffraction results were partly adopted from the results published elsewhere [20] for comparison purpose.	ALLEN AJ, 1985, ADV PHYS, V34, P445, DOI 10.1080/00018738500101791; Mahmoudi AH, 2009, EXP MECH, V49, P595, DOI 10.1007/s11340-008-9164-y; Woo W, 2013, ACTA MATER, V61, P3564, DOI 10.1016/j.actamat.2013.02.034; [Anonymous], 2001, E83701 ASTM; Smith DJ, 2000, J STRAIN ANAL ENG, V35, P287, DOI 10.1243/0309324001514422; Okolo B, 2004, J APPL PHYS, V95, P466, DOI 10.1063/1.1631733; Birkholz M, 2004, J APPL PHYS, V96, P7202, DOI 10.1063/1.1814413; de Swardt RR, 2003, J PRESS VESS-T ASME, V125, P274, DOI 10.1115/1.1593700; Hiroshi K, 1965, J SOC NAV ARCH JPN, V108, P223; Kingston EJ, 2003, THESIS U BRISTOL; Liam G, 2012, MAR STRUCT, V28, P25; Masaoka I, 2010, J JPN WELD SOC, V44, P914; Masubuchi K., 1980, ANAL WELDED STRUCTUR; Murakawa H., 1996, J SOC NAVAL ARCHITEC, V180, P739; Okido S, 1999, 7 INT C NUCL ENG ICO, P19; Park JU, 2009, 2009 SPRING ANN M KO, P105, DOI 10.1109/VTSA.2009.5159312; SCHAJER GS, 1988, J ENG MATER-T ASME, V110, P338; Segen FE, 2012, MAR STRUCT, V29, P211; Ueda Y, 1971, T JAPAN WELDING SOC, V2-2, P90; Ueda Y, 1975, T JWRI, V52, P19; Ueda Y, 1976, T JWRI, V5, P179; Ueda Y, 1979, T JWRI, V8, P89; Ueda Y., 1994, T JWRI, V23, P71; Ueda Y, 2012, WELDING DEFORMATION AND RESIDUAL STRESS PREVENTION, P1	24	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0951-8339	1873-4170		MAR STRUCT	Mar. Struct.	DEC	2014	39						424	437		10.1016/j.marstruc.2014.10.002		14	Engineering, Marine; Engineering, Civil	Engineering	AX6HZ	WOS:000347024800019		
J	Liang, F; Tanaka, M; Choi, S; Watanabe, T				Liang, Feng; Tanaka, Manabu; Choi, Sooseok; Watanabe, Takayuki			Measurement of anode surface temperature in carbon nanomaterial production by arc discharge method	MATERIALS RESEARCH BULLETIN			English	Article						Carbon nanomaterial; Arc discharge; Growth temperature; Two-color pyrometry	NANOTUBE GROWTH; GRAPHITE; DEPOSIT; FULLERENES	Nano-graphite particles, multi-wall carbon nanotube (MWNT), and pyrolytic graphite were prepared at different positions of the anode surface in an arc discharge. Graphite electrodes were employed for the arc discharge under helium environment at atmospheric pressure. Nano-sized carbon products were characterized by scanning electron microscopy and transmission electron microscopy. During the arc discharge, two-color pyrometry combined with a high-speed camera was conducted to measure the temperature distribution of the anode surface. The growth temperature of pyrolytic graphite, MWNT, and nano-graphite particles were in the ranges of 2400-2600 K, 2600-2700 K, and 2700-3500 K, respectively. The local temperature of anode surface is a critical parameter to determine the products with different morphologies. The formation mechanism of these carbon nanomaterials is suggested based on the local temperature of anode surface and their thermodynamic stability. (C) 2014 Elsevier Ltd. All rights reserved.	[Liang, Feng; Tanaka, Manabu; Choi, Sooseok; Watanabe, Takayuki] Tokyo Inst Technol, Dept Environm Chem & Engn, Yokohama, Kanagawa 2268502, Japan; [Watanabe, Takayuki] Kyushu Univ, Dept Chem Engn, Fukuoka 8190395, Japan	Watanabe, T (reprint author), Tokyo Inst Technol, Dept Environm Chem & Engn, Yokohama, Kanagawa 2268502, Japan.	watanabe@chem-eng.kyushu-u.ac.jp	Liang, Feng/Q-2404-2015				Ajayan PM, 1997, J MATER RES, V12, P244, DOI 10.1557/JMR.1997.0032; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; EBBESEN TW, 1992, NATURE, V358, P220, DOI 10.1038/358220a0; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Kim KS, 2009, NATURE, V457, P706, DOI 10.1038/nature07719; TOMANEK D, 1993, PHYS REV B, V48, P15461, DOI 10.1103/PhysRevB.48.15461; Kajiura H, 2002, CARBON, V40, P2423, DOI 10.1016/S0008-6223(02)00129-X; Shenderova OA, 2002, CRIT REV SOLID STATE, V27, P227, DOI 10.1080/10408430208500497; Subrahmanyam KS, 2009, J PHYS CHEM C, V113, P4257, DOI 10.1021/jp900791y; Berber S., 2004, PHYS REV B, V69; Cai XK, 2012, CARBON, V50, P2726, DOI 10.1016/j.carbon.2012.02.031; Gogotsi Y., 2006, CARBON NANOMATERIALS; Guellali M, 2008, COMPOS SCI TECHNOL, V68, P1122, DOI 10.1016/j.compscitech.2007.07.019; Harris PJF, 2007, CARBON, V45, P229, DOI 10.1016/j.carbon.2006.09.023; Jones JM, 1996, CARBON, V34, P231, DOI 10.1016/0008-6223(96)00162-5; Keidar M., 2008, APPL PHYS LETT, V92; Keidar M, 2006, J NANOSCI NANOTECHNO, V6, P1309, DOI 10.1166/jnn.2006.159; Keidar M., 2009, J APPL PHYS, V106; Kratschmer W., 1990, NATURE, V347, P348; Liang F, 2012, DIAM RELAT MATER, V30, P70, DOI 10.1016/j.diamond.2012.09.004; Luo SD, 2005, CARBON, V43, P109, DOI 10.1016/j.carbon.2004.08.035; Maauter M.S., 2008, ENVIRON SCI TECHNOL, V42, P5843; Moore A.W., 1981, CARBON, V7, P233; Nardelli MB, 1998, CHEM PHYS LETT, V296, P471; Yacaman MJ, 1993, APPL PHYS LETT, V62, P657; Yusoff HM, 2006, CURR APPL PHYS, V6, P422, DOI 10.1016/j.cap.2005.11.033	29	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0025-5408	1873-4227		MATER RES BULL	Mater. Res. Bull.	DEC	2014	60						158	165		10.1016/j.materresbull.2014.08.029		8	Materials Science, Multidisciplinary	Materials Science	AY4ZJ	WOS:000347583100022		
J	Rathore, AK; Pati, SP; Roychowdhury, A; Ghosh, M; Das, D				Rathore, A. K.; Pati, S. P.; Roychowdhury, A.; Ghosh, M.; Das, D.			Structural, optical, hyperfine and magnetization studies of ZnO encapsulated alpha-Fe nanoparticles	MATERIALS RESEARCH BULLETIN			English	Article						Composites; Chemical synthesis; Optical properties; Mossbauer spectroscopy	NANOCOMPOSITES; FILMS; NANOCRYSTALS; SIZE; PHOTOLUMINESCENCE; ALPHA-FE2O3; EMISSION; NANORODS; IRON	We report the successful preparation and characterization of magnetic-fluorescent nanoparticles (NPs) by overcoming the difficulty of handling alpha-Fe nanoparticles that are less stable and have high affinity to get oxidized in air even at room temperature. Nanocrystalline alpha-Fe particles embedded by ZnO have been synthesized by a two step chemical route. Concentration of alpha-Fe has been varied as 15,30 and 50 wt% of the sample. Detailed investigations on structural, hyperfine, optical and magnetic characteristics have been carried out. X-ray diffraction, transmission electron microscopy and Fourier transform infrared spectroscopy studies have been used to confirm the coexistence of Fe and ZnO phases in the nanocomposites (NCs). The presence of alpha-Fe is also confirmed by Mossbauer spectroscopy. However, other forms of iron are also detected in the sample. UV-vis spectrum of nanocomposites shows a red shift with respect to the pristine ZnO which is attributed to the electron transfer between Fe and ZnO that provides support to the formation of the Fe-ZnO NC The photoluminescence (PL) spectra of Fe-ZnO nanocomposites exhibit blue shift of the UV and weaker visible emission lines compared to the pristine ZnO. Nanocomposites are found to be magnetically soft having high saturation magnetization with very low remanence. Low temperature coercivity enhancement due to freezing of uncompensated surface spins is also found in all samples. (C) 2014 Elsevier Ltd. All rights reserved.	[Rathore, A. K.] UGC DAE Consortium Sci Res, Indore 452001, India; [Rathore, A. K.; Pati, S. P.; Roychowdhury, A.; Das, D.] UGC DAE Consortium Sci Res, Kolkata 700098, India; [Rathore, A. K.; Ghosh, M.] Indian Inst Engn Sci & Technol, Dept Met & Mat Engn, Sibpur 711103, Howrah, India; [Pati, S. P.] Tohoku Univ, Dept Elect Engn, Sendai, Miyagi 9807985, Japan	Pati, SP (reprint author), Tohoku Univ, Dept Elect Engn, Aoba Ku, 6-6-05 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	phy_satya@yahoo.co.in					Wang YG, 2003, J APPL PHYS, V94, P354, DOI 10.1063/1.1577819; Lin BX, 2001, APPL PHYS LETT, V79, P943, DOI 10.1063/1.1394173; Pati SP, 2012, MATER CHEM PHYS, V137, P303, DOI 10.1016/j.matchemphys.2012.09.025; Dabbousi BO, 1997, J PHYS CHEM B, V101, P9463, DOI 10.1021/jp971091y; Panda NR, 2014, ACTA METALL SIN-ENGL, V27, P563, DOI 10.1007/s40195-014-0093-8; Iglesias GR, 2012, J COLLOID INTERF SCI, V377, P153, DOI 10.1016/j.jcis.2012.03.077; Sun SH, 2002, J AM CHEM SOC, V124, P8204, DOI 10.1021/ja026501x; Peng XG, 1997, J AM CHEM SOC, V119, P7019, DOI 10.1021/ja970754m; Wan JQ, 2009, MATER CHEM PHYS, V114, P30, DOI 10.1016/j.matchemphys.2008.10.039; Roychowdhury A, 2014, POWDER TECHNOL, V254, P583, DOI 10.1016/j.powtec.2014.01.076; MELDRUM FC, 1992, SCIENCE, V257, P522, DOI 10.1126/science.1636086; Lei Y, 2001, APPL PHYS LETT, V78, P1125, DOI 10.1063/1.1350959; Huang KC, 2007, LANGMUIR, V23, P1419, DOI 10.1021/la0618364; Roychowdhury A, 2013, J PHYS CHEM SOLIDS, V74, P811, DOI 10.1016/j.jpcs.2013.01.012; Nasongkla N, 2006, NANO LETT, V6, P2427, DOI 10.1021/nl061412u; Liu QX, 1998, CHEM MATER, V10, P3936, DOI 10.1021/cm980370a; Kim H, 2005, J AM CHEM SOC, V127, P544, DOI 10.1021/ja047107x; Uvarov V, 2007, MATER CHARACT, V58, P883, DOI 10.1016/j.matchar.2006.09.002; Tang ZK, 1998, APPL PHYS LETT, V72, P3270, DOI 10.1063/1.121620; Zhang WQ, 2008, J PHYS CHEM C, V112, P19872, DOI 10.1021/jp804547e; Chen Y, 2008, CARBOHYD POLYM, V73, P8, DOI 10.1016/j.carbpol.2007.10.015; Yang ZX, 2009, J PHYS CHEM C, V113, P21269, DOI 10.1021/jp903130t; Asmatulu R, 2005, J MAGN MAGN MATER, V292, P108, DOI 10.1016/j.jmmm.2004.10.103; Coates J., 2000, INTERPRETATION INFRA, P10815; Corr SA, 2006, CHEM COMMUN, P4474, DOI 10.1039/b610746j; Huang C, 2007, APPL PHYS A-MATER, V87, P781, DOI 10.1007/s00339-007-3902-3; Jagadish C., 2006, ZNO BULK THIN FILMS; Liu L., 2008, NANOTECHNOLOGY, V19; Liu X.G., 2008, J PHYS D, V41, P6; Mishra A.K., 2007, J APPL PHYS, V102, P6; Morkoz A., 2007, ZINC OXIDE FUNDAMENT; Ozgur U, 2005, J APPL PHYS, V98, DOI 10.1063/1.1992666; Panda NR, 2012, J NANOSCI NANOTECHNO, V12, P6977, DOI 10.1166/jnn.2012.6567; Panda NR, 2012, PHYSICA B, V407, P2716, DOI 10.1016/j.physb.2012.03.071; Panda NR, 2012, NANOSCI NANOTECH LET, V4, P808, DOI 10.1166/nnl.2012.1430; Pati SP, 2013, J APPL PHYS, V113, DOI 10.1063/1.4795441; Pati SP, 2014, CERAM INT, V40, P10343, DOI 10.1016/j.ceramint.2014.03.007; Pati SP, 2010, J SOLID STATE CHEM, V183, P2903, DOI 10.1016/j.jssc.2010.09.037; Patil S.S., 2014, J NANOPART RES, V16, P1; PRESTON RS, 1962, PHYS REV, V128, P2207, DOI 10.1103/PhysRev.128.2207; Sedlacik M, 2013, J MAGN MAGN MATER, V326, P7, DOI 10.1016/j.jmmm.2012.08.039; Vargas JM, 2011, J APPL PHYS, V109, DOI 10.1063/1.3565190; Yang B., 2010, J PHYS D, V43; Zhao YW, 2004, J PHYS CHEM B, V108, P3691, DOI 10.1021/jp037588r	44	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0025-5408	1873-4227		MATER RES BULL	Mater. Res. Bull.	DEC	2014	60						566	571		10.1016/j.materresbull.2014.09.004		6	Materials Science, Multidisciplinary	Materials Science	AY4ZJ	WOS:000347583100081		
J	Zhang, Y; Wedderburn, J; Harris, R; Book, D				Zhang, Y.; Wedderburn, J.; Harris, R.; Book, D.			Powder properties of hydrogenated ball-milled graphite	MATERIALS RESEARCH BULLETIN			English	Article						Nanoparticle; Hydrogen storage; Milling; Carbon material	MILLING CONDITIONS; CARBON MATERIALS; STORAGE; NANOSTRUCTURES; ATMOSPHERE; ARGON	Ball milling is an effective way of producing defective and nanostructured graphite. In this work, the hydrogen storage properties of graphite, ball-milled in a tungsten carbide milling pot under 3 bar hydrogen for various times (0-40 h), were investigated by TGA-Mass Spectrometry, XRD, SEM and laser diffraction particle size analysis. For the conditions used in this study, 10 h is the optimum milling time resulting in desorption of 5.5 wt% hydrogen upon heating under argon to 990 degrees C. After milling for 40 h, the graphite became significantly more disordered, and the amount of desorbed hydrogen decreased. After milling up to 10 h, the BET surface area increased while particle size decreased; however, there is no apparent correlation between these parameters, and the hydrogen storage properties of the hydrogenated ball-milled graphite. (C) 2014 Elsevier Ltd. All rights reserved.	[Zhang, Y.] Waseda Univ, Tokyo 1620041, Japan; [Wedderburn, J.; Harris, R.; Book, D.] Univ Birmingham, Birmingham B15 2TT, W Midlands, England	Zhang, Y (reprint author), Waseda Univ, Tokyo 1620041, Japan.	y.zhang062012@gmail.com			AWM Birmingham Science City "Hydrogen Energy Project"; EPSRC SUPERGEN UK-SHEC [EP/E040071/1]	Y.Z. is grateful to the support of the AWM Birmingham Science City "Hydrogen Energy Project" and the EPSRC SUPERGEN UK-SHEC (EP/E040071/1) is gratefully acknowledged.	Orimo S, 1999, APPL PHYS LETT, V75, P3093, DOI 10.1063/1.125241; Strobel R, 2006, J POWER SOURCES, V159, P781, DOI 10.1016/j.jpowsour.2006.03.047; Dutta S, 2014, J IND ENG CHEM, V20, P1148, DOI 10.1016/j.jiec.2013.07.037; Sevilla M, 2014, ENERG ENVIRON SCI, V7, P1250, DOI 10.1039/c3ee43525c; Chen DM, 2003, J ALLOY COMPD, V354, pL5, DOI 10.1016/S0925-8388(02)01355-5; von Helmolt R, 2007, J POWER SOURCES, V165, P833, DOI 10.1016/j.jpowsour.2006.12.073; Hamilton CW, 2009, CHEM SOC REV, V38, P279, DOI 10.1039/b800312m; Book D., 2005, SAFE EFFICIENT EC LA; Huang ZG, 2007, J MATER SCI, V42, P5437, DOI 10.1007/s10853-006-0785-1; Chen Y, 1999, APPL PHYS LETT, V74, P2782, DOI 10.1063/1.124012; Francke M, 2005, CARBON, V43, P1204, DOI 10.1016/j.carbon.2004.12.013; Ichikawa T., 2005, APPL PHYS LETT, V86; Orimo S., J APPL PHYS, V90; Patchkovskii S, 2005, P NATL ACAD SCI USA, V102, P10439, DOI 10.1073/pnas.0501030102; Shindo K, 2004, J ALLOY COMPD, V372, P201, DOI 10.1016/j.jallcom.2003.08.103; Touzik A, 2006, J ALLOY COMPD, V421, P141, DOI 10.1016/j.jallcom.2005.08.090; Zfittel A., 2003, MATER TODAY, V6, P24; Zhang Y., 2012, P 2011 MAT RES SOC M; Zhang Y., 2011, INT J ENERG RES, P720; Zhang YH, 2011, J PHYS CHEM C, V115, P25285, DOI 10.1021/jp206089x; Zhou L, 2006, INT J HYDROGEN ENERG, V31, P259, DOI 10.1016/j.ijhydene.2005.04.048; Zuttel A, 2002, MRS BULL, V27, P705, DOI 10.1557/mrs2002.226	22	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0025-5408	1873-4227		MATER RES BULL	Mater. Res. Bull.	DEC	2014	60						648	651		10.1016/j.materresbull.2014.09.024		4	Materials Science, Multidisciplinary	Materials Science	AY4ZJ	WOS:000347583100093		
J	Nakano, H; Furuya, S; Fukuda, K; Yamada, S				Nakano, Hiromi; Furuya, Shohei; Fukuda, Koichiro; Yamada, Suzuya			Synthesis and luminescence enhancement of Eu3+, Sm3+ co-doped Li1.11Ta0.89Ti0.11O3 phosphor	MATERIALS RESEARCH BULLETIN			English	Article						Oxides; Luminescence; X-ray diffraction; Phosphors	LI1+X-YNB1-X-3YTIX+4YO3 SOLID-SOLUTIONS; ENERGY-TRANSFER; DIELECTRIC-PROPERTIES; RED PHOSPHOR; SUPERSTRUCTURE; MICROSTRUCTURE; CRYSTAL; ER	Phosphors based on the Li1+xTa1-xTixO3 solid solutions (0.05 <= x <= 0.25) as host materials were investigated. The optimal composition of the host for red-light emitting phosphor was found to be Li1.11Ta0.89Ti0.11O3 (x=0.11) when activated with Eu3+. In this work, in order to further enhance the emission intensity, a series of Eu3+- and Sm3+-doped Li1.11Ta0.89Ti0.11O3 phosphors was synthesized by solid-state reaction. The phosphor doped with 2.5 wt% Eu2O3 and 0.1 wt% Sm2O3 showed the highly efficient red-light emission upon excitation at 399 nm, with the internal quantum efficiency being 98%. Its PL intensity was ca. 1.4 times higher than that of the 2.5 wt% Eu3+-doped Li1.11Ta0.89Ti0.11O3 phosphor, indicating that the small amount of Sm3+ acted as an effective sensitizer. (C) 2014 Elsevier Ltd. All rights reserved.	[Nakano, Hiromi; Furuya, Shohei] Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan; [Fukuda, Koichiro] Nagoya Inst Technol, Dept Mat Sci & Engn, Nagoya, Aichi 4668555, Japan; [Yamada, Suzuya] Denki Kagaku Kogyo KK, Cent Res Inst, Machida, Tokyo 1948560, Japan	Nakano, H (reprint author), Toyohashi Univ Technol, Dept Environm & Life Sci, Toyohashi, Aichi 4418580, Japan.	hiromi@crfc.tut.ac.jp			Japan Society for the Promotion of Science [25420709]	This work (H.N.) was partially supported by a Grant-in-Aid for Scientific Research (c) No. 25420709 by the Japan Society for the Promotion of Science.	Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Biju PR, 2004, OPT MATER, V24, P671, DOI 10.1016/S0925-3467(03)00183-6; Borisevich AY, 2002, J AM CERAM SOC, V85, P573; Lee GH, 2008, J LUMIN, V128, P1922, DOI 10.1016/j.jlumin.2008.05.020; Castrejon M.E.V., 1987, J SOLID STATE CHEM, V71, P103; Castrejon M.E.V. -, 1984, J BR CERAM SOC, V83, P143; Farber L, 2002, J SOLID STATE CHEM, V166, P81, DOI 10.1006/jssc.2002.9563; Gasparotto G., 2009, J APPL PHYS, V106, P3506; Gasparotto G, 2009, J APPL PHYS, V106, DOI 10.1063/1.3204967; Gryk W, 2005, J PHYS-CONDENS MAT, V17, P5381, DOI 10.1088/0953-8984/17/35/006; Hayashi H., 1995, 4 EURO CERAMICS, V2, P391; Hayashi H, 2010, J CERAM SOC JPN, V118, P226, DOI 10.2109/jcersj2.118.226; Hayashi H, 2010, J ALLOY COMPD, V502, P360, DOI 10.1016/j.jallcom.2010.04.168; Hayashi H., 1999, KEY ENG MATER, V501, P161; Ishiwatari T., 2007, JPN ENERGY TECHNOL I, V55, P8; Kostritskii SM, 2000, APPL PHYS LETT, V76, P2161, DOI 10.1063/1.126285; Li PL, 2012, MATER RES BULL, V47, P3825, DOI 10.1016/j.materresbull.2012.03.060; Nakano H, 2012, J AM CERAM SOC, V95, P2795, DOI 10.1111/j.1551-2916.2012.05372.x; Nakano H, 2013, J ALLOY COMPD, V552, P475, DOI 10.1016/j.jallcom.2012.11.058; Nakano H, 2013, MATERIALS, V6, P2768, DOI 10.3390/ma6072768; Naknao H., 2013, OPT MATER, V35, P2045; Romanowski W.R., 2001, J APPL LETT, V78, P3610; SMITH RI, 1992, MATER RES BULL, V27, P277, DOI 10.1016/0025-5408(92)90056-6; Sokolska I, 2000, J PHYS CHEM SOLIDS, V61, P1573, DOI 10.1016/S0022-3697(00)00041-X; Uchida T, 2013, POWDER DIFFR, V28, P178, DOI 10.1017/S0885715613000018; Won YH, 2008, J ELECTROCHEM SOC, V155, pJ226, DOI 10.1149/1.2946482; Yamamoto Y, 2003, MATER RES INNOV, V7, P74, DOI 10.1007/s10019-003-0231-9	27	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0025-5408	1873-4227		MATER RES BULL	Mater. Res. Bull.	DEC	2014	60						766	770		10.1016/j.materresbull.2014.09.059		5	Materials Science, Multidisciplinary	Materials Science	AY4ZJ	WOS:000347583100111		
J	Iwabuchi, Y; Takei, T; Moriyama, T; Itabashi, M; Nitta, K				Iwabuchi, Yuko; Takei, Takashi; Moriyama, Takahito; Itabashi, Mitsuyo; Nitta, Kosaku			Long-Term Prognosis of Adult Patients with Steroid-Dependent Minimal Change Nephrotic Syndrome Following Rituximab Treatment	MEDICINE			English	Article							CHANGE DISEASE; CHILDREN	This study was to evaluate the long-term efficacy and safety of a single-dose rituximab regimen rituximab treatment in adult patients with steroid-dependent minimal change nephrotic syndrome (MCNS). We conducted a prospective cohort study with historical controls to evaluate the effect of single-dose infusions of rituximab at 375 mg/m(2) BSA per dose administered at intervals of 6 months for a period of 24 months. At the end of the 24-month period, the patients were divided into the treatment continuation (n = 20) and treatment discontinuation (n = 5) groups according to their intention to continue/discontinue the treatment. A significant reduction in the total number of relapses was observed during the 24-month period after the first rituximab infusion as compared with that during the 24-month period before the first rituximab infusion (108 vs. 8, P < 0.001). Complete remission was induced/maintained in all patients from 12 to 24 months after the first rituximab infusion. In regard to the clinical course after 24 months, 4 of the 20 patients in the treatment continuation group discontinued the rituximab treatment after the fifth infusion and 2 patients discontinued the treatment after the sixth infusion. However, complete remission was maintained in all the 20 patients of this group during the 12-month observation period after the first four single-dose rituximab infusions. On the other hand, 1 of the 5 patients in the treatment discontinuation group developed relapse during the observation period after the first four rituximab infusions, and the rituximab treatment was resumed. In our trial, rituximab therapy was associated with maintenance of complete remission. Complete remission was maintained even in most of the patients who showed B-cell repletion after discontinuation of rituximab therapy. Thus, rituximab may be considered as a radical therapeutic agent for patients with steroid-dependent MCNS.	[Iwabuchi, Yuko; Takei, Takashi; Moriyama, Takahito; Itabashi, Mitsuyo; Nitta, Kosaku] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Tokyo 1628666, Japan	Takei, T (reprint author), Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	ttakei@kc.twmu.ac.jp					Francois H, 2007, AM J KIDNEY DIS, V49, P158, DOI 10.1053/j.ajkd.2006.10.015; Ruggenenti P, 2014, J AM SOC NEPHROL, V25, P850, DOI 10.1681/ASN.2013030251; Kamei K, 2009, PEDIATR NEPHROL, V24, P1321, DOI 10.1007/s00467-009-1191-0; Maloney DG, 1997, BLOOD, V90, P2188; Leandro MJ, 2006, ARTHRITIS RHEUM-US, V54, P613, DOI 10.1002/art.21617; Iijima K, 2002, KIDNEY INT, V61, P1801, DOI 10.1046/j.1523-1755.2002.00303.x; Sellier-Leclerc AL, 2010, PEDIATR NEPHROL, V25, P1109, DOI 10.1007/s00467-010-1465-6; Kemper MJ, 2012, NEPHROL DIAL TRANSPL, V27, P1910, DOI 10.1093/ndt/gfr548; Ravani P, 2011, CLIN J AM SOC NEPHRO, V6, P1308, DOI 10.2215/CJN.09421010; Bagga A, 2007, NEW ENGL J MED, V356, P2751, DOI 10.1056/NEJMc063706; Bargman J M, 1999, Kidney Int Suppl, V70, pS3; Bruchfeld A, 2014, NEPHROL DIAL TRANSPL, V29, P851, DOI 10.1093/ndt/gft312; Fornoni A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002231; Fujinaga S, PEDIAT NEPHROL; Guigonis V, 2008, PEDIATR NEPHROL, V23, P1269, DOI 10.1007/s00467-008-0814-1; Hofstra JM, 2007, NEPHROL DIAL TRANSPL, V22, P2100, DOI 10.1093/ndt/gfm128; Iijima K, 2014, LANCET S, P60541; Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group, 2012, KIDNEY INT S, VS2, P139; Kranz B, 2008, PEDIATR NEPHROL, V23, P581, DOI 10.1007/s00467-007-0709-6; Miyazaki K, 2012, CLIN NEPHROL, V77, P261, DOI 10.5414/CN107187; Munyentwali H, 2013, KIDNEY INT, V83, P511, DOI 10.1038/ki.2012.444; Perosa F, 2005, AUTOIMMUN REV, V4, P526, DOI 10.1016/j.autrev.2005.04.004; Takei T, 2013, NEPHROL DIAL TRANSPL, V28, P1225, DOI 10.1093/ndt/gfs515	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	DEC	2014	93	29								10.1097/MD.0000000000000300		7	Medicine, General & Internal	General & Internal Medicine	AX5RW	WOS:000346985700020		
J	Izawa, KP; Watanabe, S; Brubaker, PH; Tochimoto, S; Hirano, Y; Matsushima, S; Suzuki, T; Oka, K; Saito, T; Omori, Y; Suzuki, K; Osada, N; Omiya, K; Shimizu, H; Akashi, YJ				Izawa, Kazuhiro P.; Watanabe, Satoshi; Brubaker, Peter H.; Tochimoto, Shinobu; Hirano, Yasuyuki; Matsushima, Shinya; Suzuki, Tomohiro; Oka, Koichiro; Saito, Takashi; Omori, Yutaka; Suzuki, Kengo; Osada, Naohiko; Omiya, Kazuto; Shimizu, Hiroyuki; Akashi, Yoshihiro J.			Relation Between (V) over dotE/(V) over dotCO2 Slope and Maximum Phonation Time in Chronic Heart Failure Patients	MEDICINE			English	Article							CARDIAC REHABILITATION; EXERCISE CAPACITY; DIAGNOSTIC-TESTS; DISEASE SEVERITY; ASSOCIATION; STATEMENT; PROGNOSIS; STRENGTH; THERAPY	This study aimed to determine the relation between the regression slope relating minute ventilation to carbon dioxide output ((V) over dotE/(V) over dotCO2 slope) and maximum phonation time (MPT), and the MPT required to attain a threshold value for (V) over dotE/(V) over dotCO2 slope of <= 34 in chronic heart failure (CHF) patients. This cross-sectional study enrolled 115 CHF patients (mean age, 54.5 years; men, 84.9%). (V) over dotE/(V) over dotCO2 slope was assessed during cardiopulmonary exercise testing (CPX). Thereafter, patients were divided into 2 groups according to exercise capacity: (V) over dotE/(V) over dotCO2 slope <= 34 ((V) over dotE/(V) over dotCO2 <= 34 group, n = 81) and (V) over dotE/(V) over dotCO2 slope >34 ((V) over dotE/(V) over dotCO2 >34 group, n = 34). For MPT measurements, all patients produced a sustained vowel/a:/for as long as possible during respiratory effort from the seated position. All subjects showed significant negative correlation between (V) over dotE/(V) over dotCO2 slope and MPT (r = -0.51, P < 0.001). After adjustment for clinical characteristics, MPT was significantly higher in the (V) over dotE/(V) over dotCO2 <= 34 group vs (V) over dotE/(V) over dotCO2 >34 group (21.4 +/- 6.4 vs 17.4 +/- 4.3 s, F = 7.4, P = 0.007). The appropriate MPT cut-off value for identifying a (V) over dotE/(V) over dotCO2 slope <= 34 was 18.12 seconds. An MPT value of 18.12 seconds may be a useful target value for identifying CHF patients with a (V) over dotE/(V) over dotCO2 slope <= 34 and for risk management in these patients.	[Izawa, Kazuhiro P.] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo 6540142, Japan; [Watanabe, Satoshi; Tochimoto, Shinobu; Matsushima, Shinya; Suzuki, Tomohiro] St Marianna Univ, Sch Med Hosp, Dept Rehabil Med, Kawasaki, Kanagawa, Japan; [Brubaker, Peter H.] Wake Forest Univ, Dept Hlth & Exercise Sci, Winston Salem, NC 27109 USA; [Hirano, Yasuyuki] Tokushima Bunri Univ, Dept Phys Therapy, Tokushima, Japan; [Oka, Koichiro] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Omori, Yutaka] Visiting Nursing & Rehabil Network, Dept Rehabil, Kawasaki, Kanagawa, Japan; [Suzuki, Kengo; Akashi, Yoshihiro J.] St Marianna Univ, Dept Internal Med, Div Cardiol, Sch Med, Kawasaki, Kanagawa, Japan; [Osada, Naohiko] St Marianna Univ, Toyoko Hosp, Div Cardiol, Kawasaki, Kanagawa, Japan; [Omiya, Kazuto] St Marianna Univ, Yokohama City Seibu Hosp, Div Cardiol, Yokohama, Kanagawa, Japan; [Shimizu, Hiroyuki] St Marianna Univ, Sch Med, Dept Orthoped Surg, Kawasaki, Kanagawa, Japan	Izawa, KP (reprint author), Kobe Univ, Grad Sch Hlth Sci, 10-2 Tomogaoka 7 Chome Suma, Kobe, Hyogo 6540142, Japan.	izawapk@ga2.so-net.ne.jp	Akashi, Yoshihiro/E-5227-2011	Akashi, Yoshihiro/0000-0001-7670-7326			Menezes AR, 2012, J GERIATR CARDIOL, V9, P68, DOI 10.3724/SP.J.1263.2012.00068; Hamm LF, 2013, J CARDIOPULM REHABIL, V33, P1, DOI 10.1097/HCR.0b013e31827aad9e; Fletcher GF, 2013, CIRCULATION, V128, P873, DOI 10.1161/CIR.0b013e31829b5b44; HIRANO M, 1968, FOLIA PHONIATR, V20, P185; Gitt AK, 2002, CIRCULATION, V106, P3079, DOI 10.1161/01.CIR.0000041428.99427.06; Myers J, 2013, CIRC-HEART FAIL, V6, P211, DOI 10.1161/CIRCHEARTFAILURE.112.000073; Speyer R, 2010, J VOICE, V24, P281, DOI 10.1016/j.jvoice.2008.10.004; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Myers J, 2002, NEW ENGL J MED, V346, P793, DOI 10.1056/NEJMoa011858; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8; Moore B, 2007, J CARD FAIL, V13, P259, DOI 10.1016/j.cardfai1.2006.12.005; Speyer R, 2008, J VOICE, V22, P565, DOI 10.1016/j.jvoice.2006.10.005; Izawa KP, 2009, EUR J CARDIOV PREV R, V16, P21, DOI 10.1097/HJR.0b013e32831269a3; Hanson P., 1988, RESOURCE MANUAL GUID, P205; Izawa KP, 2014, INT J CARDIOL, V174, P727, DOI 10.1016/j.ijcard.2014.04.047; Izawa KP, 2012, EUR J PHYS REHAB MED, V48, P593; Izawa KP, 2007, AM J PHYS MED REHAB, V86, P893, DOI [10.1097/PHM.0b013e318154b592, 10.1097/PHM.0b13e318150592]; Jeng C, 2004, QUAL LIFE RES, V13, P925, DOI 10.1023/B:QURE.0000025604.15624.82; Ritt LE, 2012, J CARDIOPULM REHABIL, V32, P141, DOI 10.1097/HCR.0b013e31824f9ddf; Tsuchihashi M, 2000, JPN CIRC J, V64, P953, DOI 10.1253/jcj.64.953; YANAGIHARA N, 1966, FOLIA PHONIATR, V18, P323	22	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	DEC	2014	93	29								10.1097/MD.0000000000000306		5	Medicine, General & Internal	General & Internal Medicine	AX5RW	WOS:000346985700022		
J	Konoshita, T; Nakaya, T; Sakai, A; Yamada, M; Ichikawa, M; Sato, S; Imagawa, M; Fujii, M; Yamamoto, K; Makino, Y; Arakawa, K; Suzuki, J; Ishizuka, T; Nakamura, H				Konoshita, Tadashi; Nakaya, Takahiro; Sakai, Ai; Yamada, Mika; Ichikawa, Mai; Sato, Satsuki; Imagawa, Michiko; Fujii, Miki; Yamamoto, Katsushi; Makino, Yasukazu; Arakawa, Kenichiro; Suzuki, Jinya; Ishizuka, Tamotsu; Nakamura, Hiroyuki		Genomic Dis Outcome Consortium	Determinants of Plasma Renin Activity Role of a Human Renin Gene Variant as a Genetic Factor	MEDICINE			English	Article							ANGIOTENSIN-ALDOSTERONE SYSTEM; BLOOD-PRESSURE RESPONSE; CONVERTING ENZYME; HYPERTENSION; EXPRESSION; LOCUS; MORTALITY; RISK; POLYMORPHISMS; PROMOTER	The plasma renin activity (PRA) is affected by a number of environmental factors. However, significant heritability has been shown for the activity. A hypothesis that a candidate regulatory single-nucleotide polymorphism, C-5312T, of human renin gene should have a significant effect on PRA was elucidated and updating of independent determinants of PRA was attempted. Cross sectional study. Outpatient study. We enrolled consecutive 810 subjects who had consulted our hospitals for lifestyle-related diseases. Genotypes were assayed with genomic DNA for C-5312T. Among the genetic variants, the difference of PRA was evaluated. Monovariate linear regression analysis was performed to test the correlation between PRA and clinical variables. Finally, stepwise multiple regression analysis was performed to evaluate the independent determinants. On comparing 2 genotype groups, CC/CT and T allele homozygote, the geometric means of PRA were 0.778 and 0.941 ng/ml/h, respectively (F = 5.992, P = 0.015). Monovariate linear regression analysis revealed that a number of variables have a significant correlation with the activity, including urinary salt excretion. A stepwise multivariate regression analysis revealed that renin C-5312T variant (TT) is one of the independent determinants of PRA. Thus, for the first time, a human renin gene variant was associated with a significant increase in PRA as a genetic factor and the independent determinants for the activity were updated including genetic factor.	[Konoshita, Tadashi; Nakaya, Takahiro; Sakai, Ai; Yamada, Mika; Ichikawa, Mai; Sato, Satsuki; Imagawa, Michiko; Fujii, Miki; Yamamoto, Katsushi; Makino, Yasukazu; Arakawa, Kenichiro; Suzuki, Jinya; Ishizuka, Tamotsu] Univ Fukui, Fac Med Sci, Dept Internal Med 3, Fukui 9101193, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Environm & Prevent Med, Kanazawa, Ishikawa, Japan	Konoshita, T (reprint author), Univ Fukui, Fac Med Sci, Dept Internal Med 3, 23-3 Matsuokashimoaizuki, Fukui 9101193, Japan.	konosi-ta@u-fukui.ac.jp			Ministry of Education, Science and Culture of Japan [08770879, 09770843, 14571020, 22590909, 25461245]; National Research Foundation/Japan Science and Technology Agency (NRF/JST) [J110000349]; Strategic International Research Cooperative Program (SICP)	This work was supported by grant-in-aids 08770879, 09770843, 14571020, 22590909 and 25461245 from the Ministry of Education, Science and Culture of Japan and a grant from National Research Foundation/Japan Science and Technology Agency (NRF/JST) (Project number: J110000349) and Strategic International Research Cooperative Program (SICP).	ALDERMAN MH, 1991, NEW ENGL J MED, V324, P1098, DOI 10.1056/NEJM199104183241605; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; BORENSZTEIN P, 1994, CIRC RES, V74, P764; Konoshita T, 2006, DIABETES CARE, V29, P848, DOI 10.2337/diacare.29.04.06.dc05-1873; Wakahara S, 2007, ENDOCRINOLOGY, V148, P2453, DOI 10.1210/en.2006-1287; Moore N, 2007, HYPERTENSION, V50, P340, DOI 10.1161/HYPERTENSIONAHA.107.085563; Konoshita T, 2011, CURR HYPERTENS REP, V13, P356, DOI 10.1007/s11906-011-0212-0; Konoshita T, 2009, DIABETES CARE, V32, P1485, DOI 10.2337/dc09-0348; Castrop H, 2010, PHYSIOL REV, V90, P607, DOI 10.1152/physrev.00011.2009; Konoshita T, 2004, J CELL BIOCHEM, V93, P327, DOI 10.1002/jcb.20151; MERCURE C, 1995, J BIOL CHEM, V270, P16355; Fuchs S, 2003, J HYPERTENS, V21, P327, DOI 10.1097/01.hjh.0000052414.12292.ef; Kotchen TA, 2000, HYPERTENSION, V36, P7; Tomaschitz A, 2011, EUR HEART J, V32, P2642, DOI 10.1093/eurheartj/ehr150; Germain S, 1996, BIOCHEM J, V316, P107; Daimon M, 2012, METABOLISM, V61, P504, DOI 10.1016/j.metabol.2011.08.004; Konoshita T, 2007, J CELL BIOCHEM, V102, P1043, DOI 10.1002/jcb.21341; Corvol P, 1997, PATHOL BIOL, V45, P229; Konoshita T, 1996, KIDNEY INT, V50, P1515, DOI 10.1038/ki.1996.466; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Brunner M, 2007, AM J CARDIOL, V99, P1549, DOI 10.1016/j.amjcard.2007.01.029; Dzau V, 2005, J HYPERTENS, V23, pS9, DOI 10.1097/01.hjh.0000165623.72310.dd; FROSSARD PM, 1986, NUCLEIC ACIDS RES, V14, P4380, DOI 10.1093/nar/14.10.4380; FROSSARD PM, 1986, NUCLEIC ACIDS RES, V14, P6778, DOI 10.1093/nar/14.16.6778; Fuchs S, 2002, J HYPERTENS, V20, P2391, DOI 10.1097/00004872-200212000-00018; Fuchs S, 2002, AM J PATHOL, V161, P717, DOI 10.1016/S0002-9440(10)64227-7; Germain S, 1998, J BIOL CHEM, V273, P25292, DOI 10.1074/jbc.273.39.25292; Hasimu B, 2003, HYPERTENSION, V41, P308, DOI 10.1161/01.HYP.0000049762.77830.89; Lukitasari Mifetika, 2013, Bioinformation, V9, P1010, DOI 10.6026/97320630091010; MASHARANI U, 1989, NUCLEIC ACIDS RES, V17, P467, DOI 10.1093/nar/17.1.467; MASHARANI U, 1988, NUCLEIC ACIDS RES, V16, P2357, DOI 10.1093/nar/16.5.2357; Parikh NI, 2007, EUR HEART J, V28, P2644, DOI 10.1093/eurheartj/ehm399; Satoh M, 2011, J HYPERTENS, V29, P1940, DOI 10.1097/HJH.0b013e32834ab46a; Tanabe A, 2003, J CLIN ENDOCR METAB, V88, P2489, DOI 10.1210/jc.2002-021476; Vangjeli C, 2010, CIRC-CARDIOVASC GENE, V3, P53, DOI 10.1161/CIRCGENETICS.109.899930; Vinck WJ, 2002, J HUM HYPERTENS, V16, P417, DOI 10.1038/sj/jhh.1001410	36	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	DEC	2014	93	29								10.1097/MD.0000000000000354		6	Medicine, General & Internal	General & Internal Medicine	AX5RW	WOS:000346985700040		
J	Mizuno, K; Mikami, Y; Nagae, M; Tonomura, H; Ikeda, T; Fujiwara, H; Kubo, T				Mizuno, Kentaro; Mikami, Yasuo; Nagae, Masateru; Tonomura, Hitoshi; Ikeda, Takumi; Fujiwara, Hiroyoshi; Kubo, Toshikazu			Instrumented Reduction and Monosegmental Fusion for Meyerding Grade IV Developmental Spondylolisthesis A Report of 3 Cases	MEDICINE			English	Article							DECOMPRESSION; ARTHRODESIS; MANAGEMENT	There are numerous reports of treatment methods for spondylolisthesis with a Meyerding Grade of more than III. In high dysplastic spondylosthesis, surgical treatment was selected because there is considered to be a high possibility of low back pain and lower limb neurological symptoms worsening if slippage progresses. Monosegmental lumbar interbody fusion (L5-S1) with a pedicle screw system (PPS) was used to treat three cases of Meyerding Grade IV developmental spondylolisthesis. Patients gave written informed consent. The spondylolisthesis was reduced to Meyerding Grade I and sagittal balance improved in all three cases. In two cases with severe spinal instability, there were no postoperative neurological complications and the course was favorable. However, in one case with little spinal mobility due to vertebral body dysplasia, despite performing sufficient decompression of the nerve root at L5 and slow reduction to avoid placing excessive tension on the nerve root, a transient neurological disorder was observed. A PPS was used to increase the reduction strength and favorable reduction was possible. However, in the case with a long clinical course and the case with poor spinal mobility, since the mobility and plasticity of the nerve root itself may have been reduced, it was considered that reduction should be performed carefully using intraoperative neurological monitoring.	[Mizuno, Kentaro; Mikami, Yasuo; Nagae, Masateru; Tonomura, Hitoshi; Ikeda, Takumi; Fujiwara, Hiroyoshi; Kubo, Toshikazu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kyoto 6028566, Japan	Fujiwara, H (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kamigyo Ku, 465 Kawaramachi Hirokoji, Kyoto 6028566, Japan.	fjwr@koto.kpu-m.ac.jp					Longo UG, 2014, J BONE JOINT SURG AM, V96A, P53, DOI 10.2106/JBJS.L.01012; Petraco DM, 1996, SPINE, V21, P1133, DOI 10.1097/00007632-199605150-00002; BOHLMAN HH, 1982, J BONE JOINT SURG AM, V64, P415; Harms J., 1997, TXB SPINAL SURG; Lamartina C, 2009, EUR SPINE J, V18, pS133, DOI 10.1007/s00586-009-0984-y; Lonstein JE, 1999, SPINE, V24, P2640, DOI 10.1097/00007632-199912150-00011; Marchetti PG, 1997, TXB SPINAL SURG; Nakamae Toshio, 2013, Eur J Orthop Surg Traumatol, V23 Suppl 1, pS121, DOI 10.1007/s00590-013-1199-9; PEEK RD, 1989, J BONE JOINT SURG AM, V71A, P62; Ploumis Avraam, 2005, Acta Orthop Belg, V71, P750; Robert W., 2005, SPINE PHILA PA 197 S, V30, pS66; Ruf M, 2006, SPINE, V31, P269, DOI 10.1097/01.brs.0000197204.91891.eb; Sailhan F, 2006, SPINE, V31, P161, DOI 10.1097/01.brs.0000194780.17528.6b; Shufflebarger HL, 2005, SPINE, V30, pS42, DOI 10.1097/01.brs.0000155583.55856.f9; Steffee A D, 1988, Clin Orthop Relat Res, V227, P82	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	DEC	2014	93	29								10.1097/MD.0000000000000244		5	Medicine, General & Internal	General & Internal Medicine	AX5RW	WOS:000346985700007		
J	Umetsu, RY; Xu, X; Ito, W; Kihara, T; Takahashi, K; Tokunaga, M; Kainuma, R				Umetsu, Rie Y.; Xu, Xiao; Ito, Wataru; Kihara, Takumi; Takahashi, Kohki; Tokunaga, Masashi; Kainuma, Ryosuke			Magnetic Field-Induced Reverse Martensitic Transformation and Thermal Transformation Arrest Phenomenon of Ni41Co9Mn39Sb11 Alloy	METALS			English	Article						Heusler alloy; martensitic transformation; magnetic field-induced transformation; thermal transformation arrest behavior; magnetic structure; magnetic moment	SHAPE-MEMORY ALLOY; HEUSLER ALLOYS; TWIN BOUNDARIES; KINETIC ARREST; NI2MNGA; TEMPERATURE; RECOVERY; PRESSURE; PHASES; STRAIN	In order to investigate behavior of magnetic field-induced reverse martensitic transformation for Ni-Co-Mn-Sb, magnetization experiments up to a static magnetic field of 18 T and a pulsed magnetic field of 40 T were carried out. In the thermomagnetization curves for Ni41Co9Mn39Sb11 alloy, the equilibrium transformation temperature T-0 was observed to decrease with increasing applied magnetic field, H-0, at a rate of dT(0)/d(0)H = 4.6 K/T. The estimated value of entropy change evaluated from the Clausius-Clapeyron relation was about 14.1 J/(Kkg), which was in good agreement with the value obtained by differential scanning calorimetric measurements. For the isothermal magnetization curves, metamagnetic behavior associated with the magnetic field-induced martensitic transformation was observed. The equilibrium magnetic field, H-0(0) = (H-0(Af) + H-0(Ms))/2, of the martensitic transformation tended to be saturated at lower temperature; that is, transformation arrest phenomenon was confirmed for the Ni-Co-Mn-Sb system, analogous with the Ni(Co)-Mn-Z (Z = In, Sn, Ga, Al) alloys. Temperature dependence of the magnetic field hysteresis, H-0(hys) = H-0(Af) - H-0(Ms), was analyzed based on the model for the plastic deformation introduced by the dislocations. The behavior can be explained by the model and the difference of the sweeping rate of the applied magnetic field was well reflected by the experimental results.	[Umetsu, Rie Y.; Takahashi, Kohki] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Xu, Xiao; Kainuma, Ryosuke] Tohoku Univ, Grad Sch Engn, Dept Mat Sci, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Ito, Wataru] Sendai Natl Coll Technol, Dept Mat & Environm Engn, Natori, Miyagi 9811239, Japan; [Tokunaga, Masashi] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan	Umetsu, RY (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	rieume@imr.tohoku.ac.jp; xu@material.tohoku.ac.jp; ito@sendai-nct.ac.jp; t_kihara@imr.tohoku.ac.jp; kohki@imr.tohoku.ac.jp; tokunaga@issp.u-tokyo.ac.jp; kainuma@material.tohoku.ac.jp	Tokunaga, Masashi/C-6821-2014; Kihara, Takumi/B-8515-2014; Takahashi, Kohki/A-9271-2011	Tokunaga, Masashi/0000-0002-1401-9381; 	Global COE Program, Tohoku University, from the Japanese Society for the Promotion of Science (JSPS) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This study was supported by Grant-in-Aids for Scientific Research (S) and (B), and by the Global COE Program, Tohoku University, from the Japanese Society for the Promotion of Science (JSPS) of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. This works were performed at High Field Laboratory for Superconducting Materials, Institute for Materials Research, Tohoku University and at the Institute for Solid State Physics, the University of Tokyo. Parts of this work were performed at the Center for Low Temperature Science, Institute for Materials Research, Tohoku University.	Ito W, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2833699; Umetsu RY, 2009, SCRIPTA MATER, V60, P25, DOI 10.1016/j.scriptamat.2008.08.022; Han ZD, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2385147; Niitsu K, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4840336; Sutou Y, 2004, APPL PHYS LETT, V85, P4358, DOI 10.1063/1.1808879; Umetsu RY, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3548558; KANOMATA T, 1987, J MAGN MAGN MATER, V65, P76, DOI 10.1016/0304-8853(87)90312-X; Ito W, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3525168; GHOSH G, 1994, ACTA METALL MATER, V42, P3371, DOI 10.1016/0956-7151(94)90469-3; Gavriljuk VG, 2003, SCRIPTA MATER, V49, P803, DOI 10.1016/S1359-6462(03)00360-9; TONG HC, 1974, ACTA METALL MATER, V22, P887, DOI 10.1016/0001-6160(74)90055-8; Du J, 2007, J PHYS D APPL PHYS, V40, P5523, DOI 10.1088/0022-3727/40/18/001; Sozinov A, 2002, IEEE T MAGN, V38, P2814, DOI 10.1109/TMAG.2002.803567; Krenke T, 2005, NAT MATER, V4, P450, DOI 10.1038/nmat1395; Yu SY, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2362581; Straka L, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3573860; Nayak AK, 2009, J APPL PHYS, V106, DOI 10.1063/1.3208064; Cesari E, 2011, MATER SCI FORUM, V684, P49, DOI 10.4028/www.scientific.net/MSF.684.49; MECKING H, 1981, ACTA METALL MATER, V29, P1865, DOI 10.1016/0001-6160(81)90112-7; Krenke T, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.104414; Liu J, 2012, NAT MATER, V11, P620, DOI [10.1038/nmat3334, 10.1038/NMAT3334]; Ullakko K, 1996, APPL PHYS LETT, V69, P1966, DOI 10.1063/1.117637; Koyama K, 2007, J MAGN MAGN MATER, V310, pE994, DOI 10.1016/j.jmmm.2006.10.1040; Yu SY, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2748095; Umetsu RY, 2011, J ALLOY COMPD, V509, P1389, DOI 10.1016/j.jallcom.2010.10.176; Kainuma R, 2006, NATURE, V439, P957, DOI 10.1038/nature04493; KANEKO T, 1981, J APPL PHYS, V52, P2046, DOI 10.1063/1.329610; Khan M, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2772233; KOCKS UF, 1975, PROGR MAT SCI CHALME, V19; Miyamoto T, 2010, SCRIPTA MATER, V62, P151, DOI 10.1016/j.scriptamat.2009.10.006; Nayak AK, 2011, ACTA MATER, V59, P3304, DOI 10.1016/j.actamat.2011.02.004; Nayak AK, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3365181; Nayak AK, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/11/115004; Niitsu K, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4809935; Peng ZM, 2008, MAT SCI ENG A-STRUCT, V481, P310, DOI 10.1016/j.msea.2006.11.180; Sahoo R, 2011, J APPL PHYS, V109, DOI 10.1063/1.3554219; SAOLU E, 2004, PHYS REV B, V70, P4427, DOI DOI 10.1103/PHYSREVB. 70. 024427; SEEGER A, 1957, DISLOCATIONS MECHANI, P271; SHARATH LS, 2010, PHYS REV B, V81, P5105, DOI DOI 10.1103/PHYSREVB.81.195105; SHINOHARA T, 1970, PHYS SOC JPN, V28, P313, DOI DOI 10.1143/JPSJ.28.313; Umetsu RY, 2013, MATER TRANS, V54, P291, DOI 10.2320/matertrans.M2012365; VANDERMA VK, 2006, APPL PHYS LETT, V89, P22509, DOI DOI 10.1063/1.2399365; Xu X, 2013, MATER TRANS, V54, P357, DOI 10.2320/matertrans.MBW201202; Xu X, 2010, MATER TRANS, V51, P469, DOI 10.2320/matertrans.MBW200915; Xu X, 2013, METALS-BASEL, V3, P298, DOI 10.3390/met3030298; Xu X, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4821184; Xu XA, 2010, MATER TRANS, V51, P1357, DOI 10.2320/matertrans.M2010098; Zhang B, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2753710	48	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2075-4701			METALS-BASEL	Metals	DEC	2014	4	4					609	622		10.3390/met4040609		14	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AX4MI	WOS:000346906200011		
J	Ziemnicka-Sylwester, M				Ziemnicka-Sylwester, Marta			Vaporization and Poor Wettability as the Main Challenges in Fabrication of TiB2-Cu Cermets Studied by SPS	METALS			English	Article						cermets; vaporization; wettability; TiB2; MMCs; SPS; liquid phase sintering; rietveld method	MECHANICAL-PROPERTIES; LIQUID; COMPOSITES; DENSIFICATION; COPPER; MICROSTRUCTURE; EVAPORATION; PARTICLES; MODEL; STAGE	TiB2-Cu cermets with various volume fractions of copper (from 3 to 30 vol. %) were produced via liquid phase sintering at the temperature range 1100-1200 degrees C in vacuum using spark plasma sintering (SPS) technique. Full densification could not be achieved as the consequence of poor wettability and vaporizing Cu. The quantitative Rietveld analysis indicated that insignificant reduction in Cu content occurred only in sample with initially 3 vol. % of Cu, but then densification was negligible. The relative density improved along with increasing volume content of Cu (10-20 vol. %), but then predominant amount of Cu introduced was reduced as the effect of vaporization or swelling, which caused that pellet with intended 20 or 30 vol. % of Cu contained respectively only 6 or 17 vol. % after sintering. Moreover, Cu droplets were released from the die at the temperature of 1000-1030 degrees C near the Cu melting point. The effect of vaporization was successfully reduced by increased heating rate and when isothermal annealing process was skipped, however, it could not be entirely eliminated. The experimental results on Cu vaporization are confronted with parameters that are commonly considered in the production of cermets, such as oxidation, wettability, contact angle and viscosity as well as their impact on densification.	Hokkaido Univ, Div Mat Sci & Engn, Sapporo, Hokkaido 0608628, Japan	Ziemnicka-Sylwester, M (reprint author), Hokkaido Univ, Div Mat Sci & Engn, Kita 13 Nishi 8, Sapporo, Hokkaido 0608628, Japan.	marta.zs@eng.hokudai.ac.jp					Aizenshtein M, 2006, J MATER SCI, V41, P5185, DOI 10.1007/s10853-006-0436-6; Yoon S, 2011, J EUR CERAM SOC, V31, P773, DOI 10.1016/j.jeurceramsoc.2010.11.012; Ritasalo R, 2010, MAT SCI ENG A-STRUCT, V527, P2733, DOI 10.1016/j.msea.2010.01.008; Zhang ZH, 2009, MAT SCI ENG A-STRUCT, V523, P134, DOI 10.1016/j.msea.2009.07.016; Mattia D, 2005, J EUR CERAM SOC, V25, P1797, DOI 10.1016/j.jeurceramsoc.2004.12.012; Liu HC, 1996, MATER LETT, V26, P171, DOI 10.1016/0167-577X(95)00221-9; Sobhani M, 2013, MAT SCI ENG A-STRUCT, V577, P16, DOI 10.1016/j.msea.2013.03.063; Lopez M, 2005, MATER CHARACT, V55, P252, DOI 10.1016/j.matchar.2005.04.006; NICHOLAS MG, 1990, J MATER SCI, V25, P2679, DOI 10.1007/BF00584866; Ahangarkani M, 2012, INT J REFRACT MET H, V32, P39, DOI 10.1016/j.ijrmhm.2012.01.006; BAIK S, 1987, J AM CERAM SOC, V70, P527, DOI 10.1111/j.1151-2916.1987.tb05699.x; Biswas K, 2013, SCRIPTA MATER, V69, P122, DOI 10.1016/j.scriptamat.2013.02.046; Brown C. W, 1998, ALUM INNOV 3, V50, P38; Dong LX, 2009, IEEE T NANOTECHNOL, V8, P565, DOI 10.1109/TNANO.2009.2026172; Eymann K, 2012, J ALLOY COMPD, V535, P62, DOI 10.1016/j.jallcom.2012.04.102; GESSINGE.GH, 1973, ACTA METALL MATER, V21, P715, DOI 10.1016/0001-6160(73)90082-5; HUPPMANN WJ, 1975, ACTA METALL MATER, V23, P965, DOI 10.1016/0001-6160(75)90010-3; HWANG KS, 1987, METALL TRANS A, V18, P11, DOI 10.1007/BF02646216; Lee BS, 2002, J CRYST GROWTH, V234, P599, DOI 10.1016/S0022-0248(01)01747-X; Li Gai, 2014, International Journal of Refractory Metals & Hard Materials, V45, DOI 10.1016/j.ijrmhm.2014.04.008; Sharma AS, 2013, WEAR, V306, P138, DOI 10.1016/j.wear.2013.07.009; Sigl L. S., 1993, INT J REFRACT MET H, V12, P95, DOI [10.1016/0263-4368(93)90020-G, DOI 10.1016/0263-4368(93)90020-G]; Venkateswaran T, 2006, J EUR CERAM SOC, V26, P2431, DOI 10.1016/j.jeurceramsoc.2005.05.011; Xu K, 1997, MECH MATER, V25, P137, DOI 10.1016/S0167-6636(96)00048-8; Zhang XH, 2006, SCRIPTA MATER, V55, P565, DOI 10.1016/j.scriptamat.2006.04.048; Zhang XH, 2004, J MATER SCI, V39, P4683, DOI 10.1023/B:JMSC.0000034171.47412.7f; Ziemnicka-Sylwester M, 2013, ADV SCI TECH, V77, P146, DOI 10.4028/www.scientific.net/AST.77.146; Ziemnicka-Sylwester M, 2012, ISIJ INT, V52, P1698, DOI 10.2355/isijinternational.52.1698; Ziemnicka-Sylwester M, 2014, MATER DESIGN, V53, P758, DOI 10.1016/j.matdes.2013.07.092	29	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2075-4701			METALS-BASEL	Metals	DEC	2014	4	4					623	638		10.3390/met4040623		16	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	AX4MI	WOS:000346906200012		
J	Sasaki, H; Kadoiwa, K; Koyama, H; Kamo, Y; Yamamoto, Y; Oishi, T; Hayashi, K				Sasaki, Hajime; Kadoiwa, Kaoru; Koyama, Hidetoshi; Kamo, Yoshitaka; Yamamoto, Yoshitsugu; Oishi, Toshiyuki; Hayashi, Kazuo			Decrease in on-state gate current of AlGaN/GaN HEMTs by recombination-enhanced defect reaction of generated hot carriers investigated by TCAD simulation	MICROELECTRONICS RELIABILITY			English	Article						GaN; HEMT; Reliability; Gate current; TCAD; Deep level	FIELD-EFFECT TRANSISTORS; LEAKAGE CURRENTS; MECHANISM; GAN	Changes in the on-state gate current of AlGaN/GaN high-electron-mobility transistors (HEMTs) under various electrical and thermal stress conditions have been analyzed by technology computer-aided design (TCAD) simulation. A larger gate current is observed under on-state bias condition than that under off-state bias condition. The TCAD simulation indicates that on-state gate current flows from the heated gate electrode to the AlGaN layer by tunneling or hopping through the gate depletion layer when we apply some deep-donor-type traps under the gate in the AlGaN barrier layer. The gate current is caused by electrons that flow and is pulled away by the applied gate-to-drain voltage under a high channel temperature condition. The deep traps benefit both the on- and off-state gate current behavior. We found that the on-state gate current is effectively decreased by electrical stress under the on-state condition. Electroluminescence measurement indicates that a large number of hot carriers are generated under this condition. The results suggest that the process-induced crystal defects are annealed out by non-radiative recombination of the generated hot carriers by a recombination-enhanced defect reaction mechanism. The change in the on-state gate current in the TCAD simulation can be successfully explained by the decrease in the donor traps. (C) 2014 Elsevier Ltd. All rights reserved.	[Sasaki, Hajime; Kadoiwa, Kaoru; Koyama, Hidetoshi; Kamo, Yoshitaka; Yamamoto, Yoshitsugu] Mitsubishi Electr Corp, High Frequency & Opt Device Works, Tokyo, Japan; [Oishi, Toshiyuki; Hayashi, Kazuo] Mitsubishi Electr Corp, Informat Technol R&D Ctr, Tokyo, Japan	Sasaki, H (reprint author), 4-1 Mizuhara, Itami, Hyogo 6648641, Japan.	Sasaki.Hajime@ce.MitsubishiElectric.co.jp					Oyama S, 2002, APPL SURF SCI, V190, P322, DOI 10.1016/S0169-4332(01)00902-3; Saito W, 2005, IEEE T ELECTRON DEV, V52, P159, DOI 10.1109/TED.2004.842710; del Alamo JA, 2009, MICROELECTRON RELIAB, V49, P1200, DOI 10.1016/j.microrel.2009.07.003; Hasegawa H, 2003, J VAC SCI TECHNOL B, V21, P1844, DOI 10.1116/1.1589520; Tan WS, 2006, IEEE ELECTR DEVICE L, V27, P1, DOI 10.1109/LED.2005.860383; Hasegawa H, 2002, J VAC SCI TECHNOL B, V20, P1647, DOI 10.1116/1.1491539; Miller EJ, 2000, J APPL PHYS, V88, P5951, DOI 10.1063/1.1319972; Okumura H, 2006, JPN J APPL PHYS 1, V45, P7565, DOI 10.1143/JJAP.45.7565; As DJ, 2006, MAT RES SOC MRS P, V892; Hayashi K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.124101; Hayashi K, 2013, J APPL PHYS, V52; Henderson T, 1995, INTERNATIONAL ELECTRON DEVICES MEETING, 1995 - IEDM TECHNICAL DIGEST, P811, DOI 10.1109/IEDM.1995.499341; Hoshi S, 2001, IEICE T ELECTRON, VE84C, P1350; Huebschman BD, 2011, IEEE COMP SEM INT CI, P1; Karmalkar S, 2006, IEEE ELECTR DEVICE L, V27, P87, DOI 10.1109/LED.2005.862672; Kotani J, 2006, J VAC SCI TECHNOL B, V24, P2148, DOI 10.1116/1.2216722; Kuliev A, 2003, SOLID STATE ELECTRON, V47, P117, DOI 10.1016/S0038-1101(02)00258-7; Lam ND, 2013, P INT C NAN APPL PRO, V2; Muraro JL, 2010, INT J MICROW WIREL T, V2, P121, DOI 10.1017/S1759078710000206; Rosker M, 2009, INT C COMP SEM MAN T; Rosker M., 2007, IEEE COMP SEM INT CI, P1; Sasaki H, 1997, JPN J APPL PHYS 1, V36, P2068, DOI 10.1143/JJAP.36.2068; Sasaki H, 2014, P REL COMP SEM ROCS, P79; Sathaiya DM, 2007, IEEE T ELECTRON DEV, V54, P2614, DOI 10.1109/TED.2007.904993; Takamiya S, 1997, SOLID STATE ELECTRON, V41, P391, DOI 10.1016/S0038-1101(96)00147-5; Zhou YG, 2005, PHYS STATUS SOLIDI C, V2, P2663, DOI 10.1002/pssc.200461623	26	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0026-2714			MICROELECTRON RELIAB	Microelectron. Reliab.	DEC	2014	54	12					2662	2667		10.1016/j.microrel.2014.09.013		6	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Physics, Applied	Engineering; Science & Technology - Other Topics; Physics	AX5GG	WOS:000346954100004		
J	Tavabi, AH; Arai, S; Muto, S; Tanji, T; Dunin-Borkowski, RE				Tavabi, Amir H.; Arai, Shigeo; Muto, Shunsuke; Tanji, Takayoshi; Dunin-Borkowski, Rafal E.			In Situ Transmission Electron Microscopy of Ionic Conductivity and Reaction Mechanisms in Ultrathin Solid Oxide Fuel Cells	MICROSCOPY AND MICROANALYSIS			English	Article						in situ TEM; electron holography; electron energy-loss spectroscopy; solid oxide fuel cells; gas-solid reactions	INTERMEDIATE TEMPERATURE SOFC; ENERGY-LOSS SPECTROSCOPY; PULSED-LASER DEPOSITION; REDOX REACTIONS; HOLOGRAPHY; NANOPARTICLES; TRANSISTORS; CATHODE; TEM	Solid oxide fuel cells (SOFCs) are promising candidates for use in alternative energy technologies. A full understanding of the reaction mechanisms in these dynamic material systems is required to optimize device performance and overcome present limitations. Here, we show that in situ transmission electron microscopy (TEM) can be used to study redox reactions and ionic conductivity in SOFCs in a gas environment at elevated temperature. We examine model ultrathin half and complete cells in two environmental TEMs using off-axis electron holography and electron energy-loss spectroscopy. Our results from the model cells provide insight into the essential phenomena that are important for the operation of commercial devices. Changes in the activities of dopant cations in the solid electrolyte are detected during oxygen anion conduction, demonstrating the key role of dopants in electrolyte architecture in SOFCs.	[Tavabi, Amir H.; Dunin-Borkowski, Rafal E.] Forschungszentrum Julich, Ernst Ruska Ctr Microscopy & Spect Electrons, D-52425 Julich, Germany; [Tavabi, Amir H.; Dunin-Borkowski, Rafal E.] Forschungszentrum Julich, Peter Grunberg Inst, D-52425 Julich, Germany; [Arai, Shigeo; Muto, Shunsuke; Tanji, Takayoshi] Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648603, Japan	Tavabi, AH (reprint author), Forschungszentrum Julich, Ernst Ruska Ctr Microscopy & Spect Electrons, D-52425 Julich, Germany.	a.tavabi@fz-juelich.de	Dunin-Borkowski, Rafal/G-5597-2012	Dunin-Borkowski, Rafal/0000-0001-8082-0647	Ministry of Education, Culture, Sports and Technology (MEXT) in Japan [20246013]; MEXT "Program for Development of Environmental Technology using Nanotechnology"	The authors gratefully acknowledge Dr. Kazuo Yamamoto for useful discussions and for use of the FIB facility at the Japan Fine Ceramics Center. The present work was partially supported by a Grant-in Aid (No. 20246013) from the Ministry of Education, Culture, Sports and Technology (MEXT) in Japan. This work was also partly supported by the MEXT "Program for Development of Environmental Technology using Nanotechnology."	Adhikari R, 2010, J MAGN MAGN MATER, V322, P3631, DOI 10.1016/j.jmmm.2010.07.006; REZ D, 1994, ACTA CRYSTALLOGR A, V50, P481, DOI 10.1107/S0108767393013200; Dunin-Borkowski RE, 2005, ULTRAMICROSCOPY, V103, P67, DOI 10.1016/j.ultramic.2004.11.018; Garvie LAJ, 1999, J PHYS CHEM SOLIDS, V60, P1943, DOI 10.1016/S0022-3697(99)00218-8; Lubk A, 2010, ULTRAMICROSCOPY, V110, P438, DOI 10.1016/j.ultramic.2009.09.009; Jeangros Q, 2010, ACTA MATER, V58, P4578, DOI 10.1016/j.actamat.2010.04.019; Yamamoto K, 2010, ANGEW CHEM INT EDIT, V49, P4414, DOI 10.1002/anie.200907319; Shao ZP, 2004, NATURE, V431, P170, DOI 10.1038/nature02863; Midgley PA, 2009, NAT MATER, V8, P271, DOI 10.1038/nmat2406; Dusastre V, 1999, SOLID STATE IONICS, V126, P163, DOI 10.1016/S0167-2738(99)00108-3; Vayssilov GN, 2011, NAT MATER, V10, P310, DOI [10.1038/nmat2976, 10.1038/NMAT2976]; Horita T, 2009, J POWER SOURCES, V193, P194, DOI 10.1016/j.jpowsour.2008.10.127; Crozier PA, 2008, ULTRAMICROSCOPY, V108, P1432, DOI 10.1016/j.ultramic.2008.05.015; Sickmann J, 2011, ULTRAMICROSCOPY, V111, P290, DOI 10.1016/j.ultramic.2010.12.016; Steele BCH, 1999, NATURE, V400, P619, DOI 10.1038/23144; Hytch M, 2008, NATURE, V453, P1086, DOI 10.1038/nature07049; Rau WD, 1999, PHYS REV LETT, V82, P2614, DOI 10.1103/PhysRevLett.82.2614; Arai S, 2004, MATER TRANS, V45, P2951, DOI 10.2320/matertrans.45.2951; Dunin-Borkowski R. E., 2010, MICROSC MICROANAL S2, V16, P572, DOI [10.1017/S1431927610057119, DOI 10.1017/S1431927610057119]; GAJDARDZISKAJOSIFOVSKA M, 1993, ULTRAMICROSCOPY, V50, P285, DOI 10.1016/0304-3991(93)90197-6; Hertz J. L., 2009, J ELECTROCERAM, V193, P194; Izuki M., 2000, ACTA MAT, V48, P4709, DOI [10.1016/S1359-6454(00)00261-5, DOI 10.1016/S1359-6454(00)00261-5]; Joo JH, 2007, J EUR CERAM SOC, V27, P4273, DOI 10.1016/j.jeurceramsoc.2007.02.135; Kim YB, 2011, J ELECTROCHEM SOC, V158, pB1453, DOI 10.1149/2.001112jes; Landheer D, 2001, J ELECTROCHEM SOC, V148, pG29, DOI 10.1149/1.1337607; Lichte H, 2010, MICROSC MICROANAL, V16, P434, DOI 10.1017/S1431927610093633; Lichte H, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/1/016102; Liu L. Y., 2005, SOLID STATE IONICS, V176, P435, DOI [10.1016/j.ssi.2004.08.018, DOI 10.1016/J.SSI.2004.08.018]; McCartney MR, 2005, HANDBOOK OF MICROSCOPY FOR NANOTECHNOLOGY, P629, DOI 10.1007/1-4020-8006-9_20; Mench M. M., 2008, FUEL CELL ENGINES; Mitterdorfer A, 1999, SOLID STATE IONICS, V117, P187, DOI 10.1016/S0167-2738(98)00341-5; Moritomo H., 2006, P IMC16, V16, P1154; OHayre R, 2009, FUEL CELL FUNDAMENTA; Panteix PJ, 2006, MATER CHEM PHYS, V95, P313, DOI 10.1016/j.matchemphys.2005.06.040; Rodrigo K, 2010, APPL PHYS A-MATER, V101, P601, DOI 10.1007/s00339-010-5975-7; Rui S., 2007, J POWER SOURCES, V172, P493, DOI [10.1016/j.jpowsour.2007.07.071, DOI 10.1016/J.JPOWSOUR.2007.07.071]; Sammes N., 2006, FUEL CELL TECHNOLOGY; Sharma R., 2008, IN SITU ELECT MICROS, P15, DOI 10.1142/9789812797346_0002; Singhal S.C., 2003, HIGH TEMPERATURE SOL; Soldati AL, 2011, INT J HYDROGEN ENERG, V36, P9180, DOI 10.1016/j.ijhydene.2011.04.121; TANJI T, 1994, J ELECTRON MICROSC, V43, P318; Tavabi A. H., 2013, MICR C MC 2013 ERNST, P190; Tavabi A. H., 2011, CHARACTERIZATION INT, P267; Tavabi AH, 2011, J ELECTRON MICROSC, V60, P307, DOI 10.1093/jmicro/dfr056; Tavabi AH, 2012, MICROSC MICROANAL, V18, P538, DOI 10.1017/S143192761200027X; Tonomura A, 1999, ELECT HOLOGRAPHY; Tsoga A., 2011, J POWER SOURCES, V196, P7232, DOI [10.1016/j.jpowsour.2010.11.013, DOI 10.1016/J.JPOWSOUR.2010.11.013]	47	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1431-9276	1435-8115		MICROSC MICROANAL	Microsc. microanal.	DEC	2014	20	6					1817	1825		10.1017/S143192761401349X		9	Materials Science, Multidisciplinary; Microscopy	Materials Science; Microscopy	AX9PD	WOS:000347233400020		
J	Wei, ZS; Kowalska, E; Ohtani, B				Wei, Zhishun; Kowalska, Ewa; Ohtani, Bunsho			Influence of Post-Treatment Operations on Structural Properties and Photocatalytic Activity of Octahedral Anatase Titania Particles Prepared by an Ultrasonication-Hydrothermal Reaction	MOLECULES			English	Article						titania; photocatalytic activity; octahedral anatase particles; post-treatments; time-resolved microwave conductivity	TITANIUM(IV) OXIDE PHOTOCATALYST; PHYSICAL-PROPERTIES; TIO2 NANOPARTICLES; RECOMBINATION; DIOXIDE; SUSPENSION; STABILITY; CHEMISTRY; KINETICS; PHASE	The influence of changes in structural and physical properties on the photocatalytic activity of octahedral anatase particles (OAPs), exposing eight equivalent {101} facets, caused by calcination (2 h) in air or grinding (1 h) in an agate mortar was studied with samples prepared by ultrasonication (US; 1 h)-hydrothermal reaction (HT; 24 h, 433 K). Calcination in air at temperatures up to 1173 K induced particle shape changes, evaluated by aspect ratio (AR; d(001)/d(101) = depth vertical to anatase {001} and {101} facets estimated by the Scherrer equation with data obtained from X-ray diffraction (XRD) patterns) and content of OAP and semi-OAP particles, without transformation into rutile. AR and OAP content, as well as specific surface area (SSA), were almost unchanged by calcination at temperatures up to 673 K and were then decreased by elevating the calcination temperature, suggesting that calcination at a higher temperature caused dull-edging and particle sintering, the latter also being supported by the analysis of particle size using XRD patterns and scanning electron microscopic (SEM) images. Time-resolved microwave conductivity (TRMC) showed that the maximum signal intensity (I-max), corresponding to a product of charge-carrier density and mobility, and signal-decay rate, presumably corresponding to reactivity of charge carriers, were increased with increase in AR, suggesting higher photocatalytic activity of OAPs than that of dull-edged particles. Grinding also decreased the AR, indicating the formation of dull-edged particles. The original non-treated samples showed activities in the oxidative decomposition of acetic acid (CO2 system) and dehydrogenation of methanol (H-2 system) comparable to and lower than those of a commercial anatase titania (Showa Denko Ceramics FP-6), respectively. The activities of calcined and ground samples for the CO2 system and H-2 system showed almost linear relations with AR and I-max, respectively, suggesting that those activities may depend on different properties.	[Wei, Zhishun; Kowalska, Ewa; Ohtani, Bunsho] Hokkaido Univ, Catalysis Res Ctr, Sapporo, Hokkaido 0010021, Japan	Kowalska, E (reprint author), Hokkaido Univ, Catalysis Res Ctr, Sapporo, Hokkaido 0010021, Japan.	wei@cat.hokudai.ac.jp; kowalska@cat.hokudai.ac.jp; ohtani@cat.hokudai.ac.jp	Kowalska, Ewa/D-5540-2009; Wei, Zhishun/J-4600-2015	Wei, Zhishun/0000-0001-7436-6409	CONCERT-Japan Program (Japan Science and Technology Agency); KAKENHI from Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [2510750303]; China Scholarship Council (CSC)	The authors are grateful to Christophe Colbeau-Justin, Jonathan Verrett and Hynd Remita for technical assistance and discussion on the results of TRMC analyses. This study was partly supported by CONCERT-Japan Program (Japan Science and Technology Agency) and a Grant-in-Aid (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (Grant No. 2510750303). One of the authors (Z.W.) appreciates China Scholarship Council (CSC) for support.	Amano F, 2009, CHEM COMMUN, P2311, DOI 10.1039/b822634b; Liu SW, 2010, PHYS CHEM CHEM PHYS, V12, P12308, DOI 10.1039/c0cp00036a; Ohtani B, 2010, J ADV OXID TECHNOL, V13, P247; Kowalska E, 2008, J PHYS CHEM C, V112, P1124, DOI 10.1021/jp077466p; Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0; Zhang HM, 2010, CHEM COMMUN, V46, P8395, DOI 10.1039/c0cc03196h; Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535; Ohtani B, 2014, PHYS CHEM CHEM PHYS, V16, P1788, DOI 10.1039/c3cp53653j; Ohno T, 2002, NEW J CHEM, V26, P1167, DOI 10.1039/b202140d; Ohtani B, 2013, CATALYSTS, V3, P942, DOI 10.3390/catal3040942; Kominami H, 1998, CATAL LETT, V56, P125, DOI 10.1023/A:1019052911437; Park H, 2004, J PHYS CHEM B, V108, P4086, DOI 10.1021/jp036735i; Baiju K, 2005, MATER CHEM PHYS, V90, P123, DOI 10.1016/j.matchemphys.2004.10.024; Ohtani B, 2010, J PHOTOCH PHOTOBIO C, V11, P157, DOI 10.1016/j.jphotochemrev.2011.02.001; Li W, 2004, J APPL PHYS, V96, P6663, DOI 10.1063/1.1807520; Wei ZS, 2014, CHEM LETT, V43, P346, DOI 10.1246/cl.130985; Katoh R, 2007, J PHYS CHEM C, V111, P10741, DOI 10.1021/jp072585q; Izumi F, 2007, SOL ST PHEN, V130, P15; Saggioro EM, 2011, MOLECULES, V16, P10370, DOI 10.3390/molecules161210370; Barnard AS, 2005, NANO LETT, V5, P1261, DOI 10.1021/nl050355m; Kudo A, 2009, CHEM SOC REV, V38, P253, DOI 10.1039/b800489g; Yang HG, 2008, NATURE, V453, P638, DOI 10.1038/nature06964; Katoh R, 2010, J PHYS CHEM LETT, V1, P3261, DOI 10.1021/jz1011548; Liu G, 2010, CHEM COMMUN, V46, P755, DOI 10.1039/b919895d; Ohtani B, 2010, J PHOTOCH PHOTOBIO A, V216, P179, DOI 10.1016/j.jphotochem.2010.07.024; Fujishima A, 2008, SURF SCI REP, V63, P515, DOI 10.1016/j.surfrep.2008.10.001; Zhang J, 2008, ANGEW CHEM INT EDIT, V47, P1766, DOI 10.1002/anie.200704788; Zaban A, 2000, J PHYS CHEM B, V104, P4130, DOI 10.1021/jp993198m; Amano F, 2009, CHEM MATER, V21, P2601, DOI 10.1021/cm9004344; Boettger H., 1976, PHYS STATUS SOLIDI B, V78, P9; Colombo DP, 1996, J PHYS CHEM-US, V100, P18445, DOI 10.1021/jp9610628; Grover IS, 2014, RSC ADV, V4, P24704, DOI 10.1039/c4ra01850h; Janczarek M., 2014, CHEM MAT UNPUB; Jun J.W., 2003, J AM CHEM SOC, V125, P15981; Kominami H, 2003, J PHOTOCH PHOTOBIO A, V160, P99, DOI 10.1016/S1010-6030(03)00227-2; KOMINAMI H, 1995, CHEM LETT, P693, DOI 10.1246/cl.1995.693; Murakami N., 2007, J PHYS C SOLID STATE, V113, P3062; Nitta A., 2014, ENERGY RESOLVE UNPUB; Ohtani B, 2008, CHEM LETT, V37, P217, DOI 10.1246/cl.2008.216; Ohtani B., 2010, TOP CATAL, V53, P455; Ohtani B., 2014, 0010021 HOKK U CAT R; Ohtani B, 1998, CHEM LETT, P579, DOI 10.1246/cl.1998.579; Roy P., 2010, ANGEW CHEM INT EDIT, V50, P2904; Wei Z., 2014, J MAT CHEM A UNPUB; Wei ZS, 2012, J NANOSCI NANOTECHNO, V12, P316, DOI 10.1166/jnn.2012.5135	45	2	2	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	DEC	2014	19	12					19573	19587		10.3390/molecules191219573		15	Chemistry, Organic	Chemistry	AX2SA	WOS:000346793200018		
J	Kozako, T; Suzuki, T; Yoshimitsu, M; Arima, N; Honda, S; Soeda, S				Kozako, Tomohiro; Suzuki, Takayoshi; Yoshimitsu, Makoto; Arima, Naomichi; Honda, Shin-ichiro; Soeda, Shinji			Anticancer Agents Targeted to Sirtuins	MOLECULES			English	Review						sirtuins; cancer; apoptosis; autophagy	NAD-DEPENDENT DEACETYLASES; FOXO TRANSCRIPTION FACTORS; SMALL-MOLECULE ACTIVATORS; AUTOPHAGIC CELL-DEATH; BREAST-CANCER CELLS; HISTONE DEACETYLASE; TUMOR-SUPPRESSOR; SIRT1 DEACETYLASE; DNA-DAMAGE; T-CELLS	Sirtuins are nicotinamide adenine dinucleotide(+)-dependent deacetylases of which there are seven isoforms (SIRT1-7). Sirtuin activity is linked to gene expression, lifespan extension, neurodegeneration, and age-related disorders. Numerous studies have suggested that sirtuins could be of great significance with regard to both antiaging and tumorigenesis, depending on its targets in specific signaling pathways or in specific cancers. Recent studies have identified small chemical compounds that modulate sirtuins, and these modulators have enabled a greater understanding of the biological function and molecular mechanisms of sirtuins. This review highlights the possibility of sirtuins, especially SIRT1 and SIRT2, for cancer therapy targets, and focuses on the therapeutic potential of sirtuin modulators both in cancer prevention and treatment.	[Kozako, Tomohiro; Honda, Shin-ichiro; Soeda, Shinji] Fukuoka Univ, Fac Pharmaceut Sci, Dept Biochem, Jonan Ku, Fukuoka 8140180, Japan; [Suzuki, Takayoshi] Kyoto Prefectural Univ Med, Fac Med, Sakyo Ku, Kyoto 6060823, Japan; [Yoshimitsu, Makoto; Arima, Naomichi] Kagoshima Univ Hosp, Dept Hematol & Immunol, Kagoshima 8908544, Japan	Kozako, T (reprint author), Fukuoka Univ, Fac Pharmaceut Sci, Dept Biochem, Jonan Ku, 8-19-1 Nanakuma, Fukuoka 8140180, Japan.	kozako@fukuoka-u.ac.jp; suzukit@koto.kpu-m.ac.jp; myoshimi@m.kufm.kagoshima-u.ac.jp; nao@m2.kufm.kagoshima-u.ac; sihonda@fukuoka-u.ac.jp; ssoeda@fukuoka-u.ac.jp			Japan Society for the Promotion of Science; Fukuoka Foundation for Sound Health Cancer Research Fund; Central Research Institute of Fukuoka University [141043]	We would like to express our thanks to Aikawa, Maemura, Itonaga, Mashima, Uchida, Fukugawa, Fujimura and Ohtsubo from Fukuoka University (Fukuoka, Japan). This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (to TK), the Fukuoka Foundation for Sound Health Cancer Research Fund (to TK), and funds (No. 141043) from the Central Research Institute of Fukuoka University (to TK).	Alcain FJ, 2009, EXPERT OPIN THER PAT, V19, P283, DOI 10.1517/13543770902755111; Allison SJ, 2007, CELL CYCLE, V6, P2669; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Wong S, 2007, BIOCHEM J, V407, P451, DOI 10.1042/BJ20070151; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Kozako T, 2012, INT J CANCER, V131, P2044, DOI 10.1002/ijc.27481; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Suzuki Y, 2013, LEUKEMIA RES, V37, P1674, DOI 10.1016/j.leukres.2013.09.010; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Kojima K, 2008, BIOCHEM BIOPH RES CO, V373, P423, DOI 10.1016/j.bbrc.2008.06.045; He X, 2012, BIOCHEM BIOPH RES CO, V417, P468, DOI 10.1016/j.bbrc.2011.11.141; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Suzuki T, 2012, J MED CHEM, V55, P5760, DOI 10.1021/jm3002108; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Nebbioso A, 2011, MOL CANCER THER, V10, P2394, DOI 10.1158/1535-7163.MCT-11-0525; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Inoue T, 2007, CELL CYCLE, V6, P1011, DOI 10.4161/cc.6.9.4219; Kim HB, 2012, BIOCHEM PHARMACOL, V84, P402, DOI 10.1016/j.bcp.2012.03.014; Timmers S, 2012, AGING-US, V4, P146; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Wang J, 2012, INT J ONCOL, V41, P1101, DOI 10.3892/ijo.2012.1534; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; WALES MM, 1995, NAT MED, V1, P570, DOI 10.1038/nm0695-570; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; RINE J, 1987, GENETICS, V116, P9; Han MK, 2008, CELL STEM CELL, V2, P241, DOI 10.1016/j.stem.2008.01.002; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Liu T, 2009, CANCER RES, V69, P1702, DOI 10.1158/0008-5472.CAN-08-3365; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029; Ouaissi M, 2008, ANN SURG ONCOL, V15, P2318, DOI 10.1245/s10434-008-9940-z; Lain S, 2008, CANCER CELL, V13, P454, DOI 10.1016/j.ccr.2008.03.004; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Ota H, 2006, ONCOGENE, V25, P176, DOI 10.1038/sj.onc.1209049; Imai S, 2000, NATURE, V403, P795; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2008.08.011; Wu YC, 2011, NEUROSIGNALS, V19, P163, DOI 10.1159/000328516; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Chu F, 2005, CANCER RES, V65, P10183, DOI 10.1158/0008-5472.CAN-05-2002; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Lennerz V, 2005, P NATL ACAD SCI USA, V102, P16013, DOI 10.1073/pnas.0500090102; Alcain FJ, 2009, EXPERT OPIN THER PAT, V19, P403, DOI 10.1517/13543770902762893; Eskandarian HA, 2013, SCIENCE, V341, P525, DOI 10.1126/science.1238858; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Inoue T, 2007, ONCOGENE, V26, P945, DOI 10.1038/sj.onc.1209857; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Neugebauer RC, 2008, J MED CHEM, V51, P1203, DOI 10.1021/jm700972e; Villalba JM, 2012, BIOFACTORS, V38, P349, DOI 10.1002/biof.1032; Tseng RC, 2009, NEOPLASIA, V11, P763, DOI 10.1593/neo.09470; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Lara E, 2009, ONCOGENE, V28, P781, DOI 10.1038/onc.2008.436; Sanders BD, 2010, BBA-PROTEINS PROTEOM, V1804, P1604, DOI 10.1016/j.bbapap.2009.09.009; Harting K, 2010, EUR J CELL BIOL, V89, P262, DOI 10.1016/j.ejcb.2009.11.006; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Heltweg B, 2006, CANCER RES, V66, P4368, DOI 10.1158/0008-5472.CAN-05-3617; Aziz MH, 2005, PHOTOCHEM PHOTOBIOL, V81, P25, DOI 10.1562/2004-08-13-RA-274.1; Manuyakorn A, 2010, J CLIN ONCOL, V28, P1358, DOI 10.1200/JCO.2009.24.5639; Harper CE, 2007, CARCINOGENESIS, V28, P1946, DOI 10.1093/carcin/bgm144; Matsushita N, 2005, GENES CELLS, V10, P321, DOI 10.1111/j.1365-2443.2005.00836.x; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Tait SWG, 2014, J CELL SCI, V127, P2135, DOI 10.1242/jcs.093575; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Schuetz A, 2007, STRUCTURE, V15, P377, DOI 10.1016/j.str.2007.02.002; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Farkas T, 2011, J BIOL CHEM, V286, P38904, DOI 10.1074/jbc.M111.269134; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Bonapace L, 2010, J CLIN INVEST, V120, P1310, DOI 10.1172/JCI39987; Kume S, 2007, J BIOL CHEM, V282, P151, DOI 10.1074/jbc.M605904200; Mukherjee S, 2010, CAN J PHYSIOL PHARM, V88, P1017, DOI 10.1139/y10-082; Chauhan D, 2011, BRIT J HAEMATOL, V155, P588, DOI 10.1111/j.1365-2141.2011.08888.x; Brooks CL, 2008, CANCER CELL, V13, P377, DOI 10.1016/j.ccr.2008.04.009; Chua KF, 2005, CELL METAB, V2, P67, DOI 10.1016/j.cmet.2005.06.007; Dai JM, 2007, J CELL PHYSIOL, V210, P161, DOI 10.1002/jcp.20831; Hirai S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102831; Hiraoka N, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.66; Kalle AM, 2010, BIOCHEM BIOPH RES CO, V401, P13, DOI 10.1016/j.bbrc.2010.08.118; Kong SY, 2011, J BIOL CHEM, V286, P16967, DOI 10.1074/jbc.M111.218206; Kozako T, 2011, YAKUGAKU ZASSHI, V131, P1061; Li YZ, 2011, GENES CELLS, V16, P34, DOI 10.1111/j.1365-2443.2010.01460.x; Lu WD, 2014, TUMOR BIOL, V35, P10699, DOI 10.1007/s13277-014-2372-4; MacCallum SF, 2013, SCI REP-UK, V3, DOI 10.1038/srep01275; Pirrie L, 2012, MOLECULES, V17, P12206, DOI 10.3390/molecules171012206; Rajendran R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/368276; Rodriguez RM, 2010, FUTURE ONCOL, V6, P905, DOI [10.2217/fon.10.57, 10.2217/FON.10.57]; Suzuki T, 2009, BIOORGAN MED CHEM, V17, P5900, DOI 10.1016/j.bmc.2009.07.001; Takeda-Watanabe A, 2012, BIOCHEM BIOPH RES CO, V427, P191, DOI 10.1016/j.bbrc.2012.09.042; Whitsett Timothy, 2006, J Carcinog, V5, P15, DOI 10.1186/1477-3163-5-15; Yi JJ, 2010, BBA-PROTEINS PROTEOM, V1804, P1684, DOI 10.1016/j.bbapap.2010.05.002; Zhao Y, 2010, AUTOPHAGY, V6, P988, DOI 10.4161/auto.6.7.13289	116	5	5	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	DEC	2014	19	12					20295	20313		10.3390/molecules191220295		19	Chemistry, Organic	Chemistry	AX2SA	WOS:000346793200058		
J	Munthali, MW; Elsheikh, MA; Johan, E; Matsue, N				Munthali, Moses Wazingwa; Elsheikh, Mohammed Abdalla; Johan, Erni; Matsue, Naoto			Proton Adsorption Selectivity of Zeolites in Aqueous Media: Effect of Si/Al Ratio of Zeolites	MOLECULES			English	Article						zeolite; Si/Al ratio; negative charge density; H+ selectivity; cation adsorption	ION-EXCHANGE; ACID CATALYSTS; Y ZEOLITES; HYDROGEN; FRAMEWORKS; LOCATION; STORAGE; NA	In addition to their well-known uses as catalysts, zeolites are utilized to adsorb and remove various cations from aqueous system. The adsorption of the cations is ascribed to the negative charge of zeolites derived from isomorphous substitution of Si by Al. The amount of Na+ adsorption on 4A, X, Y, Na-P1 and mordenite type zeolites were determined in aqueous media, in a two-cation (Na+ and H+) system. Although each zeolite has a constant amount of negative charge, the amount of Na+ adsorption of each zeolite decreased drastically at low pH-pNa values, where pH-pNa is equal to log{(Na+)/(H+)}. By using the plot of the amount of Na+ adsorption versus pH-pNa, an index of the H+ selectivity, which is similar to the pKa of acids, of each zeolite was estimated, and the index tended to increase with decreasing Si/Al ratio of zeolites. These indicate that zeolites with lower Si/Al and higher negative charge density have higher H+ adsorption selectivity, and in fact, such a zeolite species (4A and X) adsorbed considerable amount of H+ even at weakly alkaline pH region. The adsorption of H+ results in the decrease of cation adsorption ability, and may lead to the dissolution of zeolites in aqueous media.	[Munthali, Moses Wazingwa; Johan, Erni; Matsue, Naoto] Ehime Univ, Dept Life Environm Conservat, Fac Agr, Matsuyama, Ehime 7908566, Japan; [Elsheikh, Mohammed Abdalla] Univ Khartoum, Fac Agr, Dept Soil & Environm Sci, Khartoum 13314, Sudan	Munthali, MW (reprint author), Ehime Univ, Dept Life Environm Conservat, Fac Agr, 3-5-7 Tarumi, Matsuyama, Ehime 7908566, Japan.	munthalimw@yahoo.co.uk; mohmedelsheikh@gmail.com; Johan@agr.ehime-u.ac.jp; matsue@agr.ehime-u.ac.jp			Seki Scholarship; Saibikai Scholarship	The authors would like to thank Seki Scholarship and Saibikai Scholarship for their support.	Weitkamp J, 2000, SOLID STATE IONICS, V131, P175, DOI 10.1016/S0167-2738(00)00632-9; Querol X, 2002, INT J COAL GEOL, V50, P413, DOI 10.1016/S0166-5162(02)00124-6; Busca G, 2007, CHEM REV, V107, P5366, DOI 10.1021/cr068042e; Katada N, 2004, CATAL SURV ASIA, V8, P161, DOI 10.1023/B:CATS.0000038534.37849.16; Tansel B, 2012, SEP PURIF TECHNOL, V86, P119, DOI 10.1016/j.seppur.2011.10.033; Marcus Y, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4758071; Regli L, 2005, PHYS CHEM CHEM PHYS, V7, P3197, DOI 10.1039/b509124a; WHITE JL, 1992, J AM CHEM SOC, V114, P6182, DOI 10.1021/ja00041a041; Noda T, 2008, J CATAL, V259, P203, DOI 10.1016/j.jcat.2008.08.004; Wang SB, 2010, CHEM ENG J, V156, P11, DOI 10.1016/j.cej.2009.10.029; Su H, 2012, B KOREAN CHEM SOC, V33, P2785, DOI 10.5012/bkcs.2012.33.8.2785; Vitillo JG, 2005, PHYS CHEM CHEM PHYS, V7, P3948, DOI 10.1039/b510989b; Arbuznikov A, 1998, SURF SCI, V397, P395, DOI 10.1016/S0039-6028(97)00760-7; BERAN S, 1979, J PHYS CHEM-US, V83, P2538, DOI 10.1021/j100482a023; Bonenfant D, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/1/013007; Corbin D. R., 1995, INCLUSION CHEM ZEOLI; Davis M.E, 1992, CHEM MATER, V4, P156; Deka RC, 2004, CHEM PHYS LETT, V389, P186, DOI 10.1016/j.cplett.2004.03.094; Hartman RL, 2007, LANGMUIR, V23, P5477, DOI 10.1021/la063699g; Hiromi Y., 2000, PHOTOFUNCTIONAL ZEOL; JACOBS PA, 1982, CATAL REV, V24, P415, DOI 10.1080/03602458208079659; Kabwadza-Corner P, 2014, AM J ANAL CHEM, V5, P395; Katada N, 2009, J PHYS CHEM C, V113, P19208, DOI 10.1021/jp903788n; Kim HS, 2013, J POROUS MAT, V20, P1449, DOI 10.1007/s10934-013-9731-1; Kuronen M, 2000, PHYS CHEM CHEM PHYS, V2, P2655, DOI 10.1039/b001353f; McBride M. B., 1989, Minerals in Soil Environments, SSSA Book Series, no. 1., P35; MORTIER WJ, 1972, J PHYS CHEM-US, V76, P650, DOI 10.1021/j100649a008; Munthali M.W., 2014, J MAT SCI CHEM ENG, V2, P1; Neurock M., 2006, MOL HETEROGENEOUS CA; Misaelides P, 2011, MICROPOR MESOPOR MAT, V144, P15, DOI 10.1016/j.micromeso.2011.03.024; Sastre G, 2010, J PHYS CHEM C, V114, P15424, DOI 10.1021/jp104316e; Schulthess C.P., 2011, SOIL SCI SOC AM J, V75, P46; SENCHENYA IN, 1986, J PHYS CHEM-US, V90, P4857, DOI 10.1021/j100411a028; WADA SI, 1991, SOIL SCI PLANT NUTR, V37, P191; WATLING TC, 1994, ZEOLITES, V14, P687; Wilkin RT, 1998, AM MINERAL, V83, P746	36	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	DEC	2014	19	12					20468	20481		10.3390/molecules191220468		14	Chemistry, Organic	Chemistry	AX2SA	WOS:000346793200067		
J	Nishizaki, T; Kanno, T; Tsuchiya, A; Kaku, Y; Shimizu, T; Tanaka, A				Nishizaki, Tomoyuki; Kanno, Takeshi; Tsuchiya, Ayako; Kaku, Yoshiko; Shimizu, Tadashi; Tanaka, Akito			1-[2-(2-Methoxyphenylamino)ethylamino]-3-(naphthalene-1-yloxy)propan-2-ol May Be a Promising Anticancer Drug	MOLECULES			English	Review						HUHS1015; naftopidil analogue; anticancer drugs; necrosis; apoptosis	CELL-DEATH; ALPHA(1)-ADRENOCEPTOR ANTAGONIST; CANCER CELLS; FACTOR AIF; APOPTOSIS; NAFTOPIDIL; PROSTATE; LOCALIZATION; MESOTHELIOMA; INVOLVEMENT	We have originally synthesized the naftopidil analogue 1-[2-(2-methoxyphenylamino)ethylamino]-3-(naphthalene-1-yloxy)propan-2-ol (HUHS 1015) as a new anticancer drug. HUHS1015 induces cell death in a wide variety of human cancer cell lines originated from malignant pleural mesothelioma, lung cancer, hepatoma, gastric cancer, colorectal cancer, bladder cancer, prostate cancer, and renal cancer. HUHS1015-induced cell death includes necrosis (necroptosis) and apoptosis, and the underlying mechanism differs depending upon cancer cell types. HUHS1015 effectively suppresses tumor growth in mice inoculated with NCI-H2052, MKN45, or CW2 cells, with a potential similar to or higher than that of currently used anticancer drugs. Here we show how HUHS1015 might offer brilliant hope for cancer therapy.	[Nishizaki, Tomoyuki; Kanno, Takeshi; Tsuchiya, Ayako; Kaku, Yoshiko] Hyogo Coll Med, Dept Physiol, Div Bioinformat, Nishinomiya, Hyogo 6638501, Japan; [Shimizu, Tadashi; Tanaka, Akito] Hyogo Univ Hlth Sci, Adv Med Res Ctr, Biol Chem Lab, Chuo Ku, Kobe, Hyogo 6508530, Japan	Nishizaki, T (reprint author), Hyogo Coll Med, Dept Physiol, Div Bioinformat, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	tomoyuki@hyo-med.ac.jp; kanno@hyo-med.ac.jp; ayako-t@hyo-med.ac.jp; yoshikokaku0506@gmail.com; furanether2007@yahoo.co.jp; reprori2000@yahoo.co.jp					Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506; Brede M, 2004, BIOL CELL, V96, P343, DOI 10.1016/j.biolcel.2004.03.006; Cande C, 2002, J CELL SCI, V115, P4727, DOI 10.1242/jcs.00210; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Varecha M, 2007, APOPTOSIS, V12, P1155, DOI 10.1007/s10495-007-0061-0; Zhong HY, 1999, EUR J PHARMACOL, V375, P261, DOI 10.1016/S0014-2999(99)00222-8; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Wu M, 2002, J BIOL CHEM, V277, P25617, DOI 10.1074/jbc.M202285200; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Kanno T, 2013, PHARMACOLOGY, V91, P339, DOI 10.1159/000351747; Kim SJ, 2006, HUM MOL GENET, V15, P1826, DOI 10.1093/hmg/ddl105; Li W, 2006, MOL BIOL CELL, V17, P1802, DOI 10.1091/mbc.E05-04-0333; Zhang LN, 2013, CANCER GENE THER, V20, P1, DOI 10.1038/cgt.2012.84; Ohiro Y, 2002, FEBS LETT, V524, P163, DOI 10.1016/S0014-5793(02)03049-1; Takei R, 1999, JPN J PHARMACOL, V79, P447, DOI 10.1254/jjp.79.447; Tomek M, 2012, J PHARM PHARMACOL, V64, P1695, DOI 10.1111/j.2042-7158.2012.01526.x; Marshall KR, 2005, J BIOL CHEM, V280, P30735, DOI 10.1074/jbc.M414018200; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Daugas E, 2000, FASEB J, V14, P729; Bilyy R, 2008, APOPTOSIS, V13, P729, DOI 10.1007/s10495-008-0198-5; Binet F, 2010, BIOCHEM BIOPH RES CO, V391, P18, DOI 10.1016/j.bbrc.2009.10.141; Gotoh A, 2012, PHARMACOLOGY, V90, P242, DOI 10.1159/000342797; Hori Y, 2011, CANCER PREV RES, V4, P87, DOI 10.1158/1940-6207.CAPR-10-0189; Kaku Y, 2015, ANTI-CANCER AGENT ME, V15, P242; Kaku Y, 2014, CANCER SCI, V105, P883, DOI 10.1111/cas.12429; Kanda H, 2008, INT J CANCER, V122, P444, DOI 10.1002/ijc.23095; Kaumann AJ, 1997, N-S ARCH PHARMACOL, V355, P667, DOI 10.1007/PL00004999; Kvansakul M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.436; Masachika E, 2013, ANTICANCER RES, V33, P887; Pietra G, 2001, CANCER RES, V61, P8218; Vanags DM, 1996, J BIOL CHEM, V271, P31075	33	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	DEC	2014	19	12					21462	21472		10.3390/molecules191221462		11	Chemistry, Organic	Chemistry	AX2SA	WOS:000346793200129		
J	Suwito, H; Jumina; Mustofa; Pudjiastuti, P; Fanani, MZ; Kimata-Ariga, Y; Katahira, R; Kawakami, T; Fujiwara, T; Hase, T; Sirat, HM; Puspaningsih, NNT				Suwito, Hery; Jumina; Mustofa; Pudjiastuti, Pratiwi; Fanani, Much Zaenal; Kimata-Ariga, Yoko; Katahira, Ritsuko; Kawakami, Toru; Fujiwara, Toshimichi; Hase, Toshiharu; Sirat, Hasnah Mohd; Puspaningsih, Ni Nyoman Tri			Design and Synthesis of Chalcone Derivatives as Inhibitors of the Ferredoxin - Ferredoxin-NADP(+) Reductase Interaction of Plasmodium falciparum: Pursuing New Antimalarial Agents	MOLECULES			English	Article						methoxyamino chalcones; antimalarial; PfFd-PfFNR inhibitor	HUMAN MALARIA PARASITE; ANTICANCER; CATALYST	Some chalcones have been designed and synthesized using Claisen-Schmidt reactions as inhibitors of the ferredoxin and ferredoxin-NADP(+) reductase interaction to pursue a new selective antimalaria agent. The synthesized compounds exhibited inhibition interactions between PfFd-PfFNR in the range of 10.94%-50%. The three strongest inhibition activities were shown by (E)-1-(4-aminophenyl)-3-(4-methoxyphenyl)prop-2-en-1-one (50%), (E)-1-(4-aminophenyl)-3-(2,4-dimethoxyphenyl)prop-2-en-1-one (38.16%), and (E)-1-(4-aminophenyl)-3-(2,3-dimethoxyphenyl)prop-2-en-1-one (31.58%). From the docking experiments we established that the amino group of the methoxyamino chlacone derivatives plays an important role in the inhibition activity by electrostatic interaction through salt bridges and that it forms more stable and better affinity complexes with FNR than with Fd.	[Suwito, Hery; Jumina] Univ Gajah Mada, Fac Sci & Math, Dept Chem, Yogyakarta 55281, Indonesia; [Suwito, Hery; Pudjiastuti, Pratiwi; Puspaningsih, Ni Nyoman Tri] Airlangga Univ, Fac Sci & Technol, Dept Chem, Surabaya 60115, Indonesia; [Mustofa] Univ Gajah Mada, Dept Pharmacol & Therapy, Fac Med, Yogyakarta 55281, Indonesia; [Fanani, Much Zaenal; Puspaningsih, Ni Nyoman Tri] Airlangga Univ, Inst Trop Dis, Surabaya 60115, Indonesia; [Kimata-Ariga, Yoko; Katahira, Ritsuko; Kawakami, Toru; Fujiwara, Toshimichi; Hase, Toshiharu] Osaka Univ, Inst Prot Res, Suita, Osaka 6560871, Japan; [Sirat, Hasnah Mohd] Univ Technol Malaya, Fac Sci, Dept Chem, Johor Baharu 81310, Malaysia	Suwito, H (reprint author), Univ Gajah Mada, Fac Sci & Math, Dept Chem, Yogyakarta 55281, Indonesia.	herys08032002@yahoo.com			Ministry of Research and Technology of Republic Indonesia through the Riset Insentif Nasional (INSINAS) scheme	The authors acknowledge to the Ministry of Research and Technology of Republic Indonesia for the research supporting fund through the Riset Insentif Nasional (INSINAS) scheme.	Al-Masum M, 2011, TETRAHEDRON LETT, V52, P1008, DOI 10.1016/j.tetlet.2010.12.085; Bandgar BP, 2010, BIOORGAN MED CHEM, V18, P1364, DOI 10.1016/j.bmc.2009.11.066; Kurisu G, 2001, NAT STRUCT BIOL, V8, P117, DOI 10.1038/84097; Yoon G, 2007, ARCH PHARM RES, V30, P313, DOI 10.1007/BF02977611; Awasthi SK, 2009, MED CHEM RES, V18, P407, DOI 10.1007/s00044-008-9137-9; Liu M, 2001, J MED CHEM, V44, P4443, DOI 10.1021/jm0101747; Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57; Sebti S, 2001, TETRAHEDRON LETT, V42, P7953, DOI 10.1016/S0040-4039(01)01698-7; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Rueping M, 2011, BEILSTEIN J ORG CHEM, V7, P1680, DOI 10.3762/bjoc.7.198; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Balconi E, 2009, FEBS J, V276, P4249, DOI 10.1111/j.1742-4658.2009.07100.x; Basuki S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-135; Durst H.D., 1987, EXPT ORGANIC CHEM, P428; Garg S., 2014, IJPSR, V5, P2657; Khan Shah Alam, 2006, Pak J Pharm Sci, V19, P290; Kim BT, 2008, B KOREAN CHEM SOC, V29, P1125; Kimata-Ariga Y, 2007, J BIOCHEM, V142, P715, DOI 10.1093/jb/mvm184; Kimata-Ariga Y, 2007, J BIOCHEM, V141, P421, DOI 10.1093/jb/mvm046; Lopez J., 2000, STUD SURF SCI CATAL, V130, P491; Milani M, 2007, J MOL BIOL, V367, P501, DOI 10.1016/j.jmb.2007.01.005; Onda Y, 2000, PLANT PHYSIOL, V123, P1037, DOI 10.1104/pp.123.3.1037; Pophale RA., 2010, PHARM CHEMICA, V2, P185; Rosenthal PJ, 2001, INFEC DIS S, P1; Syam S, 2012, MOLECULES, V17, P6179, DOI 10.3390/molecules17066179; Tjitra E., 1991, B HLTH STUD, V19, P15; Wade Jr L.G., 2006, ORGANIC CHEM, P508	27	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1420-3049			MOLECULES	Molecules	DEC	2014	19	12					21473	21488		10.3390/molecules191221473		16	Chemistry, Organic	Chemistry	AX2SA	WOS:000346793200130		
J	Itoh, KM; Watanabe, H				Itoh, Kohei M.; Watanabe, Hideyuki			Isotope engineering of silicon and diamond for quantum computing and sensing applications	MRS COMMUNICATIONS			English	Article							NITROGEN-VACANCY CENTERS; NUCLEAR-MAGNETIC-RESONANCE; HIGHLY ENRICHED SI-28; SINGLE DEFECT CENTERS; SPIN COHERENCE TIME; AVOGADRO CONSTANT; HIGH-PURITY; NANOSCALE RESOLUTION; COUPLED ELECTRON; C-12 DIAMOND	Some of the stable isotopes of silicon and carbon have zero nuclear spin, whereas many of the other elements that constitute semiconductors consist entirely of stable isotopes that have nuclear spins. Silicon and diamond crystals composed of nuclear-spin-free stable isotopes (Si-28, Si-30, or C-12) are considered to be ideal host matrixes to place spin quantum bits (qubits) for quantum-computing and -sensing applications, because their coherent properties are not disrupted thanks to the absence of host nuclear spins. The present paper describes the state-of-the-art and future perspective of silicon and diamond isotope engineering for development of quantum information-processing devices.	[Itoh, Kohei M.] Keio Univ, Sch Fundamental Sci & Technol, Yokohama, Kanagawa 2238522, Japan; [Watanabe, Hideyuki] Natl Inst Adv Ind Sci & Technol, Elect & Photon Res Inst, Tsukuba, Ibaraki 3058562, Japan	Itoh, KM (reprint author), Keio Univ, Sch Fundamental Sci & Technol, Yokohama, Kanagawa 2238522, Japan.	kitoh@appi.keio.ac.jp	Itoh, Kohei/C-5738-2014		MEXT; Cannon Foundation; JSPS	We thank Mike Thewalt, John Morton, Steve Lyon, Andrea Morello, Andrew Dzurak, Martin Brandt, Thomas Schenkel, Christian Degen, Fedor Jelezko, Tokuyuki Teraji, Junichi Isoya, and Junko Hayase for their helpful discussions. The research was supported in part by a Grant-in-Aid for scientific research by MEXT, in part by Cannon Foundation, and in part by the JSPS Core-to-Core Program.	Abe E, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.033204; Abe E, 2006, PHYSICA B, V376, P28, DOI 10.1016/j.physb.2005.12.009; Abe E, 2005, J SUPERCOND, V18, P157, DOI 10.1007/s10948-005-3352-0; Acosta VM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.070801; Akhtar W, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.097601; Akhtar W, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.045204; Akhtar W, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.115206; Vrijen R, 2000, PHYS REV A, V62, part. no., DOI 10.1103/PhysRevA.62.012306; Ager JW, 2005, J ELECTROCHEM SOC, V152, pG448, DOI 10.1149/1.1901674; Michl J, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4868128; Dolde F, 2011, NAT PHYS, V7, P459, DOI [10.1038/nphys1969, 10.1038/NPHYS1969]; Verhulst AS, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.054105; Yamamoto T, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.075206; Friesen M, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.121301; Sekiguchi T, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.137402; Staudacher T, 2013, SCIENCE, V339, P561, DOI 10.1126/science.1231675; Maletinsky P, 2012, NAT NANOTECHNOL, V7, P320, DOI [10.1038/nnano.2012.50, 10.1038/NNANO.2012.50]; Steger M, 2012, SCIENCE, V336, P1280, DOI 10.1126/science.1217635; Shi Z, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.075416; Yang A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.257401; Hayashi H, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.045201; Maurer PC, 2010, NAT PHYS, V6, P912, DOI [10.1038/nphys1774, 10.1038/NPHYS1774]; Saeedi K, 2013, SCIENCE, V342, P830, DOI 10.1126/science.1239584; Shahriar MS, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.032301; Thomas-Peter N, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.113603; Shimizu Y, 2009, J APPL PHYS, V106, DOI 10.1063/1.3236673; Watanabe H, 2009, SCIENCE, V324, P1425, DOI 10.1126/science.1172419; Wu H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.140503; Zhao N, 2012, NAT NANOTECHNOL, V7, P657, DOI [10.1038/nnano.2012.152, 10.1038/NNANO.2012.152]; Shimizu Y, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.021401; Pla JJ, 2013, NATURE, V496, P334, DOI 10.1038/nature12011; Sailer J, 2009, PHYS STATUS SOLIDI-R, V3, P61, DOI 10.1002/pssr.200802275; Lo CC, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.057601; Sennikov PG, 2012, SOLID STATE COMMUN, V152, P455, DOI 10.1016/j.ssc.2012.01.008; Abe E, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.121201; BECKER P, 1995, IEEE T INSTRUM MEAS, V44, P522, DOI 10.1109/19.377897; Simmons S, 2011, NATURE, V470, P69, DOI 10.1038/nature09696; Doherty MW, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.047601; Gruber A, 1997, SCIENCE, V276, P2012, DOI 10.1126/science.276.5321.2012; Maurer PC, 2012, SCIENCE, V336, P1283, DOI 10.1126/science.1220513; Ladd TD, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.017901; Kucsko G, 2013, NATURE, V500, P54, DOI 10.1038/nature12373; de Lange G, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.080802; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Orwa JO, 2011, J APPL PHYS, V109, DOI 10.1063/1.3573768; Hirose M, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.062320; Morton JJL, 2008, NATURE, V455, P1085, DOI 10.1038/nature07295; Fukui T, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.055201; Neumann P, 2013, NANO LETT, V13, P2738, DOI 10.1021/nl401216y; Tyryshkin AM, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.193207; Becker P, 2010, PHYS STATUS SOLIDI A, V207, P49, DOI 10.1002/pssa.200925148; Li JY, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824729; Giovannetti V, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030501; Jelezko F, 2001, SINGLE MOL, V2, P255, DOI 10.1002/1438-5171(200112)2:4<255::AID-SIMO255>3.3.CO;2-4; CHIBA M, 1972, J PHYS SOC JPN, V33, P730, DOI 10.1143/JPSJ.33.730; Tetienne JP, 2014, SCIENCE, V344, P1366, DOI 10.1126/science.1250113; Rogers LJ, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.235101; Myers BA, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.027602; Wu H, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.032326; Takyu K, 1999, JPN J APPL PHYS 2, V38, pL1493, DOI 10.1143/JJAP.38.L1493; Witzel WM, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.035322; Wild A, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3701588; Ohno K, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4748280; Wolfowicz G, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.245301; Rosskopf T, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.147602; Grinolds MS, 2011, NAT PHYS, V7, P687, DOI [10.1038/nphys1999, 10.1038/NPHYS1999]; Tyryshkin AM, 2012, NAT MATER, V11, P143, DOI [10.1038/nmat3182, 10.1038/NMAT3182]; Taylor JM, 2008, NAT PHYS, V4, P810, DOI 10.1038/nphys1075; Zwanenburg FA, 2013, REV MOD PHYS, V85, P961, DOI 10.1103/RevModPhys.85.961; Mamin HJ, 2013, SCIENCE, V339, P557, DOI 10.1126/science.1231540; Yang A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.227401; Hauf MV, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.081304; Igarashi R, 2012, NANO LETT, V12, P5726, DOI 10.1021/nl302979d; Shimizu Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.095901; Steger M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3577614; Shimizu Y, 2009, J APPL PHYS, V105, DOI 10.1063/1.3054325; Degen CL, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2943282; Kojima T, 2003, APPL PHYS LETT, V83, P2318, DOI 10.1063/1.1613365; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; Jahnke KD, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4731778; Jelezko F, 2002, APPL PHYS LETT, V81, P2160, DOI 10.1063/1.1507838; Neumann P, 2010, NAT PHYS, V6, P249, DOI 10.1038/NPHYS1536; Toyli DM, 2013, P NATL ACAD SCI USA, V110, P8417, DOI 10.1073/pnas.1306825110; Lesik M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4869103; Rondin L, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3703128; Joo J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.083601; Jelezko F, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.130501; Waldherr G, 2012, NAT NANOTECHNOL, V7, P105, DOI [10.1038/nnano.2011.224, 10.1038/NNANO.2011.224]; Hayashi H, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.153201; Kolkowitz S, 2012, SCIENCE, V335, P1603, DOI 10.1126/science.1216821; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Teraji T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.055601; Stegner AR, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.115213; Itoh KM, 2005, SOLID STATE COMMUN, V133, P747, DOI 10.1016/j.ssc.2004.12.045; Ishikawa T, 2012, NANO LETT, V12, P2083, DOI 10.1021/nl300350r; Wolfowicz G, 2013, NAT NANOTECHNOL, V8, P561, DOI [10.1038/nnano.2013.117, 10.1038/NNANO.2013.117]; Becker P, 2006, MEAS SCI TECHNOL, V17, P1854, DOI 10.1088/0957-0233/17/7/025; Watanabe H, 2011, DIAM RELAT MATER, V20, P980, DOI 10.1016/j.diamond.2011.05.015; Teraji T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.090104; Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Mizuochi N, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.041201; Pla JJ, 2012, NATURE, V489, P541, DOI 10.1038/nature11449; Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; Maune BM, 2012, NATURE, V481, P344, DOI 10.1038/nature10707; Hollenberg LCL, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.045311; Bulanov AD, 2000, CRYST RES TECHNOL, V35, P1023, DOI 10.1002/1521-4079(200009)35:9<1023::AID-CRAT1023>3.0.CO;2-V; Zwierz M, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.042112; Acosta VM, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3507884; Rondin L, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.115449; Kane BE, 1998, NATURE, V393, P133, DOI 10.1038/30156; Jelezko F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076401; ANTHONY TR, 1990, PHYS REV B, V42, P1104, DOI 10.1103/PhysRevB.42.1104; Dolde F, 2013, NAT PHYS, V9, P139, DOI 10.1038/nphys2545; de Sousa R, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.115322; Wrachtrup J, 2006, J PHYS-CONDENS MAT, V18, pS807, DOI 10.1088/0953-8984/18/21/S08; Ilkhchy KS, 2013, AIP CONF PROC, V1566, P552, DOI 10.1063/1.4848530; Bracht H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.245502; Cardona M, 2005, REV MOD PHYS, V77, P1173, DOI 10.1103/RevModPhys.77.1173; McGuinness LP, 2011, NAT NANOTECHNOL, V6, P358, DOI [10.1038/nnano.2011.64, 10.1038/NNANO.2011.64]; GORDON JP, 1958, PHYS REV LETT, V1, P368, DOI 10.1103/PhysRevLett.1.368; Jelezko F, 2006, PHYS STATUS SOLIDI A, V203, P3207, DOI 10.1002/pssa.200671403; Ohashi K, 2013, NANO LETT, V13, P4733, DOI 10.1021/nl402286v; Becker P, 2009, EUR PHYS J-SPEC TOP, V172, P343, DOI 10.1140/epjst/e2009-01059-9; Bouchard LS, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/025017; Bracht H, 1998, PHYS REV LETT, V81, P393, DOI 10.1103/PhysRevLett.81.393; Bracht H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4742922; Braun D, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1220; Cappellaro P, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.032336; COLLINS AT, 1988, J PHYS C SOLID STATE, V21, P1363, DOI 10.1088/0022-3719/21/8/012; Cooper A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4141; de Sausa R., 2004, PHYS REV A, V70; Eriksson MA, 2013, MRS BULL, V38, P794, DOI 10.1557/mrs.2013.208; Fang KJ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.130802; Fujii K, 2001, MEAS SCI TECHNOL, V12, P2031, DOI 10.1088/0957-0233/12/12/302; Giovannetti V, 2011, NAT PHOTONICS, V5, P222, DOI [10.1038/nphoton.2011.35, 10.1038/NPHOTON.2011.35]; Grotz B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1729; Dutt MVG, 2007, SCIENCE, V316, P1312, DOI 10.1126/science.1139831; Hall LT, 2012, SCI REP-UK, V2, DOI 10.1038/srep00401; HALLER EE, 1995, J APPL PHYS, V77, P2857, DOI 10.1063/1.358700; Itoh KM, 2003, JPN J APPL PHYS 1, V42, P6248, DOI 10.1143/JJAP.42.6248; Kato J, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.035205; Knee GC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1614; Ladd TD, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.014401; Laraoui A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3497004; Laucht A., 2014, PHYS REV X, V4; Lo CC, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2817966; Lo CC, 2009, SEMICOND SCI TECH, V24, DOI 10.1088/0268-1242/24/10/105022; Loretz M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4862749; Mortemousque PA, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.155202; Mortemousque PA, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4747723; Muhonen JT, 2014, NAT NANOTECHNOL, V9, P986, DOI [10.1038/nnano.2014.211, 10.1038/NNANO.2014.211]; Pham LM, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/4/045021; Schaffry M, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.207210; Sekiguchi T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.106101; Shi Z, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.140503; Shimizu Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3544496; Shin CS, 2012, J APPL PHYS, V112, DOI 10.1063/1.4771924; Shlimak I, 2001, J PHYS-CONDENS MAT, V13, P6059, DOI 10.1088/0953-8984/13/26/319; Sozontov E, 2001, PHYS REV LETT, V86, P5329, DOI 10.1103/PhysRevLett.86.5329; Steger M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.177402; Tezuka H, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.161203; Thewalt MLW, 2007, J APPL PHYS, V101, DOI 10.1063/1.2723181; Thewalt MLW, 2007, PHYSICA B, V401, P587, DOI 10.1016/j.physb.2007.09.028; Veldhorst M, 2014, NAT NANOTECHNOL, V9, P981, DOI [10.1038/nnano.2014.216, 10.1038/NNANO.2014.216]; Verhulst AS, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.235206; Watanabe H, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.205420; Waxman A, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.054509; Witzel WM, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.035212; YAMAGUCHI A, 1994, JPN J APPL PHYS 2, V33, pL1063; Yamamoto T, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.201201; Yang A, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.113203; Yoshida S., 2005, APPL PHYS LETT, V87	172	6	6	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	2159-6859	2159-6867		MRS COMMUN	MRS Commun.	DEC	2014	4	4					143	157		10.1557/mrc.2014.32		15	Materials Science, Multidisciplinary	Materials Science	AX5WB	WOS:000346994400002		
J	Kirkland, D; Zeiger, E; Madia, F; Gooderham, N; Kasper, P; Lynch, A; Morita, T; Ouedraogo, G; Morte, JMP; Pfuhler, S; Rogiers, V; Schulz, M; Thybaud, V; van Benthem, J; Vanparys, P; Worth, A; Corvi, R				Kirkland, David; Zeiger, Errol; Madia, Federica; Gooderham, Nigel; Kasper, Peter; Lynch, Anthony; Morita, Takeshi; Ouedraogo, Gladys; Morte, Juan Manuel Parra; Pfuhler, Stefan; Rogiers, Vera; Schulz, Markus; Thybaud, Veronique; van Benthem, Jan; Vanparys, Philippe; Worth, Andrew; Corvi, Raffaella			Can in vitro mammalian cell genotoxicity test results be used to complement positive results in the Ames test and help predict carcinogenic or in vivo genotoxic activity? I. Reports of individual databases presented at an EURL ECVAM Workshop	MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS			English	Article						Genotoxicity in vitro; Genotoxicity in vivo; Positive Ames tests; Mammalian cell tests; Database; Carcinogenicity	MUTAGENIC NONCARCINOGEN; SALMONELLA-TYPHIMURIUM; RAT-LIVER; HETEROCYCLIC AMINES; RODENT CARCINOGENS; MUTATION ASSAY; COOKED FOOD; MOUSE; CHEMICALS; 2-AMINO-3,8-DIMETHYLIMIDAZO<4,5-F>QUINOXALINE	Positive results in the Ames test correlate well with carcinogenic potential in rodents. This correlation is not perfect because mutations are only one of many stages in tumour development. Also, situations can be envisaged where the mutagenic response may be specific to the bacteria or the test protocol, e.g., bacterial-specific metabolism, exceeding a detoxification threshold, or the induction of oxidative damage to which bacteria may be more sensitive than mammalian cells in vitro or tissues in vivo. Since most chemicals are also tested for genotoxicity in mammalian cells, the pattern of mammalian cell results may help identify whether Ames-positive results predict carcinogenic or in vivo mutagenic activity. A workshop was therefore organised and sponsored by the EU Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM) to investigate this further. Participants presented results from other genotoxicity tests with Ames-positive compounds. Data came from published, regulatory agency, and industry sources. The question was posed whether negative results in mammalian cell tests were associated with absence of carcinogenic or in vivo genotoxic activity despite a positive Ames test. In the limited time available, the presented data were combined and an initial analysis suggested that the association of negative in vitro mammalian cell test results with lack of in vivo genotoxic or carcinogenic activity could have some significance. Possible reasons why a positive Ames test may not be associated with in vivo activity and what additional investigations/tests might contribute to a more robust evaluation were discussed. Because a considerable overlap was identified among the different databases presented, it was recommended that a consolidated database be built, with overlapping chemicals removed, so that a more robust analysis of the predictive capacity for potential carcinogenic and in vivo genotoxic activity could be derived from the patterns of mammalian cell test results obtained for Ames-positive compounds. (C) 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).	[Kirkland, David] Kirkland Consulting, Tadcaster LS24 0AS, England; [Zeiger, Errol] Errol Zeiger Consulting, Chapel Hill, NC 27514 USA; [Madia, Federica; Worth, Andrew; Corvi, Raffaella] Commiss European Communities, Joint Res Ctr, Syst Toxicol Unit, European Union Reference Lab Alternat Anim Testin, I-21027 Ispra, Va, Italy; [Madia, Federica; Worth, Andrew; Corvi, Raffaella] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, I-21027 Ispra, Va, Italy; [Gooderham, Nigel] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Kasper, Peter] BfArM, D-53175 Bonn, Germany; [Lynch, Anthony] GlaxoSmithKline R&D, Ware SG12 0DP, Herts, England; [Morita, Takeshi] Natl Inst Hlth Sci, Div Safety Informat Drug Food & Chem, Setagaya Ku, Tokyo 1588501, Japan; [Ouedraogo, Gladys] LOreal, F-93601 Aulnay Sous Bois, France; [Morte, Juan Manuel Parra] European Food Safety Author, I-43126 Parma, Italy; [Pfuhler, Stefan] Procter & Gamble Co, Miami Valley Innovat Ctr, Cincinnati, OH 45239 USA; [Rogiers, Vera] Vrije Univ Brussel, Dept Toxicol, B-1090 Brussels, Belgium; [Schulz, Markus] BASF, D-67063 Ludwigshafen, Germany; [Thybaud, Veronique] Sanofi, F-94403 Vitry Sur Seine, France; [van Benthem, Jan] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Vanparys, Philippe] Gentoxicon BVBA, B-2350 Vosselaar, Belgium	Corvi, R (reprint author), Commiss European Communities, Joint Res Ctr, Syst Toxicol Unit, European Union Reference Lab Alternat Anim Testin, TP 126,Via E Fermi 2749, I-21027 Ispra, Va, Italy.	raffaella.corvi@ec.europa.eu			European Commission Joint Research Centre	The EURL ECVAM workshop on "Can in vitro mammalian cell genotoxicity test results be used to complement positive results in the Ames test and help predict carcinogenic or in vivo genotxic activity?" was sponsored by the European Commission Joint Research Centre.	[Anonymous], 2011, OP 2 AM 5 METH COLIP; MCCANN J, 1975, P NATL ACAD SCI USA, V72, P5135, DOI 10.1073/pnas.72.12.5135; [Anonymous], 2006, EMEACHMPQWP251344200; HAWORTH S, 1983, ENVIRON MUTAGEN, V5, P3, DOI 10.1002/em.2860050703; Magkoufopoulou C, 2012, CARCINOGENESIS, V33, P1421, DOI 10.1093/carcin/bgs182; Kirkland D, 2007, MUTAT RES-GEN TOX EN, V628, P31, DOI 10.1016/j.mrgentox.2006.11.008; Kirkland D, 2011, MUTAT RES-GEN TOX EN, V721, P27, DOI 10.1016/j.mrgentox.2010.12.015; JACOBSON FS, 1989, J BIOL CHEM, V264, P1488; Zeiger E, 1998, REGUL TOXICOL PHARM, V28, P85, DOI 10.1006/rtph.1998.1234; Roldan M, 2008, FEMS MICROBIOL REV, V32, P474, DOI 10.1111/j.1574-6976.2008.00107.x; Kirkland D, 2005, MUTAT RES-GEN TOX EN, V584, P1, DOI 10.1016/j.mrgentox.2005.02.004; BURKE DA, 1994, MUTAGENESIS, V9, P23, DOI 10.1093/mutage/9.1.23; Doktorova TY, 2012, ARCH TOXICOL, V86, P1703, DOI 10.1007/s00204-012-0946-8; DUNKEL VC, 1984, ENVIRON MUTAGEN, V6, P1, DOI 10.1002/em.2860060702; WINTON DJ, 1990, CANCER RES, V50, P7992; Ates G, 2014, MUTAGENESIS, V29, P115, DOI 10.1093/mutage/get068; BianchiSantamaria A, 1997, MUTAT RES-GEN TOX EN, V388, P27, DOI 10.1016/S1383-5718(96)00128-3; BRAITHWAITE I, 1988, MUTAT RES, V203, P23, DOI 10.1016/0165-1161(88)90004-0; CAMUS AM, 1982, CANCER RES, V42, P3201; CUNNINGHAM ML, 1991, TOXICOL APPL PHARM, V107, P562, DOI 10.1016/0041-008X(91)90319-A; CUNNINGHAM ML, 1989, DRUG METAB DISPOS, V17, P612; Cunningham ML, 1996, ENVIRON HEALTH PERSP, V104, P683, DOI 10.2307/3432845; Deutsche Forschungsgemeinschaft, 2011, 47 DTSCH FORSCH; Fowler P, 2012, MUTAT RES-GEN TOX EN, V747, P104, DOI 10.1016/j.mrgentox.2012.04.013; Fowler P., 2011, MUTAT RES, V742, P11; Frölichsthal P, 1996, Boll Chim Farm, V135, P541; Fukushima S, 2003, CANCER LETT, V191, P35, DOI 10.1016/S0304-3835(02)00631-6; Garrigue JL, 2006, MUTAT RES-GEN TOX EN, V608, P58, DOI 10.1016/j.mrgentox.2006.05.001; Gold L., CARCINOGENIC POTENCY; IARC (International Agency for Research on Cancer), AG CLASS IARC MON; International Agency for Research on Cancer (IARC), IARC MONOGRAPHS EVAL; Ishidate Jr M., 1981, CANCER RES, V27, P95; Japan Chemical Industry Ecology-Toxicology & Information Center (JETOC), 2000, MUTA TEST DAT EX S2; Japan Chemical Industry Ecology-Toxicology & Information Center (JETOC), 2005, MUT TEST DAT EX C S3; Japan Chemical Industry Ecology-Toxicology & Information Center (JETOC), 1997, MUT TEST DAT EX CH S; Japan Chemical Industry Ecology-Toxicology & Information Center (JETOC), 1996, MUT TEST DAT EX CHEM; Japan Chemical Industry Ecology-Toxicology & Information Center (JETOC), 2008, MUT TEST DAT EX C S4; Kalow W., 1992, PHARMACOGENETICS DRU; Kang JS, 2006, CANCER SCI, V97, P453, DOI 10.1111/j.1349-7006.2006.00201.x; Kranendonk M, 1997, MUTAGENESIS, V12, P245, DOI 10.1093/mutage/12.4.245; Lambert Iain B, 2005, Mutat Res, V590, P1, DOI 10.1016/j.mrrev.2005.04.002; Lorge E., COMMUNICATION; Matsushima T, 1999, MUTAGENESIS, V14, P569, DOI 10.1093/mutage/14.6.569; Ministry of Health and Labour and Welfare, RES CARC TESTS; Mitchell AD, 1997, MUTAT RES-GEN TOX EN, V394, P177, DOI 10.1016/S1383-5718(97)00115-0; Morita T, 1997, MUTAT RES-GEN TOX EN, V391, P259; Mueller-Tegethoff Kerstin, 1995, Mutation Research, V335, P293; Munro IC, 1999, FOOD CHEM TOXICOL, V37, P207, DOI 10.1016/S0278-6915(98)00112-4; NAGAO M, 1978, ANNU REV GENET, V12, P117, DOI 10.1146/annurev.ge.12.120178.001001; National Institute of Health Sciences, JAP EX CHEM DAT BAS; Ni Zuyao, 1993, Journal of West China University of Medical Sciences, V24, P82; OECD Guideline for the Testing of Chemicals, 2011, TRANSG ROD SOM GERM; OHGAKI H, 1991, MUTAT RES, V259, P399, DOI 10.1016/0165-1218(91)90130-E; Parkinson A, 1996, CASARETT DOULLS TOXI, P113; RICH KJ, 1992, CARCINOGENESIS, V13, P2221, DOI 10.1093/carcin/13.12.2221; Schisler MR, 2010, ENVIRON MOL MUTAGEN, V51, P732; SHELBY MD, 1984, ENVIRON MUTAGEN, V6, P871, DOI 10.1002/em.2860060613; Sugimura T, 1997, MUTAT RES-FUND MOL M, V376, P211, DOI 10.1016/S0027-5107(97)00045-6; THOMPSON LH, 1987, MUTAGENESIS, V2, P483, DOI 10.1093/mutage/2.6.483; TUCKER JD, 1989, MUTAT RES, V224, P105, DOI 10.1016/0165-1218(89)90009-8; UN, 2011, HLTH ENV HAZ 3; United Nations Environment Programme (UNEP), SCREEN INF DAT SIDS; Wei M, 2006, CANCER LETT, V231, P304, DOI 10.1016/j.canlet.2005.02.029; Williams R. T., 1959, DETOXIFICATION MECH; Zeiger E, 2001, MUTAT RES-GEN TOX EN, V492, P29, DOI 10.1016/S1383-5718(01)00153-X; Zeller A, 2014, MUTAGENESIS, V29, P37, DOI 10.1093/mutage/get053	66	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1383-5718	1879-3592		MUTAT RES-GEN TOX EN	Mutat. Res. Genet. Toxicol. Environ. Mutagen.	DEC	2014	775						55	68		10.1016/j.mrgentox.2014.10.005		14	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	AX8BN	WOS:000347135700007		
J	Matsumoto, M; Masumori, S; Hirata-Koizumi, M; Ono, A; Honma, M; Yokoyama, K; Hirose, A				Matsumoto, Mariko; Masumori, Shoji; Hirata-Koizumi, Mutsuko; Ono, Atsushi; Honma, Masamitsu; Yokoyama, Kazuhito; Hirose, Akihiko			Evaluation of in vivo mutagenicity of hydroquinone in Muta (TM) mice	MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS			English	Article						Hydroquinone; Transgenic mutation assay; Mouse	MOUSE BONE-MARROW; BLADDER CARCINOGENESIS; DNA-ADDUCTS; HL-60 CELLS; RATS; BENZENE; CATECHOL; CYTOTOXICITY; ANTIOXIDANTS; BENZOQUINONE	Hydroquinone (HQ) is used in skin bleaching agents, hair dyes, and finger nail treatments. Many skin-lightening cosmetics that contain HQ are currently marketed in Japan. Concerns have been expressed regarding health risks to the general population because the carcinogenicity of HQ was previously suggested in animal studies. HQ induced hepatocellular adenomas and forestomach hyperplasias in mice and renal tubular cell adenomas in male rats. In the present study, the lacZ transgenic mutation assay was conducted according to OECD test guideline 488 to determine whether mutagenic mechanisms were involved in HQ-induced carcinogenesis. Male Muta (TM) mice were repeatedly administered HQ orally at dosages of 0, 25, 50, 100, or 200 mg/kg bw/day for 28 days. Body weight gain was decreased in all treatment groups. No significant differences were observed in mutant frequencies in the liver, stomach, lung, or kidney between HQ-treated mice and the concurrent negative controls, whereas the significant induction of mutations was noted in the positive control, N-ethyl-N-nitrosourea. These results suggest that a mutagenic mechanism is not responsible for HQ-induced carcinogenesis. (C) 2014 Elsevier B.V. All rights reserved.	[Matsumoto, Mariko; Hirata-Koizumi, Mutsuko; Ono, Atsushi; Hirose, Akihiko] Natl Inst Hlth Sci, Div Risk Assessment, Tokyo 1588501, Japan; [Masumori, Shoji] Publ Interest Inc Fdn, Biosafety Res Ctr, Shizuoka, Japan; [Honma, Masamitsu] Natl Inst Hlth Sci, Div Genet & Mutagenesis, Tokyo 1588501, Japan; [Matsumoto, Mariko; Yokoyama, Kazuhito] Juntendo Univ, Sch Med, Dept Epidemiol & Environm Hlth, Tokyo 113, Japan	Ono, A (reprint author), Natl Inst Hlth Sci, Div Risk Assessment, Biol Safety Ctr, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	atsushi@nihs.go.jp			Ministry of Health, Labour and Welfare, Japan [H24-Tokubetsu-Shitei-08]	This study was supported by the Ministry of Health, Labour and Welfare, Japan H24-Tokubetsu-Shitei-08.	ADLER ID, 1990, MUTAT RES, V234, P115, DOI 10.1016/0165-1161(90)90002-6; Snyder R, 2012, INT J ENV RES PUB HE, V9, P2875, DOI 10.3390/ijerph9082875; Deisinger PJ, 1996, J TOXICOL ENV HEALTH, V47, P31, DOI 10.1080/009841096161915; Tsutsui T, 1997, MUTAT RES-FUND MOL M, V373, P113, DOI 10.1016/S0027-5107(96)00196-0; Levitt J, 2007, J AM ACAD DERMATOL, V57, P854, DOI 10.1016/j.jaad.2007.02.020; CIRANNI R, 1988, MUTAT RES, V209, P23, DOI 10.1016/0165-7992(88)90105-4; Cosmetic Ingredient Review, 2009, FIN REP COSM INGR RE; English JC, 2005, FOOD CHEM TOXICOL, V43, P483, DOI 10.1016/j.fct.2004.11.015; FDA, 2009, 123319 CAS FDA; FINDLAY GH, 1975, BRIT J DERMATOL, V93, P613, DOI 10.1111/j.1365-2133.1975.tb05110.x; Hard GC, 1997, TOXICOL PATHOL, V25, P132; HASEGAWA R, 1990, JPN J CANCER RES, V81, P871; Haworth S, 1983, Environ Mutagen, V5 Suppl 1, P1; Heddle JA, 1999, MUTAGENESIS, V14, P257, DOI 10.1093/mutage/14.3.257; HIROSE M, 1989, CANCER RES, V49, P5143; Horita M, 2005, FREE RADICAL RES, V39, P1035, DOI 10.1080/10715760500232008; Jiang G.F., 2003, CHIN J PREV MED, V37, P183; KURATA Y, 1990, JPN J CANCER RES, V81, P754; LEVAY G, 1991, CARCINOGENESIS, V12, P1181, DOI 10.1093/carcin/12.7.1181; LEVAY G, 1993, CARCINOGENESIS, V14, P2329; MARRAZZINI A, 1994, MUTAGENESIS, V9, P505, DOI 10.1093/mutage/9.6.505; MARUYAMA H, 1991, CARCINOGENESIS, V12, P1331, DOI 10.1093/carcin/12.7.1331; MHW Japan, 2000, STAND COSM NOT 331 2; MIYATA Y, 1985, JPN J CANCER RES, V76, P828; Nielsen H, 1996, SCAND J WORK ENV HEA, V22, P108; NTP, 1989, NAT TOX PROGR TECHN, V366; NTP, 1986, NAT TOX PROGR TECHN, V366; OKAZAKI S, 1993, TERATOGEN CARCIN MUT, V13, P127, DOI 10.1002/tcm.1770130303; PATHAK DN, 1995, CARCINOGENESIS, V16, P1803, DOI 10.1093/carcin/16.8.1803; PIFER JW, 1995, INT ARCH OCC ENV HEA, V67, P267, DOI 10.1007/BF00409409; REDDY MV, 1990, CARCINOGENESIS, V11, P1349, DOI 10.1093/carcin/11.8.1349; ROE FJC, 1955, BRIT J CANCER, V9, P177, DOI 10.1038/bjc.1955.14; SAKAI M, 1985, MUTAT RES, V156, P61, DOI 10.1016/0165-1218(85)90007-2; SHIBATA MA, 1991, JPN J CANCER RES, V82, P1211; Silva Mdo C., 2004, ENVIRON MOL MUTAGEN, V43, P258; STENIUS U, 1989, CARCINOGENESIS, V10, P593, DOI 10.1093/carcin/10.3.593; Sze CC, 1996, J APPL TOXICOL, V16, P259; Wester RC, 1998, J TOXICOL ENV HEAL A, V54, P301; WHYSNER J, 1995, REGUL TOXICOL PHARM, V21, P158, DOI 10.1006/rtph.1995.1020; YAMAGUCHI S, 1989, CANCER RES, V49, P6015	40	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1383-5718	1879-3592		MUTAT RES-GEN TOX EN	Mutat. Res. Genet. Toxicol. Environ. Mutagen.	DEC	2014	775						94	98		10.1016/j.mrgentox.2014.10.009		5	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	Biotechnology & Applied Microbiology; Genetics & Heredity; Toxicology	AX8BN	WOS:000347135700011		
J	Matsuzaki, K; Murano, K; Endo, Y; Kitanaka, S				Matsuzaki, Keiichi; Murano, Kayo; Endo, Yurika; Kitanaka, Susumu			Nortriterpene Saponins from Akebia trifoliata	NATURAL PRODUCT COMMUNICATIONS			English	Article						Akebia trifoliata; Nortriterpene; Saponin	QUINATA DECNE; TRITERPENE SAPONINS; PERICARP SAPONINS; SEED SAPONINS; GLYCOSIDES; HEDERAGENIN; GLUCOSIDES; STEMS	Three new nortriterpene saponins, 2 alpha,3 beta,20 alpha-trihydroxy-30-norolean-12-en-28-oic acid O-beta-D-xylopyranosyl-(1 -> 3)-alpha-L-rhamnopyranosyl-(1 -> 4)-beta-D-glucopyranosyl-(1 -> 6)-beta-D-glucopyranosyl ester (3), 2 alpha,3 beta,20 alpha-trihydroxy-30-norolean-12-en-28-oic acid O-beta-L-rhamnopyranosyl-(1 -> 4)-beta-D-glucopyranosyl-(1 -> 6)-beta-D-glucopyranosyl ester (4), and 2 alpha,3 beta,23-trihydroxy-30-noroleana-12,19-dien-28-oic acid O-beta-D-xylopyranosyl-(1 -> 3)-alpha-L-rhamnopyranosyl-(1 -> 4)-beta-D-glucopyranosyl-(1 -> 6)-beta-D-glucopyranosyl ester (6), were isolated from the methanol extract of the pericarps of Akebia trifoliata Koidzumi (Lardizabalaceae), together with five known nortriterpene saponins and three phenolic glycosides. Their structures were elucidated by spectroscopic analyses and acid hydrolysis.	[Matsuzaki, Keiichi; Murano, Kayo; Endo, Yurika; Kitanaka, Susumu] Nihon Univ, Dept Pharmacognosy & Nat Product Chem, Sch Pharm, Funabashi, Chiba 2748555, Japan	Matsuzaki, K (reprint author), Nihon Univ, Dept Pharmacognosy & Nat Product Chem, Sch Pharm, 7-7-1 Narashino Dai, Funabashi, Chiba 2748555, Japan.	matsuzaki.keiichi@nihon-u.ac.jp					DAMTOFT S, 1994, PHYTOCHEMISTRY, V37, P441, DOI 10.1016/0031-9422(94)85075-5; FUJITA M, 1974, YAKUGAKU ZASSHI, V94, P194; Gao HM, 2006, PHYTOCHEMISTRY, V67, P2697, DOI 10.1016/j.phytochem.2006.09.003; HIGUCHI R, 1972, CHEM PHARM BULL, V20, P2143; HIGUCHI R, 1976, CHEM PHARM BULL, V24, P1314; HIGUCHI R, 1976, CHEM PHARM BULL, V24, P1021; HIGUCHI R, 1972, CHEM PHARM BULL, V20, P1935; Iwanaga S, 2012, CHEM PHARM BULL, V60, P1264, DOI 10.1248/cpb.c12-00448; Mimaki Y, 2007, CHEM PHARM BULL, V55, P1319, DOI 10.1248/cpb.55.1319; Mimaki Y, 2003, CHEM PHARM BULL, V51, P960, DOI 10.1248/cpb.51.960; SHIMOMURA H, 1987, PHYTOCHEMISTRY, V26, P2363, DOI 10.1016/S0031-9422(00)84720-2	11	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	DEC	2014	9	12					1695	1698				4	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	AX4GY	WOS:000346892700008		
J	Nojo, R; Echigo, S; Hara, N; Fujimoto, Y				Nojo, Rie; Echigo, Shizue; Hara, Noriyuki; Fujimoto, Yoshinori			C-24 Stereochemistry of Marine Sterols: (22E)-25,28-Dimethylstigmasta-5,22,28-trien-3 beta-ol and 25,28-Dimethylstigmasta-5,28-dien-3 beta-ol	NATURAL PRODUCT COMMUNICATIONS			English	Article						Marine sterol; Stereochemistry; Orthoester Claisen rearrangement; Topsentia ophiraphidites; Epipolasterol; Axinyssasterol; Topsentinol	BRANCHED SIDE-CHAINS	The C-24 configurations of (22E)-25,28-dimethylstigmasta-5,22,28-trien-3-beta-ol (1) and 25,28-dimethylstigmasta-5,28-dien-3 beta-ol (2), isolated from the sponge Topsentia ophiraphidites in our previous work, were determined to be both S, through the synthesis of stereodefined (24S)- and (24R)-epimers of 1 and 2 and comparison of the H-1 and C-13 NMR spectroscopic data. In addition, the C-24 configurations of the marine sterols having the same structures as 1 and 2 and their derivatives were also assigned for the first time by NMR comparison.	[Nojo, Rie; Echigo, Shizue; Hara, Noriyuki; Fujimoto, Yoshinori] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan	Fujimoto, Y (reprint author), Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan.	fujimoto.y.aa@m.titech.ac.jp					Khripach VA, 2002, STEROIDS, V67, P597, DOI 10.1016/S0039-128X(02)00007-7; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Calderon GJ, 2004, STEROIDS, V69, P93, DOI 10.1016/j.steroids.2003.11.001; Echigo S, 2011, J BRAZIL CHEM SOC, V22, P995; Echigo S, 2006, CHEM PHARM BULL, V54, P1473, DOI 10.1248/cpb.54.1473; Ishibashi M, 1997, CHEM PHARM BULL, V45, P1435; Kerr RG, 1997, COMP BIOCHEM PHYS B, V117, P561, DOI 10.1016/S0305-0491(97)00012-6; LI X, 1983, TETRAHEDRON LETT, V24, P665, DOI 10.1016/S0040-4039(00)81493-8; Makareva TN, 1990, CHEM NAT COMPD, V26, P172, DOI 10.1007/BF00607536; SUCROW W, 1971, CHEM BER-RECL, V104, P3689, DOI 10.1002/cber.19711041133; TAKAHASHI T, 1981, J AM CHEM SOC, V103, P5259, DOI 10.1021/ja00407a062; WIERSIG JR, 1979, J ORG CHEM, V44, P3374, DOI 10.1021/jo01333a021; Yamada H, 1990, THESIS TOKYO I TECHN	13	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	DEC	2014	9	12					1699	1704				6	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	AX4GY	WOS:000346892700009		
J	Matsuo, Y; Kurihara, R; Akagi, N; Mimaki, Y				Matsuo, Yukiko; Kurihara, Risa; Akagi, Nana; Mimaki, Yoshihiro			Two New Homoisoflavonoids from the Bulbs of Bessera elegans	NATURAL PRODUCT COMMUNICATIONS			English	Article						Bessera elegans; Liliaceae; Scillascillin-type; Homoisoflavonoid; HL-60 cells; TIG-3 cells	CYTOTOXIC ACTIVITIES	A further chemical investigation of the bulbs of Bessera elegans (Liliaceae) led to the isolation of a new homoisoflavonoid (1), a new scillascillin-type homoisoflavonoid (2), three known flavonoids (3-5), and two known norlignans (6 and 7). The structures of the new homoisoflavonoids (1 and 2) were determined based on the results of extensive spectroscopic analysis, including two-dimensional NMR data. The isolated compounds (1-7) were evaluated for cytotoxicity against HL-60 human promyelocytic leukemia cells and TIG-3 normal human diploid fibroblasts. Compound 1 exhibited potent tumor-selective cytotoxic activity against HL-60 cells.	[Matsuo, Yukiko; Kurihara, Risa; Akagi, Nana; Mimaki, Yoshihiro] Tokyo Univ Pharm & Life Sci, Sch Pharm, Tokyo 1920392, Japan	Matsuo, Y (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, 1432-1 Horinouchi, Tokyo 1920392, Japan.	matsuoy@toyaku.ac.jp					Mutanyatta J, 2003, PHYTOCHEMISTRY, V62, P797, DOI 10.1016/S0031-9422(02)00622-2; Bao-Lin L, 2009, B KOREAN CHEM SOC, V30, P1459; BARONE G, 1988, PHYTOCHEMISTRY, V27, P921, DOI 10.1016/0031-9422(88)84120-7; CUI BL, 1993, CHEM PHARM BULL, V41, P178; Fang D, 2006, LIFE SCI, V78, P2488; KANEDA N, 1983, YAKUGAKU ZASSHI, V103, P1133; MARINIBETTOLO GB, 1985, TETRAHEDRON, V41, P665, DOI 10.1016/S0040-4020(01)96444-0; Matsuo Y, 2013, PHYTOCHEMISTRY, V96, P244, DOI 10.1016/j.phytochem.2013.09.023; Nisida Y, 2008, CHEM PHARM BULL, V56, P1022; Tsukamoto S, 1989, GRAND DICT HORTICULT, V4, P339; Yang CX, 2004, PLANTA MED, V70, P446, DOI 10.1055/s-2004-818974	11	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	DEC	2014	9	12					1725	1727				3	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	AX4GY	WOS:000346892700016		
J	Nagasawa, A; Sakasai, M; Sakaguchi, D; Moriwaki, S; Nishizawa, Y; Kitahara, T				Nagasawa, Azumi; Sakasai, Mitsuyoshi; Sakaguchi, Daishi; Moriwaki, Shigeru; Nishizawa, Yoshinori; Kitahara, Takashi			Angular-type Furocoumarins from the Roots of Angelica atropurp urea and their Inhibitory Activity on the NFAT Signal Transduction Pathway	NATURAL PRODUCT COMMUNICATIONS			English	Article						Furocoumarin; Angelica atropurpurea; NEAT; Immunosuppression	T-CELL-ACTIVATION; DETECTING PHOTOTOXICITY; CYCLOSPORINE; FURANOCOUMARIN	One new (1) and two known angular-type (2,3) furocoumarins, isoarchangelicin (1), archangelicin (2), and 2'angeloyl-3'-isovaleryl vaginate (3), were isolated from the roots of Angelica atropurpurea. The structure of the new compound was established on the basis of one- and two-dimensional NMR spectra and other spectroscopic studies. The inhibitory activity of these three compounds and a deacylated form of archangelicin (4) on the nuclear factor of activated T cells (NFAT) signal transduction pathway was tested by NFAT-responsive luciferase reporter gene assay in cultured cells. Although 4 did not exhibit inhibitory activity on NEAT signaling, 1-3 exhibited dose-dependent inhibition with IC50 values of 16.5 (1), 9.0 (2), and 9.2 (3) mu M.	[Nagasawa, Azumi; Sakasai, Mitsuyoshi; Sakaguchi, Daishi; Moriwaki, Shigeru; Nishizawa, Yoshinori; Kitahara, Takashi] Kao Corp, R&D, Core Technol, Biol Sci Res, Haga, Tochigi 3213497, Japan	Nagasawa, A (reprint author), Kao Corp, R&D, Core Technol, Biol Sci Res, 2606 Akabane,Ichikaimachi, Haga, Tochigi 3213497, Japan.	nagasawa.azumi@kao.co.jp					OKUYAMA T, 1991, PLANTA MED, V57, P242, DOI 10.1055/s-2006-960082; LIU CM, 1978, J BIOL CHEM, V253, P5892; HENDERSON DJ, 1991, IMMUNOLOGY, V73, P316; Colombain M, 2001, PLANTA MED, V67, P644, DOI 10.1055/s-2001-17364; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Marquez N, 2004, PLANTA MED, V70, P1016, DOI 10.1055/s-2004-832640; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Ojala T, 1999, PLANTA MED, V65, P715, DOI 10.1055/s-1999-14049; BERENBAUM M, 1981, ECOLOGY, V62, P1254, DOI 10.2307/1937290; HARMALA P, 1992, PLANTA MED, V58, P287, DOI 10.1055/s-2006-961461; IKESHIRO Y, 1992, PHYTOCHEMISTRY, V31, P4303, DOI 10.1016/0031-9422(92)80463-O; Martinez-Martinez S, 2004, CURR MED CHEM, V11, P997, DOI 10.2174/0929867043455576; Mor E, 1994, Transpl Int, V7 Suppl 1, pS77; Muller Melanie, 2004, Acta Pharmaceutica (Zagreb), V54, P277; Roos G., 1997, Pharmaceutical and Pharmacological Letters, V7, P157; THASTRUP O, 1985, BIOCHEM PHARMACOL, V34, P2137, DOI 10.1016/0006-2952(85)90407-1; Wiesner RH, 1998, TRANSPLANTATION, V66, P493, DOI 10.1097/00007890-199808270-00014	19	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	DEC	2014	9	12					1733	1736				4	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	AX4GY	WOS:000346892700018		
J	Toyama, T; Wada-Takahashi, S; Takamichi, M; Watanabe, K; Yoshida, A; Yoshino, F; Miyamoto, C; Maehata, Y; Sugiyama, S; Takahashi, S; Todoki, K; Lee, MCI; Hamada, N				Toyama, Toshizo; Wada-Takahashi, Satoko; Takamichi, Maomi; Watanabe, Kiyoko; Yoshida, Ayaka; Yoshino, Fumihiko; Miyamoto, Chihiro; Maehata, Yojiro; Sugiyama, Shuta; Takahashi, Shun-suke; Todoki, Kazuo; Lee, Masaichi-Chang-il; Hamada, Nobushiro			Reactive Oxygen Species Scavenging Activity of Jixueteng Evaluated by Electron Spin Resonance (ESR) and Photon Emission	NATURAL PRODUCT COMMUNICATIONS			English	Article						Jixueteng; Herbal medicine; Reactive oxygen species scavenging activity; XYZ chemiluminescence system; Electron spin resonance	SPATHOLOBUS-SUBERECTUS; ANTIOXIDANT ACTIVITY; CONSTITUENTS; RADICALS; GROWTH; PLANTS; HERBS	Jixueteng, the dried stem of Spatholobus sziberectus Dunn (Leguminosae), is a traditional Chinese herbal medicine that is commonly classified as a herb that promotes blood circulation and can be used to treat blood stasis. The aim of this study was to examine the reactive oxygen species (ROS) scavenging activity of Jixueteng and other herbal medicines. The ROS scavenging activities of the water extracts of Jixueteng, Cnidium offieinale and Salvia miltiorrhiza were examined using an electron spin resonance (ESR) technique and faint luminescence measurement. The ESR signal intensities of the superoxide anion (O-2(center dot-)) and hydroxyl radical (HO center dot) were reduced more by Jixueteng than the other herbal medicines we tested. High photon emission intensity to hydrogen peroxide (H2O2) and HO center dot was observed in Jixueteng using the XYZ chemiluminescence system that was used as faint luminescence measurement and analysis. The results of the present study revealed that the ROS scavenging activity of 8% Jixueteng was the strongest among the herbal medicines we tested. It has been reported that Jbcueteng includes various polyphenols. In the ROS scavenging activity by Jixueteng, it is supposed that the antioxidant activity caused by these polyphenols would contribute greatly. In conclusion, a water extract component of Jixueteng had potent free radical scavenging activity and an antioxidative effect that inhibited the oxidative actions of O2(center dot-), H2O2 and HO center dot. Therefore, Jixueteng represents a promising therapeutic drug for reactive oxygen-associated pathologies.	[Toyama, Toshizo; Watanabe, Kiyoko; Hamada, Nobushiro] Kanagawa Dent Univ, Grad Sch Dent, Dept Microbiol, Yokosuka, Kanagawa 2388580, Japan; [Wada-Takahashi, Satoko; Takamichi, Maomi; Yoshida, Ayaka; Yoshino, Fumihiko; Miyamoto, Chihiro; Maehata, Yojiro; Sugiyama, Shuta; Takahashi, Shun-suke] Kanagawa Dent Univ, Grad Sch Dent, Dept Oral Sci, Yokosuka, Kanagawa 2388580, Japan; [Todoki, Kazuo] Kanagawa Dent Univ, Sch Nursing, Dept Hlth Sci, Yokosuka, Kanagawa 2388580, Japan; [Lee, Masaichi-Chang-il] Kanagawa Dent Univ, Yokosuka Shonan Disaster Hlth Emergency Res Ctr, Yokosuka, Kanagawa 2388580, Japan; [Lee, Masaichi-Chang-il] Kanagawa Dent Univ, ESR Labs, Yokosuka, Kanagawa 2388580, Japan	Takahashi, S (reprint author), Kanagawa Dent Univ, Grad Sch Dent, Dept Oral Sci, 82 Inaoka Cho, Yokosuka, Kanagawa 2388580, Japan.	takahashi.shunsuke@kdu.ac.jp			JSPS KAKENHI Grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan [25460704]	This work was supported, in part, by JSPS KAKENHI Grant Number 25460704 for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We dedicate this article to the memory of Dr Yusuke Takahashi, our colleague and friend, who died in May, 2009.	Ou BX, 2001, J AGR FOOD CHEM, V49, P4619, DOI 10.1021/jf010586o; Tang RN, 2012, CHIN J NAT MEDICINES, V10, P32, DOI [10.1016/S1875-5364(12)60007-7, 10.3724/SP.J.1009.2012.00032]; Sun J, 2002, J AGR FOOD CHEM, V50, P7449, DOI 10.1021/jf0207530; Faried A, 2007, INT J ONCOL, V30, P605; Lee JH, 2007, VACCINE, V25, P3834, DOI 10.1016/j.vaccine.2007.01.108; Toyama T, 2012, ARCH ORAL BIOL, V57, P1529, DOI 10.1016/j.archoralbio.2012.05.011; LEE CI, 1995, JPN J PHARMACOL, V67, P21, DOI 10.1254/jjp.67.21; Li RW, 2003, J ETHNOPHARMACOL, V85, P61, DOI 10.1016/S0378-8741(02)00339-2; Fang YZ, 2002, NUTRITION, V18, P872, DOI 10.1016/S0899-9007(02)00916-4; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; Wang KH, 2006, J ETHNOPHARMACOL, V106, P353, DOI 10.1016/j.jep.2006.01.010; Fresco P, 2006, MED RES REV, V26, P747, DOI 10.1002/med.20060; Freidovich I, 1999, ANN NY ACAD SCI, V893, P13, DOI DOI 10.1111/J.1749-6632.1999.TB07814.X; Hagiwara S, 2012, J JPN SOC FOOD SCI, V59, P595; Hagiwara T, 2000, NEUROPHARMACOLOGY, V39, P1662, DOI 10.1016/S0028-3908(99)00240-3; Huang KC., 1993, PHARM CHINESE HERBS, P146; Huang WY, 2010, NUTR CANCER, V62, P1, DOI 10.1080/01635580903191585; Huang YW, 2013, MOLECULES, V18, P7549, DOI 10.3390/molecules18077549; Liao H, 2008, EVID-BASED COMPL ALT, V5, P429, DOI 10.1093/ecam/nem054; Okubo K, 2000, BIOFACTORS, V13, P219; Rathee JS, 2006, J AGR FOOD CHEM, V54, P9046, DOI 10.1021/jf061679e; Saito T, 2007, ECOENGINEERING, V19, P103; Srikaeo K., 2013, Rice Science, V20, P292; Su E. Y, 1997, CHINESE J INTEGRATED, V17, P213; Toyama T, 2011, ORAL THERAPEUTICS PH, V30, P51; Wada-Takahashi S, 2000, AM J PHYSIOL-GASTR L, V279, pG893; Wang DX, 2008, CHINESE MED J-PEKING, V121, P752; Zhang Yujie, 2014, Nongyaoxue Xuebao, V16, P102	28	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	DEC	2014	9	12					1755	1759				5	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	AX4GY	WOS:000346892700025		
J	Honig, G; Callsen, G; Schliwa, A; Kalinowski, S; Kindel, C; Kako, S; Arakawa, Y; Bimberg, D; Hoffmann, A				Hoenig, Gerald; Callsen, Gordon; Schliwa, Andrei; Kalinowski, Stefan; Kindel, Christian; Kako, Satoshi; Arakawa, Yasuhiko; Bimberg, Dieter; Hoffmann, Axel			Manifestation of unconventional biexciton states in quantum dots	NATURE COMMUNICATIONS			English	Article							BOSE-EINSTEIN CONDENSATION; CHEMICAL-VAPOR-DEPOSITION; OPTICAL-PROPERTIES; PIEZOELECTRIC FIELDS; SPECTRAL DIFFUSION; FINE-STRUCTURE; EXCITONS; SINGLE; ELECTRON; WELLS	Although semiconductor excitons consist of a fermionic subsystem (electron and hole), they carry an integer net spin similar to Cooper-electron-pairs. While the latter cause superconductivity by forming a Bose-Einstein-condensate, excitonic condensation is impeded by, for example, a fast radiative decay of the electron-hole pairs. Here, we investigate the behaviour of two electron-hole pairs in a quantum dot with wurtzite crystal structure evoking a charge carrier separation on the basis of large spontaneous and piezoelectric polarizations, thus reducing carrier overlap and consequently decay probabilities. As a direct consequence, we find a hybrid-biexciton complex with a water molecule-like charge distribution enabling anomalous spin configurations. In contrast to the conventional-biexciton complex with a net spin of s = 0, the hybrid-biexciton exhibits s = +/- 3, leading to completely different photoluminescence signatures in addition to drastically enhanced charge carrier-binding energies. Consequently, the biexcitonic cascade via the dark exciton can be enhanced on the rise of temperature as approved by photon cross-correlation measurements.	[Hoenig, Gerald; Callsen, Gordon; Schliwa, Andrei; Kalinowski, Stefan; Kindel, Christian; Bimberg, Dieter; Hoffmann, Axel] Tech Univ Berlin, Inst Festkorperphys, D-10623 Berlin, Germany; [Kako, Satoshi; Arakawa, Yasuhiko] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538904, Japan; [Bimberg, Dieter] King Abdulaziz Univ, Jeddah 21589, Saudi Arabia	Honig, G (reprint author), Tech Univ Berlin, Inst Festkorperphys, Hardenbergstr 36, D-10623 Berlin, Germany.	gerald.hoenig@physik.tu-berlin.de	Pahn, Gerald/P-2973-2015	Pahn, Gerald/0000-0001-7590-044X	German Research Foundation within the Collaborative Research Center [CRC 787]	This work was supported by the German Research Foundation within the Collaborative Research Center (CRC 787).	Andre R., 1990, PHYS REV B, V42, pR392; Kulakovskii VD, 1999, PHYS REV LETT, V82, P1780, DOI 10.1103/PhysRevLett.82.1780; Hoshino K, 2004, APPL PHYS LETT, V85, P1262, DOI 10.1063/1.1784524; Reimann SM, 2000, PHYS REV B, V62, P8108, DOI 10.1103/PhysRevB.62.8108; BLATT JM, 1962, PHYS REV, V126, P1691, DOI 10.1103/PhysRev.126.1691; Vurgaftman I, 2003, J APPL PHYS, V94, P3675, DOI 10.1063/1.1600519; Stier O, 1999, PHYS REV B, V59, P5688, DOI 10.1103/PhysRevB.59.5688; Egger R, 1999, PHYS REV LETT, V82, P3320, DOI 10.1103/PhysRevLett.82.3320; Daudin B, 1997, PHYS REV B, V56, pR7069; Bayer M, 1999, PHYS REV LETT, V82, P1748, DOI 10.1103/PhysRevLett.82.1748; BIMBERG D, 1971, PHYS REV B, V4, P3451, DOI 10.1103/PhysRevB.4.3451; Kindel C, 2014, PHYS STATUS SOLIDI-R, V8, P408, DOI 10.1002/pssr.201409096; Einstein A, 1924, SITZBER PREUSS AKAD, P261; Pal J, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.085211; Sallen G, 2010, NAT PHOTONICS, V4, P696, DOI 10.1038/NPHOTON.2010.174; Hayne M, 2003, APPL PHYS LETT, V82, P4355, DOI 10.1063/1.1583853; Simeonov D, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075306; Akopian N, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.130501; Kako S, 2006, NAT MATER, V5, P887, DOI 10.1038/nmat1763; Eisenstein JP, 2004, NATURE, V432, P691, DOI 10.1038/nature03081; Im JS, 1998, PHYS REV B, V57, pR9435; Moreau E, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysResLett.87.183601; Shchukin VA, 1999, REV MOD PHYS, V71, P1125, DOI 10.1103/RevModPhys.71.1125; Miyamura M, 2002, APPL PHYS LETT, V80, P3937, DOI 10.1063/1.1482416; Kindel C, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.241309; Bester G, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.161306; FUKUZAWA T, 1990, PHYS REV LETT, V64, P3066, DOI 10.1103/PhysRevLett.64.3066; Tanaka S, 1996, APPL PHYS LETT, V69, P4096, DOI 10.1063/1.117830; Ostapenko IA, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.081303; Takeuchi T, 1998, APPL PHYS LETT, V73, P1691, DOI 10.1063/1.122247; Callsen G, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.245314; EFROS AL, 1982, SOV PHYS SEMICOND+, V16, P772; Yannouleas C, 1999, PHYS REV LETT, V82, P5325, DOI 10.1103/PhysRevLett.82.5325; Shields AJ, 2007, NAT PHOTONICS, V1, P215, DOI 10.1038/nphoton.2007.46; Seguin R, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.257402; Reusch B, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.113313; BANYAI L, 1988, PHYS REV B, V38, P8142, DOI 10.1103/PhysRevB.38.8142; Bassani G. F., 1975, INT SERIES MONOGRAPH; Bernardini F, 1997, PHYS REV B, V56, P10024; CHEN YJ, 1987, PHYS REV B, V36, P4562, DOI 10.1103/PhysRevB.36.4562; Coraux J., 2006, PHYS REV B, V74, P1; Daudin B, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/47/473201; Egger R, 1999, PHYS REV LETT, V83, P462, DOI 10.1103/PhysRevLett.83.462; Einstein A, 1925, SITZUNGSBERICHTE PM, V194, P3; Favero I., 2005, PHYS REV B, V71, P3; Honig G, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.045309; Kindel C. H., 2010, THESIS; Kodriano Y., 2010, PHYS REV B, V82, P1; Liu F, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.035302; Mlinar V, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.205311; QUE WM, 1992, PHYS REV B, V45, P11036, DOI 10.1103/PhysRevB.45.11036; Rinke P., 2008, PHYS REV B, V77, P16; Rodt S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.035331; Rol F, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.125306; Roussignol P, 1998, PHYSICA E, V2, P588, DOI 10.1016/S1386-9477(98)00120-9; Schulz S, 2011, PHYS STATUS SOLIDI B, V248, P1853, DOI 10.1002/pssb.201147158; Seguin R, 2004, APPL PHYS LETT, V84, P4023, DOI 10.1063/1.1751214; Tomic S, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.159902; Tomic S, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.245330; Winkelnkemper M, 2008, PHYS STATUS SOLIDI B, V245, P2766, DOI 10.1002/pssb.200844129; Winkelnkemper M, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.155322; Yannouleas C, 2000, PHYS REV LETT, V85, P2220, DOI 10.1103/PhysRevLett.85.2220; Zwiller V, 1999, PHYS REV B, V59, P5021, DOI 10.1103/PhysRevB.59.5021	63	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC	2014	5								5721	10.1038/ncomms6721		7	Multidisciplinary Sciences	Science & Technology - Other Topics	AX9NP	WOS:000347229600004		
J	Ishii, A; Ueno, K; Orba, Y; Sasaki, M; Moonga, L; Hang'ombe, BM; Mweene, AS; Umemura, T; Ito, K; Hall, WW; Sawa, H				Ishii, Akihiro; Ueno, Keisuke; Orba, Yasuko; Sasaki, Michihito; Moonga, Ladslav; Hang'ombe, Bernard M.; Mweene, Aaron S.; Umemura, Takashi; Ito, Kimihito; Hall, William W.; Sawa, Hirofumi			A nairovirus isolated from African bats causes haemorrhagic gastroenteritis and severe hepatic disease in mice	NATURE COMMUNICATIONS			English	Article							RECEPTOR-KNOCKOUT MICE; HAZARA VIRUS-INFECTION; FEVER-VIRUS; METAGENOMIC ANALYSIS; IDENTIFICATION; PATHOGENESIS; DIVERSITY; GENERATION; RESPONSES; PROTEIN	Bats can carry important zoonotic pathogens. Here we use a combination of next-generation sequencing and classical virus isolation methods to identify novel nairoviruses from bats captured from a cave in Zambia. This nairovirus infection is highly prevalent among giant leaf-nosed bats, Hipposideros gigas (detected in samples from 16 individuals out of 38). Whole-genome analysis of three viral isolates (11SB17, 11SB19 and 11SB23) reveals a typical bunyavirus tri-segmented genome. The strains form a single phylogenetic clade that is divergent from other known nairoviruses, and are hereafter designated as Leopards Hill virus (LPHV). When i.p. injected into mice, the 11SB17 strain causes only slight body weight loss, whereas 11SB23 produces acute and lethal disease closely resembling that observed with Crimean-Congo Haemorrhagic Fever virus in humans. We believe that our LPHV mouse model will be useful for research on the pathogenesis of nairoviral haemorrhagic disease.	[Ishii, Akihiro] Hokkaido Univ, Hokudai Ctr Zoonosis Control Zambia, Res Ctr Zoonosis Control, Kita Ku, Sapporo, Hokkaido 0010020, Japan; [Ishii, Akihiro; Mweene, Aaron S.; Sawa, Hirofumi] Univ Zambia, Sch Vet Med, Dept Dis Control, Lusaka 10101, Zambia; [Ueno, Keisuke; Ito, Kimihito] Hokkaido Univ, Div Bioinformat, Res Ctr Zoonosis Control, Sapporo, Hokkaido 0010020, Japan; [Orba, Yasuko; Sasaki, Michihito; Sawa, Hirofumi] Hokkaido Univ, Div Mol Pathobiol, Res Ctr Zoonosis Control, Sapporo, Hokkaido 0010020, Japan; [Moonga, Ladslav; Hang'ombe, Bernard M.] Univ Zambia, Sch Vet Med, Dept Paraclin Studies, Lusaka 10101, Zambia; [Umemura, Takashi] Hokkaido Univ, Grad Sch Vet Med, Dept Comparat Pathol, Sapporo, Hokkaido 0010020, Japan; [Hall, William W.] Univ Coll Dublin, Ctr Res Infect Dis, Dublin 4, Ireland; [Hall, William W.; Sawa, Hirofumi] Global Virus Network, Baltimore, MD 21201 USA; [Hall, William W.; Sawa, Hirofumi] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Sapporo, Hokkaido 0010020, Japan	Ishii, A (reprint author), Hokkaido Univ, Hokudai Ctr Zoonosis Control Zambia, Res Ctr Zoonosis Control, Kita Ku, N20,W10, Sapporo, Hokkaido 0010020, Japan.	ishiia@czc.hokudai.ac.jp	Sawa, Hirofumi/F-6954-2012		Ministry of Education, Culture, Sports, Science and Technolog; Ministry of Health, Labour and Welfare, Japan (MEXT)/JSPS KAKENHI [24405043, 25660222]	We would like to thank Zambia Wildlife Authority for assistance with sample collection in Zambia. We are grateful to Dr Manabu Igarashi and Dr Edgar Simulundu for their cooperation. This study was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology; the Ministry of Health, Labour and Welfare, Japan (MEXT)/JSPS KAKENHI Grant Number 24405043 and 25660222; the Global COE programme and the Japan Initiative for Global Research Network on Infectious Diseases, MEXT Japan.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Chamberlain J, 2005, J GEN VIROL, V86, P3337, DOI 10.1099/vir.0.1213-0; Dowall SD, 2012, J GEN VIROL, V93, P560, DOI 10.1099/vir.0.038455-0; Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006; Vincent MJ, 2003, J VIROL, V77, P8640, DOI 10.1128/JVI.7716.8640-8649.2003; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; Paweska JT, 2009, EMERG INFECT DIS, V15, P1598, DOI 10.3201/eid1510.090211; CHASTEL C, 1989, ACTA VIROL, V33, P270; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Bente DA, 2010, J VIROL, V84, P11089, DOI 10.1128/JVI.01383-10; Frias-Staheli N, 2007, CELL HOST MICROBE, V2, P404, DOI 10.1016/j.chom.2007.09.014; Dacheux L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087194; Ge XY, 2012, J VIROL, V86, P4620, DOI 10.1128/JVI.06671-11; Altamura LA, 2007, J VIROL, V81, P6632, DOI 10.1128/JVI.02730-06; Sanchez AJ, 2002, J VIROL, V76, P7263, DOI 10.1128/JVI.76.14.7263-7275.2002; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Zivcec M, 2013, J INFECT DIS, V207, P1909, DOI 10.1093/infdis/jit061; SWANEPOEL R, 1989, REV INFECT DIS, V11, pS794; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275; FRAME JD, 1970, AM J TROP MED HYG, V19, P670; Dilcher M, 2012, VIRUS GENES, V45, P426, DOI 10.1007/s11262-012-0796-8; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10; Honig JE, 2004, VIROLOGY, V318, P10, DOI 10.1016/j.virol.2003.09.021; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Wu ZQ, 2012, J VIROL, V86, P10999, DOI 10.1128/JVI.01394-12; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Boyd A, 2006, J GEN VIROL, V87, P2005, DOI 10.1099/vir.0.81767-0; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Canuti M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029140; Drexler JF, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1796; Ishii A, 2012, J GEN VIROL, V93, P2247, DOI 10.1099/vir.0.044099-0; Ishii A, 2011, EMERG INFECT DIS, V17, P1921, DOI [10.3201/eid1710.101452, 10.3201/eid1710.10452]; Kading RC, 2013, J GEN VIROL, V94, P2393, DOI 10.1099/vir.0.053983-0; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Peel AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3770; SMIRNOVA SE, 1977, ACTA VIROL, V21, P128; SMIRNOVA SE, 1979, ARCH VIROL, V62, P137, DOI 10.1007/BF01318066; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Tse H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043986; Woodall J P, 1967, East Afr Med J, V44, P93; Yozwiak NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001485	42	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC	2014	5								5651	10.1038/ncomms6651		11	Multidisciplinary Sciences	Science & Technology - Other Topics	AX9MW	WOS:000347227700001		
J	Kim, K; Bang, SY; Lee, HS; Okada, Y; Han, B; Saw, WY; Teo, YY; Bae, SC				Kim, Kwangwoo; Bang, So-Young; Lee, Hye-Soon; Okada, Yukinori; Han, Buhm; Saw, Woei-Yuh; Teo, Yik-Ying; Bae, Sang-Cheol			The HLA-DR beta 1 amino acid positions 11-13-26 explain the majority of SLE-MHC associations	NATURE COMMUNICATIONS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; SEROPOSITIVE RHEUMATOID-ARTHRITIS; GENOME-WIDE ASSOCIATION; EXTENDED HUMAN MHC; HLA ALLELES; VARIANTS; HLA-DRB1; WOMEN; LOCI; MAP	Genetic association of the major histocompatibility complex (MHC) locus is well established in systemic lupus erythematosus (SLE), but the causal functional variants in this region have not yet been discovered. Here we conduct the first fine-mapping study, which thoroughly investigates the SLE-MHC associations down to the amino acid level of major HLA genes in 5,342 unrelated Korean case-control subjects, taking advantages of HLA imputation with a newly constructed Asian HLA reference panel. The most significant association is mapped to amino acid position 13 of HLA-DR beta 1 (P = 2.48 x 10(-17)) and its proxy position 11 (P = 4.15 x 10(-17)), followed by position 26 in a stepwise conditional analysis (P = 2.42 x 10(-9)). Haplotypes defined by amino acid positions 11-13-26 support the reported effects of most classical HLA-DRB1 alleles in Asian and European populations. In conclusion, our study identifies the three amino acid positions at the epitope-binding groove of HLA-DR beta 1 that are responsible for most of the association between SLE and MHC.	[Kim, Kwangwoo; Bang, So-Young; Lee, Hye-Soon; Bae, Sang-Cheol] Hanyang Univ, Hosp Rheumat Dis, Dept Rheumatol, Seoul 133792, South Korea; [Kim, Kwangwoo; Okada, Yukinori] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Kim, Kwangwoo; Okada, Yukinori; Han, Buhm] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Kim, Kwangwoo; Okada, Yukinori; Han, Buhm] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Okada, Yukinori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Human Genet & Dis Div, Tokyo 1130034, Japan; [Okada, Yukinori] RIKEN, Ctr Integrat Med Sci, Lab Stat Anal, Yokohama, Kanagawa 2300045, Japan; [Han, Buhm] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul 138736, South Korea; [Saw, Woei-Yuh; Teo, Yik-Ying] Natl Univ Singapore, Inst Life Sci, Singapore 117456, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117549, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, Dept Stat & Appl Probabil, Singapore 117546, Singapore; [Teo, Yik-Ying] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117456, Singapore; [Teo, Yik-Ying] Agcy Sci Technol & Res, Genome Inst Singapore, Singapore 138672, Singapore	Bae, SC (reprint author), Hanyang Univ, Hosp Rheumat Dis, Dept Rheumatol, Seoul 133792, South Korea.	scbae@hanyang.ac.kr			Korea Healthcare Technology R&D Project of the Ministry for Health Welfare [HI13C2124]; Life Science Institute; Office of the Deputy President (Research and Technology) from the National University of Singapore; Singapore National Research Foundation [NRF-RF-2010-05]; Korea Center for Disease Control and Prevention at the Korea National Institute of Health	We are grateful to the study participants who donated DNA samples. We also thank to Dr Soumya Raychaudhuri at Brigham and Women's Hospital for the valuable feedback over the manuscript. This work was supported by grants from the Korea Healthcare Technology R&D Project of the Ministry for Health & Welfare (HI13C2124). W.-Y.S. and Y.-Y.T. acknowledge the support from the Life Science Institute, the Office of the Deputy President (Research and Technology) from the National University of Singapore and from the Singapore National Research Foundation (NRF-RF-2010-05). A part of the Korean control data was provided from Korean Biobank Project supported by the Korea Center for Disease Control and Prevention at the Korea National Institute of Health.	Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Pillai NE, 2014, HUM MOL GENET, V23, P4443, DOI 10.1093/hmg/ddu149; Han B, 2014, AM J HUM GENET, V94, P522, DOI 10.1016/j.ajhg.2014.02.013; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Morris DL, 2012, AM J HUM GENET, V91, P778, DOI 10.1016/j.ajhg.2012.08.026; LAWRENCE JS, 1987, J RHEUMATOL, V14, P913; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Wang J, 2007, ARCH DERMATOL RES, V298, P485, DOI 10.1007/s00403-006-0719-4; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Shimane K, 2013, RHEUMATOLOGY, V52, P1172, DOI 10.1093/rheumatology/kes427; Lee HS, 2014, ANN RHEUM DIS, V73, P1240, DOI 10.1136/annrheumdis-2012-202675; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Barcellos LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000696; Boackle SA, 2013, CURR OPIN RHEUMATOL, V25, P561, DOI 10.1097/BOR.0b013e328363eb4e; Fernando MMA, 2007, PLOS GENET, V3, P2109, DOI 10.1371/journal.pgen.0030192; Foo JN, 2013, AM J HUM GENET, V93, P167, DOI 10.1016/j.ajhg.2013.05.020; Furukawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087792; International Consortium for Systemic Lupus Erythematosus G, 2008, NAT GENET, V40, P204; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Kim I, 2009, GENES IMMUN, V10, P421, DOI 10.1038/gene.2009.24; Kim K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112546; Mohd-Yusuf Y, 2011, IMMUNOL LETT, V139, P68, DOI 10.1016/j.imlet.2011.05.001; Okada Y, 2014, HUM MOL GENET, V23, P6916, DOI 10.1093/hmg/ddu387; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Yamamura T, 2012, TISSUE ANTIGENS, V80, P119, DOI 10.1111/j.1399-0039.2012.01883.x	26	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC	2014	5								5902	10.1038/ncomms6902		7	Multidisciplinary Sciences	Science & Technology - Other Topics	AX8RS	WOS:000347176800001		
J	Mashiko, H; Yamaguchi, T; Oguri, K; Suda, A; Gotoh, H				Mashiko, Hiroki; Yamaguchi, Tomohiko; Oguri, Katsuya; Suda, Akira; Gotoh, Hideki			Characterizing inner-shell with spectral phase interferometry for direct electric-field reconstruction	NATURE COMMUNICATIONS			English	Article							ISOLATED ATTOSECOND PULSES; AUTOIONIZATION RESONANCES; ABSORPTION-SPECTROSCOPY; NONSTATIONARY STATES; NONLINEAR OPTICS; TIME; RESOLUTION; NE	In many atomic, molecular and solid systems, Lorentzian and Fano profiles are commonly observed in a broad research fields throughout a variety of spectroscopies. As the profile structure is related to the phase of the time-dependent dipole moment, it plays an important role in the study of quantum properties. Here we determine the dipole phase in the inner-shell transition using spectral phase interferometry for direct electric-field reconstruction (SPIDER) with isolated attosecond pulses (IAPs). In addition, we propose a scheme for pulse generation and compression by manipulating the inner-shell transition. The electromagnetic radiation generated by the transition is temporally compressed to a few femtoseconds in the extreme ultraviolet (XUV) region. The proposed pulse-compression scheme may provide an alternative route to producing attosecond pulses of light.	[Mashiko, Hiroki; Yamaguchi, Tomohiko; Oguri, Katsuya; Gotoh, Hideki] Nippon Telegraph & Tel Corp, Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; [Yamaguchi, Tomohiko; Suda, Akira] Tokyo Univ Sci, Noda, Chiba 2788510, Japan	Mashiko, H (reprint author), Nippon Telegraph & Tel Corp, Basic Res Labs, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan.	mashiko.hiroki@lab.ntt.co.jp	Suda, Akira/P-8994-2015	Suda, Akira/0000-0002-0165-8539	JSPS KAKENHI [25706027, 23310086]	This work was supported by JSPS KAKENHI Grant No. 25706027 and 23310086.	Goulielmakis E, 2008, SCIENCE, V320, P1614, DOI 10.1126/science.1157846; Sansone G, 2006, SCIENCE, V314, P443, DOI 10.1126/science.1132838; Mashiko H, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.103906; Lepetit L, 1995, J OPT SOC AM B, V12, P2467, DOI 10.1364/JOSAB.12.002467; POLLARD WT, 1992, J PHYS CHEM-US, V96, P6147, DOI 10.1021/j100194a013; Drescher M, 2002, NATURE, V419, P803, DOI 10.1038/nature01143; Iaconis C, 1998, OPT LETT, V23, P792, DOI 10.1364/OL.23.000792; Fan JA, 2010, SCIENCE, V328, P1135, DOI 10.1126/science.1187949; Hatayama M, 2009, APPL OPTICS, V48, P5464, DOI 10.1364/AO.48.005464; Verhoef AJ, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/11/113003; FANO U, 1968, REV MOD PHYS, V40, P441, DOI 10.1103/RevModPhys.40.441; Obara Y, 2014, OPT EXPRESS, V22, P1105, DOI 10.1364/OE.22.001105; Paul PM, 2001, SCIENCE, V292, P1689, DOI 10.1126/science.1059413; TAKEDA M, 1982, J OPT SOC AM, V72, P156, DOI 10.1364/JOSA.72.000156; POLLARD WT, 1992, ANNU REV PHYS CHEM, V43, P497, DOI 10.1146/annurev.physchem.43.1.497; Dorrer C, 2000, J OPT SOC AM B, V17, P1795, DOI 10.1364/JOSAB.17.001795; Wang H, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.143002; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Mashiko H, 2009, OPT LETT, V34, P3337, DOI 10.1364/OL.34.003337; Itatani J, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.173903; CODLING K, 1967, PHYS REV, V155, P26, DOI 10.1103/PhysRev.155.26; Gilbertson S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.263003; Bernhardt B, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.023408; Chu WC, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.033426; Ingle D. J., 1988, SPECTROCHEMICAL ANAL; Kramida A., 2014, NIST ATOMIC SPECTRA; Langer B, 1997, J PHYS B-AT MOL OPT, V30, P593, DOI 10.1088/0953-4075/30/3/015; Mairesse Y, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.011401; Mashiko H, 2010, OPT EXPRESS, V18, P25887, DOI 10.1364/OE.18.025887; Mashiko H, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4803936; MEIER T, 1995, PHYS REV B, V51, P13977, DOI 10.1103/PhysRevB.51.13977; Mukamel S., 1995, NONLINEAR OPTICAL SP; Ott C., 2013, SCIENCE, V340, P717; SIEBBELES LDA, 1994, J CHEM PHYS, V101, P1019, DOI 10.1063/1.467800; Takahashi EJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3691; WU JZ, 1990, PHYS REV A, V42, P1350, DOI 10.1103/PhysRevA.42.1350	36	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC	2014	5								5599	10.1038/ncomms6599		6	Multidisciplinary Sciences	Science & Technology - Other Topics	AX9LS	WOS:000347224900003		
J	Misawa, T; Imada, M				Misawa, Takahiro; Imada, Masatoshi			Superconductivity and its mechanism in an ab initio model for electron-doped LaFeAsO	NATURE COMMUNICATIONS			English	Article							METAL-INSULATOR-TRANSITION; IRON-BASED SUPERCONDUCTORS; LAYERED SUPERCONDUCTOR; PHASE-SEPARATION; PNICTIDES; ORDER	Two families of high-temperature superconductors whose critical temperatures are higher than 50 K are known. One are the copper oxides and the other are the iron-based superconductors. Comparisons of mechanisms between these two in terms of common ground as well as distinctions will greatly help in searching for higher T-c superconductors. However, studies on mechanisms for the iron family based on first principles calculations are few. Here we first show that superconductivity emerges in the state-of-the-art numerical calculations for an ab initio multi-orbital model of an electron-doped iron-based superconductor LaFeAsO, in accordance with experimental observations. Then the mechanism of the superconductivity is identified as enhanced uniform density fluctuations by one-to-one correspondence with the instability towards inhomogeneity driven by first-order antiferromagnetic and nematic transitions. Despite many differences, certain common features with the copper oxides are also discovered in terms of the underlying orbital-selective Mottness found in the iron family.	[Misawa, Takahiro; Imada, Masatoshi] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan	Misawa, T (reprint author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	misawa@solis.t.u-tokyo.ac.jp			MEXT HPCI Strategic Programs for Innovative Research (SPIRE); Computational Materials Science Initiative (CMSI); MEXT, Japan [22104010, 22340090, 23740261];  [hp120043];  [hp120283];  [hp130007]	We thank Daisuke Tahara and Satoshi Morita for providing efficient mVMC codes. We also thank Kazuma Nakamura and Takashi Miyake for providing parameters of ab initio models. This work is financially supported by MEXT HPCI Strategic Programs for Innovative Research (SPIRE) and Computational Materials Science Initiative (CMSI). Numerical calculation was partly carried out at the Supercomputer Center, Institute for Solid State Physics, University of Tokyo. Numerical calculation was also partly carried out at K computer at RIKEN Advanced Institute for Computational Science (AICS) under grant number hp120043, hp120283 and hp130007. This work was also supported by Grant-in-Aid for Scientific Research (No. 22104010, No. 22340090 and No. 23740261) from MEXT, Japan.	Yu R, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.146402; Hiraishi M, 2014, NAT PHYS, V10, P300, DOI [10.1038/nphys2906, 10.1038/NPHYS2906]; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Lang G, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.097001; Kasahara S, 2012, NATURE, V486, P382, DOI 10.1038/nature11178; de' Medici L, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.256401; HIRSCH JE, 1987, PHYS REV B, V35, P8726, DOI 10.1103/PhysRevB.35.8726; Ferrero M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205126; Platt C, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.235121; Nakai Y, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.073701; Texier Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.237002; Yin WG, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.107004; Koga A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.216402; Nomura Y, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.027002; Kontani H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.157001; EMERY VJ, 1990, PHYS REV LETT, V64, P475, DOI 10.1103/PhysRevLett.64.475; Park JT, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.117006; Ishida K, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.062001; de' Medici L, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.177001; Tamai A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.097002; Yang J, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.187003; Nakamura K, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.123708; Mazin II, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057003; GUTZWILLER MC, 1963, PHYS REV LETT, V10, P159, DOI 10.1103/PhysRevLett.10.159; Sorella S, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.024512; Kamihara Y, 2006, J AM CHEM SOC, V128, P10012, DOI 10.1021/ja063355c; Yin ZP, 2011, NAT MATER, V10, P932, DOI [10.1038/nmat3120, 10.1038/NMAT3120]; Hardy F, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.027002; Terashima T, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.053702; Pruschke T, 2005, EUR PHYS J B, V44, P217, DOI 10.1140/epjb/e2005-00117-4; Graser S, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/2/025016; Anisimov VI, 2002, EUR PHYS J B, V25, P191, DOI 10.1140/epjb/e20020021; Scalapino DJ, 2012, REV MOD PHYS, V84, P1383, DOI 10.1103/RevModPhys.84.1383; Inosov DS, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.224503; Costi TA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.236404; Lanata N, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.045122; Greger M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.046403; Stewart GR, 2011, REV MOD PHYS, V83, P1589, DOI 10.1103/RevModPhys.83.1589; Chu JH, 2010, SCIENCE, V329, P824, DOI 10.1126/science.1190482; Ishida H, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.054513; Yi M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.067003; JASTROW R, 1955, PHYS REV, V98, P1479, DOI 10.1103/PhysRev.98.1479; de'Medici L, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.205124; Li W, 2012, NAT PHYS, V8, P126, DOI 10.1038/NPHYS2155; Miyake T, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.044705; Jakobi E, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.115109; Aichhorn M, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.064504; Arita R, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.201102; Chubukov AV, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.134512; Degiorgi L, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/023011; Fernandes RM, 2014, NAT PHYS, V10, P97; Fujiwara N, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.097002; Hackl A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/5/055064; Qazilbash MM, 2009, NAT PHYS, V5, P647, DOI 10.1038/NPHYS1343; Iimura S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1913; Imada M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.075113; Kou SP, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/17010; Kuroki K., 2008, PHYS REV LETT, V101, P0870; Li W, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.134515; Misawa T., 2014, PHYS REV B, V90, P115; Misawa T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.177007; Mukuda H, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.064511; Platt C, 2013, ADV PHYS, V62, P453, DOI 10.1080/00018732.2013.862020; Qing-Yan W, 2012, CHINESE PHYS LETT, V29; Tahara D, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.114701; Wang Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4202; Wu J, 2013, NAT MATER, V12, P877, DOI [10.1038/nmat3719, 10.1038/NMAT3719]; Yu R, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.024509; Zhang YZ, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.035123; Zhou S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.140505	70	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC	2014	5								5738	10.1038/ncomms6738		11	Multidisciplinary Sciences	Science & Technology - Other Topics	AX8SY	WOS:000347179900001		
J	Namiki, S; Iwabuchi, S; Kono, PP; Kanzaki, R				Namiki, Shigehiro; Iwabuchi, Satoshi; Kono, Poonsup Pansopha; Kanzaki, Ryohei			Information flow through neural circuits for pheromone orientation	NATURE COMMUNICATIONS			English	Article							LOBE PROJECTION NEURONS; VENTRAL NERVE CORD; MOTH MANDUCA-SEXTA; BOMBYX-MORI; COROLLARY DISCHARGE; RETICULOSPINAL NEURONS; CENTRAL COMPLEX; SILKWORM MOTH; DESCENDING INTERNEURONS; SACCADIC SUPPRESSION	Moths use a sophisticated olfactory navigation strategy for resource localization. Here we investigate the neuronal circuits involved in sensory processing to generate locomotor commands for pheromone-source orientation in the moth. We identify a candidate pathway for pheromone processing in the protocerebrum using a mass-staining technique. Our intracellular recordings of pheromone responsiveness detect four major circuits, including a newly identified unstructured neuropil, the superior medial protocerebrum, which supplies output to the lateral accessory lobe (LAL), the premotor centre for walking commands. Interneurons innervating the lower division of the LAL elicited longer responses than those innervating the upper division. Descending interneurons innervating the lower division of the LAL showed a state-dependent flip-flop response. In contrast, input from other visual areas in the protocerebrum mostly converge onto the upper division of the LAL. These results reveal the basic organization of the LAL: the upper division is identified as a protocerebral hub that receives inputs from various areas, while the lower division generates long-lasting activity for locomotor command.	[Namiki, Shigehiro; Kanzaki, Ryohei] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Namiki, Shigehiro; Iwabuchi, Satoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tennodai, Ibaraki 3058573, Japan; [Kono, Poonsup Pansopha; Kanzaki, Ryohei] Univ Tokyo, Grad Sch Informat Sci & Technol, Hongo, Tokyo 1138656, Japan	Namiki, S (reprint author), Howard Hughes Med Inst, Janelia Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	namikis@janelia.hhmi.org; kanzaki@rcast.u-tokyo.ac.jp			Research and Development of the Next Generation Integrated Simulation of Living Matter, a part of the Development and Use of the Next-Generation Supercomputer Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) [18370028]; Neuroinformatics Japan Center	We are grateful to C. Iwastsuki for technical assistance, S. Matsuyama for the purification of bombykol, M. Kinoshita for technical advice on mass staining, Y. Seki for comments on the manuscript and members of the Kanzaki laboratory for their helpful discussions. We are grateful to the FlyCircuit database from the NCHC (National Center for High-performance Computing) and NTHU (National Tsing Hua University), FlyLight Image Database from the Howard Hughes Medical Institute Janelia Research Campus, BrainBase database from Barry Dickson group at the Research Institute of Molecular Pathology. This research was supported by Research and Development of the Next Generation Integrated Simulation of Living Matter, a part of the Development and Use of the Next-Generation Supercomputer Project, a Grant-in-Aid for Scientific Research (B) (18370028) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and a grant from Neuroinformatics Japan Center to R.K.	Kyriakatos A, 2011, J NEUROSCI, V31, P8422, DOI 10.1523/JNEUROSCI.1012-11.2011; Schneider DM, 2014, NATURE, V513, P189, DOI 10.1038/nature13724; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; Mishima T, 1999, J COMP PHYSIOL A, V184, P143, DOI 10.1007/s003590050314; Strausfeld NJ, 2013, SCIENCE, V340, P157, DOI 10.1126/science.1231828; KANZAKI R, 1992, ZOOL SCI, V9, P515; Ando N, 2013, BIOINSPIR BIOMIM, V8, DOI 10.1088/1748-3182/8/1/016008; VICKERS NJ, 1994, P NATL ACAD SCI USA, V91, P5756, DOI 10.1073/pnas.91.13.5756; HOMBERG U, 1994, J COMP PHYSIOL A, V175, P597; Pfeiffer K, 2014, ANNU REV ENTOMOL, V59, P165, DOI 10.1146/annurev-ento-011613-162031; Crapse TB, 2008, NAT REV NEUROSCI, V9, P587, DOI 10.1038/nrn2457; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Takasaki T, 2012, J COMP PHYSIOL A, V198, P295, DOI 10.1007/s00359-011-0708-8; Li WZ, 2009, CELL TISSUE RES, V336, P509, DOI 10.1007/s00441-009-0781-2; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Webb B, 2004, TRENDS NEUROSCI, V27, P278, DOI 10.1016/j.tins.2004.03.004; Namiki S, 2008, J COMP PHYSIOL A, V194, P501, DOI 10.1007/s00359-008-0325-3; Antri M, 2009, J NEUROSCI, V29, P1140, DOI 10.1523/JNEUROSCI.3073-08.2009; ROBERT D, 1992, J COMP PHYSIOL A, V171, P41, DOI 10.1007/BF00195959; Kohl J, 2013, CELL, V155, P1610, DOI 10.1016/j.cell.2013.11.025; Chiang AS, 2011, CURR BIOL, V21, P1, DOI 10.1016/j.cub.2010.11.056; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Poulet JFA, 2006, SCIENCE, V311, P518, DOI 10.1126/science.1120847; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; KENNEDY JS, 1983, PHYSIOL ENTOMOL, V8, P109, DOI 10.1111/j.1365-3032.1983.tb00340.x; Wada S, 2005, J COMP NEUROL, V484, P168, DOI 10.1002/cne.20452; Porter J, 2007, NAT NEUROSCI, V10, P27, DOI 10.1038/nn1819; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Kanzaki R, 2003, CHEM SENSES, V28, P113, DOI 10.1093/chemse/28.2.113; Tahvildari B, 2007, HIPPOCAMPUS, V17, P257, DOI 10.1002/hipo.20270; Heinze S, 2013, J COMP NEUROL, V521, P267, DOI 10.1002/cne.23214; Li WC, 2006, J NEUROSCI, V26, P4026, DOI 10.1523/JNEUROSCI.4727-05.2006; OLBERG RM, 1983, J COMP PHYSIOL, V152, P297; Deliagina TG, 2000, J NEUROPHYSIOL, V83, P853; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; Major G, 2004, CURR OPIN NEUROBIOL, V14, P675, DOI 10.1016/j.conb.2004.10.017; Lin CY, 2013, CELL REP, V3, P1739, DOI 10.1016/j.celrep.2013.04.022; Iwano M, 2010, J COMP NEUROL, V518, P366, DOI 10.1002/cne.22224; Brocard F, 2010, J NEUROSCI, V30, P523, DOI 10.1523/JNEUROSCI.3433-09.2010; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; Cardona A, 2009, J COMP NEUROL, V515, P427, DOI 10.1002/cne.22086; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; DiPrisco GV, 1997, SCIENCE, V278, P1122, DOI 10.1126/science.278.5340.1122; Fagerstedt P, 2001, J NEUROPHYSIOL, V86, P2257; Fisek M., 2013, NAT NEUROSCI, V17, P280; Fujita N, 2013, CURR BIOL, V23, P2063, DOI 10.1016/j.cub.2013.08.051; HEITLER WJ, 1983, J EXP BIOL, V104, P203; Kanzaki, 1994, J COMP PHYSIOL A, V175, P1; Kanzaki R, 2013, J COMP PHYSIOL A, V199, P1037, DOI 10.1007/s00359-013-0832-8; KANZAKI R, 1991, J COMP PHYSIOL A, V169, P1; KANZAKI R, 1991, J COMP PHYSIOL A, V168, P281; Khan AG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1712; KUENEN LPS, 1994, PHYSIOL ENTOMOL, V19, P15, DOI 10.1111/j.1365-3032.1994.tb01069.x; KUPFERMA.I, 1966, ANIM BEHAV, V14, P68, DOI 10.1016/S0003-3472(66)80012-X; Lee PH, 2007, P NATL ACAD SCI USA, V104, P6824, DOI 10.1073/pnas.0701934104; Lei Hong, 2009, Journal of Biology (London), V8, P21, DOI 10.1186/jbiol120; Lei H, 2001, J COMP NEUROL, V432, P356, DOI 10.1002/cne.1108; Løfaldli Bjarte Bye, 2012, Front Syst Neurosci, V6, P64, DOI 10.3389/fnsys.2012.00064; Namiki S, 2011, J COMP NEUROL, V519, P3367, DOI 10.1002/cne.22754; Namiki S, 2013, J COMP NEUROL, V521, P1073, DOI 10.1002/cne.23219; Okada R, 2003, J COMP NEUROL, V458, P158, DOI 10.1002/cne.10580; Phillips-Portillo J, 2012, J COMP NEUROL, V520, P3070, DOI 10.1002/cne.23094; Seki Y, 2005, J COMP NEUROL, V481, P340, DOI 10.1002/cne.20392; Staudacher E, 1998, CELL TISSUE RES, V294, P187, DOI 10.1007/s004410051169; STRAUSFELD NJ, 1984, J INSECT PHYSIOL, V30, P73, DOI 10.1016/0022-1910(84)90109-4; van Breugel F, 2014, CURR BIOL, V24, P274, DOI 10.1016/j.cub.2013.12.023; Yan J. S., 2013, J COMP NEUROL, V521, P2645; ZARETSKY M, 1979, NATURE, V280, P583, DOI 10.1038/280583a0; Zorovic M, 2013, J COMP PHYSIOL A, V199, P25, DOI 10.1007/s00359-012-0765-7	70	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC	2014	5								5919	10.1038/ncomms6919		11	Multidisciplinary Sciences	Science & Technology - Other Topics	AX8SW	WOS:000347179700001		
J	Obata, Y; Toyoshima, S; Wakamatsu, E; Suzuki, S; Ogawa, S; Esumi, H; Abe, R				Obata, Yuuki; Toyoshima, Shota; Wakamatsu, Ei; Suzuki, Shunichi; Ogawa, Shuhei; Esumi, Hiroyasu; Abe, Ryo			Oncogenic Kit signals on endolysosomes and endoplasmic reticulum are essential for neoplastic mast cell proliferation	NATURE COMMUNICATIONS			English	Article							GASTROINTESTINAL STROMAL TUMORS; RECEPTOR TYROSINE KINASE; PROTOONCOGENE C-KIT; PLASMA-MEMBRANE; PI 3-KINASE; ACTIVATION; MUTATIONS; SURVIVAL; TRAFFICKING; PROTEIN	Kit is a receptor-type tyrosine kinase found on the plasma membrane. It can transform mast cells through activating mutations. Here, we show that a mutant Kit from neoplastic mast cells from mice, Kit(D814Y), is permanently active and allows cells to proliferate autonomously. It does so by activating two signalling pathways from different intracellular compartments. Mutant Kit from the cell surface accumulates on endolysosomes through clathrin-mediated endocytosis, which requires Kit's kinase activity. Kit(D814Y) is constitutively associated with phosphatidylinositol 3-kinase, but the complex activates Akt only on the cytoplasmic surface of endolysosomes. It resists destruction because it is under-ubiquitinated. Kit(D814Y) also appears in the endoplasmic reticulum soon after biosynthesis, and there, can activate STAT5 aberrantly. These mechanisms of oncogenic signalling are also seen in rat and human mast cell leukemia cells. Thus, oncogenic Kit signalling occurs from different intracellular compartments, and the mutation acts by altering Kit trafficking as well as activation.	[Obata, Yuuki; Toyoshima, Shota; Wakamatsu, Ei; Suzuki, Shunichi; Ogawa, Shuhei; Abe, Ryo] Tokyo Univ Sci, Res Inst Biomed Sci, Div Immunobiol, Noda, Chiba 2780022, Japan; [Esumi, Hiroyasu] Tokyo Univ Sci, Res Inst Biomed Sci, Div Clin Res, Noda, Chiba 2780022, Japan; [Esumi, Hiroyasu] Natl Canc Ctr Hosp East, Kashiwa, Chiba 2778577, Japan	Abe, R (reprint author), Tokyo Univ Sci, Res Inst Biomed Sci, Div Immunobiol, Noda, Chiba 2780022, Japan.	rabe@rs.noda.tus.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; NOVARTIS FOUNDATION (Japan) for the Promotion of Science	We thank Dr Hirohisa Saito and Dr Kenji Matsumoto (National Center for Child Health and Development) for providing HMC-1 cells, Dr Ko Okumura (Juntendo University) for RBL-2H3 cells, Dr Ryo Goitsuka (Tokyo University of Science) for pt18 cells, Dr Hajime Karasuyama (Tokyo Medical and Dental University) for the pBCMGS vector, Dr Masayuki Oda (Kyoto Prefectural University) for the GST-SH2 expression vector, Dr Tamas Balla (National Institutes of Health) for the PH-GFP expression vector and Dr Toshinori Nakayama (Chiba University) for an anti-phosphotyrosine antibody. We are grateful to Dr Daijiro Sugiyama (Daiichi-Sankyo), Dr Takachika Azuma and Dr Yasushi Hara (Tokyo University of Science) for their helpful advice and sharing of materials throughout this study. This work was supported by a grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology to R.A., and a research grant from the NOVARTIS FOUNDATION (Japan) for the Promotion of Science.	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Aichberger KJ, 2009, BLOOD, V114, P5342, DOI 10.1182/blood-2008-08-175190; Williams AB, 2012, BLOOD, V120, P3069, DOI 10.1182/blood-2012-01-403493; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; Kim MS, 2008, TRENDS IMMUNOL, V29, P493, DOI 10.1016/j.it.2008.07.004; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Mali RS, 2011, CANCER CELL, V20, P357, DOI 10.1016/j.ccr.2011.07.016; Ronchetti D, 2001, ONCOGENE, V20, P3553, DOI 10.1038/sj.onc.1204465; Gordon PM, 2010, J BIOL CHEM, V285, P14109, DOI 10.1074/jbc.M109.078592; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Naal RMZG, 2003, TRAFFIC, V4, P190, DOI 10.1034/j.1600-0854.2003.00073.x; Xiang ZF, 2007, MOL CELL BIOL, V27, P267, DOI 10.1128/MCB.01153-06; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Stuffers S, 2009, TRAFFIC, V10, P925, DOI 10.1111/j.1600-0854.2009.00920.x; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; YARDEN Y, 1987, EMBO J, V6, P3341; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Jahn T, 2007, BLOOD, V110, P1739, DOI 10.1182/blood-2006-05-020925; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Sridhar S, 2013, EMBO J, V32, P324, DOI 10.1038/emboj.2012.341; Blume-Jensen P, 1998, CURR BIOL, V8, P779, DOI 10.1016/S0960-9822(98)70302-1; Joffre C, 2011, NAT CELL BIOL, V13, P827, DOI 10.1038/ncb2257; Toffalini F, 2010, BLOOD, V116, P2429, DOI 10.1182/blood-2010-04-279752; Baumgartner C, 2009, AM J PATHOL, V175, P2416, DOI 10.2353/ajpath.2009.080953; Sun Y, 2013, DEV CELL, V25, P144, DOI 10.1016/j.devcel.2013.03.010; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; BESMER P, 1986, NATURE, V320, P415, DOI 10.1038/320415a0; Growney JD, 2005, BLOOD, V106, P721, DOI 10.1182/blood-2004-12-4617; Jahn T, 2002, ONCOGENE, V21, P4508, DOI 10.1038/sj.onc.1205559; Lasota J, 2008, HISTOPATHOLOGY, V53, P245, DOI 10.1111/j.1365-2559.2008.02977.x; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V338, P1307, DOI 10.1016/j.bbrc.2005.09.150; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Ma PL, 2011, MOL CELL BIOL, V31, P4052, DOI 10.1128/MCB.05750-11; Chian RJ, 2001, BLOOD, V98, P1365, DOI 10.1182/blood.V98.5.1365; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Bauer S, 2007, ONCOGENE, V26, P7560, DOI 10.1038/sj.onc.1210558; Ning ZQ, 2001, BLOOD, V97, P3559, DOI 10.1182/blood.V97.11.3559; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Boissan M, 2000, J LEUKOCYTE BIOL, V67, P135; Tabone-Eglinger S, 2008, CLIN CANCER RES, V14, P2285, DOI 10.1158/1078-0432.CCR-07-4102; MITSUI H, 1993, P NATL ACAD SCI USA, V90, P735, DOI 10.1073/pnas.90.2.735; Kitamura Y, 2004, CELL MOL LIFE SCI, V61, P2924, DOI 10.1007/s00018-004-4273-y; Kon S, 2013, J CLIN INVEST, V123, P1123, DOI 10.1172/JCI63711; Rong YG, 2012, NAT CELL BIOL, V14, P924, DOI 10.1038/ncb2557; Bandi, 2009, BLOOD, V114, P4197; Bougherara H, 2009, MOL CANCER RES, V7, P1525, DOI 10.1158/1541-7786.MCR-09-0138; Broudy, 1999, BLOOD, V94, P1979; Chaix A., 2009, J BIOL CHEM, V286, P5956; Chung BM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-84; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Edris, 2013, P NATL ACAD SCI USA, V110, P3501; Er EE, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004015; GRIFFITHS G, 1983, J CELL BIOL, V96, P835, DOI 10.1083/jcb.96.3.835; Kazi JU, 2014, J CELL SCI, V127, P653, DOI 10.1242/jcs.140590; Menard L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4907; Scaltriti, 2009, ONCOGENE, V28, P803; Schmidt-Arras D, 2014, J CELL SCI, V127, P341, DOI 10.1242/jcs.130294; Wang Y, 2004, J BIOL CHEM, V279, P8038, DOI 10.1074/jbc.M311494200; YEE NS, 1994, J BIOL CHEM, V269, P31991; Zeng S, 2005, BLOOD, V105, P226, DOI 10.1182/blood-2004-05-1768; Zermati Y, 2003, ONCOGENE, V22, P660, DOI 10.1038/sj.onc.1206120	70	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC	2014	5								5715	10.1038/ncomms6715		17	Multidisciplinary Sciences	Science & Technology - Other Topics	AX9NM	WOS:000347229300011		
J	Putzke, C; Walmsley, P; Fletcher, JD; Malone, L; Vignolles, D; Proust, C; Badoux, S; See, P; Beere, HE; Ritchie, DA; Kasahara, S; Mizukami, Y; Shibauchi, T; Matsuda, Y; Carrington, A				Putzke, C.; Walmsley, P.; Fletcher, J. D.; Malone, L.; Vignolles, D.; Proust, C.; Badoux, S.; See, P.; Beere, H. E.; Ritchie, D. A.; Kasahara, S.; Mizukami, Y.; Shibauchi, T.; Matsuda, Y.; Carrington, A.			Anomalous critical fields in quantum critical superconductors	NATURE COMMUNICATIONS			English	Article							CUPRATE SUPERCONDUCTORS; CRITICAL-POINT; MAGNETIC-FIELD; TEMPERATURE; BENEATH; DOME; BAFE2(AS1-XPX)(2); ORDER	Fluctuations around an antiferromagnetic quantum critical point (QCP) are believed to lead to unconventional superconductivity and in some cases to high-temperature superconductivity. However, the exact mechanism by which this occurs remains poorly understood. The iron-pnictide superconductor BaFe2(As1-xPx)(2) is perhaps the clearest example to date of a high-temperature quantum critical superconductor, and so it is a particularly suitable system to study how the quantum critical fluctuations affect the superconducting state. Here we show that the proximity of the QCP yields unexpected anomalies in the superconducting critical fields. We find that both the lower and upper critical fields do not follow the behaviour, predicted by conventional theory, resulting from the observed mass enhancement near the QCP. Our results imply that the energy of superconducting vortices is enhanced, possibly due to a microscopic mixing of antiferromagnetism and superconductivity, suggesting that a highly unusual vortex state is realized in quantum critical superconductors.	[Putzke, C.; Walmsley, P.; Malone, L.; Carrington, A.] Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England; [Fletcher, J. D.; See, P.] Natl Phys Lab, Teddington TW11 0LW, Middx, England; [Vignolles, D.; Proust, C.; Badoux, S.] CNRS INSA UJF UPS, Lab Natl Champs Magnet Intenses, F-31400 Toulouse, France; [Beere, H. E.; Ritchie, D. A.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Kasahara, S.; Mizukami, Y.; Shibauchi, T.; Matsuda, Y.] Kyoto Univ, Dept Phys, Sakyo Ku, Kyoto 6068502, Japan; [Mizukami, Y.] Univ Tokyo, Dept Adv Mat Sci, Kashiwa, Chiba 2778561, Japan	Carrington, A (reprint author), Univ Bristol, HH Wills Phys Lab, Tyndall Ave, Bristol BS8 1TL, Avon, England.	a.carrington@bristol.ac.uk	Shibauchi, Takasada/B-9349-2008	Shibauchi, Takasada/0000-0001-5831-4924	Engineering and Physical Sciences Research Council [EP/H025855/1]; National Physical Laboratory Strategic Research Programme, EuroMagNET II under the EU [228043]; KAKENHI from JSPS	We thank Igor Mazin and Georg Knebel for useful discussions and A. M. Adamska for experimental help. This work was supported by the Engineering and Physical Sciences Research Council (Grant No. EP/H025855/1), National Physical Laboratory Strategic Research Programme, EuroMagNET II under the EU Contract No. 228043 and KAKENHI from JSPS.	Zhang Y, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.094501; Walmsley P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.257002; Shishido H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.057008; Demler E, 2004, REV MOD PHYS, V76, P909, DOI 10.1103/RevModPhys.76.909; Chaparro C, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.184525; Sachdev S, 2011, PHYS TODAY, V64, P29, DOI 10.1063/1.3554314; Eskildsen MR, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.187003; Lake B, 2002, NATURE, V415, P299, DOI 10.1038/415299a; Sebastian SE, 2010, P NATL ACAD SCI USA, V107, P6175, DOI 10.1073/pnas.0913711107; Hashimoto K, 2012, SCIENCE, V336, P1554, DOI 10.1126/science.1219821; Kasahara S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.184519; Gurevich A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.184504; Okazaki R, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.064520; Shibauchi T, 2014, ANNU REV CONDEN MA P, V5, P113, DOI 10.1146/annurev-conmatphys-031113-133921; Kakuyanagi K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.197003; HELFAND E, 1966, PHYS REV, V147, P288, DOI 10.1103/PhysRev.147.288; Taillefer L, 2010, ANNU REV CONDEN MA P, V1, P51, DOI 10.1146/annurev-conmatphys-070909-104117; LIANG RX, 1994, PHYS REV B, V50, P4212, DOI 10.1103/PhysRevB.50.4212; Analytis JG, 2014, NAT PHYS, V10, P194, DOI [10.1038/nphys2869, 10.1038/NPHYS2869]; Nakai Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.107003; Hirschfeld PJ, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/12/124508; BURLACHKOV L, 1992, PHYS REV B, V45, P8193, DOI 10.1103/PhysRevB.45.8193; Broun DM, 2008, NAT PHYS, V4, P170, DOI 10.1038/nphys909; Brandt EH, 1999, PHYS REV B, V60, P11939, DOI 10.1103/PhysRevB.60.11939; Grissonnanche G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4280; HARTMANN U, 1994, PHYSICA B, V194, P387, DOI 10.1016/0921-4526(94)90523-1; Hashimoto K, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.220501; Huecker M., 2014, COMPETING CHARGE SPI; Klintberg LE, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.123706; Knebel G, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.114704; Koshelev AE, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.177002; Liang RX, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.117001; Serafin A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.104514; Shulga SV, 2002, J LOW TEMP PHYS, V129, P93, DOI 10.1023/A:1020053603260; Tafti F. F., 2014, NERNST EFFECT ELECT; Taylor OJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.057001; Yeninas S, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.094503	37	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC	2014	5								5679	10.1038/ncomms6679		6	Multidisciplinary Sciences	Science & Technology - Other Topics	AX9ND	WOS:000347228400002		
J	Sapra, G; Tham, YK; Cemerlang, N; Matsumoto, A; Kiriazis, H; Bernardo, BC; Henstridge, DC; Ooi, JYY; Pretorius, L; Boey, EJH; Lim, L; Sadoshima, J; Meikle, PJ; Mellet, NA; Woodcock, EA; Marasco, S; Ueyama, T; Du, XJ; Febbraio, MA; McMullen, JR				Sapra, Geeta; Tham, Yow Keat; Cemerlang, Nelly; Matsumoto, Aya; Kiriazis, Helen; Bernardo, Bianca C.; Henstridge, Darren C.; Ooi, Jenny Y. Y.; Pretorius, Lynette; Boey, Esther J. H.; Lim, Lydia; Sadoshima, Junichi; Meikle, Peter J.; Mellet, Natalie A.; Woodcock, Elizabeth A.; Marasco, Silvana; Ueyama, Tomomi; Du, Xiao-Jun; Febbraio, Mark A.; McMullen, Julie R.			The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice	NATURE COMMUNICATIONS			English	Article							PHOSPHOINOSITIDE 3-KINASE P110-ALPHA; ELECTROCARDIOGRAPHIC PR INTERVAL; POPULATION-BASED COHORT; SHOCK-PROTEIN; DILATED CARDIOMYOPATHY; CARDIAC DYSFUNCTION; INSULIN SENSITIVITY; GANGLIOSIDE GM3; TRANSGENIC MICE; INDUCER BGP-15	Heart failure (HF) and atrial fibrillation (AF) share common risk factors, frequently coexist and are associated with high mortality. Treatment of HF with AF represents a major unmet need. Here we show that a small molecule, BGP-15, improves cardiac function and reduces arrhythmic episodes in two independent mouse models, which progressively develop HF and AF. In these models, BGP-15 treatment is associated with increased phosphorylation of the insulin-like growth factor 1 receptor (IGF1R), which is depressed in atrial tissue samples from patients with AF. Cardiac-specific IGF1R transgenic overexpression in mice with HF and AF recapitulates the protection observed with BGP-15. We further demonstrate that BGP-15 and IGF1R can provide protection independent of phosphoinositide 3-kinase-Akt and heat-shock protein 70; signalling mediators often defective in the aged and diseased heart. As BGP-15 is safe and well tolerated in humans, this study uncovers a potential therapeutic approach for HF and AF.	[Sapra, Geeta; Tham, Yow Keat; Cemerlang, Nelly; Matsumoto, Aya; Kiriazis, Helen; Bernardo, Bianca C.; Henstridge, Darren C.; Ooi, Jenny Y. Y.; Pretorius, Lynette; Boey, Esther J. H.; Lim, Lydia; Meikle, Peter J.; Mellet, Natalie A.; Woodcock, Elizabeth A.; Du, Xiao-Jun; Febbraio, Mark A.; McMullen, Julie R.] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Pretorius, Lynette; Febbraio, Mark A.; McMullen, Julie R.] Monash Univ, Melbourne, Vic 3800, Australia; [Sadoshima, Junichi] Rutgers State Univ, New Jersey Med Sch, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA; [Marasco, Silvana] Alfred Hosp, Ctr Heart, Melbourne, Vic 3004, Australia; [Ueyama, Tomomi] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Cardiovasc Med, Kyoto 6028566, Japan	Febbraio, MA (reprint author), Baker IDI Heart & Diabet Inst, POB 6492, Melbourne, Vic 3004, Australia.	mark.febbraio@bakeridi.edu.au; julie.mcmullen@bakeridi.edu.au	Meikle, Peter/B-4023-2009		National Health and Medical Research Council (NHMRC) [1008682, 1004441]; Diabetes Australia Research Trust; Paceline Inc.; Victorian Government's Operational Infrastructure Support Program; NHMRC Research Fellows [1043026-SRF, 1042095-SRF, 586621-PRF, 1021168-SPRF, 586604-SRF]; Australia Research Council Future Fellowship [FT0001657]; National Heart Foundation Fellowship [PF 10M5347]	We thank Professor Garry Jennings for helpful discussions and Thawin Pongsukwechkul (Baker IDI) for technical assistance. This study was funded by National Health and Medical Research Council (NHMRC) Project Grants (1008682 to JRM and 1004441 to MAF), Diabetes Australia Research Trust (J.R.M.), Paceline Inc., and supported in part by the Victorian Government's Operational Infrastructure Support Program. X.-J.D., P.J.M., E.A.W., M.A.F. and J.R.M. are NHMRC Research Fellows (IDs 1043026-SRF, 1042095-SRF, 586621-PRF, 1021168-SPRF, 586604-SRF). J.R.M. and D.C.H. were also supported by an Australia Research Council Future Fellowship (FT0001657) and National Heart Foundation Fellowship (PF 10M5347), respectively.	Whittington HJ, 2013, CARDIOVASC RES, V99, P694, DOI 10.1093/cvr/cvt140; Bruce CR, 2012, DIABETES, V61, P3148, DOI 10.2337/db12-0029; Gehrig SM, 2012, NATURE, V484, P394, DOI 10.1038/nature10980; Yang M, 2007, CELL STRESS CHAPERON, V12, P142, DOI 10.1379/CSC-253R.1; Crul T, 2013, CURR PHARM DESIGN, V19, P309; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; Savelieva I, 2004, EUROPACE, V5, pS5, DOI 10.1016/j.eupc.2004.07.003; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Mandal K, 2005, ANN THORAC SURG, V79, P865, DOI 10.1016/j.athorascur.2004.08.018; Demirel HA, 2003, AM J PHYSIOL-HEART C, V285, pH1609, DOI 10.1152/ajpheart.00982.2002; Yamamoto S, 2003, J CLIN INVEST, V111, P1463, DOI 10.1172/JCI200317459; Rienstra M, 2013, JACC-HEART FAIL, V1, P21, DOI 10.1016/j.jchf.2012.09.002; Weeks KL, 2012, CIRC-HEART FAIL, V5, P523, DOI 10.1161/CIRCHEARTFAILURE.112.966622; Magnani JW, 2013, CIRC-ARRHYTHMIA ELEC, V6, P84, DOI 10.1161/CIRCEP.112.975342; Braunwald E, 2013, JACC-HEART FAIL, V1, P1, DOI 10.1016/j.jchf.2012.10.002; Kotecha D, 2014, LANCET, V384, P2235, DOI 10.1016/S0140-6736(14)61373-8; DeGeorge BR, 2008, CIRCULATION, V117, P1378, DOI 10.1161/CIRCULATIONAHA.107.752618; McManus DD, 2012, CIRCULATION, V126, pE143, DOI 10.1161/CIRCULATIONAHA.112.129759; Troncoso R, 2014, TRENDS ENDOCRIN MET, V25, P128, DOI 10.1016/j.tem.2013.12.002; Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07; Radford NB, 1996, P NATL ACAD SCI USA, V93, P2339, DOI 10.1073/pnas.93.6.2339; Dalle S, 2001, J BIOL CHEM, V276, P15688, DOI 10.1074/jbc.M010884200; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Hunt CR, 2004, MOL CELL BIOL, V24, P899, DOI 10.1128/MCB.24.2.899-911.2004; Bristow MR, 2013, JACC-HEART FAIL, V1, P29, DOI 10.1016/j.jchf.2012.10.001; NITTA Y, 1994, AM J PHYSIOL-HEART C, V267, pH1795; McMullen JR, 2004, J BIOL CHEM, V279, P4782, DOI 10.1074/jbc.M310405200; Hutter JJ, 1996, CIRCULATION, V94, P1408; Brundel BJJM, 2006, J MOL CELL CARDIOL, V41, P555, DOI 10.1016/j.yjmcc.2006.06.068; Prokazova NV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P235, DOI 10.1134/S0006297909030018; St Rammos K, 2002, CARDIOVASC SURG, V10, P228; Hallak H, 2000, J BIOL CHEM, V275, P2255, DOI 10.1074/jbc.275.4.2255; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Afzal AR, 2008, CARDIOLOGY, V110, P45, DOI 10.1159/000109406; Weir JM, 2013, J LIPID RES, V54, P2898, DOI 10.1194/jlr.P035808; Pretorius L, 2009, AM J PATHOL, V175, P998, DOI 10.2353/ajpath.2009.090126; Rodriguez G, 2011, CIRC-CARDIOVASC GENE, V4, P349, DOI 10.1161/CIRCGENETICS.111.959866; Lip GYH, 2005, INT J CARDIOL, V105, P319, DOI 10.1016/j.ijcard.2005.03.003; Nielsen JB, 2013, HEART RHYTHM, V10, P1249, DOI 10.1016/j.hrthm.2013.04.012; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Literati-Nagy B, 2010, BRAIN RES BULL, V83, P340, DOI 10.1016/j.brainresbull.2010.09.005; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Cheng S, 2009, JAMA-J AM MED ASSOC, V301, P2571, DOI 10.1001/jama.2009.888; de Laurentiis Angela, 2007, Open Biochem J, V1, P12, DOI 10.2174/1874091X00701010012; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; Gombos I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028818; IWAMORI M, 1984, J BIOCHEM-TOKYO, V95, P761; Kato T, 2012, CIRCULATION, V125, P203, DOI 10.1161/CIRCULATIONAHA.111.075432; Kohler D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098325; KREGEL KC, 1995, J APPL PHYSIOL, V79, P1673; Larsen Philip J, 2014, Mol Metab, V3, P252, DOI 10.1016/j.molmet.2014.01.011; Laustsen PG, 2007, MOL CELL BIOL, V27, P1649, DOI 10.1128/MCB.01110-06; Literati-Nagy B, 2009, HORM METAB RES, V41, P374, DOI 10.1055/s-0028-1128142; Literati-Nagy Z, 2012, CELL STRESS CHAPERON, V17, P517, DOI 10.1007/s12192-012-0327-5; Lubitz Steven A, 2010, Heart Fail Clin, V6, P187, DOI 10.1016/j.hfc.2009.11.001; McMullen JR, 2008, CLIN EXP PHARMACOL P, V35, P349, DOI 10.1111/j.1440-1681.2007.04873.x; Millis RM, 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/712153; Panneerselvam M, 2012, ADV EXP MED BIOL, V729, P145, DOI 10.1007/978-1-4614-1222-9_10; Riley G, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00296; Sarszegi Z, 2012, MOL CELL BIOCHEM, V365, P129, DOI 10.1007/s11010-012-1252-8; Serneri GGN, 1999, CIRC RES, V85, P57; Szabados E., BIOCH PHARM, V59; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Zhang DL, 2011, J MOL CELL CARDIOL, V51, P381, DOI 10.1016/j.yjmcc.2011.06.008	66	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC	2014	5								5705	10.1038/ncomms6705		16	Multidisciplinary Sciences	Science & Technology - Other Topics	AX9NM	WOS:000347229300001		
J	Sasaki, H; Klein, P; Qiu, B; Sasai, Y				Sasaki, Hideharu; Klein, Patrice; Qiu, Bo; Sasai, Yoshikazu			Impact of oceanic-scale interactions on the seasonal modulation of ocean dynamics by the atmosphere	NATURE COMMUNICATIONS			English	Article							CALIFORNIA CURRENT SYSTEM; WAVE-NUMBER SPECTRA; SUBMESOSCALE TRANSITION; PART I; MESOSCALE; TURBULENCE; LAYER; PARAMETERIZATION; SIMULATIONS; INSTABILITY	Ocean eddies (with a size of 100-300 km), ubiquitous in satellite observations, are known to represent about 80% of the total ocean kinetic energy. Recent studies have pointed out the unexpected role of smaller oceanic structures (with 1-50 km scales) in generating and sustaining these eddies. The interpretation proposed so far invokes the internal instability resulting from the large-scale interaction between upper and interior oceanic layers. Here we show, using a new high-resolution simulation of the realistic North Pacific Ocean, that ocean eddies are instead sustained by a different process that involves small-scale mixed-layer instabilities set up by large-scale atmospheric forcing in winter. This leads to a seasonal evolution of the eddy kinetic energy in a very large part of this ocean, with an amplitude varying by a factor almost equal to 2. Perspectives in terms of the impacts on climate dynamics and future satellite observational systems are briefly discussed.	[Sasaki, Hideharu] JAMSTEC, Applicat Lab, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan; [Klein, Patrice] IFREMER, Lab Phys Oceans, CNRS, UBO,IRD, F-29280 Plouzane, France; [Qiu, Bo] Univ Hawaii Manoa, Dept Oceanog, Honolulu, HI 96822 USA; [Sasai, Yoshikazu] JAMSTEC, Res & Dev Ctr Global Change, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan	Sasaki, H (reprint author), JAMSTEC, Applicat Lab, Kanazawa Ku, 3173-25 Showa Machi, Yokohama, Kanagawa 2360001, Japan.	sasaki@jamstec.go.jp	Klein, Patrice/M-4279-2015		MEXT/JST KAKENHI [25400473, 22106006]; IFREMER (through the MOU IFREMER-JAMSTEC), CNRS (France); Agence Nationale pour la Recherche [ANR-09-BLAN-0365-02, ANR-10-LABX-19-01]; NASA's SWOT mission [NNX13AD91G]	The simulation was done on the Earth Simulator. This work is partially supported by MEXT/JST KAKENHI (H.S. and Y.S.: 25400473; H.S.: 22106006). P.K. acknowledges the support of IFREMER (through the MOU IFREMER-JAMSTEC), CNRS (France) and the Agence Nationale pour la Recherche (Contracts ANR-09-BLAN-0365-02 (REDHOT) and ANR-10-LABX-19-01 (LabexMER)). B.Q. acknowledges support from NASA's SWOT mission through Grant NNX13AD91G. We thank Pascal Riviere and Aurelien Ponte for their useful remarks on the manuscript, Daisuke Matsuoka for making the images. At last, we dedicate this study to our colleague and friend Bach-Lien Hua, whose intellectual curiosity and scientific ideas much inspired our thoughts during this work.	Noh Y, 1999, J GEOPHYS RES-OCEANS, V104, P15621, DOI 10.1029/1999JC900068; Fox-Kemper B, 2008, J PHYS OCEANOGR, V38, P1145, DOI 10.1175/2007JPO3792.1; Ferrari R, 2011, SCIENCE, V332, P316, DOI 10.1126/science.1203632; NAKAMURA N, 1988, J ATMOS SCI, V45, P3253, DOI 10.1175/1520-0469(1988)045<3253:SSOBIO>2.0.CO;2; Levy M, 2013, GLOBAL BIOGEOCHEM CY, V27, P1139, DOI 10.1002/2012GB004518; Le Traon PY, 2008, J PHYS OCEANOGR, V38, P1137, DOI 10.1175/2007JPO3806.1; Sasaki H, 2012, J PHYS OCEANOGR, V42, P1233, DOI 10.1175/JPO-D-11-0180.1; McWilliams JC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039402; Klein P, 2009, ANNU REV MAR SCI, V1, P351, DOI 10.1146/annurev.marine.010908.163704; Shcherbina AY, 2013, GEOPHYS RES LETT, V40, P4706, DOI 10.1002/grl.50919; HOSKINS BJ, 1974, Q J ROY METEOR SOC, V100, P480, DOI 10.1002/qj.49710042520; Scott RB, 2005, J PHYS OCEANOGR, V35, P1650, DOI 10.1175/JPO2771.1; Tulloch R, 2011, J PHYS OCEANOGR, V41, P1057, DOI 10.1175/2010JPO4404.1; CHARNEY JG, 1947, J METEOROL, V4, P135; Mensa JA, 2013, OCEAN DYNAM, V63, P923, DOI 10.1007/s10236-013-0633-1; Klein P, 2008, J PHYS OCEANOGR, V38, P1748, DOI 10.1175/2007JPO3773.1; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Lapeyre G, 2006, J PHYS OCEANOGR, V36, P165, DOI 10.1175/JPO2840.1; Zhong YS, 2013, J GEOPHYS RES-OCEANS, V118, P5651, DOI 10.1002/jgrc.20402; Xu YS, 2012, J PHYS OCEANOGR, V42, P2229, DOI 10.1175/JPO-D-12-0106.1; Ferrari R, 2009, ANNU REV FLUID MECH, V41, P253, DOI 10.1146/annurev.fluid.40.111406.102139; Levy M, 2010, OCEAN MODEL, V34, P1, DOI 10.1016/j.ocemod.2010.04.001; Capet X, 2008, J PHYS OCEANOGR, V38, P29, DOI 10.1175/2007JPO3671.1; Capet X, 2008, J PHYS OCEANOGR, V38, P2256, DOI 10.1175/2008JPO3810.1; Boccaletti G, 2007, J PHYS OCEANOGR, V37, P2228, DOI 10.1175/JPO3101.1; Levy M, 2001, J MAR RES, V59, P535, DOI 10.1357/002224001762842181; Levy M, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052756; STONE PH, 1966, J ATMOS SCI, V23, P390, DOI 10.1175/1520-0469(1966)023<0390:ONGBS>2.0.CO;2; QIU B, 1993, J PHYS OCEANOGR, V23, P2027, DOI 10.1175/1520-0485(1993)023<2027:UOHBIT>2.0.CO;2; Capet X., 2008, GEOPHYS RES LETT, V35, P2; Fu L.-L., 2008, EOS T AM GEOPHYS UN, V89, DOI [10.1029/2008EO480003, DOI 10.1029/2008EO480003]; Haza AC, 2012, OCEAN MODEL, V42, P31, DOI 10.1016/j.ocemod.2011.11.005; Komori N., 2005, J EARTH SIMULATOR, V4, P31; Lumpkin R., 2010, J GEOPHYS RES, V115, pC1207; Masumoto Y., 2004, J EARTH SIMULATOR, V1, P35; MCWILLIAMS JC, 1989, J FLUID MECH, V198, P199, DOI 10.1017/S0022112089000108; Phillips NA, 1954, TELLUS, V6, P273, DOI 10.1111/j.2153-3490.1954.tb01123.x/abstract; Qiu B, 2014, J PHYS OCEANOGR, V44, P3079, DOI 10.1175/JPO-D-14-0071.1; Uematsu A., 2013, GEOSC REM SENS S IGA, P2943; Xu YS, 2011, J PHYS OCEANOGR, V41, P802, DOI 10.1175/2010JPO4558.1	40	5	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC	2014	5								5636	10.1038/ncomms6636		8	Multidisciplinary Sciences	Science & Technology - Other Topics	AX9MN	WOS:000347226900006		
J	Sone, K; Piao, LH; Nakakido, M; Ueda, K; Jenuwein, T; Nakamura, Y; Hamamoto, R				Sone, Kenbun; Piao, Lianhua; Nakakido, Makoto; Ueda, Koji; Jenuwein, Thomas; Nakamura, Yusuke; Hamamoto, Ryuji			Critical role of lysine 134 methylation on histone H2AX for gamma-H2AX production and DNA repair	NATURE COMMUNICATIONS			English	Article							DOUBLE-STRAND BREAKS; CANCER-CELLS; HUMAN CARCINOGENESIS; THERAPEUTIC TARGET; METHYLTRANSFERASE EZH2; H3 METHYLTRANSFERASE; GENOMIC INSTABILITY; PROGNOSTIC MARKER; MAMMALIAN-CELLS; DAMAGE RESPONSE	The presence of phosphorylated histone H2AX (gamma-H2AX) is associated with the local activation of DNA-damage repair pathways. Although gamma-H2AX deregulation in cancer has previously been reported, the molecular mechanism involved and its relationship with other histone modifications remain largely unknown. Here we find that the histone methyltransferase SUV39H2 methylates histone H2AX on lysine 134. When H2AX was mutated to abolish K134 methylation, the level of gamma-H2AX became significantly reduced. We also found lower gamma-H2AX activity following the introduction of double-strand breaks in Suv39h2 knockout cells or on SUV39H2 knockdown. Tissue microarray analyses of clinical lung and bladder tissues also revealed a positive correlation between H2AX K134 methylation and gamma-H2AX levels. Furthermore, introduction of K134-substituted histone H2AX enhanced radio- and chemosensitivity of cancer cells. Overall, our results suggest that H2AX methylation plays a role in the regulation of gamma-H2AX abundance in cancer.	[Sone, Kenbun; Piao, Lianhua; Nakakido, Makoto; Nakamura, Yusuke; Hamamoto, Ryuji] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Ueda, Koji] Univ Tokyo, Grad Sch Frontier Sci, Minato Ku, Tokyo 1088639, Japan; [Jenuwein, Thomas] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Hamamoto, Ryuji] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab,Minato Ku, Tokyo 1088639, Japan	Hamamoto, R (reprint author), Univ Chicago, Dept Med, Hematol Oncol Sect, 5841 South Maryland Ave,MC2115, Chicago, IL 60637 USA.	rhamamoto@medicine.bsd.uchicago.edu			Oncotherapy Science	Competing financial interests: Y. Nakamura is a stock holder and a scientific advisor of Oncotherapy Science, and also has research grants from Oncotherapy Science. All other authors declare no competing financial interests.	Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Cho HS, 2012, NEOPLASIA, V14, P476, DOI 10.1593/neo.12656; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Kogure M, 2013, CANCER LETT, V336, P76, DOI 10.1016/j.canlet.2013.04.009; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Huntoon CJ, 2013, CANCER RES, V73, P3683, DOI 10.1158/0008-5472.CAN-13-0110; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Nagelkerke A, 2011, RADIOTHER ONCOL, V101, P39, DOI 10.1016/j.radonc.2011.07.009; Cho HS, 2011, NEOPLASIA, V13, P676, DOI 10.1593/neo.11512; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Hamamoto R, 2006, CANCER SCI, V97, P113, DOI 10.1111/j.1349-7006.2006.00146.x; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Dickey JS, 2009, CHROMOSOMA, V118, P683, DOI 10.1007/s00412-009-0234-4; Prevo R, 2012, CANCER BIOL THER, V13, P1072, DOI 10.4161/cbt.21093; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Kang D, 2013, GENE CHROMOSOME CANC, V52, P126, DOI 10.1002/gcc.22012; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; Unoki M, 2009, BRIT J CANCER, V101, P98, DOI 10.1038/sj.bjc.6605123; Toyokawa G, 2011, NEOPLASIA, V13, P887, DOI 10.1593/neo.11048; Takawa M, 2011, CANCER SCI, V102, P1298, DOI 10.1111/j.1349-7006.2011.01958.x; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Bartova E, 2008, J HISTOCHEM CYTOCHEM, V56, P711, DOI 10.1369/jhc.2008.951251; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Toyokawa G, 2011, CANCER PREV RES, V4, P2051, DOI 10.1158/1940-6207.CAPR-11-0290; O'Carroll D, 2000, MOL CELL BIOL, V20, P9423, DOI 10.1128/MCB.20.24.9423-9433.2000; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Veuger SJ, 2003, CANCER RES, V63, P6008; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Kao J, 2006, CURR CANCER DRUG TAR, V6, P197, DOI 10.2174/156800906776842957; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/nchembio.573, 10.1038/NCHEMBIO.573]; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Pan MR, 2011, J BIOL CHEM, V286, P28599, DOI 10.1074/jbc.M111.256297; Sedelnikova OA, 2006, CELL CYCLE, V5, P2909, DOI 10.4161/cc.5.24.3569; Chaudhuri L, 2014, HAEMATOLOGICA, V99, P688, DOI 10.3324/haematol.2013.093187; Ayrapetov MK, 2014, P NATL ACAD SCI USA, V111, P9169, DOI 10.1073/pnas.1403565111; Yoshimatsu M, 2011, INT J CANCER, V128, P562, DOI 10.1002/ijc.25366; Cho HS, 2012, INT J CANCER, V131, pE179, DOI 10.1002/ijc.26501; Vavrova J, 2013, RADIAT ENVIRON BIOPH, V52, P471, DOI 10.1007/s00411-013-0486-5; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Kogure M, 2013, NEOPLASIA, V15, P1251, DOI 10.1593/neo.131436; Takawa M, 2012, CANCER RES, V72, P3217, DOI 10.1158/0008-5472.CAN-11-3701; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Hayami S, 2011, INT J CANCER, V128, P574, DOI 10.1002/ijc.25349; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Brunner AH, 2011, GYNECOL ONCOL, V121, P206, DOI 10.1016/j.ygyno.2010.11.037; Cho H.S., 2011, CANCER RES, V71, P1; Cho HS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2074; Daury L, 2003, BIOTECHNIQUES, V35, P326; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Gertych A, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-11; Hayami S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-59; Kao J., 2010, J CANC MOL, V5, P49; Lowndes NF, 2005, CURR BIOL, V15, pR99, DOI 10.1016/j.cub.2005.01.029; Matthaios D, 2012, ONCOTARGETS THER, V5, P309, DOI 10.2147/OTT.S36995; Moore JD, 2004, BIOCHEM CELL BIOL, V82, P446, DOI 10.1139/O04-034; Pinto DMS, 2010, SUBCELL BIOCHEM, V50, P55, DOI 10.1007/978-90-481-3471-7_4; Toyokawa G, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-65	64	7	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC	2014	5								5691	10.1038/ncomms6691		12	Multidisciplinary Sciences	Science & Technology - Other Topics	AX9NF	WOS:000347228600005		
J	Takano, S; Tanimizu, M; Hirata, T; Sohrin, Y				Takano, Shotaro; Tanimizu, Masaharu; Hirata, Takafumi; Sohrin, Yoshiki			Isotopic constraints on biogeochemical cycling of copper in the ocean	NATURE COMMUNICATIONS			English	Article							NORTH PACIFIC-OCEAN; SOUTHERN-OCEAN; DISSOLVED COPPER; TROPICAL NORTH; SEDIMENT TRAP; CADMIUM; CU; FRACTIONATION; SEAWATER; ZN	Trace elements and their isotopes are being actively studied as powerful tracers in the modern ocean and as proxies for the palaeocean. Although distributions and fractionations have been reported for stable isotopes of dissolved Fe, Cu, Zn and Cd in the ocean, the data remain limited and only preliminary explanations have been given. Copper is of great interest because it is either essential or toxic to organisms and because its distribution reflects both biological recycling and scavenging. Here we present new isotopic composition data for dissolved Cu (delta Cu-65) in seawater and rainwater. The Cu isotopic composition in surface seawater can be explained by the mixing of rain, river and deep seawater. In deep seawater, delta Cu-65 becomes heavier with oceanic circulation because of preferential scavenging of the lighter isotope (Cu-63). In addition, we constrain the marine biogeochemical cycling of Cu using a new box model based on Cu concentrations and delta Cu-65.	[Takano, Shotaro; Sohrin, Yoshiki] Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan; [Tanimizu, Masaharu] Japan Agcy Marine Earth Sci & Technol, Kochi Inst Core Sample Res, Nankoku, Kochi 7838502, Japan; [Hirata, Takafumi] Kyoto Univ, Div Earth & Planetary Sci, Lab Planetary Sci, Kyoto 6068502, Japan	Takano, S (reprint author), Kyoto Univ, Inst Chem Res, Kyoto 6110011, Japan.	shotaro@inter3.kuicr.kyoto-u.ac.jp			Steel Industry Foundation; Japanese Society for the Promotion of Science	We thank Susan Little, Corey Archer and Derek Vance (ETH, Zurich) for performing intercalibration with us and providing the South Atlantic sample. We also thank the officers and crew of the R/V Hakuho-Maru for their assistance in obtaining samples and Shoji Imai (the University of Tokushima) for sampling rainwater at the top of Mt. Kajigamori. We are grateful to Takanori Nakano and Kichoel Shin (Research Institute for Humanity and Nature) for their help with the MC-ICP-MS measurements. This work was supported by funds from the Steel Industry Foundation for the Advancement of Environmental Protection Technology and by grants-in-aid from the Japanese Society for the Promotion of Science.	Albarede F., 2004, GEOCHEMISTRY NONTRAD; Li WQ, 2009, CHEM GEOL, V258, P38, DOI 10.1016/j.chemgeo.2008.06.047; Little SH, 2014, GEOCHIM COSMOCHIM AC, V125, P673, DOI 10.1016/j.gca.2013.07.046; Bermin J, 2006, CHEM GEOL, V226, P280, DOI 10.1016/j.chemgeo.2005.09.025; ARIMOTO R, 1990, J GEOPHYS RES-ATMOS, V95, P22389, DOI 10.1029/JD095iD13p22389; Abouchami W, 2014, GEOCHIM COSMOCHIM AC, V127, P348, DOI 10.1016/j.gca.2013.10.022; Balistrieri LS, 2008, GEOCHIM COSMOCHIM AC, V72, P311, DOI 10.1016/j.gca.2007.11.013; BOYLE EA, 1981, J GEOPHYS RES-OC ATM, V86, P8048, DOI 10.1029/JC086iC09p08048; FISCHER K, 1986, GEOCHIM COSMOCHIM AC, V50, P1535, DOI 10.1016/0016-7037(86)90327-3; Abouchami W, 2011, EARTH PLANET SC LETT, V305, P83, DOI 10.1016/j.epsl.2011.02.044; Little SH, 2014, EARTH PLANET SC LETT, V396, P213, DOI 10.1016/j.epsl.2014.04.021; Zhao Y, 2014, GEOCHIM COSMOCHIM AC, V125, P653, DOI 10.1016/j.gca.2013.07.045; BRULAND KW, 1980, EARTH PLANET SC LETT, V47, P176, DOI 10.1016/0012-821X(80)90035-7; Xue ZC, 2013, EARTH PLANET SC LETT, V382, P161, DOI 10.1016/j.epsl.2013.09.014; BOYLE EA, 1977, EARTH PLANET SC LETT, V37, P38, DOI 10.1016/0012-821X(77)90144-3; Takano S, 2013, ANAL CHIM ACTA, V784, P33, DOI 10.1016/j.aca.2013.04.032; Thompson CM, 2013, ANAL CHIM ACTA, V775, P106, DOI 10.1016/j.aca.2013.03.020; HELMERS E, 1995, ATMOS ENVIRON, V29, P2475, DOI 10.1016/1352-2310(95)00159-V; Petit JCJ, 2013, CHEM GEOL, V359, P125, DOI 10.1016/j.chemgeo.2013.09.019; Pokrovsky OS, 2008, GEOCHIM COSMOCHIM AC, V72, P1742, DOI 10.1016/j.gca.2008.01.018; Bigalke M, 2010, ENVIRON SCI TECHNOL, V44, P5496, DOI 10.1021/es1017653; Desboeufs KV, 2005, CHEMOSPHERE, V58, P195, DOI 10.1016/j.chemosphere.2004.02.025; Vance D, 2008, EARTH PLANET SC LETT, V274, P204, DOI 10.1016/j.epsl.2008.07.026; BRAND LE, 1986, J EXP MAR BIOL ECOL, V96, P225, DOI 10.1016/0022-0981(86)90205-4; Ripperger S, 2007, EARTH PLANET SC LETT, V261, P670, DOI 10.1016/j.epsl.2007.07.034; Boyle EA, 2012, LIMNOL OCEANOGR-METH, V10, P653, DOI 10.4319/lom.2012.10.653; Bruland K. W., 2003, TREATISE GEOCHEMISTR; Chester R, 2012, MARINE GEOCHEMISTRY; CHESTER R, 1988, MAR CHEM, V24, P261, DOI 10.1016/0304-4203(88)90036-9; COALE KH, 1988, LIMNOL OCEANOGR, V33, P1084; DUCE R A, 1991, Global Biogeochemical Cycles, V5, P193, DOI 10.1029/91GB01778; Gaillardet J., 2003, TREATISE GEOCHEMISTR; Lupton J, 1998, J GEOPHYS RES-OCEANS, V103, P15853, DOI 10.1029/98JC00146; MARING HB, 1989, J GEOPHYS RES-OCEANS, V94, P1039, DOI 10.1029/JC094iC01p01039; Noriki S, 1997, GEOCHEM J, V31, P373; Sarmiento J. L, 2006, OCEAN BIOGEOCHEMICAL; Schlitzer R., 2002, OCEAN DATA VIEW; Vu HTD, 2013, SCI REP-UK, V3, DOI 10.1038/srep01745	38	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC	2014	5								5663	10.1038/ncomms6663		7	Multidisciplinary Sciences	Science & Technology - Other Topics	AX9NA	WOS:000347228100006		
J	Tanaka, G; Parker, AR; Hasegawa, Y; Siveter, DJ; Yamamoto, R; Miyashita, K; Takahashi, Y; Ito, S; Wakamatsu, K; Mukuda, T; Matsuura, M; Tomikawa, K; Furutani, M; Suzuki, K; Maeda, H				Tanaka, Gengo; Parker, Andrew R.; Hasegawa, Yoshikazu; Siveter, David J.; Yamamoto, Ryoichi; Miyashita, Kiyoshi; Takahashi, Yuichi; Ito, Shosuke; Wakamatsu, Kazumasa; Mukuda, Takao; Matsuura, Marie; Tomikawa, Ko; Furutani, Masumi; Suzuki, Kayo; Maeda, Haruyoshi			Mineralized rods and cones suggest colour vision in a 300 Myr-old fossil fish	NATURE COMMUNICATIONS			English	Article							RETINAL-PIGMENT EPITHELIUM; VERTEBRATES; EUMELANIN; EVOLUTION; BACKBONE; ANATOMY; PLUMAGE	Vision, which consists of an optical system, receptors and image-processing capacity, has existed for at least 520 Myr. Except for the optical system, as in the calcified lenses of trilobite and ostracod arthropods, other parts of the visual system are not usually preserved in the fossil record, because the soft tissue of the eye and the brain decay rapidly after death, such as within 64 days and 11 days, respectively. The Upper Carboniferous Hamilton Formation (300 Myr) in Kansas, USA, yields exceptionally well-preserved animal fossils in an estuarine depositional setting. Here we show that the original colour, shape and putative presence of eumelanin have been preserved in the acanthodii fish Acanthodes bridgei. We also report on the tissues of its eye, which provides the first record of mineralized rods and cones in a fossil and indicates that this 300 Myr-old fish likely possessed colour vision.	[Tanaka, Gengo] Kumamoto Univ, Ctr Marine Environm Studies, Kumamoto 8616102, Japan; [Parker, Andrew R.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Hasegawa, Yoshikazu] Gunma Museum Nat Hist, Tomioka, Gunma 3702345, Japan; [Siveter, David J.] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England; [Yamamoto, Ryoichi; Miyashita, Kiyoshi; Takahashi, Yuichi] Gunma Ind Technol Ctr, Maebashi, Gunma 3792147, Japan; [Ito, Shosuke; Wakamatsu, Kazumasa] Fujita Hlth Univ, Sch Hlth Sci, Dept Chem, Toyoake, Aichi 4701192, Japan; [Mukuda, Takao; Matsuura, Marie] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Higashihiroshima, Hiroshima 7398521, Japan; [Mukuda, Takao] Tottori Univ, Fac Med, Yonago, Tottori 6838503, Japan; [Tomikawa, Ko] Hiroshima Univ, Grad Sch Educ, Higashihiroshima, Hiroshima 7398524, Japan; [Furutani, Masumi] Okayama Univ, Sch Med, Cent Res Lab, Kita Ku, Okayama 7008558, Japan; [Suzuki, Kayo] Shinshu Univ, Res Ctr Human & Environm Sci, Matsumoto, Nagano 3908621, Japan; [Maeda, Haruyoshi] Kyushu Univ Museum, Higashi Ku, Fukuoka 8128581, Japan	Tanaka, G (reprint author), Kumamoto Univ, Ctr Marine Environm Studies, 6061 Matsushima Cho, Kumamoto 8616102, Japan.	gengo@gpo.kumamoto-u.ac.jp		Wakamatsu, Kazumasa/0000-0003-1748-9001	Science Research of Education and Science Government of Japan [24540501, 24340129]	This work was supported by the Science Research of Education and Science Government of Japan (grant no. 24540501 to G.T. and no. 24340129 to H.M.).	ALDRIDGE RJ, 1993, PHILOS T ROY SOC B, V340, P405, DOI 10.1098/rstb.1993.0082; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Davis SP, 2012, NATURE, V486, P247, DOI 10.1038/nature11080; Vinther J, 2008, BIOL LETTERS, V4, P522, DOI 10.1098/rsbl.2008.0302; Shu DG, 1999, NATURE, V402, P42, DOI 10.1038/46965; Ito S, 2013, PIGM CELL MELANOMA R, V26, P357, DOI 10.1111/pcmr.12078; Ito S, 2011, PIGM CELL MELANOMA R, V24, P605, DOI 10.1111/j.1755-148X.2011.00864.x; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740; Shu DG, 2003, NATURE, V421, P526, DOI 10.1038/nature01264; Collin SP, 2003, CURR BIOL, V13, pR864, DOI 10.1016/j.cub.2003.10.044; Li QG, 2012, SCIENCE, V335, P1215, DOI 10.1126/science.1213780; Sansom RS, 2010, NATURE, V463, P797, DOI 10.1038/nature08745; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Ito S, 2013, ANAL BIOCHEM, V434, P221, DOI 10.1016/j.ab.2012.12.005; NICOL JAC, 1973, CAN J ZOOL, V51, P69, DOI 10.1139/z73-012; Glass K, 2012, P NATL ACAD SCI USA, V109, P10218, DOI 10.1073/pnas.1118448109; Barden HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025494; Braekevelt CR, 1996, HISTOL HISTOPATHOL, V11, P437; Collette B. B., 2009, DIVERSITY FISHES; CUNNINGHAM CR, 1993, LETHAIA, V26, P225, DOI 10.1111/j.1502-3931.1993.tb01524.x; DEARRY A, 1990, J NEUROCHEM, V54, P1367, DOI 10.1111/j.1471-4159.1990.tb01971.x; Duncan IJ, 1996, NATURE, V381, P30, DOI 10.1038/381030b0; Frohlich F., 1992, Annales de Paleontologie, V78, P193; Hou X., 2004, CAMBRIAN FOSSILS CHE; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Parker AR, 2011, OPT LASER TECHNOL, V43, P323, DOI 10.1016/j.optlastec.2008.12.020; Pezzella A, 1997, TETRAHEDRON, V53, P8281, DOI 10.1016/S0040-4020(97)00494-8; Pilgrim BL, 2009, J ANAT, V214, P848, DOI 10.1111/j.1469-7580.2009.01077.x; Schoenemann B, 2013, SCI REP-UK, V3, DOI 10.1038/srep01429; Schoenemann B, 2012, P ROY SOC B-BIOL SCI, V279, P1335, DOI 10.1098/rspb.2011.1888; Tanaka G, 2009, P ROY SOC B-BIOL SCI, V276, P1015, DOI 10.1098/rspb.2008.1467; Ubukata Takao, 2004, Venus (Tokyo), V62, P149; Vinther J., 2009, BIOL LETTERS, V6, P128, DOI DOI 10.1098/RSBL.2009.0524; Voplensky P., 2009, PHILOS T R SOC B, V364, P2819; Hou XG, 2002, P ROY SOC B-BIOL SCI, V269, P1865, DOI 10.1098/rspb.2002.2104; Yokoyama S, 1996, ANNU REV ECOL SYST, V27, P543, DOI 10.1146/annurev.ecolsys.27.1.543; Zidek J., 1976, U KANSAS PALEONTOLOG, V83, P1	39	6	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC	2014	5								5920	10.1038/ncomms6920		6	Multidisciplinary Sciences	Science & Technology - Other Topics	AX8SW	WOS:000347179700002		
J	Tsutsumi, N; Kimura, T; Arita, K; Ariyoshi, M; Ohnishi, H; Yamamoto, T; Zuo, XB; Maenaka, K; Park, EY; Kondo, N; Shirakawa, M; Tochio, H; Kato, Z				Tsutsumi, Naotaka; Kimura, Takeshi; Arita, Kyohei; Ariyoshi, Mariko; Ohnishi, Hidenori; Yamamoto, Takahiro; Zuo, Xiaobing; Maenaka, Katsumi; Park, Enoch Y.; Kondo, Naomi; Shirakawa, Masahiro; Tochio, Hidehito; Kato, Zenichiro			The structural basis for receptor recognition of human interleukin-18	NATURE COMMUNICATIONS			English	Article							IFN-GAMMA PRODUCTION; SMALL-ANGLE SCATTERING; HUMAN IL-18; ATOPIC-DERMATITIS; MICE DEFICIENT; PROTEIN; SYSTEM; CYTOKINE; MUTATION; AUTOINFLAMMATION	Interleukin (IL)-18 is a proinflammatory cytokine that belongs to the IL-1 family and plays an important role in inflammation. The uncontrolled release of this cytokine is associated with severe chronic inflammatory disease. IL-18 forms a signalling complex with the IL-18 receptor alpha (R alpha) and beta (R beta) chains at the plasma membrane, which induces multiple inflammatory cytokines. Here, we present a crystal structure of human IL-18 bound to the two receptor extracellular domains. Generally, the receptors' recognition mode for IL-18 is similar to IL-1 beta; however, certain notable differences were observed. The architecture of the IL-18 receptor second domain (D2) is unique among the other IL-1R family members, which presumably distinguishes them from the IL-1 receptors that exhibit a more promiscuous ligand recognition mode. The structures and associated biochemical and cellular data should aid in developing novel drugs to neutralize IL-18 activity.	[Tsutsumi, Naotaka; Ariyoshi, Mariko; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Nishikyo Ku, Kyoto 6158510, Japan; [Kimura, Takeshi; Ohnishi, Hidenori; Yamamoto, Takahiro; Kondo, Naomi; Kato, Zenichiro] Gifu Univ, Grad Sch Med, Dept Pediat, Gifu 5011194, Japan; [Arita, Kyohei] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Ariyoshi, Mariko] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068501, Japan; [Zuo, Xiaobing] Argonne Natl Lab, Xray Sci Div, Argonne, IL 60439 USA; [Maenaka, Katsumi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biomol Sci, Sapporo, Hokkaido 0600812, Japan; [Maenaka, Katsumi] Hokkaido Univ, Fac Pharmaceut Sci, Ctr Res & Educ Drug Discovery, Sapporo, Hokkaido 0600812, Japan; [Park, Enoch Y.] Shizuoka Univ, Grad Sch Sci & Technol, Res Inst Green Sci & Technol, Dept Biosci,Suruga Ku, Shizuoka 4228529, Japan; [Kondo, Naomi] Heisei Coll Hlth Sci, Gifu 5011131, Japan; [Shirakawa, Masahiro] Japan Sci & Technol Agcy, Core Res Evolut Sci CREST, Tokyo 1020076, Japan; [Tochio, Hidehito] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; [Kato, Zenichiro] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Med Informat Sci Div, Gifu 5011194, Japan	Ohnishi, H (reprint author), Gifu Univ, Grad Sch Med, Dept Pediat, Yanagido 1-1, Gifu 5011194, Japan.	ohnishih@gifu-u.ac.jp; tochio@mb.biophys.kyoto-u.ac.jp		Park, Enoch Y./0000-0002-7840-1424; Tsutsumi, Naotaka/0000-0002-3617-7145	SPring-8 (Harima, Japan); Photon Factory (Tsukuba, Japan); Argonne National Laboratory (Illinois, USA) [DE-AC02-06CH11357]; Platform for Drug Discovery, Informatics, and Structural Life Science (Japan); NIGMS [P41-GM103311]; JSPS KAKENHI [22370038]; Ministry of Health, Labour and Welfare; MEXT KAKENHI [21790979]	X-ray data collection was supported by SPring-8 (Harima, Japan), Photon Factory (Tsukuba, Japan), Argonne National Laboratory (Illinois, USA, supported by DE-AC02-06CH11357) and Platform for Drug Discovery, Informatics, and Structural Life Science (Japan). We thank T. Tsunaka (Kyoto University) for the use of his beam time of BL44XU at SPring-8. We also thank T. Fukao, N. Kawamoto, K. Tsuji, M. Yamamoto, S. Ninomiya, T. Yano and K. Kasahara (Gifu University) for their scientific advice or technical help. Affymetrix, Inc. provided discontinued detergents to us. SAXS graphics were prepared using the UCSF Chimera package, which developed by the group at the University of California. (San Francisco, USA, supported by NIGMS P41-GM103311). This work was supported by JSPS KAKENHI Grant Number 22370038 to H.T., Grant-in-Aid for JSPS Fellows to N.T., Health and Labour Science Research Grants for Research on Intractable Diseases from the Ministry of Health, Labour and Welfare to H.O., Health and Labour Science Research Grants for Research from the Ministry of Health, Labour and Welfare to Z.K., Science Research Grant from Eishukai to Z.K, and MEXT KAKENHI Grant Number 21790979 to T.K.	Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Thomas C, 2012, NAT STRUCT MOL BIOL, V19, P455, DOI 10.1038/nsmb.2260; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Hirota T, 2012, NAT GENET, V44, P1222, DOI 10.1038/ng.2438; Liu X, 2013, P NATL ACAD SCI USA, V110, P14918, DOI 10.1073/pnas.1308651110; Park H, 2012, NAT REV IMMUNOL, V12, P570, DOI 10.1038/nri3261; Gunther S, 2014, J IMMUNOL, V193, P921, DOI 10.4049/jimmunol.1400538; Kim SHM, 2001, P NATL ACAD SCI USA, V98, P3304, DOI 10.1073/pnas.051634098; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Brydges SD, 2013, J CLIN INVEST, V123, P4695, DOI 10.1172/JCI71543; Lee W, 2009, BIOINFORMATICS, V25, P2085, DOI 10.1093/bioinformatics/btp345; Krumm B, 2008, P NATL ACAD SCI USA, V105, P20711, DOI 10.1073/pnas.0809086106; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Motohashi T, 2005, BIOCHEM BIOPH RES CO, V326, P564, DOI 10.1016/j.bbrc.2004.11.060; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Alboni S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-9; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Terada M, 2006, P NATL ACAD SCI USA, V103, P8816, DOI 10.1073/pnas.0602900103; Vigers GPA, 1997, NATURE, V386, P190, DOI 10.1038/386190a0; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Park EY, 2009, J BIOTECHNOL, V139, P108, DOI 10.1016/j.jbiotec.2008.09.013; Kumar S, 2002, CYTOKINE, V18, P61, DOI 10.1006/cyto.2002.0873; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; LI P, 1995, CELL, V80, P401, DOI 10.1016/0092-8674(95)90490-5; Mellins ED, 2011, NAT REV RHEUMATOL, V7, P416, DOI 10.1038/nrrheum.2011.68; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Wang DL, 2010, NAT IMMUNOL, V11, P905, DOI 10.1038/ni.1925; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Argiriadi MA, 2009, J BIOL CHEM, V284, P24478, DOI 10.1074/jbc.M109.023887; Bricogne G., 2011, BUSTER 2 10 0; Canna SW, 2014, NAT GENET, V46, P1140, DOI 10.1038/ng.3089; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Hamasaki T, 2005, J BIOCHEM, V138, P433, DOI 10.1093/jb/mvi148; Kajikawa M., 2012, J BIOTECHNOL BIOMA S, V9, P1; Kato Z, 2003, NAT STRUCT BIOL, V10, P966, DOI 10.1038/nsb993; Kimura T, 2014, ACTA CRYSTALLOGR F, V70, P1351, DOI 10.1107/S2053230X14016926; Krumm B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002876; Ohnishi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038423; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Romberg N, 2014, NAT GENET, V46, P1135, DOI 10.1038/ng.3066; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P2082, DOI 10.1107/S0907444902016360	55	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC	2014	5								5340	10.1038/ncomms6340		13	Multidisciplinary Sciences	Science & Technology - Other Topics	AX9JX	WOS:000347220300001		
J	Watanabe, H; Kuhn, A; Fushiki, M; Agata, K; Ozbek, S; Fujisawa, T; Holstein, TW				Watanabe, Hiroshi; Kuhn, Anne; Fushiki, Manami; Agata, Kiyokazu; Oezbek, Suat; Fujisawa, Toshitaka; Holstein, Thomas W.			Sequential actions of beta-catenin and Bmp pattern the oral nerve net in Nematostella vectensis	NATURE COMMUNICATIONS			English	Article							NEURAL INDUCTION; SEA-ANEMONE; SIGNALING PATHWAY; SYSTEM CENTRALIZATION; BILATERAL SYMMETRY; SOX GENES; EVOLUTION; WNT; EXPRESSION; METAZOAN	Animal evolution is closely linked to the emergence of the nervous system. At present it is unknown how the basic mechanisms of neural induction and formation of central nervous systems evolved. We addressed this question in Nematostella vectensis, a member of cnidarians, the ancient sister group of bilaterians. We found that beta-catenin signalling is crucial for the early induction of the embryonic nervous system. beta-Catenin activity at the blastopore induces specific neurogenic genes required for development of the oral nervous system. beta-Catenin signalling induces also Bmp signalling, which, at later larval stages, becomes indispensible for the maintenance and asymmetric patterning of the oral nervous system along the primary and secondary (directive) axes. We hypothesize that the consecutive and functionally linked involvement of beta-catenin and Bmp signalling in the formation of the cnidarian oral nervous system reflects an ancestral mechanism that evolved before the cnidarian/bilaterian split.	[Watanabe, Hiroshi; Kuhn, Anne; Fushiki, Manami; Oezbek, Suat; Fujisawa, Toshitaka; Holstein, Thomas W.] Heidelberg Univ, Dept Mol Evolut & Genom, Ctr Organismal Studies, D-69120 Heidelberg, Germany; [Fushiki, Manami; Agata, Kiyokazu] Kyoto Univ, Dept Biophys, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; [Fujisawa, Toshitaka] Grad Univ Adv Studies, Ctr Promot Integrated Sci, Okazaki, Aichi 4448585, Japan	Holstein, TW (reprint author), Heidelberg Univ, Dept Mol Evolut & Genom, Ctr Organismal Studies, Im Neuenheimer Feld 329, D-69120 Heidelberg, Germany.	Hiroshi.Watanabe@cos.uni-heidelberg.de; thomas.holstein@cos.uni-heidelberg.de	Ozbek, Suat/D-3701-2014		TOYOBO Biotechnology Foundation; Alexander von Humboldt Foundation; Heidelberg Excellence Cluster CellNetworks; German Science Foundation (DFG) [FOR1036/TP2, SFB 488/A12, HO-1088/6, FOR 1036/TP1]	We thank Fabian Rentzsch and Ulrich Technau for the NvElav1::mOrange transgenic animals, Pierre McCrea for the pCS2-MT-beta-Eng plasmid, Arne Kusserow for the pCS2-NvBmp2/4 plasmid, Stefan Wolfl for hBmp2 protein, Osamu Koizumi for the anti-GLWamide antibody; Bianca Bertulat, Barbara Kostron, Chiemi Nishimiya-Fujisawa, Mihaela Zigman, Martin Ritthaler and Ildiko Somorjai for discussions and comments on the manuscript; Hiroe Yuzawa-Watanabe for technical assistance. H.W. was supported by an initial fellowship from the TOYOBO Biotechnology Foundation and the Alexander von Humboldt Foundation. This study was also supported by the Heidelberg Excellence Cluster CellNetworks and funded by grants from the German Science Foundation (DFG) to S.O. (FOR1036/TP2) and to T.W.H. (SFB 488/A12; HO-1088/6; and FOR 1036/TP1).	Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Jager M, 2011, J EXP ZOOL PART B, V316B, P171, DOI 10.1002/jez.b.21386; Magie CR, 2005, DEV GENES EVOL, V215, P618, DOI 10.1007/s00427-005-0022-y; Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794; Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108; Rentzsch F, 2006, DEV BIOL, V296, P375, DOI 10.1016/j.ydbio.2006.06.003; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lee PN, 2007, DEV BIOL, V310, P169, DOI 10.1016/j.ydbio.2007.05.040; Guder C, 2006, ONCOGENE, V25, P7450, DOI 10.1038/sj.onc.1210052; Nakanishi N, 2012, DEVELOPMENT, V139, P347, DOI 10.1242/dev.071902; Wikramanayake AH, 2003, NATURE, V426, P446, DOI 10.1038/nature02113; Galliot B, 2009, DEV BIOL, V332, P2, DOI 10.1016/j.ydbio.2009.05.563; Koizumi O, 2007, BRAIN BEHAV EVOLUT, V69, P151, DOI 10.1159/000095204; Kirschner M, 1998, P NATL ACAD SCI USA, V95, P8420, DOI 10.1073/pnas.95.15.8420; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Wei Z, 2009, DEVELOPMENT, V136, P1179, DOI 10.1242/dev.032300; Chapman JA, 2010, NATURE, V464, P592, DOI 10.1038/nature08830; Matus DQ, 2006, CURR BIOL, V16, P499, DOI 10.1016/j.cub.2006.01.052; Layden MJ, 2012, DEVELOPMENT, V139, P1013, DOI 10.1242/dev.073221; Marlow HQ, 2009, DEV NEUROBIOL, V69, P235, DOI 10.1002/dneu.20698; Technau U, 2011, DEVELOPMENT, V138, P1447, DOI 10.1242/dev.048959; Peterson KJ, 2004, P NATL ACAD SCI USA, V101, P6536, DOI 10.1073/pnas.0401670101; Jager M, 2008, J EXP ZOOL PART B, V310B, P650, DOI 10.1002/jez.b.21244; Stern CD, 2006, CURR OPIN CELL BIOL, V18, P692, DOI 10.1016/j.ceb.2006.09.002; Marlow H, 2013, DEV BIOL, V380, P324, DOI 10.1016/j.ydbio.2013.05.022; Ulloa F, 2010, DEV DYNAM, V239, P69, DOI 10.1002/dvdy.22058; Harland R, 2000, CURR OPIN GENET DEV, V10, P357, DOI 10.1016/S0959-437X(00)00096-4; Watanabe H, 2009, DEV GROWTH DIFFER, V51, P167, DOI 10.1111/j.1440-169X.2009.01103.x; Valenta T, 2011, GENE DEV, V25, P2631, DOI 10.1101/gad.181289.111; Darras S, 2011, DEVELOPMENT, V138, P959, DOI 10.1242/dev.059493; Collins Allen G., 2009, Smithsonian Contributions to the Marine Sciences, P139; Fujisawa T, 2008, DEV GROWTH DIFFER, V50, pS257, DOI [10.1111/j.1440-169X.2008.00997.x, 10.1111/i.1440-169X.2008.00997.x]; Sandberg M, 2005, NAT NEUROSCI, V8, P995, DOI 10.1038/nn1493; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Molina MD, 2007, DEV BIOL, V311, P79, DOI 10.1016/j.ydbio.2007.08.019; Royo JL, 2011, P NATL ACAD SCI USA, V108, P14186, DOI 10.1073/pnas.1109037108; Northcutt RG, 2012, P NATL ACAD SCI USA, V109, P10626, DOI 10.1073/pnas.1201889109; Saina M, 2009, P NATL ACAD SCI USA, V106, P18592, DOI 10.1073/pnas.0900151106; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Niehrs C, 2010, DEVELOPMENT, V137, P845, DOI 10.1242/dev.039651; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Lee PN, 2006, SEMIN CELL DEV BIOL, V17, P157, DOI 10.1016/j.semcdb.2006.05.002; Technau U, 2001, BIOESSAYS, V23, P788, DOI 10.1002/bies.1114; Arendt D, 2008, PHILOS T R SOC B, V363, P1523, DOI 10.1098/rstb.2007.2242; Berking S, 2007, J THEOR BIOL, V246, P477, DOI 10.1016/j.jtbi.2007.01.008; Bier E, 1997, CELL, V89, P681, DOI 10.1016/S0092-8674(00)80250-0; Conzelmann M, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-23; Croce JC, 2014, WNT SIGNALING IN DEVELOPMENT AND DISEASE: MOLECULAR MECHANISMS AND BIOLOGICAL FUNCTIONS, P161; Darras S, 2001, DEVELOPMENT, V128, P2629; DAVIS LE, 1968, J EXP ZOOL, V167, P295, DOI 10.1002/jez.1401670305; Demilly A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2915; Grimmelikhuijzen CJP, 2012, REGUL PEPTIDES, V177, pS6, DOI 10.1016/j.regpep.2012.05.001; Holland LZ, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-27; Holstein TW, 2011, CURR TOP DEV BIOL, V97, P137, DOI 10.1016/B978-0-12-385975-4.00012-7; Holstein TW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007922; Hyman H. L, 1940, INVERTEBRATES PROTOZ, V1; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Kuroda H, 2004, PLOS BIOL, V2, P623, DOI 10.1371/journal.pbio.0020092; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; Mizutani CM, 2006, PLOS BIOL, V4, P1777, DOI 10.1371/journal.pbio.0040313; Pang K, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-10; Pang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024152; Rottinger E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003164; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Saudemont A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001259; Schierwater B, 2009, PLOS BIOL, V7, P36, DOI 10.1371/journal.pbio.1000020; Seipp S, 2010, INVERTEBR NEUROSCI, V10, P77, DOI 10.1007/s10158-010-0109-7; Shinzato C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-311	70	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-1723			NAT COMMUN	Nat. Commun.	DEC	2014	5								5536	10.1038/ncomms6536		14	Multidisciplinary Sciences	Science & Technology - Other Topics	AX8QR	WOS:000347174200001		
J	Taniuchi, K; Furihata, M; Saibara, T				Taniuchi, Keisuke; Furihata, Mutsuo; Saibara, Toshiji			KIF20A-Mediated RNA Granule Transport System Promotes the Invasiveness of Pancreatic Cancer Cells	NEOPLASIA			English	Article							MESSENGER-RNA; STRESS GRANULES; KINESIN; BINDING; LOCALIZATION; MICROTUBULES; TRANSLATION; DENDRITES; INVASION; SHANK1	Pancreatic cancers are aggressive because they are highly invasive and highly metastatic; moreover, effective treatments for aggressive pancreatic cancers are lacking. Here, we report that the motor kinesin protein KIF20A promoted the motility and invasiveness of pancreatic cancer cells through transporting the RNA-binding protein IGF2BP3 and IGF2BP3-bound transcripts toward cell protrusions along microtubules. We previously reported that IGF2BP3 and its target transcripts are assembled into cytoplasmic stress granules of pancreatic cancer cells, and that IGF2BP3 promotes the motility and invasiveness of pancreatic cancer cells through regulation of localized translation of IGF2BP3-bound transcripts in cell protrusions. We show that knockdown of KIF20A inhibited accumulation of IGF2BP3-containing stress granules in cell protrusions and suppressed local protein expression from specific IGF2BP3-bound transcripts, ARF6 and ARHGEF4, in the protrusions. Our results provide insight into the link between regulation of KIF20A-mediated trafficking of IGF2BP3-containing stress granules and modulation of the motility and invasiveness in pancreatic cancers.	[Taniuchi, Keisuke] Kochi Univ, Kochi Med Sch, Dept Endoscop Diagnost & Therapeut, Nankoku, Kochi 7838505, Japan; [Taniuchi, Keisuke; Saibara, Toshiji] Kochi Univ, Kochi Med Sch, Dept Gastroenterol & Hepatol, Nankoku, Kochi 7838505, Japan; [Furihata, Mutsuo] Kochi Univ, Kochi Med Sch, Dept Pathol, Nankoku, Kochi 7838505, Japan	Taniuchi, K (reprint author), Kochi Univ, Kochi Med Sch, Dept Endoscop Diagnost & Therapeut, Oko Cho, Nankoku, Kochi 7838505, Japan.	ktaniuchi@kochi-u.ac.jp			Pancreas Research Foundation of Japan; Japanese Foundation for Multidisciplinary Treatment of Cancer	We thank Makiko Tsuboi, Aki Tanouchi, Chiaki Okura, and Hiroko Oshita for their excellent technical assistance. This study was supported by a Grant-in-Aid for Scientific Research (KAKENHI) (to K.T.), by the Pancreas Research Foundation of Japan (to K.T.), and by the Japanese Foundation for Multidisciplinary Treatment of Cancer (to K.T.).	Pfeiffer BE, 2006, J NEUROSCI, V26, P7147, DOI 10.1523/JNEUROSCI.1797-06.2006; Niwa S, 2012, DEV CELL, V23, P1167, DOI 10.1016/j.devcel.2012.10.016; Martin KC, 2002, NAT REV NEUROSCI, V3, P813, DOI 10.1038/nrn942; Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022; Diefenbach RJ, 1998, BIOCHEMISTRY-US, V37, P16663, DOI 10.1021/bi981163r; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha N, 2002, BIOCHEM SOC T, V30, P963; Dugre-Brisson S, 2005, NUCLEIC ACIDS RES, V33, P4797, DOI 10.1093/nar/gki794; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Hirokawa N, 2006, J NEUROSCI, V26, P7139, DOI 10.1523/JNEUROSCI.1821-06.2006; Taniuchi K, 2011, CANCER RES, V71, P895, DOI 10.1158/0008-5472.CAN-10-2743; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Asahara S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-291; Carson JH, 1997, CELL MOTIL CYTOSKEL, V38, P318, DOI 10.1002/(SICI)1097-0169(1997)38:4<318::AID-CM2>3.0.CO;2-#; ELISHA Z, 1995, EMBO J, V14, P5109; Falley K, 2009, TRAFFIC, V10, P844, DOI 10.1111/j.1600-0854.2009.00912.x; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711; Imai K, 2011, BRIT J CANCER, V104, P300, DOI 10.1038/sj.bjc.6606052; IWAMURA T, 1987, JPN J CANCER RES, V78, P54; Steward O, 2001, Results Probl Cell Differ, V34, P1; Taniuchi K, 2012, NEOPLASIA, V14, P440, DOI 10.1593/neo.12352; Taniuchi K, 2005, CANCER RES, V65, P105; Taniuchi K, 2014, ONCOTARGET, V5, P6832	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1522-8002	1476-5586		NEOPLASIA	Neoplasia	DEC	2014	16	12					1082	1093		10.1016/j.neo.2014.10.007		12	Oncology	Oncology	AX8PW	WOS:000347172100009		
J	Uwaba, T; Mizuno, T; Nemoto, J; Ishitani, I; Ito, M				Uwaba, Tomoyuki; Mizuno, Tomoyasu; Nemoto, Junichi; Ishitani, Ikuo; Ito, Masahiro			Development of a mixed oxide fuel pin performance analysis code "CEDAR": Models and analyses of fuel pin irradiation behavior	NUCLEAR ENGINEERING AND DESIGN			English	Article							HIGH BURN-UP; FAST-REACTOR; THERMAL-CONDUCTIVITY; CLADDING GAP; MOX FUELS; JOYO	A deterministic computer code, CEDAR, has been developed to analyze the irradiation behaviors of mixed-oxide fuel pellet pins in sodium cooled fast breeder reactors. The finite element method was incorporated into the mechanical calculation segment of the code to enable the proper analysis of stress-strain status in the fuel pellet and cladding, and mechanical interaction between the fuel pellet and cladding (PCMI). The code features mechanistic analyses of the irradiation behaviors of fuel pins by integrating a number of models to analyze major irradiation phenomena, thus expressing actual fuel pin irradiation behaviors as accurately as possible. The analysis capabilities of the code were validated by calculations of fuel pellet temperatures, fractional fission gas releases of fuel pins and fuel pin cladding diametral strain profiles. Mechanisms of fuel pin irradiation behaviors such as redistribution of Americium, PCMI and joint oxide gain (JOG) formation were interpreted from code analyses for the actual irradiation test fuel pins. (C) 2014 Elsevier B.V. All rights reserved.	[Uwaba, Tomoyuki; Nemoto, Junichi; Ishitani, Ikuo; Ito, Masahiro] Japan Atom Energy Agcy, Oarai, Ibaraki 3111393, Japan; [Mizuno, Tomoyasu] Japan Atom Energy Agcy, Tokai, Ibaraki 3191194, Japan	Uwaba, T (reprint author), 4002 Narita Cho, Oarai, Ibaraki 3111393, Japan.	uwaba.tomoyuki@jaea.go.jp					ASAGA T, 1993, J NUCL MATER, V204, P102, DOI 10.1016/0022-3115(93)90205-D; Hisada M., 2000, TN94302000002 JNC; Inoue M, 2000, J NUCL MATER, V281, P117, DOI 10.1016/S0022-3115(00)00243-9; Inoue M, 2003, J NUCL MATER, V323, P108, DOI [10.1016/j.jnucmat.2003.08.030, 10.1016/j.nucmat.2003.08.030]; Inoue M., 2001, TN94002001080 JNC; Inoue M., 1999, TN940099070 JNC; Ishii T, 2008, J NUCL SCI TECHNOL, V45, P263, DOI 10.3327/jnst.45.263; Ishii T, 2001, J NUCL MATER, V294, P13, DOI 10.1016/S0022-3115(01)00445-7; Ishii T, 1996, J NUCL MATER, V231, P242, DOI 10.1016/0022-3115(96)00390-X; Kato M, 2011, J NUCL SCI TECHNOL, V48, P646, DOI 10.3327/jnst.48.646; Konno K, 2002, J NUCL SCI TECHNOL, V39, P771, DOI 10.3327/jnst.39.771; Maeda K, 2005, J NUCL MATER, V344, P274, DOI 10.1016/j.jnucmat.2005.04.054; Maeda K, 2004, J NUCL MATER, V327, P1, DOI 10.1016/j.jnucmat.2004.01.003; McCarthy W.H., 1979, INT C FAST BREED REA, P268; MELIS JC, 1993, J NUCL MATER, V204, P188, DOI 10.1016/0022-3115(93)90216-L; Mizuno T., 1986, INT C REL FUELS LIQ, P5; NOUROMID B, 1986, COMPUT METHOD APPL M, V54, P131, DOI 10.1016/0045-7825(86)90122-2; Ozawa T, 2006, NUCL TECHNOL, V156, P39; ROBERTS JTA, 1973, J AM CERAM SOC, V56, P472, DOI 10.1111/j.1151-2916.1973.tb12526.x; Ross A.M., 1962, CRFD1015; TOURASSE M, 1992, J NUCL MATER, V188, P49, DOI 10.1016/0022-3115(92)90453-R; Uwaba T, 2011, J NUCL MATER, V412, P294, DOI 10.1016/j.jnucmat.2011.02.052	22	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0029-5493			NUCL ENG DES	Nucl. Eng. Des.	DEC	2014	280						27	36		10.1016/j.nucengdes.2014.08.032		10	Nuclear Science & Technology	Nuclear Science & Technology	AY0CI	WOS:000347265100004		
J	Saji, G				Saji, Genn			Safety goals for seismic and tsunami risks: Lessons learned from the Fukushima Daiichi disaster	NUCLEAR ENGINEERING AND DESIGN			English	Article							REACTOR SAFETY	This paper first reviews why the potential occurrence of the Tohoku-oki earthquake with momentum magnitude M-w of 9.0 earthquake was not anticipated by Japanese seismologists, and to clarify our limitations in predicting rare but severe earthquakes at our current knowledge in the field of geosciences. Although there was a large volume of historical records related to earthquakes and tsunamis, generally this data infer high plate coupling in regions where earthquakes were known to have already occurred, with only partial or even no coupling from the Japan Trench to a point approximately midway between the trench and the coastline precisely the region where the 2011 Tohoku-Oki earthquake occurred. This phenomenon has been explained as a "silent earthquake" or a fault creep as observed at the San Andreas Faults in the US. Considering the large uncertainties in seismic events, nuclear power plants should be conservatively designed with adequate safety margins. TEPCO's preparedness against seismic and tsunami hazards were reviewed in order to clarify why the established safety margin was not sufficient during the Fukushima Daiichi. It was found that the plant incorporated the necessary safety margins against seismic oscillation however, there was a large "cliff edgel " in which the radiological consequences surged by several orders of magnitude from the design basis tsunami. Since the tsunami's height was greater than the ground level of the turbine hall, a large amount of the tsunami water leaked through the truck entrance shutters and louver windows for the Diesel Generators' air intakes. In view of the difficulties in predicting natural events when establishing the design basis for nuclear facilities, a drastic reappraisal of the safety design approach is essential when considering risks and uncertainties. The author proposes a new probabilistic seismic and tsunami safety goals be developed on the basis of lessons learned from the Fukushima disaster which would fortify the vulnerable systems thereby reducing seismic and tsunami risks as low as practical. The safety goal should also be used to enable stake-holders to find an answer to the question of 'how safe is safe enough'. Through the development of the safety goals it is demonstrated that the risks of tsunami hazards are by far the largest risk to nuclear facilities in Japan due to its high recurrence period in certain regions of the country. It is essential to guard against tsunami-induced flooding and the need for more robust emergency power supply systems as well as special provisions for the disposal of hydrogen gas in the event of severe accidents. (C) 2014 Elsevier B.V. All rights reserved.	Nucl Safety Commiss, Konan Ku, Yokohama, Kanagawa 2330015, Japan	Saji, G (reprint author), Nucl Safety Commiss, Konan Ku, 4-39-3 Higiriyama, Yokohama, Kanagawa 2330015, Japan.	sajig@bd5.so-net.ne.jp					ABE K, 1981, PHYS EARTH PLANET IN, V27, P194, DOI 10.1016/0031-9201(81)90016-9; Tajima F, 2013, TECTONOPHYSICS, V586, P15, DOI 10.1016/j.tecto.2012.09.014; Suppasri A, 2013, PURE APPL GEOPHYS, V170, P993, DOI 10.1007/s00024-012-0511-7; Simons M, 2011, SCIENCE, V332, P1421, DOI 10.1126/science.1206731; EPS, 2011, EARTH PLANETS SPACE, V63, P511; FARMER FR, 1967, NUCL SAFETY, V8, P539; Galdini F., 2012, ENG GEOL; Gutenberg B., 1944, B SEISMOL SOC AM, V34, P185; Hagiwara T., 1991, SEISMICITY JAPANESE, P215; Hijikata K., 2012, 2012 SPRING SESS 3 2; IAEA, 1990, INES INT NUCL EV SAL; International Atomic Energy Agency (IAEA), 2002, IAEA SAF STAND SER; Japan Society of Civil Engineers (JSCE), 2002, TSUN ASS METH NUCL P; Kawasumi H., 1951, B EARTHQ RES I TOKYO, V21, P467; Kumamoto T., 2004, ACTIVE FAULT RES, V24, P13; Matsuda T., 1975, ZISIN 2 SER, V28, P369; National Gov, 2012, INV COMM ACC FUK NUC; Nuc. Emergency Response HQs, 2011, JAP GOV IAEA MIN C N; Nuc. Emergency Response HQs, 2011, ADD REP JAP GOV IAEA; Nuclear Safety Commission, 2006, REG GUID REV SEISM D; Saji G., ICONE20550482012; Saji G, 2003, RELIAB ENG SYST SAFE, V80, P163, DOI 10.1016/S0951-8320(03)00026-7; Saji G, 2008, P ANS PSA 2008 TOP M; Saji G, 2003, RELIAB ENG SYST SAFE, V80, P143, DOI 10.1016/S0951-8320(03)00025-5; Saji G., 2013, ANS PSA 2013 INT TOP; Saji G., 2013, ICONE2116526; Saji G, 2008, P 16 INT C NUCL ENG; Satake K, 2013, PURE APPL GEOPHYS, V170, P955, DOI 10.1007/s00024-012-0615-0; Simizu Y., 1999, RADIAT RES, V152, P374; SSHAC, 1997, NUREGCR6372 SSHAC; Stainbrugge K.V., 1962, B SEISMOL SOC AM, V50, P389; U.S. NRC, 2007, 100 23 GEOL SEISM SI; Utsu T., 2001, JISINNGAKU	33	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0029-5493			NUCL ENG DES	Nucl. Eng. Des.	DEC	2014	280						449	463		10.1016/j.nucengdes.2014.09.013		15	Nuclear Science & Technology	Nuclear Science & Technology	AY0CI	WOS:000347265100043		
J	Katoh, A; Hayafune, H; Kotake, S				Katoh, Atsushi; Hayafune, Hiroki; Kotake, Shoji			Design features and cost reduction potential of JSFR	NUCLEAR ENGINEERING AND DESIGN			English	Article							STEEL CLADDINGS	To improve the economic competitiveness of the Japan Sodium-cooled Fast Reactor (JSFR), several innovative designs have been introduced, e.g. reduction of number of main cooling loop, shorter pipe arrangement by adopting thermally durable material, in fact high chromium ferrite steel, a compact reactor vessel (RV), integration of a primary pump and an intermediate heat exchanger (IHX). Since they had not been introduced in the past and existing reactors, a new approach for construction cost estimation has been introduced to handle innovative technologies, for example, concerning different kinds of material, fabrication processes of equipment etc. As results of JSFR construction cost estimations based on the new method and the latest conceptual JSFR design, economic goals of Generation IV nuclear energy systems can be achieved by expecting the following cost reduction effects: commodity reduction by adopting innovative design, an economy of scale by power generation increase, learning effect etc. It is well analyzed quantitatively that feasibility of innovative designs is essential for economic competitiveness of JSFR. (C) 2014 Elsevier B.V. All rights reserved.	[Katoh, Atsushi; Hayafune, Hiroki] Japan Atom Energy Agcy, Oarai, Ibaraki 3110193, Japan; [Kotake, Shoji] Japan Atom Power Co, Chiyoda Ku, Tokyo 1010053, Japan	Katoh, A (reprint author), Japan Atom Energy Agcy, 4002 Narita, Oarai, Ibaraki 3110193, Japan.	kato.atsushi@jaea.go.jp					Aizawa K., 2001, R D FAST REACTOR FUE; Chikazawa Y, 2011, NUCL ENG DES, V241, P378, DOI 10.1016/j.nucengdes.2010.10.008; Kaito T, 2009, J NUCL SCI TECHNOL, V46, P529, DOI 10.3327/jnst.46.529; Chikazawa Y., 2011, ICAPP 2011 NIC FRANC; DELENE J. G., 1993, ORNLTM10071R3; Economic Modeling Working Group of the Generation IV International Forum, 2006, GIFEMWG2007004; Katoh A, 2010, J NUCL SCI TECHNOL, V47, P642, DOI 10.3327/jnst.47.642; Katoh A., 2009, FR 09 KYOT JAP; Kotake S., 2008, NUCL TECHNOL, V170, P133; Kurome K., 2009, P INT C FAST REACT R; Loh H.P., 2002, DOENETL20021169; Miura M., 1991, P INT C FAST REACT R; Robinson T., 1988, NUREGCR5160 SCI ENG; Saito T., 1991, P INT C FAST REACT R; Sakamoto Y., 2008, ICAPP 08 AN CA US; The University of Chicago with Argonne National Laboratory, 2004, EC FUT NUCL POW; Toshiba Corporation General Electric Company USEC Bechtel Power Corporation Global Nuclear Fuel - America, 2005, DEAI0704ID14620 VTA; United Engineers & Constructions Inc, 1983, DOENE00511 UN ENG CO; United Engineers & Constructions Inc, 1982, COO68181 UN ENG CONS; United Engineers and Constructors Inc, 1987, DOENE0091 UN ENG CON; Yano Y, 2007, J NUCL SCI TECHNOL, V44, P1535, DOI 10.3327/jnst.44.1535; Zaman S.U., 1978, CEFBR78532	22	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0029-5493			NUCL ENG DES	Nucl. Eng. Des.	DEC	2014	280						586	597		10.1016/j.nucengdes.2014.08.031		12	Nuclear Science & Technology	Nuclear Science & Technology	AY0CI	WOS:000347265100056		
J	Abe, H; Hong, SM; Watanabe, Y				Abe, Hiroshi; Hong, Seung Mo; Watanabe, Yutaka			Oxidation behavior of austenitic stainless steels as fuel cladding candidate materials for SCWR in superheated steam	NUCLEAR ENGINEERING AND DESIGN			English	Article							HIGH-TEMPERATURE STEAM; SUPERCRITICAL WATER; CORROSION BEHAVIOR; STRESS-CORROSION; ALLOYS; VAPOR; RESISTANCE; T91	Oxidation behavior of austenitic stainless steels as fuel cladding candidate materials for supercritical-water-cooled reactor (SCWR), including three types of 15Cr-20Ni stainless steels (1520 SSs), in the temperature range of 700-780 degrees C superheated steam have been investigated. Effect of temperature, dissolved oxygen (DO), degree of cold work (CW), and machined layer by cold drawing process on the oxidation kinetics assuming power-law kinetics are discussed. Characteristics of oxide layers and its relation to oxidation behaviors are also discussed. The effect of DO on the weight gain behavior in superheated steam at 700 degrees C was minor for all specimens at least up to 200 ppb DO. The tube-shaped specimens of 1520 SSs showed very good oxidation resistance at 700-780 degrees C. There was no clear difference in the oxidation kinetics among the three investigated types of 1520 SSs. The machined layer formed at the tube surface has a significant role to mitigate oxidation in superheated steam. A fine-grained microstructure near the surface due to recrystallization by cold drawing process is effective to form the protective Cr2O3 layer. It has been suggested that since Cr diffusion in the outside surface of tubes is accelerated as a result of an increased dislocation density and/or grain refinement by cold drawing, tube specimens show very slow oxidation kinetics. Breakdown of the protective Cr2O3 layer and nodule oxide formation were partly observed on the tube-shaped specimens of 15Cr-20Ni SSs. The reliability of Cr2O3 layer has to be carefully examined to predict the oxidation kinetics after long-term exposure. (C) 2014 Elsevier B.V. All rights reserved.	[Abe, Hiroshi; Hong, Seung Mo; Watanabe, Yutaka] Tohoku Univ, Grad Sch Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan	Abe, H (reprint author), Tohoku Univ, Grad Sch Engn, Aoba Ku, 6-6-01-2 Aoba, Sendai, Miyagi 9808579, Japan.	hiroshi.abe@qse.tohoku.ac.jp					ABE F, 1981, CORROS SCI, V21, P819, DOI 10.1016/0010-938X(81)90024-X; Ren X, 2007, CORROSION, V63, P603, DOI 10.5006/1.3278410; Yuan JT, 2013, OXID MET, V79, P541, DOI 10.1007/s11085-013-9380-4; OTSUKA N, 1989, OXID MET, V32, P13, DOI 10.1007/BF00665267; Was GS, 2007, J NUCL MATER, V371, P176, DOI 10.1016/j.jnucmat.2007.05.017; LEISTIKOW S, 1987, WERKST KORROS, V38, P556; Nakazono Y, 2010, J PHYS CONF SER, V215, DOI 10.1088/1742-6596/215/1/012094; Wright IG, 2010, INT MATER REV, V55, P129, DOI 10.1179/095066010X12646898728165; Ampornrat P, 2007, J NUCL MATER, V371, P1, DOI 10.1016/j.jnucmat.2007.05.023; Sun CW, 2009, CORROS SCI, V51, P2508, DOI 10.1016/j.corsci.2009.07.007; Essuman E, 2008, CORROS SCI, V50, P1753, DOI 10.1016/j.corsci.2008.03.001; OTSUKA N, 1991, CORROSION, V47, P240; Chen Y, 2006, CORROS SCI, V48, P2843, DOI 10.1016/j.corsci.2005.08.021; Allen TR, 2008, NUCL TECHNOL, V162, P342; Young DJ, 2011, CORROS SCI, V53, P2131, DOI 10.1016/j.corsci.2011.02.031; Ebrahimifar H, 2011, INDIAN J ENG MATER S, V18, P314; KATSURAGAWA M, 1993, J NUCL MATER, V204, P14, DOI 10.1016/0022-3115(93)90194-4; Liu F, 2009, OXID MET, V71, P77, DOI 10.1007/s11085-008-9130-1; Oka Y., 2000, P 1 INT S SUP WAT CO; Oka Y., 2011, 5 INT S SUP WAT COOL; Oka Y., 2013, 6 NT S SUP WAT COOL; Othman NK, 2009, CORROS SCI, V51, P3039, DOI 10.1016/j.corsci.2009.08.032; Penttila S, 2013, J SUPERCRIT FLUID, V81, P157, DOI 10.1016/j.supflu.2013.05.002; Ru X, 2013, CORROSION, V69, P211, DOI 10.5006/0726; SAITO M, 1984, J NUCL SCI TECHNOL, V21, P356, DOI 10.3327/jnst.21.356; Sakurai S., 2011, 5 INT S SUP WAT COOL; US Department of Energy, 2002, TECHN ROADM GEN 4 NU; U.S. DOE, 2004, SYST RES PLAN SUP WA; Zhang LF, 2012, NUCL ENG DES, V249, P180, DOI 10.1016/j.nucengdes.2011.08.086	29	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0029-5493			NUCL ENG DES	Nucl. Eng. Des.	DEC	2014	280						652	660		10.1016/j.nucengdes.2014.08.020		9	Nuclear Science & Technology	Nuclear Science & Technology	AY0CI	WOS:000347265100064		
J	Krischok, S; Ulbrich, A; Ikari, T; Kempter, V; Marschewski, M; Hofft, O				Krischok, S.; Ulbrich, A.; Ikari, T.; Kempter, V.; Marschewski, M.; Hoefft, O.			Surface structure of [XMIm]Tf2N ultrathin ionic liquid films probed by metastable He atoms and photoelectron spectroscopies (UPS and XPS)	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article; Proceedings Paper	20th International Workshop on Inelastic Ion-Surface Collisions (IISC)	FEB 16-21, 2014	AUSTRALIA	Flinders Univ, Sch Chem & Phys Sci, Kore Technol, Pfeiffer Vacuum, Scitek, SPECS, Lastek, BoentDek Handels GmbH, Flinders Univ, Ctr NanoScale Sci & Technol, AINSE		Ionic liquids; Metastable induced electron spectroscopy; Photoemission electron spectroscopy	SUM-FREQUENCY GENERATION; ELECTRONIC-STRUCTURE; MOLECULAR COMPOSITION; SOLID-SURFACES; INTERFACE; ORIENTATION; MIES	The metastable induced electron spectroscopy (MIES), in combination with photoelectron spectroscopies, is a powerful tool to analyze the molecular arrangement at surfaces due to its high surface sensitivity. In this contribution MIES is applied to analyze structural changes at the surface of [EMIm]Tf2N and [OMIm]Tf2N films on two different substrates, Highly Ordered Pyrolytic Graphite (HOPG) and Au(111), as a function of the film thickness, starting from submonolayer coverage up to multilayers. The discussion is based on previous MIES studies of the vacuum-liquid interface of ionic liquids with imidazolium cations and on available DFT calculations. The presented data indicate that - in contrast to multilayers where the surface is dominated by the alkyl chains of the imidazolium cations - the structure of the first adlayer of [XMIm]Tf2N molecules on solid surfaces depends on the strength of their interaction with the surface resulting in alkyl chains aligned parallel or oblique to the substrate surface. (C) 2014 Elsevier B.V. All rights reserved.	[Krischok, S.; Ulbrich, A.] TU Ilmenau, Inst Phys, Ilmenau, Germany; [Krischok, S.; Ulbrich, A.] TU Ilmenau, Inst Mikro & Nanotechnol, Ilmenau, Germany; [Ikari, T.] Ube Natl Coll Technol, Dept Elect Engn, Ube, Yamaguchi 7558555, Japan; [Kempter, V.; Marschewski, M.] Tech Univ Clausthal, Inst Energy Res & Phys Technol, Clausthal Zellerfeld, Germany; [Hoefft, O.] Tech Univ Clausthal, Inst Electrochem, Clausthal Zellerfeld, Germany	Krischok, S (reprint author), TU Ilmenau, Inst Phys, Ilmenau, Germany.	stefan.krischok@tu-ilmenau.de; o.hoefft@pe.tu-clausthal.de	Hofft, Oliver/J-2830-2012	Hofft, Oliver/0000-0002-1313-3166			Endres F, 2010, PHYS CHEM CHEM PHYS, V12, P1724, DOI 10.1039/b923527m; Binnemans K, 2005, CHEM REV, V105, P4148, DOI 10.1021/cr0400919; Endres F, 2006, PHYS CHEM CHEM PHYS, V8, P2101, DOI 10.1039/b600519p; Ghatee MH, 2011, J PHYS CHEM C, V115, P5626, DOI 10.1021/jp108537q; Waldmann T, 2011, CHEMPHYSCHEM, V12, P2565, DOI 10.1002/cphc.201100413; Lovelock KRJ, 2009, J PHYS CHEM B, V113, P2854, DOI 10.1021/jp810637d; Lovelock KRJ, 2010, CHEM REV, V110, P5158, DOI 10.1021/cr100114t; Armstrong JP, 2007, PHYS CHEM CHEM PHYS, V9, P982, DOI 10.1039/b615137j; Cremer T, 2011, LANGMUIR, V27, P3662, DOI 10.1021/la105007c; Hammer T, 2010, PHYS CHEM CHEM PHYS, V12, P11070, DOI 10.1039/c004415f; Sobota M, 2010, LANGMUIR, V26, P7199, DOI 10.1021/la904319h; Lockett V, 2008, PHYS CHEM CHEM PHYS, V10, P1330, DOI 10.1039/b713584j; Iimori T, 2007, J PHYS CHEM B, V111, P4860, DOI 10.1021/jp067162n; Jeon Y, 2008, J PHYS CHEM C, V112, P19649, DOI 10.1021/jp807873j; Cremer T, 2008, CHEMPHYSCHEM, V9, P2185, DOI 10.1002/cphc.200800300; Frolov AI, 2012, FARADAY DISCUSS, V154, P235, DOI 10.1039/c1fd00080b; Smith EF, 2005, CHEM COMMUN, P5633, DOI 10.1039/b512311a; Nakajima K, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3465578; Gunster J, 1999, CHEM PHYS LETT, V306, P335, DOI 10.1016/S0009-2614(99)00476-5; Aliaga C, 2007, J PHYS CHEM B, V111, P9733, DOI 10.1021/jp072899d; Ellis AV, 2013, J PHYS CHEM C, V117, P21312, DOI 10.1021/jp405682u; Harada Y, 1997, CHEM REV, V97, P1897, DOI 10.1021/cr940315v; Baldelli S, 2011, CHEM PHYS LETT, V516, P171, DOI 10.1016/j.cplett.2011.09.084; Fedorov MV, 2014, CHEM REV, V114, P2978, DOI 10.1021/cr400374x; Iwahashi T, 2009, J PHYS CHEM C, V113, P19237, DOI 10.1021/jp9056797; Carstens T, 2014, J PHYS CHEM C, V118, P10833, DOI 10.1021/jp501260t; Steinruck HP, 2012, PHYS CHEM CHEM PHYS, V14, P5010, DOI 10.1039/c2cp24087d; Ridings C, 2012, PHYS CHEM CHEM PHYS, V14, P16088, DOI 10.1039/c2cp43035e; Souda R, 2009, J PHYS CHEM B, V113, P12973, DOI 10.1021/jp9049439; Reinmoller M, 2011, PHYS CHEM CHEM PHYS, V13, P19526, DOI 10.1039/c1cp22152c; Baldelli S, 2008, ACCOUNTS CHEM RES, V41, P421, DOI 10.1021/ar700185h; Bowers J, 2004, LANGMUIR, V20, P309, DOI 10.1021/la035495v; Caporali S, 2006, J ELECTRON SPECTROSC, V151, P4, DOI 10.1016/j.elspec.2005.09.010; Gannon TJ, 1999, LANGMUIR, V15, P8429, DOI 10.1021/la990589j; Hashimoto H, 2010, SURF SCI, V604, P464, DOI 10.1016/j.susc.2009.12.023; Hofft O, 2006, LANGMUIR, V22, P7120, DOI 10.1021/la060943v; Hofft O, 2006, J PHYS CHEM B, V110, P11971, DOI 10.1021/jp061437h; Ikari Tomonori, 2010, e-Journal of Surface Science and Nanotechnology, V8, DOI 10.1380/ejssnt.2010.241; Krischok S, 2007, J PHYS CHEM B, V111, P4801, DOI 10.1021/jp067136p; Law G, 2001, PHYS CHEM CHEM PHYS, V3, P2879, DOI 10.1039/b101952j; Maolin S., 2008, J CHEM PHYS, V128; Morgner H, 2000, ADV ATOM MOL OPT PHY, V42, P387, DOI 10.1016/S1049-250X(08)60191-3; Santos CS, 2010, CHEM SOC REV, V39, P2136, DOI 10.1039/b921580h; Sloutskin Eli, 2005, J Am Chem Soc, V127, P7796, DOI 10.1021/ja0509679; Ulbrich A, 2012, CHEMPHYSCHEM, V13, P1718, DOI 10.1002/cphc.201100972; Ulbrich A, 2014, J MOL LIQ, V192, P77, DOI 10.1016/j.molliq.2014.01.007; Yamazaki S, 2013, J PHYS CHEM C, V117, P9652, DOI 10.1021/jp309705t; Yano YF, 2008, ANAL SCI, V24, P1269, DOI 10.2116/analsci.24.1269; YATES BW, 1986, J CHEM PHYS, V85, P3840, DOI 10.1063/1.450904; Yoshimura D, 2005, J ELECTRON SPECTROSC, V144, P319, DOI 10.1016/j.elspec.2005.01.181	50	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	DEC 1	2014	340						51	57		10.1016/j.nimb.2014.07.036		7	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	AX8AI	WOS:000347132400011		
J	Nakajima, K; Lienemann, J; Eberlein, P; Kimura, K; Maass, K; Winter, H				Nakajima, K.; Lienemann, J.; Eberlein, P.; Kimura, K.; Maass, K.; Winter, H.			Emission of secondary ions after grazing impact of keV ions on solid surfaces	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article; Proceedings Paper	20th International Workshop on Inelastic Ion-Surface Collisions (IISC)	FEB 16-21, 2014	AUSTRALIA	Flinders Univ, Sch Chem & Phys Sci, Kore Technol, Pfeiffer Vacuum, Scitek, SPECS, Lastek, BoentDek Handels GmbH, Flinders Univ, Ctr NanoScale Sci & Technol, AINSE		Secondary ion mass spectroscopy (SIMS); Grazing ion surface collisions; Ultrathin film; Semiconductor surface; Sputtering	AL SURFACE; ATOMS; ORIENTATION; SIMS; FILM	We have scattered He+ and Ar+ ions with energies of 10 and 20 key from solid surfaces and investigated by means of a quadrupole mass spectrometer the emission of secondary ions. Compared to the established method of secondary ion mass spectroscopy (SIMS), the impact of ions proceeds under a grazing angle of incidence of about 2 degrees. In experiments with a Cu(100) target covered with an ultrathin Fe3O4 film as well as ZnO and ZnMgO surfaces we have explored some basic features of this variant of SIMS concerning the potential application as surface analytical tool. (C) 2014 Elsevier B.V. All rights reserved.	[Nakajima, K.; Kimura, K.] Kyoto Univ, Dept Micro Engn, Nishikyo Ku, Kyoto 6158540, Japan; [Lienemann, J.; Eberlein, P.; Maass, K.; Winter, H.] Humboldt Univ, Inst Phys, D-12489 Berlin, Germany	Winter, H (reprint author), Humboldt Univ, Inst Phys, Newtonstr 15, D-12489 Berlin, Germany.	winter@physik.hu-berlin.de					Alkemade PFA, 1998, J VAC SCI TECHNOL B, V16, P373, DOI 10.1116/1.589813; Andersen C.A., 1969, INT J MASS SPECTROM, V2, P61, DOI 10.1016/0020-7381(69)80006-9; ANDRA HJ, 1975, PHYS LETT A, V54, P315, DOI 10.1016/0375-9601(75)90274-1; Winter H, 2002, PHYS REP, V367, P387, DOI 10.1016/S0370-1573(02)00010-8; [Anonymous], NAN 10 GHZ; DELINE VR, 1978, APPL PHYS LETT, V33, P832, DOI 10.1063/1.90546; Aumayr F, 2004, PHILOS T ROY SOC A, V362, P77, DOI 10.1098/rsta.2003.1300; Benninghoven A., 1987, SECONDARY ION MASS S; Bernhard T, 2005, NUCL INSTRUM METH B, V232, P16, DOI 10.1016/j.nimb.2005.03.018; Bubert H., 2002, SURFACE THIN FILM AN, P86; Geller R., 1996, ELECT CYCLOTRON RESO; Hofmann S, 2004, PHILOS T ROY SOC A, V362, P55, DOI 10.1098/rsta.2003.1304; JOITE S, 1979, SURF SCI, V84, P462, DOI 10.1016/0039-6028(79)90149-3; KIMURA K, 1987, PHYS REV B, V36, P7, DOI 10.1103/PhysRevB.36.7; MAGEE CW, 1978, REV SCI INSTRUM, V49, P477, DOI 10.1063/1.1135438; Motohashi K, 2007, NUCL INSTRUM METH B, V264, P15, DOI 10.1016/j.nimb.2007.07.028; Motohashi K., 2007, J PHYS C SER, V80, DOI 10.1088/1742-6596/80/1/012015; Nakajima K, 2009, J PHYS CONF SER, V163, DOI 10.1088/1742-6596/163/1/012085; RAU C, 1973, PHYS LETT A, VA 43, P317, DOI 10.1016/0375-9601(73)90323-X; Vickerman J.C., 1989, SECONDARY ION MASS S; Wang TS, 2009, SURF COAT TECH, V203, P2383, DOI 10.1016/j.surfcoat.2009.02.028; Winter H, 2000, PROG SURF SCI, V63, P177, DOI 10.1016/S0079-6816(99)00020-9	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	DEC 1	2014	340						67	71		10.1016/j.nimb.2014.07.035		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	AX8AI	WOS:000347132400014		
J	Fang, H; Yamaguchi, R; Liu, X; Daigo, Y; Yew, PY; Tanikawa, C; Matsuda, K; Imoto, S; Miyano, S; Nakamura, Y				Fang, Hua; Yamaguchi, Rui; Liu, Xiao; Daigo, Yataro; Yew, Poh Yin; Tanikawa, Chizu; Matsuda, Koichi; Imoto, Seiya; Miyano, Satoru; Nakamura, Yusuke			Quantitative T cell repertoire analysis by deep cDNA sequencing of T cell receptor alpha and beta chains using next-generation sequencing (NGS)	ONCOIMMUNOLOGY			English	Article						cancer peptide vaccines; complementary determining region 3; immune responses; next-generation sequencing; T cell repertoire	CANCER-TESTIS ANTIGEN; IMMUNOTHERAPY; LUNG; AGE	Immune responses play a critical role in various disease conditions including cancer and autoimmune diseases. However, to date, there has not been a rapid, sensitive, comprehensive, and quantitative analysis method to examine T-cell or B-cell immune responses. Here, we report a new approach to characterize T cell receptor (TCR) repertoire by sequencing millions of cDNA of TCR alpha and beta chains in combination with a newly-developed algorithm. Using samples from lung cancer patients treated with cancer peptide vaccines as a model, we demonstrate that detailed information of the V-(D)-J combination along with complementary determining region 3 (CDR3) sequences can be determined. We identified extensive abnormal splicing of TCR transcripts in lung cancer samples, indicating the dysfunctional splicing machinery in T lymphocytes by prior chemotherapy. In addition, we found three potentially novel TCR exons that have not been described previously in the reference genome. This newly developed TCR NGS platform can be applied to better understand immune responses in many disease areas including immune disorders, allergies, and organ transplantations.	[Fang, Hua; Nakamura, Yusuke] Univ Chicago, Comm Clin Pharmacol & Pharmacogen, Chicago, IL 60637 USA; [Fang, Hua; Liu, Xiao; Yew, Poh Yin; Nakamura, Yusuke] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [Yamaguchi, Rui; Tanikawa, Chizu; Matsuda, Koichi; Imoto, Seiya; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; [Daigo, Yataro] Shiga Univ Med Sci Hosp, Dept Med Oncol, Shiga, Japan; [Nakamura, Yusuke] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Nakamura, Yusuke] Univ Chicago, Ctr Personalized Therapeut, Chicago, IL 60637 USA	Nakamura, Y (reprint author), Univ Chicago, Comm Clin Pharmacol & Pharmacogen, Chicago, IL 60637 USA.	ynakamura@medicine.bsd.uchicago.edu			National Institutes of Health in Clinical Therapeutics [T32 GM007019]	H.F. is supported by a training grant (T32 GM007019) the National Institutes of Health in Clinical Therapeutics. We thank Dr. Paula Friedman for editing our manuscript.	Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Harao M, 2008, INT J CANCER, V123, P2616, DOI 10.1002/ijc.23823; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Ishikawa N, 2007, CANCER RES, V67, P11601, DOI 10.1158/0008-5472.CAN-07-3243; Morris GP, 2012, NAT IMMUNOL, V13, P121, DOI 10.1038/ni.2190; Daigo Y, 2013, CLIN PHARMACOL THER, V94, P218, DOI 10.1038/clpt.2013.90; van Heijst JWJ, 2013, NAT MED, V19, P372, DOI 10.1038/nm.3100; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Bolotin DA, 2013, NAT METHODS, V10, P813, DOI [10.1038/nmeth.2555, 10.1038/NMETH.2555]; Topalian SL, 2011, J CLIN ONCOL, V29, P4828, DOI 10.1200/JCO.2011.38.0899; Freeman JD, 2009, GENOME RES, V19, P1817, DOI 10.1101/gr.092924.109; Brady BL, 2010, J IMMUNOL, V185, P3801, DOI 10.4049/jimmunol.1001158; Brower V, 2010, J NATL CANCER I, V102, P1108, DOI 10.1093/jnci/djq295; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Giudicelli Veronique, 2005, Nucleic Acids Research, V33, pD256, DOI 10.1093/nar/gki010; Giudicelli V., 2011, COLD SPRING HARB PRO, V6, P695, DOI DOI 10.1101/PDB.PR0T5633; Li S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3333; Monod MY, 2004, BIOINFORMATICS, V20, P379, DOI 10.1093/bioinformatics/bth945; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; Schuster FR, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.6	23	1	1	LANDES BIOSCIENCE	AUSTIN	1806 RIO GRANDE ST, AUSTIN, TX 78702 USA	2162-4011	2162-402X		ONCOIMMUNOLOGY	OncoImmunology	DEC	2014	3	12							e968467	10.4161/21624011.2014.968467		12	Oncology; Immunology	Oncology; Immunology	AY6MH	WOS:000347679800011		
J	Calegari, D; Monden, N; Sato, M				Calegari, Danny; Monden, Naoyuki; Sato, Masatoshi			ON STABLE COMMUTATOR LENGTH IN HYPERELLIPTIC MAPPING CLASS GROUPS	PACIFIC JOURNAL OF MATHEMATICS			English	Article						stable commutator length; mapping class groups	LEFSCHETZ FIBRATIONS; BOUNDED COHOMOLOGY; SIGNATURE; SURFACE	We give a new upper bound on the stable commutator length of Dehn twists in hyperelliptic mapping class groups and determine the stable commutator length of some elements. We also calculate values and the defects of homogeneous quasimorphisms derived from omega-signatures and show that they are linearly independent in the mapping class groups of pointed 2-spheres when the number of points is small.	[Calegari, Danny] Univ Chicago, Dept Math, Chicago, IL 60637 USA; [Monden, Naoyuki] Osaka Electrocommun Univ, Dept Engn Sci, Neyagawa, Osaka 5728530, Japan; [Sato, Masatoshi] Gifu Univ, Dept Math Educ, Gifu 5011193, Japan	Calegari, D (reprint author), Univ Chicago, Dept Math, 5734 South Univ Ave, Chicago, IL 60637 USA.	dannyc@math.uchicago.edu; n-monden@math.kyoto-u.ac.jp; msato@gifu-u.ac.jp					Baykur RI, 2013, T AM MATH SOC, V365, P5999; BARGE J, 1992, MATH ANN, V294, P235, DOI 10.1007/BF01934324; Korkmaz M, 2004, MICH MATH J, V52, P23, DOI 10.1307/mmj/1080837732; Bestvina M, 2002, GEOM TOPOL, V6, P69, DOI 10.2140/gt.2002.6.69; POWELL J, 1978, P AM MATH SOC, V68, P347, DOI 10.2307/2043120; Endo H, 2000, MATH ANN, V316, P237, DOI 10.1007/s002080050012; Bavard C., 1991, ENSEIGN MATH, V37, p[1, 109]; BIRMAN JS, 1973, ANN MATH, V97, P424, DOI 10.2307/1970830; Birman J., 1971, ANN MATH STUD, V66, P81; Calegari D., 2009, MSJ MEMOIRS, V20; Cochran T. D., 2012, INT MATH RES NOTICES, V14, P3311; Cohen F. R., 1987, CONT MATH, V58, P21; Endo H, 2001, INVENT MATH, V144, P169, DOI 10.1007/s002220100128; Endo H, 2005, T AM MATH SOC, V357, P3179, DOI 10.1090/S0002-9947-04-03643-8; Farb B., 2012, PRINCETON MATH SERIE, V49; Gambaudo JM, 2005, B SOC MATH FR, V133, P541; Kotschick D., 2008, ADV STUDIES PURE MAT, V52, P401; Louwsma J. R., 2011, THESIS CALTECH PASAD; Meyer W., 1972, BONN MATH SCHR, V53; Monden N, 2012, TOPOL APPL, V159, P1085, DOI 10.1016/j.topol.2011.11.020; Morifuji T, 2003, J MATH SOC JPN, V55, P117, DOI 10.2969/jmsj/1196890845; Turaev V. G., 1985, J SOVIET MATH, V143, p[110, 1115]	22	0	0	PACIFIC JOURNAL MATHEMATICS	BERKELEY	PO BOX 4163, BERKELEY, CA 94704-0163 USA	0030-8730			PAC J MATH	Pac. J. Math.	DEC	2014	272	2					323	351		10.2140/pjm.2014.272.323		29	Mathematics	Mathematics	AX4ME	WOS:000346905800004		
J	Fukami, M; Ogata, T				Fukami, Maki; Ogata, Tsutomu			Cytochrome P450 oxidoreductase deficiency: Rare congenital disorder leading to skeletal malformations and steroidogenic defects	PEDIATRICS INTERNATIONAL			English	Review						Antley-Bixler syndrome; congenital adrenal hyperplasia; disorder of sex development; mutation; steroid	ANTLEY-BIXLER-SYNDROME; MUTANT P450 OXIDOREDUCTASE; AROMATASE DEFICIENCY; BACKDOOR PATHWAY; 21-HYDROXYLASE DEFICIENCY; ADRENAL-HYPERPLASIA; RETINOIC ACID; DIHYDROTESTOSTERONE; MUTATIONS; IDENTIFICATION	Cytochrome P450 oxidoreductase (POR) deficiency (PORD) is a newly characterized disorder. PORD is caused by homozygous or compound heterozygous mutations in POR encoding an electron donor for several microsomal enzymes such as CYP21A2, CYP17A1, CYP19A1, CYP51A1, and CYP26A1-C1. Molecular defects of PORD include a Japanese founder mutation p.R457H, as well as various missense, nonsense, frameshift, and splice-site mutations and exonic deletions. PORD leads to unique skeletal malformations referred to as Antley-Bixler syndrome, in addition to 46,XX and 46,XY disorders of sex development, pubertal failure, adrenal dysfunction, and maternal virilization during pregnancy. Such clinical features are ascribable to impaired activities of the POR-dependent microsomal enzymes. PORD represents one form of congenital adrenal hyperplasia, although it can occur as a congenital malformation syndrome and a disorder of sex development. Phenotypic severity of PORD is highly variable and only partly depends on the residual activity of the mutant proteins. It is possible that PORD remains undiagnosed in several patients. Detailed hormonal assessment and molecular analysis are useful for diagnosis of PORD.	[Fukami, Maki; Ogata, Tsutomu] Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Tokyo 1578535, Japan; [Ogata, Tsutomu] Hamamatsu Univ Sch Med, Dept Pediat, Hamamatsu, Shizuoka 4313192, Japan	Fukami, M (reprint author), Natl Res Inst Child Hlth & Dev, Dept Mol Endocrinol, Setagaya Ku, 2-10-1 Ohkura, Tokyo 1578535, Japan.	fukami-m@ncchd.go.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology; National Center for Child Health and Development	This work was supported by grants by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and from the Ministry of Education, Culture, Sports, Science and Technology, and by the Grant of National Center for Child Health and Development.	Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Auchus RJ, 2004, TRENDS ENDOCRIN MET, V15, P432, DOI 10.1016/j.tem.2004.09.004; Pandey AV, 2007, MOL ENDOCRINOL, V21, P2579, DOI 10.1210/me.2007-0245; Homma K, 2006, J CLIN ENDOCR METAB, V91, P2643, DOI 10.1210/jc.2005-2460; MORISHIMA A, 1995, J CLIN ENDOCR METAB, V80, P3689, DOI 10.1210/jc.80.12.3689; Fukami M, 2013, DEV DYNAM, V242, P320, DOI 10.1002/dvdy.23892; Laue K, 2011, AM J HUM GENET, V89, P595, DOI 10.1016/j.ajhg.2011.09.015; Huang NW, 2005, AM J HUM GENET, V76, P729, DOI 10.1086/429417; Carani C, 1997, NEW ENGL J MED, V337, P91, DOI 10.1056/NEJM199707103370204; Scott RR, 2008, HORM RES, V69, P266, DOI 10.1159/000114857; Fukami M, 2009, J CLIN ENDOCR METAB, V94, P1723, DOI 10.1210/jc.2008-2816; Soneda S, 2011, J CLIN ENDOCR METAB, V96, pE1881, DOI 10.1210/jc.2011-1337; HANUKOGLU I, 1992, J STEROID BIOCHEM, V43, P779, DOI 10.1016/0960-0760(92)90307-5; Huang N, 2008, P NATL ACAD SCI USA, V105, P1733, DOI 10.1073/pnas.0711621105; Fluck CE, 2004, NAT GENET, V36, P228, DOI 10.1038/ng1300; Adachi M, 2006, AM J MED GENET A, V140A, P633, DOI 10.1002/ajmg.a.31112; Arlt W, 2004, LANCET, V363, P2128, DOI 10.1016/S0140-6736(04)16503-3; Fukami M, 2006, PEDIATR RES, V59, P276, DOI 10.1203/01.pdr.0000195825.31504.28; Fukami M, 2010, MOL GENET METAB, V100, P269, DOI 10.1016/j.ymgme.2010.03.023; Miller WL, 2004, TRENDS ENDOCRIN MET, V15, P311, DOI 10.1016/j.term.2004.07.005; Reardon W, 2000, J MED GENET, V37, P26, DOI 10.1136/jmg.37.1.26; Scott RR, 2007, J CLIN ENDOCR METAB, V92, P2318, DOI 10.1210/jc.2006-2345; Shackleton C, 2004, AM J MED GENET A, V129A, P105, DOI 10.1002/ajmg.a.30171; Williamson L, 2006, AM J MED GENET A, V140A, P1797, DOI 10.1002/ajmg.a.31385	24	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					805	808		10.1111/ped.12518		4	Pediatrics	Pediatrics	AX1IL	WOS:000346700900009		
J	Hasegawa, K; Tanaka, H				Hasegawa, Kosei; Tanaka, Hiroyuki			Children with short-limbed short stature in pediatric endocrinological services in Japan	PEDIATRICS INTERNATIONAL			English	Review						achondroplasia; frequency; genetic diagnosis; hypochondroplasia; short-limbed short stature	SITTING HEIGHT; LEG LENGTH; HYPOCHONDROPLASIA; MUTATIONS; ACHONDROPLASIA; DOMAIN; GENE; DISORDERS; FGFR3; AGE	Short-limbed short stature is a heterogeneous condition that can result from many diseases such as bone disorder, metabolic disease, and multiple malformation syndrome. We conducted a questionnaire survey of council members of the Japanese Society of Pediatric Endocrinology and doctors of affiliated hospitals in 2010 to investigate short-limbed short stature. Among 91 hospitals, responses were obtained from 61 hospitals (67% response rate). This study also examined data of 193 short-limbed short stature patients, among whom FGFR3-related chondrodysplasia such as achondroplasia (n = 109; 56.5%) was found the most frequently. Second to achondroplasia, hypochondroplasia (n = 47; 24.4%) was the most frequently observed. Along with achondroplasia and hypochondroplasia, 31 patients with disorders of 13 other kinds and six undiagnosed patients were identified. Genetic testing for hypochondroplasia was conducted for only 27.7% of all hypochondroplasia patients, although hypochondroplasia is a heterogeneous condition with many causes, only one of which is FGFR3 mutation. We conducted a genetic analysis of 25 patients who had been clinically diagnosed as having hypochondroplasia. In these patients, other diseases such as acromicric dysplasia, geleophysic dysplasia, and Aarskog-Scott syndrome were included in addition to FGFR3-related hypochondroplasia (n = 10). Clinical diagnosis of each disorder causing short-limbed short stature is difficult. Therefore, not only clinical diagnosis but also genetic diagnosis play an important role in the diagnosis of short-limb short stature. Diagnostic strategies must be created for each disorder.	[Hasegawa, Kosei; Tanaka, Hiroyuki] Okayama Univ Hosp, Dept Pediat, Okayama 7008558, Japan; [Tanaka, Hiroyuki] Okayama Saiseikai Gen Hosp, Dept Pediat, Okayama, Japan	Hasegawa, K (reprint author), Okayama Univ Hosp, Dept Pediat, Kita Ku, Shikata Cho 2-5-1, Okayama 7008558, Japan.	haseyan@md.okayama-u.ac.jp	Hasegawa, Kosei/B-2243-2011	Hasegawa, Kosei/0000-0002-1751-6527	Ministry of Health, Labour and Welfare [21210901]	We thank all doctors who responded to the questionnaire and Mrs Masamoto for her kind help in conducting this study. This work was supported by a grant from the Ministry of Health, Labour and Welfare (21210901). No author has any conflict of interest.	Matsui Y, 1998, J BONE JOINT SURG BR, V80B, P1052, DOI 10.1302/0301-620X.80B6.9277; Belin V, 1998, NAT GENET, V19, P67, DOI 10.1038/ng0198-67; BELLUS GA, 1995, AM J HUM GENET, V56, P368; Rousseau F, 1996, J MED GENET, V33, P749, DOI 10.1136/jmg.33.9.749; Rao E, 1997, NAT GENET, V16, P54, DOI 10.1038/ng0597-54; Fredriks AM, 2005, ARCH DIS CHILD, V90, P807, DOI 10.1136/adc.2004.050799; Le Goff C, 2011, AM J HUM GENET, V89, P7, DOI 10.1016/j.ajhg.2011.05.012; Heuertz S, 2006, EUR J HUM GENET, V14, P1240, DOI 10.1038/sj.ejhg.5201700; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; Hermanussen M, 2010, HORM RES PAEDIAT, V74, P153, DOI 10.1159/000317440; HORTON WA, 1978, J PEDIATR-US, V93, P435; Lee Tian-Shing, 2005, J Chin Med Assoc, V68, P16; PASTERIS NG, 1994, CELL, V79, P669; Prinster C, 1998, AM J MED GENET, V75, P109, DOI 10.1002/(SICI)1096-8628(19980106)75:1<109::AID-AJMG22>3.0.CO;2-P; Riepe FG, 2005, EUR J PEDIATR, V164, P397, DOI 10.1007/s00431-005-1640-0; Song SH, 2012, AM J MED GENET A, V158A, P2456, DOI 10.1002/ajmg.a.35564; SPIRT BA, 1990, RADIOGRAPHICS, V10, P217; Yorifuji T, 1996, CLIN PEDIAT ENDOCRIN, V5, P27; YUN DJ, 1995, ANN HUM BIOL, V22, P443, DOI 10.1080/03014469500004112; Zivicnjak M, 2003, COLLEGIUM ANTROPOL, V27, P321	21	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					809	812		10.1111/ped.12511		4	Pediatrics	Pediatrics	AX1IL	WOS:000346700900010		
J	Matsui, H; Hiroma, T; Hasegawa, H; Ogiso, Y				Matsui, Hikoro; Hiroma, Takehiko; Hasegawa, Hisaya; Ogiso, Yoshifumi			Decreased granulomatous reaction by polyurethane-coated stent in the trachea	PEDIATRICS INTERNATIONAL			English	Article						airway; collapse; granulation tissue; stent implantation; tracheobronchomalacia	KNITTED AIRWAY STENT; PALMAZ STENTS; TRACHEOMALACIA; COMPRESSION; CHILDREN	BackgroundReducing granulomatous reaction for stent implantation is important for the treatment of tracheobronchomalacia because formation of granuloma leads to refractory complication causing further respiratory distress. The purpose of this study was to clarify granulomatous reaction of newly innovated coated stents compared to non-coated metal stents. MethodsMaterials and animal experiments were performed using the newly invented metallic stent (laser-cut stainless steel with a coating of polyurethane). In the materials experiment, the correlation between the holding force and deformity was tested by a compressor. In the animal examination, coated stents were orally implanted into the trachea in five rabbits, while non-coated stents were implanted in another five rabbits. After 3 weeks' observation, the inner diameter was measured by 3-D computed tomography, and the number of granulation tissues was counted by bronchofiberscope. Histological investigation followed in both groups. ResultsIn the materials experiment, new stents demonstrated a holding force similar to stainless steel stents. In the animal experiment, no difference was found in the inner diameter of the coated and non-coated stent groups (5.70 0.17 vs 5.60 +/- 0.27, P = 0.07). However, the number of granulation tissues was higher in non-coated stents than in coated stents (1.60 +/- 0.55 vs 0.40 +/- 0.55, P < 0.01). Histological investigation showed direct attachment of metal to the tracheal wall around the non-coated stents where epithelial structure was destroyed, while tracheal epithelia were preserved in the group of coated stents. ConclusionsThe new polyurethane-coated metallic stent maintains enough holding force, and reduces histobiological reaction to foreign bodies in this experiment.	[Matsui, Hikoro] Nagano Childrens Hosp, Intens Care Unit, Azumino City, Nagano 3998288, Japan; [Hiroma, Takehiko] Nagano Childrens Hosp, Dept Neonatol, Azumino City, Nagano 3998288, Japan; [Ogiso, Yoshifumi] Nagano Childrens Hosp, Dept Pathol, Azumino City, Nagano 3998288, Japan; [Hasegawa, Hisaya] Tokyo Womens Med Univ, Med Ctr East, Dept Neonatol, Tokyo, Japan	Matsui, H (reprint author), Nagano Childrens Hosp, Dept Intens Care Unit, 3100 Toyoshina, Azumino City, Nagano 3998288, Japan.	hikoromatsui@googlemail.com					Saito Y, 2002, J THORAC CARDIOV SUR, V123, P161, DOI 10.1067/mtc.2002.118503; Sewall GK, 2003, ANN OTO RHINOL LARYN, V112, P515; Saito Y, 2004, ANN THORAC SURG, V78, P1438, DOI 10.1016/S0003-4975(03)01408-5; Furuzono T, 2003, J BIOMED MATER RES B, V65B, P217, DOI 10.1002/jbm.b.10002; Pelton AR, 2008, J MECH BEHAV BIOMED, V1, P153, DOI 10.1016/j.jmbbm.2007.08.001; BACKER CL, 1989, J THORAC CARDIOV SUR, V97, P725; BOYES DC, 1991, CAN MED ASSOC J, V145, P1125; Ernst A, 2007, CHEST, V132, P609, DOI 10.1378/chest.06-2708; FILLER RM, 1995, J PEDIATR SURG, V30, P1050, DOI 10.1016/0022-3468(95)90340-2; Filler RM, 1995, J PEDIATR SURG, V30, P55; Fraga JC, 1997, ARCH OTOLARYNGOL, V123, P522; Furman RH, 1999, ARCH OTOLARYNGOL, V125, P203; GROSS RE, 1955, CIRCULATION, V11, P124; Handel Neal, 2006, Aesthet Surg J, V26, P265, DOI 10.1016/j.asj.2006.04.001; Kiyama H, 2003, ANN VASC SURG, V17, P516, DOI 10.1007/s10016-003-0061-7; Perini S, 1999, J VASC INTERV RADIOL, V10, P209, DOI 10.1016/S1051-0443(99)70466-5; Pillai JB, 2005, EUR J CARDIO-THORAC, V27, P35, DOI 10.1016/j.ejcts.2004.10.001; Wigger-Albert W, 2009, J Wound Care, V18, P210; Wigger-Albert W, 2009, J WOUND CARE, V18, P10	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					817	821		10.1111/ped.12360		5	Pediatrics	Pediatrics	AX1IL	WOS:000346700900012		
J	Urakami, T; Naito, Y; Seino, Y				Urakami, Tatsuhiko; Naito, Yusuke; Seino, Yutaka			Insulin glargine in pediatric patients with type 1 diabetes in Japan	PEDIATRICS INTERNATIONAL			English	Article						degree of obesity; glycemic control; hypoglycemia; insulin glargine; pediatric patients with type 1 diabetes	NPH INSULIN; METABOLIC-CONTROL; ANALOG GLARGINE; 18 COUNTRIES; CHILDREN; ADOLESCENTS; MELLITUS; TRIAL; COMPLICATIONS; INJECTION	BackgroundWe evaluated the safety and effectiveness of insulin glargine in Japanese pediatric patients with type 1 diabetes in clinical settings based on post-marketing surveillance data. MethodsClinical data were collected from Japanese pediatric patients with type 1 diabetes for 24 weeks after initiation of glargine treatment. Baseline characteristics, hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), previous/concomitant medication, height, bodyweight, and adverse events were analyzed. ResultsOne-hundred and thirteen patients were enrolled from 20 medical institutions in Japan in 2003 and 2004. Of these patients, 73 were included in the safety analysis, and 70 of these patients were also included in the efficacy analysis. The 73 patients included 28 boys and 45 girls, with a mean age of 11.8 years at entry. Hypoglycemia occurred in three patients (three events) and was severe in two patients (two events); all patients recovered. In the efficacy evaluation, HbA1c at baseline and final assessment was 9.10% and 8.09% (P<0.001) in all patients; 8.96% and 7.85% (P<0.001) in patients aged 7-12 years (Group 1); and 9.28% and 8.37% (P=0.010) in patients aged 13-15 years (Group 2). FPG significantly decreased in all patients and in Group 1. No significant changes were observed in body mass index or degree of obesity during the study. ConclusionsGlargine therapy for Japanese pediatric patients with type 1 diabetes resulted in good glycemic control in terms of HbA1c and FPG as well as good safety in clinical settings. Glargine had little effect on the physical build of patients.	[Urakami, Tatsuhiko] Nihon Univ, Sch Med, Dept Pediat, Tokyo 1018309, Japan; [Naito, Yusuke] Sanofi KK, Dept Med Operat, Tokyo, Japan; [Seino, Yutaka] Kansai Elect Power Hosp, Div Diabet Clin Nutr & Endocrinol, Osaka, Japan	Urakami, T (reprint author), Nihon Univ, Sch Med, Dept Pediat, Chiyoda Ku, 1-8-13 Kandasurugadai, Tokyo 1018309, Japan.	urakami.tatsuhiko@nihon-u.ac.jp					Heinemann L, 2000, DIABETES CARE, V23, P644, DOI 10.2337/diacare.23.5.644; Lepore M, 2000, DIABETES, V49, P2142, DOI 10.2337/diabetes.49.12.2142; Nathan DM, 2001, DIABETES CARE, V24, P1711; Mortensen HB, 1997, DIABETES CARE, V20, P714, DOI 10.2337/diacare.20.5.714; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Mortensen HB, 1998, DIABETIC MED, V15, P752, DOI 10.1002/(SICI)1096-9136(199809)15:9<752::AID-DIA678>3.0.CO;2-W; Goykhman S, 2009, EXPERT OPIN PHARMACO, V10, P705, DOI [10.1517/14656560902775677 , 10.1517/14656560902775677]; Wang F, 2003, CLIN THER, V25, P1541, DOI 10.1016/S0149-2918(03)80156-X; Bangstad HJ, 2009, PEDIATR DIABETES, V10, P82, DOI 10.1111/j.1399-5448.2009.00578.x; Brunelle B L, 1998, Diabetes Care, V21, P1726, DOI 10.2337/diacare.21.10.1726; Chase HP, 2003, J PEDIATR-US, V143, P737, DOI 10.1067/S0022-3476(03)00415-3; Colino E, 2005, DIABETES RES CLIN PR, V70, P1, DOI 10.1016/j.diabres.2005.02.004; SHAMOON H, 1993, NEW ENGL J MED, V329, P977; Hathout Eba H, 2003, Diabetes Technol Ther, V5, P801, DOI 10.1089/152091503322527003; Jackson Anne, 2003, Pediatr Diabetes, V4, P64, DOI 10.1034/j.1399-5448.2003.00014.x; Japan Diabetes Society, 2012, TREATM GUID DIAB; Kawamori R, 2003, J CLIN THER MED, V19, P445; Miyamoto S, 2001, JPN J PEDIAT, V54, P319; Mohn A, 2000, DIABETES CARE, V23, P557; MORTENSEN HB, 1992, DIABETIC MED, V9, P834; Murphy NP, 2003, DIABETES CARE, V26, P799, DOI 10.2337/diacare.26.3.799; R Development Core Team, 2012, R LANG ENV STAT COMP; Schober E, 2002, J PEDIATR ENDOCR MET, V15, P369; Tan CY, 2004, PEDIATR DIABETES, V5, P80, DOI 10.1111/j.1399-543X.2004.00039.x; The Japanese Society for Pediatric Endocrinology, EV PHYS BUILD JAP PE; Urakami T, 2007, J PEDIATR ENDOCR MET, V20, P807; Wang F, 2003, CLIN THER, V25, P39; Werner K, 1999, EXP CLIN ENDOCR S2, V107, pS52	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					822	828		10.1111/ped.12379		7	Pediatrics	Pediatrics	AX1IL	WOS:000346700900013		
J	Fukuoka, K; Yanagisawa, T; Suzuki, T; Shirahata, M; Adachi, J; Mishima, K; Fujimaki, T; Matsutani, M; Nishikawa, R				Fukuoka, Kohei; Yanagisawa, Takaaki; Suzuki, Tomonari; Shirahata, Mitsuaki; Adachi, Jun-ichi; Mishima, Kazuhiko; Fujimaki, Takamitsu; Matsutani, Masao; Nishikawa, Ryo			Duration between onset and diagnosis in central nervous system tumors: Impact on prognosis and functional outcome	PEDIATRICS INTERNATIONAL			English	Article						childhood brain tumor; diagnosis; pediatric neuro-oncology; prediagnostic symptomatic interval; prognosis	PEDIATRIC BRAIN-TUMORS; DELAY; CHILDHOOD	BackgroundThe initial presentation of central nervous system (CNS) tumors in children frequently mimics other more common and less serious conditions, resulting in diagnostic difficulty and a prolonged time to diagnosis. Yet whether early diagnosis contributes to better life prognosis and functional outcome has not been elucidated. Only a few such reports have originated from Japan, where neuroimaging techniques are the best in the world. We examined the time to diagnosis, the so-called prediagnostic symptomatic interval (PSI), and its impact on prognosis and functional outcome in children with CNS tumors. MethodsWe reviewed the records of 127 patients aged <15 years with CNS tumors, who were treated at our two institutions between November 1993 and October 2011. ResultsThe median age at diagnosis was 7.2 years (range, 3 weeks-14.9 years). The male-to-female ratio was 63:64. Median PSI was 1.5 months (0-36 months). Overall survival and progression-free survival did not differ significantly between the groups, regardless of whether the PSI was longer than the median PSI. The PSI was significantly longer in patients with long-lasting clinical signs after the initial treatment than in patients with temporary symptoms only at onset. Both univariate and multivariate analysis showed that high histological grading was statistically correlated with short PSI. ConclusionsA short PSI was significantly associated with high-grade tumors. Earlier diagnosis did not lead to better life prognosis, but possibly to better functional outcome in children with CNS tumors.	[Fukuoka, Kohei; Yanagisawa, Takaaki; Suzuki, Tomonari] Saitama Med Univ, Int Med Ctr, Dept Neurooncol Neurosurg, Div Pediat Neurooncol, Hidaka, Saitama 3501298, Japan; [Shirahata, Mitsuaki; Adachi, Jun-ichi; Mishima, Kazuhiko; Matsutani, Masao; Nishikawa, Ryo] Saitama Med Univ, Int Med Ctr, Dept Neurooncol Neurosurg, Hidaka, Saitama 3501298, Japan; [Fujimaki, Takamitsu] Saitama Med Univ, Dept Neurosurg, Moroyama, Saitama, Japan	Fukuoka, K (reprint author), Saitama Med Univ, Int Med Ctr, Dept Neurooncol Neurosurg, Div Pediat Neurooncol, Yamane 1397-1, Hidaka, Saitama 3501298, Japan.	kohfukuoka@gmail.com					Hayashi N, 2010, BRAIN DEV-JPN, V32, P636, DOI 10.1016/j.braindev.2009.10.001; FLORES LE, 1986, AM J DIS CHILD, V140, P684; Wilne SH, 2006, ARCH DIS CHILD, V91, P502, DOI 10.1136/adc.2005.090266; Bouffet E, 1998, CANCER, V83, P2391, DOI 10.1002/(SICI)1097-0142(19981201)83:11<2391::AID-CNCR20>3.0.CO;2-0; Wilne S, 2007, LANCET ONCOL, V8, P685, DOI 10.1016/S1470-2045(07)70207-3; Edgeworth J, 1996, ARCH DIS CHILD, V74, P148; Committee of Brain Tumor Registry of Japan, 2000, NEUROL MED CHIR S, V40, P1; Crawford JR, 2007, NEUROLOGY, V68, P1668, DOI 10.1212/01.wnl.0000261908.36803.ac; Halperin EC, 2001, CANCER, V91, P1444, DOI 10.1002/1097-0142(20010415)91:8<1444::AID-CNCR1151>3.0.CO;2-U; Kukal K, 2009, EUR J PEDIATR, V168, P303, DOI 10.1007/s00431-008-0755-5; Li J, 2008, PEDIATRICS, V121, P1470; Mehta V, 2002, NEUROSURGERY, V51, P365, DOI 10.1227/01.NEU.0000019779.27789.AC; Thulesius H, 2000, ACTA ONCOL, V39, P873; Wilne S, 2009, ARCH DIS CHILD, V95, P534	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					829	833		10.1111/ped.12369		5	Pediatrics	Pediatrics	AX1IL	WOS:000346700900014		
J	Hashii, Y; Kusuki, S; Takizawa, S; Tokimasa, S; Ohta, H; Hara, J; Ozono, K				Hashii, Yoshiko; Kusuki, Shigenori; Takizawa, Sachiko; Tokimasa, Sadao; Ohta, Hideaki; Hara, Junichi; Ozono, Keiichi			Efficacy of micafungin in pediatric immunocompromised patients with invasive fungal infection	PEDIATRICS INTERNATIONAL			English	Article						immunocompromised host; invasive fungal infection; micafungin; pediatric patient	CLINICAL-PRACTICE GUIDELINES; CELL TRANSPLANT RECIPIENTS; DISEASES SOCIETY; CANDIDA; SURVEILLANCE; ASPERGILLOSIS; EPIDEMIOLOGY; AMERICA	BackgroundMicafungin, an antifungal echinocandin, has been indicated for pediatric patients with invasive fungal infection (IFI) in Japan and Europe. Its efficacy in immunocompromised pediatric patients with IFI, however, has not been fully investigated. MethodsThe safety and efficacy of micafungin as an antifungal therapy were analyzed in nine consecutive severe immunocompromised patients with IFI. ResultsThree patients with proven or probable Candida infections had complete response to micafungin therapy. Of the other six patients with proven, probable or possible Aspergillus infection, four had complete response and one had partial response to micafungin treatment. No severe adverse events were observed. ConclusionsIn this small series, micafungin was effective for IFI caused by both Candida and Aspergillus species and no severe adverse events were observed in these immunocompromised patients.	[Hashii, Yoshiko; Ozono, Keiichi] Osaka Univ, Grad Sch Med, Dept Dev Med, Suita, Osaka 5650871, Japan; [Kusuki, Shigenori] Natl Hosp Org Osaka Natl Hosp, Dept Pediat, Osaka, Japan; [Tokimasa, Sadao] Osaka City Univ, Grad Sch Med, Dept Pediat, Osaka 558, Japan; [Ohta, Hideaki] Higashitoyonakawatanabe Hosp, Dept Pediat, Osaka, Japan; [Hara, Junichi] Osaka City Gen Hosp, Dept Pediat Hematol Oncol, Osaka, Japan; [Takizawa, Sachiko] Ikeda City Hosp, Dept Pediat, Ikeda, Osaka, Japan	Hashii, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Dev Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yhashii@ped.med.osaka-u.ac.jp					Pfaller MA, 2008, J CLIN MICROBIOL, V46, P2620, DOI 10.1128/JCM.00566-08; Marr KA, 2002, CLIN INFECT DIS, V34, P909, DOI 10.1086/339202; Chandrasekar PH, 2006, CLIN INFECT DIS, V42, P1171, DOI 10.1086/501020; Takakura S, 2004, J ANTIMICROB CHEMOTH, V53, P283, DOI 10.1093/jac/dkh053; Walsh TJ, 2008, CLIN INFECT DIS, V46, P327, DOI 10.1086/525258; Messer SA, 2006, J CLIN MICROBIOL, V44, P324, DOI 10.1128/JCM.44.2.324-326.2006; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Seibel NL, 2005, ANTIMICROB AGENTS CH, V49, P3317, DOI 10.1128/AAC.49.8.3317-3324.2005; Kontoyiannis DP, 2009, TRANSPL INFECT DIS, V11, P89, DOI 10.1111/j.1399-3062.2008.00349.x; Pfaller MA, 2008, J CLIN MICROBIOL, V46, P515, DOI 10.1128/JCM.01915-07; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Denning DW, 2006, J INFECTION, V53, P337, DOI 10.1016/j.jinf.2006.03.003; Castagnola E, 2006, PEDIATR INFECT DIS J, V25, P634, DOI 10.1097/01.inf.0000220256.69385.2e; Ikawa K, 2009, J ANTIMICROB CHEMOTH, V64, P840, DOI 10.1093/jac/dkp298; Ikeda F, 2007, CURR MED CHEM, V14, P1263, DOI 10.2174/092986707780597970; Kai M, 2006, JPN J PEDIAT HEMATOL, V20, P45; Nguyen KT, 2010, INT J ANTIMICROB AG, V35, P80, DOI 10.1016/j.ijantimicag.2009.09.003; Queiroz-Telles F, 2008, PEDIATR INFECT DIS J, V27, P820, DOI 10.1097/INF.0b013e31817275e6	19	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					834	837		10.1111/ped.12356		4	Pediatrics	Pediatrics	AX1IL	WOS:000346700900015		
J	Takahashi, D; Hiroma, T; Takamizawa, S; Nakamura, T				Takahashi, Daijiro; Hiroma, Takehiko; Takamizawa, Shigeru; Nakamura, Tomohiko			Population-based study of esophageal and small intestinal atresia/stenosis	PEDIATRICS INTERNATIONAL			English	Article						esophageal atresia; stenosis; population-based study; small intestinal atresia; stenosis	BIRTH-DEFECTS; TRACHEOESOPHAGEAL FISTULA; CONGENITAL-MALFORMATIONS; PRENATAL-DIAGNOSIS; DESCRIPTIVE EPIDEMIOLOGY; ATRESIA; RISK; PREVALENCE; AUSTRALIA; ANOMALIES	BackgroundThe aim of this study was to describe the prevalence of esophageal atresia/stenosis and small intestinal atresia/stenosis in Nagano, Japan, together with associated anomalies, prenatal diagnosis and survival. MethodsA population-based cohort study of the prevalence of esophageal atresia/stenosis and small intestinal atresia/stenosis was conducted in Nagano in January 1993-December 2011. The Mann-Whitney test, (2) test and Kruskal-Wallis test were used to compare variables. P < 0.05 was considered statistically significant. ResultsIn total, 74 cases of esophageal atresia/stenosis and 87 cases of small intestinal atresia/stenosis (31 duodenal, 56 jejuno-ileal) were identified. Prevalences were 1.97 for esophageal atresia/stenosis and 2.23 for small intestinal atresia/stenosis (0.83 for duodenal atresia/stenosis and 1.49 for jejuno-ileal atresia/stenosis) per 10000 births, respectively. The prevalence of esophageal atresia/stenosis increased significantly from 1993-2001 to 2002-2011 (relative risk [RR], 1.6), as did the prevalences of duodenal atresia/stenosis (RR, 2.2) and jejuno-ileal atresia/stenosis (RR, 3.1). Chromosomal anomalies, particularly trisomy 21, were seen significantly more often in association with duodenal atresia/stenosis (55%) than with esophageal atresia/stenosis (28%, P < 0.01) or jejuno-ileal atresia/stenosis (2%, P < 0.01). The proportion of patients associated with prenatally diagnosed chromosomal anomaly was higher compared to postnatal diagnosis (P < 0.01) in the esophageal atresia/stenosis group. ConclusionThe prevalence of esophageal and small intestinal atresia/stenosis increased significantly from 1993-2001 to 2002-2011. Prenatally diagnosed esophageal atresia/stenosis is associated with multiple anomalies, particularly chromosomal anomalies, compared to other small intestine atresia/stenosis.	[Takahashi, Daijiro; Hiroma, Takehiko; Nakamura, Tomohiko] Nagano Childrens Hosp, Div Neonatol, Azumino City, Nagano 3998288, Japan; [Takamizawa, Shigeru] Nagano Childrens Hosp, Dept Surg, Azumino City, Nagano 3998288, Japan; [Takahashi, Daijiro] Fukuda Hosp, Div Pediat, Kumamoto, Japan	Nakamura, T (reprint author), Nagano Childrens Hosp, Div Neonatol, 3100 Toyoshina, Azumino City, Nagano 3998288, Japan.	tnakamura@naganoch.gr.jp		Takahashi, Daijiro/0000-0003-0921-3240	Ministry of Health and Welfare of Japan	This study was funded by a grant for scientific research from the Ministry of Health and Welfare of Japan. The authors have no conflicts of interest to declare in relation to this work.	YANG P, 1994, GENET EPIDEMIOL, V11, P141, DOI 10.1002/gepi.1370110205; DEPAEPE A, 1993, ARCH DIS CHILD, V68, P743; Mastroiacovo P, 1999, AM J MED GENET, V83, P117, DOI 10.1002/(SICI)1096-8628(19990312)83:2<117::AID-AJMG7>3.0.CO;2-4; Kallen B, 2010, BIRTH DEFECTS RES A, V88, P137, DOI 10.1002/bdra.20645; Forrester MB, 2005, PUBLIC HEALTH, V119, P483, DOI 10.1016/j.puhe.2004.07.008; ROBERT E, 1993, REPROD TOXICOL, V7, P405, DOI 10.1016/0890-6238(93)90085-L; Forrester MB, 2004, PUBLIC HEALTH, V118, P434, DOI 10.1016/j.puhe.2003.12.017; Sparey C, 2000, AM J OBSTET GYNECOL, V182, P427, DOI 10.1016/S0002-9378(00)70234-1; Torfs CP, 1995, TERATOLOGY, V52, P220, DOI 10.1002/tera.1420520408; Pedersen RN, 2012, ARCH DIS CHILD, V97, P227, DOI 10.1136/archdischild-2011-300597; Konkin DE, 2003, J PEDIATR SURG, V38, P1726, DOI 10.1016/S0022-3468(03)00637-7; HARRIS J, 1995, TERATOLOGY, V52, P15, DOI 10.1002/tera.1420520104; Lary JM, 2001, TERATOLOGY, V64, P237, DOI 10.1002/tera.1070; Davies MJ, 2012, NEW ENGL J MED, V366, P1803, DOI 10.1056/NEJMoa1008095; Best KE, 2012, ARCH DIS CHILD-FETAL, V97, pF353, DOI 10.1136/fetalneonatal-2011-300631; CRAGAN JD, 1993, TERATOLOGY, V48, P441, DOI 10.1002/tera.1420480508; desJong E M, 2010, CURR GASTROENTEROL R, V12, P215; Escobar MA, 2004, J PEDIATR SURG, V39, P867, DOI 10.1016/j.jpedsurg.2004.02.025; Ethen MK, 2002, TERATOLOGY, V66, pS32, DOI 10.1002/tera.90008; Francannet C., 1996, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, V25, P485; Garne E, 2002, EUR J PEDIATR SURG, V12, P101, DOI 10.1055/s-2002-30158; Haeusler MCH, 2002, PRENATAL DIAG, V22, P616, DOI 10.1002/pd.341; Hemming V, 2007, PRENATAL DIAG, V27, P1205, DOI 10.1002/pd.1886; Husain T, 2008, BIRTH DEFECTS RES A, V82, P435, DOI 10.1002/bdra.20449; Martinez-Frias ML, 2000, AM J MED GENET, V93, P355, DOI 10.1002/1096-8628(20000828)93:5<355::AID-AJMG3>3.0.CO;2-Q; Oddsberg J, 2012, PEDIATR SURG INT, V28, P249, DOI 10.1007/s00383-011-3014-1; Ooki Syuichi, 2013, Int J Womens Health, V5, P65, DOI 10.2147/IJWH.S32296; Rasmussen SA, 2001, J PEDIATR-US, V138, P668, DOI 10.1067/mpd.2001.112249; Riley MM, 1998, J PAEDIATR CHILD H, V34, P233, DOI 10.1046/j.1440-1754.1998.00208.x; Schieve LA, 2005, FERTIL STERIL, V84, P1320, DOI 10.1016/j.fertnstert.2005.04.066; Spitz L, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-24; Torfs CP, 1998, AM J MED GENET, V77, P431, DOI 10.1002/(SICI)1096-8628(19980605)77:5<431::AID-AJMG15>3.0.CO;2-J; Walker K, 2008, J PEDIATR SURG, V43, P484, DOI 10.1016/j.jpedsurg.2007.10.028	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					838	844		10.1111/ped.12359		7	Pediatrics	Pediatrics	AX1IL	WOS:000346700900016		
J	Inomata, K; Mizobuchi, M; Tanaka, S; Iwatani, S; Sakai, H; Yoshimoto, S; Nakao, H				Inomata, Kei; Mizobuchi, Masami; Tanaka, Satoshi; Iwatani, Sota; Sakai, Hitomi; Yoshimoto, Seiji; Nakao, Hideto			Patterns of increases in interleukin-6 and C-reactive protein as predictors for white matter injury in preterm infants	PEDIATRICS INTERNATIONAL			English	Article						C-reactive protein; interleukin-6; periventricular leukomalacia; premature infant; white matter injury	FETAL INFLAMMATORY RESPONSE; UMBILICAL-CORD PLASMA; CEREBRAL-PALSY; PERIVENTRICULAR LEUKOMALACIA; INFECTION; RISK; PATHOGENESIS; ULTRASOUND	BackgroundThe aim of this study was to determine whether patterns of increases in serum interleukin-6 (IL-6) and C-reactive protein (CRP) levels at birth were associated with the development of white matter injury (WMI) in preterm infants with a fetal inflammatory response (FIR). MethodsOne hundred infants who were born at <32 weeks gestation and had funisitis, as determined by histological evidence of FIR, were studied. Infants were divided into four groups according to IL-6 and CRP levels at birth, with cut-off values of 200pg/mL and 0.4mg/dL, respectively. We compared the incidence of WMI, determined by MRI at term-equivalent age, among these groups. ResultsThe number of infants in each group was 12, 43, 0, and 45 in the high IL-6 and high CRP (HH) group, high IL-6 and low CRP (HL) group, low IL-6 and high CRP (LH) group, and low IL-6 and low CRP (LL) group, respectively. The incidence of WMI was significantly higher in the HH group than in the HL group and LL group (83%, 40%, and 34%, respectively). Multiple logistic regression analysis revealed that a combined elevation in IL-6 and CRP levels was an independent predictor for the development of WMI (odds ratio, 8.3). ConclusionA combined elevation in serum IL-6 and CRP levels at birth was associated with the development of WMI in preterm infants with FIR.	[Inomata, Kei; Mizobuchi, Masami; Tanaka, Satoshi; Iwatani, Sota; Sakai, Hitomi; Yoshimoto, Seiji; Nakao, Hideto] Hyogo Prefectural Kobe Childrens Hosp, Perinatal Ctr, Dept Neonatol, Kobe, Hyogo 6540081, Japan	Mizobuchi, M (reprint author), Hyogo Prefectural Kobe Childrens Hosp, Perinatal Ctr, Dept Neonatol, Suma Ku, 1-1-1 Takakuradai, Kobe, Hyogo 6540081, Japan.	mizobuchi_kch@hp.pref.hyogo.jp		Iwatani, Sota/0000-0002-2871-4000			De Vries LS, 2004, J PEDIATR-US, V144, P815, DOI 10.1016/j.jpeds.2004.03.034; Bashiri A, 2006, J PERINAT MED, V34, P5, DOI 10.1515/JPM.2006.001; Mehta TS, 2005, SEMIN FETAL NEONAT M, V10, P421, DOI 10.1016/j.siny.2005.05.002; Inder TE, 2003, AM J NEURORADIOL, V24, P805; Chiesa C, 2003, CLIN CHEM, V49, P60, DOI 10.1373/49.1.60; Yoon BH, 1999, AM J OBSTET GYNECOL, V181, P773, DOI 10.1016/S0002-9378(99)70299-1; Deng WB, 2008, ARCH NEUROL-CHICAGO, V65, P1291, DOI 10.1001/archneur.65.10.1291; Yoon BH, 1996, AM J OBSTET GYNECOL, V174, P1433, DOI 10.1016/S0002-9378(96)70585-9; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Yoon BH, 2003, BJOG-INT J OBSTET GY, V110, P124, DOI 10.1016/S1470-0328(03)00063-6; Leviton A, 1999, PEDIATR RES, V46, P566, DOI 10.1203/00006450-199911000-00013; BLANC WA, 1959, CLIN OBSTET GYNECOL, V2, P705; Maalouf EF, 2001, PEDIATRICS, V107, P719, DOI 10.1542/peds.107.4.719; Kim CJ, 2001, AM J OBSTET GYNECOL, V185, P496, DOI 10.1067/mob.2001.116689; Goepfert AR, 2004, AM J OBSTET GYNECOL, V191, P1375, DOI 10.1016/j.ajog.2004.06.086; desBruine FT, 2011, RADIOLOGY, V261, P899; FILLY RA, 1989, RADIOLOGY, V172, P403; Pacora P, 2002, J Matern Fetal Neonatal Med, V11, P18, DOI 10.1080/713605445; vansWezel-Meijler G, 2010, SEMIN PERINATOL, V34, P28; Volpe JJ, 2008, NEUROLOGY NEWBORN, P347; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179; Woodward LJ, 2006, NEW ENGL J MED, V355, P685, DOI 10.1056/NEJMoa053792	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					851	855		10.1111/ped.12376		5	Pediatrics	Pediatrics	AX1IL	WOS:000346700900018		
J	Hayashi, A; Santo, Y; Satomura, K				Hayashi, Asako; Santo, Yoko; Satomura, Kenichi			Proteinuria and glomerular hypertrophy in extremely low-birthweight children	PEDIATRICS INTERNATIONAL			English	Article						extremely low-birthweight; glomerular hypertrophy; glomerular hypertension; proteinuria	SCLEROSIS; ADULT	BackgroundOf late, there is an increased awareness of the frequent occurrence of hypertension or proteinuria in adults born at low birthweight. MethodsWe retrospectively studied five children born with extremely low birthweight (ELBW) who were first diagnosed with proteinuria in a school urinary screening program. ResultsThese children were born at 23-25 weeks of gestation, and their birthweight was 532-732g. Proteinuria was identified in all the subjects in a school urinary screening program when they were 6-15 years old. Renal biopsy showed diffuse increase in glomerular size, consistent with glomerular hypertrophy. There were no findings of mesangial proliferation or glomerular sclerosis. All the subjects had a marked decrease in proteinuria after angiotensin receptor blocker (ARB) treatment. ConclusionReduced number of glomeruli associated with prematurity was speculated to have caused compensatory glomerular hyperfiltration, hypertrophy, and hypertension in children born with ELBW when they developed proteinuria. ARB could have been effective for proteinuria by reducing glomerular hypertension. Physicians should be aware of proteinuria in children born with ELBW because there is an increasing number of ELBW survivors as a result of advances in medical technology.	[Hayashi, Asako] Osaka Med Ctr, Dept Pediat Nephrol & Metab, Izumi, Osaka 5941101, Japan; [Hayashi, Asako] Res Inst Maternal & Child Hlth, Izumi, Osaka 5941101, Japan	Hayashi, A (reprint author), Osaka Med Ctr, Dept Pediat Nephrol & Metab, 840 Murodo Cho, Izumi, Osaka 5941101, Japan.	asakokko@med.hokudai.ac.jp					Anderson S., 1992, J AM SOC NEPHROL  S4, V3, P86; Manalich R, 2000, KIDNEY INT, V58, P770, DOI 10.1046/j.1523-1755.2000.00225.x; Hodgin JB, 2009, CLIN J AM SOC NEPHRO, V4, P71, DOI 10.2215/CJN.01700408; Bokyung K, 1985, AM J ROENTGENOL, V145, P611; BRENNER BM, 1982, NEW ENGL J MED, V307, P652; Drukker A, 2002, ISRAEL MED ASSOC J, V4, P191; FOGO A, 1989, SEMIN NEPHROL, V9, P329; Gielen M, 2005, J AM SOC NEPHROL, V16, P2471, DOI 10.1681/ASN.2004030210; Japanese Society of Nephrology, 2009, TOKYOIGAKUSHA, V13, P172; MOORE L, 1993, J PATHOL, V171, P145, DOI 10.1002/path.1711710212; Nakata A, 2010, JPN J PEDIAT NEPHROL, V23, P35; Unayama T, 1993, JPN J PEDIAT NEPHROL, V97, P107	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					860	864		10.1111/ped.12466		5	Pediatrics	Pediatrics	AX1IL	WOS:000346700900020		
J	Jimbo, K; Ohtsuka, Y; Kojima, Y; Hosoi, K; Ohbayashi, N; Ikuse, T; Aoyagi, Y; Fujii, T; Kudo, T; Shimizu, T				Jimbo, Keisuke; Ohtsuka, Yoshikazu; Kojima, Yuko; Hosoi, Kenji; Ohbayashi, Naho; Ikuse, Tamaki; Aoyagi, Yo; Fujii, Tohru; Kudo, Takahiro; Shimizu, Toshiaki			Increased expression of CXCR3 axis components and matrix metalloproteinase in pediatric inflammatory bowel disease patients	PEDIATRICS INTERNATIONAL			English	Article						CXCR3 axis components; inflammatory bowel disease; microarray; matrix metalloproteinase families; reverse transcription polymerase chain reaction	INTESTINAL EPITHELIAL-CELLS; CROHNS-DISEASE; ULCERATIVE-COLITIS; CHILDREN; STROMELYSIN-1; INHIBITORS; THERAPY; MMP-13	BackgroundAlthough pediatric inflammatory bowel disease (IBD) is characterized by extensive intestinal involvement and rapid early progression, the precise cause and specific factors involved in disease aggravation have not been well established. The aim of this study was to investigate the pathogenesis of pediatric IBD. MethodsThe expression of inflammatory molecules in colon samples taken from active ulcerative colitis (UC) and Crohn's disease (CD) patients was compared with those of controls. Three children each with UC and CD in both the active and remission phase and their controls were enrolled, and the inflammatory gene expression in the mucosa was examined by microarray. Additionally, six children from each group were further enrolled in a real-time reverse transcription polymerase chain reaction and an immunohistochemical study to examine the expression of CXCL9, 10, 11, CXCR3, matrix metalloproteinase (MMP)-1, -3, -7, and -10. ResultsThe microarray analysis revealed enhanced expression of the CXCL9, 10, and 11 genes in the active phase of CD. The expression of MMP-1, -3, -7, and -10 was significantly enhanced in the active phase of UC. These changes were also confirmed by real-time reverse transcription polymerase chain reaction. Immunohistochemical analysis revealed enhanced expression of CXCL9, 10, and 11 in both the lamina propria and epithelial cells in these patients. CXCR3-positive cells were also confirmed in the lamina propria. The expression of MMP-1, -3, -7, and -10 was also enhanced in the mucosal epithelial cells and the lamina propria in both CD and UC patients. ConclusionsThese findings suggest that CXCR3 axis components and MMP play an important role in the mucosal damage in pediatric IBD.	[Jimbo, Keisuke; Ohtsuka, Yoshikazu; Hosoi, Kenji; Ohbayashi, Naho; Ikuse, Tamaki; Aoyagi, Yo; Fujii, Tohru; Kudo, Takahiro; Shimizu, Toshiaki] Juntendo Univ, Grad Sch Med, Dept Pediat & Adolescent Med, Tokyo 1138421, Japan; [Kojima, Yuko] Juntendo Univ, Grad Sch Med, Lab Biomed Imaging Res, Biomed Res Ctr, Tokyo 1138421, Japan	Ohtsuka, Y (reprint author), Juntendo Univ, Grad Sch Med, Dept Pediat & Adolescent Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	yohtsuka@juntendo.ac.jp					Hosomi S, 2011, CLIN EXP IMMUNOL, V163, P215, DOI 10.1111/j.1365-2249.2010.04290.x; Turner D, 2007, AM J GASTROENTEROL, V102, P2804, DOI 10.1111/j.1572-0241.2007.01474.x; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Turunen P, 2006, INFLAMM BOWEL DIS, V12, P677, DOI 10.1097/00054725-200608000-00002; Stumpf M, 2005, J INVEST SURG, V18, P33, DOI 10.1080/08941930590905198; Lacher M, 2007, BIOCHEM BIOPH RES CO, V363, P701, DOI 10.1016/j.bbrc.2007.09.020; Kirkegaard T, 2004, GUT, V53, P701, DOI 10.1136/gut.2003.017442; Ravi A, 2007, INFLAMM BOWEL DIS, V13, P97, DOI 10.1002/ibd.20011; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Hyams J, 2007, GASTROENTEROLOGY, V132, P863, DOI 10.1053/j.gastro.2006.12.003; Suzuki K, 2007, PATHOL INT, V57, P413, DOI 10.1111/j.1440-1827.2007.02117.x; Baugh MD, 1999, GASTROENTEROLOGY, V117, P814, DOI 10.1016/S0016-5085(99)70339-2; Puthenedam M, 2011, INFLAMM BOWEL DIS, V17, P260, DOI 10.1002/ibd.21443; Washington K, 2002, AM J SURG PATHOL, V26, P1441, DOI 10.1097/00000478-200211000-00006; Singh Udai P., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P111, DOI 10.2174/187153007780832109; Heyman MB, 2005, J PEDIATR-US, V146, P35, DOI 10.1016/j.jpeds.2004.08.043; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Hait L, 2005, INFLAMM BOWEL DIS, V11, P519, DOI 10.1097/01.MIB.0000166932.66853.fd; Heuschkel RB, 2000, GUT, V47, P57, DOI 10.1136/gut.47.1.57; Ishige T, 2010, J GASTROENTEROL, V45, P911, DOI 10.1007/s00535-010-0223-7; Jeshion WC, 2000, J CLIN GASTROENTEROL, V30, P294, DOI 10.1097/00004836-200004000-00018; Kleiner DE, 1999, CANCER CHEMOTH PHARM, V43, P42; Medina C, 2001, SCAND J GASTROENTERO, V36, P1314; Monteleone G, 1999, GASTROENTEROLOGY, V117, P1069, DOI 10.1016/S0016-5085(99)70391-4; Ohtsuka Y, 2010, J GASTROEN HEPATOL, V25, P1626, DOI 10.1111/j.1440-1746.2010.06364.x; Polito JM, 1996, GASTROENTEROLOGY, V111, P580, DOI 10.1053/gast.1996.v111.pm8780560; Rath T, 2010, SCAND J GASTROENTERO, V45, P1186, DOI 10.3109/00365521.2010.499961; SaarialhoKere UK, 1996, AM J PATHOL, V148, P519; Schroepf S, 2010, INFLAMM BOWEL DIS, V16, P1882, DOI 10.1002/ibd.21312; Vaalamo M, 1998, AM J PATHOL, V152, P1005; Van Limbergent J, 2008, GASTROENTEROLOGY, V135, P1114, DOI 10.1053/j.gastro.2008.06.081; Wang YD, 2007, WORLD J GASTROENTERO, V13, P5926	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					873	883		10.1111/ped.12362		11	Pediatrics	Pediatrics	AX1IL	WOS:000346700900023		
J	Mori, M; Ohtsuka, Y; Ishida, A; Yamazaki, S; Jimbo, K; Inage, E; Aoyagi, Y; Kudo, T; Suzuki, R; Shimizu, T				Mori, Mari; Ohtsuka, Yoshikazu; Ishida, Asuka; Yamazaki, Susumu; Jimbo, Keisuke; Inage, Eisuke; Aoyagi, Yo; Kudo, Takahiro; Suzuki, Ryuyo; Shimizu, Toshiaki			Outcome of infants presenting rectal bleeding: A retrospective study in a single institution	PEDIATRICS INTERNATIONAL			English	Article						food-protein-induced proctocolitis; lymphoid hyperplasia; neonatal transient eosinophilic colitis; non-immunoglobulin-E-mediated allergic reaction; rectal bleeding in infancy	PROTEIN-INDUCED COLITIS; EOSINOPHILIC ESOPHAGITIS; EXPRESSION PROFILE; PROCTOCOLITIS; BIOPSY; CHILDREN; ALLERGY	BackgroundAlthough rectal bleeding in infancy (RBI) is not a rare phenomenon, the clinical course of RBI is not fully understood. MethodsTo investigate the outcome and pathogenesis of RBI, especially when concomitant with food-protein-induced proctocolitis (FPIP) and neonatal transient eosinophilic colitis (NTEC), 22 neonates with rectal bleeding with FPIP and NTEC from January 2008 to June 2012 were enrolled and their clinical course and mechanisms of inflammation were examined. ResultsThirteen infants showed rectal bleeding after feeding and were diagnosed with FPIP, and nine infants showed rectal bleeding before feeding and were diagnosed with NTEC. Elevated peripheral white blood cell (12685 3754/l and 30978 +/- 16166/l) and eosinophil (1084 +/- 816/l and 4456 +/- 3341/l) were confirmed in FPIP and NTEC, respectively. Colonoscopy revealed nodular lymphoid hyperplasia, a pale mucosal surface and oozing with diffuse infiltration of neutrophils, lymphocytes, and eosinophils in both groups. Reverse transcription polymerase chain reaction analysis revealed enhanced expression of the interleukin-6, CCL11, and CXCL13 genes, where CXCL13 expression was more prominent in FPIP. Mucosal infiltration by CD3- and immunoglobulin-A- but not immunoglobulin-E-positive cells was confirmed. Among them, only one infant with FPIP developed milk allergy, whereas none with NTEC had developed milk allergy at the age of 1 year. ConclusionsFPIP in infancy and NTEC are similar diseases and interleukin-6, CCL11, and CXCL13 may play a major role in the pathogenesis of rectal bleeding. Although the involvement of allergic reaction is possible, milk allergy was not a common outcome after 1 year of follow up.	[Mori, Mari; Ohtsuka, Yoshikazu; Ishida, Asuka; Yamazaki, Susumu; Jimbo, Keisuke; Inage, Eisuke; Aoyagi, Yo; Kudo, Takahiro; Suzuki, Ryuyo; Shimizu, Toshiaki] Juntendo Univ, Grad Sch Med, Dept Pediat & Adolescent Med, Tokyo 1138421, Japan	Ohtsuka, Y (reprint author), Juntendo Univ, Grad Sch Med, Dept Pediat & Adolescent Med, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	yohtsuka@juntendo.ac.jp			Japan Society for the Promotion of Science; Danone Institute of Japan Foundation	The authors are grateful to Ms Yumiko Sakurai and Takako Ikegami, PhD, of the Division of Molecular and the Biochemical Research, Biomedical Research Center, Juntendo University Graduate School of Medicine, for their extended technical support. This work was supported in part by grants from the Japan Society for the Promotion of Science and from the 2012 Danone Institute of Japan Foundation Research Grant. Authorship contributions are as follows: M. M., K. J., E. I., Y. A., and T. K. performed experiments, and analyzed data; A. I. and S. Y. performed experiments; R. S. and T. S. contributed to discussions; Y. O. designed research, performed experiments, and wrote the first draft of the paper. All authors declare no conflicts of interest.	Xanthakos SA, 2005, J PEDIATR GASTR NUTR, V41, P16, DOI 10.1097/01.MPG.0000161039.96200.F1; Blanchard C, 2011, J ALLERGY CLIN IMMUN, V127, P208, DOI 10.1016/j.jaci.2010.10.039; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, pS116, DOI 10.1016/j.jaci.2009.08.028; Ohtsuka Y, 2012, J ALLERGY CLIN IMMUN, V129, P1676, DOI 10.1016/j.jaci.2012.01.042; Rothenberg ME, 2004, J ALLERGY CLIN IMMUN, V113, P11, DOI 10.1016/j.jaci.2003.10.047; Lake AM, 2000, J PEDIATR GASTR NUTR, V30, pS58, DOI 10.1097/00005176-200001001-00009; LAKE AM, 1982, J PEDIATR-US, V101, P906, DOI 10.1016/S0022-3476(82)80008-5; Ravelli A, 2008, AM J GASTROENTEROL, V103, P2605, DOI 10.1111/j.1572-0241.2008.02035.x; ODZE RD, 1993, HUM PATHOL, V24, P668, DOI 10.1016/0046-8177(93)90248-F; Blanchard C, 2007, J ALLERGY CLIN IMMUN, V120, P1292, DOI 10.1016/j.jaci.2007.10.024; GOLDMAN H, 1986, AM J SURG PATHOL, V10, P75, DOI 10.1097/00000478-198602000-00001; Arvola T, 2006, PEDIATRICS, V117, pE760, DOI 10.1542/peds.2005-1069; WINTER HS, 1990, MODERN PATHOL, V3, P5; Blanchard C, 2006, J CLIN INVEST, V116, P536, DOI 10.1172/JCI26679; Bonnelykke K, 2008, J ALLERGY CLIN IMMUN, V121, P646, DOI 10.1016/j.jaci.2007.12.1149; Carlsen HS, 2002, GUT, V51, P364, DOI 10.1136/gut.51.3.364; Jang HJ, 2012, EUR J PEDIATR, V171, P1845, DOI 10.1007/s00431-012-1825-2; Juvonen P, 1999, PEDIATR ALLERGY IMMU, V10, P191, DOI 10.1034/j.1399-3038.1999.00030.x; KAPLAN B, 1984, J PEDIATR GASTR NUTR, V3, P704, DOI 10.1097/00005176-198411000-00012; Kukkonen K, 2010, PEDIATR ALLERGY IMMU, V21, P67, DOI 10.1111/j.1399-3038.2009.00907.x; Lawrence W W, 2001, Pediatr Rev, V22, P394; Ohtsuka Y, 2007, J PEDIATR GASTR NUTR, V44, P501, DOI 10.1097/01.mpg.0000252194.06955.18; PITTSCHIELER K, 1990, J PEDIATR GASTR NUTR, V10, P548, DOI 10.1097/00005176-199005000-00021	23	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					884	890		10.1111/ped.12366		7	Pediatrics	Pediatrics	AX1IL	WOS:000346700900024		
J	Watanabe, Y; Takasu, H; Sumida, W; Ohshima, K				Watanabe, Yoshio; Takasu, Hidemi; Sumida, Wataru; Ohshima, Kazuo			Cinematic magnetic resonance enterography for non-organic abdominal pain in infants and children	PEDIATRICS INTERNATIONAL			English	Article						cine-MR enterography; functional gastrointestinal disorders; recurrent non-organic abdominal pain	FUNCTIONAL GASTROINTESTINAL DISORDERS; DISEASE; CHILDHOOD	BackgroundRecurrent non-organic abdominal pain is the most commonly diagnosed medical problem in children. However, excluding small bowel disease remains a challenge. We evaluated our exclusion criteria for organic small intestinal diseases in pediatric patients with recurrent non-organic abdominal pain using cinematic magnetic resonance (cine-MR) enterography. MethodsThe non-intestinal organic (non-IO) group as classified by the Rome III criteria system and the intestinal organic (IO) group consisted of 81 and 19 patients, with 35 and 12 male and 46 and 7 female patients with an age range of 5-18 and 4-15 years (average 10.5 and 10.5 years), respectively. Cine-MR enterography was performed by dynamically balanced first-field-echo imaging with thick-slice water-selective excitation without breath holding. In our original small intestinal motility test, cine-MR enterography was taken at three different times (fasting state [P1], immediately after [P2] and 30min after [P3] drinking liquid material), with images taken sequentially for 5min at each time-point to evaluate the motion of water in the gastrointestinal tract. Positive findings for organic intestinal problems were concluded when persistent visible intestinal loops appeared in both the P1 and P2 phases. ResultsCine-MR enterography showed 6/81 (7.4%) and 18/19 (94.7%) (P < 0.01) positive cases of organic intestinal problems in the non-IO and IO groups, respectively. Positive and negative predictive values of this examination were 78.3% and 97.4%, respectively. ConclusionsThe unique capabilities of cine-MR enterography technology in this clinical setting render it an important additional diagnostic tool when specific disease management issues must be addressed.	[Watanabe, Yoshio; Takasu, Hidemi; Sumida, Wataru; Ohshima, Kazuo] Aichi Childrens Hlth & Med Ctr, Dept Pediat Surg, Obu City, Aichi 4748710, Japan	Watanabe, Y (reprint author), Aichi Childrens Hlth & Med Ctr, 1-2 Osakada,Morioka Cho, Obu City, Aichi 4748710, Japan.	yoshio_watanabe@mx.achmc.pref.aichi.jp					Masselli G, 2012, RADIOLOGY, V264, P333, DOI 10.1148/radiol.12111658; Zimmerman LA, 2013, INFLAMM BOWEL DIS, V19, P826, DOI 10.1097/MIB.0b013e3182802a0a; Walker LS, 2006, PAIN, V122, P43, DOI 10.1016/j.pain.2005.12.020; SARNA SK, 1989, GASTROENTEROL CLIN N, V18, P375; Rasquin A, 2006, GASTROENTEROLOGY, V130, P1527, DOI 10.1053/j.gastro.2005.08.063; Miele E, 2004, PEDIATRICS, V114, P73, DOI 10.1542/peds.114.1.73; Bufler P, 2011, DTSCH ARZTEBL INT, V108, P295, DOI 10.3238/arztebl.2011.0295; Chiou E, 2011, THERAPY, V8, P315; Dillman JR, 2011, PEDIATR RADIOL, V41, P1552, DOI 10.1007/s00247-011-2186-0; Drossman Douglas A, 2006, J Gastrointestin Liver Dis, V15, P237; Lisman-van Leeuwen Y, 2013, ANN FAM MED, V11, P238, DOI 10.1370/afm.1490; Shamir R, 2007, J PEDIATR GASTR NUTR, V44, P45, DOI 10.1097/01.mpg.0000239737.64240.72; Watanabe Y, 2005, PEDIATR SURG INT, V21, P868, DOI 10.1007/s00383-005-1532-4	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					891	895		10.1111/ped.12365		5	Pediatrics	Pediatrics	AX1IL	WOS:000346700900025		
J	Hotta, R; Fujimura, T; Shimojima, N; Nakahara, T; Fuchimoto, Y; Hoshino, K; Morikawa, Y; Matsufuji, H; Kuroda, T				Hotta, Ryo; Fujimura, Takumi; Shimojima, Naoki; Nakahara, Tadaki; Fuchimoto, Yasushi; Hoshino, Ken; Morikawa, Yasuhide; Matsufuji, Hiroshi; Kuroda, Tatsuo			Application of nuclear medicine to achieve less invasive surgery for malignant solid tumors in children	PEDIATRICS INTERNATIONAL			English	Article						children; neuroblastoma; rhabdomyosarcoma; radioguided surgery; sentinel lymph node biopsy	LYMPH-NODE BIOPSY; HIGH-RISK NEUROBLASTOMA; STAGE-4 NEUROBLASTOMA; MYCN AMPLIFICATION; PEDIATRIC-PATIENTS; SURGICAL-TREATMENT; RHABDOMYOSARCOMA; RESECTION; MIBG; PARATHYROIDECTOMY	BackgroundThe use of nuclear medicine for the management of malignant tumor, such as radioguided surgery and sentinel lymph node biopsy (SLNB), has been widely accepted in the adult practice. However, there are very few studies to apply those techniques for pediatric diseases. The aim of this study was to investigate the feasibility of application of nuclear medicine in surgery for neuroblastoma (NB) or rhabdomyosarcoma (RMS) in children. MethodsRadioguided surgery using I-123-metaiodobenzylguanidine was performed on six children with NB. SLNB using technetium-labeled tin or sulfur colloid was performed on two children with perineal RMS. Histological evaluation of resected specimens was performed to determine the accuracy of intraoperative detection and SLNB. All patients were evaluated for overall survival and complications. ResultsIntraoperative tumor localization using hand-held gamma probe was helpful in 85.7% of NB patients. Sensitivity and specificity of this technique were 81.8% and 93.3%, respectively. There were no postoperative complications, and four out of five patients with high-risk NB experienced disease-free survival (median follow up, 57 months). Sentinel lymph nodes were easily detected in patients with perineal RMS, and histological assessment revealed complete consistency with regional lymph node status. ConclusionsNuclear medicine may have a potential application in the use of less invasive surgery for advanced NB or perineal RMS, the two most challenging pediatric malignancies.	[Hotta, Ryo; Fujimura, Takumi; Shimojima, Naoki; Hoshino, Ken; Kuroda, Tatsuo] Keio Univ, Sch Med, Dept Pediat Surg, Tokyo 1608582, Japan; [Nakahara, Tadaki] Keio Univ, Sch Med, Dept Radiol, Tokyo 1608582, Japan; [Fuchimoto, Yasushi] Natl Ctr Child Hlth & Dev, Dept Surg, Tokyo, Japan; [Morikawa, Yasuhide] Int Univ Hlth & Welf, Dept Pediat Surg, Nasushiobara, Tochigi, Japan; [Matsufuji, Hiroshi] Kagoshima Univ, Grad Sch Med, Dept Pediat Surg, Kagoshima 890, Japan	Kuroda, T (reprint author), Keio Univ, Sch Med, Dept Pediat Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kuroda-t@z8.keio.jp					Adkins ES, 2004, J PEDIATR SURG, V39, P931, DOI 10.1016/j.jpedsurg.2004.02.041; Sajid MS, 2012, J SURG ONCOL, V105, P852, DOI 10.1002/jso.23016; Goldstein RE, 2000, ANN SURG, V231, P732, DOI 10.1097/00000658-200005000-00014; Wong SL, 2012, J CLIN ONCOL, V30, P2912, DOI 10.1200/JCO.2011.40.3519; Kaneko M, 2002, J PEDIAT HEMATOL ONC, V24, P613, DOI 10.1097/00043426-200211000-00004; Norman J, 1997, SURGERY, V122, P998, DOI 10.1016/S0039-6060(97)90201-4; La Quaglia MP, 2004, J PEDIATR SURG, V39, P412, DOI 10.1016/j.pedsurg.2003.11.028; Carlson RW, 2009, J NATL COMPR CANC NE, V7, P122; Aslam A, 1996, J PEDIATR SURG, V31, P719, DOI 10.1016/S0022-3468(96)90686-7; Biasotti S, 2000, MED PEDIATR ONCOL, V35, P153, DOI 10.1002/1096-911X(200008)35:2<153::AID-MPO18>3.0.CO;2-7; Blakely ML, 2003, J PEDIATR SURG, V38, P347, DOI 10.1053/jpsu.2003.50106; Castel V, 2002, J PEDIATR SURG, V37, P1574, DOI 10.1053/jpsu.2002.36187; De Corti F, 2009, PEDIATR BLOOD CANCER, V52, P51, DOI 10.1002/pbc.21777; Gow KW, 2008, J PEDIATR SURG, V43, P2193, DOI 10.1016/j.jpedsurg.2008.08.063; Heij HA, 1997, MED PEDIATR ONCOL, V28, P171, DOI 10.1002/(SICI)1096-911X(199703)28:3<171::AID-MPO2>3.0.CO;2-G; Iagaru A, 2008, MOL IMAGING BIOL, V10, P19, DOI 10.1007/s11307-007-0116-1; Kaneko M, 1997, J PEDIATR SURG, V32, P1616, DOI 10.1016/S0022-3468(97)90466-8; Kayton ML, 2008, CANCER, V112, P2052, DOI 10.1002/cncr.23403; Kubota M, 2010, SURG TODAY, V40, P526, DOI 10.1007/s00595-009-4092-8; Kuroda T, 2006, J PEDIATR SURG, V41, P2037, DOI 10.1016/j.jpedsurg.2006.08.003; Maduekwe UN, 2009, ANN SURG ONCOL, V16, P1356, DOI 10.1245/s10434-009-0393-9; Martelli H, 1998, SURGERY, V123, P51, DOI 10.1067/msy.1998.85442; MARTINEZ DA, 1995, J PEDIATR SURG, V30, P1580, DOI 10.1016/0022-3468(95)90161-2; McMulkin HM, 2003, PEDIATR SURG INT, V19, P453, DOI 10.1007/s00383-003-0956-y; MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392; Neville HL, 2000, J PEDIATR SURG, V35, P961, DOI 10.1053/jpsu.2000.6936; Carty SE, 1997, SURGERY, V122, P1003; Okamura K, 2006, PEDIATR SURG INT, V22, P129, DOI 10.1007/s00383-005-1592-5; Parida L, 2012, PEDIATR SURG INT, V28, P571, DOI 10.1007/s00383-012-3066-x; Ricard F, 2011, CLIN NUCL MED, V36, P672, DOI 10.1097/RLU.0b013e318217ae2e; Schwarz KB, 1997, BRIT J RADIOL, V70, P90; Suita S, 2007, J PEDIATR SURG, V42, P489, DOI 10.1016/j.jpedsurg.2006.10.056; Wiener E S, 2001, Semin Pediatr Surg, V10, P146, DOI 10.1053/spsu.2001.24695	33	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					896	901		10.1111/ped.12368		6	Pediatrics	Pediatrics	AX1IL	WOS:000346700900026		
J	Kitamura, A; Kondoh, T; Noguchi, M; Hatada, T; Tohbu, S; Mori, K; Matsuo, M; Kunitsugu, I; Kanetake, H; Moriuchi, H				Kitamura, Atsuko; Kondoh, Tatsuro; Noguchi, Mitsuru; Hatada, Teppei; Tohbu, Shohei; Mori, Ken-ichi; Matsuo, Manabu; Kunitsugu, Ichiro; Kanetake, Hiroshi; Moriuchi, Hiroyuki			Assessment of lower urinary tract function in children with Down syndrome	PEDIATRICS INTERNATIONAL			English	Article						Down syndrome; lower urinary tract symptoms; uroflowmetry	CHRONIC PERITONEAL-DIALYSIS; NONINVASIVE EVALUATION; VOIDING FUNCTION; MALFORMATIONS; PATIENT; ANOMALIES; DEFECTS; BLADDER; FLOW	BackgroundDespite the fact that functional lower urinary tract symptoms are common among people with Down syndrome (DS), their voiding function has not been studied precisely. Our goal was to assess the lower urinary tract functions in DS. MethodsFifty-five DS children aged 5-15 years old and 35 age-matched control children were evaluated by ultrasonography and uroflowmetry. ResultsEleven (20%) DS children had no uresiesthesia, 21 (38%) were urinated under guidance, nine (16%) urinated fewer than three times a day, two (4%) urinated more than 10 times a day, three (5%) used diapers, and 26 (47%) had urinary incontinence. Seven (13%), 15 (27%), and 10 (18%) DS children had weak, prolonged and intermittent urination, respectively, and seven (13%) had urination with straining. In contrast, none of the control subjects had urinary problems. In the uroflowmetrical analysis, 10 (18%), 20 (37%), 11 (20%) and five (9%) DS children showed bell-shaped, plateau, staccato and interrupted patterns, respectively; the remaining nine (16%) could not be analyzed. In contrast, 21 (60%), one (3%), four (11%), three (9%) and two (6%) control subjects showed bell-shaped, tower-shaped, plateau, staccato and interrupted patterns, respectively; the remaining four (11%) could not be analyzed. Residual urine was demonstrated in four (7%) DS children and one (3%) control child. ConclusionsLower urinary tract symptoms and abnormal uroflowmetry findings, which can lead to further progressive renal and urinary disorders, are common in DS children. Therefore, lower urinary tract functions should be assessed at the life-long regular medical check-ups for subjects with DS.	[Kitamura, Atsuko; Kondoh, Tatsuro; Moriuchi, Hiroyuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pediat, Nagasaki 8528501, Japan; [Kitamura, Atsuko; Moriuchi, Hiroyuki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Nagasaki 8528501, Japan; [Noguchi, Mitsuru; Hatada, Teppei; Tohbu, Shohei; Mori, Ken-ichi; Matsuo, Manabu; Kanetake, Hiroshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Urol, Nagasaki 8528501, Japan; [Kondoh, Tatsuro] Misakaenosono Mutsumi Inst Persons Severe Intelle, Isahaya, Japan; [Kunitsugu, Ichiro] Yamaguchi Univ, Grad Sch Med, Dept Publ Hlth, Yamaguchi, Japan	Moriuchi, H (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Pediat, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	hiromori@nagasaki-u.ac.jp					AHMED S, 1990, AUST NZ J SURG, V60, P113; Cleves MA, 2007, BIRTH DEFECTS RES A, V79, P657, DOI 10.1002/bdra.20393; Neveus T, 2006, J UROLOGY, V176, P314, DOI 10.1016/S0022-5347(06)00305-3; Yang PY, 2010, NEUROUROL URODYNAM, V29, P1272, DOI 10.1002/nau.20824; Ersoz M, 2009, AM J PHYS MED REHAB, V88, P735, DOI 10.1097/PHM.0b013e3181a5f004; ARIEL I, 1991, Pediatric Pathology, V11, P879; Baqi N, 1998, Pediatr Transplant, V2, P211; Barkai G, 2003, LANCET, V361, P1331, DOI 10.1016/S0140-6736(03)13080-2; BERG JM, 1960, BRIT HEART J, V22, P331; Bower WF, 2004, J UROLOGY, V171, P2657, DOI 10.1097/01.ju.0000108682.00414.04; Chang Shang-Jen, 2008, J Pediatr Urol, V4, P422, DOI 10.1016/j.jpurol.2008.05.002; Chang SJ, 2009, LUTS, V1, P63, DOI 10.1111/j.1757-5672.2009.00047.x; desJong TP, 2009, NAT REV UROL, V6, P585; Dogan HS, 2008, PEDIATR NEPHROL, V23, P1115, DOI 10.1007/s00467-008-0776-3; Ebert AK, 2008, UROLOGE, V47, P337, DOI 10.1007/s00120-007-1614-0; EDVARDSSON VO, 1995, PEDIATR NEPHROL, V9, P398; EGLI F, 1973, HUMANGENETIK, V18, P1; Ehrich J H, 1998, Pediatr Transplant, V2, P182; Handel LN, 2003, J UROLOGY, V169, P646, DOI 10.1097/01.ju.0000047125.89679.28; Hausmann MJ, 2002, NEPHRON, V92, P484, DOI 10.1159/000063317; KRAVTZOVA GI, 1975, VIRCHOWS ARCH A, V368, P167, DOI 10.1007/BF00432416; Kupferman JC, 1996, PEDIATR NEPHROL, V10, P143; KUPFERMAN JC, 1994, PEDIATR NEPHROL, V8, P644; Kupferman JC, 2009, PEDIATRICS, V124, P615; Laecke EV, 2001, J UROLOGY, V166, P2404; Malaga S, 2005, PEDIATR NEPHROL, V20, P614, DOI 10.1007/s00467-005-1825-9; Segura CG, 1997, J UROLOGY, V157, P1426, DOI 10.1016/S0022-5347(01)65010-9; SUBRAHMANYAM AB, 1995, PEDIATR NEPHROL, V9, P253; Torfs CP, 1998, AM J MED GENET, V77, P431, DOI 10.1002/(SICI)1096-8628(19980605)77:5<431::AID-AJMG15>3.0.CO;2-J; WEBB N, 1993, PEDIATR NEPHROL, V7, P771; Yang SSD, 2008, J UROLOGY, V180, P2177, DOI 10.1016/j.juro.2008.07.063; Yavascan O, 2008, PERITON DIALYSIS INT, V28, P558	32	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					902	908		10.1111/ped.12367		7	Pediatrics	Pediatrics	AX1IL	WOS:000346700900027		
J	Adachi, H; Takahashi, I; Takahashi, T				Adachi, Hiroyuki; Takahashi, Ikuko; Takahashi, Tsutomu			Novel TRAPPC2 mutation in a boy with X-linked spondylo-epiphyseal dysplasia tarda	PEDIATRICS INTERNATIONAL			English	Article						short stature; skeletal dysplasia; splice-site mutation; TRAPPC2; X-linked spondylo-epiphyseal dysplasia tarda	IDENTIFICATION; PEDIGREE; SITE; RARE	X-linked spondylo-epiphyseal dysplasia tarda (SEDT) is an X-linked recessive, late-onset, progressive skeletal disorder characterized by mild-to-moderate short-trunked short stature. X-linked SEDT is caused by mutations in the gene TRAPPC2, which is located on chromosome Xp22. In the present study, we identified a novel splice-site mutation, c.93+1G>A, in TRAPPC2 in a 9-year-old Japanese patient who had X-linked SEDT and no family history of the disease. On reverse transcription-polymerase chain reaction, the mutation resulted in a 4bp frame-shift insertion between exon 3 and exon 4. The present case highlights the importance of genetic analysis for confirmatory diagnosis of X-linked SEDT, especially in cases without a positive family history.	[Adachi, Hiroyuki; Takahashi, Ikuko; Takahashi, Tsutomu] Akita Univ, Grad Sch Med, Dept Pediat, Akita 0108543, Japan	Takahashi, I (reprint author), Akita Univ, Grad Sch Med, Dept Pediat, 1-1-1 Hondo, Akita 0108543, Japan.	takaiku@doc.med.akita-u.ac.jp					Gedeon AK, 2001, AM J HUM GENET, V68, P1386, DOI 10.1086/320592; Gedeon AK, 1999, NAT GENET, V22, P400; Tiller GE, 2001, AM J HUM GENET, V68, P1398, DOI 10.1086/320594; Fiedler Jörg, 2004, Hum Mutat, V24, P103, DOI 10.1002/humu.9254; Matsui Y, 2001, AM J MED GENET, V99, P328, DOI 10.1002/ajmg.1179; Ryu H, 2012, ANN LAB MED, V32, P234, DOI 10.3343/alm.2012.32.3.234; Shaw MA, 2003, CLIN GENET, V64, P235, DOI 10.1034/j.1399-0004.2003.00132.x; Takahashi T, 2002, CLIN GENET, V61, P319; Xia XY, 2009, CLIN CHIM ACTA, V410, P39, DOI 10.1016/j.cca.2009.09.016; Xiong F, 2009, EUR J HUM GENET, V17, P510, DOI 10.1038/ejhg.2008.219	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					925	928		10.1111/ped.12397		4	Pediatrics	Pediatrics	AX1IL	WOS:000346700900033		
J	Ito, Y; Kitamura, H				Ito, Yasuo; Kitamura, Hajime			Antenatal ultrasound visualization of left testis that then vanished after birth	PEDIATRICS INTERNATIONAL			English	Article						antenatal ultrasound; compensatory hypertrophy; non-palpable testis; testicular torsion; vanishing testis	NONPALPABLE TESTIS; HYPERTROPHY; PREDICT; ABSENCE	A 10-month-old infant was referred for disappearance of the left testis, which had been confirmed as present on antenatal ultrasound at 38 weeks of gestation, as well as at the newborn physical exam and the 4 month exam. The right testis was enlarged, whereas the left testis was palpated as a nubbin. The right testis measured on ultrasound was 1.6 x 0.8 x 1.0cm; the testicular volume was 0.67cm(3). The left nubbin was hyperechoic, and accurate measurement of testicular components was difficult. At the age of 1 year 8 months, with the diagnosis of left vanishing testis, inguinal exploration was undertaken to rule out intra-abdominal cryptorchidism. A fibrous nodule that connected to the spermatic vessels and the vas deferens was resected. Histopathology indicated a testicular remnant containing seminiferous tubules, hemosiderin deposits, calcification and marked fibrosis of the stroma, suggesting hemorrhagic infarction in utero.	[Ito, Yasuo] Int Univ Hlth & Welf, Atami Hosp, Dept Pediat Surg, Atami 4130012, Japan; [Kitamura, Hajime] Int Univ Hlth & Welf, Atami Hosp, Dept Pathol, Atami 4130012, Japan	Ito, Y (reprint author), Int Univ Hlth & Welf, Atami Hosp, Dept Pediat Surg, 13-1 Higashikaiganncho, Atami 4130012, Japan.	yasuito@iuhw.ac.jp					KOFF SA, 1991, J UROLOGY, V146, P632; Hurwitz RS, 2001, J UROLOGY, V165, P588, DOI 10.1097/00005392-200102000-00077; Emir H, 2007, PEDIATR SURG INT, V23, P41, DOI 10.1007/s00383-006-1802-9; Gong M, 1996, UROLOGY, V48, P306, DOI 10.1016/S0090-4295(96)00172-0; HUFF DS, 1992, J UROLOGY, V148, P627; Kuijper EAM, 2008, HUM REPROD, V23, P792, DOI 10.1093/humrep/den021; Miyata I, 2007, J PEDIATR ENDOCR MET, V20, P449; Oak Sanjay N, 2013, J Indian Assoc Pediatr Surg, V18, P128, DOI 10.4103/0971-9261.116053; Renzulli JF, 2005, J UROLOGY, V174, P1584, DOI 10.1097/01.ju.0000179541.92934.17; Shibata Y, 2010, UROLOGY, V76, P78, DOI 10.1016/j.urology.2010.02.043	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					928	930		10.1111/ped.12401		3	Pediatrics	Pediatrics	AX1IL	WOS:000346700900034		
J	Takama, Y; Kubota, A; Nakayama, M; Higashimoto, K; Jozaki, K; Soejima, H				Takama, Yuichi; Kubota, Akio; Nakayama, Masahiro; Higashimoto, Ken; Jozaki, Kosuke; Soejima, Hidenobu			Fibroadenoma in Beckwith-Wiedemann syndrome with paternal uniparental disomy of chromosome 11p15.5	PEDIATRICS INTERNATIONAL			English	Article						11p15; Beckwith-Wiedemann syndrome; breast tumor; fibroadenoma; uniparental disomy	BREAST; TUMOR; HEMIHYPERTROPHY	Herein is described a case of breast fibroadenomas in a 16-year-old girl with Beckwith-Wiedemann syndrome (BWS) and uniparental disomy (UPD) of chromosome 11p15.5. She was clinically diagnosed with BWS and direct closure was performed for an omphalocele at birth. Subtotal and 90% pancreatectomy were performed for nesidioblastosis at the ages 2 months and 8 years, respectively. Bilateral multiple breast fibroadenomas were noted at the age of 16 and 17 years. In this case, paternal UPD of chromosome 11p15.5 was identified on microsatellite marker analysis. The relevant imprinted chromosomal region in BWS is 11p15.5, and UPD of chromosome 11p15 is a risk factor for BWS-associated tumorigenicity. Chromosome 11p15.5 consists of imprinting domains of IGF2, the expression of which is associated with the tumorigenesis of various breast cancers. This case suggests that fibroadenomas occurred in association with BWS.	[Takama, Yuichi; Kubota, Akio] Osaka Med Ctr, Dept Pediat Surg, Izumi, Osaka 5941101, Japan; [Nakayama, Masahiro] Osaka Med Ctr, Dept Pathol, Izumi, Osaka 5941101, Japan; Res Maternal & Child Hlth, Osaka, Japan; [Takama, Yuichi] Osaka City Gen Hosp, Dept Pediat Surg, Osaka, Japan; [Higashimoto, Ken; Jozaki, Kosuke; Soejima, Hidenobu] Saga Univ, Fac Med, Dept Biomol Sci, Div Mol Genet & Epigenet, Saga 840, Japan	Kubota, A (reprint author), Osaka Med Ctr, Dept Pediat Surg, Izumi, Osaka 5941101, Japan.	kubota@wakayama-med.ac.jp					Soejima H, 2013, J HUM GENET, V58, P402, DOI 10.1038/jhg.2013.51; Sawyer EJ, 2003, J PATHOL, V200, P627, DOI 10.1002/path.1391; Poh MM, 2010, ANN PLAS SURG, V64, P803, DOI 10.1097/SAP.0b013e3181b025f6; Bemurat L, 2002, J HUM HYPERTENS, V16, P281, DOI 10.1038/sj/jhh/1001378; Bergman D, 2013, GERONTOLOGY, V59, P240, DOI 10.1159/000343995; Gebeshuber CA, 2012, ONCOGENE, V32, P3306; Gogiel M, 2013, EUR J HUM GENET, V21, P788, DOI 10.1038/ejhg.2012.259; Kubota A, 2000, J PEDIATR SURG, V35, P1661, DOI 10.1053/jpsu.2000.18346; LABRUNE B, 1988, ARCH FR PEDIATR, V45, P413; MULLER S, 1978, EUR J PEDIATR, V127, P219, DOI 10.1007/BF00442064; RAINE PAM, 1979, J PEDIATR-US, V94, P633, DOI 10.1016/S0022-3476(79)80039-6	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					931	934		10.1111/ped.12406		4	Pediatrics	Pediatrics	AX1IL	WOS:000346700900035		
J	Fujishiro, J; Sugiyama, M; Ishimaru, T; Uotani, C; Tsuchida, S; Takahashi, N; Shiozawa, R; Takita, J; Iwanaka, T				Fujishiro, Jun; Sugiyama, Masahiko; Ishimaru, Tetsuya; Uotani, Chizue; Tsuchida, Shinya; Takahashi, Naoto; Shiozawa, Ryosuke; Takita, Junko; Iwanaka, Tadashi			Cyclic fluctuation of blood pressure in neonatal neuroblastoma	PEDIATRICS INTERNATIONAL			English	Article						catecholamine; cyclic fluctuation; hypertension; neuroblastoma; -adrenergic blocker	SEVERE HYPERTENSION; PHEOCHROMOCYTOMA; MANAGEMENT; INFANT; CHILD	Herein is described a case of neonatal neuroblastoma with cyclic blood pressure fluctuation and elevated catecholamines. The fluctuations stabilized after treatment with -adrenergic blocker and the perioperative course was uneventful. The possibility of catecholamine-related symptoms including hypertension, heart failure, and blood pressure fluctuations should be considered in the treatment for neuroblastoma; if they are present, treatment with -blockers is effective.	[Fujishiro, Jun; Sugiyama, Masahiko; Ishimaru, Tetsuya; Uotani, Chizue; Iwanaka, Tadashi] Univ Tokyo, Dept Pediat Surg, Fac Med, Tokyo 1138655, Japan; [Tsuchida, Shinya; Takahashi, Naoto; Shiozawa, Ryosuke; Takita, Junko] Univ Tokyo, Dept Pediat, Fac Med, Tokyo 1138655, Japan	Fujishiro, J (reprint author), Univ Tokyo, Dept Pediat Surg, Fac Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.	jfujishi-tky@umin.ac.jp					ALVARADO CS, 1985, AM J PEDIAT HEMATOL, V7, P221; Brouwers FM, 2006, ENDOCRIN METAB CLIN, V35, P699, DOI 10.1016/j.ecl.2006.09.014; Madre C, 2006, J PEDIAT HEMATOL ONC, V28, P659, DOI 10.1097/01.mph.0000212995.56812.bb; Brisse HJ, 2011, RADIOLOGY, V261, P243, DOI 10.1148/radiol.11101352; El-Hayek M, 2004, J PEDIAT HEMATOL ONC, V26, P523, DOI 10.1097/01.mph.0000134464.86671.67; GANGULY A, 1984, HYPERTENSION, V6, P281; Hernandez MR, 2009, J CLIN ANESTH, V21, P54, DOI 10.1016/j.jclinane.2008.06.021; Kako H, 2013, J ANESTH, V27, P464, DOI 10.1007/s00540-012-1544-x; KEDAR A, 1981, CANCER, V47, P2077, DOI 10.1002/1097-0142(19810415)47:8<2077::AID-CNCR2820470828>3.0.CO;2-O; Lindner W, 2001, EUR J PEDIATR, V160, P436, DOI 10.1007/s004310100772; OISHI S, 1988, JPN HEART J, V29, P389; Sendo D, 1996, J PEDIATR SURG, V31, P1688, DOI 10.1016/S0022-3468(96)90051-2; Shinohara M, 2004, J PEDIATR SURG, V39, P103, DOI 10.1016/S0022-3468(03)00727-9; WOLFF JEA, 1993, MED PEDIATR ONCOL, V21, P460, DOI 10.1002/mpo.2950210615; Zheng XY, 2012, HYPERTENS RES, V35, P1201, DOI 10.1038/hr.2012.121	15	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					934	937		10.1111/ped.12399		4	Pediatrics	Pediatrics	AX1IL	WOS:000346700900036		
J	Iwatani, S; Takeoka, E; Mizobuchi, M; Yoshimoto, S; Iwaki, R; Bitoh, Y; Nakao, H				Iwatani, Sota; Takeoka, Emiko; Mizobuchi, Masami; Yoshimoto, Seiji; Iwaki, Ryuma; Bitoh, Yuko; Nakao, Hideto			Trisomy 8 mosaicism with pyloric atresia and situs ambiguous	PEDIATRICS INTERNATIONAL			English	Editorial Material									[Iwatani, Sota; Takeoka, Emiko; Mizobuchi, Masami; Yoshimoto, Seiji; Nakao, Hideto] Hyogo Prefectural Kobe Childrens Hosp, Dept Neonatol, Perinatal Ctr, Kobe, Hyogo 6540081, Japan; [Iwaki, Ryuma; Bitoh, Yuko] Hyogo Prefectural Kobe Childrens Hosp, Dept Pediat Surg, Perinatal Ctr, Kobe, Hyogo 6540081, Japan	Iwatani, S (reprint author), Hyogo Prefectural Kobe Childrens Hosp, Dept Neonatol, Perinatal Ctr, Suma Ku, 1-1-1 Takakuradai, Kobe, Hyogo 6540081, Japan.	iwatani_kch@hp.pref.hyogo.jp		Iwatani, Sota/0000-0002-2871-4000			van Haelst MM, 2001, PRENATAL DIAG, V21, P1075, DOI 10.1002/pd.215; Chen CP, 2011, TAIWAN J OBSTET GYNE, V50, P331, DOI 10.1016/j.tjog.2011.07.013; Schinzel A., 2001, CATALOGUE UNBALANCED, P384	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					938	939		10.1111/ped.12519		2	Pediatrics	Pediatrics	AX1IL	WOS:000346700900037		
J	Urakami, T; Habu, M; Suzuki, J				Urakami, Tatsuhiko; Habu, Masako; Suzuki, Junichi			Diabetic ketoacidosis and severe hypoglycemia in management of type 1 diabetes during 2003-2013	PEDIATRICS INTERNATIONAL			English	Letter							ADOLESCENTS; CHILDREN		[Urakami, Tatsuhiko; Habu, Masako; Suzuki, Junichi] Nihon Univ, Sch Med, Dept Pediat, Tokyo 1018309, Japan	Urakami, T (reprint author), Nihon Univ, Sch Med, Dept Pediat, Chiyoda Ku, 1-6 Kandasurugadai, Tokyo 1018309, Japan.	urakami.tatsuhiko@nihon-u.ac.jp					Clarke W, 2009, PEDIATR DIABETES, V10, P134, DOI 10.1111/j.1399-5448.2009.00583.x; Wolfsdorf J, 2009, PEDIATR DIABETES, V10, P118, DOI 10.1111/j.1399-5448.2009.00569.x; Bangstad HJ, 2009, PEDIATR DIABETES, V10, P82, DOI 10.1111/j.1399-5448.2009.00578.x; Ludvigsson Johnny, 2007, Pediatr Endocrinol Rev, V5, P666; Orsini-Federici M, 2006, DIABETES TECHNOL THE, V8, P67, DOI 10.1089/dia.2006.8.67	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					940	940		10.1111/ped.12521		1	Pediatrics	Pediatrics	AX1IL	WOS:000346700900038		
J	Cho, Y; Shimono, T; Morikawa, H; Shintaku, H; Tokuhara, D				Cho, Yuki; Shimono, Taro; Morikawa, Hiroyasu; Shintaku, Haruo; Tokuhara, Daisuke			Hepatic focal nodular hyperplasia with congenital portosystemic shunt	PEDIATRICS INTERNATIONAL			English	Article						contrast-enhanced ultrasonography; galactosemia; hepatic focal nodular hyperplasia; portosystemic shunt	VENOUS SHUNT; FOLLOW-UP; LIVER; ASSOCIATION; CHILDREN	Hepatic focal nodular hyperplasia (FNH) is a rare benign tumor in children. Vascular anomalies have been identified as pathological features of FNH, but the etiology remains unclear. We describe a rare case including the time course of formation of hepatic FNH in response to congenital portosystemic shunt (PSS). A 4-month-old girl was identified on newborn mass screening to have hypergalactosemia, but no inherited deficiencies in galactose-metabolizing enzymes were found. Ultrasonography and per-rectal portal scintigraphy showed intrahepatic PSS of the right lobe as a cause of the hypergalactosemia. At age 12 months, the patient had elevated hepatic enzymes and small hypoechoic hepatic lesions around the shunt. On abdominal contrast-enhanced ultrasonography spoke-wheel sign and central stellate scar were seen, which are typical features of hepatic FNH without biopsy. Congenital intrahepatic PSS should be evaluated on abdominal contrast-enhanced ultrasonography and observed over time because of its potential to develop into hepatic FNH.	[Cho, Yuki; Shintaku, Haruo; Tokuhara, Daisuke] Osaka City Univ, Grad Sch Med, Dept Pediat, Osaka 5458585, Japan; [Shimono, Taro] Osaka City Univ, Grad Sch Med, Dept Radiol, Osaka 5458585, Japan; [Morikawa, Hiroyasu] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka 5458585, Japan	Tokuhara, D (reprint author), Osaka City Univ, Grad Sch Med, Dept Pediat, Abeno Ku, 1-4-3 Asahimachi, Osaka 5458585, Japan.	m1155519@med.osaka-cu.ac.jp					Bouyn CID, 2003, CANCER, V97, P3107, DOI 10.1002/cncr.11452; Attal P, 2003, RADIOLOGY, V228, P465, DOI 10.1148/radiol.2282020040; Ohno T, 2008, PEDIATRICS, V121, pE892, DOI 10.1542/peds.2006-3411; Bartolotta TV, 2010, EUR RADIOL, V20, P2248, DOI 10.1007/s00330-010-1775-x; Cho Y, 2014, PEDIATR RES, V75, P658, DOI 10.1038/pr.2014.11; Fukukura Y, 1998, J HEPATOL, V29, P470, DOI 10.1016/S0168-8278(98)80067-6; Greenberg M, 1989, PRINCIPLES PRACTICE, P569; Kumagai H, 2000, J GASTROEN HEPATOL, V15, P1344, DOI 10.1046/j.1440-1746.2000.02354.x; LALONDE L, 1992, GASTROINTEST RADIOL, V17, P154, DOI 10.1007/BF01888534; LEE MJ, 1991, AM J ROENTGENOL, V156, P317; REYMOND D, 1995, J PEDIATR SURG, V30, P1590, DOI 10.1016/0022-3468(95)90162-0; WANLESS IR, 1985, HEPATOLOGY, V5, P1194, DOI 10.1002/hep.1840050622	12	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					E102	E105		10.1111/ped.12456		4	Pediatrics	Pediatrics	AX1IL	WOS:000346700900008		
J	Miyashita, E; Yoshida, H; Mori, D; Nakagawa, N; Miyamura, T; Ohta, H; Seki, M; Tomono, K; Hashii, Y; Ozono, K				Miyashita, Emiko; Yoshida, Hisao; Mori, Daisuke; Nakagawa, Natsuki; Miyamura, Takako; Ohta, Hideaki; Seki, Masafumi; Tomono, Kazunori; Hashii, Yoshiko; Ozono, Keiichi			Mycobacterium avium complex-associated peritonitis with CAPD after unrelated bone marrow transplantation	PEDIATRICS INTERNATIONAL			English	Article						B-cell; immunosuppression; non-tuberculous mycobacteria	STEM-CELL TRANSPLANTATION; B-CELL; INFECTIONS; DIALYSIS; CD40	Peritonitis remains an important complication of peritoneal dialysis and is mostly caused by aerobic enteric bacteria. Non-tuberculous mycobacteria (NTM)-associated peritonitis is an unusual but serious infection, requiring special culture techniques to avoid delay in diagnosis. We report the case of an 11-year-old girl with aplastic anemia on ambulatory peritoneal dialysis who had Mycobacterium avium complex-associated peritonitis after allogeneic hematopoietic stem cell transplantation (allo-HSCT). This case emphasizes that we should be constantly cautious about NTM infection in allo-HSCT recipients, especially when standard cultures are negative and the infection is refractory to empirical antibiotic therapy.	[Miyashita, Emiko; Yoshida, Hisao; Nakagawa, Natsuki; Miyamura, Takako; Ohta, Hideaki; Hashii, Yoshiko; Ozono, Keiichi] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka 5650871, Japan; [Yoshida, Hisao; Seki, Masafumi; Tomono, Kazunori] Osaka Univ, Grad Sch Med, Div Infect Control & Prevent, Suita, Osaka 5650871, Japan; [Mori, Daisuke] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan	Miyashita, E (reprint author), Osaka Univ, Grad Sch Med, Dept Pediat, Yamadaoka 2-2, Suita, Osaka 5650871, Japan.	emiko.st@ped.med.osaka-u.ac.jp					Xie M, 2012, INT J HEMATOL, V96, P109, DOI 10.1007/s12185-012-1099-5; HOLLAND SM, 1994, NEW ENGL J MED, V330, P1348, DOI 10.1056/NEJM199405123301904; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; CAMERON JS, 1995, PEDIATR NEPHROL, V9, P647; Corre E, 2010, HAEMATOL-HEMATOL J, V95, P1025, DOI 10.3324/haematol.2009.018853; Florido M, 2004, IMMUNOLOGY, V111, P323, DOI 10.1111/j.1365-2567.2004.01812.x; Kozakiewicz L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003472; Song Y, 2012, NEPHROL DIAL TRANSPL, V27, P1639, DOI 10.1093/ndt/gfr504; Unal E, 2006, BIOL BLOOD MARROW TR, V12, P1188, DOI 10.1016/j.bbmt.2006.07.006; ZANBAR I, 1983, EUR J IMMUNOL, V13, P35, DOI 10.1002/eji.1830130109	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					E96	E98		10.1111/ped.12463		3	Pediatrics	Pediatrics	AX1IL	WOS:000346700900006		
J	Nishida, K; Tamura, S; Yamazaki, S; Sugita, R; Yamagishi, M; Noriki, S; Morisaki, H				Nishida, Koichi; Tamura, Satoshi; Yamazaki, Sachiko; Sugita, Ryo; Yamagishi, Masaaki; Noriki, Sakon; Morisaki, Hiroko			Postoperative mitral leaflet rupture in an infant with Loeys-Dietz syndrome	PEDIATRICS INTERNATIONAL			English	Article						congenital heart disease; interruption of aortic arch; Loeys-Dietz syndrome; Marfan syndrome; mitral valve rupture	VALVE-SPARING REPLACEMENT; MARFAN-SYNDROME; BETA RECEPTOR; AORTIC ROOT; MUTATIONS; DISORDERS; CHILD	This report describes an infantile case of Loeys-Dietz syndrome (LDS) with spontaneous mitral leaflet rupture. The patient was diagnosed with a type B interruption of the aortic arch. Bilateral pulmonary artery banding was performed 5days after birth. On the 53rd day, intra-cardiac repair was performed without valvuloplasty. Although the operation was successful, mitral regurgitation deteriorated at 4weeks after operation. On the 88th day, a mitral valvuloplasty was performed and a severely ruptured anterior leaflet was observed. Sevendays after valvuloplasty, the mitral valve insufficiency again worsened and a fourth operation was performed. Two tears were observed in the anterior and posterior mitral valve leaflets, and a mitral valve replacement was required. Subsequently, the patient was diagnosed with LDS according to gene mutational status. LDS is known to have a poor prognosis with cardiovascular complications, but valve rupture has not been previously reported in other cases.	[Nishida, Koichi; Tamura, Satoshi] Fukui Cardiovasc Ctr, Dept Pediat, Fukui 9100833, Japan; [Yamazaki, Sachiko; Sugita, Ryo] Fukui Cardiovasc Ctr, Dept Cardiovasc Surg, Fukui 9100833, Japan; [Noriki, Sakon] Univ Fukui, Sch Med Sci, Dept Pathol Sci, Div Tumor Pathol, Fukui 910, Japan; [Morisaki, Hiroko] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Biosci & Genet, Osaka, Japan; [Yamagishi, Masaaki] Kyoto Prefectural Univ Med, Childrens Med Ctr, Dept Pediat Cardiovasc Surg, Kyoto, Japan	Nishida, K (reprint author), Fukui Cardiovasc Ctr, Dept Pediat, 2-228 Shinbo, Fukui 9100833, Japan.	kounishi@fcvc.or.jp					Kawazu Y, 2012, CARDIOL YOUNG, V22, P116, DOI 10.1017/S1047951111001028; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; Muramatsu Y, 2010, AM J MED GENET A, V152A, P417, DOI 10.1002/ajmg.a.33263; Judge DP, 2011, J CARDIOVASC TRANSL, V4, P741, DOI 10.1007/s12265-011-9314-y; Akutsu K, 2007, CIRC J, V71, P1305, DOI 10.1253/circj.71.1305; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Everitt MD, 2009, J THORAC CARDIOV SUR, V137, P1327, DOI 10.1016/j.jtcvs.2009.02.007; Ootaki Y, 2010, CARDIOL YOUNG, V20, P94, DOI 10.1017/S1047951109991557; Ozker E, 2012, EUR J CARDIO-THORAC, V41, P1184, DOI 10.1093/ejcts/ezr235	9	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					E82	E85		10.1111/ped.12430		4	Pediatrics	Pediatrics	AX1IL	WOS:000346700900002		
J	Yamaguchi, H; Tamura, T; Abe, M; Ogiwara, S; Sai, S; Kosugiyama, K; Sugihara, A; Nagumo, K; Iwata, S; Kinugawa, Y				Yamaguchi, Hiroshi; Tamura, Takuya; Abe, Michiko; Ogiwara, Shigetoshi; Sai, Shuji; Kosugiyama, Kiyotaka; Sugihara, Akemi; Nagumo, Kiyoshi; Iwata, Seido; Kinugawa, Yoshikazu			Prolonged incubation period in neonatal Pasteurella multocida meningitis and bacteremia	PEDIATRICS INTERNATIONAL			English	Article						meningitis; newborn; Pasteurella multocida		Pasteurella multocida, often found as part of the human oral flora and in finger/toenails, also exists in many animals, especially cats, dogs, and pigs. Although rare, pasteurella infection in neonates can cause serious systemic disease, such as meningitis. In this article, a 23-day-old girl presented with decreased appetite and irritability for >2days. Eighteendays previously her pet cat had jumped onto the left side of her head while she was sleeping. On laboratory data C-reactive protein was high, and on cerebrospinal fluid (CSF) analysis leukocyte count was extremely high, with low glucose and high protein. P.multocida grew out of the blood and CSF cultures, and she was successfully treated with antibiotics for 3weeks. Although pasteurellosis rarely occurs, it can sometimes lead to life-threatening situations, so parents should exercise caution when having pets around their children.	[Yamaguchi, Hiroshi; Tamura, Takuya; Abe, Michiko; Ogiwara, Shigetoshi; Sai, Shuji; Kosugiyama, Kiyotaka; Sugihara, Akemi; Nagumo, Kiyoshi; Iwata, Seido; Kinugawa, Yoshikazu] Teine Keijinkai Hosp, Dept Pediat, Sapporo, Hokkaido, Japan	Yamaguchi, H (reprint author), 1 Jo 12-1-40 Maeda,Teine Ku, Sapporo, Hokkaido 0068555, Japan.	sunamausu_kyu@oasis.ocn.ne.jp					WEBER DJ, 1984, MEDICINE, V63, P133; Siahanidou T, 2012, PEDIATR INFECT DIS J, V31, P536, DOI 10.1097/INF.0b013e318245debd; ARDITI M, 1989, PEDIATRICS, V84, P132; Green BT, 2002, SCAND J INFECT DIS, V34, P213, DOI 10.1080/00365540110076949; Japan Pet Food Association, SURV DOM DOGS CATS 2; KLEIN J O, 1986, Pediatrics, V78, P959; LIN TY, 1984, PEDIATR INFECT DIS J, V3, P319, DOI 10.1097/00006454-198407000-00009; Nakwan N, 2009, ARCH DIS CHILD-FETAL, V94, P373; Pickering LK, 2006, PASTEURELLA INFECTIO, P487; Schuur PMH, 1997, CLIN INFECT DIS, V24, P1004	10	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1328-8067	1442-200X		PEDIATR INT	Pediatr. Int.	DEC	2014	56	6					E79	E81		10.1111/ped.12432		3	Pediatrics	Pediatrics	AX1IL	WOS:000346700900001		
J	Tajiri, M; Maeda, T; Isobe, Y; Tanimoto, K; Shibayama, K				Tajiri, Minoru; Maeda, Takamasa; Isobe, Yoshiharu; Tanimoto, Katsuyuki; Shibayama, Koichi			Correction method for the physical dose calculated using Clarkson integration at the center of the spread-out Bragg peak for asymmetric field in carbon-ion radiotherapy	PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS			English	Article						Heavy-ion radiotherapy; Clarkson integration; Asymmetric field	IRRADIATION SYSTEM; RADIATION-THERAPY; BEAMS; HIMAC	Purpose: We previously proposed a calculation method using Clarkson integration to obtain the physical dose at the center of the spread-out Bragg peak (SOBP) for a treatment beam, the measurement point of which agrees with the isocenter [Tajiri et al. Med. Phys. 2013; 40: 071733-1-5]. However, at the measurement point which does not agree with the isocenter, the physical dose calculated by this method might have a large error. For this error, we propose a correction method. Materials and methods: To confirm whether the error can be corrected using in-air off axis ratio (OAR), we measured the physical dose at the center of an asymmetric square field and a symmetric square field and in-air OAR. For beams of which the measurement point does not agree with the isocenter, as applied to prostate cancer patients, the physical dose calculated using Clarkson integration was corrected with in-air OAR. Results: The maximum difference between the physical dose measured at the center of an asymmetric square field and the product of in-air OAR and the physical dose at the center of a symmetric square field was -0.12%. For beams as applied to prostate cancer patients, the differences between the measured physical doses and the physical doses corrected using in-air OAR were -0.17 +/- 0.23%. Conclusions: The physical dose at the measurement point which does not agree with the isocenter, can be obtained from in-air OAR at the isocenter plane and the physical dose at the center of the SOBP on the beam axis. (C) 2014 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.	[Tajiri, Minoru; Maeda, Takamasa; Isobe, Yoshiharu; Tanimoto, Katsuyuki; Shibayama, Koichi] Natl Inst Radiol Sci, Dept Hosp, Res Ctr Charged Particle Therapy, Inage Ku, Chiba 2638555, Japan	Tajiri, M (reprint author), Natl Inst Radiol Sci, Dept Hosp, Res Ctr Charged Particle Therapy, Inage Ku, 4-9-1 Anagawa, Chiba 2638555, Japan.	m_tajiri@nirs.go.jp					Zahra N, 2010, PHYS MEDICA, V26, P202, DOI 10.1016/j.ejmp.2009.12.001; Ishikawa H, 2012, INT J UROL, V19, P296, DOI 10.1111/j.1442-2042.2012.02961.x; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; International Commission on Radiation Units and Measurements (ICRU), 1999, 62 ICRU; Kanai T, 1998, PHYS MEDICA, V14, P63; Kanematsu N, 2011, PHYS MEDICA, V27, P97, DOI 10.1016/j.ejmp.2010.05.001; Kohno R, 2004, MED PHYS, V31, P1153, DOI 10.1118/1.1707727; Kusano Y, 2007, MED PHYS, V34, P4016, DOI 10.1118/1.2779126; Kusano Y, 2003, JPN J MED PHYS S2, V23, P65; Shimbo Munefumi, 2000, Nippon Acta Radiologica, V60, P274; Tajiri M, 2013, MED PHYS, V40, DOI 10.1118/1.4812426; Tsujii H., 2014, CARBON ION RADIOTHER	12	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1120-1797	1724-191X		PHYS MEDICA	Phys. Medica	DEC	2014	30	8					985	988		10.1016/j.ejmp.2014.07.003		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	AX7NS	WOS:000347103100019		
J	Watanabe, T; Honda, Y; Kanda, K; Einaga, Y				Watanabe, Takeshi; Honda, Yuki; Kanda, Kazuhiro; Einaga, Yasuaki			Tailored design of boron-doped diamond electrodes for various electrochemical applications with boron-doping level and sp(2)-bonded carbon impurities	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						boron; carbon; doping; diamond; electrodes; electrochemical properties	THIN-FILM ELECTRODES; HYDROGENATED GLASSY-CARBON; FLOW-INJECTION ANALYSIS; POLYCRYSTALLINE DIAMOND; SURFACE TERMINATION; OXIDATION; STABILITY; DOPAMINE; GRAPHITE	The effects of sp(2)-bonded carbon impurities on the electrochemical properties of boron-doped diamond were investigated in moderately ([B]<10(20) cm(-3)) and heavily ([B]>10(21) cm(-3)) boron doping levels. Significant influences of sp(2)-bonded carbon impurities, which show glassy carbon-like electrochemical properties after anodic oxidation, were observed in heavily boron-doped diamond. This indicated that the significant effects of enhanced adsorption properties were possibly caused by surface relaxation of the strains induced by heavy boron doping and sp(2)-bonded carbon impurities. On the other hand, their durability was still similar to diamond electrodes rather than glassy-carbon electrodes because of the low fraction of sp(2)-bonded carbon impurities. Such "active" diamond electrodes are much less suitable for wastewater treatment than ordinary diamond electrodes due to a different oxygen-evolution mechanism. On the other hand, "active" BDD electrodes have a much higher efficiency for electrochemical ozone production than other BDD electrodes. The electrode properties of BDD can be designed by controlling the boron doping level and introducing the sp(2)-bonded carbon impurities. The guidelines proposed in this study can be used effectively to design electrodes according to their individual application, such as for use as electrochemical sensors, in wastewater treatment or electrochemical ozone production. (C) 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Watanabe, Takeshi; Honda, Yuki; Einaga, Yasuaki] Keio Univ, Dept Chem, Yokohama, Kanagawa 2238522, Japan; [Kanda, Kazuhiro] Univ Hyogo, Lab Adv Sci & Technol Ind, Kamigori, Hyogo 6781205, Japan; [Einaga, Yasuaki] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Einaga, Y (reprint author), Keio Univ, Dept Chem, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	einaga@chem.keio.ac.jp	Einaga, Yasuaki/F-1833-2014				Chen QY, 1997, J ELECTROCHEM SOC, V144, P3806, DOI 10.1149/1.1838096; Suzuki A, 2007, ANAL CHEM, V79, P8608, DOI 10.1021/ac071519h; Yu HB, 2009, ENVIRON SCI TECHNOL, V43, P1935, DOI 10.1021/es8033878; ALEHASHEM S, 1995, ANAL CHEM, V67, P2812, DOI 10.1021/ac00113a014; Gonon P, 1995, J APPL PHYS, V78, P7059, DOI 10.1063/1.360410; Levy-Clement C, 1999, NEW DIAM FRONT C TEC, V9, P189; Maier F, 2000, PHYS REV LETT, V85, P3472, DOI 10.1103/PhysRevLett.85.3472; Iniesta J, 2001, ELECTROCHIM ACTA, V46, P3573, DOI 10.1016/S0013-4686(01)00630-2; Compton RG, 2003, ELECTROANAL, V15, P1349, DOI 10.1002/elan.200302830; Latto MN, 2004, ELECTROANAL, V16, P434, DOI 10.1002/elan.200302857; Pruvost F, 2001, DIAM RELAT MATER, V10, P531, DOI 10.1016/S0925-9635(00)00378-2; SWAIN GM, 1994, ADV MATER, V6, P388, DOI 10.1002/adma.19940060511; COMNINELLIS C, 1994, ELECTROCHIM ACTA, V39, P1857, DOI 10.1016/0013-4686(94)85175-1; Bustarret E, 2008, PHILOS T R SOC A, V366, P267, DOI 10.1098/rsta.2007.2151; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Watanabe T, 2010, DIAM RELAT MATER, V19, P772, DOI 10.1016/j.diamond.2010.02.022; Xu JS, 1998, ANAL CHEM, V70, P3146, DOI 10.1021/ac9800661; Tryk DA, 2007, DIAM RELAT MATER, V16, P881, DOI 10.1016/j.diamond.2007.02.002; LANDSTRASS MI, 1989, APPL PHYS LETT, V55, P975, DOI 10.1063/1.101694; Bennett JA, 2004, J ELECTROCHEM SOC, V151, pE306, DOI 10.1149/1.1780111; Granger MC, 1999, ANAL CHIM ACTA, V397, P145, DOI 10.1016/S0003-2670(99)00400-6; Rao TN, 1999, ANAL CHEM, V71, P2506, DOI 10.1021/ac981376m; Arihara K, 2007, J ELECTROCHEM SOC, V154, pE71, DOI 10.1149/1.2509385; Bard AJ, 2001, ELECTROCHEMICAL METH; Chen QY, 1998, LANGMUIR, V14, P7017, DOI 10.1021/la980907z; Marselli B, 2003, J ELECTROCHEM SOC, V150, pD79, DOI 10.1149/1.1553790; Robertson J., 1997, UNPUB; Tryk DA, 2001, DIAM RELAT MATER, V10, P1804, DOI 10.1016/S0925-9635(01)00453-8; WADA N, 1981, PHYSICA B & C, V105, P353, DOI 10.1016/0378-4363(81)90274-6	29	3	3	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	DEC	2014	211	12					2709	2717		10.1002/pssa.201431455		9	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	AX8UB	WOS:000347182700006		
J	Iwase, M; Suzuki, A; Akiyama, T; Oku, T				Iwase, Makoto; Suzuki, Atsushi; Akiyama, Tsuyoshi; Oku, Takeo			Fabrication and characterization of organic solar cells using titanylphthalocyanine as hole transport layer	PHYSICA STATUS SOLIDI A-APPLICATIONS AND MATERIALS SCIENCE			English	Article						copper; hole transport layer; optical absorption; organic solar cells; phthalocyanine	TITANYL PHTHALOCYANINE/C-60 HETEROJUNCTIONS; NAPHTHALOCYANINE	Organic solar cells using titanylphthalocyanine as a hole transport layer (HTL) were fabricated and characterized. Photovoltaic properties of the solar cells with inverted structures were investigated by optical absorption and current density-voltage (J-V) characteristic. The titanylphthalocyanine was mainly used as a buffer layer instead of PEDOT:PSS, and worked as HTL protecting the active layers. (C) 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim	[Iwase, Makoto; Suzuki, Atsushi; Akiyama, Tsuyoshi; Oku, Takeo] Univ Shiga Prefecture, Dept Mat Sci, Hikone, Shiga 5228533, Japan	Suzuki, A (reprint author), Univ Shiga Prefecture, Dept Mat Sci, 2500 Hassaka, Hikone, Shiga 5228533, Japan.	suzuki@mat.usp.ac.jp; oku@mat.usp.ac.jp	AKIYAMA, Tsuyoshi/D-9033-2015				Placencia D, 2011, J PHYS CHEM C, V115, P18873, DOI 10.1021/jp2052085; Takeda A, 2013, SYNTHETIC MET, V177, P48, DOI 10.1016/j.synthmet.2013.06.011; Bamsey NM, 2011, SOL ENERG MAT SOL C, V95, P1970, DOI 10.1016/j.solmat.2011.01.042; Kouskoussa B, 2009, PHYS STATUS SOLIDI A, V206, P311, DOI 10.1002/pssa.200824343; Varotto A, 2010, J AM CHEM SOC, V132, P2552, DOI 10.1021/ja907851x; Hori T, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.101602; Bechara R, 2012, SOL ENERG MAT SOL C, V98, P482, DOI 10.1016/j.solmat.2011.11.005; Brumbach M, 2008, J PHYS CHEM C, V112, P3142, DOI 10.1021/jp0772171; Hori T, 2011, SOL ENERG MAT SOL C, V95, P3087, DOI 10.1016/j.solmat.2011.06.039; Cheng F, 2011, SOL ENERG MAT SOL C, V95, P2914, DOI 10.1016/j.solmat.2011.06.027; Placencia D, 2009, ADV FUNCT MATER, V19, P1913, DOI 10.1002/adfm.200801723; Huang CJ, 2011, SOL ENERG MAT SOL C, V95, P3460, DOI 10.1016/j.solmat.2011.08.006; Norton JE, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2806803; Liao M. S., 2001, J CHEM PHYS, V114, P8; Liua Y. D., 2012, ORG ELECTRON, V13, P2865; Obata N, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.121603; Oku T, 2013, MATER TECHNOL, V28, P21, DOI 10.1179/1753555712Y.0000000042; Oku T, 2013, J PHYS CONF SER, V433, DOI 10.1088/1742-6596/433/1/012025; Oku T, 2013, PHYS STATUS SOLIDI C, V10, P1836, DOI 10.1002/pssc.201300369; Kuwabara T, 2008, SOL ENERG MAT SOL C, V92, P1476, DOI 10.1016/j.solmat.2008.06.012; Takeda A, 2011, PROG NAT SCI, V21, P27; Thuy T., 2010, SOL ENERG MAT SOL C, V94, P1059; YAMASHITA A, 1994, J PHYS CHEM-US, V98, P12695, DOI 10.1021/j100099a037; Yoshida K., 2013, MAT SCI APPL, V4, P1; Yoshida Kazumi, 2012, ADV CHEM ENG SCI, V2, P461; Zhang LJ, 2012, J MOL GRAPH MODEL, V35, P57, DOI 10.1016/j.jmgm.2011.11.005	26	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1862-6300	1862-6319		PHYS STATUS SOLIDI A	Phys. Status Solidi A-Appl. Mat.	DEC	2014	211	12					2861	2864		10.1002/pssa.201431068		4	Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	AX8UB	WOS:000347182700031		
J	Takagi, M; Ishii, T; Torii, C; Kosaki, K; Hasegawa, T				Takagi, Masaki; Ishii, Tomohiro; Torii, Chiharu; Kosaki, Kenjiro; Hasegawa, Tomonobu			A novel mutation in SOX3 polyalanine tract: a case of kabuki syndrome with combined pituitary hormone deficiency harboring double mutations in MLL2 and SOX3	PITUITARY			English	Article						CPHD; SOX3; PA tract	NIIKAWA-KUROKI SYNDROME; MAKE-UP SYNDROME; MENTAL-RETARDATION; GROWTH; SPECTRUM; GENES; EARS	Introduction Both duplications encompassing SOX3 and loss-of function mutations in SOX3 have been reported in a minor portion of X-linked isolated growth hormone deficiency (GHD) or combined pituitary hormone deficiency (CPHD) patients with or without mental retardation. Patients and methods We report a Japanese male patient with molecularly confirmed Kabuki syndrome who was found to have CPHD. We analyzed all coding exons and flanking introns of currently known nine genes responsible for CPHD by PCR-based sequencing. Results In this CPHD patient, we identified a novel hemizygous 21-base pair deletion, resulting in the loss of 7 alanine residues from polyalanine (PA) tracts of SOX3. The clinically and endocrinologically normal mother of the patient carried the same deletion in a heterozygous manner. In vitro experiments showed that the del 7A SOX3 had increased transactivation of the HESX1 promoter. Conclusion Our study provides additional evidence that deletion in PA tracts of SOX3 is associated with hypopituitarism. Female carriers of SOX3 PA tract deletions will show a broad phenotypic spectrum, ranging from clinically normal to CPHD.	[Takagi, Masaki; Ishii, Tomohiro; Hasegawa, Tomonobu] Keio Univ, Sch Med, Dept Pediat, Shinjuku Ku, Tokyo 1608582, Japan; [Takagi, Masaki] Tokyo Metropolitan Childrens Med Ctr, Dept Endocrinol & Metab, Tokyo, Japan; [Torii, Chiharu; Kosaki, Kenjiro] Keio Univ, Sch Med, Ctr Med Genet, Tokyo 1608582, Japan	Hasegawa, T (reprint author), Keio Univ, Sch Med, Dept Pediat, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	thaseg@a6.keio.jp		Ishii, Tomohiro/0000-0001-7360-2465	Ministry of Health, Labour and Welfare of Japan [Jitsuyoka (Nanbyo)-Ippan-014 (23300102)]	We thank the patient and his family for participation in this study. We thank Kazue Kinoshita for technical assistance. This work was supported by a Grant-in-Aid for the Health Science Research Grant for Research on Applying Health Technology [Jitsuyoka (Nanbyo)-Ippan-014 (23300102)] from the Ministry of Health, Labour and Welfare of Japan.	Alatzoglou KS, 2011, J CLIN ENDOCR METAB, V96, P685; Hannibal MC, 2011, AM J MED GENET A, V155A, P1511, DOI 10.1002/ajmg.a.34074; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; KUROKI Y, 1981, J PEDIATR-US, V99, P570, DOI 10.1016/S0022-3476(81)80256-9; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Collignon J, 1996, DEVELOPMENT, V122, P509; Laumonnier F, 2002, AM J HUM GENET, V71, P1450, DOI 10.1086/344661; Woods KS, 2005, AM J HUM GENET, V76, P833, DOI 10.1086/430134; NIIKAWA N, 1988, AM J MED GENET, V31, P565, DOI 10.1002/ajmg.1320310312; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Li Y, 2011, HUM GENET, V130, P715, DOI 10.1007/s00439-011-1004-y; Wright EMMB, 2009, CLIN DYSMORPHOL, V18, P218, DOI 10.1097/MCD.0b013e32832d06f0; DEVRIENDT K, 1995, HORM RES, V43, P303, DOI 10.1159/000184355; Gabrielli O, 2002, CLIN DYSMORPHOL, V11, P71, DOI 10.1097/00019605-200201000-00015; HANDA Y, 1991, J CRANIO MAXILL SURG, V19, P99, DOI 10.1016/S1010-5182(05)80570-0; Micale L, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-38; NIIKAWA N, 1981, J PEDIATR-US, V99, P565, DOI 10.1016/S0022-3476(81)80255-7; Paulussen AD, 2011, HUM MUTAT, V32, P2018; Satoh M, 1993, CLIN PEDIAT ENDOCRIN, V2, P13; Tawa Ritsuko, 1994, Acta Paediatrica Japonica, V36, P412	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1386-341X	1573-7403		PITUITARY	Pituitary	DEC	2014	17	6					569	574		10.1007/s11102-013-0546-5		6	Endocrinology & Metabolism	Endocrinology & Metabolism	AX5JW	WOS:000346963100011		
J	Akaishi, R; Yamada, T; Nakabayashi, K; Nishihara, H; Furuta, I; Kojima, T; Morikawa, M; Yamada, T; Fujita, N; Minakami, H				Akaishi, R.; Yamada, T.; Nakabayashi, K.; Nishihara, H.; Furuta, I.; Kojima, T.; Morikawa, M.; Yamada, T.; Fujita, N.; Minakami, H.			Autophagy in the placenta of women with hypertensive disorders in pregnancy	PLACENTA			English	Article						Autophagy; Gestational hypertension; Preeclampsia; Pregnancy-induced hypertension	LC3; PREECLAMPSIA; PROTEINURIA	Introduction: Autophagy has not been studied extensively in the human placenta. This study was performed to determine whether autophagy is increased in the placentas of women with hypertensive disorders in pregnancy compared to normotensive pregnancies. Methods: LC3-II and p62 protein expression were examined by quantitative Western blotting analysis in 40 placentas from women not experiencing labor pains. The 40 placentas were from 13, 8, and 19 women with preeclampsia, gestational hypertension, and normal pregnancy, respectively. Hypertensive disorders in pregnancy included preeclampsia and gestational hypertension. Results: LC3-II expression was significantly increased, while that of p62 was significantly reduced in 21 placentas of women with hypertensive disorders compared to those with normal blood pressure irrespective of the presence or absence of fetal growth restriction (FGR). LC3-II expression was also significantly increased in 13 placentas of women with preeclampsia irrespective of the presence or absence of FGR. Discussion: The results of this study suggested that autophagy is active in the placenta of hypertensive disorders even in the absence of FGR. (C) 2014 Elsevier Ltd. All rights reserved.	[Akaishi, R.; Yamada, T.; Furuta, I.; Kojima, T.; Morikawa, M.; Yamada, T.; Minakami, H.] Hokkaido Univ, Dept Obstet & Gynecol, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan; [Nakabayashi, K.] Natl Res Inst Child Hlth, Dept Maternal Fetal Biol, Tokyo, Japan; [Nishihara, H.] Hokkaido Univ, Dept Translat Pathol, Grad Sch Med, Sapporo, Hokkaido 0608638, Japan; [Fujita, N.] Osaka Univ, Grad Sch Med, Dept Genet, Suita, Osaka, Japan	Yamada, T (reprint author), Hokkaido Univ, Dept Obstet & Gynecol, Grad Sch Med, Kita Ku, N15W7, Sapporo, Hokkaido 0608638, Japan.	taka0197@med.hokudai.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [18791140, 26462468]; Takeda Scientific Foundation; JAOG Ogyaa Donation Foundation	This study was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (No. 18791140 and No. 26462468), by grants from the Takeda Scientific Foundation, and by the JAOG Ogyaa Donation Foundation.	Oh SY, 2008, REPROD SCI, V15, P912, DOI 10.1177/1933719108319159; Saudan P, 1998, BRIT J OBSTET GYNAEC, V105, P1177, DOI 10.1111/j.1471-0528.1998.tb09971.x; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Chang YL, 2013, PRENATAL DIAG, V33, P187, DOI 10.1002/pd.4040; Curtis S, 2013, J MATERN-FETAL NEO M, V26, P339, DOI 10.3109/14767058.2012.733764; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Signorelli P, 2011, PLACENTA, V32, P482, DOI 10.1016/j.placenta.2011.03.005; Morikawa M, 2008, J PERINAT MED, V36, P419, DOI 10.1515/JPM.2008.062; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Yamada T, 2014, J OBSTET GYNAECOL RE, V40, P161, DOI 10.1111/jog.12148; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Avagliano L, 2013, PLACENTA, V34, P1091, DOI 10.1016/j.placenta.2013.09.004; Avagliano L, 2013, BIOMED RES INT, DOI 10.1155/2013/689768; Huang JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094382; Hung TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040957; Hung TH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083475; Itabashi K, 2010, J JPN PEDIAT SOC, V114, P1271; Jahania SM, 2013, J AM COLL SURGEONS, V216, P719, DOI 10.1016/j.jamcollsurg.2012.12.034	19	2	2	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0143-4004	1532-3102		PLACENTA	Placenta	DEC	2014	35	12					974	980		10.1016/j.placenta.2014.10.009		7	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	Developmental Biology; Obstetrics & Gynecology; Reproductive Biology	AX5GA	WOS:000346953500002		
J	Kishi-Kaboshi, M; Muto, H; Takeda, A; Murata, T; Hasebe, M; Watanabe, Y				Kishi-Kaboshi, Mitsuko; Muto, Hirona; Takeda, Atsushi; Murata, Takashi; Hasebe, Mitsuyasu; Watanabe, Yuichiro			Localization of tobacco germin-like protein 1 in leaf intercellular space	PLANT PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Cell wall; Germin-like protein; Intercellular space; Nicotiana tabacum; Bifurcation; GLP1	SUPEROXIDE-DISMUTASE ACTIVITY; OXALATE OXIDASE; GENE FAMILY; EXPRESSION; LEAVES; PLASMODESMATA; PURIFICATION; ARABIDOPSIS; RESISTANCE; SEQUENCE	To characterize leaf cell wall proteins relating the architectural changes of leaves, we analyzed Nicotiana tabacum leaf cell wall proteins that were extracted by the treatment with lithium chloride. Some of these proteins showed amino acid sequence homology to some germin-like proteins (GLP). Based of those sequences, we isolated the cDNA encoding the GLPs (NtGLP1-1, NtGLP2-1). Phylogenetic analysis including de novo assembled tobacco GLPs using EST clones, revealed that tobacco GLPs belong to at least 5 different subgroups of GLP and both NtGLP1 and NtGLP2 belong to GLP subfamily 3. We showed that the NtGLP1 actually localizes to cell wall and revealed that it predominantly localized at specific sites on the leaf cell wall where intercellular attachment was just bifurcated. Expression of the NtGLP1 mRNA was mainly detected in leaves especially at elongating stage. NtGLP1 is possibly relevant to development of leaf intercellular space. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Kishi-Kaboshi, Mitsuko; Muto, Hirona; Takeda, Atsushi; Watanabe, Yuichiro] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan; [Murata, Takashi; Hasebe, Mitsuyasu] Natl Inst Basic Biol, Div Evolutionary Biol, Okazaki, Aichi 444, Japan; [Murata, Takashi; Hasebe, Mitsuyasu] Grad Univ Adv Studies, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4440867, Japan	Watanabe, Y (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan.	solan@bio.c.u-tokyo.ac.jp			Japan Society for Promotion of Science KAKENHI [20370019];  [21027008]	We thank Yumiko Makino at National Institute for Basic Biology Center for Analytical Instruments for amino acid sequencing procedure. We are grateful to Haruki Hashimoto at Univ. of Tokyo for guidance on the use of electron microscopy. We thank Miki Miyanokoshi and Eitaro Oami at Univ. of Tokyo for support to construct GST fusion vectors. This work was supported by the Japan Society for Promotion of Science KAKENHI (20370019) and Grant-in-Aid for Scientific Research on Priority Areas (21027008) to Y.W.	LANE BG, 1993, J BIOL CHEM, V268, P12239; Manosalva PM, 2009, PLANT PHYSIOL, V149, P286, DOI 10.1104/pp.108.128348; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Khuri S, 2001, MOL BIOL EVOL, V18, P593; Woo EJ, 2000, NAT STRUCT BIOL, V7, P1036; Kim HJ, 2004, PLANTA, V218, P516, DOI 10.1007/s00425-003-1133-1; Nakata M, 2004, PLANT MOL BIOL, V56, P381, DOI 10.1007/s11103-004-3475-x; Fujioka Y, 2007, PLANT CELL PHYSIOL, V48, P1243, DOI 10.1093/pep/pcm099; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Christensen AB, 2004, MOL PLANT MICROBE IN, V17, P109, DOI 10.1094/MPMI.2004.17.1.109; Ono M, 1996, PLANT CELL PHYSIOL, V37, P855; Yamahara T, 1999, J BIOL CHEM, V274, P33274, DOI 10.1074/jbc.274.47.33274; Dani V, 2005, PROTEOMICS, V5, P737, DOI 10.1002/pmic.200401119; Davidson RM, 2009, PLANT SCI, V177, P499, DOI 10.1016/j.plantsci.2009.08.012; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Avery GS, 1933, AM J BOT, V20, P565, DOI 10.2307/2436259; Carter C, 2000, J BIOL CHEM, V275, P36726, DOI 10.1074/jbc.M006461200; Ohmiya A, 1998, PLANT CELL PHYSIOL, V39, P492; Ham BK, 2012, PLANT CELL, V24, P3630, DOI 10.1105/tpc.112.101063; HEINTZEN C, 1994, PLANT PHYSIOL, V106, P905, DOI 10.1104/pp.106.3.905; Kim HJ, 2004, PLANTA, V218, P525, DOI 10.1007/s00425-003-1134-0; Kishi-Kaboshi M, 2005, PROTOPLASMA, V225, P85, DOI 10.1007/s00709-004-0080-4; Membre N, 1997, PLANT MOL BIOL, V35, P459, DOI 10.1023/A:1005833028582; Roberts IM, 2001, PROTOPLASMA, V218, P31, DOI 10.1007/BF01288358; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Schweizer Patrick, 1999, Plant Journal, V20, P541, DOI 10.1046/j.1365-313X.1999.00624.x; Staiger D, 1999, PLANT MOL BIOL, V40, P873, DOI 10.1023/A:1006278030024; TANG WJY, 1993, METHOD CELL BIOL, V37, P95, DOI 10.1016/S0091-679X(08)60245-9; Vallelian-Bindschedler L, 1998, PLANT MOL BIOL, V37, P297, DOI 10.1023/A:1005982715972; Zimmermann G, 2006, PLANT PHYSIOL, V142, P181, DOI 10.1104/pp.106.083824	30	3	3	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0981-9428			PLANT PHYSIOL BIOCH	Plant Physiol. Biochem.	DEC	2014	85						1	8		10.1016/j.plaphy.2014.10.005		8	Plant Sciences	Plant Sciences	AY0FP	WOS:000347273300001		
J	Huang, SH; Zhang, JY; Tao, Z; Lei, L; Yu, YH; Huang, LQ				Huang, ShuoHao; Zhang, JianYun; Tao, Zhen; Lei, Liang; Yu, YongHui; Huang, LongQuan			Enzymatic conversion from pyridoxal to pyridoxine caused by microorganisms within tobacco phyllosphere	PLANT PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Nicotiana tabacum; Phyllosphere microorganism; Pyridoxal; Enzymatic reduction; Vitamin B-6	SCHIZOSACCHAROMYCES-POMBE; VITAMIN-B6 BIOSYNTHESIS; ARABIDOPSIS-THALIANA; DIFFERENT FORMS; PLANTS; INTERCONVERSIONS; DEHYDROGENASE; COLONIZATION; COMMUNITIES; DERIVATIVES	Vitamin B-6 (VB6) comprises six interconvertible pyridine compounds (vitamers), among which pyridoxal 5'-phosphate (PLP) is a coenzyme involved in a high diversity of biochemical reactions. In plants, PLP is de novo synthesized, and pyridoxine (PN) is usually maintained as the predominant B-6 vitamer. Although the conversion from pyridoxal (PL) to PN catalyzed by PL reductase in plants has been confirmed, the enzyme itself remains largely unknown. We previously found pre-incubation at 35 degrees C dramatically enhanced PL reductase activity in tobacco leaf homogenate. In this study, we demonstrated that the increase in the reductase activity was a consequence of phyllosphere microbial proliferation. VB6 was detected from tobacco phyllosphere, and PL level was the highest among three non-phosphorylated B-6 vitamers. When the sterile tobacco rich in PL were kept in an open, warm and humid environment to promote microorganism proliferation, a significant change from PL to PN was observed. Our results suggest that there may be a plant microbe interaction in the conversion from PL to PN within tobacco phyllosphere. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Huang, ShuoHao; Tao, Zhen; Lei, Liang; Yu, YongHui; Huang, LongQuan] Anhui Agr Univ, Sch Tea & Food Sci, Hefei 230036, Peoples R China; [Huang, ShuoHao] Takara Bio Inc, Ctr Cell & Gene Therapy, Otsu, Shiga 5202193, Japan; [Zhang, JianYun] Anhui Agr Univ, Sch Life Sci, Hefei 230036, Peoples R China	Huang, LQ (reprint author), Anhui Agr Univ, Sch Tea & Food Sci, Hefei 230036, Peoples R China.	lqhuang218@aliyun.com			National Natural Science Foundation of China [31372262]	This study was supported by the National Natural Science Foundation of China (No. 31372262). We would like to thank Professor Shu Wei for kindly revising this manuscript for English language usage.	Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Tambasco-Studart M, 2005, P NATL ACAD SCI USA, V102, P13687, DOI 10.1073/pnas.0506228102; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Ehrenshaft M, 1999, P NATL ACAD SCI USA, V96, P9374, DOI 10.1073/pnas.96.16.9374; Nakano M, 1999, J BIOL CHEM, V274, P23185, DOI 10.1074/jbc.274.33.23185; Gerdes S, 2012, J EXP BOT, V63, P5379, DOI 10.1093/jxb/ers208; Yadav RKP, 2005, MICROB ECOL, V50, P185, DOI 10.1007/s00248-004-0171-y; Bilski P, 2000, PHOTOCHEM PHOTOBIOL, V71, P129, DOI 10.1562/0031-8655(2000)071<0129:SIPVBP>2.0.CO;2; Denslow SA, 2005, PHYSIOL MOL PLANT P, V66, P244, DOI 10.1016/j.pmpp.2005.09.004; Densiow SA, 2007, PLANT PHYSIOL BIOCH, V45, P152, DOI 10.1016/j.plaphy.2007.01.007; GUIRARD B M, 1988, Biofactors, V1, P187; Herrero S, 2011, PLANT MOL BIOL, V76, P157, DOI 10.1007/s11103-011-9777-x; HOLZER H, 1961, BIOCHIM BIOPHYS ACTA, V48, P71, DOI 10.1016/0006-3002(61)90516-9; Huang SH, 2011, PLANT PHYSIOL BIOCH, V49, P1299, DOI 10.1016/j.plaphy.2011.08.008; Huang SH, 2012, PLANT PHYSIOL BIOCH, V57, P114, DOI 10.1016/j.plaphy.2012.05.017; Huang SH, 2013, PLANT SCI, V212, P55, DOI 10.1016/j.plantsci.2013.08.001; Huang SH, 2011, PHYTOCHEMISTRY, V72, P2124, DOI 10.1016/j.phytochem.2011.07.019; Jurkevitch EJ, 2000, MICROBIAL ECOL, V40, P300; Leuendorf JE, 2008, FEBS J, V275, P960, DOI 10.1111/j.1742-4658.2008.06275.x; MORINO Y, 1960, J BIOCHEM-TOKYO, V48, P733; Morita T, 2004, J BIOCHEM, V135, P225, DOI 10.1093/jb/mvh026; Morris CE, 1998, APPL ENVIRON MICROB, V64, P4789; MURTY MG, 1984, APPL ENVIRON MICROB, V48, P713; Ollilainen Velimatti, 1999, Agricultural and Food Science in Finland, V8, P515; SHANE B, 1976, J BIOL CHEM, V251, P1042; Yagi T., 1998, FEMS MICROBIOL LETT, V161, P1450; Zhang JY, 2004, CHEM J CHINESE U, V25, P638; Zhou Yu, 2006, Bulletin of Botanical Research, V26, P233	28	1	1	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0981-9428			PLANT PHYSIOL BIOCH	Plant Physiol. Biochem.	DEC	2014	85						9	13		10.1016/j.plaphy.2014.10.006		5	Plant Sciences	Plant Sciences	AY0FP	WOS:000347273300002		
J	Scalera, V; Gena, P; Mastrodonato, M; Kitagawa, Y; Carulli, S; Svelto, M; Calamita, G				Scalera, Vito; Gena, Patrizia; Mastrodonato, Maria; Kitagawa, Yoshichika; Carulli, Salvatore; Svelto, Maria; Calamita, Giuseppe			Functional reconstitution of a rice aquaporin water channel, PIP1;1, by a micro-batchwise methodology	PLANT PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Oryza sativa; AQP channels; PIP1; Osmotic water transport; Liposomes; Membrane protein reconstitution; Micro-batchwise technology	AMMONIA TRANSPORT; EXPRESSION; PERMEABILITY; RAT; PROTEIN; CARRIER; PROTEOLIPOSOMES; MITOCHONDRIA; SELECTIVITY; SYSTEM	Assessing the selectivity, regulation and physiological relevance of aquaporin membrane channels (AQPs) requires structural and functional studies of wild type and modified proteins. In particular, when characterizing their transport properties, reconstitution in isolation from native cellular or membrane processes is of pivotal importance. Here, we describe rapid and efficient incorporation of OsPIP1;1, a rice AQP, in liposomes at analytical scale. PIP1;1 was produced as a histidine-tagged form, 10His-OsPIP1;1, in an Escherichia co/i-based expression system. The recombinant protein was purified by affinity chromatography and incorporated into liposomes by a micro-batchwise technology using egg-yolk phospholipids and the non-polar Amberlite resin. PIP1;1 proteoliposomes and control empty liposomes had good size homogeneity as seen by quasi-elastic light scattering and electron microscopy analyses. By stopped-flow light scattering, indicating correct protein folding of the incorporated protein, the osmotic water permeability exhibited by the PIP1;1 proteoliposomes was markedly higher than empty liposomes. Functional reconstitution of OsPIP1;1 was further confirmed by the low Arrhenius activation energy (3.37 kcal/mol) and sensitivity to HgCl2, a known AQP blocker, of the PIP1;1-mediated osmotic water conductance. These results provide a valuable contribution in fully elucidating the regulation and water-conducting property of PIP1;1, an AQP that needs to hetero-multimerize with AQPs of the PIP2 subgroup to reach the native plasma membrane and play its role. The micro-batchwise methodology is suitable for the functional reconstitution of whichever AQPs and other membrane transport proteins. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Scalera, Vito; Gena, Patrizia; Carulli, Salvatore; Svelto, Maria; Calamita, Giuseppe] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, I-70125 Bari, Italy; [Mastrodonato, Maria] Univ Bari, Dept Biol, I-70125 Bari, Italy; [Kitagawa, Yoshichika] Akita Prefectural Univ, Grad Sch Bioresources Sci, Akita, Japan; [Calamita, Giuseppe] WAFITECH, Network Apulian Publ Res Labs, Bari, Italy	Calamita, G (reprint author), Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Via Orabona 4, I-70125 Bari, Italy.	giuseppe.calamita@uniba.it		Svelto, Maria/0000-0002-5584-9541; Mastrodonato, Maria/0000-0002-0799-8032	Regione Puglia (PO Puglia FESR, Asse I, Linea 1.2, Rete di Laboratori Pubblici di Ricerca WAFITECH)	Financial support from Regione Puglia (PO Puglia FESR 2007-2013, Asse I, Linea 1.2, Rete di Laboratori Pubblici di Ricerca WAFITECH) to G.C. is gratefully acknowledged.	Soria LR, 2013, HEPATOLOGY, V57, P2061, DOI 10.1002/hep.26236; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Yu X, 2006, CELL RES, V16, P599, DOI 10.1038/sj.cr.7310077; Fetter K, 2004, PLANT CELL, V16, P215, DOI 10.1105/tpc.017194; Lian HL, 2004, PLANT CELL PHYSIOL, V45, P481, DOI 10.1093/pcp/pch058; Liu CW, 2013, PLANT PHYSIOL BIOCH, V63, P151, DOI 10.1016/j.plaphy.2012.11.018; Ishibashi K, 2011, AM J PHYSIOL-REG I, V300, pR566, DOI 10.1152/ajpregu.90464.2008; Uehlein N, 2003, NATURE, V425, P734, DOI 10.1038/nature02027; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Boron WF, 2010, EXP PHYSIOL, V95, P1107, DOI 10.1113/expphysiol.2010.055244; Soria LR, 2010, BIOCHEM BIOPH RES CO, V393, P217, DOI 10.1016/j.bbrc.2010.01.104; Wu B, 2007, CELL MOL LIFE SCI, V64, P2413, DOI 10.1007/s00018-007-7163-2; Ding XD, 2013, BIOL CELL, V105, P118, DOI 10.1111/boc.201200057; Bellati J, 2010, PLANT MOL BIOL, V74, P105, DOI 10.1007/s11103-010-9658-8; Meinild AK, 1998, J BIOL CHEM, V273, P32446, DOI 10.1074/jbc.273.49.32446; Zelazny E, 2007, P NATL ACAD SCI USA, V104, P12359, DOI 10.1073/pnas.0701180104; Borgnia MJ, 1999, J MOL BIOL, V291, P1169, DOI 10.1006/jmbi.1999.3032; Gena P, 2011, FOOD BIOPHYS, V6, P241, DOI 10.1007/s11483-010-9193-9; Almasalmeh A, 2014, FEBS J, V281, P647, DOI 10.1111/febs.12653; Calamita G, 2006, BBA-BIOMEMBRANES, V1758, P1018, DOI 10.1016/j.bbamem.2006.07.008; Calamita G, 2005, BIOL CELL, V97, P351, DOI 10.1042/BC20050017; Yaneff A, 2014, P NATL ACAD SCI USA, V111, P231, DOI 10.1073/pnas.1316537111; ZEIDEL ML, 1994, BIOCHEMISTRY-US, V33, P1606, DOI 10.1021/bi00172a042; Saparov SM, 2007, J BIOL CHEM, V282, P5296, DOI 10.1074/jbc.M609343200; Li LG, 2000, PLANT SCI, V154, P43, DOI 10.1016/S0168-9452(99)00269-1; Bienert GP, 2014, BBA-GEN SUBJECTS, V1840, P1596, DOI 10.1016/j.bbagen.2013.09.017; Yasui M, 1999, P NATL ACAD SCI USA, V96, P5808, DOI 10.1073/pnas.96.10.5808; Calamita G, 2008, AM J PHYSIOL-GASTR L, V295, pG682, DOI 10.1152/ajpgi.90226.2008; Girard P, 2004, EUR PHYS J E, V14, P387, DOI 10.1140/epje/i2004-10020-6; INDIVERI C, 1987, BIOCHIM BIOPHYS ACTA, V890, P310, DOI 10.1016/0005-2728(87)90158-7; Jozefkowicz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057993; MANCINI GMS, 1992, P NATL ACAD SCI USA, V89, P6609, DOI 10.1073/pnas.89.14.6609; Mastrodonato M, 2009, J HISTOCHEM CYTOCHEM, V57, P215, DOI 10.1369/jhc.2008.952234; Muller-Lucks A, 2013, NEW BIOTECHNOL, V30, P545, DOI 10.1016/j.nbt.2013.03.007; Sade N., 2014, PLANT PHYSL IN PRESS; Secchi F, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00507; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Spagnoletta A, 2008, J BIOCHEM BIOPH METH, V70, P954, DOI 10.1016/j.jprot.2007.11.003; YAO SYM, 1993, BIOCHEM J, V292, P655	40	0	0	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS	23 RUE LINOIS, 75724 PARIS, FRANCE	0981-9428			PLANT PHYSIOL BIOCH	Plant Physiol. Biochem.	DEC	2014	85						78	84		10.1016/j.plaphy.2014.10.013		7	Plant Sciences	Plant Sciences	AY0FP	WOS:000347273300010		
J	Sugiyama, M; Saitou, T; Kurokawa, H; Sakaue-Sawano, A; Imamura, T; Miyawaki, A; Iimura, T				Sugiyama, Mayu; Saitou, Takashi; Kurokawa, Hiroshi; Sakaue-Sawano, Asako; Imamura, Takeshi; Miyawaki, Atsushi; Iimura, Tadahiro			Live Imaging-Based Model Selection Reveals Periodic Regulation of the Stochastic G1/S Phase Transition in Vertebrate Axial Development	PLOS COMPUTATIONAL BIOLOGY			English	Article							CELL-CYCLE PROGRESSION; EUKARYOTIC GENE-EXPRESSION; RESTRICTION POINT; SEGMENTATION CLOCK; SINGLE-CELL; CHICK-EMBRYO; BODY AXIS; PROLIFERATION; NOISE; PROBABILITY	In multicellular organism development, a stochastic cellular response is observed, even when a population of cells is exposed to the same environmental conditions. Retrieving the spatiotemporal regulatory mode hidden in the heterogeneous cellular behavior is a challenging task. The G1/S transition observed in cell cycle progression is a highly stochastic process. By taking advantage of a fluorescence cell cycle indicator, Fucci technology, we aimed to unveil a hidden regulatory mode of cell cycle progression in developing zebrafish. Fluorescence live imaging of Cecyil, a zebrafish line genetically expressing Fucci, demonstrated that newly formed notochordal cells from the posterior tip of the embryonic mesoderm exhibited the red (G1) fluorescence signal in the developing notochord. Prior to their initial vacuolation, these cells showed a fluorescence color switch from red to green, indicating G1/S transitions. This G1/S transition did not occur in a synchronous manner, but rather exhibited a stochastic process, since a mixed population of red and green cells was always inserted between newly formed red (G1) notochordal cells and vacuolating green cells. We termed this mixed population of notochordal cells, the G1/S transition window. We first performed quantitative analyses of live imaging data and a numerical estimation of the probability of the G1/S transition, which demonstrated the existence of a posteriorly traveling regulatory wave of the G1/S transition window. To obtain a better understanding of this regulatory mode, we constructed a mathematical model and performed a model selection by comparing the results obtained from the models with those from the experimental data. Our analyses demonstrated that the stochastic G1/S transition window in the notochord travels posteriorly in a periodic fashion, with doubled the periodicity of the neighboring paraxial mesoderm segmentation. This approach may have implications for the characterization of the pathophysiological tissue growth mode.	[Sugiyama, Mayu; Kurokawa, Hiroshi; Sakaue-Sawano, Asako; Miyawaki, Atsushi; Iimura, Tadahiro] RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct & Dynam, Wako, Saitama, Japan; [Saitou, Takashi; Imamura, Takeshi] Ehime Univ, Grad Sch Med, Dept Mol Med Pathogenesis, Toon City, Ehime, Japan; [Imamura, Takeshi; Iimura, Tadahiro] Ehime Univ, Proteo Sci Ctr PROS, Div Bio Imaging, Toon City, Ehime, Japan; [Imamura, Takeshi; Iimura, Tadahiro] Ehime Univ Hosp, Translat Res Ctr, Toon City, Ehime, Japan	Sugiyama, M (reprint author), RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct & Dynam, Wako, Saitama, Japan.	timamura@m.ehime-u.ac.jp; matsushi@brain.riken.go.jp; iimura@m.ehime-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [22113002]	The current work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS) to Tim, and TIi, and a Grant-in-Aid for Scientific Research on Innovative Areas "Fluorescence Live Imaging" (No. 22113002) of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) MEXT to Tim, AM and TIi. This work was supported in part by the Japan Science Technology Agency (JST), Core Research for Evolutional Science and Technology (CREST) to TS, TIm and TIi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguda BD, 1999, CELL PROLIFERAT, V32, P321, DOI 10.1046/j.1365-2184.1999.3250321.x; Tyson DR, 2012, NAT METHODS, V9, P923, DOI 10.1038/nmeth.2138; Qu ZL, 2003, BIOPHYS J, V85, P3600, DOI 10.1016/S0006-3495(03)74778-X; Pascoal S, 2007, J MOL BIOL, V368, P303, DOI 10.1016/j.jmb.2007.01.089; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Sugiyama M, 2009, P NATL ACAD SCI USA, V106, P20812, DOI 10.1073/pnas.0906464106; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Iimura T, 2007, DEV GROWTH DIFFER, V49, P265, DOI 10.1111/j.1440-169x.2007.00928.x; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Goldbeter A, 2008, J THEOR BIOL, V252, P574, DOI 10.1016/j.jtbi.2008.01.006; SMITH JA, 1973, P NATL ACAD SCI USA, V70, P1263, DOI 10.1073/pnas.70.4.1263; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; SHIELDS R, 1977, NATURE, V267, P704, DOI 10.1038/267704a0; Spencer SL, 2013, CELL, V155, P369, DOI 10.1016/j.cell.2013.08.062; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Hatzimanikatis V, 1999, BIOTECHNOL BIOENG, V65, P631; Zhang LX, 2008, DEVELOPMENT, V135, P2065, DOI 10.1242/dev.022673; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Novak M, 2004, J THEOR BIOL, V230, P563, DOI 10.1016/j.jtbi.2004.04.039; Goldbeter A, 2007, DEV DYNAM, V236, P1495, DOI 10.1002/dvdy.21193; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Wilson V, 2009, DEVELOPMENT, V136, P1591, DOI 10.1242/dev.021246; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365; CASTOR LN, 1980, NATURE, V287, P857, DOI 10.1038/287857a0; Cooper S, 2003, FASEB J, V17, P333, DOI 10.1096/fj.02-0352rev; Volfson D, 2006, NATURE, V439, P861, DOI 10.1038/nature04281; COOKE J, 1976, J THEOR BIOL, V58, P455, DOI 10.1016/S0022-5193(76)80131-2; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; West GB, 2001, NATURE, V413, P628, DOI 10.1038/35098076; LEWIS JH, 1975, J EMBRYOL EXP MORPH, V33, P419; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Abe T, 2013, DEVELOPMENT, V140, P237, DOI 10.1242/dev.084111; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Soroldoni D, 2014, SCIENCE, V345, P222, DOI 10.1126/science.1253089; Aoki K, 2013, MOL CELL, V52, P529, DOI 10.1016/j.molcel.2013.09.015; Benazeraf B, 2013, ANNU REV CELL DEV BI, V29, P1, DOI 10.1146/annurev-cellbio-101011-155703; BROOKS RF, 1979, CELL BIOL INT REP, V3, P707, DOI 10.1016/0309-1651(79)90075-4; Cooper S, 1998, FASEB J, V12, P367; COOPER S, 1987, BIOESSAYS, V7, P220, DOI 10.1002/bies.950070507; Diez del Corral R., 2003, NEURON, V40, P65, DOI DOI 10.1016/S0896-6273(03)00565-8; Gillespie D.T., 1991, MARKOV PROCESSES INT; Johnson MH, 2000, BIOESSAYS, V22, P57, DOI 10.1002/(SICI)1521-1878(200001)22:1<57::AID-BIES10>3.3.CO;2-C; Koch AL, 1999, J BIOTECHNOL, V71, P143, DOI 10.1016/S0168-1656(99)00019-X; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lee TJ, 2010, PLOS BIOL, V8; Miller SA, 1999, DEV DYNAM, V216, P398, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<398::AID-DVDY8>3.0.CO;2-7; MILLS CL, 1989, ANAT EMBRYOL, V180, P301, DOI 10.1007/BF00315888; Pourquite O, 2007, COLD SPRING HARB SYM, V72, P445, DOI 10.1101/sqb.2007.72.016; Press W. H., 2007, NUMERICAL RECIPES; SHIELDS R, 1978, NATURE, V273, P755, DOI 10.1038/273755a0; SHIELDS R, 1977, J CELL PHYSIOL, V91, P345, DOI 10.1002/jcp.1040910304; STERN CD, 1984, ANAT EMBRYOL, V169, P97, DOI 10.1007/BF00300591; Thron CD, 1997, ONCOGENE, V15, P317, DOI 10.1038/sj.onc.1201190; Tyson DR, 2013, PERS MED, V10, P221, DOI 10.2217/PME.13.6; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Venters SJ, 2008, DEV DYNAM, V237, P377, DOI 10.1002/dvdy.21424; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0	65	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-734X	1553-7358		PLOS COMPUT BIOL	PLoS Comput. Biol.	DEC	2014	10	12							e1003957	10.1371/journal.pcbi.1003957		16	Biochemical Research Methods; Mathematical & Computational Biology	Biochemistry & Molecular Biology; Mathematical & Computational Biology	AX0QL	WOS:000346656700019		
J	Hori, C; Ishida, T; Igarashi, K; Samejima, M; Suzuki, H; Master, E; Ferreira, P; Ruiz-Duenas, FJ; Held, B; Canessa, P; Larrondo, LF; Schmoll, M; Druzhinina, IS; Kubicek, CP; Gaskell, JA; Kersten, P; St John, F; Glasner, J; Sabat, G; BonDurant, SS; Syed, K; Yadav, J; Mgbeahuruike, AC; Kovalchuk, A; Asiegbu, FO; Lackner, G; Hoffmeister, D; Rencoret, J; Gutierrez, A; Sun, H; Lindquist, E; Barry, K; Riley, R; Grigoriev, IV; Henrissat, B; Kues, U; Berka, RM; Martinez, AT; Covert, SF; Blanchette, RA; Cullen, D				Hori, Chiaki; Ishida, Takuya; Igarashi, Kiyohiko; Samejima, Masahiro; Suzuki, Hitoshi; Master, Emma; Ferreira, Patricia; Ruiz-Duenas, Francisco J.; Held, Benjamin; Canessa, Paulo; Larrondo, Luis F.; Schmoll, Monika; Druzhinina, Irina S.; Kubicek, Christian P.; Gaskell, Jill A.; Kersten, Phil; St John, Franz; Glasner, Jeremy; Sabat, Grzegorz; BonDurant, Sandra Splinter; Syed, Khajamohiddin; Yadav, Jagjit; Mgbeahuruike, Anthony C.; Kovalchuk, Andriy; Asiegbu, Fred O.; Lackner, Gerald; Hoffmeister, Dirk; Rencoret, Jorge; Gutierrez, Ana; Sun, Hui; Lindquist, Erika; Barry, Kerrie; Riley, Robert; Grigoriev, Igor V.; Henrissat, Bernard; Kuees, Ursula; Berka, Randy M.; Martinez, Angel T.; Covert, Sarah F.; Blanchette, Robert A.; Cullen, Daniel			Analysis of the Phlebiopsis gigantea Genome, Transcriptome and Secretome Provides Insight into Its Pioneer Colonization Strategies of Wood	PLOS GENETICS			English	Article							WHITE-ROT FUNGUS; BASIDIOMYCETE PHANEROCHAETE-CHRYSOSPORIUM; LIGNIN MODEL COMPOUNDS; CELLOBIOSE DEHYDROGENASE; BROWN-ROT; ALCOHOL-DEHYDROGENASE; MOLECULAR EVOLUTION; MULTICOPPER OXIDASE; COPRINOPSIS-CINEREA; PENIOPHORA-GIGANTEA	Collectively classified as white-rot fungi, certain basidiomycetes efficiently degrade the major structural polymers of wood cell walls. A small subset of these Agaricomycetes, exemplified by Phlebiopsis gigantea, is capable of colonizing freshly exposed conifer sapwood despite its high content of extractives, which retards the establishment of other fungal species. The mechanism(s) by which P. gigantea tolerates and metabolizes resinous compounds have not been explored. Here, we report the annotated P. gigantea genome and compare profiles of its transcriptome and secretome when cultured on fresh-cut versus solvent-extracted loblolly pine wood. The P. gigantea genome contains a conventional repertoire of hydrolase genes involved in cellulose/hemicellulose degradation, whose patterns of expression were relatively unperturbed by the absence of extractives. The expression of genes typically ascribed to lignin degradation was also largely unaffected. In contrast, genes likely involved in the transformation and detoxification of wood extractives were highly induced in its presence. Their products included an ABC transporter, lipases, cytochrome P450s, glutathione S-transferase and aldehyde dehydrogenase. Other regulated genes of unknown function and several constitutively expressed genes are also likely involved in P. gigantea's extractives metabolism. These results contribute to our fundamental understanding of pioneer colonization of conifer wood and provide insight into the diverse chemistries employed by fungi in carbon cycling processes.	[Hori, Chiaki; Ishida, Takuya; Igarashi, Kiyohiko; Samejima, Masahiro] Univ Tokyo, Dept Biomat Sci, Tokyo, Japan; [Suzuki, Hitoshi; Master, Emma] Univ Toronto, Dept Chem Engn, Toronto, ON, Canada; [Ferreira, Patricia] Univ Zaragoza, Dept Biochem & Mol & Cellular Biol, Zaragoza, Spain; [Ferreira, Patricia] Univ Zaragoza, Inst Biocomputat & Phys Complex Syst, Zaragoza, Spain; [Ruiz-Duenas, Francisco J.; Martinez, Angel T.] CSIC, Ctr Invest Biol, Madrid, Spain; [Held, Benjamin; Blanchette, Robert A.] Univ Minnesota, Dept Plant Pathol, St Paul, MN USA; [Canessa, Paulo; Larrondo, Luis F.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Millennium Nucleus Fungal Integrat & Synthet Biol, Santiago, Chile; [Canessa, Paulo; Larrondo, Luis F.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Genet Mol & Microbiol, Santiago, Chile; [Schmoll, Monika] Austrian Inst Technol GmbH, Hlth & Environm Dept, Tulin, Austria; [Druzhinina, Irina S.; Kubicek, Christian P.] Vienna Univ Technol, Austrian Ctr Ind Biotechnol, A-1040 Vienna, Austria; [Druzhinina, Irina S.; Kubicek, Christian P.] Vienna Univ Technol, Inst Chem Engn, A-1040 Vienna, Austria; [Gaskell, Jill A.; Kersten, Phil; St John, Franz; Cullen, Daniel] USDA, Forest Prod Lab, Madison, WI 53705 USA; [Glasner, Jeremy; Sabat, Grzegorz; BonDurant, Sandra Splinter] Univ Wisconsin, Ctr Biotechnol, Madison, WI 53705 USA; [Syed, Khajamohiddin; Yadav, Jagjit] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA; [Mgbeahuruike, Anthony C.; Kovalchuk, Andriy; Asiegbu, Fred O.] Univ Helsinki, Dept Forest Sci, Helsinki, Finland; [Lackner, Gerald; Hoffmeister, Dirk] Univ Jena, Dept Pharmaceut Biol, Hans Knoll Inst, Jena, Germany; [Rencoret, Jorge; Gutierrez, Ana] CSIC, Inst Recursos Nat & Agrobiol, E-41080 Seville, Spain; [Sun, Hui; Lindquist, Erika; Barry, Kerrie; Riley, Robert; Grigoriev, Igor V.] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Henrissat, Bernard] Aix Marseille Univ, Unite Mixte Rech 7257, CNRS, Marseille, France; [Kuees, Ursula] Univ Gottingen, Busgen Inst, D-37073 Gottingen, Germany; [Berka, Randy M.] Novozymes Inc, Davis, CA USA; [Covert, Sarah F.] Univ Georgia, Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA	Hori, C (reprint author), Univ Tokyo, Dept Biomat Sci, Tokyo, Japan.	dcullen@wisc.edu	Master, Emma/O-3554-2014; Partearroyo, CIB-Biblioteca/L-3262-2014; Ruiz-Duenas, Francisco/L-9837-2015; 	Partearroyo, CIB-Biblioteca/0000-0002-1692-4481; St John, Franz/0000-0003-3458-5628	US Department of Agriculture Cooperative State, Research, Education, and Extension Service Grant [2007-35504-18257]; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; HIPOP project of the Spanish Ministry of Economy and Competitiveness (MINECO) [BIO2011-26694]; PEROXICATS European project [KBBE-2010-4-265397]; INDOX European project [KBBE-2013-.3.3-04-613549]; Chilean National Fund for Scientific and Technological Development Grant [1131030]	The major portions of this work were performed under US Department of Agriculture Cooperative State, Research, Education, and Extension Service Grant 2007-35504-18257 (to DC and RAB). The US Department of Energy Joint Genome Institute is supported by the Office of Science of the US Department of Energy under Contract DE-AC02-05CH11231. This work was also supported by the HIPOP (BIO2011-26694) project of the Spanish Ministry of Economy and Competitiveness (MINECO) (to FJRD), the PEROXICATS (KBBE-2010-4-265397) and INDOX (KBBE-2013-.3.3-04-613549) European projects (to ATM), and the Chilean National Fund for Scientific and Technological Development Grant 1131030 (to LFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annesi T, 2005, FOREST PATHOL, V35, P127, DOI 10.1111/j.1439-0329.2004.00394.x; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Kawai S, 1999, FEMS MICROBIOL LETT, V170, P51, DOI 10.1111/j.1574-6968.1999.tb13354.x; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; Martinez-Inigo MJ, 1999, HOLZFORSCHUNG, V53, P247, DOI 10.1515/HF.1999.042; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Olson A, 2012, NEW PHYTOL, V194, P1001, DOI 10.1111/j.1469-8137.2012.04128.x; Yadav JS, 2003, FUNGAL GENET BIOL, V38, P10, DOI 10.1016/S1087-1845(02)00508-X; Hofrichter M, 2010, APPL MICROBIOL BIOT, V87, P871, DOI 10.1007/s00253-010-2633-0; Kumar SVS, 2003, BIOTECHNOL BIOENG, V83, P386, DOI 10.1002/bit.10681; Bastian S, 2005, APPL MICROBIOL BIOT, V67, P654, DOI 10.1007/s00253-004-1813-1; Kues U, 2011, CURR GENOMICS, V12, P72, DOI 10.2174/138920211795564377; Morgenstern I, 2008, J MOL EVOL, V66, P243, DOI 10.1007/s00239-008-9079-3; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Hibbett DS, 2001, SYST BIOL, V50, P215, DOI 10.1080/10635150151125879; Syed K, 2012, CRIT REV MICROBIOL, V38, P339, DOI 10.3109/1040841X.2012.682050; Gutierrez A, 2009, APPL MICROBIOL BIOT, V82, P1005, DOI 10.1007/s00253-009-1905-z; REISER J, 1994, J BIOL CHEM, V269, P28152; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Eggert C, 1997, FEBS LETT, V407, P89, DOI 10.1016/S0014-5793(97)00301-3; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Larrondo LF, 2003, APPL ENVIRON MICROB, V69, P6257, DOI 10.1128/AEM.69.10.6257-6263.2003; de Koker TH, 2004, APPL ENVIRON MICROB, V70, P5794, DOI 10.1128/AEM.70.10.5794-5800.2004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Grigoriev IV, 2006, APPL MYCOL BIOTECH, V6, P123; Ferreira P, 2006, FEBS J, V273, P4878, DOI 10.1111/j.1742-4658.2006.05488.x; Fernandez-Fueyo E, 2012, P NATL ACAD SCI USA, V109, P5458, DOI 10.1073/pnas.1119912109; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Ruhl M, 2013, ANTON LEEUW INT J G, V103, P1029, DOI 10.1007/s10482-013-9883-7; RZHETSKY A, 1992, J MOL EVOL, V35, P367, DOI 10.1007/BF00161174; Daniel G, 2007, APPL ENVIRON MICROB, V73, P6241, DOI 10.1128/AEM.00977-07; Adomas A, 2006, FEMS MICROBIOL ECOL, V57, P26, DOI 10.1111/j.1574-6941.2006.00094.x; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; KERSTEN PJ, 1990, P NATL ACAD SCI USA, V87, P2936, DOI 10.1073/pnas.87.8.2936; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; Matsuzaki F, 2008, J PROTEOME RES, V7, P2342, DOI 10.1021/pr700617s; Liers C, 2013, APPL MICROBIOL BIOT, V97, P5839, DOI 10.1007/s00253-012-4521-2; Syed K, 2013, APPL ENVIRON MICROB, V79, P2692, DOI 10.1128/AEM.03767-12; Shimizu M, 2005, PROTEOMICS, V5, P3919, DOI 10.1002/pmic.200401251; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; CAVENER DR, 1992, J MOL BIOL, V223, P811, DOI 10.1016/0022-2836(92)90992-S; GUILLEN F, 1994, APPL ENVIRON MICROB, V60, P2811; MacDonald J, 2011, APPL ENVIRON MICROB, V77, P3211, DOI 10.1128/AEM.02490-10; Munir E, 2001, P NATL ACAD SCI USA, V98, P11126, DOI 10.1073/pnas.191389598; Hori C, 2013, MYCOLOGIA, V105, P1412, DOI 10.3852/13-072; Hoegger PJ, 2006, FEBS J, V273, P2308, DOI 10.1111/j.1742-4658.2006.05247.x; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Adams AS, 2013, APPL ENVIRON MICROB, V79, P3468, DOI 10.1128/AEM.00068-13; Wang Y, 2013, NEW PHYTOL, V197, P886, DOI 10.1111/nph.12063; Garbelotto M, 2013, MOL ECOL, V22, P4855, DOI 10.1111/mec.12452; Bey M, 2013, APPL ENVIRON MICROB, V79, P488, DOI 10.1128/AEM.02942-12; Lettera V, 2010, FUNGAL BIOL-UK, V114, P724, DOI 10.1016/j.funbio.2010.06.004; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Kilaru S, 2006, CURR GENET, V50, P45, DOI 10.1007/s00294-006-0074-1; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Behrendt CJ, 1997, APPL ENVIRON MICROB, V63, P1995; Behrendt CJ, 2001, HOLZFORSCHUNG, V55, P238, DOI 10.1515/HF.2001.039; Blanchette RA, 2010, MICROB ECOL, V60, P29, DOI 10.1007/s00248-010-9664-z; BLANCHETTE RA, 1991, ANNU REV PHYTOPATHOL, V29, P381, DOI 10.1146/annurev.py.29.090191.002121; Bourbonnais R, 1997, APPL ENVIRON MICROB, V63, P4627; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Dorado J, 2000, J BIOTECHNOL, V80, P231, DOI 10.1016/S0168-1656(00)00264-9; Dowd CA, 1997, BIOCHEM J, V324, P243; Eriksson K., 1990, MICROBIAL ENZYMATIC; FISCHER K, 1994, HOLZFORSCHUNG, V48, P285, DOI 10.1515/hfsg.1994.48.4.285; Giffhorn F, 2000, APPL MICROBIOL BIOT, V54, P727, DOI 10.1007/s002530000446; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Gutierrez A, 1998, J CHROMATOGR A, V823, P449, DOI 10.1016/S0021-9673(98)00356-2; Hallberg BM, 2003, J BIOL CHEM, V278, P7160, DOI 10.1074/jbc.M210961200; Kaarik A.A., 1974, BIOLOGY PLANT LITTER, V1, P129; Kersten P, 2013, RECENT ADV GENOMICS, P311; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Rayner ADM, 1988, FUNGAL DECOMPOSITION; RISHBETH J, 1963, ANN APPL BIOL, V52, P63, DOI 10.1111/j.1744-7348.1963.tb03728.x; Ryu JS, 2011, APPL ENVIRON MICROB, V77, P7933, DOI 10.1128/AEM.05496-11; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; SHIGO A. L., 1967, Int. Rev, For. Res., V2, P237; Sjostrom E., 1993, WOOD CHEM FUNDAMENTA; SUN HW, 1992, J MOL EVOL, V34, P522, DOI 10.1007/BF00160465; GIBSON TJ, 1994, NUCLEIC ACIDS RES, V22, P2552, DOI 10.1093/nar/22.13.2552; van Beek TA, 2007, J NAT PROD, V70, P154, DOI 10.1021/np060325e; Vanden Wymelenberg A, 2009, APPL ENVIRON MICROB, V75, P4058, DOI 10.1128/AEM.00314-09; Vanden Wymelenberg A, 2006, FUNGAL GENET BIOL, V43, P343, DOI 10.1016/j.fgb.2006.01.003; Vanden Wymelenberg Amber, 2010, Appl Environ Microbiol, V76, P3599, DOI 10.1128/AEM.00058-10; Vanden Wymelenberg A, 2006, APPL ENVIRON MICROB, V72, P4871, DOI 10.1128/AEM.00375-06; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; Zuckerkandl J, 1965, EVOLVING GENES PROTE	92	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7390	1553-7404		PLOS GENET	PLoS Genet.	DEC	2014	10	12							e1004759	10.1371/journal.pgen.1004759		20	Genetics & Heredity	Genetics & Heredity	AX0NW	WOS:000346649900006		
J	Nishide, K; Hirano, T				Nishide, Kenji; Hirano, Tatsuya			Overlapping and Non-overlapping Functions of Condensins I and II in Neural Stem Cell Divisions	PLOS GENETICS			English	Article							DNA-DAMAGE; NEURONAL MATURATION; NERVOUS-SYSTEM; MECP2; GENES; BRAIN; DIFFERENTIATION; CHECKPOINT; SENESCENCE; APOPTOSIS	During development of the cerebral cortex, neural stem cells (NSCs) divide symmetrically to proliferate and asymmetrically to generate neurons. Although faithful segregation of mitotic chromosomes is critical for NSC divisions, its fundamental mechanism remains unclear. A class of evolutionarily conserved protein complexes, known as condensins, is thought to be central to chromosome assembly and segregation among eukaryotes. Here we report the first comprehensive genetic study of mammalian condensins, demonstrating that two different types of condensin complexes (condensins I and II) are both essential for NSC divisions and survival in mice. Simultaneous depletion of both condensins leads to severe defects in chromosome assembly and segregation, which in turn cause DNA damage and trigger p53-induced apoptosis. Individual depletions of condensins I and II lead to slower loss of NSCs compared to simultaneous depletion, but they display distinct mitotic defects: chromosome missegregation was observed more prominently in NSCs depleted of condensin II, whereas mitotic delays were detectable only in condensin I-depleted NSCs. Remarkably, NSCs depleted of condensin II display hyperclustering of pericentric heterochromatin and nucleoli, indicating that condensin II, but not condensin I, plays a critical role in establishing interphase nuclear architecture. Intriguingly, these defects are taken over to postmitotic neurons. Our results demonstrate that condensins I and II have overlapping and non-overlapping functions in NSCs, and also provide evolutionary insight into intricate balancing acts of the two condensin complexes.	[Nishide, Kenji; Hirano, Tatsuya] RIKEN, Chromosome Dynam Lab, Wako, Saitama, Japan	Nishide, K (reprint author), RIKEN, Chromosome Dynam Lab, Wako, Saitama, Japan.	hiranot@riken.jp	Hirano, Tatsuya/F-6008-2011		JSPS [24770194, 20002010, 25251023]	This work was supported by Grant-in-Aid for Scientific Research B (to KN; grant number 24770194) and Grant-in-Aid for Specially Promoted Research (to TH; grant number 20002010) and Grant-in-Aid for Scientific Research A (to TH; grant number 25251023) from JSPS (http://www.jsps.go.jp/english/index.html). KN was a RIKEN Special Postdoctoral Researcher (http://www.riken.jp/en/careers/programs/spdr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2011, HUM MOL GENET, V20, P4187, DOI 10.1093/hmg/ddr346; Lee J, 2011, MOL BIOL CELL, V22, P3465, DOI 10.1091/mbc.E11-05-0423; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Roque T, 2012, STEM CELLS, V30, P537, DOI 10.1002/stem.1010; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Hartl TA, 2008, SCIENCE, V322, P1384, DOI 10.1126/science.1164216; Kawauchi T, 2013, GENES CELLS, V18, P176, DOI 10.1111/gtc.12029; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Probst AV, 2011, TRENDS GENET, V27, P177, DOI 10.1016/j.tig.2011.02.002; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Rawlings JS, 2011, EMBO J, V30, P263, DOI 10.1038/emboj.2010.314; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Ganem NJ, 2012, J CELL BIOL, V199, P871, DOI 10.1083/jcb.201210040; Green LC, 2012, J CELL SCI, V125, P1591, DOI 10.1242/jcs.097790; Yamashita D, 2011, J CELL BIOL, V194, P841, DOI 10.1083/jcb.201106141; Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011; Orth JD, 2012, MOL BIOL CELL, V23, P567, DOI 10.1091/mbc.E11-09-0781; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Bushman DM, 2013, SEMIN CELL DEV BIOL, V24, P357, DOI 10.1016/j.semcdb.2013.02.003; Panier S, 2013, NAT REV MOL CELL BIO, V14, P661, DOI 10.1038/nrm3659; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Shintomi K, 2011, GENE DEV, V25, P1464, DOI 10.1101/gad.2060311; Paridaen JTML, 2014, EMBO REP, V15, P351, DOI 10.1002/embr.201438447; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Hayashi MT, 2012, NAT STRUCT MOL BIOL, V19, P387, DOI 10.1038/nsmb.2245; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Singleton MK, 2011, NEUROBIOL DIS, V43, P190, DOI 10.1016/j.nbd.2011.03.011; Ono T, 2013, J CELL BIOL, V200, P429, DOI 10.1083/jcb.201208008; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189; Murakami-Tonami Y, 2014, CELL CYCLE, V13, P1115, DOI 10.4161/cc.27983; Brero A, 2005, J CELL BIOL, V169, P733, DOI 10.1083/jcb.200502062; Bauer CR, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002873; Csankovszki G, 2009, CURR BIOL, V19, P9, DOI 10.1016/j.cub.2008.12.006; Davalos V, 2012, J BIOL CHEM, V287, P43472, DOI 10.1074/jbc.M112.428466; Fazzio TG, 2010, J CELL BIOL, V188, P491, DOI 10.1083/jcb.200908026; Fujiwara T, 2013, MOL BIOL CELL, V24, P2515, DOI 10.1091/mbc.E13-04-0208; Gosling KM, 2007, P NATL ACAD SCI USA, V104, P12445, DOI 10.1073/pnas.0704870104; Hartl TA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000228; James A, 2014, NUCLEUS, V5, P1; Nishide K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006869; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Sakamoto T, 2011, PLANT CELL, V23, P3533, DOI 10.1105/tpc.111.086314	52	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7390	1553-7404		PLOS GENET	PLoS Genet.	DEC	2014	10	12							e1004847	10.1371/journal.pgen.1004847		16	Genetics & Heredity	Genetics & Heredity	AX0NW	WOS:000346649900048		
J	Okae, H; Chiba, H; Hiura, H; Hamada, H; Sato, A; Utsunomiya, T; Kikuchi, H; Yoshida, H; Tanaka, A; Suyama, M; Arima, T				Okae, Hiroaki; Chiba, Hatsune; Hiura, Hitoshi; Hamada, Hirotaka; Sato, Akiko; Utsunomiya, Takafumi; Kikuchi, Hiroyuki; Yoshida, Hiroaki; Tanaka, Atsushi; Suyama, Mikita; Arima, Takahiro			Genome-Wide Analysis of DNA Methylation Dynamics during Early Human Development	PLOS GENETICS			English	Article							EMBRYONIC STEM-CELLS; PREIMPLANTATION EMBRYOS; EPIGENETIC INHERITANCE; MAMMALIAN DEVELOPMENT; IMPRINTS; LANDSCAPE; GERM; ESTABLISHMENT; TECHNOLOGIES; EVOLUTION	DNA methylation is globally reprogrammed during mammalian preimplantation development, which is critical for normal development. Recent reduced representation bisulfite sequencing (RRBS) studies suggest that the methylome dynamics are essentially conserved between human and mouse early embryos. RRBS is known to cover 5-10% of all genomic CpGs, favoring those contained within CpG-rich regions. To obtain an unbiased and more complete representation of the methylome during early human development, we performed whole genome bisulfite sequencing of human gametes and blastocysts that covered >70% of all genomic CpGs. We found that the maternal genome was demethylated to a much lesser extent in human blastocysts than in mouse blastocysts, which could contribute to an increased number of imprinted differentially methylated regions in the human genome. Global demethylation of the paternal genome was confirmed, but SINE-VNTR-Alu elements and some other tandem repeat-containing regions were found to be specifically protected from this global demethylation. Furthermore, centromeric satellite repeats were hypermethylated in human oocytes but not in mouse oocytes, which might be explained by differential expression of de novo DNA methyltransferases. These data highlight both conserved and species-specific regulation of DNA methylation during early mammalian development. Our work provides further information critical for understanding the epigenetic processes underlying differentiation and pluripotency during early human development.	[Okae, Hiroaki; Chiba, Hatsune; Hiura, Hitoshi; Hamada, Hirotaka; Sato, Akiko; Arima, Takahiro] Tohoku Univ, Grad Sch Med, Environm & Genome Res Ctr, Dept Informat Genet, Sendai, Miyagi 980, Japan; [Okae, Hiroaki; Chiba, Hatsune; Hiura, Hitoshi; Hamada, Hirotaka; Suyama, Mikita; Arima, Takahiro] CREST, JST, Saitama, Japan; [Sato, Akiko; Utsunomiya, Takafumi] St Luke Clin Lab, Oita, Japan; [Kikuchi, Hiroyuki; Yoshida, Hiroaki] Yoshida Ladies Clin Ctr Reprod Med, Sendai, Miyagi, Japan; [Tanaka, Atsushi] St Mother Clin Lab, Kitakyushu, Fukuoka, Japan; [Suyama, Mikita] Kyushu Univ, Med Inst Bioregulat, Div Bioinformat, Fukuoka 812, Japan	Okae, H (reprint author), Tohoku Univ, Grad Sch Med, Environm & Genome Res Ctr, Dept Informat Genet, Sendai, Miyagi 980, Japan.	tarima@med.tohoku.ac.jp			KAKENHI [2567091, 26112502, 24613001]; Health and Labour Sciences Research Grant [H25-Jisedai-Ippan-001]; Takeda Science Foundation	This work was supported by Grants-in-Aid for Scientific Research (KAKENHI) (2567091), Health and Labour Sciences Research Grant (H25-Jisedai-Ippan-001) and the Takeda Science Foundation (TA) and KAKENHI (26112502, 24613001) (HO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khtib M, 2012, HUM REPROD, V27, P2948, DOI 10.1093/humrep/des284; van Montfoort APA, 2012, HUM REPROD UPDATE, V18, P171, DOI 10.1093/humupd/dmr047; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Proudhon C, 2012, MOL CELL, V47, P909, DOI 10.1016/j.molcel.2012.07.010; Hiura H, 2012, HUM REPROD, V27, P2541, DOI 10.1093/humrep/des197; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Messerschmidt DM, 2014, GENE DEV, V28, P812, DOI 10.1101/gad.234294.113; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Wang H, 2005, J MOL BIOL, V354, P994, DOI 10.1016/j.jmb.2005.09.085; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Huntriss J, 2004, MOL REPROD DEV, V67, P323, DOI 10.1002/mrd.20030; Wang L, 2014, CELL, V157, P979, DOI 10.1016/j.cell.2014.04.017; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Ushijima C, 2000, HUM REPROD, V15, P1107, DOI 10.1093/humrep/15.5.1107; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; HARDY K, 1989, DEVELOPMENT, V107, P597; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Saitou M, 2012, DEVELOPMENT, V139, P15, DOI 10.1242/dev.050849; Gopalakrishnan S, 2009, HUM MOL GENET, V18, P3178, DOI 10.1093/hmg/ddp256; Chandler VL, 2010, SCIENCE, V330, P628, DOI 10.1126/science.1191044; Kobayashi H, 2013, EPIGENETICS-US, V8, P635, DOI 10.4161/epi.24887; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; Ueda Y, 2006, DEVELOPMENT, V133, P1183, DOI 10.1242/dev.02293; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Schueler MG, 2006, ANNU REV GENOM HUM G, V7, P301, DOI 10.1146/annurev.genom.7.080505.115613; Denomme MM, 2012, REPRODUCTION, V144, P393, DOI 10.1530/REP-12-0237; Fang F, 2012, P NATL ACAD SCI USA, V109, P7332, DOI 10.1073/pnas.1201310109; Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113; BAHNAK BR, 1988, NUCLEIC ACIDS RES, V16, P1208, DOI 10.1093/nar/16.3.1208; Beaujean N, 2004, CURR BIOL, V14, pR266, DOI 10.1016/j.cub.2004.03.019; Das R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-685; Hancks DC, 2010, SEMIN CANCER BIOL, V20, P234, DOI 10.1016/j.semcancer.2010.04.001; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; LANIA L, 1992, VIROLOGY, V191, P464, DOI 10.1016/0042-6822(92)90211-7; Miura F, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks454; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Shirane K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003439; Yamagata K, 2007, DEV BIOL, V312, P419, DOI 10.1016/j.ydbio.2007.09.041	45	11	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7390	1553-7404		PLOS GENET	PLoS Genet.	DEC	2014	10	12							e1004868	10.1371/journal.pgen.1004868		12	Genetics & Heredity	Genetics & Heredity	AX0NW	WOS:000346649900062		
J	Shiba-Fukushima, K; Arano, T; Matsumoto, G; Inoshita, T; Yoshida, S; Ishihama, Y; Ryu, KY; Nukina, N; Hattori, N; Imai, Y				Shiba-Fukushima, Kahori; Arano, Taku; Matsumoto, Gen; Inoshita, Tsuyoshi; Yoshida, Shigeharu; Ishihama, Yasushi; Ryu, Kwon-Yul; Nukina, Nobuyuki; Hattori, Nobutaka; Imai, Yuzuru			Phosphorylation of Mitochondrial Polyubiquitin by PINK1 Promotes Parkin Mitochondrial Tethering	PLOS GENETICS			English	Article							UBIQUITIN-LIKE DOMAIN; E3 LIGASE PARKIN; DOPAMINERGIC-NEURONS; DAMAGED MITOCHONDRIA; MITOPHAGY; DROSOPHILA; TRANSLOCATION; ACTIVATION; MUTATIONS; PROTEIN	The kinase PINK1 and the E3 ubiquitin (Ub) ligase Parkin participate in mitochondrial quality control. The phosphorylation of Ser65 in Parkin's ubiquitin-like (UBl) domain by PINK1 stimulates Parkin activation and translocation to damaged mitochondria, which induces mitophagy generating polyUb chain. However, Parkin Ser65 phosphorylation is insufficient for Parkin mitochondrial translocation. Here we report that Ser65 in polyUb chain is also phosphorylated by PINK1, and that phosphorylated polyUb chain on mitochondria tethers Parkin at mitochondria. The expression of Tom70(MTS)-4xUb SE, which mimics phospho-Ser65 polyUb chains on the mitochondria, activated Parkin E3 activity and its mitochondrial translocation. An E3-dead form of Parkin translocated to mitochondria with reduced membrane potential in the presence of Tom70(MTS)-4xUb SE, whereas non-phospho-polyUb mutant Tom70(MTS)-4xUb SA abrogated Parkin translocation. Parkin binds to the phospho-polyUb chain through its RING1-In-Between-RING (IBR) domains, but its RING0-linker is also required for mitochondrial translocation. Moreover, the expression of Tom70(MTS)-4xUb SE improved mitochondrial degeneration in PINK1-deficient, but not Parkin-deficient, Drosophila. Our study suggests that the phosphorylation of mitochondrial polyUb by PINK1 is implicated in both Parkin activation and mitochondrial translocation, predicting a chain reaction mechanism of mitochondrial phospho-polyUb production by which rapid translocation of Parkin is achieved.	[Shiba-Fukushima, Kahori; Hattori, Nobutaka] Juntendo Univ, Grad Sch Med, Dept Neurol, Tokyo, Japan; [Arano, Taku; Inoshita, Tsuyoshi; Hattori, Nobutaka; Imai, Yuzuru] Juntendo Univ, Grad Sch Med, Dept Res Parkinsons Dis, Tokyo, Japan; [Matsumoto, Gen; Nukina, Nobuyuki] Juntendo Univ, Grad Sch Med, Dept Neurosci Neurodegenerat Disorders, Tokyo, Japan; [Yoshida, Shigeharu; Ishihama, Yasushi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Mol & Cellular BioAnal, Kyoto, Japan; [Ryu, Kwon-Yul] Univ Seoul, Dept Life Sci, Seoul, South Korea	Shiba-Fukushima, K (reprint author), Juntendo Univ, Grad Sch Med, Dept Neurol, Tokyo, Japan.	nhattori@juntendo.ac.jp; yzimai@juntendo.ac.jp			Takeda Science Foundation; Life Science Foundation of Japan; Daiichi-Sankyo Foundation for Life Science; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Otsuka Pharmaceutical; MEXT in Japan [26461280, 26293070];  [23111003];  [26117727]	This study was supported by the Takeda Science Foundation (YIm), the Life Science Foundation of Japan (YIm), the Daiichi-Sankyo Foundation for Life Science (YIm), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (YIm), and Otsuka Pharmaceutical (NH, YIm), the Grant-in-Aid for Scientific Research 26461280 (KSF) and 26293070 (YIm) from MEXT in Japan, and a Grant-in-Aid for Scientific Research on Innovative Areas 23111003 (NH) and 26117727 (YIm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Woodroof HI, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110012; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Spratt DE, 2014, BIOCHEM J, V458, P421, DOI 10.1042/BJ20140006; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Hristova VA, 2009, J BIOL CHEM, V284, P14978, DOI 10.1074/jbc.M808700200; Iwasaki M, 2012, J CHROMATOGR A, V1228, P292, DOI 10.1016/j.chroma.2011.10.059; Kazlauskaite A, 2014, BIOCHEM J, V460, P127, DOI 10.1042/BJ20140334; Kane LA, 2014, J CELL BIOL, V205, P143, DOI 10.1083/jcb.201402104; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Narendra DP, 2013, HUM MOL GENET, V22, P2572, DOI 10.1093/hmg/ddt106; Yamano K, 2013, AUTOPHAGY, V9, P1758, DOI 10.4161/auto.24633; Trempe JF, 2013, SCIENCE, V340, P1451, DOI 10.1126/science.1237908; Kawajiri S, 2010, FEBS LETT, V584, P1073, DOI 10.1016/j.febslet.2010.02.016; Ryu KY, 2007, EMBO J, V26, P2693, DOI 10.1038/sj.emboj.7601722; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Wauer T, 2013, EMBO J, V32, P2099, DOI 10.1038/emboj.2013.125; Takatori S, 2008, NEUROSCI LETT, V430, P13, DOI 10.1016/j.neulet.2007.10.019; Muller-Rischart AK, 2013, MOL CELL, V49, P908, DOI 10.1016/j.molcel.2013.01.036; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; Rana A, 2013, P NATL ACAD SCI USA, V110, P8638, DOI 10.1073/pnas.1216197110; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Kitada T, 1998, NATURE, V392, P605; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Chaugule VK, 2011, EMBO J, V30, P2853, DOI 10.1038/emboj.2011.204; Wakabayashi M, 2014, J PROTEOME RES, V13, P915, DOI 10.1021/pr400960r; Zheng XD, 2013, CELL RES, V23, P886, DOI 10.1038/cr.2013.66; Lazarou M, 2013, J CELL BIOL, V200, P163, DOI 10.1083/jcb.201210111; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107; Imai Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001229; Kondapalli C, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120080; Koyano K, 2014, NATURE, V510, P162; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okatsu K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2016; Ordureau A, 2014, MOL CELL IN PRESS; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Shiba- Fukushima K, 2014, J BIOL CHEM IN PRESS; Shiba K, 2009, BIOCHEM BIOPH RES CO, V383, P331, DOI 10.1016/j.bbrc.2009.04.006; Shiba-Fukushima K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004391; Shiba-Fukushima K, 2012, SCI REP-UK, V2, DOI 10.1038/srep01002	51	21	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7390	1553-7404		PLOS GENET	PLoS Genet.	DEC	2014	10	12							e1004861	10.1371/journal.pgen.1004861		18	Genetics & Heredity	Genetics & Heredity	AX0NW	WOS:000346649900058		
J	Shibuya, H; Morimoto, A; Watanabe, Y				Shibuya, Hiroki; Morimoto, Akihiro; Watanabe, Yoshinori			The Dissection of Meiotic Chromosome Movement in Mice Using an In Vivo Electroporation Technique	PLOS GENETICS			English	Article							SYNAPTONEMAL COMPLEX; NUCLEAR-ENVELOPE; HOMOLOG RECOGNITION; TELOMERE ATTACHMENT; MAMMALIAN MEIOSIS; RNA INTERFERENCE; ELEGANS MEIOSIS; BOUQUET; COHESIN; VITRO	During meiosis, the rapid movement of telomeres along the nuclear envelope (NE) facilitates pairing/synapsis of homologous chromosomes. In mammals, the mechanical properties of chromosome movement and the cytoskeletal structures responsible for it remain poorly understood. Here, applying an in vivo electroporation (EP) technique in live mouse testis, we achieved the quick visualization of telomere, chromosome axis and microtubule organizing center (MTOC) movements. For the first time, we defined prophase sub-stages of live spermatocytes morphologically according to (GFP-)TRF1 and (GFP-)SCP3 signals. We show that rapid telomere movement and subsequent nuclear rotation persist from leptotene/zygotene to pachytene, and then decline in diplotene stage concomitant with the liberation of SUN1 from telomeres. Further, during bouquet stage, telomeres are constrained near the MTOC, resulting in the transient suppression of telomere mobility and nuclear rotation. MTs are responsible for these movements by forming cable-like structures on the NE, and, probably, by facilitating the rail-tacking movements of telomeres on the MT cables. In contrast, actin regulates the oscillatory changes in nuclear shape. Our data provide the mechanical scheme for meiotic chromosome movement throughout prophase I in mammals.	[Shibuya, Hiroki; Morimoto, Akihiro; Watanabe, Yoshinori] Univ Tokyo, Lab Chromosome Dynam, Inst Mol & Cellular Biosci, Tokyo, Japan	Shibuya, H (reprint author), Univ Tokyo, Lab Chromosome Dynam, Inst Mol & Cellular Biosci, Tokyo, Japan.	ywatanab@iam.u-tokyo.ac.jp			JSPS Research Fellowship; Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms) from MEXT, Japan; MEXT, Japan	This work was supported in part by a JSPS Research Fellowship (to HS), the Global COE Program (Integrative Life Science Based on the Study of Biosignaling Mechanisms), a Grant-in-Aid for Specially Promoted Research (to YW) from MEXT, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sato A, 2009, CELL, V139, P907, DOI 10.1016/j.cell.2009.10.039; Wynne DJ, 2012, J CELL BIOL, V196, P47, DOI 10.1083/jcb.201106022; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Trelles-Sticken E, 2005, J CELL BIOL, V170, P213, DOI 10.1083/jcb.200501042; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6; Scherthan H, 2001, NAT REV MOL CELL BIO, V2, P621, DOI 10.1038/35085086; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619; Lee J, 2011, J CELL BIOL, V192, P263, DOI 10.1083/jcb.201008005; Herran Y, 2011, EMBO J, V30, P3091, DOI 10.1038/emboj.2011.222; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Horn HF, 2013, J CELL BIOL, V202, P1023, DOI 10.1083/jcb.201304004; Penkner A, 2007, DEV CELL, V12, P873, DOI 10.1016/j.devcel.2007.05.004; Liebe B, 2004, MOL BIOL CELL, V15, P827, DOI 10.1091/mbc.E03-07-0524; Shibuya H, 2014, CELL CYCLE, V13, P2024, DOI 10.4161/cc.29350; Penkner AM, 2009, CELL, V139, P920, DOI 10.1016/j.cell.2009.10.045; Hiraoka Y, 2009, DEV CELL, V17, P598, DOI 10.1016/j.devcel.2009.10.014; Ding DQ, 1998, J CELL SCI, V111, P701; Koszul R, 2008, CELL, V133, P1188, DOI 10.1016/j.cell.2008.04.050; Scherthan H, 2007, P NATL ACAD SCI USA, V104, P16934, DOI 10.1073/pnas.0704860104; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Koszul R, 2009, TRENDS CELL BIOL, V19, P716, DOI 10.1016/j.tcb.2009.09.007; Shibuya H, 2014, NAT CELL BIOL, V16, P145, DOI 10.1038/ncb2896; Conrad MN, 2008, CELL, V133, P1175, DOI 10.1016/j.cell.2008.04.047; Harper L, 2004, J CELL SCI, V117, P4025, DOI 10.1242/jcs.01363; Sato T, 2013, NAT PROTOC, V8, P2098, DOI 10.1038/nprot.2013.138; Morimoto A, 2012, J CELL BIOL, V198, P165, DOI 10.1083/jcb.201204085; Trelles-Sticken E, 2000, J CELL BIOL, V151, P95, DOI 10.1083/jcb.151.1.95; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9; McKee BD, 2004, BBA-GENE STRUCT EXPR, V1677, P165, DOI 10.1016/j.bbaexp.2003.11.017; Yoshida M, 2013, J CELL BIOL, V200, P385, DOI 10.1083/jcb.201207168; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Bass HW, 1997, J CELL BIOL, V137, P5, DOI 10.1083/jcb.137.1.5; Baudrimont A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001219; Bisig CG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002701; Carlton PM, 2003, MOL BIOL CELL, V14, P2832, DOI 10.1091/mbc.E02-11-0760; Cowan CR, 2002, J CELL SCI, V115, P3747, DOI 10.1242/jcs.00055; Cowan CR, 2002, J CELL SCI, V115, P3757, DOI 10.1242/jcs.00054; ELLINGSO.DJ, 1970, J CELL SCI, V6, P195; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Gutierrez-Caballero C, 2011, CELL CYCLE, V10, P1477, DOI 10.4161/cc.10.9.15515; Ishiguro K, 2014, GENE DEV, V28, P594, DOI 10.1101/gad.237313.113; Joseph I, 2005, CURR BIOL, V15, P231, DOI 10.1016/j.cub.2005.01.039; Kosaka H, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000196; MOSES MJ, 1969, GENETICS, V61, P41; PARVINEN M, 1976, NATURE, V260, P534, DOI 10.1038/260534a0; Polakova S, 2011, CELL CYCLE, V10, P1892, DOI 10.4161/cc.10.12.15691; Qiao HY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002790; SALONEN K, 1982, CHROMOSOMA, V85, P611, DOI 10.1007/BF00330775; Schramm S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002088; Shoji M, 2005, DEV BIOL, V282, P524, DOI 10.1016/j.ydbio.2005.03.030; VANTARD M, 1990, P NATL ACAD SCI USA, V87, P8825, DOI 10.1073/pnas.87.22.8825; von Wettstein D, 1984, Symp Soc Exp Biol, V38, P195; Wanat JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000188; YAO KTS, 1969, EXP CELL RES, V55, P39, DOI 10.1016/0014-4827(69)90451-0	56	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7390	1553-7404		PLOS GENET	PLoS Genet.	DEC	2014	10	12							e1004821	10.1371/journal.pgen.1004821		16	Genetics & Heredity	Genetics & Heredity	AX0NW	WOS:000346649900026		
J	Iizuka, S; Oridate, N; Nashimoto, M; Fukuda, S; Tamura, M				Iizuka, Satoshi; Oridate, Nobuhiko; Nashimoto, Masayuki; Fukuda, Satoshi; Tamura, Masato			Growth Inhibition of Head and Neck Squamous Cell Carcinoma Cells by sgRNA Targeting the Cyclin D1 mRNA Based on TRUE Gene Silencing	PLOS ONE			English	Article							3' PROCESSING ENDORIBONUCLEASE; HEPTAMER-TYPE SGRNA; PROGNOSTIC-SIGNIFICANCE; CANCER STATISTICS; INTERFERING RNAS; OVARIAN-CANCER; ANTISENSE; EXPRESSION; OLIGONUCLEOTIDE; APOPTOSIS	Head and neck squamous cell carcinoma (HNSCC) exhibits increased expression of cyclin D1 (CCND1). Previous studies have shown a correlation between poor prognosis of HNSCC and cyclin D1 overexpression. tRNase ZL-utilizing efficacious gene silencing (TRUE gene silencing) is one of the RNA-mediated gene expression control technologies that have therapeutic potential. This technology is based on a unique enzymatic property of mammalian tRNase ZL, which is that it can cleave any target RNA at any desired site by recognizing a pre-tRNA-like complex formed between the target RNA and an artificial small guide RNA (sgRNA). In this study, we designed several sgRNAs targeting human cyclin D1 mRNA to examine growth inhibition of HNSCC cells. Transfection of certain sgRNAs decreased levels of cyclin D1 mRNA and protein in HSC-2 and HSC-3 cells, and also inhibited their proliferation. The combination of these sgRNAs and cisplatin showed more than additive inhibition of cancer cell growth. These findings demonstrate that TRUE gene silencing of cyclin D1 leads to inhibition of the growth of HNSCC cells and suggest that these sgRNAs alone or combined with cisplatin may be a useful new therapy for HNSCCs.	[Iizuka, Satoshi; Fukuda, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sapporo, Hokkaido, Japan; [Oridate, Nobuhiko] Yokohama City Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Yokohama, Kanagawa 232, Japan; [Nashimoto, Masayuki] Niigata Univ Pharm & Appl Life Sci, Res Inst Healthy Living, Niigata, Japan; [Tamura, Masato] Hokkaido Univ, Dept Biochem & Mol Biol, Grad Sch Dent Med, Sapporo, Hokkaido, Japan	Tamura, M (reprint author), Hokkaido Univ, Dept Biochem & Mol Biol, Grad Sch Dent Med, Sapporo, Hokkaido, Japan.	mtamura@den.hokudai.ac.jp	TAMURA, MASATO/B-7304-2009	TAMURA, MASATO/0000-0003-3700-5203	JSPS [24592588]	This research was supported by the JSPS Grants-in-Aid for scientific research #24592588 (NO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Elbarbary RA, 2009, BIOCHEM BIOPH RES CO, V379, P924, DOI 10.1016/j.bbrc.2008.12.173; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Sano T, 2011, BIOCHEM BIOPH RES CO, V416, P427, DOI 10.1016/j.bbrc.2011.11.091; Arber N, 1997, CANCER RES, V57, P1569; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; ZHOU P, 1995, ONCOGENE, V11, P571; Sauter ER, 1999, CANCER RES, V59, P4876; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Takahashi M, 2013, CANCER LETT, V328, P362, DOI 10.1016/j.canlet.2012.10.016; Shibata HS, 2005, J BIOL CHEM, V280, P22326, DOI 10.1074/jbc.M502048200; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Jares P, 2007, NAT REV CANCER, V7, P750, DOI 10.1038/nrc2230; Bova RJ, 1999, CLIN CANCER RES, V5, P2810; Mineta H, 2000, ORAL ONCOL, V36, P194, DOI 10.1016/S1368-8375(99)00078-0; Sazani P, 2002, NAT BIOTECHNOL, V20, P1228, DOI 10.1038/nbt759; Oridate N, 2005, CANCER BIOL THER, V4, P318; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Vickers TA, 2006, J IMMUNOL, V176, P3652; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Kastelein JJP, 2006, CIRCULATION, V114, P1729, DOI 10.1161/CIRCULATIONAHA.105.606442; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Takaku H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh092; Thomas GR, 2005, INT J EXP PATHOL, V86, P347, DOI 10.1111/j.0959-9673.2005.00447.x; Nakashima A, 2007, GENE THER, V14, P78, DOI 10.1038/sj.gt.3302841; BILLIAU A, 1977, ANTIMICROB AGENTS CH, V12, P11; Tamura M, 2003, NUCLEIC ACIDS RES, V31, P4354, DOI 10.1093/nar/gkg641; Watanabe N, 2013, LEUKEMIA RES, V37, P580, DOI 10.1016/j.leukres.2013.01.015; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Koller E, 2011, NUCLEIC ACIDS RES, V39, P4795, DOI 10.1093/nar/gkr089; Nashimoto M, 2000, FEBS LETT, V472, P179, DOI 10.1016/S0014-5793(00)01462-9; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Sato MM, 2009, GENES CELLS, V14, P141, DOI 10.1111/j.1365-2443.2008.01258.x; TONKINSON JL, 1994, NUCLEIC ACIDS RES, V22, P4268, DOI 10.1093/nar/22.20.4268; Bali A, 2004, CLIN CANCER RES, V10, P5168, DOI 10.1158/1078-0432.CCR-03-0751; Cagnoli M, 1998, GYNECOL ONCOL, V70, P372, DOI 10.1006/gyno.1998.5062; Driscoll B, 1997, AM J PHYSIOL-LUNG C, V273, pL941; Higuchl E, 2007, HEAD NECK-J SCI SPEC, V29, P940, DOI 10.1002/hed.20632; Hung WC, 1996, BIOCHEM BIOPH RES CO, V220, P719, DOI 10.1006/bbrc.1996.0470; Izzo JG, 1998, ONCOGENE, V17, P2313, DOI 10.1038/sj.onc.1202153; Kornmann M, 1998, J CLIN INVEST, V101, P344, DOI 10.1172/JCI1323; LOKE SL, 1989, P NATL ACAD SCI USA, V86, P3474, DOI 10.1073/pnas.86.10.3474; MOMOSE F, 1989, J ORAL PATHOL MED, V18, P391, DOI 10.1111/j.1600-0714.1989.tb01570.x; Nashimoto M, 1998, NUCLEIC ACIDS RES, V26, P2565, DOI 10.1093/nar/26.11.2565; Schrump DS, 1996, CANCER GENE THER, V3, P131; Scott EN, 2009, CANCER CHEMOTH PHARM, V64, P425, DOI 10.1007/s00280-009-0968-y; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; Takahashi M, 2014, LEUKEMIA RES, V38, P808, DOI 10.1016/j.leukres.2014.03.021; Volavsek M, 2003, J LARYNGOL OTOL, V117, P286; Wang MB, 1998, OTOLARYNG HEAD NECK, V119, P593, DOI 10.1016/S0194-5998(98)70017-8	53	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114121	10.1371/journal.pone.0114121		19	Multidisciplinary Sciences	Science & Technology - Other Topics	AX7SK	WOS:000347114900121		
J	Ito, T; Sendai, Y; Yamazaki, S; Seki-Soma, M; Hirose, K; Watanabe, M; Fukawa, K; Nakauchi, H				Ito, Tetsuya; Sendai, Yutaka; Yamazaki, Satoshi; Seki-Soma, Marie; Hirose, Kensuke; Watanabe, Motoo; Fukawa, Kazuo; Nakauchi, Hiromitsu			Generation of Recombination Activating Gene-1-Deficient Neonatal Piglets: A Model of T and B Cell Deficient Severe Combined Immune Deficiency	PLOS ONE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; IN-VITRO FERTILIZATION; V(D)J RECOMBINATION; NUCLEAR TRANSFER; RAG MUTATIONS; CLONED PIGS; BLASTOCYST COMPLEMENTATION; DNA METHYLATION; HUMANIZED MICE; OMENN-SYNDROME	Although severe combined immune deficiency (SCID) is a very important research model for mice and SCID mice are widely used, there are only few reports describing the SCID pig models. Therefore, additional research in this area is needed. In this study, we describe the generation of Recombination activating gene-1 (Rag-1)-deficient neonatal piglets in Duroc breed using somatic cell nuclear transfer (SCNT) with gene targeting and analysis using fluorescence-activated cell sorting (FACS) and histology. We constructed porcine Rag-1 gene targeting vectors for the Exon 2 region and obtained heterozygous/homozygous Rag-1 knockout cell colonies using SCNT. We generated two Rag-1-deficient neonatal piglets and compared them with wild-type neonatal piglets. FACS analysis showed that Rag-1 disruption causes a lack of Immunoglobulin M-positive B cells and CD3-positive T cells in peripheral blood mononuclear cells. Consistent with FACS analysis, histological analysis revealed structural defects and an absence of mature lymphocytes in the spleen, mesenteric lymph node (MLNs), and thymus in Rag-1-deficient piglets. These results confirm that Rag-1 is necessary for the generation of lymphocytes in pigs, and Rag-1-deficient piglets exhibit a T and B cell deficient SCID (T-B-SCID) phenotype similar to that of rodents and humans. The T-B-SCID pigs with Rag-1 deficiency generated in this study could be a suitably versatile model for laboratory, translational, and biomedical research, including the development of a humanized model and assessment of pluripotent stem cells.	[Ito, Tetsuya; Hirose, Kensuke; Fukawa, Kazuo] ZEN NOH Natl Federat Agr Cooperat Assoc, Cent Res Inst Feed & Livestock, Pig Breeding Lab, Kamishihoro, Hokkaido, Japan; [Sendai, Yutaka] ZEN NOH Natl Federat Agr Cooperat Assoc, Cent Res Inst Feed & Livestock, Biol Sci Sect, Ibaraki, Japan; [Yamazaki, Satoshi; Watanabe, Motoo; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Tokyo, Japan; [Seki-Soma, Marie] ZEN NOH Natl Federat Agr Cooperat Assoc, Zen Noh Inst Anim Hlth, Chiba, Japan; [Yamazaki, Satoshi; Watanabe, Motoo; Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Nakauchi Stem Cell & Organ Regenerat Project, Tokyo, Japan	Ito, T (reprint author), ZEN NOH Natl Federat Agr Cooperat Assoc, Cent Res Inst Feed & Livestock, Pig Breeding Lab, Kamishihoro, Hokkaido, Japan.	itou-tetsuya@zennoh.or.jp			Japan Science and Technology Agency; Ministry of Education, Culture, Sport, Science, and Technology, Japan	This work was supported by grants from the Japan Science and Technology Agency, the Ministry of Education, Culture, Sport, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Renner S, 2010, DIABETES, V59, P1228, DOI 10.2337/db09-0519; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Prather RS, 2013, ANNU REV ANIM BIOSCI, V1, P203, DOI 10.1146/annurev-animal-031412-103715; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Butler JE, 2006, VET RES, V37, P417, DOI 10.1051/vetres:2006009; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Suzuki S, 2012, CELL STEM CELL, V10, P753, DOI 10.1016/j.stem.2012.04.021; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; Yoshioka K, 2003, BIOL REPROD, V69, P2092, DOI 10.1095/biolreprod.103.020081; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Schuetz C, 2008, NEW ENGL J MED, V358, P2030, DOI 10.1056/NEJMoa073966; Mendicino M, 2011, TRANSGENIC RES, V20, P625, DOI 10.1007/s11248-010-9444-z; Schwarz K, 1996, SCIENCE, V274, P97, DOI 10.1126/science.274.5284.97; Lee K, 2014, P NATL ACAD SCI USA, V111, P7260, DOI 10.1073/pnas.1406376111; Peat JR, 2012, NAT GENET, V44, P965, DOI 10.1038/ng.2393; Kuzmuk KN, 2011, GENETICS OF THE PIG, 2ND EDITION, P426, DOI 10.1079/9781845937566.0426; Fan NN, 2013, J GENET GENOMICS, V40, P67, DOI 10.1016/j.jgg.2012.07.014; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Nishana M, 2012, IMMUNOLOGY, V137, P271, DOI 10.1111/imm.12009; Huang J, 2014, J IMMUNOL, V193, P1496, DOI [10.4049/jimmunol.1400915, 10.4049/jimmuno1.1400915]; Zhao JG, 2010, CELL TISSUE RES, V341, P13, DOI 10.1007/s00441-010-1000-x; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Sun XZ, 2012, IMMUNOLOGY, V137, P149, DOI 10.1111/j.1365-2567.2012.03615.x; Deshmukh RS, 2011, EPIGENETICS-US, V6, P177, DOI 10.4161/epi.6.2.13519; Akkina R, 2013, VIROLOGY, V435, P14, DOI 10.1016/j.virol.2012.10.007; Ross JW, 2012, INVEST OPHTH VIS SCI, V53, P501, DOI 10.1167/iovs.11-8784; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; Matsunari H, 2013, P NATL ACAD SCI USA, V110, P4557, DOI 10.1073/pnas.1222902110; Cho SK, 2007, DEV DYNAM, V236, P3369, DOI 10.1002/dvdy.21308; Suemizu H, 2008, BIOCHEM BIOPH RES CO, V377, P248, DOI 10.1016/j.bbrc.2008.09.124; Bility MT, 2012, NAT PROTOC, V7, P1608, DOI 10.1038/nprot.2012.083; Flisikowska T, 2012, GASTROENTEROLOGY, V143, P1173, DOI 10.1053/j.gastro.2012.07.110; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; Betthauser J, 2000, NAT BIOTECHNOL, V18, P1055, DOI 10.1038/80242; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81; Archer GS, 2003, BIOL REPROD, V69, P430, DOI 10.1095/biolreprod.103.016147; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Corneo B, 2001, BLOOD, V97, P2772, DOI 10.1182/blood.V97.9.2772; Hwang KC, 2009, DEV DYNAM, V238, P1701, DOI 10.1002/dvdy.21986; Ito R, 2012, EFFICIENT XENOENGRAF; KARALUS U, 1990, ANIM REPROD SCI, V22, P235, DOI 10.1016/0378-4320(90)90064-M; Kollet O, 2000, BLOOD, V95, P3102; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Menoret S, 2012, FASEB J, V27, P703; Nischang M, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13618; Noguchi M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-157; Santagata S, 2000, P NATL ACAD SCI USA, V97, P14572, DOI 10.1073/pnas.97.26.14572; Sechin A, 1999, THERIOGENOLOGY, V51, P1175, DOI 10.1016/S0093-691X(99)80020-X; Sendai Y, 2006, TRANSPLANTATION, V81, P760, DOI 10.1097/01.tp.0000190422.66657.f1; Shiota K, 2002, DIFFERENTIATION, V69, P162, DOI 10.1046/j.1432-0436.2002.690406.x; Shultz LD, 2005, J IMMUNOL, V174, P6477; Suzuki S, 2014, EXP ANIM TOKYO, V63, P215; Walters EM, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-55; Watanabe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076478; Zschemisch NH, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-60	63	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113833	10.1371/journal.pone.0113833		17	Multidisciplinary Sciences	Science & Technology - Other Topics	AX7SK	WOS:000347114900083		
J	Ohmura-Kakutani, H; Akiyama, K; Maishi, N; Ohga, N; Hida, Y; Kawamoto, T; Iida, J; Shindoh, M; Tsuchiya, K; Shinohara, N; Hida, K				Ohmura-Kakutani, Hitomi; Akiyama, Kosuke; Maishi, Nako; Ohga, Noritaka; Hida, Yasuhiro; Kawamoto, Taisuke; Iida, Junichiro; Shindoh, Masanobu; Tsuchiya, Kunihiko; Shinohara, Nobuo; Hida, Kyoko			Identification of Tumor Endothelial Cells with High Aldehyde Dehydrogenase Activity and a Highly Angiogenic Phenotype	PLOS ONE			English	Article							PROMOTES ANGIOGENESIS; STEM-CELLS; CANCER; VEGF; POPULATION; MARKER; GENES	Tumor blood vessels play an important role in tumor progression and metastasis. It has been reported that tumor endothelial cells (TECs) exhibit highly angiogenic phenotypes compared with those of normal endothelial cells (NECs). TECs show higher proliferative and migratory abilities than those NECs, together with upregulation of vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR2). Furthermore, compared with NECs, stem cell markers such as Sca-1, CD90, and multidrug resistance 1 are upregulated in TECs, suggesting that stem-like cells exist in tumor blood vessels. In this study, to reveal the biological role of stem-like TECs, we analyzed expression of the stem cell marker aldehyde dehydrogenase (ALDH) in TECs and characterized ALDH(high) TECs. TECs and NECs were isolated from melanoma-xenografted nude mice and normal dermis, respectively. ALDH mRNA expression and activity were higher in TECs than those in NECs. Next, ALDH(high/low) TECs were isolated by fluorescence-activated cell sorting to compare their characteristics. Compared with ALDH(low) TECs, ALDH(high) TECs formed more tubes on Matrigel-coated plates and sustained the tubular networks longer. Furthermore, VEGFR2 expression was higher in ALDHhigh TECs than that in ALDH(low) TECs. In addition, ALDH was expressed in the tumor blood vessels of in vivo mouse models of melanoma and oral carcinoma, but not in normal blood vessels. These findings indicate that ALDH(high) TECs exhibit an angiogenic phenotype. Stem-like TECs may have an essential role in tumor angiogenesis.	[Ohmura-Kakutani, Hitomi; Akiyama, Kosuke; Maishi, Nako; Ohga, Noritaka; Kawamoto, Taisuke; Hida, Kyoko] Hokkaido Univ, Grad Sch Dent Med, Dept Vasc Biol, Sapporo, Hokkaido, Japan; [Akiyama, Kosuke; Maishi, Nako; Hida, Kyoko] Hokkaido Univ, Inst Med Genet, Div Vasc Biol, Sapporo, Hokkaido, Japan; [Hida, Yasuhiro] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc & Thorac Surg, Sapporo, Hokkaido, Japan; [Ohmura-Kakutani, Hitomi; Iida, Junichiro] Hokkaido Univ, Grad Sch Dent Med, Dept Orthodont, Sapporo, Hokkaido, Japan; [Shindoh, Masanobu] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathol & Biol, Sapporo, Hokkaido, Japan; [Tsuchiya, Kunihiko; Shinohara, Nobuo] Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan	Hida, K (reprint author), Hokkaido Univ, Grad Sch Dent Med, Dept Vasc Biol, Sapporo, Hokkaido, Japan.	khida@igm.hokudai.ac.jp	Hida, Kyoko/A-8444-2012; Shindoh, Masanobu/A-4799-2012; Hida, Yasuhiro/A-7761-2012	Shindoh, Masanobu/0000-0002-7782-5823; Hida, Yasuhiro/0000-0003-1759-4215			Aird WC, 2009, CELL TISSUE RES, V335, P271, DOI 10.1007/s00441-008-0672-y; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Silva IA, 2011, CANCER RES, V71, P3991, DOI 10.1158/0008-5472.CAN-10-3175; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Osawa T, 2013, BRIT J CANCER, V109, P2237, DOI 10.1038/bjc.2013.535; Akiyama K, 2012, AM J PATHOL, V180, P1283, DOI 10.1016/j.ajpath.2011.11.029; Osawa T, 2012, CANCER SCI, V103, P1038, DOI 10.1111/j.1349-7006.2012.02261.x; Naito H, 2012, EMBO J, V31, P842, DOI 10.1038/emboj.2011.465; Dudley AC, 2008, CANCER CELL, V14, P201, DOI 10.1016/j.ccr.2008.06.017; Matsuda K, 2010, BIOCHEM BIOPH RES CO, V394, P947, DOI 10.1016/j.bbrc.2010.03.089; KOZLOWSKI JM, 1984, J NATL CANCER I, V72, P913; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Ohga N, 2012, AM J PATHOL, V180, P1294, DOI 10.1016/j.ajpath.2011.11.035; Yamamoto K, 2012, BRIT J CANCER, V106, P1214, DOI 10.1038/bjc.2012.59; Corti S, 2006, STEM CELLS, V24, P975, DOI 10.1634/stemcells.2005-0217; KASTAN MB, 1990, BLOOD, V75, P1947; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Maishi N, 2012, PATHOL INT, V62, P309, DOI 10.1111/j.1440-1827.2012.02792.x; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Akino T, 2009, AM J PATHOL, V175, P2657, DOI 10.2353/ajpath.2009.090202; Kurosu T, 2011, BRIT J CANCER, V104, P819, DOI 10.1038/bjc.2011.20; St Croix B, 2000, SCIENCE, V289, P1197	25	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113910	10.1371/journal.pone.0113910		17	Multidisciplinary Sciences	Science & Technology - Other Topics	AX7SK	WOS:000347114900094		
J	Fukuhara, T; Wada, M; Nakamura, S; Ono, C; Shiokawa, M; Yamamoto, S; Motomura, T; Okamoto, T; Okuzaki, D; Yamamoto, M; Saito, I; Wakita, T; Koike, K; Matsuura, Y				Fukuhara, Takasuke; Wada, Masami; Nakamura, Shota; Ono, Chikako; Shiokawa, Mai; Yamamoto, Satomi; Motomura, Takashi; Okamoto, Toru; Okuzaki, Daisuke; Yamamoto, Masahiro; Saito, Izumu; Wakita, Takaji; Koike, Kazuhiko; Matsuura, Yoshiharu			Amphipathic alpha-Helices in Apolipoproteins Are Crucial to the Formation of Infectious Hepatitis C Virus Particles	PLOS PATHOGENS			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; B TYPE-I; HCV INFECTION; CRYSTAL-STRUCTURE; NONHEPATIC CELLS; CORE PROTEIN; LIFE-CYCLE; A-I; GENOME; REPLICATION	Apolipoprotein B (ApoB) and ApoE have been shown to participate in the particle formation and the tissue tropism of hepatitis C virus (HCV), but their precise roles remain uncertain. Here we show that amphipathic alpha-helices in the apolipoproteins participate in the HCV particle formation by using zinc finger nucleases-mediated apolipoprotein B (ApoB) and/or ApoE gene knockout Huh7 cells. Although Huh7 cells deficient in either ApoB or ApoE gene exhibited slight reduction of particles formation, knockout of both ApoB and ApoE genes in Huh7 (DKO) cells severely impaired the formation of infectious HCV particles, suggesting that ApoB and ApoE have redundant roles in the formation of infectious HCV particles. cDNA microarray analyses revealed that ApoB and ApoE are dominantly expressed in Huh7 cells, in contrast to the high level expression of all of the exchangeable apolipoproteins, including ApoA1, ApoA2, ApoC1, ApoC2 and ApoC3 in human liver tissues. The exogenous expression of not only ApoE, but also other exchangeable apolipoproteins rescued the infectious particle formation of HCV in DKO cells. In addition, expression of these apolipoproteins facilitated the formation of infectious particles of genotype 1b and 3a chimeric viruses. Furthermore, expression of amphipathic alpha-helices in the exchangeable apolipoproteins facilitated the particle formation in DKO cells through an interaction with viral particles. These results suggest that amphipathic alpha-helices in the exchangeable apolipoproteins play crucial roles in the infectious particle formation of HCV and provide clues to the understanding of life cycle of HCV and the development of novel anti-HCV therapeutics targeting for viral assembly.	[Fukuhara, Takasuke; Wada, Masami; Ono, Chikako; Shiokawa, Mai; Yamamoto, Satomi; Motomura, Takashi; Okamoto, Toru; Matsuura, Yoshiharu] Osaka Univ, Microbial Dis Res Inst, Dept Mol Virol, Osaka, Japan; [Nakamura, Shota] Osaka Univ, Microbial Dis Res Inst, Dept Infect Metagen, Osaka, Japan; [Okuzaki, Daisuke] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, Osaka, Japan; [Yamamoto, Masahiro] Osaka Univ, Microbial Dis Res Inst, Dept Immunoparasitol, Osaka, Japan; [Saito, Izumu] Univ Tokyo, Inst Med Sci, Mol Genet Lab, Tokyo, Japan; [Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan	Matsuura, Y (reprint author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Virol, Osaka, Japan.	matsuura@biken.osaka-u.ac.jp			Japanese Ministry of Health, Labor, and Welfare; Japanese Ministry of Education, Culture, Sports, Science, and Technology; Naito Foundation; Takeda Science Foundation	This work was supported in part by grants-in-aid from the Japanese Ministry of Health, Labor, and Welfare (Research on Hepatitis), the Japanese Ministry of Education, Culture, Sports, Science, and Technology, the Naito Foundation, and the Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai LS, 2009, J VIROL, V83, P9923, DOI 10.1128/JVI.00066-09; Dorner M, 2013, NATURE, V501, P237, DOI 10.1038/nature12427; Cheng G, 2008, P NATL ACAD SCI USA, V105, P3088, DOI 10.1073/pnas.0712380105; Hueging K, 2014, J VIROL, V88, P1433, DOI 10.1128/JVI.01815-13; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Narayanaswami V, 2010, COMP BIOCHEM PHYS A, V155, P123, DOI 10.1016/j.cbpa.2009.09.009; Da Costa D, 2012, J VIROL, V86, P11919, DOI 10.1128/JVI.01066-12; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Mancone C, 2011, GUT, V60, P378, DOI 10.1136/gut.2010.211292; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Rozek A, 1999, BIOCHEMISTRY-US, V38, P14475, DOI 10.1021/bi982966h; Fukuhara T, 2013, J GASTROENTEROL, V48, P169, DOI 10.1007/s00535-012-0661-5; Dreux M, 2007, J BIOL CHEM, V282, P32357, DOI 10.1074/jbc.M705358200; Meunier JC, 2008, J VIROL, V82, P9647, DOI 10.1128/JVI.00914-08; RIEDER CL, 1985, J HISTOCHEM CYTOCHEM, V33, P165; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Coller KE, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002466; Jiang JY, 2009, J VIROL, V83, P12680, DOI 10.1128/JVI.01476-09; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; Fukuhara T, 2012, J VIROL, V86, P7918, DOI 10.1128/JVI.00567-12; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Mei XH, 2011, J BIOL CHEM, V286, P38570, DOI 10.1074/jbc.M111.260422; Prentoe J, 2014, J VIROL, V88, P1725, DOI 10.1128/JVI.02017-13; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Russell RS, 2008, P NATL ACAD SCI USA, V105, P4370, DOI 10.1073/pnas.0800422105; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Saito H, 2004, PROG LIPID RES, V43, P350, DOI 10.1016/j.plipres.2004.05.002; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; Boson B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002144; Catanese TM, 2013, P NATL ACAD SCI USA, V110, P9505; Eichinger A, 2007, J BIOL CHEM, V282, P31068, DOI 10.1074/jbc.M703552200; Gentzsch J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003355; Guschin YD, 2010, METHOD MOL BIOL, V649, P247; Jammart B, 2013, J VIROL, V87, P1405; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jirasko V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001233; Kim S, 2014, HEPATOLOGY, V60, P1838, DOI 10.1002/hep.27197; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Maasoumy B, 2012, BEST PRACT RES CLIN, V26, P410; Miyanari Y, 2007, NAT CELL BIOL, V9, P961; Sevvana M, 2010, J MOL BIOL, V404, P363, DOI 10.1016/j.jmb.2010.09.062; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Takebe Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064449	57	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1553-7366	1553-7374		PLOS PATHOG	PLoS Pathog.	DEC	2014	10	12							e1004534	10.1371/journal.ppat.1004534		14	Microbiology; Parasitology; Virology	Microbiology; Parasitology; Virology	AX1JB	WOS:000346702400022		
J	Shi, JJ; Hu, XL; Zhang, JB; Tang, WP; Li, HT; Shen, XD; Saito, N				Shi, Junjun; Hu, Xiulan; Zhang, Jianbo; Tang, Weiping; Li, Hongtao; Shen, Xiaodong; Saito, Nagahiro			One-step facile synthesis of Pd nanoclusters supported on carbon and their electrochemical property	PROGRESS IN NATURAL SCIENCE-MATERIALS INTERNATIONAL			English	Article						Pd nanoclusters; Solution plasma sputtering; Electrochemical property; Stability	LITHIUM-AIR BATTERY; ETHANOL OXIDATION; FUEL-CELLS; CATALYST; OXYGEN; ELECTROCATALYSTS; REDUCTION; CATHODE	Well-crystallized Pd nanoclusters supported on Ketjen Black (KB) were successfully fabricated when Pd wires were served as an electrode pair by a solution plasma technique at atmospheric pressure. The synthesis of Pd nanoclusters was almost simultaneous with their dispersion on KB. Pd nanoclusters with the average diameter of about 2 urn were equably distributed on KB, and showed good electrochemical property corresponding to their obvious characteristic peaks. Multi-scan cyclic voltammetry and chronoamperometry clarified that as-prepared Pd nanoclusters have better electrochemical stability in alkaline solution than that of in acidic solution. Thus as-obtained Pd nanoclusters would become a promising electrocatalyst for fuel cells or Li-air batteries. (C) 2014 Chinese Materials Research Society. Production and hosting by Elsevier B.V. All rights reserved.	[Shi, Junjun; Hu, Xiulan; Zhang, Jianbo; Li, Hongtao; Shen, Xiaodong] Nanjing Tech Univ, Coll Mat Sci & Engn, Nanjing 210009, Jiangsu, Peoples R China; [Tang, Weiping] Shanghai Inst Space Power Sources, Shanghai, Peoples R China; [Saito, Nagahiro] Nagoya Univ, Grad Sch Engn, Dept Mat Phys & Energy Engn, Nagoya, Aichi 4648601, Japan	Hu, XL (reprint author), Nanjing Tech Univ, Coll Mat Sci & Engn, Xin Mo Fan Rd 5, Nanjing 210009, Jiangsu, Peoples R China.	whoxiulan@163.com	Saito, Nagahiro/I-6113-2014	Saito, Nagahiro/0000-0001-8757-3933	New Century Excellent Talents in University (China) [NCET-12-0733]; Specially-Appointed Professors by Universities in Jiangsu Province (China) [SPUJP-2012]; National Natural Science Foundation of China [51372113]; scientific research foundation for Returned Overseas Students; Jiangsu Higher Education Institutions Natural Science Research Project - Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [12KJB430008]	This work was supported by Program for New Century Excellent Talents in University (NCET-12-0733, China), Specially-Appointed Professors by Universities in Jiangsu Province (SPUJP-2012, China), the National Natural Science Foundation of China (Grant no. 51372113), the scientific research foundation for Returned Overseas Students, the Jiangsu Higher Education Institutions Natural Science Research Project (Grant no. 12KJB430008), and Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Siracusano S, 2009, ELECTROCHIM ACTA, V54, P4844, DOI 10.1016/j.electacta.2009.03.070; Yan ZX, 2013, J POWER SOURCES, V243, P336, DOI 10.1016/j.jpowsour.2013.06.063; Sun W, 2011, J POWER SOURCES, V196, P4491, DOI 10.1016/j.jpowsour.2011.01.031; Qi J, 2010, CARBON, V48, P163, DOI 10.1016/j.carbon.2009.08.044; Erikson H, 2012, ELECTROCHIM ACTA, V59, P329, DOI 10.1016/j.electacta.2011.10.074; Jukk K, 2013, ELECTROCATALYSIS-US, V4, P42, DOI 10.1007/s12678-012-0117-y; Ayesh AI, 2011, J NANOPART RES, V13, P1125, DOI 10.1007/s11051-010-0104-2; Antolini E, 2009, ENERG ENVIRON SCI, V2, P915, DOI 10.1039/b820837a; Hu XL, 2012, CRYST GROWTH DES, V12, P119, DOI 10.1021/cg2008528; Wang L, 2014, FUEL PROCESS TECHNOL, V122, P23, DOI 10.1016/j.fuproc.2014.01.009; Shen Y, 2013, CARBON, V62, P288, DOI 10.1016/j.carbon.2013.05.066; Thapa AK, 2011, J ELECTROCHEM SOC, V158, pA1483, DOI 10.1149/2.090112jes; Xu CW, 2007, ADV MATER, V19, P4256, DOI 10.1002/adma.200602911; Zhao C, 2008, J CATAL, V254, P244, DOI 10.1016/j.jcat.2008.01.003; Shen PK, 2006, ELECTROCHEM COMMUN, V8, P184, DOI 10.1016/j.elecom.2005.11.013; Sethuraman VA, 2009, ELECTROCHIM ACTA, V54, P5571, DOI 10.1016/j.electacta.2009.04.062; Gaikwad AV, 2006, PHYS CHEM CHEM PHYS, V8, P3669, DOI 10.1039/b604665g; Mori K, 2004, J AM CHEM SOC, V126, P10657, DOI 10.1021/ja0488683; Hu XL, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.01AN05; Tian N, 2009, CHEM COMMUN, P1502, DOI 10.1039/b819751b; Xue X, 2011, FUEL CELLS, V11, P286, DOI 10.1002/fuce.200900204; Zhou P, 2007, J PHYS CHEM C, V111, P12609, DOI 10.1021/jp072898l	22	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1002-0071	1745-5391		PROG NAT SCI-MATER	Prog. Nat. Sci.	DEC	2014	24	6					593	598		10.1016/j.pnsc.2014.10.011		6	Materials Science, Multidisciplinary; Multidisciplinary Sciences	Materials Science; Science & Technology - Other Topics	AX3SK	WOS:000346858900004		
J	Ifuku, S; Suzuki, N; Izawa, H; Morimoto, M; Saimoto, H				Ifuku, S.; Suzuki, N.; Izawa, H.; Morimoto, M.; Saimoto, H.			Surface maleylation and naphthaloylation of chitin nanofibers for property enhancement	REACTIVE & FUNCTIONAL POLYMERS			English	Article						Chitin; Nanofiber; Modification; Maleylation; Naphthaloylation	ALPHA-CHITIN; IMPROVE DISPERSIBILITY; UNIFORM WIDTH; PHTHALOYLATION; PROTECTION; CHITOSAN	Surface N-maleylation and N-naphthaloylation of chitin nanofiber (NF) were achieved by reaction with maleic and naphthalic anhydrides in water, respectively. Maleyl and naphthaloyl groups were sufficiently introduced to an amino group on a surface-deacetylated chitin NF. The characteristic nanofiber morphology was maintained after maleylation and naphthaloylation. These NFs were homogeneously dispersed in several organic solvents. Especially, naphthaloyl chitin NF was dispersed even in aromatic solvents, owing to the high level of solvation interactions with the naphthaloyl group. The NF dispersions in those aromatic solvents exhibited a dispersive-to-precipitate transition response at approximately 29 degrees C. Moreover, the naphthaloyl chitin NF dispersion cut harmful ultraviolet light. The maleyl chitin NF formed a self-standing gel after cross-linking polymerization. (C) 2014 Elsevier B.V. All rights reserved.	[Ifuku, S.; Suzuki, N.; Izawa, H.; Morimoto, M.; Saimoto, H.] Tottori Univ, Dept Chem & Biotechnol, Tottori 6808552, Japan	Ifuku, S (reprint author), Tottori Univ, Dept Chem & Biotechnol, Tottori 6808552, Japan.	sifuku@chem.tottori-u.ac.jp	Izawa, Hironori/M-7037-2014	Izawa, Hironori/0000-0002-8715-8462			Abe K, 2014, CELLULOSE, V21, P535, DOI 10.1007/s10570-013-0095-0; Ito I, 2014, CARBOHYD POLYM, V101, P464, DOI 10.1016/j.carbpol.2013.09.074; Ifuku S, 2011, CARBOHYD POLYM, V84, P762, DOI 10.1016/j.carbpol.2010.04.039; Ifuku S, 2009, BIOMACROMOLECULES, V10, P1584, DOI 10.1021/bm900163d; MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3; Kurita K, 2002, BIOMACROMOLECULES, V3, P1, DOI 10.1021/bm0101163; Azuma K, 2012, CARBOHYD POLYM, V87, P1399, DOI 10.1016/j.carbpol.2011.09.036; Ifuku S, 2011, GREEN CHEM, V13, P1708, DOI 10.1039/c1gc15321h; Fan YM, 2010, CARBOHYD POLYM, V79, P1046, DOI 10.1016/j.carbpol.2009.10.044; Ifuku S, 2012, NANOSCALE, V4, P3308, DOI 10.1039/c2nr30383c; Ifuku S, 2013, CARBOHYD POLYM, V98, P1198, DOI 10.1016/j.carbpol.2013.07.033; Ifuku S, 2011, MATERIALS, V4, P1417, DOI 10.3390/ma4081417; Nogi M, 2010, CARBOHYD POLYM, V81, P919, DOI 10.1016/j.carbpol.2010.04.006; Ifuku S, 2011, GREEN CHEM, V13, P1499, DOI 10.1039/c0gc00860e; Ifuku S, 2010, BIOMACROMOLECULES, V11, P1326, DOI 10.1021/bm100109a; Ifuku S, 2014, RSC ADV, V4, P19246, DOI 10.1039/c4ra01975j; Ifuku S, 2012, CARBOHYD POLYM, V90, P623, DOI 10.1016/j.carbpol.2012.05.087; Kumar S., 2014, CARBOHYD POLYM, V94, P221	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-5148	1873-166X		REACT FUNCT POLYM	React. Funct. Polym.	DEC	2014	85				SI		121	125		10.1016/j.reactfunctpolym.2014.06.008		5	Chemistry, Applied; Engineering, Chemical; Polymer Science	Chemistry; Engineering; Polymer Science	AY0GF	WOS:000347274800012		
J	Kuramae, R; Saito, T; Isogai, A				Kuramae, Ryota; Saito, Tsuguyuki; Isogai, Akira			TEMPO-oxidized cellulose nanofibrils prepared from various plant holocelluloses	REACTIVE & FUNCTIONAL POLYMERS			English	Article						Cellulose microfibril; Holocellulose; Nanofibrillation; Sugar composition; TEMPO-mediated oxidation	MEDIATED OXIDATION; NATIVE CELLULOSE; FIBERS; WATER; PULP; NANOCELLULOSES; FAMILY	Plant holocelluloses were prepared from softwood, gymnosperm, hardwood, and herbaceous species, and subjected to TEMPO-mediated oxidation using the TEMPO/NaBr/NaOCl and TEMPO/NaOCl/NaO2Cl systems in water at pH 10 and 6.8, respectively. Weight recovery ratios of the water-insoluble TEMPO-oxidized holocellulose (TOH) fractions and their carboxylate contents, sugar compositions, and X-ray diffraction patterns were measured. When the oxidation at pH 10 was used, the carboxylate content of the TOHs increased up to 1.4-1.7 mmol g(-1). The oxidation at pH 6.8 resulted in higher weight recovery ratios of TOHs and their lower carboxylate contents (0.8-1.2 mmol g(-1)) than those prepared by the oxidation at pH 10. Hemicelluloses in plant holocelluloses are preferentially degraded to water-soluble fractions and removed from TOHs in the oxidation at pH 10. In contrast, the TEMPO-mediated oxidation at pH 6.8 provides hemicellulose-rich TOHs in high weight recovery ratios, although their nanofibrillation yields were low. All TEMPO-oxidized holocellulose nanofibrils (TOHNs) obtained by mechanical disintegration treatment of TOHs in water had the same average widths of similar to 3 nm, when measured by atomic force microscopy in water, which were consistent with those of TOHs determined from X-ray diffraction patterns. The number-average lengths of TOHNs were 500-600 nm. (C) 2014 Elsevier B.V. All rights reserved.	[Kuramae, Ryota; Saito, Tsuguyuki; Isogai, Akira] Univ Tokyo, Dept Biomat Sci, Bunkyo Ku, Tokyo 1138657, Japan	Isogai, A (reprint author), Univ Tokyo, Dept Biomat Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	aisogai@mail.ecc.u-tokyo.ac.jp			Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST)	This research was supported by Core Research for Evolutional Science and Technology (CREST) of the Japan Science and Technology Agency (JST).	Akiyama T., 2005, HOLZFORSCHUNG, V59; Alexander L.E., 1979, XRAY DIFFRACTION MET; Saito T, 2007, BIOMACROMOLECULES, V8, P2485, DOI 10.1021/bm0703970; Moon RJ, 2011, CHEM SOC REV, V40, P3941, DOI 10.1039/c0cs00108b; Saito T, 2013, BIOMACROMOLECULES, V14, P248, DOI 10.1021/bm301674e; Milanovic J, 2012, IND ENG CHEM RES, V51, P9750, DOI 10.1021/ie300713x; [Anonymous], 2001, 1762 ISO; Abe K, 2009, CELLULOSE, V16, P1017, DOI 10.1007/s10570-009-9334-9; Puangsin B, 2013, J POLYM ENVIRON, V21, P555, DOI 10.1007/s10924-012-0548-9; [Anonymous], 1999, T203CM99 TAPP STAND; Saito T, 2006, BIOMACROMOLECULES, V7, P1687, DOI 10.1021/bm060154s; Okita Y, 2009, HOLZFORSCHUNG, V63, P529, DOI 10.1515/HF.2009.096; Isogai A, 2013, J WOOD SCI, V59, P449, DOI 10.1007/s10086-013-1365-z; Perez DD, 2003, BIOMACROMOLECULES, V4, P1417, DOI 10.1021/bm034144s; Iwamoto S, 2009, BIOMACROMOLECULES, V10, P2571, DOI 10.1021/bm900520n; Isogai A, 2011, NANOSCALE, V3, P71, DOI 10.1039/c0nr00583e; Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273; Tanaka R, 2012, INT J BIOL MACROMOL, V51, P228, DOI 10.1016/j.ijbiomac.2012.05.016; Fukuzumi H, 2009, BIOMACROMOLECULES, V10, P162, DOI 10.1021/bm801065u; Takaichi S, 2014, CARBOHYD POLYM, V110, P499, DOI 10.1016/j.carbpol.2014.03.085; Saito T, 2004, BIOMACROMOLECULES, V5, P1983, DOI 10.1021/bm0497769; Saito T, 2009, BIOMACROMOLECULES, V10, P1992, DOI 10.1021/bm900414t; Wada M, 2004, BIOMACROMOLECULES, V5, P1385, DOI 10.1021/bm0345357; Iwamoto S, 2008, BIOMACROMOLECULES, V9, P1022, DOI 10.1021/bm701157n; Mao LS, 2008, IND ENG CHEM RES, V47, P3809, DOI 10.1021/ie071274z; Berzins V., 1966, PULP PAP-CANADA, V67, pT206; BORCHARD.LG, 1970, TAPPI, V53, P257; Fujisawa S, 2010, CELLULOSE, V17, P607, DOI 10.1007/s10570-010-9407-9; Mao LS, 2008, J PULP PAP SCI, V34, P198; Matsumura Shuichi, 1993, Journal of Environmental Polymer Degradation, V1, P23, DOI 10.1007/BF01457650; MATSUMURA S, 1990, MAKROMOL CHEM, V191, P1269; Saxena IM, 2005, ANN BOT-LONDON, V96, P9, DOI 10.1093/aob/mci155; Shinoda R., 2010, BIOMACROMOLECULES, V13, P842; SUGIYAMA J, 1991, MACROMOLECULES, V24, P4168, DOI 10.1021/ma00014a033; Takahashi N, 2006, PLANT PROD SCI, V9, P168, DOI 10.1626/pps.9.168; Wise L.E., 1946, PAP TRADE J, V122, P11	36	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-5148	1873-166X		REACT FUNCT POLYM	React. Funct. Polym.	DEC	2014	85				SI		126	133		10.1016/j.reactfunctpolym.2014.06.011		8	Chemistry, Applied; Engineering, Chemical; Polymer Science	Chemistry; Engineering; Polymer Science	AY0GF	WOS:000347274800013		
J	Dlouha, J; Suryanegara, L; Yano, H				Dlouha, Jana; Suryanegara, Lisrnan; Yano, Hiroyuki			Cellulose nanofibre-poly(lactic acid) microcellular foams exhibiting high tensile toughness	REACTIVE & FUNCTIONAL POLYMERS			English	Article						Polylactic acid; Cellulose nanofibres; Microcellular nanocomposites; Mechanical properties	SUPERCRITICAL CARBON-DIOXIDE; ACETYLATED MICROFIBRILLATED CELLULOSE; POLYMER THIN-FILMS; POLY(LACTIC ACID); TOUGHENING POLYPROPYLENE; POLYLACTIC ACID; CELL-SIZE; NANOCOMPOSITES; POLYCARBONATE; MORPHOLOGY	We report here the morphology and tensile properties of polylactic acid-cellulose nanofibre (PLA-CNF) microcellular nanocomposites. Two types of CNF were used for the nanocomposite preparation, native and surface acetylated CNF (ac-CNF). Samples were foamed in a mould to enable tensile testing. The effect of the mould use on the foam morphology was first assessed by comparison with free foamed samples. We found that the mould affected the cell growth stage of the foaming process in neat PLA foam while its effect was less important in nanocomposites. Stiffening and strengthening effect of CNF was greatly enhanced by foaming when compared to their solid counterparts. The most notable change in tensile properties was however the large increase in strain at break resulting in the high tensile toughness of microcellular PLA-CNF nanocomposites. Strain at break increased up to 7.5 times in neat PLA and up to 31.5 times in the foam containing 3% of CNF. Surface acetylation of CNF significantly affected the properties of foams with 9% of CNF loading: while foams with ac-CNF were stiffer, foams with native CNF exhibited higher strain at break and so higher overall toughness. (C) 2014 Elsevier B.V. All rights reserved.	[Dlouha, Jana; Suryanegara, Lisrnan; Yano, Hiroyuki] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto 6110011, Japan; [Dlouha, Jana] AgroParisTech, UMR LERFOB 1092, F-54000 Nancy, France; [Dlouha, Jana] INRA, UMR LERFOB 1029, F-54280 Champenoux, France; [Suryanegara, Lisrnan] Indonesian Inst Sci, Lab Biocomposites, Res & Dev Unit Biomat, Bogor 16911, Indonesia	Dlouha, J (reprint author), Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto 6110011, Japan.	jana.dlouha@nancy.inra.fr			Japanese Society of Promotion of Science; French National Research Agency through the Laboratory of Excellence ARBRE [ANR-12-LABXARBRE-01]	The first author sincerely thanks the Japanese Society of Promotion of Science for supporting this work. Authors would also like to acknowledge Dr. Hironari Sano from Mitsubishi Chemical Corporation, Japan for his precious help with TEM observations. The UMR 1092 LERFoB is supported by the French National Research Agency through the Laboratory of Excellence ARBRE (ANR-12-LABXARBRE-01).	Ameli A., 2013, J CELL PLAST; Zhang HB, 2011, ACS APPL MATER INTER, V3, P918, DOI 10.1021/am200021v; Miller D, 2011, POLYMER, V52, P2910, DOI 10.1016/j.polymer.2011.04.049; Dlouha J, 2012, SOFT MATTER, V8, P8704, DOI 10.1039/c2sm25909e; Rasal RM, 2010, PROG POLYM SCI, V35, P338, DOI 10.1016/j.progpolymsci.2009.12.003; Matuana LM, 2008, BIORESOURCE TECHNOL, V99, P3643, DOI 10.1016/j.biortech.2007.07.062; Kramschuster A, 2007, J BIOBASED MATER BIO, V1, P37, DOI 10.1166/jbmb.2007.004; Mihai M, 2009, J APPL POLYM SCI, V113, P2920, DOI 10.1002/app.30338; Jonoobi M, 2010, COMPOS SCI TECHNOL, V70, P1742, DOI 10.1016/j.compscitech.2010.07.005; Julien JM, 2012, POLYMER, V53, P5885, DOI 10.1016/j.polymer.2012.10.005; Suryanegara L, 2009, COMPOS SCI TECHNOL, V69, P1187, DOI 10.1016/j.compscitech.2009.02.022; Doroudiani S, 1998, POLYM ENG SCI, V38, P1205, DOI 10.1002/pen.10289; Iwatake A, 2008, COMPOS SCI TECHNOL, V68, P2103, DOI 10.1016/j.compscitech.2008.03.006; Tingaut P, 2010, BIOMACROMOLECULES, V11, P454, DOI 10.1021/bm901186u; Henriksson M, 2008, BIOMACROMOLECULES, V9, P1579, DOI 10.1021/bm800038n; Li DC, 2011, IND ENG CHEM RES, V50, P1997, DOI 10.1021/ie101723g; Ma P, 2012, EUR POLYM J, V48, P146, DOI 10.1016/j.eurpolymj.2011.10.015; Bagheri R, 1996, POLYMER, V37, P4529, DOI 10.1016/0032-3861(96)00295-9; Thio YS, 2004, POLYMER, V45, P3139, DOI 10.1016/j.polymer.2004.02.064; Ema Y, 2006, POLYMER, V47, P5350, DOI 10.1016/j.polymer.2006.05.050; Dasari A, 2010, MACROMOLECULES, V43, P5734, DOI 10.1021/ma100633y; Pilla S, 2010, J MATER SCI, V45, P2732, DOI 10.1007/s10853-010-4261-6; Boissard CIR, 2011, J REINF PLAST COMP, V30, P709, DOI 10.1177/0731684411407233; Jiang L, 2007, POLYMER, V48, P7632, DOI 10.1016/j.polymer.2007.11.001; Weller JE, 2010, POLYM ENG SCI, V50, P2170, DOI 10.1002/pen.21737; Arora KA, 1998, MACROMOLECULES, V31, P4614, DOI 10.1021/ma971811z; Barlow C, 2001, J ENG MATER-T ASME, V123, P229, DOI 10.1115/1.1339004; Bergeret A., 2011, INT J POLYM SCI, V2011, P14; Bulota M, 2012, J MATER SCI, V47, P5517, DOI 10.1007/s10853-012-6443-x; Bulota M, 2012, J APPL POLYM SCI, V126, pE448, DOI 10.1002/app.36787; COLLIAS DI, 1995, POLYM ENG SCI, V35, P1167, DOI 10.1002/pen.760351407; COLLIAS DI, 1994, POLYMER, V35, P3978, DOI 10.1016/0032-3861(94)90283-6; Gibson L. J., 1997, CELLULAR SOLIDS STRU; Javadi A, 2010, COMPOS PART A-APPL S, V41, P982, DOI 10.1016/j.compositesa.2010.04.002; Ji GY, 2013, J CELL PLAST, V49, P101, DOI 10.1177/0021955X13477437; Kearney AV, 2008, ACTA MATER, V56, P5946, DOI 10.1016/j.actamat.2008.08.009; LIU NC, 1994, POLYMER, V35, P988, DOI 10.1016/0032-3861(94)90943-1; Pilla S, 2009, MAT SCI ENG C-BIO S, V29, P1258, DOI 10.1016/j.msec.2008.10.027; Siripurapu S, 2004, MACROMOLECULES, V37, P9872, DOI 10.1021/ma0484983; Wang J, 2011, IND ENG CHEM RES, V50, P13840, DOI 10.1021/ie201643j; Zeng CC, 2013, COMPOS SCI TECHNOL, V82, P29, DOI 10.1016/j.compscitech.2013.03.024	41	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-5148	1873-166X		REACT FUNCT POLYM	React. Funct. Polym.	DEC	2014	85				SI		201	207		10.1016/j.reactfunctpolym.2014.07.016		7	Chemistry, Applied; Engineering, Chemical; Polymer Science	Chemistry; Engineering; Polymer Science	AY0GF	WOS:000347274800022		
J	Lee, KY; Blaker, JJ; Heng, JYY; Murakami, R; Bismarck, A				Lee, Koon-Yang; Blaker, Jonny J.; Heng, Jerry Y. Y.; Murakami, Ryo; Bismarck, Alexander			pH-triggered phase inversion and separation of hydrophobised bacterial cellulose stabilised Pickering emulsions	REACTIVE & FUNCTIONAL POLYMERS			English	Article						Pickering emulsions; Bacterial cellulose; Esterification; Phase inversion; Phase separation	COLLOIDAL MICROCRYSTALLINE CELLULOSE; MICROFIBRILLATED CELLULOSE; PARTICLES; NANOCRYSTALS; INTERFACE	The pH-triggered transitional phase behaviour of Pickering emulsions stabilised by hydrophobised bacterial cellulose (BC) is reported in this work. Neat BC was esterified with acetic (C-2-), hexanoic (C-6-) and dodecanoic (C-12-) acids, respectively. We observed that C-6- and C-12-BC stabilised emulsions exhibited a pH-triggered reversible transitional phase separation. Water-in-toluene emulsions containing of 60 vol.% dispersed phase stabilised by C-6- and C-12-BC were produced at pH 5. Lowering the pH of the aqueous phase to 1 did not affect the emulsion type. Increasing the pH to 14, however, caused the emulsions to phase separate. This phase separation was caused by electrostatic repulsion between modified BC due to dissociable acidic surface groups at high pH, which lowered the surface coverage of the water droplets by modified BC. When the pH was re-adjusted to 1 again, w/o emulsions re-formed for C-6- and C-12-BC stabilised emulsions. C-2-BC stabilised emulsions, on the other hand, underwent an irreversible pH-triggered transitional phase separation and inversion. This difference in phase behaviour between C-2-BC and C-6-/C-12-BC was attributed to the hydrolysis of the ester bonds of C-2-BC at high pH. This hypothesis is in good agreement with the measured degree of surface substitution (DSS) of modified BC after the pH-triggered experiments. The DSS of C-2-BC decreased by 20% whilst the DSS remained constant for C-6- and C-12-BC. Crown Copyright (C) 2014 Published by Elsevier B.V. All rights reserved.	[Lee, Koon-Yang] UCL, Dept Chem Engn, London WC1E 7JE, England; [Blaker, Jonny J.] Univ Manchester, Sch Mat, Ctr Mat Sci, Manchester M1 7HS, Lancs, England; [Heng, Jerry Y. Y.] Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, Surfaces & Particle Engn Lab, London SW7 2AZ, England; [Murakami, Ryo] Konan Univ, Dept Chem Funct Mol, Kobe, Hyogo 6588501, Japan; [Bismarck, Alexander] Univ Vienna, Fac Chem, Inst Mat Chem & Res, Polymer & Composite Engn PaCE Grp, A-1090 Vienna, Austria; [Bismarck, Alexander] Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, Polymer & Composite Engn PaCE Grp, London SW7 2AZ, England	Lee, KY (reprint author), UCL, Dept Chem Engn, Torrington Pl, London WC1E 7JE, England.	koonyang.lee@ucl.ac.uk	Heng, Jerry/E-7761-2015	Heng, Jerry/0000-0003-2659-5500	UK Engineering and Physical Science Research Council (EPSRC) [EP/F032005/1]; EPSRC Challenging Engineering Programme [EP/E007538/1]; University of Vienna	The authors would like to thank the UK Engineering and Physical Science Research Council (EPSRC) for funding KYL (EP/F032005/1) and the EPSRC Challenging Engineering Programme for funding JIB (EP/E007538/1). We also greatly appreciate the University of Vienna for continuing the support for KYL.	Xhanari K, 2011, J DISPER SCI TECHNOL, V32, P447, DOI 10.1080/01932691003658942; Lee KY, 2012, CELLULOSE, V19, P891, DOI 10.1007/s10570-012-9680-x; Capron I, 2013, BIOMACROMOLECULES, V14, P291, DOI 10.1021/bm301871k; Andresen M, 2007, J DISPER SCI TECHNOL, V28, P837, DOI 10.1080/01932690701341827; Finkle P, 1923, J AM CHEM SOC, V45, P2780, DOI 10.1021/ja01665a002; Lee KY, 2014, LANGMUIR, V30, P452, DOI 10.1021/la4032514; Horozov TS, 2006, ANGEW CHEM INT EDIT, V45, P773, DOI 10.1002/anie.200503131; Lee KY, 2009, COMPOS SCI TECHNOL, V69, P2724, DOI 10.1016/j.compscitech.2009.08.016; TOYOSAKI H, 1995, BIOSCI BIOTECH BIOCH, V59, P1498; Aveyard R, 2003, ADV COLLOID INTERFAC, V100, P503, DOI 10.1016/S0001-8686(02)00069-6; Aveyard R, 2000, LANGMUIR, V16, P1969, DOI 10.1021/la990887g; OZA KP, 1986, J DISPER SCI TECHNOL, V7, P543, DOI 10.1080/01932698608943478; Binks BP, 2000, LANGMUIR, V16, P2539, DOI 10.1021/la991081j; Kalashnikova I, 2012, BIOMACROMOLECULES, V13, P267, DOI 10.1021/bm201599j; SCHELUDKO A, 1976, J CHEM SOC FARAD T 1, V72, P2815, DOI 10.1039/f19767202815; Kalashnikova I, 2011, LANGMUIR, V27, P7471, DOI 10.1021/la200971f; Ramsden W, 1903, P R SOC LONDON, V72, P156, DOI 10.1098/rspl.1903.0034; Ougiya H, 1997, BIOSCI BIOTECH BIOCH, V61, P1541; Kargar M, 2012, J COLLOID INTERF SCI, V366, P209, DOI 10.1016/j.jcis.2011.09.073; Blaker JJ, 2009, GREEN CHEM, V11, P1321, DOI 10.1039/b913740h; Arditty S, 2003, EUR PHYS J E, V11, P273, DOI 10.1140/epje/i2003-10018-6; Pickering SU, 1907, J CHEM SOC, V91, P2001, DOI 10.1039/ct9079102001; Lee KY, 2011, CELLULOSE, V18, P595, DOI 10.1007/s10570-011-9525-z; Abend S, 1998, COLLOID POLYM SCI, V276, P730, DOI 10.1007/s003960050303; LEVINE S, 1989, COLLOID SURFACE, V38, P325, DOI 10.1016/0166-6622(89)80271-9; Aveyard R., 2002, PHYS REV LETT, V88; AVEYARD R, 1986, J CHEM SOC FARAD T 1, V82, P1755, DOI 10.1039/f19868201755; Haaj S.B., 2014, ACS APPL MATER INTER, P8263; Hunter RJ, 1993, INTRO MODERN COLLOID; Kalashnikova I., 2013, SOFT MATTER, P952; KORETSKY AF, 1971, IZV SIB OTD AKAD NAU, V2, P139; Lee KY, 2014, MATER ENERG, V5, P185; Lif A., 2010, J COLLOID INTERF SCI, V352, P585; OZA KP, 1989, J DISPER SCI TECHNOL, V10, P163, DOI 10.1080/01932698908943168; OZA KP, 1989, J DISPER SCI TECHNOL, V10, P187, DOI 10.1080/01932698908943169; Pickering S.U., 1910, Z CHEM IND KOLL KOLL, V7, P11; Rautkari L, 2013, J MATER SCI, V48, P6352, DOI 10.1007/s10853-013-7434-2; Scarlett A. J., 1927, J PHYS CHEM-US, V31, P1566, DOI 10.1021/j150280a010; Sinks B.P., 2002, CURR OPIN COLLOID IN, V7, P21; VANWAGENEN RA, 1981, J COLLOID INTERF SCI, V84, P155, DOI 10.1016/0021-9797(81)90269-1; Zemplen G, 1929, BER DTSCH CHEM GES, V62, P1613, DOI 10.1002/cber.19290620640; Zoppe JO, 2012, J COLLOID INTERF SCI, V369, P202, DOI 10.1016/j.jcis.2011.12.011	42	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-5148	1873-166X		REACT FUNCT POLYM	React. Funct. Polym.	DEC	2014	85				SI		208	213		10.1016/j.reactfunctpolym.2014.09.016		6	Chemistry, Applied; Engineering, Chemical; Polymer Science	Chemistry; Engineering; Polymer Science	AY0GF	WOS:000347274800023		
J	Salas, C; Ago, M; Lucia, LA; Rojas, OJ				Salas, Carlos; Ago, Mariko; Lucia, Lucian A.; Rojas, Orlando J.			Synthesis of soy protein-lignin nanofibers by solution electrospinning	REACTIVE & FUNCTIONAL POLYMERS			English	Article						Soy protein; Composite fibers; Lignin; Electrospinning	CELLULOSE NANOCRYSTALS; POLY(ETHYLENE OXIDE); FIBERS; PLASTICS; GLYCININ; POLYMERS; FILLER; FILMS	Nanofibers were produced by electrospinning aqueous alkaline solutions containing different mass ratios of soy protein and lignin in the presence of poly(ethylene glycol) coadjutant, all of which presented shear thinning behavior. SEM revealed that the addition of polyethylene oxide as a coadjutant indeed facilitated the formation of defect-free fibers whose diameter increased with lignin concentration, in the range between approximate to 124 and approximate to 1400 nm. Favorable interactions between lignin and soy protein were identified from data provided by differential scanning calorimetry. In addition, an increased hydrogen bonding and the loss of secondary structure of the proteins as the lignin concentration increased were observed from the disappearance of amide II (similar to 1500 cm(-1)) and III (similar to 1400-1200 cm(-1)) bands and a red shift of amide I band in the FT-IR spectrum. The unfolding of the protein contributed to a better interaction with lignin macromolecules, which further improved the electrospinning process. It is concluded that mixtures of lignin and soy proteins, two major renewable resources with interesting chemical features, are suitable for the development of composite sub-micron fibers. (C) 2014 Elsevier B.V. All rights reserved.	[Salas, Carlos; Lucia, Lucian A.; Rojas, Orlando J.] N Carolina State Univ, Dept Forest Biomat, Raleigh, NC 27695 USA; [Salas, Carlos] Univ Los Andes, Dept Ingn Quim, Merida 5101, Venezuela; [Ago, Mariko] Tokushima Bunri Univ, Fac Sci & Engn, Sanuki, Kagawa, Japan; [Lucia, Lucian A.] Qilu Univ Technol, Key Lab Pulp & Paper Sci & Technol, Jinan 250353, Peoples R China; [Rojas, Orlando J.] Aalto Univ, Sch Chem Technol, Dept Forest Prod Technol, FI-00076 Espoo, Finland	Salas, C (reprint author), N Carolina State Univ, Dept Forest Biomat, Raleigh, NC 27695 USA.	clsalasa@ncsu.edu; orlando.rojas@aalto.fi	Rojas, Orlando/O-2890-2014	Rojas, Orlando/0000-0003-4036-4020	United Soybean Board (USB) [0426, 0490]; HYBER's Academy of Finland's Centres of Excellence Programme	The authors acknowledge partial support from United Soybean Board (USB) under Project Numbers 0426 and 0490 and HYBER's Academy of Finland's Centres of Excellence Programme (2014-2019).	Abdelgawad AM, 2014, CARBOHYD POLYM, V100, P166, DOI 10.1016/j.carbpol.2012.12.043; Ago M, 2012, ACS APPL MATER INTER, V4, P6848, DOI 10.1021/am302008p; Ohkawa K, 2004, MACROMOL RAPID COMM, V25, P1600, DOI 10.1002/marc.200400253; Sun XS, 2008, MACROMOL BIOSCI, V8, P295, DOI 10.1002/mabi.200700235; Teng NY, 2013, J WOOD CHEM TECHNOL, V33, P299, DOI 10.1080/02773813.2013.795807; Huang J, 2004, J APPL POLYM SCI, V93, P624, DOI 10.1002/app.20478; Um IC, 2004, BIOMACROMOLECULES, V5, P1428, DOI 10.1021/bm034539b; Ruiz-Rosas R, 2010, CARBON, V48, P696, DOI 10.1016/j.carbon.2009.10.014; Greiner A, 2007, ANGEW CHEM INT EDIT, V46, P5670, DOI 10.1002/anie.200604646; Kong J, 2007, ACTA BIOCH BIOPH SIN, V39, P549, DOI 10.1111/j.1745-7270.2007.00320.x; Bhardwaj N, 2010, BIOTECHNOL ADV, V28, P325, DOI 10.1016/j.biotechadv.2010.01.004; Stalder AF, 2006, COLLOID SURFACE A, V286, P92, DOI 10.1016/j.colsurfa.2006.03.008; Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481; Vallejos ME, 2012, J POLYM ENVIRON, V20, P1075, DOI 10.1007/s10924-012-0499-1; Teo WE, 2006, NANOTECHNOLOGY, V17, pR89, DOI 10.1088/0957-4484/17/14/R01; Deng LB, 2013, CARBON, V58, P66, DOI 10.1016/j.carbon.2013.02.032; Hasek J, 2006, Z KRISTALLOGR, P613; Ago M, 2012, BIOMACROMOLECULES, V13, P918, DOI 10.1021/bm201828g; Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516; PENG IC, 1984, CEREAL CHEM, V61, P480; Salas C, 2012, BIOMACROMOLECULES, V13, P387, DOI 10.1021/bm2014153; Burger C, 2006, ANNU REV MATER RES, V36, P333, DOI 10.1146/annurev.matsci.36.011205.123537; Zoppe JO, 2009, ACS APPL MATER INTER, V1, P1996, DOI 10.1021/am9003705; Kim CW, 2006, POLYMER, V47, P5097, DOI 10.1016/j.polymer.2006.05.033; GHORPADE VM, 1995, CEREAL CHEM, V72, P559; Rodriguez K, 2012, CELLULOSE, V19, P1583, DOI 10.1007/s10570-012-9734-0; Schiffman JD, 2008, POLYM REV, V48, P317, DOI 10.1080/15583720802022182; Rocco AM, 2003, EUR POLYM J, V39, P1925, DOI 10.1016/S0014-3057(03)00098-3; Lallave M, 2007, ADV MATER, V19, P4292, DOI 10.1002/adma.200700963; Lora JH, 2002, J POLYM ENVIRON, V10, P39, DOI 10.1023/A:1021070006895; Dallmeyer I, 2010, J WOOD CHEM TECHNOL, V30, P315, DOI 10.1080/02773813.2010.527782; BADLEY RA, 1975, BIOCHIM BIOPHYS ACTA, V412, P214, DOI 10.1016/0005-2795(75)90036-7; Cho D, 2010, MACROMOL MATER ENG, V295, P763, DOI 10.1002/mame.201000161; Huang J, 2003, J APPL POLYM SCI, V88, P3291, DOI 10.1002/app.12184; Huang J, 2003, J APPL POLYM SCI, V88, P3284, DOI 10.1002/app.12185; Kim CW, 2005, J POLYM SCI POL PHYS, V43, P1673, DOI 10.1002/polb.20475; KRIMM S, 1983, BIOPOLYMERS, V22, P217, DOI 10.1002/bip.360220130; Lin S. Y., 1992, METHODS LIGNIN CHEM; Montero G.A, 2008, 82 ACS COLL SURF S A; Ohkawa K., 2009, TEXT RES J, P1396; Qin W, 2011, IND ENG CHEM RES, V50, P12548, DOI 10.1021/ie201319p; Salas C., 2012, ACS APPL MATER INTER, V5, P199; Schmitz J. F., 2008, SOYBEANS CHEM PRODUC, P539; Scilingo AA, 1996, J AGR FOOD CHEM, V44, P3751, DOI 10.1021/jf960035b; Swain SN, 2004, J POLYM ENVIRON, V12, P35, DOI 10.1023/B:JOOE.0000003126.14448.04; Vega-Lugo AC, 2008, J BIOBASED MATER BIO, V2, P223, DOI 10.1166/jbmb.2008.408; Xu XZ, 2012, ACS APPL MATER INTER, V4, P4331, DOI 10.1021/am300991e	47	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1381-5148	1873-166X		REACT FUNCT POLYM	React. Funct. Polym.	DEC	2014	85				SI		221	227		10.1016/j.reactfunctpolym.2014.09.022		7	Chemistry, Applied; Engineering, Chemical; Polymer Science	Chemistry; Engineering; Polymer Science	AY0GF	WOS:000347274800025		
J	Detante, O; Jaillard, A; Moisan, A; Barbieux, M; Favre, IM; Garambois, K; Hommel, M; Remy, C				Detante, O.; Jaillard, A.; Moisan, A.; Barbieux, M.; Favre, I. M.; Garambois, K.; Hommel, M.; Remy, C.			Biotherapies in stroke	REVUE NEUROLOGIQUE			English	Article						Plasticity; Neural repair; Cell therapy; Transplantation; Stem cells	MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; FOCAL CEREBRAL-ISCHEMIA; AUTOLOGOUS BONE-MARROW; COLONY-STIMULATING FACTOR; ENDOTHELIAL GROWTH-FACTOR; NEURAL PROGENITOR CELLS; CORD BLOOD-CELLS; THERAPEUTIC TIME WINDOW; PROMOTE FUNCTIONAL RECOVERY	Stroke is the second leading cause of death worldwide and the most common cause of severe disability. Neuroprotection and repair mechanisms supporting endogenous brain plasticity are often insufficient to allow complete recovery. While numerous neuroprotective drugs trials have failed to demonstrate benefits for patients, they have provided interesting translational research lessons related to neurorestorative therapy mechanisms in stroke. Stroke damage is not limited to neurons but involve all brain cell type including the extracellular matrix in a ''glio-neurovascular niche''. Targeting a range of host brain cells, biotherapies such as growth factors and therapeutic cells, currently hold great promise as a regenerative medical strategy for stroke. These techniques can promote both neuroprotection and delayed neural repair through neuro-synaptogenesis, angiogenesis, oligodendrogliogenesis, axonal sprouting and immunomodulatory effects. Their complex mechanisms of action are interdependent and vary according to the particular growth factor or grafted cell type. For example, while ''peripheral'' stem or stromal cells can provide paracrine trophic support, neural stem/progenitor cells (NSC) or mature neurons can act as more direct neural replacements. With a wide therapeutic time window after stroke, biotherapies could be used to treat many patients. However, guidelines for selecting the optimal time window, and the best delivery routes and doses are still debated and the answers may depend on the chosen product and its expected mechanism including early neuroprotection, delayed neural repair, trophic systemic transient effects or graft survival and integration. Currently, the great variety of growth factors, cell sources and cell therapy products form a therapeutic arsenal that is available for stroke treatment. Their effective clinical use will require prior careful considerations regarding safety (e. g. tumorgenicity, immunogenicity), potential efficacy, cell characterization, delivery route and in vivo biodistribution. Bone marrow-derived cell populations such as mesenchymal stromal/stem cells (MSC) or mononuclear cells (MNC), umbilical cord stem cells and NSC are most investigated notably in clinical trials. Finally, we discuss perspectives concerning potential novel biotherapies such as combinatorial approaches (growth factor combined with cell therapy, in vitro optimization of cell products, or co-transplantation) and the development of biomaterials, which could be used as injectable hydrogel scaffold matrices that could protect a cell graft or selectively deliver drugs and growth factors into the post-stroke cavity at chronic stages. Considering the remaining questions about the best procedure and the safety cautions, we can hope that future translational research about biotherapies will bring more efficient treatments that will decrease post-stroke disability for many patients. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Detante, O.; Barbieux, M.; Favre, I. M.; Garambois, K.] Univ Hosp Grenoble, Stroke Unit, Dept Neurol, F-38700 La Tronche, France; [Detante, O.; Moisan, A.; Barbieux, M.; Favre, I. M.; Remy, C.] INSERM, U836, F-38042 Grenoble 9, France; [Detante, O.; Moisan, A.; Barbieux, M.; Favre, I. M.; Remy, C.] Grenoble Univ, Grenoble Inst Neurosci, Team 5, F-38042 Grenoble 9, France; [Detante, O.] Kyoto Univ, Inst Frontier Med Sci, Dept Reparat Mat, Kyoto 6068507, Japan; [Jaillard, A.] CHU Grenoble, Dept Neuroradiol, MRI Res Unit 3T, F-38700 La Tronche, France; [Moisan, A.] EFS Rhone Alpes, Cell Therapy & Engn Unit, F-38330 Saint Ismier, France; [Hommel, M.] CHU Grenoble, Dept Clin Res, F-38700 La Tronche, France	Detante, O (reprint author), Univ Hosp Grenoble, Stroke Unit, Dept Neurol, CS 10217,Blvd Chantourne, F-38700 La Tronche, France.	ODetante@chu-grenoble.fr			French National Research Agency [ANR-11-INBS-0005]	The authors acknowledge Thomas Zeffiro (Neural Systems Group, Massachusetts General Hospital, Charlestown, USA) for proofreading. This work is supported by the French National Research Agency as part of the '' Investments for the future'' (ANR-11-INBS-0005) for ECell-France national network for regenerative medicine (ecellfrance. com).	Aimone JB, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00150; Alasheev AM, 2011, TRANSL STROKE RES, V2, P358, DOI 10.1007/s12975-011-0091-3; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Amariglio N, 2010, NAT MED, V16, P157, DOI 10.1038/nm0210-157b; Chen JL, 2001, STROKE, V32, P1005; Darsalia V, 2005, STROKE, V36, P1790, DOI 10.1161/01.STR.0000173151.36031.be; Tornero D, 2013, BRAIN, V136, P3561, DOI 10.1093/brain/awt278; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Borlongan CV, 2010, STEM CELLS DEV, V19, P439, DOI 10.1089/scd.2009.0340; Yuan JY, 2009, APOPTOSIS, V14, P469, DOI 10.1007/s10495-008-0304-8; Zhong J, 2010, NEUROREHAB NEURAL RE, V24, P636, DOI 10.1177/1545968310361958; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Chu K, 2005, NEUROSCI RES, V53, P384, DOI 10.1016/j.neures.2005.08.010; Shyu WC, 2004, CIRCULATION, V110, P1847, DOI 10.1161/01.CIR.0000142616.07367.66; Valable S, 2003, FASEB J, V17, P443, DOI 10.1096/fj.02-0372fje; Kim JM, 2007, BRAIN RES, V1183, P43, DOI 10.1016/j.brainres.2007.09.005; Sinden JD, 2012, INT J STROKE, V7, P426, DOI 10.1111/j.1747-4949.2012.00840.x; Leong WK, 2012, STEM CELL TRANSL MED, V1, P177, DOI 10.5966/sctm.2011-0039; Sahota P, 2011, NEUROTHERAPEUTICS, V8, P434, DOI 10.1007/s13311-011-0040-6; Ishikawa H, 2013, STROKE, V44, P3473, DOI 10.1161/STROKEAHA.113.001943; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Pannasch U, 2011, P NATL ACAD SCI USA, V108, P8467, DOI 10.1073/pnas.1016650108; Lappalainen RS, 2008, NEUROSCI LETT, V440, P246, DOI 10.1016/j.neulet.2008.05.090; Schmidt A, 2014, STROKE, V45, P239, DOI 10.1161/STROKEAHA.113.002048; Wagner J, 2009, CURR OPIN BIOTECH, V20, P531, DOI 10.1016/j.copbio.2009.08.009; Borlongan CV, 2004, STROKE, V35, P2385, DOI 10.1161/01.STR.0000141680.49960.d7; Park DH, 2010, STEM CELLS DEV, V19, P175, DOI 10.1089/scd.2009.0172; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; Shyu WC, 2008, J PHARMACOL EXP THER, V324, P834, DOI 10.1124/jpet.107.127746; Ma J, 2007, BIOMED MATER, V2, P233, DOI 10.1088/1748-6041/2/4/005; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Macrez R, 2011, LANCET NEUROL, V10, P471, DOI 10.1016/S1474-4422(11)70066-7; Andres RH, 2011, BRAIN, V134, P1777, DOI 10.1093/brain/awr094; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; Chen JL, 2003, ANN NEUROL, V53, P743, DOI 10.1002/ana.10555; Chen JL, 2011, STROKE, V42, P3551, DOI 10.1161/STROKEAHA.111.627174; Englund U, 2002, P NATL ACAD SCI USA, V99, P17089, DOI 10.1073/pnas.252589099; Zhang ZG, 2002, NEUROSCIENCE, V113, P683, DOI 10.1016/S0306-4522(02)00175-6; Onda T, 2008, J CEREBR BLOOD F MET, V28, P329, DOI 10.1038/sj.jcbfm.9600527; Li ZM, 2013, CLIN NEUROL NEUROSUR, V115, P72, DOI 10.1016/j.clineuro.2012.04.030; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Bulte JWM, 1999, P NATL ACAD SCI USA, V96, P15256, DOI 10.1073/pnas.96.26.15256; Li L, 2010, J CEREBR BLOOD F MET, V30, P653, DOI 10.1038/jcbfm.2009.238; Komatsu K, 2010, BRAIN RES, V1334, P84, DOI 10.1016/j.brainres.2010.04.006; Cooke MJ, 2011, BIOMATERIALS, V32, P5688, DOI 10.1016/j.biomaterials.2011.04.032; Eve DJ, 2010, CELL TRANSPLANT, V19, P1493, DOI 10.3727/096368910X540612; Cui X, 2012, CELL TRANSPLANT, V21, P845, DOI 10.3727/096368911X627417; Chen JL, 2001, J NEUROL SCI, V189, P49, DOI 10.1016/S0022-510X(01)00557-3; Shuaib A, 2007, NEW ENGL J MED, V357, P562, DOI 10.1056/NEJMoa070240; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Teng H, 2008, J CEREBR BLOOD F MET, V28, P764, DOI 10.1038/sj.jcbfm.9600573; Guzman R, 2008, STROKE, V39, P1300, DOI 10.1161/STROKEAHA.107.500470; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Honmou O, 2012, TRENDS MOL MED, V18, P292, DOI 10.1016/j.molmed.2012.02.003; Xing CH, 2012, INT J STROKE, V7, P378, DOI 10.1111/j.1747-4949.2012.00839.x; Smith EJ, 2012, STEM CELLS, V30, P785, DOI 10.1002/stem.1024; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Hassiotou F, 2012, STEM CELLS, V30, P2164, DOI 10.1002/stem.1188; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Willing AE, 2003, J NEUROSCI RES, V73, P296, DOI 10.1002/jnr.10659; Fischer UM, 2009, STEM CELLS DEV, V18, P683, DOI 10.1089/scd.2008.0253; Grefkes C, 2014, LANCET NEUROL, V13, P206, DOI 10.1016/S1474-4422(13)70264-3; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Hermann DM, 2009, J CEREBR BLOOD F MET, V29, P1620, DOI 10.1038/jcbfm.2009.100; Li WY, 2008, CELL TRANSPLANT, V17, P1045; Pekna M, 2012, STROKE, V43, P2819, DOI 10.1161/STROKEAHA.112.654228; Reitmeir R, 2011, BRAIN, V134, P84, DOI 10.1093/brain/awq344; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; Ringelstein EB, 2013, STROKE, V44, P2681, DOI 10.1161/STROKEAHA.113.001531; da Fonseca LMB, 2010, EXP NEUROL, V221, P122, DOI 10.1016/j.expneurol.2009.10.010; Osanai T, 2010, NEUROSURGERY, V66, P1140, DOI 10.1227/01.NEU.0000369610.76181.CF; Fagan SC, 2010, STROKE, V41, P2283, DOI 10.1161/STROKEAHA.110.582601; De Keyser J, 1999, TRENDS NEUROSCI, V22, P535, DOI 10.1016/S0166-2236(99)01463-0; Battistella V, 2011, REGEN MED, V6, P45, DOI [10.2217/rme.10.97, 10.2217/RME.10.97]; Onteniente B, 2013, CURR MOL MED, V13, P821; Moisan A, 2012, NMR BIOMED, V25, P1340, DOI 10.1002/nbm.2806; Savitz SI, 2005, CEREBROVASC DIS, V20, P101, DOI 10.1159/000086518; Macas J, 2006, J NEUROSCI, V26, P13114, DOI 10.1523/JNEUROSCI.4667-06.2006; Horie N, 2011, STEM CELLS, V29, P274, DOI 10.1002/stem.584; Paczkowska E, 2009, STROKE, V40, P1237, DOI 10.1161/STROKEAHA.108.535062; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Iihoshi S, 2004, BRAIN RES, V1007, P1, DOI 10.1016/j.brainres.2003.09.184; Yang B, 2013, STROKE, V44, P3463, DOI 10.1161/STROKEAHA.111.000821; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Eckert MA, 2013, J CEREBR BLOOD F MET, V33, P1322, DOI 10.1038/jcbfm.2013.91; Pham LDD, 2012, GLIA, V60, P875, DOI 10.1002/glia.22320; Liepert J, 2000, STROKE, V31, P1210; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Willing AE, 2003, CELL TRANSPLANT, V12, P449; Ben-Hur T, 2008, J NEUROL SCI, V265, P102, DOI 10.1016/j.jns.2007.05.007; Li Y, 2014, GLIA, V62, P1, DOI 10.1002/glia.22585; Davalos A, 2012, LANCET, V380, P349, DOI 10.1016/S0140-6736(12)60813-7; Savitz SI, 2011, STROKE, V42, P825, DOI 10.1161/STROKEAHA.110.601914; Herz J, 2012, NEUROBIOL DIS, V45, P1077, DOI 10.1016/j.nbd.2011.12.026; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Kondziolka D, 2000, NEUROLOGY, V55, P565; Abe T, 2009, J CEREBR BLOOD F MET, V29, P66, DOI 10.1038/jcbfm.2008.88; Wechsler LR, 2009, STROKE, V40, pS149, DOI 10.1161/STROKEAHA.108.533208; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Crain BJ, 2005, J NEUROL SCI, V233, P121, DOI 10.1016/j.jns.2005.03.017; Ukai R, 2007, J NEUROTRAUM, V24, P508, DOI 10.1089/neu.2006.0161; Yu CY, 2013, TRANSL STROKE RES, V4, P477, DOI 10.1007/s12975-013-0281-2; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Shahdadfar A, 2005, STEM CELLS, V23, P1357, DOI 10.1634/stemcells.2005-0094; Mergenthaler P, 2004, METAB BRAIN DIS, V19, P151, DOI 10.1023/B:MEBR.0000043966.46964.e6; Misra V, 2012, NEUROLOGY, V79, pS207, DOI 10.1212/WNL.0b013e31826959d2; Chen CLH, 2013, STROKE, V44, P2093, DOI 10.1161/STROKEAHA.113.002055; Moniche F, 2012, STROKE, V43, P2242, DOI 10.1161/STROKEAHA.112.659409; Rehme AK, 2012, NEUROIMAGE, V59, P2771, DOI 10.1016/j.neuroimage.2011.10.023; Horita Y, 2006, J NEUROSCI RES, V84, P1495, DOI 10.1002/jnr.21056; Lin CY, 2008, J CEREBR BLOOD F MET, V28, P1491, DOI 10.1038/jcbfm.2008.42; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Jaillard A, 2005, BRAIN, V128, P1122, DOI 10.1093/brain/awh456; Nih LR, 2012, EUR J NEUROSCI, V35, P1208, DOI 10.1111/j.1460-9568.2012.08041.x; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Minnerup J, 2010, J CEREBR BLOOD F MET, V30, P1619, DOI 10.1038/jcbfm.2010.74; Arai K, 2009, J NEUROSCI, V29, P4351, DOI 10.1523/JNEUROSCI.0035-09.2009; Kim DW, 2013, INT J MOL SCI, V14, P11692, DOI 10.3390/ijms140611692; Murphy TH, 2009, NAT REV NEUROSCI, V10, P861, DOI 10.1038/nrn2735; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Stroemer P, 2009, NEUROREHAB NEURAL RE, V23, P895, DOI 10.1177/1545968309335978; Chen JL, 2004, BRAIN RES, V1005, P21, DOI 10.1016/j.brainres.2003.11.080; Chen ZZ, 2008, NEUROSCI LETT, V445, P36, DOI 10.1016/j.neulet.2008.08.039; Toth ZE, 2008, BLOOD, V111, P5544, DOI 10.1182/blood-2007-10-119073; Nomura T, 2005, NEUROSCIENCE, V136, P161, DOI 10.1016/j.neuroscience.2005.06.062; Song MK, 2013, CELL TRANSPLANT, V22, P2001, DOI 10.3727/096368912X657909; Detante O, 2009, CELL TRANSPLANT, V18, P1369, DOI 10.3727/096368909X474230; Minnerup J, 2011, STROKE, V42, P1757, DOI 10.1161/STROKEAHA.110.599282; Jin KL, 2010, J CEREBR BLOOD F MET, V30, P534, DOI 10.1038/jcbfm.2009.219; Darsalia V, 2007, EUR J NEUROSCI, V26, P605, DOI 10.1111/j.1460-9568.2007.05702.x; Burns TC, 2011, EXPERT OPIN BIOL TH, V11, P447, DOI 10.1517/14712598.2011.552883; Seminatore C, 2010, STROKE, V41, P153, DOI 10.1161/STROKEAHA.109.563015; Liang Y, 2013, BIOMATERIALS, V34, P5521, DOI 10.1016/j.biomaterials.2013.03.095; Ikegame Y, 2011, CYTOTHERAPY, V13, P675, DOI 10.3109/14653249.2010.549122; Park DH, 2009, STEM CELLS DEV, V18, P693, DOI 10.1089/scd.2009.0008; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Subramanian A, 2012, J CELL BIOCHEM, V113, P1886, DOI 10.1002/jcb.24057; Hermann DM, 2012, LANCET NEUROL, V11, P369, DOI 10.1016/S1474-4422(12)70039-X; Nelson PT, 2002, AM J PATHOL, V160, P1201, DOI 10.1016/S0002-9440(10)62546-1; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Ginsberg MD, 2013, LANCET NEUROL, V12, P1049, DOI 10.1016/S1474-4422(13)70223-0; Ergul A, 2012, STROKE, V43, P2270, DOI 10.1161/STROKEAHA.111.642710; Minger SL, 2007, REGEN MED, V2, P69, DOI 10.2217/17460751.2.1.69; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Haas S, 2005, CURR OPIN NEUROL, V18, P59, DOI 10.1097/00019052-200502000-00012; Borlongan CV, 2004, BRAIN RES, V1010, P108, DOI 10.1016/j.brainres.2004.02.072; Rosenblum S, 2012, STROKE, V43, P1624, DOI 10.1161/STROKEAHA.111.637884; Caicco MJ, 2013, J CONTROL RELEASE, V166, P197, DOI 10.1016/j.jconrel.2013.01.002; Walker MR, 2009, J PATHOL, V217, P169, DOI 10.1002/path.2474; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; Honmou O, 2011, BRAIN, V134, P1790, DOI 10.1093/brain/awr063; Bliss TM, 2010, NEUROBIOL DIS, V37, P275, DOI 10.1016/j.nbd.2009.10.003; Polentes J, 2012, CELL TRANSPLANT, V21, P2587, DOI 10.3727/096368912X653228; Lees JS, 2012, INT J STROKE, V7, P582, DOI 10.1111/j.1747-4949.2012.00797.x; Koch P, 2009, LANCET NEUROL, V8, P819, DOI 10.1016/S1474-4422(09)70202-9; Zhao YJ, 2010, NEUROL RES, V32, P748, DOI 10.1179/016164109X12445616596562; Hao Q, 2011, STROKE, V42, P453, DOI 10.1161/STROKEAHA.110.596452; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Brenneman M, 2010, J CEREBR BLOOD F MET, V30, P140, DOI 10.1038/jcbfm.2009.198; Boltze J, 2012, CELL TRANSPLANT, V21, P1199, DOI 10.3727/096368911X589609; Chopp M, 2007, STROKE, V38, P827, DOI 10.1161/01.STR.0000250235.80253.e9; Cook DJ, 2012, NATURE, V483, P213, DOI 10.1038/nature10841; Shen LH, 2010, GLIA, V58, P1074, DOI 10.1002/glia.20988; Saver JL, 2004, STROKE, V35, pE106, DOI 10.1161/01.STR.0000124458.98123.52; Emerich DF, 2010, CELL TRANSPLANT, V19, P1063, DOI 10.3727/096368910X498278; Dirnagl U, 2012, ANN NY ACAD SCI, V1268, P21, DOI 10.1111/j.1749-6632.2012.06691.x; Bhasin A, 2013, CLIN NEUROL NEUROSUR, V115, P1003, DOI 10.1016/j.clineuro.2012.10.015; Macrez R, 2011, STROKE, V42, P2315, DOI 10.1161/STROKEAHA.110.606293; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Teixeira FG, 2013, CELL MOL LIFE SCI, V70, P3871, DOI 10.1007/s00018-013-1290-8; Prass K, 2003, STROKE, V34, P1981, DOI 10.1161/01.STR.0000080381.76409.B2; Zhang JH, 2012, NAT REV NEUROL, V8, P711, DOI 10.1038/nrneurol.2012.210; Newman MB, 2005, STEM CELLS DEV, V14, P29, DOI 10.1089/scd.2005.14.29; Yang B, 2011, J NEUROSCI RES, V89, P833, DOI 10.1002/jnr.22614; Hurst RW, 2013, MUSCLE NERVE, V48, P831, DOI 10.1002/mus.23920; Miyamoto N, 2010, J CEREBR BLOOD F MET, V30, P299, DOI 10.1038/jcbfm.2009.210; Rabinovich SS, 2005, B EXP BIOL MED+, V139, P126, DOI 10.1007/s10517-005-0229-y; Mack GS, 2011, NAT BIOTECHNOL, V29, P95, DOI 10.1038/nbt0211-95; Zhang ZG, 2009, LANCET NEUROL, V8, P491, DOI 10.1016/S1474-4422(09)70061-4; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Li Q, 2002, EXP NEUROL, V177, P531, DOI 10.1006/exnr.2002.7994; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Prasad K, 2012, INDIAN J MED RES, V136, P221; Barlow S, 2008, STEM CELLS DEV, V17, P1095, DOI 10.1089/scd.2007.0154; Minnerup J, 2009, STROKE, V40, P3113, DOI 10.1161/STROKEAHA.109.555789; Shyu WC, 2008, J CLIN INVEST, V118, P2482, DOI 10.1172/JCI34363; Kobayashi T, 2006, STROKE, V37, P2361, DOI 10.1161/01.STR.0000236025.44089.e1; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Darsalia V, 2011, J CEREBR BLOOD F MET, V31, P235, DOI 10.1038/jcbfm.2010.81; Carey LM, 2007, INT J STROKE, V2, P245, DOI 10.1111/j.1747-4949.2007.00164.x; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Zhang L, 2011, STROKE, V42, P1437, DOI 10.1161/STROKEAHA.110.593129; Dirnagl U, 2006, J CEREBR BLOOD F MET, V26, P1465, DOI 10.1038/sj.jcbfm.9600298; Delcroix GJR, 2010, BIOMATERIALS, V31, P2105, DOI 10.1016/j.biomaterials.2009.11.084; Morizane A, 2013, STEM CELL REP, V1, P283, DOI 10.1016/j.stemcr.2013.08.007; Wang YF, 2012, BIOMATERIALS, V33, P2681, DOI 10.1016/j.biomaterials.2011.12.031; Savitz SI, 2011, ANN NEUROL, V70, P59, DOI 10.1002/ana.22458; Bath PM, 2013, COCHRANE DB SYST REV, V6; Bejot Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029405; Bhasin Ashu, 2011, Cerebrovasc Dis Extra, V1, P93, DOI 10.1159/000333381; Boehm-Sturm P, 2013, CONTRAST MEDIA MOL I, V8, P383, DOI 10.1002/cmmi.1534; Bonn D, 1998, LANCET, V352, P119, DOI 10.1016/S0140-6736(98)85026-5; Borlongan CV, 2009, STROKE, V40, pS146, DOI 10.1161/STROKEAHA.108.533091; Borlongan CV, 1998, EXP NEUROL, V149, P310, DOI 10.1006/exnr.1997.6730; Borlongan CV, 2005, BRAIN RES, V1048, P116, DOI 10.1016/j.brainres.2005.04.087; Bouleti C, 2013, EUR HEART J, V34, P3657, DOI 10.1093/eurheartj/eht153; Carmichael ST, 2010, STROKE S, V41, pS124; Castro RF, 2002, SCIENCE, V297, P1299; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chang YC, 2007, CELL TRANSPLANT, V16, P171; Chen JL, 2013, CELL TRANSPLANT, V22, P871, DOI 10.3727/096368911X637380; Chollet F, 2013, J NEUROL; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; Cramer SC, 2010, STROKE, V41, P927, DOI 10.1161/STROKEAHA.109.574343; Daadi MM, 2009, CELL TRANSPLANT, V18, P815, DOI 10.3727/096368909X470829; Daadi MM, 2008, PLOS ONE, V3, pe1644; Deb Prabal, 2010, Pathophysiology, V17, P197, DOI 10.1016/j.pathophys.2009.12.001; Ding XS, 2013, J CEREBR BLOOD F MET, V33, P1015, DOI 10.1038/jcbfm.2013.50; Doeppner TR, 2011, J CEREBR BLOOD F MET, V31, P1251, DOI 10.1038/jcbfm.2010.211; Dronne MA, 2008, PROG BIOPHYS MOL BIO, V97, P60, DOI 10.1016/j.pbiomolbio.2007.10.001; Ellsworth JL, 2003, STROKE, V34, P1507, DOI 10.1161/01.STR.0000071760.66720.5F; Esneault E, 2008, J CEREBR BLOOD F MET, V28, P1552, DOI 10.1038/jcbfm.2008.40; Friedrich MAG, 2012, CELL TRANSPLANT, V21, pS13, DOI 10.3727/096368912X612512; Gao Q, 2005, NEUROSCIENCE, V136, P123, DOI 10.1016/j.neuroscience.2005.06.091; Gao S, 2013, TISSUE ENG A; Ge J, 2014, STEM CELL REV; Ghezzi P, 2010, LANCET, V375, P2142, DOI 10.1016/S0140-6736(10)60992-0; Grade S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055039; Gutierrez M, 2009, CEREBROVASC DIS, V27, P177, DOI 10.1159/000200457; Gutierrez-Fernandez M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt159; Guzman R, 2008, NEUROSURG FOCUS, V24, pE15; He XY, 2010, CYTOTHERAPY, V13, P46; Hicks A, 2009, CELL STEM CELL, V5, P139, DOI 10.1016/j.stem.2009.07.009; Hossmann KA, 2009, FOLIA NEUROPATHOL, V47, P213; Hsieh JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072604; Ishibashi S, 2004, J NEUROSCI RES, V78, P215, DOI 10.1002/jnr.20246; Jiang Y, 2007, NATURE, V447, P880, DOI DOI 10.1038/NATURE05812; Kawabori M, 2012, NEUROPATHOLOGY, V32, P217, DOI 10.1111/j.1440-1789.2011.01260.x; Kim S, 2006, BRAIN RES, V1123, P27, DOI 10.1016/j.brainres.2006.09.044; Kimura K, 2012, J NEUROL SCI, V313, P132, DOI 10.1016/j.jns.2011.09.006; Lemmens R, 2013, CURR OPIN NEUROL; Li Yi, 2005, Glia, V49, P407, DOI 10.1002/glia.20126; Li Y, 2006, EXP NEUROL, V198, P313, DOI 10.1016/j.expneurol.2005.11.029; Liu YP, 2009, J CEREBR BLOOD F MET, V29, P780, DOI 10.1038/jcbfm.2009.1; Lyden PD, 2013, INT J STROKE; Madinier A, 2009, PLOS ONE, V4, pe8101; Mendonça Maria Lúcia Furtado de, 2006, Arq Bras Cardiol, V86, P52; Minnerup J, 2014, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00288; Moshayedi P, 2013, BIOMATTER, V3; Nakaji-Hirabayashi T, 2009, BIOMATERIALS, V30, P4581, DOI 10.1016/j.biomaterials.2009.05.009; Nakase T, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-39; Newman MB, 2005, STEM CELLS DEV, V14, P576, DOI 10.1089/scd.2005.14.576; Omori Y, 2008, BRAIN RES, V1236, P30, DOI 10.1016/j.brainres.2008.07.116; Onteniente B, 2011, CEREBROVASC DIS, V31, P544, DOI 10.1159/000324325; Osanai T, 2010, NEUROSURGERY, V66; Park DH, 2009, CELL TRANSPLANT, V18, P985, DOI 10.3727/096368909X471279; Piironen K, 2014, STROKE; Poli S, 2009, CURR MOL MED, V9, P227; Portalska KJ, 2013, TISSUE ENG A; Ramos-Cabrer P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012779; Reitmeir R, 2012, ACTA NEUROPATHOL, V123, P273, DOI 10.1007/s00401-011-0914-z; Riegelsberger UM, 2011, EXP NEUROL, V227, P218, DOI 10.1016/j.expneurol.2010.11.008; Roitbak T, 2008, J CEREBR BLOOD F MET, V28, P1530, DOI 10.1038/jcbfm.2008.38; Rosell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073244; Roybon L, 2006, STEM CELLS, V24, P1594, DOI 10.1634/stemcells.2005-0548; Sarnowska A, 2013, CELL TRANSPLANT; Sarraj A, 2014, LANCET NEUROL, V13, P2, DOI 10.1016/S1474-4422(13)70281-3; Savitz SI, 2013, STROKE, V44, pS107, DOI 10.1161/STROKEAHA.112.679605; Savitz SI, 2013, STROKE, V44, P314, DOI 10.1161/STROKEAHA.111.000353; Savitz SI, 2013, STROKE; Schabitz WR, 2000, STROKE, V31, P2212; Schwarting S, 2008, STROKE, V39, P2867, DOI 10.1161/STROKEAHA.108.513978; Seyfried DM, 2008, BRAIN RES, V1224, P12, DOI 10.1016/j.brainres.2008.05.080; Sheikh AM, 2010, NEUROBIOL DIS, V41, P717; Shinozuka Kazutaka, 2013, Brain Sci, V3, P239, DOI 10.3390/brainsci3010239; Shinozuka K, 2013, J STEM CELL RES THER, V4, P12912; Slevin M, 2000, STROKE, V31, P1863; Stair, 1999, STROKE, V30, P2752; Wechsler L, 2009, STROKE, V40, P510, DOI 10.1161/STROKEAHA.108.526863; Suarez-Monteagudo C, 2009, RESTOR NEUROL NEUROS, V27, P151, DOI 10.3233/RNN-2009-0483; Svensson J, 2012, CEREBROVASC DIS, V33, P532, DOI 10.1159/000337765; Taguchi A, 2007, EUR J NEUROSCI, V26, P126, DOI 10.1111/j.1460-9568.2007.05640.x; Tajiri N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043779; Toyama K, 2009, EXP NEUROL, V216, P47, DOI 10.1016/j.expneurol.2008.11.010; Tu J, 2014, GLIA, V62, P106, DOI 10.1002/glia.22590; Villmann C, 2007, NEUROSCIENTIST, V13, P594, DOI 10.1177/1073858406296259; Vosler PS, 2009, STROKE, V40, pS119, DOI 10.1161/STROKEAHA.108.533109; Wagner DC, 2014, STROKE; Wang LQ, 2014, CNS NEUROSCI THER; Weise G, 2014, J CEREB BLOOD FLOW M, V34; Yamashita T, 2011, CELL TRANSPLANT, V20, P95, DOI 10.3727/096368910X532800; Yu GL, 2004, BRAIN RES, V1018, P32, DOI 10.1016/j.brainres.2004.05.056; Zhang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011016; Zhang QW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080139; Zhang RL, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00201; Zhang RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048141; Zhang XM, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-61	313	2	2	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0035-3787	2213-0004		REV NEUROL-FRANCE	Rev. Neurol.	DEC	2014	170	12					779	798		10.1016/j.neurol.2014.10.005		20	Clinical Neurology	Neurosciences & Neurology	AX8PS	WOS:000347171800009		
J	Nakayama, T; Otori, N; Asaka, D; Okushi, T; Haruna, S				Nakayama, Tsuguhisa; Otori, Nobuyoshi; Asaka, Daiya; Okushi, Tetsushi; Haruna, Shin-ichi			Endoscopic modified medial maxillectomy for odontogenic cysts and tumours	RHINOLOGY			English	Article						endoscopic sinus surgery; keratocystic odontogenic tumour; radicular cyst; dentigerous cyst; maxillary sinus	SQUAMOUS-CELL CARCINOMA; INVERTED PAPILLOMA; INFERIOR TURBINATE; DENTIGEROUS CYST; SURGERY; LESIONS	Background: Odontogenic maxillary cysts and tumours originate from the tooth root and have traditionally been treated through an intraoral approach. Here, we report the efficacy and utility of endoscopic modified medial maxillectomy (EMMM) for the treatment of odontogenic maxillary cysts and a tumour. Methodology: We undertook EMMM under general anaesthesia in six patients: four had radicular cysts, one had a dentigerous cyst, and one had a keratocystic odontogenic tumour. Results; The cysts and tumours were completely excised and the inferior turbinate and nasolacrimal duct were preserved in all patients. There were no peri- or postoperative complications, and no incidences of recurrence. Conclusion: Endoscopic modified medial maxillectomy appears to be an effective and safe technique for treating odontogenic cysts and tumours.	[Nakayama, Tsuguhisa; Haruna, Shin-ichi] Dokkyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Mibu, Tochigi 3210293, Japan; [Nakayama, Tsuguhisa; Otori, Nobuyoshi; Asaka, Daiya; Okushi, Tetsushi] Jikei Univ, Sch Med, Dept Otorhinolaryngol, Tokyo, Japan	Nakayama, T (reprint author), Dokkyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, 880 Kita Kobayashi, Mibu, Tochigi 3210293, Japan.	nakayama-t@jikei.ac.jp					Nakayama T, 2012, AM J RHINOL ALLERGY, V26, P405, DOI 10.2500/ajra.2012.26.3791; KAMEL RH, 1995, LARYNGOSCOPE, V105, P847, DOI 10.1288/00005537-199508000-00015; Manor E, 2012, INT J MED SCI, V9, P20; Wormald PJ, 2003, LARYNGOSCOPE, V113, P867, DOI 10.1097/00005537-200305000-00017; Bodner L, 2011, J ORAL PATHOL MED, V40, P733, DOI 10.1111/j.1600-0714.2011.01058.x; Bodner L, 1998, DENTOMAXILLOFAC RAD, V27, P166, DOI 10.1038/sj.dmfr.4600344; Boffano P, 2010, J ORAL MAXIL SURG, V68, P2994, DOI 10.1016/j.joms.2010.05.068; Chen XB, 2010, RHINOLOGY, V48, P394, DOI 10.4193/Rhino09.196; Di Pasquale Paul, 2006, Ear Nose Throat J, V85, P747; Gulbranson SH, 2002, OTOLARYNG HEAD NECK, V127, P463, DOI 10.1067/mhn.2002.129039; Heathcote KJ, 2009, RHINOLOGY, V47, P339, DOI 10.4193/Rhin09.033; Hyo Y, 2007, JAP J RHINOL, V46, P97; Modrzynski M, 2011, AM J RHINOL ALLERGY, V25, P103, DOI 10.2500/ajra.2011.25.3577; Ohki M., 2012, CASE REP OTOLARYNGOL, V2012, P1; Seno Satoshi, 2009, Rhinology, V47, P305; Yasuoka T, 2000, J ORAL MAXIL SURG, V58, P900, DOI 10.1053/joms.2000.8219	16	2	2	INT RHINOLOGIC SOC	UTRECHT	UNIV MEDICAL CENTER UTRECHT, RM G05 127, DEPT OTORHINOL, HEIDELBERGLAAN 100, 3584 CX UTRECHT, NETHERLANDS	0300-0729			RHINOLOGY	Rhinology	DEC	2014	52	4					376	380		10.4193/Rhino13.134		5	Otorhinolaryngology	Otorhinolaryngology	AX8CI	WOS:000347137700015		
J	Khan, MA; Sagara, N				Khan, M. Ali; Sagara, Nobusumi			The Bang-Bang, Purification and Convexity Principles in Infinite Dimensions Additional Characterizations of the Saturation Property	SET-VALUED AND VARIATIONAL ANALYSIS			English	Article						Lyapunov theorem; Dvoretsky-Wald-Wolfowitz theorem; Saturated measure space; Bang-bang principle; Relaxed control; Purification principle; Convexity principle	WALD-WOLFOWITZ THEOREM; VARIATIONAL PROBLEM; RELAXED TRAJECTORIES; EVOLUTION-EQUATIONS; VECTOR MEASURES; EXACT VERSION; BANACH-SPACE; LOEB SPACES; CORRESPONDENCES; COMPACTNESS	The authors apply their recent work on the Lyapunov theorem in locally convex Hausdorff spaces to the bang-bang principle for control systems in infinite dimensions. They show that the bang-bang principle holds for every integrably bounded, measurable, weakly compact convex-valued multifunction if and only if the underlying measure space is saturated. They also demonstrate the equivalence of the bang-bang principle to what is termed the purification and convexity principles. Applications to variational problems with integral constraints are indicated.	[Khan, M. Ali] Johns Hopkins Univ, Dept Econ, Baltimore, MD 21218 USA; [Sagara, Nobusumi] Hosei Univ, Dept Econ, Machida, Tokyo 1940298, Japan	Sagara, N (reprint author), Hosei Univ, Dept Econ, 4342 Aihara, Machida, Tokyo 1940298, Japan.	akhan@jhu.edu; nsagara@hosei.ac.jp					AHMED NU, 1983, SIAM J CONTROL OPTIM, V21, P953, DOI 10.1137/0321058; Ali Khan M., 2002, HDB GAME THEORY EC A, VIII, P1761, DOI 10.1016/S1574-0005(02)03009-6; Podczeck K, 2009, ECON THEOR, V38, P399, DOI 10.1007/s00199-007-0319-3; WAGNER DH, 1977, SIAM J CONTROL OPTIM, V15, P859, DOI 10.1137/0315056; AUMANN RJ, 1965, J MATH ANAL APPL, V12, P1, DOI 10.1016/0022-247X(65)90049-1; Maharam D, 1942, P NATL ACAD SCI USA, V28, P108, DOI 10.1073/pnas.28.3.108; BALDER EJ, 1984, SIAM J CONTROL OPTIM, V22, P570, DOI 10.1137/0322035; SWARTZ C, 1973, MATH ANN, V202, P77, DOI 10.1007/BF01351207; HOOVER DN, 1984, T AM MATH SOC, V286, P159, DOI 10.2307/1999401; Sun Y, 1996, J FUNCT ANAL, V139, P68, DOI 10.1006/jfan.1996.0079; Keisler HJ, 2009, ADV MATH, V221, P1584, DOI 10.1016/j.aim.2009.03.003; DIESTEL J, 1993, P AM MATH SOC, V118, P447, DOI 10.2307/2160321; Sun YN, 1997, T AM MATH SOC, V349, P129, DOI 10.1090/S0002-9947-97-01825-4; BLACKWELL D, 1951, ANN MATH STAT, V22, P112, DOI 10.1214/aoms/1177729699; Podczeck K, 2008, J MATH ECON, V44, P836, DOI 10.1016/j.jmateco.2007.03.003; Khan MA, 2006, INT J GAME THEORY, V34, P91, DOI 10.1007/s00182-005-0004-3; Sun YN, 2008, J MATH ECON, V44, P861, DOI 10.1016/j.jmateco.2007.07.005; BLACKWELL D, 1951, P AM MATH SOC, V2, P390, DOI 10.2307/2031763; Artstein Z, 1998, SET-VALUED ANAL, V6, P237, DOI 10.1023/A:1008692602576; ARTSTEIN Z, 1980, ECONOMETRICA, V48, P899, DOI 10.2307/1912939; ARTSTEIN Z, 1974, J MATH ANAL APPL, V45, P404, DOI 10.1016/0022-247X(74)90081-X; Aubin J. P., 1990, SET VALUED ANAL; AUMANN RJ, 1965, J MATH ANAL APPL, V11, P488, DOI 10.1016/0022-247X(65)90100-9; Balder EJ, 2000, REND I MAT U TRIESTE, VXXXI, P1; BERLIOCC.H, 1973, B SOC MATH FR, V101, P129; Bourbaki N., 1965, INTEGRATION CHAPITRE, V4; Castaing C., 1977, LECT NOTES MATH, V580; CUTLAND NJ, 1983, J LOND MATH SOC, V27, P130; CUTLAND NJ, 1986, ACTA APPL MATH, V5, P105, DOI 10.1007/BF00046584; DEBREU G, 1967, P 5 BERK S MATH STAT, V2, P351; Diestel J., 1977, VECTOR MEASURES; Dunford N., 1958, LINEAR OPERATORS 1; DVORETZKY A, 1950, P NATL ACAD SCI USA, V36, P256, DOI 10.1073/pnas.36.4.256; Dvoretsky A., 1951, ANN MATH STAT, V22, P59; Dvoretzky A., 1951, PAC J MATH, V1, P59; EDWARDS DA, 1987, GLASGOW MATH J, V29, P205; Fajardo S., 2002, MODEL THEORY STOCHAS; Fattorini F.O, 1999, INFINITE DIMENSIONAL; Fremlin D. H., 2012, MEASURE THEORY 1, V3; Gonzalez-Hernandez J, 2005, SIAM J OPTIMIZ, V15, P1085, DOI 10.1137/040605345; Halkin H, 1962, ARCH RATION MECH AN, V15, P1085; Hermes H., 1969, FUNCTIONAL ANAL TIME; Hildenbrand W., 1974, CORE EQUILIBRIA LARG; HOFFMANN.J, 1971, MATH SCAND, V28, P5; Ioffe A, 2006, ADV MATH ECON, V8, P297, DOI 10.1007/4-431-30899-7_12; KARLIN S, 1953, P AM MATH SOC, V4, P603, DOI 10.2307/2032534; Karlin S., 1966, TCHEBYCHEFF SYSTEMS; Khan M. A., 2013, MAHARAM TYPES UNPUB; Khan M.A., 2013, ADV MATH, V229, P1080; Khan MA, 2014, J MATH ANAL APPL, V412, P554, DOI 10.1016/j.jmaa.2013.10.082; Khan MA, 2009, J MATH ECON, V45, P830, DOI 10.1016/j.jmateco.2009.06.003; Khan M.A., 2012, ILLINOIS J IN PRESS; Kluvanek I., 1975, VECTOR MEASURES CONT; Kudo H., 1954, NAT SCI REP OCHANOMI, V4, P151; Lasalle J P, 1959, Proc Natl Acad Sci U S A, V45, P573, DOI 10.1073/pnas.45.4.573; LASALLE JP, 1954, B AM MATH SOC, V60, P154; LaSalle J.P., 1960, ANN MATH STUD, VV, P1; LINDENST.J, 1966, J MATH MECH, V15, P971; Loeb P, 2006, ILLINOIS J MATH, V50, P747; Loeb P, 2009, P AM MATH SOC, V137, P2719; MARUYAMA T, 1986, P JPN ACAD A-MATH, V62, P163; MORDUKHOVICH B. S., 2006, VARIATIONAL ANAL GEN; Mordukhovich BS, 2013, ESAIM CONTR OPTIM CA, V19, P811, DOI 10.1051/cocv/2012034; Neustadt L. W., 1963, J MATH ANAL APPL, V7, P110, DOI 10.1016/0022-247X(63)90081-7; OLECH C, 1966, J DIFFER EQUATIONS, V2, P74, DOI 10.1016/0022-0396(66)90064-7; PAPAGEORGIOU NS, 1989, SIAM J CONTROL OPTIM, V27, P267, DOI 10.1137/0327014; Richter H., 1963, MATH ANN, V150, p[85, 440]; RUSTICHINI A, 1989, ARCH MATH, V52, P357, DOI 10.1007/BF01194410; Sainte-Beuve M.-F., 1978, ANN PURA MATH APP, V116, P317, DOI 10.1007/BF02413878; Schaefer H.H., 1999, TOPOLOGICAL VECTOR S; TOPSOE F., 1970, LECT NOTES MATH, V133; Warga J., 1972, OPTIMAL CONTROL DIFF; YAARI ME, 1964, ECONOMETRICA, V32, P576, DOI 10.2307/1910179	73	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1877-0533	1877-0541		SET-VALUED VAR ANAL	Set-Valued Var. Anal.	DEC	2014	22	4					721	746		10.1007/s11228-014-0282-7		26	Mathematics, Applied	Mathematics	AX8QI	WOS:000347173300004		
J	Otani, M; Staicu, V				Otani, Mitsuharu; Staicu, Vasile			Existence Results for Quasilinear Elliptic Equations with Multivalued Nonlinear Terms	SET-VALUED AND VARIATIONAL ANALYSIS			English	Article						Strong solutions; Quasilinear elliptic equations; Multivalued perturbations; Subdifferential operator	2ND-ORDER DIFFERENTIAL-INCLUSIONS; BOUNDARY-VALUE-PROBLEMS; P-LAPLACIAN; SUBDIFFERENTIAL OPERATORS; PERIODIC-SOLUTIONS; PERTURBATIONS	In this paper we study the existence of solutions u is an element of W-0(1,p) (Omega) with Delta(p)u is an element of L-2(Omega) for the Dirichlet problem -Delta(p)u(x) is an element of- partial derivative Phi (u (x)) + G (x, u (x)), x is an element of Omega, u vertical bar(partial derivative Omega)=0, (1) where Omega subset of R-N is a bounded open set with boundary partial derivative Omega, Delta(p) stands for the p-Laplace differential operator, partial derivative Phi denotes the subdifferential (in the sense of convex analysis) of a proper convex and lower semicontinuous function Phi and G : Omega x R -> 2(R) is a multivalued map. We prove two existence results: the first one deals with the case where the multivalued map u bar right arrow G (x, u) is upper semicontinuous with closed convex values and the second one deals with the case when u bar right arrow G (x, u) is lower semicontinuous with closed (not necessarily convex) values.	[Otani, Mitsuharu] Waseda Univ, Sch Sci & Engn, Dept Appl Phys, Tokyo 1698555, Japan; [Staicu, Vasile] Univ Aveiro, CIDMA, P-3810193 Aveiro, Portugal; [Staicu, Vasile] Univ Aveiro, Dept Math, P-3810193 Aveiro, Portugal	Staicu, V (reprint author), Univ Aveiro, CIDMA, P-3810193 Aveiro, Portugal.	otani@waseda.jp; vasile@ua.pt			Ministry of Education, Culture, Sports, Science and Technology, Japan [24654036]; Portuguese funds through the CIDMA - Center for Research and Development in Mathematics and Applications; Portuguese Foundation for Science and Technology ("FCT-Fundacao para a Ciencia e a Tecnologia") [PEst-OE/MAT/UI4106/2014]	This joint research was partially supported by the Grant-in-Aid for Scientific Research. #24654036, The Ministry of Education, Culture, Sports, Science and Technology, Japan, and by Portuguese funds through the CIDMA - Center for Research and Development in Mathematics and Applications, and the Portuguese Foundation for Science and Technology ("FCT-Fundacao para a Ciencia e a Tecnologia"), within project PEst-OE/MAT/UI4106/2014.	Aizicovici S, 2006, J MATH ANAL APPL, V322, P913, DOI 10.1016/j.jmaa.2005.09.077; Kyritsi S, 2002, J DIFFER EQUATIONS, V183, P279, DOI 10.1006/jdeq.2001.4110; OTANI M, 1982, J DIFFER EQUATIONS, V46, P268, DOI 10.1016/0022-0396(82)90119-X; Aubin J. P., 1984, DIFFERENTIAL INCLUSI; Bader R, 2002, MATH NACHR, V244, P5, DOI 10.1002/1522-2616(200210)244:1<5::AID-MANA5>3.0.CO;2-G; Barbu V., 1976, NONLINEAR SEMIGROUPS; BREZIS H., 1973, OPERATEURS MAXIMAUX; Carl S., 2010, HDB NONCONVEX ANAL A, P353; DELPINO M, 1989, J DIFFER EQUATIONS, V80, P1, DOI 10.1016/0022-0396(89)90093-4; Douka P, 2005, MATH NACHR, V278, P43, DOI 10.1002/mana.200310225; Dunford N., 1958, LINEAR OPERATORS 1; FRYSZKOWSKI A, 1983, STUD MATH, V76, P163; Gasinski L., 2005, NONSMOOTH CRITICAL P; Gilbarg D., 1998, ELLIPTIC PARTIAL DIF; Halidias N, 2000, CZECH MATH J, V50, P803, DOI 10.1023/A:1022416729213; Himmelberg C. J., 1975, FUND MATH, V87, P53; Hu S, 2000, HDB MULTIVALUED ANAL, VII; Hu Sh., 1997, HDB MULTIVALUED ANAL; Iannizzotto A, 2013, ADV NONLINEAR STUD, V13, P431; Kourogenis N, 2000, GLASGOW MATH J, V42, P359, DOI 10.1017/S0017089500030056; Manasevich R, 1998, J DIFFER EQUATIONS, V145, P367, DOI 10.1006/jdeq.1998.3425; Marano SA, 2012, B AUST MATH SOC, V86, P83, DOI 10.1017/S0004972711002905; Marano S.A., 2013, LIBERTAS MATH, V33, P109; OTANI M, 1984, J DIFFER EQUATIONS, V54, P248, DOI 10.1016/0022-0396(84)90161-X; Papageorgiou NS, 2007, NONLINEAR ANAL-THEOR, V67, P708, DOI 10.1016/j.na.2006.06.023; Papalini F, 2007, NONLINEAR ANAL-THEOR, V66, P2166, DOI 10.1016/j.na.2006.03.007; Zhang M, 2000, J DIFF EQNS, V166, P35; Zhang Z., 2010, NONLINEAR ANAL, V72, P151; Zhang Z., 2009, NONLINEAR ANAL, V70, P3390	29	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1877-0533	1877-0541		SET-VALUED VAR ANAL	Set-Valued Var. Anal.	DEC	2014	22	4					859	877		10.1007/s11228-014-0289-0		19	Mathematics, Applied	Mathematics	AX8QI	WOS:000347173300010		
J	Kumar, VN; Suriakarthick, R; Hayakawa, Y; Hussain, S; Bhalerao, GM; Gupta, M; Sathe, V; Gopalakrishnan, R				Kumar, V. Nirmal; Suriakarthick, R.; Hayakawa, Y.; Hussain, Shamima; Bhalerao, G. M.; Gupta, Mukul; Sathe, Vasant; Gopalakrishnan, R.			Deposition of CuCdS2 thin film by single step solution process at low temperature as a novel absorber for photovoltaic applications	SUPERLATTICES AND MICROSTRUCTURES			English	Article						CuCdS2; Chemical bath deposition; Ternary compound; Optical properties; Electrical properties	CHEMICAL BATH DEPOSITION; ELECTRICAL-PROPERTIES; CADMIUM-SULFIDE; SOLAR-CELLS; CDS FILMS; PYROLYSIS DEPOSITION; SPRAY-PYROLYSIS; COPPER SULFIDE; CU; FABRICATION	Thin film of ternary compound semiconductor, copper cadmium sulphide (CuCdS2) was deposited on glass substrate by low temperature solution process. The deposited CuCdS2 thin film was found to suitable for the fabrication of efficient thin film solar cells at low cost. Hexagonal structure of poly crystalline CuCdS2 was formed from the combination of its binary constituents CuxS and CdS. The film was continuously coated and particles were aggregated like spherical granules. The presence of elements Cu, Cd and S were confirmed by electron energy loss spectroscopy and X-ray photoelectron spectroscopy. The absorption spectrum showed that the deposited material had wide range of absorption in visible and near-IR region (300-1100 nm) and band gap was estimated to be 1.42 eV using Tauc's plot. Vibration modes of CdS and Cu S binary phases were observed and shift between them revealed the existence of binding state between CdS and CuxS. Hall measurement showed p-type conducting nature of charge carriers with higher carrier concentration 3.48 x 10(18) cm(-3). The mobility and resistivity were measured to be 10.63 cm(2)/V s and 0.17 Omega cm, respectively. The analyses revealed that the deposited CuCdS2 thin film was suitable material for the fabrication of thin film solar cells at low cost. (C) 2014 Elsevier Ltd. All rights reserved.	[Kumar, V. Nirmal; Suriakarthick, R.; Gopalakrishnan, R.] Anna Univ, Dept Phys, Crystal Res Lab, Chennai 600025, Tamil Nadu, India; [Kumar, V. Nirmal; Hayakawa, Y.] Shizuoka Univ, Grad Sch Sci & Technol, Elect Res Inst, Hamamatsu, Shizuoka 4328011, Japan; [Hussain, Shamima; Bhalerao, G. M.] UGC DAE Consortium Sci Res, Kalpakkam, Tamil Nadu, India; [Gupta, Mukul; Sathe, Vasant] UGC DAE Consortium Sci Res, Indore, India	Gopalakrishnan, R (reprint author), Anna Univ, Dept Phys, Chennai 600025, Tamil Nadu, India.	krgkrishnan@annauniv.edu					Adurodija FO, 1996, SOL ENERG MAT SOL C, V40, P359, DOI 10.1016/0927-0248(95)00160-3; KAZMERSKI LL, 1976, APPL PHYS LETT, V29, P268, DOI 10.1063/1.89041; Chopra KL, 2004, PROG PHOTOVOLTAICS, V12, P69, DOI 10.1002/pip.541; KAUR I, 1980, J ELECTROCHEM SOC, V127, P943, DOI 10.1149/1.2129792; Kim H, 1999, J APPL PHYS, V86, P6451, DOI 10.1063/1.371708; Shin B, 2013, PROG PHOTOVOLTAICS, V21, P72, DOI 10.1002/pip.1174; RIEKE PC, 1993, CHEM MATER, V5, P43, DOI 10.1021/cm00025a012; BOUDREAU RA, 1983, J ELECTROCHEM SOC, V130, P513, DOI 10.1149/1.2119741; STOLT L, 1993, APPL PHYS LETT, V62, P597, DOI 10.1063/1.108867; Pathan HM, 2002, APPL SURF SCI, V202, P47, DOI 10.1016/S0169-4332(02)00843-7; PAVASKAR NR, 1977, J ELECTROCHEM SOC, V124, P743, DOI 10.1149/1.2133398; Wan Q, 2004, APPL PHYS LETT, V84, P3654, DOI 10.1063/1.1738932; Zhang L, 2012, SOL ENERG MAT SOL C, V99, P356, DOI 10.1016/j.solmat.2012.01.002; Zhai XZ, 2014, CRYSTENGCOMM, V16, P6244, DOI 10.1039/c4ce00174e; Harati M, 2010, PHYS CHEM CHEM PHYS, V12, P15282, DOI 10.1039/c0cp00586j; CHUU DS, 1991, J APPL PHYS, V69, P8402, DOI 10.1063/1.347405; He YB, 2001, PHYSICA B, V308, P1069, DOI 10.1016/S0921-4526(01)00851-1; Egerton RF, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/1/016502; Jackson P, 2011, PROG PHOTOVOLTAICS, V19, P894, DOI 10.1002/pip.1078; ARJONA F, 1979, SOL ENERG MATER, V1, P379, DOI 10.1016/0165-1633(79)90005-4; Benedetto F.D., 2014, PROG PHOTOVOLTAICS, V22, P97; Borges R.O., 1993, J ELECTROCHEM SOC, V140, P3464; BRIGGS RJ, 1976, PHYS REV B, V13, P5518, DOI 10.1103/PhysRevB.13.5518; Cha D, 2004, MAT SCI ENG B-SOLID, V106, P63, DOI 10.1016/j.mseb.2003.09.010; Cho J.W., 2012, NANOTECHNOLOGY, V23, P1; COOK WR, 1970, J APPL PHYS, V41, P3058, DOI 10.1063/1.1659365; DJURLE S, 1958, ACTA CHEM SCAND, V12, P1415, DOI 10.3891/acta.chem.scand.12-1415; Dofia J.M., 1992, J ELECTROCHEM SOC, V139, P2810; FABRICIUS ED, 1962, J APPL PHYS, V33, P1597, DOI 10.1063/1.1728778; Gretener C, 2013, PROG PHOTOVOLTAICS, V21, P1580, DOI 10.1002/pip.2233; Isac LA, 2007, J PHYS CONF SER, V61, P477, DOI 10.1088/1742-6596/61/1/096; Kim MY, 2013, THIN SOLID FILMS, V546, P308, DOI 10.1016/j.tsf.2013.05.033; Ortuno-Lopez MB, 2004, VACUUM, V76, P181, DOI 10.1016/j.vacuum.2004.07.01-8; NAIR MTS, 1989, SEMICOND SCI TECH, V4, P191, DOI 10.1088/0268-1242/4/3/009; Patel M., 2012, J PHYS D, V45, P1; Pentia E, 2004, J ELECTROCHEM SOC, V151, pG729, DOI 10.1149/1.1800673; Poirier D. M., 1993, Surface Science Spectra, V2, DOI 10.1116/1.1247706; Wang SY, 2003, MAT SCI ENG B-SOLID, V103, P184, DOI 10.1016/S0921-5107(03)00199-5	38	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0749-6036			SUPERLATTICE MICROST	Superlattices Microstruct.	DEC	2014	76						125	134		10.1016/j.spmi.2014.09.030		10	Physics, Condensed Matter	Physics	AY0CE	WOS:000347264700013		
J	Yao, YZ; Kuroda, T; Dirin, DN; Sokolikova, MS; Vasiliev, RB				Yao, Yuanzhao; Kuroda, Takashi; Dirin, Dmitry N.; Sokolikova, Maria S.; Vasiliev, Roman B.			Strain effects on optical properties of tetrapod-shaped CdTe/CdS core-shell nanocrystals	SUPERLATTICES AND MICROSTRUCTURES			English	Article						Tetrapod; Core-shell; Semiconductor; Exciton; Strain	COLLOIDAL NANOCRYSTALS; SEEDED GROWTH; NANOHETEROSTRUCTURES; CDSE; HETEROSTRUCTURES; SEMICONDUCTORS; MORPHOLOGY; DYNAMICS; STATES; ROD	The exciton states of strained CdTe/CdS core-shell tetrapod-shaped nanocrystals were theoretically investigated by the numerical diagonalization of a configuration interaction Hamiltonian based on the single-band effective mass approximation. We found that the inclusion of strain promotes the type-II nature by confining the electrons and holes in nonadjacent regions. This carrier separation is more efficient than that with type-II spherical nanocrystals. The strain leads to a small blue shift of the lowest exciton energy. Its magnitude is smaller than the red shift induced by increasing the shell thickness. Moreover, the larger arm diameter reduces the influence of both shell thickness and strain on the exciton energy. Considering the broken symmetry, a randomness induced carrier separation was revealed which is unique to a branched core-shell structure. The calculated shell thickness dependence of the emission energy agrees well with available experimental data. (C) 2014 Elsevier Ltd. All rights reserved.	[Yao, Yuanzhao; Kuroda, Takashi] Natl Inst Mat Sci, Photon Mat Unit, Tsukuba, Ibaraki 3050044, Japan; [Dirin, Dmitry N.; Sokolikova, Maria S.; Vasiliev, Roman B.] Moscow MV Lomonosov State Univ, Fac Mat Sci, Moscow 119991, Russia	Yao, YZ (reprint author), Natl Inst Mat Sci, Photon Mat Unit, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.	yao.yuanzhao@nims.go.jp	Sokolikova, Maria/A-7503-2014; KURODA, Takashi/G-5600-2010	Sokolikova, Maria/0000-0001-7717-3768; KURODA, Takashi/0000-0001-6445-7673			Adachi S, 2005, WILEY SER MATER ELEC, P1, DOI 10.1002/0470090340; Choi CL, 2009, NANO LETT, V9, P3544, DOI 10.1021/nl9017572; Manna L, 2000, J AM CHEM SOC, V122, P12700, DOI 10.1021/ja003055+; Wei SH, 2000, PHYS REV B, V62, P6944, DOI 10.1103/PhysRevB.62.6944; Boxberg F, 2010, NANO LETT, V10, P1108, DOI 10.1021/nl9040934; Cui Y, 2005, NANO LETT, V5, P1519, DOI 10.1021/nl051064g; Tyrrell EJ, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.165328; Povolotskyi M, 2006, J APPL PHYS, V100, DOI 10.1063/1.2337110; Tari D, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2335801; Zhou Y, 2006, NANOTECHNOLOGY, V17, P4041, DOI 10.1088/0957-4484/17/16/008; Cai XC, 2012, J PHYS CHEM C, V116, P8118, DOI 10.1021/jp301374u; Vitukhnovsky AG, 2009, PHYS LETT A, V373, P2287, DOI 10.1016/j.physleta.2009.04.053; Sun BQ, 2003, NANO LETT, V3, P961, DOI 10.1021/nl0342895; Peng P, 2005, NANO LETT, V5, P1809, DOI 10.1021/nl0511667; Milliron DJ, 2004, NATURE, V430, P190, DOI 10.1038/nature02695; Smith AM, 2009, NAT NANOTECHNOL, V4, P56, DOI [10.1038/nnano.2008.360, 10.1038/NNANO.2008.360]; Talapin DV, 2007, NANO LETT, V7, P2951, DOI 10.1021/nl072003g; Lutich AA, 2010, NANO LETT, V10, P4646, DOI 10.1021/nl1028057; Manna L, 2003, NAT MATER, V2, P382, DOI 10.1038/nmat902; Li JB, 2003, NANO LETT, V3, P1357, DOI 10.1021/nl034488o; Rivest JB, 2011, ACS NANO, V5, P3811, DOI 10.1021/nn2001454; Fairclough SM, 2012, J PHYS CHEM C, V116, P26898, DOI 10.1021/jp3087804; Fiore A, 2009, J AM CHEM SOC, V131, P2274, DOI 10.1021/ja807874e; Bechstedt F., 1988, SEMICONDUCTOR SURFAC; de Walle C. G. V., 1989, PHYS REV B, V39, P1871; Dirin DN, 2011, INORG MATER+, V47, P23, DOI 10.1134/S0020168511010031; De Giorgi M, 2005, MICROELECTRON J, V36, P552, DOI 10.1016/j.mejo.2005.02.074; Goodman MD, 2010, ACS NANO, V4, P2043, DOI 10.1021/nn1002584; Kuo MK, 2008, J APPL PHYS, V103, DOI 10.1063/1.2891418; Landolt-Bornstein Group III: Condensed Matter, 1979, NUMERICAL DATA FUNCT; Li YQ, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3186074; Long F, 1997, J APPL PHYS, V82, P3414, DOI 10.1063/1.365657; Malkmus S, 2006, J PHYS CHEM B, V110, P17334, DOI 10.1021/jp0615306; Mauser C, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.081306; Mauser C, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.153303; Morello G, 2011, J PHYS CHEM C, V115, P18094, DOI 10.1021/jp2048162; Morello G, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2924306; Park SH, 2011, J APPL PHYS, V109, DOI 10.1063/1.3594743; Sakoda K., 2011, OPT MATER EXPRESS, V11, P379; STUCKES AD, 1964, J PHYS CHEM SOLIDS, V25, P477, DOI 10.1016/0022-3697(64)90120-9; Tari D, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2130727; Vasiliev RB, 2009, MENDELEEV COMMUN, V19, P126, DOI 10.1016/j.mencom.2009.05.003; Vasiliev RB, 2009, MENDELEEV COMMUN, V19, P128, DOI 10.1016/j.mencom.2009.05.004; Yao YZ, 2013, OPT MATER EXPRESS, V3, DOI 10.1364/OME.3.000977	44	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0749-6036			SUPERLATTICE MICROST	Superlattices Microstruct.	DEC	2014	76						244	252		10.1016/j.spmi.2014.10.017		9	Physics, Condensed Matter	Physics	AY0CE	WOS:000347264700025		
J	Takeuchi, O				Takeuchi, Osamu			Living for Jesus and Japan: The Social and Theological Thought of Uchimura Kanzo	THEOLOGICAL STUDIES			English	Book Review									[Takeuchi, Osamu] Sophia Univ, Tokyo 102, Japan	Takeuchi, O (reprint author), Sophia Univ, Tokyo 102, Japan.						HIROSHI S, 2013, LIVING JESUS JAPAN S	1	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0040-5639	2169-1304		THEOL STUD	Theol. Stud.	DEC	2014	75	4					943	944		10.1177/0040563914548659d		3	Religion	Religion	AW9UK	WOS:000346602900040		
J	Amini, S; Azizi, M; Joharchi, MR; Shafei, MN; Moradinezhad, F; Fujii, Y				Amini, S.; Azizi, M.; Joharchi, M. R.; Shafei, M. N.; Moradinezhad, F.; Fujii, Y.			Determination of allelopathic potential in some medicinal and wild plant species of Iran by dish pack method	THEORETICAL AND EXPERIMENTAL PLANT PHYSIOLOGY			English	Article						Allelochemicals; Volatile compounds; Essential oil; Secondary metabolites	ESSENTIAL OILS; BOISS.; BIOACTIVITY; INHIBITION; INDUCTION; SEEDS; L.	Introduction Plants have the ability to interfere with other organisms in their immediate environment, a phenomenon called allelopathy. Allelopathy is a common phenomenon in nature (Qian Chemosphere 75(368):375, 2009). The use of allelopathic compounds for the development of new agrochemicals has several benefits as opposed to common synthetic products. Cognizant of reports on the allelopathic action of medicinal and invasive plants, 118 Iranian plants from 104 species which belongs to 34 families have been screened for allelopathic volatiles by the dish pack method. Materials and methods A total of 118 plants (104 species) belonging to 34 families were collected in 2009 from the tropical, subtropical and temperate regions of Iran. The Dish pack method as described by Fujii et al. (Weed Sci Technol 45(80):81, 2000) utilized for screening the presence of allelopathic volatiles released from different parts of the plant specimen. This method can be used to recognize allelopathic properties very easy and quickly. Results Results of bioassay with lettuce seed (Lactuca sativa cv. Great Lakes 366) revealed that 23 species elicited growth inhibitory action with the greatest (>= 96% reduction) observed in the inflorescences of Achillea wilhelmsii and Achillea filipendula. Furthermore, a high suppression (83-95 %) in radicle elongation was observed in lettuce exposed to:flowers of Achillea nobilis, Lavandula vera, and Perovskia abrotanoides; fruit of Ruta graveolens; seeds of Bunium persicum and Trachyspermum copticum; leaves of Achillea biebersteinii, Pulicaria gnaphalodes, Ziziphora clinopodioides, Zataria multiflora; gum of Ferula foetida; and stigma of Crocus sativus. On the other hand, 14 species instead exhibited growth-promoting properties. Of these, the greatest promoting effect were exhibited by the leaves of Cardaria draba, Verbascum speciosum and Urtica dioica eliciting 69 %, 56 %, and 53 %, respectively, which had longer radicles compare to the control. Conclusion The results hereby presented provide insight into the allelopathic action of the medicinal and wild plants of Iran. Data herein reported serves as benchmark information for further research on the characterization of the allelochemicals in these plants.	[Amini, S.; Azizi, M.] Ferdowsi Univ Mashhad, Dept Hort Sci, Mashhad, Iran; [Joharchi, M. R.] Ferdowsi Univ Mashhad, Res Ctr Plant Sci, Mashhad, Iran; [Shafei, M. N.] Mashhad Univ Med Sci, Sch Med, Dept Physiol, Mashhad, Iran; [Shafei, M. N.] Mashhad Univ Med Sci, Pharmaceut Res Ctr, Mashhad, Iran; [Fujii, Y.] Tokyo Univ Agr & Technol, Dept Agr, Fuchu, Tokyo, Japan	Moradinezhad, F (reprint author), Univ Birjand, Coll Agr, Dept Hort Sci, Birjand, Iran.	f_moradinezhad@yahoo.com	FUJII, Yoshiharu/C-8800-2013	FUJII, Yoshiharu/0000-0002-5412-395X			Abd El-Razek MH, 2007, J CHIN CHEM SOC-TAIP, V54, P238; Amjad L, 2011, INT J BIOSC BIOCH BI, V1, P216; Andrianjafinandrasana SN, 2013, ALLELOPATH J, V31, P33; Mancini E, 2009, MOLECULES, V14, P4725, DOI 10.3390/molecules14114725; Wang RL, 2009, ALLELOPATHY J, V24, P35; Qian HF, 2009, CHEMOSPHERE, V75, P368, DOI 10.1016/j.chemosphere.2008.12.040; Dayan FE, 2009, BIOORGAN MED CHEM, V17, P4022, DOI 10.1016/j.bmc.2009.01.046; Mazidi S, 2012, J AGR SCI TECH-IRAN, V14, P1013; Young GP, 2009, J CHEM ECOL, V35, P74, DOI 10.1007/s10886-008-9585-1; Liu LL, 2010, CHEM BIODIVERS, V7, P327, DOI 10.1002/cbdv.200900014; Vitalini S, 2011, ACTA BIOCHIM POL, V58, P203; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Nishida N, 2005, J CHEM ECOL, V31, P1187, DOI 10.1007/s10886-005-4256-y; Araniti F, 2012, NAT PROD RES, V27, P880; Barbosa L. C. A., 2007, Química Nova, V30, P1959, DOI 10.1590/S0100-40422007000800030; Batish DR, 2006, POTENTIAL ALLELOPATH; Daizy R, 1995, AUST J PLANT PHYSL, V22, P99; De'Albuquerque MB, 2011, REV AGRON SUSTAIN DE, V31, P395; Dudai N, 2004, ACTA HORTIC, P505; Eftekhar F, 2011, JUNDISHAPUR J MICROB, V4, P43; Einhelling FA, 1988, CHEM ECOL, V14, P1829; Fujii Y, 2000, WEED SCI TECHNOL, V45, P81; Ghani A., 2008, Journal of Science and Technology of Agriculture and Natural Resources, V12, P581; Greger H, 1984, PLANTA MED, V50, P375; Hegazy AK, 2007, GLOBAL J BIOTECHNOLO, V2, P1; Inderjit Duke SO, 2003, PLANTA, V217, P539; Isik D, 2009, PHYTOPARASITICA, V37, P203; Javidnia K, 2004, DARU, V12, P36; Kareparamban JA, 2012, J PHARM BIOL CHEM SC, V3, P775; Khanh TD, 2005, CROP PROT, V24, P421, DOI 10.1016/j.cropro.2004.09.020; Khani Abbas, 2012, Journal of Insect Science (Tucson), V12, P1; Kpoviessi DSS, 2009, J ESSENT OIL RES, V21, P83; Kropff MJ, 2000, WEED RES, V1, P10; Lage M, 2009, SCI HORTIC-AMSTERDAM, V121, P366, DOI 10.1016/j.scienta.2009.02.017; Macias FA, 2007, PEST MANAG SCI, V63, P348; Magdalini AP, 2006, J AGR FOOD CHEM, V54, P8768; Mahboubi M, 2011, Iran J Microbiol, V3, P194; Narayan CB, 1994, J CHEM ECOL, V20, P1885; Isfahan M. N., 2007, American-Eurasian Journal of Agricultural and Environmental Science, V2, P534; Nishida R, 2005, CHEM SENSES, V30, P294; Rashed MH, 2010, J AGRON RES IRAN, V7, P53; Saeidnia S, 2011, DARU, V19, P186; Safaei-ghomi J, 2010, DIG J NANOMATER BIOS, V5, P601; Salar Bashi D, 2013, TEOP, V16, P252; Scognamiglio M, 2012, BIOCH SYST ECOL, V43, P113; Sharififar F, 2010, PAK J PHARM SCI, V23, P300; Sonboli A, 2006, Z NATURFORSCH C, V61, P677; Wink M, 1992, ALLELOCHEMICAL PROPE; Sen Zeng R, 2007, J CHEM ECOL, V33, P449, DOI 10.1007/s10886-006-9238-1	49	3	3	BRAZILIAN SOC PLANT PHYSIOLOGY	CAMPINAS	DEPT FISIOLOGIA VEGETAL - IB, UNICAMP, CP 6109, CAMPINAS, SP 00000, BRAZIL	2197-0025			THEOR EXP PLANT PHYS	Theor. Exp. Plant Physiol.	DEC	2014	26	3-4					189	199		10.1007/s40626-014-0017-z		11	Plant Sciences	Plant Sciences	AX7IB	WOS:000347088700003		
J	Nakai, S; Hanafusa, N; Masakane, I; Taniguchi, M; Hamano, T; Shoji, T; Hasegawa, T; Itami, N; Yamagata, K; Shinoda, T; Kazama, JJ; Watanabe, Y; Shigematsu, T; Marubayashi, S; Morita, O; Wada, A; Hashimoto, S; Suzuki, K; Nakamoto, H; Kimata, N; Wakai, K; Fujii, N; Ogata, S; Tsuchida, K; Nishi, H; Iseki, K; Tsubakihara, Y				Nakai, Shigeru; Hanafusa, Norio; Masakane, Ikuto; Taniguchi, Masatomo; Hamano, Takayuki; Shoji, Tetsuo; Hasegawa, Takeshi; Itami, Noritomo; Yamagata, Kunihiro; Shinoda, Toshio; Kazama, Junichiro James; Watanabe, Yuzo; Shigematsu, Takashi; Marubayashi, Seiji; Morita, Osamu; Wada, Atsushi; Hashimoto, Seiji; Suzuki, Kazuyuki; Nakamoto, Hidetomo; Kimata, Naoki; Wakai, Kenji; Fujii, Naohiko; Ogata, Satoshi; Tsuchida, Kenji; Nishi, Hiroshi; Iseki, Kunitoshi; Tsubakihara, Yoshiharu			An Overview of Regular Dialysis Treatment in Japan (as of 31 December 2012)	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Chronic kidney diseasemineral and bone disorder; Dialysis patient population; Erythropoiesis-stimulating agent; On-line hemodiafiltration; Survival rate	CLINICAL-PRACTICE GUIDELINE; MANAGEMENT	A nationwide statistical survey of 4279 dialysis facilities was conducted at the end of 2012, among which 4238 responded (99.0%). The number of new dialysis patients was 38055 in 2012. Since 2008, the number of new dialysis patients has remained almost the same without any marked increase or decrease. The number of dialysis patients who died in 2012 was 30710; a slight decrease from 2011 (30743). The dialysis patient population has been growing every year in Japan; it was 310007 at the end of 2012, which exceeded 310000 for the first time. The number of dialysis patients per million at the end of 2012 was 2431.2. The crude death rate of dialysis patients in 2012 was 10.0%, a slight decrease from that in 2011 (10.2%). The mean age of new dialysis patients was 68.5 years and the mean age of the entire dialysis patient population was 66.9 years. The most common primary cause of renal failure among new dialysis patients was diabetic nephropathy (44.2%). The actual number of new dialysis patients with diabetic nephropathy has been approximately 16000 for the last few years. Diabetic nephropathy was also the most common primary disease among the entire dialysis patient population (37.1%), followed by chronic glomerulonephritis (33.6%). The percentage of dialysis patients with diabetic nephropathy has been continuously increasing, whereas not only the percentage but also the actual number of dialysis patients with chronic glomerulonephritis has decreased. The number of patients who underwent hemodiafiltration (HDF) at the end of 2012 was 21725, a marked increase from that in 2011 (14115). In particular, the number of patients who underwent on-line HDF increased threefold from 4890 in 2011 to 14069 in 2012. From the results of the facility survey, the number of patients who underwent peritoneal dialysis (PD) was 9514 and that of patients who did not undergo PD despite having a PD catheter in the abdominal cavity was 347. From the results of the patient survey, among the PD patients, 1932 also underwent another dialysis method using extracorporeal circulation, such as hemodialysis (HD) and HDF. The number of patients who underwent HD at home in 2012 was 393, a marked increase from that in 2011 (327).	[Nakai, Shigeru; Hanafusa, Norio; Masakane, Ikuto; Taniguchi, Masatomo; Hamano, Takayuki; Shoji, Tetsuo; Hasegawa, Takeshi; Itami, Noritomo; Yamagata, Kunihiro; Shinoda, Toshio; Kazama, Junichiro James; Watanabe, Yuzo; Shigematsu, Takashi; Marubayashi, Seiji; Morita, Osamu; Wada, Atsushi; Hashimoto, Seiji; Suzuki, Kazuyuki; Nakamoto, Hidetomo; Kimata, Naoki; Wakai, Kenji; Fujii, Naohiko; Ogata, Satoshi; Tsuchida, Kenji; Nishi, Hiroshi; Iseki, Kunitoshi; Tsubakihara, Yoshiharu] Japanese Soc Dialysis Therapy, Comm Renal Data Registry, Tokyo, Japan	Tsubakihara, Y (reprint author), Osaka Univ, Grad Sch Med, Dept Comprehens Kidney Dis Res, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	cyq06075@nifty.ne.jp					Nakai S, 2012, THER APHER DIAL, V16, P483, DOI 10.1111/j.1744-9987.2012.01143.x; Shinzato T, 1997, ARTIF ORGANS, V21, P864; Nakai S, 2010, THER APHER DIAL, V14, P505, DOI 10.1111/j.1744-9987.2010.00893.x; Nakai S, 2013, THER APHER DIAL, V17, P567, DOI 10.1111/1744-9987.12147; SHINZATO T, 1994, NEPHRON, V67, P280; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7; Fukagawa M, 2008, THER APHER DIAL, V12, P514, DOI 10.1111/j.1744-9987.2008.00648.x; Japanese Society for Dialysis Therapy, 2012, ILL OV REG DIAL TREA; Japanese Society for Dialysis Therapy, 2012, OV REG DIAL TREATM J; Kawanishi H, 2009, THER APHER DIAL, V13, P161, DOI 10.1111/j.1744-9987.2009.00674.x; Ministry of Health Labour and Welfare, MED INS SYST REV 201; Nakai S, 2012, J JPN SOC DIAL THER, V45, P599; Nakai S., 2010, J JPN SOC DIAL THER, V43, P119; Tsubakihara Y, 2008, THER APHER DIAL, V14, P240, DOI DOI 10.1111/J.1744-9987.2010.00836.X	15	8	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	DEC	2014	18	6					535	602		10.1111/1744-9987.12281		68	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	AX1JD	WOS:000346702600002		
J	Kikuchi, K; Akiba, T; Nitta, K; Masakane, I; Ando, R; Izumi, N; Atsukawa, M; Yamazaki, C; Kato, F; Hotta, N; Tominaga, Y; Orito, E; Hora, K; Nagasawa, M; Kasahara, H; Kawaguchi, M; Kimura, H; Ikebe, N; Kawanishi, H; Moriishi, M; Shigemoto, K; Harada, T; Hirakata, H; Watanabe, H; Nosaki, T; Tsubouchi, H; Imawari, M; Akizawa, T				Kikuchi, Kan; Akiba, Takashi; Nitta, Kosaku; Masakane, Ikuto; Ando, Ryoichi; Izumi, Namiki; Atsukawa, Masanori; Yamazaki, Chikao; Kato, Fumi; Hotta, Naoki; Tominaga, Yoshihiro; Orito, Etsuro; Hora, Kazuhiko; Nagasawa, Masaki; Kasahara, Hiroshi; Kawaguchi, Masanori; Kimura, Hiroyuki; Ikebe, Norisato; Kawanishi, Hideki; Moriishi, Misaki; Shigemoto, Kenichiro; Harada, Takashi; Hirakata, Hideki; Watanabe, Hiroshi; Nosaki, Tsuyoshi; Tsubouchi, Hirohito; Imawari, Michio; Akizawa, Tadao			Multicenter Study of Pegylated Interferon alpha-2a Monotherapy for Hepatitis C Virus-Infected Patients on Hemodialysis: REACH Study	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Hemodialysis; Hepatitis C virus; Pegylated interferon-2a; Rapid virological response; Sustained virological response	DIALYSIS THERAPY GUIDELINES; JAPANESE SOCIETY; CLINICAL-TRIALS; PLUS RIBAVIRIN; METAANALYSIS; MANAGEMENT; ANTIBODY; DISEASE	Many studies have reported poor vital prognosis in hepatitis C virus (HCV)-infected dialysis patients. The rate of HCV-infected dialysis patients in Japan is as high as 9.8%, and antiviral therapy is believed to be important for improving vital prognosis. We conducted a multicenter study to examine the administration method for pegylated interferon -2a (PEG-IFN-2a) monotherapy in HCV-infected dialysis. We studied 56 patients: 14 with low viral loads (HCV RNA < 5.0 log IU/mL) were treated with 90g PEG-IFN-2a weekly, 42 with high viral loads (HCV RNA 5.0 log IU/mL) were treated with 135g PEG-IFN-2a weekly. We examined the sustained virological response (SVR), factors affecting the SVR, and treatment safety. The overall SVR rate was 39% (22/56); that for genotype 1, genotype 2, low viral loads, and high viral loads was 29%, 67%, 93%, and 21%, respectively. From receiver operating characteristic (ROC) analysis, the HCV RNA cutoff values likely to achieve SVR for genotypes 1 and 2 were <5.7 log IU/mL (SVR rate: 64% 9/14) and <6.5 log IU/mL (SVR rate: 88% 7/8), respectively. If there was HCV RNA negativation at 4 weeks (rapid virological response), the SVR rate was 94% (16/17), whereas it was 6% (1/16) if there was HCV RNA positivity at 24 weeks. The rate of treatment discontinuation from adverse events or aggravated complications was 25% (14/56). High SVR rates can potentially be achieved with PEG-IFN monotherapy by identifying the target patients, based on virus type and viral load before initiating treatment and by modifying therapy during treatment according to responsiveness.	[Kikuchi, Kan; Akiba, Takashi] Tokyo Womens Med Univ, Dept Blood Purificat, Kidney Ctr, Tokyo, Japan; [Nitta, Kosaku] Tokyo Womens Med Univ, Dept Med, Kidney Ctr, Tokyo, Japan; [Kikuchi, Kan] Showa Univ, Sch Med, Shimoochiai Clin, Tokyo 142, Japan; [Ando, Ryoichi] Showa Univ, Sch Med, Dept Nephrol, Musashino Red Cross Hosp, Tokyo 142, Japan; [Izumi, Namiki] Showa Univ, Sch Med, Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo 142, Japan; [Imawari, Michio] Showa Univ, Sch Med, Dept Med, Div Gastroenterol, Tokyo 142, Japan; [Akizawa, Tadao] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan; [Masakane, Ikuto] Yabuki Shima Clin, Yamagata, Japan; [Atsukawa, Masanori] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Internal Med, Div Gastroenterol, Chiba, Japan; [Yamazaki, Chikao] Masuko Mem Hosp, Masuko Clin Subaru, Nagoya, Aichi, Japan; [Kato, Fumi] Masuko Mem Hosp, Dept Internal Med, Div Nephrol, Nagoya, Aichi, Japan; [Hotta, Naoki] Masuko Mem Hosp, Dept Internal Med, Div Hepatol, Nagoya, Aichi, Japan; [Tominaga, Yoshihiro] Nagoya Daini Cross Hosp, Dept Transplant & Endocrine Surg, Div Endocrine Surg, Aichi, Japan; [Orito, Etsuro] Nagoya Second Red Cross Hosp, Dept Gastroenterol, Aichi, Japan; [Hora, Kazuhiko] Hokushin Gen Hosp, Dept Nephrol, Nakano, Japan; [Nagasawa, Masaki] Shinonoi Gen Hosp, Dept Nephrol, Nagano, Japan; [Kasahara, Hiroshi] Suwa Red Cross Hosp, Dept Nephrol, Nagano, Japan; [Kawaguchi, Masanori] Japanese Red Cross Kyoto Daiichi Hosp, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Kimura, Hiroyuki] Saiseikai Wakayama Hosp, Dept Gastroenterol, Wakayama, Japan; [Ikebe, Norisato] Kochi Takasu Hosp, Div Gastroenterol, Dept Surg, Kochi, Japan; [Kawanishi, Hideki] Tsuchiya Gen Hosp, Hiroshima, Japan; [Shigemoto, Kenichiro] Harada Hosp, Hiroshima, Japan; [Harada, Takashi] Nagasaki Kidney Hosp, Nagasaki, Japan; [Hirakata, Hideki] Fukuoka Red Cross Hosp, Div Nephrol, Fukuoka, Japan; [Hirakata, Hideki] Fukuoka Red Cross Hosp, Dialysis Ctr, Fukuoka, Japan; [Watanabe, Hiroshi] Fukuoka Red Cross Hosp, Dept Gastroenterol & Hepatol, Fukuoka, Japan; [Nosaki, Tsuyoshi; Tsubouchi, Hirohito] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima 890, Japan	Kikuchi, K (reprint author), Tokyo Womens Med Univ, Dept Blood Purificat, Kidney Ctr, Tokyo, Japan.	kankikuchi@nifty.com					Akiba T, 2012, THER APHER DIAL, V16, P289, DOI 10.1111/j.1744-9987.2012.01078.x; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Nakai S, 2012, THER APHER DIAL, V16, P483, DOI 10.1111/j.1744-9987.2012.01143.x; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Carriero D, 2008, INT J ARTIF ORGANS, V31, P295; Namiki I, 2010, HEPATOL RES, V40, P347, DOI 10.1111/j.1872-034X.2010.00642.x; Termorshuizen F, 2003, J AM SOC NEPHROL, V14, P2851, DOI 10.1097/01.ASN.0000091585.45723.9E; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; Deng G, 2011, J ETHNOPHARMACOL, V136, P83, DOI 10.1016/j.jep.2011.04.008; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Nakayama E, 2000, J AM SOC NEPHROL, V11, P1896; [Anonymous], 2008, KIDNEY INT S109, V73, pS46; Rendina M, 2007, J HEPATOL, V46, P768, DOI 10.1016/j.jhep.2006.12.016; Nakai S, 2009, THER APHER DIAL, V13, P457, DOI 10.1111/j.1744-9987.2009.00789.x; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; Fabrizi F, 2008, J VIRAL HEPATITIS, V15, P79, DOI 10.1111/j.1365-2893.2007.00907.x; Bruchfeld A, 2006, J VIRAL HEPATITIS, V13, P316, DOI 10.1111/j.1365-2893.2005.00680.x; Fabrizi F, 2010, J MED VIROL, V82, P768, DOI 10.1002/jmv.21542; Iwasa Y, 2008, CLIN EXP NEPHROL, V12, P53, DOI 10.1007/s10157-007-0005-6; Liu CH, 2011, J GASTROEN HEPATOL, V26, P228, DOI 10.1111/j.1440-1746.2010.06488.x; Liu CH, 2008, GUT, V57, P525, DOI 10.1136/gut.2007.133884; MSD, 2005, REB DRUG INT FORM, P2; vansLeusen R, 2008, NEPHROL DIAL TRANSPL, V23, P721	23	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	DEC	2014	18	6					603	611		10.1111/1744-9987.12189		9	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	AX1JD	WOS:000346702600003		
J	Morishita, Y; Kubo, K; Haga, Y; Miki, A; Ishibashi, K; Kusano, E; Nagata, D				Morishita, Yoshiyuki; Kubo, Kazuya; Haga, Yumi; Miki, Atushi; Ishibashi, Kenichi; Kusano, Eiji; Nagata, Daisuke			Skeletal Muscle Loss Is Negatively Associated With Single-Pool Kt/V and Dialysis Duration in Hemodialysis Patients	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Bioelectrical impedance analysis; Handgrip strength test; Hemodialysis; Skeletal muscle loss	UREA REDUCTION RATIO; STAGE RENAL-DISEASE; BODY-COMPOSITION; MORTALITY; PREDIALYSIS; MASS; MALNUTRITION; INFLAMMATION; PERFORMANCE; SARCOPENIA	We evaluated the skeletal muscle loss in hemodialysis (HD) patients by bioelectrical impedance analysis (BIA) and handgrip strength test. Thirty-four HD patients and 16 healthy subjects (control group) were measured for skeletal muscle mass normalized as the skeletal muscle mass index (SMI), calculated as skeletal muscle mass (kg)/height (m)(2) using a tetrapolar bioelectrical impedance plethysmograph. Handgrip strength test was also performed using a hand dynamometer in both groups. In HD patients, the associations of SMI and handgrip strength with age, sex, HD conditions, and HD parameters such as body mass index (BMI), single-pool Kt/V (spKt/V), normalized protein catabolic rate (nPCR), creatinine generation rate (CGR) and serum albumin level (Alb) were investigated. SMI of HD patients (4.58 +/- 0.95kg/m(2)) was significantly lower than that of the control group (5.55 +/- 0.80kg/m(2), P<0.01). The handgrip strength of HD patients (19.9 +/- 7.74kg) was also significantly lower than that of the control group (33.0 +/- 8.94kg, P<0.01). In HD patients, HD duration was associated with both SMI and handgrip strength. Among HD parameters, spKt/V was negatively associated with both SMI and handgrip strength, BMI and Alb were positively associated with SMI, while nPCR and CGR were associated with neither SMI nor handgrip strength. HD duration independently contributed to skeletal muscle loss and the value of spKt/V may be affected by skeletal muscle loss in HD patients.	[Morishita, Yoshiyuki; Miki, Atushi; Kusano, Eiji; Nagata, Daisuke] Jichi Med Univ, Div Nephrol, Dept Internal Med, Shimotsuke, Tochigi 3290498, Japan; [Morishita, Yoshiyuki; Kubo, Kazuya; Haga, Yumi; Miki, Atushi] Haga Red Cross Hosp, Dept Dialysis Ctr, Mooka, Tochigi, Japan; [Ishibashi, Kenichi] Meiji Pharmaceut Univ, Dept Med Physiol, Tokyo, Japan; [Kusano, Eiji] Utsunomiya Social Insurance Hosp, Dept Internal Med, Utsunomiya, Tochigi, Japan	Morishita, Y (reprint author), Jichi Med Univ, Div Nephrol, Dept Internal Med, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	ymori@jichi.ac.jp					Al Snih Soham, 2004, Aging Clin Exp Res, V16, P481; Ramirez SPB, 2012, CLIN J AM SOC NEPHRO, V7, P1977, DOI 10.2215/CJN.00390112; Bonanni A, 2011, INT J ENV RES PUB HE, V8, P1631, DOI 10.3390/ijerph8051631; Storer TW, 2005, NEPHROL DIAL TRANSPL, V20, P1429, DOI 10.1093/ndt/gfh784; Shen W, 2003, OBES RES, V11, P217, DOI 10.1038/oby.2003.34; Kaysen GA, 2005, AM J CLIN NUTR, V82, P988; Shinzato T, 1997, ARTIF ORGANS, V21, P864; Carrero JJ, 2008, CLIN NUTR, V27, P557, DOI 10.1016/j.clnu.2008.04.007; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P864, DOI 10.1053/S0272-6386(03)01005-9; Nakao T, 2007, CONTRIB NEPHROL, V155, P18; SVENDSEN OL, 1993, AM J CLIN NUTR, V57, P605; Stenvinkel P, 2004, NEPHROL DIAL TRANSPL, V19, P2181, DOI 10.1093/ndt/gfh296; SHINZATO T, 1994, NEPHRON, V67, P280; Delmonico MJ, 2007, J AM GERIATR SOC, V55, P769, DOI 10.1111/j.1532-5415.2007.01140.x; Boyce ML, 1997, AM J KIDNEY DIS, V30, P180, DOI 10.1016/S0272-6386(97)90051-2; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Donadio C, 2005, J RENAL NUTR, V15, P332, DOI 10.1016/j.jrn.2005.04.001; Desmeules S, 2004, NEPHROL DIAL TRANSPL, V19, P1182, DOI 10.1093/ndt/gfh016; Cheema B, 2010, NEPHROLOGY, V15, P454, DOI 10.1111/j.1440-1797.2009.01261.x; Chertow GM, 1999, KIDNEY INT, V56, P1872, DOI 10.1046/j.1523-1755.1999.00734.x; CLYNE N, 1994, NEPHRON, V67, P322; Di Iorio BR, 2004, KIDNEY INT, V65, P2435, DOI 10.1111/j.1523-1755.2004.00660.x; Heiwe S, 2001, NEPHRON, V88, P48, DOI 10.1159/000045959; Hemodialysis Adequacy 2006 Work Group, 2006, AM J KIDNEY DIS S, V48, pS2, DOI DOI 10.1053/J.AJKD.2006.03.051.MEDLINE; Li ZS, 2000, AM J KIDNEY DIS, V35, P598, DOI 10.1016/S0272-6386(00)70004-7; Remuzzi A, 2007, KIDNEY INT, V71, P96, DOI 10.1038/sj.ki.5002047	27	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	DEC	2014	18	6					612	617		10.1111/1744-9987.12174		6	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	AX1JD	WOS:000346702600004		
J	Kono, K; Nishida, Y; Moriyama, Y; Yabe, H; Taoka, M; Sato, T				Kono, Kenichi; Nishida, Yusuke; Moriyama, Yoshihumi; Yabe, Hiroki; Taoka, Masahiro; Sato, Takashi			Investigation of Factors Affecting the Six-Minute Walk Test Results in Hemodialysis Patients	THERAPEUTIC APHERESIS AND DIALYSIS			English	Article						Hemodialysis; Iron-deficiency; Muscle; Physical endurance; Walking	CHRONIC HEART-FAILURE; CHRONIC KIDNEY-DISEASE; QUALITY-OF-LIFE; EXERCISE CAPACITY; IRON-DEFICIENCY; FUNCTIONAL-CAPACITY; PHYSICAL-ACTIVITY; METAANALYSIS; CARNITINE; THERAPY	Renal anemia, uremic myopathy, and malnutrition are some of the factors that affect the results of the 6-minute walk test (6MWT) in hemodialysis patients. We hypothesized that skeletal muscle dysfunction caused by skeletal myolysis, protein hypercatabolism, and mitochondrial deficiency are strongly related factors. The purpose of this study was to clarify the factors that affect the 6MWT results in hemodialysis patients to assess their exercise tolerance. The study included 43 outpatients from the hemodialysis unit. The 6MWT was performed, and knee extension strength, 1-leg standing time, and grip were measured. In addition, the subjects' characteristics such as age, preexisting coronary artery disease, hemoglobin level, total iron binding capacity, serum albumin level, creatinine generation rate, and normalized protein catabolic rate were investigated. A stepwise multiple regression model was used to examine the factors affecting the 6MWT results. Multiple regression analysis revealed that knee extension strength (=0.446, P=0.001), total iron binding capacity (=-0.299, P=0.021), and preexisting coronary artery disease (=-0.272, P=0.035) significantly affected the 6MWT results (R=0.66, R-2=0.44). The 6MWT in hemodialysis patients was strongly affected by muscle strength, iron deficiency anemia, and preexisting coronary artery disease, suggesting that resistance training is important for improving 6MWT results. Our findings indicate that iron deficiency and cardiac function should be assessed before exercising or undergoing an exercise tolerance test.	[Kono, Kenichi] Aichi Med Univ, Dept Rehabil, Kiyosu, Aichi Pref 4521931, Japan; [Nishida, Yusuke] Seirei Christopher Univ, Dept Rehabil, Hamamatsu, Shizuoka, Japan; [Moriyama, Yoshihumi] Nagoya Kyoritsu Hosp, Wellness Ctr, Nagoya, Aichi, Japan; [Yabe, Hiroki] Nagoya Kyoritsu Hosp, Dept Rehabil, Nagoya, Aichi, Japan; [Taoka, Masahiro; Sato, Takashi] Meiko Kyoritsu Clin, Hemodialysis Ctr, Nagoya, Aichi, Japan	Kono, K (reprint author), Aichi Med Univ, Dept Rehabil, 519 Ichiba, Kiyosu, Aichi Pref 4521931, Japan.	kohno@yuai.ac.jp					Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Enright PL, 1998, AM J RESP CRIT CARE, V158, P1384; Sietsema KE, 2004, KIDNEY INT, V65, P719, DOI 10.1111/j.1523-1755.2004.00411.x; Tay ELW, 2011, INT J CARDIOL, V151, P307, DOI 10.1016/j.ijcard.2010.05.066; Nakai S, 2012, THER APHER DIAL, V16, P483, DOI 10.1111/j.1744-9987.2012.01143.x; Kouidi E, 1998, NEPHROL DIAL TRANSPL, V13, P685, DOI 10.1093/ndt/13.3.685; Lord SR, 2002, ARCH PHYS MED REHAB, V83, P907, DOI 10.1053/apmr.2002.33227; Boudville N, 2010, CLIN ENDOCRINOL, V73, P299, DOI 10.1111/j.1365-2265.2010.03821.x; Bischoff-Ferrari HA, 2004, AM J CLIN NUTR, V80, P752; FINCH CA, 1976, J CLIN INVEST, V58, P447, DOI 10.1172/JCI108489; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; Arduini A, 2008, PHARMACOL THERAPEUT, V120, P149, DOI 10.1016/j.pharmthera.2008.08.008; Jankowska EA, 2011, J CARD FAIL, V17, P899, DOI 10.1016/j.cardfail.2011.08.003; SHINZATO T, 1994, NEPHRON, V67, P280; Painter P, 2009, ADV CHRONIC KIDNEY D, V16, P437, DOI 10.1053/j.ackd.2009.09.002; Roul G, 1998, AM HEART J, V136, P449, DOI 10.1016/S0002-8703(98)70219-4; Johansen KL, 2000, KIDNEY INT, V57, P2564, DOI 10.1046/j.1523-1755.2000.00116.x; King S, 1999, J RHEUMATOL, V26, P2233; Pulz C, 2008, CAN J CARDIOL, V24, P131; Avni T, 2012, EUR J HEART FAIL, V14, P423, DOI 10.1093/eurjhf/hfs017; BUTLAND RJA, 1982, BRIT MED J, V284, P1607; Capitanini A, 2008, J NEPHROL, V21, P738; Constantin-Teodosiu D, 2002, NEPHROL DIAL TRANSPL, V17, P1808, DOI 10.1093/ndt/17.10.1808; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Harigae Hideo, 2010, Rinsho Byori, V58, P1211; Kosmadakis GC, 2010, NEPHRON CLIN PRACT, V115, pE7, DOI 10.1159/000286344; Ministry of Education Culture Sports, 2000, NEW FITN TEST IMPL G; Morales FJ, 1999, AM HEART J, V138, P291, DOI 10.1016/S0002-8703(99)70114-6; Nishida Y, 2009, RIGAKURYOHO KAGAKU, V24, P539; Peeters P, 1996, J GERONTOL A-BIOL, V51, pM147; Pollentier Brittany, 2010, Cardiopulm Phys Ther J, V21, P13; Rao M, 2009, J AM SOC NEPHROL, V20, P189, DOI 10.1681/ASN.2007091031; RILEY M, 1992, EUR HEART J, V13, P789; Takenaka H, 2000, JPN J CLIN PHYSL S, V30, P103	34	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	DEC	2014	18	6					623	627		10.1111/1744-9987.12177		5	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	AX1JD	WOS:000346702600006		
J	Watanabe, C; Hokari, R; Miura, S				Watanabe, Chikako; Hokari, Ryota; Miura, Soichiro			Chronic Antibiotic-Refractory Diversion Pouchitis Successfully Treated With Leukocyteapheresis	THERAPEUTIC APHERESIS AND DIALYSIS			English	Letter									[Watanabe, Chikako; Hokari, Ryota; Miura, Soichiro] Natl Def Med Coll, Dept Internal Med, Saitama, Japan	Watanabe, C (reprint author), Natl Def Med Coll, Dept Internal Med, Saitama, Japan.	yqw03070@nifty.com					Matsumoto T, 2008, THER APHER DIAL, V12, P484, DOI 10.1111/j.1744-9987.2008.00639.x; Shen B, 2012, NAT REV GASTRO HEPAT, V9, P323, DOI 10.1038/nrgastro.2012.58; SANDBORN WJ, 1994, MAYO CLIN PROC, V69, P409; Shibata H, 2003, THER APHER DIAL, V7, P44, DOI 10.1046/j.1526-0968.2003.00009.x	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1744-9979	1744-9987		THER APHER DIAL	Ther. Apher. Dial.	DEC	2014	18	6					644	645		10.1111/1744-9987.12175		2	Hematology; Urology & Nephrology	Hematology; Urology & Nephrology	AX1JD	WOS:000346702600010		
J	Felizola, SJA; Nakamura, Y; Ozawa, Y; Ono, Y; Morimoto, R; Midorikawa, S; Suzuki, S; Satoh, F; Sasano, H				Felizola, Saulo J. A.; Nakamura, Yasuhiro; Ozawa, Yohei; Ono, Yoshikiyo; Morimoto, Ryo; Midorikawa, Sanae; Suzuki, Shinichi; Satoh, Fumitoshi; Sasano, Hironobu			Activating Transcription Factor 3 (ATF3) in the Human Adrenal Cortex: Its Possible Involvement in Aldosterone Biosynthesis	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						adrenal cortex; adrenocortical adenoma; cell signaling pathways; immunohistochemistry; zona glomerulosa	RAPID RESPONSE GENES; ADRENOCORTICAL-CELLS; DNA-DAMAGE; INFLAMMATION; HOMEOSTASIS; RECEPTORS; REGULATOR; ADENOMAS; PROTEIN; STRESS	The activating transcription factor 3 (ATF3) is a member of the cAMP-responsive element-binding (CREB) protein family of transcription factors. ATF3 is expressed in H295R human adrenocortical carcinoma cells and considered a rapid-responder gene to angiotensin-II stimulation. However, the functions of ATF3 in human adrenocortical tissues have remained unknown. In this study, we analyzed the localization and possible regulatory mechanisms of ATF3 in human adrenocortical cells and tissues. The expression levels of ATF3 mRNA were analyzed in 66 aldosterone-producing adenomas (APA) and 14 cortisol-producing adenomas (CPA) using real-time RT-PCR. To localize the ATF3 protein, we performed immunohistochemical analysis in 20 non-pathological adrenal glands, 9 adrenal glands with idiopathic hyperaldosteronism (IHA), 20 APA, and 5 CPA using a mouse monoclonal antibody against human ATF3. We showed that ATF3 mRNA levels were higher in APA compared to CPA (P = 0.0053). ATF3 was immunolocalized to the zona glomerulosa of non-pathological adrenal glands and adrenal glands with IHA, and diffusely detected in the tumor cells of APA and CPA. Subsequently, H295R cells were treated for 6 h with each inhibitor of Src kinase (SRC), PKC, JAK2, and calcium-dependent calmodulin kinase-II (CaMKII) in the presence or absence of angiotensin-II. The expression levels of ATF3 mRNA were increased by angiotensin-II (about 3.5-fold induction), but the magnitude of the induction was significantly decreased in the presence of an inhibitor for SRC (PP2) or CaMKII (KN93). These results suggest that ATF3 is a downstream target of SRC and CaMKII signaling, and may be involved in adrenocortical aldosterone synthesis.	[Felizola, Saulo J. A.; Nakamura, Yasuhiro; Ozawa, Yohei; Sasano, Hironobu] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808575, Japan; [Ono, Yoshikiyo; Morimoto, Ryo; Satoh, Fumitoshi] Tohoku Univ Hosp, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi, Japan; [Midorikawa, Sanae] Fukushima Med Univ, Dept Radiat Hlth Management, Fukushima, Japan; [Suzuki, Shinichi] Fukushima Med Univ, Dept Organ Regulatory Surg, Fukushima, Japan	Felizola, SJA (reprint author), Tohoku Univ, Grad Sch Med, Dept Pathol, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	felizola@med.tohoku.ac.jp					Allen-Jennings AE, 2001, J BIOL CHEM, V276, P29507, DOI 10.1074/jbc.M100986200; Nogueira EF, 2009, J MOL ENDOCRINOL, V42, P319, DOI 10.1677/JME-08-0112; Bhoumik A, 2005, MOL CELL, V18, P577, DOI 10.1016/j.molcel.2005.04.015; Ye P, 2007, J ENDOCRINOL, V195, P39, DOI 10.1677/JOE-07-0037; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hai T, 1999, GENE EXPRESSION, V7, P321; Bhoumik A, 2008, J BIOL CHEM, V283, P17605, DOI 10.1074/jbc.M802030200; Cho SG, 2001, MOL CELL BIOL, V21, P8398, DOI 10.1128/MCB.21.24.8398-8413.2001; Seijffers R, 2007, J NEUROSCI, V27, P7911, DOI 10.1523/JNEUROSCI.5313-06.2007; Lau E, 2012, CELL, V148, P543, DOI 10.1016/j.cell.2012.01.016; Lau E, 2012, J CELL SCI, V125, P2815, DOI 10.1242/jcs.095000; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Nogueira EF, 2007, J MOL ENDOCRINOL, V39, P365, DOI 10.1677/JME-07-0094; BIRD IM, 1995, ENDOCR RES, V21, P169; CHEN BPC, 1994, J BIOL CHEM, V269, P15819; Felizola SJA, 2014, ENDOCR PATHOL, V25, P229, DOI 10.1007/s12022-013-9280-9; Felizola SJA, 2014, J MOL ENDOCRINOL, V52, P159, DOI 10.1530/JME-13-0248; Felizola SJA, 2014, MOL CELL ENDOCRINOL, V382, P170, DOI 10.1016/j.mce.2013.09.025; Felizola SJA, 2014, J STEROID BIOCHEM, V144, P410, DOI 10.1016/j.jsbmb.2014.08.012; HSU JC, 1991, P NATL ACAD SCI USA, V88, P3511, DOI 10.1073/pnas.88.9.3511; Hunt D, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00007; Lefebvre H, 2002, J CLIN ENDOCR METAB, V87, P1211, DOI 10.1210/jc.87.3.1211; Nakamura Y, 2014, PATHOL INT, V64, P482, DOI 10.1111/pin.12200; Thompson MR, 2009, J MOL MED-JMM, V87, P1053, DOI 10.1007/s00109-009-0520-x; Zmuda EJ, 2010, DIABETOLOGIA, V53, P1438, DOI 10.1007/s00125-010-1696-x	25	0	0	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	DEC	2014	234	4					249	254		10.1620/tjem.234.249		6	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	AX5EW	WOS:000346950600001		
J	Kitanishi, R; Matsuda, T; Watanabe, S; Saito, M; Hanita, T; Watanabe, T; Kobayashi, Y				Kitanishi, Ryuta; Matsuda, Tadashi; Watanabe, Shinpei; Saito, Masatoshi; Hanita, Takushi; Watanabe, Tatsuya; Kobayashi, Yoshiyasu			Cerebral Ischemia or Intrauterine Inflammation Promotes Differentiation of Oligodendroglial Precursors in Preterm Ovine Fetuses: Possible Cellular Basis for White Matter Injury	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						accelerated maturation; immunohistochemical staining; oligodendroglia; periventricular leukomalacia; white matter injury	ANTENATAL PERIVENTRICULAR LEUKOMALACIA; INSTRUMENTED FETAL SHEEP; HEMORRHAGIC HYPOTENSION; NECROTIZING FUNISITIS; GLUCOCORTICOIDS; INDUCTION; DEATH; ENCEPHALOPATHY; PREMATURITY; MATURATION	White matter injury in premature infants is known to be major cause of long-term neurocognitive disability, but the pathogenic mechanism remains unclear, hampering our ability to develop preventions. Periventricular leukomalacia is a severe form of white matter injury. In the present study, we explored the effects of cerebral ischemia and/or intrauterine inflammation on the development of oligodendroglia in the cerebral white matter using chronically instrumented fetal sheep. Each fetus received one of three insults: hemorrhage, inflammation and their combination. In the hemorrhage group, 40% of the fetoplacental blood volume was acutely withdrawn, and 24 hours after removal, the blood was returned to the fetus. The inflammation group received intravenous granulocyte-colony stimulating factor and intra-amniotic endotoxin and thus suffered from necrotizing funisitis and chorioamnionitis. The inflammatory hemorrhage group underwent acute hemorrhage under the inflammatory state. The sham group received no insults. Importantly, periventricular leukomalacia was not detected in the sham and the inflammation groups. Differentiating oligodendroglia at various developmental stages were identified by immunohistochemical analysis with specific antibodies. No difference in the density of oligodendroglial progenitors was detected among the four groups, whereas oligodendroglial precursors were significantly reduced in the three insult groups, compared to sham control. Moreover, the density of immature oligodendroglia was higher in the inflammation group and the inflammatory hemorrhage group, while the density of mature oligodendroglia was highest in the hemorrhage group. We propose that cerebral ischemia or intrauterine inflammation induces the differentiation of oligodendroglial precursors in preterm fetuses, eventually resulting in their exhaustion.	[Kitanishi, Ryuta; Matsuda, Tadashi; Watanabe, Shinpei; Saito, Masatoshi; Hanita, Takushi; Watanabe, Tatsuya] Tohoku Univ Hosp, Ctr Perinatal Neonatal Med, Sendai, Miyagi 9808574, Japan; [Kobayashi, Yoshiyasu] Obihiro Univ Agr & Vet Med, Dept Vet Pathol, Obihiro, Hokkaido 080, Japan	Matsuda, T (reprint author), Tohoku Univ Hosp, Ctr Perinatal Neonatal Med, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	choku@med.tohoku.ac.jp					Chan JR, 1998, P NATL ACAD SCI USA, V95, P10459, DOI 10.1073/pnas.95.18.10459; Antonow-Schlorke I, 2009, OBSTET GYNECOL, V113, P142, DOI 10.1097/AOG.0b013e3181924d3b; Billiards SS, 2008, BRAIN PATHOL, V18, P153, DOI 10.1111/j.1750-3639.2007.00107.x; BARRES BA, 1994, DEVELOPMENT, V120, P1097; Welin AK, 2007, PEDIATR RES, V61, P153, DOI 10.1203/01.pdr.0000252546.20451.la; Riddle A, 2006, J NEUROSCI, V26, P3045, DOI 10.1523/JNEUROSCI.5220-05.2006; Duncan JR, 2002, PEDIATR RES, V52, P941, DOI 10.1203/01.PDR.0000034224.13885.BE; Back SA, 2007, STROKE, V38, P724, DOI 10.1161/01.STR.0000254729.27386.05; Khwaja O, 2008, ARCH DIS CHILD-FETAL, V93, pF153, DOI 10.1136/adc.2006.108837; Deng WB, 2010, NAT REV NEUROL, V6, P328, DOI 10.1038/nrneurol.2010.53; KUMAR S, 1989, P NATL ACAD SCI USA, V86, P6807, DOI 10.1073/pnas.86.17.6807; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800; BANKER BQ, 1962, ARCH NEUROL-CHICAGO, V7, P386; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005; de Vries L.S., 2002, MRI NEONATAL BRAIN, P155; Jauregui-Huerta Fernando, 2010, Current Immunology Reviews, V6, P195; Matsuda T, 1999, AM J OBSTET GYNECOL, V181, P725, DOI 10.1016/S0002-9378(99)70519-3; Matsuda T, 2006, AM J OBSTET GYNECOL, V194, P1057, DOI 10.1016/j.ajog.2005.10.820; NAVARRO C, 1974, J PEDIATR-US, V85, P689, DOI 10.1016/S0022-3476(74)80521-4; Riddle A, 2012, STROKE, V43, P178, DOI 10.1161/STROKEAHA.111.632265; Saito M., 2009, AM J OBSTET GYNECOL, V200; Volpe JJ, 2011, INT J DEV NEUROSCI, V29, P423, DOI 10.1016/j.ijdevneu.2011.02.012; Volpe J.J., 2008, NEUROLOGY NEWBORN HU, P99; Watanabe T, 2007, PEDIATR RES, V62, P670	25	0	0	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	DEC	2014	234	4					299	307		10.1620/tjem.234.299		9	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	AX5EW	WOS:000346950600008		
J	Kuroyanagi, Y; Kawasaki, H; Noda, Y; Ohmachi, T; Sekiya, S; Yoshimura, K; Ohe, C; Michigami, T; Ozono, K; Kaneko, K				Kuroyanagi, Yuichi; Kawasaki, Hirohide; Noda, Yukihiro; Ohmachi, Taichi; Sekiya, Shin-ichiro; Yoshimura, Ken; Ohe, Chisato; Michigami, Toshimi; Ozono, Keiichi; Kaneko, Kazunari			A Fatal Case of Infantile Malignant Osteopetrosis Complicated by Pulmonary Arterial Hypertension after Hematopoietic Stem Cell Transplantation	TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE			English	Article						graft versus host disease; hematopoietic stem cell transplantation; infantile malignant osteopetrosis; pulmonary arterial hypertension; T-cell immune regulator 1	AUTOSOMAL RECESSIVE OSTEOPETROSIS; SUBUNIT	Infantile malignant osteopetrosis (IMO) is a rare and fatal autosomal recessive condition characterized by a generalized increased in bone density. Hematopoietic stem cell transplantation (HSCT) is the only effective and rational therapy with achieving long-term disease-free survival. However, complications with HSCT for IMO remain unclear. Here we describe a male infant with IMO, carrying two novel mutations in the T-cell immune regulator 1 (TCIRG1) gene. The TCIRG1 gene encodes the a3 subunit of vacuolar H+-ATPase that plays an essential role in the resorptive function of osteoclasts. Direct sequencing of all 20 exons of the TCIRG1 gene revealed a single nucleotide change in exon 11 (c1305 G > T), which causes the substitution of Asp (GAT) for Glu (GAG) at position 435, and a two-nucleotide deletion in exon 16 (c19521953 del CA), causing a frame-shift mutation. However, the functional consequence of each mutation remains to be determined. Allogeneic HSCT was performed in the patient at the age of nine months. Donor engraftment was achieved, and abnormal bone metabolism and extramedullary hematopoiesis were corrected. Graft-versus-host disease was mild (grade I). However, the patient died of complication of pulmonary arterial hypertension at seven months after the HSCT. Postmortem examination revealed prominent vascular wall thickening of the pulmonary artery and macrophage infiltration to alveoli. It should be noted that a patient with IMO has a risk for pulmonary arterial hypertension, and the evaluation of pulmonary arterial flow should be included in the assessment of each patient with IMO even after HSCT.	[Kuroyanagi, Yuichi; Kawasaki, Hirohide; Noda, Yukihiro; Ohmachi, Taichi; Sekiya, Shin-ichiro; Yoshimura, Ken; Kaneko, Kazunari] Kansai Med Univ, Dept Pediat, Hirakata, Osaka 5731010, Japan; [Ohe, Chisato] Kansai Med Univ, Dept Pathol, Hirakata, Osaka 5731010, Japan; [Michigami, Toshimi] Osaka Med Ctr, Dept Bone & Mineral Res, Izumi, Osaka, Japan; [Michigami, Toshimi] Res Inst Maternal & Child Hlth, Izumi, Osaka, Japan; [Ozono, Keiichi] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka, Japan	Kawasaki, H (reprint author), Kansai Med Univ, Dept Pediat, 2-5-1 Shinmachi, Hirakata, Osaka 5731010, Japan.	kawasaki@hirakata.kmu.ac.jp					Frattini A, 2000, NAT GENET, V25, P343; Vergadi E, 2011, CIRCULATION, V123, P1986, DOI 10.1161/CIRCULATIONAHA.110.978627; Driessen GJA, 2003, BONE MARROW TRANSPL, V32, P657, DOI 10.1038/sj.bmt.1704194; Askmyr MK, 2008, BRIT J HAEMATOL, V140, P597, DOI 10.1111/j.1365-2141.2008.06983.x; Cheow HK, 2001, PEDIATR RADIOL, V31, P869, DOI 10.1007/s002470100008; Jaing TH, 2006, PEDIATR TRANSPLANT, V10, P629, DOI 10.1111/j.1399-3046.2006.00537.x; Kapelushnik J, 2001, BONE MARROW TRANSPL, V27, P129, DOI 10.1038/sj.bmt.1702743; Kasow KA, 2004, PEDIATR BLOOD CANCER, V42, P190, DOI 10.1002/pbc.10455; Michigami T, 2002, BONE, V30, P436, DOI 10.1016/S8756-3282(01)00684-6; ORCHARD PJ, 1992, EXP HEMATOL, V20, P103; Steward CG, 2004, BRIT J HAEMATOL, V124, P63, DOI 10.1046/j.1365-2141.2003.04739.x	11	0	0	TOHOKU UNIV MEDICAL PRESS	SENDAI	2-1, SEIRYO-MACHI, AOBA-KU, SENDAI, MIYAGI 980-8575, JAPAN	0040-8727	1349-3329		TOHOKU J EXP MED	Tohoku J. Exp. Med.	DEC	2014	234	4					309	312		10.1620/tjem.234.309		4	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	AX5EW	WOS:000346950600009		
J	Huang, YX; Chen, YS				Huang, Yongxi; Chen, Yihsu			Analysis of an imperfectly competitive cellulosic biofuel supply chain	TRANSPORTATION RESEARCH PART E-LOGISTICS AND TRANSPORTATION REVIEW			English	Article						Biofuel; Supply chain; Cournot; Complementarity	MARKET EQUILIBRIUM; DESIGN; MANAGEMENT; SYSTEM; MODEL; UNCERTAINTIES; LOCATION; DEMAND	We study the strategic behavior in an imperfectly competitive cellulosic biofuel supply chain. An optimization-based supply chain model is used to obtain long-run planning outcomes, based on which we develop market models considering both perfect and imperfect competitions. The equilibrium among stakeholders in the multi-echelon supply chain can be obtained by solving a collection of first-order conditions associated with their profit-maximization problems. For the imperfect competition, the model, additionally, allows firms with significant market share at different segment of the supply chain to exercise market power. We apply the models to an illustrative case study of California. (C) 2014 Elsevier Ltd. All rights reserved.	[Huang, Yongxi] Clemson Univ, Glenn Dept Civil Engn, Clemson, SC 29634 USA; [Chen, Yihsu] Univ Calif Merced, Sch Engn, Sch Social Sci Humil & Arts, Merced, CA 95340 USA; [Chen, Yihsu] Natl Grad Inst Policy Studies GRIPS, Tokyo 1068677, Japan	Huang, YX (reprint author), Clemson Univ, Glenn Dept Civil Engn, Clemson, SC 29634 USA.	yxhuang@clemson.edu; yihsu.chen@ucmerced.edu					Acharya A. M., 2008, 2008 IND ENG RES C, P1296; Eksioglu SD, 2010, TRANSPORT RES REC, P144, DOI 10.3141/2191-18; Min H, 2002, COMPUT IND ENG, V43, P231, DOI 10.1016/S0360-8352(02)00066-9; Zhang D, 2006, OMEGA-INT J MANAGE S, V34, P283, DOI 10.1016/j.omega.2004.11.001; An HJ, 2011, BIORESOURCE TECHNOL, V102, P7860, DOI 10.1016/j.biortech.2011.05.060; Nagurney A, 2010, TRANSPORT RES E-LOG, V46, P281, DOI 10.1016/j.tre.2009.11.002; Chen CW, 2012, TRANSPORT RES E-LOG, V48, P150, DOI 10.1016/j.tre.2011.08.004; Melo MT, 2009, EUR J OPER RES, V196, P401, DOI 10.1016/j.ejor.2008.05.007; Wang XL, 2013, TRANSPORT RES B-METH, V57, P158, DOI 10.1016/j.trb.2013.07.008; Chen YH, 2011, OPER RES, V59, P696, DOI 10.1287/opre.1110.0917; Walther G, 2012, EUR J OPER RES, V218, P280, DOI 10.1016/j.ejor.2011.09.050; Beamon BM, 1998, INT J PROD ECON, V55, P281, DOI 10.1016/S0925-5273(98)00079-6; Meixell MJ, 2005, TRANSPORT RES E-LOG, V41, P531, DOI 10.1016/j.tre.2005.06.003; Cundiff JS, 1997, BIORESOURCE TECHNOL, V59, P47, DOI 10.1016/S0960-8524(96)00129-0; Huang YX, 2010, TRANSPORT RES E-LOG, V46, P820, DOI 10.1016/j.tre.2010.03.002; Awudu I, 2012, RENEW SUST ENERG REV, V16, P1359, DOI 10.1016/j.rser.2011.10.016; Gan JB, 2011, BIOMASS BIOENERG, V35, P3350, DOI 10.1016/j.biombioe.2010.08.062; Bai Y, 2012, ENERG ECON, V34, P1623, DOI 10.1016/j.eneco.2012.01.003; Hobbs BF, 2001, IEEE T POWER SYST, V16, P194, DOI 10.1109/59.918286; Bai Y, 2011, TRANSPORT RES B-METH, V45, P162, DOI 10.1016/j.trb.2010.04.006; BSI Group, 2011, 20502011 PAS BSI GRO; Bushnell J. B., 2007, NATL BUREAU EC RES W, V13507; Chen X., 2011, NATL BUREAU EC RES W, V16697; Cottle R., 1992, LINEAR COMPLEMENTARI; KREPS DM, 1983, BELL J ECON, V14, P326, DOI 10.2307/3003636; Dirkse S. P., 1994, PATH SOLVER COMPLEME; Eksioglu SD, 2009, COMPUT IND ENG, V57, P1342, DOI 10.1016/j.cie.2009.07.003; Energy Information Administration, 2010, ETH BLEND WALL; EPA, 2013, NEW SOURC REV; EPA, 2011, EPA BIOF PRIM EPAS A; Evans D. A., 2007, ENVIRON SCI TECHNOL, V42, P347; Fourer R., 2003, AMPL MODELING LANGUA; Geunes J, 2003, NETWORKS, V42, P66, DOI 10.1002/net.10082; Gunnarsson H, 2004, EUR J OPER RES, V158, P103, DOI 10.1016/S0377-2217(03)00354-0; Huang YX, 2014, J ENERG ENG, V140, DOI 10.1061/(ASCE)EY.1943-7897.0000138; Jenkins B., 2007, CALIFORNIA IN PRESS; Jing-Yuan W., 1999, OPER RES, V47, P102, DOI 10.1287/opre.47.1.102; Limpaitoon T, 2011, J REGUL ECON, V40, P237, DOI 10.1007/s11149-011-9161-4; Lin CYC, 2013, ENERG ECON, V38, P111, DOI 10.1016/j.eneco.2013.03.001; Mas-Colell A., 1995, MICROECONOMIC THEORY; Metzler C., 2003, NETW SPAT ECON, V3, P123, DOI DOI 10.1023/A:1023907818360; Nagurney A, 2002, TRANSPORT RES E-LOG, V38, P281, DOI 10.1016/S1366-5545(01)00020-5; Nagurney A, 2006, TRANSPORT RES E-LOG, V42, P293, DOI 10.1016/j.tre.2005.02.001; Parker N., 2007, THESIS U CALIFORNIA; Parker N., 2007, STRATEGIC DEV BIOENE; Raphael S., 2009, BIOTECHNOL BIOFUELS, V2; Solecki M, 2013, ADV BIOFUEL MARKET R; Stoft S, 2002, POWER SYSTEM EC DESI; Sun JC, 2011, J CLEAN PROD, V19, P121, DOI 10.1016/j.jclepro.2010.02.007; Tirole J., 1988, THEORY IND ORG; Wang M., 2005, OPERATING MANUAL GRE; White EM, 2010, WOODY BIOMASS BIOENE; Zhang D., 2003, SUPPLY CHAIN NETWORK	53	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1366-5545			TRANSPORT RES E-LOG	Transp. Res. Pt. e-Logist. Transp. Rev.	DEC	2014	72						1	14		10.1016/j.tre.2014.09.008		14	Economics; Engineering, Civil; Operations Research & Management Science; Transportation; Transportation Science & Technology	Business & Economics; Engineering; Operations Research & Management Science; Transportation	AX4HR	WOS:000346894600001		
J	Imai, A; Yamakawa, Y; Huang, KC				Imai, Akio; Yamakawa, Yukiko; Huang, Kuancheng			The strategic berth template problem	TRANSPORTATION RESEARCH PART E-LOGISTICS AND TRANSPORTATION REVIEW			English	Article						Berth template problem; Berth allocation problem; Subgradient optimization; Lagrangian relaxation; Container terminal; Heuristics	ALLOCATION PROBLEM; SCHEDULING PROBLEM; CONTAINER TERMINALS; MEGA-CONTAINERSHIPS; TABU SEARCH; JOB SHOPS; OPTIMIZATION; ALGORITHM; DIFFERENTIATION; MANAGEMENT	A marine container terminal operator may have a situation with excessive calling requests to be served especially when some new service contracts are under consideration. For this situation, we propose a strategic berth template problem (BTPS) that selects the ships among the requesting ones to be served and arrange their berth-windows within a limited planning horizon. The BTPS employs the subgradient optimization procedure, which is an improved version of the procedure that the authors developed for the operational berth allocation problem. A wide variety of numerical experiments indicate the improved subgradient procedure works well for the BTPS. (C) 2014 Elsevier Ltd. All rights reserved.	[Imai, Akio; Yamakawa, Yukiko] Kobe Univ, Grad Sch Maritime Sci, Kobe, Hyogo 6580022, Japan; [Imai, Akio] Port & Airport Res Inst, Yokosuka, Kanagawa 2390826, Japan; [Huang, Kuancheng] Natl Chiao Tung Univ, Dept Transportat Technol & Management, Hsinchu 300, Taiwan	Imai, A (reprint author), Kobe Univ, Grad Sch Maritime Sci, Kobe, Hyogo 6580022, Japan.	imai@maritime.kobe-u.ac.jp			JSPS Grant-in-Aid for Scientific Research-B Grant [25282093]	The authors would like to thank the three anonymous referees for their constructive comments. This research is supported by the JSPS Grant-in-Aid for Scientific Research-B Grant 25282093.	Nishimura E, 2001, EUR J OPER RES, V131, P282, DOI 10.1016/S0377-2217(00)00128-4; Pinedo ML, 2012, SCHEDULING: THEORY, ALGORITHMS, AND SYSTEMS, FOURTH EDITION, P1, DOI 10.1007/978-1-4614-2361-4; ROUNDY R, 1992, MATH OPER RES, V17, P842, DOI 10.1287/moor.17.4.842; Zhen L, 2011, TRANSPORT SCI, V45, P483, DOI 10.1287/trsc.1100.0364; Hall NG, 1997, OPER RES, V45, P421, DOI 10.1287/opre.45.3.421; Golias MM, 2009, TRANSPORT RES E-LOG, V45, P878, DOI 10.1016/j.tre.2009.05.006; Imai A, 2007, EUR J OPER RES, V179, P579, DOI 10.1016/j.ejor.2006.03.034; Lee DH, 2010, TRANSPORT RES E-LOG, V46, P1017, DOI 10.1016/j.tre.2010.01.009; Crama Y, 1997, OPER RES, V45, P952, DOI 10.1287/opre.45.6.952; Imai A, 2008, TRANSPORT RES E-LOG, V44, P136, DOI 10.1016/j.tre.2006.05.002; de Oliveira RM, 2012, EXPERT SYST APPL, V39, P5499, DOI 10.1016/j.eswa.2011.11.072; Moorthy R, 2006, OR SPECTRUM, V28, P495, DOI 10.1007/s00291-006-0036-5; Norman BA, 1999, NAV RES LOG, V46, P199, DOI 10.1002/(SICI)1520-6750(199903)46:2<199::AID-NAV5>3.0.CO;2-L; Cheong CY, 2010, ANN OPER RES, V180, P63, DOI 10.1007/s10479-008-0493-0; Vacca I, 2013, TRANSPORT SCI, V47, P148, DOI 10.1287/trsc.1120.0428; Monaco MF, 2007, TRANSPORT SCI, V41, P265, DOI 10.1287/trsc.1060.0171; Imai A, 2005, TRANSPORT RES B-METH, V39, P199, DOI 10.1016/j.trb.2004.04.004; Lee DH, 2013, TRANSPORT RES E-LOG, V49, P201, DOI 10.1016/j.tre.2012.08.006; Imai A, 2003, TRANSPORT RES B-METH, V37, P437, DOI 10.1016/S0191-2615(02)00023-1; Imai A, 2001, TRANSPORT RES B-METH, V35, P401, DOI 10.1016/S0191-2615(99)00057-0; Hansen P, 2008, EUR J OPER RES, V191, P636, DOI 10.1016/j.ejor.2006.12.057; Brucker P, 2008, DISCRETE APPL MATH, V156, P2561, DOI 10.1016/j.dam.2008.03.029; Park KT, 2002, J OPER RES SOC, V53, P1054, DOI 10.1057/palgrave.jors.2601412; Hendriks MPM, 2013, OR SPECTRUM, V35, P441, DOI 10.1007/s00291-012-0305-4; Li CL, 1998, IIE TRANS, V30, P433, DOI 10.1023/A:1026487022192; Imai A, 1997, J ADV TRANSPORT, V31, P75; Giallombardo G, 2010, TRANSPORT RES B-METH, V44, P232, DOI 10.1016/j.trb.2009.07.003; Lim A, 1998, OPER RES LETT, V22, P105, DOI 10.1016/S0167-6377(98)00010-8; Xu DS, 2012, EUR J OPER RES, V216, P47, DOI 10.1016/j.ejor.2011.07.012; Cordeau JF, 2005, TRANSPORT SCI, V39, P526, DOI 10.1287/trsc.1050.0120; Ting CJ, 2014, EXPERT SYST APPL, V41, P1543, DOI 10.1016/j.eswa.2013.08.051; Crama Y, 2000, ANN OPER RES, V96, P97, DOI 10.1023/A:1018995317468; Buhrkal K, 2011, TRANSPORT RES E-LOG, V47, P461, DOI 10.1016/j.tre.2010.11.016; Bramel J., 1997, LOGIC LOGISTICS; Golias MM, 2010, TRANSPORT RES C-EMER, V18, P794, DOI 10.1016/j.trc.2009.07.001; HANEN C, 1994, EUR J OPER RES, V72, P82, DOI 10.1016/0377-2217(94)90332-8; Hendriks MPM, 2012, FLEX SERV MANUF J, V24, P248, DOI 10.1007/s10696-011-9120-5; Imai A, 2005, TRANSPORT RES B-METH, V39, P197, DOI 10.1016/j.trb.2004.03.004; Imai A, 2013, TRANSPORT RES E-LOG, V49, P141, DOI 10.1016/j.tre.2012.07.006; JICT, 2014, JAK INT CONT TERM BE; Lalla-Ruiz E, 2012, ENG APPL ARTIF INTEL, V25, P1132, DOI 10.1016/j.engappai.2012.06.001; Lee TE, 1997, OPER RES, V45, P72, DOI 10.1287/opre.45.1.72; MATSUO H, 1991, MANAGE SCI, V37, P587, DOI 10.1287/mnsc.37.5.587; Mauri GR, 2008, LECT NOTES COMPUT SC, V4972, P110, DOI 10.1007/978-3-540-78604-7_10; MCCORMICK ST, 1994, MATH COMPUT MODEL, V20, P107, DOI 10.1016/0895-7177(94)90210-0; Mongelluzzo B., 2013, J COMMERCE, V14, P36; Saharidis GKD, 2010, INT J ADV MANUF TECH, V46, P377, DOI 10.1007/s00170-009-2068-x	47	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1366-5545			TRANSPORT RES E-LOG	Transp. Res. Pt. e-Logist. Transp. Rev.	DEC	2014	72						77	100		10.1016/j.tre.2014.09.013		24	Economics; Engineering, Civil; Operations Research & Management Science; Transportation; Transportation Science & Technology	Business & Economics; Engineering; Operations Research & Management Science; Transportation	AX4HR	WOS:000346894600005		
J	Cook, ND; Carvalho, GB; Damasio, A				Cook, Norman D.; Carvalho, Gil B.; Damasio, Antonio			From membrane excitability to metazoan psychology	TRENDS IN NEUROSCIENCES			English	Review							CORTICAL-NEURONS; CEREBRAL-CORTEX; CONSCIOUSNESS; MECHANISMS; SYNCHRONY; NEOCORTEX; EVOLUTION; BINDING	Unlike the nonexcitable cell membranes that are ubiquitous in all domains of life, excitable membranes are found almost exclusively in animal organisms (Protozoa and Metazoa). Their transient permeability to ion flow makes possible the rapid detection of, and response to, external stimuli, and results in the phenomena that most clearly distinguish fauna from flora: perception, cognition, and motor activity. Interestingly, all known forms of membrane excitability are a consequence of one unique mechanism: the influx of positively charged ions into the normally alkaline cytoplasm. Here, we suggest that the sudden reversal of the membrane potential during the sensory potential and the action potential is an electrostatic disturbance of homeostasis that is the necessary first step in the processes of 'sentience' and 'irritability'.	[Cook, Norman D.] Kansai Univ, Dept Informat, Osaka 5691095, Japan; [Cook, Norman D.; Carvalho, Gil B.; Damasio, Antonio] Univ So Calif, Brain & Creat Inst, Los Angeles, CA 90089 USA	Cook, ND (reprint author), Kansai Univ, Dept Informat, Osaka 5691095, Japan.	nc_876@usc.edu			Mathers Foundation; National Institute of Neurological Disorders and Stroke (NINDS) [P50 NS0 19632]	Supported in part by grants from the Mathers Foundation and National Institute of Neurological Disorders and Stroke (NINDS) (P50 NS0 19632).	Aidley D J, 1998, PHYSL EXCITABLE CELL; Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Llinas RR, 2002, P NATL ACAD SCI USA, V99, P449, DOI 10.1073/pnas.012604899; Black JA, 2013, NEURON, V80, P280, DOI 10.1016/j.neuron.2013.09.012; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Anastassiou CA, 2011, NAT NEUROSCI, V14, P217, DOI 10.1038/nn.2727; Rao SG, 2000, J NEUROSCI, V20, P485; Mashour GA, 2013, P NATL ACAD SCI USA, V110, P10357, DOI 10.1073/pnas.1301188110; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Tomassy GS, 2014, SCIENCE, V344, P319, DOI 10.1126/science.1249766; Lewin GR, 2004, J NEUROBIOL, V61, P30, DOI 10.1002/neu.20078; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; Larkum M, 2013, TRENDS NEUROSCI, V36, P141, DOI 10.1016/j.tins.2012.11.006; Damasio A, 2013, NAT REV NEUROSCI, V14, P143, DOI 10.1038/nrn3403; Jones EG, 2009, ANN NY ACAD SCI, V1157, P10, DOI 10.1111/j.1749-6632.2009.04534.x; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Hodgkin AL, 1939, NATURE, V144, P710, DOI 10.1038/144710a0; Lehmann D, 2010, NEUROIMAGE, V49, P1073, DOI 10.1016/j.neuroimage.2009.07.054; Ashcroft F., 2009, SPARK LIFE ELECT HUM; Aur D, 2010, BIOMED HEALTH RES, V74, P1, DOI 10.3233/978-1-60750-473-3-i; Baars BJ, 2010, COGNITION, BRAIN, AND CONSCIOUSNESS: INTRODUCTION TO COGNITIVE NEUROSCIENCE, 2ND EDITION, P1; Bernstein J., 1912, ELEKTROBIOLOGIE; Binet A., 1888, PSYCHIC LIFE MICROOR; Butt A.M., 2013, GLIAL PHYSL PATHOPHY; Chalmers D., 1996, CONSCIOUS MIND; Chester R., 2000, MARINE GEOCHEMISTRY; Creutzfeldt O., 1995, CORTEX CEREBRI PERFO; Deacon T, 2012, INCOMPLETE NATURE MI; Deamer D., 2007, 1 LIFE DISCOVERING C; Donald M., 2001, MIND SO RARE EVOLUTI; Duncan J., 2010, INTELLIGENCE HAPPENS; Edelman G. M., 2000, UNIVERSE CONSCIOUSNE; Fain G.L., 2007, SENSORY TRANSDUCTION; Fields R. D., 2009, THE OTHER BRAIN; Glynn I., 1999, ANATOMY THOUGHT ORIG; Gross M., 1998, LIFE ON THE EDGE; Hazen R., 2012, STORY EARTH 1 4 5 BI; Hille B, 2001, ION CHANNELS EXCITAB; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P424; Humphrey N, 2011, SOUL DUST: THE MAGIC OF CONSCIOUSNESS, P1; Hunt H., 1995, NATURE CONSCIOUSNESS; Islam M.S., 2011, ADV EXPT MED BIOL; Jennings H.S., 1906, BEHAV LOWER ORGANISM; JONES EG, 1993, CEREB CORTEX, V3, P361, DOI 10.1093/cercor/3.5.361-a; Kaila Kai, 1998, P3; KATZ B, 1949, ARCH SCI PHYSIOL, V3, P285; Koch C., 2004, QUEST CONSCIOUSNESS; Kuga N, 2011, J NEUROSCI, V31, P2607, DOI 10.1523/JNEUROSCI.5319-10.2011; Lane N, 2009, LIFE ASCENDING 10 GR; Llinas R., 2001, I OF THE VORTEX; Loewenstein W. R., 1999, TOUCHSTONE LIFE MOL; Lopez-Larrea C., 2012, ADV EXPT MED BIOL; Luisi PL, 2006, EMERGENCE OF LIFE: FROM CHEMICAL ORIGINS TO SYNTHETIC BIOLOGY, P1; Mann M.D, 1981, NERVOUS SYSTEM BEHAV; Minor D.L., 2011, FUNCTIONING TRANSMEM, P351; Minsky M, 1988, PERCEPTRONS INTRO CO; Muller TJ, 2005, J NEURAL TRANSM, V112, P565, DOI 10.1007/s00702-004-0194-z; Raghanti MA, 2010, FRONT NEUROANAT, V4, DOI 10.3389/neuro.05.003.2010; Randall D, 2002, ECKERT ANIMAL PHYSL; Revonsuo A, 2010, CONSCIOUSNESS SCI SU; Searle J., 1997, MYSTERY CONSCIOUSNES; Singer W, 1998, PHILOS T ROY SOC B, V353, P1829, DOI 10.1098/rstb.1998.0335; Sonner JM, 2013, ANNU REV BIOPHYS, V42, P143, DOI 10.1146/annurev-biophys-083012-130341; Sonner JM, 2008, ANESTH ANALG, V107, P849, DOI 10.1213/ane.0b013e31817ee684; Sqmre L.E., 2013, FUNDAMENTAL NEUROSCI; Tortora G.J., 2012, MICROBIOLOGY INTRO; von von der Malsburg C., 2010, DYNAMIC COORDINATION	68	1	1	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0166-2236			TRENDS NEUROSCI	Trends Neurosci.	DEC	2014	37	12					698	705		10.1016/j.tins.2014.07.011		8	Neurosciences	Neurosciences & Neurology	AY0CX	WOS:000347266500004		
J	Ishii, K; Furuichi, T				Ishii, Kazuei; Furuichi, Toru			Influence of moisture content, particle size and forming temperature on productivity and quality of rice straw pellets	WASTE MANAGEMENT			English	Article						Rice straw; Pellets; Renewable energy; Yield ratio; Heating value; Durability	BIOMASS; DURABILITY; ENERGY	A large amount of rice straw is generated and left as much in paddy fields, which causes greenhouse gas emissions as methane. Rice straw can be used as bioenergy. Rice straw pellets are a promising technology because pelletization of rice straw is a form of mass and energy densification, which leads to a product that is easy to handle, transport, store and utilize because of the increase in the bulk density. The operational conditions required to produce high quality rice straw pellets have not been determined. This study determined the optimal moisture content range required to produce rice straw pellets with high yield ratio and high heating value, and also determined the influence of particle size and the forming temperature on the yield ratio and durability of rice straw pellets. The optimal moisture content range was between 13% and 20% under a forming temperature of 60 or 80 degrees C. The optimal particle size was between 10 and 20 mm, considering the time and energy required for shredding, although the particle size did not significantly affect the yield ratio and durability of the pellets. The optimized conditions provided high quality rice straw pellets with nearly 90% yield ratio, >= 12 MJ/kg for the lower heating value, and >95% durability. (C) 2014 Elsevier Ltd. All rights reserved.	[Ishii, Kazuei; Furuichi, Toru] Hokkaido Univ, Grad Sch Engn, Lab Sound Mat Cycle Syst Planning, Kita Ku, Sapporo, Hokkaido 0608628, Japan	Ishii, K (reprint author), Hokkaido Univ, Grad Sch Engn, Lab Sound Mat Cycle Syst Planning, Kita Ku, Kita 13,Nishi 8, Sapporo, Hokkaido 0608628, Japan.	k-ishii@eng.hokudai.ac.jp			Ministry of the Environment, Japan	Part of this study was supported by a Grant-in-Aid for Scientific Research from the Ministry of the Environment, Japan. We thank Mr. Tomokawa and Mr. Watanabe for experiments in our laboratory and also thank Mr. Mitsushi Kamide in Industrial Research Institute of Hokkaido Research Organization and Atsushi Yamada in Hokkaido Forest Products Research Institute.	Mani S, 2006, BIOMASS BIOENERG, V30, P648, DOI 10.1016/j.biombioe.2005.01.004; Stelte W, 2011, FUEL, V90, P3285, DOI 10.1016/j.fuel.2011.05.011; Kaliyan N, 2009, BIOMASS BIOENERG, V33, P337, DOI 10.1016/j.biombioe.2008.08.005; Stelte W, 2011, BIOMASS BIOENERG, V35, P910, DOI 10.1016/j.biombioe.2010.11.003; Lim JS, 2012, RENEW SUST ENERG REV, V16, P3084, DOI 10.1016/j.rser.2012.02.051; Chou CS, 2009, FUEL PROCESS TECHNOL, V90, P980, DOI 10.1016/j.fuproc.2009.04.012; Fasina OO, 2008, BIORESOURCE TECHNOL, V99, P1259, DOI 10.1016/j.biortech.2007.02.041; Liu ZJ, 2013, RENEW ENERG, V55, P1, DOI 10.1016/j.renene.2012.12.014; Chou CS, 2009, FUEL PROCESS TECHNOL, V90, P1041, DOI 10.1016/j.fuproc.2009.04.007; Said N, 2013, WASTE MANAGE, V33, P2250, DOI 10.1016/j.wasman.2013.07.019; Gadde B, 2009, BIOMASS BIOENERG, V33, P1532, DOI 10.1016/j.biombioe.2009.07.018; Matsumura Y, 2005, BIOMASS BIOENERG, V29, P347, DOI 10.1016/j.biombioe.2004.06.015; Carone M.T., 2011, BIOMASS BIOENERG, V35, P401; Fasina O.O., 1996, POWDER HANDL PROCESS, V8, P361; Gil MV, 2010, BIORESOURCE TECHNOL, V101, P8859, DOI 10.1016/j.biortech.2010.06.062; Ishii K., 2013, P 28 INT C SOL WAST, V28; Japan Wood Pellet Association, 2011, QUAL STAND WOOD PELL; Japanese Industrial Standards, 2004, M8812 JIS; Japanese Industrial Standards, 1999, Z73023 JIS; Japanese Industrial Standards, 1993, M8814 JIS; Kaliyan N, 2010, BIORESOURCE TECHNOL, V101, P1082, DOI 10.1016/j.biortech.2009.08.064; New Energy Foundation, 2011, JAP PROJ BIOETH PROD; Tabil L., 1996, APPL ENG AGR, V12, P345; Theerarattananoon K, 2011, IND CROP PROD, V33, P325, DOI 10.1016/j.indcrop.2010.11.014; Zamorano A., 2011, RENEW ENERG, V36, P3133	25	1	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0956-053X			WASTE MANAGE	Waste Manage.	DEC	2014	34	12					2621	2626		10.1016/j.wasman.2014.08.008		6	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	AX6FY	WOS:000347019700022		
J	Mashiko, M; Toquenaga, Y				Mashiko, Miyuki; Toquenaga, Yukihiko			Grey Heron (Ardea cinerea) Expansion Promotes the Persistence of Mixed-species Heron Colonies	WATERBIRDS			English	Article						Ardea cinerea; breeding site selection; Grey Heron; range expansion	HETEROSPECIFIC ATTRACTION; CLIMATE-CHANGE; CATTLE EGRETS; CENTRAL JAPAN; RICE FIELDS; COMPETITION; INVASIONS; CONSEQUENCES; SELECTION; MIGRANT	Range expansion of native as well as exotic species often causes effects on the original species; however, not all range expansions are negative for breeding colonies consisting of mixed species. The Grey Heron (Ardea cinerea) has increased and expanded its distribution in Japan in the last 20 years. Its solitary and early nesting habits may facilitate establishment and persistence of colonies of mixed heron species. To examine whether the addition of Grey Herons has affected colony persistence and the number of established and abandoned colonies, 16 years of monitoring data from before and after the expansion of Grey Herons around Ibaraki Prefecture in Japan were analyzed. Most newly established colonies were without Grey Herons before their expansion, but more than half of the established colonies contained Grey Herons after the expansion. The number of colony abandonments decreased after the Grey Heron expansion and most of these occurred in colonies that were without Grey Herons both before and after the expansion. Persistence periods were longer in colonies with Grey Herons than in colonies without Grey Herons. The expansion of Grey Herons into mixed heron colonies has promoted the persistence of mixed heron colonies, and local populations of colonial herons seemed to gain the benefit of colony sustainability.	[Mashiko, Miyuki; Toquenaga, Yukihiko] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki 3058572, Japan	Mashiko, M (reprint author), Natl Inst Agroenvironm Sci, Biodivers Div, Ibaraki 3058604, Japan.	mashiko@pe.ies.life.tsukuba.ac.jp			Global Environment Research Fund from the Ministry of the Environment, Japan [F-1]; JSPS KAKENHI Grant [13740433, 19570014]	We thank T. Tohyama, T. Yamaguchi, R. Yamagishi, C. Koshida, H. Takeda, A. Abe, K. Nabeya, and L. Carrasco for colony censuses, S. Ikeno for supplying information about the location of some colonies, and the Biodiversity Center of Japan for use of the map of breeding distributions of Grey Herons in Japan shown in the report of the 6th national survey on the natural environment. We also thank K. Ohashi and M. Fujioka for their valuable comments and suggestions on an early draft of the manuscript. We are grateful to the anonymous reviewers for their useful comments and suggestions. This study was partly supported by the Global Environment Research Fund (F-1) from the Ministry of the Environment, Japan, and by JSPS KAKENHI Grant Number 13740433 and 19570014.	ADAMS CE, 1995, BIRD STUDY, V42, P44; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Thomson RL, 2003, OECOLOGIA, V134, P431, DOI 10.1007/s00442-002-1140-0; Seppanen JT, 2007, ECOLOGY, V88, P1622, DOI 10.1890/06-1757.1; Mashiko M, 2013, FORKTAIL, P71; Ruiz GM, 1997, AM ZOOL, V37, P621; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Lane SJ, 1998, BIOL CONSERV, V83, P221, DOI 10.1016/S0006-3207(97)00054-2; Maeda T, 2001, ECOL RES, V16, P569, DOI 10.1046/j.1440-1703.2001.00418.x; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; Vitousek PM, 1996, AM SCI, V84, P468; Rahel FJ, 2008, CONSERV BIOL, V22, P521, DOI 10.1111/j.1523-1739.2008.00950.x; BELZER WR, 1989, COLON WATERBIRD, V12, P115, DOI 10.2307/1521321; Biodiversity Center of Japan, 2004, NAT SURV NAT ENV REP; BURGER J, 1978, AUK, V95, P252; BURGER J, 1978, CONDOR, V80, P15, DOI 10.2307/1367786; Dami L, 2006, WATERBIRDS, V29, P154, DOI 10.1675/1524-4695(2006)29[154:DCEELE]2.0.CO;2; DUSI JL, 1968, WILSON BULL, V80, P458; Elton CS, 1958, ECOLOGY INVASIONS AN; Environmental Agency of Japan, 1994, DISTR POP STAT UNPUB; Fujioka M., 2001, RES SPADOTEMPO UNPUB; Jakubas D, 2004, WATERBIRDS, V27, P304, DOI 10.1675/1524-4695(2004)027[0304:TROTGH]2.0.CO;2; Kaneko Y, 1998, HIST BLACK BASS INTR; Kleinbaum D. G., 1996, STAT HLTH SCI SURVIV; Koshida C., 2007, THESIS U TSUKUBA IBA; Kurata A., 1972, MIE PREFECTURE TORI, V21, P308; Kushlan J. A., 2005, HERONS; Matsunaga Katsutoshi, 2000, Japanese Journal of Ornithology, V49, P9, DOI 10.3838/jjo.49.9; MONKKONEN M, 1990, OECOLOGIA, V85, P218, DOI 10.1007/BF00319404; Monkkonen M, 1999, EVOL ECOL, V13, P91; Ohtsuka Y, 2009, J THEOR BIOL, V260, P261, DOI 10.1016/j.jtbi.2009.06.002; Ohtsuka Y, 2009, J ETHOL, V27, P131, DOI 10.1007/s10164-008-0096-x; Quintana F, 1998, AUK, V115, P1068; R Development Core Team, 2013, R LANG ENV STAT COMP; Rahel FJ, 2008, CONSERV BIOL, V22, P551, DOI 10.1111/j.1523-1739.2008.00953.x; RICE DALE W., 1956, AUK, V73, P259; Sasaki Minako, 2001, Strix, V19, P149; Sato Nolbuhiko, 1996, Journal of the Yamashina Institute for Ornithology, V28, P19; Sawara Yuji, 1994, Japanese Journal of Ornithology, V43, P61, DOI 10.3838/jjo.43.61; TRIVELPIECE W, 1979, AUK, V96, P675; Werschkul D. F., 1978, P COLONIAL WATERBIRD, V1, P131, DOI 10.2307/1520910; WESTERSKOV K E, 1974, Notornis, V21, P239; Wild Bird Society of Japan, 1981, RES COL ROOSTS UNPUB	43	0	0	WATERBIRD SOC	WASHINGTON	NATL MUSEUM NATURAL HISTORY SMITHSONIAN INST, WASHINGTON, DC 20560 USA	1524-4695	1938-5390		WATERBIRDS	Waterbirds	DEC	2014	37	4					362	370				9	Ornithology	Zoology	AY2RI	WOS:000347436500002		
J	Okada, M				Okada, Maiko			Switching of chromatin-remodelling complexes for oestrogen receptor-alpha (Retraction of vol 9, pg 563, 2008)	EMBO REPORTS			English	Article									Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan							Okada M, 2008, EMBO REP, V9, P563, DOI 10.1038/embor.2008.55	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1469-221X	1469-3178		EMBO REP	EMBO Rep.	DEC	2014	15	12					1330	1330		10.15252/embr.201471210		1	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AU7FI	WOS:000345765800017		
J	Genestreti, KJ; Fuselier, SA; Goldstein, J; Nagai, T; Eastwood, JP				Genestreti, K. J.; Fuselier, S. A.; Goldstein, J.; Nagai, T.; Eastwood, J. P.			The location and rate of occurrence of near-Earth magnetotail reconnection as observed by Cluster and Geotail	JOURNAL OF ATMOSPHERIC AND SOLAR-TERRESTRIAL PHYSICS			English	Article						Magnetotail; Magnetic reconnection; MMS	MAGNETIC RECONNECTION; CURRENT SHEET; SUBSTORM ONSET; NEUTRAL SHEET; PLASMA SHEET; BULK FLOWS; FIELD; MAGNETOSPHERE; DYNAMICS; MISSION	A statistical characterization of the location and rate of occurrence of magnetic reconnection in the near-Earth magnetotail is performed by analyzing the set of ion diffusion region (DR) observations made by the Cluster and Geotail spacecraft during solar maximum and the declining phase. The occurrence rate is analyzed in terms of its dependence on both X-GSM* and Y-GSM* (where coordinates are in the solar wind aberrated geocentric solar magnetospheric system). Within the limits of the statistics available to this study, we find the purely X-GSM* - dependent occurrence rate to be roughly constant over a large portion of the near-Earth magnetotail. In contrast, we find the purely Y-GSM* dependent occurrence rate to be biased towards dusk with a local maximum between 0 R-E <= Y-GSM* <= 5 R-E. The Y-GSM* - dependent occurrence rate is then used to construct a quasi-2D formulation of the DR occurrence rate, which has explicit dependence on X-GSM* and implicit dependence on Y-GSM*. The quasi-2D occurrence rate is then used to examine the predicted ephemeris of the Magnetospheric MultiScale (MMS) spacecraft. We estimate that, during its near-Earth magnetotail survey phase, MMS will likely observe 11 +/- 4 DR events. (C) 2014 Elsevier Ltd. All rights reserved.	[Genestreti, K. J.; Fuselier, S. A.; Goldstein, J.] Univ Texas San Antonio, Dept Phys & Astron, San Antonio, TX 78249 USA; [Genestreti, K. J.; Fuselier, S. A.; Goldstein, J.] Southwest Res Inst, Space Sci & Engn Div, San Antonio, TX USA; [Nagai, T.] Tokyo Inst Technol, Dept Earth & Planetary Sci, Tokyo 152, Japan; [Eastwood, J. P.] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, London, England	Genestreti, KJ (reprint author), Univ Texas San Antonio, Dept Phys & Astron, San Antonio, TX 78249 USA.	kgenestreti@swri.edu			MMS NASA grant [NNG04EB99C]; STFC Advanced Fellowship at ICL	This study was supported by the MMS NASA grant (number NNG04EB99C). This study made use of the CAA, CDAweb, and DARTS/ISAS data archives. The predicted ephemeris for the MMS spacecraft was calculated by the Goddard Space Flight Center. The authors would like to thank those who contributed to the success of the Geotail and Cluster missions. The authors would also like to thank Steve Petrinec, Yanhua Liu, and Tai Phan for helpful discussions. J.P.E. holds an STFC Advanced Fellowship at ICL.	Nakamura R, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019558; Frey HU, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2004JA010607; SPEISER TW, 1967, J GEOPHYS RES, V72, P131, DOI 10.1029/JZ072i001p00131; Imber SM, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016026; Nagai T, 1998, GEOPH MONOG SERIES, V105, P211; COWLEY SWH, 1981, PLANET SPACE SCI, V29, P809, DOI 10.1016/0032-0633(81)90071-4; Nagai T, 2013, J GEOPHYS RES-SPACE, V118, P7703, DOI 10.1002/2013JA019135; Eastwood JP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022509; Nagai T, 1998, J GEOPHYS RES-SPACE, V103, P4419, DOI 10.1029/97JA02190; Eastwood JP, 2010, J GEOPHYS RES-SPACE, V115, DOI 10.1029/2009JA014962; Burch JL, 2009, AM SCI, V97, P392; Tsyganenko NA, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2007JA012260; Runov A, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013493; NISHIDA A, 1994, GEOPHYS RES LETT, V21, P2871, DOI 10.1029/94GL01223; Escoubet CP, 2001, ANN GEOPHYS-GERMANY, V19, P1197; Angelopoulos V, 2008, SCIENCE, V321, P931, DOI 10.1126/science.1160495; Baker DN, 1996, J GEOPHYS RES-SPACE, V101, P12975, DOI 10.1029/95JA03753; Nagai T, 2011, J GEOPHYS RES-SPACE, V116, DOI 10.1029/2010JA016283; Miyashita Y, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013225; SIBECK DG, 1985, J GEOPHYS RES-SPACE, V90, P4011, DOI 10.1029/JA090iA05p04011; FAIRFIELD DH, 1980, J GEOPHYS RES-SPACE, V85, P775, DOI 10.1029/JA085iA02p00775; Nagai T, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2005JA011207; Tsyganenko NA, 2004, J GEOPHYS RES-SPACE, V109, DOI 10.1029/2003JA010062; Baumjohann W, 2000, ADV SPACE RES-SERIES, V25, P1663, DOI 10.1016/S0273-1177(99)00681-X; Gabrielse C, 2009, J GEOPHYS RES-SPACE, V114, DOI 10.1029/2008JA013583; Genestreti KJ, 2013, J GEOPHYS RES-SPACE, V118, P6389, DOI 10.1002/2013JA019125; MACHIDA, 2009, ANN GEOPHYS, V27, P1035; NAGAI T, 2013, J GEOPHYS RES, V118; NAKAMURA R, 2002, GEOPHYS RES LETT, V29; Oka M, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049350; PETRUKOVICH AA, 2009, J GEOPHYS RES, V114; Raj A, 2002, J GEOPHYS RES-SPACE, V107, DOI 10.1029/2001JA007547; Reme H, 2001, ANN GEOPHYS-GERMANY, V19, P1303; Shay MA, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016267; Thompson SM, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010714	35	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1364-6826	1879-1824		J ATMOS SOL-TERR PHY	J. Atmos. Sol.-Terr. Phys.	DEC	2014	121		A				98	109		10.1016/j.jastp.2014.10.005		12	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	Geochemistry & Geophysics; Meteorology & Atmospheric Sciences	AX6GY	WOS:000347022200012		
J	Lemire, P; Roy, D; Fittipaldi, N; Okura, M; Takamatsu, D; Bergman, E; Segura, M				Lemire, Paul; Roy, David; Fittipaldi, Nahuel; Okura, Masatoshi; Takamatsu, Daisuke; Bergman, Eugenia; Segura, Mariela			Implication of TLR- but Not of NOD2-Signaling Pathways in Dendritic Cell Activation by Group B Streptococcus Serotypes III and V	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PATTERN-RECOGNITION RECEPTORS; INNATE IMMUNITY; CAPSULAR POLYSACCHARIDES; PATHOGEN RECOGNITION; NONPREGNANT ADULTS; DISEASE; NOD2; PHAGOCYTOSIS; MACROPHAGES	Group B Streptococcus (GBS) is an important agent of life-threatening invasive infection. It has been previously shown that encapsulated type III GBS is easily internalized by dendritic cells (DCs), and that this internalization had an impact on cytokine production. The receptors underlying these processes are poorly characterized. Knowledge on the mechanisms used by type V GBS to activate DCs is minimal. In this work, we investigated the role of Toll-like receptor (TLR)/MyD88 signaling pathway, the particular involvement of TLR2, and that of the intracellular sensing receptor NOD2 in the activation of DCs by types III and V GBS. The role of capsular polysaccharide (CPS, one of the most important GBS virulence factors) in bacterial-DC interactions was evaluated using non-encapsulated mutants. Despite differences in the role of CPS between types III and V GBS in bacterial internalization and intracellular survival, no major differences were observed in their capacity to modulate release of cytokines by DC. For both serotypes, CPS had a minor role in this response. Production of cytokines by DCs was shown to strongly rely on MyD88-dependent signaling pathways, suggesting that DCs recognize GBS and become activated mostly through TLR signaling. Yet, GBS-infected TLR2(-/-) DCs only showed a partial reduction in the production of IL-6 and CXCL1 compared to control DCs. Surprisingly, CXCL10 release by type III or type V GBS-infected DCs was MyD88-independent. No differences in DC activation were observed between NOD2(-/-) and control DCs. These results demonstrate the involvement of various receptors and the complexity of the cytokine production pathways activated by GBS upon DC infection.	[Lemire, Paul; Roy, David; Bergman, Eugenia; Segura, Mariela] Univ Montreal, Fac Vet Med, Immunol Lab, St Hyacinthe, PQ J2S 7C6, Canada; [Fittipaldi, Nahuel] Publ Hlth Ontario, Toronto, ON, Canada; [Fittipaldi, Nahuel] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Okura, Masatoshi; Takamatsu, Daisuke] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki, Japan; [Takamatsu, Daisuke] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan	Segura, M (reprint author), Univ Montreal, Fac Vet Med, Immunol Lab, St Hyacinthe, PQ J2S 7C6, Canada.	mariela.segura@umontreal.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [342150]; "Fonds de recherche du Quebec - Nature et technologies" PhD Awards	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC, http://www.nserc-crsng.gc.ca/index_eng.asp) through a grant to Mariela Segura (#342150). Paul Lemire and David Roy were the recipients of "Fonds de recherche du Quebec - Nature et technologies" PhD Awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya RA, 2004, J AM GERIATR SOC, V52, P46, DOI 10.1111/j.1532-5415.2004.52009.x; Andrade EB, 2013, J IMMUNOL, V191, P4759, DOI 10.4049/jimmunol.1301752; Costa A, 2012, J IMMUNOL, V188, P1953, DOI 10.4049/jimmunol.1102543; Dharancy S, 2010, GASTROENTEROLOGY, V138, P1546, DOI 10.1053/j.gastro.2009.12.008; Chaffin DO, 2005, J BACTERIOL, V187, P4615, DOI 10.1128/JB.187.13.4615-4626.2005; Skoff TH, 2009, CLIN INFECT DIS, V49, P85, DOI 10.1086/599369; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Da Costa AFE, 2011, INT J MOL MED, V27, P739, DOI 10.3892/ijmm.2011.635; Cieslewicz MJ, 2005, INFECT IMMUN, V73, P3096, DOI 10.1128/IAI.73.5.3096-3103.2005; Davis KM, 2011, J CLIN INVEST, V121, P3666, DOI 10.1172/JCI57761; Calzas C, 2013, INFECT IMMUN, V81, P3106, DOI 10.1128/IAI.00113-13; Selvanantham T, 2013, J IMMUNOL, V191, P5646, DOI 10.4049/jimmunol.1301412; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Lemire P, 2013, MICROB PATHOGENESIS, V65, P41, DOI 10.1016/j.micpath.2013.09.006; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Warner N, 2013, J IMMUNOL, V190, P3, DOI 10.4049/jimmunol.1203103; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Mancuso G, 2004, J IMMUNOL, V172, P6324; Clarke TB, 2011, IMMUNOL REV, V243, P9, DOI 10.1111/j.1600-065X.2011.01039.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; Letiembre M, 2005, INFECT IMMUN, V73, P8397, DOI 10.1128/IAI.73.12.8397-8401.2005; Bandow K, 2012, FEBS LETT, V586, P1540, DOI 10.1016/j.febslet.2012.04.018; Lemire P, 2012, CELL MICROBIOL, V14, P1707, DOI 10.1111/j.1462-5822.2012.01830.x; Segura M, 2007, EUR J IMMUNOL, V37, P1887, DOI 10.1002/eji.200636553; Deshmukh HS, 2009, INFECT IMMUN, V77, P1376, DOI 10.1128/IAI.00940-08; Lemire P, 2012, MICROBES INFECT, V14, P1064, DOI 10.1016/j.micinf.2012.05.015; Monroe KM, 2010, CELL MICROBIOL, V12, P881, DOI 10.1111/j.1462-5822.2010.01478.x; Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Fujieda M, 2012, INFECT IMMUN, V80, P2053, DOI 10.1128/IAI.06232-11; Nagl M, 2002, CLIN DIAGN LAB IMMUN, V9, P1165, DOI 10.1128/CDLI.9.6.1165-1168.2002; Sendi P, 2008, INFECTION, V36, P100, DOI 10.1007/s15010-007-7251-0; Liu XJ, 2010, GLIA, V58, P839, DOI 10.1002/glia.20968; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Henneke P, 2005, J IMMUNOL, V174, P6449; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Henneke P, 2001, J IMMUNOL, V167, P7069; Flo TH, 2000, J IMMUNOL, V164, P2064; Bebien M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002812; Bodazewska-Lubas M, 2013, POL J MICROBIOL, V62, P85; Cheng Q, 2001, INFECT IMMUN, V69, P2302, DOI 10.1128/IAI.69.4.2302-2308.2001; Davies HD, 2001, J INFECT DIS, V184, P285, DOI 10.1086/322029; Deshmukh SD, 2011, EMBO REP, V12, P71, DOI 10.1038/embor.2010.189; dos Santos MHB, 2013, ANTON LEEUW INT J G, V104, P1125, DOI 10.1007/s10482-013-0034-y; Draper DW, 2006, IMMUNOL LETT, V102, P202, DOI 10.1016/j.imlet.2005.09.005; Henneke P, 2002, J IMMUNOL, V169, P3970; Johri AK, 2007, INFECT IMMUN, V75, P1473, DOI 10.1128/IAI.00638-06; Kenzel S, 2009, INFECT IMMUN, V77, P2474, DOI 10.1128/IAI.01343-08; Koedel U, 2009, CURR TOP MICROBIOL, V336, P15, DOI 10.1007/978-3-642-00549-7_2; Koenig JM, 2009, PEDIATR CLIN N AM, V56, P689, DOI 10.1016/j.pcl.2009.04.003; Lecours MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044746; Lysenko ES, 2007, PLOS PATHOG, V3, P1073, DOI 10.1371/journal.ppat.0030118; Puliti M, 2009, INFECT IMMUN, V77, P1524, DOI 10.1128/IAI.00965-08; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Talati AJ, 2008, MICROBES INFECT, V10, P1106, DOI 10.1016/j.micinf.2008.06.001; Teixeira CF, 2001, MICROSC RES TECHNIQ, V54, P254, DOI 10.1002/jemt.1137; Tyrrell GJ, 2002, MICROBIOL-SGM, V148, P3921	61	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							UNSP e113940	10.1371/journal.pone.0113940		20	Multidisciplinary Sciences	Science & Technology - Other Topics	AX7SK	WOS:000347114900100		
J	Onda, K; Yamochi, H; Koshihara, S				Onda, Ken; Yamochi, Hideki; Koshihara, Shin-ya			Diverse Photoinduced Dynamics in an Organic Charge-Transfer Complex Having Strong Electron-Phonon Interactions	ACCOUNTS OF CHEMICAL RESEARCH			English	Review							INFRARED VIBRATIONAL SPECTROSCOPY; PHASE-TRANSITION; TTF-CA; (EDO-TTF)(2)PF6; PULSES; DIFFRACTION	Conspectus Phenomena that occur in nonequilibrium states created by photoexcitation differ qualitatively from those that occur at thermal equilibrium, and various physical theories developed for thermal equilibrium states can hardly be applied to such phenomena. Recently it has been realized that understanding phenomena in nonequilibrium states in solids is important for photoenergy usage and ultrafast computing. Consequently, much effort has been devoted to revealing such phenomena by developing various ultrafast observation techniques and theories applicable to nonequilibrium states. This Account describes our recent studies of diverse photoinduced dynamics in a strongly correlated organic solid using various ultrafast techniques. Solids in which the electronic behavior is affected by Coulomb interactions between electrons are designated as strongly correlated materials and are known to exhibit unique physical properties even at thermal equilibrium. Among them, many organic charge-transfer (CT) complexes have low dimensionality and flexibility in addition to strong correlations; thus, their physical properties change sensitively in response to changes in pressure or electric field. Photoexcitation is also expected to drastically change their physical properties and would be useful for ultrafast photoswitching devices. However, in nonequilibrium states, the complicated dynamics due to these characteristics prevents us from understanding and using these materials for photonic devices. The CT complex (EDO-TTF)(2)PF6 (EDO-TTF = 4,5-ethylenedioxytetrathiafulvalene) exhibits unique photoinduced dynamics due to strong electron-electron and electron-phonon interactions. We have performed detailed studies of the dynamics of this complex using transient electronic spectroscopy at the 10 and 100 fs time scales. These studies include transient vibrational spectroscopy, which is sensitive to the charges and structures of constituent molecules, and transient electron diffraction, which provides direct information on the crystal structure. Photoexcitation of the charge-ordered low-temperature phase of (EDO-TTF)(2)PF6 creates a new photoinduced phase over 40 fs via the Franck-Condon state, in which electrons and vibrations are coherently and strongly coupled. This new photoinduced phase is assigned to an insulator-like state in which the charge order differs from that of the initial state. In the photoinduced phase, translations of component molecules proceed before the rearrangements of intramolecular conformations. Subsequently, the charge order and structure gradually approach those of the high-temperature phase over 100 ps. This unusual two-step photoinduced phase transition presumably originates from steric effects due to the bent EDO-TTF as well as strong electron-lattice interactions.	[Onda, Ken] Tokyo Inst Technol, Interact Res Ctr Sci, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Onda, Ken] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Yamochi, Hideki] Kyoto Univ, Res Ctr Low Temp & Mat Sci, Sakyo Ku, Kyoto 6068501, Japan; [Koshihara, Shin-ya] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan; [Koshihara, Shin-ya] Japan Sci & Technol Agcy JST, CREST, Meguro Ku, Tokyo 1528551, Japan	Onda, K (reprint author), Tokyo Inst Technol, Interact Res Ctr Sci, Midori Ku, Yokohama, Kanagawa 2268502, Japan.	onda.k.aa@m.titecha.jp	Onda, Ken/H-3389-2014	Onda, Ken/0000-0003-1724-2009			Yamamoto T, 2005, J PHYS CHEM B, V109, P15226, DOI 10.1021/jp050247o; HAMM P, 1995, CHEM PHYS, V200, P415, DOI 10.1016/0301-0104(95)00262-6; Iwai S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.097402; Chollet M, 2005, SCIENCE, V307, P86, DOI 10.1126/science.1105067; Kawakami Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.246402; Ota A, 2002, J MATER CHEM, V12, P2600, DOI 10.1039/b206293c; POLLARD WT, 1992, J PHYS CHEM-US, V96, P6147, DOI 10.1021/j100194a013; Drozdova O, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.075107; Gahlmann A, 2008, PHYS CHEM CHEM PHYS, V10, P2894, DOI 10.1039/b802136h; Matsubara Y, 2012, ACTA PHYS POL A, V121, P340; Seo H, 2004, CHEM REV, V104, P5005, DOI 10.1021/cr030646k; Iwai S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.057402; Aidelsburger M, 2010, P NATL ACAD SCI USA, V107, P19714, DOI 10.1073/pnas.1010165107; Matsubara Y, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.124711; Gao M, 2013, NATURE, V496, P343, DOI 10.1038/nature12044; CRUZ CHB, 1988, IEEE J QUANTUM ELECT, V24, P261; van Oudheusden T, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.264801; Mori T, 1998, B CHEM SOC JPN, V71, P2509, DOI 10.1246/bcsj.71.2509; Gao M, 2012, OPT EXPRESS, V20, P12048, DOI 10.1364/OE.20.012048; Fukazawa N, 2013, J PHYS CHEM C, V117, P13187, DOI 10.1021/jp403193a; Yonemitsu K, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.075105; Uemura H, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.113714; KOSHIHARA S, 1990, PHYS REV B, V42, P6853, DOI 10.1103/PhysRevB.42.6853; Ishikawa T, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.115108; Aoyagi S, 2004, ANGEW CHEM INT EDIT, V43, P3670, DOI 10.1002/anie.200454075; Kobayashi T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.037402; Tanimura K, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.144112; Freyer B, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4800223; Saito G, 2007, B CHEM SOC JPN, V80, P1, DOI 10.1246/bcsj.80.1; Brooks JS, 2010, CHEM SOC REV, V39, P2667, DOI 10.1039/b913417b; Drozdova O, 2003, SYNTHETIC MET, V133, P277, DOI 10.1016/S0379-6779(02)00400-9; Fukazawa N, 2012, J PHYS CHEM C, V116, P5892, DOI 10.1021/jp210708q; Gonokami M., 2006, J PHYS SOC JPN, V75; Kagoshima S., 2006, J PHYS SOC JPN, V75; Kawakami K., 2009, PHYS REV LETT, V103; Matsubara Y, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.161102; Mori T, 1999, B CHEM SOC JPN, V72, P179; Nasu K, 2003, PHOTOINDUCED PHASE T; Okamato H., 2004, PHYS REV B, V70; Okamoto H, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.037405; Onda K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.067403; Onda K, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/22/224018; Ota A, 2003, SYNTHETIC MET, V133, P463, DOI 10.1016/S0379-6779(02)00295-3; Siwick BJ, 2005, OPT LETT, V30, P1057, DOI 10.1364/OL.30.001057; Uji S, 2009, SCI TECHNOL ADV MAT, V10, DOI 10.1088/1468-6996/10/2/020301; Yamamoto T, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.074717	46	2	2	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0001-4842	1520-4898		ACCOUNTS CHEM RES	Accounts Chem. Res.	DEC	2014	47	12					3494	3503		10.1021/ar500257b		10	Chemistry, Multidisciplinary	Chemistry	AX1BK	WOS:000346683200009		
J	Soai, K; Kawasaki, T; Matsumoto, A				Soai, Kenso; Kawasaki, Tsuneomi; Matsumoto, Arimasa			Asymmetric Autocatalysis of Pyrimidyl Alkanol and Its Application to the Study on the Origin of Homochirality	ACCOUNTS OF CHEMICAL RESEARCH			English	Review							HIGHLY ENANTIOSELECTIVE SYNTHESIS; CIRCULARLY-POLARIZED LIGHT; MIRROR-SYMMETRY BREAKING; ENANTIOMERIC EXCESS; SOAI REACTION; ORGANIC-COMPOUND; NUCLEOBASE CYTOSINE; CHIRAL MOLECULES; AMINO-ALCOHOLS; CRYSTAL WATER	Conspectus Amplification of enantiomeric excess (ee) is a key feature for the chemical evolution of biological homochirality from the origin of chirality. We describe the amplification of ee in the asymmetric autocatalysis of 5-pyrimidyl alkanols in the reaction between diisopropylzinc (i-Pr2Zn) and pyrimidine-5-carbaldehydes. During the reaction, an extremely low ee (ca. 0.00005% ee) can be amplified to >99.5% ee, and therefore, the initial slightly major enantiomer is automultiplied by a factor of ca. 630000, while the initial slightly minor enantiomer is automultiplied by a factor of less than 1000. In addition, pyrimidyl alkanols with various substituents at the 2-position of the pyrimidine ring, 3-quinolyl alkanol, 5-carbamoyl-3-pyridyl alkanol, and large multifunctionalized pyrimidyl alkanols also act as highly efficient asymmetric autocatalysts in the addition of i-Pr2Zn to the corresponding aldehydes. The asymmetric autocatalysis of pyrimidyl alkanol can discriminate the chirality of various compounds. Chiral substances such as alcohols, amino acids, hydrocarbons, metal complexes, and heterogeneous chiral materials can act as chiral triggers for asymmetric autocatalysis to afford pyrimidyl alkanols with the corresponding absolute configuration of the initiator. This recognition ability of chiral compounds is extremely high, and chiral discrimination of a cryptochiral quaternary saturated hydrocarbon was established by applying asymmetric autocatalysis. By using the large amplification effect of the asymmetric autocatalysis, we can link various proposed origins of chirality with highly enantioenriched organic compounds in conjunction with asymmetric autocatalysis. Thus, a statistical fluctuation in ee of racemic compounds can be amplified to high ee by using asymmetric autocatalysis. Enantiomeric imbalance induced by irradiation of circularly polarized light can affect the enantioselectivity of asymmetric autocatalysis. The asymmetric autocatalysis was also triggered by the morphology of inorganic chiral crystals such as quartz, sodium chlorate, and cinnabar. Chiral organic crystals of achiral compounds also act as chiral initiators, and during the study of a crystal of cytosine, enantioselective chiral crystal phase transformation of the cytosine crystal was achieved by removal of the water of crystallization in an achiral monohydrate crystal. Enantioselective C-C bond formation was realized on the surfaces of achiral single crystals based on the oriented prochirality of achiral aldehydes. Furthermore, asymmetric autocatalysis of pyrimidyl alkanols is a highly sensitive reaction that can recognize and amplify the significantly small effect of a chiral compound arising solely from isotope substitution of hydrogen, carbon, and oxygen (D/H, (CC)-C-13-C-12, and O-18/O-16). These examples show that asymmetric autocatalysis with an amplification of chirality is a powerful tool for correlating the origin of chirality with highly enantioenriched organic compounds. Asymmetric autocatalysis using two b-amino alcohols reveals a reversal of enantioselectivity in the addition of i-Pr2Zn to aldehyde and is one approach toward understanding the mechanism of asymmetric dialkylzinc addition, where heteroaggregates act as the catalytic species.	[Soai, Kenso; Matsumoto, Arimasa] Tokyo Univ Sci, Res Inst Sci & Technol, Dept Appl Chem, Shinjuku Ku, Tokyo 1628601, Japan; [Soai, Kenso; Kawasaki, Tsuneomi] Tokyo Univ Sci, Res Ctr Chiral, Dept Appl Chem, Shinjuku Ku, Tokyo 1628601, Japan; [Kawasaki, Tsuneomi] Univ Fukui, Dept Mat Sci & Engn, Bunkyo Ku, Fukui 9108507, Japan	Soai, K (reprint author), Tokyo Univ Sci, Res Inst Sci & Technol, Dept Appl Chem, Shinjuku Ku, Tokyo 1628601, Japan.	soai@rs.kagu.tus.ac.jp			Japan Society for the Promotion of Science (JSPS); MEXT	This work was supported by a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (JSPS) and MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2012-2016.	FRANK FC, 1953, BIOCHIM BIOPHYS ACTA, V11, P459, DOI 10.1016/0006-3002(53)90082-1; Saito Y, 2013, REV MOD PHYS, V85, P603, DOI 10.1103/RevModPhys.85.603; Bailey J, 1998, SCIENCE, V281, P672, DOI 10.1126/science.281.5377.672; Kuhn A, 2009, ANGEW CHEM INT EDIT, V48, P6857, DOI 10.1002/anie.200902841; Kawasaki T, 2009, SCIENCE, V324, P492, DOI 10.1126/science.1170322; Mislow K, 2003, COLLECT CZECH CHEM C, V68, P849, DOI 10.1135/cccc20030849; Ernst KH, 2012, PHYS STATUS SOLIDI B, V249, P2057, DOI 10.1002/pssb.201248188; Mineki H, 2013, TETRAHEDRON-ASYMMETR, V24, P1365, DOI 10.1016/j.tetasy.2013.09.020; Soai K, 2003, TETRAHEDRON-ASYMMETR, V14, P185, DOI 10.1016/S0957-4166(02)00791-7; Carter DJ, 2012, CRYST GROWTH DES, V12, P2138, DOI 10.1021/cg300207d; SOAI K, 1995, NATURE, V378, P767, DOI 10.1038/378767a0; Weissbuch I, 2011, CHEM REV, V111, P3236, DOI 10.1021/cr1002479; Quaranta M, 2010, J AM CHEM SOC, V132, P15104, DOI 10.1021/ja103204w; Soai K, 2000, ACCOUNTS CHEM RES, V33, P382, DOI 10.1021/ar9900820; Kawasaki T, 2006, J AM CHEM SOC, V128, P6032, DOI 10.1021/ja061429e; Crusats J, 2009, CHEMPHYSCHEM, V10, P2123, DOI 10.1002/cphc.200900181; Satyanarayana T, 2009, ANGEW CHEM INT EDIT, V48, P456, DOI 10.1002/anie.200705241; KITAMURA M, 1989, J AM CHEM SOC, V111, P4028, DOI 10.1021/ja00193a040; Noorduin WL, 2009, ANGEW CHEM INT EDIT, V48, P9600, DOI 10.1002/anie.200905215; INOUE Y, 1992, CHEM REV, V92, P741, DOI 10.1021/cr00013a001; Kawasaki T, 2011, ANGEW CHEM INT EDIT, V50, P6796, DOI 10.1002/anie.201102031; Soloshonok VA, 2007, J AM CHEM SOC, V129, P12112, DOI 10.1021/ja065603a; Sato I, 2001, ANGEW CHEM INT EDIT, V40, P1096, DOI 10.1002/1521-3773(20010316)40:6<1096::AID-ANIE10960>3.0.CO;2-K; Matsumoto A, 2013, ORG BIOMOL CHEM, V11, P2928, DOI 10.1039/c3ob40293b; Viedma C, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.065504; Barabas B, 2009, B CHEM SOC JPN, V82, P1372, DOI 10.1246/bcsj.82.1372; Barabas B, 2008, ORIGINS LIFE EVOL B, V38, P317, DOI 10.1007/s11084-008-9138-1; Blackmond DG, 2001, J AM CHEM SOC, V123, P10103, DOI 10.1021/ja0165133; CHENCHAIAH PC, 1986, J CHEM SOC PERK T 2, P1775, DOI 10.1039/p29860001775; Cordova A, 2005, CHEM COMMUN, P2047, DOI 10.1039/b5000589b; Doka E, 2011, J AM CHEM SOC, V133, P17878, DOI 10.1021/ja207408y; Ercolani G, 2011, J ORG CHEM, V76, P2619, DOI 10.1021/jo102525t; Feringa B. L., 1999, ANGEW CHEM INT EDIT, V38, P3418, DOI 10.1002/(SICI)1521-3773(19991203)38:23<3418::AID-ANIE3418>3.0.CO;2-V; Gehring T, 2012, ANGEW CHEM INT EDIT, V51, P9539, DOI 10.1002/anie.201203398; Green M. M., 1999, Angewandte Chemie (International Edition), V38, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3138::AID-ANIE3138>3.0.CO;2-C; Green MM, 2010, ORIGINS LIFE EVOL B, V40, P111, DOI 10.1007/s11084-009-9180-7; Gridnev ID, 2012, ACS CATAL, V2, P2137, DOI 10.1021/cs300497h; Guijarro A, 2009, ORIGIN CHIRALITY MOL; Hayashi Y, 2006, ANGEW CHEM INT EDIT, V45, P4593, DOI 10.1002/anie.200601506; Hazen RM, 2003, NAT MATER, V2, P367, DOI 10.1038/nmat879; Hitosugi S, 2014, ORG LETT, V16, P645, DOI 10.1021/ol403384q; Islas JR, 2005, P NATL ACAD SCI USA, V102, P13743, DOI 10.1073/pnas.0503171102; Katagiri T, 1996, CHEM LETT, P115, DOI 10.1246/cl.1996.115; Kawasaki T, 2009, ORG BIOMOL CHEM, V7, P1073, DOI 10.1039/b823282b; Kawasaki T, 2005, J AM CHEM SOC, V127, P3274, DOI 10.1021/ja0422108; Kawasaki T, 2011, ANGEW CHEM INT EDIT, V50, P8131, DOI 10.1002/anie.201102263; Kawasaki T, 2005, ANGEW CHEM INT EDIT, V44, P2774, DOI 10.1002/anie.200462963; Kawasaki T, 2008, ANGEW CHEM INT EDIT, V47, P496, DOI 10.1002/anie.200703634; Kawasaki T, 2010, J AM CHEM SOC, V132, P2874, DOI 10.1021/ja1000938; Kawasaki T, 2009, CHEM COMMUN, P5621, DOI 10.1039/b912813a; Kawasaki T, 2006, CHIRALITY, V18, P479, DOI 10.1002/chir.20273; Kawasaki T, 2014, ANGEW CHEM INT EDIT, V53, P11199, DOI 10.1002/anie.201405441; Kawasaki T, 2009, CHEM COMMUN, P4396, DOI 10.1039/b908754k; Kawasaki T, 2011, CHEM COMMUN, V47, P5277, DOI 10.1039/c1cc10136f; Kawasaki T, 2006, CHEM COMMUN, P1869, DOI 10.1039/b602442d; Lutz F, 2005, J AM CHEM SOC, V127, P12206, DOI 10.1021/ja054323c; Lutz F, 2008, J AM CHEM SOC, V130, P2956, DOI 10.1021/ja077156k; Lutz F, 2006, TETRAHEDRON-ASYMMETR, V17, P486, DOI 10.1016/j.tetasy.2006.01.022; Lutz F, 2004, ORG LETT, V6, P1613, DOI 10.1021/ol049559k; Micheau JC, 2010, CHEMPHYSCHEM, V11, P3417, DOI 10.1002/cphc.201000526; Micheau JC, 2012, PHYS CHEM CHEM PHYS, V14, P13239, DOI 10.1039/c2cp42041d; Micskei K, 2008, J PHYS CHEM B, V112, P9196, DOI 10.1021/jp803334b; Mineki H, 2012, CHEM COMMUN, V48, P10538, DOI 10.1039/c2cc34928k; Palyi G., 2008, ORGANOMETALLIC CHIRA; Sato I, 2003, TETRAHEDRON-ASYMMETR, V14, P975, DOI 10.1016/S0957-4166(03)00164-2; Sato I, 2004, ANGEW CHEM INT EDIT, V43, P4490, DOI 10.1002/anie.200454162; Sato I, 2003, ANGEW CHEM INT EDIT, V42, P315, DOI 10.1002/anie.200390105; Sato I, 2007, J ORGANOMET CHEM, V692, P1783, DOI 10.1016/j.jorganchem.2006.11.042; Sato I, 2001, TETRAHEDRON-ASYMMETR, V12, P1965, DOI 10.1016/S0957-4166(01)00351-2; Sato I, 2002, CHIRALITY, V14, P166, DOI 10.1002/chir.10068; Sato I, 2000, ANGEW CHEM INT EDIT, V39, P1510, DOI 10.1002/(SICI)1521-3773(20000417)39:8<1510::AID-ANIE1510>3.0.CO;2-R; Sato I, 2003, TETRAHEDRON LETT, V44, P721, DOI 10.1016/S0040-4039(02)02707-7; Sato I, 2000, J AM CHEM SOC, V122, P11739, DOI 10.1021/ja002992e; Schiaffino L, 2009, CHEMPHYSCHEM, V10, P2508, DOI 10.1002/cphc.200900369; Schiaffino L, 2008, ANGEW CHEM INT EDIT, V47, P6832, DOI 10.1002/anie.200802450; Shibata T, 1996, J AM CHEM SOC, V118, P471, DOI 10.1021/ja953066g; Shibata T, 1996, CHEM COMMUN, P1235, DOI 10.1039/cc9960001235; Shibata T, 1999, ANGEW CHEM INT EDIT, V38, P659, DOI 10.1002/(SICI)1521-3773(19990301)38:5<659::AID-ANIE659>3.0.CO;2-P; Shibata T, 2007, TETRAHEDRON-ASYMMETR, V18, P1759, DOI 10.1016/j.tetasy.2007.07.030; Shibata T, 1998, J AM CHEM SOC, V120, P12157, DOI 10.1021/ja980815w; Shindo H, 2013, ANGEW CHEM INT EDIT, V52, P9135, DOI 10.1002/anie.201304284; SOAI K, 1990, J CHEM SOC CHEM COMM, P982, DOI 10.1039/c39900000982; Soai K., 1996, Jpn. Kokai Tokkyo Koho JP, Patent No. [19960121140, 19960418]; Soai K, 1999, J AM CHEM SOC, V121, P11235, DOI 10.1021/ja993128t; Soai K, 2014, CHEM REC, V14, P70, DOI 10.1002/tcr.201300028; Soai K., 2012, SOAI REACTION RELATE, P9; Tanji S, 2000, TETRAHEDRON-ASYMMETR, V11, P4249, DOI 10.1016/S0957-4166(00)00420-1; Weissbuch I, 2011, ISR J CHEM, V51, P1017, DOI 10.1002/ijch.201100066; Weissbuch I., 2011, ACCOUNTS CHEM RES, V42, P1128	89	6	6	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0001-4842	1520-4898		ACCOUNTS CHEM RES	Accounts Chem. Res.	DEC	2014	47	12					3643	3654		10.1021/ar5003208		12	Chemistry, Multidisciplinary	Chemistry	AX1BK	WOS:000346683200024		
J	Izawa, KP; Watanabe, S; Oka, K; Osada, N; Omiya, K; Brubaker, PH; Shimizu, H				Izawa, Kazuhiro P.; Watanabe, Satoshi; Oka, Koichiro; Osada, Naohiko; Omiya, Kazuto; Brubaker, Peter H.; Shimizu, Hiroyuki			Differences in daily in-hospital physical activity and geriatric nutritional risk index in older cardiac inpatients: preliminary results	AGING CLINICAL AND EXPERIMENTAL RESEARCH			English	Article						Geriatric nutritional risk index; Hospitalized physical activity; Older cardiac inpatients	CHRONIC HEART-FAILURE; SCREENING TOOLS; MEASURING STEPS; MORTALITY; MAINTENANCE; PROGNOSIS; REHABILITATION; PEDOMETERS; SURGERY; TARGET	Background Little is known about the differences in the geriatric nutritional risk index (GNRI) status in older patients and their relationship to accelerometer-derived measures of physical activity (PA) levels. We determined both differences in daily measured PA based on the GNRI and related cut-off values for PA in elderly cardiac inpatients. Methods We divided 235 consecutive elderly cardiac inpatients (mean age 73.6 years, men 70.6 %) into four groups by age and GNRI: older-high group, 65-74 years with high GNRI (>= 92 points) (n = 111); older-low group, low GNRI (< 92 points) (n = 30); very old-high group, >= 75 years with high GNRI (n = 55); and very old-low group with low GNRI (n = 39). Average step count and physical activity energy expenditure (PAEE in kcal) per day for 2 days of these inpatients were assessed by accelerometer and compared between the four groups to determine cut-off values of PA. Results Step counts and PAEE were significantly lower in the low-GNRI versus high-GNRI groups in the older (2,742.1 vs. 4,198.1 steps, 55.4 vs. 101.3 kcal, P < 0.001), and very old (2,469.6 vs. 3,423.7 steps, 54.5 vs. 79.1 kcal, P < 0.001) cardiac inpatients. Respective cut-off values for step counts and PAEE were 3,017.6 steps/day and 69.4 kcal (P < 0.01) in the older and 2,579.4 steps/day and 58.8 kcal in the very old cardiac inpatients (P < 0.01). Conclusion Poor nutritional status, as indicated by a low GNRI, may be a useful predictor of step counts and PAEE. The cut-off values determined in this study might be target values to be attained by older cardiac inpatients.	[Izawa, Kazuhiro P.] Kobe Univ, Grad Sch Hlth Sci, Kobe, Hyogo 6540142, Japan; [Watanabe, Satoshi] St Marianna Univ, Sch Med, Dept Rehabil Med, Kawasaki, Kanagawa, Japan; [Oka, Koichiro] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Osada, Naohiko; Omiya, Kazuto] St Marianna Univ, Sch Med, Dept Internal Med, Div Cardiol, Kawasaki, Kanagawa, Japan; [Brubaker, Peter H.] Wake Forest Univ, Dept Hlth & Exercise Sci, Winston Salem, NC 27109 USA; [Shimizu, Hiroyuki] St Marianna Univ, Sch Med, Dept Orthoped Surg, Kawasaki, Kanagawa, Japan	Izawa, KP (reprint author), Kobe Univ, Grad Sch Hlth Sci, 10-2 Tomogaoka 7 Chome Suma, Kobe, Hyogo 6540142, Japan.	izawapk@ga2.so-net.ne.jp			Japanese Association for the Promotion of Rehabilitation (Tokyo, Japan)	This study was supported in part by a Grant-inAid for Scientific Research from the Japanese Association for the Promotion of Rehabilitation (Tokyo, Japan).	Ayabe M, 2008, CIRC J, V72, P299, DOI 10.1253/circj.72.299; Bock BC, 2001, ANN BEHAV MED, V23, P79, DOI 10.1207/S15324796ABM2302_2; Menezes AR, 2012, J GERIATR CARDIOL, V9, P68, DOI 10.3724/SP.J.1263.2012.00068; Schneider PL, 2003, MED SCI SPORT EXER, V35, P1779, DOI 10.1249/01.MSS.0000089342.96098.C4; Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033; Lomivorotov VV, 2013, NUTRITION, V29, P436, DOI 10.1016/j.nut.2012.08.006; Walsh JT, 1997, AM J CARDIOL, V79, P1364, DOI 10.1016/S0002-9149(97)00141-0; Cereda E, 2006, J AM GERIATR SOC, V54, P1011, DOI 10.1111/j.1532-5415.2006.00754.x; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777; Kinugasa Y, 2013, CIRC J, V77, P705, DOI 10.1253/circj.CJ-12-1091; Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8; Crouter SE, 2003, MED SCI SPORT EXER, V35, P1455, DOI 10.1249/01.MSS.0000078932.61440.A2; Izawa KP, 2004, AM J PHYS MED REHAB, V83, P884, DOI 10.1097/01.PHM.0000143404.59050.11; Yamada K, 2008, AM J CLIN NUTR, V87, P106; Cereda E, 2007, CLIN NUTR, V26, P78, DOI 10.1016/j.clnu.2006.09.007; Chan M, 2012, J RENAL NUTR, V22, P547, DOI 10.1053/j.jrn.2011.11.002; Izawa KP, 2013, AM J CARDIOL, V111, P1767, DOI 10.1016/j.amjcard.2013.02.034; Izawa KP, 2012, DISABIL REHABIL, V34, P2018, DOI 10.3109/09638288.2012.667502; Jimenez FJJ, 2011, NUTR HOSP, V26, P76, DOI 10.1590/S0212-16112011000800017; Matos AC, 2012, NUTR HOSP, V27, P1981, DOI 10.3305/nh.2012.27.6.5891; Nery RM, 2010, REV BRAS CIR CARDIOV, V25, P73, DOI 10.1590/S0102-76382010000100016; Oishi Daisuke, 2012, Adv Perit Dial, V28, P148; Tsuchihashi M, 2000, JPN CIRC J, V64, P953, DOI 10.1253/jcj.64.953; Tsuchihashi-Makaya M, 2013, CIRC J, V77, P604, DOI 10.1253/circj.CJ-13-0028	25	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1594-0667	1720-8319		AGING CLIN EXP RES	Aging Clin. Exp. Res.	DEC	2014	26	6					599	605		10.1007/s40520-014-0233-z		7	Geriatrics & Gerontology	Geriatrics & Gerontology	AX2YZ	WOS:000346809400005		
J	Ito, Y; Sakata-Sogawa, K; Tokunaga, M				Ito, Yuma; Sakata-Sogawa, Kumiko; Tokunaga, Makio			A Facile Preparation of Glass-supported Lipid Bilayers for Analyzing Molecular Dynamics	ANALYTICAL SCIENCES			English	Article						Lipid bilayer; biotin-avidin; dynamics; molecular imaging; single molecule tracking	T-CELL-ACTIVATION; PLANAR MEMBRANES; ANTIGEN	Many research programs focus on the molecular dynamics of living cells. This research requires cells to be adhered to a substrate while retaining the innate motility of their surface molecules. Lipid bilayer-based systems fulfill this requirement, although current methods are complicated and their utility is limited. We developed a simple and rapid method for reproducible preparation of homogeneous glass-supported lipid bilayers. Our method provides a facile means for bioimaging and analysis of molecular dynamics in living cells.	[Ito, Yuma; Sakata-Sogawa, Kumiko; Tokunaga, Makio] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Ito, Yuma; Sakata-Sogawa, Kumiko; Tokunaga, Makio] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa 2300045, Japan	Sakata-Sogawa, K (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	mtoku@bio.titech.ac.jp					BRIAN AA, 1984, P NATL ACAD SCI-BIOL, V81, P6159, DOI 10.1073/pnas.81.19.6159; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Balagopalan L, 2011, NAT REV IMMUNOL, V11, P21, DOI 10.1038/nri2903; Crane JM, 2004, BIOPHYS J, V86, P2965, DOI 10.1016/S0006-3495(04)74347-7; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Spiller DG, 2010, NATURE, V465, P736, DOI 10.1038/nature09232; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Khan MS, 2013, INT J MOL SCI, V14, P21561, DOI 10.3390/ijms141121561; MCCONNELL HM, 1986, BIOCHIM BIOPHYS ACTA, V864, P95, DOI 10.1016/0304-4157(86)90016-X; Bunnell SC, 2002, J CELL BIOL, V158, P1263, DOI 10.1083/jcb.200203043; BALAKRISHNAN K, 1982, J BIOL CHEM, V257, P6427; HAFEMAN DG, 1981, P NATL ACAD SCI-BIOL, V78, P4552, DOI 10.1073/pnas.78.7.4552; Hsu CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032398; Ma ZY, 2011, MICROSC RES TECHNIQ, V74, P1174, DOI 10.1002/jemt.21012; Manza BN, 2011, P NATL ACAD SCI USA, V108, P9089, DOI 10.1073/pnas.1018771108; TAMM LK, 1985, BIOPHYS J, V47, P105	17	1	1	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	DEC	2014	30	12					1103	1106				4	Chemistry, Analytical	Chemistry	AX4GQ	WOS:000346892000001		
J	Kuroda, A; Ishigaki, Y; Nilsson, M; Sato, K; Sato, K				Kuroda, Arisa; Ishigaki, Yuri; Nilsson, Mats; Sato, Kiichi; Sato, Kae			Microfluidics-based in situ Padlock/Rolling Circle Amplification System for Counting Single DNA Molecules in a Cell	ANALYTICAL SCIENCES			English	Article						Padlock probe; rolling circle amplification; microfluidics; DNA analysis	PADLOCK PROBES; RNA-ANALYSIS; HYBRIDIZATION; CHIP; FISH; DEVICE; ASSAYS	In situ padlock/rolling circle amplification (RCA) is a method used to amplify, visualize, and quantify target DNA molecules in cells. However, the multiple reaction steps involved make this technique costly and cumbersome. We developed a novel, simplified, automated microfluidic system for RCA, and demonstrated its effectiveness by counting amplified mitochondria' DNA fragments in HeLa cells. After optimizing the volume of the reaction solutions and washing buffer composition, the product yield was equal to that obtained by the conventional manual method. The required volume of reagents was reduced to 10 mu L, which is less than half the volume used in the conventional method. To the best of our knowledge, this is the first report of an automated microfluidic method for in situ padlock/RCA, which can be useful for making highly efficient pathological diagnoses.	[Kuroda, Arisa; Ishigaki, Yuri; Sato, Kae] Japan Womens Univ, Fac Sci, Dept Chem & Biol Sci, Bunkyo Ku, Tokyo 1128681, Japan; [Nilsson, Mats] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, SE-17121 Solna, Sweden; [Sato, Kiichi] Gunma Univ, Sch Sci & Technol, Div Mol Sci, Kiryu, Gumma 3768515, Japan	Sato, K (reprint author), Japan Womens Univ, Fac Sci, Dept Chem & Biol Sci, Bunkyo Ku, Tokyo 1128681, Japan.	satouk@fc.jwu.ac.jp	Sato, Kae/J-4592-2015	Sato, Kae/0000-0002-1618-2086	NEDO; JSPS; Core Research for Evolutional Science and Technology (CREST) Program; Swedish Research Council; JST; VINNOVA; SSF	The authors thank Mr. Toshinori Ohashi and Mr. Hidekatsu. Tazawa (Institute of Microchemical Technology Co., Ltd.) for helpful discussions. This work was partially supported by the NEDO Industrial Technology Research Assistance Project, the JSPS Core-to-Core Program, and the Core Research for Evolutional Science and Technology (CREST) Program, the Swedish Research Council, and the joint JST, VINNOVA and SSF grant Multidisciplinary Bio.	Grundberg I, 2013, ONCOTARGET, V4, P2407; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Larsson C, 2004, NAT METHODS, V1, P227, DOI 10.1038/NMETH723; Larsson C, 2010, NAT METHODS, V7, P395, DOI [10.1038/nmeth.1448, 10.1038/NMETH.1448]; PARDUE ML, 1969, P NATL ACAD SCI USA, V64, P600, DOI 10.1073/pnas.64.2.600; Mahmoudian L, 2008, ANAL CHEM, V80, P2483, DOI 10.1021/ac702289j; Sato K, 2010, LAB CHIP, V10, P1262, DOI 10.1039/b927460j; Tanaka Y, 2011, ANAL CHEM, V83, P3352, DOI 10.1021/ac103185j; Soe MJ, 2011, LAB CHIP, V11, P3896, DOI 10.1039/c1lc20748b; BAUMAN JGJ, 1980, EXP CELL RES, V128, P485, DOI 10.1016/0014-4827(80)90087-7; Sieben VJ, 2007, IET NANOBIOTECHNOL, V1, P27, DOI 10.1049/iet-nbt:20060021; Vedarethinam I, 2010, SENSORS-BASEL, V10, P9831, DOI 10.3390/s101109831; Sieben VJ, 2008, LAB CHIP, V8, P2151, DOI 10.1039/b812443d; Nilsson M, 2006, HISTOCHEM CELL BIOL, V126, P159, DOI 10.1007/s00418-006-0213-2; Ohashi T, 2009, LAB CHIP, V9, P991, DOI 10.1039/b815475a; Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563; Biswas G, 2014, APPL MICROBIOL BIOT, V98, P2881, DOI 10.1007/s00253-014-5531-z; Ceulemans S, 2012, METHODS MOL BIOL, V838, P311, DOI 10.1007/978-1-61779-507-7_15; Devadhasan JP, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-33; Henriksson S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-37; Jang K, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.4771968; NILSSON M, 1994, SCIENCE, V265, P2085, DOI 10.1126/science.7522346; Sasaki N, 2012, ELECTROPHORESIS, V33, P1729, DOI 10.1002/elps.201100691; Szemes M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni069; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI [10.1586/epr.10.10, 10.1586/EPR.10.10]	25	2	2	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	DEC	2014	30	12					1107	1112				6	Chemistry, Analytical	Chemistry	AX4GQ	WOS:000346892000002		
J	Imasaka, T; Imasaka, T				Imasaka, Tomoko; Imasaka, Totaro			An Evaluation of the Spectral Properties of Nerve Agents for Laser Ionization Mass Spectrometry	ANALYTICAL SCIENCES			English	Article						Multiphoton ionization mass spectrometry; ionization energy; absorption spectrum; nerve agent; density functional theory	ALKYL METHYLPHOSPHONIC ACIDS; BIOLOGICAL SAMPLES; HUMAN URINE; FLUE-GASES; BASIS-SETS; METABOLITES; DENSITY; INCINERATION; PRODUCTS; IDENTIFICATION	Excitation energies, oscillator strengths, and vacuum-ultraviolet/deep-ultraviolet absorption spectra were calculated for nerve agents, such as sarin, soman, VX, tabun, mustard gas, and analogs. We used time-dependent density functional theory (TD-DFT) methods that included B3LYP combined with basis sets of cc-pVDZ and cc-pVTZ, and omega B97XD with cc-pVTZ. The vertical ionization energies were also calculated for these compounds, in order to collect additional information relative to the optimal pathways for multiphoton ionization in mass spectrometry.	[Imasaka, Tomoko] Kyushu Univ, Grad Sch Design, Chem Lab, Minami Ku, Fukuoka 8158540, Japan; [Imasaka, Totaro] Kyushu Univ, Grad Sch Engn, Dept Appl Chem, Nishi Ku, Fukuoka 8190395, Japan; [Imasaka, Totaro] Kyushu Univ, Ctr Future Chem, Div Optoelect & Photon, Nishi Ku, Fukuoka 8190395, Japan	Imasaka, T (reprint author), Kyushu Univ, Grad Sch Design, Chem Lab, Minami Ku, 4-9-1 Shiobaru, Fukuoka 8158540, Japan.	imasaka@design.kyushu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [23245017, 24510227, 26220806]	This research was supported by a Grant-in-Aid from the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Nos. 23245017, 24510227, and 26220806. The quantum chemical calculations were mainly carried out using the computer facilities at the Research Institute for Information Technology, Kyushu University.	Heger HJ, 1999, ANAL CHEM, V71, P46, DOI 10.1021/ac980611y; Li A, 2011, ANAL CHIM ACTA, V701, P52, DOI 10.1016/j.aca.2011.06.003; KENDALL RA, 1992, J CHEM PHYS, V96, P6796, DOI 10.1063/1.462569; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bauernschmitt R, 1996, CHEM PHYS LETT, V256, P454, DOI 10.1016/0009-2614(96)00440-X; Kim K, 2011, CHEM REV, V111, P5345, DOI 10.1021/cr100193y; Smith JN, 2011, RAPID COMMUN MASS SP, V25, P1437, DOI 10.1002/rcm.5018; [Anonymous], 2009, GAUSSIAN 09 REVISION; Chai JD, 2008, PHYS CHEM CHEM PHYS, V10, P6615, DOI 10.1039/b810189b; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Zimmermann R, 1997, RAPID COMMUN MASS SP, V11, P1095, DOI 10.1002/(SICI)1097-0231(19970630)11:10<1095::AID-RCM960>3.0.CO;2-Q; Shitamichi O, 2011, ANAL METHODS-UK, V3, P2322, DOI 10.1039/c1ay05355h; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Black RM, 2013, ARCH TOXICOL, V87, P421, DOI 10.1007/s00204-012-1005-1; Black RM, 2005, CHEMICAL WEAPONS CONVENTION CHEMICALS ANALYSIS: SAMPLE COLLECTION, PREPARATION AND ANALYTICAL METHODS, P403; Blumenstock M, 2001, CHEMOSPHERE, V42, P507, DOI 10.1016/S0045-6535(00)00223-X; Capacio B. R., 2008, Chemical warfare agents: chemistry, pharmacology, toxicology and therapeutics, P501; Ciner FL, 2007, J CHROMATOGR B, V846, P42, DOI 10.1016/j.jchromb.2006.08.008; Dennington II R., 2009, GAUSS VIEW VERSION 5; FREDRIKSSON SA, 1995, J MASS SPECTROM, V30, P1133, DOI 10.1002/jms.1190300810; Jokanovic M, 2009, TOXICOL LETT, V188, P1, DOI 10.1016/j.toxlet.2009.03.017; Kanamori-Kataoka M, 2008, J HEALTH SCI, V54, P513, DOI 10.1248/jhs.54.513; Mawhinney DB, 2007, J CHROMATOGR B, V852, P235, DOI 10.1016/j.jchromb.2007.01.023; Midey AJ, 2009, J PHYS CHEM A, V113, P4982, DOI 10.1021/jp900614a; Minami M, 1997, J CHROMATOGR B, V695, P237, DOI 10.1016/S0378-4347(97)00203-X; Oser H, 1998, CHEMOSPHERE, V37, P2361, DOI 10.1016/S0045-6535(98)00292-6; Reddy MK, 2013, RAPID COMMUN MASS SP, V27, P1128, DOI 10.1002/rcm.6541; Riches J, 2005, J CHROMATOGR B, V816, P251, DOI 10.1016/j.jchromb.2004.11.039; SHIH ML, 1991, BIOL MASS SPECTROM, V20, P717, DOI 10.1002/bms.1200201111; Shu YR, 2006, ANAL CHEM, V78, P4697, DOI 10.1021/ac060007k; Uchimura T, 2003, APPL SPECTROSC, V57, P461, DOI 10.1366/00037020360626014; Watanabe-Ezoe Y, 2010, ANAL CHEM, V82, P6519, DOI 10.1021/ac1009063; WILKERSON CW, 1990, ANAL CHEM, V62, P1804, DOI 10.1021/ac00216a015; Zydel F, 2012, DRUG TEST ANAL, V4, P308, DOI 10.1002/dta.1331	34	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	DEC	2014	30	12					1113	1120				8	Chemistry, Analytical	Chemistry	AX4GQ	WOS:000346892000003		
J	Okamura, K; Kimoto, H; Noguchi, T; Hatta, M; Kawakami, H; Suzue, T				Okamura, Kei; Kimoto, Hideshi; Noguchi, Takuroh; Hatta, Mayumi; Kawakami, Hiroaki; Suzue, Takahiko			Colorimetric pH Measurement for Seawater Samples Using a Three Light-Emitting Diodes Detector and a Calibration Method for Temperature Dependence	ANALYTICAL SCIENCES			English	Article						Seawater; pH; colorimetric measurement; LED detector	ION CONCENTRATION SCALE; SEA-WATER; ANTHROPOGENIC CO2; CRESOL PURPLE; SYSTEM; RED; INDICATORS; PRECISION; BUFFERS; OCEANS	A colorimetric pH measurement of seawater samples using a light source comprising a three light-emitting diodes (TLED) detector and meta-cresol purple (mCP) as an indicator was investigated. The molar absorption ratios (e(1), e(2), and e(3)/e(2)) for mCP using the TLED detector at 25 degrees C were determined to be 0, 1.9994, and 0.1010, respectively. Next, the pH values of 2-amino-2-hydroxymethyl-1,3-propanediol (TRIS) and 2-aminopyride (AMP) seawater buffers were determined. Notably, the raw pH of TRIS buffer (similar to 8.1) agreed with the reference value, while that for the AMP buffer (similar to 6.8) had an error of +0.004 due to the small absorption ratio (R) and being out of the lower adequate pH range (>7.2) for mCP. pHT measurements obtained for seawater samples using the present colorimetric method agreed with those obtained using a glass electrode. These results demonstrate that this low-cost TLED detection system with a short cell length, 5 cm, can be used for seawater pHT analysis.	[Okamura, Kei; Noguchi, Takuroh; Hatta, Mayumi] Kochi Univ, Ctr Adv Marine Core Res, Nanko Ku, Kochi 7838502, Japan; [Kimoto, Hideshi; Suzue, Takahiko] Kimoto Elect Co Ltd, Tennoji Ku, Osaka 5430024, Japan; [Kawakami, Hiroaki] Kochi Univ, Grad Sch Integrated Arts & Sci, Kochi 7808520, Japan	Okamura, K (reprint author), Kochi Univ, Ctr Adv Marine Core Res, Nanko Ku, B200 Monobe, Kochi 7838502, Japan.	okamurak@kochi-u.ac.jp	OKAMURA, Kei/C-7817-2011	OKAMURA, Kei/0000-0002-7796-4284	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This study was supported by a grant from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan for the "Development of new tools for the exploration of seafloor resources" project. We acknowledge the officers and crew of R/V Hakuho Maru (JAMSTEC) and chief scientist K. Iizasa (The University of Tokyo) for their support during the KH-11-05 cruise. This manuscript was improved by constructive comments from two anonymous reviewers.	DICKSON AG, 1993, DEEP-SEA RES PT I, V40, P107, DOI 10.1016/0967-0637(93)90055-8; Millero FJ, 2007, CHEM REV, V107, P308, DOI 10.1021/cr0503557; MILLERO FJ, 1995, GEOCHIM COSMOCHIM AC, V59, P661, DOI 10.1016/0016-7037(94)00354-O; Yao WS, 2007, MAR CHEM, V107, P167, DOI 10.1016/j.marchem.2007.06.012; Gattuso JP, 1999, P NATL ACAD SCI USA, V96, P13017, DOI 10.1073/pnas.96.23.13017; McElligott S, 1998, MAR CHEM, V60, P63, DOI 10.1016/S0304-4203(97)00080-7; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Patsavas MC, 2013, MAR CHEM, V155, P158, DOI 10.1016/j.marchem.2013.06.007; Liu XW, 2011, ENVIRON SCI TECHNOL, V45, P4862, DOI 10.1021/es200665d; Friis K, 2004, LIMNOL OCEANOGR-METH, V2, P126; Michaelidis B, 2005, MAR ECOL PROG SER, V293, P109, DOI 10.3354/meps293109; Bate C. F., 1976, HYDROLYSIS CATIONS; BYRNE RH, 1989, DEEP-SEA RES, V36, P803, DOI 10.1016/0198-0149(89)90152-0; CLAYTON TD, 1993, DEEP-SEA RES PT I, V40, P2115, DOI 10.1016/0967-0637(93)90048-8; CLAYTON TD, 1995, DEEP-SEA RES PT II, V42, P411, DOI 10.1016/0967-0645(95)00028-O; Dickson A.G., 2007, PICES SPECIAL PUBLIC, V3; DICKSON AG, 1984, GEOCHIM COSMOCHIM AC, V48, P2299, DOI 10.1016/0016-7037(84)90225-4; HANSSON I, 1973, DEEP-SEA RES, V20, P479, DOI 10.1016/0011-7471(73)90101-0; KING DW, 1990, APPL SPECTROSC, V44, P722, DOI 10.1366/0003702904087578; Lau KT, 2006, ANAL CHIM ACTA, V569, P221, DOI 10.1016/j.aca.2006.03.073; Okamura K, 2014, GEOCHEM J, V48, P153, DOI 10.2343/geochemj.2.0296; Peng TH, 2003, DEEP-SEA RES PT II, V50, P3065, DOI 10.1016/j.dsr2.2003.09 001; ROBERTBALDO GL, 1985, ANAL CHEM, V57, P2564, DOI 10.1021/ac00290a030	23	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	DEC	2014	30	12					1135	1141				7	Chemistry, Analytical	Chemistry	AX4GQ	WOS:000346892000006		
J	Kojima, I; Kakita, K				Kojima, Isao; Kakita, Kazutoshi			Comparative Study of Robustness of Statistical Methods for Laboratory Proficiency Testing	ANALYTICAL SCIENCES			English	Article						Robustness; proficiency testing; Monte Carlo approach; median-nIQR; Algorithm A; Q-method		A Monte Carlo approach has been applied to investigate the statistical properties of data analysis methods for proficiency testing, namely, the median-nIQR, Q-method, Algorithm A and Classical method. Simulations were carried out by using a population consisting of two normal distributions, a main population without bias and a sub-population with bias. The difference for robustness among the methods has been discussed. An actual PT for a dioxin isomer was well interpreted by using the population model employed in this study.	[Kojima, Isao] Japan Accreditat Board, Shinagawa Ku, Tokyo 1410022, Japan; [Kakita, Kazutoshi] Nippon Steel & Sumikin Technol Co Ltd, Takatsu Ku, Kawasaki, Kanagawa 2130012, Japan	Kojima, I (reprint author), Japan Accreditat Board, Shinagawa Ku, 1-22-1 Higashi Gotanda, Tokyo 1410022, Japan.	Isao.Kojima@jab.or.jp					[Anonymous], 1995, GUID EXPR UNC MEAS G; [Anonymous], ISODIS213528; [Anonymous], 17043 ISOIEC; [Anonymous], 17025 ISOIEC; [Anonymous], 2010, 12 PROF TEST DIOX AN; Jaroslava S., 2009, ACCREDIT QUAL ASSUR, V14, P467; Pedro R., 2008, ACCREDIT QUAL ASSUR, V13, P493	7	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	DEC	2014	30	12					1165	1168				4	Chemistry, Analytical	Chemistry	AX4GQ	WOS:000346892000010		
J	Inoshima, Y; Ishiguro, N				Inoshima, Yasuo; Ishiguro, Naotaka			On-site Visual Diagnosis of Parapoxvirus Infection Using a Portable Cordless Incubator	ANALYTICAL SCIENCES			English	Article						Cordless; LAMP; on-site visual diagnosis; parapoxvirus infection; portable; zoonosis	MEDIATED ISOTHERMAL AMPLIFICATION; SEROWS CAPRICORNIS-CRISPUS; POCKET-WARMER; ORF VIRUS; DNA; ACCURATE; DISEASES; LESIONS; MOBILE; SHEEP	A portable cordless incubator was developed for on-site visual diagnosis of parapoxvirus infection on farms and in areas with no electricity or laboratory equipment. The battery-powered thermoregulator can maintain a stable temperature for more than 1 h. The incubator successfully amplified parapoxvirus DNA isolated from sheep and wild Japanese serows (Capricornis crispus) by loop-mediated isothermal amplification (LAMP). Although different absorbance values were obtained for the LAMP reactions performed using the same sample on the incubator and the turbidimeter, visual assessments of whether the results were positive or negative were the same irrespective of the platform used to perform the LAMP reaction. Consequently, using the portable cordless incubator in conjunction with the LAMP assay is considered to be a powerful tool for on-site visual diagnosis of parapoxvirus infection on farms with no electricity.	[Inoshima, Yasuo; Ishiguro, Naotaka] Gifu Univ, Cooperat Dept Vet Med, Lab Food & Environm Hyg, Gifu 5011193, Japan	Inoshima, Y (reprint author), Gifu Univ, Cooperat Dept Vet Med, Lab Food & Environm Hyg, 1-1 Yanagido, Gifu 5011193, Japan.	inoshima@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Koshiyama Research Grant, Japan	We thank Mr. K. Yoshimura (Cosoc Electronics, Nagoya, Japan) for his cooperation with manufacturing the portable cordless incubator. We also thank Dr. K. Murakami (Iwate University, Morioka, Japan) and Dr. H. Sentsui (Nihon University, Fujisawa, Japan) for providing FBM and FLL cells, respectively. This study was partly supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. This study was also supported in part by the Koshiyama Research Grant, Japan.	Clark C, 2005, BRIT J DERMATOL, V152, P791, DOI 10.1111/j.1365-2133.2005.06451.x; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Tsai SM, 2009, J VIROL METHODS, V157, P200, DOI 10.1016/j.jviromet.2009.01.003; Mori Y, 2001, BIOCHEM BIOPH RES CO, V289, P150, DOI 10.1006/bbrc.2001.5921; SUZUKI T, 1993, J WILDLIFE DIS, V29, P384; Hatano B, 2010, JPN J INFECT DIS, V63, P36; Fu SJ, 2011, APPL BIOCHEM BIOTECH, V163, P845, DOI 10.1007/s12010-010-9088-8; Kanou Y, 2005, JARQ-JPN AGR RES Q, V39, P197; Damon IK, 2013, FIELDS VIROLOGY, P2160; Hatano B, 2011, J MED VIROL, V83, P568, DOI 10.1002/jmv.22031; Holliman A, 2005, IN PRACTICE, V27, P2; Hosamani Madhusudan, 2009, Expert Rev Anti Infect Ther, V7, P879, DOI 10.1586/eri.09.64; Inoshima Y, 2010, J VET MED SCI, V72, P701; Ito A., 1970, BUNSEKI KAGAKU, V19, P393; Ito M., 2009, JPN J ZOO WILDL MED, V14, P111; Kennedy-Stoskopf S, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P285; Kohyama K., 2010, Journal of Japanese Association of Zoos and Aquariums, V51, P9; Kumagai T., 1971, P 71 M JAP SOC VET S; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; ROBINSON AJ, 1982, ARCH VIROL, V71, P43, DOI 10.1007/BF01315174	21	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	DEC	2014	30	12					1169	1172				4	Chemistry, Analytical	Chemistry	AX4GQ	WOS:000346892000011		
J	Mori, M; Misawa, K; Itabashi, H				Mori, Masanobu; Misawa, Keiko; Itabashi, Hideyuki			Highly Selective Detection of Trace Copper(II) Using Bathocuproinesulfonate by Flow-Injection Electrospray Ionization Mass Spectrometry	ANALYTICAL SCIENCES			English	Article						Electrospray ionization mass spectrometry; flow injection; copper; chelating agent; complexing capacity	COMPLEXES	Trace Cu2+ was detected with high selectivity using specific complexation with bathocuproinesulfonate (BCS) through flow-injection electrospray ionization mass spectrothetry (FT-ESI-MS), which separates Cu2+ from coexisting metal ions by forming a Cu-BCS complex with a high mass number. Here, only [Cu-I(BCS)(2)](3-) was obtained with a high ion count. Its calibration curve was linear from 1.0 x 10(-8) to 1.0 x 10(-5) M. This method was applied to determine the Cu-complexing capacities of humic acid solution and river water samples by adding traces of Cu2+.	[Mori, Masanobu; Misawa, Keiko; Itabashi, Hideyuki] Gunma Univ, Grad Sch Sci & Technol, Kiryu, Gumma 3768515, Japan	Mori, M (reprint author), Gunma Univ, Grad Sch Sci & Technol, 1-5-1 Tenjin Cho, Kiryu, Gumma 3768515, Japan.	mori@gunma-u.ac.jp					Kumazawa K, 2005, CHEM-EUR J, V11, P2519, DOI 10.1002/chem.200401216; Jeong EY, 2011, J HAZARD MATER, V185, P1311, DOI 10.1016/j.jhazmat.2010.10.047; Barnett D. A., 2000, ELEMENTAL SPECIATION, P384; Boija S, 2014, J MASS SPECTROM, V49, P550, DOI 10.1002/jms.3372; Campbell PG, 1995, IUPAC SERIES ANAL PH, P45; Dixon DW, 2004, J PORPHYR PHTHALOCYA, V8, P1300; Hotta H, 2009, ANAL CHEM, V81, P6357, DOI 10.1021/ac9006842; IMAMURA T, 1975, B CHEM SOC JPN, V48, P2971, DOI 10.1246/bcsj.48.2971; Itabashi H, 2003, ANAL SCI, V19, P1277, DOI 10.2116/analsci.19.1277; Minakata K, 2012, FORENSIC TOXICOL, V30, P149, DOI 10.1007/s11419-012-0134-9; ZAK B, 1962, MICROCHEM J, V6, P67	11	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340	1348-2246		ANAL SCI	Anal. Sci.	DEC	2014	30	12					1173	1176				4	Chemistry, Analytical	Chemistry	AX4GQ	WOS:000346892000012		
J	Stoeber, J; Kobori, O; Brown, A				Stoeber, Joachim; Kobori, Osamu; Brown, Anna			Examining Mutual Suppression Effects in the Assessment of Perfectionism Cognitions: Evidence Supporting Multidimensional Assessment	ASSESSMENT			English	Article						perfectionistic strivings; perfectionistic concerns; automatic thoughts; positive and negative affect; depressive symptoms; suppression	PSYCHOLOGICAL DISTRESS; UNIVERSITY-STUDENTS; NEGATIVE AFFECT; CES-D; PERSONALITY; PERFORMANCE; DIMENSIONS; VALIDATION; SITUATIONS; STRIVINGS	Perfectionism cognitions capture automatic perfectionistic thoughts and have explained variance in psychological adjustment and maladjustment beyond trait perfectionism. The aim of the present research was to investigate whether a multidimensional assessment of perfectionism cognitions has advantages over a unidimensional assessment. To this aim, we examined in a sample of 324 university students how the Perfectionism Cognitions Inventory (PCI) and the Multidimensional Perfectionism Cognitions Inventory (MPCI) explained variance in positive affect, negative affect, and depressive symptoms when factor or subscale scores were used as predictors compared to total scores. Results showed that a multidimensional assessment (PCI factor scores, MPCI subscale scores) explained more variance than a unidimensional assessment (PCI and MPCI total scores) because, when the different dimensions were entered simultaneously as predictors, perfectionistic strivings cognitions and perfectionistic concerns cognitions acted as mutual suppressors thereby increasing each others' predictive validity. With this, the present findings provide evidence that-regardless of whether the PCI or the MPCI is used-a multidimensional assessment of perfectionism cognitions has advantages over a unidimensional assessment in explaining variance in psychological adjustment and maladjustment.	[Stoeber, Joachim; Brown, Anna] Univ Kent, Canterbury CT2 7NP, Kent, England; [Kobori, Osamu] Chiba Univ, Chiba, Japan	Stoeber, J (reprint author), Univ Kent, Sch Psychol, Canterbury CT2 7NP, Kent, England.	J.Stoeber@kent.ac.uk	Stoeber, Joachim/B-6729-2009	Stoeber, Joachim/0000-0002-6439-9917			Slade PD, 1998, BEHAV MODIF, V22, P372, DOI 10.1177/01454455980223010; Pulford BD, 2005, PERS INDIV DIFFER, V39, P727, DOI 10.1016/j.paid.2005.02.008; Hill RW, 2010, PERS INDIV DIFFER, V48, P584, DOI 10.1016/j.paid.2009.12.011; Hewitt PL, 2003, BEHAV RES THER, V41, P1221, DOI 10.1016/S0005-9767(03)00021-4; Flett GL, 1998, J PERS SOC PSYCHOL, V75, P1363, DOI 10.1037/0022-3514.75.5.1363; Russell DW, 2002, PERS SOC PSYCHOL B, V28, P1629, DOI 10.1177/014616702237645; Gotwals JK, 2012, CAN PSYCHOL, V53, P263, DOI 10.1037/a0030288; FROST RO, 1990, COGNITIVE THER RES, V14, P449, DOI 10.1007/BF01172967; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037//1082-989X.4.3.272; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Lo A, 2013, BEHAV CHANGE, V30, P96, DOI 10.1017/bec.2013.9; Stoeber J, 2006, PERS SOC PSYCHOL REV, V10, P295, DOI 10.1207/s15327957pspr1004_2; Stoeber J, 2011, PERS INDIV DIFFER, V51, P991, DOI 10.1016/j.paid.2011.08.006; Slaney RB, 2001, MEAS EVAL COUNS DEV, V34, P130; Rice KG, 2007, ASSESSMENT, V14, P385, DOI 10.1177/1073191107303217; Paulhus DL, 2004, MULTIVAR BEHAV RES, V39, P303, DOI 10.1207/s15327906mbr3902_7; Bardone-Cone AM, 2010, INT J EAT DISORDER, V43, P139, DOI 10.1002/eat.20674; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Cox BJ, 2002, PSYCHOL ASSESSMENT, V14, P365, DOI 10.1037//1040-3590.14.3.365; Cole JC, 2004, PSYCHOL ASSESSMENT, V16, P360, DOI 10.1037/1040-3590.16.4.360; Lo A, 2013, COGNITIVE THER RES, V37, P762, DOI 10.1007/s10608-013-9528-1; Besser A., 2008, J RATION-EMOT COGN-B, V26, P206, DOI DOI 10.1007/S10942-007-0067-0; British Psychological Society, 2009, COD ETH COND; Burns J. L., 2011, J COLL STUDENT PSYCH, V25, P132; Cattell R.B., 1977, J MULTIVARIATE BEHAV, V12, P289; Cheung YB, 2007, SUICIDE LIFE-THREAT, V37, P79, DOI 10.1521/suli.2007.37.1.79; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; DiStefano C, 2009, PRACTICAL ASSESSMENT, V14; Enns M. W., 2002, PERFECTIONISM THEORY, P33, DOI DOI 10.1037/10458-002; Enzmann D, 1997, APPL PSYCH MEAS, V21, P232, DOI 10.1177/01466216970213003; Fleeson W., 2012, OXFORD HDB PERSONALI, P33; Flett G. L., 2011, J RAT EMO COGNITIVE, V29, P192, DOI DOI 10.1007/S10942-011-0135-3; Flett G. L., 2007, J RATION-EMOT COGN-B, V25, P255, DOI [10.1007/s10942-007-0055-4, DOI 10.1007/S10942-007-0055-4]; Flett GL, 2012, J RATION-EMOT COGN-B, V30, P91, DOI 10.1007/s10942-011-0131-7; Flett G.L., 2002, PERFECTIONISM THEORY, P5, DOI DOI 10.1037/10458-001; HEWITT PL, 1991, J PERS SOC PSYCHOL, V60, P456, DOI 10.1037/0022-3514.60.3.456; Hill A. P., INT J SPORT IN PRESS; Hill AP, 2011, J SPORT SCI, V29, P695, DOI 10.1080/02640414.2010.551216; Horst P., 1941, SOCIAL SCI RES COUNC, V48, P431; Kobori O, 2011, J ANXIETY DISORD, V25, P674, DOI 10.1016/j.janxdis.2011.03.001; Kobori O., 2004, JAPANESE J PERSONALI, V13, P34, DOI 10.2132/personality.13.34; Kobori O., 2006, THESIS U TOKYO TOKYO; Kobori O., 2005, COGNITIVE THERAPY RE, V29, P559; Kutner M., 2004, APPL LINEAR REGRESSI; Meyers L. S., 2005, APPL MULTIVARIATE RE; Nunnally J. C., 1994, PSYCHOMETRIC THEORY; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Revelle W, 2013, PSYCH PROCEDURES PSY; Rudolph S. G., 2007, J RATIONAL EMOTIVE C, V25, P343, DOI DOI 10.1007/S10942-007-0056-3; Shafran R., 2010, OVERCOMING PERFECTIO; Sherry S. B., 2012, PERSONALITY INDIVIDU, V54, P692; Sherry SB, 2009, BODY IMAGE, V6, P83, DOI 10.1016/j.bodyim.2008.12.002; Stoeber J, 2010, J PERS ASSESS, V92, P16, DOI 10.1080/00223890903379159; Stoeber J, 2013, MEAS EVAL COUNS DEV, V46, P178, DOI 10.1177/0748175613481981; Tabachnick B. G., 2007, USING MULTIVARIATE S; TZELGOV J, 1991, PSYCHOL BULL, V109, P524, DOI 10.1037/0033-2909.109.3.524; Wimberley TE, 2013, COGNITIVE THER RES, V37, P277, DOI 10.1007/s10608-012-9462-7; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037//0033-2909.99.3.432	59	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	DEC	2014	21	6					647	660		10.1177/1073191114534884		14	Psychology, Clinical	Psychology	AX0LS	WOS:000346644500001		
J	Benitez-Garcia, SE; Kanda, I; Wakamatsu, S; Okazaki, Y; Kawano, M				Benitez-Garcia, Sandy-Edith; Kanda, Isao; Wakamatsu, Shinji; Okazaki, Yukiyo; Kawano, Masahide			Analysis of Criteria Air Pollutant Trends in Three Mexican Metropolitan Areas	ATMOSPHERE			English	Article						air quality standards; criteria pollutants; Guadalajara; Mexico; Monterrey	FIELD CAMPAIGN; CITY; EMISSIONS; PM10; O-3	Data from the annual, seasonal, and hourly behavior of the criteria air pollutants CO, NO2, SO2, O-3, and PM10 in three Mexican metropolitan areas (the Mexico City Metropolitan Area (MCMA), Guadalajara Metropolitan Area (GMA), and Monterrey Metropolitan Area (MMA)) over the period 2000-2011 were analyzed; and compliance with Mexican air quality standards was evaluated, highlighting causes of specific episodes of high and low concentrations. Data analyzed were collected from automatic air-monitoring networks located in the MCMA (32 stations), GMA (8 stations), and MMA (5 stations). In the MCMA and MMA, correlations between wind direction and concentrations of SO2 suggest that there was a considerable contribution of trans-boundary transport from outside of these areas. Analysis of annual trends revealed large reductions of CO in the MCMA, and SO2 in the three metropolitan areas. However, the annual mean concentration of O-3 increased by 47% and 42% in the GMA and MMA, respectively, from 2000 to 2011, but decreased by 13% in the MCMA from 2005 to 2010. The annual mean concentration of PM10 in the MMA was about 58% and 76% higher than that in the MCMA and GMA, respectively, from 2001 to 2010.	[Benitez-Garcia, Sandy-Edith; Kawano, Masahide] Ehime Univ, United Grad Sch Agr Sci, Dept Life Environm Conservat Sci, Matsuyama, Ehime 7908566, Japan; [Kanda, Isao; Wakamatsu, Shinji; Okazaki, Yukiyo] Ehime Univ, Fac Agr, Matsuyama, Ehime 7908566, Japan	Benitez-Garcia, SE (reprint author), Ehime Univ, United Grad Sch Agr Sci, Dept Life Environm Conservat Sci, Matsuyama, Ehime 7908566, Japan.	edithiq@gmail.com; ikanda@agr.ehime-u.ac.jp; wakamatu@agr.ehime-u.ac.jp; okazaki.yukiyo.mc@ehime-u.ac.jp; mkawano@agr.ehime-u.ac.jp			SATREPS (Science and Technology Research Partnership for Sustainable Development); SEMARNAT (Secretaria de Medio Ambiente y Recursos Naturales) of Mexico	We thank SATREPS (Science and Technology Research Partnership for Sustainable Development) for support through the project "Joint Research Project on Formation Mechanism of Ozone, VOC's and PM<INF>2.5</INF> and Proposal of Countermeasure Scenarios" and SEMARNAT (Secretaria de Medio Ambiente y Recursos Naturales) of Mexico for providing the INEM 2005, 2008, and 2010 source data. We appreciate the valuable advices from Mitsuhiro Yamamoto during the revision of the manuscript.	Alcántar González F. S., 2011, Revista Internacional de Contaminación Ambiental, V27, P153; Alfaro-Barbosa J.M., 2008, REV LATINOAM RECUR N, V4, P60; Contini D, 2014, ATMOSPHERE-BASEL, V5, P435, DOI 10.3390/atmos5020435; Putaud JP, 2010, ATMOS ENVIRON, V44, P1308, DOI 10.1016/j.atmosenv.2009.12.011; Stephens S, 2008, ATMOS CHEM PHYS, V8, P5313; Molina LT, 2007, ATMOS CHEM PHYS, V7, P2447; Aldape F, 1999, NUCL INSTRUM METH B, V150, P439, DOI 10.1016/S0168-583X(98)01046-5; [Anonymous], 2012, PRIM CAT EST MON ATM; Bishop GA, 1997, ENVIRON SCI TECHNOL, V31, P3505, DOI 10.1021/es9702475; Calvillo A., 2008, EFICIENCIA TRANSPORT; CONAPO, 2012, DEL ZON METR MEX 201; Davydova-Belitskaya V., 2001, REV INT CONTAM AMBIE, V17, P97; Davydova-Belitskaya V., 1999, REV INT CONTAM AMBIE, V15, P103; de Foy B, 2009, ATMOS CHEM PHYS, V9, P4419; Diario Oficial de la Federacion (DOF), 2006, NOM086SEMARNATSENERS; Fast JD, 2007, ATMOS CHEM PHYS, V7, P2233; INEM-2005, 2011, INEM 2005 NAT INV EM; Instituto Nacional de Ecologia (INE), 2011, SECR MED AMB REC NAT; Limon-Sanchez MT, 2011, ATMOS POLLUT RES, V2, P358, DOI 10.5094/APR.2011.040; Marcotullio P., 2007, SCALING URBAN ENV CH; Medina-Ramirez S, 2012, IMPORTANCIA REDUCCIO; Mexico State Government Federal District Government SEMARNAT SSA, 2011, PROAIRE MCMA PROGR M; Moya M, 2003, ATMOS ENVIRON, V37, P3581, DOI 10.1016/S1352-2310(03)00345-5; Pasquill F., 1961, MET MAG LONDON, V90, P33; Ramirez-Sanchez H.U., 2009, J HAZARD MATER, V165, P1128; Rivera C, 2009, ATMOS CHEM PHYS, V9, P6351; Schifter I, 2005, ATMOS ENVIRON, V39, P931, DOI 10.1016/j.atmosenv.2004.09.079; Secretaria del Medio Ambiente Gobierno del Distrito Federal (SMA-GDF), 2012, INV EM ZON METR VALL; Seinfeld J. H., 2006, ATMOSPHERIC CHEM PHY; SEMARNAT Gobierno del Estado de Jalisco, 2011, PROAIRE JAL PROGR ME; SEMARNAT Gobierno del estado de Nuevo Leon, 2008, PROAIRE MONT PROGR G; Ying ZM, 2011, ATMOS ENVIRON, V45, P2549, DOI 10.1016/j.atmosenv.2011.02.018; Zhang YX, 2009, ATMOS ENVIRON, V43, P4622, DOI 10.1016/j.atmosenv.2009.05.039	33	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2073-4433			ATMOSPHERE-BASEL	Atmosphere	DEC	2014	5	4					806	829		10.3390/atmos5040806		24	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	AX2UN	WOS:000346800300007		
J	Matsuda, M; Hatanaka, W; Takeo, M; Kim, CW; Niidome, T; Yamamoto, T; Kishimura, A; Mori, T; Katayama, Y				Matsuda, Masayoshi; Hatanaka, Wataru; Takeo, Masafumi; Kim, Chan Woo; Niidome, Takuro; Yamamoto, Tatsuhiro; Kishimura, Akihiro; Mori, Takeshi; Katayama, Yoshiki			Short Peptide Motifs for Long-Lasting Anchoring to the Cell Surface	BIOCONJUGATE CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; MAMMALIAN-CELLS; ENDOCYTOSIS; RECEPTORS; PROTEINS; DELIVERY; CHOLESTEROL; MEMBRANES; DYNAMICS; LIPIDS	A rational design strategy has been developed for the construction of stable peptide-based anchors for the efficient modification of cell surfaces. Six types of peptide composed of five residues with divalent hydrophobic groups have been designed using this new strategy. Among them, a peptide with a sequence of NBD-Lys-Lys(X)-Lys-Lys-Lys(X)-NH2 (NBD: fluorophore, Lys(X): N-e-palmitoyl-l-lysine) was found to show the highest modification efficacy and longevity in culture medium. The good performance of this peptide was attributed to (1) its high aqueous solubility, which allowed it to partition from the medium to the cell surface, and (2) the high binding affinity of the saturated palmitoyl groups to the cell membrane. We found that the distribution of the peptide was affected by recycling endosome, which enabled the representation of the peptide following its endocytotic disappearance from the cell membrane. Biotin was also presented on the cell surface using this peptide-based anchor to examine its recognition by streptavidin. The efficacy of the recognition process increased as the length of the oligoethylene glycol spacer increased, indicating that it was necessary for the biotin tag to move away from the membrane glycoproteins on the cell surface to facilitate its efficient recognition by streptavidin.	[Matsuda, Masayoshi; Hatanaka, Wataru; Takeo, Masafumi; Kim, Chan Woo; Niidome, Takuro; Kishimura, Akihiro; Mori, Takeshi; Katayama, Yoshiki] Kyushu Univ, Grad Sch Syst Life Sci, Nishi Ku, Fukuoka 8190395, Japan; [Kim, Chan Woo; Niidome, Takuro; Kishimura, Akihiro; Mori, Takeshi; Katayama, Yoshiki] Kyushu Univ, Dept Appl Chem, Nishi Ku, Fukuoka 8190395, Japan; [Kim, Chan Woo; Niidome, Takuro; Yamamoto, Tatsuhiro; Kishimura, Akihiro; Mori, Takeshi; Katayama, Yoshiki] Kyushu Univ, Ctr Future Chem, Nishi Ku, Fukuoka 8190395, Japan; [Kishimura, Akihiro; Katayama, Yoshiki] Kyushu Univ, Ctr Mol Syst, Nishi Ku, Fukuoka 8190395, Japan; [Katayama, Yoshiki] Kyushu Univ, Ctr Adv Med Innovat, Higashi Ku, Fukuoka 8128582, Japan	Mori, T (reprint author), Kyushu Univ, Grad Sch Syst Life Sci, Nishi Ku, 744 Moto Oka, Fukuoka 8190395, Japan.	mori.takeshi.880@m.kyushu-u.ac.jp; ykatatcm@mail.cstm.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [23700539]	We are grateful for financial support in the form of a Grant-in-Aid for Young Scientists (B) (23700539) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We would also like to thank Professor Masahiro Goto (Kyushu University) for his assistance with the CLSM study.	Ferguson SSG, 2001, PHARMACOL REV, V53, P1; STAHL P, 1980, CELL, V19, P207, DOI 10.1016/0092-8674(80)90402-X; Baba T, 2001, TRAFFIC, V2, P501, DOI 10.1034/j.1600-0854.2001.20707.x; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Tokunaga T, 2012, J AM CHEM SOC, V134, P9561, DOI 10.1021/ja302551p; Jeong JH, 2013, J AM CHEM SOC, V135, P8770, DOI 10.1021/ja400636d; Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125; Stephan MT, 2011, NANO TODAY, V6, P309, DOI 10.1016/j.nantod.2011.04.001; Ishiwata H, 1997, BBA-MOL CELL RES, V1359, P123, DOI 10.1016/S0167-4889(97)00061-X; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; WEISGRABER KH, 1978, J BIOL CHEM, V253, P9053; Medof ME, 1996, FASEB J, V10, P574; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Inui O, 2010, ACS APPL MATER INTER, V2, P1514, DOI 10.1021/am100134v; Kellam B, 2003, CHEM SOC REV, V32, P327, DOI 10.1039/b211643j; Ko IK, 2009, BIOMATERIALS, V30, P3702, DOI 10.1016/j.biomaterials.2009.03.038; Teramura Y, 2008, BIOMATERIALS, V29, P1345, DOI 10.1016/j.biomaterials.2007.11.048; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Dennis JE, 2004, J ORTHOPAED RES, V22, P735, DOI 10.1016/j.orthres.2003.12.002; Tokunaga T, 2013, CHEM LETT, V42, P127, DOI 10.1246/cl.2013.127; Zhao WA, 2010, MATER TODAY, V13, P14; Boonyarattanakalin S, 2004, J AM CHEM SOC, V126, P16379, DOI 10.1021/ja046663o; Debanjan S., 2011, BLOOD, V118, pe184; Dong Y. L., 2006, TISSUE ENG, V12, P615; Irwin N, 2006, BIOCHEM PHARMACOL, V72, P719, DOI 10.1016/j.bcp.2006.06.013; Joel P. S., 1995, CHEM REV, V95, P2168; Kato K, 2004, BIOTECHNOL PROGR, V20, P897, DOI 10.1021/bp0342093; Marilyn D. R, 2006, NAT CHEM BIOL, V2, P584; Martin SE, 2003, BIOCONJUGATE CHEM, V14, P67, DOI 10.1021/bc025601p; Morgan D., 2011, NAT CHEM, V3, P582; Notohamiprodjo M, 2006, PROTEIN ENG DES SEL, V19, P27, DOI 10.1093/protein/gzi072; Panza J. L., 2000, BIOMATERIALS, V21, P1154; Selden N. S., 2011, J AM CHEM SOC, V134, P765; SHAHINIAN S, 1995, BIOCHEMISTRY-US, V34, P3813, DOI 10.1021/bi00011a039; Su L., 1991, PHOTOCHEM PHOTOBIOL, V54, P361; Takafuji Y, 2013, BIOL PHARM BULL, V36, P1731; Tobinaga K, 2014, J CONTROL RELEASE, V177, P27, DOI 10.1016/j.jconrel.2013.12.024	37	3	3	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	DEC	2014	25	12					2134	2143		10.1021/bc500465j		10	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Biochemistry & Molecular Biology; Chemistry	AX1BB	WOS:000346682300008		
J	Ho, SH; Ye, XT; Hasunuma, T; Chang, JS; Kondo, A				Ho, Shih-Hsin; Ye, Xiaoting; Hasunuma, Tomohisa; Chang, Jo-Shu; Kondo, Akihiko			Perspectives on engineering strategies for improving biofuel production from microalgae - A critical review	BIOTECHNOLOGY ADVANCES			English	Review						Microalgae; Biofuel; Environmental stress; Engineering operation strategy; Fed-batch operation; Semi-continuous operation; Continuous operation; Two-stage operation; Salinity-gradient operation	OBLIQUUS CNW-N; ALGA CHLAMYDOMONAS-REINHARDTII; FATTY-ACID-COMPOSITION; LIFE-CYCLE ASSESSMENT; FED-BATCH CULTIVATION; SCENEDESMUS-OBLIQUUS; LIPID PRODUCTION; CHLORELLA-VULGARIS; BIODIESEL PRODUCTION; LIGHT-INTENSITY	Although the potential for biofuel production from microalgae via photosynthesis has been intensively investigated, information on the selection of a suitable operation strategy for microalgae-based biofuel production is lacking. Many published reports describe competitive strains and optimal culture conditions for use in biofuel production; however, the major impediment to further improvements is the absence of effective engineering strategies for microalgae cultivation and biofuel production. This comprehensive review discusses recent advances in understanding the effects of major environmental stresses and the characteristics of various engineering operation strategies on the production of biofuels (mainly biodiesel and bioethanol) using microalgae. The performances of microalgae-based biofuel-producing systems under various environmental stresses (i.e., irradiance, temperature, pH, nitrogen depletion, and salinity) and cultivation strategies (i.e., fed-batch, semi-continuous, continuous, two-stage, and salinity-gradient) are compared. The reasons for variations in performance and the underlying theories of the various production strategies are also critically discussed. The aim of this review is to provide useful information to facilitate development of innovative and feasible operation technologies for effectively increasing the commercial viability of microalgae-based biofuel production. (c) 2014 Elsevier Inc. All rights reserved.	[Ho, Shih-Hsin; Ye, Xiaoting; Hasunuma, Tomohisa] Kobe Univ, Grad Sch Engn, Org Adv Sci & Technol, Nada Ku, Kobe, Hyogo 6578501, Japan; [Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, Kobe, Hyogo 6578501, Japan; [Chang, Jo-Shu] Natl Cheng Kung Univ, Dept Chem Engn, Tainan 701, Taiwan; [Chang, Jo-Shu] Natl Cheng Kung Univ, Res Ctr Energy Technol & Strategy, Tainan 701, Taiwan; [Chang, Jo-Shu] Natl Cheng Kung Univ, Ctr Biosci & Biotechnol, Tainan 701, Taiwan; [Kondo, Akihiko] RIKEN, Biomass Engn Program, Yokohama, Kanagawa 2300045, Japan	Chang, JS (reprint author), Natl Cheng Kung Univ, Dept Chem Engn, Tainan 701, Taiwan.	changjs@mail.ncku.edu.tw; akondo@kobe-u.ac.jp	Hasunuma, Tomohisa/A-1949-2015	Hasunuma, Tomohisa/0000-0002-8382-2362	New Energy and Industrial Technology Development Organization (NEDO) [P07015]	This work has been supported through project P07015 by the New Energy and Industrial Technology Development Organization (NEDO).	John Andrews T, 2003, Arch Biochem Biophys, V414, P159, DOI 10.1016/S0003-9861(03)00100-0; Chen CY, 2011, BIORESOURCE TECHNOL, V102, P71, DOI 10.1016/j.biortech.2010.06.159; Sobczuk TM, 2010, J CHEM TECHNOL BIOT, V85, P100, DOI 10.1002/jctb.2272; Liu JH, 2012, APPL BIOCHEM BIOTECH, V166, P2127, DOI 10.1007/s12010-012-9639-2; Zhou XP, 2013, BIORESOURCE TECHNOL, V138, P131, DOI 10.1016/j.biortech.2013.03.169; Kim MS, 2006, INT J HYDROGEN ENERG, V31, P812, DOI 10.1016/j.ijhydene.2005.06.009; Pittman JK, 2011, BIORESOURCE TECHNOL, V102, P17, DOI 10.1016/j.biortech.2010.06.035; VOELKER TA, 1992, SCIENCE, V257, P72, DOI 10.1126/science.1621095; Genkov T, 2010, J BIOL CHEM, V285, P19833, DOI 10.1074/jbc.M110.124230; Wang H, 2013, BIORESOURCE TECHNOL, V128, P745, DOI 10.1016/j.biortech.2012.10.158; Harwati TU, 2012, BIORESOURCE TECHNOL, V121, P54, DOI 10.1016/j.biortech.2012.06.098; Gardner R, 2011, J APPL PHYCOL, V23, P1005, DOI 10.1007/s10811-010-9633-4; Santos AM, 2012, BIORESOURCE TECHNOL, V104, P593, DOI 10.1016/j.biortech.2011.10.084; John RP, 2011, BIORESOURCE TECHNOL, V102, P186, DOI 10.1016/j.biortech.2010.06.139; Cheirsilp B, 2012, BIORESOURCE TECHNOL, V110, P510, DOI 10.1016/j.biortech.2012.01.125; NEUHAUS HE, 1990, PLANTA, V182, P445; Neupert J, 2012, METHODS MOL BIOL, V847, P35, DOI 10.1007/978-1-61779-558-9_4; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; Han FF, 2013, BIORESOURCE TECHNOL, V136, P418, DOI 10.1016/j.biortech.2013.03.017; Cai T, 2013, RENEW SUST ENERG REV, V19, P360, DOI 10.1016/j.rser.2012.11.030; Zhou WG, 2012, BIORESOURCE TECHNOL, V110, P448, DOI 10.1016/j.biortech.2012.01.063; SUKENIK A, 1989, J PHYCOL, V25, P686, DOI 10.1111/j.0022-3646.1989.00686.x; Ho SH, 2012, BIORESOURCE TECHNOL, V105, P106, DOI 10.1016/j.biortech.2011.11.091; Bondioli P, 2012, BIORESOURCE TECHNOL, V114, P567, DOI 10.1016/j.biortech.2012.02.123; Sun X, 2014, BIORESOURCE TECHNOL, V155, P204, DOI 10.1016/j.biortech.2013.12.109; Ho SH, 2013, BIORESOURCE TECHNOL, V145, P142, DOI 10.1016/j.biortech.2013.02.119; Converti A, 2009, CHEM ENG PROCESS, V48, P1146, DOI 10.1016/j.cep.2009.03.006; Lam MK, 2012, BIOTECHNOL ADV, V30, P673, DOI 10.1016/j.biotechadv.2011.11.008; Guedes AC, 2010, J AM OIL CHEM SOC, V87, P791, DOI 10.1007/s11746-010-1559-0; Takagi M, 2000, APPL MICROBIOL BIOT, V54, P112; Ho SH, 2014, BIORESOURCE TECHNOL, V152, P275, DOI 10.1016/j.biortech.2013.11.031; Talebi AF, 2013, ALGAL RES, V2, P258, DOI 10.1016/j.algal.2013.04.003; Jamers A, 2009, AQUAT TOXICOL, V92, P114, DOI 10.1016/j.aquatox.2009.02.012; Ho SH, 2013, BIORESOURCE TECHNOL, V135, P157, DOI 10.1016/j.biortech.2012.10.100; Dunahay TG, 1995, J PHYCOL, V31, P1004, DOI 10.1111/j.0022-3646.1995.01004.x; Jiang LL, 2011, APPL ENERG, V88, P3336, DOI 10.1016/j.apenergy.2011.03.043; Kim M, 2012, ANTIVIR RES, V93, P253, DOI 10.1016/j.antiviral.2011.12.006; Gouveia L, 2009, J IND MICROBIOL BIOT, V36, P269, DOI 10.1007/s10295-008-0495-6; Liu ZY, 2008, BIORESOURCE TECHNOL, V99, P4717, DOI 10.1016/j.biortech.2007.09.073; Parmar A, 2011, BIORESOURCE TECHNOL, V102, P10163, DOI 10.1016/j.biortech.2011.08.030; Deschamps P, 2008, TRENDS PLANT SCI, V13, P574, DOI 10.1016/j.tplants.2008.08.009; Pal D, 2011, APPL MICROBIOL BIOT, V90, P1429, DOI 10.1007/s00253-011-3170-1; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Khalil ZI, 2010, WORLD J MICROB BIOT, V26, P1225, DOI 10.1007/s11274-009-0292-z; Singh J, 2010, RENEW SUST ENERG REV, V14, P2596, DOI 10.1016/j.rser.2010.06.014; Whitney SM, 2001, P NATL ACAD SCI USA, V98, P14738, DOI 10.1073/pnas.261417298; Khotimchenko SV, 2005, PHYTOCHEMISTRY, V66, P73, DOI 10.1016/j.phytochem.2004.10.024; Mata TM, 2010, RENEW SUST ENERG REV, V14, P217, DOI 10.1016/j.rser.2009.07.020; Guo SL, 2013, J BIOTECHNOL, V163, P61, DOI 10.1016/j.jbiotec.2012.10.020; Abdollahi J, 2012, CHEM ENG SCI, V84, P619, DOI 10.1016/j.ces.2012.09.005; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Yen HW, 2013, BIORESOURCE TECHNOL, V135, P166, DOI 10.1016/j.biortech.2012.10.099; Sims REH, 2010, BIORESOURCE TECHNOL, V101, P1570, DOI 10.1016/j.biortech.2009.11.046; Ramazanov A, 2006, PHYCOL RES, V54, P255, DOI 10.1111/j.1440-1835.2006.00416.x; San Pedro A, 2013, BIORESOURCE TECHNOL, V134, P353, DOI 10.1016/j.biortech.2013.02.032; Ho SH, 2010, BIORESOURCE TECHNOL, V101, P8725, DOI 10.1016/j.biortech.2010.06.112; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Dehesh K, 1996, PLANT J, V9, P167, DOI 10.1046/j.1365-313X.1996.09020167.x; Chen CY, 2013, BIOCHEM ENG J, V78, P1, DOI 10.1016/j.bej.2013.03.006; Tang HY, 2012, BIOTECHNOL BIOENG, V109, P2468, DOI 10.1002/bit.24516; Fortier MOP, 2014, APPL ENERG, V122, P73, DOI 10.1016/j.apenergy.2014.01.077; Mujtaba G, 2012, BIORESOURCE TECHNOL, V123, P279, DOI 10.1016/j.biortech.2012.07.057; Ho SH, 2013, BIORESOURCE TECHNOL, V135, P191, DOI 10.1016/j.biortech.2012.10.015; Ritte G, 2006, FEBS LETT, V580, P4872, DOI 10.1016/j.febslet.2006.07.085; Naik SN, 2010, RENEW SUST ENERG REV, V14, P578, DOI 10.1016/j.rser.2009.10.003; Smith AM, 2008, PLANT J, V54, P546, DOI 10.1111/j.1365-313X.2008.03468.x; Tang HY, 2011, APPL ENERG, V88, P3324, DOI 10.1016/j.apenergy.2010.09.013; Xu YY, 2014, RENEW SUST ENERG REV, V32, P29, DOI 10.1016/j.rser.2014.01.002; Hsieh CH, 2009, BIORESOURCE TECHNOL, V100, P3921, DOI 10.1016/j.biortech.2009.03.019; Bartley ML, 2013, BIOMASS BIOENERG, V54, P83, DOI 10.1016/j.biombioe.2013.03.026; Moheimani NR, 2013, J APPL PHYCOL, V25, P167, DOI 10.1007/s10811-012-9850-0; Wang X, 2011, J INTEGR PLANT BIOL, V53, P246, DOI 10.1111/j.1744-7909.2010.01024.x; Wu LF, 2013, INT BIODETER BIODEGR, V85, P506, DOI 10.1016/j.ibiod.2013.05.016; Borowitzka MA, 1999, J BIOTECHNOL, V70, P313, DOI 10.1016/S0168-1656(99)00083-8; Munkel R, 2013, BIOTECHNOL BIOENG, V110, P2882, DOI 10.1002/bit.24948; Ho SH, 2014, BIORESOURCE TECHNOL, V156, P108, DOI 10.1016/j.biortech.2014.01.017; Kilian O, 2011, P NATL ACAD SCI USA, V108, P21265, DOI 10.1073/pnas.1105861108; Lv JM, 2010, BIORESOURCE TECHNOL, V101, P6797, DOI 10.1016/j.biortech.2010.03.120; Hong WK, 2011, APPL BIOCHEM BIOTECH, V164, P1468, DOI 10.1007/s12010-011-9227-x; Brennan L, 2010, RENEW SUST ENERG REV, V14, P557, DOI 10.1016/j.rser.2009.10.009; James GO, 2013, BIORESOURCE TECHNOL, V127, P441, DOI 10.1016/j.biortech.2012.09.090; Takagi M, 2006, J BIOSCI BIOENG, V101, P223, DOI 10.1263/jbb.101.223; Marchetti J, 2012, AQUACULTURE, V326, P106, DOI 10.1016/j.aquaculture.2011.11.020; Feng YJ, 2011, BIORESOURCE TECHNOL, V102, P101, DOI 10.1016/j.biortech.2010.06.016; Ho SH, 2012, BIORESOURCE TECHNOL, V113, P244, DOI 10.1016/j.biortech.2011.11.133; Ho SH, 2011, BIOTECHNOL ADV, V29, P189, DOI 10.1016/j.biotechadv.2010.11.001; Breuer G, 2013, BIORESOURCE TECHNOL, V143, P1, DOI 10.1016/j.biortech.2013.05.105; Ceron-Garcia MC, 2013, BIORESOURCE TECHNOL, V147, P569, DOI 10.1016/j.biortech.2013.08.092; CHAMPIGNY ML, 1985, PHOTOSYNTH RES, V6, P273, DOI 10.1007/BF00049283; Chen CH, 2013, J NURS RES, V21, P74, DOI 10.1097/JNR.0b013e318295dda0; Collet P, 2014, RENEW ENERG, V71, P525, DOI 10.1016/j.renene.2014.06.009; Gonzalez-Fernandez C, 2012, BIOTECHNOL ADV, V30, P1655, DOI 10.1016/j.biotechadv.2012.07.003; Guarnieri MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025851; Ho SH, 2013, BIORESOURCE TECHNOL, V143, P163, DOI 10.1016/j.biortech.2013.05.043; Ho SH, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-97; HOSONO H, 1994, J FERMENT BIOENG, V78, P235, DOI 10.1016/0922-338X(94)90296-8; Jeffryes C, 2013, ALGAL RES, V2, P16, DOI 10.1016/j.algal.2012.11.002; Nakanishi A, 2014, BIORESOURCE TECHNOL, V152, P247, DOI 10.1016/j.biortech.2013.11.009; Pragya N, 2013, RENEW SUST ENERG REV, V24, P159, DOI 10.1016/j.rser.2013.03.034; Rao AR, 2012, BIORESOURCE TECHNOL, V123, P528, DOI 10.1016/j.biortech.2012.07.009; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Sforza E, 2013, CHEM ENG RES DES, V92, P1153; Siaut M, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-7; Su CH, 2011, J APPL PHYCOL, V23, P903, DOI 10.1007/s10811-010-9609-4; SUKENIK A, 1991, AQUACULTURE, V97, P61, DOI 10.1016/0044-8486(91)90279-G; Vanthoor-Koopmans M, 2013, BIORESOURCE TECHNOL, V135, P142, DOI 10.1016/j.biortech.2012.10.135; Wan C, 2013, BIOCHEM ENG J, V78, P32, DOI 10.1016/j.bej.2013.04.014; Xia L, 2013, BIORESOURCE TECHNOL, V144, P261, DOI 10.1016/j.biortech.2013.06.112; Xin L, 2011, BIORESOURCE TECHNOL, V102, P3098, DOI 10.1016/j.biortech.2010.10.055; Yu WL, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-91; Zhila NO, 2011, J APPL PHYCOL, V23, P47, DOI 10.1007/s10811-010-9532-8; Zhou XP, 2013, BIORESOURCE TECHNOL, V134, P24, DOI 10.1016/j.biortech.2013.02.008	112	18	18	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0734-9750	1873-1899		BIOTECHNOL ADV	Biotechnol. Adv.	DEC	2014	32	8					1448	1459		10.1016/j.biotechadv.2014.09.002		12	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	AX6FU	WOS:000347019400007		
J	Kawamura, S; Kato, T; Fantel, AG				Kawamura, Satoshi; Kato, Terushige; Fantel, Alan G.			Close Link between Protoporphyrin IX Accumulation and Developmental Toxicity Induced by N-Phenylimide Herbicides in Rats	BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY			English	Article						N-phenylimide herbicide; compound-specific difference; peak period; porphyrin accumulation; teratogenicity; developmental toxicity; rats; rabbits	DIPHENYL ETHER HERBICIDES; SIDEROBLASTIC ANEMIA; OXIDASE; HEME; TRANSPORTER; DIFFERENCE; OXADIAZON; DEFECTS; RABBITS; PLANTS	BACKGROUNDS-53482, 7-fluoro-6-[(3,4,5,6-tetrahydro)phthalimido]-4-(2-propynyl)-1,4-benzoxazin-3(2H)-one (flumioxazin), is an N-phenylimide herbicide and developmentally toxic to rats, but not to rabbits. The day of greatest sensitivity to S-53482 is gestational day (GD) 12 in rats. There is a compound-specific difference in developmental toxicity among structurally similar compounds including S-23121 (N-[4-chloro-2-fluoro-5-[(1-methyl-2-propynyl)oxy]phenyl]-3,4,5,6-tetrahydrophthalimide; teratogenic) and S-23031 (pentyl 2-chloro-4-fluoro-5-(3,4,5,6-tetrahydrophthalimido)phenoxyacetate (flumiclorac pentyl); nonteratogenic). The herbicidal action is due to photodynamic action of accumulating protoporphyrin IX (PPIX), resulting from the inhibition of protoporphyrinogen oxidase (PPO), an enzyme in porphyrin biosynthesis. Species difference in PPIX accumulation in embryos corresponded to those of the developmental toxicity. Our objective in this study was to further investigate a link between PPIX accumulation resulting from PPO inhibition and developmental toxicity. This article is part of a series of studies to be published serially. METHODSTo investigate compound-specific differences, each compound was orally administered to rats on GD 12. To define peak period of PPIX accumulation, single oral treatments of S-53482 were given to rats or rabbits at 19:30 on GD 10 through GD 15. PPIX was extracted from embryos 14 hr after treatment. RESULTSRemarkable PPIX accumulation was observed when treated with S-53482 or S-23121, but not with S-23031. The greatest accumulation of PPIX was observed when treated with S-53482 at 19:30 on GD 11 or GD 12. No PPIX accumulation was found on any GDs in rabbits. CONCLUSIONSThe developmentally toxic compounds caused PPIX accumulation in embryos. The peak period of PPIX accumulation corresponded to that of developmental effects. This correlation suggests a close link between PPO inhibition and developmental abnormality (C) 2014 Wiley Periodicals, Inc.	[Kawamura, Satoshi; Kato, Terushige] Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Konohana Ku, Osaka 5548558, Japan; [Fantel, Alan G.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	Kawamura, S (reprint author), Sumitomo Chem Co Ltd, Environm Hlth Sci Lab, Konohana Ku, 1-98,Kasugade Naka 3 Chome, Osaka 5548558, Japan.	kawamuras2@sc.sumitomo-chem.co.jp					Shaner DL, 2004, PEST MANAG SCI, V60, P17, DOI 10.1002/ps.782; Krishnamurthy P, 2007, PHARMACOL THERAPEUT, V114, P345, DOI 10.1016/j.pharmthera.2007.02.001; MATRINGE M, 1989, BIOCHEM J, V260, P231; TAVASSOLI M, 1991, BLOOD CELLS, V17, P269; Zhou S, 2005, BLOOD, V105, P2571, DOI 10.1182/blood-2004-04-1566; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; AOKI Y, 1980, J CLIN INVEST, V66, P43, DOI 10.1172/JCI109833; FERREIRA GC, 1988, J BIOL CHEM, V263, P3835; Ghadially FN, 1997, ULTRASTRUCT PATHOL, VI, P324; Hao GF, 2011, CHIMIA, V65, P961, DOI 10.2533/chimia.2011.961; Hirasawa K, 1981, JIKKEN DOBUTSU GIZYU, V16, P103; JACOBS JM, 1992, J BIOCHEM TOXICOL, V7, P87, DOI 10.1002/jbt.2570070206; Kappas A, 1995, METABOLIC MOL BASES, P2103; Kawamura S, 2013, BIRTH DEFECTS RES B, V98, P437, DOI 10.1002/bdrb.21087; Kawamura S, 1996, TOXICOL APPL PHARM, V141, P520, DOI 10.1006/taap.1996.0317; Kawamura Satoshi, 1995, Congenital Anomalies, V35, P123, DOI 10.1111/j.1741-4520.1995.tb00306.x; Kawamura S, 2014, BIRTH DEFECTS RES B, V101, P162, DOI 10.1002/bdrb.21103; Kawamura S, 1996, TERATOLOGY, V54, P237, DOI 10.1002/(SICI)1096-9926(199611)54:5<237::AID-TERA4>3.0.CO;2-X; KONOPKA L, 1979, BRIT J HAEMATOL, V42, P73, DOI 10.1111/j.1365-2141.1979.tb03699.x; KRIJT J, 1992, PESTIC BIOCHEM PHYS, V42, P180, DOI 10.1016/0048-3575(92)90064-7; Langerberg JWM, 1996, BIOCHIM BIOPHYS ACTA, V1278, P247; Machemer L, 1992, RISK ASSESSMENT PREN, P85; MATRINGE M, 1989, FEBS LETT, V245, P35, DOI 10.1016/0014-5793(89)80186-3; MITO N, 1991, PESTIC BIOCHEM PHYS, V40, P128, DOI 10.1016/0048-3575(91)90107-W; Murata S, 2004, J PESTIC SCI, V29, P195, DOI 10.1584/jpestics.29.195; Schardein J.L., 1993, CHEM INDUCED BIRTH D	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1542-9733	1542-9741		BIRTH DEFECTS RES B	Birth Defects Res. Part B-Dev. Reprod. Toxicol.	DEC	2014	101	6					429	437		10.1002/bdrb.21133		9	Oncology; Genetics & Heredity; Toxicology	Oncology; Genetics & Heredity; Toxicology	AX1KF	WOS:000346705300004		
J	Komori, Y; Burrage, K				Komori, Yoshio; Burrage, Kevin			A stochastic exponential Euler scheme for simulation of stiff biochemical reaction systems	BIT NUMERICAL MATHEMATICS			English	Article						Explicit method; Mean square stability; Chemical Langevin equation	RUNGE-KUTTA METHODS; S-ROCK METHODS; LOCAL LINEARIZATION SCHEMES; DIFFERENTIAL-EQUATIONS; CHEBYSHEV METHODS; ADDITIVE NOISE; APPROXIMATION; CONVERGENCE; INTEGRATORS; STABILITY	In order to simulate stiff biochemical reaction systems, an explicit exponential Euler scheme is derived for multi-dimensional, non-commutative stochastic differential equations with a semilinear drift term. The scheme is of strong order one half and A-stable in mean square. The combination with this and the projection method shows good performance in numerical experiments dealing with an alternative formulation of the chemical Langevin equation for a human ether a-go-go related gene ion channel model.	[Komori, Yoshio] Kyushu Inst Technol, Dept Syst Design & Informat, Iizuka, Fukuoka 8208502, Japan; [Burrage, Kevin] Univ Oxford, Dept Comp Sci, Oxford OX1 3QD, England; [Burrage, Kevin] Queensland Univ Technol, Sch Math, Brisbane, Qld 4001, Australia	Komori, Y (reprint author), Kyushu Inst Technol, Dept Syst Design & Informat, Iizuka, Fukuoka 8208502, Japan.	komori@ces.kyutech.ac.jp; kevin.burrage@cs.ox.ac.uk	Komori, Yoshio/A-9957-2008; 	Komori, Yoshio/0000-0002-2334-6843; Burrage, Kevin/0000-0002-8111-1137	JSPS [23540143]; Kyushu Institute of Technology	An initial presentation relating to this work was given in the 19th IMACS World Congress. This work was partially supported by JSPS Grant-in-Aid for Scientific Research No. 23540143. It was also partially supported by overseas study program of faculty at Kyushu Institute of Technology.	Adamu I.A., 2011, THESIS HERIOT WATT U; Alfonsi A, 2010, MATH COMPUT, V79, P209, DOI 10.1090/S0025-5718-09-02252-2; VANDERHOUWEN PJ, 1980, Z ANGEW MATH MECH, V60, P479, DOI 10.1002/zamm.19800601005; Abdulle A, 2001, NUMER MATH, V90, P1, DOI 10.1007/s002110100292; Higham DJ, 2000, BIT, V40, P404, DOI 10.1023/A:1022355410570; Komori Y, 2012, J COMPUT APPL MATH, V236, P2895, DOI 10.1016/j.cam.2012.01.033; Abdulle A, 2008, SIAM J SCI COMPUT, V30, P997, DOI 10.1137/070679375; Hochbruck M, 1998, SIAM J SCI COMPUT, V19, P1552, DOI 10.1137/S1064827595295337; Jentzen A, 2009, P ROY SOC A-MATH PHY, V465, P649, DOI 10.1098/rspa.2008.0325; Komori Y, 2013, J COMPUT APPL MATH, V242, P261, DOI 10.1016/j.cam.2012.10.026; Jimenez JC, 1999, J STAT PHYS, V94, P587, DOI 10.1023/A:1004504506041; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; Hochbruck M, 2010, ACTA NUMER, V19, P209, DOI 10.1017/S0962492910000048; Rossler A, 2010, SIAM J NUMER ANAL, V48, P922, DOI 10.1137/09076636X; Abdulle A, 2008, COMMUN MATH SCI, V6, P845; Biscay R, 1996, ANN I STAT MATH, V48, P631, DOI 10.1007/BF00052324; Abdulle A, 2002, SIAM J SCI COMPUT, V23, P2041, DOI 10.1137/S1064827500379549; Wiktorsson M, 2001, ANN APPL PROBAB, V11, P470; Brennan T, 2009, EUR J PHARM SCI, V36, P62, DOI 10.1016/j.ejps.2008.09.013; Hochbruck M, 2005, SIAM J NUMER ANAL, V43, P1069, DOI 10.1137/040611434; Arnold L., 1974, STOCHASTIC DIFFERENT; Bayer Christian, 2010, Monte Carlo Methods and Applications, V16, DOI 10.1515/MCMA.2010.001; Butcher J. C., 2008, NUMERICAL METHODS OR; Carbonell F, 2006, J COMPUT APPL MATH, V197, P578, DOI 10.1016/j.cam.2005.11.032; Chen Y., 2011, ARXIV11016081V2; Cruz dl, 2010, BIT, V50, P509; Dangerfield CE, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051907; EHLE BL, 1975, J I MATH APPL, V16, P11; Ilie S., 2013, APPL MATH, V4, P235; Jimenez JC, 2012, BIT, V52, P357, DOI 10.1007/s10543-011-0360-2; Jimenez JC, 2002, APPL MATH LETT, V15, P775, DOI 10.1016/S0893-9659(02)00041-1; Kiehn J., 1999, AM J PHYSIOL, V277, P199; Lawson J.D., 1967, SIAM J NUMER ANAL, V4, P372, DOI 10.1137/0704033; Melykuti B, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3380661; Mitsui T., 1999, NUMERICAL SOLUTION S; Mora CM, 2005, IMA J NUMER ANAL, V25, P486, DOI 10.1093/imanum/dri001; PETTERSSON R, 1995, STOCH PROC APPL, V59, P295, DOI 10.1016/0304-4149(95)00040-E; POPE DA, 1963, COMMUN ACM, V6, P491, DOI 10.1145/366707.367592; Shi C., 2012, ABSTR APPL ANAL, V2012; Shoji I, 2011, COMMUN NONLINEAR SCI, V16, P2667, DOI 10.1016/j.cnsns.2010.09.008; Skorohod A V., 1961, TEOR VEROYA PRIMEN, V6, P287; Skorohod A V., 1962, THEO VEROYATNOST PRI, V7, P5; Tanaka H., 1979, HIROSHIMA MATH J, V9, P163	43	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0006-3835	1572-9125		BIT	Bit	DEC	2014	54	4					1067	1085		10.1007/s10543-014-0485-1		19	Computer Science, Software Engineering; Mathematics, Applied	Computer Science; Mathematics	AX0QJ	WOS:000346656400009		
J	Miyatake, Y; Matsuo, T				Miyatake, Yuto; Matsuo, Takayasu			A general framework for finding energy dissipative/conservative -Galerkin schemes and their underlying -weak forms for nonlinear evolution equations	BIT NUMERICAL MATHEMATICS			English	Article						Discrete partial derivative method; Dissipation; Conservation; Galerkin method; Structure-preserving integration; L-2-projection; Discrete gradient method	FINITE-DIFFERENCE SCHEMES; DISCRETE; DISSIPATION; INTEGRATION; PDES	A general framework for constructing energy dissipative or conservative Galerkin schemes for time-dependent partial differential equations (PDEs) is presented. The framework embraces a variety of dissipative and conservative PDEs with variational structure. An advantageous feature is that implementation of the resulting scheme requires only P1 elements. The schemes and their underlying -weak forms are derived from the concept of formal weak form and an -projection technique.	[Miyatake, Yuto; Matsuo, Takayasu] Univ Tokyo, Grad Sch Informat Sci & Technol, Bunkyo Ku, Tokyo 1130033, Japan	Miyatake, Y (reprint author), Univ Tokyo, Grad Sch Informat Sci & Technol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	yuto_miyatake@mist.i.u-tokyo.ac.jp; matsuo@mist.i.u-tokyo.ac.jp			JSPS [25287030, 23560063]	We are thankful for various comments by the reviewers. We are also grateful to Takaharu Yaguchi and Norikazu Saito for many useful discussions. This work was partly supported by JSPS KAKENHI Grant Numbers 25287030, 23560063. It was also partly supported by the Aihara Project, the FIRST program from JSPS, initiated by CSTP. The first author is supported by the Research Fellowship of the Japan Society for the Promotion of Science for Young Scientists.	CAMASSA R, 1993, PHYS REV LETT, V71, P1661, DOI 10.1103/PhysRevLett.71.1661; FUCHSSTEINER B, 1981, PHYSICA D, V4, P47, DOI 10.1016/0167-2789(81)90004-X; DU Q, 1991, SIAM J NUMER ANAL, V28, P1310, DOI 10.1137/0728069; Quispel GRW, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/4/045206; Celledoni E, 2012, J COMPUT PHYS, V231, P6770, DOI 10.1016/j.jcp.2012.06.022; KAWAHARA T, 1972, J PHYS SOC JPN, V33, P260, DOI 10.1143/JPSJ.33.260; SWIFT J, 1977, PHYS REV A, V15, P319, DOI 10.1103/PhysRevA.15.319; Wazwaz AM, 2006, APPL MATH COMPUT, V182, P1642, DOI 10.1016/j.amc.2006.06.002; Furihata D, 1999, J COMPUT PHYS, V156, P181, DOI 10.1006/jcph.1999.6377; Constantin A, 2000, COMMUN PUR APPL MATH, V53, P603; Camassa R., 1994, ADV APPL MECH, V31, P1, DOI 10.1016/S0065-2156(08)70254-0; Constantin A., 1998, ANN SCUOLA NORM SU S, V26, P303; Dahlby M, 2011, SIAM J SCI COMPUT, V33, P2318, DOI 10.1137/100810174; Degasperis A., 1999, SYMMETRY PERTURBATIO, V7, P23; Furihata D., 2011, DISCRETE VARIATIONAL; Gonzalez O, 1996, J NONLINEAR SCI, V6, P449, DOI 10.1007/BF02440162; Atkinson K, 2009, TEXTS APPL MATH, V39, P1, DOI 10.1007/978-1-4419-0458-4_1; ITOH T, 1988, J COMPUT PHYS, V76, P85, DOI 10.1016/0021-9991(88)90132-5; Kuramae H., 2012, THESIS U TOKYO; Matsuo T, 2010, J COMPUT APPL MATH, V234, P1258, DOI 10.1016/j.cam.2009.09.020; Matsuo T, 2008, J COMPUT APPL MATH, V218, P506, DOI 10.1016/j.cam.2007.08.001; Matsuo T, 2009, J COMPUT PHYS, V228, P4346, DOI 10.1016/j.jcp.2009.03.003; Matsuo T, 2001, J COMPUT PHYS, V171, P425, DOI 10.1006/jcph.2001.6775; Miyatake Y, 2012, PHYS LETT A, V376, P2633, DOI 10.1016/j.physleta.2012.07.022; Miyatake Y, 2012, J COMPUT PHYS, V231, P4542, DOI 10.1016/j.jcp.2012.02.027; Yaguchi T, 2010, J COMPUT PHYS, V229, P4382, DOI 10.1016/j.jcp.2010.02.018; Yaguchi T, 2012, J COMPUT PHYS, V231, P3963, DOI 10.1016/j.jcp.2012.01.035	27	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0006-3835	1572-9125		BIT	Bit	DEC	2014	54	4					1119	1154		10.1007/s10543-014-0483-3		36	Computer Science, Software Engineering; Mathematics, Applied	Computer Science; Mathematics	AX0QJ	WOS:000346656400012		
J	Iwahana, Y; Koike, Y; Nakamura, T				Iwahana, Yuki; Koike, Yuya; Nakamura, Toshihiro			Monitoring of Radioactive Nuclides in Incinerator Fly Ash and Adsorption of Cs in Simulated and Actual Eluate of the Fly Ash onto Clay and Soil	BUNSEKI KAGAKU			Japanese	Article						incinerator fly ash; modified notification No. 13 elution test; radioactive Cs; andosol; Cs adsorption	FUKUSHIMA; ELEMENTS	Radioactive nuclides in the incinerator fly ash of municipal solid waste was determined and monitored. For leaching radioactive Cs from incinerating fly ash in reclaimed land, a modified No. 13 elution test and adsorption with stable Cs onto andosol were performed. The activity concentration of radioactive nuclides in incinerator fly ash was constant within the range of the activity concentration before the accident at Fukushima Daiichi Nuclear Power Station. The Cs-134/Cs-137 activity concentration ratio was almost equal to 1, corresponding to Cs-137 existing in environment before the accident. 40 % of 137Cs in incinerator fly ash eluted with the modified No. 13 elution test, and adsorption ratio of Cs+ onto the andosol showed 90 % as being the primary concentration was equal to or more than 5000 mu g L-1. In addition, the desorption results used for 5 types of solvent showed that desorption ratio of adsorbed Cs+ from the soil was 3.6 % at the maximum. Hence, it is anticipated that using a soil that is similar in composition to the andosol suppresses the leaching out of radioactive Cs from reclaimed land.	[Iwahana, Yuki; Koike, Yuya; Nakamura, Toshihiro] Meiji Univ, Dept Appl Chem, Tama Ku, Kawasaki, Kanagawa 2148571, Japan	Iwahana, Y (reprint author), Meiji Univ, Dept Appl Chem, Tama Ku, 1-1-1 Higashimita, Kawasaki, Kanagawa 2148571, Japan.	toshina@meiji.ac.jp					Iwahana Y, 2013, ANAL SCI, V29, P61; ROWE JJ, 1977, TALANTA, V24, P433, DOI 10.1016/0039-9140(77)80125-2; Ioannidou A, 2013, ATMOS ENVIRON, V75, P163, DOI 10.1016/j.atmosenv.2013.04.008; Mester Z, 1999, ANAL CHIM ACTA, V395, P157, DOI 10.1016/S0003-2670(99)00342-6; Ohbuchi A, 2008, X-RAY SPECTROM, V37, P237, DOI 10.1002/xrs.1046	5	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	DEC	2014	63	12					933	938				6	Chemistry, Analytical	Chemistry	AX4GO	WOS:000346891800001		
J	Shimada, H; Ashino, T; Wagatsuma, K				Shimada, Haruhiko; Ashino, Tetsuya; Wagatsuma, Kazuaki			Modification of an Analyical Appratus in Helium Carrier Fusion - Thermal Conductivity Method for Reducing the Quantification Errors of Nitrogen in Oxide Samples	BUNSEKI KAGAKU			Japanese	Article						oxygen; nitrogen; by-pass column; molecular sieve 5A; calibration line		A conventional analytical apparatus for simultaneous determination of oxygen and nitrogen was modified by inserting a by-pass column filled with an appropriate amount of molecular sieve 5A into the gas flowing path. The extraction curve of oxygen could be fully separated from that of nitrogen when the measuring conditions were optimized When high-purity potassium nitrate was employed as a certified material for the calibration, a linear relationship of the signal response was obtained up to the upper limit of nitrogen that the equipment could quantify. Using these optimized parameters for the measurement, analytical results of nitrogen in steel standard samples agreed to the corresponding guaranteed values.	[Shimada, Haruhiko; Ashino, Tetsuya; Wagatsuma, Kazuaki] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan	Shimada, H (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.	h-shimada@imr.tohoku.ac.jp	Wagatsuma, Kazuaki/B-3079-2012				ONO A, 1994, ANAL SCI, V10, P393, DOI 10.2116/analsci.10.393	1	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	DEC	2014	63	12					939	942				4	Chemistry, Analytical	Chemistry	AX4GO	WOS:000346891800002		
J	Kitagawa, F; Kai, M; Otsuka, K				Kitagawa, Fumihiko; Kai, Minako; Otsuka, Koji			Preparation of Quantum Dots for Highly Sensitive Analysis of Alkali Metal and Ammonium Ions	BUNSEKI KAGAKU			Japanese	Article						crown ether; quantum dots; energy transfer; alkali metal ions; fluorescence		A highly sensitive and selective analysis of alkali metal and ammonium ions was investigated on the basis of a Forster-type excitation energy transfer between two quantum dots (QDs) with different sizes. QDs are semiconductor nanoparticles and their emission wavelengths depend on their sizes. For the molecular recognition of potassium ion, mercaptoalkanoic 15-crown-5 ether was introduced onto the surface of QDs with their diameter of 2.1 (15C5-QDs2.1) and 2.6 nm (15C5-QDs2.6). When K+ is added to a mixed suspension of 15C5-QDs2.1 and 15C5-QDs2.6, the efficiency of the excitation energy transfer will be enhanced since the recognition of K+ brings a 1:2 sandwich-type complexation between the different size of QDs. As the concentration of K+ was increased, actually, the fluorescence intensity at longer wavelength derived from 15C5-QDs2.6 was increased. Thus, the signal transduction can be accomplished through the energy transfer resulting in a ratiometric change in the emission intensity. The limit of detection (LOD) of K+ was evaluated to be 0.50 mu M, so that the sensitive detection of K+ was successful. When Na+ was added to the mixed suspension, the change in the fluorescence spectrum was not observed. Therefore, it was found that 15C5-QDs was K+ selective fluorescent probe. We also prepared Na+ or NH4(+) selective QDs probes by inducing mercaptoalkanoic 12-crown-4 ether or 18-crown-6 ether on QDs, respectively. The obtained LODs for Na+ and NH4(+) were 1.3 mu M and 0.31 mu M, respectively.	[Kitagawa, Fumihiko] Hirosaki Univ, Grad Sch Sci & Technol, Dept Frontier Mat Chem, Hirosaki, Aomori 0368561, Japan; [Kai, Minako; Otsuka, Koji] Kyoto Univ, Grad Sch Engn, Dept Chem Mat, Nishikyo Ku, Kyoto 6158510, Japan	Kitagawa, F (reprint author), Hirosaki Univ, Grad Sch Sci & Technol, Dept Frontier Mat Chem, 3 Bunkyo Cho, Hirosaki, Aomori 0368561, Japan.	kitagawa@cc.hirosaki-u.ac.jp					Chen CY, 2006, CHEM COMMUN, P263, DOI 10.1039/b512677k; Resch-Genger U, 2008, NAT METHODS, V5, P763, DOI [10.1038/nmeth.1248, 10.1038/NMETH.1248]; Han CP, 2010, ANAL BIOANAL CHEM, V397, P1437, DOI 10.1007/s00216-009-3361-0; Buchberger WW, 2000, J CHROMATOGR A, V884, P3, DOI 10.1016/S0021-9673(00)00283-1; Kavamos G. J., 1993, FUNDAMENTALS PHOTOIN; KIMURA K, 1979, J ELECTROANAL CHEM, V95, P91, DOI 10.1016/S0022-0728(79)80222-3; Murphy CJ, 2002, ANAL CHEM, V74, p520A, DOI 10.1021/ac022124v; Timerbaev AR, 2000, ELECTROPHORESIS, V21, P4179, DOI 10.1002/1522-2683(200012)21:18<4179::AID-ELPS4179>3.0.CO;2-C; Velu R, 2012, NEW J CHEM, V36, P1725, DOI 10.1039/c2nj40444c	9	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	DEC	2014	63	12					943	949				7	Chemistry, Analytical	Chemistry	AX4GO	WOS:000346891800003		
J	Isaji, Y; Kitagawa, S; Ohtani, H				Isaji, Yuka; Kitagawa, Shinya; Ohtani, Hajime			Development of Microsyringe-based Capillary LC-GC Interface with Carrier Gas Flow Switching for GC Injection	BUNSEKI KAGAKU			Japanese	Article						capillary LC; LC-GC; comprehensive analysis; syringe-type interface; flow-pass switching	LIQUID-CHROMATOGRAPHY; X GC; OIL	A microsyringe-based capillary LC-GC interface with GC carrier gas flow switching for GC injection was developed. The carrier gas flow to GC was divided into two ways: one way was connected to a general carrier gas port of GC and the other to a syringe interface inserted into an injection port of GC. The solution from capillary LC was stored in the syringe and successfully injected by switching the carrier gas flow-pass. The repeatability of the injection amount was sufficient (< 5.5 % in %RSD for the peak area, <1.5 % for the relative peak area, n = 8). LC-GC analyses of the test mixture (alkylbenzenes and phthalates) were successfully demonstrated.	[Isaji, Yuka; Kitagawa, Shinya; Ohtani, Hajime] Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Nagoya, Aichi 4668555, Japan	Isaji, Y (reprint author), Nagoya Inst Technol, Grad Sch Engn, Dept Mat Sci & Engn, Gokiso Cho, Nagoya, Aichi 4668555, Japan.	kitagawa.shinya@nitech.ac.jp					Quigley WWC, 2000, J MICROCOLUMN SEP, V12, P160, DOI 10.1002/(SICI)1520-667X(2000)12:3<160::AID-MCS5>3.0.CO;2-8; de Koning S, 2004, J SEP SCI, V27, P397, DOI 10.1002/jssc.200301676; Tranchida PQ, 2011, J CHROMATOGR A, V1218, P7476, DOI 10.1016/j.chroma.2011.06.089; Dugo P, 2006, ANAL CHEM, V78, P7743, DOI 10.1021/ac061290q; Janssen H.-G., 2004, ANAL BIOANAL CHEM, V378, P1755; Xu Y, 2008, J CHROMATOGR A, V1181, P95, DOI 10.1016/j.chroma.2007.12.040	6	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	DEC	2014	63	12					951	954				4	Chemistry, Analytical	Chemistry	AX4GO	WOS:000346891800004		
J	Isagai, H				Isagai, Hiroo			Effect of Volcanic Emissions on Rain-water Acidification in Satsumasendai City, Japan	BUNSEKI KAGAKU			Japanese	Article						rain water; acidity; volcano; NO3-; SO42-		The primary contributors to the acidification of rainfall are the oxides of sulfur and nitrogen, which originate from both human activity and natural sources, the latter of which includes volcanic emissions. Two active volcanoes, Mt. Sakurajima and Mt. Shinmoe, are located equidistant from Satsumasendai City, Kagoshima, Japan, and large eruptions of Mt. Shinmoe occurred several times during 2010-2011. The present study examines the effects of these volcanoes on the acidification of rainfall in Satsumasendai City by analyzing the electrical conductivity (EC), pH, and SO42- and NO3- contents of rain water. It was observed that the values of EC, SO42-, and NO3- were high, and the pH was low, during the eruption of both volcanoes. These results indicate that the volcanic activity of Mt. Sakurajima and Mt. Shinmoe influenced the acidity of rain water in the vicinity of Satsumasendai City. In particular, the ratio of SO42-/NO3- was low compared to the values for rain water in other areas of Japan, suggesting that rain water acidity in Satsumasendai City is influenced primarily by SO42- rather than by NO3-.	Kagoshima Univ, Educ Ctr, Kagoshima 8900065, Japan	Isagai, H (reprint author), Kagoshima Univ, Educ Ctr, 1-21-30 Korimoto, Kagoshima 8900065, Japan.						Sugawara K., 1950, B CHEM SOC JPN, V22, P49	1	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	DEC	2014	63	12					955	958				4	Chemistry, Analytical	Chemistry	AX4GO	WOS:000346891800005		
J	Taketoshi, A; Haruta, M				Taketoshi, Ayako; Haruta, Masatake			Creation of Novel Catalytic Functions by Nanoparticulation of Gold	BUNSEKI KAGAKU			Japanese	Article						gold; nanoparticles; clusters; catalysis; green chemistry	CARBON-MONOXIDE; OXIDATION; CLUSTERS; SIZE; ACID; AIR; CO	Gold was regarded as an inactive element for longer than a century. However, it exhibited unique catalytic properties when deposited on base metal oxides as nanoparticles with mean diameters smaller than 10 nm. Especially, gold nanoparticles catalysts with 2 to 6 nm diameters are active for many reactions, such as CO oxidation at a temperature as low as - 70 degrees C. Some typical reactions in liquid and gas phases are listed. A new area is clusters that are smaller than 2 nm and less than 200 atoms. Unique catalytic performances of gold clusters have recently been found. This paper summarizes the characteristic features of gold nanopardcles and clusters catalysts as well as their applications.	[Taketoshi, Ayako; Haruta, Masatake] Tokyo Metropolitan Univ, Res Ctr Gold Chem, Grad Sch Urban Environm Sci, Hachioji, Tokyo 1920397, Japan; [Taketoshi, Ayako; Haruta, Masatake] Tokyo Metropolitan Univ, Grad Sch Urban Environm Sci, Div Appl Chem, Hachioji, Tokyo 1920397, Japan; [Haruta, Masatake] Dalian Inst Chem Phys, Gold Catalysis Res Ctr, Dalian 116023, Peoples R China	Taketoshi, A (reprint author), Tokyo Metropolitan Univ, Res Ctr Gold Chem, Grad Sch Urban Environm Sci, 1-1 Minamiosawa, Hachioji, Tokyo 1920397, Japan.	haruta-masatake@center.tmu.ac.jp					Akita S., 2012, 6 INT C GOLD SCI TEC, V1P-011; Shimada S, 2010, STUD SURF SCI CATAL, V175, P843, DOI 10.1016/S0167-2991(10)75174-0; Fujitani T, 2011, ANGEW CHEM INT EDIT, V50, P10144, DOI 10.1002/anie.201104694; Huang JH, 2009, ANGEW CHEM INT EDIT, V48, P7862, DOI 10.1002/anie.200903011; HARUTA M, 1987, CHEM LETT, P405, DOI 10.1246/cl.1987.405; HARUTA M, 1989, J CATAL, V115, P301, DOI 10.1016/0021-9517(89)90034-1; Ishida T, 2012, CHEMSUSCHEM, V5, P2243, DOI 10.1002/cssc.201200324; Ishida T, 2008, ANGEW CHEM INT EDIT, V47, P9265, DOI 10.1002/anie.200802845; Qian HF, 2013, J CHEM TECHNOL BIOT, V88, P735, DOI 10.1002/jctb.4030; Suzuki K, 2013, ACS CATAL, V3, P1845, DOI 10.1021/cs4004084; Taketoshi A, 2014, CHEM LETT, V43, P380, DOI 10.1246/cl.131232; Ikegami M, 2013, APPL CATAL B-ENVIRON, V134, P130, DOI 10.1016/j.apcatb.2012.12.018; Corma A, 2006, SCIENCE, V313, P332, DOI 10.1126/science.1128383; Yoshida H, 2012, SCIENCE, V335, P317, DOI 10.1126/science.1213194; Takei T, 2011, NEW J CHEM, V35, P2227, DOI 10.1039/c1nj20297a; Christensen CH, 2006, ANGEW CHEM INT EDIT, V45, P4648, DOI 10.1002/anie.200601180; Haruta Masatake, 2003, Chem Rec, V3, P75, DOI 10.1002/tcr.10053; Peplow M, 2013, NATURE, V495, pS10, DOI 10.1038/495S10a	18	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	DEC	2014	63	12					959	964				6	Chemistry, Analytical	Chemistry	AX4GO	WOS:000346891800006		
J	Sumida, T; Yano, Y; Okazaki, Y; Yamashita, M; Kawakita, H; Fukutomi, T				Sumida, Takashi; Yano, Yuya; Okazaki, Yuka; Yamashita, Minoru; Kawakita, Hirohisa; Fukutomi, Takashi			Preparation of Polyallylamine Type Noble Metal Element Adsorbent Based on Wood Powder and Its Application to Collection of Au in Gold-plating Waste	BUNSEKI KAGAKU			Japanese	Article						wood powder; cellulose; gold adsorbent; gold-plating waste	PRECIOUS METALS; ADSORPTION; CHITOSAN	Novel cellulose functionalized with polyallylamine based on wood powder was synthesized. It was applied to the collection of gold in gold-plating waste. The synthesized adsorbent, cellulose-pentaerythritol polyglycidyl ether-polyallylamine-glutaraldehyde-polyvinyl alcohol (CPP-GP), showed good adsorption behavior toward gold and palladium compared to other anions. The pH range for the adsorption of gold was about 4-6, and this maximum adsorption capacity was 8.4 % in gold-plating waste. By X-ray photoelectron spectroscopy (XPS) and thermal desorption spectroscopy (TDS) of CPP-GP adsorbent, which adsorbed gold in plating waste, the adsorbent was found to be combined in form of gold(I) cyanide. A column method with CPP-GP adsorbent was successfully applied to the collection of gold in 90 L of gold-plating waste with satisfactory results, which this recovery of gold could obtain about 87 %.	[Sumida, Takashi; Yano, Yuya; Okazaki, Yuka; Kawakita, Hirohisa] Kochi Prefectural Ind Technol Ctr, Kochi 7815101, Japan; [Yamashita, Minoru] Kochi Prefectural Paper Technol Ctr, Kochi 7812128, Japan; [Fukutomi, Takashi] Former Kochi Prefectural Ind Technol Ctr, Kochi 7815101, Japan	Sumida, T (reprint author), Kochi Prefectural Ind Technol Ctr, 3992-3 Nunoshida, Kochi 7815101, Japan.	takashi_sumida@ken3.pref.kochi.lg.jp					BABA Y, 1994, CHEM LETT, P117, DOI 10.1246/cl.1994.117; Adhikari CR, 2007, CHEM LETT, V36, P1254, DOI 10.1246/cl.2007.1254; Ni CH, 1996, J APPL POLYM SCI, V59, P499; Parajuli D, 2005, CHEM LETT, V34, P34, DOI 10.1246/cl.2005.34; Qu RJ, 2005, EUR POLYM J, V41, P1525, DOI 10.1016/j.europolymj.2005.02.003; Qu RJ, 2005, POLYM ENG SCI, V45, P1515, DOI 10.1002/pen.20431; Sumida T, 2012, ANAL SCI, V28, P767	7	0	0	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0525-1931			BUNSEKI KAGAKU	Bunseki Kagaku	DEC	2014	63	12					965	970				6	Chemistry, Analytical	Chemistry	AX4GO	WOS:000346891800007		
J	Nurhayati, RW; Ojima, Y; Nomura, N; Taya, M				Nurhayati, Retno Wahyu; Ojima, Yoshihiro; Nomura, Naoki; Taya, Masahito			Promoted megakaryocytic differentiation of K562 cells through oxidative stress caused by near ultraviolet irradiation	CELLULAR & MOLECULAR BIOLOGY LETTERS			English	Article						Near ultraviolet; Irradiation; K562 cells; Megakaryocytic differentiation; Polyploidization; Reactive oxygen species; Cell cycle; Phorbol 12-myristate 13-acetate	POLYPLOIDIZATION; ACTIVATION; EXPRESSION; ARREST; CYCLE; PMA	Reactive oxygen species (ROS) have been proven to be important activators for various cellular activities, including cell differentiation. Several reports showed the necessity of ROS during cell differentiation of the megakaryocytic (MK) lineage. In this study, we employed near ultraviolet (near-UV) irradiation to generate endogenous oxidative stress in an MK differentiation process of K562 cells with phorbol 12-myristate 13-acetate (PMA) induction. A significant increase in the intracellular ROS level was detected on day 1 after near-UV irradiation. In the initial stage of differentiation, a shifted fraction of G(1) and G(2) phase cells was obtained using near-UV irradiation, giving an increased percentage of G(2) phase cells (up from 31.1 to 68.7%). The near-UV irradiation-induced upregulation of the p21 gene, which is a cell cycle inhibitor, suggested that the G(2) phase cells were prevented from undergoing cell division. It was found that the percentage of high ploidy (8N and 16N) cells was enhanced significantly at the later stage of the K562 cell culture with near-UV irradiation. Moreover, time-lapse analysis showed that near-UV irradiation encouraged the expression of CD41, a specific surface marker of megakaryocytes. This is the first report that the elevated oxidative stress through the near-UV irradiation promoted the MK differentiation of PMA-induced K562 cells.	[Nurhayati, Retno Wahyu; Ojima, Yoshihiro; Nomura, Naoki; Taya, Masahito] Osaka Univ, Grad Sch Engn Sci, Dept Mat Engn Sci, Div Chem Engn, Toyonaka, Osaka 5608531, Japan	Taya, M (reprint author), Osaka Univ, Grad Sch Engn Sci, Dept Mat Engn Sci, Div Chem Engn, 1-3 Machikaneyama Cho, Toyonaka, Osaka 5608531, Japan.	taya@cheng.es.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25289295]; Multidisciplinary Research Laboratory System for Future Developments of the Graduate School of Engineering Science of Osaka University	This research was in part supported by Grant-in-Aids for Scientific Researches (No. 25289295) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. It was also supported by the Multidisciplinary Research Laboratory System for Future Developments of the Graduate School of Engineering Science of Osaka University.	Nagata Y, 1997, J CELL BIOL, V139, P449, DOI 10.1083/jcb.139.2.449; Mostafa SS, 2000, BRIT J HAEMATOL, V111, P879, DOI 10.1046/j.1365-2141.2000.02457.x; Sardina JL, 2010, CELL DEATH DIFFER, V17, P1842, DOI 10.1038/cdd.2010.67; Ojima Y, 2013, EXP CELL RES, V319, P2205, DOI 10.1016/j.yexcr.2013.06.002; Wuerzberger-Davis SM, 2005, MOL CANCER RES, V3, P345, DOI 10.1158/1541-7786.MCR-05-0028; TETTEROO PAT, 1984, LEUKEMIA RES, V8, P197, DOI 10.1016/0145-2126(84)90143-7; Baccini V, 2001, BLOOD, V98, P3274, DOI 10.1182/blood.V98.12.3274; BUTLER TM, 1990, CANCER RES, V50, P6323; Collamonici O. R., 1986, MOL CELL BIOL, V6, P1847; FUKUDA M, 1981, CANCER RES, V41, P4621; Giammona LM, 2006, BRIT J HAEMATOL, V135, P554, DOI 10.1111/j.1365-2141.2006.06341.x; Gruijl F. R., 2001, J PHOTOCH PHOTOBIO B, V63, P19; HALLIWELL B, 1989, BRIT J EXP PATHOL, V70, P737; Halliwell B., 1991, FEBS LETT, V28, P9; Hirose K, 2013, J RADIAT RES, V54, P438, DOI 10.1093/jrr/rrs125; Kang CD, 1998, CANCER LETT, V132, P99, DOI 10.1016/S0304-3835(98)00165-7; Kulkarni AP, 2009, FREE RADICAL RES, V43, P1090, DOI 10.1080/10715760903179673; Mitjavila-Garcia MT, 2002, DEVELOPMENT, V129, P2003; Shelly C, 2000, CELL GROWTH DIFFER, V11, P501	19	1	1	DE GRUYTER OPEN LTD	WARSAW	SOLIPSKA 14A-1, 02-482 WARSAW, POLAND	1425-8153	1689-1392		CELL MOL BIOL LETT	Cell. Mol. Biol. Lett.	DEC	2014	19	4					590	600		10.2478/s11658-014-0215-3		11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AX0IP	WOS:000346636500006		
J	Mishima, T; Toda, S; Ando, Y; Matsunaga, T; Inobe, M				Mishima, Takuya; Toda, Shoko; Ando, Yoshiaki; Matsunaga, Tsukasa; Inobe, Manabu			Rapid proliferation of activated lymph node CD4(+) T cells is achieved by greatly curtailing the duration of gap phases in cell cycle progression	CELLULAR & MOLECULAR BIOLOGY LETTERS			English	Article						CD4(+) T cells; Cell cycle; G0/G1 transition; Gap phase; In vitro; PMA plus ionomycin; Proliferation; T cell activation	PHOSPHORYLATION SITE; MONOCLONAL-ANTIBODY; ADAPTIVE TOLERANCE; IN-VIVO; IDENTIFICATION; RNA; DNA	Peripheral T cells are in G0 phase and do not proliferate. When they encounter an antigen, they enter the cell cycle and proliferate in order to initiate an active immune response. Here, we have determined the first two cell cycle times of a leading population of CD4(+) T cells stimulated by PMA plus ionomycin in vitro. The first cell cycle began around 10 h after stimulation and took approximately 16 h. Surprisingly, the second cell cycle was extremely rapid and required only 6 h. T cells might have a unique regulatory mechanism to compensate for the shortage of the gap phases in cell cycle progression. This unique feature might be a basis for a quick immune response against pathogens, as it maximizes the rate of proliferation.	[Mishima, Takuya; Toda, Shoko; Ando, Yoshiaki; Matsunaga, Tsukasa; Inobe, Manabu] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Lab Human Mol Genet, Kanazawa, Ishikawa 9201192, Japan	Inobe, M (reprint author), Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Lab Human Mol Genet, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	inobem@p.kanazawa-u.ac.jp	INOBE, Manabu/D-8393-2015				ABE R, 1995, J IMMUNOL, V154, P985; Ando Y, 2014, IN VITRO CELL DEV-AN, V50, P313, DOI 10.1007/s11626-013-9705-2; Buck SB, 2008, BIOTECHNIQUES, V44, P927, DOI 10.2144/000112812; Singh NJ, 2003, J EXP MED, V198, P1107, DOI 10.1084/jem.20030913; Yarke CA, 2008, J IMMUNOL, V180, P156; Onoyama I, 2007, J EXP MED, V204, P2875, DOI 10.1084/jem.20062299; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; Sojka DK, 2004, J IMMUNOL, V172, P6136; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Li GM, 2004, J IMMUNOL, V173, P2383; Mohapatra S, 2001, J BIOL CHEM, V276, P21976, DOI 10.1074/jbc.M009788200; CRISSMAN HA, 1985, SCIENCE, V228, P1321, DOI 10.1126/science.2408339; Hirata A, 2004, J HISTOCHEM CYTOCHEM, V52, P1503, DOI 10.1369/jhc.4A6285.2004; Inobe M, 2004, J IMMUNOL, V173, P7239; KIRSCHNER M, 1985, TRENDS GENET, V1, P41, DOI 10.1016/0168-9525(85)90021-6; Lea NC, 2003, MOL CELL BIOL, V23, P2351, DOI 10.1128/MCB.23.7.2351-2361.2003; TOBA K, 1995, J IMMUNOL METHODS, V182, P193, DOI 10.1016/0022-1759(95)00050-K	18	0	0	DE GRUYTER OPEN LTD	WARSAW	SOLIPSKA 14A-1, 02-482 WARSAW, POLAND	1425-8153	1689-1392		CELL MOL BIOL LETT	Cell. Mol. Biol. Lett.	DEC	2014	19	4					638	648		10.2478/s11658-014-0219-z		11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	AX0IP	WOS:000346636500010		
J	Ezema, FI; Kayama, Y; Amaechi, IC; Hiramatsu, T; Nwanya, AC; Osuji, RU; Maaza, M; Sugiyama, M				Ezema, F. I.; Kayama, Y.; Amaechi, I. C.; Hiramatsu, T.; Nwanya, A. C.; Osuji, R. U.; Maaza, M.; Sugiyama, M.			EFFECT OF ANNEALING ON THE PROPERTIES OF CHEMICAL BATH DEPOSITED CdS BUFFER LAYER OF CIS SOLAR CELLS	CHALCOGENIDE LETTERS			English	Article						Chemical bath deposition (CBD); Cadmium sulfide (CdS); Buffer layer CuInS2 (CIS); solar cell	SPRAYED CUINS2 FILMS; THIN-FILMS; OPTICAL-PROPERTIES; ELECTRODEPOSITION; INDIUM; EFFICIENCY; PYROLYSIS; MODULES; COPPER; CBD	The effect of annealing on the properties of chemical bath deposited (CBD) cadmium sulfide (CdS) buffer layer CuInS2 (CIS) solar cell with respect to cell performance is reported. The CdS layer was deposited on the CIS film from CdI2 and thiourea [CS(NH2)(2)] solutions using ammonia as the complexing agent. Results showed that post-conditional process of chemical bath deposition of CdS layer affected the performance of the CIS solar cells. X-ray diffraction (XRD) results indicated that CdS buffer layers show a hexagonal structure with preferred orientation along the (101) axis without Cd(OH)(2) peak at 200 degrees C. The morphologies of CdS films were investigated using scanning electron microscopy (SEM) and atomic force microscopy (AFM). The performance of the CdS/CIGS solar cells was discussed on the basis of characteristics and post-deposition conditions of the chemical bath deposited CdS layer.	[Ezema, F. I.; Amaechi, I. C.; Nwanya, A. C.; Osuji, R. U.] Univ Nigeria, Dept Phys & Astron, Nsukka, Enugu State, Nigeria; [Ezema, F. I.; Osuji, R. U.; Maaza, M.] Natl Res Fdn, Nanosci African Network NANOAFNET, iThemba LABS, ZA-7129 Somerset, Western Cape Pr, South Africa; [Ezema, F. I.; Osuji, R. U.; Maaza, M.] Univ South Africa UNISA, Coll Grad Studies, UNESCO UNISA Africa Chair Nanosci Nanotechnol, Pretoria, South Africa; [Ezema, F. I.; Kayama, Y.; Hiramatsu, T.; Sugiyama, M.] Tokyo Univ Sci, Fac Sci & Technol, Dept Elect Engn, Noda, Chiba 2788510, Japan; [Nwanya, A. C.] Univ Nigeria, Natl Ctr Energy Res & Dev, Nsukka, Nigeria	Ezema, FI (reprint author), Univ Nigeria, Dept Phys & Astron, Nsukka, Enugu State, Nigeria.	fiezema@yahoo.com	Ezema, Fabian/G-9867-2015		Research Center for Green and Safety Sciences; Photovoltaic Science and Technology Research Division, under the Research Institute for Science and Technology, Tokyo University of Science; Matsumae International Foundation (MIF)	The authors thank S. Yamaguchi, Y. Yamaguchi, and S-W Chang for their assistance in conducting the experiments. This work was supported in part by the Research Center for Green and Safety Sciences, and the Photovoltaic Science and Technology Research Division, under the Research Institute for Science and Technology, Tokyo University of Science. Fabian I. Ezema thanks immensely Prof. Kohei Soga for inviting him to use his laboratory as Matsumae International Foundation (MIF) research fellow and for giving him unhindered visit to Sugiyama Lab. Fabian I. Ezema is grateful to Matsumae International Foundation (MIF) for fellowship award at Tokyo University of Science, Japan.	ORTEGABORGES R, 1993, J ELECTROCHEM SOC, V140, P3464, DOI 10.1149/1.2221111; Huang Q, 2011, J ELECTROCHEM SOC, V158, pD57, DOI 10.1149/1.3518440; Klaer J, 2007, THIN SOLID FILMS, V515, P5929, DOI 10.1016/j.tsf.2006.12.153; Wilson KC, 2014, J ALLOY COMPD, V585, P555, DOI 10.1016/j.jallcom.2013.09.185; Lee SM, 2012, ELECTROCHIM ACTA, V79, P189, DOI 10.1016/j.electacta.2012.06.103; BRITT J, 1993, APPL PHYS LETT, V62, P2851, DOI 10.1063/1.109629; Han JF, 2011, SOL ENERG MAT SOL C, V95, P816, DOI 10.1016/j.solmat.2010.10.027; Zhai TY, 2010, NANOSCALE, V2, P168, DOI 10.1039/b9nr00415g; Hiie J, 2006, THIN SOLID FILMS, V511, P443, DOI 10.1016/j.tsf.2005.11.070; Jinesh KB, 2003, PHYSICA E, V19, P303, DOI 10.1016/S1386-9477(03)00351-5; Sakurai T, 2008, THIN SOLID FILMS, V516, P7036, DOI 10.1016/j.tsf.2007.12.135; Siemer K, 2001, SOL ENERG MAT SOL C, V67, P159, DOI 10.1016/S0927-0248(00)00276-2; Chung YD, 2011, CURR APPL PHYS, V11, pS65, DOI 10.1016/j.cap.2010.11.018; Katerski A, 2008, THIN SOLID FILMS, V516, P7110, DOI 10.1016/j.tsf.2007.12.027; WAGNER S, 1974, APPL PHYS LETT, V25, P434, DOI 10.1063/1.1655537; Powalla M, 2013, SOL ENERG MAT SOL C, V119, P51, DOI 10.1016/j.solmat.2013.05.002; Oja I, 2005, THIN SOLID FILMS, V480, P82, DOI 10.1016/j.tsf.2004.11.013; Zhao PT, 2008, CRYST GROWTH DES, V8, P717, DOI 10.1021/cg070252c; Asenjo B, 2006, THIN SOLID FILMS, V511, P117, DOI 10.1016/j.tsf.2005.11.092; Bandyopadhyaya S, 2000, SOL ENERG MAT SOL C, V60, P323, DOI 10.1016/S0927-0248(99)00064-1; Bohua Wen, 2011, Materials Chemistry and Physics, V131, DOI 10.1016/j.matchemphys.2011.09.051; Camus C, 2008, THIN SOLID FILMS, V516, P7026, DOI 10.1016/j.tsf.2007.12.069; Ezema FI, 2010, J OVONIC RES, V6, P99; Hibberd C. J., 2010, PROGR PHOTOVOLTAICS, V18, P432; Klaer J, 1998, SEMICOND SCI TECH, V13, P1456, DOI 10.1088/0268-1242/13/12/022; Klopmann C. V., 2006, J CRYST GROWTH, V289, P121; Krunks M, 2005, SOL ENERG MAT SOL C, V87, P207, DOI 10.1016/j.solmat.2004.07.024; Krunks M, 1999, THIN SOLID FILMS, V338, P125, DOI 10.1016/S0040-6090(98)01069-4; Moons E, 1996, SOL ENERG MAT SOL C, V43, P73, DOI 10.1016/0927-0248(95)00167-0; Nakamura S, 1997, SOL ENERG MAT SOL C, V49, P415, DOI 10.1016/S0927-0248(97)00122-0; Nakamura S, 2003, SOL ENERG MAT SOL C, V75, P81, DOI 10.1016/S0927-0248(02)00097-1; Rusu M, 2003, J PHYS CHEM SOLIDS, V64, P1849, DOI 10.1016/S0022-3697(03)00067-2; Shafarman W., 2003, HDB PHOTOVOLTAIC SCI; Sugiyama M, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.065503; Valderrama RC, 2008, ELECTROCHIM ACTA, V53, P3714, DOI 10.1016/j.electacta.2007.11.069	35	0	0	NATL INST R&D MATERIALS PHYSICS	BUCHAREST-MAGURELE	ATOMISTILOR STR 105 BIS, PO BOX MG-7, BUCHAREST-MAGURELE, 077125, ROMANIA	1584-8663			CHALCOGENIDE LETT	Chalcogenide Lett.	DEC	2014	11	12					629	638				10	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	AX4BJ	WOS:000346878800002		
J	Ohya, M; Shigematsu, T				Ohya, Masaki; Shigematsu, Takashi			A new xanthine oxidase inhibitor: the uric acid reduction and additional efficacy in CKD patients	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Editorial Material							CHRONIC KIDNEY-DISEASE; HYPERURICEMIA; FEBUXOSTAT; ALLOPURINOL; RISK		[Ohya, Masaki; Shigematsu, Takashi] Wakayama Med Univ, Div Nephrol, Dept Internal Med, Wakayama 6418509, Japan	Ohya, M (reprint author), Wakayama Med Univ, Div Nephrol, Dept Internal Med, 811-1 Kimiidera, Wakayama 6418509, Japan.	m-ohya@wakayama-med.ac.jp					Sanchez-Lozada LG, 2008, NEPHRON PHYSIOL, V108, P69, DOI 10.1159/000127837; Halevy S, 2008, J AM ACAD DERMATOL, V58, P25, DOI 10.1016/j.jaad.2007.08.036; Sanchez-Lozada LG, 2008, NEPHROL DIAL TRANSPL, V23, P1179, DOI 10.1093/ndt/gfm783; Toda A, 2014, NEPHRON CLIN PRACT, V126, P33, DOI 10.1159/000355639; Gagliardi ACM, 2009, ATHEROSCLEROSIS, V202, P11, DOI 10.1016/j.atherosclerosis.2008.05.022; Omori H, 2012, CLIN EXP NEPHROL, V16, P549, DOI 10.1007/s10157-012-0609-3; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Fagugli RM, 2008, CLIN NEPHROL, V70, P523; Kansui Y, 2011, CIRC J, V75, P2827, DOI 10.1253/circj.CJ-11-0592; Kobayashi S, 2013, J CLIN PHARM THER, V38, P258, DOI 10.1111/jcpt.12057	10	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2014	18	6					835	836		10.1007/s10157-014-0989-7		2	Urology & Nephrology	Urology & Nephrology	AX0IQ	WOS:000346636600001		
J	Ishizawa, S; Takahashi-Fujigasaki, J; Kanazawa, Y; Matoba, K; Kawanami, D; Yokota, T; Iwamoto, T; Tajima, N; Manome, Y; Utsunomiya, K				Ishizawa, Sho; Takahashi-Fujigasaki, Junko; Kanazawa, Yasushi; Matoba, Keiichiro; Kawanami, Daiji; Yokota, Tamotsu; Iwamoto, Takeo; Tajima, Naoko; Manome, Yoshinobu; Utsunomiya, Kazunori			Sphingosine-1-phosphate induces differentiation of cultured renal tubular epithelial cells under Rho kinase activation via the S1P2 receptor	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Sphingosine-1-phosphate; S1P2 receptor; Rho kinase; Epithelial-mesenchymal transition	DIABETIC-NEPHROPATHY; MESENCHYMAL TRANSITION; PHOSPHO-MYOSIN; HIGH GLUCOSE; E-CADHERIN; PATHWAY; FIBROSIS; FASUDIL; MODEL; RATS	Sphingosine-1-phosphate (S1P) is reportedly involved in the pathogenesis of kidney disease; however, the precise role played by S1P in renal disorders still remains controversial. Rho kinase plays an important role in the development of diabetic nephropathy by inducing glomerular and tubulointerstitial fibrosis. Rho kinase is known to be stimulated by S1P through its specific receptor, S1P2 receptor (S1P2). Hence, we investigated whether S1P-S1P2 signaling plays a role in the epithelial-mesenchymal transition (EMT) through Rho kinase activation in renal tubules. To characterize the distribution of the S1P2, an immunohistochemical examination of the receptor was performed in the kidney of the non-diabetic and diabetic mice. Next, we examined Rho kinase activity as well as E-cadherin and alpha-smooth muscle actin (alpha-SMA) expression by real-time RT-PCR and western blotting in cultured rat tubular epithelial cells under S1P stimulation with and without a Rho kinase inhibitor and an S1P2 blocker. In addition, the distribution of E-cadherin and alpha-SMA was examined by immunocytochemistry. S1P2 was expressed mainly in the renal tubules; expression was intense in collecting ducts and distal tubules compared to other segments. S1P induced activation of Rho kinase through the S1P2, which changed the distribution of E-cadherin and increased the expression of alpha-SMA. Rho kinase activation by S1P via S1P2 initiated EMT changes in cultured renal tubular cells. Our results suggest that excessive stimulation of S1P might facilitate renal fibrosis via activation of Rho kinase through S1P2.	[Ishizawa, Sho; Kanazawa, Yasushi; Matoba, Keiichiro; Kawanami, Daiji; Yokota, Tamotsu; Tajima, Naoko; Utsunomiya, Kazunori] Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol,Minato Ku, Tokyo 1058461, Japan; [Takahashi-Fujigasaki, Junko] Jikei Univ, Sch Med, Div Neuropathol, Minato Ku, Tokyo 1058461, Japan; [Iwamoto, Takeo] Jikei Univ, Sch Med, Core Res Facil, Minato Ku, Tokyo 1058461, Japan; [Manome, Yoshinobu] Jikei Univ, Sch Med, Dept Mol Cell Biol, Minato Ku, Tokyo 1058461, Japan	Ishizawa, S (reprint author), Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol,Minato Ku, 3-25-8 Nishishinbashi, Tokyo 1058461, Japan.	ishizawa@jikei.ac.jp					Bischoff A, 2000, BRIT J PHARMACOL, V130, P1878, DOI 10.1038/sj.bjp.0703516; Sanchez T, 2004, J CELL BIOCHEM, V92, P913, DOI 10.1002/jcb.20127; Zhou HP, 2003, AM J PHYSIOL-CELL PH, V284, pC1255, DOI 10.1152/ajpcell.00520.2002; Fox TE, 2011, J LIPID RES, V52, P509, DOI 10.1194/jlr.M010595; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Avizienyte E, 2004, MOL BIOL CELL, V15, P2794, DOI 10.1091/mbc.E03-12-0879; Chun J, 2010, PHARMACOL REV, V62, P579, DOI 10.1124/pr.110.003111; Sahai E, 2002, NAT CELL BIOL, V4, P408, DOI 10.1038/ucb796; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Surendran K, 2005, J AM SOC NEPHROL, V16, P2373, DOI 10.1681/ASN.2004110949; Tumbarello DA, 2007, J CELL PHYSIOL, V211, P736, DOI 10.1002/jcp.20991; Sugimoto H, 2007, DIABETES, V56, P1825, DOI 10.2337/db06-1226; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; Gu LJ, 2013, CHEM PHARM BULL, V61, P688; Yatomi Y, 2006, CURR PHARM DESIGN, V12, P575, DOI 10.2174/138161206775474404; Bischoff A, 2001, BRIT J PHARMACOL, V132, P1925, DOI 10.1038/sj.bjp.0703969; Faulkner JL, 2005, AM J PATHOL, V167, P1193, DOI 10.1016/S0002-9440(10)61208-4; Gojo A, 2007, EUR J PHARMACOL, V568, P242, DOI 10.1016/j.ejphar.2007.04.011; Hills CE, 2009, AM J PHYSIOL-RENAL, V296, pF614, DOI 10.1152/ajprenal.90500.2008; Huang KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043874; Imasawa T, 2010, EXP TOXICOL PATHOL, V62, P53, DOI 10.1016/j.etp.2009.02.068; Jinde K, 2001, AM J KIDNEY DIS, V38, P761, DOI 10.1053/ajkd.2001.27693; Liu WH, 2012, EXP CELL RES, V318, P936, DOI 10.1016/j.yexcr.2012.02.020; Randriamboavonjy V, 2009, BASIC RES CARDIOL, V104, P333, DOI 10.1007/s00395-008-0769-1; Wu GL, 2010, BIOMED PHARMACOTHER, V64, P124, DOI 10.1016/j.biopha.2009.06.001; Zhang H, 2011, IN VITRO CELL DEV-AN, V47, P165, DOI 10.1007/s11626-010-9369-0; Zhu Q, 2011, AM J PHYSIOL-RENAL, V301, pF35, DOI 10.1152/ajprenal.00014.2011	28	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2014	18	6					844	852		10.1007/s10157-014-0933-x		9	Urology & Nephrology	Urology & Nephrology	AX0IQ	WOS:000346636600003		
J	Ishizawa, S; Takahashi-Fujigasaki, J; Kanazawa, Y; Matoba, K; Kawanami, D; Yokota, T; Iwamoto, T; Tajima, N; Manome, Y; Utsunomiya, K				Ishizawa, Sho; Takahashi-Fujigasaki, Junko; Kanazawa, Yasushi; Matoba, Keiichiro; Kawanami, Daiji; Yokota, Tamotsu; Iwamoto, Takeo; Tajima, Naoko; Manome, Yoshinobu; Utsunomiya, Kazunori			Sphingosine-1-phosphate induces differentiation of cultured renal tubular epithelial cells under Rho kinase activation via the S1P2 receptor (vol 18, pg 844, 2014)	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Correction									[Ishizawa, Sho; Kanazawa, Yasushi; Matoba, Keiichiro; Kawanami, Daiji; Yokota, Tamotsu; Tajima, Naoko; Utsunomiya, Kazunori] Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol,Minato Ku, Tokyo 1058461, Japan; [Takahashi-Fujigasaki, Junko] Jikei Univ, Sch Med, Div Neuropathol, Minato Ku, Tokyo 1058461, Japan; [Iwamoto, Takeo] Jikei Univ, Sch Med, Core Res Facil, Minato Ku, Tokyo 1058461, Japan; [Manome, Yoshinobu] Jikei Univ, Sch Med, Dept Mol Cell Biol, Minato Ku, Tokyo 1058461, Japan	Ishizawa, S (reprint author), Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol,Minato Ku, 3-25-8 Nishishinbashi, Tokyo 1058461, Japan.	ishizawa@jikei.ac.jp					Ishizawa S, 2014, CLIN EXP NEPHROL, V18, P844, DOI 10.1007/s10157-014-0933-x	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2014	18	6					853	854		10.1007/s10157-014-0963-4		2	Urology & Nephrology	Urology & Nephrology	AX0IQ	WOS:000346636600004		
J	Hosoya, T; Ohno, I; Nomura, S; Hisatome, I; Uchida, S; Fujimori, S; Yamamoto, T; Hara, S				Hosoya, Tatsuo; Ohno, Iwao; Nomura, Shinsuke; Hisatome, Ichiro; Uchida, Shunya; Fujimori, Shin; Yamamoto, Tetsuya; Hara, Shigeko			Effects of topiroxostat on the serum urate levels and urinary albumin excretion in hyperuricemic stage 3 chronic kidney disease patients with or without gout	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Hyperuricemia; Gout; CKD; Topiroxostat; FYX-051	URIC-ACID; XANTHINE OXIDOREDUCTASE; CARDIOVASCULAR RISK; CRYSTAL-STRUCTURE; RENAL-DISEASE; ALLOPURINOL; PROGRESSION; MANAGEMENT; POPULATION; INHIBITION	Topiroxostat, a selective xanthine oxidase inhibitor, shows effective reduction in the serum urate level in hyperuricemic patients with or without gout. The objective of this study was to evaluate the efficacy and safety of topiroxostat in hyperuricemic stage 3 chronic kidney disease patients with or without gout. The study design was a 22-week, randomized, multicenter, double-blind study. The enrolled patients were randomly assigned to treatment with topiroxostat 160 mg/day (n = 62) or to the placebo (n = 61). The endpoints were the percent change in the serum urate level, change in the estimated glomerular filtration rate, the urinary albumin-to-creatinine ratio, the proportion of patients with serum urate levels of 356.88 mu mol/L or less, blood pressure, and serum adiponectin. After 22 weeks, although the changes in the estimated glomerular filtration rate and blood pressure were not significant, the percent change in the serum urate level (-45.38 vs. -0.08 %, P < 0.0001) and the percent change in urinary albumin-to-creatinine ratio (-33.0 vs. -6.0 %, P = 0.0092) were found to have decreased in the topiroxostat as compared with the placebo. Although the incidence of 'alanine aminotransferase increased' was higher in the topiroxostat, serious adverse event rates were similar in the two groups. Topiroxostat 160 mg effectively reduced the serum urate level in the hyperuricemic stage 3 chronic kidney disease patients with or without gout.	[Hosoya, Tatsuo] Jikei Univ, Sch Med, Dept Pathophysiol & Therapy Chron Kidney, Minato Ku, Tokyo 1058461, Japan; [Ohno, Iwao] Jikei Univ, Sch Med, Dept Internal Med, Div Gen Med,Minato Ku, Tokyo 1058461, Japan; [Nomura, Shinsuke] Suzuka Kaisei Hosp, Kidney Ctr, Nephrol & Dialysis Unit, Suzuka, Mie, Japan; [Hisatome, Ichiro] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Div Regenerat Med & Therapeut, Yonago, Tottori, Japan; [Uchida, Shunya; Fujimori, Shin] Teikyo Univ, Sch Med, Dept Internal Med, Itabashi Ku, Tokyo 173, Japan; [Yamamoto, Tetsuya] Hyogo Coll Med, Dept Internal Med, Div Endocrinol & Metab, Nishinomiya, Hyogo, Japan; [Hara, Shigeko] Toranomon Gen Hosp, Ctr Hlth Management, Minato Ku, Tokyo, Japan; [Hara, Shigeko] Toranomon Gen Hosp, Okinaka Mem Inst Med Res, Minato Ku, Tokyo, Japan	Hosoya, T (reprint author), Jikei Univ, Sch Med, Dept Pathophysiol & Therapy Chron Kidney, Minato Ku, 3-25-8 Nishi Shimbashi, Tokyo 1058461, Japan.	t-hosoya@jikei.ac.jp			SKK	We are grateful to the investigators, local study coordinators, and patients for their valuable contributions to this study; Yoshimi Ogawa, employee of Sanwa Kagaku Kenkyusho co., ltd. (SKK), for contribution to the study designs; Hiroya Hashimoto, employee of SKK, for statistical programming support; and Ryusuke Sakamoto, employee of SKK for medical writing support. This study was funded by SKK.	Chonchol M, 2007, AM J KIDNEY DIS, V50, P239, DOI 10.1053/j.ajkd.2007.05.013; Sato T, 2009, BIOORG MED CHEM LETT, V19, P6225, DOI 10.1016/j.bmcl.2009.08.091; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Zhu YY, 2012, AM J MED, V125, P679, DOI 10.1016/j.amjmed.2011.09.033; ARELLANO F, 1993, ANN PHARMACOTHER, V27, P337; Gagliardi ACM, 2009, ATHEROSCLEROSIS, V202, P11, DOI 10.1016/j.atherosclerosis.2008.05.022; HANDE KR, 1984, AM J MED, V76, P47, DOI 10.1016/0002-9343(84)90743-5; Kosugi T, 2009, AM J PHYSIOL-RENAL, V297, pF481, DOI 10.1152/ajprenal.00092.2009; Siu YP, 2006, AM J KIDNEY DIS, V47, P51, DOI 10.1053/j.ajkd.2005.10.006; Yamanaka H, 2011, NUCLEOS NUCLEOT NUCL, V30, P1018, DOI 10.1080/15257770.2011.596496; Omori H, 2012, CLIN EXP NEPHROL, V16, P549, DOI 10.1007/s10157-012-0609-3; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Iseki K, 2001, HYPERTENS RES, V24, P691, DOI 10.1291/hypres.24.691; Curiel RV, 2012, SEMIN ARTHRITIS RHEU, V42, P166, DOI 10.1016/j.semarthrit.2012.03.013; Choi HK, 2007, AM J MED, V120, P442, DOI 10.1016/j.amjmed.2006.06.040; Matsumoto K, 2011, J PHARMACOL EXP THER, V336, P95, DOI 10.1124/jpet.110.174540; Chang HY, 2010, AM J MED SCI, V339, P509, DOI 10.1097/MAJ.0b013e3181db6e16; Okamoto K, 2003, J BIOL CHEM, V278, P1848, DOI 10.1074/jbc.M208307200; Goicoechea M, 2010, CLIN J AM SOC NEPHRO, V5, P1388, DOI 10.2215/CJN.01580210; Okamoto K, 2004, P NATL ACAD SCI USA, V101, P7931, DOI 10.1073/pnas.0400973101; EMMERSON BT, 1987, BRIT J RHEUMATOL, V26, P445; Collins AJ, 2012, AM J KIDNEY DIS, V59, pe1, DOI DOI 10.1053/J.AJKD.2011.11.015; Collins AJ, 2012, AM J KIDNEY DIS, V59, pEVII, DOI 10.1053/j.ajkd.2011.11.015; Dalbeth N, 2006, J RHEUMATOL, V33, P1646; Feig DI, 2009, CURR OPIN NEPHROL HY, V18, P526, DOI 10.1097/MNH.0b013e328330d9d0; Ng W. Y., 2000, Annals Academy of Medicine Singapore, V29, P62; Schumacher HR, 2008, ARTHRIT RHEUM-ARTHR, V59, P1540, DOI 10.1002/art.24209	27	1	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2014	18	6					876	884		10.1007/s10157-014-0935-8		9	Urology & Nephrology	Urology & Nephrology	AX0IQ	WOS:000346636600007		
J	Kondo, M; Yamagata, K; Hoshi, SL; Saito, C; Asahi, K; Moriyama, T; Tsuruya, K; Konta, T; Fujimoto, S; Narita, I; Kimura, K; Iseki, K; Watanabe, T				Kondo, Masahide; Yamagata, Kunihiro; Hoshi, Shu-Ling; Saito, Chie; Asahi, Koichi; Moriyama, Toshiki; Tsuruya, Kazuhiko; Konta, Tsuneo; Fujimoto, Shouichi; Narita, Ichiei; Kimura, Kenjiro; Iseki, Kunitoshi; Watanabe, Tsuyoshi			Budget impact analysis of chronic kidney disease mass screening test in Japan	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						CKD; Budget impact; Dipstick test; Mass screening; Proteinuria; Serum creatinine assay	DRUG DISCOVERY; COST-EFFECTIVENESS; CKD; PERSPECTIVES; PROGRESSION; PREVENTION; PROGRAM	Our recently published cost-effectiveness study on chronic kidney disease mass screening test in Japan evaluated the use of dipstick test, serum creatinine (Cr) assay or both in specific health checkup (SHC). Mandating the use of serum Cr assay additionally, or the continuation of current policy mandating dipstick test only was found cost-effective. This study aims to examine the affordability of previously suggested reforms. Budget impact analysis was conducted assuming the economic model would be good for 15 years and applying a population projection. Costs expended by social insurers without discounting were counted as budgets. Annual budget impacts of mass screening compared with do-nothing scenario were calculated as Ayen79-Ayen-1,067 million for dipstick test only, Ayen2,505-Ayen9,235 million for serum Cr assay only and Ayen2,517-Ayen9,251 million for the use of both during a 15-year period. Annual budget impacts associated with the reforms were calculated as Ayen975-Ayen4,129 million for mandating serum Cr assay in addition to the currently used mandatory dipstick test, and Ayen963-Ayen4,113 million for mandating serum Cr assay only and abandoning dipstick test. Estimated values associated with the reform from Ayen963-Ayen4,129 million per year over 15 years are considerable amounts of money under limited resources. The most impressive finding of this study is the decreasing additional expenditures in dipstick test only scenario. This suggests that current policy which mandates dipstick test only would contain medical care expenditure.	[Kondo, Masahide; Hoshi, Shu-Ling] Univ Tsukuba, Dept Hlth Care Policy & Hlth Econ, Fac Med, Tsukuba, Ibaraki 3058577, Japan; [Yamagata, Kunihiro; Saito, Chie] Univ Tsukuba, Dept Nephrol, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Asahi, Koichi] Fukushima Med Univ, Sch Med, Dept Chron Kidney Dis Initiat, Fukushima 9601295, Japan; [Moriyama, Toshiki] Osaka Univ, Hlth Care Ctr, Toyonaka, Osaka 5600043, Japan; [Tsuruya, Kazuhiko] Kyushu Univ, Grad Sch Med Sci, Dept Integrated Therapy Chron Kidney Dis, Higashi Ku, Fukuoka 8128582, Japan; [Konta, Tsuneo] Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata 9909585, Japan; [Fujimoto, Shouichi] Miyazaki Univ, Dept Hemovasc Med & Artificial Organs, Fac Med, Miyazaki 8891692, Japan; [Narita, Ichiei] Niigata Univ, Grad Sch Med & Dent Sci, Div Clin Nephrol & Rheumatol, Niigata 9518510, Japan; [Kimura, Kenjiro] St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens,Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan; [Iseki, Kunitoshi] Univ Hosp Ryukyus, Dialysis Unit, Nishihara, Okinawa 9030215, Japan; [Watanabe, Tsuyoshi] Fukushima Med Univ, Sch Med, Dept Nephrol Hypertens Diabetol Endocrinol & Meta, Fukushima 9601295, Japan	Kondo, M (reprint author), Univ Tsukuba, Dept Hlth Care Policy & Hlth Econ, Fac Med, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan.	mkondo@md.tsukuba.ac.jp			Ministry of Health, Labour and Welfare of Japan [H20-circulatory(lifestyle)-ippan-008, H24-intractible(renal)-ippan-006, H19-renal disease-senryaku-001]	This work was supported by Health and Labour Sciences Research Grants for "Research on the positioning of chronic kidney disease (CKD) in Specific Health Check and Guidance in Japan" (H20-circulatory(lifestyle)-ippan-008), "Design of the comprehensive health care system for chronic kidney disease (CKD) based on the individual risk assessment by specific health checkup" (H24-intractible(renal)-ippan-006), and a grant for strategic outcome study project for renal disease (H19-renal disease-senryaku-001), the Ministry of Health, Labour and Welfare of Japan.	Adang E, 2005, HEALTH POLICY, V74, P146, DOI 10.1016/j.healthpol.2004.12.015; Li PKT, 2011, NEPHROLOGY, V16, P633, DOI 10.1111/j.1440-1797.2011.01503.x; Peralta CA, 2011, JAMA-J AM MED ASSOC, V305, P1545, DOI 10.1001/jama.2011.468; Mauskopf JA, 2007, VALUE HEALTH, V10, P336, DOI 10.1111/j.1524-4733.2007.00187.x; Kohro T, 2008, INT HEART J, V49, P193, DOI 10.1536/ihj.49.193; Imai E, 2007, CLIN J AM SOC NEPHRO, V2, P1360, DOI 10.2215/CJN.00980207; Tsukamoto Y, 2009, CLIN EXP NEPHROL, V13, P249, DOI 10.1007/s10157-009-0156-8; Kondo M, 2012, CLIN EXP NEPHROL, V16, P279, DOI 10.1007/s10157-011-0567-1; de Jong PE, 2008, CLIN J AM SOC NEPHRO, V3, P616, DOI 10.2215/CJN.04381007; Chen N, 2010, NEPHROLOGY, V15, P31, DOI 10.1111/j.1440-1797.2010.01309.x; Cohen Joshua, 2006, Appl Health Econ Health Policy, V5, P177, DOI 10.2165/00148365-200605030-00004; Collins AJ, 2009, AM J KIDNEY DIS, V53, pS71, DOI 10.1053/j.ajkd.2008.07.057; Culyer AJ, 2010, DICT HLTH EC; El Nahas AM, 2005, LANCET, V365, P331; Iseki K., 2011, JMAJ, V54, P27; Ishizawa K, 2009, J PHARMACOL SCI, V109, P14, DOI 10.1254/jphs.08R08FM; Kiberd B, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c5734; Levey AS, 2010, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, AM J KIDNEY DIS, V53, P522, DOI 10.1053/j.ajkd.2008.11.019; Ministry of Health Labour and Welfare, 2010, HEIS 20 NEND TOK KEN; Ministry of Health Labour and Welfare, 2013, EST NAT MED CAR EXP; National Institute of Population and Social Security Research Tokyo Japan, 2008, POP PROJ JAP SUPPL 2; Nishiyama A, 2009, J PHARMACOL SCI, V109, P1, DOI 10.1254/jphs.08R12FM; Ohkita M, 2009, J PHARMACOL SCI, V109, P7, DOI 10.1254/jphs/08R10FM; Seino Yutaka, 2010, Nihon Rinsho, V68, P2357; Yamagata K, 2008, CLIN EXP NEPHROL, V12, P1, DOI 10.1007/s10157-007-0010-9; Yamagata K, 2010, CLIN EXP NEPHROL, V14, P144, DOI 10.1007/s10157-009-0249-4	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2014	18	6					885	891		10.1007/s10157-014-0943-8		7	Urology & Nephrology	Urology & Nephrology	AX0IQ	WOS:000346636600008		
J	Ishigami, T; Yamamoto, R; Nagasawa, Y; Isaka, Y; Rakugi, H; Iseki, K; Yamagata, K; Tsuruya, K; Yoshida, H; Fujimoto, S; Asahi, K; Kurahashi, I; Ohashi, Y; Moriyama, T; Watanabe, T				Ishigami, Toshihiro; Yamamoto, Ryohei; Nagasawa, Yasuyuki; Isaka, Yoshitaka; Rakugi, Hiromi; Iseki, Kunitoshi; Yamagata, Kunihiro; Tsuruya, Kazuhiko; Yoshida, Hideaki; Fujimoto, Shouichi; Asahi, Koichi; Kurahashi, Issei; Ohashi, Yasuo; Moriyama, Toshiki; Watanabe, Tsuyoshi			An association between serum gamma-glutamyltransferase and proteinuria in drinkers and non-drinkers: a Japanese nationwide cross-sectional survey	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Proteinuria; gamma-Glutamyltransferase; Alcohol	CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; MODERATE ALCOHOL-CONSUMPTION; STAGE RENAL-DISEASE; ISCHEMIC-HEART-DISEASE; LIFE-STYLE FACTORS; DIPSTICK PROTEINURIA; OXIDATIVE STRESS; RISK-FACTOR; ALL-CAUSE	The association between alcohol consumption and chronic kidney disease (CKD), characterized by reduced glomerular filtration rate and proteinuria, is controversial. Recent studies suggest that serum gamma-glutamyltransferase (GGT) level, a conventional marker of excessive alcohol consumption, predicts the CKD incidence. Little information is available on the difference in the clinical impact of alcohol consumption and GGT on proteinuria. The present cross-sectional survey included 332,296 Japanese people aged a parts per thousand yen40 years in 2008. To examine the associations of GGT and alcohol consumption with proteinuria, 134,600 men and 197,696 women were classified into 20 categories based on GGT quartiles and alcohol consumption categories, and their prevalence rate ratios (PRR) of proteinuria defined as a parts per thousand yen1+ of dipstick urinary protein were calculated after adjusting for clinically relevant factors. Prevalence of proteinuria was 7.5 and 3.7 % in men and women, respectively. In both gender an association between alcohol consumption and proteinuria was in a J-shaped fashion with the lowest PRR of mild drinkers with a parts per thousand currency sign19 g/day of ethanol consumption, whereas an association between serum GGT level and proteinuria was linear. Compared with rare drinkers in the lowest GGT quartile, the subjects in higher GGT quartiles had a higher probability of proteinuria, irrespective of alcohol consumption. An optimal cutoff level of serum GGT was 43.6 and 23.2 IU/L in men and women, respectively. The subjects with higher serum GGT level had a higher probability of proteinuria, regardless of alcohol consumption, suggesting that GGT has a clinically greater impact on CKD than alcohol consumption.	[Ishigami, Toshihiro; Yamamoto, Ryohei; Nagasawa, Yasuyuki; Isaka, Yoshitaka; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan; [Iseki, Kunitoshi; Yamagata, Kunihiro; Tsuruya, Kazuhiko; Yoshida, Hideaki; Fujimoto, Shouichi; Asahi, Koichi; Moriyama, Toshiki; Watanabe, Tsuyoshi] Steering Comm Res Positioning Chron Kidney Dis CK, Tokyo, Japan; [Kurahashi, Issei] Univ Tokyo, Sch Med, Dept Med Informat & Econ, Bunkyo Ku, Tokyo 1130033, Japan; [Ohashi, Yasuo] Univ Tokyo, Sch Publ Hlth, Dept Biostat, Bunkyo Ku, Tokyo 1130033, Japan; [Moriyama, Toshiki] Osaka Univ, Healthcare Ctr, Toyonaka, Osaka 5600043, Japan	Moriyama, T (reprint author), Osaka Univ, Healthcare Ctr, 1-17 Machikaneyama Cho, Toyonaka, Osaka 5600043, Japan.	moriyama@wellness.hss.osaka-u.ac.jp			Ministry of Health, Labor and Welfare of Japan [20230601]	The present study was supported by Health and Labor Sciences Research Grants for "Research on the positioning of CKD in Specific Health Check and Guidance in Japan" (20230601), the Ministry of Health, Labor and Welfare of Japan.	Briasoulis A, 2012, J CLIN HYPERTENS, V14, P792, DOI 10.1111/jch.12008; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Vupputuri S, 2003, ANN EPIDEMIOL, V13, P712, DOI 10.1016/S1047-2797(03)00066-8; Wakasugi M, 2013, HYPERTENS RES, V36, P328, DOI 10.1038/hr.2012.186; Roerecke M, 2011, AM J EPIDEMIOL, V173, P245, DOI 10.1093/aje/kwq364; Iseki K, 2012, CLIN EXP NEPHROL, V16, P244, DOI 10.1007/s10157-011-0551-9; Guo R, 2010, INT J ENV RES PUB HE, V7, P1285, DOI 10.3390/ijerph7041285; Ishani A, 2006, J AM SOC NEPHROL, V17, P1444, DOI 10.1681/ASN.2005091012; Lim JS, 2004, FREE RADICAL BIO MED, V37, P1018, DOI 10.1016/j.freeradbiomed.2004.06.032; Fraser A, 2009, DIABETES CARE, V32, P741, DOI 10.2337/dc08-1870; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Du GL, 2013, PREV MED, V57, P31, DOI 10.1016/j.ypmed.2013.03.011; Koppes LLJ, 2005, DIABETES CARE, V28, P719, DOI 10.2337/diacare.28.3.719; Shankar A, 2006, AM J EPIDEMIOL, V164, P263, DOI 10.1093/aje/kwj173; Robinson-Cohen C, 2009, ARCH INTERN MED, V169, P2116, DOI 10.1001/archinternmed.2009.438; Hanigan MH, 1996, J HISTOCHEM CYTOCHEM, V44, P1101; Obi Y, 2010, CLIN J AM SOC NEPHRO, V5, P1558, DOI 10.2215/CJN.08061109; Yamamoto R, 2010, AM J KIDNEY DIS, V56, P313, DOI 10.1053/j.ajkd.2010.02.351; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Peng Giia-Sheun, 2009, Human Genomics, V3, P121; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Lee DH, 2004, FREE RADICAL RES, V38, P535, DOI 10.1080/10715760410001694026; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; Roerecke M, 2012, ADDICTION, V107, P1246, DOI 10.1111/j.1360-0443.2012.03780.x; Yano Y, 2012, KIDNEY INT, V81, P293, DOI 10.1038/ki.2011.346; Stengel B, 2003, EPIDEMIOLOGY, V14, P479, DOI [10.1097/01.EDE.0000071413.55296.c4, 10.1097/00001648-200307000-00018]; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Stickel F, 2006, ALCOHOL ALCOHOLISM, V41, P209, DOI 10.1093/alcalc/ag1011; Drozdz R, 1998, FREE RADICAL BIO MED, V25, P786, DOI 10.1016/S0891-5849(98)00127-0; Turgut O, 2011, J ATHEROSCLER THROMB, V18, P177; Kronborg J, 2008, NEPHROL DIAL TRANSPL, V23, P2818, DOI 10.1093/ndt/gfn148; Stockwell T, 2004, ADDICTION, V99, P1024, DOI 10.1111/j.1360-0443.2004.00815.x; Gunzerath L, 2004, ALCOHOL CLIN EXP RES, V28, P829, DOI 10.1097/01.ALC.0000128382.79375.B6; Carlsson S, 2005, DIABETOLOGIA, V48, P1051, DOI 10.1007/s00125-005-1768-5; Ryu S, 2007, CLIN CHEM, V53, P71, DOI 10.1373/clinchem.2006.078980; Fraser A, 2007, ARTERIOSCL THROM VAS, V27, P2729, DOI 10.1161/ATVBAHA.107.152298; Yamada J, 2006, ATHEROSCLEROSIS, V189, P198, DOI 10.1016/j.atherosclerosis.2005.11.036; Shah SV, 2007, J AM SOC NEPHROL, V18, P16, DOI 10.1681/ASN.2006050500; Kondo M, 2012, CLIN EXP NEPHROL, V16, P279, DOI 10.1007/s10157-011-0567-1; Hines LM, 2001, NEW ENGL J MED, V344, P549, DOI 10.1056/NEJM200102223440802; Ravuri C, 2011, FREE RADICAL RES, V45, P600, DOI 10.3109/10715762.2011.564164; Dawson DA, 2013, ADDICTION, V108, P712, DOI 10.1111/add.12079; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263; Barros Aluísio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Boniface S, 2013, ALCOHOL CLIN EXP RES, V37, P978, DOI 10.1111/acer.12046; Buja A, 2011, PUBLIC HEALTH NUTR, V14, P1907, DOI 10.1017/S1368980011000863; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Drogan D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032176; Han HG, 2013, GENE, V526, P134, DOI 10.1016/j.gene.2013.05.002; Hashimoto Y, 2008, DIABETES RES CLIN PR, V80, P469, DOI 10.1016/j.diabres.2008.01.025; Hozawa A, 2010, J ATHEROSCLER THROMB, V17, P195; Ichikawa K, 2011, CLIN EXP NEPHROL, V15, P841, DOI 10.1007/s10157-011-0509-y; Knight EL, 2003, NEPHROL DIAL TRANSPL, V18, P1549, DOI 10.1093/ndt/gfg228; Konta T, 2012, AM J HYPERTENS, V25, P342, DOI 10.1038/ajh.2011.217; Lee DH, 2005, CLIN CHEM, V51, P1185, DOI 10.1373/clinchem.2004.045872; Liu CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048878; Menon V, 2010, NEPHROL DIAL TRANSPL, V25, P3301, DOI 10.1093/ndt/gfq188; Nagasawa Y, 2012, HYPERTENS RES, V35, P161; Nakagawa H, 2012, J GASTROENTEROL, V47, P187, DOI 10.1007/s00535-011-0477-8; Paolicchi A, 1999, J INVEST MED, V47, P151; Patra J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-258; Reynolds K, 2008, KIDNEY INT, V73, P870, DOI 10.1038/sj.ki.5002774; Ronksley PE, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d671; Sato Y, 2013, CLIN EXP NE IN PRESS; Schaeffner E, 2012, KIDNEY INT, V81, P816, DOI 10.1038/ki.2012.14; Schaeffner ES, 2005, ARCH INTERN MED, V165, P1048, DOI 10.1001/archinte.165.9.1048; Scouller K, 2000, CLIN CHEM, V46, P1894; Wakasugi M, 2012, CLIN EXP NEPHROL, V16, P259, DOI 10.1007/s10157-011-0565-3; White SL, 2009, NEPHROL DIAL TRANSPL, V24, P2464, DOI 10.1093/ndt/gfp114; Yamamoto R, 2012, AM J KIDNEY DIS, V59, P343, DOI 10.1053/j.ajkd.2011.08.032; Younis J, 2005, ATHEROSCLEROSIS, V180, P225, DOI 10.1016/j.athersclerosis.2004.12.010; Zambon S, 2012, ATHEROSCLEROSIS, V220, P201, DOI 10.1016/j.atherosclerosis.2011.09.023	73	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2014	18	6					899	910		10.1007/s10157-014-0938-5		12	Urology & Nephrology	Urology & Nephrology	AX0IQ	WOS:000346636600010		
J	Okamoto, H; Kawamura, T; Okonogi, H; Tsuboi, N; Miyazaki, Y; Yokoo, T				Okamoto, Hidekazu; Kawamura, Tetsuya; Okonogi, Hideo; Tsuboi, Nobuo; Miyazaki, Yoichi; Yokoo, Takashi			The role of a low glomerular density and being overweight in the etiology of proteinuria in CKD patients without known glomerular diseases	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Chronic kidney disease; Glomerular hypertrophy; Proteinuria; Overweight; Obesity; Body mass index; Renal biopsy; Glomerular density	CHRONIC KIDNEY-DISEASE; OBESITY-RELATED GLOMERULOPATHY; MASSIVE OBESITY; UNITED-STATES; PREVALENCE; POPULATION; PROGRESSION	Among the proteinuric patients with chronic kidney disease (CKD) who undergo a renal biopsy, we sometimes encounter those who cannot be classified as having a known primary or secondary glomerular disease. The pathogenesis and pathophysiology of these CKD patients have not been sufficiently elucidated. We recruited 34 proteinuric patients without known glomerular diseases. The glomerular volumes (GV) of the biopsy specimens from those patients were determined by a morphometric analysis. Glomerular hypertrophy (GH) was defined as having more than 3.6 x 10(6) mu m(3). The patients were divided in two groups: those with GH (Group 1) and those without GH (Group 2). We compared the clinical and pathological parameters between Group 1 and Group 2, and among the three groups of patients: non-obese, overweight and obese group. The patients with Group 1 had significantly higher values for the proportion of males, the body mass index (BMI), uric acid and significantly lower values for the glomerular density (GD). Of note, a multivariate regression analysis revealed that sex, the BMI and GD were significant factors correlated with the mean GV. The values for the mean GV were significantly higher in the overweight and obese groups as compared to the non-obese group, and the values for the GD were significantly lower in the obese group than in the non-obese group. We identified a subgroup of patients who were characterized as having a high BMI and GV, and a low GD among the proteinuric CKD patients without known glomerular diseases.	[Okamoto, Hidekazu; Kawamura, Tetsuya; Okonogi, Hideo; Tsuboi, Nobuo; Miyazaki, Yoichi; Yokoo, Takashi] Jikei Univ, Sch Med, Dept Internal Med, Div Kidney & Hypertens,Minato Ku, Tokyo 1058461, Japan	Kawamura, T (reprint author), Jikei Univ, Sch Med, Dept Internal Med, Div Kidney & Hypertens,Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	kawatetu@coral.ocn.ne.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Irie F, 2006, KIDNEY INT, V69, P1264, DOI 10.1038/sj.ki.5000284; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009; Tsuboi N, 2012, CLIN J AM SOC NEPHRO, V7, P735, DOI 10.2215/CJN.07270711; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Gambaro G, 2010, CLIN J AM SOC NEPHRO, V5, P1946, DOI 10.2215/CJN.02400310; de Jong PE, 2008, CLIN J AM SOC NEPHRO, V3, P616, DOI 10.2215/CJN.04381007; COHEN AH, 1975, AM J PATHOL, V81, P117; Eknoyan G, 2004, KIDNEY INT, V66, P2681; FOGO A, 1990, KIDNEY INT, V38, P115, DOI 10.1038/ki.1990.175; Fulladosa X, 2003, J AM SOC NEPHROL, V14, P2662, DOI 10.1097/01.ASN.0000088025.33462.B0; Hughson MD, 2007, ARCH PATHOL LAB MED, V131, P1665; Imai Enyu, 2007, Clin Exp Nephrol, V11, P156, DOI 10.1007/s10157-007-0463-x; JUNGERS P, 1995, NEPHROL DIAL TRANSPL, V10, P1353; Sasatomi Y, 2001, PATHOBIOLOGY, V69, P113, DOI 10.1159/000048764; Weibel ER, 1979, STEREOLOGICAL METHOD, V1, p[44, 131]; WEISINGE.JR, 1974, ANN INTERN MED, V81, P440; YOSHIDA Y, 1989, KIDNEY INT, V36, P626, DOI 10.1038/ki.1989.239	20	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2014	18	6					911	917		10.1007/s10157-014-0940-y		7	Urology & Nephrology	Urology & Nephrology	AX0IQ	WOS:000346636600011		
J	Okamoto, H; Kawamura, T; Okonogi, H; Tsuboi, N; Miyazaki, Y; Yokoo, T				Okamoto, Hidekazu; Kawamura, Tetsuya; Okonogi, Hideo; Tsuboi, Nobuo; Miyazaki, Yoichi; Yokoo, Takashi			The role of a low glomerular density and being overweight in the etiology of proteinuria in CKD patients without known glomerular diseases (vol 18, pg 911, 2014)	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Correction									[Okamoto, Hidekazu; Kawamura, Tetsuya; Okonogi, Hideo; Tsuboi, Nobuo; Miyazaki, Yoichi; Yokoo, Takashi] Jikei Univ, Sch Med, Dept Internal Med, Div Kidney & Hypertens,Minato Ku, Tokyo 1058461, Japan	Kawamura, T (reprint author), Jikei Univ, Sch Med, Dept Internal Med, Div Kidney & Hypertens,Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	kawatetu@coral.ocn.ne.jp					OKAMOTO I, 2014, CLIN EXP NEPHROL, V18, P911, DOI DOI 10.1007/S10157-014-0940-Y	1	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2014	18	6					918	918		10.1007/s10157-014-0964-3		1	Urology & Nephrology	Urology & Nephrology	AX0IQ	WOS:000346636600012		
J	Goto, S; Nakai, K; Kono, K; Yonekura, Y; Ito, J; Fujii, H; Nishi, S				Goto, Shunsuke; Nakai, Kentaro; Kono, Keiji; Yonekura, Yuriko; Ito, Jun; Fujii, Hideki; Nishi, Shinichi			Dietary phosphorus restriction by a standard low-protein diet decreased serum fibroblast growth factor 23 levels in patients with early and advanced stage chronic kidney disease	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Chronic kidney disease; Fibroblast growth factor 23; Protein restriction	LEFT-VENTRICULAR HYPERTROPHY; VITAMIN-D; SECONDARY HYPERPARATHYROIDISM; CARDIOVASCULAR EVENTS; LANTHANUM CARBONATE; MINERAL METABOLISM; CKD PATIENTS; HEALTHY-MEN; FGF23; FGF-23	Elevated serum fibroblast growth factor 23 (FGF23) levels are associated with mortality, cardiovascular disease, and disease progression in patients with chronic kidney disease (CKD). Although recent studies demonstrated that FGF23 levels decreased in response to dietary restriction of phosphorus and/or use of phosphate binders, research on the effects of a standard low-protein diet is lacking. The effects of a standard low-protein diet on serum FGF23, intact parathyroid hormone, and 1,25-dihydroxyvitamin D levels were investigated in patients with early (n = 15) and advanced (n = 20) CKD. Serum FGF23 levels decreased in both groups. Changes in FGF23 levels correlated with changes in 24 h urinary phosphorus excretion in the advanced CKD group. Decreased serum intact parathyroid hormone levels were observed only in the advanced CKD group and increased serum 1,25-dihydroxyvitamin D levels only in the early CKD group. These findings suggest that consuming standard low-protein diet decreased serum FGF23 levels in patients with CKD. Serum FGF23 levels may therefore be a useful marker to monitor the effects of a low-protein diet in early and advanced stage CKD.	[Goto, Shunsuke; Nakai, Kentaro; Kono, Keiji; Yonekura, Yuriko; Ito, Jun; Fujii, Hideki; Nishi, Shinichi] Kobe Univ, Grad Sch Med, Div Nephrol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Goto, Shunsuke; Nakai, Kentaro; Kono, Keiji; Yonekura, Yuriko; Ito, Jun; Fujii, Hideki; Nishi, Shinichi] Kobe Univ, Grad Sch Med, Kidney Ctr, Chuo Ku, Kobe, Hyogo 6500017, Japan	Fujii, H (reprint author), Kobe Univ, Grad Sch Med, Div Nephrol, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	fhideki@med.kobe-u.ac.jp			Himeji Nephrology Research Grant; Kidney Foundation, Japan [JKFB12-43]	This study is supported by the Himeji Nephrology Research Grant and a grant from The Kidney Foundation, Japan (JKFB12-43). Preliminary results of this study were presented in part at the American Society of Nephrology Kidney Week 2013 Annual Meeting in Atlanta, GA, USA, on November 8, 2013.	Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Ito N, 2007, J BONE MINER METAB, V25, P419, DOI 10.1007/s00774-007-0779-3; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Seiler S, 2010, NEPHROL DIAL TRANSPL, V25, P3983, DOI 10.1093/ndt/gfq309; Shigematsu T, 2004, AM J KIDNEY DIS, V44, P250, DOI 10.1053/j.ajkd.2004.04.029; Di Iorio B, 2012, CLIN J AM SOC NEPHRO, V7, P581, DOI 10.2215/CJN.07640711; PAYNE RB, 1973, BRIT MED J, V4, P643; Saito H, 2005, J BIOL CHEM, V280, P2543, DOI 10.1074/jbc.M408903200; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Nishida Y, 2006, KIDNEY INT, V70, P2141, DOI 10.1038/sj.ki.5002000; Fliser D, 2007, J AM SOC NEPHROL, V18, P2600, DOI 10.1681/ASN.2006080936; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Koiwa F, 2005, THER APHER DIAL, V9, P336, DOI 10.1111/j.1744-9987.2005.00293.x; Isakova T, 2011, NEPHROL DIAL TRANSPL, V26, P584, DOI 10.1093/ndt/gfq419; Yilmaz MI, 2012, AM J KIDNEY DIS, V59, P177, DOI 10.1053/j.ajkd.2011.11.007; Antoniucci DM, 2006, J CLIN ENDOCR METAB, V91, P3144, DOI 10.1210/jc.2006-0021; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Isakova T, 2008, J AM SOC NEPHROL, V19, P615, DOI 10.1681/ASN.2007060673; Burnett SAM, 2006, J BONE MINER RES, V21, P1187, DOI 10.1359/JBMR.060507; Sigrist M, 2013, NEPHROL DIAL TRANSPL, V28, P161, DOI 10.1093/ndt/gfs405; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P2792, DOI 10.1093/ndt/gfp191; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Kendrick J, 2011, J AM SOC NEPHROL, V22, P1913, DOI 10.1681/ASN.2010121224; Nakano C, 2012, CLIN J AM SOC NEPHRO, V7, P810, DOI 10.2215/CJN.08680811; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Oliveira RB, 2010, CLIN J AM SOC NEPHRO, V5, P286, DOI 10.2215/CJN.05420709; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Bleskestad IH, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-49; Calvo MS, 1996, J NUTR, V126, pS1168; Gonzalez-Parra E, 2011, NEPHROL DIAL TRANSPL, V26, P2567, DOI 10.1093/ndt/gfr144; Ito M, 2005, AM J PHYSIOL-ENDOC M, V288, pE1101, DOI 10.1152/ajpendo.00502.2004; Moe SM, 2011, CLIN J AM SOC NEPHRO, V6, P257, DOI 10.2215/CJN.05040610; Nakano C, 2012, BONE, V50, P1266, DOI 10.1016/j.bone.2012.02.634; Shigematsu T, 2012, NEPHROL DIAL TRANSPL, V27, P1050, DOI 10.1093/ndt/gfr388; Titan SM, 2011, CLIN J AM SOC NEPHRO, V6, P241, DOI 10.2215/CJN.04250510	36	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2014	18	6					925	931		10.1007/s10157-014-0947-4		7	Urology & Nephrology	Urology & Nephrology	AX0IQ	WOS:000346636600014		
J	Uemura, O; Hattori, M; Hataya, H; Ito, S; Ito, N; Akizawa, T				Uemura, Osamu; Hattori, Motoshi; Hataya, Hiroshi; Ito, Shuichi; Ito, Naoko; Akizawa, Tadao			Pharmacokinetics of darbepoetin alfa after single, intravenous or subcutaneous administration in Japanese pediatric patients with chronic kidney disease	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Anemia; Chronic kidney disease; Darbepoetin alfa; Pharmacokinetic	RECOMBINANT-HUMAN-ERYTHROPOIETIN; INJECTION	Darbepoetin alfa (DA) is beneficial for pediatric patients for its less injection frequency and greater maximum dose compared to recombinant human erythropoietin. Here, we evaluated pharmacokinetics of DA in Japanese pediatric patients with chronic kidney disease (CKD). CKD patients (2-18 years old, n = 8 each) received a single dose of body weight adjusted DA either intravenously or subcutaneously. When administered intravenously, the area under the concentration-time curve from time zero to infinity (AUC(0-a)), clearance (CL) and terminal half-life (t (1/2)) of DA were 263.7 ng center dot A h/mL, 1.77 mL/h/kg and 26.25 h, respectively (mean). In patients under 12 years old, AUC(0-a), CL and t (1/2) were 219.1 ng center dot A h/mL, 2.19 mL/h/kg, 23.62 h, respectively. These values were mostly similar to those of Japanese adult CKD patients, though AUC(0-a) tended to be lower and CL tended to be higher in the subjects under 12 years old. When administered subcutaneously, time to reach maximum concentration (t (max)) and maximum concentration (C (max)) were 24.47 h and 1.704 ng/mL, and AUC(0-a), apparent clearance (CL/F) and t (1/2) were 141.1 ng center dot A h/mL, 3.23 mL/h/kg and 46.73 h, respectively. In patients under 12 years old, t (max) and C (max) were 7.50 h and 2.053 ng/mL, and AUC(0-a), CL/F and t (1/2) were 136.7 ng center dot A h/mL, 3.29 mL/h/kg and 37.75 h, respectively, which was higher in C (max), faster in t (max) and shorter t (1/2) compared to adult CKD patients, while AUC was not obviously different. The pharmacokinetics of DA in pediatric CKD patients is not obviously different from those in adult.	[Uemura, Osamu] Aichi Childrens Hlth & Med Ctr, Dept Pediat Nephrol, Obu, Aichi 4748710, Japan; [Hattori, Motoshi] Tokyo Womens Med Univ, Sch Med, Dept Pediat Nephrol, Tokyo, Japan; [Hataya, Hiroshi] Tokyo Metropolitan Childrens Med Ctr, Dept Nephrol, Tokyo, Japan; [Ito, Shuichi] Natl Ctr Child Hlth & Dev, Div Nephrol & Rheumatol, Tokyo, Japan; [Ito, Naoko] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka, Japan; [Akizawa, Tadao] Showa Univ, Sch Med, Dept Med, Div Nephrol, Tokyo 142, Japan	Uemura, O (reprint author), Aichi Childrens Hlth & Med Ctr, Dept Pediat Nephrol, 1-2 Osakada,Morioka Cho, Obu, Aichi 4748710, Japan.	o_uemura@hkg.odn.ne.jp			Kyowa Hakko Kirin Co., Ltd (Japan); Kyowa Hakko Kirin Co., Ltd; Chugai Pharmaceutical Co., Ltd.; Astellas Pharma Inc.	This study was sponsored by Kyowa Hakko Kirin Co., Ltd (Japan). Advisory role: Tadao Akizawa (Kyowa Hakko Kirin Co., Ltd), Honoraria: Tadao Akizawa (Kyowa Hakko Kirin Co., Ltd, Chugai Pharmaceutical Co., Ltd., Bayer Holding Ltd., Astellas Pharma Inc., Mitsubishi Tanabe Pharma Corporation), Manuscript fees: Tadao Akizawa (Kyowa Hakko Kirin Co., Ltd, Chugai Pharmaceutical Co., Ltd., Astellas Pharma Inc.), Subsidies: Tadao Akizawa (Kyowa Hakko Kirin Co., Ltd, Chugai Pharmaceutical Co., Ltd., Bayer Holding Ltd., Daiich Sankyo Co., Ltd, Shionogi Co., Ltd, Nippon Boehringer Ingelheim Co., Ltd.). The other authors have declared that no conflict of interest exists.	Jelkmann W, 2002, EUR J HAEMATOL, V69, P265, DOI 10.1034/j.1600-0609.2002.02813.x; SUPERSAXO A, 1990, PHARMACEUT RES, V7, P167, DOI 10.1023/A:1015880819328; Brahm M, 1999, SCAND J UROL NEPHROL, V33, P192, DOI 10.1080/003655999750015989; Iino Y, 2010, KIDNEY DIAL, V68, P111; Iino Y, 2010, KIDNEY DIAL, V68, P121; JENSEN JD, 1994, EUR J CLIN PHARMACOL, V46, P333; Lerner Gary, 2002, Pediatric Nephrology, V17, P933; Michio T, 1992, J CLIN THERAP MED, P2549; Porter CJH, 2000, J PHARM SCI, V89, P297, DOI 10.1002/(SICI)1520-6017(200003)89:3<297::AID-JPS2>3.0.CO;2-P; Suga A, 2007, JPN J CLIN PHARM THE, V38, P331; WALTER J, 1993, NEPHROL DIAL TRANSPL, V8, P1428	11	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2014	18	6					932	938		10.1007/s10157-014-0936-7		7	Urology & Nephrology	Urology & Nephrology	AX0IQ	WOS:000346636600015		
J	Honda, M; Iijima, K; Ishikura, K; Kaneko, K				Honda, Masataka; Iijima, Kazumoto; Ishikura, Kenji; Kaneko, Kazunari			The problem of transition from pediatric to adult healthcare in patients with steroid-sensitive nephrotic syndrome (SSNS): a survey of the experts	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Transition; Nephrotic syndrome; Steroid; Adolescent; Young adult	ADOLESCENT MEDICINE; POSITION PAPER; SOCIETY; CHILDREN	The importance of the transition from pediatric to adult healthcare has recently been recognized. In patients with steroid-sensitive nephrotic syndrome (SSNS), the shift in steroid dose during the transition period is a big problem. Thus, change in treatment methods during this transition need to be clarified. Questionnaires were sent to all councilors of the Japanese Society for Pediatric Nephrology who managed SSNS in children. The questionnaires asked about steroid dose, informed consent, and transition programs. Councilors in 50 of 57 (87.7 %) institutes responded within 2 weeks. About one-third of pediatric nephrologists (PNs) did not transfer patients to adult units, and half of PNs followed patients after they reached adulthood (i.e., age > 20 years). The dose of steroids after puberty varied between doctors, but 74 % of PNs provided short-term daily therapy. 72 % of PNs informed the patients of the shift in steroid dose, but 26 % of PNs did not. About two-thirds of PNs did not consult with adult nephrologists before the transition from pediatric to adult care. No institute had a transition program for SSNS and 2 institutes had transition coordinators. Transition programs are needed in Japan. But the difference in the steroid regimen between pediatric and adult patients with SSNS is a barrier to transition. This difference needs to be discussed.	[Honda, Masataka] Tokyo Metropolitan Childrens Med Ctr, Dept Pediat Nephrol, JSPN, Fuchu, Tokyo 1838561, Japan; [Iijima, Kazumoto] Kobe Univ, Grad Sch Med, Dept Pediat, Acad Comm,JSPN, Kobe, Hyogo 657, Japan; [Ishikura, Kenji] Tokyo Metropolitan Childrens Med Ctr, Acad Comm, Dept Pediat Nephrol, JSPN, Tokyo, Japan; [Kaneko, Kazunari] Kansai Med Univ, Dept Pediat, JSPN, Acad Comm, Moriguchi, Osaka 570, Japan	Honda, M (reprint author), Tokyo Metropolitan Childrens Med Ctr, Dept Pediat Nephrol, JSPN, Musashidai 2-8-29, Fuchu, Tokyo 1838561, Japan.	mhond@fol.hi-ho.ne.jp					American Academy of Pediatrics; American Academy of Family Physicians; American College of Physicians-American Society of Internal Medicine, 2002, PEDIATRICS, V110, P1304; Reiss J, 2002, PEDIATRICS, V110, P1307; Fakhouri F, 2003, AM J KIDNEY DIS, V41, P550, DOI 10.1053/ajkd.2003.50116; Watson AR, 2011, PEDIATR NEPHROL, V26, P1753, DOI 10.1007/s00467-011-1981-z; Ruth EM, 2005, J PEDIATR-US, V147, P202, DOI 10.1016/j.jpeds.2005.03.050; Chaturvedi S, 2009, PEDIATR NEPHROL, V24, P1055, DOI 10.1007/s00467-009-1124-y; Bell L, 2007, PEDIATR NEPHROL, V22, P720, DOI 10.1007/s00467-006-0404-z; Watson AR, 2005, PEDIATR NEPHROL, V20, P113, DOI 10.1007/s00467-004-1763-y; Rosen DS, 2003, J ADOLESCENT HEALTH, V33, P309, DOI 10.1016/S1054-139X(03)00208-8; BLUM RW, 1993, J ADOLESCENT HEALTH, V14, P570, DOI 10.1016/1054-139X(93)90143-D; Ferris ME, 2009, SEMIN NEPHROL, V29, P435, DOI 10.1016/j.semnephrol.2009.03.018; Ishikura K, 2010, J AM SOC NEPHROL, V21, p403A; Ishizaki Yuko, 2012, Biopsychosoc Med, V6, P8, DOI 10.1186/1751-0759-6-8; Japanese Society for Pediatric Nephrology, 2013, CLIN PRACT GUID ID N; Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group, 2012, KIDNEY INT S2, V2012, P139; Kyrieleis HAC, 2009, CLIN J AM SOC NEPHRO, V4, P1593, DOI 10.2215/CJN.05691108; Maru M, 2008, GUIDEBOOK TRANSITION; Nakanishi K, 2013, CLIN J AM SOC NEPHRO, V8, P756, DOI 10.2215/CJN.09010912; Niaudet P, 2009, CLIN J AM SOC NEPHRO, V4, P1547, DOI 10.2215/CJN.05950809; The Japanese Society of Nephrology, 2011, NIHON JINZO GAKKAI S, V53, P78	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2014	18	6					939	943		10.1007/s10157-014-0941-x		5	Urology & Nephrology	Urology & Nephrology	AX0IQ	WOS:000346636600016		
J	Sugano, N; Yokoyama, K; Kato, N; Hara, Y; Endo, S; Mitome, J; Kin, T; Tokudome, G; Kuriyama, S; Hosoya, T; Yokoo, T				Sugano, Naoki; Yokoyama, Keitaro; Kato, Naohiko; Hara, Yoichiro; Endo, Satoshi; Mitome, Jun; Kin, Taisei; Tokudome, Goro; Kuriyama, Satoru; Hosoya, Tatsuo; Yokoo, Takashi			Monitoring of body water composition by the simultaneous use of bioelectrical impedance analysis and Crit-Line(A (R)) during hemodialysis	CLINICAL AND EXPERIMENTAL NEPHROLOGY			English	Article						Bioimpedance; Clit-line; Body water; Hemodialysis	BIOIMPEDANCE ANALYSIS; DRY-WEIGHT; EXTRACELLULAR WATER; DIALYSIS; VOLUME; EQUATIONS; SINGLE; OBESE	Bioelectrical impedance analysis (BIA) is a non-invasive method to estimate total body water (TBW) and extracellular water (ECW) volume. Crit-Line(A (R)) (CL), on the other hand, assesses intravascular water (IVW) volume. We evaluate continuous changes in body water composition during hemodialysis (HD) with concurrent use of BIA and CL. BIA at the start and the end of the HD session was measured using a BIA device. To investigate the shifting pattern of body water composition, patients were subjected to simultaneous monitoring of BIA with CL. Both TBW resistance (Rt) and ECW resistance (Re) increased in response to changes in the ultrafiltration (UF) ratio. There was a positive correlation between Delta Re/Rt and the UF ratio, and the ratio of Re/Rt at the end of HD was significantly higher than that at the start of HD. Simultaneous monitoring of BIA with CL showed a parallel shift of the change in the Re (Delta Re) and the change in hematocrit (Delta Ht). In one patient with increasing inflammatory response, change in Delta Ht was dissociated from change in Delta Re. One hyponatremic patient showed a different pattern of changing Delta Re between the first half and the latter half of the HD session. Our study suggests that the concurrent use of BIA and CL may be a useful technique to simulate water shift patterns across the different compartments in HD.	[Sugano, Naoki; Yokoyama, Keitaro; Hara, Yoichiro; Endo, Satoshi; Mitome, Jun; Kuriyama, Satoru; Hosoya, Tatsuo; Yokoo, Takashi] Jikei Univ, Sch Med, Dept Internal Med, Div Kidney & Hypertens,Minato Ku, Tokyo 1058461, Japan; [Kato, Naohiko] Shinagawa Jin Clin, Tokyo, Japan; [Kin, Taisei] Kawagoe Ekimae Clin, Saitama, Japan; [Tokudome, Goro] Tokyu Hosp, Dept Internal Med, Tokyo, Japan	Sugano, N (reprint author), Jikei Univ, Sch Med, Dept Internal Med, Div Kidney & Hypertens,Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	n-sugano@jikei.ac.jp					Alvarez-Lara MA, 2001, NEPHROL DIAL TRANSPL, V16, P94; Gudivaka R, 1999, J APPL PHYSIOL, V87, P1087; CHARRA B, 1992, KIDNEY INT, V41, P1286, DOI 10.1038/ki.1992.191; WATSON PE, 1980, AM J CLIN NUTR, V33, P27; Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906; Kraemer M, 2006, KIDNEY INT, V69, P1609, DOI 10.1038/sj.ki.5000286; HUME R, 1971, J CLIN PATHOL, V24, P234, DOI 10.1136/jcp.24.3.234; DeLorenzo A, 1997, J APPL PHYSIOL, V82, P1542; Chamney PW, 2002, KIDNEY INT, V61, P2250, DOI 10.1046/j.1523-1755.2002.00377.x; Basile C, 2007, CLIN J AM SOC NEPHRO, V2, P675, DOI 10.2215/CJN.00240107; Basile C, 2008, NEPHROL DIAL TRANSPL, V23, P1997, DOI 10.1093/ndt/gfm909; CHA KC, 1995, J APPL PHYSIOL, V79, P1316; Chen YC, 2002, NEPHRON, V92, P91, DOI 10.1159/000064471; Chertow GM, 1997, KIDNEY INT, V51, P1578, DOI 10.1038/ki.1997.216; HANNAN WJ, 1994, CLIN SCI, V86, P479; Hara Shigeko, 2003, Nihon Jinzo Gakkai Shi, V45, P65; Jaffrin MY, 1997, MED BIOL ENG COMPUT, V35, P266, DOI 10.1007/BF02530048; Piccoli A, 2005, KIDNEY INT, V67, P301, DOI 10.1111/j.1523-1755.2005.00083.x; PRESTA E, 1983, AM J CLIN NUTR, V37, P735; Sinning W E, 1993, ASAIO J, V39, pM584; Steijaert M, 1997, INT J OBESITY, V21, P930, DOI 10.1038/sj.ijo.0800497; VISSER M, 1995, EUR J CLIN NUTR, V49, P256; WIZEMANN V, 1995, NEPHROL DIAL TRANSPL, V10, P2114; Zhu FS, 2000, KIDNEY INT, V57, P299, DOI 10.1046/j.1523-1755.2000.00815.x	24	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1342-1751	1437-7799		CLIN EXP NEPHROL	Clin. Exp. Nephrol.	DEC	2014	18	6					944	951		10.1007/s10157-014-0944-7		8	Urology & Nephrology	Urology & Nephrology	AX0IQ	WOS:000346636600017		
J	Callan, DE; Naito, E				Callan, Daniel E.; Naito, Eiichi			Neural Processes Distinguishing Elite from Expert and Novice Athletes	COGNITIVE AND BEHAVIORAL NEUROLOGY			English	Editorial Material						functional magnetic resonance imaging; supplementary motor area; cerebellum; athlete; neural efficiency	PRIMARY MOTOR CORTEX; BRAIN; PLAYERS; FMRI; ACTIVATION; PLASTICITY; SKILL; REPRESENTATION; STIMULATION; PERFORMANCE	This commentary builds on a companion article in which Kim et al compare brain activation in elite, expert, and novice archers during a simulated target aiming task (Kim et al. 2014. Cogn Behav Neurol. 27:173-182). With the archery study as our starting point, we address 4 neural processes that may be responsible in general for elite athletes' superior performance over experts and novices: neural efficiency, cortical expansion, specialized processes, and internal models. In Kim et al's study, the elite archers' brains showed more activity in the supplementary motor area and the cerebellum than those of the novices and experts, and showed minimal widespread activity, especially in frontal areas involved with executive control. Kim et al's results are consistent with the idea of specialized neural processes that help coordinate motor planning and control. As athletes become more skilled, these processes may mediate the reduction in widespread activity in regions mapping executive control, and may produce a shift toward more automated processing. Kim et al's finding that activity in the cerebellum rose with increasing skill is consistent both with expansion of the finger representational area in the cerebellum and with internal models that simulate how archers manipulate the bow and arrow when aiming. Kim et al prepare the way for testing of neuromodulation techniques to improve athletic performance, refine highly technical job skills, and rehabilitate patients.	[Callan, Daniel E.; Naito, Eiichi] Osaka Univ, Natl Inst Informat & Commun Technol NICT, Ctr Informat & Neural Networks CiNet, Suita, Osaka 5650871, Japan; [Callan, Daniel E.] Natl Inst Informat & Commun Technol NICT, Universal Commun Res Inst, Multisensory Cognit & Computat Lab, Kyoto, Japan	Callan, DE (reprint author), Osaka Univ, Natl Inst Informat & Commun Technol NICT, Ctr Informat & Neural Networks CiNet, 2A6,1-4 Yamadaoka, Suita, Osaka 5650871, Japan.	dcallan@nict.go.jp					Dum RP, 2003, J NEUROPHYSIOL, V89, P634, DOI 10.1152/jn.00626.2002; KARNI A, 1995, NATURE, V377, P155; Picard N, 2013, NAT NEUROSCI, V16, P1340, DOI 10.1038/nn.3477; Floyer-Lea A, 2006, J NEUROPHYSIOL, V95, P1639, DOI 10.1152/jn.00346.2005; Haslinger B, 2004, HUM BRAIN MAPP, V22, P206, DOI 10.1002/hbm.20028; Naito E, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00594; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Bangert M, 2006, EUR J NEUROSCI, V24, P1832, DOI 10.1111/j.1460-9568.2006.05031.x; Ward NS, 2003, BRAIN, V126, P1430, DOI 10.1093/brain/awg145; Meister I, 2005, HUM BRAIN MAPP, V25, P345, DOI 10.1002/hbm.20112; Hanggi J, 2010, HUM BRAIN MAPP, V31, P1196, DOI 10.1002/hbm.20928; Jang SH, 2004, NEUROREPORT, V15, P395, DOI 10.1097/01.wnr.0000115813.26073.63; Shibata K, 2011, SCIENCE, V334, P1413, DOI 10.1126/science.1212003; Lotze M, 1999, J COGNITIVE NEUROSCI, V11, P491, DOI 10.1162/089892999563553; Krings T, 2000, NEUROSCI LETT, V278, P189, DOI 10.1016/S0304-3940(99)00930-1; Kasess CH, 2008, NEUROIMAGE, V40, P828, DOI 10.1016/j.neuroimage.2007.11.040; Floel A, 2014, NEUROIMAGE, V85, P934, DOI 10.1016/j.neuroimage.2013.05.098; Lotze M, 2003, NEUROIMAGE, V20, P1817, DOI 10.1016/j.neuroimage.2003.07.018; Jancke L, 2000, COGNITIVE BRAIN RES, V10, P177, DOI 10.1016/S0926-6410(00)00028-8; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Coffman BA, 2014, NEUROIMAGE, V85, P895, DOI 10.1016/j.neuroimage.2013.07.083; PASCUALLEONE A, 1995, J NEUROPHYSIOL, V74, P1037; Prichard G, 2014, BRAIN STIMUL, V7, P532, DOI 10.1016/j.brs.2014.04.005; Park IS, 2009, CEREBELLUM, V8, P334, DOI 10.1007/s12311-009-0100-1; HAIER RJ, 1992, BRAIN RES, V570, P134, DOI 10.1016/0006-8993(92)90573-R; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Callan DE, 2013, NEUROIMAGE, V72, P55, DOI 10.1016/j.neuroimage.2013.01.028; Grodd W, 2001, HUM BRAIN MAPP, V13, P55, DOI 10.1002/hbm.1025; Indovina I, 2001, NEUROIMAGE, V13, P1027, DOI 10.1006/nimg.2001.0776; Floyer-Lea A, 2005, J NEUROPHYSIOL, V94, P512, DOI 10.1152/jn.00717.2004; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Nudo RJ, 1996, J NEUROSCI, V16, P785; Gaser C, 2003, J NEUROSCI, V23, P9240; Di Paola M, 2013, HUM BRAIN MAPP, V34, P2707, DOI 10.1002/hbm.22095; Pearce AJ, 2000, EXP BRAIN RES, V130, P238, DOI 10.1007/s002219900236; Bernardi G, 2013, PLOS ONE, V8, P1; Callan D, 2012, PLOS ONE, V7, P1; Callan DE, 2007, CEREBELLUM, V6, P321, DOI 10.1080/14734220601187733; Chang Y, 2014, FRONT HUM NEUROSCI, V8, P1; Chang Y, 2011, NMR BIOMED, V24, P366, DOI 10.1002/nbm.1600; Debarnot U, 2014, FRONT HUM NEUROSCI, V8, P1; Di Xin, 2012, Brain Connect, V2, P225; Gartner H, 2013, FRONT PSYCHOL, V4, P1; Głodzik-Sobańska Lidia, 2004, Med Sci Monit, V10 Suppl 3, P88; Kim J, 2008, NEUROSCI LETT, V445, P236, DOI 10.1016/j.neulet.2008.09.018; Kim W, 2014, COGN BEHAV NEUROL, V27, P173, DOI 10.1097/WNN.0000000000000042; Koeneke S, 2004, NEUROREPORT, V15, P1279, DOI 10.1097/01.wnr.0000127463.10147.e7; Milton J, 2007, NEUROIMAGE, V35, P804, DOI 10.1016/j.neuroimage.2007.01.003; Nakata H, 2010, BRAIN RES REV, V62, P197, DOI 10.1016/j.brainresrev.2009.11.006; Park IS, 2012, CEREBELLUM, V11, P925, DOI 10.1007/s12311-012-0366-6; Ross JS, 2003, AM J NEURORADIOL, V24, P1036; Yamagishi N, 2013, PLOS ONE, V8, P1	54	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1543-3633	1543-3641		COGN BEHAV NEUROL	Cogn. Behav. Neurol.	DEC	2014	27	4					183	188				6	Behavioral Sciences; Clinical Neurology	Behavioral Sciences; Neurosciences & Neurology	AX3OE	WOS:000346847900002		
J	Cheng, C; Lin, CH; Chou, PH; Tsai, CJ; Lan, TH; Nestadt, G				Cheng, Chin; Lin, Ching-Heng; Chou, Po-Han; Tsai, Chia-Jui; Lan, Tsuo-Hung; Nestadt, Gerald			SEASON OF BIRTH IN OBSESSIVE-COMPULSIVE DISORDER	DEPRESSION AND ANXIETY			English	Article						anxiety/anxiety disorders; OCD/obsessive-compulsive disorder; seasonal; affective disorder; gene-environment; gender	VITAMIN-D DEFICIENCY; EATING-DISORDERS; STREPTOCOCCAL INFECTIONS; NORTHERN-HEMISPHERE; ANOREXIA-NERVOSA; BIPOLAR DISORDER; SCHIZOPHRENIA; RISK; ADOLESCENTS; POPULATION	Background: Effects of season of birth (SOB) have been documented in numerous neuropsychiatric disorders. To date, few studies have evaluated this issue in obsessive-compulsive disorder (OCD). The aim of this study was to investigate the birth seasonality in OCD. Methods: This study was based on Taiwan National Health Insurance Research Database. Data for the birth-year period 1956-1991 were extracted for analysis (273,837 males and 292,207 females). The International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM), code 300.3 was used as the diagnosis of OCD. Birth seasonality was compared between the OCD patients (519 males and 528 females) and the general population. Results: The birth distributions across the 12 months were significantly different between the OCD patients and the general population (P-value for the Walter & Elwood's test = .04). A significant decrease of births from March to July and an excess from August to November in OCD patients as compared to the general population was noted (the relative risk of these months vs. the rest months of the year: 0.85 (95% CI 0.74-0.96) and 1.19 (95% CI 1.05-1.36). Effects of SOB in OCD were present in males (P-value for the Walter & Elwood's test = .03) but not in females. Conclusion: The findings support an effect of SOB in people with OCD, especially for men. (C) 2013 Wiley Periodicals, Inc.	[Cheng, Chin] Univ Cambridge, Sch Clin Med, Dept Publ Hlth & Primary Care, Cambridge CB2 1TN, England; [Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chou, Po-Han; Lan, Tsuo-Hung] Taichung Vet Gen Hosp, Dept Psychiat, Taichung, Taiwan; [Chou, Po-Han] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Tsai, Chia-Jui] Changhua Christian Hosp, Dept Psychiat, Changhua, Taiwan; [Lan, Tsuo-Hung] Natl Yang Ming Univ, Fac Med, Dept Psychiat, Taipei 112, Taiwan; [Nestadt, Gerald] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA	Lan, TH (reprint author), Natl Yang Ming Univ, Dept Psychiat, 155,Sec 2,Linong St, Taipei 112, Taiwan.	thlan@ym.edu.tw			Taichung Veteran General Hospital, Taichung, Taiwan [TCVGH-100-3105]	Contract grant sponsor: Taichung Veteran General Hospital, Taichung, Taiwan; contract grant number: TCVGH-100-3105.	ANDREWS RCR, 1990, MED HYPOTHESES, V31, P141; Bernstein GA, 2010, J CHILD ADOL PSYCHOP, V20, P333, DOI 10.1089/cap.2010.0034; Leckman JF, 2011, J AM ACAD CHILD PSY, V50, P108, DOI 10.1016/j.jaac.2010.10.011; McGrath JJ, 2010, SCHIZOPHRENIA BULL, V36, P1073, DOI 10.1093/schbul/sbq101; Serpell L, 2002, CLIN PSYCHOL REV, V22, P647, DOI 10.1016/S0272-7358(01)00112-X; Altman SE, 2009, CLIN PSYCHOL REV, V29, P638, DOI 10.1016/j.cpr.2009.08.001; de Abreu DAF, 2011, J NEUROL SCI, V311, P64, DOI 10.1016/j.jns.2011.08.044; WALTER SD, 1975, BRIT J PREV SOC MED, V29, P18; Torrey EF, 1997, SCHIZOPHR RES, V28, P1, DOI 10.1016/S0920-9964(97)00092-3; Swedo SE, 1998, AM J PSYCHIAT, V155, P264; Kalra SK, 2009, J CLIN INVEST, V119, P737, DOI 10.1172/JCI37563; de Graaf R, 2005, AM J EPIDEMIOL, V162, P654, DOI 10.1093/aje/kwi264; Torrey EF, 2000, NEUROEPIDEMIOLOGY, V19, P177, DOI 10.1159/000026253; Davies G, 2003, SCHIZOPHRENIA BULL, V29, P587; Kinney DK, 2009, SCHIZOPHRENIA BULL, V35, P582, DOI 10.1093/schbul/sbp023; BRADBURY TN, 1985, PSYCHOL BULL, V98, P569, DOI 10.1037//0033-2909.98.3.569; VALLENIBASILE LA, 1994, J AM ACAD CHILD PSY, V33, P782, DOI 10.1097/00004583-199407000-00002; SWEDO SE, 1989, ARCH GEN PSYCHIAT, V46, P335; Atladottir HO, 2007, EPIDEMIOLOGY, V18, P240, DOI 10.1097/01.ede.0000254064.92806.13; BARAK Y, 1995, AM J PSYCHIAT, V152, P798; BERRY T, 1994, MED HYPOTHESES, V43, P409, DOI 10.1016/0306-9877(94)90017-5; BROCHARD A, 1994, ENCEPHALE, V20, P459; BROWN JS, 1994, SCHIZOPHRENIA BULL, V20, P387; Button E, 2007, INT J EAT DISORDER, V40, P468, DOI 10.1002/eat.20381; Castrogiovanni P, 1999, NEUROPSYCHOBIOLOGY, V40, P177, DOI 10.1159/000026616; Castrogiovanni P, 1998, NEUROPSYCHOBIOLOGY, V37, P175, DOI 10.1159/000026499; de Abreu DA F, 2009, PSYCHONEUROENDOCR S1, V34, pS265; Dickel DE, 2007, BIOL PSYCHIAT, V61, P322, DOI 10.1016/j.biopsych.2006.09.030; Disanto G, 2011, BRIT J PSYCHIAT, V198, P404, DOI 10.1192/bjp.bp.110.085944; Eyles D W, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS247, DOI 10.1016/j.psyneuen.2009.04.015; Gloria-Bottini F, 2009, EARLY HUM DEV, V85, P439, DOI 10.1016/j.earlhumdev.2009.02.004; GREENBERG ED, 1981, BIOL PSYCHIAT, V16, P513; HARE EH, 1975, ACTA PSYCHIAT SCAND, V52, P69, DOI 10.1111/j.1600-0447.1975.tb00024.x; Kolevzon A, 2006, AM J PSYCHIAT, V163, P1288, DOI 10.1176/appi.ajp.163.7.1288; Lewy H, 2008, PEDIATR DIABETES, V9, P46; Lochner Christine, 2004, Eur Neuropsychopharmacol, V14, P437, DOI 10.1016/j.euroneuro.2004.05.002; McGrath J, 1995, BRIT J PSYCHIAT, V167, P783, DOI 10.1192/bjp.167.6.783; Pfaff JJ, 2006, PSYCHIAT RES, V144, P217, DOI 10.1016/j.psychres.2006.04.019; Rezaul I, 1996, INT J EAT DISORDER, V19, P53, DOI 10.1002/(SICI)1098-108X(199601)19:1<53::AID-EAT7>3.0.CO;2-V; Roncero M, 2011, BEHAV COGN PSYCHOTH, V39, P457, DOI 10.1017/S1352465811000099; Rosario-Campos M C, 2001, Am J Psychiatry, V158, P1899; Sadock V., 2007, KAPLAN SADOCKS SYNOP; Stevens MC, 2000, J CLIN EXP NEUROPSYC, V22, P399, DOI 10.1076/1380-3395(200006)22:3;1-V;FT399; Stolwijk AM, 1997, J EPIDEMIOL COMMUN H, V51, P350, DOI 10.1136/jech.51.4.350; TAKEI N, 1995, EUR ARCH PSY CLIN N, V245, P255, DOI 10.1007/BF02191805; Mathis Maria Alice de, 2011, Rev Bras Psiquiatr, V33, P390; Torres AR, 2013, COMPR PSYCHIAT, V54, P1042, DOI 10.1016/j.comppsych.2013.04.013; Torrey EF, 1996, SCHIZOPHR RES, V21, P141; TORREY EF, 1991, SCHIZOPHRENIA BULL, V17, P15; WEISSMAN MM, 1994, J CLIN PSYCHIAT, V55, P5; Winje E, 2008, INT J EAT DISORDER, V41, P479, DOI 10.1002/eat.20540; YASSA R, 1979, INT PHARMACOPSYCHIAT, V14, P57	52	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1091-4269	1520-6394		DEPRESS ANXIETY	Depress. Anxiety	DEC	2014	31	12					972	978		10.1002/da.22200		7	Psychology, Clinical; Psychiatry; Psychology	Psychology; Psychiatry	AX3GJ	WOS:000346827900003		
J	Tsai, CH; Miki, T; Chang, CW; Ishikawa, K; Ichise, S; Kumagai, M; Hsieh, CH				Tsai, Cheng-Han; Miki, Takeshi; Chang, Chun-Wei; Ishikawa, Kanako; Ichise, Satoshi; Kumagai, Michio; Hsieh, Chih-Hao			Phytoplankton functional group dynamics explain species abundance distribution in a directionally changing environment	ECOLOGY			English	Article						functional response group; Lake Biwa; lake environmental changes; phytoplankton biodiversity; reservoir management; species abundance distribution	WATER-LEVEL FLUCTUATIONS; COMMUNITY STRUCTURE; NEUTRAL THEORY; LAKE BIWA; BIODIVERSITY; PATTERNS; EUTROPHICATION; DIVERSITY; NICHE; CORE	The mechanism underlying species abundance distribution (SAD), particularly the characteristics of "excess of rare species,'' remains controversial. The current equilibrium theory cannot explain the transient dynamics of SAD, which is essential for predicting biodiversity response to environmental changes. Using a unique 32-yr-long phytoplankton community data set from a pelagic site of Lake Biwa, Japan, we show that the dynamics of functional groups driven by environmental variation explain the excess of rare species over time. First, most of the rare species belong to the littoral group supplied through dispersal, whereas the common species belong to the pelagic group. Second, the littoral group was negatively influenced by environmental changes (i.e., lake warming, water-level manipulation, and partial re-oligotrophication), mechanistically explaining truncation of the excess of rare species in the SAD associated with biodiversity loss in Lake Biwa. Our findings imply the significance of an ecological trait-based approach for SAD theory and managing biodiversity in a changing environment.	[Tsai, Cheng-Han; Miki, Takeshi; Chang, Chun-Wei; Hsieh, Chih-Hao] Natl Taiwan Univ, Inst Oceanog, Taipei 10617, Taiwan; [Miki, Takeshi; Chang, Chun-Wei] Acad Sinica, Res Ctr Environm Changes, Taipei 10617, Taiwan; [Ishikawa, Kanako; Ichise, Satoshi; Kumagai, Michio] Lake Biwa Environm Res Inst, Otsu, Shiga 5200022, Japan; [Kumagai, Michio] Ritsumeikan Univ, Lake Biwa Sigma Res Ctr, Kusatsu 5250058, Japan; [Hsieh, Chih-Hao] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10617, Taiwan	Hsieh, CH (reprint author), Natl Taiwan Univ, Inst Oceanog, Taipei 10617, Taiwan.	chsieh@ntu.edu.tw	Hsieh, Chih-hao/B-3797-2008	Hsieh, Chih-hao/0000-0001-5935-7272	National Taiwan University; Ministry of Science and Technology of Taiwan [101-2621-B-002-004-MY3]	This study was supported by the National Taiwan University and Ministry of Science and Technology of Taiwan (101-2621-B-002-004-MY3). Comments from Akash Sastri, Tzung-Su Ding, Wei-Ting Lin, and George Sugihara improved the manuscript. Algorithms developed by Meng-Tsung Tsai greatly improved the simulation efficiency in null model test. This is a contribution of Bio-Asia FASCICLE.	Akitomo K, 2009, LIMNOLOGY, V10, P119, DOI 10.1007/s10201-009-0268-6; Chisholm RA, 2010, P NATL ACAD SCI USA, V107, P15821, DOI 10.1073/pnas.1009387107; GRAY JS, 1981, MAR POLLUT BULL, V12, P173, DOI 10.1016/0025-326X(81)90230-7; Coyle JR, 2013, AM NAT, V181, pE83, DOI 10.1086/669903; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Zohary T, 2011, INLAND WATERS, V1, P47, DOI 10.5268/IW-1.1.406; Dumbrell AJ, 2010, ISME J, V4, P337, DOI 10.1038/ismej.2009.122; Savage C, 2010, LIMNOL OCEANOGR, V55, P1033, DOI 10.4319/lo.2010.55.3.1033; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; SUGIHARA G, 1980, AM NAT, V116, P770, DOI 10.1086/283669; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Reynolds CS, 2002, J PLANKTON RES, V24, P417, DOI 10.1093/plankt/24.5.417; CASWELL H, 1978, AM NAT, V112, P127, DOI 10.1086/283257; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Sugihara G, 2003, P NATL ACAD SCI USA, V100, P5246, DOI 10.1073/pnas.0831096100; Locey KJ, 2013, ECOL LETT, V16, P1177, DOI 10.1111/ele.12154; Ulrich W, 2010, ECOLOGY, V91, P3384, DOI 10.1890/09-2157.1; Volkov I, 2003, NATURE, V424, P1035, DOI 10.1038/nature01883; Huertas IE, 2011, P ROY SOC B-BIOL SCI, V278, P3534, DOI 10.1098/rspb.2011.0160; Ulrich W, 2006, OIKOS, V114, P338, DOI 10.1111/j.2006.0030-1299.14773.x; MACARTHUR RH, 1957, P NATL ACAD SCI USA, V43, P293, DOI 10.1073/pnas.43.3.293; Sizling AL, 2009, P NATL ACAD SCI USA, V106, P6691, DOI 10.1073/pnas.0810096106; Magurran AE, 2010, TRENDS ECOL EVOL, V25, P574, DOI 10.1016/j.tree.2010.06.016; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Engen S, 1996, MATH BIOSCI, V132, P169, DOI 10.1016/0025-5564(95)00054-2; Wantzen KM, 2008, HYDROBIOLOGIA, V613, P1, DOI 10.1007/s10750-008-9466-1; Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904; McGill BJ, 2003, ECOL LETT, V6, P766, DOI 10.1046/j.1461-0248.2003.00491.x; Chase JM, 2010, SCIENCE, V328, P1388, DOI 10.1126/science.1187820; Magurran AE, 2007, ECOL LETT, V10, P347, DOI 10.1111/j.1461-0248.2007.01024.x; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Winder M, 2009, P ROY SOC B-BIOL SCI, V276, P427, DOI 10.1098/rspb.2008.1200; POLITIS DN, 1994, J AM STAT ASSOC, V89, P1303, DOI 10.2307/2290993; Connolly SR, 2005, SCIENCE, V309, P1363, DOI 10.1126/science.1113281; Dolan JR, 2009, J BIOGEOGR, V36, P887, DOI 10.1111/j.1365-2699.2008.02046.x; Efron B., 1993, INTRO BOOTSTRAP; GRAY JS, 1989, BIOL J LINN SOC, V37, P19; Harte J, 2003, NATURE, V424, P1006, DOI 10.1038/4241006a; Hsieh CH, 2011, BIOGEOSCIENCES, V8, P1383, DOI 10.5194/bg-8-1383-2011; Hsieh CH, 2010, AQUAT SCI, V72, P467, DOI 10.1007/s00027-010-0149-4; Magurran AE, 2004, MEASURING BIOL DIVER; Magurran AE, 2012, P ROY SOC B-BIOL SCI, V279, P3722, DOI 10.1098/rspb.2012.1379; May R.M., 1975, P81; Nakanishi M., 1996, GeoJournal, V40, P63; NEE S, 1991, P ROY SOC B-BIOL SCI, V243, P161, DOI 10.1098/rspb.1991.0026; Palardy JE, 2011, ECOL LETT, V14, P63, DOI 10.1111/j.1461-0248.2010.01555.x; Politis D. N., 2004, ECON REV, V23, P53, DOI DOI 10.1081/ETC-120028836; R Development Core Team, 2011, R LANG ENV STAT COMP; Reynolds CS, 2006, ECOL BIODIVERS CONS, P1, DOI 10.2277/ 0521605199; Schoener TW, 1996, NATURE, V381, P691, DOI 10.1038/381691a0; SUGIHARA G, 1989, AM NAT, V133, P458, DOI 10.1086/284929; Supp SR, 2012, ECOLOGY, V93, P2505, DOI 10.1890/12-0370.1; Van Geest GJ, 2007, ECOSYSTEMS, V10, P36, DOI 10.1007/s10021-006-9000-0; Vergnon R., 2012, NATURE COMMUNICATION, V3, P1	55	0	0	ECOLOGICAL SOC AMER	WASHINGTON	1990 M STREET NW, STE 700, WASHINGTON, DC 20036 USA	0012-9658	1939-9170		ECOLOGY	Ecology	DEC	2014	95	12					3335	3343				9	Ecology	Environmental Sciences & Ecology	AX3PN	WOS:000346851400011		
J	Wang, SP; Meng, FD; Duan, JC; Wang, YF; Cui, XY; Piao, SL; Niu, HS; Xu, GP; Luo, CY; Zhang, ZH; Zhu, XX; Shen, MG; Li, YN; Du, MY; Tang, YH; Zhao, XQ; Ciais, P; Kimball, B; Penuelas, J; Janssens, IA; Cui, SJ; Zhao, L; Zhang, FW				Wang, S. P.; Meng, F. D.; Duan, J. C.; Wang, Y. F.; Cui, X. Y.; Piao, S. L.; Niu, H. S.; Xu, G. P.; Luo, C. Y.; Zhang, Z. H.; Zhu, X. X.; Shen, M. G.; Li, Y. N.; Du, M. Y.; Tang, Y. H.; Zhao, X. Q.; Ciais, P.; Kimball, B.; Penuelas, J.; Janssens, I. A.; Cui, S. J.; Zhao, L.; Zhang, F. W.			Asymmetric sensitivity of first flowering date to warming and cooling in alpine plants	ECOLOGY			English	Article						early spring flowering; first flowering date; global warming; midsummer flowering; temperature sensitivity; Tibetan Plateau; warming and cooling	REPRODUCTIVE PHENOLOGY; TEMPERATURE-CHANGES; CLIMATE-CHANGE; RESPONSES; TIMES	Understanding how flowering phenology responds to warming and cooling (i.e., symmetric or asymmetric response) is needed to predict the response of flowering phenology to future climate change that will happen with the occurrence of warm and cold years superimposed upon a long-term trend. A three-year reciprocal translocation experiment was performed along an elevation gradient from 3200 m to 3800 m in the Tibetan Plateau for six alpine plants. Transplanting to lower elevation (warming) advanced the first flowering date (FFD) and transplanting to higher elevation (cooling) had the opposite effect. The FFD of early spring flowering plants (ESF) was four times less sensitive to warming than to cooling (by -2.1 d/degrees C and 8.4 d/degrees C, respectively), while midsummer flowering plants (MSF) were about twice as sensitive to warming than to cooling (-8.0 d/degrees C and 4.9 d/degrees C, respectively). Compared with pooled warming and cooling data, warming alone significantly underpredicted 3.1 d/degrees C for ESF and overestimated 1.7 d/degrees C for MSF. These results suggest that future empirical and experimental studies should consider nonlinear temperature responses that can cause such warming-cooling asymmetries as well as differing life strategies (ESF vs. MSF) among plant species.	[Wang, S. P.; Meng, F. D.; Piao, S. L.; Shen, M. G.] Chinese Acad Sci, Inst Tibetan Plateau Res, Key Lab Alpine Ecol & Biodivers, Beijing 100101, Peoples R China; [Meng, F. D.; Wang, Y. F.; Cui, X. Y.; Niu, H. S.; Zhu, X. X.; Li, Y. N.; Cui, S. J.] Chinese Acad Sci, Beijing 100049, Peoples R China; [Duan, J. C.; Luo, C. Y.; Zhang, Z. H.; Zhu, X. X.; Zhao, X. Q.; Cui, S. J.; Zhao, L.; Zhang, F. W.] Chinese Acad Sci, Northwest Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota, Xining 810008, Peoples R China; [Duan, J. C.] Binhai Res Inst Tianjin, Tianjin 300457, Peoples R China; [Xu, G. P.] Guangxi Zhuang Autonomous Reg & Chinese Acad Sci, Guangxi Inst Bot, Guangxi 541006, Peoples R China; [Du, M. Y.] Natl Inst Agroenvironm Sci, Tsukuba, Ibaraki 3058604, Japan; [Tang, Y. H.] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Ciais, P.] CNRS, CEA, UVSQ, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; [Kimball, B.] ARS, US Arid Land Agr Res Ctr, USDA, Maricopa, AZ 85138 USA; [Penuelas, J.] CREAF, Barcelona 08193, Catalonia, Spain; [Penuelas, J.] Consejo Super Invest CSIC, Global Ecol Unit CREAF CEAB CSIC UAB, Barcelona 08193, Catalonia, Spain; [Janssens, I. A.] Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium	Wang, SP (reprint author), Chinese Acad Sci, Inst Tibetan Plateau Res, Key Lab Alpine Ecol & Biodivers, Beijing 100101, Peoples R China.	wangsp@itpcas.ac.cn	Shen, Miaogen/A-8374-2011; Janssens, Ivan/P-1331-2014; Penuelas, Josep/D-9704-2011	Shen, Miaogen/0000-0001-5742-8807; Janssens, Ivan/0000-0002-5705-1787; Penuelas, Josep/0000-0002-7215-0150	Chinese Academy of Sciences [XDB03030403]; National Basic Research Programs [2013CB956000]; National Science Foundation of China [41230750, 31272488]	This work was supported by programs from Strategic Priority Research Program (B) of the Chinese Academy of Sciences (XDB03030403), National Basic Research Programs (2013CB956000), and National Science Foundation of China (41230750 and 31272488).	Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI 10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y; Sherry RA, 2007, P NATL ACAD SCI USA, V104, P198, DOI 10.1073/pnas.0605642104; Stevens MT, 2007, EVOL ECOL, V21, P829, DOI 10.1007/s10682-006-9154-4; Pau S, 2011, GLOBAL CHANGE BIOL, V17, P3633, DOI 10.1111/j.1365-2486.2011.02515.x; Marin IC, 2011, PLANTA, V233, P539, DOI 10.1007/s00425-010-1316-5; Sparks TH, 2009, CLIM RES, V39, P221, DOI 10.3354/cr00812; Rutishauser T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032545; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Dorji T, 2013, GLOBAL CHANGE BIOL, V19, P459, DOI 10.1111/gcb.12059; Ishizuka W, 2012, EVOL APPL, V5, P229, DOI 10.1111/j.1752-4571.2011.00216.x; Menzel A, 2011, INT J BIOMETEOROL, V55, P921, DOI 10.1007/s00484-011-0466-x; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Thorhallsdottir TE, 1998, OECOLOGIA, V114, P43, DOI 10.1007/s004420050418; Miller-Rushing AJ, 2008, ECOLOGY, V89, P332, DOI 10.1890/07-0068.1; Wolkovich EM, 2012, NATURE, V485, P494, DOI 10.1038/nature11014; Primack RB, 2009, BIOL CONSERV, V142, P2569, DOI 10.1016/j.biocon.2009.06.003; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Robbirt KM, 2011, J ECOL, V99, P235, DOI 10.1111/j.1365-2745.2010.01727.x; Hulber K, 2010, FUNCT ECOL, V24, P245, DOI 10.1111/j.1365-2435.2009.01645.x; Cook BI, 2012, P NATL ACAD SCI USA, V109, P9000, DOI 10.1073/pnas.1118364109; Amano T, 2010, P ROY SOC B-BIOL SCI, V277, P2451, DOI 10.1098/rspb.2010.0291; Richardson AD, 2013, AGR FOREST METEOROL, V169, P156, DOI 10.1016/j.agrformet.2012.09.012; Iler AM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0489; Kalbarczyk R, 2009, HORTIC SCI, V36, P75; Korner C, 2003, ALPINE PLANT LIFE FU; Li Ying-nian, 2011, Xibei Zhiwu Xuebao, V31, P788; R Development Core Team, 2013, R LANG ENV STAT COMP; Ranjitkar S, 2013, INT J BIOMETEOROL, V57, P225, DOI 10.1007/s00484-012-0548-4; Schleip C, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000646; Seghieri J, 2009, J HYDROL, V375, P78, DOI 10.1016/j.jhydrol.2009.01.023; Sparks TH, 2000, INT J BIOMETEOROL, V44, P82, DOI 10.1007/s004840000049; Wang Q. J., 1999, KOBRESIA MEADOW CHIN, P131; [周华坤 Zhou Huakum], 2002, [草地学报, Acta agrestia sinica], V10, P279	34	2	2	ECOLOGICAL SOC AMER	WASHINGTON	1990 M STREET NW, STE 700, WASHINGTON, DC 20036 USA	0012-9658	1939-9170		ECOLOGY	Ecology	DEC	2014	95	12					3387	3398				12	Ecology	Environmental Sciences & Ecology	AX3PN	WOS:000346851400016		
J	Nozu, T; Takakusaki, K; Okumura, T				Nozu, Tsukasa; Takakusaki, Kaoru; Okumura, Toshikatsu			A Balance Theory of Peripheral Corticotropin-Releasing Factor Receptor Type 1 and Type 2 Signaling to Induce Colonic Contractions and Visceral Hyperalgesia in Rats	ENDOCRINOLOGY			English	Article							STRESS-RELATED ALTERATIONS; IRRITABLE-BOWEL-SYNDROME; ENTERIC NERVOUS-SYSTEM; CONSCIOUS RATS; MAST-CELLS; FACTOR CRF; COLORECTAL DISTENSION; RESTRAINT STRESS; DISTAL COLON; GASTRIC TRANSIT	Several recent studies suggest that peripheral corticotropin-releasing factor (CRF) receptor type 1 (CRF1) and CRF2 have a counter regulatory action on gastrointestinal functions. We hypothesized that the activity balance of each CRF subtype signaling may determine the changes in colonic motility and visceral sensation. Colonic contractions were assessed by the perfused manometry, and contractions of colonic muscle strips were measured in vitro in rats. Visceromotor response was determined by measuring contractions of abdominal muscle in response to colorectal distensions (CRDs) (60 mm Hg for 10 min twice with a 30-min rest). All drugs were administered through ip route in in vivo studies. CRF increased colonic contractions. Pretreatment with astressin, a nonselective CRF antagonist, blocked the CRF-induced response, but astressin(2)-B, a selective CRF2 antagonist, enhanced the response by CRF. Cortagine, a selective CRF1 agonist, increased colonic contractions. In in vitro study, CRF increased contractions of muscle strips. Urocortin 2, a selective CRF2 agonist, itself did not alter the contractions but blocked this increased response by CRF. Visceromotor response to the second CRD was significantly higher than that of the first. Astressin blocked this CRD-induced sensitization, but astressin(2)-B or CRF did not affect it. Meanwhile, astressin(2)- B together with CRF significantly enhanced the sensitization. Urocortin 2 blocked, but cortagine significantly enhanced, the sensitization. These results indicated that peripheral CRF1 signaling enhanced colonic contractility and induced visceral sensitization, and these responses were modulated by peripheral CRF2 signaling. The activity balance of each subtype signaling may determine the colonic functions in response to stress.	[Nozu, Tsukasa] Asahikawa Med Univ, Dept Reg Med & Educ, Asahikawa, Hokkaido 0788510, Japan; [Okumura, Toshikatsu] Asahikawa Med Univ, Dept Gen Med, Asahikawa, Hokkaido 0788510, Japan; [Takakusaki, Kaoru] Asahikawa Med Univ, Res Ctr Brain Funct & Med Engn, Asahikawa, Hokkaido 0788510, Japan	Nozu, T (reprint author), Asahikawa Med Univ, Dept Reg Med & Educ, Midorigaoka Higashi 2-1-1-1, Asahikawa, Hokkaido 0788510, Japan.	tnozu@sea.plala.or.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [C-23590252, C-22590753]	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (C-23590252 [to T.N.] and C-22590753 [to T.O.]).	Stasi C, 2014, TECH COLOPROCTOL, V18, P613, DOI 10.1007/s10151-013-1106-8; Million M, 2006, GUT, V55, P172, DOI 10.1136/gut.2005.051391; Wallon C, 2008, GUT, V57, P50, DOI 10.1136/gut.2006.117549; NESS TJ, 1988, BRAIN RES, V450, P153, DOI 10.1016/0006-8993(88)91555-7; Tache Y, 2004, BRIT J PHARMACOL, V141, P1321, DOI 10.1038/sj.bjp.0705760; Gaudreau GA, 2004, BEHAV BRAIN RES, V150, P185, DOI 10.1016/j.bbr.2003.07.004; Trimble N, 2007, NEUROGASTROENT MOTIL, V19, P754, DOI 10.1111/j.1365-2982.2007.00951.x; Wu SV, 2011, ENDOCRINOLOGY, V152, P126, DOI 10.1210/en.2010-0997; Tache Y, 2007, J CLIN INVEST, V117, P33, DOI 10.1172/JCI30085; Nakade Y, 2005, AM J PHYSIOL-REG I, V288, pR427, DOI 10.1152/ajpregu.00499.2004; Fekete EM, 2007, FRONT NEUROENDOCRIN, V28, P1, DOI 10.1016/j.yfrne.2006.09.002; Bohm SK, 1997, BIOCHEM J, V322, P1; Fukumoto S, 2003, AM J PHYSIOL-REG I, V284, pR1269, DOI 10.1152/ajpregu.00442.2002; Gue M, 1997, NEUROGASTROENT MOTIL, V9, P271, DOI 10.1046/j.1365-2982.1997.d01-63.x; Reyes TM, 2001, P NATL ACAD SCI USA, V98, P2843, DOI 10.1073/pnas.051626398; VAUGHAN J, 1995, NATURE, V378, P287, DOI 10.1038/378287a0; Nozu T, 2011, NEUROSCI LETT, V498, P143, DOI 10.1016/j.neulet.2011.04.078; Lewis K, 2001, P NATL ACAD SCI USA, V98, P7570, DOI 10.1073/pnas.121165198; Maillot C, 2000, GASTROENTEROLOGY, V119, P1569, DOI 10.1053/gast.2000.20251; Stengel A, 2009, ANNU REV PHYSIOL, V71, P219, DOI 10.1146/annurev.physiol.010908.163221; Yuan PQ, 2007, NEUROGASTROENT MOTIL, V19, P923, DOI 10.1111/j.1365-2982.2007.00978.x; Hillhouse EW, 2006, ENDOCR REV, V27, P260, DOI 10.1210/er.2005-0034; Martinez V, 2004, J PHYSIOL-LONDON, V556, P221, DOI 10.1113/jphysiol.2003.059659; Million M, 2005, PEPTIDES, V26, P1188, DOI 10.1016/j.peptides.2005.02.004; Kastin AJ, 2002, NEUROENDOCRINOLOGY, V75, P367, DOI 10.1159/000059433; Nakade Y, 2007, J GASTROENTEROL, V42, P279, DOI 10.1007/s00535-006-1947-2; Mawe GM, 2006, ALIMENT PHARM THERAP, V23, P1067, DOI 10.1111/j.1365-2036.2006.02858.x; Theoharides TC, 2004, TRENDS PHARMACOL SCI, V25, P563, DOI 10.1016/j.tips.2004.09.007; Ataka K, 2007, AUTON NEUROSCI-BASIC, V133, P136, DOI 10.1016/j.autneu.2006.11.002; Frieling T, 1999, N-S ARCH PHARMACOL, V359, P71, DOI 10.1007/PL00005327; Grady EF, 1996, J NEUROSCI, V16, P6975; Kimura T, 2007, AM J PHYSIOL-GASTR L, V293, pG903, DOI 10.1152/ajpgi.00066.2007; Larauche M, 2012, NEUROGASTROENT MOTIL, V24, P201, DOI 10.1111/j.1365-2982.2011.01867.x; Larauche M, 2008, AM J PHYSIOL-GASTR L, V294, pG1033, DOI 10.1152/ajpgi.00507.2007; Liu S, 2010, BRIT J PHARMACOL, V159, P222, DOI 10.1111/j.1476-5381.2009.00516.x; Martinez V, 2004, PEPTIDES, V25, P1733, DOI 10.1016/j.peptides.2004.05.025; Million M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073749; Million M, 2002, AM J PHYSIOL-GASTR L, V282, pG34; Nakade Y, 2007, AM J PHYSIOL-GASTR L, V292, pG1037, DOI 10.1152/ajpgi.00419.2006; Nijsen M, 2005, NEUROGASTROENT MOTIL, V17, P423, DOI 10.1111/j.1365-2982.2005.00644.x; Nozu T, 2013, NEUROGASTROENT MOTIL, V25, P190, DOI 10.1111/nmo.12050; Nozu T, 1999, AM J PHYSIOL-GASTR L, V276, pG867; Nozu T, 2013, J GASTROENTEROL, V49, P7; O'Malley D, 2010, NEUROGASTROENT MOTIL, V22, P301, DOI 10.1111/j.1365-2982.2009.01412.x; Overman EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039935; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312; Tache Y, 2008, ANN NY ACAD SCI, V1148, P29, DOI 10.1196/annals.1410.007; Tache Y, 2004, NEUROGASTROENT MOTIL, V16, P137, DOI 10.1111/j.1743-3150.2004.00490.x; Taché Yvette, 2009, Curr Gastroenterol Rep, V11, P270; Tsukamoto K, 2006, AM J PHYSIOL-REG I, V290, pR1537, DOI 10.1152/ajpregu.00713.2005; van den Wijngaard RM, 2010, AUTON NEUROSCI-BASIC, V153, P99, DOI 10.1016/j.autneu.2009.07.004; von Mentzer B, 2007, BIOCHEM PHARMACOL, V73, P805, DOI 10.1016/j.bcp.2006.11.019; Yuan PQ, 2012, AM J PHYSIOL-GASTR L, V303, pG20, DOI 10.1152/ajpgi.00547.2011	53	3	3	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	DEC	2014	155	12					4655	4664		10.1210/en.2014-1421		10	Endocrinology & Metabolism	Endocrinology & Metabolism	AX0UN	WOS:000346668000007		
J	Nakagawa, Y; Satoh, A; Yabe, S; Furusawa, M; Tokushige, N; Tezuka, H; Mikami, M; Iwata, W; Shingyouchi, A; Matsuzaka, T; Kiwata, S; Fujimoto, Y; Shimizu, H; Danno, H; Yamamoto, T; Ishii, K; Karasawa, T; Takeuchi, Y; Iwasaki, H; Shimada, M; Kawakami, Y; Urayama, O; Sone, H; Takekoshi, K; Kobayashi, K; Yatoh, S; Takahashi, A; Yahagi, N; Suzuki, H; Yamada, N; Shimano, H				Nakagawa, Yoshimi; Satoh, Aoi; Yabe, Sachiko; Furusawa, Mika; Tokushige, Naoko; Tezuka, Hitomi; Mikami, Motoki; Iwata, Wakiko; Shingyouchi, Akiko; Matsuzaka, Takashi; Kiwata, Shiori; Fujimoto, Yuri; Shimizu, Hidehisa; Danno, Hirosuke; Yamamoto, Takashi; Ishii, Kiyoaki; Karasawa, Tadayoshi; Takeuchi, Yoshinori; Iwasaki, Hitoshi; Shimada, Masako; Kawakami, Yasushi; Urayama, Osamu; Sone, Hirohito; Takekoshi, Kazuhiro; Kobayashi, Kazuto; Yatoh, Shigeru; Takahashi, Akimitsu; Yahagi, Naoya; Suzuki, Hiroaki; Yamada, Nobuhiro; Shimano, Hitoshi			Hepatic CREB3L3 Controls Whole-Body Energy Homeostasis and Improves Obesity and Diabetes	ENDOCRINOLOGY			English	Article							GROWTH-FACTOR 21; TRANSCRIPTION FACTOR CREBH; INDUCED INSULIN-RESISTANCE; ACTIVATED RECEPTOR-ALPHA; BINDING PROTEIN-H; PPAR-ALPHA; LIPID-METABOLISM; ADIPOSE-TISSUE; HORMONE FGF21; FATTY-ACIDS	Transcriptional regulation of metabolic genes in the liver is the key to maintaining systemic energy homeostasis during starvation. The membrane-bound transcription factor cAMP-responsive element-binding protein 3-like 3 (CREB3L3) has been reported to be activated during fasting and to regulate triglyceride metabolism. Here, we show that CREB3L3 confers a wide spectrum of metabolic responses to starvation in vivo. Adenoviral and transgenic overexpression of nuclear CREB3L3 induced systemic lipolysis, hepatic ketogenesis, and insulin sensitivity with increased energy expenditure, leading to marked reduction in body weight, plasma lipid levels, and glucose levels. CREB3L3 overexpression activated gene expression levels and plasma levels of antidiabetic hormones, including fibroblast growth factor 21 and IGF-binding protein 2. Amelioration of diabetes by hepatic activation of CREB3L3 was also observed in several types of diabetic obese mice. Nuclear CREB3L3 mutually activates the peroxisome proliferator-activated receptor(PPAR) alpha promoter in an autoloop fashion and is crucial for the ligand transactivation of PPAR alpha by interacting with its transcriptional regulator, peroxisome proliferator-activated receptor gamma coactivator-1 alpha. CREB3L3 directly and indirectly controls fibroblast growth factor 21 expression and its plasma level, which contributes at least partially to the catabolic effects of CREB3L3 on systemic energy homeostasis in the entire body. Therefore, CREB3L3 is a therapeutic target for obesity and diabetes.	[Nakagawa, Yoshimi; Satoh, Aoi; Yabe, Sachiko; Furusawa, Mika; Tokushige, Naoko; Tezuka, Hitomi; Mikami, Motoki; Iwata, Wakiko; Shingyouchi, Akiko; Matsuzaka, Takashi; Kiwata, Shiori; Fujimoto, Yuri; Shimizu, Hidehisa; Danno, Hirosuke; Yamamoto, Takashi; Ishii, Kiyoaki; Karasawa, Tadayoshi; Takeuchi, Yoshinori; Iwasaki, Hitoshi; Shimada, Masako; Kawakami, Yasushi; Urayama, Osamu; Sone, Hirohito; Takekoshi, Kazuhiro; Kobayashi, Kazuto; Yatoh, Shigeru; Takahashi, Akimitsu; Yahagi, Naoya; Suzuki, Hiroaki; Yamada, Nobuhiro; Shimano, Hitoshi] Univ Tsukuba, Fac Med, Dept Internal Med Endocrinol & Metab, Div Clin Med, Tsukuba, Ibaraki 3058575, Japan; [Nakagawa, Yoshimi; Shimano, Hitoshi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058575, Japan	Shimano, H (reprint author), Univ Tsukuba, Fac Med Endocrinol & Metab, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	hshimano@md.tsukuba.ac.jp			Ministry of Science, Education, Culture and Technology of Japan; Scientific Research on Innovative Areas (research in a proposed research area) Molecular Basis and Disorders of Control of Appetite and Fat Accumulation; Suzuken Memorial Foundation; Uehara Memorial Foundation; Kanae Foundation for The Promotion of Medical Science; Astellas Foundation for Research on Metabolic Disorders; Ono Medical Research Foundation; Japan Diabetes Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation; Banyu Life Science Foundation International	This work was supported by Grants-in-Aid from the Ministry of Science, Education, Culture and Technology of Japan (Y.N. and H.Shima.), Scientific Research on Innovative Areas (research in a proposed research area) Molecular Basis and Disorders of Control of Appetite and Fat Accumulation (Y.N.), Suzuken Memorial Foundation (Y.N.), Uehara Memorial Foundation (Y.N. and H. Shima.), Kanae Foundation for The Promotion of Medical Science (Y.N.), Astellas Foundation for Research on Metabolic Disorders (Y.N.), Ono Medical Research Foundation (Y.N. and H. Shima.), Japan Diabetes Foundation (Y.N.), Mochida Memorial Foundation for Medical and Pharmaceutical Research (Y.N.), Takeda Science Foundation (Y.N.), and Banyu Life Science Foundation International (Y.N.).	Nakanishi N, 2009, BIOCHEM BIOPH RES CO, V385, P492, DOI 10.1016/j.bbrc.2009.05.058; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; Chin KT, 2005, NUCLEIC ACIDS RES, V33, P1859, DOI 10.1093/nar/gki332; Torra IP, 2002, MOL ENDOCRINOL, V16, P1013; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Hedbacker K, 2010, CELL METAB, V11, P11, DOI 10.1016/j.cmet.2009.11.007; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Luebke-Wheeler J, 2008, HEPATOLOGY, V48, P1242, DOI 10.1002/hep.22439; Jobgen WJ, 2009, J NUTR, V139, P230, DOI 10.3945/jn.108.096362; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Inagaki T, 2008, CELL METAB, V8, P77, DOI 10.1016/j.cmet.2008.05.006; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Satterfield MC, 2011, FRONT BIOSCI-LANDMRK, V16, P1589, DOI 10.2741/3807; Fu WJJ, 2005, J NUTR, V135, P714; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Laeger T, 2010, APPETITE, V54, P450, DOI 10.1016/j.appet.2010.04.005; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Mizuno TM, 1999, ENDOCRINOLOGY, V140, P4551, DOI 10.1210/en.140.10.4551; Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Erion DM, 2013, J BIOL CHEM, V288, P16167, DOI 10.1074/jbc.M113.460246; Im SS, 2011, J BIOL CHEM, V286, P1157, DOI 10.1074/jbc.M110.157875; Kim H, 2014, ENDOCRINOLOGY, V155, P769, DOI 10.1210/en.2013-1490; Murphy M, 2013, J NEUROENDOCRINOL, V25, P180, DOI 10.1111/j.1365-2826.2012.02383.x; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Danno H, 2010, BIOCHEM BIOPH RES CO, V391, P1222, DOI 10.1016/j.bbrc.2009.12.046; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Fujimoto Y, 2013, ENDOCRINOLOGY, V154, P3577, DOI 10.1210/en.2013-1203; Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334	40	2	2	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	DEC	2014	155	12					4706	4719		10.1210/en.2014-1113		14	Endocrinology & Metabolism	Endocrinology & Metabolism	AX0UN	WOS:000346668000012		
J	Hasebe, M; Kanda, S; Shimada, H; Akazome, Y; Abe, H; Oka, Y				Hasebe, Masaharu; Kanda, Shinji; Shimada, Hiroyuki; Akazome, Yasuhisa; Abe, Hideki; Oka, Yoshitaka			Kiss1 Neurons Drastically Change Their Firing Activity in Accordance With the Reproductive State: Insights From a Seasonal Breeder	ENDOCRINOLOGY			English	Article							GREEN FLUORESCENT PROTEIN; MEDAKA ORYZIAS-LATIPES; HORMONE NEURONS; RECEPTOR GPR54; EVOLUTIONARY INSIGHTS; KISSPEPTIN NEURONS; TRANSGENIC MEDAKA; MIDBRAIN TARGET; PREOPTIC AREA; IN-VIVO	Kisspeptin (Kiss) neurons show drastic changes in kisspeptin expression in response to the serum sex steroid concentration in various vertebrate species. Thus, according to the reproductive states, kisspeptin neurons are suggested to modulate various neuronal activities, including the regulation of GnRH neurons in mammals. However, despite their reproductive state-dependent regulation, there is no physiological analysis of kisspeptin neurons in seasonal breeders. Here we generated the first kiss1-enhanced green fluorescent protein transgenic line of a seasonal breeder, medaka, for histological and electrophysiological analyses using a whole-brain in vitro preparation in which most synaptic connections are intact. We found histologically that Kiss1 neurons in the nucleus ventralis tuberis (NVT) projected to the preoptic area, hypothalamus, pituitary, and ventral telencephalon. Therefore, NVT Kiss1 neurons may regulate various homeostatic functions and innate behaviors. Electrophysiological analyses revealed that they show various firing patterns, including bursting. Furthermore, we found that their firings are regulated by the resting membrane potential. However, bursting was not induced from the other firing patterns with a current injection, suggesting that it requires some chronic modulations of intrinsic properties such as channel expression. Finally, we found that NVT Kiss1 neurons drastically change their neuronal activities according to the reproductive state and the estradiol levels. Taken together with the previous reports, we here conclude that the breeding condition drastically alters the Kiss1 neuron activities in both gene expression and firing activities, the latter of which is strongly related to Kiss1 release, and the Kiss1 peptides regulate the activities of various neural circuits through their axonal projections.	[Hasebe, Masaharu; Kanda, Shinji; Shimada, Hiroyuki; Akazome, Yasuhisa; Oka, Yoshitaka] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; [Abe, Hideki] Nagoya Univ, Grad Sch Bioagr Sci, Lab Fish Biol, Nagoya, Aichi 4648601, Japan	Oka, Y (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	okay@bs.s.u-tokyo.ac.jp	OKA, YOSHITAKA/G-4952-2014; Oka, Yoshitaka/C-9670-2010; Abe, Hideki/D-2791-2011	OKA, YOSHITAKA/0000-0002-3482-3051; Oka, Yoshitaka/0000-0002-3482-3051; Abe, Hideki/0000-0002-8931-5767	Japan Society for the Promotion of Science (JSPS) [268559]; JSPS Grant [24870007, 20247005]; SUNBOR; Ministry of Education, Culture, Sports, Science, and Technology [20021012]; Program for Promotion of Basic Research Activities for Innovative Biosciences of Japan	This work was supported by Grants-in-Aid from Japan Society for the Promotion of Science (JSPS) Grant 268559 (to M.H.), JSPS Grant 24870007; and SUNBOR (to S.K.) and JSPS Grant 20247005, Ministry of Education, Culture, Sports, Science, and Technology Grant 20021012, and the Program for Promotion of Basic Research Activities for Innovative Biosciences of Japan (to Y.O.).	Liu XH, 2008, ENDOCRINOLOGY, V149, P4605, DOI 10.1210/en.2008-0321; Gottsch ML, 2011, ENDOCRINOLOGY, V152, P4298, DOI 10.1210/en.2011-1521; Kitahashi T, 2009, ENDOCRINOLOGY, V150, P821, DOI 10.1210/en.2008-0940; Um HN, 2010, ANN NY ACAD SCI, V1200, P67, DOI 10.1111/j.1749-6632.2010.05508.x; Servili A, 2011, ENDOCRINOLOGY, V152, P1527, DOI 10.1210/en.2010-0948; DUTTON A, 1979, J PHYSIOL-LONDON, V290, P433; Kanda S, 2012, J NEUROENDOCRINOL, V24, P897, DOI 10.1111/j.1365-2826.2012.02296.x; Tamamaki N, 2000, NEUROSCI RES, V38, P231, DOI 10.1016/S0168-0102(00)00176-0; Okubo K, 2006, ENDOCRINOLOGY, V147, P1076, DOI 10.1210/en.2005-0468; Scott V, 2011, ENDOCRINOLOGY, V152, P3862, DOI 10.1210/en.2011-1181; Funes S, 2003, BIOCHEM BIOPH RES CO, V312, P1357, DOI 10.1016/j.bbrc.2003.11.066; Akazome Y, 2010, J FISH BIOL, V76, P161, DOI 10.1111/j.1095-8649.2009.02496.x; Liu XH, 2011, J NEUROSCI, V31, P2421, DOI 10.1523/JNEUROSCI.5759-10.2011; Lapatto R, 2007, ENDOCRINOLOGY, V148, P4927, DOI 10.1210/en.2007-0078; Cravo RM, 2011, NEUROSCIENCE, V173, P37, DOI 10.1016/j.neuroscience.2010.11.022; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Felip A, 2009, MOL CELL ENDOCRINOL, V312, P61, DOI 10.1016/j.mce.2008.11.017; Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Ludwig M, 2002, NATURE, V418, P85, DOI 10.1038/nature00822; Zhang CG, 2013, AM J PHYSIOL-ENDOC M, V305, pE1384, DOI 10.1152/ajpendo.00406.2013; Kanda S, 2008, ENDOCRINOLOGY, V149, P2467, DOI 10.1210/en.2007-1503; Pielecka-Fortuna J, 2008, ENDOCRINOLOGY, V149, P1979, DOI 10.1210/en.2007-1365; Han SK, 2005, J NEUROSCI, V25, P11349, DOI 10.1523/JNEUROSCI.3328-05.2005; Ogawa S, 2012, ENDOCRINOLOGY, V153, P2398, DOI 10.1210/en.2012-1062; Dumalska I, 2008, J NEUROSCI, V28, P8003, DOI 10.1523/JNEUROSCI.1225-08.2008; Frazao R, 2013, J NEUROSCI, V33, P2807, DOI 10.1523/JNEUROSCI.1610-12.2013; Augustinaite S, 2007, J PHYSIOL-LONDON, V582, P297, DOI 10.1113/jphysiol.2007.131540; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Gamse JT, 2005, DEVELOPMENT, V132, P4869, DOI 10.1242/dev.02046; de Croft S, 2012, ENDOCRINOLOGY, V153, P5384, DOI 10.1210/en.2012-1616; Li SS, 2009, J ENDOCRINOL, V201, P407, DOI 10.1677/JOE-09-0016; Lee YR, 2009, ENDOCRINOLOGY, V150, P2837, DOI 10.1210/en.2008-1679; Zhang CG, 2008, J NEUROSCI, V28, P4423, DOI 10.1523/JNEUROSCI.5352-07.2008; Nakamura KC, 2008, J HISTOCHEM CYTOCHEM, V56, P647, DOI 10.1369/jhc.2008.950915; Mitani Y, 2010, ENDOCRINOLOGY, V151, P1751, DOI 10.1210/en.2009-1174; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; d'Anglemont de Tassigny X., 2007, P NATL ACAD SCI USA, V104, P10714, DOI [DOI 10.1073/PNAS.0704114104, 10.1073/PNAS.0704114104]; Ducret E, 2010, ENDOCRINOLOGY, V151, P2223, DOI 10.1210/en.2009-1480; Escobar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070177; Kanda S, 2010, ENDOCRINOLOGY, V151, P695, DOI 10.1210/en.2009-0842; Kanda S, 2009, 39 ANN M SOC NEUR CH, V665, P11; Kanda S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062776; Moon JS, 2009, PEPTIDES, V30, P171, DOI 10.1016/j.peptides.2008.04.015; OKA Y, 1993, J NEUROSCI, V13, P2161; Piet R, 2013, J NEUROSCI, V33, P10828, DOI 10.1523/JNEUROSCI.1021-13.2013; Smith M, 2006, J NEUROPHYSIOL, V96, P2670, DOI 10.1152/jn.00609.2006; Tomikawa J, 2012, P NATL ACAD SCI USA, V109, pE1294, DOI 10.1073/pnas.1114245109; Venkatesh B, 1997, P NATL ACAD SCI USA, V94, P12462, DOI 10.1073/pnas.94.23.12462	49	0	0	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	DEC	2014	155	12					4868	4880		10.1210/en.2014-1472		13	Endocrinology & Metabolism	Endocrinology & Metabolism	AX0UN	WOS:000346668000026		
J	Azuma, Y; Hagiwara, D; Lu, WJ; Morishita, Y; Suga, H; Goto, M; Banno, R; Sugimura, Y; Oyadomari, S; Mori, K; Shiota, A; Asai, N; Takahashi, M; Oiso, Y; Arima, H				Azuma, Yoshinori; Hagiwara, Daisuke; Lu, Wenjun; Morishita, Yoshiaki; Suga, Hidetaka; Goto, Motomitsu; Banno, Ryoichi; Sugimura, Yoshihisa; Oyadomari, Seiichi; Mori, Kazutoshi; Shiota, Akira; Asai, Naoya; Takahashi, Masahide; Oiso, Yutaka; Arima, Hiroshi			Activating Transcription Factor 6 alpha Is Required for the Vasopressin Neuron System to Maintain Water Balance Under Dehydration in Male Mice	ENDOCRINOLOGY			English	Article							NEUROHYPOPHYSEAL DIABETES-INSIPIDUS; UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; PROGRESSIVE MYOCLONUS EPILEPSY; QUALITY-CONTROL PROTEINS; ER STRESS; MOUSE MODEL; HYPOTHALAMIC NEURONS; INCLUSION-BODIES; FACTOR ATF6	Activating transcription factor 6 alpha (ATF6 alpha) is a sensor of endoplasmic reticulum (ER) stress and increases the expression of ER chaperones and molecules related to the ER-associated degradation of unfolded/misfolded proteins. In this study, we used ATF6 alpha knockout (ATF6 alpha(-/-)) mice to clarify the role of ATF6 alpha in the arginine vasopressin (AVP) neuron system. Although urine volumes were not different between ATF6 alpha(-/-) and wild-type (ATF6 alpha(-/-)) mice with access to water ad libitum, they were increased in ATF6 alpha(-/-) mice compared with those in ATF6 alpha(-/-) mice under intermittent water deprivation (WD) and accompanied by less urine AVP in ATF6 alpha(-/-) mice. The mRNA expression of immunoglobulin heavy chain binding protein, an ER chaperone, was significantly increased in the supraoptic nucleus in ATF6 alpha(-/-) but not ATF6 alpha(-/-) mice after WD. Electron microscopic analyses demonstrated that the ER lumen of AVP neurons was more dilated in ATF6 alpha(-/-) mice than in ATF6 alpha(-/-) mice after WD. ATF6 alpha(-/-) mice that were mated with mice possessing a mutation causing familial neurohypophysial diabetes insipidus (FNDI), which is characterized by progressive polyuria and AVP neuronal loss due to the accumulation of mutant AVP precursor in the ER, manifested increased urine volume under intermittent WD. The aggregate formation in the ER of AVP neurons was further impaired in FNDI/ATF6 alpha(-/-) mice compared with that in FNDI mice, and AVP neuronal loss was accelerated in FNDI/ATF6 alpha(-/-) mice under WD. These data suggest that ATF6 alpha is required for the AVP neuron system to maintain water balance under dehydration.	[Azuma, Yoshinori; Hagiwara, Daisuke; Lu, Wenjun; Morishita, Yoshiaki; Suga, Hidetaka; Goto, Motomitsu; Banno, Ryoichi; Sugimura, Yoshihisa; Oiso, Yutaka; Arima, Hiroshi] Nagoya Univ, Grad Sch Med, Dept Endocrinol & Diabet, Nagoya, Aichi 4668550, Japan; [Asai, Naoya; Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Dept Pathol, Nagoya, Aichi 4668550, Japan; [Shiota, Akira] Inst Immunol Co Ltd, Utsunomiya, Tochigi 3210973, Japan; [Oyadomari, Seiichi] Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan; [Mori, Kazutoshi] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan	Arima, H (reprint author), Nagoya Univ, Grad Sch Med, Dept Endocrinol, Showa Ku, 65 Tsuruma Cho, Nagoya, Aichi 4668550, Japan.	arima105@med.nagoya-u.ac.jp	Hagiwara, Daisuke/P-9736-2015; SUGA, HIDETAKA/I-7452-2014		Japanese Society for Promotion of Science, Japan [23659475]; Ministry of Health, Labor and Welfare, Japan	This work was supported in part by the Japanese Society for Promotion of Science, Japan (Grant-in-Aid for Scientific Research 23659475) and the Ministry of Health, Labor and Welfare, Japan (Grant-in-Aid for Scientific Research, Research on Hypothalamo-Hypophyseal Disorders).	Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Cao SS, 2013, GASTROENTEROLOGY, V144, P989, DOI 10.1053/j.gastro.2013.01.023; Oslowski CM, 2010, DIABETES OBES METAB, V12, P58, DOI 10.1111/j.1463-1326.2010.01277.x; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; BENBARAK Y, 1985, J NEUROSCI, V5, P81; Hagen MC, 2011, BRAIN PATHOL, V21, P575, DOI 10.1111/j.1750-3639.2011.00481.x; Greene CM, 2008, J INHERIT METAB DIS, V31, P21, DOI 10.1007/s10545-007-0748-y; Usui M, 2012, METABOLISM, V61, P1118, DOI 10.1016/j.metabol.2012.01.004; Arima H, 2014, EXP PHYSIOL, V99, P66, DOI 10.1113/expphysiol.2013.072553; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Christensen JH, 2006, SEMIN NEPHROL, V26, P209, DOI 10.1016/j.semnephrol.2006.03.003; Gidalevitz T, 2013, BBA-MOL CELL RES, V1833, P2410, DOI 10.1016/j.bbamcr.2013.03.007; Carrell RW, 2002, NEW ENGL J MED, V346, P45, DOI 10.1056/NEJMra010772; Haze K, 1999, MOL BIOL CELL, V10, P3787; Thuerauf DJ, 2004, J BIOL CHEM, V279, P21078, DOI 10.1074/jbc.M400713200; Takao M, 2000, J NEUROPATH EXP NEUR, V59, P1070; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; WARD CL, 1994, J BIOL CHEM, V269, P25710; Saliba RS, 2002, J CELL SCI, V115, P2907; BISSET GW, 1988, Q J EXP PHYSIOL CMS, V73, P811; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yoshida H, 2001, MOL CELL BIOL, V21, P1239, DOI 10.1128/MCB.21.4.1239-1248.2001; Braakman I, 2011, ANNU REV BIOCHEM, V80, P71, DOI 10.1146/annurev-biochem-062209-093836; Davies J, 2002, J NEUROENDOCRINOL, V14, P629, DOI 10.1046/j.1365-2826.2002.00822.x; Chen X, 2002, J BIOL CHEM, V277, P13045, DOI 10.1074/jbc.M110636200; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Hayashi M, 2009, AM J PHYSIOL-REG I, V296, pR1641, DOI 10.1152/ajpregu.00034.2009; Thuerauf DJ, 2007, J BIOL CHEM, V282, P22865, DOI 10.1074/jbc.M701213200; Egawa N, 2011, J BIOL CHEM, V286, P7947, DOI 10.1074/jbc.M110.156430; Ushioda R, 2013, MOL BIOL CELL, V24, P3155, DOI 10.1091/mbc.E13-03-0138; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Arima H, 1999, J NEUROENDOCRINOL, V11, P337; Babey M, 2011, NAT REV ENDOCRINOL, V7, P701, DOI 10.1038/nrendo.2011.100; CASTEL M, 1984, INT REV CYTOL, V88, P303, DOI 10.1016/S0074-7696(08)62760-6; Castino R, 2005, FASEB J, V19, P1021, DOI 10.1096/fj.04-3162fje; Castino R, 2005, FASEB J, V19, P1024, DOI 10.1096/fj.04-3163fje; Castino R, 2008, J NEUROENDOCRINOL, V20, P1165, DOI 10.1111/j.1365-2826.2008.01769.x; Chiang WC, 2012, MOL BIOL CELL, V23, P758, DOI 10.1091/mbc.E11-08-0663; Granell S, 2008, MOL BIOL CELL, V19, P572, DOI 10.1091/mbc.E07-06-0587; Hagiwara D, 2012, PEPTIDES, V33, P346, DOI 10.1016/j.peptides.2011.12.011; Hagiwara D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.124; Hashida K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047950; Hiroi M, 2010, AM J PHYSIOL-REG I, V298, pR486, DOI 10.1152/ajpregu.00529.2009; KRISCH B, 1974, CELL TISSUE RES, V151, P117; Mori K, 2010, MOL BIOL CELL, V21, P1435, DOI 10.1091/mbc.E09-07-0600; Morris J F, 1978, Int Rev Exp Pathol, V18, P1; Paxinos G., 2000, MOUSE BRAIN STEREOTA; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; SACHS H, 1967, AM J MED, V42, P687, DOI 10.1016/0002-9343(67)90089-7; Si-Hoe SL, 2000, FASEB J, V14, P1680; Smith SE, 2011, J BIOL CHEM, V286, P41563, DOI 10.1074/jbc.M111.280073; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018	58	0	0	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0013-7227	1945-7170		ENDOCRINOLOGY	Endocrinology	DEC	2014	155	12					4905	4914		10.1210/en.2014-1522		10	Endocrinology & Metabolism	Endocrinology & Metabolism	AX0UN	WOS:000346668000029		
J	Aziz, M; Oda, T; Kashiwagi, T				Aziz, Muhammad; Oda, Takuya; Kashiwagi, Takao			Advanced Energy Harvesting from Macroalgae-Innovative Integration of Drying, Gasification and Combined Cycle	ENERGIES			English	Article						macroalgae; energy harvesting; drying; gasification; combined cycle; exergy recovery; process integration; energy efficiency	FLUE-GAS; BIOMASS GASIFICATION; SUPERCRITICAL WATER; HEAT-TRANSFER; MICROALGAE; CO2; MITIGATION; FIXATION	State-of-the-art integrated macroalgae utilization processes, consisting of drying, gasification, and combined cycle, are proposed and their performance with respect to energy efficiency are evaluated. To achieve high exergy efficiency, the integration is performed through two main principles: exergy recovery and process integration. Initially, the energy involved in one process is recirculated intensively through exergy elevation and effective heat coupling. Furthermore, the unrecoverable energy from one process will be utilized in the other processes through process integration. As the result, the total exergy destruction from the whole integrated processes can be minimized significantly leading to significant improvement in energy efficiency. The first analysis relates to the performance of integrated drying process, especially the influence of target moisture content to energy consumption. Furthermore, the influences of gasification fluidization velocity to the total generated power and power generation efficiency are also calculated. As the results of study, the proposed integrated-processes proved a very high energy efficiency. A positive energy harvesting with the total power generation efficiency of about 40% could be achieved.	[Aziz, Muhammad; Oda, Takuya; Kashiwagi, Takao] Tokyo Inst Technol, Solut Res Lab, Meguro Ku, Tokyo 1528550, Japan	Aziz, M (reprint author), Tokyo Inst Technol, Solut Res Lab, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan.	maziz@ssr.titech.ac.jp; oda@ssr.titech.ac.jp; kashiwagi@ssr.titech.ac.jp	Aziz, Muhammad/B-9248-2015	Aziz, Muhammad/0000-0003-2433-8500	Solutions Research Laboratory, Tokyo Institute of Technology, Japan	A part of this research is supported by research development program at Solutions Research Laboratory, Tokyo Institute of Technology, Japan.	Duman G, 2014, BIORESOURCE TECHNOL, V166, P24, DOI 10.1016/j.biortech.2014.04.096; SHAH MM, 1979, INT J HEAT MASS TRAN, V22, P547, DOI 10.1016/0017-9310(79)90058-9; Matsumura Y, 2005, BIOMASS BIOENERG, V29, P269, DOI 10.1016/j.biombioe.2005.04.006; BORODULYA VA, 1991, INT J HEAT MASS TRAN, V34, P47, DOI 10.1016/0017-9310(91)90171-A; Antal MJ, 2000, IND ENG CHEM RES, V39, P4040, DOI 10.1021/ie0003436; Benemann JR, 1997, ENERG CONVERS MANAGE, V38, pS475, DOI 10.1016/S0196-8904(96)00313-5; Gu ZH, 2014, RSC ADV, V4, P47191, DOI 10.1039/c4ra06715k; Demirbas MF, 2011, APPL ENERG, V88, P3473, DOI 10.1016/j.apenergy.2011.01.059; Adams JMM, 2011, BIORESOURCE TECHNOL, V102, P226, DOI 10.1016/j.biortech.2010.06.152; GAO K, 1994, J APPL PHYCOL, V6, P45, DOI 10.1007/BF02185904; Wang B, 2008, APPL MICROBIOL BIOT, V79, P707, DOI 10.1007/s00253-008-1518-y; MATSUMOTO H, 1995, APPL BIOCHEM BIOTECH, V51-2, P681, DOI 10.1007/BF02933469; Vunjak-Novakovic G, 2005, IND ENG CHEM RES, V44, P6154, DOI 10.1021/ie049099z; Aziz M, 2014, ENERGY, V70, P307, DOI 10.1016/j.energy.2014.03.126; Aziz M, 2015, DRY TECHNOL, V33, P395, DOI 10.1080/07373937.2014.970257; Aziz M, 2014, DRY TECHNOL, V32, P1621, DOI 10.1080/07373937.2014.915219; Aziz M, 2015, APPL ENERG, V139, P188, DOI 10.1016/j.apenergy.2014.11.038; Aziz M., 2012, APPL ENERG, V109, P163; Borodulya V.A., 1989, J ENG PHYS, V56, P767; Brinkhuis BH, 1987, SEAWEED CULTIVATION, P107; Chelf P., 1994, BIOMASS BIOENERG, V4, P175; Chen JC, 1998, FLUIDIZATION SOLIDS, P153, DOI 10.1016/B978-081551427-5.50005-3; Craig K.R., 1996, NRELTP43021657; Kunii D., 1991, FLUIDIZATION ENG; Matsumoto H, 1997, J CHEM ENG JPN, V30, P620, DOI 10.1252/jcej.30.620; Mohamed LA, 2005, J STORED PROD RES, V41, P199, DOI 10.1016/j.jspr.2004.03.001; Parparita E, 2015, J MATER CYCLES WASTE, V17, P756, DOI 10.1007/s10163-014-0308-0; Pradesh A., PROCESS DESIGN ROTAR; Sato N., 2004, CHEM ENERGY EXERGY; YANAGI M, 1995, ENERG CONVERS MANAGE, V36, P713, DOI 10.1016/0196-8904(95)00104-L	30	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1996-1073			ENERGIES	Energies	DEC	2014	7	12					8217	8235		10.3390/en7128217		19	Energy & Fuels	Energy & Fuels	AX2UC	WOS:000346799100020		
J	Iliyasu, AM; Venegas-Andraca, SE; Yan, F; Salama, AS				Iliyasu, Abdullah M.; Venegas-Andraca, Salvador E.; Yan, Fei; Salama, Ahmed S.			Hybrid Quantum-Classical Protocol for Storage and Retrieval of Discrete-Valued Information (vol 16, pg 3537, 2014)	ENTROPY			English	Correction									[Iliyasu, Abdullah M.; Salama, Ahmed S.] Salman Bin Abdulaziz Univ, Coll Engn, Riyadh 11942, Saudi Arabia; [Iliyasu, Abdullah M.; Yan, Fei] Tokyo Inst Technol, Dept Computat Intelligence & Syst Sci, Yokohama, Kanagawa 2268502, Japan; [Venegas-Andraca, Salvador E.] Tecnol Monterrey, Escuela Nacl Posgrado Ciencias Ingn & Tecnol, Atizapan De Zaragoza 52926, Estado De Mexic, Mexico; [Venegas-Andraca, Salvador E.] Tecnol Monterrey, Atizapan De Zaragoza 52926, Estado De Mexic, Mexico; [Yan, Fei] Changchun Univ Sci & Technol, Sch Comp Sci & Technol, Changchun 130022, Peoples R China	Venegas-Andraca, SE (reprint author), Tecnol Monterrey, Escuela Nacl Posgrado Ciencias Ingn & Tecnol, Campus Estado Mexico, Atizapan De Zaragoza 52926, Estado De Mexic, Mexico.	a.iliyasu@sau.edu.sa; salvador.venegas-andraca@keble.oxon.org; yanfei@cust.edu.cn; a.salama@sau.edu.sa					Iliyasu AM, 2014, ENTROPY-SWITZ, V16, P3537, DOI 10.3390/e16063537	1	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1099-4300			ENTROPY-SWITZ	Entropy	DEC	2014	16	12					6382	6383		10.3390/e16126382		2	Physics, Multidisciplinary	Physics	AX2TX	WOS:000346798600010		
J	Mino, H				Mino, Hiroyuki			The Effects of Spontaneous Random Activity on Information Transmission in an Auditory Brain Stem Neuron Model	ENTROPY			English	Article						fluctuation; stochastic Hodgkin-Huxley model; filtered Poisson process; second-order auditory neuron; information rates; computer simulation	STOCHASTIC RESONANCE; COCHLEAR NUCLEUS; DIFFUSION-APPROXIMATION; ACTION-POTENTIALS; NOISE; FLUCTUATIONS; SIMULATION; IMPLANTS; CHANNELS; SYSTEMS	This paper presents the effects of spontaneous random activity on information transmission in an auditory brain stem neuron model. In computer simulations, the supra-threshold synaptic current stimuli ascending from auditory nerve fibers (ANFs) were modeled by a filtered inhomogeneous Poisson process modulated by sinusoidal functions at a frequency of 220-3520 Hz with regard to the human speech spectrum. The stochastic sodium and stochastic high- and low-threshold potassium channels were incorporated into a single compartment model of the soma in spherical bushy neurons, so as to realize threshold fluctuations or a variation of spike firing times. The results show that the information rates estimated from the entropy of inter-spike intervals of spike trains tend toward a convex function of the spontaneous rates when the intensity of sinusoidal functions decreases. Furthermore, the results show that a convex function of the spontaneous rates tends to disappear as the frequency of the sinusoidal function increases, such that the phase-locked response can be unobserved. It is concluded that this sort of stochastic resonance (SR) phenomenon, which depends on the spontaneous rates with supra-threshold stimuli, can better enhance information transmission in a smaller intensity of sinusoidal functions within the human speech spectrum, like the situation in which the regular SR can enhance weak signals.	Kanto Gakuin Univ, Dept Elect Engn, Kanazawa Ku, Yokohama, Kanagawa 2368501, Japan	Mino, H (reprint author), Kanto Gakuin Univ, Dept Elect Engn, Kanazawa Ku, 1-50-1 Mutsuura E, Yokohama, Kanagawa 2368501, Japan.	mino@ieee.org					Stocks NG, 2000, PHYS REV LETT, V84, P2310, DOI 10.1103/PhysRevLett.84.2310; vanSteveninck RRD, 1997, SCIENCE, V275, P1805; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3097, DOI 10.1152/jn.00127.2002; COLLINS JJ, 1995, NATURE, V376, P236, DOI 10.1038/376236a0; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Hoch T, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011911; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Chow CC, 1996, BIOPHYS J, V71, P3013; CLAY JR, 1983, BIOPHYS J, V42, P151; Stocks NG, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.030902; Collins JJ, 1996, J NEUROPHYSIOL, V76, P642; Mino H, 2002, ANN BIOMED ENG, V30, P578, DOI 10.1114/1.1475343; Ostapoff EM, 1997, J COMP NEUROL, V381, P500, DOI 10.1002/(SICI)1096-9861(19970519)381:4<500::AID-CNE9>3.0.CO;2-6; SKAUGEN E, 1979, ACTA PHYSIOL SCAND, V107, P343, DOI 10.1111/j.1748-1716.1979.tb06486.x; Stocks NG, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.041114; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500; Kobayashi R, 2011, NEURAL COMPUT, V23, P3070, DOI 10.1162/NECO_a_00205; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; Hancock KE, 2012, J NEUROPHYSIOL, V108, P714, DOI 10.1152/jn.00269.2012; Morse RP, 1996, NAT MED, V2, P928, DOI 10.1038/nm0896-928; Arata H, 2012, IEEE ENG MED BIO, P1370, DOI 10.1109/EMBC.2012.6346193; Arata H., 2013, T JPN SOC MED BIOL E, V51, P405; BENZI R, 1981, J PHYS A-MATH GEN, V14, pL453, DOI 10.1088/0305-4470/14/11/006; Blauert J., 1997, SPATIAL HEARING PSYC; BULSARA A, 1991, J THEOR BIOL, V152, P531, DOI 10.1016/S0022-5193(05)80396-0; Bulsara AR, 1996, PHYS REV E, V54, pR2185; Chen B., 2010, NEURAL COMPUT, V22, P7137; Cover T. M., 2006, ELEMENTS INFORM THEO; Dayan P, 2001, THEORETICAL NEUROSCI; Gai Y, 2009, J NEUROPHYSIOL, V102, P3447, DOI 10.1152/jn.00538.2009; JOHNSON DH, 1976, BIOPHYS J, V16, P719; Kandel E R, 2000, PRINCIPLES NEURAL SC; Kumsa P, 2012, IEEE ENG MED BIO, P2993, DOI 10.1109/EMBC.2012.6346593; LANSKY P, 1983, MATH BIOSCI, V67, P247, DOI 10.1016/0025-5564(83)90103-7; Liberman L.C., 1991, J COMP NEUROL, V313, P240; Liberman L.C., 1993, J COMP NEUROL, V327, P17; Liberman L.C., 1982, SCIENCE, V216, P1239; Liberman L.C., 1978, J ACOUST SOC AM, V63, P442; Lorente de No R, 1981, PRIMARY ACOUSTIC NUC; Miller M. I., 1991, RANDOM POINT PROCESS; PFEIFFER RR, 1966, SCIENCE, V154, P667, DOI 10.1126/science.154.3749.667; Press W.H., 1993, NUMERICAL RECIPES C; RICCIARDI LM, 1976, BIOL CYBERN, V24, P237, DOI 10.1007/BF00335984; RICCIARDI LM, 1983, MATH BIOSCI, V64, P29, DOI 10.1016/0025-5564(83)90026-3; Rieke F., 1999, SPIKES EXPLORING NEU; RUBINSTEIN JT, 1995, BIOPHYS J, V68, P779; Tuckwell HC, 1989, STOCHASTIC PROCESSES	47	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1099-4300			ENTROPY-SWITZ	Entropy	DEC	2014	16	12					6654	6666		10.3390/e16126654		13	Physics, Multidisciplinary	Physics	AX2TX	WOS:000346798600026		
J	Shudo, A; Hanada, Y; Okushima, T; Ikeda, KS				Shudo, Akira; Hanada, Yasutaka; Okushima, Teruaki; Ikeda, Kensuke S.			Instanton-noninstanton transition in nonintegrable tunneling processes: A renormalized perturbation approach	EPL			English	Article							CHAOS	The instanton-noninstanton (I-NI) transition in the tunneling process, which has been numerically observed in classically nonintegrable quantum maps, can be described by a perturbation theory based on an integrable Hamiltonian renormalized so as to incorporate the integrable part of the map. The renormalized perturbation theory is successfully applied to the two quantum maps, the Henon and standard maps. In spite of the different nature of tunneling in the two systems, the I-NI transition exhibits very common characteristics. In particular, the manifestation of I-NI transition is obviously explained by a remarkable quenching of the renormalized transition matrix element. The enhancement of tunneling probability after the transition can be understood as a sudden change of the tunneling mechanism from the instanton to quite a different mechanism supported by classical flows just outside of the stable-unstable manifolds of the saddle on the top of the potential barrier. Copyright (C) EPLA, 2014	[Shudo, Akira; Hanada, Yasutaka] Tokyo Metropolitan Univ Minami Osawa, Dept Phys, Hachioji, Tokyo 1920397, Japan; [Okushima, Teruaki] Chubu Univ, Coll Engn, Gen Educ Div, Sci & Technol Sect, Kasugai, Aichi 4878501, Japan; [Ikeda, Kensuke S.] Ritsumeikan Univ, Coll Sci & Engn, Kusatsu 525, Japan	Shudo, A (reprint author), Tokyo Metropolitan Univ Minami Osawa, Dept Phys, Hachioji, Tokyo 1920397, Japan.	shudo@tmu.ac.jp; hanada-yasutaka@ed.tmu.ac.jp; okushima@isc.chubu.ac.jp; ahoo@ike-dyn.ritsumei.ac.jp			Kakenhi [24340094]; Chubu University Grant [26IIS06AII]	Discussions with Y. SHIMIZU, K. TAKAHASHI, A. BACKER, R. KETZMERICK, N. MERTIG and A. MOUCHET are appreciated. This work was supported by Kakenhi 24340094 based on the tax of Japanese people, and the authors would like to acknowledge them. This was also supported by Chubu University Grant (26IIS06AII). The authors are very grateful to Shoji TSUJI and KANKIKAI for using their facilities at Kawaraya during this study.	Steck DA, 2001, SCIENCE, V293, P274, DOI 10.1126/science.1061569; Shudo A, 1998, PHYSICA D, V115, P234, DOI 10.1016/S0167-2789(97)00239-X; TOMSOVIC S, 1994, PHYS REV E, V50, P145, DOI 10.1103/PhysRevE.50.145; LIN WA, 1990, PHYS REV LETT, V65, P2927, DOI 10.1103/PhysRevLett.65.2927; Backer A, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.056208; Backer A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.104101; Bohigas O., 1992, PHYS REP, V223, P45; Brodier O, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.064101; Brodier O., 1984, J PHYS CHEM-US, V88, P6139; Brodier O, 2002, ANN PHYS-NEW YORK, V300, P88, DOI 10.1006/aphy.2002.6281; Creagh S. C., 1998, TUNNELING COMPLEX SY, P35; Creagh S. C., 2001, J PHYS A, V34, P3792; Greene M., 1981, PHYSICA D, V3D, P530; Hanada Y., UNPUB; Hensinger WK, 2001, NATURE, V412, P52, DOI 10.1038/35083510; Keshavamurthy S, 2011, DYNAMICAL TUNNELING: THEORY AND EXPERIMENT, P1; Lock S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.114101; Mouchet A, 2007, J PHYS A-MATH THEOR, V40, pF663, DOI 10.1088/1751-8113/40/29/F02; Podolskiy VA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.263601; RONCAGLIA R, 1994, PHYS REV LETT, V73, P802, DOI 10.1103/PhysRevLett.73.802; Schulman L S, 1996, TECHNIQUES APPL PATH; Sheinman M, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.052110; Shudo A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.154102; Shudo A, 2009, J PHYS A-MATH THEOR, V42, DOI 10.1088/1751-8113/42/26/265101; Takahashi K, 2010, J PHYS A-MATH THEOR, V43, DOI 10.1088/1751-8113/43/19/192001; WILKINSON M, 1986, PHYSICA D, V21, P341, DOI 10.1016/0167-2789(86)90009-6	26	1	1	EPL ASSOCIATION, EUROPEAN PHYSICAL SOCIETY	MULHOUSE	6 RUE DES FRERES LUMIERE, MULHOUSE, 68200, FRANCE	0295-5075	1286-4854		EPL-EUROPHYS LETT	EPL	DEC	2014	108	5							50004	10.1209/0295-5075/108/50004		6	Physics, Multidisciplinary	Physics	AX2RR	WOS:000346792400004		
J	Shimokawa, H				Shimokawa, Hiroaki			2014 Williams Harvey Lecture: importance of coronary vasomotion abnormalities-from bench to bedside	EUROPEAN HEART JOURNAL			English	Review						Coronary vasomotion; Endothelial cells; Vascular smooth muscle; Coronary spasm; Rho-kinase	MYOSIN LIGHT-CHAIN; VASCULAR SMOOTH-MUSCLE; PIGS IN-VIVO; ENDOTHELIUM-DEPENDENT HYPERPOLARIZATION; LONG-TERM PROGNOSIS; PROTEIN-KINASE-C; HUMAN MESENTERIC-ARTERIES; DRUG-ELUTING STENTS; COD-LIVER OIL; RHO-KINASE	Coronary vasomotion abnormalities play important roles in the pathogenesis of ischaemic heart disease, in which endothelial dysfunction and coronary artery spasm are substantially involved. Endothelial vasodilator functions are heterogeneous depending on the vessel size, with relatively greater role of nitric oxide (NO) in conduit arteries and predominant role of endothelium-derived hyperpolarizing factor (EDHF) in resistance arteries, where endothelium-derived hydrogen peroxide serves as an important EDHF. The functions of NO synthases in the endothelium are also heterogeneous with multiple mechanisms involved, accounting for the diverse functions of the endothelium in vasomotor as well as metabolic modulations. Cardiovascular abnormalities and metabolic phenotypes become evident when all three NO synthases are deleted, suggesting the importance of both NO and EDHF. Coronary artery spasm plays important roles in the pathogenesis of a wide range of ischaemic heart disease. The central mechanism of the spasm is hypercontraction of vascular smooth muscle cells (VSMCs), but not endothelial dysfunction, where activation of Rho-kinase, a molecular switch of VSMC contraction, plays a major role through inhibition of myosin light-chain phosphatase. The Rho-kinase pathway is also involved in the pathogenesis of a wide range of cardiovascular diseases and new Rho-kinase inhibitors are under development for various indications. The registry study by the Japanese Coronary Spasm Association has demonstrated many important aspects of vasospastic angina. The ongoing international registry study of vasospastic angina in six nations should elucidate the unknown aspects of the disorder. Coronary vasomotion abnormalities appear to be an important therapeutic target in cardiovascular medicine.	Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan	Shimokawa, H (reprint author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 9808574, Japan.	shimo@cardio.med.tohoku.ac.jp					Aizawa K, 2012, CIRC J, V76, P2552, DOI 10.1253/circj.CJ-12-0662; KAMM KE, 1989, ANNU REV PHYSIOL, V51, P299; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Urakami-Harasawa L, 1997, J CLIN INVEST, V100, P2793, DOI 10.1172/JCI119826; Matoba T, 2002, BIOCHEM BIOPH RES CO, V290, P909, DOI 10.1006/bbrc.2001.6278; Shimokawa H, 1999, J MOL CELL CARDIOL, V31, P23, DOI 10.1006/jmcc.1998.0841; Tanaka S, 2013, ARTERIOSCL THROM VAS, V33, P1591, DOI 10.1161/ATVBAHA.112.300922; Katsumata N, 1997, CIRCULATION, V96, P4357; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Shimokawa H, 1999, CARDIOVASC RES, V43, P1029, DOI 10.1016/S0008-6363(99)00144-3; SHIMOKAWA H, 1988, INT J CARDIOL, V18, P331, DOI 10.1016/0167-5273(88)90052-6; Matoba T, 2000, J CLIN INVEST, V106, P1521, DOI 10.1172/JCI10506; Do E Z, 2009, CIRC J, V73, P1731; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; HIRATA K, 1992, J BIOL CHEM, V267, P8719; MASERI A, 1978, AM J CARDIOL, V42, P1019, DOI 10.1016/0002-9149(78)90691-4; Griffith TM, 2004, PHARMACOL RES, V49, P551, DOI 10.1016/j.phrs.2003.11.014; Ozkor MA, 2011, CIRCULATION, V123, P2244, DOI 10.1161/CIRCULATIONAHA.110.990317; FELETOU M, 1988, BRIT J PHARMACOL, V93, P515; KELM M, 1990, CIRC RES, V66, P1561; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Beltrame JF, 1999, J AM COLL CARDIOL, V33, P1442, DOI 10.1016/S0735-1097(99)00073-X; Takagi Y, 2013, J AM COLL CARDIOL, V62, P1144, DOI 10.1016/j.jacc.2013.07.018; Shimokawa H, 1996, J CLIN INVEST, V97, P769, DOI 10.1172/JCI118476; Shimokawa H, 1996, J CARDIOVASC PHARM, V28, P703, DOI 10.1097/00005344-199611000-00014; Ong P, 2014, CIRCULATION, V129, P1723, DOI 10.1161/CIRCULATIONAHA.113.004096; YASUE H, 1988, CIRCULATION, V78, P1; Ohashi J, 2012, CIRC J, V76, P1768, DOI 10.1253/circj.CJ-12-0197; Duncker DJ, 2012, J MOL CELL CARDIOL, V52, P802, DOI 10.1016/j.yjmcc.2011.10.007; Deussen A, 2012, J MOL CELL CARDIOL, V52, P794, DOI 10.1016/j.yjmcc.2011.10.001; Shiroto T, 2009, J AM COLL CARDIOL, V54, P2321, DOI 10.1016/j.jacc.2009.07.045; Heusch G, 2012, CARDIOVASC RES, V94, P237, DOI 10.1093/cvr/cvr271; Enkhjargal B, 2014, ARTERIOSCL THROM VAS, V34, P1505, DOI 10.1161/ATVBAHA.114.303735; Shimokawa H, 2007, TRENDS PHARMACOL SCI, V28, P296, DOI 10.1016/j.tips.2007.04.006; Satoh K, 2014, J MOL CELL CARDIOL, V73, P50, DOI 10.1016/j.yjmcc.2013.12.022; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; KITAZAWA T, 1991, P NATL ACAD SCI USA, V88, P9307, DOI 10.1073/pnas.88.20.9307; Fisslthaler B, 1999, NATURE, V401, P493; ETO M, 1995, J BIOCHEM-TOKYO, V118, P1104; Edwards G, 1998, NATURE, V396, P269; Matoba T, 2003, ARTERIOSCL THROM VAS, V23, P1224, DOI 10.1161/01.ATV.0000078601.79536.6C; ITO A, 1994, CIRCULATION, V90, P2425; Fukumoto Y, 1997, J CARDIOVASC PHARM, V29, P222, DOI 10.1097/00005344-199702000-00011; Amano M, 1998, GENES CELLS, V3, P177, DOI 10.1046/j.1365-2443.1998.00181.x; Kikuchi Y, 2011, J AM COLL CARDIOL, V58, P1231, DOI 10.1016/j.jacc.2011.05.046; Inokuchi K, 2004, J CARDIOVASC PHARM, V44, P275, DOI 10.1097/01.fjc.0000134775.76636.3f; CHEN G, 1988, BRIT J PHARMACOL, V95, P1165; Nakajima S, 2012, CIRC RES, V111, P87, DOI 10.1161/CIRCRESAHA.112.270215; Prysyazhna O, 2012, NAT MED, V18, P286, DOI 10.1038/nm.2603; Vanhoutte PM, 2009, CIRC J, V73, P595; Amano M, 1996, J BIOL CHEM, V271, P20246; ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Morikawa K, 2003, J CLIN INVEST, V112, P1871, DOI 10.1172/JCI200319351; Kureishi Y, 1997, J BIOL CHEM, V272, P12257, DOI 10.1074/jbc.272.19.12257; Heusch G, 2000, CIRCULATION, V101, P689; Kajikawa M, 2014, HYPERTENSION, V63, P856, DOI 10.1161/HYPERTENSIONAHA.113.02296; Masumoto A, 2002, CIRCULATION, V105, P1545, DOI 10.1161/hc1302.105938; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; Kandabashi T, 2000, CIRCULATION, V101, P1319; Duncker DJ, 2008, PHYSIOL REV, V88, P1009, DOI 10.1152/physrev.00045.2006; Takaki A, 2008, J EXP MED, V205, P2053, DOI 10.1084/jem.20080106; Yada T, 2003, CIRCULATION, V107, P1040, DOI 10.1161/01.CIR.0000050145.25589.65; LANGE RA, 1989, NEW ENGL J MED, V321, P1557, DOI 10.1056/NEJM198912073212301; Shimokawa H, 2010, PFLUG ARCH EUR J PHY, V459, P915, DOI 10.1007/s00424-010-0790-8; Campbell WB, 1996, CIRC RES, V78, P415; Ong P, 2012, J AM COLL CARDIOL, V59, P655, DOI 10.1016/j.jacc.2011.11.015; Suzuki J, 2006, CIRC RES, V98, P811, DOI 10.1161/01.RES.0000216405.85080.a6; Bugiardini R, 2005, JAMA-J AM MED ASSOC, V293, P477, DOI 10.1001/jama.293.4.477; Takagi Y, 2011, CIRC-ARRHYTHMIA ELEC, V4, P295, DOI 10.1161/CIRCEP.110.959809; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Takamura Y, 1999, J CARDIOVASC PHARM, V34, P381, DOI 10.1097/00005344-199909000-00010; Butler WE, 1996, NEUROSURGERY, V38, P781; CAMPBELL GR, 1985, EXP MOL PATHOL, V42, P139, DOI 10.1016/0014-4800(85)90023-1; Canty Jr J. M., 2012, BRAUNWALDS HEART DIS, P1049; Chihara K, 1997, J BIOL CHEM, V272, P25121, DOI 10.1074/jbc.272.40.25121; CHILIAN WM, 1993, EUR HEART J, V14, P55; Crea F, 2009, ESC TXB CARDIOVASCUL, P596; Crea F, 2014, CORONARY MICROVASCUL, P1; Do e Zhulanqiqige, 2013, Circ J, V77, P2542; EGASHIRA K, 1992, J CLIN INVEST, V89, P1047, DOI 10.1172/JCI115646; FORMAN MB, 1985, NEW ENGL J MED, V313, P1138, DOI 10.1056/NEJM198510313131807; IKEBE M, 1985, J BIOL CHEM, V260, P27; Inokuchi K, 2003, HYPERTENSION, V42, P919, DOI 10.1161/01.HYP.0000097548.92665.16; ITO A, 1995, J CLIN INVEST, V96, P1288, DOI 10.1172/JCI118163; Ito A, 1996, CARDIOVASC RES, V32, P570, DOI 10.1016/S0008-6363(96)00120-4; JOUGASAKI M, 1989, PATHOLOGY, V21, P304; Kadokami T, 1996, CIRCULATION, V94, P190; Kawana A, 2013, CIRC J, V77, P1267, DOI 10.1253/circj.CJ-12-1486; Kozai T, 1997, CORONARY ARTERY DIS, V8, P423, DOI 10.1097/00019501-199707000-00004; Kuga T, 2000, J CARDIOVASC PHARM, V35, P822, DOI 10.1097/00005344-200005000-00021; KUGA T, 1995, CIRCULATION, V92, P183; Lacza Z, 2002, AM J PHYSIOL-HEART C, V283, pH406, DOI 10.1152/ajpheart.00007.2002; Li J, 2012, J MOL CELL CARDIOL, V52, P865, DOI 10.1016/j.yjmcc.2011.08.027; MASERI A, 1990, CIRCULATION, V81, P1983; MCFADDEN EP, 1993, CIRCULATION, V88, P2076; Miura H, 2003, CIRC RES, V92, pE31, DOI 10.1161/01.RES.0000054200.44505.AB; MIWA Y, 1994, CIRC RES, V75, P1096; Miyata K, 1999, CIRCULATION, V100, P1432; Miyata K, 2000, J CARDIOVASC PHARM, V35, P294, DOI 10.1097/00005344-200002000-00018; Mohri M, 2003, J AM COLL CARDIOL, V41, P15, DOI 10.1016/S0735-1097(02)02632-3; Morikawa K, 2004, J CARDIOVASC PHARM, V44, P552, DOI 10.1097/00005344-200411000-00006; Morishita T, 2005, P NATL ACAD SCI USA, V102, P10616, DOI 10.1073/pnas.0502236102; Nihei T, 2014, CIRC J, V78, P1183, DOI 10.1253/circj.CJ-13-1458; NODA M, 1995, FEBS LETT, V367, P246, DOI 10.1016/0014-5793(95)00573-R; OKUMURA K, 1992, J AM COLL CARDIOL, V20, P838; OZAKI Y, 1995, CIRCULATION, V92, P2446; OZAKI Y, 1995, J AM COLL CARDIOL, V26, P1606, DOI 10.1016/0735-1097(95)00398-3; Satoh K, 2011, AM J PHYSIOL-HEART C, V301, P287; SATOH S, 1990, AM J PHYSIOL, V259, pH9; Seto M, 1996, PFLUG ARCH EUR J PHY, V432, P7, DOI 10.1007/s004240050099; SETO M, 1993, EXP MOL PATHOL, V58, P1, DOI 10.1006/exmp.1993.1001; SETO M, 1990, PFLUG ARCH EUR J PHY, V415, P484, DOI 10.1007/BF00373627; SHIMIZU H, 1994, J BIOL CHEM, V269, P30407; SHIMOKAWA H, 1988, CIRCULATION, V78, P1421; SHIMOKAWA H, 1985, AM HEART J, V110, P300, DOI 10.1016/0002-8703(85)90148-6; SHIMOKAWA H, 1983, SCIENCE, V221, P560, DOI 10.1126/science.6408736; SHIMOKAWA H, 1987, CIRCULATION, V76, P898; SHIMOKAWA H, 1989, J AM COLL CARDIOL, V13, P1402; SHIMOKAWA H, 1989, CIRC RES, V65, P740; SHIMOKAWA H, 1987, CIRC RES, V61, P256; Shimokawa H, 2000, JPN CIRC J, V64, P1, DOI 10.1253/jcj.64.1; SHIMOKAWA H, 1982, AM HEART J, V103, P142, DOI 10.1016/0002-8703(82)90544-0; Shimokawa H, 2010, PFLUG ARCH EUR J PHY, V459, P959, DOI 10.1007/s00424-010-0796-2; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Spilk S, 2013, AM J PHYSIOL-HEART C, V305, pH1639, DOI 10.1152/ajpheart.00073.2013; Tagawa H, 1997, J CARDIOVASC PHARM, V30, P481, DOI 10.1097/00005344-199710000-00012; Tagawa H, 1999, J CARDIOVASC PHARM, V33, P633, DOI 10.1097/00005344-199904000-00017; Takagi Y, 2013, EUR HEART J, V34, P258, DOI 10.1093/eurheartj/ehs199; Takahashi J, EUR HEART J IN PRESS; Takaki A, 2008, J CARDIOVASC PHARM, V52, P510, DOI 10.1097/FJC.0b013e318190358b; TASHIRO H, 1993, JPN CIRC J, V57, P117; Tsuburaya R, 2012, EUR HEART J, V33, P791, DOI 10.1093/eurheartj/ehr145; Tsutsui M, 2010, PHARMACOL THERAPEUT, V128, P499, DOI 10.1016/j.pharmthera.2010.08.010; VANHOUTTE PM, 1989, CIRCULATION, V80, P1; Yada T, 2006, AM J PHYSIOL-HEART C, V291, pH1138, DOI 10.1152/ajpheart.00187.2006; Yada T, 2007, J AM COLL CARDIOL, V50, P1271; YAMAMOTO H, 1995, JPN CIRC J, V59, P608; YAMAMOTO H, 1992, AM HEART J, V123, P298, DOI 10.1016/0002-8703(92)90638-C; YAMAMOTO Y, 1987, CIRC RES, V61, P772; YASUE H, 1983, CIRC RES, V52, P147; YOKOYAMA M, 1990, AM J MED, V89, P507, DOI 10.1016/0002-9343(90)90383-O	141	12	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0195-668X	1522-9645		EUR HEART J	Eur. Heart J.	DEC 1	2014	35	45					3180	3193		10.1093/eurheartj/ehu427		14	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	AW6UY	WOS:000346404800008		
J	Matsui, Y; Tomaru, U; Miyoshi, A; Ito, T; Fukaya, S; Miyoshi, H; Atsumi, T; Ishizu, A				Matsui, Yuki; Tomaru, Utano; Miyoshi, Arina; Ito, Tomoki; Fukaya, Shinji; Miyoshi, Hideaki; Atsumi, Tatsuya; Ishizu, Akihiro			Overexpression of TNF-alpha converting enzyme promotes adipose tissue inflammation and fibrosis induced by high fat diet	EXPERIMENTAL AND MOLECULAR PATHOLOGY			English	Article						Adipose tissue inflammation; High fat diet; Obesity; TACE; TNF-alpha	INSULIN-RESISTANCE; OBESITY; MICE	Obesity is a state in which chronic low-grade inflammation persists in adipose tissues. Pro-inflammatory cytokines, including TNF-alpha, produced by adipose tissues have been implicated as active participants in the development of obesity-related diseases. Since TNF-alpha converting enzyme (TACE) is the major factor that induces soluble TNF-alpha, TACE has been noted as a pivotal regulator in this field. To reveal the role of TACE in adipose tissue inflammation, TACE-transgenic (TACE-Tg) and wild type (WT) mice were fed with high fat diet (HFD) or control diet for 16 weeks. At 13 weeks after the beginning of the diet, serum TNF-alpha and macrophage-related cytokine/chemokine levels were elevated in TACE-Tg mice fed with HFD (Tg-HFD mice), and the number of the so-called crown-like adipocyte was significantly increased in adipose tissues of Tg-HFD mice at the end of the experiment. Although macrophage infiltration was not detected in the adipose tissues at this time, fibrosis was observed around the crown-like adipocytes. These findings suggested that TACE overexpression induced macrophage infiltration and subsequent fibrosis in adipose tissues under HFD regimen. The collective evidence suggested that TACE could be a therapeutic target of HFD-induced obesity-related adipose tissue inflammation. (C) 2014 Elsevier Inc. All rights reserved.	[Matsui, Yuki] Hokkaido Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido 0608012, Japan; [Tomaru, Utano; Ito, Tomoki] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido 0608012, Japan; [Miyoshi, Arina; Fukaya, Shinji; Miyoshi, Hideaki; Atsumi, Tatsuya] Hokkaido Univ, Grad Sch Med, Dept Internal Med 2, Sapporo, Hokkaido 0608012, Japan; [Ishizu, Akihiro] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido 0608012, Japan	Ishizu, A (reprint author), Hokkaido Univ, Fac Hlth Sci, Kita Ku, Kita 12,Nishi 5, Sapporo, Hokkaido 0608012, Japan.	aishizu@med.hokudai.ac.jp					Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Menghini R, 2013, ATHEROSCLEROSIS, V228, P12, DOI 10.1016/j.atherosclerosis.2013.01.024; Holm C, 2003, BIOCHEM SOC T, V31, P1120; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Menghini R, 2009, GASTROENTEROLOGY, V136, P663, DOI 10.1053/j.gastro.2008.10.079; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Fiorentino L, 2010, HEPATOLOGY, V51, P103, DOI 10.1002/hep.23250; Tomaru U, 2012, AM J PATHOL, V180, P963, DOI 10.1016/j.ajpath.2011.11.012; Serino M, 2007, DIABETES, V56, P2541, DOI 10.2337/db07-0360; Surmi BK, 2008, FUTURE LIPIDOL, V3, P545, DOI 10.2217/17460875.3.5.545; de Meijer VE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025587; Fukaya S, 2013, LAB INVEST, V93, P72, DOI 10.1038/labinvest.2012.153; Lee Hansongyi, 2013, Pediatr Gastroenterol Hepatol Nutr, V16, P143, DOI 10.5223/pghn.2013.16.3.143	14	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4800	1096-0945		EXP MOL PATHOL	Exp. Mol. Pathol.	DEC	2014	97	3					354	358		10.1016/j.yexmp.2014.09.017		5	Pathology	Pathology	AX1CK	WOS:000346685700006		
J	Shimokado, A; Sun, YJ; Nakanishi, M; Sato, F; Oikawa, K; Akasaka, T; Muragaki, Y				Shimokado, Aiko; Sun, Yujing; Nakanishi, Masako; Sato, Fuyuki; Oikawa, Kosuke; Akasaka, Takashi; Muragaki, Yasuteru			Smad3 plays an inhibitory role in phosphate-induced vascular smooth muscle cell calcification	EXPERIMENTAL AND MOLECULAR PATHOLOGY			English	Article						TGF-beta; Smad3; Vascular calcification; Enpp1; Pyrophosphate	GROWTH-FACTOR-BETA; INFANTILE ARTERIAL CALCIFICATION; INORGANIC PYROPHOSPHATE; TGF-BETA; EXPRESSION; PC-1; MINERALIZATION; CHONDROCYTES; OSTEOPONTIN; ANK	Arterial medial calcification is a major complication in patients with chronic kidney disease and diabetes. It has been hypothesized that a high concentration of inorganic phosphate (Pi) induces calcification in vascular smooth muscle cells (vSMCs). However, the role of transforming growth factor-beta (TGF-beta)/Smad3 signaling in Pi-induced vascular calcification remains controversial. The aim of this study was to investigate the possible involvement of Smad3 in Pi-induced vascular calcification. We compared the degree of Pi-induced vSMC calcification between vSMCs isolated from wild-type (Smad3(+/+)) and Smad3-deficient (Smad3(-/-)) mice. We found that vSMCs from Smad3(+/+) mice had less calcium (Ca) than those from smad3(-/-) mice when they were exposed to high concentrations of Pi and Ca (Pi + Ca). The phosphorylation of Smad3 was induced in Smad3(+/+) vSMCs by exposure to Pi + Ca. The concentration of extracellular pyrophosphate (ePPi) was lower in Smad3(-/-) vSMCs than in Smad3(+/+) vSMCs and was significantly increased in Smad3(+/+) vSMCs by treatment with TGF-beta 1. Also, the addition of a small amount of PPi to culture medium significantly decreased the deposition of Ca in both Smad3(+/+) and Smad3(-/-) vSMCs. Ectonucleotide phosphatase/phosphodiesterase1 (Enpp1) was decreased at the mRNA, protein, and enzymatic activity levels in Smad3(-/-) vSMCs compared with Smad3(-/-) vSMCs. A ChIP assay showed that phosphotylated Smad3 directly binds to the Enpp1 gene. Furthermore, the calcification of aortic segments was attenuated by treatment with TGF-beta 1 only in Smad3(+/+) mice. Taken together, we conclude that Pi-induced vSMC calcification is suppressed by Smad3 via an increase in ePPi. C) 2014 Elsevier Inc All rights reserved.	[Shimokado, Aiko; Sun, Yujing; Nakanishi, Masako; Sato, Fuyuki; Oikawa, Kosuke; Akasaka, Takashi; Muragaki, Yasuteru] Wakayama Med Univ, Sch Med, Dept Pathol 1, Wakayama 6410012, Japan; [Shimokado, Aiko; Akasaka, Takashi] Wakayama Med Univ, Sch Med, Dept Cardiovasc Med, Wakayama 6410012, Japan	Muragaki, Y (reprint author), Wakayama Med Univ, Sch Med, Dept Pathol 1, 811-1 Kimiidera, Wakayama 6410012, Japan.	ymuragak@wakayama-med.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology [24590488]	We thank Dr. Syunji Itoh and Ms. Mayumi Akira for their technical assistance. This work was supported in part by a Grant-in-Aid for Scientific Research (24590488) from the Ministry of Education, Culture, Sports, Science, and Technology (to Y.M.).	Johnson K, 2003, J BONE MINER RES, V18, P994, DOI 10.1359/jbmr.2003.18.6.994; Zeadin M, 2009, ARTERIOSCL THROM VAS, V29, P2069, DOI 10.1161/ATVBAHA.109.195255; Zhao GX, 2012, KIDNEY INT, V82, P34, DOI 10.1038/ki.2012.40; Speer MY, 2009, CIRC RES, V104, P733, DOI 10.1161/CIRCRESAHA.108.183053; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Su N, 2010, HUM MOL GENET, V19, P1199, DOI 10.1093/hmg/ddp590; Prosdocimo DA, 2010, AM J PHYSIOL-CELL PH, V298, pC702, DOI 10.1152/ajpcell.00419.2009; MEYER JL, 1984, ARCH BIOCHEM BIOPHYS, V231, P1, DOI 10.1016/0003-9861(84)90356-4; Lau WL, 2011, ADV CHRONIC KIDNEY D, V18, P105, DOI 10.1053/j.ackd.2010.12.002; Ogawa K, 2003, J BIOL CHEM, V278, P30373, DOI 10.1074/jbc.M304856200; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Zhu K, 2010, ONCOGENE, V29, P451, DOI 10.1038/onc.2009.343; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; van de Laar IMBH, 2012, J MED GENET, V49, P47, DOI 10.1136/jmedgenet-2011-100382; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; WATSON KE, 1994, J CLIN INVEST, V93, P2106, DOI 10.1172/JCI117205; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Kanno Y, 2008, CARDIOVASC RES, V77, P221, DOI 10.1093/cvr/cvm049; Johnson K, 1999, ARTHRITIS RHEUM, V42, P1986, DOI 10.1002/1529-0131(199909)42:9<1986::AID-ANR26>3.0.CO;2-O; Kaji H, 2006, HORM METAB RES, V38, P740, DOI 10.1055/s-2006-955085; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; BERBERIAN G, 1991, BIOCHIM BIOPHYS ACTA, V1063, P217, DOI 10.1016/0005-2736(91)90374-H; Cailotto F, 2011, J BIOL CHEM, V286, P19215, DOI 10.1074/jbc.M110.175448; Fitzgerald K. K., 2014, CASE REP GENET, V2014; Johnson K, 2001, ARTHRITIS RHEUM, V44, P1071, DOI 10.1002/1529-0131(200105)44:5<1071::AID-ANR187>3.0.CO;2-3; Lomashvili KA, 2005, J AM SOC NEPHROL, V16, P2495, DOI 10.1681/ASN.2004080694; LOTZ M, 1995, P NATL ACAD SCI USA, V92, P10364, DOI 10.1073/pnas.92.22.10364; REES JA, 1988, ANN RHEUM DIS, V47, P747, DOI 10.1136/ard.47.9.747; Rutsch F, 2001, AM J PATHOL, V158, P543, DOI 10.1016/S0002-9440(10)63996-X; Sowa H, 2002, J BIOL CHEM, V277, P36024, DOI 10.1074/jbc.M206030200; Spina Annamaria, 2013, Biores Open Access, V2, P47, DOI 10.1089/biores.2012.0266; Yamazaki M, 2010, J CELL BIOCHEM, V111, P1210, DOI 10.1002/jcb.22842; Zhu DX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019595	34	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4800	1096-0945		EXP MOL PATHOL	Exp. Mol. Pathol.	DEC	2014	97	3					458	464		10.1016/j.yexmp.2014.10.005		7	Pathology	Pathology	AX1CK	WOS:000346685700019		
J	Hayashi, R; Hayashi, S; Arai, K; Sakai, M; Okamoto, H; Chikuda, M				Hayashi, Rijo; Hayashi, Shimmin; Arai, Kiyomi; Sakai, Miki; Okamoto, Hiroyuki; Chikuda, Makoto			The gender-differentiated antioxidant effects of a lutein-containing supplement in the aqueous humor of patients with senile cataracts	EXPERIMENTAL EYE RESEARCH			English	Article						Senile cataract; Antioxidant supplements; Human aqueous humor; Superoxide scavenging activity; Hydrogen peroxide; Total amount of hydroperoxides; Lutein; Gender differences	AGE-RELATED CATARACT; BEAVER DAM EYE; OXIDATIVE STRESS; LENS OPACITIES; VITAMIN-C; NUTRIENT INTAKE; BETA-CAROTENE; LIPID-PEROXIDATION; OPTICAL-DENSITY; CLINICAL-TRIAL	Antioxidant supplements are expected to decrease oxidative damage and prevent ocular diseases. In this study, changes in the anti-oxidative ability and oxidative status in the aqueous humor before and after intake of a lutein-containing supplement were measured. Forty patients who all had identical grades of cataracts in both eyes were included. The aqueous humor was collected as pre-intake samples during cataract surgery. Ocuvite + Lutein (R), an antioxidant supplement, was administered orally beginning the day after surgery. Six weeks later, the aqueous humor was collected as a post-intake sample during cataract surgery of the opposite eye. To determine the anti-oxidative ability, the levels of superoxide (O-2(center dot-)) scavenging activity were measured. To determine the oxidative status, the levels of hydrogen peroxide (H2O2) and total amount of hydroperoxides (TH, including H2O2 and peroxides of lipids, proteins, and nucleic acids) were measured. In post-intake samples, the O-2(center dot-) scavenging activities were significantly higher in both genders (p <0.05). The levels of H2O2 were significantly higher (p < 0.01) while the levels of TH were significantly lower (p < 0.01) only in females. The level of H2O2 was significantly negatively correlated to the TH in the post-intake samples of both genders (r = -0.50 and p < 0.05 for males; r = -0.59 and p < 0.01 for females) while the level of H2O2 was significantly positively correlated to the O-2(center dot-) scavenging activity in both pre- and post-intake aqueous humor in females only (r = 0.66 and p < 0.01 for pre-intake samples, r = 0.71 and p < 0.01 for post-intake samples). After the introduction of the antioxidant supplement, O-2(center dot-) scavenging activity increased while H2O2 levels remained the same in males, suggesting that scavenging rates are proportional. In postmenopausal females, the superoxide scavenging activity also increased, however unlike in males, the H2O2 levels also increased meaning H2O2 was not completely scavenged. H2O2 is a non-free radical and can be excreted from the aqueous humor to prevent further oxidation of lipids, proteins, and nucleic acids, which was confirmed by the low levels of TH in post-intake samples. Antioxidant supplements are suggested to be effective in reducing oxidation in the aqueous humor by different mechanisms in both genders. (C) 2014 Elsevier Ltd. All rights reserved.	[Hayashi, Rijo; Hayashi, Shimmin; Arai, Kiyomi; Sakai, Miki; Okamoto, Hiroyuki; Chikuda, Makoto] Dokkyo Med Univ, Koshigaya Hosp, Dept Ophthalmol, Koshigaya, Saitama 3438555, Japan; [Hayashi, Shimmin] Lively Eye Clin, Soka 3400053, Japan	Hayashi, R (reprint author), Dokkyo Med Univ, Koshigaya Hosp, Dept Ophthalmol, 2-1-50 Minamikoshigaya, Koshigaya, Saitama 3438555, Japan.	lhayashi@dokkyomed.ac.jp					Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417; Gale CR, 2001, OPHTHALMOLOGY, V108, P1992, DOI 10.1016/S0161-6420(01)00833-8; Christen WG, 2008, ARCH OPHTHALMOL-CHIC, V126, P102, DOI 10.1001/archopht.126.1.102; KNEKT P, 1992, BRIT MED J, V305, P1392; Jacques PF, 2001, ARCH OPHTHALMOL-CHIC, V119, P1009; Alberti A, 2000, RES CHEM INTERMEDIAT, V26, P253, DOI 10.1163/156856700X00769; Gao SS, 2011, MOL VIS, V17, P3180; SPECTOR A, 1995, FASEB J, V9, P1173; Mares JA, 2006, AM J CLIN NUTR, V84, P1107; Bone RA, 2010, ARCH BIOCHEM BIOPHYS, V504, P50, DOI 10.1016/j.abb.2010.06.019; Chasan-Taber L, 1999, AM J CLIN NUTR, V70, P509; Ruiz-Larrea MB, 2000, CHEM PHYS LIPIDS, V105, P179, DOI 10.1016/S0009-3084(00)00120-1; Borras C, 2005, AGING CELL, V4, P113, DOI 10.1111/j.1474-9726.2005.00151.x; Delcourt C, 2006, INVEST OPHTH VIS SCI, V47, P2329, DOI 10.1167/iovs.05-1235; Woodall AA, 1997, BBA-GEN SUBJECTS, V1336, P33, DOI 10.1016/S0304-4165(97)00006-8; YEUM KJ, 1995, INVEST OPHTH VIS SCI, V36, P2756; MOORADIAN AD, 1993, J STEROID BIOCHEM, V45, P509, DOI 10.1016/0960-0760(93)90166-T; LESKE MC, 1991, ARCH OPHTHALMOL-CHIC, V109, P244; Lyle BJ, 1999, AM J EPIDEMIOL, V149, P801; Kim JH, 2008, FREE RADICAL BIO MED, V45, P885, DOI 10.1016/j.freeradbiomed.2008.06.019; McCarty CA, 1999, AM J OPHTHALMOL, V128, P446, DOI 10.1016/S0002-9394(99)00218-4; Tan AG, 2008, AM J CLIN NUTR, V87, P1899; Moeller SM, 2008, ARCH OPHTHALMOL-CHIC, V126, P354, DOI 10.1001/archopht.126.3.354; Cesarone MR, 1999, INT ANGIOL, V18, P127; Klein BEK, 1998, ARCH OPHTHALMOL-CHIC, V116, P219; MACHLIN LJ, 1987, FASEB J, V1, P441; YAN DB, 1991, INVEST OPHTH VIS SCI, V32, P2515; KLEIN BEK, 1994, ARCH OPHTHALMOL-CHIC, V112, P85; HANKINSON SE, 1992, BRIT MED J, V305, P335; Williams AW, 1998, P SOC EXP BIOL MED, V218, P106; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831; Berger J., 1989, J NUTR, V119, P1; BLONDIN J, 1986, Journal of Free Radicals in Biology and Medicine, V2, P275, DOI 10.1016/S0748-5514(86)80010-1; Brady WE, 1996, J NUTR, V126, P129; Brown L, 1999, AM J CLIN NUTR, V70, P517; Cai Qiu-Yin, 1994, Biomedical and Environmental Sciences, V7, P109; Gomez-Zubeldia MA, 2001, MENOPAUSE, V8, P274; Hales AM, 1997, J EXP MED, V185, P273, DOI 10.1084/jem.185.2.273; Hayashi R, 2012, EXP EYE RES, V96, P48, DOI 10.1016/j.exer.2012.01.001; JACQUES PF, 1991, AM J CLIN NUTR, V53, pS352; KOSTIC D, 1995, AM J CLIN NUTR, V62, P604; LEVINE M, 1986, NEW ENGL J MED, V314, P892; Lin J, 1996, J JPN OPHTHALMOL SOC, V100, P672; Maraini G, 2009, ANN I SUPER SANITA, V45, P119; Mares-Perlman JA, 2000, ARCH OPHTHALMOL-CHIC, V118, P1556; Obara Y, 1995, J JPN OPHTHALMOL SOC, V99, P1303; Offord EA, 2002, FREE RADICAL BIO MED, V32, P1293, DOI 10.1016/S0891-5849(02)00831-6; OJIMA F, 1993, FREE RADICAL BIO MED, V15, P377, DOI 10.1016/0891-5849(93)90037-U; Olofsson EM, 2009, INVEST OPHTH VIS SCI, V50, P2913, DOI 10.1167/iovs.09-3510; Patti P.F., 1953, B STE CHIM BIOL, V35, P1177; Rahim A, 2011, J PAK MED ASSOC, V61, P853; Renzi LM, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-33; Rosenthal JM, 2006, INVEST OPHTH VIS SCI, V47, P5227, DOI 10.1167/iovs.05-1513; SEDDON JM, 1994, AM J PUBLIC HEALTH, V84, P788, DOI 10.2105/AJPH.84.5.788; SPECTOR A, 1993, CURR EYE RES, V12, P163, DOI 10.3109/02713689308999484; TAYLOR A, 1991, CURR EYE RES, V10, P751, DOI 10.3109/02713689109013869; Truscott R.J., 2005, EXP EYE RES, V80, P701; Vu HTV, 2006, INVEST OPHTH VIS SCI, V47, P3783, DOI 10.1167/iovs.05-0587; Wefer H., 1988, FEBS LETT, V174, P353; Yoshida M, 2007, EUR J NUTR, V46, P118, DOI 10.1007/s00394-006-0641-8	61	0	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	DEC	2014	129						5	12		10.1016/j.exer.2014.10.009		8	Ophthalmology	Ophthalmology	AX4HJ	WOS:000346893800002		
J	Imamura, T; Hirayama, T; Tsuruma, K; Shimazawa, M; Nagasawa, H; Hara, H				Imamura, Tomoyo; Hirayama, Tasuku; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Nagasawa, Hideko; Hara, Hideaki			Hydroxyl radicals cause fluctuation in intracellular ferrous ion levels upon light exposure during photoreceptor cell death	EXPERIMENTAL EYE RESEARCH			English	Article						Age-related macular degeneration; Light-induced retinal damage; Ferrous; Iron; Hydroxyl radical	RETINAL DEGENERATION; IRON-DEFICIENCY; MOUSE RETINA; LABILE IRON; STRESS; ERYTHROPOIESIS; INVOLVEMENT; EXPRESSION; PROTECTS; MICE	Iron accumulation is a potential pathogenic event often seen in age-related macular degeneration (AMD) patients. In this study, we focused on the relationship between AMD pathology and concentrations of ferrous ion, which is a highly reactive oxygen generator in biological systems. Murine cone-cells-derived 661W cells were exposed to white florescence light at 2500 lx for 1, 3, 6, or 12 h. Levels of ferrous ions, reactive oxygen species (ROS), and hydroxyl radicals were detected by RhoNox-1, a novel fluorescent probe for the selective detection of ferrous ion, 5-(and-6)-chloromethy1-2',7'-dichlorodihydrofluorescein diacetate, acetyl ester (CM-H(2)DCFDA), and 3'-p-(aminophenyl) fluorescein, respectively. Reduced glutathione, total iron levels and photoreceptor cell death were also measured. Two genes related to iron metabolism, transferrin receptor 1 (TfR1) and H ferritin (HFt), were quantified by RT-PCR. The effects of ferrous ion on cell death and hydroxyl radical production were determined by treatment with a ferrous ion chelating agent, 2,2'-bipyridyl. We found that the ferrous ion level decreased with light exposure in the short time frame, whereas it was upregulated during a 6-h light exposure. Total iron, ROS, cell death rate, and expression of TfR and HFt genes were significantly increased in a time-dependent manner in 661W cells exposed to light. Chelation with 2,2'-bipyridyl reduced the level of hydroxyl radicals and protected against light-induced cell death. These results suggest that light exposure decreases ferrous ion levels and enhances iron uptake in photoreceptor cells. Ferrous ion may be involved in light-induced photoreceptor cell death through production of hydroxyl radicals. (C) 2014 Elsevier Ltd. All rights reserved.	[Imamura, Tomoyo; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu 5011196, Japan; [Hirayama, Tasuku; Nagasawa, Hideko] Gifu Pharmaceut Univ, Dept Organ & Med Chem, Gifu 5011196, Japan	Hara, H (reprint author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	hidehara@gifu-pu.ac.jp					Abo-Krysha N, 2008, MULT SCLER J, V14, P602, DOI 10.1177/1352458507085550; Hider RC, 2011, BIOMETALS, V24, P1179, DOI 10.1007/s10534-011-9476-8; Rezaie T, 2012, INVEST OPHTH VIS SCI, V53, P7847, DOI 10.1167/iovs.12-10793; Song DL, 2012, FREE RADICAL BIO MED, V53, P64, DOI 10.1016/j.freeradbiomed.2012.04.020; Kell DB, 2010, ARCH TOXICOL, V84, P825, DOI 10.1007/s00204-010-0577-x; Goss DJ, 2011, ACCOUNTS CHEM RES, V44, P1320, DOI 10.1021/ar2001149; Imai S, 2010, EUR J PHARMACOL, V642, P77, DOI 10.1016/j.ejphar.2010.05.057; Krishnamoorthy RR, 1999, J BIOL CHEM, V274, P3734, DOI 10.1074/jbc.274.6.3734; Nakanishi T, 2013, J NEUROCHEM, V125, P111, DOI 10.1111/jnc.12116; Munoz M, 2011, J CLIN PATHOL, V64, P281, DOI 10.1136/jcp.2010.079046; Lane DJR, 2013, BBA-MOL CELL RES, V1833, P1527, DOI 10.1016/j.bbamcr.2013.02.010; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Valavanidis A, 2009, INT J ENV RES PUB HE, V6, P445, DOI 10.3390/ijerph6020445; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Yamauchi M, 2011, EUR J PHARMACOL, V650, P110, DOI 10.1016/j.ejphar.2010.09.081; SOFIC E, 1991, J NEUROCHEM, V56, P978, DOI 10.1111/j.1471-4159.1991.tb02017.x; McCarthy RC, 2013, J BIOL CHEM, V288, P17932, DOI 10.1074/jbc.M113.455428; Casarrubea D, 2013, J MOL MED, V91, P871, DOI 10.1007/s00109-013-1008-2; Christova T, 2007, MOL CELL BIOCHEM, V301, P21, DOI 10.1007/s11010-006-9393-2; Hegde NV, 2011, AM J PHYSIOL-GASTR L, V300, pG470, DOI 10.1152/ajpgi.00463.2010; Hirayama T, 2013, CHEM SCI, V4, P1250, DOI 10.1039/c2sc21649c; JELLINGER KA, 1993, ADV NEUROL, V60, P267; Khandakar J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00331; Kortman GAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029968; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; Mizukami S, 2010, ARCH TOXICOL, V84, P319, DOI 10.1007/s00204-009-0496-x; Popovic Z, 2004, MOL CELL BIOCHEM, V265, P37, DOI 10.1023/B:MCBI.0000044313.19574.c6; Rolfs A, 1999, J PHYSIOL-LONDON, V518, P1, DOI 10.1111/j.1469-7793.1999.0001r.x; Rolston R.K., 2009, AGRO FOOD IND HI TEC, V19, P33; Song D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00024; Synowiec E, 2012, MOL BIOL REP, V39, P7077, DOI 10.1007/s11033-012-1539-6; Tang HY, 2014, J MAGN RESON IMAGING, V39, P307, DOI 10.1002/jmri.24171; Wolkow N, 2011, ARCH OPHTHALMOL-CHIC, V129, P1466, DOI 10.1001/archophthalmol.2011.309	33	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	DEC	2014	129						24	30		10.1016/j.exer.2014.10.019		7	Ophthalmology	Ophthalmology	AX4HJ	WOS:000346893800005		
J	Miki, A; Kanamori, A; Nakamura, M; Matsumoto, Y; Mizokami, J; Negi, A				Miki, Akiko; Kanamori, Akiyasu; Nakamura, Makoto; Matsumoto, Yoshiko; Mizokami, Junji; Negi, Akira			The expression of syntaphilin is down-regulated in the optic nerve after axonal injury	EXPERIMENTAL EYE RESEARCH			English	Article						Syntaphilin; Axonal injury; Optic nerve; Visual pathway; Axonal transport	RETINAL GANGLION-CELLS; IN-VIVO; AXOPLASMIC-TRANSPORT; MITOCHONDRIA; GLAUCOMA; DOCKING; DISEASE; BRAIN; DEGENERATION; ASTROCYTES	The impairment of mitochondrial function is an important pathogenic factor in glaucoma and other optic neuropathies in which retinal ganglion cell (RGC) death is the fundamental pathology. Syntaphilin was recently discovered as a docking protein that affects mitochondrial mobility. However, no reports have investigated the involvement of syntaphilin in the visual system. We investigated the expression of syntaphilin in the rat retina, optic nerve and brain. The expression of syntaphilin exhibited varying patterns in the visual system. Syntaphilin was expressed in retinal ganglion cells in the retina, in the cell bodies of neurons in the superior colliculus and was abundant in the astrocytes of rat optic nerves (similar to the findings that syntaphilin is expressed in human optic nerves). After optic nerve transection, which caused RGC death and axonal degeneration, quantitative real-time RT-PCR was used to assess changes in gene expression in the rat retina and optic nerve. Syntaphilin gene and protein expression in the optic nerve was downregulated 3 and 7 days after optic nerve transection. Our study suggests that syntaphilin expression in astrocytes at the optic nerve might be involved in axonal injury. (C) 2014 Elsevier Ltd. All rights reserved.	[Miki, Akiko; Kanamori, Akiyasu; Nakamura, Makoto; Matsumoto, Yoshiko; Mizokami, Junji; Negi, Akira] Kobe Univ, Grad Sch Med, Div Ophthalmol, Dept Surg, Kobe, Hyogo 6500017, Japan	Kanamori, A (reprint author), Kobe Univ, Grad Sch Med, Div Ophthalmol, Dept Surg,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kanaaki@med.kobe-u.ac.jp			Scientific Research by the Ministry of Education [23592568, 23791983]; Culture, Sports, and Science and Technology of the Japanese Government; Suda Memorial Foundation; Mishima Memorial Foundation	The authors thank Keiko Hayashibe for experimental assistance. This work was supported by the Scientific Research by the Ministry of Education (23592568 (M.N.) and 23791983 (A.K.)), the Culture, Sports, and Science and Technology of the Japanese Government, the Suda Memorial Foundation (A.K.) and the Mishima Memorial Foundation (A.K.).	Kanamori A, 2010, BRAIN, V133, P2612, DOI 10.1093/brain/awq105; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Son JL, 2010, GLIA, V58, P780, DOI 10.1002/glia.20962; Crish SD, 2010, P NATL ACAD SCI USA, V107, P5196, DOI 10.1073/pnas.0913141107; Vrabec JP, 2007, EYE, V21, pS11, DOI 10.1038/sj.eye.6702880; Zhu YB, 2011, J BIOL CHEM, V286, P23432, DOI 10.1074/jbc.M111.237818; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Salinas-Navarro M, 2010, EXP EYE RES, V90, P168, DOI 10.1016/j.exer.2009.10.003; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Sun D, 2010, J NEUROSCI, V30, P14008, DOI 10.1523/JNEUROSCI.3605-10.2010; Kang JS, 2008, CELL, V132, P137, DOI 10.1016/j.cell.2007.11.024; Mahad DJ, 2009, BRAIN, V132, P1161, DOI 10.1093/brain/awp046; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Kanamori A, 2004, BRAIN RES, V1022, P195, DOI 10.1016/j.brainres.2004.06.007; Chada SR, 2003, J EXP BIOL, V206, P1985, DOI 10.1242/jeb.00263; Butt AM, 2004, EYE, V18, P1110, DOI 10.1038/sj.eye.6701595; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.02745; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Johnson JE, 2007, MOL VIS, V13, P887; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Kanamori A, 2010, INVEST OPHTH VIS SCI, V51, P2011, DOI 10.1167/iovs.09-4021; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Chidlow G, 2011, ACTA NEUROPATHOL, V121, P737, DOI 10.1007/s00401-011-0807-1; Belforte N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034574; Chen YM, 2009, J NEUROSCI, V29, P9429, DOI 10.1523/JNEUROSCI.1472-09.2009; Coelho DJ, 2005, NEUROSCIENCE, V134, P907, DOI 10.1016/j.neuroscience.205.04.060; Das S, 2003, MOL BRAIN RES, V116, P38, DOI 10.1016/S0169-328X(03)00212-2; Haenold R, 2012, NEUROIMAGE, V59, P363, DOI 10.1016/j.neuroimage.2011.07.069; ANDERSON DR, 1974, INVEST OPHTH VISUAL, V13, P771; Kanamori A, 2009, EXP EYE RES, V88, P535, DOI 10.1016/j.exer.2008.11.012; Knox DL, 2007, ARCH OPHTHALMOL-CHIC, V125, P347, DOI 10.1001/archopht.125.3.347; Lao GF, 2000, NEURON, V25, P191, DOI 10.1016/S0896-6273(00)80882-X; Mao PZ, 2010, BBA-MOL BASIS DIS, V1802, P66, DOI 10.1016/j.bbadis.2009.07.002; Podhajsky RJ, 1997, EXP NEUROL, V143, P153, DOI 10.1006/exnr.1996.6354	36	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	DEC	2014	129						38	47		10.1016/j.exer.2014.10.017		10	Ophthalmology	Ophthalmology	AX4HJ	WOS:000346893800007		
J	Yagasaki, R; Nakahara, T; Mori, A; Sakamoto, K; Ishii, K				Yagasaki, Rina; Nakahara, Tsutomu; Mori, Asami; Sakamoto, Kenji; Ishii, Kunio			Effects of mTOR inhibition on normal retinal vascular development in the mouse	EXPERIMENTAL EYE RESEARCH			English	Article						Mammalian target of rapamycin; Vascular development; Vascular endothelial growth factor; Retina; Rapamycin; Ribosomal protein S6	ENDOTHELIAL GROWTH-FACTOR; VEGF EXPRESSION; TYROSINE KINASE; ANGIOGENESIS; MICE; NEOVASCULARIZATION; KRN633; APELIN; MODEL	We aimed to determine the role of age-related changes in the mammalian target of rapamycin (mTOR) activity in endothelial cell growth during retinal vascular development in mice. Mice were administered the mTOR inhibitor rapamycin as follows: (i) for 6 days from postnatal day 0 (P0) to P5, (ii) for 2 days on P6 and P7, and (iii) for 2 days on P12 and P13. For comparison, we examined the effects of KRN633, an inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinase, on retinal vascular development. The retinal vasculature and phosphorylated ribosomal protein S6 (pS6), a downstream indicator of mTOR activity, were evaluated using immunohistochemistry. Vascularization was delayed and capillary density was reduced in mice administered rapamycin from PO to P5 compared to the vehicle-treated mice. Rapamycin administration on P6 and P7 decreased the vascular density but did not significantly delay the radial vascular growth. Rapamycin administration on P12 and P13 did not significantly affect the retinal superficial blood vessels. Immunoreactivity for pS6 was detected in both endothelial cells in the vascular front and non-vascular cells in the retinal parenchyma, and rapamycin markedly diminished the pS6 immunoreactivity. KRN633 administration on PO and P1 completely inhibited retinal vascularization. The effects of KRN633 on retinal blood vessels decreased in magnitude in an age-dependent manner. These results suggest that the mTOR pathway in endothelial cells activated by VEGF contributes to physiologic vascular development, and that the mTOR pathway in endothelial cells is modulated in a postnatal age-dependent manner. (C) 2014 Elsevier Ltd. All rights reserved.	[Yagasaki, Rina; Nakahara, Tsutomu; Mori, Asami; Sakamoto, Kenji; Ishii, Kunio] Kitasato Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol, Minato Ku, Tokyo 1088641, Japan	Nakahara, T (reprint author), Kitasato Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	nakaharat@pharm.kitasato-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23122517, 25122712, 23590112]	This study was supported by Grants-in-Aid for Scientific Research on Innovative Areas (Nos. 23122517, 25122712, T.N.) and a Grant-in-Aid for Scientific Research (C) (No. 23590112, T.N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Ichikawa A, 2014, J NEUROSCI RES, V92, P692, DOI 10.1002/jnr.23358; Ozaki H, 2000, AM J PATHOL, V156, P697, DOI 10.1016/S0002-9440(10)64773-6; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Kasai A, 2010, ARTERIOSCL THROM VAS, V30, P2182, DOI 10.1161/ATVBAHA.110.209775; Saint-Geniez M, 2004, INT J DEV BIOL, V48, P1045, DOI 10.1387/ijdb.041895ms; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Leibinger M, 2012, NEUROBIOL DIS, V46, P314, DOI 10.1016/j.nbd.2012.01.004; STONE J, 1995, J NEUROSCI, V15, P4738; Park HYL, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.26; Checchin D, 2006, INVEST OPHTH VIS SCI, V47, P3595, DOI 10.1167/iovs.05-1522; Stahl A, 2008, FEBS LETT, V582, P3097, DOI 10.1016/j.febslet.2008.08.005; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; Rodriguez-Muela N, 2012, CELL DEATH DIFFER, V19, P162, DOI 10.1038/cdd.2011.88; Morita A, 2014, EXP EYE RES, V120, P127, DOI 10.1016/j.exer.2014.01.009; Masri B, 2004, FASEB J, V18, P1909, DOI 10.1096/fj.04-1930fje; Xue Q, 2009, ARTERIOSCL THROM VAS, V29, P1172, DOI 10.1161/ATVBAHA.109.185918; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Kasai A, 2008, ARTERIOSCL THROM VAS, V28, P1717, DOI 10.1161/ATVBAHA.108.163402; Dejneka NS, 2004, MOL VIS, V10, P964; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; Nakamura K, 2004, MOL CANCER THER, V3, P1639	23	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0014-4835	1096-0007		EXP EYE RES	Exp. Eye Res.	DEC	2014	129						127	134		10.1016/j.exer.2014.11.005		8	Ophthalmology	Ophthalmology	AX4HJ	WOS:000346893800016		
J	Neriya, Y; Maejima, K; Nijo, T; Tomomitsu, T; Yusa, A; Himeno, M; Netsu, O; Hamamoto, H; Oshima, K; Namba, S				Neriya, Yutaro; Maejima, Kensaku; Nijo, Takamichi; Tomomitsu, Tatsuya; Yusa, Akira; Himeno, Misako; Netsu, Osamu; Hamamoto, Hiroshi; Oshima, Kenro; Namba, Shigetou			Onion yellow phytoplasma P38 protein plays a role in adhesion to the hosts	FEMS MICROBIOLOGY LETTERS			English	Article						phytoplasma; mollicutes; adhesin; Mollicutes adhesin motif	IMMUNODOMINANT MEMBRANE-PROTEIN; SEQUENCE; INSECT; CELLS; MYCOPLASMAS; EXPRESSION; PREDICTION; DIVERSITY; CLONING; SYSTEM	Adhesins are microbial surface proteins that mediate the adherence of microbial pathogens to host cell surfaces. In Mollicutes, several adhesins have been reported in mycoplasmas and spiroplasmas. Adhesins P40 of Mycoplasma agalactiae and P89 of Spiroplasma citri contain a conserved amino acid sequence known as the Mollicutes adhesin motif (MAM), whose function in the host cell adhesion remains unclear. Here, we show that phytoplasmas, which are plant-pathogenic mollicutes transmitted by insect vectors, possess an adhesion-containing MAM that was identified in a putative membrane protein, PAM289 (P38), of the Candidatus Phytoplasma asteris,' OY strain. P38 homologs and their MAMs were highly conserved in related phytoplasma strains. While P38 protein was expressed in OY-infected insect and plant hosts, binding assays showed that P38 interacts with insect extract, and weakly with plant extract. Interestingly, the interaction of P38 with the insect extract depended on MAM. These results suggest that P38 is a phytoplasma adhesin that interacts with the hosts. In addition, the MAM of adhesins is important for the interaction between P38 protein and hosts.	[Neriya, Yutaro; Maejima, Kensaku; Nijo, Takamichi; Tomomitsu, Tatsuya; Yusa, Akira; Himeno, Misako; Netsu, Osamu; Namba, Shigetou] Univ Tokyo, Grad Sch Agr & Life Sci, Plant Pathol Lab, Dept Agr & Environm Biol,Bunkyo Ku, Tokyo 1138657, Japan; [Hamamoto, Hiroshi; Oshima, Kenro] Hosei Univ, Fac Biosci, Dept Clin Plant Sci, Koganei, Tokyo 184, Japan	Namba, S (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Plant Pathol Lab, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	anamba@mail.ecc.u-tokyo.ac.jp	Netsu, Osamu/O-1225-2015		Japan Society for the Promotion of Science [25221201]; JSPS from Ministry of Education, Culture, Sports and Arts, Japan [24-7695]	This work was supported by grants-in-aid for Scientific Research from the Japan Society for the Promotion of Science (category S of Scientific Research Grant 25221201) and by JSPS Fellowship (24-7695) from the Ministry of Education, Culture, Sports and Arts, Japan.	Kakizawa S, 2004, MICROBIOL-SGM, V150, P135, DOI 10.1099/mic.0.26521-0; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; Kakizawa S, 2006, TRENDS MICROBIOL, V14, P254, DOI 10.1016/j.tim.2006.04.008; Bai XD, 2006, J BACTERIOL, V188, P3682, DOI 10.1128/JB.188.10.3682-3696.2006; Yu J, 2000, PHYTOPATHOLOGY, V90, P716, DOI 10.1094/PHYTO.2000.90.7.716; Suzuki S, 2006, P NATL ACAD SCI USA, V103, P4252, DOI 10.1073/pnas.0508668103; Fleury B, 2002, INFECT IMMUN, V70, P5612, DOI 10.1128/IAI.70.10.5612-5621.2002; Maejima K, 2014, J GEN PLANT PATHOL, V80, P210, DOI 10.1007/s10327-014-0512-8; Tran-Nguyen LTT, 2008, J BACTERIOL, V190, P3979, DOI 10.1128/JB.01301-07; Neriya Y, 2011, FEMS MICROBIOL LETT, V324, P38, DOI 10.1111/j.1574-6968.2011.02384.x; Boonrod K, 2012, MOL PLANT MICROBE IN, V25, P889, DOI 10.1094/MPMI-11-11-0303; Soto GE, 1999, J BACTERIOL, V181, P1059; Oshima K, 2004, NAT GENET, V36, P27, DOI 10.1038/ng1277; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Kakizawa S, 2009, FEMS MICROBIOL LETT, V293, P92, DOI 10.1111/j.1574-6968.2009.01509.x; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Galetto L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022571; Giron JA, 1996, INFECT IMMUN, V64, P197; Ishii Y, 2009, MICROBIOL-SGM, V155, P2058, DOI 10.1099/mic.0.027409-0; Jung Hee-Young, 2003, Journal of General Plant Pathology, V69, P208; Kube M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-306; Oshima K, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00230; Oshima K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023242; Oshima K, 2001, PHYTOPATHOLOGY, V91, P1024, DOI 10.1094/PHYTO.2001.91.11.1024; Shiomi T., 1996, Annals of the Phytopathological Society of Japan, V62, P258	28	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0378-1097	1574-6968		FEMS MICROBIOL LETT	FEMS Microbiol. Lett.	DEC	2014	361	2					115	122		10.1111/1574-6968.12620		8	Microbiology	Microbiology	AX2QB	WOS:000346787900004		
J	Nakasa, T; Adachi, N; Kato, T; Ochi, M				Nakasa, Tomoyuki; Adachi, Nobuo; Kato, Tomohiro; Ochi, Mitsuo			Correlation Between Subchondral Bone Plate Thickness and Cartilage Degeneration in Osteoarthritis of the Ankle	FOOT & ANKLE INTERNATIONAL			English	Article						osteoarthritis; ankle; subchondral bone plate; computed tomography	ARTICULAR-CARTILAGE; CANCELLOUS BONE; JOINTS; DAMAGE; MODEL; KNEE; LIGAMENT; CT	Background: Osteoarthritis (OA) is characterized not only by cartilage degeneration, but also subchondral bone changes. The subchondral bone plate (SBP) plays an important role in cartilage metabolism, and elucidation of the relationship between the SBP and cartilage degeneration would be helpful to determine the most appropriate treatment strategy for ankle OA. The purpose of this study was to evaluate the SBP and to compare it with cartilage degeneration with arthroscopic findings. Methods: Computed tomography (CT) was used to compare the thickness of the SBP of 11 ankle OA patients with that of 11 non-ankle OA patients in 9 areas of the talar dome. The French Society of Arthroscopy (SFA) grading system was used to analyze the relationship between findings on the thickness of SBP and on articular cartilage degeneration in ankle OA. Results: The SBP in ankle OA was significantly thicker than that of the non-OA ankle. The more severe the articular cartilage degeneration, the thicker the SBP became. The SBP on the sclerotic trabecular bone was significantly thicker than that on decreased trabecular bone. The SFA grade for sclerotic subchondral bone was significantly higher than that for decreased trabecular bone. Conclusion: This study shows that the thickness of SBP and the findings of subchondral bone such as decreased trabecular bone and sclerosis in CT are related to the cartilage degeneration of ankle OA, although a small number of patients were analyzed.	[Nakasa, Tomoyuki; Adachi, Nobuo; Kato, Tomohiro; Ochi, Mitsuo] Hiroshima Univ, Dept Orthopaed Surg Integrated Hlth & Sci, Inst Biomed & Hlth Sci, Hiroshima, Japan	Nakasa, T (reprint author), Inst Biomed & Hlth Sci, Dept Orthopaed Surg Integrated Hlth & Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348551, Japan.	tnakasa0@gmail.com					Madry H, 2010, KNEE SURG SPORT TR A, V18, P419, DOI 10.1007/s00167-010-1054-z; TAKAKURA Y, 1995, J BONE JOINT SURG BR, V77B, P50; Wang SX, 2007, ARTHRITIS RHEUM, V56, P1537, DOI 10.1002/art.22574; Creamer P, 1997, LANCET, V350, P503, DOI 10.1016/S0140-6736(97)07226-7; Haq I, 2003, POSTGRAD MED J, V79, P377, DOI 10.1136/pmj.79.933.377; Botter SM, 2008, OSTEOARTHR CARTILAGE, V16, P506, DOI 10.1016/j.joca.2007.08.005; Lee S, 2013, CLIN RADIOL, V68, pE355, DOI 10.1016/j.crad.2013.01.023; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; Kuettner KE, 2005, OSTEOARTHR CARTILAGE, V13, P93, DOI 10.1016/j.joca.2004.11.006; Muraoka T, 2007, ARTHRITIS RHEUM, V56, P3366, DOI 10.1002/art.22921; Bobinac D, 2003, BONE, V32, P284, DOI 10.1016/S8756-3282(02)00982-1; DOUGADOS M, 1994, ARTHROSCOPY, V10, P69, DOI 10.1016/S0749-8063(05)80295-6; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Day JS, 2001, J ORTHOPAED RES, V19, P914, DOI 10.1016/S0736-0266(01)00012-2; RADIN EL, 1973, J BIOMECH, V6, P51, DOI 10.1016/0021-9290(73)90037-7; Intema F, 2010, OSTEOARTHR CARTILAGE, V18, P691, DOI 10.1016/j.joca.2010.01.004; Conti SF, 2001, CLIN ORTHOP RELAT R, P105; Ding M, 2003, J BONE JOINT SURG BR, V85B, P906, DOI 10.1302/0301-620X.85B6.12595; van den Berg WB, 2001, CURR OPIN RHEUMATOL, V13, P452, DOI 10.1097/00002281-200109000-00019; Boyd SK, 2000, CLIN BIOMECH, V15, P624, DOI 10.1016/S0268-0033(00)00023-1; Buettner O, 2013, FOOT ANKLE INT, V34, P1025, DOI 10.1177/1071100713477636; Cole Ada A, 2003, Foot Ankle Clin, V8, P305, DOI 10.1016/S1083-7515(03)00012-3; Daud R, 2013, J FOOT ANKLE SURG, V52, P426, DOI 10.1053/j.jfas.2013.03.007; Hough AJ, 2001, OSTEOARTHRITIS DIAGN, P69; Koepp H, 1999, J Orthop Sci, V4, P407, DOI 10.1007/s007760050123; Kuo CC, 2014, CLIN ANAT, V27, P659, DOI 10.1002/ca.22296; Mann RA., 1984, OSTEOARTHRITIS DIAGN, P397; Muehleman C, 2002, ANAT REC, V266, P81, DOI 10.1002/ar.10040; Pardy CK, 2004, J APPL PHYSIOL, V97, P1254, DOI 10.1152/japplphysiol.00122.2004; Peyron JG, 1984, OSTEOARTHRITIS DIAGN, P9; RADIN EL, 1986, CLIN ORTHOP RELAT R, P34; Sniekers YH, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-20; Valderrabano V, 2004, CLIN ORTHOP RELAT R, P47, DOI 10.1097/01.blo.0000132245.18548.09	33	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1071-1007	1944-7876		FOOT ANKLE INT	Foot Ankle Int.	DEC	2014	35	12					1341	1349		10.1177/1071100714548061		9	Orthopedics	Orthopedics	AX1FL	WOS:000346693300017		
J	Nakayama, Y; Oota, N				Nakayama, Yu; Oota, Noriyuki			N Rate N+1 Color Marking: Per-Flow Fairness in Ring Aggregation Networks	IEEE TRANSACTIONS ON COMMUNICATIONS			English	Article						Communication system traffic control; quality of service; metropolitan area networks; packet switching	RESILIENT PACKET RING; BANDWIDTH ALLOCATION; PROTOCOL; DESIGN	Our study is motivated by the need for per-flow fairness in a ring aggregation network. This paper proposes a multicolor marking and queuing delay suppression scheme called N rate N + 1 color marking (NRN + 1 CM) that is designed to achieve per-flow fairness. The key idea is to assign a color to a frame according to the flow input rate with high burst tolerance using a simple marker. The color indicates the dropping priority. When congestion occurs, frames are selectively discarded based on their color and the dropping threshold. The accumulation of queuing delay is suppressed with a dropping threshold notification process. The effect of NRN + 1 CM was confirmed by a theoretical analysis and computer simulations.	[Nakayama, Yu; Oota, Noriyuki] NTT Corp, NTT Access Network Serv Syst Labs, Yokosuka, Kanagawa 2390847, Japan	Nakayama, Y (reprint author), NTT Corp, NTT Access Network Serv Syst Labs, Yokosuka, Kanagawa 2390847, Japan.						Alharbi F., 2004, P 2004 WORKSH HIGH P, P277; DEMERS A, 1989, COMP COMM R, V19, P1; Shreedhar M, 1996, IEEE ACM T NETWORK, V4, P375, DOI 10.1109/90.502236; Zoric S, 2010, IEEE MEDITERR ELECT, P1591, DOI 10.1109/MELCON.2010.5476298; [Anonymous], 2004, 80217 IEEE; Tang WS, 2010, J OPT COMMUN NETW, V2, P230, DOI 10.1364/JOCN.2.000230; Ryoo JD, 2008, IEEE COMMUN MAG, V46, P136, DOI 10.1109/MCOM.2008.4623718; [Anonymous], 1999, RFC2698; Nurujjaman M, 2013, IEEE COMMUN LETT, V17, P162, DOI 10.1109/LCOMM.2012.111612.121860; Ott TJ, 1999, IEEE INFOCOM SER, P1346, DOI 10.1109/INFCOM.1999.752153; Cobb JA, 2008, LECT NOTES COMPUT SC, V5340, P156, DOI 10.1007/978-3-540-89335-6_14; Floyd S, 1993, IEEE ACM T NETWORK, V1, P397, DOI 10.1109/90.251892; Nichols K, 2012, COMMUN ACM, V55, P42, DOI 10.1145/2209249.2209264; Alharbi F, 2005, COMPUT NETW, V49, P161, DOI 10.1016/j.comnet.2004.12.004; Stoica I, 2003, IEEE ACM T NETWORK, V11, P33, DOI 10.1109/TNET.2002.808414; Gambiroza V, 2004, IEEE ACM T NETWORK, V12, P85, DOI 10.1109/TNET.2003.820432; Yilmaz M, 2014, COMPUT NETW, V62, P43, DOI 10.1016/j.bjp.2014.01.003; Gettys J, 2012, COMMUN ACM, V55, P57, DOI 10.1145/2063176.2063196; Rosberg Z, 2010, COMPUT NETW, V54, P1358, DOI 10.1016/j.comnet.2009.11.011; Cao Z., 2000, P IEEE INFOCOM 2000, V2, P922; Carofiglio G., 2010, P IEEE INFOCOM, P1; Domzal J, 2012, IEEE ICC, DOI 10.1109/ICC.2012.6364201; Hu C, 2010, IET COMMUN, V4, P472, DOI 10.1049/iet-com.2009.0404; Jain R, 1999, P ATM FOR 99 0045 FE; Kim JH, 2011, IEEE T PARALL DISTR, V22, P571, DOI 10.1109/TPDS.2010.104; Lu F, 2012, 2012 PROCEEDINGS IEEE INFOCOM, P2981; Mozo A., 2011, Proceedings of the 2011 IEEE 10th International Symposium on Network Computing and Applications (NCA 2011), DOI 10.1109/NCA.2011.10; Mukherjee Sabyasachi, 2013, International Journal of Information and Electronics Engineering, V3, DOI 10.7763/IJIEE.2013.V3.349; Nakayama Y., 2011, P FAST TOK JAP, P1; Pan R., 2000, P IEEE INFOCOM, P942; Pauwels K, 2000, LECT NOTES COMPUT SC, V1922, P221	31	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0090-6778	1558-0857		IEEE T COMMUN	IEEE Trans. Commun.	DEC	2014	62	12					4401	4412		10.1109/TCOMM.2014.2369038		12	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	AX2SG	WOS:000346793800019		
J	Zhuang, H; Ohtsuki, T				Zhuang, He; Ohtsuki, Tomoaki			A Model Based on Poisson Point Process for Analyzing MIMO Heterogeneous Networks Utilizing Fractional Frequency Reuse	IEEE TRANSACTIONS ON WIRELESS COMMUNICATIONS			English	Article						Poisson point process (PPP); multiple-input multiple-output (MIMO); fractional frequency reuse (FFR); heterogeneous networks (HetNets)	CELLULAR NETWORKS; INTERFERENCE COORDINATION; TIER	In this paper, we propose a tractable and flexible model for K-tier multiple-input-multiple-output (MIMO) heterogeneous networks (HetNets), with the fractional frequency reuse (FFR) technique, based on the spatial Poisson point process (PPP). The MIMO HetNets consist of K tiers of base stations (BSs), where each tier may differ in terms of the transmit power, the BSs' deployment density, the target signal-to-interference ratio, the number of antennas, and the MIMO technique. Since HetNets experience serious cross-tier interference, FFR, as an interference management technique, is found as a suitable solution. Due to the randomness of the BSs' locations, the PPP is more and more used to model them in HetNets. In this paper, we use different independent PPPs to model the BSs' locations of each tier, and we take different MIMO techniques into consideration. We focus on two main types of FFR techniques, i.e., strict FFR and soft frequency reuse, and we derive the coverage probability expressions of cell-edge users (the users at the cell edge). We also derive the average rate expressions and show the impact of the main parameters on the coverage probability under closed-access and open-access cases.	[Zhuang, He; Ohtsuki, Tomoaki] Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa 2238522, Japan	Zhuang, H (reprint author), Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa 2238522, Japan.	zhuang@ohtsuki.ics.keio.ac.jp; ohtsuki@ics.keio.ac.jp					Al-Shalash M, 2010, 2010 IEEE 21ST INTERNATIONAL SYMPOSIUM ON PERSONAL INDOOR AND MOBILE RADIO COMMUNICATIONS (PIMRC), P1882, DOI 10.1109/PIMRC.2010.5671621; Xia P, 2010, IEEE T WIREL COMMUN, V9, P3798, DOI 10.1109/TWC.2010.101310.100231; Dhillon HS, 2012, IEEE J SEL AREA COMM, V30, P550, DOI 10.1109/JSAC.2012.120405; Hamza AS, 2013, IEEE COMMUN SURV TUT, V15, P1642, DOI 10.1109/SURV.2013.013013.00028; Andrews JG, 2011, IEEE T COMMUN, V59, P3122, DOI 10.1109/TCOMM.2011.100411.100541; ElSawy H, 2013, IEEE COMMUN SURV TUT, V15, P996, DOI 10.1109/SURV.2013.052213.00000; Dhillon HS, 2013, IEEE T WIREL COMMUN, V12, P5208, DOI 10.1109/TWC.2013.090513.130142; Boudreau G, 2009, IEEE COMMUN MAG, V47, P74, DOI 10.1109/MCOM.2009.4907410; Chandrasekhar V, 2008, IEEE COMMUN MAG, V46, P59, DOI 10.1109/MCOM.2008.4623708; SALEH AAM, 1987, IEEE T COMMUN, V35, P1245, DOI 10.1109/TCOM.1987.1096716; Novlan TD, 2012, IEEE T COMMUN, V60, P2029, DOI 10.1109/TCOMM.2012.061112.110477; Wang LC, 2011, IEEE J SEL AREA COMM, V29, P1185, DOI 10.1109/JSAC.2011.110607; Zhang J, 2008, IEEE T WIREL COMMUN, V7, P3636, DOI 10.1109/TWC.2008.070425; Himayat N, 2010, IEEE COMMUN MAG, V48, P86, DOI 10.1109/MCOM.2010.5534591; Novlan TD, 2011, IEEE T WIREL COMMUN, V10, P4294, DOI 10.1109/TWC.2011.100611.110181; Dhillon HS, 2012, CONF REC ASILOMAR C, P683, DOI 10.1109/ACSSC.2012.6489098; Doppler K., 2009, P IEEE INT C COMM WO, P1; Huang H., 2012, MIMO COMMUNICATION C; Mhatre V., 2004, P IEEE INT C COMM, V6, P3646; Novlan T. D., 2010, P IEEE GLOBECOM, P1; STOYAN D, 1996, STOCHASTIC GEOMETRY	21	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1536-1276	1558-2248		IEEE T WIREL COMMUN	IEEE Trans. Wirel. Commun.	DEC	2014	13	12					6839	6850		10.1109/TWC.2014.2364219		12	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	AX0GA	WOS:000346629900025		
J	Zhou, XB; Cheng, M; He, X; Matsumoto, T				Zhou, Xiaobo; Cheng, Meng; He, Xin; Matsumoto, Tad			Exact and Approximated Outage Probability Analyses for Decode-and-Forward Relaying System Allowing Intra-Link Errors	IEEE TRANSACTIONS ON WIRELESS COMMUNICATIONS			English	Article						Decode-and-forward; relay channel; intra-link errors; source coding with side information theorem; Slepian-Wolf theorem; Shannon's lossy source-channel separation theorem; outage probability	WIRELESS NETWORKS; COOPERATIVE DIVERSITY; CHANNELS; PROTOCOLS; PERFORMANCE; INFORMATION; CODES	In this paper, we theoretically analyze the outage probability of decode-and-forward (DF) relaying system allowing intra-link errors (DF-IE), where the relay always forwards the decoder output to the destination regardless of whether errors are detected after decoding in the information part or not. The results apply to practical fading scenarios where all the links between the nodes suffer from independent block Rayleigh fading. The key idea of DF-IE system is that the data sequence forwarded by the relay is highly correlated with the original information sequence sent from the source, and hence with a proper joint decoding technique at the destination, the correlation knowledge can well be exploited to improve the system performance. We analyze this problem in the information theoretical framework of correlated source coding. Using the theorems for lossy source-channel separation and for source coding with side information, the exact outage probability is derived. It is then shown that the exact expression can be reduced to a simple, yet accurate approximation by replacing the theorem for source coding with side information by the Slepian-Wolf theorem. Compared with conventional DF relaying where relay keeps silent if errors are detected after decoding, DF-IE can achieve even lower outage probability. Moreover, by allowing intra-link errors, the optimal position of the relay is found to be exactly the midpoint between the source and destination. Results of the simulations are provided to verify the accuracy of the analytical results.	[Zhou, Xiaobo; Cheng, Meng; He, Xin; Matsumoto, Tad] Japan Adv Inst Sci & Technol, Sch Informat Sci, Nomi, Ishikawa 9231292, Japan; [He, Xin; Matsumoto, Tad] Univ Oulu, Ctr Wireless Commun, Oulu 90014, Finland	Zhou, XB (reprint author), Japan Adv Inst Sci & Technol, Sch Informat Sci, Nomi, Ishikawa 9231292, Japan.	xiaobo@jaist.ac.jp; chengmeng@jaist.ac.jp; hexin@jaist.ac.jp; matumoto@jaist.ac.jp			European Union [ICT-619555]; Japanese government funding program;  [23360170]	This work was supported in part by the European Union's FP7 project ICT-619555 RESCUE (Links-on-the-fly Technology for Robust, Efficient and Smart Communication in Unpredictable Environments), and in part by the Japanese government funding program, Grant-in-Aid for Scientific Research (B), No. 23360170. The associate editor coordinating the review of this paper and approving it for publication was C. Li.	Azarian K, 2005, IEEE T INFORM THEORY, V51, P4152, DOI 10.1109/TIT.2005.858920; Zhu GC, 2006, IEEE T WIREL COMMUN, V5, P1065, DOI 10.1109/TWC.2006.05014; Zhao B, 2003, ELECTRON LETT, V39, P786, DOI 10.1049/el:20030526; WYNER AD, 1975, IEEE T INFORM THEORY, V21, P294, DOI 10.1109/TIT.1975.1055374; Anwar K, 2012, IEEE COMMUN LETT, V16, P1114, DOI 10.1109/LCOMM.2012.050112.120629; Li YH, 2009, IEEE COMMUN MAG, V47, P71; Beaulieu NC, 2006, IEEE COMMUN LETT, V10, P813, DOI 10.1109/LCOMM.2006.061048; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Liu P, 2006, IEEE WIREL COMMUN, V13, P84; SLEPIAN D, 1973, IEEE T INFORM THEORY, V19, P471, DOI 10.1109/TIT.1973.1055037; Laneman JN, 2003, IEEE T INFORM THEORY, V49, P2415, DOI 10.1109/TIT.2003.817829; Shampine LF, 2008, APPL MATH COMPUT, V202, P266, DOI 10.1016/j.amc.2008.02.012; Stefanov A, 2004, IEEE T COMMUN, V52, P1470, DOI 10.1109/TCOMM.2004.833070; Cheng M, 2013, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2013-34; Cover T. M., 2006, ELEMENTS INFORM THEO; Duyck D, 2009, 2009 IEEE INFORMATION THEORY WORKSHOP (ITW 2009), P248, DOI 10.1109/ITW.2009.5351467; Garcia-Frias J, 2005, IEEE T COMMUN, V53, P555, DOI 10.1109/TCOMM.2005.844959; Laneman JN, 2004, IEEE T INFORM THEORY, V50, P3062, DOI 10.1109/TIT.2004.838089; Li Y, 2009, IEEE COMMUN LETT, V13, P600, DOI 10.1109/LCOMM.2009.090201; Prasad N, 2010, IEEE T WIREL COMMUN, V9, P328, DOI 10.1109/TWC.2010.01.090473; Schwartz M., 1996, IEEE COMMUN MAG, V34, P9, DOI 10.1109/MCOM.1996.492967; Shannon C. E., 1959, P IRE NAT CONV REC M, P142; Vazquez-Araujo FJ, 2014, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2014-25; Youssef R, 2011, IEEE T WIREL COMMUN, V10, P253, DOI 10.1109/TWC.2010.102810.100422; Zhao Y, 2005, IEEE COMMUN LETT, V9, P700, DOI [10.1109/LCOMM.2005.1496587, 10.1109/LCOMM.2005.08025]; Zhou X., 2014, P 20 EW C BARC SPAIN, P1	26	0	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1536-1276	1558-2248		IEEE T WIREL COMMUN	IEEE Trans. Wirel. Commun.	DEC	2014	13	12					7062	7071		10.1109/TWC.2014.2354337		10	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	AX0GA	WOS:000346629900042		
J	Kotaki, T; Yamanaka, A; Mulyatno, KC; Churrotin, S; Labiqah, A; Sucipto, TH; Soegijanto, S; Kameoka, M; Konishi, E				Kotaki, Tomohiro; Yamanaka, Atsushi; Mulyatno, Kris Cahyo; Churrotin, Siti; Labiqah, Amaliah; Sucipto, Teguh Hari; Soegijanto, Soegeng; Kameoka, Masanori; Konishi, Eiji			Continuous dengue type 1 virus genotype shifts followed by co-circulation, clade shifts and subsequent disappearance in Surabaya, Indonesia, 2008-2013	INFECTION GENETICS AND EVOLUTION			English	Article						Dengue virus; Indonesia; Phylogeny; Genotype shift; Clade shift; Co-circulation	HEMORRHAGIC-FEVER; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; DEPENDENT ENHANCEMENT; DOMAIN-III; INFECTION; PROTECTION; EPITOPES; IMMUNITY	Four serotypes of dengue virus (DENV-1 to DENV-4) and their genotypes are distributed in tropical and subtropical regions. Indonesia has been recently suggested as the origin of some dengue virus genotypes. In Surabaya, the second biggest city of Indonesia, we previously reported a shift of the predominantly circulating serotype from DENV-2 to DENV-1 in November 2008, followed by a genotype shift of DENV-1 from genotype IV (GIV) to genotype I (GI) in September 2009, based on nucleotide sequences in the envelope protein coding region. Since then, GI strains had predominantly circulated until December 2010. In this report, we investigated further DENV-1 transitions in Surabaya during 2011-2013 in order to comprehend dengue dynamics during 2008-2013 in more detail. From January 2011 through December 2011, only GIV strains were isolated, indicating that a genotype shift again took place from GI to GIV. In January 2012, GI and GIV strains started co-circulating, which continued until June 2013. To further investigate this phenomenon, analysis was performed at a clade level. GI and GIV strains isolated in Surabaya formed four and three distinct clades, respectively. Concomitant with co-circulation, new clade strains appeared in both genotypes. In contrast, some previously circulating clades were not isolated during co-circulation, indicating clade shifts. Among our Surabaya isolates, nucleotide and amino acid differences in the E region were, respectively, 1.0-2.3% and 0.2-1.0% for GI isolates and 2.0-6.3% and 0.0-1.8% for GIV isolates. Several characteristic amino acid substitutions in the envelope ectodomain were observed in some clades. After July 2013, DENV-1 strains were not isolated and were replaced with DENV-2. This study showed that continuous shifts of more than one genotype resulted in their co-circulation and subsequent disappearance and suggested the relevance of clade replacement to genotype co-circulation and disappearance in Surabaya. (C) 2014 Elsevier B.V. All rights reserved.	[Kotaki, Tomohiro; Yamanaka, Atsushi; Mulyatno, Kris Cahyo; Churrotin, Siti; Labiqah, Amaliah; Sucipto, Teguh Hari; Soegijanto, Soegeng] Airlangga Univ, Inst Trop Dis, Indonesia Japan Collaborat Res Ctr Emerging & Ree, Surabaya 60115, Indonesia; [Kotaki, Tomohiro; Kameoka, Masanori; Konishi, Eiji] Kobe Univ, Grad Sch Med, Ctr Infect Dis, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Yamanaka, Atsushi; Konishi, Eiji] Mahidol Univ, Fac Trop Med, BIKEN Endowed Dept Dengue Vaccine Dev, Bangkok 10400, Thailand; [Yamanaka, Atsushi; Konishi, Eiji] Osaka Univ, Microbial Dis Res Inst, BIKEN Endowed Dept Dengue Vaccine Dev, Suita, Osaka 5650871, Japan; [Kameoka, Masanori] Kobe Univ, Grad Sch Hlth Sci, Dept Int Hlth, Suma Ku, Kobe, Hyogo 6540142, Japan	Kotaki, T (reprint author), Airlangga Univ, Inst Trop Dis, Indonesia Japan Collaborat Res Ctr Emerging & Ree, Surabaya 60115, Indonesia.	tkotaki@people.kobe-u.ac.jp; knmya@biken.osaka-u.ac.jp; cris_tdc@yahoo.com; sitichurrotin@yahoo.com; labiqah_amaliah@yahoo.com; teguhharisucipto@yahoo.co.id; tu.soerya_rsab@yahoo.co.id; mkameoka@port.kobe-u.ac.jp; ekon@biken.osaka-u.ac.jp			program of the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); Ministry of Education, Culture, Sports, Science and Technology of Japan; Center of Excellence (COE) program by the Ministry for Research and Technology (RISTEK) of Indonesia	This work was supported by the program of the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID); by the Ministry of Education, Culture, Sports, Science and Technology of Japan; and the Center of Excellence (COE) program by the Ministry for Research and Technology (RISTEK) of Indonesia.	AASKOV JG, 1989, ARCH VIROL, V105, P209, DOI 10.1007/BF01311358; Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545; Brien JD, 2010, J VIROL, V84, P10630, DOI 10.1128/JVI.01190-10; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Khan E, 2008, J CLIN VIROL, V43, P176, DOI 10.1016/j.jcv.2008.06.003; Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404; Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Williams KL, 2012, VIROLOGY, V429, P12, DOI 10.1016/j.virol.2012.03.003; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Olkowski S, 2013, J INFECT DIS, V208, P1026, DOI 10.1093/infdis/jit273; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480; Konishi E, 2010, J VIROL METHODS, V163, P360, DOI 10.1016/j.jviromet.2009.10.026; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374; Messer WB, 2014, P NATL ACAD SCI USA, V111, P1939, DOI 10.1073/pnas.1317350111; Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005; Weaver SC, 2005, ARCH VIROL, P33; Sukupolvi-Petty S, 2013, J VIROL, V87, P8826, DOI 10.1128/JVI.01314-13; Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215; Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10; HOTTA S, 1952, J INFECT DIS, V90, P1; Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014; Mulyatno KC, 2012, JPN J INFECT DIS, V65, P274; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Araujo JMG, 2009, INFECT GENET EVOL, V9, P716, DOI 10.1016/j.meegid.2008.10.005; Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102; Fahri S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002354; Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686; Jiang T, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-125; Kimura R, 1944, NIPPON IGAKKU, V3379, P629; Kotaki T, 2014, JPN J INFECT DIS, V67, P227; Li DS, 2010, EMERG INFECT DIS, V16, P123, DOI 10.3201/eid1601.091275; Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357; Organization WH, 2012, HDB CLIN MAN DENG; Rabaa MA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002581; ROEHRIG JT, 1990, VIROLOGY, V177, P668, DOI 10.1016/0042-6822(90)90532-V; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Setiati T. E., 2006, Dengue Bulletin, V30, P1; Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823; Suwandono A, 2006, T ROY SOC TROP MED H, V100, P855, DOI 10.1016/j.trstmh.2005.11.010; Thu HM, 2005, VIROLOGY, V336, P163, DOI 10.1016/j.virol.2005.03.018; Villabona-Arenas CJ, 2011, INFECT GENET EVOL, V11, P878, DOI 10.1016/j.meegid.2011.02.007; Villabona-Arenas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062649; Wikramaratna PS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012347; Yamanaka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027322	55	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1348	1567-7257		INFECT GENET EVOL	Infect. Genet. Evol.	DEC	2014	28						48	54		10.1016/j.meegid.2014.09.002		7	Infectious Diseases	Infectious Diseases	AX1YI	WOS:000346739500008		
J	Okitsu, S; Khamrin, P; Thongprachum, A; Nishimura, S; Kalesaran, AFC; Takanashi, S; Shimizu, H; Hayakawa, S; Mizuguchi, M; Ushijima, H				Okitsu, Shoko; Khamrin, Pattara; Thongprachum, Aksara; Nishimura, Shuichi; Kalesaran, Angela F. C.; Takanashi, Sayaka; Shimizu, Hiroyuki; Hayakawa, Satoshi; Mizuguchi, Masashi; Ushijima, Hiroshi			Detection and molecular characterization of human cosavirus in a pediatric patient with acute gastroenteritis, Japan	INFECTION GENETICS AND EVOLUTION			English	Article						Child; Diarrhea; Genotype; Human cosavirus; Japan	HUMAN BOCAVIRUS; MULTIPLEX PCR; CHILDREN; DIARRHEA; INFECTIONS; ASTROVIRUS; DIVERSITY; VIRUS	Human cosavirus (HCoSV) is a genus recently identified in the family Picornaviridae, which includes important pathogens in human health. The pathogenicity of HCoSV remains unclear. This study reports that an HCoSV strain, 10928/2012/JPN, was identified and collected from the stool sample of a child with acute gastroenteritis in Japan, with the detection rate of 0.16%. The patient was not co-infected with other common diarrhea-causal viruses, suggesting HCoSV as a causal pathogen in this pediatric patient. Phylogenetic and sequence analyses exhibited that the virus strain was classified as a new genotype in HCoSV A species, and this study is first to detect HCoSV in a clinical specimen collected in Japan. These results showed that surveillance of HCoSV is important for detecting viral agents in children with diarrhea, despite being the low detection rate. (C) 2014 Elsevier B.V. All rights reserved.	[Okitsu, Shoko; Hayakawa, Satoshi; Ushijima, Hiroshi] Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol, Tokyo 1738610, Japan; [Okitsu, Shoko; Thongprachum, Aksara; Kalesaran, Angela F. C.; Takanashi, Sayaka; Mizuguchi, Masashi; Ushijima, Hiroshi] Univ Tokyo, Dept Dev Med Sci, Sch Int Hlth, Grad Sch Med, Tokyo, Japan; [Khamrin, Pattara] Chiang Mai Univ, Dept Microbiol, Fac Med, Chiang Mai 50000, Thailand; [Nishimura, Shuichi] Nishimura Clin, Kyoto, Japan; [Shimizu, Hiroyuki] Natl Inst Infect Dis, Tokyo, Japan	Okitsu, S (reprint author), Nihon Univ, Sch Med, Dept Pathol & Microbiol, Div Microbiol,Itabashi Ku, 30-1 Oyaguchi Kamicho, Tokyo 1738610, Japan.	shoko-tky@umin.ac.jp			Japan Society for the Promotion Science (JSPS) [25460791]; Ministry of Health, Labor and Welfare, Japan	This research was supported by a Grant-in-Aid from Japan Society for the Promotion Science (JSPS) (Grant number: 25460791) and the Grant-in-Aid for Scientific Research from the Ministry of Health, Labor and Welfare, Japan.	Adams M.J., 2014, ARCH VIROL IN PRESS; Blinkova O, 2009, J CLIN MICROBIOL, V47, P3507, DOI 10.1128/JCM.01062-09; Haramoto E, 2014, FOOD ENVIRON VIROL, V6, P62, DOI 10.1007/s12560-013-9120-6; Donnelly MLL, 1997, J GEN VIROL, V78, P13; Yan HN, 2003, J VIROL METHODS, V114, P37, DOI 10.1016/j.jviromet.2003.08.009; Khamrin P, 2012, J MED VIROL, V84, P901, DOI 10.1002/jmv.23274; Jiang HB, 2013, VIROLOGY, V436, P8, DOI 10.1016/j.virol.2012.09.040; Nix WA, 2013, J GEN VIROL, V94, P2017, DOI 10.1099/vir.0.053827-0; Rovida F, 2013, DIAGN MICR INFEC DIS, V77, P231, DOI 10.1016/j.diagmicrobio.2013.07.020; Luke GA, 2008, J GEN VIROL, V89, P1036, DOI 10.1099/vir.0.83428-0; Khamrin P, 2013, INFECT GENET EVOL, V13, P339, DOI 10.1016/j.meegid.2012.11.004; Kapoor A, 2008, P NATL ACAD SCI USA, V105, P20482, DOI 10.1073/pnas.0807979105; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Campanini G, 2013, EMERG INFECT DIS, V19, P1667, DOI 10.3201/eid1910.130352; Dai XQ, 2010, J CLIN VIROL, V48, P228, DOI 10.1016/j.jcv.2010.03.024; Holtz LR, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-159; Kapusinszky B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036685; Khamrin P, 2012, VIRUS GENES, V44, P244, DOI 10.1007/s11262-011-0700-y; Khamrin P, 2014, ARCH VIROL, V159, P2485, DOI 10.1007/s00705-014-2091-6; Maan HS, 2013, J CLIN VIROL, V58, P183, DOI 10.1016/j.jcv.2013.04.023; Pham NTK, 2010, J VIROL METHODS, V169, P193, DOI 10.1016/j.jviromet.2010.07.038; Rezig D, 2014, J VIROL METHODS, V207, P12, DOI 10.1016/j.jviromet.2014.06.011; Stocker A, 2012, EMERG INFECT DIS, V18, P656, DOI 10.3201/eid1804.111415; Thongprachum A, 2014, INFECT GENET EVOL, V23, P65, DOI 10.1016/j.meegid.2014.01.030; Ushijima H, 2014, JPN J INFECT DIS, V67, P374, DOI 10.7883/yoken.67.374; Yan Hainian, 2004, Kansenshogaku Zasshi, V78, P699	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1348	1567-7257		INFECT GENET EVOL	Infect. Genet. Evol.	DEC	2014	28						125	129		10.1016/j.meegid.2014.09.019		5	Infectious Diseases	Infectious Diseases	AX1YI	WOS:000346739500021		
J	Hirano, E; Kobayashi, M; Tsukagoshi, H; Yoshida, LM; Kuroda, M; Noda, M; Ishioka, T; Kozawa, K; Ishii, H; Yoshida, A; Oishi, K; Ryo, A; Kimura, H				Hirano, Eiko; Kobayashi, Miho; Tsukagoshi, Hiroyuki; Yoshida, Lay Myint; Kuroda, Makoto; Noda, Masahiro; Ishioka, Taisei; Kozawa, Kunihisa; Ishii, Haruyuki; Yoshida, Ayako; Oishi, Kazunori; Ryo, Akihide; Kimura, Hirokazu			Molecular evolution of human respiratory syncytial virus attachment glycoprotein (G) gene of new genotype ON1 and ancestor NA1	INFECTION GENETICS AND EVOLUTION			English	Article						HRSV; Genotype ON1; Molecular evolution; Attachment glycoprotein (G) gene	G-PROTEIN; SOUTH-AFRICA; GROUP-A; 60-NUCLEOTIDE DUPLICATION; CONSECUTIVE SEASONS; RAPID SPREAD; B GENOTYPES; JAPAN; CHILDREN; DIVERSIFICATION	We conducted a comprehensive genetic analysis of the C-terminal 3rd hypervariable region of the attachment glycoprotein (G) gene in human respiratory syncytial virus subgroup A (HRSV-A) genotype ON1 (93 strains) and ancestor NA1 (125 strains). Genotype ON1 contains a unique mutation of a 72 nucleotide tandem repeat insertion (corresponding to 24 amino acids) in the hypervariable region. The Bayesian Markov chain Monte Carlo (MCMC) method was used to conduct phylogenetic analysis and a time scale for evolution. We also calculated pairwise distances (p-distances) and estimated the selective pressure. Phylogenetic analysis showed that the analyzed ON1 and NA1 strains formed 4 lineages. A strain belonging to lineage 4 of ON1 showed wide genetic divergence (p-distance, 0.072), which suggests that it might be a candidate new genotype, namely ON2. The emergence of genotype NA1 was estimated to have occurred in 2000 (95% of highest probability density, HPD; 1997-2002) and that of genotype ON1 in 2005 (95% HPD; 2000-2010) based on the time-scaled phylogenetic tree. The evolutionary rate of genotype ON1 was higher than that of ancestral genotype NA1 (6.03 x 10(-3) vs. 4.61 x 10(-3) substitutions/site/year, p < 0.05). Some positive and many negative selection sites were found in both ON1 and NA1 strains. The results suggested that the new genotype ON1 is rapidly evolving with antigenic changes, leading to epidemics of HRSV infection in various countries. (C) 2014 Elsevier B.V. All rights reserved.	[Hirano, Eiko] Fukui Prefectural Inst Publ Hlth & Environm Sci, Fukui 9108851, Japan; [Kobayashi, Miho; Tsukagoshi, Hiroyuki; Kozawa, Kunihisa] Gunma Prefectural Inst Publ Hlth & Environm Sci, Maebashi, Gunma 3710052, Japan; [Yoshida, Lay Myint] Nagasaki Univ, Inst Trop Med, Dept Pediat Infect Dis, Nagasaki 8528523, Japan; [Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Shinjuku Ku, Tokyo 1628640, Japan; [Noda, Masahiro; Ishioka, Taisei; Oishi, Kazunori; Kimura, Hirokazu] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Musashimurayama, Tokyo 2080011, Japan; [Ishii, Haruyuki] Kyorin Univ, Sch Med, Dept Resp Med, Mitaka, Tokyo 1818611, Japan; [Yoshida, Ayako] Aomori Prefectural Inst Publ Hlth & Environm, Aomori 0308566, Japan; [Ryo, Akihide; Kimura, Hirokazu] Yokohama City Univ, Grad Sch Med, Dept Microbiol & Mol Biodefense Res, Kanagawa Ku, Yokohama, Kanagawa 2360004, Japan	Ryo, A (reprint author), Yokohama City Univ, Grad Sch Med, Dept Microbiol & Mol Biodefense Res, Kanagawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	aryo@yokohama-cu.ac.jp; kimhiro@nih.go.jp			Ministry of Health, Labour and Welfare of Japan [H25-Shiko-Ippan-015]	This work was partly supported by a Grant-in-Aid (H25-Shiko-Ippan-015) for Research on Emerging and Re-emerging Infectious Diseases, Labour and Welfare Programs, from the Ministry of Health, Labour and Welfare of Japan.	Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Venter M, 2001, J GEN VIROL, V82, P2117; Kushibuchi I, 2013, INFECT GENET EVOL, V18, P168, DOI 10.1016/j.meegid.2013.05.010; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Gago S, 2009, SCIENCE, V323, P1308, DOI 10.1126/science.1169202; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Collins PL, 2011, VIRUS RES, V162, P80, DOI 10.1016/j.virusres.2011.09.020; Forcic D, 2012, J MED VIROL, V84, P1985, DOI 10.1002/jmv.23425; Lee N, 2013, CLIN INFECT DIS, V57, P1069, DOI 10.1093/cid/cit471; Holmes EC, 2011, J VIROL, V85, P5247, DOI 10.1128/JVI.02203-10; Kim YJ, 2014, INFECT GENET EVOL, V26, P103, DOI 10.1016/j.meegid.2014.05.007; Valley-Omar Z, 2013, EMERG INFECT DIS, V19, P668, DOI 10.3201/eid1904.121465; Pretorius MA, 2013, J INFECT DIS, V208, pS227, DOI 10.1093/infdis/jit477; Peret TCT, 1998, J GEN VIROL, V79, P2221; Agoti CN, 2014, EMERG INFECT DIS, V20, P950, DOI 10.3201/eid2006.131438; Tsukagoshi H, 2013, MICROBIOL IMMUNOL, V57, P655, DOI 10.1111/1348-0421.12075; Prifert C, 2013, EMERG INFECT DIS, V19, P1029, DOI 10.3201/eid1906.121582; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; Melero JA, 1997, J GEN VIROL, V78, P2411; HALL CB, 1991, J INFECT DIS, V163, P693; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; MUFSON MA, 1985, J GEN VIROL, V66, P2111, DOI 10.1099/0022-1317-66-10-2111; DOMINGO E, 1993, J GEN VIROL, V74, P2039, DOI 10.1099/0022-1317-74-10-2039; Khor CS, 2013, INFECT GENET EVOL, V14, P357, DOI 10.1016/j.meegid.2012.12.017; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; Auksornkitti V., 2013, ARCH VIROL, V159, P499; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; Collins P.L., 2006, FIELDS VIROLOGY, P1601; Cui GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075020; De-Paris F, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-36; Domingo E., 2006, FIELDS VIROLOGY, P389; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Etemadi Mohammad Reza, 2013, Evol Bioinform Online, V9, P151, DOI 10.4137/EBO.S10999; Galiano MC, 2005, J CLIN MICROBIOL, V43, P2266, DOI 10.1128/JCM.43.5.2266-2273.2005; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Leung Alexander K C, 2005, J Natl Med Assoc, V97, P1708; PALOMO C, 1991, J GEN VIROL, V72, P669, DOI 10.1099/0022-1317-72-3-669; Pierangeli A, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.26.20843; Rebuffo-Scheer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025468; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Tran DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0045436; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Yamaguchi M, 2011, J CLIN MICROBIOL, V49, P1034, DOI 10.1128/JCM.02132-10; Yorita KL, 2007, PEDIATR INFECT DIS J, V26, P1081, DOI 10.1097/INF.0b013e31812e62c2	53	5	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1348	1567-7257		INFECT GENET EVOL	Infect. Genet. Evol.	DEC	2014	28						183	191		10.1016/j.meegid.2014.09.030		9	Infectious Diseases	Infectious Diseases	AX1YI	WOS:000346739500029		
J	Fujii, Y; Nakagomi, T; Nishimura, N; Noguchi, A; Miura, S; Ito, H; Doan, YH; Takahashi, T; Ozaki, T; Katayama, K; Nakagomi, O				Fujii, Yoshiki; Nakagomi, Toyoko; Nishimura, Naoko; Noguchi, Atsuko; Miura, Sinobu; Ito, Hisato; Doan, Yen Hai; Takahashi, Tsutomu; Ozaki, Takao; Katayama, Kazuhiko; Nakagomi, Osamu			Spread and predominance in Japan of novel G1P[8] double-reassortant rotavirus strains possessing a DS-1-like genotype constellation typical of G2P[4] strains	INFECTION GENETICS AND EVOLUTION			English	Article						Rotavirus; Genotype constellation; Reassortment; Evolution	GROUP-A ROTAVIRUSES; POLYMERASE CHAIN-REACTION; RNA-RNA HYBRIDIZATION; REPUBLIC-OF-CHINA; MOLECULAR CHARACTERIZATION; SURVEILLANCE NETWORK; VACCINATION PROGRAMS; DIFFERENT GENOGROUPS; CHILDREN; DIARRHEA	Rotavirus is a major cause of severe gastroenteritis in children <5 years of age worldwide, and two, live attenuated rotavirus vaccines are globally available. As rotavirus vaccines are introduced into national immunization programs, there is an increasing need to monitor circulating wild-type strains. However, few studies have systematically examined their full genotype constellation. This study was therefore undertaken to characterize the whole genotype constellation of circulating rotavirus strains in three widely-separated locations in Japan during the 2012 rotavirus season when rotavirus vaccines became available in the country for the first time. Of 107 rotavirus-positive specimens, 50 (46.7%) strains collected from all three locations possessed an unusual G1-P[8]-I2-R2-C2-M2-A2-N2-T2-E2-H2 constellation in which a typical G2P[4] strain appeared to have acquired its two surface protein genes from the most common G1P[8] strain. These G1P[8] double-reassortant strains were shown to possess the 11 genome segments virtually indistinguishable from each other in their nucleotide sequences and phylogenetic lineages except for two strains that underwent further intra-genotype reassortment. Successful spread to and predominance in broad locations across Japan of novel rotavirus strains possessing a genotype constellation that was previously thought not to be preferred suggests unexpected genomic flexibility of the genotype constellation. (C) 2014 Elsevier B.V. All rights reserved.	[Fujii, Yoshiki; Katayama, Kazuhiko] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Nakagomi, Toyoko; Doan, Yen Hai; Nakagomi, Osamu] Nagasaki Univ, Grad Sch Biomed Sci, Dept Hyg & Mol Epidemiol, Nagasaki 8528523, Japan; [Nishimura, Naoko; Ozaki, Takao] Konan Kosei Hosp, Dept Pediat, Konan, Aichi, Japan; [Noguchi, Atsuko; Takahashi, Tsutomu] Akita Univ, Grad Sch Med, Dept Pediat, Akita 010, Japan; [Miura, Sinobu] Yuri Kumiai Gen Hosp, Dept Pediat, Akita, Japan; [Ito, Hisato] Nantan Gen Hosp, Dept Pediat, Kyoto, Japan	Nakagomi, O (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Hyg & Mol Epidemiol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.	onakagom@nagasaki-u.ac.jp			Ministry of Health, Labour and Welfare, Japan	This study was supported by the grants in-aid for scientific research from the Ministry of Health, Labour and Welfare, Japan.	Abdel-Haq NM, 2003, J CLIN MICROBIOL, V41, P2680, DOI 10.1128/JCM.41.6.2680-2682.2003; Adhikary AK, 1998, ACTA PAEDIATR JAPON, V40, P641; Ahmed K, 2005, J MED VIROL, V77, P323, DOI 10.1002/jmv.20451; Banyai K, 2012, VACCINE, V30, pA122, DOI 10.1016/j.vaccine.2011.09.111; Doan YH, 2012, INFECT GENET EVOL, V12, P1202, DOI 10.1016/j.meegid.2012.04.023; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; NAKAGOMI T, 1989, J VIROL, V63, P1431; Matthijnssens J, 2008, ARCH VIROL, V153, P1621, DOI 10.1007/s00705-008-0155-1; WU H, 1994, EPIDEMIOL INFECT, V112, P615; Iturriza-Gomara M, 2011, EPIDEMIOL INFECT, V139, P895, DOI 10.1017/S0950268810001810; Nakagomi T, 2013, JPN J INFECT DIS, V66, P269; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Yamamoto SP, 2014, EMERG INFECT DIS, V20, P1030, DOI 10.3201/eid2006.131326; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Heiman EM, 2008, J VIROL, V82, P11106, DOI 10.1128/JVI.01402-08; Tran T N Hoa, 2013, Trop Med Health, V41, P13, DOI 10.2149/tmh.2012-29; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; Asmah RH, 2001, J CLIN MICROBIOL, V39, P1981, DOI 10.1128/JCM.39.5.1981-1984.2001; Serhan F, 2013, MMWR-MORBID MORTAL W, V62, P409; Duan ZJ, 2009, J INFECT DIS, V200, pS167, DOI 10.1086/605039; Estes M. K., 2013, FIELDS VIROLOGY, P1347; Fang ZY, 2002, J CLIN MICROBIOL, V40, P1875, DOI 10.1128/JCM.40.5.1875.1878.2002; Fang ZY, 2005, J INFECT DIS, V192, pS94, DOI 10.1086/431505; Fujii Y, 2012, MICROBIOL IMMUNOL, V56, P630, DOI 10.1111/j.1348-0421.2012.00479.x; Ghosh S, 2011, J GEN VIROL, V92, P2201, DOI 10.1099/vir.0.033001-0; KAGA E, 1994, MICROBIOL IMMUNOL, V38, P317; Kuzuya M., 2013, J MED VIROL, V86, P1056; Li DD, 2009, VACCINE, V27, pF40, DOI 10.1016/j.vaccine.2009.08.073; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; NAKAGOMI O, 1991, ARCH VIROL, V119, P67, DOI 10.1007/BF01314324; NAKAGOMI O, 1989, MOL CELL PROBE, V3, P251, DOI 10.1016/0890-8508(89)90006-6; Nakagomi T, 2002, ARCH VIROL, V147, P2187, DOI 10.1007/s00705-002-0861-z; Rosa E., 2002, J CLIN MICROBIOL, V40, P2837; WARD RL, 1991, J VIROL, V65, P2699; WARD RL, 1990, J VIROL, V64, P3219	37	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-1348	1567-7257		INFECT GENET EVOL	Infect. Genet. Evol.	DEC	2014	28						426	433		10.1016/j.meegid.2014.08.001		8	Infectious Diseases	Infectious Diseases	AX1YI	WOS:000346739500062		
J	Watanabe, M; Wang, DH; Ijichi, A; Shirai, C; Zou, Y; Kubo, M; Takemoto, K; Masatomi, C; Ogino, K				Watanabe, Masako; Wang, Da-Hong; Ijichi, Akihiro; Shirai, Chika; Zou, Yu; Kubo, Masayuki; Takemoto, Kei; Masatomi, Chie; Ogino, Keiki			The Influence of Lifestyle on the Incidence of Dental Caries among 3-Year-Old Japanese Children	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						dental caries; 3-year-olds; lifestyles; risk factors; cohort study; child's bedtime	EARLY-CHILDHOOD CARIES; PRESCHOOL-CHILDREN; FLUORIDE VARNISHES; ORAL HYGIENE; STREPTOCOCCI; ASSOCIATION; EXPERIENCE; FREQUENCY; HABITS; HEALTH	The present cohort study examined how lifestyle, household environment, and caries activity test score of Japanese children at age 1.5 years affected their dental caries incidence at age 3. Inclusion criteria were 1.5-year-old children with no dental caries. Dental examinations were performed for 33,655 children who participated in routine dental examinations at 1.5 years of age, and the exam was repeated approximately 21 months later (at age 3) at the Kobe City Public Health Center in Japan. After excluding 622 children who had caries at age 1.5 and 1831 children with missing lifestyle and household environment data in the questionnaires, the final data analysis was performed on a total of 31,202 children (16,052 boys, 15,150 girls). The multivariate logistic regression analysis indicated a strong association of the consumption of sugar-sweetened beverages/snacks, less frequent tooth brushing by the parents, lack of fluoride varnish, family history of smoking, with the risk of developing dental caries. A child's late bedtime is also one of the major risk factors for dental caries development. Further investigation is needed to examine whether the short duration or the irregularity of the sleep-wake cycle would affect early childhood oral health and whether there is a relationship between late bedtime and late night snack intake.	[Watanabe, Masako; Zou, Yu; Kubo, Masayuki; Takemoto, Kei; Masatomi, Chie; Ogino, Keiki] Okayama Univ, Dept Publ Hlth, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan; [Watanabe, Masako; Ijichi, Akihiro; Shirai, Chika] Kobe City Publ Hlth Ctr, Chuo Ku, Kobe, Hyogo 6508570, Japan; [Wang, Da-Hong] Okayama Univ Sci, Dept Biochem, Okayama 7000005, Japan	Watanabe, M (reprint author), Okayama Univ, Dept Publ Hlth, Grad Sch Med Dent & Pharmaceut Sci, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	masako_iwasawa@office.city.kobe.lg.jp; dahong@dbc.ous.ac.jp; akihiro_ijichi@office.city.kobe.lg.jp; chika_shirai@office.city.kobe.lg.jp; rainyjo@gmail.com; masakubo@cc.okayama-u.ac.jp; kei_takemoto@okayama-u.ac.jp; ma.sa.chi.n.0409@gmail.com; kogino@md.okayama-u.ac.jp					ANDLAW RJ, 1978, INT DENT J, V28, P1; Hanioka T, 2011, INT J ENV RES PUB HE, V8, P1503, DOI 10.3390/ijerph8051503; Valaitis R, 2000, CAN J PUBLIC HEALTH, V91, P411; Armfield JM, 2013, AM J PUBLIC HEALTH, V103, P494, DOI 10.2105/AJPH.2012.300889; Hanioka T, 2008, PAEDIATR PERINAT EP, V22, P546, DOI 10.1111/j.1365-3016.2008.00950.x; Iida H, 2007, PEDIATRICS, V120, pE944, DOI 10.1542/peds.2006-0124; Lingstrom P, 2000, CRIT REV ORAL BIOL M, V11, P366; Tahmassebi JF, 2006, J DENT, V34, P2, DOI 10.1016/j.jdent.2004.11.006; Qin M, 2008, PEDIATR DENT, V30, P122; Do LG, 2012, J DENT RES, V91, P536, DOI 10.1177/0022034511434355; Johansson I, 2010, CARIES RES, V44, P421, DOI 10.1159/000318569; FIRESTONE AR, 1982, ARCH ORAL BIOL, V27, P759, DOI 10.1016/0003-9969(82)90026-7; Costa SM, 2013, INT J ENV RES PUB HE, V10, P2401, DOI 10.3390/ijerph10062401; BURT BA, 1988, J DENT RES, V67, P1422, DOI 10.1177/00220345880670111201; BELLINI HT, 1981, ACTA ODONTOL SCAND, V39, P257; Burt B A, 2001, J Dent Educ, V65, P1017; Centers for Disease Control and Prevention, 2001, MMWR-MORBID MORTAL W, V50, P1; DEBRUYN H, 1987, J BIOL BUCCALE, V15, P71; FOGELS HR, 1982, J DENT CHILD, V49, P424; KOHLER B, 1988, Oral Microbiology and Immunology, V3, P14, DOI 10.1111/j.1399-302X.1988.tb00598.x; Leroy R, 2008, COMMUNITY DENT ORAL, V36, P249, DOI 10.1111/j.1600-0528.2007.00393.x; LINDEMEYER RG, 1981, J AM DENT ASSOC, V103, P719; Marquis R E, 1990, J Dent Res, V69 Spec No, P672; Mattila ML, 2001, CARIES RES, V35, P435, DOI 10.1159/000047487; Mizoguchi Kyoko, 2003, Nihon Koshu Eisei Zasshi, V50, P867; Mohebbi SZ, 2008, COMMUNITY DENT ORAL, V36, P363, DOI 10.1111/j.1600-0528.2007.00408.x; National Institute of Public Health, RES DENT HLTH EX JAP; Nishimura M., 1994, PEDIAT DENT J, V4, P23; Ribeiro Nilza M E, 2004, J Pediatr (Rio J), V80, pS199, DOI 10.1590/S0021-75572004000700012; Rodis O.M.M., 2005, PEDIAT DENT J, V15, P6; ROSEN S, 1978, J DENT RES, V57, P180, DOI 10.1177/00220345780570020301; Seppa L, 2004, MED PRIN PRACT, V13, P307, DOI 10.1159/000080466; Tanaka K, 2013, J PUBLIC HEALTH DENT, V73, P217, DOI 10.1111/jphd.12016; Tanaka K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-335; Twetman S, 1996, CARIES RES, V30, P347; Yonezu Takuro, 2006, Bull Tokyo Dent Coll, V47, P157, DOI 10.2209/tdcpublication.47.157	36	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	DEC	2014	11	12					12611	12622		10.3390/ijerph111212611		12	Environmental Sciences	Environmental Sciences & Ecology	AX2TJ	WOS:000346797100034		
J	Inoue, Y; Umezaki, M; Jiang, HW; Li, DD; Du, JW; Jin, YM; Yang, B; Li, B; Li, YF; Watanabe, C				Inoue, Yosuke; Umezaki, Masahiro; Jiang, Hongwei; Li, Dandan; Du, Jianwei; Jin, Yuming; Yang, Bin; Li, Bai; Li, Yufeng; Watanabe, Chiho			Urinary Concentrations of Toxic and Essential Trace Elements among Rural Residents in Hainan Island, China	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						toxic elements; heavy; trace elements; urine; economic development; China	LIFE-STYLE CHANGES; ARSENIC SPECIATION; GENERAL-POPULATION; CADMIUM LEVELS; COPPER-STATUS; HUMAN HEALTH; LEAD; EXPOSURE; SELENIUM; BANGLADESH	Background: Toxic element exposure and essential trace element consumption may have changed after the Chinese economy transformed to a market-oriented system. The objectives of this study were to measure urinary concentrations of toxic (arsenic, cadmium, lead) and essential trace (selenium, zinc, copper) elements among rural residents in Hainan, China and to examine if variations in economic development are linked to differences in toxic and trace element exposure. Methods: We conducted a questionnaire-based survey and undertook anthropometric measurements of residents aged >= 20 years (n = 599). Urinary samples were collected and analyzed using inductively coupled plasma mass spectrometry. Results: The median (mu g/g creatinine) element concentrations were: arsenic, 73.2; cadmium, 1.8; lead, 3.1; selenium, 36.5; zinc, 371; and copper, 11.0. Intra-community variation in element concentrations was explained by age (arsenic, cadmium, zinc and copper), sex (arsenic, cadmium and selenium: higher in females; zinc: higher in males), body mass index (cadmium) and individual involvement in the market economy as indexed by agrochemical use (lead and selenium). The degree of community-level economic development, which was determined by the proportion of people living in better housing among the study communities, was positively associated with cadmium concentration. Conclusions: The degree of community-level economic development was positively associated with urinary cadmium concentration while individual involvement in the market economy was positively associated with lead and selenium.	[Inoue, Yosuke; Umezaki, Masahiro; Watanabe, Chiho] Univ Tokyo, Grad Sch Med, Dept Human Ecol, Bunkyo Ku, Tokyo 1130033, Japan; [Jiang, Hongwei] Res Inst Humanity & Nat, Kita Ku, Kyoto 6038047, Japan; [Li, Dandan; Du, Jianwei; Jin, Yuming; Yang, Bin] Hainan Prov Ctr Dis Control & Prevent, Haikou 57023, Hainan, Peoples R China; [Li, Bai; Li, Yufeng] Chinese Acad Sci, Inst High Energy Phys, Beijing 100049, Peoples R China	Inoue, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Human Ecol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	inoyo@humeco.m.u-tokyo.ac.jp; umezaki@humeco.m.u-tokyo.ac.jp; jianghw@gmail.com; adanleee0898@gmail.com; djwei22@sohu.com; jym1030@126.com; ybdoctor@163.com; libai@ihep.ac.cn; liyf@ihep.ac.cn; chiho@humeco.m.u-tokyo.ac.jp		li, yufeng/0000-0002-5013-5849	Ministry of the Environment, Japan; Japan Society for the Promotion of Science [21406021]	The authors greatly appreciate the kind cooperation of the residents of the study communities. The authors also thank Andrew Stickley of the University of Tokyo for constructive advice on the article. This work was financially supported by the Ministry of the Environment, Japan, under the Global Environment Research Fund (H-063); and the Japan Society for the Promotion of Science under Grant-in-Aid for Scientific Research (KAKENHI project No.: 21406021).	Aguilera I, 2008, SCI TOTAL ENVIRON, V407, P669, DOI 10.1016/j.scitotenv.2008.08.041; Andriollo-Sanchez M, 2005, EUR J CLIN NUTR, V59, pS37, DOI 10.1038/sj.ejcn.1602296; Gil F, 2011, SCI TOTAL ENVIRON, V409, P1172, DOI 10.1016/j.scitotenv.2010.11.033; Abernathy CO, 1999, ENVIRON HEALTH PERSP, V107, P593, DOI 10.2307/3434403; Menke A, 2009, ENVIRON HEALTH PERSP, V117, P190, DOI 10.1289/ehp.11236; Jiang HW, 2006, ANTHROPOL SCI, V114, P165, DOI 10.1537/ase.050810; Batariova A, 2006, INT J HYG ENVIR HEAL, V209, P359, DOI 10.1016/j.ijheh..2006.02.005; Chen JW, 2011, CHEMOSPHERE, V84, P17, DOI 10.1016/j.chemosphere.2011.02.091; Watanabe C, 2001, ENVIRON HEALTH PERSP, V109, P1265, DOI 10.2307/3454749; Popkin BM, 1999, WORLD DEV, V27, P1905, DOI 10.1016/S0305-750X(99)00094-7; Wang JP, 2009, ENVIRON INT, V35, P507, DOI 10.1016/j.envint.2008.07.015; Borak J, 2007, REGUL TOXICOL PHARM, V47, P204, DOI 10.1016/j.yrtph.2006.09.005; Rodrigues EG, 2012, BIOMARKERS, V17, P240, DOI 10.3109/1354750X.2012.658863; Hata A, 2007, J OCCUP HEALTH, V49, P217, DOI 10.1539/joh.49.217; Monda KL, 2007, SOC SCI MED, V64, P858, DOI 10.1016/j.socscimed.2006.10.019; Calderon J, 2001, ENVIRON RES, V85, P69, DOI 10.1006/enrs.2000.4106; Heck JE, 2009, ENVIRON HEALTH PERSP, V117, P99, DOI 10.1289/ehp.11589; Asante KA, 2012, SCI TOTAL ENVIRON, V424, P63, DOI 10.1016/j.scitotenv.2012.02.072; Zubero MB, 2010, SCI TOTAL ENVIRON, V408, P4468, DOI 10.1016/j.scitotenv.2010.07.003; Carrizales L, 2006, ENVIRON RES, V101, P1, DOI 10.1016/j.envres.2005.07.010; Roels HA, 1999, RENAL FAILURE, V21, P251, DOI 10.3109/08860229909085087; Quandt SA, 2010, ENVIRON RES, V110, P83, DOI 10.1016/j.envres.2009.09.007; Yazawa A, 2014, AM J HUM BIOL, V26, P36, DOI 10.1002/ajhb.22467; Ruiz P, 2010, TOXICOL LETT, V198, P44, DOI 10.1016/j.toxlet.2010.04.022; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Cui YJ, 2005, ENVIRON INT, V31, P784, DOI 10.1016/j.envint.2005.05.025; Inoue Y, 2012, ANTHROPOL SCI, V120, P51, DOI 10.1537/ase.110523; Komaromy-Hiller G, 2000, CLIN CHIM ACTA, V296, P71, DOI 10.1016/S0009-8981(00)00205-9; MERTZ W, 1981, SCIENCE, V213, P1332, DOI 10.1126/science.7022654; Turnlund JR, 2004, AM J CLIN NUTR, V79, P1037; Fierens S, 2007, J TOXICOL ENV HEAL A, V70, P222, DOI 10.1080/15287390600884628; Castano A, 2012, INT J HYG ENVIR HEAL, V215, P191, DOI 10.1016/j.ijheh.2011.09.001; Burjonrappa SC, 2012, J PEDIATR SURG, V47, P760, DOI 10.1016/j.jpedsurg.2012.01.015; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Kristiansen J, 1997, SCI TOTAL ENVIRON, V204, P147, DOI 10.1016/S0048-9697(97)00155-1; Brima EI, 2006, TOXICOL APPL PHARM, V216, P122, DOI 10.1016/j.taap.2006.04.004; Brown K M, 2001, Public Health Nutr, V4, P593; Buat-Menard P., 1987, LEAD MERCURY CADMIUM, V31, P43; CONNOR RJ, 2010, TOB CONTROL, V19, P47; Fraga Cesar G., 2005, Molecular Aspects of Medicine, V26, P235, DOI 10.1016/j.mam.2005.07.013; Fukui Y, 1999, INT ARCH OCC ENV HEA, V72, P516, DOI 10.1007/s004200050409; GAD SCZ, 1998, ENCY TOXICOLOGY, V3, P424; Gidlow DA, 2004, OCCUP MED-OXFORD, V54, P76, DOI 10.1093/occmed/kqh019; Godt J., 2006, J OCCUP MED TOXICOL, V1, P1, DOI DOI 10.1186/1745-6673-1-22; *HAIN PROV BUR STA, 2010, HAIN STAT YB; Hanazawa K, 1991, Sangyo Igaku, V33, P221; HASUNUMA R, 1990, B ENVIRON CONTAM TOX, V44, P501; Hutton M., 1987, LEAD MERCURY CADMIUM, P35; *IARC, 2012, ARS MET FIBR DUSTS; IARC, 2006, IN ORG LEAD COMP; *INT PROGR CHEM SA, 2001, ZINC; *INT PROGR CHEM SA, 1986, SEL; *INT PROGR CHEM SA, 1995, IN LEAD; JAWORSKI JF, 1987, LEAD MERCURY CADMIUM, P3; Jin YP, 2000, TOXICOL LETT, V114, P91, DOI 10.1016/S0378-4274(99)00289-1; Kanumakala S, 2002, J INHERIT METAB DIS, V25, P391, DOI 10.1023/A:1020103901969; Li X, 2008, B ENVIRON CONTAM TOX, V81, P406, DOI 10.1007/s00128-008-9471-0; Lindberg AL, 2008, ENVIRON RES, V106, P110, DOI 10.1016/j.envres.2007.08.011; LLOYD B, 1983, J EPIDEMIOL COMMUN H, V37, P213, DOI 10.1136/jech.37.3.213; Lowe NM, 2009, AM J CLIN NUTR, V89, P2040; Milne DB, 1996, AM J CLIN NUTR, V63, P358; Moomaw W., 2012, CRITICAL ROLE GLOBAL; Nordberg GF, 2005, TOXICOL APPL PHARM, V206, P191, DOI 10.1016/j.taap.2004.11.028; Pinheiro J., 2014, PACKAGE NLME; RODRIGUEZ EMR, 1994, CLIN CHIM ACTA, V231, P39, DOI 10.1016/0009-8981(94)90252-6; SCHUHMACHER M, 1994, SCI TOTAL ENVIRON, V148, P67, DOI 10.1016/0048-9697(94)90376-X; SHINOHARA T, 2004, DEATH SLASH AND BURN; 2001, ARS ARS COMP	68	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	DEC	2014	11	12					13047	13064		10.3390/ijerph111213047		18	Environmental Sciences	Environmental Sciences & Ecology	AX2TJ	WOS:000346797100060		
J	Yoshikawa, A; Nakamachi, T; Shibato, J; Rakwal, R; Shioda, S				Yoshikawa, Akira; Nakamachi, Tomoya; Shibato, Junko; Rakwal, Randeep; Shioda, Seiji			Comprehensive Analysis of Neonatal versus Adult Unilateral Decortication in a Mouse Model Using Behavioral, Neuroanatomical, and DNA Microarray Approaches	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						neonatal; adult; brain; motor functional recovery; DNA microarray; 8 x 60 K; transcriptome profiling; gene inventory	MEDIAL PREFRONTAL CORTEX; RAT PYRAMIDAL TRACT; SPINAL-CORD-INJURY; CORTICOSPINAL TRACT; ISCHEMIC BRAIN; MOTOR CORTEX; COLLATERAL ELIMINATION; POSTNATAL-DEVELOPMENT; ANTEROGRADE TRACER; HEMISPHERECTOMY	Previously, studying the development, especially of corticospinal neurons, it was concluded that the main compensatory mechanism after unilateral brain injury in rat at the neonatal stage was due in part to non-lesioned ipsilateral corticospinal neurons that escaped selection by axonal elimination or neuronal apoptosis. However, previous results suggesting compensatory mechanism in neonate brain were not correlated with high functional recovery. Therefore, what is the difference among neonate and adult in the context of functional recovery and potential mechanism(s) therein? Here, we utilized a brain unilateral decortication mouse model and compared motor functional recovery mechanism post-neonatal brain hemisuction (NBH) with adult brain hemisuction (ABH). Three analyses were performed: (1) Quantitative behavioral analysis of forelimb movements using ladder walking test; (2) neuroanatomical retrograde tracing analysis of unlesioned side corticospinal neurons; and (3) differential global gene expressions profiling in unlesioned-side neocortex (rostral from bregma) in NBH and ABH on a 8 x 60 K mouse whole genome Agilent DNA chip. Behavioral data confirmed higher recovery ability in NBH over ABH is related to non-lesional frontal neocortex including rostral caudal forelimb area. A first inventory of differentially expressed genes genome-wide in the NBH and ABH mouse model is provided as a resource for the scientific community.	[Yoshikawa, Akira; Nakamachi, Tomoya; Shibato, Junko; Rakwal, Randeep; Shioda, Seiji] Showa Univ, Sch Med, Dept Anat, Shinagawa, Tokyo 1428555, Japan; [Yoshikawa, Akira] Tokoha Univ, Fac Hlth Sci, Dept Phys Therapy, Shizuoka 4200831, Japan; [Nakamachi, Tomoya] Toyama Univ, Grad Sch Sci & Engn, Lab Regulatory Biol, Toyama 9308555, Japan; [Shibato, Junko] Univ Tsukuba, Inst Hlth & Sports Sci, Lab Exercise Biochem & Neuroendocrinol, Tsukuba, Ibaraki 3058574, Japan; [Rakwal, Randeep] Univ Tsukuba, Org Educ Initiat, Tsukuba, Ibaraki 3058577, Japan	Rakwal, R (reprint author), Showa Univ, Sch Med, Dept Anat, 1-5-8 Hatanodai, Shinagawa, Tokyo 1428555, Japan.	yoshi-aki@med.showa-u.ac.jp; nakamachi@med.showa-u.ac.jp; rjunko@nifty.com; plantproteomics@gmail.com; shioda@med.showa-u.ac.jp					Peacock WJ, 1996, CHILD NERV SYST, V12, P376, DOI 10.1007/BF00395089; Qureshi IA, 2010, PROG BRAIN RES, V186, P77, DOI 10.1016/B978-0-444-53630-3.00006-3; Harel NY, 2006, NAT REV NEUROSCI, V7, P603, DOI 10.1038/nrn1957; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Ueno M, 2012, BRAIN, V135, P1253, DOI 10.1093/brain/aws053; van Empelen R, 2004, BRAIN, V127, P2071, DOI 10.1093/brain/awh224; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Hori M, 2012, DIS MODEL MECH, V5, P270, DOI 10.1242/dmm.008276; Devlin AM, 2003, BRAIN, V126, P556, DOI 10.1093/brain/awg052; Liu ZW, 2009, STROKE, V40, P2546, DOI 10.1161/STROKEAHA.109.547265; Wu P, 2013, BRAIN RES BULL, V97, P69, DOI 10.1016/j.brainresbull.2013.06.001; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Starkey ML, 2005, EXP NEUROL, V195, P524, DOI 10.1016/j.expneurol.2005.06.017; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Ghosh A, 2009, J NEUROSCI, V29, P12210, DOI 10.1523/JNEUROSCI.1828-09.2009; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Tennant KA, 2011, CEREB CORTEX, V21, P865, DOI 10.1093/cercor/bhq159; Ogawa T, 2011, CONGENIT ANOM, V51, P110, DOI 10.1111/j.1741-4520.2011.00315.x; BENECKE R, 1991, EXP BRAIN RES, V83, P419; Canty AJ, 2008, PROG NEUROBIOL, V85, P214, DOI 10.1016/j.pneurobio.2008.02.001; Gianino S, 1999, DEV BRAIN RES, V112, P189, DOI 10.1016/S0165-3806(98)00168-0; GORGELS TGMF, 1990, DEV BRAIN RES, V54, P51, DOI 10.1016/0165-3806(90)90064-6; GRIBNAU AAM, 1986, ANAT EMBRYOL, V175, P101, DOI 10.1007/BF00315460; Hori M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-256; Hsu JYC, 2006, BRAIN RES, V1084, P16, DOI 10.1016/j.brainres.2006.02.036; JOOSTEN EAJ, 1992, J COMP NEUROL, V326, P133, DOI 10.1002/cne.903260112; JOOSTEN EAJ, 1989, DEV BRAIN RES, V45, P313, DOI 10.1016/0165-3806(89)90051-5; Kamiyama T, 2006, J NEUROPHYSIOL, V95, P2304, DOI 10.1152/jn.00295.2005; Lin HY, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00029; McClelland S, 2007, ANN NEUROL, V61, P372, DOI 10.1002/ana.21084; Nemati F, 2012, BEHAV BRAIN RES, V229, P168, DOI 10.1016/j.bbr.2012.01.002; Ogawa T, 2014, CONGENIT ANOM, V54, P195, DOI [10.1111/cga.12062, 10.1111/cga.12089]; OUDEGA M, 1994, J COMP NEUROL, V347, P115, DOI 10.1002/cne.903470109; Paxonos G., 1996, MOUSE BAIN STEROTAXI; Pronichev I V, 1998, Neurosci Behav Physiol, V28, P80, DOI 10.1007/BF02461916; Qureshi IA, 2010, ARCH NEUROL-CHICAGO, V67, P1435, DOI 10.1001/archneurol.2010.300; Santos SD, 2010, J NEUROCHEM, V115, P1434, DOI 10.1111/j.1471-4159.2010.07047.x; Semeralul MO, 2006, J NEUROBIOL, V66, P1646, DOI 10.1002/neu.20302; STANFIELD BB, 1982, NATURE, V298, P371, DOI 10.1038/298371a0; Takahashi M, 2009, EUR J NEUROSCI, V30, P1878, DOI 10.1111/j.1460-9568.2009.06989.x; Umeda T, 2011, EUR J NEUROSCI, V34, P1453, DOI 10.1111/j.1460-9568.2011.07866.x; Umeda T, 2010, J NEUROPHYSIOL, V104, P1707, DOI 10.1152/jn.00968.2009; van Empelen R, 2005, BRAIN, V128, P1536, DOI 10.1093/brain/awh499; WILSON PJE, 1970, BRAIN, V93, P147, DOI 10.1093/brain/93.1.147; Yager JY, 2006, BEHAV BRAIN RES, V173, P171, DOI 10.1016/j.bbr.2006.06.019; Yoshikawa A, 2011, DEV NEUROSCI-BASEL, V33, P539, DOI 10.1159/000335526; Yoshioka N, 2009, J COMP NEUROL, V513, P164, DOI 10.1002/cne.21950; Z'Graggen WJ, 2000, J NEUROSCI, V20, P6561	48	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	DEC	2014	15	12					22492	22517		10.3390/ijms151222492		26	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	AX2TM	WOS:000346797400056		
J	Nishizuka, M; Hayashi, T; Asano, M; Osada, S; Imagawa, M				Nishizuka, Makoto; Hayashi, Takahiro; Asano, Mami; Osada, Shigehiro; Imagawa, Masayoshi			KCNK10, a Tandem Pore Domain Potassium Channel, Is a Regulator of Mitotic Clonal Expansion during the Early Stage of Adipocyte Differentiation	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						KCNK10; tandem pore domain potassium channel; adipocyte differentiation; mitotic clonal expansion; insulin signaling	MESENCHYMAL STEM-CELLS; BINDING PROTEIN-BETA; ACTIN CYTOSKELETON; K-2P CHANNELS; K+ CHANNELS; ADIPOGENESIS; ACTIVATION; GENE; TREK; TRANSCRIPTION	KCNK10, a member of tandem pore domain potassium channel family, gives rise to leak K+ currents. It plays important roles in stabilizing the negative resting membrane potential and in counterbalancing depolarization. We previously demonstrated that kcnk10 expression is quickly elevated during the early stage of adipogenesis of 3T3-L1 cells and that reduction of kcnk10 expression inhibits adipocyte differentiation. However, the molecular mechanism of KCNK10 in adipocyte differentiation remains unclear. Here we revealed that kcnk10 is induced by 3-isobutyl-1-methylxanthine, a cyclic nucleotide phosphodiesterase inhibitor and a potent inducer of adipogenesis, during the early stage of adipocyte differentiation. We also demonstrated that KCNK10 functions as a positive regulator of mitotic clonal expansion (MCE), a necessary process for terminal differentiation. The reduction of kcnk10 expression repressed the expression levels of CCAAT/enhancer-binding protein beta (C/EBP beta) and C/EBPd as well as the phosphorylation level of Akt during the early phase of adipogenesis. In addition, knockdown of kcnk10 expression suppressed insulin-induced Akt phosphorylation. These results indicate that KCNK10 contributes to the regulation of MCE through the control of C/EBP beta and C/EBPd expression and insulin signaling.	[Nishizuka, Makoto; Hayashi, Takahiro; Asano, Mami; Osada, Shigehiro; Imagawa, Masayoshi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Mizuho Ku, Nagoya, Aichi 4678603, Japan	Imagawa, M (reprint author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Mol Biol, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.	prmakoto@phar.nagoya-cu.ac.jp; p052759@phar.nagoya-cu.ac.jp; p112711@phar.nagoya-cu.ac.jp; osada@phar.nagoya-cu.ac.jp; imagawa@phar.nagoya-cu.ac.jp			Japan Society for the Promotion of Science (JSPS) [21390024]; Nagoya City University [2012-41]	We thank Masahiro Ohsawa for suggestion in statistical analysis. This study was supported in part by grants from the Japan Society for the Promotion of Science (JSPS) (No. 21390024, MI) as well as a grant-in-aid for research in Nagoya City University (No. 2012-41, MN).	Petersen RK, 2008, MOL CELL BIOL, V28, P3804, DOI 10.1128/MCB.00709-07; Hishida T, 2009, BIOCHIMIE, V91, P654, DOI 10.1016/j.biochi.2009.02.002; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Zhang YY, 2014, J CELL PHYSIOL, V229, P202, DOI 10.1002/jcp.24435; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Bayliss DA, 2008, TRENDS PHARMACOL SCI, V29, P566, DOI 10.1016/j.tips.2008.07.013; Deng PY, 2009, NEURON, V63, P230, DOI 10.1016/j.neuron.2009.06.022; You MH, 2013, ACTA PHARMACOL SIN, V34, P129, DOI 10.1038/aps.2012.142; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Gagnon A, 1999, DIABETES, V48, P691, DOI 10.2337/diabetes.48.4.691; Sato S, 2006, ANIM GENET, V37, P113, DOI 10.1111/j.1365-2052.2005.01397.x; Auld CA, 2007, J CELL PHYSIOL, V211, P101, DOI 10.1002/jcp.20915; Bang H, 2000, J BIOL CHEM, V275, P17412, DOI 10.1074/jbc.M000445200; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Chatterjee S, 2012, AM J PHYSIOL-HEART C, V302, pH105, DOI 10.1152/ajpheart.00298.2011; Franks NP, 2004, TRENDS PHARMACOL SCI, V25, P601, DOI 10.1016/j.tips.2004.09.003; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Hishida T, 2007, FEBS LETT, V581, P4272, DOI 10.1016/j.febslet.2007.07.074; Honore E, 2007, NAT REV NEUROSCI, V8, P251, DOI 10.1038/nrn2117; Lauritzen I, 2005, EMBO REP, V6, P642, DOI 10.1038/sj.embor.7400449; Auld CA, 2007, J CELL BIOCHEM, V100, P204, DOI 10.1002/jcb.21063; Cadaveira-Mosquera A, 2011, J NEUROSCI, V31, P1375, DOI 10.1523/JNEUROSCI.2791-10.2011; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; Fox KE, 2006, J BIOL CHEM, V281, P40341, DOI 10.1074/jbc.M605077200; Johmura Y, 2008, J BIOL CHEM, V283, P2265, DOI 10.1074/jbc.M707880200; Kawaji A, 2010, BIOL PHARM BULL, V33, P404; MACDOUGALD OA, 1995, J BIOL CHEM, V270, P647; Mathie A, 2010, J PHYSIOL-LONDON, V588, P3149, DOI 10.1113/jphysiol.2010.192344; Nobusue H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4368; Noel J, 2011, CHANNELS, V5, P400, DOI 10.4161/chan.5.5.16469; Sato S, 2010, COMP BIOCHEM PHYS B, V157, P46, DOI 10.1016/j.cbpb.2010.04.015; Sundelacruz S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003737	32	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	DEC	2014	15	12					22743	22756		10.3390/ijms151222743		14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	AX2TM	WOS:000346797400069		
J	Adams, E; Diaz, C; Hong, JP; Shin, R				Adams, Eri; Diaz, Celine; Hong, Jong-Pil; Shin, Ryoung			14-3-3 Proteins Participate in Light Signaling through Association with PHYTOCHROME INTERACTING FACTORs	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						PHYTOCHROME INTERACTING FACTOR (PIF); 14-3-3 protein; light signaling; photomorphogenesis; Arabidopsis thaliana; plant; protein-protein interaction	ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; FUNCTIONAL-CHARACTERIZATION; CHLOROPLAST DEVELOPMENT; INDUCED PHOSPHORYLATION; NUCLEAR ACCUMULATION; A PHOTORECEPTOR; FACTOR PIF3; DEGRADATION; TRANSDUCTION	14-3-3 proteins are regulatory proteins found in all eukaryotes and are known to selectively interact with phosphorylated proteins to regulate physiological processes. Through an affinity purification screening, many light-related proteins were recovered as 14-3-3 candidate binding partners. Yeast two-hybrid analysis revealed that the 14-3-3 kappa isoform (14-3-3.) could bind to PHYTOCHROME INTERACTING FACTOR3 (PIF3) and CONSTITUTIVE PHOTOMORPHOGENIC1 (COP1). Further analysis by in vitro pull-down assay confirmed the interaction between 14-3-3. and PIF3. Interruption of putative phosphorylation sites on the 14-3-3 binding motifs of PIF3 was not sufficient to inhibit 14-3-3. from binding or to disturb nuclear localization of PIF3. It was also indicated that 14-3-3. could bind to other members of the PIF family, such as PIF1 and PIF6, but not to LONG HYPOCOTYL IN FAR-RED1 (HFR1). 14-3-3 mutants, as well as the PIF3 overexpressor, displayed longer hypocotyls, and a pif3 mutant displayed shorter hypocotyls than the wild-type in red light, suggesting that 14-3-3 proteins are positive regulators of photomorphogenesis and function antagonistically with PIF3. Consequently, our results indicate that 14-3-3 proteins bind to PIFs and initiate photomorphogenesis in response to a light signal.	[Adams, Eri; Diaz, Celine; Hong, Jong-Pil; Shin, Ryoung] RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Diaz, Celine] Univ Autonoma Barcelona, Ctr Res Agr Genom CRAG, E-08193 Barcelona, Spain	Shin, R (reprint author), RIKEN Ctr Sustainable Resource Sci, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	eri.adams@riken.jp; celine.diaz@cragenomica.es; jongpil.hong@riken.jp; ryoung.shin@riken.jp			RIKEN	The authors appreciate Takae Miyazaki's assistance in taking care of the plants. We would like to thank Minami Matsui (RIKEN) for providing plant growth facilities and fruitful discussion and Tatsuya Sakai (Niigata University) for providing phyB mutant seeds and assistance with the light experiments. Special thanks also go to Giltsu Choi (Korea Advanced Institute of Science and Technology) for advice on PIF3 behavior and Michael Adams for comments and discussion on the paper. This work was supported by funding from RIKEN.	Yoon GM, 2013, PLANT CELL, V25, P1016, DOI 10.1105/tpc.113.110106; Pfeiffer A, 2012, P NATL ACAD SCI USA, V109, P5892, DOI 10.1073/pnas.1120764109; Chang IF, 2009, PROTEOMICS, V9, P2967, DOI 10.1002/pmic.200800445; Luo Q, 2014, PLANT CELL, V26, P2441, DOI 10.1105/tpc.113.121657; Leivar P, 2008, CURR BIOL, V18, P1815, DOI 10.1016/j.cub.2008.10.058; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; AITKEN A, 1992, TRENDS BIOCHEM SCI, V17, P498, DOI 10.1016/0968-0004(92)90339-B; Jang IC, 2010, PLANT CELL, V22, P2370, DOI 10.1105/tpc.109.072520; Sullivan S, 2009, FEBS LETT, V583, P2187, DOI 10.1016/j.febslet.2009.06.011; Hiltbrunner A, 2006, PLANT CELL PHYSIOL, V47, P1023, DOI 10.1093/pcp/pcj087; Bu QY, 2011, PLANT MOL BIOL, V77, P501, DOI 10.1007/s11103-011-9827-4; Oecking C, 2009, CURR OPIN PLANT BIOL, V12, P760, DOI 10.1016/j.pbi.2009.08.003; Pnueli L, 2001, PLANT CELL, V13, P2687, DOI 10.1105/tpc.13.12.2687; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; Van Buskirk EK, 2014, PLANT PHYSIOL, V165, P595, DOI 10.1104/pp.114.236661; Kim JY, 2003, PLANT CELL, V15, P2399, DOI 10.1105/tpc.014498; Ni WM, 2013, PLANT CELL, V25, P2679, DOI 10.1105/tpc.113.112342; Wang YQ, 2014, P NATL ACAD SCI USA, V111, P10359, DOI 10.1073/pnas.1409457111; Shen H, 2008, PLANT CELL, V20, P1586, DOI 10.1105/tpc.108.060020; Tseng TS, 2012, PLANT CELL, V24, P1114, DOI 10.1105/tpc.111.092130; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Mayfield JD, 2007, PLANT PHYSIOL, V145, P1692, DOI 10.1104/pp.107.108654; Zhu YX, 2000, P NATL ACAD SCI USA, V97, P13419, DOI 10.1073/pnas.230433797; Kinoshita T, 2003, PLANT PHYSIOL, V133, P1453, DOI 10.1104/pp.103.029629; Fairchild CD, 2000, GENE DEV, V14, P2377; Monte E, 2004, P NATL ACAD SCI USA, V101, P16091, DOI 10.1073/pnas.0407107101; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Park E, 2012, PLANT J, V72, P537, DOI 10.1111/j.1365-313X.2012.05114.x; Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; Ni WM, 2014, SCIENCE, V344, P1160, DOI 10.1126/science.1250778; Khanna R, 2004, PLANT CELL, V16, P3033, DOI 10.1105/tpc.104.025643; Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; Chevalier D, 2009, ANNU REV PLANT BIOL, V60, P67, DOI 10.1146/annurev.arplant.59.032607.092844; Hiltbrunner A, 2005, CURR BIOL, V15, P2125, DOI 10.1016/j.cub.2005.10.042; Jaspert N, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00096; Liu XC, 2013, PLANT CELL, V25, P1258, DOI 10.1105/tpc.113.109710; Mayfield JD, 2012, J EXP BOT, V63, P3061, DOI 10.1093/jxb/ers022; Moorhead G, 1999, PLANT J, V18, P1, DOI 10.1046/j.1365-313X.1999.00417.x; Park E, 2004, PLANT CELL PHYSIOL, V45, P968, DOI 10.1093/pcp/pch125; Sehnke PC, 2006, PLANT PHYSIOL, V140, P647, DOI 10.1104/pp.105.073916; Sepulveda-Garcia E, 2012, PLANT SCI, V195, P36, DOI 10.1016/j.plantsci.2012.06.009; SHARROCK RA, 1989, GENE DEV, V3, P1745, DOI 10.1101/gad.3.11.1745; Shin R, 2007, P NATL ACAD SCI USA, V104, P6460, DOI 10.1073/pnas.0610208104; Shin R, 2011, FEBS LETT, V585, P143, DOI 10.1016/j.febslet.2010.11.025; Viczian A, 2005, PLANT CELL PHYSIOL, V46, P1591, DOI 10.1093/pcp/pci175	47	0	0	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	DEC	2014	15	12					22801	22814		10.3390/ijms151222801		14	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	AX2TM	WOS:000346797400073		
J	Marutani, Y; Yamauchi, Y; Miyoshi, A; Inoue, K; Ikeda, K; Mizutani, M; Sugimoto, Y				Marutani, Yoko; Yamauchi, Yasuo; Miyoshi, Akihito; Inoue, Kanako; Ikeda, Ken-ichi; Mizutani, Masaharu; Sugimoto, Yukihiro			Regulation of Photochemical Energy Transfer Accompanied by Structural Changes in Thylakoid Membranes of Heat-Stressed Wheat	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						heat stress; state transition; wheat; thylakoid membrane; photosystem; phosphorylation	PHOTOSYSTEM-II; STATE TRANSITIONS; ELECTRON-TRANSPORT; CHLOROPHYLL FLUORESCENCE; ARABIDOPSIS-THALIANA; BARLEY LEAVES; PROTEINS; THERMOTOLERANCE; ISOPRENE; PHOSPHORYLATION	Photosystems of higher plants alleviate heat-induced damage in the presence of light under moderate stressed conditions; however, in the absence of light (i.e., in the dark), the same plants are damaged more easily. (Yamauchi and Kimura, 2011) We demonstrate that regulating photochemical energy transfer in heat-treated wheat at 40 degrees C with light contributed to heat tolerance of the photosystem. Chlorophyll fluorescence analysis using heat-stressed wheat seedlings in light showed increased non-photochemical quenching (NPQ) of chlorophyll fluorescence, which was due to thermal dissipation that was increased by state 1 to state 2 transition. Transmission electron microscopy revealed structural changes in thylakoid membranes, including unstacking of grana regions under heat stress in light. It was accompanied by the phosphorylation of thylakoid proteins such as D1 and D2 proteins and the light harvesting complex II proteins Lhcb1 and Lhcb2. These results suggest that heat stress at 40 degrees C in light induces state 1 to state 2 transition for the preferential excitation of photosystem I (PSI) by phosphorylating thylakoid proteins more strongly. Structural changes of thylakoid membrane also assist the remodeling of photosystems and regulation of energy distribution by transition toward state 2 probably contributes to plastoquione oxidation; thus, light-driven electrons flowing through PSI play a protective role against PSII damage under heat stress.	[Marutani, Yoko; Yamauchi, Yasuo; Inoue, Kanako; Ikeda, Ken-ichi; Mizutani, Masaharu; Sugimoto, Yukihiro] Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan; [Miyoshi, Akihito] Kobe Univ, Fac Agr, Kobe, Hyogo 6578501, Japan	Yamauchi, Y (reprint author), Kobe Univ, Grad Sch Agr Sci, Kobe, Hyogo 6578501, Japan.	yoko.marutani@stu.kobe-u.ac.jp; yamauchi@kobe-u.ac.jp; miyoshi.akihito.53v@st.kyoto-u.ac.jp; i-kana@people.kobe-u.ac.jp; ikeken@phoenix.kobe-u.ac.jp; mizutani@gold.kobe-u.ac.jp; yukihiro@kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23580456]; JSPS [251843]	We acknowledge the Integrated Center for Mass Spectrometry, Kobe University, Graduate School of Medicine for their assistance in determination of phosphorylated proteins. We thank Dr. N. Ohnishi for helpful discussions. This work was supported by Grant-in-Aids for Scientific Research (Yasuo Yamauchi, 23580456) from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and JSPS Research Fellowship for Young Scientists (Yoko Marutani, 251843).	Hatano N, 2008, J PROTEOME RES, V7, P809, DOI 10.1021/pr700566d; Wientjes E, 2013, BBA-BIOENERGETICS, V1827, P420, DOI 10.1016/j.bbabio.2012.12.009; Peng LW, 2008, J BIOL CHEM, V283, P34873, DOI 10.1074/jbc.M803207200; Strasser BJ, 1997, PHOTOSYNTH RES, V52, P147, DOI 10.1023/A:1005896029778; DemmigAdams B, 1996, PHYSIOL PLANTARUM, V98, P253, DOI 10.1034/j.1399-3054.1996.980206.x; Shapiguzov A, 2010, P NATL ACAD SCI USA, V107, P4782, DOI 10.1073/pnas.0913810107; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Fristedt R, 2009, PLANT CELL, V21, P3950, DOI 10.1105/tpc.109.069435; Wientjes E, 2013, J BIOL CHEM, V288, P32821, DOI 10.1074/jbc.M113.511691; Heckathorn SA, 1998, PLANT PHYSIOL, V116, P439, DOI 10.1104/pp.116.1.439; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Nellaepalli S, 2011, BBA-BIOENERGETICS, V1807, P1177, DOI 10.1016/j.bbabio.2011.05.016; Zhang R, 2010, PHOTOSYNTH RES, V105, P123, DOI 10.1007/s11120-010-9572-6; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Velikova V, 2005, PLANT CELL ENVIRON, V28, P318, DOI 10.1111/j.1365-3040.2004.01314.x; Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; Sharkey TD, 2010, J INTEGR PLANT BIOL, V52, P712, DOI 10.1111/j.1744-7909.2010.00975.x; CAO J, 1990, BIOCHIM BIOPHYS ACTA, V1015, P180, DOI 10.1016/0005-2728(90)90018-Y; Bukhov NG, 1999, PHOTOSYNTH RES, V59, P81, DOI 10.1023/A:1006149317411; Chaitanya KV, 2002, PLANT GROWTH REGUL, V36, P175, DOI 10.1023/A:1015092628374; Marutani Y, 2012, PLANTA, V236, P753, DOI 10.1007/s00425-012-1647-5; Minagawa J, 2011, BBA-BIOENERGETICS, V1807, P897, DOI 10.1016/j.bbabio.2010.11.005; Leoni C, 2013, PLANT J, V76, P236, DOI 10.1111/tpj.12297; Sharkey TD, 2005, PLANT CELL ENVIRON, V28, P269, DOI 10.1111/j.1365-3040.2005.01324.x; Jarvi S, 2011, BIOCHEM J, V439, P207, DOI 10.1042/BJ20102155; Chuartzman SG, 2008, PLANT CELL, V20, P1029, DOI 10.1105/tpc.107.055830; Samol I, 2012, PLANT CELL, V24, P2596, DOI 10.1105/tpc.112.095703; Galka P, 2012, PLANT CELL, V24, P2963, DOI 10.1105/tpc.112.100339; Penuelas J, 2005, PLANT CELL ENVIRON, V28, P278, DOI 10.1111/j.1365-3040.2004.01250.x; DREIER W, 1995, J PLANT PHYSIOL, V145, P342; Ducruet JM, 2007, PHOTOSYNTH RES, V93, P159, DOI 10.1007/s11120-007-9132-x; Eckardt NA, 1997, PLANT PHYSIOL, V113, P243; HAVAUX M, 1993, PLANT CELL ENVIRON, V16, P461, DOI 10.1111/j.1365-3040.1993.tb00893.x; Havaux M, 1996, PLANTA, V198, P324, DOI 10.1007/BF00620047; Heckathorn SA, 1999, AM ZOOL, V39, P865; Khatoon M, 2009, J BIOL CHEM, V284, P25343, DOI 10.1074/jbc.M109.007740; Mohanty P, 2002, Z NATURFORSCH C, V57, P836; Pietrzykowska M, 2014, PLANT CELL, V26, P3646, DOI 10.1105/tpc.114.127373; Pribil M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000288; QUICK WP, 1989, BIOCHIM BIOPHYS ACTA, V977, P287, DOI 10.1016/S0005-2728(89)80082-9; SANTARIUS KA, 1979, PLANTA, V146, P529, DOI 10.1007/BF00388828; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Schilling M, 2008, J PROTEOME RES, V7, P4164, DOI 10.1021/pr800120f; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Yamamoto Y, 2011, PROCEEDINGS OF THE 13TH INTERNATIONAL CONFERENCE ON ENVIRONMENTAL REMEDIATION AND RADIOACTIVE WASTE MANAGEMENT, 2010, VOL 2, P203	45	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	DEC	2014	15	12					23042	23058		10.3390/ijms151223042		17	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Biochemistry & Molecular Biology; Chemistry	AX2TM	WOS:000346797400088		
J	Tanaka, M; Yonemitsu, Y; Kawamoto, R				Tanaka, Michiko; Yonemitsu, Yoshikazu; Kawamoto, Rieko			Nursing professionalism: A national survey of professionalism among Japanese nurses	INTERNATIONAL JOURNAL OF NURSING PRACTICE			English	Article						behaviour; inventories; Japanese; professionalism; surveys	EDUCATION; BEHAVIORS; MASTERS	The aim of this study was to quantify the professionalism of nurses in Japan. The Japanese version of the Behavioural Inventory for Professionalism in Nursing was conducted as a national survey. Computer-generated random selection of nurses in Japan obtained responses from 1501 nurses. A descriptive design examined the levels of and differences in nursing professionalism. Comparisons of the total level of professionalism in educational preparation, current position, years of experience, and current practice setting were analysed by one-way analysis of variance and post hoc Tukey-Kramer multiple comparison test. The results revealed that Japanese nurses had low levels of professionalism, and professionalism was related significantly to higher educational preparation, years of experience as a nurse, and current position as a nursing administrator or faculty. The results can be used as a benchmark for continued assessments of the level of nursing professionalism and for further development of nursing professionalism.	[Tanaka, Michiko] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Fukuoka 8128582, Japan; [Yonemitsu, Yoshikazu] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka 8128582, Japan; [Kawamoto, Rieko] Japan Nursing Assoc, Tokyo, Japan	Tanaka, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Collaborat Res Stn 2,Higashi Ku, Rm 601,3-1-1 Maidashi, Fukuoka 8128582, Japan.	tmiciko@med.kyushu-u.ac.jp					Adams D, 2001, J PROF NURS, V17, P203, DOI 10.1053/jpnu.2001.25913; Adams D, 1996, WESTERN J NURS RES, V18, P77, DOI 10.1177/019394599601800106; Adams D, 1994, ASPENS ADVISOR NURS, V10, P1; Aiken LH, 2003, JAMA-J AM MED ASSOC, V290, P1617, DOI 10.1001/jama.290.12.1617; Andrew N, 2011, NURS EDUC TODAY, V31, P429, DOI 10.1016/j.nedt.2010.08.013; Wynd CA, 2003, J PROF NURS, V19, P251, DOI 10.1016/S8755-7223(03)00104-2; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Fulbrook P, 2012, INT J NURS STUD, V49, P191, DOI 10.1016/j.ijnurstu.2011.06.001; Celik S, 2012, INT J NURS PRACT, V18, P180, DOI 10.1111/j.1440-172X.2012.02019.x; Asakura K., 2007, JAPANESE J HLTH BEHA, V22, P106; Baumann A, 2009, J ADV NURS, V65, P2216, DOI 10.1111/j.1365-2648.2009.05104.x; Cornett BS, 2006, J COMMUN DISORD, V39, P301, DOI 10.1016/j.jcomdis.2006.02.005; Drennan J, 2012, J NURS MANAGE, V20, P102, DOI 10.1111/j.1365-2834.2011.01346.x; Gallagher L, 2007, NURS EDUC TODAY, V27, P466, DOI 10.1016/j.nedt.2006.08.007; Gordon S., 2005, NURSING ODDS; HALL RH, 1968, AM SOCIOL REV, V33, P92, DOI 10.2307/2092242; Japanese Nursing Association, 2011, NURS JAP 2011; Kasai A., 2005, HIROSAKI U J FACULTY, V94, P91; Kearney NR, 2012, ADV YOUR CAREER CONC; McCloskey JD, 2008, J NURS SCHOLARSHIP, V40, P39; Miller B K, 1988, Todays OR Nurse, V10, P18; Miller B K, 1993, J Prof Nurs, V9, P290, DOI 10.1016/8755-7223(93)90055-H; National personnel Authority at Ministry of Internal Affairs and Communications, 2011, SURV SAL OCC 2011; Price Bob, 2010, Nurs Stand, V24, P35; Schwirian P.M., 1998, PROFESSIONALIZATION; Scott SD, 2008, NURS EDUC TODAY, V28, P240, DOI 10.1016/j.nedt.2007.04.004; Takahashi A., 2004, DEV JAPANESE NURSING; Tanaka M, 2012, INT NURSING CARE RES, V11, P21; van Mook Walther N K A, 2009, Eur J Intern Med, V20, pe85, DOI 10.1016/j.ejim.2008.10.006; Wakabayashi C, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001181; Watkins D, 2011, J ADV NURS, V67, P2605, DOI 10.1111/j.1365-2648.2011.05698.x; Watson R, 2006, NURS EDUC TODAY, V26, P622, DOI 10.1016/j.nedt.2006.07.008	32	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1322-7114	1440-172X		INT J NURS PRACT	Int. J. Nurs. Pract.	DEC	2014	20	6					579	587		10.1111/ijn.12201		9	Nursing	Nursing	AX2IF	WOS:000346766000006		
J	Kamide, N				Kamide, Norihiro			Inconsistency-Tolerant Multi-Agent Calculus	INTERNATIONAL JOURNAL OF UNCERTAINTY FUZZINESS AND KNOWLEDGE-BASED SYSTEMS			English	Article						Inconsistencey-tolerant logic; paraconsistency; sequent calculus; completeness theorem; cut-elimination theorem; decidability	LOGICS	Verifying and specifying multi-agent systems in an appropriate inconsistency-tolerant logic are of growing importance in Computer Science since computer systems are generally used by or composed of inconsistency-tolerant multi-agents. In this paper, an inconsistency-tolerant logic for representing multi-agents is introduced as a Gentzen-type sequent calculus. This logic (or calculus) has multiple negation connectives that correspond to each agent, and these negation connectives have the property of para-consistency that guarantees inconsistency-tolerance. The logic proposed is regarded as a modified generalization of trilattice logics, which are known to be useful for expressing fine-grained truth-values in computer networks. The completeness, cut-elimination and decidability theorems for the proposed logic (or sequent calculus) are proved as the main results of this paper.	Cyber Univ, Fac Informat Technol & Business, Minato Ku, Tokyo 1050011, Japan	Kamide, N (reprint author), Cyber Univ, Fac Informat Technol & Business, Minato Ku, 4F Izumishibakouen Bldg, Tokyo 1050011, Japan.	drnkamide08@kpd.biglobe.ne.jp					ALMUKDAD A, 1984, J SYMBOLIC LOGIC, V49, P231, DOI 10.2307/2274105; Kamide N, 2012, THEOR COMPUT SCI, V415, P1, DOI 10.1016/j.tcs.2011.11.001; Kamide N, 2011, FUND INFORM, V106, P1, DOI 10.3233/FI-2011-374; Arieli O, 1998, ARTIF INTELL, V102, P97, DOI 10.1016/S0004-3702(98)00032-0; Shramko Y, 2005, J PHILOS LOGIC, V34, P121, DOI 10.1007/s10992-005-0556-5; Arieli O., 1996, Journal of Logic, Language and Information, V5; Belnap Jr N.D., 1977, MODERN USES MULTIPLE, P5; Belnap N., 1977, CONT ASPECTS PHILOS, P30; Carnielli W. A., 1999, P 12 EBL ADV CONT LO, V235, P33; DUNN JM, 1976, PHILOS STUD, V29, P149, DOI 10.1007/BF00373152; Fagin R., 1995, REASONING KNOWLEDGE; Fernandez V., 2003, J APPL NONCLASSICAL, V13, P21, DOI 10.3166/jancl.13.21-46; Kamide N, 2012, LECT NOTES COMPUT SC, V7190, P181, DOI 10.1007/978-3-642-29356-6_9; Kamide N, 2010, J APPL LOGIC, V8, P33, DOI 10.1016/j.jal.2009.06.001; Konikowska B, 2003, STUD FUZZ SOFT COMP, V114, P193; Konikowska B., 2006, P 5 INT C AUT AG MUL, P169, DOI 10.1145/1160633.1160661; Odintsov S. P., 2008, J APPL LOGIC, V6, P343, DOI 10.1016/j.jal.2007.06.001; Odintsov S. P., 2009, STUDIA LOGICA, V91, P407, DOI DOI 10.1007/S11225-009-9181-6; Priest G., 2002, HDB PHILOS LOGIC, V6, P287; Shramko Y., 2011, TRENDS LOGIC, V36, P1; Takeuti G., 1975, PROOF THEORY; Wagner G., 1991, Journal of Logic and Computation, V1, DOI 10.1093/logcom/1.6.835; Wansing H., 1993, LECT NOTES ARTIF INT, V681, P1; Wansing H, 2011, STUD LOGICA, V99, P365, DOI 10.1007/s11225-011-9357-8	24	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-4885	1793-6411		INT J UNCERTAIN FUZZ	Int. J. Uncertainty Fuzziness Knowl.-Based Syst.	DEC	2014	22	6					815	829		10.1142/S0218488514500433		15	Computer Science, Artificial Intelligence	Computer Science	AX0KK	WOS:000346641200002		
J	Rehman, HU; Tsujimori, T; Okamoto, K; Spengler, D				Rehman, Hafiz Ur; Tsujimori, Tatsuki; Okamoto, Kazuaki; Spengler, Dirk			Petrogenesis and chemogenesis of oceanic and continental orogens in Asia: Current topics, Part I Preface	ISLAND ARC			English	Editorial Material							JAPAN		[Rehman, Hafiz Ur] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan; [Tsujimori, Tatsuki] Okayama Univ, Inst Study Earths Interior, Misasa, Tottori 6820193, Japan; [Okamoto, Kazuaki] Saitama Univ, Fac Educ, Saitama 3388570, Japan; [Spengler, Dirk] Univ Potsdam, Inst Earth & Environm Sci, D-14476 Potsdam, Germany	Rehman, HU (reprint author), Kagoshima Univ, Grad Sch Sci & Engn, Korimoto 1-21 35, Kagoshima 8900065, Japan.		Tsujimori, Tatsuki/D-2677-2009	Tsujimori, Tatsuki/0000-0001-9202-7312			Akizawa N, 2014, ISL ARC, V23, P312, DOI 10.1111/iar.12074; Fukuyama M, 2014, ISL ARC, V23, P281, DOI 10.1111/iar.12086; Kouketsu Y, 2014, ISL ARC, V23, P263, DOI 10.1111/iar.12075; Park M, 2014, ISL ARC, V23, P299, DOI 10.1111/iar.12089; Wei CJ, 2014, ISL ARC, V23, P254, DOI 10.1111/iar.12087	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1038-4871	1440-1738		ISL ARC	Isl. Arc.	DEC	2014	23	4					251	253		10.1111/iar.12097		3	Geosciences, Multidisciplinary	Geology	AX4JI	WOS:000346898700001		
J	Kouketsu, Y; Enami, M; Mouri, T; Okamura, M; Sakurai, T				Kouketsu, Yui; Enami, Masaki; Mouri, Takashi; Okamura, Mitsuya; Sakurai, Tsuyoshi			Composite metamorphic history recorded in garnet porphyroblasts of Sambagawa metasediments in the Besshi region, central Shikoku, Southwest Japan	ISLAND ARC			English	Article						chemical zoning; garnet porphyroblast; metasediment; Raman spectroscopy; residual pressure; Sambagawa belt; sodic phase mineral	ECLOGITE-FACIES METAMORPHISM; OMPHACITE-BEARING METAPELITE; DEFORMATION MODE SWITCHES; PELITIC SCHISTS; SW JAPAN; RESIDUAL PRESSURE; IRATSU ECLOGITE; RAMAN-SPECTRA; LU-HF; BELT	This report describes an investigation of the composite metamorphic history recorded in garnet porphyroblasts of Sambagawa metasediments, and presents discussions of the possible distribution of eclogite facies lithologies in the Besshi region, central Shikoku, southwest Japan. Garnet grains usually show chemically composite zoning with resolved inner and overgrown outer segments, respectively. The inner segment usually contains paragonite as a sodic phase inclusion and rarely contains omphacite or glaucophane, whereas the outer segment rarely includes albite but no paragonite. The inner segment often includes quartz grains that preserve high residual pressures corresponding to the eclogite facies conditions, whereas the outer segment includes quartz grains that preserve lower residual pressures corresponding to the epidote-amphibolite facies conditions. For this composite-zoned garnet, the assemblage of sodic phase inclusions and the values of the residual pressure of quartz inclusions imply the following successive metamorphic path: prograde eclogite facies stagedecompression and hydration reaction stageprograde epidote-amphibolite facies stage. Metasediments containing this composite-zoned garnet with such evidence for eclogite facies conditions are more widely distributed than the eclogitic lithologies that contain the assemblage of omphacite+garnet. These results imply that the combination of (i) the chemical composite zoning of garnet, (ii) the nature of sodic phase inclusions, and (iii) the residual pressure of quartz inclusions is useful as criteria to ascertain the true distribution of the lithologies that have experienced eclogite facies metamorphism for the Sambagawa metasediments, which was difficult to recognize in earlier studies.	[Kouketsu, Yui; Mouri, Takashi; Okamura, Mitsuya] Nagoya Univ, Grad Sch Environm Studies, Dept Earth & Planetary Sci, Nagoya, Aichi 4648602, Japan; [Enami, Masaki] Nagoya Univ, Ctr Chronol Res, Nagoya, Aichi 4648602, Japan; [Sakurai, Tsuyoshi] Shimane Univ, Dept Geosci, Matsue, Shimane 6908504, Japan	Kouketsu, Y (reprint author), Univ Tokyo, Grad Sch Sci, Geochem Res Ctr, Tokyo 1130033, Japan.	kouketsu.yui@eqchem.s.u-tokyo.ac.jp	Enami, Masaki/I-7136-2014	Enami, Masaki/0000-0001-9232-6646	Japan Society for the Promotion of Science (JSPS) [22.7116, 25.2303, 18340172, 19654080, 21244083]	The authors thank S. Wallis, T. Mizukami, and T. Masuda for helpful discussions, and T. Ohama, S. Endo, M. Tsuboi, T. Miyazoe, and Y. Masumoto for assistance in the field studies. We are also grateful to T. Kobayashi and R. Compagnoni for their careful reading and constructive suggestions, which considerably improved of the manuscript. This project was supported financially in part by Research Fellowships for Young Scientists (Kouketsu: 22.7116 and 25.2303) and Grant-in-Aids for Scientific Research (Enami: 18340172, 19654080, and 21244083) from Japan Society for the Promotion of Science (JSPS).	Aoya M, 2001, J PETROL, V42, P1225, DOI 10.1093/petrology/42.7.1225; Maruyama S, 2010, GONDWANA RES, V18, P106, DOI 10.1016/j.gr.2010.03.007; Enami M, 2004, J METAMORPH GEOL, V22, P1, DOI 10.1111/j.1525-1314.2003.00492.x; Schmidt C, 2000, AM MINERAL, V85, P1725; Endo S, 2009, J METAMORPH GEOL, V27, P371, DOI 10.1111/j.1525-1314.2009.00821.x; Mouri T, 2008, GEOLOGY, V36, P503, DOI 10.1130/G24599A.1; Wallis SR, 2009, J METAMORPH GEOL, V27, P93, DOI 10.1111/j.1525-1314.2008.00806.x; Aoya M, 2013, GEOLOGY, V41, P451, DOI 10.1130/G33834.1; ENAMI M, 1994, CONTRIB MINERAL PETR, V116, P182, DOI 10.1007/BF00310699; Ota T, 2004, LITHOS, V73, P95, DOI 10.1016/j.lithos.2004.01.001; Whitney DL, 2010, AM MINERAL, V95, P185, DOI 10.2138/am.2010.3371; Song SG, 2007, J METAMORPH GEOL, V25, P547, DOI 10.1111/j.1525-1314.2007.00713.x; Carswell DA, 2000, LITHOS, V52, P121, DOI 10.1016/S0024-4937(99)00088-2; Guillot S, 2009, FRONT EARTH SCI SER, P175, DOI 10.1007/978-3-540-87974-9_10; Endo S, 2012, LITHOS, V146, P183, DOI 10.1016/j.lithos.2012.05.010; Wain A, 1997, GEOLOGY, V25, P927, DOI 10.1130/0091-7613(1997)025<0927:NEFCIE>2.3.CO;2; Inui M, 2002, J METAMORPH GEOL, V20, P563, DOI 10.1046/j.1525-1314.2002.00389.x; Enami M, 2007, AM MINERAL, V92, P1303, DOI 10.2138/am.2007.2438; Leake BE, 1997, MINERAL MAG, V61, P295, DOI 10.1180/minmag.1997.061.405.13; Kouketsu Y, 2010, J MINER PETROL SCI, V105, P9, DOI 10.2465/jmps.090217; Bebout GE, 2007, EARTH PLANET SC LETT, V260, P373, DOI 10.1016/j.epsl.2007.05.050; Banno S., 1976, J GEOLOGICAL SOC JAP, V82, P199; Beltrando M, 2007, EARTH PLANET SC LETT, V256, P372, DOI 10.1016/j.epsl.2007.01.022; Beltrando M, 2008, J STRUCT GEOL, V30, P194, DOI 10.1016/j.jsg.2007.10.008; Carswell D. A., 2003, EUROPEAN MINERALOGIC, V5; Enami M, 2012, J MINER PETROL SCI, V107, P173, DOI 10.2465/jmps.111216; Enami M., 1982, J GEOL SOC JAPAN, V88, P887; ENAMI M, 1983, J METAMORPH GEOL, V1, P141, DOI 10.1111/j.1525-1314.1983.tb00269.x; Endo S, 2010, ISL ARC, V19, P313, DOI 10.1111/j.1440-1738.2010.00708.x; ETCHEPAR.J, 1974, J CHEM PHYS, V60, P1873, DOI 10.1063/1.1681287; HARA I, 1990, J METAMORPH GEOL, V8, P441, DOI 10.1111/j.1525-1314.1990.tb00630.x; Hara I., 1992, J SCI HIROSHIMA U C, V9, P495; HIGASHINO T, 1990, J METAMORPH GEOL, V8, P413, DOI 10.1111/j.1525-1314.1990.tb00628.x; Higashino T., 1975, J GEOL SOC JAPAN, V81, P653; Inui M, 2004, J GEOGR, V113, P571; Ko ZW, 2005, LITHOS, V81, P79, DOI 10.1016/j.lithos.2004.09.018; Kouketsu Y, 2010, ISL ARC, V19, P165, DOI 10.1111/j.1440-1738.2009.00690.x; Kouketsu Y, 2011, J METAMORPH GEOL, V29, P301, DOI 10.1111/j.1525-1314.2010.00919.x; Kouketsu Y, 2014, AM MINERAL, V99, P433, DOI 10.2138/am.2014.4427; Matsumoto M, 2003, J METAMORPH GEOL, V21, P363; Miller JA, 2002, MINERAL MAG, V66, P93, DOI 10.1180/0026461026610016; Miyagi Y, 2005, ISL ARC, V14, P215, DOI 10.1111/j.1440-1738.2005.00468.x; Miyamoto A, 2007, J MINER PETROL SCI, V102, P352, DOI 10.2465/jmps.070120; Nomizo A, 1992, J GEOLOGICAL SOC JAP, V98, P49; Parkinson C. D., 2002, FRONTIRS SCI SERIES, V38; Sakurai T., 2009, J GEOLOGICAL SOC JAP, V115, P101; Shirahata K., 1995, J MINERALOGY PETROLO, V90, P69, DOI 10.2465/ganko.90.69; Taguchi T, 2014, J MINER PETROL SCI, V109, P1, DOI 10.2465/jmps.130624; Takasu A., 1989, EVOLUTION METAMORPHI, V43, P533; Takasu A., 1986, J GEOLOGICAL SOC JAP, V92, P781; Tsujimori T., 2000, B RES I NATURAL SCI, V26, P19; Ubukawa T, 2007, ISL ARC, V16, P553, DOI 10.1111/j.1440-1738.2007.00582.x; Wallis S, 2000, J METAMORPH GEOL, V18, P653, DOI 10.1046/j.1525-1314.2000.00285.x; Wallis S. R., 2000, B RES I NATURAL SCI, V26, P3; Ko ZW, 2005, J MINER PETROL SCI, V100, P43, DOI 10.2465/jmps.100.43	55	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1038-4871	1440-1738		ISL ARC	Isl. Arc.	DEC	2014	23	4					263	280		10.1111/iar.12075		18	Geosciences, Multidisciplinary	Geology	AX4JI	WOS:000346898700003		
J	Fukuyama, M; Ogasawara, M; Dunkley, DJ; Wang, KL; Lee, DC; Hokada, T; Maki, K; Hirata, T; Kon, Y				Fukuyama, Mayuko; Ogasawara, Masatsugu; Dunkley, Daniel J.; Wang, Kuo-Lung; Lee, Der-Chuen; Hokada, Tomokazu; Maki, Kenshi; Hirata, Takafumi; Kon, Yoshiaki			The formation of rodingite in the Nagasaki metamorphic rocks at Nomo Peninsula, Kyushu, Japan - Zircon U-Pb and Hf isotopes and trace element evidence	ISLAND ARC			English	Article						rodingite; the Nagasaki metamorphic rocks; zircon SHRIMP U-Pb dating; Hf isotope; Cretaceous subduction	ZERMATT-SAAS OPHIOLITE; ULTRAMAFIC ROCKS; LU-HF; HYDROTHERMAL ZIRCON; SOUTHWEST JAPAN; CENTRAL GREECE; SERPENTINIZATION; EVOLUTION; MANTLE; INSIGHTS	Rodingites occur in serpentine-matrix melange of the Nagasaki metamorphic rocks in Japan. Two types of rodingites can be distinguished on the basis of their mode of occurrence and mineralogical composition. One occurs as dikes, which contain a mineral assemblage of grossular, vesuvianite, diopside, apatite, titanite, and zircon. The other occurs as a block, which consists of zoisite, clinozoisite, diopside, chlorite, apatite, titanite, and zircon. The former type of rodingites posses two types of zircons: prismatic and porous. The prismatic zircons contain primary fluid inclusions indicating their crystallization in the presence of fluids. The porous zircons have extensive fractures filled by zircon, which are indicative of a hydrothermal origin. Both zircon types were thought to have formed under the influence of fluids. U-Pb ion probe analyses of prismatic zircons from the rodingites yield a weighted mean age of 108-105Ma, suggesting the Early Cretaceous as the time of rodingitization in the subduction zone. Hafnium isotopic compositions of prismatic zircons are close to or overlap with the mid ocean ridge basalt (MORB) Hf isotopic ratio. This indicates that the fluid composition may have been reflected by the MORB composition during rodingitization. On the other hand, the low epsilon(Hf) values (11.8-18.9) of porous zircons suggest that they incorporate a small amount of Hf from fluid contaminated by subducted sediments. The rodingites are significantly enriched in Sr and depleted in large ion lithophile elements (LILE) (Cs, Rb, Ba). The fluid during rodingitization is able to extracts LILEs from the protolith of rodingites and adds Sr to the protolith of rodingites. The high field strength elements (HFSE) (Zr, Th, U, Nb, Ta) concentrations in the rodingites are similar to those of MORB, thus indicate their relatively immobile nature during rodingitization.	[Fukuyama, Mayuko; Maki, Kenshi] Akita Univ, Grad Sch Engn & Resource Sci, Akita 0108502, Japan; [Ogasawara, Masatsugu; Kon, Yoshiaki] Geol Survey Japan, Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058567, Japan; [Dunkley, Daniel J.] Curtin Univ Technol, Fac Sci & Engn, Perth, WA 6845, Australia; [Wang, Kuo-Lung; Lee, Der-Chuen; Maki, Kenshi] Acad Sinica, Inst Earth Sci, Taipei 11529, Taiwan; [Hokada, Tomokazu] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [Hirata, Takafumi] Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan	Fukuyama, M (reprint author), Akita Univ, Grad Sch Engn & Resource Sci, 1-1 Tegata Gakuen Machi, Akita 0108502, Japan.	mayuko@gipc.akita-u.ac.jp	Lee, Der-Chuen/N-9225-2013				Griffin WL, 2002, LITHOS, V61, P237, DOI 10.1016/S0024-4937(02)00082-8; SHIBATA K, 1977, GEOCHEM J, V11, P57; Hoskin PWO, 2003, REV MINERAL GEOCHEM, V53, P27, DOI 10.2113/0530027; Tsikouras B, 2009, LITHOS, V113, P540, DOI 10.1016/j.lithos.2009.06.013; Bach W, 2009, LITHOS, V112, P103, DOI 10.1016/j.lithos.2008.10.022; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Iizuka T, 2004, GEOCHEM J, V38, P229; Fu B, 2009, CHEM GEOL, V259, P131, DOI 10.1016/j.chemgeo.2008.10.035; Frost BR, 2007, J PETROL, V48, P1351, DOI 10.1093/petrology/egm021; Li XP, 2004, INT GEOL REV, V46, P28, DOI 10.2747/0020-6814.46.1.28; Wiedenbeck M, 2004, GEOSTAND GEOANAL RES, V28, P9, DOI 10.1111/j.1751-908X.2004.tb01041.x; WIEDENBECK M, 1995, GEOSTANDARD NEWSLETT, V19, P1, DOI 10.1111/j.1751-908X.1995.tb00147.x; Nowell GM, 1998, CHEM GEOL, V149, P211, DOI 10.1016/S0009-2541(98)00036-9; Lan CY, 2009, GEOSCI J, V13, P233, DOI 10.1007/s12303-009-0023-3; Black LP, 2003, CHEM GEOL, V200, P155, DOI 10.1016/S0009-2541(03)00165-7; Isozaki Y, 1997, ISL ARC, V6, P25, DOI 10.1111/j.1440-1738.1997.tb00039.x; Griffin WL, 2000, GEOCHIM COSMOCHIM AC, V64, P133, DOI 10.1016/S0016-7037(99)00343-9; BlichertToft J, 1997, EARTH PLANET SC LETT, V148, P243, DOI 10.1016/S0012-821X(97)00040-X; Li XP, 2004, J METAMORPH GEOL, V22, P159, DOI 10.1111/j.1525-1314.2004.00503.x; Harley SL, 2007, ELEMENTS, V3, P25, DOI 10.2113/gselements.3.1.25; Frost BR, 2008, J PETROL, V49, P1579, DOI 10.1093/petrology/egn038; Woodhead JD, 2001, EARTH PLANET SC LETT, V192, P331, DOI 10.1016/S0012-821X(01)00453-8; Austrheim H, 2008, LITHOS, V104, P177, DOI 10.1016/j.lithos.2007.12.006; Yui TF, 2013, LITHOS, V160, P268, DOI 10.1016/j.lithos.2012.12.011; BARNES I, 1967, SCIENCE, V156, P830, DOI 10.1126/science.156.3776.830; BARNES I, 1969, GEOL SOC AM BULL, V80, P1947, DOI 10.1130/0016-7606(1969)80[1947:TRBFIS]2.0.CO;2; BARRIGA F, 1983, CONTRIB MINERAL PETR, V84, P146, DOI 10.1007/BF00371281; Coleman RG, 1977, OPHIOLITES ANCIENT O, P229; Dubinska E, 2004, CHEM GEOL, V203, P183, DOI 10.1016/j.chemgeo.2003.10.005; Fukuyama M, 2013, J ASIAN EARTH SCI, V63, P206, DOI 10.1016/j.jseaes.2012.10.031; Hattori H., 1982, B GEOL SURV JPN, V33, P57; Hatzipanagiotou K, 2001, GEOL J, V36, P93, DOI 10.1002/gj.887; Hatzipanagiotou K, 2003, OFIOLITI, V28, P13; Igi S., 1979, BASEMENT JAPANESE IS, P261; Koutsovitis P, 2013, LITHOS, V172, P139, DOI 10.1016/j.lithos.2013.04.009; Li XP, 2008, J METAMORPH GEOL, V26, P347, DOI 10.1111/j.1525-1314.2008.00761.x; Li XP, 2010, LITHOS, V118, P17, DOI 10.1016/j.lithos.2010.03.009; Ludwig K.R., 2008, BERKELEY GEOCHRONOLO, V4, P1; Ludwig K.R., 2005, BERKELEY GEOCHRONOLO, V2, P1; MIYASHIRO A, 1961, J PETROL, V2, P277; Miyazaki K., 1989, MEMOIRS GEOLOGICAL S, V33, P217; Miyazaki T., 2013, LITHOS, V162-163, P14; Neal C., 1985, CHEM WEATHERING, P249, DOI [DOI 10.1007/978-94-009-5333-8_15, 10.1007/978-94-009-5333-8_15]; Nelson D. R., 1996, W AUSTR GEOLOGICAL S, V5, P1; Nishimura Y, 1998, J METAMORPH GEOL, V16, P129, DOI 10.1111/j.1525-1314.1998.00059.x; Nishimura Y., 2004, J GEOLOGICAL SOC JAP, V110, P372; Nishiyama T., 1987, SCI REPORTS DEP GEOL, V15, P89; O'Hanley D.S., 1996, OXFORD MONOGRAPHS GE, V34; OHANLEY DS, 1992, GEOCHIM COSMOCHIM AC, V56, P97, DOI 10.1016/0016-7037(92)90119-4; Pomonis P, 2008, CAN MINERAL, V46, P569, DOI 10.3749/canmin.46.3.569; SCHANDL ES, 1989, CAN MINERAL, V27, P579; Schulz B, 2006, GEOCHIM COSMOCHIM AC, V70, P697, DOI 10.1016/j.gca.2005.10.001; Soderlund U, 2004, EARTH PLANET SC LETT, V219, P311, DOI 10.1016/S0012-821X(04)00012-3; Sun SS, 1989, SPECIAL PUBLICATIONS, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; Tsikouras B, 2013, LITHOS, V175, P16, DOI 10.1016/j.lithos.2013.04.021; Tsutsumi Y., 2003, J MINERALOGICAL PETR, V98, P181, DOI 10.2465/jmps.98.181; Ueda Y., 1968, J JAPANESE ASS MINER, V60, P159; Ujiie M., 1995, J MINERAL PETROL EC, V90, P419, DOI 10.2465/ganko.90.419	58	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1038-4871	1440-1738		ISL ARC	Isl. Arc.	DEC	2014	23	4					281	298		10.1111/iar.12086		18	Geosciences, Multidisciplinary	Geology	AX4JI	WOS:000346898700004		
J	Akizawa, N; Arai, S				Akizawa, Norikatsu; Arai, Shoji			Petrology of mantle diopsidite from Wadi Fizh, northern Oman ophiolite: Cr and REE mobility by hydrothermal solution	ISLAND ARC			English	Article						chromite; Cr mobility; diopside; hydrothermal solution; mantle diopsidite; REE mobility	TRACE-ELEMENT COMPOSITIONS; ICP-MS; GEOCHEMISTRY; PERIDOTITE; LAYERS; CONSTRAINTS; CIRCULATION; CHROMITE; BEHAVIOR; MOHO	Diopsidite, mainly composed of diopsidic clinopyroxene (diopside for simplicity), was precipitated from a high-temperature hydrothermal solution, rich in silicate components mainly in the mantle peridotite. We present here a new type of diopsidite in the uppermost mantle section, which contains Cr-rich minerals such as chromite, Cr-rich diopside (<2.5wt.% Cr2O3) and Cr-rich grossular (<7wt.% Cr2O3). The chromites are varied in shape, subhedral to anhedral, and sometimes contain globular inclusions of grossular and chlorite. Film-like chromite branches off from coarse partially dissolved chromite grains, filling diopside grain boundaries. The diopside is Cr-rich solely around the chromite seam or chromite concentrate, but is almost free from Cr elsewhere. The diopsidite is surrounded by a whitish rock, which is composed of tremolite with a trace amount of chromite, diopside and grossular. The coarse chromite grain (<1mm) in the whitish rock is highly vermicular in shape. The petrological and chemical characteristics of the mantle diopsidite suggest that a hydrothermal solution had collected Cr by partial to complete dissolution of chromite when replacing the mantle peridotite, and possibly transported Cr upward to the crust. Abundances of trace elements (rare earth elements(REE), Sr, Zr, Ti and Y) in the mantle diopsidite indicate their mobility in a hydrothermal solution together with Cr.	[Akizawa, Norikatsu; Arai, Shoji] Kanazawa Univ, Dept Earth Sci, Kanazawa, Ishikawa 9201192, Japan	Akizawa, N (reprint author), Kanazawa Univ, Dept Earth Sci, Kanazawa, Ishikawa 9201192, Japan.	nori.plus.x@gmail.com			 [11J04217]	We thank M. Python, J. Uesugi, S. Ishimaru, H. Negishi and M. Miura for their assistance in the field expeditions in Oman. We appreciate A. Tamura for his assistance of LA-ICP-MS analyses. We are grateful to Salim Al Busaidi and others of the Ministry of Commerce and Industry, Sultanate of Oman for their hospitality and assistance. The comments provided by S. Umino (Editor), E. Takazawa and M. Python were greatly helpful in improving the manuscript. We appreciate H. Rehman for his thankful encouragement to submit a paper to this special issue. This study was supported in part by Grant-in-aid for JSPS Fellows (11J04217).	Akizawa N, 2009, J MINER PETROL SCI, V104, P389, DOI 10.2465/jmps.090622a; Akizawa N, 2012, CONTRIB MINERAL PETR, V164, P601, DOI 10.1007/s00410-012-0762-4; Akizawa N, 2011, J MINER PETROL SCI, V106, P261, DOI 10.2465/jmps.110621b; Longerich HP, 1996, J ANAL ATOM SPECTROM, V11, P899, DOI 10.1039/ja9961100899; Godard M, 2000, EARTH PLANET SC LETT, V180, P133, DOI 10.1016/S0012-821X(00)00149-7; Cowan RJ, 2014, GEOL SOC SPEC PUBL, V392, P155, DOI 10.1144/SP392.8; Bach W, 2009, LITHOS, V112, P103, DOI 10.1016/j.lithos.2008.10.022; Kusano Y, 2014, GEOL SOC SPEC PUBL, V392, P177, DOI 10.1144/SP392.9; Nicolas A, 2000, MAR GEOPHYS RES, V21, P147, DOI 10.1023/A:1026769727917; ALT JC, 1993, EARTH PLANET SC LETT, V119, P477, DOI 10.1016/0012-821X(93)90057-G; Arai S, 2014, AM MINERAL, V99, P28, DOI 10.2138/am.2014.4473; Borisova AY, 2012, J PETROL, V53, P2411, DOI 10.1093/petrology/egs054; Ishida Y, 2004, SCI REPORTS KANAZAWA, V48, P31; Kawahata H, 2001, J GEOPHYS RES-SOL EA, V106, P11083, DOI 10.1029/2000JB900456; Kelemen P.B., 2003, GEOPHYS MONOGR SER, V138, P223, DOI DOI 10.1029/138GM11; LIEFTINK DJ, 1994, CAN MINERAL, V32, P149; Lippard S. J., 1986, MEMOIR, V11; Morishita T, 2005, GEOCHEM J, V39, P327, DOI 10.2343/geochemj.39.327; Morishita T, 2005, GEOSTAND GEOANAL RES, V29, P107, DOI 10.1111/j.1751-908X.2005.tb00659.x; Pearce NJG, 1997, GEOSTANDARD NEWSLETT, V21, P115, DOI 10.1111/j.1751-908X.1997.tb00538.x; Python M., 2011, DYKE SWARMS KEYS GEO, P401; Python M, 2007, J MINER PETROL SCI, V102, P143, DOI 10.2465/jmps.060830; Python M, 2007, EARTH PLANET SC LETT, V255, P289, DOI 10.1016/j.epsl.2006.12.030; Sun SS, 1989, SPECIAL PUBLICATIONS, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; TAKAZAWA E, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI DOI 10.1029/2001GC000232; TROMMSDORFF V, 1990, CONTRIB MINERAL PETR, V104, P1, DOI 10.1007/BF00310641; Warren JM, 2010, J PETROL, V51, P395, DOI 10.1093/petrology/egp096	27	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1038-4871	1440-1738		ISL ARC	Isl. Arc.	DEC	2014	23	4					312	323		10.1111/iar.12074		12	Geosciences, Multidisciplinary	Geology	AX4JI	WOS:000346898700006		
J	Haraguchi, S; Ishizuka, H; Ishii, T; Fujioka, K; Yuasa, M; Shibasaki, H				Haraguchi, Satoru; Ishizuka, Hideo; Ishii, Teruaki; Fujioka, Kantaro; Yuasa, Makoto; Shibasaki, Hiroshi			Low- and high-temperature alterations of volcanic rocks in the northwestern Philippine Sea, and association with volcanic settings	ISLAND ARC			English	Article						alteration ratio; Amami Plateau; deposition in voids; Kyushu-Palau Ridge; low- and high-temperature alteration; mineral composition; secondary mineralization; tectonic setting; Urdaneta Plateau	BONIN FORE-ARC; HYDROTHERMAL ALTERATION; ISLAND GROUP; CA BONINITE; EVOLUTION; BASIN; MAGMATISM; AGE; SEAMOUNT; BASALT	Petrological and geochemical characteristics of low- and high-temperature alterations were investigated in volcanic rocks from the northern Philippine Sea. The assemblage of secondary minerals is divided into two groups based on microprobe and XRD analyses. The first group, comprising samples from the Kyushu-Palau Ridge and Urdaneta Plateau, includes calcite, phillipsite, clay minerals and Fe-oxyhydroxides, reflecting low-temperature alteration. The content of secondary deposition is high in the Kyushu-Palau Ridge, but low in the Urdaneta Plateau. The second group, consisting of samples from the Amami Plateau, includes secondary alkali feldspar, analcime, and chlorite, reflecting high-temperature hydrothermal alteration. As groundmass alteration is dominant in the studied volcanic rocks, the alteration index, defined as the ratio of secondary minerals in voids to the total material count, is useful for estimating alteration degree when precise identification of secondary materials is difficult in highly vesicular rocks. Alteration indexes correlate with bulk H2O+ and loss on ignition (LOI) contents, and bulk major and trace element compositions of the studied volcanic rocks change with alteration. The difference of alteration types in three regions may depend on the tectonic setting of volcanism. That is: (i) the Kyushu-Palau Ridge is covered with the last lava flow of rifting volcanism associated with spreading of the Shikoku Basin, and the volcanics reacted with circulating seawater under low temperatures and oxidative conditions; (ii) the Urdaneta Plateau was formed as a result of intra-plate volcanism, and the volcanics were under seafloor weathering without seawater circulation associated with volcanic activity; and (iii) the Amami Plateau was produced by Cretaceous arc volcanism, which suffered high-temperature alteration associated with intrusive activity of tonalite.	[Haraguchi, Satoru] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Solid Earth Geochem, Yokosuka, Kanagawa 2370061, Japan; [Ishizuka, Hideo] Kochi Univ, Dept Geol, Kochi 7808520, Japan; [Ishii, Teruaki] Fukada Geol Inst, Bunkyo Ku, Tokyo 1130021, Japan; [Fujioka, Kantaro] Kanagawa Univ, Fac Engn, Kawagawa Ku, Yokohama, Kanagawa 2218686, Japan; [Yuasa, Makoto] Geol Survey Japan, Natl Inst Adv Ind Sci & Technol AIST, Ex Inst Geol & Geoinformat, Tsukuba, Ibaraki 3058567, Japan; [Shibasaki, Hiroshi] Japan Oil Gas & Met Natl Corp JOGMEC, Minato Ku, Tokyo 1050001, Japan	Haraguchi, S (reprint author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Dept Solid Earth Geochem, 2-15 Natsushima Cho, Yokosuka, Kanagawa 2370061, Japan.	s-haraguchi@jamstec.go.jp					ALT JC, 1986, J GEOPHYS RES-SOLID, V91, P309, DOI 10.1029/JB091iB10p10309; OKINO K, 1994, J GEOMAGN GEOELECTR, V46, P463; HALL R, 1995, TECTONICS, V14, P1117, DOI 10.1029/95TC01694; Macpherson CG, 2001, EARTH PLANET SC LETT, V186, P215, DOI 10.1016/S0012-821X(01)00248-5; Li YB, 2013, J PETROL, V54, P1149, DOI 10.1093/petrology/egt008; Hickey-Vargas R, 2013, J ASIAN EARTH SCI, V70-71, P193, DOI 10.1016/j.jseaes.2013.03.013; Reagan MK, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002871; MOTTL MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P1103, DOI 10.1016/0016-7037(78)90107-2; Haraguchi S, 2003, CONTRIB MINERAL PETR, V145, P151, DOI 10.1007/s00410-002-0433-y; Nakamura K, 2007, MAR GEOL, V239, P125, DOI 10.1016/j.margeo.2007.01.003; TOMASSON J, 1972, CONTRIB MINERAL PETR, V36, P123, DOI 10.1007/BF00371183; Ishizuka O, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003440; Cosca MA, 1998, ISL ARC, V7, P579, DOI 10.1111/j.1440-1738.1998.00211.x; Ishizuka O, 2013, GEOLOGY, V41, P1011, DOI 10.1130/G34525.1; Hickey-Vargas R, 2005, ISL ARC, V14, P653, DOI 10.1111/j.1440-1738.2005.00474.x; Honza E, 2004, TECTONOPHYSICS, V384, P23, DOI 10.1016/j.tecto.2004.02.006; Ishizuka O, 2006, EARTH PLANET SC LETT, V250, P385, DOI 10.1016/j.epsl.2006.08.007; HILDE TWC, 1984, TECTONOPHYSICS, V102, P85, DOI 10.1016/0040-1951(84)90009-X; COOMBS DS, 1959, GEOCHIM COSMOCHIM AC, V17, P53, DOI 10.1016/0016-7037(59)90079-1; Deschamps A, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB001706; Bence S. E., 1968, J GEOL, V76, P382; Crawford A.J., 1989, BONINITES RELATED RO, P1; Deer W. A., 1962, ROCK FORMING MINERAL, V5; FUJIOKA K, 1992, P OC DRILL PROGR SCI, V0126; Fujioka K, 1999, GEOLOGY, V27, P1135, DOI 10.1130/0091-7613(1999)027<1135:EESCIT>2.3.CO;2; Gifkins C., 2005, ALTERED VOLCANIC ROC; Gillis K. M., 1992, P ODP SCI RES, V123, P191; Haraguchi S, 2012, CONTRIB MINERAL PETR, V163, P483, DOI 10.1007/s00410-011-0680-x; Hickey-Vargas R, 1998, J GEOPHYS RES-SOL EA, V103, P20963, DOI 10.1029/98JB02052; Honnorez J, 1981, THE SEA, V6, P525; Honnorez J., 1996, P OCEAN DRILL PROGRA, V148, P171; Ishiwatari A, 2006, ISL ARC, V15, P102, DOI 10.1111/j.1440-1738.2006.00512.x; Kanayama K, 2012, ISL ARC, V21, P288, DOI 10.1111/iar.12000; Kanayama K, 2014, J ASIAN EARTH SCI, V85, P1, DOI 10.1016/j.jseaes.2014.01.012; Karig DE, 1975, INITIAL REP DEEP SEA, V31, P857; Laverne C., 1996, P ODP SCI RESULTS, V148, P151; Laverne C., 1995, P ODP SCI RESULTS, V137/140, P167; Maehara K, 2004, ISL ARC, V13, P452, DOI 10.1111/j.1440-1738.2004.00437.x; Matsuda J., 1975, S GEOL PROBL PHIL SE, P91; Miyashiro A., 1970, LITHOS, V3, P251, DOI 10.1016/0024-4937(70)90077-0; Miyashiro A., 1973, METAMORPHISM METAMOR; MOTTL MJ, 1983, GEOL SOC AM BULL, V94, P161, DOI 10.1130/0016-7606(1983)94<161:MAHSAT>2.0.CO;2; Nakajima W., 1990, CLAY SCI SOC JAPAN, V30, P57; NAKAMURA Y, 1970, CONTRIB MINERAL PETR, V26, P265, DOI 10.1007/BF00390075; Ohara Y, 2007, ISL ARC, V16, P319, DOI 10.1111/j.1440-1738.2007.00596.x; Ohara Y, 2002, CHEM GEOL, V189, P35, DOI 10.1016/S0009-2541(02)00062-1; Okino K, 1999, GEOPHYS RES LETT, V26, P2287, DOI 10.1029/1999GL900537; Scott R., 1980, GEOPHYS MONOGR SER, V23, P283; Shiki T, 1985, GEOLOGY NO PHILIPPIN; Tatsumi Y., 1989, BONINITES RELATED RO, P50; Taylor B., 1992, P OCEAN DRILLING PRO, V126, P627; TAYLOR RT, 1992, P OCEAN DRILLING PRO, V0126; TEAGLE DAH, 1996, P OCEAN DRILLING PRO, V0148; Yajima K., 2001, JAPANESE MAGAZINE MI, V30, P164, DOI 10.2465/gkk.30.164; Yajima K., 2003, JAP MAGAG MINERAL PE, V32, P51, DOI 10.2465/gkk.32.51; Yajima L., 2001, JAPANESE MAGAZINES M, V30, P217	56	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1038-4871	1440-1738		ISL ARC	Isl. Arc.	DEC	2014	23	4					324	343		10.1111/iar.12078		20	Geosciences, Multidisciplinary	Geology	AX4JI	WOS:000346898700007		
J	Fujibayashi, N; Asakura, K; Hattori, T; Allen, S				Fujibayashi, Norie; Asakura, Kensuke; Hattori, Takeshi; Allen, Sharon			Pillow lava and spasmodic submarine fire fountaining in the middle Miocene marginal basin, Sado Island, Japan	ISLAND ARC			English	Article						back-arc basin; basalt; Ogi Basalt; pillow lava; Sawasaki basalt; scoria agglomerate; spasmodic fire fountain; submarine explosive eruption; submarine volcanic hill	GRAVITY-FLOW DEPOSITS; SEAMOUNT VOLCANISM; SHIMANE PENINSULA; NORTH-ISLAND; NEW-ZEALAND; SW JAPAN; RIDGE; EMPLACEMENT; MORPHOLOGY; BASALT	The Sawasaki basalt unit of the Ogi Basalt Member is a middle Miocene submarine volcano formed in a marginal basin, cropping out on the coast of the Ogi Peninsula, Sado Island, Japan. It is approx. 100m thick, more than 4km wide, and is composed of pillow lavas (Sawasaki pillow lava) and overlying fire fountain deposits (Sawasaki pyroclastic rocks). The Sawasaki pillow lava is a pile of nearly-horizontal lava flows. Massive sheet lavas and lava pods grade into pillow lavas. The flat surfaces of the sheet lavas suggest that they spread over a summit plain. The margin of the Sawasaki pillow lava is dominated by thin elongated pillow lobes (20-30cm across) dipping at 45-60 degrees, contrast with the large pillows (40-100cm across) in the core. The proximal lithofacies of the Sawasaki pyroclastic rocks is scoria agglomerate which is composed of tens of stratified beds. Individual beds have a range of clast sizes and abundance of subaqueous bombs (sometimes up to >70%), which suggests that they were formed by submarine spasmodic fire fountain eruptions. Progressive aggradation from a turbulent flow allowed settling of well-preserved fluidal-shaped subaqueous bombs in a fines-depleted matrix. The basal layer shows lamina, scour and imbrication of scoria clasts. The thick scoria agglomerate beds with large subaqueous bombs, derived from energetic fire fountains, were emplaced during transition to higher degrees of hydrovolcanic fragmentation. Alternating scoria lapilli tuff and tuff beds in the distal area may represent the coupled topset and foreset beds formed by deposition from dilute, turbulent flows, and cascading of volcanic debris from the crest of the volcanic hill.	[Fujibayashi, Norie; Asakura, Kensuke; Hattori, Takeshi] Niigata Univ, Dept Nat Sci, Fac Educ, Niigata 9502181, Japan; [Allen, Sharon] Univ Tasmania, CODES ARC Ctr Excellence Ore Deposits, Hobart, Tas 7001, Australia; [Allen, Sharon] Univ Tasmania, Sch Earth Sci, Hobart, Tas 7001, Australia	Fujibayashi, N (reprint author), Niigata Univ, Dept Nat Sci, Fac Educ, Niigata 9502181, Japan.	fujib@ed.niigata-u.ac.jp			INPEX corporation	This research was partly granted by the Teikoku Oil Company (present INPEX corporation). We would like to express our deep gratitude to H. Arato for his support. We also thank K. Kano, K. Kurokawa, H. Yamagishi, Y. Takashimizu, and K. Kataoka for their helpful discussions on this research. Finally, we greatly appreciate J. White, associate Editor of the Island Arc, M. Jutzeler, and S. Umino, Editor In Chief of the Island Arc who reviewed the manuscript and provided us many constructive and concrete comments for revision.	Allen R. L., 1997, ECON GEOL, V91, P1022; GREGG TKP, 1995, GEOLOGY, V23, P73, DOI 10.1130/0091-7613(1995)023<0073:QOSLFM>2.3.CO;2; Sumner JM, 2005, J VOLCANOL GEOTH RES, V142, P49, DOI 10.1016/j.jvolgeores.2004.10.013; POSTMA G, 1986, GEOLOGY, V14, P291, DOI 10.1130/0091-7613(1986)14<291:CFSGDB>2.0.CO;2; POSTMA G, 1988, SEDIMENT GEOL, V58, P47, DOI 10.1016/0037-0738(88)90005-X; Kano K, 1996, B VOLCANOL, V58, P131, DOI 10.1007/s004450050131; BATIZA R, 1984, J GEOPHYS RES, V89, P8371, DOI 10.1029/JB089iB10p08371; White JDL, 2000, PRECAMBRIAN RES, V101, P87, DOI 10.1016/S0301-9268(99)00096-0; Sohn YK, 1997, J SEDIMENT RES, V67, P502; SMITH TL, 1989, B VOLCANOL, V51, P96, DOI 10.1007/BF01081979; APPELGATE B, 1992, B VOLCANOL, V54, P447, DOI 10.1007/BF00301391; Ballard R. D., 1977, PHOTOGRAPHIC ATLAS M; BALLARD RD, 1979, J GEOPHYS RES, V84, P5407, DOI 10.1029/JB084iB10p05407; Banik TJ, 2014, B VOLCANOL, V76, DOI 10.1007/s00445-013-0785-3; Basaltic Volcanism Study Project, 1981, BAS VOLC TERR PLAN; BATIZA R, 1989, J GEOL, V97, P209; Bear AN, 2007, J VOLCANOL GEOTH RES, V160, P1, DOI 10.1016/j.jvolgeores.2006.09.002; Befus KS, 2009, J VOLCANOL GEOTH RES, V181, P155, DOI 10.1016/j.jvolgeores.2008.12.017; BERGH SG, 1991, B VOLCANOL, V53, P597, DOI 10.1007/BF00493688; Carlisle D., 1963, J GEOL, V70, P48; Cas R. A. F., 2003, GEOPHYS MONOGR SER, V140, P299; Cas R.A.F., 1988, VOLCANIC SUCCESSIONS; DIMROTH E, 1978, CAN J EARTH SCI, V15, P902, DOI 10.1139/e78-101; Dzulynski S., 1962, T CONNECTICUT ACAD A, V42, P57; Fujibayashi N., 2003, EXPLOSIVE SUBMARINE, V140, P259; GILL J, 1990, SCIENCE, V248, P1214, DOI 10.1126/science.248.4960.1214; Gregg TKP, 2003, J VOLCANOL GEOTH RES, V126, P63, DOI 10.1016/S0377-0273(03)00116-1; GRIFFITHS RW, 1992, J GEOPHYS RES-SOL EA, V97, P19729, DOI 10.1029/92JB01594; Hiscott R. N., 1979, SPECIAL PUBLICATION, V27, P307; Hiscott R. N., 2006, 17 INT SED C FUK JAP, P24; HISCOTT RN, 1994, J SEDIMENT RES A, V64, P204; KANO K, 1994, J VOLCANOL GEOTH RES, V60, P1, DOI 10.1016/0377-0273(94)90094-9; Kusano Y, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC004006; LOWE DR, 1976, J SEDIMENT PETROL, V46, P188; LOWE DR, 1982, J SEDIMENT PETROL, V52, P279; MADGE LS, 1995, J GEOPHYS RES-SOL EA, V100, P8449; Matsunaga T., 1963, Science Reports of the Tohoku University Ser 2 Geol, V35, P67; Middleton G. V., 1970, GEOLOGICAL ASS CANAD, V7, P253; MOORE JG, 1975, AM SCI, V63, P269; MUELLER W, 1992, J VOLCANOL GEOTH RES, V54, P117, DOI 10.1016/0377-0273(92)90118-W; Naruse H, 2006, J SEDIMENT RES, V76, P854, DOI 10.2110/jsr.2006.063; Nemec W., 1990, SPEC PUBL INT ASS SE, V10, P29; OGI Collaborative Research Group, 1986, EARTH SCI CHIK KAG, V40, P417; Research Group of the OGI Basalts, 1977, PUBL SAD MUS, V7, P3; Richter D. H., 1970, US GEOLOGICAL SURV E; Schmidt RALF, 2000, ENCY VOLCANOES, P383; Schmincke H.U., 1990, OPHIOLITES OCEANIC C, P185; Self S., 1997, GEOPH MONOG SERIES, V100, P381; Shinmura T., 1995, PETROLOGY EC GEOLOGY, V90, P403; Simpson K, 2001, J VOLCANOL GEOTH RES, V109, P339, DOI 10.1016/S0377-0273(01)00199-8; SMITH DK, 1992, J GEOPHYS RES-SOL EA, V97, P1645, DOI 10.1029/91JB02507; Sohn YK, 2000, J SEDIMENT RES, V70, P491, DOI 10.1306/2DC40922-0E47-11D7-8643000102C1865D; STAUDIGEL H, 1984, J GEOPHYS RES, V89, P1195, DOI 10.1029/JB089iB13p11195; Stovall WK, 2011, B VOLCANOL, V73, P511, DOI 10.1007/s00445-010-0426-z; Stow D. A. V., 1986, SEDIMENTARY ENV FACI, P399; Tamaki K., 1992, P OCEAN DRILLING PRO, V127/128, P1333; Toramaru A, 1996, B VOLCANOL, V58, P393, DOI 10.1007/s004450050147; TRIBBLE GW, 1991, GEOLOGY, V19, P633, DOI 10.1130/0091-7613(1991)019<0633:UOOALF>2.3.CO;2; TSUNAKAWA H, 1983, GEOCHEM J, V17, P269; Umino S, 2002, GEOPH MONOG SERIES, V128, P85; Umino S, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009198; Vallence J. W., 2000, ENCY VOLCANOES, P601; Wolfe E. W., 1987, US GEOL SURV PROF PA, V1350, P471; Yamagishi H, 1987, REP GEOL SURV HOKKAI, V59, P55; YAMAGISHI H, 1985, GEOLOGY, V13, P499, DOI 10.1130/0091-7613(1985)13<499:GOPLFP>2.0.CO;2; Yamagishi H, 1982, J GEOL SOC JPN, V88, P19; Yamagishi H., 1994, SUBAQUEOUS VOLCANIC; Yamakawa M., 1968, NIIGATA UNIERSITY, V2, P41; Yanagisawa Y, 2012, OPEN FILE REPORT GEO, V569, P1	69	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1038-4871	1440-1738		ISL ARC	Isl. Arc.	DEC	2014	23	4					344	364		10.1111/iar.12091		21	Geosciences, Multidisciplinary	Geology	AX4JI	WOS:000346898700008		
J	Miura, R; Hino, R; Kawamura, K; Kanamatsu, T; Kaiho, Y				Miura, Ryo; Hino, Ryota; Kawamura, Kiichiro; Kanamatsu, Toshiya; Kaiho, Yuka			Accidental sediments trapped in ocean bottom seismometers during the 2011 Tohoku-Oki earthquake	ISLAND ARC			English	Article									[Miura, Ryo] Nippon Marine Enterprises Ltd, Yokosuka, Kanagawa 2380004, Japan; [Hino, Ryota] Tohoku Univ, Int Res Inst Disaster Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Kawamura, Kiichiro] Yamaguchi Univ, Grad Sch Sci & Engn, Yamaguchi 7538512, Japan; [Kanamatsu, Toshiya] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Kaiho, Yuka] Japan Agcy Marine Earth Sci & Technol, Kanazawa Ku, Yokohama, Kanagawa 2360001, Japan	Miura, R (reprint author), Nippon Marine Enterprises Ltd, 14-1 Ogawa Cho, Yokosuka, Kanagawa 2380004, Japan.	miurar@nme.co.jp					Suzuki K, 2012, EARTH PLANETS SPACE, V64, P1125, DOI 10.5047/eps.2012.04.010; Arai K, 2013, GEOLOGY, V41, P1195, DOI 10.1130/G34777.1	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1038-4871	1440-1738		ISL ARC	Isl. Arc.	DEC	2014	23	4					365	367		10.1111/iar.12079		3	Geosciences, Multidisciplinary	Geology	AX4JI	WOS:000346898700009		
J	Stern, RJ; Ren, MH; Kelley, KA; Ohara, Y; Martinez, F; Bloomer, SH				Stern, Robert J.; Ren, Minghua; Kelley, Katherine A.; Ohara, Yasuhiko; Martinez, Fernando; Bloomer, Sherman H.			Basaltic volcaniclastics from the Challenger Deep forearc segment, Mariana convergent margin: Implications for tectonics and magmatism of the southernmost Izu-Bonin-Mariana arc	ISLAND ARC			English	Article						basalt; Challenger Deep; Mariana Arc; subduction	SUBDUCTION ZONES; OCEANIC-CRUST; MODEL; CONTINENTS; EVOLUTION; ORIGIN; TROUGH; RIFT	Convergent margin igneous activity is generally limited to 100-200km from the trench except where spreading ridges are subducted or in association with Subduction-Transform Edge Propagators (STEP faults). The southernmost Mariana forearc, facing the Challenger Deep, subducts Mesozoic seafloor and is not in a STEP fault setting but includes at least one site where tholeiitic basalts recently erupted close to the trench, the SE Mariana Forearc Rift (SEMFR). We present evidence of young basaltic volcanism from ca. 100km west of SEMFR. Shinkai 6500 diving during YK13-08 (Dive 1363) recovered volcaniclastics from 5.5 to 6km deep in the inner wall of the Mariana Trench, 50km NE of the Challenger Deep. Glassy fragments are tholeiitic basalts similar to MORB except for much higher contents of magmatic water (approx. 2% H2O vs. <0.2% H2O in MORB) and enrichments in trace elements Rb-Cs-Ba, K, Pb, and Sr. Dive 1363 glasses are similar to basalts from SEMFR erupted near the trench and to Mariana Trough backarc basin basalts. Basalt fragments and palagonitized matrix dominate the studied samples, but small xenocrysts and xenoliths derived from mantle peridotite and Neogene volcanics are also present, probably torn from the vent walls. Dive 1363 hyaloclastites erupted at 3-6km water depth accompanied by vigorous degassing of volatiles, most likely CO2. These results provide further evidence that the forearc adjacent to the Challenger Deep has been invaded by asthenospheric mantle and derivative hydrous melts. Extension, hydration, and melt invasion combine to further weaken Challenger Deep forearc lithosphere. Combined effects of: (i) absence of strong, cold lithosphere of the overriding plate; (ii) rapid rollback of a narrow, short subducted slab; and (iii) weak coupling between the subducting Pacific plate and the overriding Mariana plate may be responsible for the great depth of the Challenger Deep.	[Stern, Robert J.] Univ Texas Dallas, Geosci Dept, Richardson, TX 75080 USA; [Ren, Minghua] Univ Nevada, Dept Geosci, Las Vegas, NV 89154 USA; [Kelley, Katherine A.] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [Ohara, Yasuhiko] Hydrog & Oceanog Dept Japan, Tokyo 1350064, Japan; [Ohara, Yasuhiko] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Martinez, Fernando] Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, SOEST, Honolulu, HI 96822 USA; [Bloomer, Sherman H.] Oregon State Univ, Geosci Dept, Corvallis, OR 97331 USA	Stern, RJ (reprint author), Univ Texas Dallas, Geosci Dept, 800 W Campbell Rd, Richardson, TX 75080 USA.	rjstern@utdallas.edu			NSF [OCE-0961811, OCE- 0961559, EAR- 1258940]; NSF-OCE [0961352]	Funding for this research includes NSF grant OCE-0961811 to Martinez; NSF OCE- 0961559 and NSF EAR- 1258940 to Kelley, and NSF-OCE 0961352 to Stern. This study was conducted under the special use permit #12541-12001 of US Fish and Wildlife Service for activities in the Mariana Trench Marine National Monument. We thank US Fish and Wildlife Service for approval of our study in the monument. We gratefully acknowledge the support of the crews of R/V Yokosuka and DSV Shinkai, R/V Thomas G. Thompson and the Hawaii Mapping Research Group without whom this research would have been impossible. We greatly appreciate the detailed comments of two anonymous referees and Associate Editor Ryuichi Shinjo.	Govers R, 2005, EARTH PLANET SC LETT, V236, P505, DOI 10.1016/j.epsl.2005.03.022; Kelley KA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000435; Bird P, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000252; Gale A, 2013, GEOCHEM GEOPHY GEOSY, V14, P489, DOI 10.1029/2012GC004334; Kitada K, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001119; Pearce JA, 2008, LITHOS, V100, P14, DOI 10.1016/j.lithos.2007.06.016; Ohara Y, 2012, P NATL ACAD SCI USA, V109, P2831, DOI 10.1073/pnas.1112005109; Putirka KD, 2008, REV MINERAL GEOCHEM, V69, P61, DOI 10.2138/rmg.2008.69.3; Newman S, 2002, COMPUT GEOSCI-UK, V28, P597, DOI 10.1016/S0098-3004(01)00081-4; Kelley KA, 2012, EARTH PLANET SC LETT, V329, P109, DOI 10.1016/j.epsl.2012.02.010; MILLER DM, 1994, NATURE, V368, P514, DOI 10.1038/368514a0; Stern RJ, 2013, ISL ARC, V22, P133, DOI 10.1111/iar.12008; MATSUDA T, 1971, TECTONOPHYSICS, V11, P5, DOI 10.1016/0040-1951(71)90076-X; Resing JA, 2011, NAT GEOSCI, V4, P799, DOI [10.1038/ngeo1275, 10.1038/NGEO1275]; MICHAEL P, 1995, EARTH PLANET SC LETT, V131, P301, DOI 10.1016/0012-821X(95)00023-6; [Anonymous], 2001, MANTLE PLUMES THEIR; Martinez F, 2000, J GEOPHYS RES-SOL EA, V105, P16591, DOI 10.1029/2000JB900117; Plank T, 2005, J PETROL, V46, P921, DOI 10.1093/petrology/egi005; ARMSTRONG A. A., 2011, CRUISE REPORT USNS S; Becker NC, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002719; BOYNTON W. V., 1985, RARE EARTH ELEMENT G, V2, P115; Brounce MN, 2014, J PETROL, V55, P2513, DOI 10.1093/petrology/egu065; DVORKIN J, 1993, TECTONOPHYSICS, V227, P63, DOI 10.1016/0040-1951(93)90087-Z; Fisher R.V., 1984, GEOL SOC LOND SPEC P, V16, P5, DOI 10.1144/GSL.SP.1984.016.01.02; Fryer P, 2003, EARTH PLANET SC LETT, V211, P259, DOI 10.1016/S0012-821X(03)00202-4; Fryer P., 1995, BACKARC BASINS TECTO, P237; Gvirtzman Z, 2004, TECTONICS, V23, DOI 10.1029/2003TC001581; Kato T, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016757; Kelley KA, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB003732; Lytle ML, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004233; Martinez F., 2012, EGU20126643; Martinez F., 2003, GEOL SOC SPEC PUBL, V219, P19, DOI DOI 10.1144/GSL.SP.2003.219.01.02; Ribeiro JM, 2013, ISL ARC, V22, P453, DOI 10.1111/iar.12039; Ribeiro JM, 2013, GEOCHEM GEOPHY GEOSY, V14, P4585, DOI 10.1002/ggge.20244; Sandwell DT, 1997, J GEOPHYS RES-SOL EA, V102, P10039, DOI 10.1029/96JB03223; SHERVAIS JW, 1982, EARTH PLANET SC LETT, V59, P101, DOI 10.1016/0012-821X(82)90120-0; Sun S. S., 1989, GEOL SOC SPEC PUBL, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19	37	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1038-4871	1440-1738		ISL ARC	Isl. Arc.	DEC	2014	23	4					368	382		10.1111/iar.12088		15	Geosciences, Multidisciplinary	Geology	AX4JI	WOS:000346898700010		
J	Ganeev, RA; Suzuki, M; Baba, M; Yoneya, S; Kuroda, H				Ganeev, R. A.; Suzuki, M.; Baba, M.; Yoneya, Sh; Kuroda, H.			Graphene-containing plasma: a medium for the coherent extreme ultraviolet light generation	JETP LETTERS			English	Article								We demonstrate the high-order harmonic generation of femtosecond pulses in the laser ablation plume containing the graphene nanoparticles. The harmonics up to the 33rd order were observed. The presence of graphene nanoparticles in the laser plasma was confirmed during the analysis of ablation debris. The comparative studies of harmonic generation from the ablation of graphene, carbon nanotubes, and diamond nanoparticles showed the advanced properties of the latter medium.	[Ganeev, R. A.; Suzuki, M.; Baba, M.; Yoneya, Sh; Kuroda, H.] Saitama Med Univ, Ophthalmol & Adv Laser Med Ctr, Saitama 3500495, Japan	Ganeev, RA (reprint author), Saitama Med Univ, Ophthalmol & Adv Laser Med Ctr, Saitama 3500495, Japan.	Rashid_ganeev@mail.ru			JSPS KAKENHI [24760048]	We are grateful to Prof. Y. Sakamoto and Division of Analytical Science, Biomedical Research Centre, Saitama Medical School for time-of-flight mass spectrometry and TEM measurements. This work was supported by JSPS KAKENHI (grant no. 24760048).	Ganeev RA, 2005, PHYS LETT A, V339, P103, DOI 10.1016/j.physleta.2005.02.073; Hendry E, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.097401; Ganeev RA, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.013903; Mikhailov SA, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.045432; Ishikawa KL, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.201402; Wu SF, 2012, NANO LETT, V12, P2032, DOI 10.1021/nl300084j; Gullans M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.247401; Hutchison C, 2012, OPT LETT, V37, P2064, DOI 10.1364/OL.37.002064; Bom LBE, 2011, OPT EXPRESS, V19, P3077, DOI 10.1364/OE.19.003077; Ganeev RA, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.033803; Ganeev RA, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.013820; Geim K., 2007, NAT MATER, V6, P183, DOI DOI 10.1038/NMAT1849; Sorngard SA, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.053803	13	1	1	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	0021-3640	1090-6487		JETP LETT+	Jetp Lett.	DEC	2014	100	7					434	438		10.1134/S0021364014190047		5	Physics, Multidisciplinary	Physics	AX2ME	WOS:000346777300004		
J	Maeda, T; Yoshitani, K; Inatomi, Y; Ohnishi, Y				Maeda, Takuma; Yoshitani, Kenji; Inatomi, Yuzuru; Ohnishi, Yoshihiko			Inaccuracy of the FloTrac/Vigileo (TM) System in Patients With Low Cardiac Index	JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA			English	Article						cardiac output; intraoperative monitoring; thermodilution; pulse-wave analysis; low cardiac output syndrome; heart failure	TIME 3-DIMENSIONAL ECHOCARDIOGRAPHY; LEFT-VENTRICULAR VOLUMES; CARDIOVASCULAR MAGNETIC-RESONANCE; ACUTE MYOCARDIAL-INFARCTION; WAVE-FORM ANALYSIS; OUTPUT MEASUREMENT; INTERSTUDY REPRODUCIBILITY; PERIPHERAL RESISTANCE; CIRRHOTIC-PATIENTS; VIGILEO-FLOTRAC	Objectives: The goal of this study was to compare cardiac output derived from the FloTrac/Vigileo (TM) system (COFT) with cardiac output measured by 3-dimensional transesophageal echocardiography (CO3D) in patients with severe heart failure undergoing cardiac resynchronization therapy. The impact of preoperative systemic vascular resistance index on the accuracy of the FloTrac/Vigileo (TM) system also was investigated. Design: Prospective clinical study. Setting: Cardiac surgery operating room of a single cardiovascular center. Participants: Forty-one patients undergoing elective cardiac resynchronization therapy lead implantation. Interventions: CO3D as the reference method and COFT were determined simultaneously after induction of anesthesia. Measurements and Main Results: Linear regression analysis showed a poor correlation between CO3D and COFT(R-2 = 0.16). Bland-Altman plots showed wide limits of agreement between CO3D and COFT. Bias was 0.60 +/- 0.63 L/min with a high percentage error of 58.2%. Subgroup analysis showed that the percentage error between CO3D and COFT was 74.1% in patients with a cardiac index <2.2 L/min/m(2) and 17.2% in patients with a cardiac index >= 2.2 L/min/m(2). Systemic vascular resistance index was significantly higher in patients with a cardiac index <2.2 L/min/m(2) (3,037 +/- 820 v 2,461 +/- 878; p = 0.039). Conclusions: The FloTrac/Vigileo (TM) system is not accurate in patients with low cardiac output, especially those with a cardiac index <2.2 L/min/m(2). A high systemic vascular resistance index in patients with low cardiac index may contribute to this inaccuracy. (C) 2014 Elsevier Inc. All rights reserved.	[Maeda, Takuma; Yoshitani, Kenji; Inatomi, Yuzuru; Ohnishi, Yoshihiko] Natl Cerebral & Cardiovasc Ctr, Dept Anesthesiol, Suita, Osaka 5658565, Japan	Maeda, T (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Anesthesiol, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	takuma@ncyc.go.jp					Akiyoshi K, 2011, J ANESTH, V25, P178, DOI 10.1007/s00540-010-1087-y; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3; FORRESTER JS, 1977, AM J CARDIOL, V39, P137, DOI 10.1016/S0002-9149(77)80182-3; Metzelder S, 2011, BRIT J ANAESTH, V106, P776, DOI 10.1093/bja/aer066; LANGEWOUTERS GJ, 1985, J BIOMECH, V18, P613, DOI 10.1016/0021-9290(85)90015-6; Mor-Avi V, 2008, JACC-CARDIOVASC IMAG, V1, P413, DOI 10.1016/j.jcmg.2008.02.009; Dorosz JL, 2012, J AM COLL CARDIOL, V59, P1799, DOI 10.1016/j.jacc.2012.01.037; Suehiro K, 2013, BRIT J ANAESTH, V111, P170, DOI 10.1093/bja/aet022; ZELIS R, 1968, J CLIN INVEST, V47, P960, DOI 10.1172/JCI105788; Chen E, 2005, DEV BIOL, V284, P364, DOI 10.1016/j.ydbio.2005.05.032; Critchley LAH, 1999, J CLIN MONITOR COMP, V15, P85, DOI 10.1023/A:1009982611386; Soliman OII, 2007, J AM SOC ECHOCARDIOG, V20, P1042, DOI 10.1016/j.echo.2007.02.011; Biancofiore G, 2011, ANESTH ANALG, V113, P515, DOI 10.1213/ANE.0b013e31822401b2; Grothues F, 2004, AM HEART J, V147, P218, DOI 10.1016/j.ahj.2003.10.005; Junttila EK, 2011, BRIT J ANAESTH, V107, P581, DOI 10.1093/bja/aer170; Lee D, 2001, J AM SOC ECHOCARDIOG, V14, P1001, DOI 10.1067/mje.2001.113647; Biancofiore G, 2009, BRIT J ANAESTH, V102, P47, DOI 10.1093/bja/aen343; Grothues F, 2002, AM J CARDIOL, V90, P29, DOI 10.1016/S0002-9149(02)02381-0; Jenkins C, 2007, J AM SOC ECHOCARDIOG, V20, P862, DOI 10.1016/j.echo.2006.12.010; Meng LZ, 2011, ANESTH ANALG, V113, P751, DOI 10.1213/ANE.0b013e31822649fb; BLAND JM, 1986, LANCET, V1, P307; Culp WC, 2007, ANESTH ANALG, V105, P1219, DOI 10.1213/01.ane.0000287282.21055.db; Fleming SM, 2005, AM J CARDIOL, V95, P308, DOI 10.1016/j.amjcard.2004.08.101; Jenkins C, 2009, EUR HEART J, V30, P98, DOI 10.1093/eurheartj/ehn484; Kusaka Y, 2012, J CARDIOTHOR VASC AN, V26, P223, DOI 10.1053/j.jvca.2011.07.011; Marsan NA, 2009, HEART, V95, P1881, DOI 10.1136/hrt.2008.151613; Mor-Avi V, 2009, CURR OPIN CARDIOL, V24, P402, DOI 10.1097/HCO.0b013e32832cbb8a; Shimada YJ, 2012, ECHOCARDIOGR-J CARD, V29, P1091, DOI 10.1111/j.1540-8175.2012.01753.x	28	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1053-0770	1532-8422		J CARDIOTHOR VASC AN	J. Cardiothorac. Vasc. Anesth.	DEC	2014	28	6					1521	1526		10.1053/j.jvca.2014.04.013		6	Anesthesiology; Cardiac & Cardiovascular Systems; Respiratory System; Peripheral Vascular Disease	Anesthesiology; Cardiovascular System & Cardiology; Respiratory System	AX2FK	WOS:000346758800015		
J	Shimizu, S; Koyama, T; Mizota, T; Fukuda, K				Shimizu, Satoshi; Koyama, Tomohiro; Mizota, Toshiyuki; Fukuda, Kazuhiko			Acute Obstruction of Craniocervical Venous Drainage in a Lung-Transplant Patient	JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA			English	Article						central venous catheter; jugular vein system; thrombosis; lung transplantation	THROMBOSIS		[Shimizu, Satoshi; Koyama, Tomohiro; Mizota, Toshiyuki; Fukuda, Kazuhiko] Kyoto Univ Hosp, Dept Anesthesia, Sakyo Ku, Kyoto 6068507, Japan	Shimizu, S (reprint author), Kyoto Univ Hosp, Dept Anesthesia, Sakyo Ku, 54 Shogoinkawaharacho, Kyoto 6068507, Japan.	satosyl@gmail.com	Mizota, Toshiyuki/I-7355-2015	Mizota, Toshiyuki/0000-0003-2770-4262			Izbicki G, 2006, CHEST, V129, P412, DOI 10.1378/chest.129.2.412; Badesch DB, 2007, CHEST, V131, P1917, DOI 10.1378/chest.06-2674; Timsit JF, 1998, CHEST, V114, P207, DOI 10.1378/chest.114.1.207; Braun JP, 1997, NEURORADIOLOGY, V31, P155; Conkbayir I, 2002, J CLIN ULTRASOUND, V30, P392, DOI 10.1002/jcu.10081; Duke BJ, 1997, NEUROSURGERY, V41, P680, DOI 10.1097/00006123-199709000-00036; FOURESTIE V, 1985, CHEST, V88, P636, DOI 10.1378/chest.88.4.636; Tam PYI, 2008, AM J HEMATOL, V83, P323, DOI 10.1002/ajh.21107	8	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1053-0770	1532-8422		J CARDIOTHOR VASC AN	J. Cardiothorac. Vasc. Anesth.	DEC	2014	28	6					1586	1588		10.1053/j.jvca.2013.04.018		3	Anesthesiology; Cardiac & Cardiovascular Systems; Respiratory System; Peripheral Vascular Disease	Anesthesiology; Cardiovascular System & Cardiology; Respiratory System	AX2FK	WOS:000346758800027		
J	Higashi, H; Miyake, Y; Tamura, K; Seto, T; Otani, Y				Higashi, Hidenori; Miyake, Yasufumi; Tamura, Kazuhiro; Seto, Takafumi; Otani, Yoshio			Intra- and Inter-Molecular Potential Parameters for Molecular Dynamics Simulation of Benzene and Cyclohexane Mixture	JOURNAL OF CHEMICAL ENGINEERING OF JAPAN			English	Article						Potential Parameter; Interaction Parameter; Molecular Dynamics; Density; Self-Diffusion Coeffcients	FLUID TRANSPORT-PROPERTIES; UNITED-ATOM DESCRIPTION; EXPLICIT-HYDROGEN DESCRIPTION; SUPERCRITICAL CARBON-DIOXIDE; LIQUID PHASE-EQUILIBRIA; TRANSFERABLE POTENTIALS; DIFFUSION-COEFFICIENTS; BRANCHED ALKANES; FORCE-FIELD; N-ALKANES	Intra-and inter-molecular potential parameters have been newly derived to calculate the density and the self-diffusion coeffcients of benzene, cyclohexane and their mixtures by molecular dynamics (MD) simulation using a six-center Lennard- Jones model. First, the validity of new parameters was examined in comparison with the reference experimental densities of pure components. Then, these parameters were adopted to the simulation of a benzene and cyclohexane mixture. Since simple combining rules (Lorentz-Berthelot) underestimated the density of the mixture, a concentration-dependent interaction parameter was newly introduced to predict the density of the mixture. The agreement between the experimental data and the simulated self-diffusion coeffcients of benzene and cyclohexane in their mixture were improved by introducing the concentration-dependent interaction parameter.	[Higashi, Hidenori; Miyake, Yasufumi; Tamura, Kazuhiro; Seto, Takafumi; Otani, Yoshio] Kanazawa Univ, Coll Sci & Engn, Sch Nat Syst, Kanazawa, Ishikawa 9201192, Japan	Higashi, H (reprint author), Kanazawa Univ, Coll Sci & Engn, Sch Nat Syst, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan.	hhigashi@mail.kanazawa-u.ac.jp	Tamura, Kazuhiro/F-2513-2014; Seto, Takafumi/D-2874-2012; HIGASHI, Hidenori/E-1572-2012; OTANI, Yoshio/L-3581-2015	Tamura, Kazuhiro/0000-0002-0885-6132; HIGASHI, Hidenori/0000-0002-6609-8472; OTANI, Yoshio/0000-0002-5751-6898			ADACHI Y, 1985, FLUID PHASE EQUILIBR, V24, P353, DOI 10.1016/0378-3812(85)85013-5; ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Martin MG, 1999, J PHYS CHEM B, V103, P4508, DOI 10.1021/jp984742e; Higashi H, 2010, MOL SIMULAT, V36, P772, DOI 10.1080/08927021003752846; Chen B, 1999, J PHYS CHEM B, V103, P5370, DOI 10.1021/jp990822m; Higashi H, 2005, FLUID PHASE EQUILIBR, V234, P51, DOI 10.1016/j.fluid.2005.05.013; Wick CD, 2000, J PHYS CHEM B, V104, P8008, DOI 10.1021/jp001004x; Dysthe DK, 1999, J CHEM PHYS, V110, P4060, DOI 10.1063/1.478287; Zhang MM, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2042427; Rai N, 2007, J PHYS CHEM B, V111, P10790, DOI 10.1021/jp073586l; JONAS J, 1980, J PHYS CHEM-US, V84, P109, DOI 10.1021/j100438a024; JORGENSEN WL, 1984, J AM CHEM SOC, V106, P6638, DOI 10.1021/ja00334a030; Milano G, 2004, J PHYS CHEM B, V108, P7415, DOI 10.1021/jp0494382; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Martin MG, 1998, J PHYS CHEM B, V102, P2569, DOI 10.1021/jp972543+; SMIT B, 1995, J CHEM PHYS, V102, P2126, DOI 10.1063/1.469563; CASEWIT CJ, 1992, J AM CHEM SOC, V114, P10035, DOI 10.1021/ja00051a041; BEG SA, 1993, J CHEM ENG DATA, V38, P461, DOI 10.1021/je00011a035; BEG SA, 1994, FLUID PHASE EQUILIBR, V94, P289, DOI 10.1016/0378-3812(94)87063-2; Dysthe DK, 2000, J CHEM PHYS, V112, P7581, DOI 10.1063/1.481353; Dysthe DK, 1999, J CHEM PHYS, V110, P4047, DOI 10.1063/1.478286; Errington JR, 1999, J CHEM PHYS, V111, P9731, DOI 10.1063/1.480308; Kim JH, 2002, B KOR CHEM SOC, V23, P441; Lee JS, 2005, MOL PHYS, V103, P99, DOI 10.1080/00268970412331303341; MILLS R, 1965, J PHYS CHEM-US, V69, P3116, DOI 10.1021/j100893a051; Pan FS, 2007, CHEM ENG SCI, V62, P703, DOI 10.1016/j.ces.2006.07.046; RODWIN L, 1965, J PHYS CHEM-US, V69, P2783, DOI 10.1021/j100892a503; SANNI SA, 1973, J CHEM ENG DATA, V18, P317, DOI 10.1021/je60058a028; SANNI SA, 1971, J CHEM ENG DATA, V16, P424, DOI 10.1021/je60051a009; SCHAINK HM, 1993, J CHEM PHYS, V99, P9912, DOI 10.1063/1.466207; Siepmann JI, 1997, MOL PHYS, V90, P687, DOI 10.1080/002689797172048; SUN TF, 1988, J CHEM THERMODYN, V20, P1089, DOI 10.1016/0021-9614(88)90115-2	32	0	0	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0021-9592			J CHEM ENG JPN	J. Chem. Eng. Jpn.	DEC	2014	47	12					849	854		10.1252/jcej.14we127		6	Engineering, Chemical	Engineering	AX4RU	WOS:000346919900001		
J	Okada, Y; Oshio, N; Kudoh, S				Okada, Yoshiki; Oshio, Nao; Kudoh, Satoshi			Fragmentation of Nanoparticle Agglomerates by Collisions	JOURNAL OF CHEMICAL ENGINEERING OF JAPAN			English	Article						Fragmentation; Nanoparticle Agglomerates; Supersonic Flow; Collision; Dry Ice Particles	HIGH-PRESSURE SUSPENSIONS; RAPID EXPANSION	We have developed a technology for producing nonagglomerated nanoparticles by causing collisions of the agglomerates in supersonic flows. To form these nonagglomerated nanoparticles, we conducted three experiments: the collision of agglomerated particles in a supersonic flow with a metal plate, the collision of agglomerated particles contained in two counter-current supersonic flows, and the collision of agglomerated particles in a supersonic flow with dry ice particles. The possibility that these collisions could fragment the agglomerates was investigated by measuring the size distribution of the agglomerates after the collisions using a differential mobility analyzer. Based on the experimental results, we propose that the most efficient technology for the fragmentation of the agglomerates depends on the concentration of the agglomerates. When the concentration is high, two counter-current supersonic flows containing the agglomerates should be used. When the concentrations are low, collision of agglomerates with dry ice particles should be performed.	[Okada, Yoshiki; Oshio, Nao; Kudoh, Satoshi] Kansai Univ, Grad Sch Sci & Engn, Suita, Osaka 5648680, Japan	Okada, Y (reprint author), Kansai Univ, Grad Sch Sci & Engn, 3-3-35 Yamate Cho, Suita, Osaka 5648680, Japan.	yokada@kansai-u.ac.jp					Wei DG, 2002, J NANOPART RES, V4, P21, DOI 10.1023/A:1020184524538; Liu Y, 2012, INT J NONLIN SCI NUM, V13, P1; To D, 2009, AICHE J, V55, P2807, DOI 10.1002/aic.11887; Levine I. N., 1988, PHYS CHEM; Liepmann H.W., 1957, ELEMENTS GASDYNAMICS; Okada Y, 2013, J CHEM ENG JPN, V46, P530, DOI 10.1252/jcej.13we044; Wu T., 2007, EUR AER C 2007 SALZB; Wu T, 2009, CHEM-ING-TECH, V81, P797; Yang J, 2003, ADV POWDER TECHNOL, V14, P471, DOI 10.1163/156855203769710681	9	0	0	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0021-9592			J CHEM ENG JPN	J. Chem. Eng. Jpn.	DEC	2014	47	12					864	868		10.1252/jcej.14we143		5	Engineering, Chemical	Engineering	AX4RU	WOS:000346919900003		
J	Iritani, E; Katagiri, N; Wakamatsu, Y; Cho, JH				Iritani, Eiji; Katagiri, Nobuyuki; Wakamatsu, Yuta; Cho, Jun-Hyung			Influence of Ultrasonic Pretreatment on Deliquoring Properties in Expression of Carrots	JOURNAL OF CHEMICAL ENGINEERING OF JAPAN			English	Article						Expression; Carrot; Ultrasonic Irradiation; Cake Moisture Content; Heating Effect; Pretreatment	CELLULAR MATERIALS; POWER ULTRASOUND; ELECTRIC-FIELD; MASS-TRANSFER; FILTER CAKES; SLUDGE; CONSOLIDATION; CREEP; DEHYDRATION; IMPROVEMENT	The effect of the pretreatment of ultrasonic irradiation on the deliquoring properties in expression was investigated by using carrots as an example of vegetables. The results indicated that the ultrasonic pretreatment produced a noticeable improvement in deliquoring behaviors such as the deliquoring rate and cake moisture content due to the physical damage of cell tissue, although the carrots were maintained in the original shape before and after ultrasonic irradiation. The time variation of the cake moisture content during the course of expression was well described by the three-stage creep model combined with the modified Terzaghi model. It was necessary to heat carrots above 50 degrees C during ultrasonic irradiation in order to attain a desired effect in expression since carrots lost cell turgor pressure rapidly through beta-elimination reaction occurring at about 50 degrees C. The ultrasonic pretreatment was well evaluated from the viewpoint of the ultrasonic energy dissipated in the sample. The cake moisture content after 24 h from the beginning of expression dramatically decreased from 69 to 47% by increasing the pressure from 0.5 to 10 MPa, indicating that the cake consisting of treated carrots behaved as the compressible material in the expression operation.	[Iritani, Eiji; Katagiri, Nobuyuki; Wakamatsu, Yuta] Nagoya Univ, Dept Chem Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Cho, Jun-Hyung] Kangwon Univ, Dept Paper Sci & Engn, Chunchon 200701, South Korea	Iritani, E (reprint author), Nagoya Univ, Dept Chem Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	iritani@nuce.nagoya-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of the Environment, Japan; Steel Foundation for Environmental Protection Technology	This work has been partially supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan and from the Ministry of the Environment, Japan, and by the Steel Foundation for Environmental Protection Technology. The authors wish to acknowledge with sincere gratitude the financial support leading to the publication of this article.	Riera E, 2004, ULTRASON SONOCHEM, V11, P241, DOI 10.1016/j.ultsonch.2004,01.019; Garcia-Perez JV, 2009, DRY TECHNOL, V27, P281, DOI 10.1080/07373930802606428; GREVE LC, 1994, J AGR FOOD CHEM, V42, P2896, DOI 10.1021/jf00048a047; Grimi N, 2007, SEP PURIF TECHNOL, V58, P267, DOI 10.1016/j.seppur.2007.03.020; Sila DN, 2006, J FOOD SCI, V71, pE1; Gallego-Juarez JA, 2007, DRY TECHNOL, V25, P1893, DOI 10.1080/07373930701677371; Xie BZ, 2009, J ENVIRON MANAGE, V90, P260, DOI 10.1016/j.jenvman.2007.09.004; GRACE HP, 1953, CHEM ENG PROG, V49, P303; Hu QG, 2006, DRY TECHNOL, V24, P1025, DOI 10.1080/07373930600776217; Carcel JA, 2007, J FOOD ENG, V78, P472, DOI 10.1016/j.jfoodeng.2005.10.018; Grimi N, 2010, J FOOD ENG, V96, P29, DOI 10.1016/j.jfoodeng.2009.06.039; Yu Q, 2009, CHEM ENG J, V155, P88, DOI 10.1016/j.cej.2009.07.010; Bouzrara H, 2003, CHEM ENG PROCESS, V42, P249, DOI 10.1016/S0255-2701(02)00010-7; Venter MJ, 2007, J FOOD ENG, V80, P1157, DOI 10.1016/j.jfoodeng.2006.09.005; Chen K, 2011, PROCESS SAF ENVIRON, V89, P327, DOI 10.1016/j.psep.2011.06.011; COHEN JS, 1995, TRENDS FOOD SCI TECH, V6, P20, DOI 10.1016/S0924-2244(00)88913-X; Koda S, 2003, ULTRASON SONOCHEM, V10, P149, DOI 10.1016/S1350-4177(03)00084-1; Ozuna C, 2011, J SCI FOOD AGR, V91, P2511, DOI 10.1002/jsfa.4344; BUTTERSACK C, 1994, CHEM ENG SCI, V49, P1145, DOI 10.1016/0009-2509(94)85086-0; Christensen ML, 2007, POWDER TECHNOL, V177, P23, DOI [10.1016/j.powtec.2007.02.034, 10.1016/j.powtee.2007.02.034]; Day L, 2012, ULTRASON SONOCHEM, V19, P427, DOI 10.1016/j.ultsonch.2011.10.019; Erden G, 2010, J CHEM TECHNOL BIOT, V85, P145, DOI 10.1002/jctb.2298; Iritani E, 2010, J CHEM ENG JPN, V43, P140; Iritani E, 2007, AICHE J, V53, P129, DOI 10.1002/aic.11045; Kamst GF, 1997, AICHE J, V43, P665, DOI 10.1002/aic.690430312; Kawasaki K, 1996, KAGAKU KOGAKU RONBUN, V22, P294; Lanoiselle JL, 1996, AICHE J, V42, P2057, DOI 10.1002/aic.690420726; Okamura S, 1955, KAGAKU KOGAKU, V19, P104; Rebouillat S, 1996, J CHEM ENG JPN, V29, P29, DOI 10.1252/jcej.29.29; Ruiz-Hernando M, 2013, CHEM ENG J, V230, P102, DOI 10.1016/j.cej.2013.06.046; Schwartzberg HG, 1997, SEPAR PURIF METHOD, V26, P1, DOI 10.1080/03602549708014156; Shirato M., 1967, KAGAKU KOGAKU, V31, P1125; Shirato M, 1974, J CHEM ENG JAP, V7, P229, DOI 10.1252/jcej.7.229; Zhang PY, 2007, BIORESOURCE TECHNOL, V98, P207, DOI 10.1016/j.biortech.2005.12.002	34	1	1	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0021-9592			J CHEM ENG JPN	J. Chem. Eng. Jpn.	DEC	2014	47	12					869	875		10.1252/jcej.14we150		7	Engineering, Chemical	Engineering	AX4RU	WOS:000346919900004		
J	Todaka, M; Oshima, T; Baba, Y				Todaka, Masaya; Oshima, Tatsuya; Baba, Yoshinari			Production and Characterization of Hydrophilic Heme Iron Preparation from Fish Blood	JOURNAL OF CHEMICAL ENGINEERING OF JAPAN			English	Article						Heme Iron Preparation; Fish Blood; Peptide; Hydrocolloid; Solubility	HEMOGLOBIN HYDROLYSATE; SOLUBILITY; ABSORPTION; COMPLEXATION; DEFICIENCY; PH	Heme iron preparation (HIP) is a complex comprising heme iron and peptide fragments formed by enzymatic hydrolysis of hemoglobin. This complex was enriched by ultrafiltration and in heme-iron and is assumed to be water-soluble. In the present study, HIP was prepared using the blood of cultured yellowtail fish (fish-HIP) as a novel nutritional supplement. This method of preparation eliminated the need for mammalian sources. The optimal pH required for preparation of hydrophilic fish-HIP, with apparent water solubility similar to that prepared from bovine hemoglobin, was determined. An aqueous solution of fish-HIP was fractionated by centrifugation followed by filtration using membrane and ultra filters. Dynamic light scattering and ultraviolet-visible light spectroscopy demonstrated that fish-HIP was present in the hydrocolloidal form in aqueous media, with a particle size of 80-100 nm. This is the first report that demonstrated the hydrocolloidal nature of HIP. High-performance liquid chromatography (HPLC) and mass spectroscopy showed that the peptides in fish-HIP are more hydrophobic than those separated by ultra ulltration and have molecular weights ranging from 2,000 Da to 3,600 Da.	[Todaka, Masaya; Oshima, Tatsuya; Baba, Yoshinari] Miyazaki Univ, Fac Engn, Dept Appl Chem, Nishi Ku, Miyazaki 8892192, Japan	Oshima, T (reprint author), Miyazaki Univ, Fac Engn, Dept Appl Chem, Nishi Ku, 1-1 Gakuen Kibanadai, Miyazaki 8892192, Japan.	oshimat@cc.miyazaki-u.ac.jp			Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-leading Researchers (NEXT Program); Council for Science and Technology Policy (CSTP)	This research was funded by a Grant from the Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-leading Researchers (NEXT Program) initiated by the Council for Science and Technology Policy (CSTP).	Yokoyama T, 2004, J BIOL CHEM, V279, P28632, DOI 10.1074/jbc.M401740200; Uzel C, 1998, SEMIN HEMATOL, V35, P27; Lebrun F, 1998, J AGR FOOD CHEM, V46, P5017, DOI 10.1021/jf9805698; Inada A, 2013, INT J PHARMACEUT, V453, P587, DOI 10.1016/j.ijpharm.2013.05.058; Seligman PA, 2000, NUTR RES, V20, P1279, DOI 10.1016/S0271-5317(00)00215-3; TURNBULL A, 1962, J CLIN INVEST, V41, P1897, DOI 10.1172/JCI104646; Heurtault B, 2003, BIOMATERIALS, V24, P4283, DOI 10.1016/S0142-9612(03)00331-4; Leuner C, 2000, EUR J PHARM BIOPHARM, V50, P47, DOI 10.1016/S0939-6411(00)00076-X; Muller RH, 2001, ADV DRUG DELIVER REV, V47, P3, DOI 10.1016/S0169-409X(00)00118-6; Matsushita N, 2013, J AGR FOOD CHEM, V61, P5972, DOI 10.1021/jf4003297; Alleyne M, 2008, AM J MED, V121, P943, DOI 10.1016/j.amjmed.2008.07.012; Antonini E., 1971, Hemoglobin and Myoglobin in Their Reaction with Ligands, P98, Patent No. 4411915; Bjorn Rasmussen E., 1974, J CLIN INVEST, V53, P247; In MJ, 2003, BIOSCI BIOTECH BIOCH, V67, P365; Lebrun F, 1998, J MEMBRANE SCI, V146, P113, DOI 10.1016/S0376-7388(98)00087-8; Martinez-Navarrete N, 2002, FOOD RES INT, V35, P225, DOI 10.1016/S0963-9969(01)00189-2; Matsuyama M., 2006, BIOL STOCK ENHANCEME; Oshima T, 2011, KAGAKU KOGAKU RONBUN, V37, P51, DOI 10.1252/kakoronbunshu.37.51; Ovissipour M., 2009, International Aquatic Research, V1, P31; Pandey AV, 1999, ANAL BIOCHEM, V268, P159, DOI 10.1006/abio.1998.2997; Saito K., 1963, NIPPON SUISAN GAKKIS, V29, P1104; Vaghefi N, 2005, J NUTR BIOCHEM, V16, P347, DOI 10.1016/j.jnutbio.2005.01.003; Vaghefi N, 2002, J AGR FOOD CHEM, V50, P4969, DOI [10.1021/jf0109165, 10.1021/jf01090165]	23	0	0	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0021-9592			J CHEM ENG JPN	J. Chem. Eng. Jpn.	DEC	2014	47	12					893	899		10.1252/jcej.14we147		7	Engineering, Chemical	Engineering	AX4RU	WOS:000346919900007		
J	Furusawa, T; Kadota, Y; Matsuzuka, A; Kurayama, F; Bahadur, NM; Sato, M; Suzuki, N				Furusawa, Takeshi; Kadota, Yusaku; Matsuzuka, Aya; Kurayama, Fumio; Bahadur, Newaz Mohammed; Sato, Masahide; Suzuki, Noboru			Surface Modification of Silica Coated ZnO Nanoparticles with 3-Aminopropyltriethoxysilane by Microwave-Assisted Method and Its Effect on the Properties of Coated Samples	JOURNAL OF CHEMICAL ENGINEERING OF JAPAN			English	Article						ZnO Nanoparticles; Microwave Irradiation; SiO2 Coating; Silane Coupling Agent; Dispersion Property	ZINC-OXIDE NANOPARTICLES; PHOTOCATALYTIC ACTIVITY; IRRADIATION METHOD; OPTICAL-PROPERTIES; COUPLING AGENT; PARTICLES; TIO2; AMINOPROPYLTRIETHOXYSILANE; NANOCOMPOSITE	The present study investigates silica coated ZnO prepared by microwave-assisted sol-gel method from tetraethoxysilane (TEOS) and commercial ZnO nanoparticles, and further treated with 3-aminopropyltriethoxysilane (APTES) to change the surface characteristics. For the silica coating of ZnO nanoparticles in a batch type microwave apparatus, two kinds of TEOS/ZnO starting ratios (=0.3, 0.5) were used. The transmission electron microscope (TEM) images of coated samples with different TEOS/ZnO starting ratios suggested that uniform silica coating on the ZnO surface was observed for the coated sample with a TEOS/ZnO ratio of 0.5; whereas, the ZnO surface was partly exposed on the sample with a TEOS/ ZnO ratio of 0.3. When these silica coated ZnO nanoparticles were used as starting materials for APTES treatment, it was revealed that 5 wt% (=APTES/silica coated ZnO) of APTES loading was enough to change the dispersion property of the sample with a TEOS/ZnO ratio of 0.5 in the organic solvent/water system. On the contrary, a higher APTES loading amount (10 wt%) was needed for the sample with a TEOS/ZnO ratio of 0.3 to observe the same phenomenon. The results of TEM observation, Fourier Transform Infrared (FT-IR) analysis, and Zeta potentials for the coated samples supported the results of dispersion tests in the organic solvent/water system. Photo-catalytic activities of the samples with a TEOS/ZnO ratio of 0.5 kept at low level (less than 5% compared to bare ZnO) with increasing APTES loading amounts. In contrast, those of the samples with a TEOS/ZnO ratio of 0.3 were reduced with increasing APTES loading amounts.	[Furusawa, Takeshi; Kadota, Yusaku; Matsuzuka, Aya; Sato, Masahide; Suzuki, Noboru] Utsunomiya Univ, Grad Sch Engn, Dept Adv Interdisciplinary Sci, Utsunomiya, Tochigi 3218585, Japan; [Furusawa, Takeshi; Kurayama, Fumio; Suzuki, Noboru] Utsunomiya Univ, Ctr Opt Res & Educ, Utsunomiya, Tochigi 3218585, Japan; [Bahadur, Newaz Mohammed] Utsunomiya Univ, Venture Business Lab, Utsunomiya, Tochigi 3218585, Japan	Furusawa, T (reprint author), Utsunomiya Univ, Grad Sch Engn, Dept Adv Interdisciplinary Sci, 7-1-2 Yoto, Utsunomiya, Tochigi 3218585, Japan.	furusawa@cc.utsunomiya-u.ac.jp					Rahman IA, 2009, CERAM INT, V35, P1883, DOI 10.1016/j.ceramint.2008.10.028; Schmidtke K, 2010, COLLOID POLYM SCI, V288, P333, DOI 10.1007/s00396-009-2148-3; Hong RY, 2006, POWDER TECHNOL, V163, P160, DOI 10.1016/j.powtec.2006.01.015; Wang JF, 2010, COLLOID POLYM SCI, V288, P1705, DOI 10.1007/s00396-010-2313-8; Wang RH, 2005, INORG CHEM, V44, P3926, DOI 10.1021/ic0503176; Moon JH, 1996, LANGMUIR, V12, P4621, DOI 10.1021/la9604339; Ukaji E, 2007, APPL SURF SCI, V254, P563, DOI 10.1016/j.apsusc.2007.06.061; Becheri A, 2008, J NANOPART RES, V10, P679, DOI 10.1007/s11051-007-9318-3; Cao Z, 2009, COLLOID SURFACE A, V340, P161, DOI 10.1016/j.colsurfa.2009.03.024; Hong RY, 2009, POWDER TECHNOL, V189, P426, DOI 10.1016/j.powtec.2008.07.004; Bahadur NM, 2011, J COLLOID INTERF SCI, V355, P312, DOI 10.1016/j.jcis.2010.12.016; Hong RY, 2007, POLYM ADVAN TECHNOL, V18, P901, DOI 10.1002/pat.926; Posthumus W, 2004, J COLLOID INTERF SCI, V269, P109, DOI 10.1016/j.jcis.2003.07.008; Bahadur NM, 2010, MATER RES BULL, V45, P1383, DOI 10.1016/j.materresbull.2010.06.048; Siddiquey IA, 2008, APPL SURF SCI, V255, P2419, DOI 10.1016/j.apsusc.2008.07.112; Tang EJ, 2006, APPL SURF SCI, V252, P5227, DOI 10.1016/j.apsusc.2005.08.004; Yoshida W, 2001, LANGMUIR, V17, P5882, DOI 10.1021/la001780s; Siddiquey IA, 2008, MATER RES BULL, V43, P3416, DOI 10.1016/j.materresbull.2008.02.002; Grasset F, 2003, J ALLOY COMPD, V360, P298, DOI 10.1016/S0925-8388(03)00371-2; Zhai J, 2010, APPL SURF SCI, V257, P393, DOI 10.1016/j.apsusc.2010.06.091; Mclaren A, 2009, J AM CHEM SOC, V131, P12540, DOI 10.1021/ja9052703; Siddiquey IA, 2007, MATER CHEM PHYS, V105, P162, DOI [10.1016/j.matchemphys.2007.04.017, 10.1016/j.matchemphys.2007.04-017]; Bahadur NM, 2011, COLLOID SURFACE A, V392, P137, DOI 10.1016/j.colsurfa.2011.09.046; Cao Z, 2011, APPL SURF SCI, V257, P4151, DOI 10.1016/j.apsusc.2010.11.188; Fuji M, 1999, COLLOID SURFACE A, V154, P13, DOI 10.1016/S0927-7757(98)00905-4; Furusawa T., 2007, J JPN SOC COLOUR MAT, V80, P369; Furusawa T, 2008, MATER RES BULL, V43, P946, DOI 10.1016/j.materresbull.2007.04.031; Li F, 2009, MATER RES BULL, V44, P437, DOI 10.1016/j.materresbull.2008.04.024; Siddiquey IA, 2012, ULTRASON SONOCHEM, V19, P750, DOI 10.1016/j.ultsonch.2011.12.011; Smijs Threes G, 2011, Nanotechnol Sci Appl, V4, P95, DOI 10.2147/NSA.S19419; Turkoglu M., 1997, International Journal of Cosmetic Science, V19, P193; Wang HZ, 2002, J AM CERAM SOC, V85, P1937; Wang JF, 2009, J AM CERAM SOC, V92, P2083, DOI 10.1111/j.1551-2916.2009.03142.x	33	0	0	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0021-9592			J CHEM ENG JPN	J. Chem. Eng. Jpn.	DEC	2014	47	12					900	907		10.1252/jcej.14we164		8	Engineering, Chemical	Engineering	AX4RU	WOS:000346919900008		
J	Wakabayashi, N; Taguchi, M; Funazukuri, T				Wakabayashi, Natsumi; Taguchi, Minori; Funazukuri, Toshitaka			Hydrothermal Conversion of Poly(ethylene naphthalate) to Naphthalene Dicarboxylic Acid and Ethylene Glycol in the Presence of Trimethylamine	JOURNAL OF CHEMICAL ENGINEERING OF JAPAN			English	Article						Aqueous; Depolymerization; Hydrothermal; Poly(ethylene naphthalate); Rate; Trimethylamine	AQUEOUS AMMONIA SOLUTION; SUPERCRITICAL METHANOL; POLYETHYLENE TEREPHTHALATE; HIGH-TEMPERATURE; POLY(ETHYLENE-TEREPHTHALATE); DEPOLYMERIZATION; RECOVERY; WATER; POLYCARBONATE; DECOMPOSITION	Poly(ethylene naphthalate) (PEN) pellets were converted to monomers (naphthalene dicarboxylic acid (NDC) and ethylene glycol (EG)) in an aqueous amine solution under hydrothermal conditions using a small semi-batch reactor. Three amines (methylamine, dimethylamine, and trimethylamine) were evaluated as reactants for depolymerization of PEN and compared with ammonia. The total yield of both monomers (NDC + EG) on the basis of the carbon mass of the initial PEN pellets, at 493 K and 5.0 MPa, for a reaction time of 50 min, using an amine concentration of 0.6 mol/kg was highest with trimethylamine (97.2%) followed by methylamine (86.6%) and dimethylamine (89.8%) in succession. The differences in the total yields resulted primarily from the differences in the NDC yields, and were affected by the amine species, although the EG yield was similar with all amines. The yields were higher than 95% of the theoretical value with all evaluated amines. The difference in the yields may be affected by the stabilities of the intermediate products with the primary and secondary amines in the aqueous solutions. The reaction rates with respect to the unreacted mass of PEN were represented by the surface reaction model, i.e., 2/3rd order reaction kinetics, as previously observed for poly(ethylene terephthalate) in aqueous solutions of ammonia and amine at low concentrations. The apparent rate constant from the surface reaction model was proportional to the amine concentration.	[Wakabayashi, Natsumi; Taguchi, Minori; Funazukuri, Toshitaka] Chuo Univ, Dept Appl Chem, Bunkyo Ku, Tokyo 1128551, Japan	Funazukuri, T (reprint author), Chuo Univ, Dept Appl Chem, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	tfunazo@kc.chuo-u.ac.jp			Ministry of Education, Sports, Culture, Science and Technology of Japan [23651075]; Japan Society for the Promotion of Science and Technology through the A-step grant	The authors are grateful to the Ministry of Education, Sports, Culture, Science and Technology of Japan for financial support through Grant-in-Aid No. 23651075 and to the Japan Society for the Promotion of Science and Technology through the A-step grant.	Paszun D, 1997, IND ENG CHEM RES, V36, P1373, DOI 10.1021/ie960563c; Hodge P, 2000, J MATER CHEM, V10, P1533, DOI 10.1039/b002786n; Kim BK, 2001, J APPL POLYM SCI, V81, P2102, DOI 10.1002/app.1645.abs; Yagihashi M, 2010, IND ENG CHEM RES, V49, P1247, DOI 10.1021/ie9008925; Sato O, 2006, CATAL TODAY, V111, P297, DOI 10.1016/j.cattod.2005.10.040; Adschiri T, 1997, KAGAKU KOGAKU RONBUN, V23, P505; Arai R, 2010, CHEM ENG SCI, V65, P36, DOI 10.1016/j.ces.2009.03.023; Goto M, 2002, AICHE J, V48, P136, DOI 10.1002/aic.690480114; Hatakeyama K, 2014, J MATER CYCLES WASTE, V16, P124, DOI 10.1007/s10163-013-0151-8; JSME (Japan Society of Mechanical Engineers), 1999, STEAM TABL BAS IAPWS; Sako T, 1997, J CHEM ENG JPN, V30, P342, DOI 10.1252/jcej.30.342; Sako T., 1997, JASCO REPORT SUPERCR, V1, P19; Sato O, 2005, FLUID PHASE EQUILIBR, V228, P523, DOI 10.1016/j.fluid.2004.08.001; Wakabayashi N, 2012, IND ENG CHEM RES, V51, P5699, DOI 10.1021/ie202885u; Yamaye M, 2006, POLYM DEGRAD STABIL, V91, P2014, DOI 10.1016/j.polymdegradstab.2006.02.005; Zenda K, 2008, J CHEM TECHNOL BIOT, V83, P1381, DOI 10.1002/jctb.1951	16	0	0	SOC CHEMICAL ENG JAPAN	BUNKYO KU TOKYO	KYORITSU BUILDING 4-16-19 KOHINATA, BUNKYO KU TOKYO, 112, JAPAN	0021-9592			J CHEM ENG JPN	J. Chem. Eng. Jpn.	DEC	2014	47	12					908	913		10.1252/jcej.14we065		6	Engineering, Chemical	Engineering	AX4RU	WOS:000346919900009		
J	Nio-Kobayashi, J; Boswell, L; Amano, M; Iwanaga, T; Duncan, WC				Nio-Kobayashi, Junko; Boswell, Lyndsey; Amano, Maho; Iwanaga, Toshihiko; Duncan, W. Colin			The Loss of Luteal Progesterone Production in Women Is Associated With a Galectin Switch via alpha 2,6-Sialylation of Glycoconjugates	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							CORPUS-LUTEUM; DEATH RECEPTOR; APOPTOSIS; BINDING; RECOGNITION; LUTEOLYSIS; EXPRESSION; LOCALIZATION; SIALYLATION; PREGNANCY	Context: Luteal progesterone is fundamental for reproduction, but the molecular regulation of the corpus luteum (CL) in women remains unclear. Galectin-1 and galectin-3 bind to the sugar chains on cells to control key biological processes including cell function and fate. Methods: The expression and localization of LGALS1 and LGALS3 were analyzed by quantitative PCR and histochemical analysis, with special reference to alpha 2,6-sialylation of glycoconjugates in carefully dated human CL collected across the menstrual cycle and after exposure to human chorionic gonadotrophin (hCG) in vivo. The effects of hCG and prostaglandin E-2 on the expression of galectins and an alpha 2,6-sialyltransferase 1 (ST6GAL1) in granulosa lutein cells were analyzed in vitro. Results: Galectin-1 was predominantly localized to healthy granulosa lutein cells and galectin-3 was localized to macrophages and regressing granulosa lutein cells. Acute exposure to luteotrophic hormones (hCG and prostaglandin E2) up-regulated LGALS1 expression (P < .001). ST6GAL1, which catalyzes alpha 2,6-sialylation to block galectin-1 binding, increased during luteolysis (P < .05) as did LGALS3 (P < .05). Luteotrophic hormones reduced ST6GAL1 and LGALS3 in vivo (P < .05) and in vitro (P < .001). There was an inverse correlation between the expression of ST6GAL1 and HSD3B1 (P < .01) and a distinct cellular relationship among alpha 2,6-sialylation, 3 beta-hydroxysteroid dehydrogenase, and galectin expression. Conclusions: Galectin-1 is a luteotrophic factor whose binding is inhibited by alpha 2,6-sialylation in the human CL during luteolysis. ST6GAL1 and galectin-3 expression is increased during luteolysis and associated with a loss of progesterone synthesis. Luteotrophic hormones differentially regulate galectin-1 and galectin-3/alpha 2,6-sialylation in granulosa lutein cells, suggesting a novel galectin switch regulated by luteotrophic stimuli during luteolysis and luteal rescue.	[Nio-Kobayashi, Junko; Boswell, Lyndsey; Duncan, W. Colin] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Reprod Hlth, Edinburgh EH16 4TJ, Midlothian, Scotland; [Amano, Maho] Hokkaido Univ, Creat Res Inst, Sapporo, Hokkaido 0010021, Japan; [Nio-Kobayashi, Junko; Iwanaga, Toshihiko] Hokkaido Univ, Grad Sch Med, Lab Histol & Cytol, Sapporo, Hokkaido 0608638, Japan	Nio-Kobayashi, J (reprint author), Hokkaido Univ, Grad Sch Med, Lab Histol & Cytol, Kita Ku, Kita 15 Nishi 7, Sapporo, Hokkaido 0608638, Japan.	niojun@med.hokudai.ac.jp			Cunningham Trust; Japan Society for the Promotion of Science; Suntory Foundation for Life Sciences	This work was supported by the Cunningham Trust (to W.C.D.) and the Postdoctoral Fellowship for Research Abroad and Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science and the Suntory Foundation for Life Sciences (to J.N.-K.).	Kim M, 2008, ACTA HISTOCHEM, V110, P473, DOI 10.1016/j.acthis.2008.02.004; Dickinson RE, 2008, ENDOCRINOLOGY, V149, P5024, DOI 10.1210/en.2008-0204; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Duncan WC, 1998, HUM REPROD, V13, P2435, DOI 10.1093/humrep/13.9.2435; Nio-Kobayashi J, 2010, J HISTOCHEM CYTOCHEM, V58, P741, DOI 10.1369/jhc.2010.956227; Kopitz J, 1998, J BIOL CHEM, V273, P11205, DOI 10.1074/jbc.273.18.11205; Nangia-Makker P, 2007, J BIOENERG BIOMEMBR, V39, P79, DOI 10.1007/s10863-006-9063-9; Nio J, 2007, J HISTOCHEM CYTOCHEM, V55, P423, DOI 10.1369/jhc.6A7053.2007; Liu ZY, 2011, J BIOL CHEM, V286, P39654, DOI 10.1074/jbc.M111.276063; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Arredondo F, 2006, SEMIN REPROD MED, V24, P33, DOI 10.1055/s-2006-931799; Duncan W. C., 2009, Animal Reproduction, V6, P34; Hashiba K, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119057; HIRABAYASHI J, 1993, GLYCOBIOLOGY, V3, P297, DOI 10.1093/glycob/3.4.297; Horlacher T, 2010, CHEMBIOCHEM, V11, P1563, DOI 10.1002/cbic.201000020; Iwaki J, 2011, BBA-GEN SUBJECTS, V1810, P643, DOI 10.1016/j.bbagen.2011.04.001; JONES GS, 1991, CURR OPIN OBSTET GYN, V3, P641; Nio J, 2012, REPRODUCTION, V144, P617; Nio J, 2006, HISTOCHEM CELL BIOL, V126, P45, DOI 10.1007/s00418-005-0142-5; Nio-Kobayashi J, 2009, J HISTOCHEM CYTOCHEM, V57, P41, DOI 10.1369/jhc.2008.952317	22	3	3	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	DEC	2014	99	12					4616	4624		10.1210/jc.2014-2716		9	Endocrinology & Metabolism	Endocrinology & Metabolism	AX1ZP	WOS:000346743300033		
J	Tanaka, S; Tanaka, S; Iimuro, S; Akanuma, Y; Ohashi, Y; Yamada, N; Araki, A; Ito, H; Sone, H				Tanaka, Shiro; Tanaka, Sachiko; Iimuro, Satoshi; Akanuma, Yasuo; Ohashi, Yasuo; Yamada, Nobuhiro; Araki, Atsushi; Ito, Hideki; Sone, Hirohito		Japan Diabet Complications Study G; Japanese Elderly Diabet Interventi	Body Mass Index and Mortality Among Japanese Patients With Type 2 Diabetes: Pooled Analysis of the Japan Diabetes Complications Study and the Japanese Elderly Diabetes Intervention Trial	JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM			English	Article							RISK; OBESITY; ASSOCIATIONS; ADULTS; DEATH	Context: Previous studies on the association between body mass index (BMI) and mortality in diabetes do not necessarily provide a comprehensive view in terms of the global population because of the exclusion of individuals with a BMI less than 18.5 kg/m(2). Objective: The objective of the study was to examine the association between BMI and mortality. Design, Setting, and Participants: We analyzed pooled data from 2 cohorts of 2620 Japanese patients with type 2 diabetes followed up for 6.3 years. Patients with a history of cardiovascular disease or cancer were excluded. Main Outcome Measure: The end point was all-cause mortality. Hazard ratios were estimated by Cox regression adjusted for age, smoking, leisure-time physical activity, and other confounders. Results: An analysis using BMI categories of 14.4-18.5 (5.2%), 18.5-22.4 (37.3%), 22.5-24.9 (31.0%), and 25.0-37.5 kg/m(2) (26.6%) revealed no significant trend in mortality among patients with a BMI of 18.5 kg/m(2) or greater (trend P = .69). In contrast, the hazard ratio of patients with a BMI less than 18.5 kg/m(2) vs 22.5-24.9 kg/m(2) was 2.58 (95% confidence interval 1.38-4.84; P = .01). Exclusion of deaths in the first 4 years of follow-up decreased the hazard ratio only slightly. Conclusions: The lowest mortality rate was observed among patients with a BMI of 18.5-24.9 kg/m2, and obesity hadnobenefits regarding mortality. Further research is needed in lean patients, especially among aging populations in East Asia.	[Tanaka, Shiro; Tanaka, Sachiko] Kyoto Univ, Dept Pharmacoepidemiol, Grad Sch Med & Publ Hlth, Sakyo Ku, Kyoto 6068507, Japan; [Iimuro, Satoshi; Ohashi, Yasuo] Univ Tokyo, Dept Biostat, Sch Publ Hlth, Bunkyo Ku, Tokyo 1130033, Japan; [Akanuma, Yasuo] Asahi Life Fdn, Inst Adult Dis, Tokyo 1000005, Japan; [Yamada, Nobuhiro] Univ Tsukuba, Inst Clin Med, Dept Internal Med, Tsukuba, Ibaraki 3058577, Japan; [Araki, Atsushi; Ito, Hideki] Tokyo Metropolitan Geriatr Hosp, Tokyo 1730015, Japan; [Sone, Hirohito] Niigata Univ, Fac Med, Dept Hematol Endocrinol & Metab, Niigata 9518510, Japan	Sone, H (reprint author), Niigata Univ, Fac Med, Dept Hematol Endocrinol & Metab, 1-754 Asahimachi, Niigata 9518510, Japan.	sone@med.niigata-u.ac.jp			Ministry of Health, Labor, and Welfare, Japan	This work was supported by the Ministry of Health, Labor, and Welfare, Japan.	American Diabetes Association, 2010, DIABETES CARE S1, V33, pS11, DOI DOI 10.2337/DC10-S011; Tseng CH, 2013, ATHEROSCLEROSIS, V226, P186, DOI 10.1016/j.atherosclerosis.2012.09.004; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Lear SA, 2007, AM J CLIN NUTR, V86, P353; Logue J, 2013, DIABETES CARE, V36, P887, DOI 10.2337/dc12-0944; McNeely MJ, 2012, DIABETES CARE, V35, P296, DOI 10.2337/dc11-1193; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Sone H, 2003, LANCET, V361, P85, DOI 10.1016/S0140-6736(03)12151-4; Tanaka S, 2013, DIABETES CARE, V36, P1193, DOI 10.2337/dc12-0958; Araki A, 2012, GERIATR GERONTOL INT, V12, P7, DOI 10.1111/j.1447-0594.2011.00808.x; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Friedman GD, 2014, AM J EPIDEMIOL, V180, P233, DOI 10.1093/aje/kwu121; Ministry of Health Labour and Welfare, NAT HLTH NUTR SURV J; Ma Seung Hyun, 2012, J Prev Med Public Health, V45, P394, DOI 10.3961/jpmph.2012.45.6.394; Sone H, 2010, DIABETOLOGIA, V53, P419, DOI 10.1007/s00125-009-1622-2; Tanaka S, 2014, INT J EPIDEMIOL, V43, P1054, DOI 10.1093/ije/dyt057; The Japan Diabetes Society, 2010, EV BAS PRACT GUID TR; Tobias DK, 2014, NEW ENGL J MED, V370, P233, DOI 10.1056/NEJMoa1304501; Yano Y, 2013, DIABETES CARE, V36, P1186, DOI 10.2337/dc12-1736	19	2	2	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0021-972X	1945-7197		J CLIN ENDOCR METAB	J. Clin. Endocrinol. Metab.	DEC	2014	99	12					E2692	E2696		10.1210/jc.2014-1855		5	Endocrinology & Metabolism	Endocrinology & Metabolism	AX1ZP	WOS:000346743300079		
J	Onishi, A; Furukawa, TA				Onishi, Akira; Furukawa, Toshi A.			Publication bias is underreported in systematic reviews published in high-impact-factor journals: metaepidemiologic study	JOURNAL OF CLINICAL EPIDEMIOLOGY			English	Review						Publication bias; Small-study effects; Funnel plot symmetry; Systematic review; Meta-analysis; Impact factor	RANDOMIZED CONTROLLED-TRIALS; METHODOLOGICAL QUALITY; MEASUREMENT TOOL; METAANALYSES; STATEMENT; ASYMMETRY; AMSTAR	Objectives: To examine how often a significant publication bias (PB) existed when the assessment of PB was not reported in systematic reviews. Study Design and Setting: All systematic reviews with meta-analyses of interventions and risk/prognostic factors published in the general medical journals with the top 10 impact factors in 2011 and 2012 were included. The results regarding PB were extracted. When the assessment of PB was not reported, we examined the presence of PB using the Egger test and contour-enhanced funnel plot and the impact of unreported PB by regression-based method. Results: Among all the identified 116 reviews, the assessment of PB was not reported in 36 reviews (31.0%), particularly in reviews without a comprehensive literature search. Of these 56 reviews, seven (19.4%) were found to have a significant PB. The original pooled results may have been overestimated by a median of 50.9% if corrected for PB. Among the 28 reviews with PB including both reviews that did or did not report the assessment of PB, seven reviews (25.0%) did not report the presence of PB. Conclusion: Significant PB was underreported in systematic reviews published in high-impact-factor journals (eg, 19.4% of those that did not report assessment of PB had significant PB). Readers of systematic reviews should not assume that PB does not exist when not reported whereas researchers should report the results of assessments for PB. (C) 2014 Elsevier Inc. All rights reserved.	[Onishi, Akira; Furukawa, Toshi A.] Kyoto Univ, Dept Hlth Promot & Human Behav, Grad Sch Med, Sch Publ Hlth,Sakyo Ku, Kyoto 6068501, Japan	Onishi, A (reprint author), Kyoto Univ, Dept Hlth Promot & Human Behav, Grad Sch Med, Sch Publ Hlth,Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	aonishi@med.kobe-u.ac.jp			Asahi Kasei; Eli Lilly; GlaxoSmithKline; Mochida; MSD; Otsuka; Pfizer; Shionogi; Tanabe-Mitsubishi; Japanese Ministry of Education, Science, and Technology; Japanese Ministry of Health, Labor and Welfare; Japan Foundation for Neuroscience and Mental Health	T.A.F. has received honoraria for speaking at CME meetings sponsored by Asahi Kasei, Eli Lilly, GlaxoSmithKline, Mochida, MSD, Otsuka, Pfizer, Shionogi, and Tanabe-Mitsubishi. He is a diplomate of the Academy of Cognitive Therapy. He has received royalties from Igaku-Shoin, Seiwa-Shoten, and Nihon Bunka Kagaku-sha. He is on advisory board for Sekisui Chemicals and Takeda Science Foundation. The Japanese Ministry of Education, Science, and Technology; the Japanese Ministry of Health, Labor and Welfare; and the Japan Foundation for Neuroscience and Mental Health have funded his other research projects; no other relationships or activities that could appear to have influenced the submitted work.	Yank V, 2007, BRIT MED J, V335, P1202, DOI 10.1136/bmj.39376.447211.BE; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Sena ES, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000344; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Korevaar DA, 2011, LAB ANIM-UK, V45, P225, DOI 10.1258/la.2011.010121; Egger M, 1997, BRIT MED J, V315, P629; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Vavken P, 2011, J ORTHOP SCI, V16, P238, DOI 10.1007/s00776-011-0040-8; Pimouguet C, 2011, CAN MED ASSOC J, V183, pE115, DOI 10.1503/cmaj.091786; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Lee KP, 2002, JAMA-J AM MED ASSOC, V287, P2805, DOI 10.1001/jama.287.21.2805; Mavridis Dimitris, 2014, Evid Based Ment Health, V17, P11, DOI 10.1136/eb-2013-101700; Moher D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2535; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Souza João P, 2007, Reprod Health, V4, P3, DOI 10.1186/1742-4755-4-3; Sterne JAC, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4002; Sterne JAC, 2001, SYSTEMATIC REV HLTH, P189, DOI DOI 10.1002/9780470693926.CH11; Sterne JAC, 2011, COCHRANE HDB SYSTEMA; Turner EH, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001189	23	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0895-4356	1878-5921		J CLIN EPIDEMIOL	J. Clin. Epidemiol.	DEC	2014	67	12					1320	1326		10.1016/j.jclinepi.2014.07.002		7	Health Care Sciences & Services; Public, Environmental & Occupational Health	Health Care Sciences & Services; Public, Environmental & Occupational Health	AX4DI	WOS:000346883700007		
J	Kasuya, A; Tokura, Y				Kasuya, Akira; Tokura, Yoshiki			Attempts to accelerate wound healing	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Review						Wound healing; Stem cell; Inflammation; TGF-beta	MESENCHYMAL STEM-CELLS; TGF-BETA; SKIN; EXPRESSION; MICE; FIBROBLASTS; PHENOTYPE; ULCERS; REPAIR; PROLIFERATION	Wound healing is a well-orchestrated process, where numerous factors are activated or inhibited in a sequence of steps. Immediately after the infliction of damage, the repair of wound stars. The initial step is an inflammatory change with activation of innate immunity, which is followed by proliferation phase, including fibroplasia, angiogenesis and re-epithelialization. Pathological impairment of wound healing process may lead to persistent ulceration as seen in diabetic patients. Various signaling pathways are involved in wound healing. TGF beta/Smad pathway is a representative and well known to participate in fibroplasia, however, its comprehensive effect on wound healing is controversial. Experimental and clinical remedies have been being tried to promote wound healing. Advancement of cell engineering allows us to use stem cells and living skin equivalents. (C) 2014 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Kasuya, Akira; Tokura, Yoshiki] Hamamatsu Univ Sch Med, Dept Dermatol, Hamamatsu, Shizuoka 4313192, Japan	Kasuya, A (reprint author), Hamamatsu Univ Sch Med, Dept Dermatol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	casuaki@hama-med.ac.jp					Ananta M, 2012, TISSUE ENG PT A, V18, P353, DOI [10.1089/ten.TEA.2011.0208, 10.1089/ten.tea.2011.0208]; Liu JQ, 2012, J DERMATOL SCI, V65, P38, DOI 10.1016/j.jdermsci.2011.09.012; Lamkanfi M, 2011, NAT REV IMMUNOL, V11, P213, DOI 10.1038/nri2936; Bosanquet DC, 2013, J DERMATOL SCI, V71, P115, DOI 10.1016/j.jdermsci.2013.04.008; Felder JM, 2012, PLAST RECONSTR SURG, V130, P145, DOI 10.1097/PRS.0b013e318254b1ea; Hirsiger S, 2012, MEDIAT INFLAMM, DOI 10.1155/2012/315941; Gallucci RM, 2000, FASEB J, V14, P2525, DOI 10.1096/fj.00-0073com; Straino S, 2008, J INVEST DERMATOL, V128, P1545, DOI 10.1038/sj.jid.5701212; Eming SA, 2007, AM J PATHOL, V170, P188, DOI 10.2353/ajpath.2007.060370; Ishida Y, 2006, J IMMUNOL, V176, P5598; Huang S, 2012, J DERMATOL SCI, V66, P29, DOI 10.1016/j.jdermsci.2012.02.002; Brancato SK, 2011, AM J PATHOL, V178, P19, DOI 10.1016/j.ajpath.2010.08.003; Ishida Y, 2004, J IMMUNOL, V172, P1848; Hasegawa M, 2013, J DERMATOL SCI, V70, P34, DOI 10.1016/j.jdermsci.2013.01.007; Greaves NS, 2013, J DERMATOL SCI, V72, P206, DOI 10.1016/j.jdermsci.2013.07.008; Mori R, 2002, FASEB J, V16, P963, DOI 10.1096/fj.01-0776com; Rivas-Santiago B, 2012, J DERMATOL SCI, V65, P19, DOI 10.1016/j.jdermsci.2011.09.013; Bellavia G, 2014, J DERMATOL SCI, V73, P3, DOI 10.1016/j.jdermsci.2013.08.007; Canady J, 2013, J DERMATOL SCI, V70, P151, DOI 10.1016/j.jdermsci.2013.03.005; Cheret J, 2014, J DERMATOL SCI, V74, P193, DOI 10.1016/j.jdermsci.2014.02.001; Ebaid H, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-31; Hsu CC, 2013, J DERMATOL SCI, V70, P196, DOI 10.1016/j.jdermsci.2013.03.007; Iwata Y, 2013, J DERMATOL SCI, V71, P122, DOI 10.1016/j.jdermsci.2013.04.006; Kann E, 2013, J DERMATOL SCI, V70, P130, DOI 10.1016/j.jdermsci.2013.01.004; Kim H, 2012, J DERMATOL SCI, V68, P149, DOI 10.1016/j.jdermsci.2012.09.013; Koh TJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001943; Lee CH, 2012, J DERMATOL SCI, V67, P173, DOI 10.1016/j.jdermsci.2012.06.004; Lee MJ, 2013, J DERMATOL SCI, V69, P95, DOI 10.1016/j.jdermsci.2012.11.009; Liang MR, 2014, J DERMATOL SCI, V76, P104, DOI 10.1016/j.jdermsci.2014.08.002; Matias MAT, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-39; Morhenn VB, 2013, J DERMATOL SCI, V72, P87, DOI 10.1016/j.jdermsci.2013.06.001; Renner R, 2012, J DERMATOL SCI, V67, P15, DOI 10.1016/j.jdermsci.2012.04.007; Samuel GH, 2012, J DERMATOL SCI, V67, P166, DOI 10.1016/j.jdermsci.2012.06.001; Song SH, 2012, J DERMATOL SCI, V66, P98, DOI 10.1016/j.jdermsci.2012.02.010; Suga H, 2014, J DERMATOL SCI, V73, P117, DOI 10.1016/j.jdermsci.2013.10.009; Ueda-Hayakawa I, 2013, J DERMATOL SCI, V69, P54, DOI 10.1016/j.jdermsci.2012.10.003; Webster J, 2014, COCHRANE DB SYST REV, V10, DOI DOI 10.1002/14651858.CD009261.PUB3; Yamaoka H, 2014, J DERMATOL SCI, V74, P204, DOI 10.1016/j.jdermsci.2014.03.002; Yang LJ, 2012, J DERMATOL SCI, V65, P50, DOI 10.1016/j.jdermsci.2011.10.008	39	2	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	DEC	2014	76	3					169	172		10.1016/j.jdermsci.2014.11.001		4	Dermatology	Dermatology	AX4DA	WOS:000346882900002		
J	Andoh, T; Kuraishi, Y				Andoh, Tsugunobu; Kuraishi, Yasushi			Antipruritic mechanisms of topical E6005, a phosphodiesterase 4 inhibitor: Inhibition of responses to proteinase-activated receptor 2 stimulation mediated by increase in intracellular cyclic AMP	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Article						cAMP; Itch; Phosphodiesterase; Proteinase-activated receptor 2; Pruritus; Scratch	ITCH-ASSOCIATED RESPONSE; ATOPY-LIKE DERMATITIS; LEUKOTRIENE B-4; SKIN-LESIONS; MAST-CELLS; MICE; INVOLVEMENT; AGENTS; PHOSPHORYLATION; 5-LIPOXYGENASE	Background: Phosphodiesterase 4 (PDE4), which catalyses the conversion of cyclic adenosine 3',5'-monophosphate (cAMP) to 5'-AMP, plays a critical role in the pathogenesis of inflammatory disorders. Pruritus is the main symptom of dermatitides, such as atopic dermatitis, and is very difficult to control. Recent studies have shown that the activation of proteinase-activated receptor 2 (PAR(2)) is involved in pruritus in dermatoses in humans and rodents. Objective: To investigate the inhibitory effect of E6005, a topically effective PDE4 inhibitor, on PAR(2)-associated itching in mice. Methods: Mice were given an intradermal injection of SLIGRL-NH2 (100 nmol/site), a PAR(2) agonist peptide, into the rostral part of the back. E6005 and 8-bromo-cAMP were applied topically and injected intradermally, respectively, to the same site. Scratching bouts were observed as an itch-related behavior, and firing activity of the cutaneous nerve was electrophysiologically recorded. Keratinocytes were isolated from the skin of neonatal mice and cultured for in vitro experiments. The concentrations of cAMP and leukotriene B-4 (LTB4) were measured by enzyme immunoassay. The distribution of PDE4 subtypes in the skin was investigated by immunostaining. Results: Topical E6005 and intradermal 8-bromo-cAMP significantly inhibited SLIGRL-NH2-induced scratching and cutaneous nerve firing. Topical E6005 increased cutaneous CAMP content. Topical E6005 and intradermal 8-bromo-cAMP inhibited cutaneous LTB4 production induced by SLIGRL-NH2, which has been shown to elicit LTB4-mediated scratching. E6005 and 8-bromo-cAMP inhibited SLIGRL-NH2-induced LTB4 production in the cultured murine keratinocytes also. PDE4 subtypes were mainly expressed in keratinocytes and mast cells in the skin. Conclusions: The results suggest that topical E6005 treatment inhibits PAR(2)-associated itching. Inhibition of LTB4 production mediated by an increase in cAMP may be partly involved in the antipruritic action of E6005. (C) 2014 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Andoh, Tsugunobu; Kuraishi, Yasushi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Appl Pharmacol, Toyama 9300194, Japan	Kuraishi, Y (reprint author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Appl Pharmacol, 2630 Sugitani, Toyama 9301094, Japan.	kuraisiy@pha.u-toyama.ac.jp			Eisai Co. Ltd. (Tokyo, Japan); Health, Labour and Welfare Ministry, Japan [H24-007, H26-007]	This study was supported in part by Eisai Co. Ltd. (Tokyo, Japan) and Grants for Health Science from the Health, Labour and Welfare Ministry, Japan [H24-007, H26-007].	Andoh T, 2004, J INVEST DERMATOL, V123, P196, DOI 10.1111/j.0022-202X.2004.22704.x; Andoh T, 2001, J INVEST DERMATOL, V117, P1621, DOI 10.1046/j.0022-202x.2001.01585.x; Andoh T, 2014, EXP DERMATOL, V23, P359, DOI 10.1111/exd.12377; Andoh T, 1998, EUR J PHARMACOL, V353, P93, DOI 10.1016/S0014-2999(98)00440-3; Andoh T, 2011, EXP DERMATOL, V20, P894, DOI 10.1111/j.1600-0625.2011.01346.x; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Steinhoff M, 2000, NAT MED, V6, P151; Stander S, 2008, EXP DERMATOL, V17, P161, DOI 10.1111/j.1600-0625.2007.00664.x; Tsujii K, 2009, J PHARMACOL SCI, V109, P388, DOI 10.1254/jphs.08332FP; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Baeumer Wolfgang, 2007, Inflammation & Allergy Drug Targets, V6, P17, DOI 10.2174/187152807780077318; Akama T, 2009, BIOORG MED CHEM LETT, V19, P2129, DOI 10.1016/j.bmcl.2009.03.007; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; Jin SLC, 2002, P NATL ACAD SCI USA, V99, P7628, DOI 10.1073/pnas.122041599; Furue M, 2014, J DERMATOL, V41, P577, DOI 10.1111/1346-8138.12534; Jin SLC, 2005, J IMMUNOL, V175, P1523; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Lakics V, 2010, NEUROPHARMACOLOGY, V59, P367, DOI 10.1016/j.neuropharm.2010.05.004; Ishii N, 2013, J PHARMACOL EXP THER, V346, P105, DOI 10.1124/jpet.113.205542; Barreto EO, 2004, INT IMMUNOPHARMACOL, V4, P755, DOI 10.1016/j.intimp.2004.03.001; Doherty AM, 1999, CURR OPIN CHEM BIOL, V3, P466, DOI 10.1016/S1367-5931(99)80068-4; Hanifin JM, 1996, J INVEST DERMATOL, V107, P51, DOI 10.1111/1523-1747.ep12297888; Harada D, 2009, INT IMMUNOPHARMACOL, V9, P55, DOI 10.1016/j.intimp.2008.09.011; Hoppmann J, 2005, J PHARM PHARMACOL, V57, P1609, DOI 10.1211/jpp.57.12.0011; Jin S-L Catherine, 2012, Chang Gung Med J, V35, P197; Jin SLC, 2010, J ALLERGY CLIN IMMUN, V126, P1252, DOI 10.1016/j.jaci.2010.08.014; Luo M, 2004, J BIOL CHEM, V279, P41512, DOI 10.1074/jbc.M312568200; Mccoy KL, 2010, MOL PHARMACOL, V77, P1005, DOI 10.1124/mol.109.062018; Moormann C, 2006, J INVEST DERMATOL, V126, P746, DOI 10.1038/sj.jid.5700169; Sriwai W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066743; Torphy TJ, 1998, AM J RESP CRIT CARE, V157, P351; Tsujii K, 2008, J PHARMACOL SCI, V108, P385, DOI 10.1254/jphs.08200SC; Ye YM, 2008, J IMMUNOL, V181, P3515; Zhu Y, 2009, INT IMMUNOPHARMACOL, V9, P1332, DOI 10.1016/j.intimp.2009.08.006	34	4	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	DEC	2014	76	3					206	213		10.1016/j.jdermsci.2014.10.005		8	Dermatology	Dermatology	AX4DA	WOS:000346882900007		
J	Nakajima, R; Takeda, S				Nakajima, Ryota; Takeda, Shizu			Efficient fabrication of epidermal cell sheets using gamma-secretase inhibitor	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Article						Stratified epithelium; Keratinocytes; Epidermal cell sheet; Feeder free; Cell culture process; gamma-Secretase inhibitor	ENDOSCOPIC SUBMUCOSAL DISSECTION; ESOPHAGEAL STRICTURE; FEEDER CELLS; DIFFERENTIATION; SKIN; KERATINOCYTES; SURFACE; MODEL; NOTCH; TRANSPLANTATION	Background: Epidermal cell sheets have been utilized for regeneration of skin when skin defects occur and prevention of esophageal stricture after endoscopic submucosal dissection. To reduce the cost of cultivation, a novel culture method to shorten a culture process needs to be developed. Objectives: To shorten a culture process of epidermal cell sheets, we developed a novel culture method to accelerate the fabrication of epidermal cell sheets using gamma-secretase inhibitor. Methods: Normal human epidermal keratinocytes (NHEKs) were cultured using gamma-secretase inhibitor, DAPT, during expansion of the cells to confluence and culture without DAPT during stratification. The cell growth, quantitative gene expression of stem/progenitor or differentiation markers, and protein expression of these markers were analyzed to verify the effectiveness of the novel method. Results: The proliferation of NHEKs on cell-culture inserts was promoted using DAPT. However, NHEKs were not stratified completely in the presence of DAFT. In contrast, NHEKs cultured using DAPT were stratified and differentiated by eliminating the inhibitor after the cells reached confluence. Real-time PCR analyses showed that the gene expressions of putative epithelial stem/progenitor cell markers and epidermis differentiation markers in the cell sheets fabricated using this novel method were significantly higher than those in the cell sheets fabricated without DAPT. Histological and immunofluorescence analyses revealed that it was possible to fabricate well-differentiated epidermal cell sheets efficiently by the novel culture method. The culture period was shortened to 67% of the time required for the control group. In feeder-free conditions, stratified epidermal cell sheets were also fabricated using DAFT. Conclusions: The novel culture method using gamma-secretase inhibitor, DAPT, was found to be effective for fabricating epidermal cell sheets. (C) 2014 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.	[Nakajima, Ryota; Takeda, Shizu] Hitachi Ltd, Cent Res Lab, Saitama 3500395, Japan	Takeda, S (reprint author), Hitachi Ltd, Cent Res Lab, 2520 Hatoyama, Saitama 3500395, Japan.	iyota.nakajima.kd@hitachi.com; shizu.takeda.me@hitachi.com					Doles J, 2012, GENE DEV, V26, P2144, DOI 10.1101/gad.192294.112; Kulukian A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0016; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; Murakami D, 2006, BIOMATERIALS, V27, P5518, DOI 10.1016/j.biomaterials.2006.05.042; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Mason C, 2010, REGEN MED, V5, P307, DOI [10.2217/rme.10.37, 10.2217/RME.10.37]; Oie Y, 2010, BRIT J OPHTHALMOL, V94, P1244, DOI 10.1136/bjo.2009.175042; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Takagi R, 2011, PATHOBIOLOGY, V78, P311, DOI 10.1159/000322575; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Ohki T, 2006, GUT, V55, P1704, DOI 10.1136/gut.2005.088518; Ohki T, 2012, GASTROENTEROLOGY, V143, P582, DOI 10.1053/j.gastro.2012.04.050; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Okuyama R, 2007, ONCOGENE, V26, P4478, DOI 10.1038/sj.onc.1210235; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Kobayashi T, 2013, BIOMATERIALS, V34, P9010, DOI 10.1016/j.biomaterials.2013.07.065; GALLICO GG, 1989, PLAST RECONSTR SURG, V84, P1; Kanai N, 2012, GASTROINTEST ENDOSC, V76, P873, DOI 10.1016/j.gie.2012.06.017; Kondo M, 2013, BIOMATERIALS, V34, P121, DOI 10.1016/j.biomaterials.2012.09.036; Kopan R, 2010, CURR TOP DEV BIOL, V92, P1; Nakajima R, 2013, J TISSUE EN IN PRESS; Nakajima R, 2014, EXP EYE RES, V118, P53, DOI 10.1016/j.exer.2013.10.019; Nakajima R, 2012, J TISSUE EN IN PRESS; Nakajima R, 2013, EXP EYE RES, V116, P434, DOI 10.1016/j.exer.2013.07.008; PHILLIPS TJ, 1989, J AM ACAD DERMATOL, V21, P191, DOI 10.1016/S0190-9622(89)70160-2; PRUNIERAS M, 1983, J INVEST DERMATOL, V81, pS28, DOI 10.1111/1523-1747.ep12540324; Reznikova TV, 2009, J INVEST DERMATOL, V129, P155, DOI 10.1038/jid.2008.207	30	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	DEC	2014	76	3					246	254		10.1016/j.jdermsci.2014.09.006		9	Dermatology	Dermatology	AX4DA	WOS:000346882900012		
J	Ishii, N; Wakita, H; Shirato, M				Ishii, Naoto; Wakita, Hisashi; Shirato, Manabu			Effect of the phosphodiesterase 4 inhibitor E6005 on nerve growth factor elevation in irritated skin of NC/Nga mice	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Letter							ATOPIC-DERMATITIS MODEL; KERATINOCYTES; MOUSE		[Ishii, Naoto; Wakita, Hisashi; Shirato, Manabu] Eisai & Co Ltd, Tsukuba Res Labs, Tsukuba, Ibaraki 3002635, Japan	Shirato, M (reprint author), Eisai & Co Ltd, Tsukuba Res Labs, 5-1-3 Tokodai, Tsukuba, Ibaraki 3002635, Japan.	m-shirato@hhc.eisai.co.jp					Raap U, 2010, GIORN ITAL DERMAT V, V145, P205; Rukwied RR, 2013, J INVEST DERMATOL, V133, P268, DOI 10.1038/jid.2012.242; Ikezawa Z, 2010, ALLERGY ASTHMA IMMUN, V2, P235, DOI 10.4168/aair.2010.2.4.235; Schafer PH, 2010, BRIT J PHARMACOL, V159, P842, DOI 10.1111/j.1476-5381.2009.00559.x; Furue M, 2014, J DERMATOL, V41, P577, DOI 10.1111/1346-8138.12534; Ishii N, 2013, J PHARMACOL EXP THER, V346, P105, DOI 10.1124/jpet.113.205542; Chujor CSN, 1998, J INVEST DERMATOL, V110, P287, DOI 10.1046/j.1523-1747.1998.00114.x; Roggenkamp D, 2012, J INVEST DERMATOL, V132, P1892, DOI 10.1038/jid.2012.44; Takano N, 2005, J PHARMACOL SCI, V99, P277, DOI 10.1254/jphs.FP0050564; Tominaga M, 2014, J DERMATOL, V41, P205, DOI 10.1111/1346-8138.12317	10	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	DEC	2014	76	3					263	264		10.1016/j.jdermsci.2014.09.010		2	Dermatology	Dermatology	AX4DA	WOS:000346882900016		
J	Nakagawa, Y; Egawaa, G; Miyachi, Y; Kabashima, K				Nakagawa, Yujin; Egawaa, Gyohei; Miyachi, Yoshiki; Kabashima, Kenji			A line of human keratin 5-Cre transgenic mice harbor a risk of ubiquitous Cre-recombination	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Letter							SKIN; KNOCKOUT		[Nakagawa, Yujin; Egawaa, Gyohei; Miyachi, Yoshiki; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan; [Kabashima, Kenji] Japan Sci & Technol Agcy, PRESTO, Chiyoda Ku, Tokyo 1020075, Japan	Egawaa, G (reprint author), Kyoto Univ, Grad Sch Med, Dept Dermatol, 54 Shogoin Kawahara, Kyoto 6068507, Japan.	gyohei@kuhp.kyoto-u.ac.jp					Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816f1; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Tarutani M, 2013, J DERMATOL SCI, V72, P110, DOI 10.1016/j.jdermsci.2013.06.007; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Le YZ, 2000, METH MOL B, V136, P477	8	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	DEC	2014	76	3					264	267		10.1016/j.jdermsci.2014.10.006		4	Dermatology	Dermatology	AX4DA	WOS:000346882900017		
J	Hayashi, M; Nakayama, T; Hirota, T; Saeki, H; Nobeyama, Y; Ito, T; Umezawa, Y; Fukuchi, O; Yanaba, K; Kikuchi, S; Nakagawa, H; Tsunemi, Y; Shibata, S; Sato, S; Tada, Y; Miyatake, A; Fujieda, S; Tamari, M				Hayashi, Mitsuha; Nakayama, Tsuguhisa; Hirota, Tomomitsu; Saeki, Hidehisa; Nobeyama, Yoshimasa; Ito, Toshihiro; Umezawa, Yoshinori; Fukuchi, Osamu; Yanaba, Koichi; Kikuchi, Sota; Nakagawa, Hidemi; Tsunemi, Yuichiro; Shibata, Sayaka; Sato, Shinichi; Tada, Yayoi; Miyatake, Akihiko; Fujieda, Shigeharu; Tamari, Mayumi			Novel IL36RN gene mutation revealed by analysis of 8 Japanese patients with generalized pustular psoriasis	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Letter							DEFICIENCY; ANTAGONIST; VULGARIS		[Hayashi, Mitsuha; Nobeyama, Yoshimasa; Ito, Toshihiro; Umezawa, Yoshinori; Fukuchi, Osamu; Yanaba, Koichi; Kikuchi, Sota; Nakagawa, Hidemi] Jikei Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Nakayama, Tsuguhisa] Jikei Univ, Sch Med, Dept Otorhinolaryngol, Tokyo, Japan; [Nakayama, Tsuguhisa; Hirota, Tomomitsu; Tamari, Mayumi] RIKEN, Ctr Integrat Med Sci, Lab Resp & Allerg Dis, Tokyo, Japan; [Saeki, Hidehisa] Nippon Med Sch, Dept Dermatol, Tokyo 1138603, Japan; [Tsunemi, Yuichiro] Tokyo Womens Med Univ, Dept Dermatol, Tokyo, Japan; [Shibata, Sayaka; Sato, Shinichi] Univ Tokyo, Fac Med, Dept Dermatol, Tokyo 1138654, Japan; [Tada, Yayoi] Teikyo Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Miyatake, Akihiko] Miyatake Asthma Clin, Osaka, Japan; [Fujieda, Shigeharu] Univ Fukui, Fac Med Sci, Dept Otorhinolaryngol, Fukui, Japan	Saeki, H (reprint author), Nippon Med Sch, Dept Dermatol, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	h-saeki@nms.ac.jp	Tamari, Mayumi/N-5378-2015				Onoufriadis A, 2011, AM J HUM GENET, V89, P432, DOI 10.1016/j.ajhg.2011.07.022; Setta-Kaffetzi N, 2013, J INVEST DERMATOL, V133, P1366, DOI 10.1038/jid.2012.490; Sugiura K, 2013, J INVEST DERMATOL, V133, P2514, DOI 10.1038/jid.2013.230; Li M, 2013, J INVEST DERMATOL, V133, P2637, DOI 10.1038/jid.2013.267; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Farooq M, 2012, HUM MUTAT, V34, P176; Iwatsuki K, 2010, JPN J DERMATOL, V120, P815; Kanazawa N, 2013, J DERMATOL, V40, P749, DOI 10.1111/1346-8138.12227; Korber A, 2013, J INVEST DERMATOL, V133, P2634, DOI 10.1038/jid.2013.214; Sugiura K, 2012, BRIT J DERMATOL, V167, P699, DOI 10.1111/j.1365-2133.2012.10953.x	10	3	3	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	DEC	2014	76	3					267	269		10.1016/j.jdermsci.2014.10.008		3	Dermatology	Dermatology	AX4DA	WOS:000346882900018		
J	Togawa, Y; Kambe, N; Shimojo, N; Nakano, T; Sato, Y; Mochizuki, H; Tanaka, A; Matsuda, H; Matsue, H				Togawa, Yaei; Kambe, Naotomo; Shimojo, Naoki; Nakano, Taiji; Sato, Yasunori; Mochizuki, Hiroyuki; Tanaka, Akane; Matsuda, Hiroshi; Matsue, Hiroyuki			Ultra-pure soft water improves skin barrier function in children with atopic dermatitis: A randomized, double-blind, placebo-controlled, crossover pilot study	JOURNAL OF DERMATOLOGICAL SCIENCE			English	Letter						Atopic dermatitis; Ultra-pure soft water; Skin barrier function; Out-in skin transparency	HARDNESS; CALCIUM; ECZEMA; AREA		[Togawa, Yaei; Kambe, Naotomo; Matsue, Hiroyuki] Chiba Univ, Grad Sch Med, Dept Dermatol, Chiba 2608670, Japan; [Shimojo, Naoki; Nakano, Taiji] Chiba Univ, Grad Sch Med, Dept Pediat, Chiba 2608670, Japan; [Sato, Yasunori] Chiba Univ Hosp, Clin Res Ctr, Chiba, Japan; [Mochizuki, Hiroyuki] Tokai Univ, Sch Med, Dept Pediat, Isehara, Kanagawa 25911, Japan; [Tanaka, Akane; Matsuda, Hiroshi] Tokyo Univ Agr & Technol, Div Anim Life Sci, Inst Agr, Fuchu, Tokyo, Japan	Kambe, N (reprint author), Chiba Univ, Grad Sch Med, Dept Dermatol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	nkambe@faculty.chiba-u.jp	TANAKA, Akane/G-1158-2013; Matsuda, Hiroshi/C-8358-2013	TANAKA, Akane/0000-0002-7906-5047; Matsuda, Hiroshi/0000-0003-3189-6842			Miyake Y, 2004, ENVIRON RES, V94, P33, DOI 10.1016/S0013-9351(03)00068-9; Ohmori K, 2010, VET DERMATOL, V21, P477, DOI 10.1111/j.1365-3164.2010.00900.x; MENON GK, 1994, J INVEST DERMATOL, V102, P789, DOI 10.1111/1523-1747.ep12377921; McNally NJ, 1998, LANCET, V352, P527, DOI 10.1016/S0140-6736(98)01402-0; Hanifin JM, 2001, EXP DERMATOL, V10, P11, DOI 10.1034/j.1600-0625.2001.100102.x; LEE SH, 1994, J INVEST DERMATOL, V102, P976, DOI 10.1111/1523-1747.ep12384225; LEE SH, 1992, J CLIN INVEST, V89, P530, DOI 10.1172/JCI115617; Mochizuki H, 2009, BRIT J DERMATOL, V160, P972, DOI 10.1111/j.1365-2133.2009.09036.x; Thomas KS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000395; Thomas K S, 2008, Br J Dermatol, V159, P561, DOI 10.1111/j.1365-2133.2008.08704.x	10	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0923-1811	1873-569X		J DERMATOL SCI	J. Dermatol. Sci.	DEC	2014	76	3					269	271		10.1016/j.jdermsci.2014.10.009		3	Dermatology	Dermatology	AX4DA	WOS:000346882900019		
J	Ueki, N; Wan, JR; Watabe, S				Ueki, Nobuhiko; Wan, Jianrong; Watabe, Shugo			The Pepsin Digestibility of Thermal Gel Products Made from White Croaker (Pennahia argentata) Muscle in Associating with Myosin Polymerization Levels	JOURNAL OF FOOD SCIENCE			English	Article						myosin heavy chain polymerization; pepsin digestibility; thermal gel; transglutaminase; white croaker	ENZYME INHIBITORY PEPTIDES; FAST SKELETAL MYOSIN; FISH MEAT PASTE; WALLEYE POLLACK; ALASKA POLLACK; CROSS-LINKING; MICROBIAL TRANSGLUTAMINASE; RHEOLOGICAL PROPERTIES; FORMING ABILITY; SURIMI PASTE	Thermal gels were made from white croaker (Pennahia argentata) surimi at various polymerization levels of myosin heavy chains induced by suwari treatment at 38 degrees C for various time periods and subsequently heated at 85 degrees C for 20 min. Myosin heavy chain polymerization levels were also achieved in the presence of microbial transglutaminase (MTG) added at various concentrations in the surimi. The breaking strength and breaking strain rate were markedly increased during suwari treatment up to 60 min in accordance with the increased levels of myosin heavy chain polymerization. MTG enhanced myosin heavy chain polymerization during suwari treatment for 15 and 30 min, resulting in the increase of breaking strength. The solubilization in 8 M urea and pepsin digestibility of these gels as well as angiotensin I-converting enzyme (ACE) inhibitory activity of their pepsin digests were decreased with the increased levels of myosin heavy chain polymerization. These results suggest that myosin heavy chain polymerization affects not only rheological properties of thermal gels but also their functional properties for human health.	[Ueki, Nobuhiko; Wan, Jianrong; Watabe, Shugo] Suzuhiro Kamaboko Honten Co Ltd, Ctr Res & Dev, Fish Prot Lab, Odawara, Kanagawa 2500862, Japan; [Watabe, Shugo] Kitasato Univ, Sch Marine Biosci, Minami Ku, Sagamihara, Kanagawa 2520373, Japan	Ueki, N (reprint author), Suzuhiro Kamaboko Honten Co Ltd, Ctr Res & Dev, Fish Prot Lab, Odawara, Kanagawa 2500862, Japan.	ueki@kamaboko.com					AKAHANE T, 1984, B JPN SOC SCI FISH, V50, P1029; Vercruysse L, 2005, J AGR FOOD CHEM, V53, P8106, DOI 10.1021/jf0508908; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Chanarat S, 2012, J SCI FOOD AGR, V92, P844, DOI 10.1002/jsfa.4656; Wijesekara I, 2010, MAR DRUGS, V8, P1080, DOI 10.3390/md8041080; Wu JP, 2002, J CHROMATOGR A, V950, P125, DOI 10.1016/S0021-9673(02)00052-3; Fukushima H, 2005, J AGR FOOD CHEM, V53, P9193, DOI 10.1021/jf051223h; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Je JY, 2004, J AGR FOOD CHEM, V52, P7842, DOI [10.1021/jf0494027, 10.1021/jf049364r]; SEKI N, 1990, NIPPON SUISAN GAKK, V56, P125; Kuba M, 2003, BIOSCI BIOTECH BIOCH, V67, P1278, DOI 10.1271/bbb.67.1278; WAN JR, 1994, FISHERIES SCI, V60, P107; KIMURA I, 1991, NIPPON SUISAN GAKK, V57, P1389; Ueki N, 2007, BIOPOLYMERS, V88, P190, DOI 10.1002/bip.20687; Cho JH, 2011, J ANIM PHYSIOL AN N, V95, P685, DOI 10.1111/j.1439-0396.2010.01109.x; FOLK JE, 1980, ANNU REV BIOCHEM, V49, P517, DOI 10.1146/annurev.bi.49.070180.002505; Fukushima H, 2007, J FOOD ENG, V81, P492, DOI 10.1016/j.jfoodeng.2006.11.029; Hasan F, 2006, PROCESS BIOCHEM, V41, P505, DOI 10.1016/j.procbio.2005.06.032; Hosomi R, 2011, J FOOD SCI, V76, P116; Hosomi Ryota, 2012, Glob J Health Sci, V4, P72, DOI 10.5539/gjhs.v4n3p72; IWATA K, 1977, B JPN SOC SCI FISH, V43, P237; IWAYA M, 1979, Japanese Journal of Nutrition, V37, P247; Jiang ST, 2000, J FOOD SCI, V65, P241, DOI 10.1111/j.1365-2621.2000.tb15987.x; JOSEPH D, 1994, J FOOD SCI, V59, P1018, DOI 10.1111/j.1365-2621.1994.tb08180.x; KOHAMA Y, 1988, BIOCHEM BIOPH RES CO, V155, P332, DOI 10.1016/S0006-291X(88)81089-1; KUMAZAWA Y, 1995, J FOOD SCI, V60, P715, DOI 10.1111/j.1365-2621.1995.tb06213.x; MATSUNO N., 1971, Japanese Journal of Nutrition, V29, P250; Matsuoka Y, 2013, FISHERIES SCI, V79, P715, DOI 10.1007/s12562-013-0640-7; Montero P, 1997, J AGR FOOD CHEM, V45, P4612, DOI 10.1021/jf970400e; NISHIMOTO S, 1987, NIPPON SUISAN GAKK, V53, P2011; NISHIOKA F, 1983, B JPN SOC SCI FISH, V49, P1233; NIWA E, 1971, B JPN SOC SCI FISH, V37, P877; NIWA E, 1983, B JPN SOC SCI FISH, V49, P245; NUMAKURA T, 1989, NIPPON SUISAN GAKK, V55, P1083; NUMAKURA T, 1987, NIPPON SUISAN GAKK, V53, P633; NUMAKURA T, 1985, Nippon Suisan Gakkaishi, V51, P1559; Park J. W., 2005, Surimi and surimi seafood, P375; Phu N. V., 2010, J BIOL SCI, V10, P499; Satoh Y, 2006, FISHERIES SCI, V72, P646, DOI 10.1111/j.1444-2906.2006.01195.x; SHIMIZU Y, 1981, B JPN SOC SCI FISH, V47, P95; WAN JR, 1995, FISHERIES SCI, V61, P711; Wan JR, 1995, FISHERIES SCI, V61, P968	43	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1147	1750-3841		J FOOD SCI	J. Food Sci.	DEC	2014	79	12					C2427	C2433		10.1111/1750-3841.12704		7	Food Science & Technology	Food Science & Technology	AX0PS	WOS:000346654800003		
J	O'Charoen, S; Hayakawa, S; Matsumoto, Y; Ogawa, M				O'Charoen, Siwaporn; Hayakawa, Shigeru; Matsumoto, Yoshiki; Ogawa, Masahiro			Effect of D-Psicose Used as Sucrose Replacer on the Characteristics of Meringue	JOURNAL OF FOOD SCIENCE			English	Article						d-psicose; egg white protein; meringue; sucrose; sugar replacement	DIETARY D-PSICOSE; RARE SUGAR; RATS; PROTEINS; SYSTEM; MASS	Excessive intake of sugar-rich foods leads to metabolic syndrome. d-Psicose (Psi) not commonly found in nature, is noncalorie sweetener with a suppressive effect on the blood glucose level. Thus, Psi has the potential to be utilized as a sucrose (Suc) replacer in sugar-rich foods, including meringue-based confectionery (MBC). In this study, we investigated the effect of Psi on the physical and chemical properties of meringue. Meringue was made by whipping egg white and Suc (at a weight ratio of 1:1) and baking at 93 degrees C for 2 h. Thirty percent of the total weight of Suc was replaced with d-ketohexoses such as Psi, d-fructose, d-tagatose, and d-sorbose. The meringues containing d-ketohexoses had higher specific volume than the meringue not containing d-ketohexoses (Ct-meringue). Baking of meringue caused differences between Psi and the other d-ketohexose meringues. Meringue containing Psi (P30-meringue) had the highest breaking stress (7.00 x 10(5) N/m(2)) and breaking strain (4.40%), resulting in the crunchiest texture. In addition, P30-meringue also had the highest antioxidant activity (491.84 M TE/mg-meringue determined by ABTS method) and was the brownest due to a Maillard reaction occurring during baking. The replacement of Suc with Psi improved the characteristics of baked meringue. Thus, Psi was found to be useful in modifying the physical and chemical properties of MBC. Practical Application d-Psicose, a noncalorie sweetener with a suppressive effect on the blood glucose level, can be utilized as a sucrose replacer in sugar-rich foods such as meringue-based confectionery (MBC). d-Psicose creates a crunchy texture and enhances the antioxidant activity of baked meringue. Thus, d-psicose may be useful in modification of MBC.	[O'Charoen, Siwaporn; Hayakawa, Shigeru; Matsumoto, Yoshiki; Ogawa, Masahiro] Kagawa Univ, Fac Agr, Dept Appl Biol Sci, Miki, Kagawa 7610795, Japan	Hayakawa, S (reprint author), Kagawa Univ, Fac Agr, Dept Appl Biol Sci, 2393 Ikenobe, Miki, Kagawa 7610795, Japan.	hayakawa@ag.kagawa-u.ac.jp			City Area Program, the Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was partially supported by the City Area Program, the Ministry of Education, Culture, Sports, Science and Technology, Japan. The authors also thank Peter Lutes, associate professor of Faculty of Agriculture, Kagawa Univ., for language editing.	Takeshita K, 2000, J BIOSCI BIOENG, V90, P453, DOI 10.1263/jbb.90.453; Liu JH, 2012, FOOD RES INT, V49, P170, DOI 10.1016/j.foodres.2012.07.034; Fukada K, 2010, B CHEM SOC JPN, V83, P1193, DOI 10.1246/bcsj.20100148; Matsuo T, 2002, J NUTR SCI VITAMINOL, V48, P77; TOONE EJ, 1994, CURR OPIN STRUC BIOL, V4, P719, DOI 10.1016/S0959-440X(94)90170-8; Song WO, 2012, NUTRITION, V28, P1137, DOI 10.1016/j.nut.2012.03.008; Foegeding EA, 2006, FOOD HYDROCOLLOID, V20, P284, DOI 10.1016/j.foodhyd.2005.03.014; Chung YM, 2012, J FOOD SCI, V77, pH53, DOI 10.1111/j.1750-3841.2011.02571.x; Ochiai M, 2013, BIOSCI BIOTECH BIOCH, V77, P1123, DOI 10.1271/bbb.130019; PHILLIPS LG, 1990, J FOOD SCI, V55, P1441, DOI 10.1111/j.1365-2621.1990.tb03953.x; Mu WM, 2012, APPL MICROBIOL BIOT, V94, P1461, DOI 10.1007/s00253-012-4093-1; Hishiike T, 2013, J AGR FOOD CHEM, V61, P7381, DOI 10.1021/jf401449m; Hodge J. E., 1976, PRINCIPLES FOOD SC 1, P41; Izumori K, 2006, J BIOTECHNOL, V124, P712; Levin GV, 2002, J MED FOOD, V5, P29; Licciardello F, 2012, J FOOD ENG, V108, P453, DOI 10.1016/j.jfoodeng.2011.08.021; Namiki M, 1988, Adv Food Res, V32, P115, DOI 10.1016/S0065-2628(08)60287-6; Roberg M., 2012, IEEE MTT S INT MICR, P1; ROSSI M, 1992, THERMOCHIM ACTA, V199, P115, DOI 10.1016/0040-6031(92)80255-U; Sahin S, 2006, PHYS PROPERTIES FOOD, P258; Sun Y, 2008, J AGR FOOD CHEM, V56, P4789, DOI 10.1021/jf800050d; Vega C, 2012, FOOD BIOPHYS, V7, P103, DOI 10.1007/s11483-011-9247-7; WALKER ARP, 1971, ATHEROSCLEROSIS, V14, P137, DOI 10.1016/0021-9150(71)90045-1	23	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1147	1750-3841		J FOOD SCI	J. Food Sci.	DEC	2014	79	12					E2463	E2469		10.1111/1750-3841.12699		7	Food Science & Technology	Food Science & Technology	AX0PS	WOS:000346654800008		
J	Terano, A				Terano, Akira			Special Issue: The 15th Taishotoyama International Symposium on Gastroenterology (1). The publication of this supplement has been supported by Taisho Toyama Pharmaceutical Co., Ltd. FOREWORD	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Terano, Akira] Dokkyo Med Univ, Tokyo, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	DEC	2014	29			4	SI		1	1		10.1111/jgh.12813		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW9MA	WOS:000346580200001		
J	Kitajima, M				Kitajima, Masaki			Special Issue: The 15th Taishotoyama International Symposium on Gastroenterology (1). The publication of this supplement has been supported by Taisho Toyama Pharmaceutical Co., Ltd. PREFACE	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material									[Kitajima, Masaki] Keio Univ, Tokyo 108, Japan								0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	DEC	2014	29			4	SI		2	2		10.1111/jgh.12814		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW9MA	WOS:000346580200002		
J	Amagase, K; Izumi, N; Takahira, Y; Wada, T; Takeuchi, K				Amagase, Kikuko; Izumi, Nahoko; Takahira, Yuka; Wada, Tomoko; Takeuchi, Koji			Importance of cyclooxygenase-1/prostacyclin in modulating gastric mucosal integrity under stress conditions	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						cold-restraint stress; cyclooxygenase isozyme; EP and IP receptors; gastric ulcer; mouse; prostaglandins	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CHRONIC MILD RESTRAINT; ENDOGENOUS PROSTAGLANDINS; COLD RESTRAINT; NITRIC-OXIDE; RAT STOMACH; ULCEROGENIC RESPONSES; HEALING RESPONSES; KNOCKOUT MICE; UP-REGULATION	Background and AimWe investigated the roles of cyclooxygenase (COX) isozymes and prostaglandins (PGs) and their receptors in mucosal defense against cold-restraint stress (CRS)-induced gastric lesions. MethodsMale C57BL/6 wild-type (WT) mice and those lacking COX-1 or COX-2 as well as those lacking EP1, EP3, or IP receptors were used after 18h fasting. Animals were restrained in Bollman cages and kept in a cold room at 10 degrees C for 90min. ResultsCRS induced multiple hemorrhagic lesions in WT mouse stomachs. The severity of these lesions was significantly worsened by pretreatment with the nonselective COX inhibitors (indomethacin, loxoprofen) or selective COX-1 inhibitor (SC-560), while neither of the selective COX-2 inhibitors (rofecoxib and celecoxib) had any effect. These lesions were also aggravated in animals lacking COX-1, but not COX-2. The expression of COX-2mRNA was not detected in the stomach after CRS, while COX-1 expression was observed under normal and stressed conditions. The gastric ulcerogenic response to CRS was similar between EP1 or EP3 knockout mice and WT mice, but was markedly worsened in animals lacking IP receptors. Pretreating WT mice with iloprost (the PGI(2) analog) significantly prevented CRS-induced gastric lesions in the presence of indomethacin. PGE(2) also reduced the severity of these lesions, and the effect was mimicked by the EP4 agonist, AE1-329. ConclusionsThese results suggest that endogenous PGs derived from COX-1 play a crucial role in gastric mucosal defense during CRS, and this action is mainly mediated by PGI(2)/IP receptors and partly by PGE(2)/EP4 receptors.	[Amagase, Kikuko; Izumi, Nahoko; Takahira, Yuka; Wada, Tomoko; Takeuchi, Koji] Kyoto Pharmaceut Univ, Dept Pharmacol & Expt Therapeut, Div Pathol Sci, Yamashina, Japan; [Takeuchi, Koji] Gen Inc Assoc, Kyoto Res Ctr Gastrointestinal Dis, Kyoto 6048106, Japan	Takeuchi, K (reprint author), Gen Inc Assoc, Kyoto Res Ctr Gastrointestinal Dis, Karasuma Oike 671, Kyoto 6048106, Japan.	takeuchi@mb.kyoto-phu.ac.jp					Araki H, 2000, ALIMENT PHARM THERAP, V14, P116, DOI 10.1046/j.1365-2036.2000.014s1116.x; Takeuchi K, 1999, J PHYSIOLOGY-PARIS, V93, P423, DOI 10.1016/S0928-4257(99)00125-4; VANE JR, 1995, INFLAMM RES, V44, P1, DOI 10.1007/BF01630479; Ushikubi F, 1998, NATURE, V395, P281; Kargman S, 1996, GASTROENTEROLOGY, V111, P445, DOI 10.1053/gast.1996.v111.pm8690211; Kunikata T, 2002, DIGEST DIS SCI, V47, P894, DOI 10.1023/A:1014725024519; Narumiya S, 2001, J CLIN INVEST, V108, P25, DOI 10.1172/JCI13455; SUGIMOTO Y, 1992, J BIOL CHEM, V267, P6463; TSO JY, 1985, NUCLEIC ACIDS RES, V13, P2485, DOI 10.1093/nar/13.7.2485; Takeuchi K, 2010, J PHARMACOL SCI, V114, P248, DOI 10.1254/jphs.10R06CR; Takeuchi K, 2001, J PHARMACOL EXP THER, V297, P1160; Wallace JL, 2000, GASTROENTEROLOGY, V119, P706, DOI 10.1053/gast.2000.16510; Hoshino T, 2003, J BIOL CHEM, V278, P12752, DOI 10.1074/jbc.M212097200; FENG L, 1993, ARCH BIOCHEM BIOPHYS, V307, P361, DOI 10.1006/abbi.1993.1601; Aoi M, 2004, AM J PHYSIOL-GASTR L, V287, pG96, DOI 10.1152/ajpgi.00038.2004; Brzozowski T, 2000, J PHYSIOLOGY-PARIS, V94, P83, DOI 10.1016/S0928-4257(00)00145-5; Davies NM, 1997, ALIMENT PHARM THERAP, V11, P1101, DOI 10.1046/j.1365-2036.1997.00247.x; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; GARRICK T, 1986, AM J PHYSIOL, V250, pG191; Harada N, 1999, PROSTAG OTH LIPID M, V57, P291, DOI 10.1016/S0090-6980(98)00077-X; Koga T, 2004, HEPATO-GASTROENTEROL, V51, P1626; KONTUREK PK, 1990, GASTROENTEROLOGY, V99, P1607; KONTUREK SJ, 1982, DIGESTION, V25, P155; Kotani T, 2006, J PHARMACOL EXP THER, V316, P547, DOI 10.1124/jpet.105.093195; Laudanno OM, 2001, DIGEST DIS SCI, V46, P779, DOI 10.1023/A:1010748316889; Maricic N, 1999, BRIT J PHARMACOL, V128, P1659, DOI 10.1038/sj.bjp.0702966; Muscara MN, 2000, BRIT J PHARMACOL, V129, P1423, DOI 10.1038/sj.bjp.0703232; SOLL AH, 1991, ANN INTERN MED, V114, P307; Suzuki K, 2001, DIGESTION, V63, P92, DOI 10.1159/000051876; Takeeda M, 2003, J PHARMACOL EXP THER, V307, P713, DOI 10.1124/jpet.103.054973; Takeuchi K, 2003, J PHARMACOL EXP THER, V304, P1055, DOI 10.1124/jpet.102.044156; Takeuchi K, 2001, J PHYSIOLOGY-PARIS, V95, P75, DOI 10.1016/S0928-4257(01)00011-0; Takeuchi K, 1998, J PHARMACOL EXP THER, V286, P115; Tanaka A, 2007, DIGEST DIS SCI, V52, P478, DOI 10.1007/s10620-006-9394-8; Tanaka A, 2002, J PHARMACOL EXP THER, V300, P754, DOI 10.1124/jpet.300.3.754; Ukawa H, 1998, DIGEST DIS SCI, V43, P2003, DOI 10.1023/A:1018846912032; WALLACE JL, 1984, AM J PHYSIOL, V247, pG127; WALLACE JL, 1983, GASTROENTEROLOGY, V85, P370; WHITTLE BJR, 1984, EUR J PHARMACOL, V100, P277, DOI 10.1016/0014-2999(84)90003-7; ZIMMERMAN BJ, 1990, GASTROENTEROLOGY, V99, P1358	40	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	DEC	2014	29			4	SI		3	10		10.1111/jgh.12767		8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW9MA	WOS:000346580200003		
J	Takeuchi, T; Ota, K; Harada, S; Kojima, Y; Inoue, T; Iwakiri, R; Sakata, Y; Fujimoto, K; Fujita, T; Azuma, T; Higuchi, K				Takeuchi, Toshihisa; Ota, Kazuhiro; Harada, Satoshi; Kojima, Yuichi; Inoue, Takuya; Iwakiri, Ryuichi; Sakata, Yasuhisa; Fujimoto, Kazuma; Fujita, Tsuyoshi; Azuma, Takeshi; Higuchi, Kazuhide			Comparison of teprenone and famotidine against gastroduodenal mucosal damage in patients taking low-dose aspirin	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						famotidine; gastroduodenal injury; low-dose aspirin; teprenone	COMMUNITY-ACQUIRED PNEUMONIA; PROTON PUMP INHIBITORS; GASTRIC-ACID; RISK; ESOMEPRAZOLE; SECRETION; ULCERS; COMPLICATIONS; CLOPIDOGREL; PREVENTION	Background and AimProton-pump inhibitors are known to be effective in the treatment and prevention of ulcers related to low-dose aspirin (LDA), but few reports address H-2-receptor antagonists (H2RAs) and gastroprotective agents (GPs). This study was intended to compare the therapeutic effects of an H2RA and a GP against gastroduodenal mucosal injuries in patients taking LDA. MethodsThe subjects consisted of patients requiring continuous LDA treatment, in whom no peptic ulcer was found on endoscopy at enrollment. The patients were randomized to either famotidine 20mg/day (group F) or teprenone 150mg/day (group T). The study medication was administered for 12 weeks. The patients underwent endoscopy after administration of the study medication in order to obtain a Lanza score. ResultsA total of 66 patients (38 in group F, 28 in group T) were included in the efficacy analysis population. The Lanza score changed as follows: in group F, it improved significantly, from 0.891.03 (mean +/- standard deviation) before medication to 0.39 +/- 0.75 after medication (P=0.006); in group T, no significant difference was observed: 0.75 +/- 0.93 before medication and 0.68 +/- 0.82 after medication. ConclusionFamotidine is better than teprenone in terms of reducing the number of the erosions under use of LDA.	[Takeuchi, Toshihisa; Ota, Kazuhiro; Harada, Satoshi; Kojima, Yuichi; Inoue, Takuya; Higuchi, Kazuhide] Osaka Med Coll, Dept Internal Med 2, Osaka, Japan; [Iwakiri, Ryuichi; Sakata, Yasuhisa; Fujimoto, Kazuma] Saga Med Sch, Dept Internal Med, Osaka, Japan; [Fujita, Tsuyoshi; Azuma, Takeshi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Gastroenterol, Osaka, Japan	Takeuchi, T (reprint author), Osaka Med Coll, Dept Internal Med 2, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	in2097@poh.osaka-med.ac.jp					Lai KC, 2002, NEW ENGL J MED, V346, P2033, DOI 10.1056/NEJMoa012877; Sugano K, 2011, J GASTROENTEROL, V46, P724, DOI 10.1007/s00535-011-0397-7; Moceri P, 2011, THROMB RES, V128, P458, DOI 10.1016/j.thromres.2011.06.029; Yeomans ND, 2005, ALIMENT PHARM THERAP, V22, P795, DOI 10.1111/j.1365-2036.2005.02649.x; Naylor GM, 2006, GUT, V55, P1545, DOI 10.1136/gut.2005.080358; Sarkar M, 2008, ANN INTERN MED, V149, P391; Yeomans N, 2008, AM J GASTROENTEROL, V103, P2465, DOI [10.1111/j.1572-0241.2008.01995.x, 10.1111/j.1572-2008.01995.x]; Ng FH, 2010, GASTROENTEROLOGY, V138, P82, DOI 10.1053/j.gastro.2009.09.063; Taha AS, 2009, LANCET, V374, P119, DOI 10.1016/S0140-6736(09)61246-0; Feldman M, 1996, GASTROENTEROLOGY, V110, P1043, DOI 10.1053/gast.1996.v110.pm8612992; Gaglia MA, 2010, AM J CARDIOL, V105, P833, DOI 10.1016/j.amjcard.2009.10.063; Fernando H, 2011, J THROMB HAEMOST, V9, P1582, DOI 10.1111/j.1538-7836.2011.04414.x; Forgacs I, 2008, BMJ-BRIT MED J, V336, P2, DOI 10.1136/bmj.39406.449456.BE; Rodriguez LAG, 2007, CLIN GASTROENTEROL H, V5, P1418, DOI 10.1016/j.cgh.2007.09.010; Rodriguez LAG, 2001, BRIT J CLIN PHARMACO, V52, P563, DOI 10.1046/j.0306-5251.2001.01476.x; Ho M, 2009, JAMA-J AM MED ASSOC, V301, P937; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; LANZA FL, 1981, AM J GASTROENTEROL, V75, P17; Naito Y, 1998, DIGEST DIS SCI, V43, P83; Nakamura H, 2011, YAKUGAKU ZASSHI, V131, P445, DOI 10.1248/yakushi.131.445; Sokic-Milutinovic A, 2010, DIGEST DIS SCI, V55, P2887, DOI 10.1007/s10620-009-1097-5; TAHIR H, 1984, HIROSHIMA J MED SCI, V33, P125; Targownik LE, 2008, CAN MED ASSOC J, V179, P319, DOI 10.1503/cmaj.071330; vansBoxel OS, 2010, AM J GASTROENTEROL, V105, P2430; Yajima K, 2009, J PHARM HLTH CARE SC, V35, P649; Yamao J, 2006, J GASTROENTEROL, V41, P1178, DOI 10.1007/s00535-006-1952-5; Yang YX, 2006, JAMA-J AM MED ASSOC, V296, P2947, DOI 10.1001/jama.296.24.2947	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	DEC	2014	29			4	SI		11	15		10.1111/jgh.12768		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW9MA	WOS:000346580200004		
J	Hirayama, Y; Kawai, T; Otaki, J; Kawakami, K; Harada, Y				Hirayama, Yoji; Kawai, Takashi; Otaki, Junji; Kawakami, Kohei; Harada, Yoshimi			Prevalence of Helicobacter pylori infection with healthy subjects in Japan	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						Helicobacter pylori; infection rate; anti-H; pylori antibody	SOCIOECONOMIC-STATUS; UNITED-STATES; POPULATION	Background and AimOnly few large-scale epidemiological studies have examined the prevalence of Helicobacter pylori (H.pylori) infection in Japan. The aim of the present study was to estimate the prevalence and incidence of H.pylori infection in Japan in terms of gender, age and region. MethodsSerum anti-H.pylori antibody testing was included in workers' annual health checks conducted by T-company's health insurance association in 2008. The testing was continued for the next 5 years in 35-year-old subjects. ResultsThe total number of subjects was 21144 (18398 males and 2746 females). Stratified for age, there were 5016 subjects (male:female=4219:797) in their 30s, 8748 (7770:978) in their 40s, 5589 (4807:782) in their 50s, and 1769 (1584:185) in their 60s. The H.pylori seropositive rate (male:female) was 27.5% (27.5:27.7) overall, 18.0% (18.3:16.1) in subjects in their 30s, 22.9% (22.7:24.7) in those in their 40s, 37.4% (37.2:38.2) in those in their 50s, and 46.1% (45.7:49.2) in those in their 60s. The prevalence of H.pylori seropositivity increased as age increased; however, no significant differences were seen between genders or among regions ((2) test). The numbers of 35-year-old subjects from 2008 to 2012 were 1072, 1107, 941, 1065, and 940, respectively. The corresponding H.pylori seropositive rates were 17.4, 17.4, 14.3, 13.3, and 14.0%, respectively. ConclusionThe Japanese H.pylori infection rate had already declined to 27.5% in 2008, with subjects in the 35-70 age range. The prevalence of H.pylori infection is also decreasing gradually from 2008 to 2012.	[Hirayama, Yoji; Kawakami, Kohei; Harada, Yoshimi] Tokyo Med Univ Hosp, Dept Gen Med & Primary Care, Tokyo 1600023, Japan; [Kawai, Takashi] Tokyo Med Univ Hosp, Endoscopy Ctr, Tokyo 1600023, Japan; [Otaki, Junji] Hokkaido Univ, Grad Sch Med, Ctr Med Educ, Tokyo, Japan	Kawai, T (reprint author), Tokyo Med Univ Hosp, Endoscopy Ctr, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	t-kawai@tokyo-med.ac.jp					Matsuo T, 2011, HELICOBACTER, V16, P415, DOI 10.1111/j.1523-5378.2011.00889.x; MALATY HM, 1994, GUT, V35, P742, DOI 10.1136/gut.35.6.742; Tamura T, 2012, NAGOYA J MED SCI, V74, P63; Akamatsu T, 2011, J GASTROENTEROL, V46, P1353, DOI 10.1007/s00535-011-0450-6; GRAHAM DY, 1991, GASTROENTEROLOGY, V100, P1495; Fujisawa T, 1999, AM J GASTROENTEROL, V94, P2094; Chong SKF, 2003, AM J GASTROENTEROL, V98, P2162, DOI 10.1016/S0002-9270(03)00668-3; Graham DY, 1989, GASTROENTEROL CLIN B, V13, P84; GRAHAM DY, 1991, DIGEST DIS SCI, V36, P1084, DOI 10.1007/BF01297451; Karita M, 2003, DIGEST DIS SCI, V48, P1062, DOI 10.1023/A:1023752326137; Kawai T, 2010, J GASTROEN HEPATOL, V25, pS80, DOI 10.1111/j.1440-1746.2010.06228.x; Megraud F, 1993, HELICOBACTER PYLORI, P107; Megraud F, 1989, J CLIN MICROBIOL, V27, P1871	13	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	DEC	2014	29			4	SI		16	19		10.1111/jgh.12795		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW9MA	WOS:000346580200005		
J	Nishizawa, T; Nishizawa, Y; Yahagi, N; Kanai, T; Takahashi, M; Suzuki, H				Nishizawa, Toshihiro; Nishizawa, Yuko; Yahagi, Naohisa; Kanai, Takanori; Takahashi, Masahiko; Suzuki, Hidekazu			Effect of supplementation with rebamipide for Helicobacter pylori eradication therapy: A systematic review and meta-analysis	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						eradication; Helicobacter pylori; rebamipide	SONIC HEDGEHOG EXPRESSION; RANDOMIZED DOUBLE-BLIND; GASTRIC-ULCER PATIENTS; COMBINATION THERAPY; MONGOLIAN GERBILS; CONTROLLED-TRIAL; PROTECTIVE DRUG; ANTIULCER AGENT; TRIPLE THERAPY; AMOXICILLIN	Background and AimSeveral studies have reported that the application of rebamipide during the eradication of Helicobacter pylori can improve the eradication rate. However, the efficacy and safety are controversial. The present study systematically evaluated whether rebamipide improves the eradication rate of H.pylori by conducting a meta-analysis based on randomized controlled trials (RCTs). MethodsLiterature searches were conducted in the following database: PubMed, the Cochrane Library, and the Igaku-chuo-zasshi database in Japan. A meta-analysis of all RCTs comparing rebamipide supplementation with non-rebamipide-containing therapy was performed. ResultsWe identified six randomized trials (611 patients). Pooled H.pylori eradication rates by per-protocol analysis were 73.3% and 61.4% for patients with or without rebamipide, respectively. The odds ratio was 1.74 (95% confidence interval. 1.19-2.53). ConclusionsSupplementation with rebamipide might be effective in increasing the H.pylori eradication rates of proton-pump inhibitor-amoxicillin dual therapy.	[Nishizawa, Toshihiro; Yahagi, Naohisa] Keio Univ, Sch Med, Div Res & Dev Minimally Invas Treatment, Ctr Canc, Tokyo 1608582, Japan; [Nishizawa, Toshihiro; Kanai, Takanori; Suzuki, Hidekazu] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo 1608582, Japan; [Nishizawa, Yuko] Natl Ctr Global Hlth & Med, Dept Pharmaceut, Tokyo, Japan; [Takahashi, Masahiko] Natl Hosp Org Tokyo Med Ctr, Div Gastroenterol, Tokyo, Japan	Suzuki, H (reprint author), Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hsuzuki@a6.keio.jp	Suzuki, Hidekazu/J-4396-2013				Nomura H, 2000, J GASTROEN HEPATOL, V15, P1377, DOI 10.1046/j.1440-1746.2000.02228.x; Nishizawa T, 2009, DIGESTION, V79, P259, DOI 10.1159/000213241; Suzuki H, 2010, FUTURE MICROBIOL, V5, P639, DOI [10.2217/fmb.10.25, 10.2217/FMB.10.25]; Fujioka T, 2003, ALIMENT PHARM THERAP, V18, P146, DOI 10.1046/j.1365-2036.18.s1.20.x; Terano A, 2007, J GASTROENTEROL, V42, P690, DOI 10.1007/s00535-007-2076-2; SUZUKI M, 1994, GUT, V35, P1375, DOI 10.1136/gut.35.10.1375; Song KH, 2011, DIGESTION, V84, P221, DOI 10.1159/000329353; Nishizawa T, 2008, J GASTROEN HEPATOL, V23, pS167, DOI 10.1111/j.1440-1746.2008.05407.x; Naito Y, 2010, EXPERT REV GASTROENT, V4, P261, DOI [10.1586/egh.10.25, 10.1586/EGH.10.25]; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Nishizawa T, 2011, ANTIMICROB AGENTS CH, V55, P3012, DOI 10.1128/AAC.00188-11; Hayashi S, 1998, ANTIMICROB AGENTS CH, V42, P1895; Hahm KB, 1998, DIGEST DIS SCI, V43, P235, DOI 10.1023/A:1018825532059; Hojo M, 2000, ALIMENT PHARM THERAP, V14, P193; Kamata T, 2013, J JPN SOC GASTROENTE, V110, pA893; Kato M, 1998, DIGEST DIS SCI, V43, p198S; Kimura M, 1999, FRONTIERS GASTROENTE, V4, P202; Nebiki H, 1998, DIGEST DIS SCI, V43, p203S; Nishizawa T, 2009, DIGESTION, V79, P99, DOI 10.1159/000209219; Nishizawa T, 2014, J CLIN GASTROENTEROL; Nishizawa T, 2012, J CLIN BIOCHEM NUTR, V51, P114, DOI 10.3164/jcbn.D-11-00029R1; Nishizawa T, 2006, ANTIMICROB AGENTS CH, V50, P1538, DOI 10.1128/AAC.50.4.1538-1540.2006; Nishizawa T, 2013, J GASTROEN HEPATOL, V28, P1608, DOI 10.1111/jgh.12281; Saita Hiroshi, 1996, Japanese Archives of Internal Medicine, V43, P15; Suzuki H, 1998, DIGEST DIS SCI, V43, p181S; Terano A, 2006, J GASTROEN HEPATOL, V21, P103, DOI 10.1111/j.1440-1746.2005.04191.x	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	DEC	2014	29			4	SI		20	24		10.1111/jgh.12769		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW9MA	WOS:000346580200006		
J	Shimoyama, T; Chinda, D; Matsuzaka, M; Takahashi, I; Nakaji, S; Fukuda, S				Shimoyama, Tadashi; Chinda, Daisuke; Matsuzaka, Masashi; Takahashi, Ippei; Nakaji, Shigeyuki; Fukuda, Shinsaku			Decrease of serum level of gastrin in healthy Japanese adults by the change of Helicobacter pylori infection	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						eradication therapy; gastrin; Helicobacter pylori	ACID-SECRETION; PEPSINOGEN I; ERADICATION; ANTIBODY; ULCER	Background and AimIn Japan, the prevalence of Helicobacter pylori infection is decreasing and the number of patients who receive eradication therapy is increasing. Although the serum level of gastrin is affected by H.pylori infection, the normal level has been unchanged for more than 20 years. The aim of this study was to study whether the present normal range for the serum gastrin level is appropriate for Japanese at present or in the near future. MethodsWe studied 810 adults (40-80 years old) who participated in a health survey in 2012. We measured H.pylori stool antigen, titer of serum antibody to H.pylori, and serum level of gastrin. The patient's H.pylori status was defined as positive or negative when the results of both stool antigen and serology were concordant. Subjects who were taking proton-pump inhibitor and had a previous history of gastric surgery were excluded. ResultsMean serum level of gastrin was 66.249.6pg/mL in 281 H.pylori-negative subjects and 69.7 +/- 42.2pg/mL in 115 patients who had H.pylori eradicated at least 2 years ago. The level of gastrin was 134.4 +/- 145.6pg/mL in 224 patients with H.pylori infection and the level was significantly higher when compared with those in uninfected subjects and eradicated patients (P<0.01). ConclusionsBecause the situation of H.pylori infection has changed remarkably in Japan, a new appropriate normal range of gastrin should be established using current Japanese populations.	[Shimoyama, Tadashi; Chinda, Daisuke; Fukuda, Shinsaku] Hirosaki Univ, Grad Sch Med, Dept Gastroenterol, Hirosaki, Aomori 0368562, Japan; [Matsuzaka, Masashi] Hirosaki Univ, Grad Sch Med, Dept Canc Epidemiol & Community Hlth, Hirosaki, Aomori 0368562, Japan; [Takahashi, Ippei; Nakaji, Shigeyuki] Hirosaki Univ, Grad Sch Med, Dept Social Med, Hirosaki, Aomori 0368562, Japan	Shimoyama, T (reprint author), Hirosaki Univ, Grad Sch Med, Dept Gastroenterol, 5 Zaifu Cho, Hirosaki, Aomori 0368562, Japan.	tsimo-hki@umin.ac.jp	Shimoyama, Tadashi/G-5519-2014; Chinda, Daisuke/K-1198-2015				Schubert ML, 2008, GASTROENTEROLOGY, V134, P1842, DOI 10.1053/j.gastro.2008.05.021; Ito M, 2008, DIGESTION, V78, P163, DOI 10.1159/000181146; Shimoyama T, 2012, GASTRIC CANCER, V15, P331, DOI 10.1007/s10120-012-0141-x; Asaka M, 2010, HELICOBACTER, V15, P1, DOI 10.1111/j.1523-5378.2009.00738.x; Gisbert JP, 1999, EUR J GASTROEN HEPAT, V11, P189, DOI 10.1097/00042737-199902000-00022; Kawai T, 2002, INTERNAL MED, V41, P780, DOI 10.2169/internalmedicine.41.780; Maconi G, 1997, AM J GASTROENTEROL, V92, P1844; Miki Kazumasa, 2006, Gastric Cancer, V9, P245, DOI 10.1007/s10120-006-0397-0; Ohkusa T, 2004, ALIMENT PHARM THERAP, V20, P25, DOI 10.1111/j.1365-2036.2004.01970.x; PARENTE F, 1995, GUT, V37, P210, DOI 10.1136/gut.37.2.210; Pianov SI, 2008, J GASTROEN HEPATOL, V23, P1666; Sato M, 2012, J GASTROEN HEPATOL, V27, P23, DOI 10.1111/j.1440-1746.2012.07066.x; Shimoyama T, 2008, HELICOBACTER, V14, P87	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	DEC	2014	29			4	SI		25	28		10.1111/jgh.12773		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW9MA	WOS:000346580200007		
J	Kawai, T; Takahashi, S; Suzuki, H; Sasaki, H; Nagahara, A; Asaoka, D; Matsuhisa, T; Masaoaka, T; Nishizawa, T; Suzuki, M; Ito, M; Kurihara, N; Omata, F; Mizuno, S; Torii, A; Kawakami, K; Ohkusa, T; Tokunaga, K; Mine, T; Sakaki, N				Kawai, Takashi; Takahashi, Shin'ichi; Suzuki, Hidekazu; Sasaki, Hitoshi; Nagahara, Akihito; Asaoka, Daisuke; Matsuhisa, Takeshi; Masaoaka, Tatsuhiro; Nishizawa, Toshihiro; Suzuki, Masayuki; Ito, Masayoshi; Kurihara, Naoto; Omata, Fumio; Mizuno, Shigeaki; Torii, Akira; Kawakami, Kohei; Ohkusa, Toshifumi; Tokunaga, Kengo; Mine, Tetsuya; Sakaki, Nobuhiro			Changes in the first line Helicobacter pylori eradication rates using the triple therapy-a multicenter study in the Tokyo metropolitan area (Tokyo Helicobacter pylori study group)	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						Helicobacter pylori; eradication rate; triple therapy; proton pump inhibitor; clarithromycin	GASTRIC-CANCER; DOUBLE-BLIND; CLARITHROMYCIN; JAPAN; INFECTION; LANSOPRAZOLE; AMOXICILLIN; METRONIDAZOLE; IMPACT	Background and AimHelicobacter pylori (H.pylori) infection is a strong risk factor for the development of gastric cancer. In 2013, the Japanese government approved H.pylori eradication therapy in patients with chronic gastritis as well as peptic ulcer. However, the continuing decline in eradication rates for first-line H.pylori eradication therapies is an urgent problem. In this study, we investigated changes in the first-line eradication rate from 2001 to 2010. MethodsEradication rates for 7-day triple therapy [proton pump inhibitor (rabeprazole 20mg, lansoprazole 60mg, or omeprazole 40mg)+amoxicillin 1500mg+clarithromycin (CAM) 400 or 800mg, daily] were collated from 14 hospitals in the Tokyo metropolitan area. The urea breath test was used for the evaluation of eradication. The cut-off value was less than 2.5%. ResultsThe yearly eradication rates (intention to treat/per protocol) were 78.5/79.5% (2001, n=242), 71.2%/72.9% (2002, n=208), 67.8%/70.5% (2003, n=183), 75.6%/84.6% (2004, n=131), 56.4%/70.5% (2005, n=114), 70.5%/75.8% (2006, n=271), 67.4%/82.0% (2007,n=135), 64.0%/76.3% (2008, n=261), 60.5%/74.3% (2009, n=329), and 66.5%/78.8% (2010, n=370), respectively. Examination of eradication rates according to CAM dosage revealed an eradication rate of 65.6% (383/584) for CAM 400mg daily, and 68.5% (1124/1642) for CAM 800mg daily, with no significant difference seen between dosages. ConclusionIn recent years, eradication rates for first-line triple therapy have obviously decreased, but no noticeable decrease has occurred after 2001.	[Kawai, Takashi] Tokyo Med Univ, Endoscopy Ctr, Tokyo 1608402, Japan; [Kawakami, Kohei] Tokyo Med Univ, Dept Gen Med & Primary Care, Tokyo 1608402, Japan; [Takahashi, Shin'ichi; Tokunaga, Kengo] Kyorin Univ, Sch Med, Dept Internal Med 3, Tokyo, Japan; [Suzuki, Hidekazu; Masaoaka, Tatsuhiro] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Sasaki, Hitoshi; Nagahara, Akihito; Asaoka, Daisuke] Juntendo Univ, Sch Med, Dept Gastroenterol, Tokyo 113, Japan; [Matsuhisa, Takeshi] Nippon Med Sch, Tama Nagayama Univ Hosp, Dept Gastrointestinal Endoscopy, Tokyo 113, Japan; [Nishizawa, Toshihiro; Suzuki, Masayuki] Natl Hosp Org Tokyo Med Ctr, Div Gastroenterol, Tokyo, Japan; [Ito, Masayoshi] Yotsuya Med Cube, Tokyo, Japan; [Kurihara, Naoto] Nerima Gen Hosp, Dept Surg, Tokyo, Japan; [Omata, Fumio] St Lukes Int Hosp, Dept Internal Med, Tokyo, Japan; [Mizuno, Shigeaki] Nihon Univ, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Torii, Akira] Torii Med Clin, Tokyo, Japan; [Sakaki, Nobuhiro] Fdn Detect Early Gastr Canc, Tokyo, Japan; [Ohkusa, Toshifumi] Jikei Univ, Kashiwa Hosp, Dept Gastroenterol & Hepatol, Chiba, Japan; [Mine, Tetsuya] Tokai Univ, Sch Med, Dept Gastroenterol, Hiratsuka, Kanagawa 25912, Japan	Kawai, T (reprint author), Tokyo Med Univ Hosp, Endoscopy Ctr, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	t-kawai@tokyo-med.ac.jp	Suzuki, Hidekazu/J-4396-2013				Ando K, 2003, INT J HEMATOL, V77, P239, DOI 10.1007/BF02983780; Wermeille J, 2002, GASTROEN CLIN BIOL, V26, P216; Kawai T, 2008, J GASTROEN HEPATOL, V23, pS171, DOI 10.1111/j.1440-1746.2008.05408.x; Venerito M, 2013, DIGESTION, V88, P33, DOI 10.1159/000350719; STRANZ MH, 1981, DRUG INTEL CLIN PHAR, V15, P838; Bazzoli F, 1998, ALIMENT PHARM THERAP, V12, P439; Asaka M, 2013, INT J CANCER, V132, P1272, DOI 10.1002/ijc.27965; Kobayashi I, 2007, J CLIN MICROBIOL, V45, P4006, DOI 10.1128/JCM.00740-07; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Nakamura S, 2012, GUT, V61, P507, DOI 10.1136/gutjnl-2011-300495; Asaka M, 2003, J GASTROENTEROL, V38, P339, DOI 10.1007/s005350300061; Bazzoli F, 1997, J Physiol Pharmacol, V48 Suppl 4, P39; Kawai T, 2006, J CLIN BIOCHEM NUTR, V38, P73, DOI 10.3164/jcbn.38.73; Kihira K, 1996, J GASTROENTEROL, V31, P66; Matsukawa J, 2011, BIOCHEM PHARMACOL, V81, P1145, DOI 10.1016/j.bcp.2011.02.009; Miwa H, 2004, HELICOBACTER, V9, P9, DOI 10.1111/j.1083-4389.2004.00194.x; Miwa H, 2001, DIGEST DIS SCI, V46, P2445, DOI 10.1023/A:1012371702918; Miwa H, 1999, ALIMENT PHARM THERAP, V13, P741, DOI 10.1046/j.1365-2036.1999.00526.x; Modlin IM, 2005, DIGESTION, V72, P129, DOI 10.1159/000088368; Rimbara E, 2005, CLIN MICROBIOL INFEC, V11, P307, DOI 10.1111/j.1469-0691.2005.01099.x; Saita H, 1998, J GASTROEN HEPATOL, V13, P725, DOI 10.1111/j.1440-1746.1998.tb00721.x; Suzuki M, 1998, GASTROENTEROL ENDOSC, V10, P989	22	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	DEC	2014	29			4	SI		29	32		10.1111/jgh.12796		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW9MA	WOS:000346580200008		
J	Kawai, T; Yanagizawa, K; Naito, S; Sugimoto, H; Fukuzawa, M; Gotoda, T; Matsubayashi, J; Nagao, T; Hoshino, S; Tsuchida, A; Moriyasu, F				Kawai, Takashi; Yanagizawa, Kyosuke; Naito, Sakiko; Sugimoto, Hiroko; Fukuzawa, Masakatsu; Gotoda, Takuji; Matsubayashi, Jun; Nagao, Toshitaka; Hoshino, Sumito; Tsuchida, Akihiko; Moriyasu, Fuminori			Evaluation of gastric cancer diagnosis using new ultrathin transnasal endoscopy with narrow-band imaging: Preliminary study	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						transnasal endoscopy; gastric cancer; Narrow band imaging; close examination; mucosal structure		Background and AimThe new developed ultrathin transnasal endoscope, the GIF-XP290N, makes possible a resolving power similar to the GIF-H260 at a distance of 3mm. In this study, using the GIF-XP290N, we evaluated whether endoscopic diagnosis (discrimination between benign and malignant) of gastric lesions is possible using nonmagnified narrow-band imaging (NBI) endoscopy. MethodsThe subjects were 255 consecutive patients who underwent screening of the gastrointestinal tract using new ultrathin transnasal endoscopy. Their average age was 65.211.4 years. The male-female ratio was 2.5:1. All cases were examined using conventional white-light imaging (WLI) and nonmagnified NBI. When a depressed lesion was detected in the stomach, it was examined using WLI, then NBI close examination (at about 3mm). We observed the mucosal structure of the lesion using close visualization with NBI. Concerning mucosal structural changes, we looked for a clear demarcation line between the lesion and the surrounding mucosa, and loss, irregularity, or nonuniformity of the lesion mucosal microsurface pattern. ResultsA total of 52 depressed lesions were examined. The histological diagnosis was cancer for 8 lesions, and noncancer for 44 lesions. WLI examination yielded a sensitivity of 50.0% (4/8), specificity of 63.6% (28/44), and accuracy 61.5% (32/52). On the other hand, NBI close examination yielded a sensitivity of 87.5% (7/8), specificity of 93.2% (41/44), and accuracy of 92.3% (48/52), significantly higher. ConclusionNBI close examination using ultrathin transnasal endoscopy enables mucosal diagnosis even without magnification and was considered to be an effective technique for improving endoscopic diagnosis.	[Kawai, Takashi; Yanagizawa, Kyosuke; Naito, Sakiko; Sugimoto, Hiroko] Tokyo Med Univ Hosp, Endoscopy Ctr, Tokyo 1600023, Japan; [Hoshino, Sumito; Tsuchida, Akihiko] Tokyo Med Univ Hosp, Dept Surg 3, Tokyo 1600023, Japan; [Fukuzawa, Masakatsu; Gotoda, Takuji; Moriyasu, Fuminori] Tokyo Med Univ Hosp, Dept Gastroenterol & Hepatol, Tokyo 1600023, Japan; [Matsubayashi, Jun; Nagao, Toshitaka] Tokyo Med Univ Hosp, Dept Anat Pathol, Tokyo 1600023, Japan	Kawai, T (reprint author), Tokyo Med Univ Hosp, Endoscopy Ctr, Shinjuku Ku, 6-7-1 Nishi Shinjuku, Tokyo 1600023, Japan.	t-kawai@tokyo-med.ac.jp					[Anonymous], 2002, BMJ, V324, P71; Toyoizumi H, 2009, GASTROINTEST ENDOSC, V70, P240, DOI 10.1016/j.gie.2008.10.064; Inoue H, 2006, ENDOSCOPY, V38, P891, DOI 10.1055/s-2006-944667; Yao K, 2007, CLIN GASTROENTEROL H, V5, P869, DOI 10.1016/j.cgh.2007.02.034; Kaise M, 2009, ENDOSCOPY, V41, P310, DOI 10.1055/s-0028-1119639; Li Z, 2013, ENDOSCOPY, V45, P79, DOI 10.1055/s-0032-1325762; Ezoe Y, 2011, GASTROENTEROLOGY, V141, P2017, DOI 10.1053/j.gastro.2011.08.007; Kawai T, 2007, HEPATO-GASTROENTEROL, V54, P770; Kato M, 2010, GASTROINTEST ENDOSC, V72, P523, DOI 10.1016/j.gie.2010.04.041; Fujimoto K, 2014, DIGEST ENDOSC, V26, P1, DOI 10.1111/den.12183; Biondi-Zoccai GGL, 2006, EUR HEART J, V27, P2667, DOI 10.1093/eurheartj/ehl334; Kawai T, 2013, DIGEST ENDOSC, V25, P46; Yoshida Y, 2008, DIGEST ENDOSC, V20, P184, DOI 10.1111/j.1443-1661.2008.00804.x	13	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	DEC	2014	29			4	SI		33	36		10.1111/jgh.12797		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW9MA	WOS:000346580200009		
J	Takeuchi, K; Takayama, S; Hashimoto, E; Itayama, M; Amagase, K; Izuhara, C				Takeuchi, Koji; Takayama, Shinichi; Hashimoto, Erika; Itayama, Misaki; Amagase, Kikuko; Izuhara, Chitose			Effect of rebamipide on gastric bleeding and ulcerogenic responses induced by aspirin plus clopidogrel under stimulation of acid secretion in rats	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						aspirin; clopidogrel; gastric bleeding; histamine-stimulated acid secretion; mucosal protective drug; rebamipide	ANTIULCER DRUG; IRSOGLADINE; LESIONS; NEUTROPHILS; OPC-12759; RECEPTOR; DAMAGE; ULCER; CELLS	Background and AimWe examined the prophylactic effect of rebamipide on gastric bleeding induced by the perfusion of aspirin (acetylsalicylic acid [ASA]) plus clopidogrel under the stimulation of acid secretion in rats. MethodsUnder urethane anesthesia, acid secretion was stimulated by the i.v. infusion of histamine (8mg/kg/h), and the stomach was perfused with 25mmol/L ASA at a rate of 0.4mL/min. Gastric bleeding was evaluated as the concentration of hemoglobin in the perfusate. Clopidogrel (30mg/kg) was given p.o. 24h before the perfusion. Rebamipide (3-30mg/kg) or other antiulcer drugs were given i.d. before the ASA perfusion. ResultsSlight gastric bleeding or damage was observed with the perfusion of ASA under the stimulation of acid secretion, whereas these responses were significantly increased in the presence of clopidogrel. Both omeprazole and famotidine inhibited acid secretion and prevented these responses to ASA plus clopidogrel. Rebamipide had no effect on acid secretion, but dose-dependently prevented gastric bleeding in response to ASA plus clopidogrel, with the degree of inhibition being almost equivalent to that of the antisecretory drugs, and the same effects were obtained with the gastroprotective drugs, irsogladine and teprenone. These agents also reduced the severity of gastric lesions, although the effects were less than those of the antisecretory drugs. ConclusionsThese results suggest that the antiplatelet drug, clopidogrel, increases gastric bleeding induced by ASA under the stimulation of acid secretion, and the gastroprotective drug, rebamipide, is effective in preventing the gastric bleeding induced under such conditions, similar to antisecretory drugs.	[Takeuchi, Koji; Takayama, Shinichi; Hashimoto, Erika; Itayama, Misaki; Amagase, Kikuko; Izuhara, Chitose] Kyoto Pharmaceut Univ, Div Pathol Sci, Dept Pharmacol & Expt Therapeut, Kyoto 607, Japan; [Takeuchi, Koji] Gen Inc Assoc, Kyoto Res Ctr Gastrointestinal Dis, Kyoto 6048106, Japan	Takeuchi, K (reprint author), Gen Inc Assoc, Kyoto Res Ctr Gastrointestinal Dis, Karasuma Oike 671, Kyoto 6048106, Japan.	takeuchi@mb.kyoto-phu.ac.jp					KLEINE A, 1993, DIGEST DIS SCI, V38, P1441, DOI 10.1007/BF01308601; Suemasu S, 2009, J BIOL CHEM, V284, P19705, DOI 10.1074/jbc.M109.006817; Akagi M, 2013, CURR PHARM DESIGN, V19, P106; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; YAMASAKI K, 1987, EUR J PHARMACOL, V142, P23; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; YAMASAKI K, 1989, JPN J PHARMACOL, V49, P441, DOI 10.1254/jjp.49.441; [Anonymous], 1994, BMJ, V308, P81; Ibanez L, 2006, ALIMENT PHARM THERAP, V23, P235, DOI 10.1111/j.1365-2036.2006.02759.x; Gilard M, 2006, J THROMB HAEMOST, V4, P2508, DOI 10.1111/j.1538-7836.2006.02162.x; Takeuchi K, 2011, J PHARMACOL EXP THER, V338, P850, DOI 10.1124/jpet.111.183293; Lin KJ, 2011, GASTROENTEROLOGY, V141, P71, DOI 10.1053/j.gastro.2011.03.049; DAVENPOR.HW, 1969, GASTROENTEROLOGY, V56, P439; Ghassemi Kevin A, 2009, Curr Gastroenterol Rep, V11, P462; Gill JM, 2011, ANN FAM MED, V9, P200, DOI 10.1370/afm.1269; Hallas Jesper, 2007, Ugeskr Laeger, V169, P1577; HOLZER P, 1989, GASTROENTEROLOGY, V96, P1425; Izuhara C, 2011, JPN PHARMACOL THER, V39, P421; Kyoi T, 2004, LIFE SCI, V76, P71, DOI 10.1016/j.lfs.2004.06.016; lzuhara C, 2010, PHARMACOL THERAPEUT, V38, P333; Mashita Y, 2006, DIGESTION, V73, P124, DOI 10.1159/000094098; Naito Y, 1998, DIGEST DIS SCI, V43, P30; Ng FH, 2003, ALIMENT PHARM THERAP, V18, P443, DOI 10.1046/j.0269-2813.2003.01693.x; OKABE S, 1974, JPN J PHARMACOL, V24, P363, DOI 10.1254/jjp.24.363; RITCHIE WP, 1975, GASTROENTEROLOGY, V68, P699; Sakurai K, 2005, DIGEST DIS SCI, V50, pS90, DOI 10.1007/s10620-005-2812-5; Takayama S, 2012, J PHYSIOL PHARMACOL, V63, P41; TAKEUCHI K, 1986, AM J PHYSIOL, V250, pG842; Tanigawa T, 2011, J CLIN BIOCHEM NUTR, V48, P1; TERANO A, 1986, DIGESTION, V33, P206; UEDA F, 1995, J PHARMACOL EXP THER, V274, P815; vansRensburg C, 2009, ALIMENT PHARM THER, V229, P497; Watanabe S, 1998, DIGEST DIS SCI, V43, p107S; Yamasaki K, 2009, PHARM MED, V27, P106; Yoshikawa T, 1993, ARZNEIMITTEL-FORSCH, V38, P1441	35	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	DEC	2014	29			4	SI		37	46		10.1111/jgh.12774		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW9MA	WOS:000346580200010		
J	Shiotani, A; Murao, T; Fujita, Y; Fujimura, Y; Sakakibara, T; Nishio, K; Haruma, K				Shiotani, Akiko; Murao, Takahisa; Fujita, Yoshihiko; Fujimura, Yoshinori; Sakakibara, Takashi; Nishio, Kazuto; Haruma, Ken			Single nucleotide polymorphism markers for low-dose aspirin-associated peptic ulcer and ulcer bleeding	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						angiotensin type 1 receptor (AT1R) blockers (ARBs); CHST2; DMET; HMG-Co A reductase inhibitors (statins); SLCO1B	OATP-C SLC21A6; GENETIC POLYMORPHISMS; PRAVASTATIN PHARMACOKINETICS; SLCO1B1 POLYMORPHISM; VARIANTS; INJURY; RATS; SULFOTRANSFERASES; TRANSPORTERS; SIMVASTATIN	Background and AimIn our previous study, the SLCO1B1 521TT genotype and the SLCO1B1*1b haplotype were significantly associated with the risk of peptic ulcer in patients taking low-dose aspirin (LDA). The aim of the present study was to investigate pharmacogenomic profile of LDA-induced peptic ulcer and ulcer bleeding. MethodsPatients taking 100mg of enteric-coated aspirin for cardiovascular diseases and with a peptic ulcer or ulcer bleeding and patients who also participated in endoscopic surveillance were studied. Genome-wide analysis of single nucleotide polymorphisms (SNPs) was performed using the Affymetrix DME Plus Premier Pack. SLCO1B1*1b haplotype and candidate genotypes of genes associated with ulcer bleeding or small bowel bleeding identified by genome-wide analysis were determined using TaqMan SNP Genotyping Assay kits, polymerase chain reaction-restriction fragment length polymorphism, and direct sequencing. ResultsOf 593 patients enrolled, 111 patients had a peptic ulcer and 45 had ulcer bleeding. The frequencies of the SLCO1B1*1b haplotype and CHST2 2082 T allele were significantly greater in patients with peptic ulcer and ulcer bleeding compared to the controls. After adjustment for significant factors, the SLCO1B1*1b haplotype was associated with peptic ulcer (OR 2.20, 95% CI 1.24-3.89) and CHST2 2082 T allele with ulcer bleeding (2.57, 1.07-6.17). ConclusionThe CHST2 2082 T allele as well as SLCO1B1*1b haplotype may identify patients at increased risk for aspirin-induced peptic ulcer or ulcer bleeding.	[Shiotani, Akiko; Murao, Takahisa; Haruma, Ken] Kawasaki Med Univ, Dept Internal Med, Div Gastroenterol, Kurashiki, Okayama 7010192, Japan; [Fujimura, Yoshinori; Sakakibara, Takashi] Sakakibara Heart Inst Okayama, Dept Gastroenterol, Kita Ku, Okayama, Japan; [Fujita, Yoshihiko; Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Sayama, Osaka, Japan	Shiotani, A (reprint author), Kawasaki Med Univ, Dept Internal Med, Div Gastroenterol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	shiotani@med.kawasaki-m.ac.jp					[Anonymous], 2002, BMJ, V324, P71; Link E, 2008, NEW ENGL J MED, V359, P789; Tariq M, 2007, J GASTROEN HEPATOL, V22, P2316, DOI 10.1111/j.1440-1746.2007.05021.x; Shiotani A, 2009, J GASTROENTEROL, V44, P717, DOI 10.1007/s00535-009-0068-0; Shiotani A, 2012, DIGEST LIVER DIS, V44, P201, DOI 10.1016/j.dld.2011.10.005; Nishizato Y, 2003, CLIN PHARMACOL THER, V73, P554, DOI 10.1016/S0009-9236(03)00060-2; Kameyama Y, 2005, PHARMACOGENET GENOM, V15, P513, DOI 10.1097/01.fpc.0000170913.73780.5f; Nozawa T, 2005, DRUG METAB DISPOS, V33, P434, DOI 10.1124/dmd.104.001909; Derry S, 2000, BRIT MED J, V321, P1183, DOI 10.1136/bmj.321.7270.1183; Fukuda M, 2001, J BIOL CHEM, V276, P47747, DOI 10.1047/jbc.R100049200; Shiotani A, 2009, J GASTROENTEROL, V44, P126, DOI 10.1007/s00535-008-2290-6; Scalia R, 2001, CIRCULATION, V103, P2598; Tirona RG, 2003, J PHARMACOL EXP THER, V304, P223, DOI 10.1124/jpet.102.043026; Cryer B, 1999, GASTROENTEROLOGY, V117, P17, DOI 10.1016/S0016-5085(99)70545-7; MCCAFFERTY DM, 1995, GASTROENTEROLOGY, V109, P1173, DOI 10.1016/0016-5085(95)90576-6; Niemi M, 2004, PHARMACOGENETICS, V14, P429, DOI 10.1097/01.fpc.0000114750.08559.32; Pasanen MK, 2006, EUR J CLIN PHARMACOL, V62, P409, DOI 10.1007/s00228-006-0123-1; Shiotani A, 2011, DIGEST DIS SCI, V56, P465, DOI 10.1007/s10620-010-1382-3; Pasanen MK, 2007, CLIN PHARMACOL THER, V82, P726, DOI 10.1038/sj.clpt.6100220; Nozawa T, 2002, J PHARMACOL EXP THER, V302, P804, DOI 10.1124/jpet.302.2.804; Bistrup A, 1999, J CELL BIOL, V145, P899, DOI 10.1083/jcb.145.4.899; Mwinyi J, 2004, CLIN PHARMACOL THER, V75, P415, DOI 10.1016/j.clpt.2003.12.016; Dai XM, 2009, REV CARDIOVASC MED, V10, P14; Tirona RG, 2001, J BIOL CHEM, V276, P35669, DOI 10.1074/jbc.M103792200; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Maeda K, 2008, DRUG METAB PHARMACOK, V23, P223, DOI 10.2133/dmpk.23.223; SANTUCCI L, 1994, GUT, V35, P909, DOI 10.1136/gut.35.7.909; Awtry EH, 2000, CIRCULATION, V101, P1206; Niemi M, 2006, CLIN PHARMACOL THER, V80, P356, DOI 10.1016/j.clpt.2006.06.010; Shiotani A, 2010, J GASTROEN HEPATOL, V25, pS31, DOI 10.1111/j.1440-1746.2009.06212.x; Niemi M, 2005, PHARMACOGENET GENOM, V15, P303; Antiplatelet Trialists' Collaboration, 1994, BMJ-BRIT MED J, V308, P159; HERNANDEZ LA, 1987, AM J PHYSIOL, V253, pH699; Kivisto KT, 2007, PHARM RES, V24, P239, DOI 10.1007/s11095-006-9159-2; Shiotani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084244; Tan Victoria P, 2009, Cardiovasc Revasc Med, V10, P36, DOI 10.1016/j.carrev.2008.11.001; vansOijen MG, 2006, DIGEST DIS SCI, V51, P2348	37	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	DEC	2014	29			4	SI		47	52		10.1111/jgh.12770		6	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW9MA	WOS:000346580200011		
J	Fukuhara, S; Matsuzaki, J; Tsugawa, H; Masaoka, T; Miyoshi, S; Mori, H; Fukushima, Y; Yasui, M; Kanai, T; Suzuki, H				Fukuhara, Seiichiro; Matsuzaki, Juntaro; Tsugawa, Hitoshi; Masaoka, Tatsuhiro; Miyoshi, Sawako; Mori, Hideki; Fukushima, Yasushi; Yasui, Masato; Kanai, Takanori; Suzuki, Hidekazu			Mucosal expression of aquaporin-4 in the stomach of histamine type 2 receptor knockout mice and Helicobacter pylori-infected mice	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						acid suppression; aquaporin-4; SPEM; Helicobacter pylori	PROTON PUMP INHIBITORS; HUMAN GASTRIC-MUCOSA; SONIC HEDGEHOG; MONGOLIAN-GERBILS; MOLECULAR-BIOLOGY; PARIETAL-CELLS; ACID-SECRETION; GROWTH-FACTOR; MOUSE MODEL; CANCER	Background and AimBasolateral water channel, aquaporin-4 (AQP4), is known to be expressed in gastric parietal cells, especially in the basal side of gastric mucosa. However, the role of AQP4 in the stomach is still unknown. Histamine type 2 receptor (H2R) knockout mice, which are characterized by suppressed gastric acid secretion, are known as formation of mucosal hyperplasia with cystic dilatation and spasmolytic polypeptide-expressing metaplasia (SPEM) in the stomach. The aim of the present study is to investigate whether the expression of AQP4 is changed by the condition of acid suppression and Helicobacter pylori infection. MethodsMale H2R knockout mice and their controls (C57BL/6) were used. H.pylori was orally infected at the age of 5 weeks. The distributions of AQP4 and H+/K+-ATPase in the gastric mucosa were investigated by fluorescent immunohistochemistry. The mRNA expressions of AQP4, H+/K+- ATPase, sonic hedgehog (Shh), and trefoil factor-2 (TFF2) were investigated by quantitative reverse transcription polymerase chain reaction (RT-PCR). ResultsIn the H2R knockout mice, the distribution of AQP4-positive parietal cells was extended toward the surface of the fundic glands. Although the mRNA expression levels of AQP4 and H+/K(+)ATPase were elevated in H2R knockout mice at the age of 20 weeks, the elevations were not maintained by aging or H.pylori infection. In H2R knockout mice with H.pylori infection, the expression level of TFF2mRNA was elevated while the ratio between AQP4 and H+/K+ ATPase mRNA expression was decreased compared with the H2R knockout mice without H.pylori infection. ConclusionsIn the H2R knockout mice, massive SPEM was induced by H.pylori colonization and the ratio between AQP4 and H+/K+ ATPase mRNA expression was decreased.	[Fukuhara, Seiichiro; Matsuzaki, Juntaro; Tsugawa, Hitoshi; Masaoka, Tatsuhiro; Miyoshi, Sawako; Mori, Hideki; Kanai, Takanori; Suzuki, Hidekazu] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo 1608582, Japan; [Yasui, Masato] Keio Univ, Sch Med, Dept Pharmacol, Tokyo 1608582, Japan; [Fukushima, Yasushi] Tokyo Eki Ctr Bldg Clin, Tokyo, Japan	Suzuki, H (reprint author), Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol,Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hsuzuki@a6.keio.ac.jp	Suzuki, Hidekazu/J-4396-2013				Abe S, 1997, DIGEST DIS SCI, V42, P1199, DOI 10.1023/A:1018897922644; Xie KP, 2003, CANCER CELL, V4, P245, DOI 10.1016/S1535-6108(03)00246-0; Freeman HJ, 2008, WORLD J GASTROENTERO, V14, P1318, DOI 10.3748/wjg.14.1318; Xu H, 2009, GASTROEN CLIN BIOL, V33, P72, DOI 10.1016/j.gcb.2008.07.010; Aikou S, 2009, DIGEST DIS SCI, V54, P1625, DOI 10.1007/s10620-009-0832-2; Watkins DN, 2004, BIOCHEM PHARMACOL, V68, P1055, DOI 10.1016/j.bcp.2004.04.025; Wang KS, 2000, AM J PHYSIOL-GASTR L, V279, pG448; Leung WK, 2002, J PATHOL, V197, P582, DOI 10.1002/path.1147; Shiotani A, 2005, AM J GASTROENTEROL, V100, P581, DOI 10.1111/j.1572-0241.2005.41001.x; Ishibashi K, 2009, CLIN EXP NEPHROL, V13, P107, DOI 10.1007/s10157-008-0118-6; Li W, 2009, MULT SCLER, V15, P1411, DOI 10.1177/1352458509348961; Hu GY, 2003, WORLD J GASTROENTERO, V9, P910; Hongo M, 2010, J GASTROENTEROL, V45, P618, DOI 10.1007/s00535-010-0207-7; Jain RN, 2006, PHYSIOL GENOMICS, V24, P124, DOI 10.1152/physiolgenomics.00133.2005; Ramalho-Santos M, 2000, DEVELOPMENT, V127, P2763; Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425; Jalving M, 2006, ALIMENT PHARM THERAP, V24, P1341, DOI 10.1111/j.1365-2036.2006.03127.x; Yoshizawa N, 2007, LAB INVEST, V87, P1265, DOI 10.1038/labinvest.3700682; Wang TC, 2000, GASTROENTEROLOGY, V118, P36, DOI 10.1016/S0016-5085(00)70412-4; BEAUCHAMP RD, 1989, J CLIN INVEST, V84, P1017, DOI 10.1172/JCI114223; El-Zaatari M, 2007, BRIT J CANCER, V96, P1855, DOI 10.1038/sj.bjc.6603782; Ishibashi K, 2000, REV PHYSIOL BIOCH P, V141, P1, DOI 10.1007/BFb0119576; Jianu CS, 2012, ALIMENT PHARM THER, V36, P644, DOI 10.1111/apt.12012; Matsuzaki J, 2010, DIGEST DIS SCI, V55, P3339, DOI 10.1007/s10620-010-1167-8; Minegishi Y, 2007, J PATHOL, V213, P161, DOI 10.1002/path.2221; MURAYAMA Y, 1995, GASTROENTEROLOGY, V109, P1051, DOI 10.1016/0016-5085(95)90562-6; Nishizawa T, 2009, DIGESTION, V79, P99, DOI 10.1159/000209219; Suzuki H, 2005, EXPERT OPIN PHARMACO, V6, P59, DOI 10.1517/14656566.6.1.59; Suzuki H, 2005, J PATHOL, V206, P186, DOI 10.1002/path.1763; Tamim H, 2008, DRUG SAFETY, V31, P675; Xia HHX, 2004, J CLIN PATHOL, V57, P861, DOI 10.1136/jcp.2003.015487	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	DEC	2014	29			4	SI		53	59		10.1111/jgh.12771		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW9MA	WOS:000346580200012		
J	Sakakibara, M; Ando, T; Ishiguro, K; Maeda, O; Watanabe, O; Hirayama, Y; Morise, K; Maeda, K; Matsushita, M; Furukawa, K; Funasaka, K; Nakamura, M; Miyahara, R; Goto, H				Sakakibara, Masatoshi; Ando, Takafumi; Ishiguro, Kazuhiro; Maeda, Osamu; Watanabe, Osamu; Hirayama, Yutaka; Morise, Kazuhiro; Maeda, Keiko; Matsushita, Masanobu; Furukawa, Kazuhiro; Funasaka, Kohei; Nakamura, Masanao; Miyahara, Ryoji; Goto, Hidemi			Usefulness of Helicobacter pylori eradication for precancerous lesions of the gastric remnant	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						gastric remnant; Helicobacter pylori eradication; metachronous gastric carcinoma	PEPTIC-ULCERATION; MONGOLIAN GERBILS; INFECTION; CANCER; STOMACH; NORMALIZATION; INFLAMMATION; GASTRECTOMY; CARCINOMA; SURGERY	Background and AimSecondary stomach cancer in lesions of the remnant stomach occurs relatively soon after distal gastrectomy using the Billroth I reconstruction procedure. Prophylactic eradication of Helicobacter pylori after endoscopic resection of early gastric cancer should be used to prevent the development of metachronous gastric carcinoma. However, the effect of H.pylori eradication on the gastric remnant has not been clearly determined. MethodsEight patients who were H.pylori-positive after distal gastrectomy for primary gastric cancer underwent eradication therapy and were followed by endoscopy for 9 years. Upper gastroenteroscopy series were done before and at 1, 3, 5, 7 and 9 years after eradication, and biopsy specimens were taken from the lesser and greater curvatures, respectively. Histological changes, including chronic inflammation, activity, atrophy, and intestinal metaplasia, were evaluated using the updated Sydney system. ResultsSuccessful eradication was confirmed using the urea breath test in all eight patients. Chronic inflammation scores were improved after eradication at both the lesser (mean scoresSD: before eradication, 2.9 +/- 0.5; 1 year after, 2.3 +/- 0.4; 3 years, 1.8 +/- 0.3; 5 years, 1.5 +/- 0.3; 7 years, 1.3 +/- 0.3; and 9 years, 1.0 +/- 0.3) and greater curvatures (before, 2.9 +/- 0.4; 1 year after, 1.9 +/- 0.3; 3 years, 1.4 +/- 0.4; 5 years, 1.3 +/- 0.3; 7 years, 1.1 +/- 0.2; and 9 years, 0.6 +/- 0.3). Atrophy scores improved more quickly after eradication than chronic inflammation scores at both the lesser (before, 2.4 +/- 0.5; 1 year after, 1.8 +/- 0.4; 3 years, 0.8 +/- 0.3; 5 years, 0.3 +/- 0.1; 7 years, 0.0; and 9 years, 0.0) and greater curvatures (before, 2.2 +/- 0.4; 1 year after, 1.3 +/- 0.3; 3 years, 0.5 +/- 0.3; 5 years, 0.0; 7 years, 0.0; and 9 years, 0.0). No secondary stomach cancers were found on endoscopy. ConclusionsUndergoing H.pylori eradication improved possible precancerous lesions of the gastric remnant among patients who had undergone distal gastrectomy. Prophylactic H.pylori eradication in the gastric remnant may be useful in preventing the development of metachronous gastric carcinoma.	[Sakakibara, Masatoshi; Ando, Takafumi; Ishiguro, Kazuhiro; Maeda, Osamu; Watanabe, Osamu; Hirayama, Yutaka; Morise, Kazuhiro; Maeda, Keiko; Matsushita, Masanobu; Furukawa, Kazuhiro; Funasaka, Kohei; Nakamura, Masanao; Miyahara, Ryoji; Goto, Hidemi] Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Nagoya, Aichi 4668550, Japan; [Sakakibara, Masatoshi] Aichi Hosp, Aichi Canc Ctr, Dept Gastroenterol, Okazaki, Aichi, Japan	Ando, T (reprint author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	takafumiando-gi@umin.ac.jp	MAEDA, Osamu/Q-1016-2015				Ando T, 1998, INFECT IMMUN, V66, P4742; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Kato M, 2013, GUT, V62, P1425, DOI 10.1136/gutjnl-2011-301647; Danesh J, 1998, BRIT MED J, V316, P746; MARSHALL BJ, 1984, LANCET, V1, P1311; Watanabe T, 1998, GASTROENTEROLOGY, V115, P642, DOI 10.1016/S0016-5085(98)70143-X; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Honda S, 1998, CANCER RES, V58, P4255; BLASER MJ, 1992, GASTROENTEROLOGY, V102, P720; International Agency for Research on Cancer, 1994, IARC MONOGRAPHS EVAL, V61; Kato S, 2008, J GASTROEN HEPATOL, V23, pS258, DOI 10.1111/j.1440-1746.2008.05447.x; Lee Y, 2004, J GASTROENTEROL, V39, P520, DOI 10.1007/s00535-003-1337-y; OCONNOR HJ, 1986, LANCET, V2, P1178; Safatle-Ribeiro AV, 1998, DIGEST DIS, V16, P159, DOI 10.1159/000016860; SIPPONEN P, 1985, INT J CANCER, V35, P173; Tomtitchong P, 1998, J CLIN GASTROENTEROL, V27, pS154, DOI 10.1097/00004836-199800001-00025	17	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	DEC	2014	29			4	SI		60	64		10.1111/jgh.12772		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW9MA	WOS:000346580200013		
J	Okabe, S; Okamoto, T; Zhao, CM; Chen, D; Matsui, H				Okabe, Susumu; Okamoto, Toshihiro; Zhao, Chun-Mei; Chen, Duan; Matsui, Hirofumi			Acetic acid induces cell death: An in vitro study using normal rat gastric mucosal cell line and rat and human gastric cancer and mesothelioma cell lines	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						acetic acid; KATO III cells; mesothelioma; RGK-1 cells; RGM-1 cells	HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; NITRO-N-NITROSOGUANIDINE; OF-THE-ART; PERITONEAL CARCINOMATOSIS; MOUSE MODEL; EFFICACY; ULCER; PROTEIN; MICE	Background and AimWe recently reported that topical application of acetic acid promptly caused tumor necrosis in a mouse model of gastric cancer. The aim of the present study was to examine whether acetic acid can directly induce cancer cell death. MethodsRat gastric epithelial cell line (RGM-1), rat gastric carcinoma cell line (RGK-1), human gastric cancer cell line (KATO III), and human mesothelioma cell lines (ACC-MESO1 and MSTO-211H) were used. Acetic acid was added into the cell culture at different concentrations for different time periods. Cell death was analyzed by MTT assay, flow cytometry, and trypan blue exclusion test. ResultsAcetic acid promptly induced the cell death of RGM-1, RGK-1 cells, and KATO III cells in a concentration-dependent manner from 0.01% to 0.5%. Acetic acid at 0.5% for 1min induced the cell death by 80%. RGK-1 cells were more sensitive to acetic acid than RGM-l cells. KATO III cells were more sensitive to acetic acid than RGK-1 cells. Acetic acid at 0.5% for 10min induced almost complete cell death of ACC-MESO1 and MSTO-211H. ConclusionsAcetic acid is a powerful anticancer agent. Topical application of acetic acid may be a feasible approach for the treatments of gastric cancer and possibly other malignancies.	[Okabe, Susumu] Gen Corporat Assoc, Kyoto GI Dis Res Ctr, Kyoto 6048106, Japan; [Okamoto, Toshihiro] Juntendo Univ, Grad Sch Med, Dept Therapy Dev & Innovat Immune Disorders & Can, Tokyo, Japan; [Matsui, Hirofumi] Univ Tsukuba, Div Gastroenterol, Tsukuba, Ibaraki, Japan; [Okabe, Susumu; Zhao, Chun-Mei; Chen, Duan] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway	Okabe, S (reprint author), Gen Corporat Assoc, Kyoto GI Dis Res Ctr, Nakagyo Ku, Eclane Oike 1006,671 Marukizaimokucho, Kyoto 6048106, Japan.	susumuokabe@icloud.com					Gunji S, 2013, SURGERY, V154, P991, DOI 10.1016/j.surg.2013.04.054; Haslinger M, 2013, CANCER MED-US, V2, P334, DOI 10.1002/cam4.80; TAKAGI K, 1969, JPN J PHARMACOL, V19, P418, DOI 10.1254/jjp.19.418; Solass W, 2014, ANN SURG ONCOL, V21, P553, DOI 10.1245/s10434-013-3213-1; OKABE S, 1971, AM J DIG DIS, V16, P277, DOI 10.1007/BF02235252; Zucali PA, 2012, LUNG CANCER, V75, P360, DOI 10.1016/j.lungcan.2011.08.011; Yan TD, 2006, J CLIN ONCOL, V24, P4011, DOI 10.1200/JCO.2006.07.1142; Okabe S, 2005, BIOL PHARM BULL, V28, P1321, DOI 10.1248/bpb.28.1321; Wang TC, 2000, GASTROENTEROLOGY, V118, P36, DOI 10.1016/S0016-5085(00)70412-4; Beaujard AC, 2000, CANCER, V88, P2512, DOI 10.1002/1097-0142(20000601)88:11<2512::AID-CNCR12>3.0.CO;2-J; Cheng XY, 2010, ANTI-CANCER DRUG, V21, P362, DOI 10.1097/CAD.0b013e3283355227; Gu ML, 2014, ONCOL LETT, V8, P1739, DOI 10.3892/ol.2014.2354; Kang LY, 2013, J CHIN MED ASSOC, V76, P425, DOI 10.1016/j.jcma.2013.04.004; Kitayama J, 2014, CANCER CHEMOTH PHARM, V73, P605, DOI 10.1007/s00280-014-2393-0; Koga S, 1987, CANCER, V15, P134; Kuribayashi K, 2012, LUNG CANCER, V75, P353, DOI 10.1016/j.lungcan.2011.08.002; Okabe S, 2012, FRONT GASTROINT RES, V30, P32; Okabe S, 2010, GASTROENTEROLOGICA P, V17, P165; Okabe S, 2012, J GASTROEN HEPATOL, V27, P40, DOI 10.1111/j.1440-1746.2012.07070.x; Okada H, 2012, J CLIN BIOCHEM NUTR, V50, P47, DOI 10.3164/jcbn.11-39; Oya-Ito T, 2011, BBA-MOL BASIS DIS, V1812, P769, DOI 10.1016/j.bbadis.2011.03.017; Raphael J, 2014, LUNG CANCER, V85, P251, DOI 10.1016/j.lungcan.2014.05.006; Sano T, 2001, JPN J CLIN ONCOL, V31, P571, DOI 10.1093/jjco/hye141; Shimokawa O, 2008, IN VITRO CELL DEV-AN, V44, P26, DOI 10.1007/s11626-007-9067-8; Sugarbaker PH, 2008, CANCEROLOGIA, V3, P119; Sugarbaker PH, 2012, LANCET ONCOL, V13, P362; Tang L, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-53; Wallace JL, 2011, AM J PATHOL, V178, P1126, DOI 10.1016/j.ajpath.2010.11.048; Zhao CM, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009569	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	DEC	2014	29			4	SI		65	69		10.1111/jgh.12775		5	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW9MA	WOS:000346580200014		
J	Nakamura, M; Takahashi, T; Matsui, H; Baniwa, Y; Takahashi, S; Murayama, SY; Serizawa, H; Suzuki, H; Hibi, T				Nakamura, Masahiko; Takahashi, Tetsufumi; Matsui, Hidenori; Baniwa, Yuko; Takahashi, Shinichi; Murayama, Somay Y.; Serizawa, Hiroshi; Suzuki, Hidekazu; Hibi, Toshifumi			Alteration of angiogenesis in Helicobacter heilmannii-induced mucosa-associated lymphoid tissue lymphoma: Interaction with c-Met and hepatocyte growth factor	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						angiogenesis; c-Met; HGF; MALT lymphoma	TYROSINE KINASE RECEPTOR; B-CELL LYMPHOMA; MESENCHYMAL TRANSITION; MICE; INFECTION; HYPOXIA; CANCER; HGF	Background and AimThe hepatocyte growth factor (HGF)/c-Met pathway has attracted attention in the formation of malignant tumors, as HGF secreted from the microcirculatory components as well as residing macrophages has been suggested to act on the c-Met receptors of cancer cells to decrease apoptosis and increase proliferation, invasion, and metastasis. The present study was undertaken to elucidate the interaction of the gastric, hepatic, and pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma induced by Helicobacter heilmannii infection with c-Met and HGF. MethodsC57BL/6 female mice, infected with H.heilmannii for 3 months were used. The localization of the HGF, c-Met, and HGF activator immunoreactivities was observed by the indirect immunohistochemical methods. In addition, the effect of c-Met antibody and c-Met inhibitor, PHA-665752, was also investigated. Resultsc-Met immunoreactivity was found in the lymphocytes composing the MALT lymphoma, and HGF immunoreactivity was recognized mostly in the endothelial cells and macrophages in the MALT lymphoma. HGFA was localized on mesenchymal cells other than the lymphocytes. The administration of the antibody against c-Met or the c-Met inhibitor to the infected mice induced the significant suppression of hepatic and pulmonary MALT lymphoma, while the gastric MALT lymphoma showed only a tendency to decrease in size, while the active caspase 3 positive cells markedly decreased in the gastric, hepatic, and pulmonary MALT lymphoma after the treatment with the c-Met antibody or the c-Met antagonist. ConclusionsHGF and c-Met pathway were suggested to contribute to the lymphomagenesis in the MALT lymphoma after H.heilmannii infection.	[Nakamura, Masahiko; Takahashi, Tetsufumi; Baniwa, Yuko] Kitasato Univ, Sch Pharmaceut Sci, Res & Educ Ctr Clin Pharm, Div Pathophysiol, Tokyo 1088641, Japan; [Matsui, Hidenori] Kitasato Univ, Kitasato Inst Life Sci, Tokyo 1088641, Japan; [Serizawa, Hiroshi; Hibi, Toshifumi] Kitasato Inst Hosp, Dept Internal Med, Tokyo, Japan; [Suzuki, Hidekazu] Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan; [Takahashi, Shinichi] Kyorin Univ, Dept Internal Med 3, Mitaka, Tokyo, Japan; [Murayama, Somay Y.] Nihon Univ, Sch Pharm, Mol Cell Biol Lab, Funabashi, Chiba, Japan	Nakamura, M (reprint author), Kitasato Univ, Sch Pharmaceut Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	nakamuram@pharm.kitasato-u.ac.jp	Suzuki, Hidekazu/J-4396-2013				Tjin EPM, 2006, BLOOD, V107, P760, DOI 10.1182/blood-2005-05-1929; Goetsch L, 2013, FRONT BIOSCI-LANDMRK, V18, P454, DOI 10.2741/4114; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Cooke VG, 2012, CANCER CELL, V21, P66, DOI 10.1016/j.ccr.2011.11.024; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Lemma S, 2013, HISTOPATHOLOGY, V62, P326, DOI 10.1111/his.12000; Capello D, 2000, LEUKEMIA, V14, P285, DOI 10.1038/sj.leu.2401666; Due AO, 2012, ROM J MORPHOL EMBRYO, V53, P985; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; ITOH T, 1994, GASTROENTEROLOGY, V106, pA99; Jahn SC, 2012, CANCER LETT, V326, P183, DOI 10.1016/j.canlet.2012.08.013; Matsui H, 2008, ANTIMICROB AGENTS CH, V52, P2988, DOI 10.1128/AAC.01662-07; Nakamura M, 2007, INFECT IMMUN, V75, P1214, DOI 10.1128/IAI.01459-06; Nakamura M., 2007, Inflammopharmacology, V15, P115, DOI 10.1007/s10787-006-1549-x; Nishikawa K, 2007, FEMS IMMUNOL MED MIC, V50, P268, DOI 10.1111/j.1574-695X.2007.00252.x	15	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	DEC	2014	29			4	SI		70	76		10.1111/jgh.12776		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW9MA	WOS:000346580200015		
J	Yoshida, M; Goto, N; Kawaguchi, M; Koyama, H; Kuroda, J; Kitahora, T; Iwasaki, H; Suzuki, S; Kataoka, M; Takashi, F; Kitajima, M				Yoshida, Masashi; Goto, Naoki; Kawaguchi, Minoru; Koyama, Hidehiko; Kuroda, Junko; Kitahora, Tetsuji; Iwasaki, Hiroyuki; Suzuki, Shinji; Kataoka, Mikinori; Takashi, Fujii; Kitajima, Masaki			Initial clinical trial of a novel hemostat, TDM-621, in the endoscopic treatments of the gastric tumors	JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY			English	Article						bleeding; endoscopic mucosal resection; endoscopic submucosal dissection; gastric cancer; hemostasis	SUBMUCOSAL DISSECTION; MULTICENTER SURVEY; RISK-FACTORS; PERFORATION; NEOPLASMS; LESIONS	Background and AimThe feasibility of TDM-621, the synthetic infectious agent-free peptides, was tested in hemostasis of the bleeding after endoscopic treatments of the gastric tumors. MethodsThe patients who underwent endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) were enrolled in the present study. The subject of hemostasis was the oozing after the EMR or ESD. The hemostatic effect, the secondary hemorrhage from one postoperative day to the day before discharge and operability were studied. ResultsThe hemostatic effects were assessed in 12 patients. It was remarkably effective in 11 patients and effective in 1 patient. The operability was very easy in two patients, easy in eight patients and acceptable in two patients. No secondary hemorrhage was observed in all of 12 patients. No adverse effect considered to be related to TDM-621 was observed. ConclusionIt was shown that hemostasis using TDM-621 was feasible after endoscopic treatments of the gastric tumors without any technical trouble or adverse event.	[Yoshida, Masashi; Kuroda, Junko; Suzuki, Shinji; Kataoka, Mikinori; Takashi, Fujii; Kitajima, Masaki] Int Univ Hlth & Welf, Mita Hosp, Surg & Digest Dis Ctr, Minato Ku, Tokyo 1088329, Japan; [Goto, Naoki; Kawaguchi, Minoru; Kitahora, Tetsuji; Iwasaki, Hiroyuki] Int Univ Hlth & Welf, Atami Hosp, Ctr Digest Dis, Shizuoka, Japan; [Koyama, Hidehiko] Kurosawa Clin, Chiba, Japan	Yoshida, M (reprint author), Int Univ Hlth & Welf, Mita Hosp, Surg & Digest Dis Ctr, Minato Ku, 1-4-3 Mita, Tokyo 1088329, Japan.	masashi@iuhw.ac.jp					McAvoy NC, 2012, WORLD J GASTROENTERO, V18, P5912, DOI 10.3748/wjg.v18.i41.5912; Ye ZY, 2008, J PEPT SCI, V14, P152, DOI 10.1002/psc.988; Kim HH, 2012, GUT LIVER, V6, P316, DOI 10.5009/gnl.2012.6.3.316; Miyahara K, 2012, DIGESTION, V86, P273, DOI 10.1159/000341422; Masuhara H, 2012, ANN THORAC CARDIOVAS, V18, P444, DOI 10.5761/atcs.oa.12.01977; Akasaka T, 2011, DIGEST ENDOSC, V23, P73, DOI 10.1111/j.1443-1661.2010.01062.x; Chung IK, 2009, GASTROINTEST ENDOSC, V69, P1228, DOI 10.1016/j.gie.2008.09.027; Toyokawa T, 2012, J GASTROEN HEPATOL, V27, P907, DOI 10.1111/j.1440-1746.2011.07039.x; Takizawa K, 2008, ENDOSCOPY, V40, P179, DOI 10.1055/s-2007-995530; Goto O, 2012, DIGEST DIS SCI, V57, P435, DOI 10.1007/s10620-011-1886-5; Matsuhisa T, 1999, Nihon Ika Daigaku Zasshi, V66, P199, DOI 10.1272/jnms.66.199; Nam JG, 2011, ACTA OTO-LARYNGOL, V131, P1293, DOI 10.3109/00016489.2011.611533; Oda I, 2005, DIGEST ENDOSC, V17, P54, DOI 10.1111/j.1443-1661.2005.00459.x	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0815-9319	1440-1746		J GASTROEN HEPATOL	J. Gastroenterol. Hepatol.	DEC	2014	29			4	SI		77	79		10.1111/jgh.12798		3	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AW9MA	WOS:000346580200016		
J	Akahoshi, K; Oya, M; Koga, T; Koga, H; Motomura, Y; Kubokawa, M; Gibo, J; Nakamura, K				Akahoshi, Kazuya; Oya, Masafumi; Koga, Tadashi; Koga, Hidenobu; Motomura, Yasuaki; Kubokawa, Masaru; Gibo, Jyuya; Nakamura, Kazuhiko			Clinical Usefulness of Endoscopic Ultrasound-Guided Fine Needle Aspiration for Gastric Subepithelial Lesions Smaller than 2 cm	JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES			English	Article						EUS-FNA; GIST; SMT; subepithelial lesion; stomach; early diagnosis	GASTROINTESTINAL STROMAL TUMORS; SUBMUCOSAL TUMORS; PROSPECTIVE MULTICENTER; FOLLOW-UP; DIAGNOSIS; BIOPSY; STOMACH; ULTRASONOGRAPHY; GUIDELINES; CONSENSUS	Background & Aims: There is no evidence of postoperative metastasis of gastric gastrointestinal stromal tumors (GISTs) smaller than 2 cm. The aim of this study was to evaluate the clinical usefulness of endoscopic ultrasound guided fine needle aspiration (EUS-FNA) for gastric subepithelial lesions (SELs) smaller than 2 cm. Methods: Using a prospectively maintained EUS-FNA database, 90 consecutive EUS-FNAs of gastric hypoechoic solid SELs smaller than 2 cm diagnosed by EUS were evaluated retrospectively. The reference standards for the final diagnosis were surgery (n=44) and/or clinical follow-up (n=46) using esophagogastroduodenoscopy (EGD), CT, and/or ultrasonography (US). Additionally, immunophenotyping of specimens obtained by EUS-FNA and surgical resection specimens were compared. Results: The diagnostic rate of EUS-FNA for gastric hypoechoic solid SELs smaller than 2 cm was 73% (66/90). Histological diagnosis of EUS-FNA showed 47 (52%) malignant SELs (44 GISTs, 1 glomus tumor, 1 SEL like cancer, and 1 malignant lymphoma), 19 (21%) benign SELs (14 leiomyomas, 4 ectopic pancreas, and 1 neurinoma), and 24 (27%) indeterminate SELs. In 44 surgically resected cases, the diagnostic accuracy of EUS-FNA using immunohistochemical analysis was 98% (43/44). There were no complications. Appropriate management was performed in 65 out of 66 SELs (98%) diagnosed by definitive EUS-FNA. After surgery, there was no recurrence of malignant SELs. Conclusions: EUS-FNA is an accurate and safe method in the pre-therapeutic diagnosis of gastric SELs smaller than 2 cm. EUS-FNA for gastric SELs smaller than 2 cm is a promising way to permit early management of patients with gastric SELs including GIST.	[Akahoshi, Kazuya; Motomura, Yasuaki; Kubokawa, Masaru; Gibo, Jyuya] Aso Iizuka Hosp, Dept Gastroenterol, Iizuka, Fukuoka 8208505, Japan; [Oya, Masafumi] Aso Iizuka Hosp, Dept Pathol, Iizuka, Fukuoka 8208505, Japan; [Koga, Tadashi] Aso Iizuka Hosp, Dept Surg, Iizuka, Fukuoka 8208505, Japan; [Koga, Hidenobu] Aso Iizuka Hosp, Div Cent Lab, Iizuka, Fukuoka 8208505, Japan; [Nakamura, Kazuhiko] Kyushu Univ, Grad Sch Med Sci, Dept Med & Bioregulatory Sci, Fukuoka, Japan	Akahoshi, K (reprint author), Aso Iizuka Hosp, Dept Gastroenterol, 3-83 Yoshio Town, Iizuka, Fukuoka 8208505, Japan.	kakahoshi2@aol.com					Akahoshi Kazuya, 2010, World J Gastrointest Endosc, V2, P271, DOI 10.4253/wjge.v2.i8.271; Sepe PS, 2009, GASTROINTEST ENDOSC, V70, P254, DOI 10.1016/j.gie.2008.11.038; Miettinen M, 2005, AM J SURG PATHOL, V29, P52, DOI 10.1097/01.pas.0000146010.92933.de; Eckardt AJ, 2012, EUR J GASTROEN HEPAT, V24, P1135, DOI 10.1097/MEG.0b013e328356eae2; Polkowski M, 2009, ENDOSCOPY, V41, P329, DOI 10.1055/s-0029-1214447; Joensuu H, 2012, LANCET ONCOL, V13, P265, DOI 10.1016/S1470-2045(11)70299-6; Blay JY, 2005, ANN ONCOL, V16, P566, DOI 10.1093/annonc/mdi127; Akahoshi K, 2007, WORLD J GASTROENTERO, V13, P2077; Lee CK, 2010, GASTROINTEST ENDOSC, V71, P188, DOI 10.1016/j.gie.2009.07.029; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Iglesias-Garcia J, 2011, GASTROINTEST ENDOSC, V73, P1189, DOI 10.1016/j.gie.2011.01.053; Okubo K, 2004, J GASTROENTEROL, V39, P747, DOI 10.1007/s00535-004-1383-0; Casali PG, 2009, ANN ONCOL, V20, P64, DOI 10.1093/annonc/mdp131; Binmoeller KF, 2014, GASTROINTEST ENDOSC, V79, P750, DOI 10.1016/j.gie.2013.09.028; Nishida T, 2008, INT J CLIN ONCOL, V13, P416, DOI 10.1007/s10147-008-0798-7; Ando N, 2002, GASTROINTEST ENDOSC, V55, P37, DOI 10.1067/mge.2002.120323; Chatzipantelis P, 2008, J GASTROINTEST LIVER, V17, P15; Ihara Eikichi, 2013, World J Gastrointest Endosc, V5, P191, DOI 10.4253/wjge.v5.i4.191; Kannengiesser K, 2012, SCAND J GASTROENTERO, V47, P1515, DOI 10.3109/00365521.2012.729082; Larghi A, 2014, ENDOSCOPY, V46, P39, DOI 10.1055/s-0033-1344895; Nishida T, 2013, DIGEST ENDOSC, V25, P479, DOI 10.1111/den.12149; Polkowski M, 2010, ENDOSCOPY, V42, P324, DOI 10.1055/s-0029-1244070; Reichardt P, 2010, EXPERT REV ANTICANC, V10, P221, DOI [10.1586/era.09.171, 10.1586/ERA.09.171]; Rosch T, 2002, SCAND J GASTROENTERO, V37, P856, DOI 10.1080/713786521; Sawaki A, 2006, DIGEST ENDOSC, V18, P40, DOI 10.1111/j.1443-1661.2006.00573.x; Blay JY, 2012, ANN ONCOL, V23, P49, DOI 10.1093/annonc/mds252; von Mehren M, 2014, J NATL COMPR CANC NE, V12, P473	27	1	1	MEDICAL UNIV PRESS	CLUJ-NAPOCA	3RD MEDICAL CLINIC, STR CROITORILOR NO 19-21, CLUJ-NAPOCA, 400162, ROMANIA	1841-8724	1842-1121		J GASTROINTEST LIVER	J. Gastrointest. Liver Dis.	DEC	2014	23	4					405	412				8	Gastroenterology & Hepatology	Gastroenterology & Hepatology	AX1FB	WOS:000346692300012		
J	Dissanayake, AL; Yapa, PD; Nakata, K				Dissanayake, Anusha L.; Yapa, Poojitha D.; Nakata, Kisaburo			Simulation of hydrothermal vents in the Izena Cauldron, Mid Okinawa trough, Japan and other Pacific locations	JOURNAL OF HYDRO-ENVIRONMENT RESEARCH			English	Article						Dante; Endeavour ridge; Hydrothermal vents; Izena; Jade; Mineral distribution	DE-FUCA RIDGE; BUOYANT JETS; HEAT-FLUX; ENDEAVOR; PLUME; MODEL; FIELD; JADE; OIL; DISSOLUTION	Simulation results of Jade hydrothermal vent in Okinawa trough, Japan and Dante hydrothermal vent in Endeavour ridge in the north east Pacific are presented using an improved version of MOHTV model. The results are presented along with some limited field comparisons. A limited study on the sensitivity of model results to key model parameters is also presented. The model used is capable of simulating the hydrodynamics, thermodynamics, and mineral formations in underwater hydrothermal vents. The transport and spread of the plume fluid and minerals formed are simulated in three stages: plume dynamics stage that is momentum and buoyancy driven; transition to far field conditions as a gravity current; and far field conditions where the mineral particles move according to advection diffusion governed by the ambient currents and mineral particle settling velocities that eventually lead to their bed deposition. Thermodynamics include the changes in plume temperature and its related properties such as the vent fluid density. Physico-chemical processes are the chemical reactions that occur in the plume due to the hot vent fluid mixing with cold ambient water. Chemical reactions form new compounds (mostly minerals), which change the plume properties and therefore its behavior. Model simulates the formation of minerals namely FeS, FeS2, ZnS, CuFeS2, CuS, PbS, CaSO4, BaSO4, and Particulate Manganese - PMn. This improved version of MOHTV considers a user defined particles size distribution, the bathymetry of the ocean bottom, and can be used to run long-term simulations. The model results compare reasonably well with the field data. The parametric analyses show, which input and/or ambient conditions most affect the distribution of particles. (C) 2014 International Association for Hydro-environment Engineering and Research, Asia Pacific Division. Published by Elsevier B.V. All rights reserved.	[Dissanayake, Anusha L.; Yapa, Poojitha D.] Clarkson Univ, Dept Civil & Environm Engn, Potsdam, NY 13699 USA; [Nakata, Kisaburo] Meijo Univ, Fac Marine Sci & Technol, Tenpaku, Japan	Yapa, PD (reprint author), Clarkson Univ, Dept Civil & Environm Engn, Potsdam, NY 13699 USA.	dissanal@clarkson.edu; pyapa@clarkson.edu; knakata@ccalumni.meijo-u.ac.jp			Marine Biological Research Institute of Japan, Tokyo; Meijo University, Tenpaku, Japan	This work is supported by Marine Biological Research Institute of Japan, Tokyo and Meijo University, Tenpaku, Japan.	Veirs SR, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC000952; Xu GY, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004188; BAKER ET, 1987, EARTH PLANET SC LETT, V85, P59, DOI 10.1016/0012-821X(87)90021-5; WALKER SL, 1988, MAR GEOL, V78, P217, DOI 10.1016/0025-3227(88)90110-7; Bemis K, 2006, CAH BIOL MAR, V47, P379; Zheng L, 2000, J HYDRAUL ENG-ASCE, V126, P852, DOI 10.1061/(ASCE)0733-9429(2000)126:11(852); GERMAN CR, 1993, EARTH PLANET SC LETT, V116, P129, DOI 10.1016/0012-821X(93)90049-F; HALBACH P, 1989, NATURE, V338, P496, DOI 10.1038/338496a0; Thomson RE, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002337; Toner BM, 2009, NAT GEOSCI, V2, P197, DOI 10.1038/NGEO433; Breier JA, 2012, GEOCHIM COSMOCHIM AC, V88, P216, DOI 10.1016/j.gca.2012.04.003; Kawagucci S, 2010, GEOCHEM J, V44, P507; COWEN JP, 1990, DEEP-SEA RES, V37, P1619, DOI 10.1016/0198-0149(90)90065-4; BUTTERFIELD DA, 1994, J GEOPHYS RES-SOL EA, V99, P9561, DOI 10.1029/93JB03132; KADKO DC, 1990, EARTH PLANET SC LETT, V99, P315, DOI 10.1016/0012-821X(90)90137-M; Marumo K, 1999, GEOCHIM COSMOCHIM AC, V63, P2785, DOI 10.1016/S0016-7037(99)00158-1; Zheng L, 2003, J HYDRAUL RES, V41, P339; Tivey MK, 2007, OCEANOGRAPHY, V20, P50; Glasby GP, 2003, ORE GEOL REV, V23, P299, DOI 10.1016/j.orgeorev.2003.07.001; GINSTER U, 1994, J GEOPHYS RES-SOL EA, V99, P4937, DOI 10.1029/93JB02800; Toner BM, 2012, OCEANOGRAPHY, V25, P209; Anantharaman K, 2013, P NATL ACAD SCI USA, V110, P330, DOI 10.1073/pnas.1215340110; Thomson RE, 2003, NATURE, V424, P545, DOI 10.1038/nature01824; Clift R, 1978, BUBBLES DROPS PARTIC; Dasanayaka LK, 2009, J HYDRO-ENVIRON RES, V2, P243, DOI 10.1016/j.jher.2009.01.004; Dissanayake AL, 2014, J HYDRAUL RES, V52, P49, DOI 10.1080/00221686.2013.854845; DYMOND J, 1988, GEOCHIM COSMOCHIM AC, V52, P2525, DOI 10.1016/0016-7037(88)90310-9; ERI, 2012, PREL ENV IMP ASS HAR; FEELY RA, 1987, J GEOPHYS RES-SOLID, V92, P11347, DOI 10.1029/JB092iB11p11347; GRANBAKKEN D, 1991, ACTA CHEM SCAND, V45, P892, DOI 10.3891/acta.chem.scand.45-0892; Halbach P, 1997, MINER DEPOSITA, V32, P70, DOI 10.1007/s001260050073; Ishibashi J. I., 1991, THESIS U TOKYO; LEE JHW, 1990, J ENVIRON ENG-ASCE, V116, P1085, DOI 10.1061/(ASCE)0733-9372(1990)116:6(1085); Luther GW, 2005, J NANOPART RES, V7, P389, DOI 10.1007/s11051-005-4272-4; Nakashima K., 1995, BIOGEOCHEMICAL PROCE, P487; Tao T., 2013, OCEAN MODEL, V61, P68; Watanabe S., 1995, J OCEANOGR, V51, P239, DOI DOI 10.1007/BF02236527; Yapa PD, 1997, J HYDRAUL RES, V35, P673	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-6443	1876-4444		J HYDRO-ENVIRON RES	J. Hydro-environ. Res.	DEC	2014	8	4					343	357		10.1016/j.jher.2014.05.003		15	Engineering, Civil; Environmental Sciences; Water Resources	Engineering; Environmental Sciences & Ecology; Water Resources	AX1FO	WOS:000346693600003		
J	Sun, G; Gatoh, S; Zhao, ZJ; Kim, S; Suzuki, S; Imamoglu, N; Yu, WW; Matsui, T				Sun, Guanghao; Gatoh, Shinji; Zhao, Zijun; Kim, Seokjin; Suzuki, Satoshi; Imamoglu, Nevrez; Yu, Wenwei; Matsui, Takemi			Vital-CUBE: A Non-Contact Vital Sign Monitoring System Using Medical Radar for Ubiquitous Home Healthcare	JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS			English	Article						Home Healthcare; Medical Radar; Embedded Linux; Heart Rate; Respiration; Smart Phone	MICROWAVE RADAR; FEVER	The aging population and the escalation of healthcare costs are leading concerns for many developed countries, such as Japan. The government has attempted to reduce hospital costs, which can easily be done by using home healthcare. In this study, we developed a non-contact vital sign monitoring system (Vital-CUBE) that uses microwave radar for ubiquitous home healthcare. Microwave radar can contactless monitor tiny movements on the surface of a human body induced by heartbeat and respiration. With the intent to design a system for home healthcare, we developed this system on an embedded Linux platform to create an inexpensive, self-contained, and modular design. Moreover, we connected the system to a smart phone using virtual network computing (VNC) technology, allowing users to immediately and conveniently access the results of measurements. To assess the performance of Vital-CUBE, we tested the system on 16 subjects (22 +/- 3 years old). We compared the heart and respiration rates determined by Vital-CUBE with those measured using contact-type electrocardiograms (ECG) and respiratory effort belts. The Vital-CUBE measurements exhibited a strong positive correlation with those of the reference contact-type sensors (ECG: r = 0.87, p < 0.01; respiratory effort belt: r = 0.91, p < 0.01). The system can be used without attaching biological electrodes to the users and allows fully unconstrained vital sign measurements for home healthcare.	[Sun, Guanghao; Zhao, Zijun; Kim, Seokjin; Matsui, Takemi] Tokyo Metropolitan Univ, Grad Sch Syst Design, Hino, Tokyo 1910065, Japan; [Gatoh, Shinji] Tau Giken Co Ltd, Yokohama, Kanagawa 2240054, Japan; [Suzuki, Satoshi] Kansai Univ, Fac Engn Sci, Dept Engn Mech, Suita, Osaka 5648680, Japan; [Imamoglu, Nevrez; Yu, Wenwei] Chiba Univ, Grad Sch Engn, Dept Med Syst Engn, Chiba 2638522, Japan	Sun, G (reprint author), Tokyo Metropolitan Univ, Grad Sch Syst Design, 6-6 Asahigaoka, Hino, Tokyo 1910065, Japan.				Japan Society for the Promotion of Science (JSPS)	This work was supported by Japan Society for the Promotion of Science (JSPS) Research Fellowships for Young Scientists.	Poh MZ, 2011, IEEE T BIO-MED ENG, V58, P7, DOI 10.1109/TBME.2010.2086456; Kao TYJ, 2013, IEEE T MICROW THEORY, V61, P1649, DOI 10.1109/TMTT.2013.2247620; Li CZ, 2013, IEEE T MICROW THEORY, V61, P2046, DOI 10.1109/TMTT.2013.2256924; Suzuki S, 2008, MED BIOL ENG COMPUT, V46, P709, DOI 10.1007/s11517-007-0298-3; Garbey M, 2007, IEEE T BIO-MED ENG, V54, P1418, DOI 10.1109/TBME.2007.891930; BLAND JM, 1986, LANCET, V1, P307; BRUCE N, 1991, FAM PRACT, V8, P373, DOI 10.1093/fampra/8.4.373; Edwards Chris, 2013, Engineering & Technology, V8, DOI 10.1049/et.2013.0301; Gotoh S., 2011, Journal of Medical Engineering & Technology, V35, P416, DOI 10.3109/03091902.2011.626836; Kamei T, 2013, JPN J NURS SCI, V10, P154, DOI 10.1111/jjns.12039; Kok L., 2014, EUR J HEALTH ECON, P1; LIN JC, 1975, P IEEE, V63, P1530, DOI 10.1109/PROC.1975.9992; Matsui T, 2010, J INFECTION, V60, P271, DOI 10.1016/j.jinf.2010.01.005; Matsui T, 2013, J CLIN MONIT COMPUT, V27, P351, DOI 10.1007/s10877-013-9448-3; Ng EYK, 2005, MED PHYS, V32, P93, DOI 10.1118/1.1819532; OECD, 2013, OECD FACTB 2013 EC E; So I., 2007, P SYNCHR RAD INSTR B; Sun GH, 2014, INT J INFECT DIS, V25, P56, DOI 10.1016/j.ijid.2014.03.1398; Sun G., 2013, P 15 INT C BIOM ENG; Sun GH, 2012, J INFECTION, V65, P591, DOI 10.1016/j.jinf.2012.10.010; Ulyanov S., 1993, P SPIE; Zivin P., 2009, IEEE ANTENN WIREL PR, V8, P939	22	0	0	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	2156-7018	2156-7026		J MED IMAG HEALTH IN	J. Med. Imaging Health Inform.	DEC	2014	4	6					863	867		10.1166/jmihi.2014.1334		5	Mathematical & Computational Biology; Radiology, Nuclear Medicine & Medical Imaging	Mathematical & Computational Biology; Radiology, Nuclear Medicine & Medical Imaging	AX2EY	WOS:000346757500006		
J	Jenny, NZN; Faust, O; Yu, WW				Jenny, Nam Zheng Ning; Faust, Oliver; Yu, Wenwei			Automated Classification of Normal and Premature Ventricular Contractions in Electrocardiogram Signals	JOURNAL OF MEDICAL IMAGING AND HEALTH INFORMATICS			English	Article						Premature Ventricular Contraction; Electrocardiogram; Computer Aided Diagnosis; Discrete Wavelet Transform; Independent Component Analysis; Fuzzy C-Means	ATRIAL-FIBRILLATION; ARRHYTHMIA DETECTION; PATTERN-RECOGNITION; WAVELET TRANSFORMS; SYSTEM; SELECTION; ECG; COMBINATION; PARAMETERS; DIAGNOSIS	The objective of this project was to improve the accuracy of cardiac arrhythmia detection by using advanced signal processing and machine learning methods. The proposed Computer-Aided Diagnosis (CAD) system classified Premature Ventricular Contraction (PVC) and normal Electrocardiogram (ECG) signals using unsupervised machine learning algorithms. The classification quality was measured and expressed as accuracy, Positive Predictive Value (PPV), sensitivity and specificity. The ECG records, which were used to establish the CAD system quality, were obtained from the MIT-BIH arrhythmia database. These signals were analyzed in four stages. The pre-processing stage standardized and improved the ECG signals by subjecting them to Discrete Wavelet Transform (DWT) based noise reduction. The second stage used Independent Component Analysis (ICA) for dimension reduction. The third stage assessed the extracted features with Student's t-test to determine if the features were discriminative enough to serve as classifier input. At the last stage, two unsupervised classifiers, k-means and Fuzzy C-Means (FCM), were used to find clusters. The proposed system achieved: accuracy = 80.94%, sensitivity = 81.10% and specificity = 80.1%.	[Jenny, Nam Zheng Ning] Ngee Ann Polytech, Dept Elect & Comp Engn, Singapore 599489, Singapore; [Faust, Oliver] Habib Univ, Sch Sci & Engn, Karachi 75350, Pakistan; [Yu, Wenwei] Chiba Univ, Dept Med Syst Engn, Chiba 2638522, Japan	Faust, O (reprint author), Ngee Ann Polytech, Dept Elect & Comp Engn, Singapore 599489, Singapore.						Acharya U., 2011, BIOM ENG MECBME 2011, P371; Acharya UR, 2011, IEEE ENG MED BIO, P4489, DOI 10.1109/IEMBS.2011.6091113; Acharya UR, 2012, COMPUT METH PROG BIO, V107, P233, DOI 10.1016/j.cmpb.2011.10.001; Alfaouri M., 2008, AM J APPL SCI, V5, P276; Al-Nashash H, 2000, Technol Health Care, V8, P363; Aman S., 1996, ADV NEURAL INFORM PR, V8, P757; Amo A, 2004, EUR J OPER RES, V156, P495, DOI [10.1016/S0377-2217(03)00002-X, 10.1016/s0377-2217(03)00002-x]; Anand SS, 2011, LANCET, V377, P529, DOI 10.1016/S0140-6736(10)62346-X; Silverman ME, 2006, CIRCULATION, V113, P2775, DOI 10.1161/CIRCULATIONAHA.106.616771; Jekova I, 2004, COMPUT CARDIOL, V31, P357; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Pham DT, 2005, P I MECH ENG C-J MEC, V219, P103, DOI 10.1243/095440605X8298; Acharya UR, 2013, COMPUT METHOD BIOMEC, V16, P222, DOI 10.1080/10255842.2011.616945; Calkins H, 2007, EUROPACE, V9, P335, DOI 10.1093/europace/eum120; Tripathi ON, 2011, HEART RATE AND RHYTHM: MOLECULAR BASIS, PHARMACOLOGICAL MODULATION AND CLINICAL IMPLICATIONS, P3, DOI 10.1007/978-3-642-17575-6_1; Singh BN, 2006, DIGIT SIGNAL PROCESS, V16, P275, DOI 10.1016/j.dsp.2005.12.003; Christov I, 2005, PHYSIOL MEAS, V26, P123, DOI 10.1088/0967-3334/26/1/011; Kanungo T, 2002, IEEE T PATTERN ANAL, V24, P881, DOI 10.1109/TPAMI.2002.1017616; Lim JS, 2009, IEEE T NEURAL NETWOR, V20, P522, DOI 10.1109/TNN.2008.2012031; Martis RJ, 2012, EXPERT SYST APPL, V39, P11792, DOI 10.1016/j.eswa.2012.04.072; Huang C, 2011, IEEE T BIO-MED ENG, V58, P1113, DOI 10.1109/TBME.2010.2096506; Jalife J, 1998, CHAOS, V8, P79, DOI 10.1063/1.166289; Tateno K, 2001, MED BIOL ENG COMPUT, V39, P664, DOI 10.1007/BF02345439; Addison PS, 2005, PHYSIOL MEAS, V26, pR155, DOI 10.1088/0967-3334/26/5/R01; SENHADJI L, 1995, IEEE ENG MED BIOL, V14, P167, DOI 10.1109/51.376755; Martis RJ, 2013, BIOMED SIGNAL PROCES, V8, P888, DOI 10.1016/j.bspc.2013.08.008; Martis RJ, 2013, BIOMED SIGNAL PROCES, V8, P193, DOI 10.1016/j.bspc.2012.08.004; Acharya UR, 2011, PHYSIOL MEAS, V32, P287, DOI 10.1088/0967-3334/32/3/002; Sarkar S, 2008, IEEE T BIO-MED ENG, V55, P1219, DOI 10.1109/TBME.2007.903707; SINGER DH, 1967, CIRC RES, V21, P537; Acharya UR, 2012, IEEE T INSTRUM MEAS, V61, P1045, DOI 10.1109/TIM.2011.2174897; Ball G.H., 1965, ISODATA NOVEL METHOD; Bezdek J. C., 1981, PATTERN RECOGNITION; Cannon C. P., 2008, RAPID ECG INTERPRETA; Cerutti S, 1997, COMPUT CARDIOL, V24, P77; Christov I, 2004, PHYSIOL MEAS, V25, P1281, DOI 10.1088/0967-3334/25/5/017; Dallali A., 2011, ARPN J ENG APPL SCI, V6, P10; Faust O., 2013, J MECH MED BIOL, V13; Faust O., 2012, BIOMEDICAL ENG IEEE, V5, P15; Faust O, 2011, COMPUT METH PROG BIO, V102, P267, DOI 10.1016/j.cmpb.2010.05.002; Faust O, 2014, IMAGE ANALYSIS AND MODELING IN OPHTHALMOLOGY, P245; Fay MP, 2010, STAT SURVEYS, V4, P1, DOI DOI 10.1214/09-SS051; Hadhoud M. M. A., 2006, COMP ENG SYST 2006 I, P262; Huff J., 2006, ECG WORKOUT EXERCISE; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Inan O. T., 2006, BIOMEDICAL ENG IEEE, V53, P2507; Langlois D., 2010, TUTORIALS QUANTITATI, V6, P31; Logan B, 2005, COMPUT CARDIOL, V32, P619; MacQueen J., 1967, P 5 BERK S MATH STAT, P281, DOI DOI 10.1234/12345678; Martis R. J., 2013, INT J NEURAL SYST, V23; Martis RJ, 2013, KNOWL-BASED SYST, V54, P269, DOI 10.1016/j.knosys.2013.09.016; McDonald J. H., 2009, HDB BIOL STAT; Moody GB, 1990, COMPUT CARDIOL, V17, P185; Natale A., 2009, VENTRICULAR TACHYCAR; OLIVER GC, 1971, COMPUT BIOMED RES, V4, P523, DOI 10.1016/0010-4809(71)90063-2; Podrid P. J., 2001, CARDIAC ARRHYTHMIA M; Rowell LB, 1993, HUMAN CARDIOVASCULAR; Sanam T. F., 2011, DETERMINATION PREMAT; SLOCUM J, 1992, J ELECTROCARDIOL, V25, P1, DOI 10.1016/0022-0736(92)90123-H; Sufi F, 2011, IEEE T INF TECHNOL B, V15, P33, DOI 10.1109/TITB.2010.2094197; THAKOR NV, 1991, IEEE T BIO-MED ENG, V38, P785, DOI 10.1109/10.83591; Wang Y, 2001, IEEE T BIO-MED ENG, V48, P989; Wu D, 2012, IND EL APPL ICIEA 20, P1836; Zhou J, 2003, THIRD IEEE SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING - BIBE 2003, PROCEEDINGS, P169	64	1	1	AMER SCIENTIFIC PUBLISHERS	VALENCIA	26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA	2156-7018	2156-7026		J MED IMAG HEALTH IN	J. Med. Imaging Health Inform.	DEC	2014	4	6					886	892		10.1166/jmihi.2014.1336		7	Mathematical & Computational Biology; Radiology, Nuclear Medicine & Medical Imaging	Mathematical & Computational Biology; Radiology, Nuclear Medicine & Medical Imaging	AX2EY	WOS:000346757500010		
J	Madi, M; Zakaria, O; Kasugai, S				Madi, Marwa; Zakaria, Osama; Kasugai, Shohei			Coated vs Uncoated Implants: Bone Defect Configurations After Progressive Peri-implantitis in Dogs	JOURNAL OF ORAL IMPLANTOLOGY			English	Article						dental implants; peri-implantitis; bone defects; hydroxyapatite coat	SURFACE CHARACTERISTICS INFLUENCE; REGENERATION; HUMANS	In this study, hydroxyapatite coated vs uncoated implants were used to evaluate the type and dimensions of bone defects after progressive peri-implantitis in dogs. Thirty-two dental implants with 4 different surfaces-machined (M), sandblasted acid-etched (SA), 1-mu m thin sputter hydroxyapatite (HA)-coated (S), and plasma-sprayed HA-coated (P)-were inserted into the mandibles of 4 beagle dogs after extracting all mandibular premolars. Experimental peri-implantitis was induced after 3 months using ligature to allow for plaque accumulation. After 4 months, ligatures were removed and plaque accumulation continued for 5 months (progression period). The open flap surgery demonstrated 3 patterns of peri-implantitis bone defect: (1) Class I defect: represented as circumferential intra-alveolar bone loss; (2) Class II defect: circumferential intra-alveolar defect with supra-alveolar bone loss exposing the implant surface; and (3) Class III defect: represented as circumferential intra-alveolar defect with supra-alveolar bone loss and buccal dehiscence. Class I was the most frequent (62.5%) defect pattern around implant types M, SA, and S; while implant type-P showed a recurring majority of Class II (62.5%). Comparison among the 4 implant groups revealed a significant defect width (DW) in implant type-P relative to other types (P < 0.01). However, no statistically significant differences were noted for defect depth (DD) (P > 0.05). We concluded that the shape and size of peri-implantitis bone defects were influenced by the type and thickness of the HA coat together with the quantity of the available peri-implant bone. Plasma-sprayed HA-coated implants showed larger peri-implant defects than did thin sputter HA-coated implants.	[Madi, Marwa; Zakaria, Osama; Kasugai, Shohei] Tokyo Med & Dent Univ, Dept Oral Implantol & Regenerat Dent Med, Tokyo, Japan; [Madi, Marwa] Tokyo Med & Dent Univ, Global Ctr Excellence GCOE, Tokyo, Japan	Madi, M (reprint author), Tokyo Med & Dent Univ, Dept Oral Implantol & Regenerat Dent Med, Tokyo, Japan.	marwirm@tmd.ac.jp					Renvert S, 2011, J CLIN PERIODONTOL, V38, P214, DOI 10.1111/j.1600-051X.2010.01661.x; Hayek RRA, 2005, J PERIODONTOL, V76, P1275, DOI 10.1902/jop.2005.76.8.1275; Tatakis DN, 2002, J PERIODONTAL RES, V37, P93, DOI 10.1034/j.1600-0765.2002.00021.x; Schwarz F, 2007, CLIN ORAL IMPLAN RES, V18, P161, DOI 10.1111/j.1600-0501.2006.01320.x; Albouy JP, 2008, CLIN ORAL IMPLAN RES, V19, P997, DOI 10.1111/j.1600-0501.2008.01589.x; Zechner W, 2004, CLIN ORAL IMPLAN RES, V15, P23, DOI 10.1111/j.1600-0501.2004.00984.x; Salvi GE, 2004, INT J ORAL MAX IMPL, V19, P116; Thomas MV, 2011, J DENT RES, V90, P1052, DOI 10.1177/0022034510393967; Shibli JA, 2006, CLIN ORAL IMPLAN RES, V17, P273, DOI 10.1111/j.1600-0501.2005.01167.x; Baron M, 2000, INT J ORAL MAX IMPL, V15, P533; Renvert S, 2009, CLIN ORAL IMPLAN RES, V20, P216, DOI 10.1111/j.1600-0501.2009.01786.x; Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663; Albouy JP, 2011, J CLIN PERIODONTOL, V38, P58, DOI 10.1111/j.1600-051X.2010.01631.x; TONETTI MS, 1993, J PERIODONTOL, V64, P934, DOI 10.1902/jop.1993.64.10.934; Stubinger S, 2005, INT J ORAL MAX IMPL, V20, P203; Zitzmann NU, 2008, J CLIN PERIODONTOL, V35, P286, DOI 10.1111/j.1600-051X.2008.01274.x; Junker R, 2010, CLIN ORAL IMPLAN RES, V21, P189, DOI 10.1111/j.1600-0501.2009.01819.x; Pearce AI, 2007, EUR CELLS MATER, V13, P1; Roos-Jansaker AM, 2003, J CLIN PERIODONTOL, V30, P467, DOI 10.1034/j.1600-051X.2003.00296.x; Hao J, 2011, J MATER SCI-MATER M, V22, P1489, DOI 10.1007/s10856-011-4329-0; Lindhe J, 1992, Clin Oral Implants Res, V3, P9, DOI 10.1034/j.1600-0501.1992.030102.x; Martins MC, 2005, J PERIODONTOL, V76, P1367, DOI 10.1902/jop.2005.76.8.1367; Hulshoff JEG, 1996, J BIOMED MATER RES, V31, P329; Lang N P, 1993, Clin Oral Implants Res, V4, P2, DOI 10.1034/j.1600-0501.1993.040101.x; Madi M, 2012, J BIOINTEGRATION, V2, P111; Mombelli A, 1994, Periodontol 2000, V4, P74, DOI 10.1111/j.1600-0757.1994.tb00007.x; PONTORIERO R, 1994, CLIN ORAL IMPLAN RES, V5, P254, DOI 10.1034/j.1600-0501.1994.050409.x; Serino G, 2011, J BIOMECH, V44, P267, DOI 10.1016/j.jbiomech.2010.10.014; SYED SA, 1980, J PERIODONTAL RES, V15, P123, DOI 10.1111/j.1600-0765.1980.tb00266.x	29	1	1	ALLEN PRESS INC	LAWRENCE	810 E 10TH ST, LAWRENCE, KS 66044 USA	0160-6972	1548-1336		J ORAL IMPLANTOL	J. Oral Implant.	DEC	2014	40	6					661	669		10.1563/AAID-JOI-D-12-00089		9	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	AX1NR	WOS:000346714100005		
J	Murakoshi, K; Itoh, T				Murakoshi, Kei; Itoh, Tamitake			Special issue on Surface-Enhanced Raman Scattering (SERS) Preface	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY C-PHOTOCHEMISTRY REVIEWS			English	Editorial Material									[Murakoshi, Kei] Hokkaido Univ, Fac Sci, Dept Chem, Sapporo, Hokkaido 0600810, Japan; [Itoh, Tamitake] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa 7610395, Japan	Murakoshi, K (reprint author), Hokkaido Univ, Fac Sci, Dept Chem, Sapporo, Hokkaido 0600810, Japan.							0	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-5567	1873-2739		J PHOTOCH PHOTOBIO C	J. Photochem. Photobiol. C-Photochem. Rev.	DEC	2014	21				SI		1	1		10.1016/j.jphotochemrev.2014.10.004		1	Chemistry, Physical	Chemistry	AX4ER	WOS:000346887100001		
J	Yamamoto, YS; Ozaki, Y; Itoh, T				Yamamoto, Yuko S.; Ozaki, Yukihiro; Itoh, Tamitake			Recent progress and frontiers in the electromagnetic mechanism of surface-enhanced Raman scattering	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY C-PHOTOCHEMISTRY REVIEWS			English	Review						Electromagnetic; EM; Vibrational spectroscopy; SERS; Plasmon; Molecular electron	SINGLE QUANTUM-DOT; GOLD SOL PARTICLES; SILVER ELECTRODE; FIELD GRADIENT; MOLECULE DETECTION; METAL-SURFACES; DYE MOLECULES; SPECTROSCOPY; PLASMON; SPECTRA	The electromagnetic (EM) enhancement of the optical responses of molecules close to plasmonic metal nanostructures has been applied for ultra-sensitive detection in vibrational spectroscopy. Recently, the research fields of EM enhancement entered a new regime wherein the enhancement effects are connected to photochemical and photobiological phenomena. For this regime, the conventional theorem used to understand the EM enhancement effect should be re-examined because the experimental conditions are beyond the assumptions in the theorem. Thus, in this review, we firstly overview and summarize the EM mechanism in surface-enhanced Raman scattering (SERS), which is the most general optical response using an EM enhancement, and determine the limitations and problems of the EM mechanism in SERS. Secondly, we discuss the necessity of re-examining the EM mechanism with respect to three breakdowns of the approximations in Fermi's golden rule: the breakdown of the molecular electronic dynamics by the ultra-fast plasmonic de-excitation, the breakdown of the weak coupling between the plasmon and molecular exciton by strong EM enhancement, and the breakdown of the selection rule of SERS by the field-gradient effect. These breakdowns allow the observation and control of molecular functions that remain hidden by previous spectroscopic methods. (C) 2014 Elsevier B.V. All rights reserved.	[Yamamoto, Yuko S.] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1028472, Japan; [Yamamoto, Yuko S.] Kagawa Univ, Fac Engn, Dept Adv Mat Sci, Takamatsu, Kagawa 7610396, Japan; [Ozaki, Yukihiro] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Chem, Sanda, Hyogo 6691337, Japan; [Itoh, Tamitake] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Nanobioanal Res Grp, Takamatsu, Kagawa 7610395, Japan	Ozaki, Y (reprint author), Kwansei Gakuin Univ, Sch Sci & Technol, Dept Chem, Sanda, Hyogo 6691337, Japan.	ozaki@kwansei.ac.jp; tamitake-itou@aist.go.jb			Japan Society for the Promotion of Science (JSPS) KAKENHI [20510111, 26286066, 26810013]; JSPS [26.40216]	We thank Mr. Yuya Kayano (Kagawa Univ., Japan) for his support of format collection in References section and obtaining permissions of Figures from publishers. This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grantin-Aid for Scientific Research (C) number 20510111, (B) number 26286066, WAKATE (B) number 26810013. This work was also supported by JSPS Restart Postdoctral Fellowship (RPD) number 26.40216.	Aikens CM, 2013, NAT PHOTONICS, V7, P508, DOI 10.1038/nphoton.2013.153; Anger Pascal, 2006, Phys Rev Lett, V96, P113002; Wang S, 2014, J PHYS CHEM LETT, V5, P1433, DOI 10.1021/jz5004439; Takase M, 2013, NAT PHOTONICS, V7, P550, DOI [10.1038/nphoton.2013.129, 10.1038/NPHOTON.2013.129]; SASS JK, 1981, J PHYS CHEM-US, V85, P621, DOI 10.1021/j150606a002; WANG DS, 1981, PHYS REV B, V24, P1777, DOI 10.1103/PhysRevB.24.1777; VONRABEN KU, 1981, CHEM PHYS LETT, V79, P465, DOI 10.1016/0009-2614(81)85015-4; Dulkeith E, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.203002; RITCHIE G, 1981, PHYS REV B, V24, P4843, DOI 10.1103/PhysRevB.24.4843; Reithmaier JP, 2004, NATURE, V432, P197, DOI 10.1038/nature02969; Jain PK, 2012, P NATL ACAD SCI USA, V109, P8016, DOI 10.1073/pnas.1121319109; Ueno K, 2013, J PHOTOCH PHOTOBIO C, V15, P31, DOI 10.1016/j.jphotochemrev.2013.04.001; Kneipp K, 1998, PHYS REV E, V57, pR6281, DOI 10.1103/PhysRevE.57.R6281; Andreani LC, 1999, PHYS REV B, V60, P13276, DOI 10.1103/PhysRevB.60.13276; WETZEL H, 1980, CHEM PHYS LETT, V76, P460, DOI 10.1016/0009-2614(80)80647-6; Itoh T, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3675567; MOSKOVITS M, 1985, REV MOD PHYS, V57, P783, DOI 10.1103/RevModPhys.57.783; Tam F, 2007, NANO LETT, V7, P496, DOI 10.1021/nl062901x; Perry SS, 1996, J CHEM PHYS, V104, P6856, DOI 10.1063/1.471352; MOSKOVITS M, 1978, J CHEM PHYS, V69, P4159, DOI 10.1063/1.437095; Kneipp K, 1997, PHYS REV LETT, V78, P1667, DOI 10.1103/PhysRevLett.78.1667; Yoshie T, 2004, NATURE, V432, P200, DOI 10.1038/nature03119; Cho CH, 2013, NAT PHOTONICS, V7, P285, DOI 10.1038/NPHOTON.2013.25; Dirac PAM, 1927, P R SOC LOND A-CONTA, V114, P243, DOI 10.1098/rspa.1927.0039; Le Ru EC, 2006, CHEM PHYS LETT, V423, P63, DOI 10.1016/j.cplett.2006.03.042; Cho CH, 2011, NAT MATER, V10, P669, DOI [10.1038/nmat3067, 10.1038/NMAT3067]; Polubotko AM, 2005, J RAMAN SPECTROSC, V36, P522, DOI 10.1002/jrs.1344; Taylor JR, 2000, ANAL CHEM, V72, P1979, DOI 10.1021/ac9913311; Nagasawa F, 2014, J PHYS CHEM LETT, V5, P14, DOI 10.1021/jz402243a; Haslett TL, 2000, J CHEM PHYS, V113, P1641, DOI 10.1063/1.481952; Iida T, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3551710; Xu HX, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.243002; Itoh T, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3489920; Wu DY, 2008, CHEM SOC REV, V37, P1025, DOI 10.1039/b707872m; LIPPITSCH ME, 1980, CHEM PHYS LETT, V74, P125; Schlather AE, 2013, NANO LETT, V13, P3281, DOI 10.1021/nl4014887; Zhang Q, 2012, NANO LETT, V12, P6420, DOI 10.1021/nl3037867; Itoh T, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.085405; Birke RL, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3431210; ALBRECHT MG, 1977, J AM CHEM SOC, V99, P5215, DOI 10.1021/ja00457a071; Xu HX, 1999, PHYS REV LETT, V83, P4357, DOI 10.1103/PhysRevLett.83.4357; LOMBARDI JR, 1986, J CHEM PHYS, V84, P4174, DOI 10.1063/1.450037; Dong ZC, 2010, NAT PHOTONICS, V4, P50, DOI 10.1038/NPHOTON.2009.257; CREIGHTON JA, 1979, J CHEM SOC FARAD T 2, V75, P790, DOI 10.1039/f29797500790; OTTO A, 1992, J PHYS-CONDENS MAT, V4, P1143, DOI 10.1088/0953-8984/4/5/001; Itoh T, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3146788; Cade NI, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.241404; Xu HX, 2000, PHYS REV E, V62, P4318, DOI 10.1103/PhysRevE.62.4318; Savage KJ, 2012, NATURE, V491, P574, DOI 10.1038/nature11653; Manjavacas A, 2011, NANO LETT, V11, P2318, DOI 10.1021/nl200579f; Dintinger J, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.035424; Kneipp K, 1996, PHYS REV LETT, V76, P2444, DOI 10.1103/PhysRevLett.76.2444; Itoh T, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.195436; Iida T, 2009, PHYS STATUS SOLIDI A, V206, P980, DOI 10.1002/pssa.200881299; MOSKOVITS M, 1982, J CHEM PHYS, V77, P1655, DOI 10.1063/1.444008; JEANMAIRE DL, 1977, J ELECTROANAL CHEM, V84, P1, DOI 10.1016/S0022-0728(77)80224-6; Le Ru EC, 2007, J PHYS CHEM C, V111, P16076, DOI 10.1021/jp076003g; Kneipp K, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.081401; Galloway CM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.063003; Wu XH, 2010, OPT EXPRESS, V18, P23633, DOI 10.1364/OE.18.023633; Campion A, 1998, CHEM SOC REV, V27, P241, DOI 10.1039/a827241z; Chulhai DV, 2013, J PHYS CHEM C, V117, P19622, DOI 10.1021/jp4062626; Savasta S, 2010, ACS NANO, V4, P6369, DOI 10.1021/nn100585h; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Christ A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.183901; Ni WH, 2010, NANO LETT, V10, P77, DOI 10.1021/nl902851b; Yoshida K, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.085419; Ayars EJ, 2000, PHYS REV LETT, V85, P4180, DOI 10.1103/PhysRevLett.85.4180; Bellessa J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.036404; Bohren C. F., 1983, ABSORPTION SCATTERIN; Brolo AG, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.045424; Buckingham A. D., 1967, ADV CHEM PHYS, V12, P107, DOI DOI 10.1002/9780470143582.CH2; FLEISCHMANN M, 1974, CHEM PHYS LETT, V26, P163, DOI 10.1016/0009-2614(74)85388-1; Fox M, 2006, QUANTUM OPTICS INTRO; Hakala TK, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.053602; INOUE M, 1983, J PHYS SOC JPN, V52, P3853, DOI 10.1143/JPSJ.52.3853; Itoh T, 2006, J PHOTOCH PHOTOBIO A, V183, P322, DOI 10.1016/j.jphotochem.2006.06.031; Itoh T, 2006, J PHYS CHEM B, V110, P9579, DOI 10.1021/jp0609939; Itoh T, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.235408; Jayachandra B., 2014, PLASMONICS, V9, P349; Johansson P, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.035427; Kedziora GS, 1999, SPECTROCHIM ACTA A, V55, P625, DOI 10.1016/S1386-1425(98)00266-2; Kneipp K, 1998, APPL SPECTROSC, V52, P175, DOI 10.1366/0003702981943275; LeRu EC, 2009, PRINCIPLES OF SURFACE-ENHANCED RAMAN SPECTROSCOPY: AND RELATED PLASMONIC EFFECTS, P1; Ru EC, 2008, CURR APPL PHYS, V8, P467, DOI 10.1016/j.cap.2007.10.073; Morral AFI, 2012, NAT MATER, V11, P272, DOI 10.1038/nmat3284; MOSKOVITS M, 1980, J CHEM PHYS, V73, P6068, DOI 10.1063/1.440142; Polubotko AM, 2012, CHEM PHYS LETT, V519-20, P110, DOI 10.1016/j.cplett.2011.10.008; Purcell E.M., 1953, PHYS REV, V92, P1069; SELANGER KA, 1977, J PHYS CHEM-US, V81, P1960, DOI 10.1021/j100535a016; Sun G, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.063410; van Hulst NF, 2012, NAT NANOTECHNOL, V7, P775, DOI 10.1038/nnano.2012.213; Yamamoto YS, 2014, FRONT PHYS-BEIJING, V9, P31, DOI 10.1007/s11467-013-0347-3; Yoshida K, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3276564; Yoshida K, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.115406	95	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-5567	1873-2739		J PHOTOCH PHOTOBIO C	J. Photochem. Photobiol. C-Photochem. Rev.	DEC	2014	21				SI		81	104		10.1016/j.jphotochemrev.2014.10.001		24	Chemistry, Physical	Chemistry	AX4ER	WOS:000346887100006		
J	Takahashi, R; Sato, Y; Oue, S; Heguri, S; Nakano, H				Takahashi, Ryo; Sato, Yuki; Oue, Satoshi; Heguri, Shinichi; Nakano, Hiroaki			Effect of Electrolysis Condition on the Lightness and Surface Morphology of Ni Deposited from Chloride Electro-Winning Solutions	JOURNAL OF THE JAPAN INSTITUTE OF METALS			Japanese	Article						electrodeposition; nickel; lightness of deposits; morphology; microstructure; chloride solution; surface oxide	ELECTROGALVANIZED STEEL SHEETS; PREADSORPTION; APPEARANCE; ADDITIVES; NICKEL	To investigate the effect of current density and pH in solution on the lightness and surface morphology of deposited Ni, Ni electrodeposition was performed at current density 100 to 500 A. m(-2) and the amount of charge 7.2x105 C. m(-2) in unagitated chloride solution of pH 1 to 3 at 333 K. The composition and structure of the surface of the deposits were analyzed by radio frequency glow discharge optical emission spectroscopy and three dimensional SEM. The lightness of deposited Ni decreased with increasing pH, and became to be minimum at 300 A. m(-2). The concentration of the surface oxide of deposits increased with pH, and became high at 300 A. m(-2), which shows that the surface oxide of the deposits causes the decrease in the lightness. On the other hand, the surface of the deposited Ni was composed of both the pyramid microcrystals of several micrometers and the hill formed by the aggregations of pyramid microcrystals. To separate the two structural units of the pyramid microcrystals and the hill, the deposits were cut every 200 nm from the top to the thickness direction in three dimensional SEM, and the number and area of deposits in the cutting plane were measured, as a result, it was found that the lightness of the deposited Ni depended on the surface structure. The lightness of deposited Ni seems to depend on both the surface oxide and the microstructure of deposits.	[Takahashi, Ryo; Sato, Yuki] Kyushu Univ, Grad Sch Engn, Dept Mat Proc Engn, Fukuoka 8128581, Japan; [Oue, Satoshi; Nakano, Hiroaki] Kyushu Univ, Fac Engn, Dept Mat Sci & Engn, Fukuoka 8128581, Japan; [Heguri, Shinichi] Sumitomo Met Min Co Ltd, Niihama Res Labs, Niihama, Ehime 7920002, Japan	Takahashi, R (reprint author), Kyushu Univ, Grad Sch Engn, Dept Mat Proc Engn, Fukuoka 8128581, Japan.						Nakano H, 2009, ISIJ INT, V49, P1769; Nakano H, 2013, TETSU TO HAGANE, V99, P700, DOI 10.2355/tetsutohagane.99.700; Holm M, 2000, MINER ENG, V13, P193, DOI 10.1016/S0892-6875(99)00165-X; JI J, 1995, J APPL ELECTROCHEM, V25, P642; WINAND R, 1991, J APPL ELECTROCHEM, V21, P377, DOI 10.1007/BF01024572; Nakano H, 2008, ISIJ INT, V48, P634, DOI 10.2355/isijinternational.48.634; Hayashi T., 1986, KINO MEKKI HIMAKU BU, P71; Ise H., 1996, DENCHU GIZYUTSU OUYO, P74; Ishikawa Y., 1994, J MMIJ, V110, P913; Kawasaki M., 1988, MEKKI KYOHON, P79; Kurokawa M., 2007, J MMIJ, V123, P678; Lu J., 2010, T NONFERR METAL SOC, V20, P97; The Japan Inst. Metals, 1980, HIT KINZ SEIR, p[240, 279]; Watanabe T., 1989, J FINISH SOC JPN, V40, P280; Wesley W.A., 1939, Transactions of the Electrochemical Society, V75, DOI 10.1149/1.3498368; Willson K. S., 1964, TECH P AM ELECTROPLA, V51, P92; Yasuda M., 1990, J SURF FINISH SOC JP, V41, P312	17	0	0	JAPAN INST METALS	SENDAI	1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN	0021-4876	1880-6880		J JPN I MET	J. Jpn. Inst. Met.	DEC	2014	78	12					427	433		10.2320/jinstmet.J2014033		7	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	AX3TO	WOS:000346861800001		
J	Takemoto, Y; Wada, K; Asakura, K; Senuma, T; Kunieda, T; Fujii, H				Takemoto, Yoshito; Wada, Keita; Asakura, Kenta; Senuma, Takehide; Kunieda, Tomonori; Fujii, Hideki			Influence of Predeformation on Tempering Structure of Ti-5Al-2Fe-3 Mo Alloy	JOURNAL OF THE JAPAN INSTITUTE OF METALS			English	Article						lilanium alloy; alpha"-martensite; age hardening; variant; tempering	MECHANICAL-PROPERTIES; TI-4FE-7AL ALLOY; TI-MO; BEHAVIOR; MICROSTRUCTURE; TRANSFORMATION	A near-beta-type Ti-5Al-2Fe-3Mo alloy (Super-TIX (R) 523AFM) was developed as a low-cost and high-strength material for automotive components such as intake valves. Its mechanical properties, such as strength, elongation and Young's modulus, are adjustable via the solution treatment temperature. Furthermore, a unique phenomenon different from the shape memory effect that appears after tempering has recently been discovered in the alloy. In this study, the influence of predeformation on the microstructural evolution attributed to the tempering of the alloy quenched from 900 degrees C (alpha + beta) was investigated to clarify the cause of the unique phenomenon. Although the phase constitution of the quenched specimen was alpha + beta, the effective Mo equivalency (6.5Mo(effeq)) of the phase was lower than the minimum beta composition (10Mo(effeq)) in common beta alloys. Work. induced alpha" martensite plates consisting of single alpha" variant including nanosize beta domains were formed in the beta-phase by cold-rolling. Upon heating the rolled specimen to around 250 degrees C, the plates vanished owing to the alpha"->beta inverse transformation and the hardness decreased. However, when the rolled specimen was heated to 450 degrees C, the hardness markedly increased as a result of the beta ->alpha" transformation, and the plates were formed again. The plates consist of a single alpha" variant, but the alpha" lattice is not extensively continuous and is divided into nanosize domains by boundaries containing many faults. It is considered that the evolution of single-alpha"-variant plates generates a large distortion due to the transformation strain and leads to the unique shape change. Such plates were not formed in undeformed specimen by aging at 450 degrees C, and the beta-phase was transformed into a nanosize domain structure composed of multiple alpha" variants. Consequently, these fine structure in the undeformed specimen led to its higher hardness than that of the rolled specimen.	[Takemoto, Yoshito; Wada, Keita; Asakura, Kenta; Senuma, Takehide] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Asakura, Kenta; Kunieda, Tomonori; Fujii, Hideki] Nippon Steel & Sumitomo Met Co Ltd, Futtsu 2938511, Japan	Takemoto, Y (reprint author), Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan.						Takemoto Y, 2013, J JPN I MET, V77, P368, DOI 10.2320/jinstmet.J2013027; Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019; Takemoto Y, 2004, MATER TRANS, V45, P1571, DOI 10.2320/matertrans.45.1571; Takemoto Y, 2012, J JPN I MET, V76, P332, DOI 10.2320/jinstmet.76.332; Takemoto Y, 2012, J JPN I MET, V76, P449, DOI 10.2320/jinstmet.76.449; Takemoto Y, 2009, J JPN I MET, V73, P752, DOI 10.2320/jinstmet.73.752; Collings E. W., 1994, MAT PROPERTIES HDB T, P1; Ikeda M., 2004, DENKI SEIKO, V75, P107; Kunieda T., 2012, CAMP ISIJ, V25, P1285; Kunieda T., 2013, CAMP ISIJ, V26, P442; Nishimura T., 1999, TITAN NO KAKOUGIJYUT, P1; Takemoto Y, 2006, J JPN I MET, V70, P110, DOI 10.2320/jinstmet.70.110	12	0	0	JAPAN INST METALS	SENDAI	1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN	0021-4876	1880-6880		J JPN I MET	J. Jpn. Inst. Met.	DEC	2014	78	12					434	440		10.2320/jinstmet.J2014035		7	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	AX3TO	WOS:000346861800002		
J	Tobiyama, Y; Tada, M; Fujita, S; Takeyama, M				Tobiyama, Yoichi; Tada, Masahiko; Fujita, Sakae; Takeyama, Masao			Effect of Iron Sulfide on Oxidation of Si. Bearing Steel Prior to Reducing Anneal during Galvanizing Process	JOURNAL OF THE JAPAN INSTITUTE OF METALS			Japanese	Article						silicon; manganese; steel; oxidation; galvanizability; diffusion; iron oxide; sulfur; ammonium sulfate; iron sulfide; silicate	MN; GALVANIZABILITY; ALLOYS; ATMOSPHERES; WETTABILITY; BEHAVIOR; OXIDE	Effect of pre-treatment by sulfate solution on the oxidation of Si. bearing steel prior to reducing anneal was investigated to improve the galvanizability of the steel in galvanizing. Ammonium sulfate and diluted sulfuric acid accelerate the oxidation of the Si-bearing steel: they produce the same amount of iron oxide as a steel without silicon. Silicate containing iron and manganese, which retards the outer diffusion of iron ions during oxidation, is continuously formed at the interface between an iron oxide film and the steel without ammonium sulfate. FeS, generated by the reaction of SO2 from (NH4) 2SO4 and steel, is observed in the iron oxide film near the interface between the iron oxide film and the steel treated with ammonium sulfate. Iron ions diffuse through FeS after this reaction. Ammonium sulfate accelerates the oxidation of the Si-bearing steel not only because FeS acts as the outer diffusion path of iron ions but also because the formation of silicate is delayed due to the generation of SO2.	[Tobiyama, Yoichi; Tada, Masahiko; Fujita, Sakae; Takeyama, Masao] JFE Steel Corp, Steel Res Lab, Fukuyama, Hiroshima 7218501, Japan; [Tada, Masahiko; Takeyama, Masao] Tokyo Inst Technol, Dept Met & Ceram Sci, Tokyo 1528552, Japan	Tobiyama, Y (reprint author), JFE Steel Corp, Steel Res Lab, Fukuyama, Hiroshima 7218501, Japan.						Bellhouse EM, 2012, METALL MATER TRANS A, V43A, P2426, DOI 10.1007/s11661-011-0983-6; Bellhouse EM, 2010, METALL MATER TRANS A, V41A, P1539, DOI 10.1007/s11661-010-0192-8; Li F, 2011, J COAT TECHNOL RES, V8, P639, DOI 10.1007/s11998-011-9334-1; ARNOLD JL, 1977, METALL TRANS B, V8, P399, DOI 10.1007/BF02696926; De Bruycker E, 2004, STEEL RES INT, V75, P147; Fujibayashi N., 1997, CAMP ISIJ, V10, P609; Fushiwaki Y., 2009, CAMP ISIJ, V22, P1407; Hashimoto I, 2003, TETSU TO HAGANE, V89, P31; Hertveldt I, 2001, MATER SCI TECH-LOND, V17, P1508; Himeno M., 1981, TETSU TO HAGANE, V67, pS1000; Hirose Y., 1982, TETSU TO HAGANE, V68, P2551; Hirose Y., 1982, TETSU TO HAGANE, V68, P665; Hori M., 1996, CAMP ISIJ, V9, P512; Hori M., 1997, CAMP ISIJ, V10, P607; Hori M., 1994, CAMP ISIJ, V7, P602; Ikeda Y., 1982, KINZOKUZAIRYO KOUONS, P85; Ikeda Y., 1982, KINZOKUZAIRYO KOUONS, P139; Ikeda Y., 1982, KINZOKUZAIRYO KOUONS, P63; Ikeda Y., 1982, KINZOKUZAIRYO KOUONS, P103; Ikeda Y., 1982, KINZOKUZAIRYO KOUONS, P158; Ikeda Y., 1982, KINZOKUZAIRYO KOUONS, P15; Isobe M., 1995, CAMP ISIJ, V8, P649; Kim Y, 2010, METALL MATER TRANS B, V41, P872, DOI 10.1007/s11663-010-9366-4; Komatsu A., 1998, NISSHIN STEEL TECH R, V77, P1; Kubaschewski O., 1965, METALLURGICAL THERMO, P421; Kurokawa K., 1981, CORROS ENG, V30, P396; KUSABIRAKI K, 1991, TETSU TO HAGANE, V77, P123; Li XS, 2007, SCRIPTA MATER, V57, P113, DOI 10.1016/j.scriptamat.2007.03.040; MORITO N, 1977, CORROS SCI, V17, P961; NAKAMURA H, 1980, NIPPON KAGAKU KAISHI, P706; Nishimoto A., 1982, TETSU TO HAGANE, V68, P1404; Ooi T., 1994, CAMP ISIJ, V7, P1513; Ooi T., 1994, CAMP ISIJ, V7, P603; Suzuki Y., 2005, CAMP ISIJ, V18, P1501; Suzuki Y, 2007, TETSU TO HAGANE, V93, P489; Suzuki Y., 2004, J SURF FINISH SOC JP, V55, P48; Takada Y, 2006, TETSU TO HAGANE, V92, P21; Tobiyama Y, 2012, ISIJ INT, V52, P115, DOI 10.2355/isijinternational.52.115; Tsuchiya Y, 2000, TETSU TO HAGANE, V86, P396; Turkdogan E.T., 1980, PHYSICAL CHEM HIGH T, P5; Umino S., 1994, CAMP ISIJ, V7, P1512; Yamato K., 1991, 138 NISHIYAMA KINEN, P1	42	1	1	JAPAN INST METALS	SENDAI	1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN	0021-4876	1880-6880		J JPN I MET	J. Jpn. Inst. Met.	DEC	2014	78	12					441	448		10.2320/jinstmet.J2014030		8	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	AX3TO	WOS:000346861800003		
J	Yamada, M; Yamasaki, T; Fujita, K; Yokoyama, Y; Kim, DH				Yamada, Masahiro; Yamasaki, Tohru; Fujita, Kazutaka; Yokoyama, Yoshihiko; Kim, Do Hyang			Effects of Au-Addition on Plastic Deformation Ability of Zr-Cu-Ni-Al Bulk Metallic Glasses	JOURNAL OF THE JAPAN INSTITUTE OF METALS			Japanese	Article						zirconium-copper-nickel-aluminum-gold; bulk metallic glass; viscosity of a supercooled liquid; plastic deformation	INDUCED NANOCRYSTAL FORMATION; QUASI-CRYSTALLINE PHASE; SUPERCOOLED-LIQUID; SHEAR-BAND; AMORPHOUS-ALLOYS; MECHANICAL-PROPERTIES; ROOM-TEMPERATURE; SERRATED FLOW; MOLECULAR DIMENSIONS; VISCOUS-FLOW	Effects of Au-addition on plastic deformation ability of Zr-Cu-Ni-Al bulk metallic glasses (BMGs) during compression and tensile tests have been examined. Zr65Cu20Ni5Al10 BMG(Zr-65) and Zr60+xCu22-xNi5Al10Au3(x= 0, 5, 6.5, 8, 9 at.) BMGs (Zr60Au3-Zr69Au3) have been prepared by a tilt casting method. By the Au. addition on the BMGs containing Zr. content of 65 at. and more, precipitation of icosahedral quasicrystalline phase (I. phase) in supercooled liquids was observed, resulting in large increase of viscosity in the supercooled liquids. Compression and tensile tests were carried out in these BMGs under various strain rates of 1 similar to 5x10 (4)/s at room temperature. In the compression test of the Zr65 BMG, plastic strain at fracture was about 10. and only several localized shear bands were observed. In the Zr65Au3 and Zr66.5Au3 BMGs, plastic strains at fracture were largely increased to 20. and above. In these cases, initial plastic strains of about 5. with large number of shear band were observed as macroscopically homogeneous deformation, and successive plastic strains along main shear band was observed. In the tensile test, large plastic strain at fracture of about 0.5% was also observed for the Zr66.5Au3 BMG. By transmission electron microscopic observations of the Au. addition BMGs, precipitation of nano. crystallites having about 10 nm in diameter was observed near the fractured surfaces of the compressive and tensile test specimens. Viscosity of supercooled liquids in shear bands was estimated by the stress. drop of serrations in the compressive stress. strain curves. It is considered that the large increase of the plastic strain is due to the drastic increase of the viscosity of the supercooled liquids formed inside shear bands during plastic deformation.	[Yamada, Masahiro; Yamasaki, Tohru] Univ Hyogo, Grad Sch Engn, Himeji, Hyogo 6712280, Japan; [Fujita, Kazutaka] Ube Natl Coll Technol, Ube, Yamaguchi 7558555, Japan; [Yokoyama, Yoshihiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Kim, Do Hyang] Yonsei Univ, Seoul 120749, South Korea	Yamada, M (reprint author), Univ Hyogo, Grad Sch Engn, Himeji, Hyogo 6712280, Japan.						KRIEGER IM, 1959, T SOC RHEOL, V3, P137; Kim JJ, 2002, SCIENCE, V295, P654; Lewandowski JJ, 2006, NAT MATER, V5, P15, DOI 10.1038/nmat1536; Ashby MF, 2006, SCRIPTA MATER, V54, P321, DOI 10.1016/j.scriptamat.2005.09.051; MULFORD RA, 1979, ACTA METALL MATER, V27, P1125, DOI 10.1016/0001-6160(79)90130-5; HE Y, 1995, ACTA METALL MATER, V43, P83, DOI 10.1016/0956-7151(95)90264-3; Busch R, 1998, ACTA MATER, V46, P4725, DOI 10.1016/S1359-6454(98)00122-0; ALTOUNIAN Z, 1987, J APPL PHYS, V61, P149, DOI 10.1063/1.338847; Gilbert CJ, 1999, APPL PHYS LETT, V74, P3809, DOI 10.1063/1.124187; Bruck HA, 1996, J MATER RES, V11, P503, DOI 10.1557/JMR.1996.0060; Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6; ALTOUNIAN Z, 1982, J APPL PHYS, V53, P4755, DOI 10.1063/1.331304; Inoue A, 1999, MATER T JIM, V40, P1181; Saotome Y, 2001, J MATER PROCESS TECH, V113, P64, DOI 10.1016/S0924-0136(01)00605-7; Zhang Y, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2336598; ALTOUNIAN Z, 1983, J APPL PHYS, V54, P3111, DOI 10.1063/1.332465; PAMPILLO CA, 1975, J MATER SCI, V10, P1194, DOI 10.1007/BF00541403; Cheng YQ, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.134115; Andrade ENDC, 1930, NATURE, V125, P309, DOI 10.1038/125309b0; Koster U, 1996, APPL PHYS LETT, V69, P179; Song SX, 2011, INTERMETALLICS, V19, P1968, DOI 10.1016/j.intermet.2011.06.018; Han Z, 2009, ACTA MATER, V57, P1367, DOI 10.1016/j.actamat.2008.11.018; Qiao JW, 2010, SCRIPTA MATER, V63, P1081, DOI 10.1016/j.scriptamat.2010.08.010; Li QK, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2212059; Sun BA, 2012, ACTA MATER, V60, P4160, DOI 10.1016/j.actamat.2012.04.013; Louzguine-Luzgin DV, 2014, J NON-CRYST SOLIDS, V396, P20, DOI 10.1016/j.jnoncrysol.2014.04.014; Gonzalez S, 2011, MAT SCI ENG A-STRUCT, V528, P3506, DOI 10.1016/j.msea.2011.01.049; CHEN H, 1994, NATURE, V367, P541, DOI 10.1038/367541a0; Inoue A, 2011, ACTA MATER, V59, P2243, DOI 10.1016/j.actamat.2010.11.027; Qiao JW, 2010, INTERMETALLICS, V18, P2057, DOI 10.1016/j.intermet.2010.06.013; Lee SW, 2006, ACTA MATER, V54, P349, DOI 10.1016/j.actamat.2005.09.007; Inoue A, 2000, MAT SCI ENG A-STRUCT, V294, P727, DOI 10.1016/S0921-5093(00)01307-1; Saida J, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2081124; Hajlaoui K, 2006, SCRIPTA MATER, V54, P1829, DOI 10.1016/j.scriptamat.2006.02.030; Boucharat N, 2005, SCRIPTA MATER, V53, P823, DOI 10.1016/j.scriptamat.2005.06.004; CHEN HS, 1973, SCRIPTA METALL MATER, V7, P931, DOI 10.1016/0036-9748(73)90143-9; CHEN HS, 1976, APPL PHYS LETT, V29, P328, DOI 10.1063/1.89084; Chen MW, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.245502; Deng YF, 2004, ULTRAMICROSCOPY, V98, P201, DOI 10.1016/j.ultramic.2003.08.013; DONOVAN PE, 1981, ACTA METALL MATER, V29, P1419, DOI 10.1016/0001-6160(81)90177-2; Einstein A, 1906, ANN PHYS-BERLIN, V19, P289; Einstein A, 1911, ANN PHYS-BERLIN, V34, P591; Fornell J, 2010, SCRIPTA MATER, V62, P13, DOI 10.1016/j.scriptamat.2009.09.014; Gao MC, 2001, MATER TRANS, V42, P1741, DOI 10.2320/matertrans.42.1741; Georgarakis K, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2956666; Hata S., 1999, T JSME, V65, P2080; Inoue A, 1996, MATER T JIM, V37, P1726; Jiang WH, 2003, SCRIPTA MATER, V48, P1195, DOI 10.1016/S1359-6462(02)00568-7; Jiang WH, 2003, ACTA MATER, V51, P4095, DOI 10.1016/S1359-6454(03)00229-5; Kato H, 1997, MATER T JIM, V38, P793; Kim DH, 2008, MATER TRANS, V49, P2405, DOI 10.2320/matertrans.MER2008140; Kunugi M., 1966, J SOC MATER SCI JPN, V15, P45; Lee JC, 2004, ACTA MATER, V52, P1525, DOI 10.1016/j.actamat.2003.11.034; Liu Y., 2014, MAT RES LETT, V2, P209; Nakajima H, 1997, DEFECT DIFFUS FORUM, V143, P803; Pan J, 2012, INTERMETALLICS, V24, P79, DOI 10.1016/j.intermet.2012.01.006; Qiu F, 2012, MATER DESIGN, V36, P168, DOI 10.1016/j.matdes.2011.10.034; Saida J, 2007, MATER TRANS, V48, P1327, DOI 10.2320/matertrans.MF200615; Saida J, 2009, MATER TRANS, V50, P2079, DOI 10.2320/matertrans.M2009135; Saida J, 2000, MATER T JIM, V41, P1505; Shewmon P., 1989, MINERALS; Shirota A., 2010, J SOC MATER SCI JPN, V59, P118; Tokunaga H, 2011, J JPN I MET, V75, P569, DOI 10.2320/jinstmet.75.569; Torre F. H. D., 2010, ACTA MAT, V58, P3742; Wang D., 2001, J ALLOY COMPD, V484, P118; Wang K, 2008, ACTA MATER, V56, P2834, DOI 10.1016/j.actamat.2008.02.015; Wenwer F, 1997, DEFECT DIFFUS FORUM, V143, P831; Wright WJ, 2001, MAT SCI ENG A-STRUCT, V319, P229, DOI 10.1016/S0921-5093(01)01066-8; Yamada M., 2009, 7 INT C BMG, P64; Yamada M, 2014, J JPN I MET, V78, P90, DOI 10.2320/jinstmet.J2013055; Yamada M., 2014, MATER SCI ENG, V63; Yamasaki T, 2010, MATER SCI FORUM, V654-656, P1046, DOI 10.4028/www.scientific.net/MSF.654-656.1046; Yamasaki T, 2005, MATER TRANS, V46, P2746, DOI 10.2320/matertrans.46.2746; Yamasaki T., 2014, MICRO TECHNOL, V20, P1941; YAMASAKI T, 1992, J JPN I MET, V56, P1229; Yamasaki T., 2012, COLLECTED ABSTRACTS, P105; Yokoyama Y, 2011, INTERMETALLICS, V19, P1683, DOI 10.1016/j.intermet.2011.06.017; Yokoyama Y., 2009, ACTA MAT, V56, P6091; Yokoyama Y, 2009, PHIL MAG LETT, V89, P322, DOI 10.1080/09500830902873575; Yokoyama Y, 2014, MAT SCI ENG A-STRUCT, V606, P74, DOI 10.1016/j.msea.2014.03.041; Yoshida N, 2007, J JPN I MET, V71, P730, DOI 10.2320/jinstmet.71.730; Zhang H, 2007, J APPL PHYS, V102, DOI 10.1063/1.2771043	82	0	0	JAPAN INST METALS	SENDAI	1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN	0021-4876	1880-6880		J JPN I MET	J. Jpn. Inst. Met.	DEC	2014	78	12					449	458		10.2320/jinstmet.J2014042		10	Metallurgy & Metallurgical Engineering	Metallurgy & Metallurgical Engineering	AX3TO	WOS:000346861800004		
J	Sato, M; Fujinami, K				Sato, Makoto; Fujinami, Kaori			Nonoverlapped view management for augmented reality by tabletop projection	JOURNAL OF VISUAL LANGUAGES AND COMPUTING			English	Article						Spatial augmented reality; View management; Label placement; Physical object; Projector		Augmented reality (AR) by a projector allows for the easy association of information by labeling the objects. When a projector is installed above a workspace and pointed downward, supportive information can be presented; however, the label will be deformed if the object is nonplanar. Also, a label might be projected in a region where it is hidden by the object, i.e., a blind area. In this paper, we propose a view management technique to allow interpretation by improving the legibility of the information. We propose the nonoverlapped gradient descent (NGD) method, which determines the position of a newly added label by avoiding overlap with the surrounding labels and linkage lines. The issues of presenting in a shadow or blind area are also addressed by estimating these areas based on the approximation of objects as a simple solid. The results of an experiment show that the visibility of the labels was improved by using this method. (C) 2014 Elsevier Ltd. All rights reserved.	[Sato, Makoto; Fujinami, Kaori] Tokyo Univ Agr & Technol, Dept Comp & Informat Sci, Fuchu, Tokyo 183, Japan	Fujinami, K (reprint author), Tokyo Univ Agr & Technol, Dept Comp & Informat Sci, Fuchu, Tokyo 183, Japan.	jawdp3@gmail.com; fujinami@cc.tuat.ac.jp			MEXT [24500142]	This work was supported by MEXT Grant-in-Aid for Scientific Research (C) No. 24500142.	Tanaka K, 2008, INT SYM MIX AUGMENT, P139, DOI 10.1109/ISMAR.2008.4637340; Kane SK, 2009, UIST 2009: PROCEEDINGS OF THE 22ND ANNUAL ACM SYMPOSIUM ON USER INTERFACE SOFTWARE AND TECHNOLOGY, P129; Azuma R., 2003, Proceedings Second IEEE and ACM International Symposium on Mixed and Augmented Reality; BELL B., 2001, P S US INT SOFTW TEC, P101; Crow F.C., 1977, P SIGGRAPH 77, P242, DOI 10.1145/563858.563901; Grasset R, 2012, INT SYM MIX AUGMENT, P177, DOI 10.1109/ISMAR.2012.6402555; Iwai D, 2013, IEEE T VIS COMPUT GR, V19, P1415, DOI 10.1109/TVCG.2012.321; Jorda S., 2007, P 1 INT C TANG EMB I, P139, DOI DOI 10.1145/1226969.1226998; Makita K, 2009, IEEE INT CON MULTI, P982; Morioka S., 2011, P 12 IAPR C MACH VIS, P271; Piper B., 2002, P SIGCHI C HUM FACT, P355, DOI DOI 10.1145/503376.503439; Reeves W.T., 1987, P SIGGRAPH 87, P283, DOI 10.1145/37401.37435; Shibata F, 2008, P 14 EUR C VIRT ENV, P17; Siriborvornratanakul T., 2008, P ACM S VIRT REAL SO, P241, DOI 10.1145/1450579.1450633; Sokan A, 2012, J AMB INTEL HUM COMP, V3, P125, DOI 10.1007/s12652-011-0079-6; Uemura K., 2010, P INT C ART REAL TEL, P202; Williams L., 1978, P SIGGRAPH 78, P270, DOI 10.1145/800248.807402; Wu Mike, 2003, P 16 ANN ACM S US IN, P193, DOI DOI 10.1145/964696.964718	18	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1045-926X	1095-8533		J VISUAL LANG COMPUT	J. Vis. Lang. Comput.	DEC	2014	25	6			SI		891	902		10.1016/j.jvlc.2014.10.030		12	Computer Science, Software Engineering	Computer Science	AX3CK	WOS:000346818000029		
J	Hofhine, T; Grosser, Z; Krantz, E; Barta, CA; Doolittle, P; Buco, R; Koeritz, R; Lilla, Z; Claus, J; Espenschied, K; Ye, M				Hofhine, Toni; Grosser, Zoe; Krantz, Elizabeth; Barta, Cheri A.; Doolittle, Pamela; Buco, Robert; Koeritz, Richard; Lilla, Zachary; Claus, Jennifer; Espenschied, Kenneth; Ye, Michael			A Novel Method for Precolumn Derivatization of Aflatoxin B1, B2, G1, and G2 Prior to HPLC Analysis Using the XcelVap System as a Thermostatically Controlled Heated Water Chamber	LC GC NORTH AMERICA			English	Article									[Hofhine, Toni; Grosser, Zoe] Horizon Technol, Salem, NH 03079 USA; [Krantz, Elizabeth; Barta, Cheri A.; Doolittle, Pamela] Univ Wisconsin, Madison, WI 53706 USA; [Buco, Robert; Koeritz, Richard; Lilla, Zachary] Shimadzu Sci Instruments, Kyoto, Japan; [Claus, Jennifer; Espenschied, Kenneth; Ye, Michael] Sigma Aldrich, St Louis, MO USA	Hofhine, T (reprint author), Horizon Technol, 16 Northwestern Dr, Salem, NH 03079 USA.							0	0	0	ADVANSTAR COMMUNICATIONS INC	DULUTH	131 W 1ST STREET, DULUTH, MN 55802 USA	1527-5949	1939-1889		LC GC N AM	LC GC N. AM.	DEC	2014				S			66	66				1	Chemistry, Analytical	Chemistry	AX3DH	WOS:000346820200005		
J	Jiang, WN; Tan, S; Hanaki, Y; Irie, K; Uchida, H; Watanabe, R; Suzuki, T; Sakamoto, B; Kamio, M; Nagai, H				Jiang, Weina; Tan, Satoshi; Hanaki, Yusuke; Irie, Kazuhiro; Uchida, Hajime; Watanabe, Ryuichi; Suzuki, Toshiyuki; Sakamoto, Bryan; Kamio, Michiya; Nagai, Hiroshi			Two New Lyngbyatoxin Derivatives from the Cyanobacterium, Moorea producens	MARINE DRUGS			English	Article						lyngbyatoxin A; cyanobacteria; Moorea producens; toxicity; protein kinase C	PROTEIN-KINASE-C; PHORBOL ESTER BINDING; TELEOCIDIN-RELATED METABOLITES; GRACILARIA-CORONOPIFOLIA; RED ALGA; TUMOR PROMOTERS; SECONDARY METABOLITES; MARINE CYANOBACTERIA; CAUSATIVE AGENTS; INDOLE ALKALOIDS	The toxin-producing cyanobacterium, Moorea producens, is a known causative organism of food poisoning and seaweed dermatitis (also known as "swimmer's itch"). Two new toxic compounds were isolated and structurally elucidated from an ethyl acetate extract of M. producens collected from Hawaii. Analyses of HR-ESI-MS and NMR spectroscopies, as well as optical rotations and CD spectra indicated two new lyngbyatoxin derivatives, 2-oxo-3(R)-hydroxy-lyngbyatoxin A (1) and 2-oxo-3(R)-hydroxy-13-N-desmethyl- lyngbyatoxin A (2). The cytotoxicity and lethal activities of 1 and 2 were approximately 10- to 150-times less potent than lyngbyatoxin A. Additionally, the binding activities of 1 and 2 possessed 10,000-times lower affinity for the protein kinase C delta (PKC delta)-C1B peptide when compared to lyngbyatoxin A. These findings suggest that these new lyngbyatoxin derivatives may mediate their acute toxicities through a non-PKC activation pathway.	[Jiang, Weina; Tan, Satoshi; Uchida, Hajime; Kamio, Michiya; Nagai, Hiroshi] Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Tokyo 1088477, Japan; [Hanaki, Yusuke; Irie, Kazuhiro] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Kyoto 6068502, Japan; [Watanabe, Ryuichi; Suzuki, Toshiyuki] Natl Res Inst Fisheries Sci, Yokohama, Kanagawa 2368648, Japan; [Sakamoto, Bryan] Richard L Roudebush VA Med Ctr, Indianapolis, IN 46202 USA	Nagai, H (reprint author), Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Tokyo 1088477, Japan.	jwnkouina@gmail.com; sa19901-31@gc4.so-net.ne.jp; y_hanaki_0625@yahoo.co.jp; irie@kais.kyoto-u.ac.jp; huchida.msr181823@gmail.com; rwatanabe@affrc.go.jp; tsuzuki@affrc.go.jp; bryan.sakamoto@va.gov; mkamio@kaiyodai.ac.jp; nagai@kaiyodai.ac.jp	Irie, Kazuhiro/A-6121-2014; Kamio, Michiya/O-1923-2014; NAGAI, Hiroshi/O-1894-2014	Irie, Kazuhiro/0000-0001-7109-8568; Kamio, Michiya/0000-0003-3505-1978; 	Japan Society for the Promotion of Science (JSPS) [24510294]	This work was supported partly by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research Grant Number 24510294 (to Hiroshi Nagai).	FUJIKI H, 1981, P NATL ACAD SCI-BIOL, V78, P3872, DOI 10.1073/pnas.78.6.3872; Irie K, 2002, PHARMACOL THERAPEUT, V93, P271, DOI 10.1016/S0163-7258(02)00196-1; CARMICHAEL WW, 1992, J APPL BACTERIOL, V72, P445, DOI 10.1111/j.1365-2672.1992.tb01858.x; Singh RK, 2011, J ANTIBIOT, V64, P401, DOI 10.1038/ja.2011.21; Engene N, 2012, INT J SYST EVOL MICR, V62, P1171, DOI 10.1099/ijs.0.033761-0; Osborne NJT, 2001, ENVIRON INT, V27, P381, DOI 10.1016/S0160-4120(01)00098-8; Ito E, 2002, TOXICON, V40, P551, DOI 10.1016/S0041-0101(01)00251-3; Yasumoto T, 1998, TOXICON, V36, P1515, DOI 10.1016/S0041-0101(98)00142-1; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; AIMI N, 1990, J NAT PROD, V53, P1593, DOI 10.1021/np50072a035; Nunnery JK, 2010, CURR OPIN BIOTECH, V21, P787, DOI 10.1016/j.copbio.2010.09.019; Irie K, 1998, J AM CHEM SOC, V120, P9159, DOI 10.1021/ja981087f; MYNDERSE JS, 1977, SCIENCE, V196, P538, DOI 10.1126/science.403608; CARDELLINA JH, 1979, SCIENCE, V204, P193, DOI 10.1126/science.107586; Nagai H, 1996, TOXICON, V34, P753, DOI 10.1016/0041-0101(96)00014-1; BANNER A H, 1959, Hawaii Med J, V19, P35; Champetier R.G., 1998, ARCH I PASTEUR MADAG, V64, P71; FUJIKI H, 1984, BIOCHEM BIOPH RES CO, V120, P339, DOI 10.1016/0006-291X(84)91259-2; FUJIKI H, 1987, ADV CANCER RES, V49, P223, DOI 10.1016/S0065-230X(08)60799-X; GRAUER F H, 1959, Hawaii Med J, V19, P32; HAGIWARA N, 1988, AGR BIOL CHEM TOKYO, V52, P641; Hanne M., 1995, MMWR-MORBID MORTAL W, V44, P724; Hoffmann L, 1999, EUR J PHYCOL, V34, P371; Irie K, 1996, J AM CHEM SOC, V118, P10733, DOI 10.1021/ja961727j; IRIE K, 1987, AGR BIOL CHEM TOKYO, V51, P285; Ito E, 1998, TOXICON, V36, P1913, DOI 10.1016/S0041-0101(98)00113-5; Izumikawa M, 2010, J ANTIBIOT, V63, P33, DOI 10.1038/ja.2009.113; Jiang WN, 2014, MAR DRUGS, V12, P2748, DOI 10.3390/md12052748; Kawabata T, 2013, FISHERIES SCI, V79, P487, DOI 10.1007/s12562-013-0612-y; Marshall KLE, 1998, WESTERN J MED, V169, P293; MOORE RE, 1984, J ORG CHEM, V49, P2484, DOI 10.1021/jo00187a035; MOORE RE, 1986, CARCINOGENESIS, V7, P641, DOI 10.1093/carcin/7.4.641; MURATAKE H, 1991, TETRAHEDRON, V47, P8545, DOI 10.1016/S0040-4020(01)82398-X; Nagai H, 1998, BIOSCI BIOTECH BIOCH, V62, P1011, DOI 10.1271/bbb.62.1011; Nagai H, 1997, J NAT PROD, V60, P925, DOI 10.1021/np970193c; SHARKEY NA, 1985, CANCER RES, V45, P19; Shindo M, 2001, BIOORGAN MED CHEM, V9, P2073, DOI 10.1016/S0968-0896(01)00100-6; SZALLASI Z, 1994, MOL PHARMACOL, V46, P840; Tan LT, 2013, MARINE MICROBIOLOGY: BIOACTIVE COMPOUNDS AND BIOTECHNOLOGICAL APPLICATIONS, P59	39	1	1	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-3397			MAR DRUGS	Mar. Drugs	DEC	2014	12	12					5788	5800		10.3390/md12125788		13	Chemistry, Medicinal	Pharmacology & Pharmacy	AX2TE	WOS:000346796500003		
J	Bu, YY; Yamazaki, H; Ukai, K; Namikoshi, M				Bu, Ying-Yue; Yamazaki, Hiroyuki; Ukai, Kazuyo; Namikoshi, Michio			Anti-Mycobacterial Nucleoside Antibiotics from a Marine-Derived Streptomyces sp TPU1236A	MARINE DRUGS			English	Article						marine-derived actinomycete; Streptomyces sp.; streptcytosines A-E; anti-mycobacterium activity; amicetin	TUBERCULOSIS; AMICETIN; DISCOVERY; DRUGS	Five new nucleoside antibiotics, named streptcytosines A-E (1-5), and six known compounds, de-amosaminyl-cytosamine (6), plicacetin (7), bamicetin (8), amicetin (9), collismycin B (10), and SF2738 C (11), were isolated from a culture broth of Streptomyces sp. TPU1236A collected in Okinawa, Japan. The structures of new compounds were elucidated on the basis of their spectroscopic data (HRFABMS, IR, UV, and 2D NMR experiments including H-1-H-1 COSY, HMQC, HMBC, and NOESY spectra). Streptcytosine A (1) belonged to the amicetin group antibiotics, and streptcytosines B-E (2-5) were derivatives of de-amosaminyl-cytosamine (6), 2,3,6-trideoxyglucopyranosyl cytosine. Compound 1 inhibited the growth of Mycobacterium smegmatis (MIC = 32 mu g/mL), while compounds 2-5 were not active at 50 mu g/disc. Bamicetin (8) and amicetin (9) showed the MICs of 16 and 8 mu g/mL, respectively.	[Bu, Ying-Yue; Yamazaki, Hiroyuki; Ukai, Kazuyo; Namikoshi, Michio] Tohoku Pharmaceut Univ, Fac Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9818558, Japan	Yamazaki, H (reprint author), Tohoku Pharmaceut Univ, Fac Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9818558, Japan.	21252502@is.tohoku-pharm.ac.jp; yamazaki@tohoku-pharm.ac.jp; ukai_k@tohoku-pharm.ac.jp; mnami@tohoku-pharm.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [25870660]; Foundation for Japanese Chemical Research	This work was supported in part by a Grant-in-Aid for Scientific Research (25870660) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan to HY and the Foundation for Japanese Chemical Research to HY. We thank T. Matsuki and S. Sato for measuring mass spectra.	Amsterdam D, 1996, ANTIBIOTICS LAB MED, V4, P52; Ryan NJ, 2014, DRUGS, V74, P1041, DOI 10.1007/s40265-014-0241-5; SHIOMI K, 1994, J ANTIBIOT, V47, P782; SHINDO K, 1994, J ANTIBIOT, V47, P1072; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894; Chen RD, 2013, J AM CHEM SOC, V135, P12152, DOI 10.1021/ja401016e; Espinal MA, 2003, TUBERCULOSIS, V83, P44, DOI 10.1016/S1472-9792(02)00058-6; Mincer TJ, 2002, APPL ENVIRON MICROB, V68, P5005, DOI 10.1128/AEM.68.10.5005-5011.2002; DEBOER C, 1953, J AM CHEM SOC, V75, P499, DOI 10.1021/ja01098a518; ERICSSON H, 1960, SCAND J CLIN LAB INV, V12, P408; FLYNN EH, 1953, J AM CHEM SOC, V75, P5867, DOI 10.1021/ja01119a025; GOMI S, 1994, J ANTIBIOT, V47, P1385; HASKELL TH, 1958, J AM CHEM SOC, V80, P747, DOI 10.1021/ja01536a056; HASKELL TH, 1958, J AM CHEM SOC, V80, P743, DOI 10.1021/ja01536a055; HINMAN JW, 1953, J AM CHEM SOC, V75, P5864, DOI 10.1021/ja01119a024; Koyama N, 2010, J ANTIBIOT, V63, P183, DOI 10.1038/ja.2010.14; Ntie-Kang F, 2014, CURR MED CHEM, V21, P3466; Reyrat JM, 2001, TRENDS MICROBIOL, V9, P472, DOI 10.1016/S0966-842X(01)02168-0; Riccardi G, 2014, J ANTIBIOT, V67, P655, DOI 10.1038/ja.2014.109; Shammas C, 2007, MAGN RESON CHEM, V45, P133, DOI 10.1002/mrc.1932; World Health Organization, GLOB TUB REP 2013; Xavier Alphienes Stanley, 2014, J Pharmacol Pharmacother, V5, P222, DOI 10.4103/0976-500X.136121	22	2	2	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	1660-3397			MAR DRUGS	Mar. Drugs	DEC	2014	12	12					6102	6112		10.3390/md12126102		11	Chemistry, Medicinal	Pharmacology & Pharmacy	AX2TE	WOS:000346796500022		
J	Huang, JW; Tang, W; Hernandez-Alejandro, R; Bertens, KA; Wu, H; Liao, MH; Li, JX; Zeng, Y				Huang, Jiwei; Tang, Wei; Hernandez-Alejandro, Roberto; Bertens, Kimberly A.; Wu, Hong; Liao, Mingheng; Li, Jiaxin; Zeng, Yong			Intermittent Hepatic Inflow Occlusion During Partial Hepatectomy for Hepatocellular Carcinoma Does Not Shorten Overall Survival or Increase the Likelihood of Tumor Recurrence	MEDICINE			English	Article							COLORECTAL LIVER METASTASES; ISCHEMIA/REPERFUSION-ACCELERATED OUTGROWTH; ISCHEMIA-REPERFUSION; PRINGLE-MANEUVER; BLOOD-LOSS; RANDOMIZED-TRIAL; MILAN CRITERIA; COLON-CANCER; RESECTION; GROWTH	Aim: To investigate whether the long-term outcomes of hepatocellular carcinoma (HCC) was adversely impacted by intermittent hepatic inflow occlusion (HIO) during hepatic resection. Methods: 1549 HCC patients who underwent hepatic resection between 1998 and 2008 were identified from a prospectively maintained database. Intermittent HIO was performed in 931 patients (HIO group); of which 712 patients had a Pringle maneuver as the mechanism for occlusion (PM group), and 219 patients had selective hemi-hepatic occlusion (SO group). There were 618 patients that underwent partial hepatectomy without occlusion (occlusion-free, OF group). Results: The 1-, 3-, and 5-year overall survival (OS) rates were 79%, 59%, and 42% in the HIO group, and 83%, 53%, and 35% in the OF group, respectively. The corresponding recurrence free survival (RFS) rates were 68%, 39%, and 22% in the HIO group, and 74%, 41%, and 18% in the OF group, respectively. There was no significant difference between the 2 groups in OS or RFS (P = 0.325 and P = 0.416). Subgroup analysis showed patients with blood loss over 3000 mL and those requiring transfusion suffered significantly shorter OS and RFS. Blood loss over 3000 mL and blood transfusion were independent risk factors to OS and RFS. Conclusions: The application of intermittent HIO (PM and SO) during hepatic resection did not adversely impact either OS or RFS in patients with HCC. Intermittent HIO is still a valuable tool in hepatic resection, because high intraoperative blood loss resulting in transfusion is associated with a reduction in both OS and RFS.	[Huang, Jiwei; Wu, Hong; Liao, Mingheng; Li, Jiaxin; Zeng, Yong] Sichuan Univ, Dept Liver Surg, Div Liver Transplantat, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Tang, Wei] Univ Tokyo, Tokyo Univ Hosp, Dept Hepatobiliary Pancreat Surg, Tokyo, Japan; [Hernandez-Alejandro, Roberto; Bertens, Kimberly A.] Univ Western Ontario, London Hlth Sci Ctr, Dept Hepatobiliary Pancreat Surg, London, ON, Canada	Zeng, Y (reprint author), Sichuan Univ, Dept Liver Surg, Div Liver Transplantat, West China Hosp, Chengdu 610064, Sichuan, Peoples R China.	zengyongmd@gmail.com					Yoshida M, 2003, J SURG RES, V111, P255, DOI 10.1016/S0022-4804(03)00082-9; Scatton O, 2011, BRIT J SURG, V98, P1236, DOI 10.1002/bjs.7626; O'Neill S, 2013, BRIT J SURG, V100, P1689, DOI 10.1002/bjs.9277; Man K, 2007, LIVER TRANSPLANT, V13, P1669, DOI 10.1002/It.21193; Imamura H, 2002, LANCET, V360, P2049, DOI 10.1016/S0140-6736(02)11995-7; Kooby DA, 2003, ANN SURG, V237, P860; Petrowsky H, 2006, ANN SURG, V244, P921, DOI 10.1097/01.sla.0000246834.07130.5d; Man K, 1997, ANN SURG, V226, P704, DOI 10.1097/00000658-199712000-00007; Doi K, 2002, J SURG RES, V105, P243, DOI 10.1006/jsre.2002.6356; Huang JW, 2010, ANN SURG, V252, P903, DOI 10.1097/SLA.0b013e3181efc656; van der Bilt JDW, 2005, HEPATOLOGY, V42, P165, DOI 10.1002/hep.20739; Huang JW, 2011, J GASTROINTEST SURG, V15, P311, DOI 10.1007/s11605-010-1372-y; Yamamoto J, 2007, JPN J CLIN ONCOL, V37, P287, DOI 10.1093/jjco/hym025; de Boer MT, 2007, DIGEST SURG, V24, P259, DOI 10.1159/000103656; Kurata M, 2006, WORLD J GASTROENTERO, V12, P60; Xia F, 2013, WORLD J SURG, V37, P192, DOI 10.1007/s00268-012-1781-z; Eguchi S, 2008, SURGERY, V143, P469, DOI 10.1016/j.surg.2007.12.003; Figueras J, 2005, ANN SURG, V241, P582, DOI 10.1097/01.sla.0000157168.26021.b8; Katz SC, 2009, ANN SURG, V249, P617, DOI 10.1097/SLA.0b013e31819ed22f; Man K, 2008, ANN SURG, V247, P1049, DOI 10.1097/SLA.0b013e31816ffab6XXX; Pringle JH, 1908, ANN SURG, V48, P541, DOI 10.1097/00000658-190810000-00005; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Nicoud IB, 2007, CANCER RES, V67, P2720, DOI 10.1158/0008-5772.CAN-06-3923; Lim C, 2013, J SURG RES, V184, P888, DOI 10.1016/j.jss.2013.04.069; Strasberg SM, 2009, ANN SURG, V250, P177, DOI 10.1097/SLA.0b013e3181afde41; van der Bilt JDW, 2007, DIGEST SURG, V24, P423, DOI 10.1159/000108325; Buell JF, 2001, ARCH SURG-CHICAGO, V136, P569, DOI 10.1001/archsurg.136.5.569; Doi K, 2002, EUR J SURG, V168, P507, DOI 10.1080/110241502321116541; Ferrero A, 2010, WORLD J SURG, V34, P2418, DOI 10.1007/s00268-010-0682-2; Fortner JG, 2001, J AM COLL SURGEONS, V193, P210, DOI 10.1016/S1072-7515(01)00910-3; Giuliante F, 2010, ANN SURG, V252, P1020, DOI 10.1097/SLA.0b013e3181f66918; Gurusamy KS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007629; Gurusamy KS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006409.pub3; Gurusamy KS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007632; Hanazaki K, 2005, HEPATO-GASTROENTEROL, V52, P524; Huang JW, 2012, J SURG RES, V178, P743, DOI 10.1016/j.jss.2012.04.058; Huntington JT, 2014, J SURG ONCOL, V109, P81, DOI 10.1002/jso.23455; Ishizuka M, 2011, BRIT J SURG, V98, P1284, DOI 10.1002/bjs.7567; Kim YI, 2007, HEPATO-GASTROENTEROL, V54, P2055; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064261; Matsuda A, 2013, ANN SURG ONCOL, V20, P3771, DOI 10.1245/s10434-013-3048-9; Ozaki M, 2007, LIVER TRANSPLANT, V13, P1623, DOI 10.1002/It.21230; Radojkovic M, 2013, BRATISL MED J, V114, P3, DOI 10.4149/BLL_2013_301; Sakamoto Y, 1999, HEPATO-GASTROENTEROL, V46, P457; Shimoda M, 2007, PATHOBIOLOGY, V74, P42, DOI 10.1159/000101050; Song PP, 2010, BIOSCI TRENDS, V4, P283; Sugawara Yasuhiko, 2008, Oncology, V75 Suppl 1, P119, DOI 10.1159/000173433; Tamagawa K, 2008, J SURG RES, V148, P158, DOI 10.1016/j.jss.2007.12.787; Torzilli G, 2012, ANN SURG, V255, P270, DOI 10.1097/SLA.0b013e318232b375; van der Bilt JDW, 2008, ANN SURG ONCOL, V15, P1392, DOI 10.1245/s10434-007-9758-0; van der Bilt JDW, 2007, AM J PATHOL, V170, P1379, DOI 10.2353/ajpath.2007.061028; Weiss MJ, 2013, ANN SURG ONCOL, V20, P285, DOI 10.1245/s10434-012-2583-0; Wong KHV, 2008, BRIT J SURG, V95, P985, DOI 10.1002/bjs.6129; Yoshimoto K, 2012, ONCOL REP, V28, P791, DOI 10.3892/or.2012.1896	54	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	DEC	2014	93	28								10.1097/MD.0000000000000288		9	Medicine, General & Internal	General & Internal Medicine	AX2GS	WOS:000346762200037		
J	Inokuchi, R; Kurata, H; Endo, K; Kitsuta, Y; Nakajima, S; Hatamochi, A; Yahagi, N				Inokuchi, Ryota; Kurata, Hideaki; Endo, Kiyoshi; Kitsuta, Yoichi; Nakajima, Susumu; Hatamochi, Atsushi; Yahagi, Naoki			Vascular Ehlers-Danlos Syndrome Without the Characteristic Facial Features A Case Report	MEDICINE			English	Article							SYNDROME TYPE-IV; MANAGEMENT	As a type of Ehlers-Danlos syndrome (EDS), vascular EDs (vEDS) is typified by a number of characteristic facial features (eg, large eyes, small chin, sunken cheeks, thin nose and lips, lobeless ears). However, vEDs does not typically display hypermobility of the large joints and skin hyperextensibility, which are features typical of the more common forms of EDS. Thus, colonic perforation or aneurysm rupture may be the first presentation of the disease. Because both complications are associated with a reduced life expectancy for individuals with this condition, an awareness of the clinical features of vEDS is important. Here, we describe the treatment of vEDS lacking the characteristic facial attributes in a 24-year-old healthy man who presented to the emergency room with abdominal pain. Enhanced computed tomography revealed diverticula and perforation in the sigmoid colon. The lesion of the sigmoid colon perforation was removed, and Hartmann procedure was performed. During the surgery, the control of bleeding was required because of vascular fragility. Subsequent molecular and genetic analysis was performed based on the suspected diagnosis of vEDS. These analyses revealed reduced type III collagen synthesis in cultured skin fibroblasts and identified a previously undocumented mutation in the gene for a1 type III collagen, confirming the diagnosis of vEDS. After eliciting a detailed medical profile, we learned his mother had a history of extensive bruising since childhood and idiopathic hematothorax. Both were prescribed oral celiprolol. One year after admission, the patient was free of recurrent perforation. This case illustrates an awareness of the clinical characteristics of vEDS and the family history is important because of the high mortality from this condition even in young people. Importantly, genetic assays could help in determining the surgical procedure and offer benefits to relatives since this condition is inherited in an autosomal dominant manner.	[Inokuchi, Ryota; Kurata, Hideaki; Kitsuta, Yoichi; Nakajima, Susumu; Yahagi, Naoki] Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, Tokyo 1138655, Japan; [Inokuchi, Ryota; Endo, Kiyoshi] JR Gen Hosp, Dept Emergency Med, Shibuya Ku, Tokyo 1518528, Japan; [Kurata, Hideaki] Hanna Cent Hosp, Dept Surg, Ikoma City, Nara 6300243, Japan; [Hatamochi, Atsushi] Dokkyo Med Univ, Sch Med, Dept Dermatol, Mibu, Tochigi 3210293, Japan	Inokuchi, R (reprint author), Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	inokuchir-icu@h.u-tokyo.ac.jp					Oderich GS, 2005, J VASC SURG, V42, P98, DOI 10.1016/j.jvs.2005.03.053; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Ong KT, 2010, LANCET, V376, P1476, DOI 10.1016/S0140-6736(10)60960-9; Bergqvist D, 2013, ANN SURG, V258, P257, DOI 10.1097/SLA.0b013e31829c7a59; Bergqvist D, 1996, EUR J SURG, V162, P163; FLEISCHMAJER R, 1981, J INVEST DERMATOL, V76, P400, DOI 10.1111/1523-1747.ep12520933; Fuchs JR, 2004, J PEDIATR SURG, V39, DOI 10.1016/j.jpedsurg.2003.10.027; Lum YW, 2011, CURR OPIN CARDIOL, V26, P494, DOI 10.1097/HCO.0b013e32834ad55a	8	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	DEC	2014	93	28								10.1097/MD.0000000000000291		3	Medicine, General & Internal	General & Internal Medicine	AX2GS	WOS:000346762200040		
J	Iwase, T; Yamamoto, N; Ichihara, H; Togawa, T; Nagashima, T; Miyazaki, M				Iwase, Toshiaki; Yamamoto, Naohito; Ichihara, Hironori; Togawa, Takashi; Nagashima, Takeshi; Miyazaki, Masaru			The Relationship Between Skeletal-Related Events and Bone Scan Index for the Treatment of Bone Metastasis With Breast Cancer Patients	MEDICINE			English	Article							METABOLIC MARKERS; PROSTATE-CANCER; FOLLOW-UP; DISEASE	The aim of the present study was to investigate the relationships between the automated bone scan index (aBSI) and skeletal-related events (SRE) in breast cancer patients with bone metastasis. A computer-aided software (BONENAVI (TM)) that was developed using an Artificial Neural Network (Artificial Neural Network) was used for the present analysis. Forty-five patients diagnosed with bone metastasis due to breast cancer from April 2005 through March 2013 were retrospectively analyzed. Before and after the time of initial treatment, aBSI, Artificial Neural Network score, and hotspot number were calculated, and the relationships between these scores and SRE were analyzed. Twenty cases showed decreased (improved) aBSI values after initial treatment (Group A), and 25 cases showed unchanged/increased (worsened) aBSI values (Group B). Chi-square analysis revealed a significant difference in incident numbers of SRE between the two groups-one case in Group A and 12 in Group B (P < 0.001). Event-free survival was significantly shorter in Group B (hazard ratio: 8.31, 95% CI: 1.33-12.14, log-rank test; P < 0.05). The groupswere also divided by the results of 2 radiologists' visual scan interpretations, and no significant differenceswere shown in the number of SRE (P = 0.82, P = 0.10). When correlation analyses were performed between aBSI and bone metabolic or tumor markers, alkaline phosphatase was significantly correlated with aBSI at the time of initial treatment (R = 0.69, P < 0.05). In conclusion, aBSI is proposed as a useful and objective imaging biomarker in the detection of breast-cancer patients with bone metastasis at high risk of SRE.	[Iwase, Toshiaki; Yamamoto, Naohito] Chiba Canc Ctr, Div Breast Surg, Chiba 2608717, Japan; [Ichihara, Hironori; Togawa, Takashi] Chiba Canc Ctr, Div Nucl Med, Chiba 2608717, Japan; [Iwase, Toshiaki; Nagashima, Takeshi; Miyazaki, Masaru] Chiba Grad Sch Med, Dept Gen Surg, Chiba, Japan	Iwase, T (reprint author), Chiba Canc Ctr, Div Breast Surg, Chuo Ku, 666-2 Nitonacho, Chiba 2608717, Japan.	tiwase@outlook.com			Pfizer; Bayer; Parexel; Eli Lilly	Naohito Yamamoto received research funding from Pfizer, Bayer, Parexel, and Eli Lilly. Those funders had no control over the interpretation, or publication of this work. This study was presented on the 9th European breast cancer conference, 19-21 March 2014 at Glasgow, Scotland.	Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Brown JE, 2010, BREAST CANCER RES TR, V123, P767, DOI 10.1007/s10549-010-0981-1; Erdi YE, 1997, J NUCL MED, V38, P1401; Dennis ER, 2012, J CLIN ONCOL, V30, P519, DOI 10.1200/JCO.2011.36.5791; Stopeck AT, 2010, J CLIN ONCOL, V28, P5132, DOI 10.1200/JCO.2010.29.7101; Khatcheressian JL, 2013, J CLIN ONCOL, V31, P961, DOI 10.1200/JCO.2012.45.9859; Sabbatini P, 1999, J CLIN ONCOL, V17, P948; Horikoshi H, 2012, ANN NUCL MED, V26, P622, DOI 10.1007/s12149-012-0620-5; Ulmert D, 2012, EUR UROL, V62, P78, DOI 10.1016/j.eururo.2012.01.037; Kaboteh R, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-64; KOIZUMI M, 1995, J CANCER RES CLIN, V121, P542, DOI 10.1007/BF01197767; Koizumi M, 2002, ANN NUCL MED, V16, P161, DOI 10.1007/BF02996296; Maffioli L, 2004, EUR J NUCL MED MOL I, V31, pS143, DOI 10.1007/s00259-004-1537-6	13	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	DEC	2014	93	28								10.1097/MD.0000000000000269		7	Medicine, General & Internal	General & Internal Medicine	AX2GS	WOS:000346762200027		
J	Sogabe, M; Okahisa, T; Yamanoi, A; Takayama, T				Sogabe, Masahiro; Okahisa, Toshiya; Yamanoi, Akira; Takayama, Tetsuji			Subtypes of Metabolic Syndrome and of Other Risk Factors in Japanese Women With Erosive Esophagitis	MEDICINE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; BODY-MASS INDEX; VISCERAL FAT; COMPUTED-TOMOGRAPHY; ABDOMINAL OBESITY; SUBCUTANEOUS FAT; ACID EXPOSURE; ULTRASONOGRAPHY; ASSOCIATION; SYMPTOMS	Obesity and metabolic syndrome (MS) are strongly associated with erosive esophagitis (EE). The prevalence of MS and EE, and the distribution of adipose tissue have been known to differ markedly between men and women. Although the prevalence of EE in men with MS is known to be higher in visceral fat type MS (V-type MS) than in subcutaneous fat type MS (S-type MS), the association between EE and the types of MS in women with MS is unclear. This study was a cross-sectional study elucidating the association between EE and the types of MS in women with MS. Subjects were 454 women with MS who underwent a regular health check-up. A distinction was made between V-type MS and S-type MS and the prevalence of EE and the association between EE and other data were elucidated. Although there were some significant different factors in characteristics between V-type MS and S-type MS, there was no significant difference in the prevalence of EE between V-type MS and S-type MS. The presence of Helicobacter pylori (H. pylori) was significantly lower than in subjects with EE (13.7%) than in subjects without EE (41.9%). The frequency of hiatal hernia was significantly higher in subjects with EE (60.8%) than in subjects without EE (24.6%). Logistic regression analysis showed hiatal hernia (odds ratio: 4.673; 95% confidence interval: 2.448-8.920; P < 0.001), hemoglobin A1c (HbA1c) (2.325; 1.110-4.870; P < 0.05), and the presence of H. pylori (0.239; 0.101-0.567; P < 0.005) were significant predictors of the prevalence of EE. V-type MS may not be such an important factor for the prevalence of EE in women with MS as in men with MS. The absence of H. pylori, hiatal hernia, and HbA1c may be more important for the prevalence of EE than the types of MS in women with MS.	[Sogabe, Masahiro; Okahisa, Toshiya] Univ Tokushima, Dept Gen Med & Community Hlth Sci, Grad Sch, Inst Hlth Biosci, Tokushima 7708503, Japan; [Sogabe, Masahiro; Yamanoi, Akira] Kagawa Prefectural Canc Detect Ctr, Dept Gastroenterol, Takamatsu, Kagawa, Japan; [Takayama, Tetsuji] Univ Tokushima, Dept Gastroenterol & Oncol, Grad Sch, Inst Hlth Biosci, Tokushima 7708503, Japan	Sogabe, M (reprint author), Univ Tokushima, Dept Gen Med & Community Hlth Sci, Grad Sch, Inst Hlth Biosci, 3-18-15 Kuramoto Cho, Tokushima 7708503, Japan.	tokushimakena-nanshi@yahoo.co.jp					Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; LEMIEUX S, 1993, AM J CLIN NUTR, V58, P463; Pandolfino JE, 2006, GASTROENTEROLOGY, V130, P639, DOI 10.1053/j.gastro.2005.12.016; Moki F, 2007, ALIMENT PHARM THERAP, V26, P1069, DOI 10.1111/j.1365-2036.2007.03454.x; Lonardo A, 1997, ITAL J GASTROENTEROL, V29, P351; Nilsson M, 2002, SCAND J GASTROENTERO, V37, P626, DOI 10.1080/00365520212502; Sogabe M, 2012, J GASTROENTEROL, V47, P293, DOI 10.1007/s00535-011-0489-4; Niigaki M, 2013, J GASTROENTEROL, V48, P463, DOI 10.1007/s00535-012-0671-3; Lee YC, 2009, GUT, V58, P174, DOI 10.1136/gut.2008.162305; Nam SY, 2010, GASTROENTEROLOGY, V139, P1902, DOI 10.1053/j.gastro.2010.08.019; El-Serag HB, 2005, AM J GASTROENTEROL, V100, P1243, DOI 10.1111/j.1572-0241.2005.41703.x; Chung SJ, 2008, GUT, V57, P1360, DOI 10.1136/gut.2007.147090; de Vries DR, 2008, AM J GASTROENTEROL, V103, P1349, DOI 10.1111/j.1572-0241.2008.01909.x; Lee HL, 2008, J CLIN GASTROENTEROL, V42, P672, DOI 10.1097/MCG.0b013e31806daf64; Gunji T, 2011, J GASTROENTEROL, V46, P448, DOI 10.1007/s00535-010-0359-5; KVIST H, 1988, AM J CLIN NUTR, V48, P1351; Lee SJ, 2001, J GASTROEN HEPATOL, V16, P373, DOI 10.1046/j.1440-1746.2001.02464.x; Corley DA, 2007, GUT, V56, P756, DOI 10.1136/gut.2006.109413; El-Serag HB, 2006, SCAND J GASTROENTERO, V41, P887, DOI 10.1080/00365520500535402; Corley DA, 2006, AM J GASTROENTEROL, V101, P2619, DOI 10.1111/j.1572-0241.2006.00849.x; Lagergren J, 2000, GUT, V47, P26, DOI 10.1136/gut.47.1.26; Healy LA, 2010, DIS ESOPHAGUS, V23, P386, DOI 10.1111/j.1442-2050.2010.01052.x; Kang MS, 2007, J GASTROEN HEPATOL, V22, P1656, DOI 10.1111/j.1440-1746.2006.04518.x; Hirooka M, 2005, INTERNAL MED, V44, P794, DOI 10.2169/internalmedicine.44.794; El-Serag HB, 2007, GUT, V56, P749, DOI 10.1136/gut.2006.100263; Beasley LE, 2009, OBESITY, V17, P1062, DOI 10.1038/oby.2008.627; Ierardi E, 2010, WORLD J GASTROINTEST, V15, P91; Liu ES, 2001, J GASTROEN HEPATOL, V16, P740, DOI 10.1046/j.1440-1746.2001.02506.x; Machowska A, 2004, J Physiol Pharmacol, V55 Suppl 2, P91; Meining A, 2000, AM J GASTROENTEROL, V95, P2692, DOI 10.1016/S0002-9270(00)01968-7; Miyamoto M, 2008, J GASTROEN HEPATOL, V23, P393, DOI 10.1111/j.1440-1746.2007.05043.x; Park JH, 2008, WORLD J GASTROENTERO, V14, P5442, DOI 10.3748/wjg.14.5442; Rajendra S, 2007, HELICOBACTER, V12, P177, DOI 10.1111/j.1523-5378.2007.00489.x; Sakaguchi M, 2008, J GASTROENTEROL, V43, P57, DOI 10.1007/s00535-007-2128-7; Sogabe M, 2012, EUR J GASTROEN HEPAT, V24, P910, DOI 10.1097/MEG.0b013e328354a354; SUZUKI R, 1993, AM J MED, V95, P309, DOI 10.1016/0002-9343(93)90284-V; Vakil N, 2010, AM J GASTROENTEROL, V105, P572, DOI 10.1038/ajg.2009.709; Wu JCY, 2008, J GASTROEN HEPATOL, V23, P1785, DOI 10.1111/j.1440-1746.2008.05684.x; Zhang F Q, 2003, AM J PHYSIOL-GASTR L, DOI [10.1152/ajpgi.00383, DOI 10.1152/AJPGI.00383]	40	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	DEC	2014	93	28								10.1097/MD.0000000000000276		7	Medicine, General & Internal	General & Internal Medicine	AX2GS	WOS:000346762200029		
J	Stasevich, TJ; Sato, Y; Nozaki, N; Kimura, H				Stasevich, Timothy J.; Sato, Yuko; Nozaki, Naohito; Kimura, Hiroshi			Quantifying histone and RNA polymerase II post-translational modification dynamics in mother and daughter cells	METHODS			English	Article						Histone modifications; RNA polymerase II; Gene regulation; FabLEM; Live-cell imaging	LIVING CELLS; TRANSCRIPTION FACTORS; CHROMATIN; ORGANIZATION; MECHANISMS; INITIATION; PROMOTERS; LANGUAGE; THERAPY; REVEALS	Post-translational histone modifications are highly correlated with transcriptional activity, but the relative timing of these marks and their dynamic interplay during gene regulation remains controversial. To shed light on this problem and clarify the connections between histone modifications and transcription, we demonstrate how FabLEM (Fab-based Live Endogenous Modification labeling) can be used to simultaneously track histone H3 Lysine 9 acetylation (H3K9ac) together with RNA polymerase II Serine 2 and Serine 5 phosphorylation (RNAP2 Ser2ph/Ser5ph) in single living cells and their progeny. We provide a detailed description of the FabLEM methodology, including helpful tips for preparing and loading fluorescently conjugated antigen binding fragments (Fab) into cells for optimal results. We also introduce simple procedures for analyzing and visualizing FabLEM data, including color-coded scatterplots to track correlations between modifications through the cell cycle and temporal cross-correlation analysis to dissect modification dynamics. Using these methods, we find significant correlations that span cell generations, with a relatively strong correlation between H3K9ac and Ser5ph that appears to peak a few hours before mitosis and may reflect the bookmarking of genes for efficient re-initiation following mitosis. The techniques we have developed are broadly applicable and should help clarify how histone modifications dynamically contribute to gene regulation. (C) 2014 Elsevier Inc. All rights reserved.	[Stasevich, Timothy J.; Sato, Yuko; Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Stasevich, Timothy J.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Stasevich, Timothy J.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Nozaki, Naohito] Mob Inst Inc, Sapporo, Hokkaido 0010021, Japan; [Kimura, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Sci, Yokohama, Kanagawa 227, Japan	Stasevich, TJ (reprint author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	tim.stasevich@colostate.edu; hkimura@bio.titech.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to H.K. and T.J.S.). We thank Dr. Daniel R. Sisan for permission to reproduce Fig. 7A and for helpful comments and Dr. Yoko Hayashi-Takanaka for experimental advice.	Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Kimura H, 2013, J HUM GENET, V58, P439, DOI 10.1038/jhg.2013.66; Zhao R, 2011, NAT CELL BIOL, V13, P1295, DOI 10.1038/ncb2341; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Andrews AJ, 2011, ANNU REV BIOPHYS, V40, P99, DOI 10.1146/annurev-biophys-042910-155329; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Manders EMM, 1999, J CELL BIOL, V144, P813, DOI 10.1083/jcb.144.5.813; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Vermot J, 2008, HFSP J, V2, P143, DOI 10.2976/1.2907579; Lavis LD, 2007, ANAL CHEM, V79, P6775, DOI 10.1021/ac070907g; Strahl BD, 2000, NATURE, V403, P41; Hayashi-Takanaka Y, 2009, J CELL BIOL, V187, P781, DOI 10.1083/jcb.200904137; Egloff S, 2012, TRENDS GENET, V28, P333, DOI 10.1016/j.tig.2012.03.007; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Hattori T, 2013, NAT METHODS, V10, P992, DOI 10.1038/nmeth.2605; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Fussner E, 2011, TRENDS BIOCHEM SCI, V36, P1, DOI 10.1016/j.tibs.2010.09.002; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Chen JJ, 2014, CELL, V156, P1274, DOI 10.1016/j.cell.2014.01.062; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Hayashi-Takanaka Y, 2011, NUCLEIC ACIDS RES, V39, P6475, DOI 10.1093/nar/gkr343; Lionnet T, 2012, EMBO REP, V13, P313, DOI 10.1038/embor.2012.31; Grigoryev SA, 2012, EXP CELL RES, V318, P1448, DOI 10.1016/j.yexcr.2012.02.014; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Biancotto C, 2010, ADV GENET, V70, P341, DOI [10.1016/B978-0-12-380866-0.60013-7, 10.1016/S0065-2660(10)70013-4]; das Neves RP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000560; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kimura H, 1999, MOL CELL BIOL, V19, P5383; Kimura H, 2010, CURR OPIN CELL BIOL, V22, P412, DOI 10.1016/j.ceb.2010.02.004; Mazza D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks701; MCNEIL PL, 1987, J CELL SCI, V88, P669; Sato Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02436; Sisan DR, 2010, BIOPHYS J, V98, P2432, DOI 10.1016/j.bpj.2010.02.041; Weiner A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001369	43	3	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	DEC	2014	70	2-3					77	88		10.1016/j.ymeth.2014.08.002		12	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AX4GG	WOS:000346891000002		
J	Taguchi, H; Horikoshi, N; Arimura, Y; Kurumizaka, H				Taguchi, Hiroyuki; Horikoshi, Naoki; Arimura, Yasuhiro; Kurumizaka, Hitoshi			A method for evaluating nucleosome stability with a protein-binding fluorescent dye	METHODS			English	Article						Chromatin; Nucleosome; Histone variant; Histone octamer; Tetrasome; SYPRO Orange	RESONANCE ENERGY-TRANSFER; HISTONE H3 VARIANTS; CRYSTAL-STRUCTURE; CHROMATIN FRAGMENTS; STRUCTURAL BASIS; CORE PARTICLES; DNA; ACETYLATION; RECONSTITUTION; ACCESSIBILITY	Nucleosomes are extremely stable histone-DNA complexes that form the building blocks of chromatin, which accommodates genomic DNA within the nucleus. The dynamic properties of chromatin play essential roles in regulating genomic DNA functions, such as DNA replication, recombination, repair, and transcription. Histones are the protein components of nucleosomes, and their diverse modifications and variants increase the versatility of nucleosome structures and their dynamics in chromatin. Therefore, a technique to evaluate the physical properties of nucleosomes would facilitate functional studies of the various nucleosomes. In this report, we describe a convenient assay for evaluating the thermal stability of nucleosomes in vitro. (C) 2014 Elsevier Inc. All rights reserved.	[Taguchi, Hiroyuki; Arimura, Yasuhiro; Kurumizaka, Hitoshi] Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, Tokyo 1628480, Japan; [Horikoshi, Naoki; Kurumizaka, Hitoshi] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan	Kurumizaka, H (reprint author), Waseda Univ, Grad Sch Adv Sci & Engn, Struct Biol Lab, Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	kurumizaka@waseda.jp			MEXT KAKENHI [25116002]; JSPS KAKENHI [25250023]; Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan; Waseda Research Institute for Science and Engineering; Waseda University	This work was supported in part by MEXT KAKENHI Grant Number 25116002 [to H.K.], JSPS KAKENHI Grant Number 25250023 [to H.K.], and the Platform for Drug Discovery, Informatics, and Structural Life Science from MEXT, Japan [to H.K.]. H.K. was also supported by the Waseda Research Institute for Science and Engineering and Waseda University.	ALMAGOR M, 1989, J BIOL CHEM, V264, P6515; Andresen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078587; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Horikoshi N, 2013, ACTA CRYSTALLOGR D, V69, P2431, DOI 10.1107/S090744491302252X; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Jimenez-Useche I, 2012, BIOPHYS J, V103, P2502, DOI 10.1016/j.bpj.2012.11.012; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Tachiwana H, 2010, P NATL ACAD SCI USA, V107, P10454, DOI 10.1073/pnas.1003064107; Gautier T, 2004, EMBO REP, V5, P715, DOI 10.1038/sj.embor.7400182; Tachiwana H, 2011, NATURE, V476, P232, DOI 10.1038/nature10258; Harp JM, 1996, ACTA CRYSTALLOGR D, V52, P283, DOI 10.1107/S0907444995009139; Deindl S, 2013, CELL, V152, P442, DOI 10.1016/j.cell.2012.12.040; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Bao YH, 2004, EMBO J, V23, P3314, DOI 10.1038/sj.emboj.7600316; Ye JX, 2005, MOL CELL, V18, P123, DOI 10.1016/j.molcel.2005.02.031; Shimko JC, 2011, J MOL BIOL, V408, P187, DOI 10.1016/j.jmb.2011.01.003; Chakravarthy S, 2005, MOL CELL BIOL, V25, P7616, DOI 10.1128/MCB.25.17.7616-7624.2005; Bonisch C, 2012, NUCLEIC ACIDS RES, V40, P10719, DOI 10.1093/nar/gks865; Luger K, 1997, NATURE, V389, P251; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Andrews AJ, 2010, MOL CELL, V37, P834, DOI 10.1016/j.molcel.2010.01.037; Skene PJ, 2013, DEVELOPMENT, V140, P2513, DOI 10.1242/dev.091439; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Duan MR, 2010, J BIOL CHEM, V285, P26295, DOI 10.1074/jbc.M110.140087; Arimura Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03510; Gansen A, 2009, P NATL ACAD SCI USA, V106, P15308, DOI 10.1073/pnas.0903005106; Urahama T, 2014, ACTA CRYSTALLOGR F, V70, P444, DOI 10.1107/S2053230X14004695; Tachiwana H, 2011, ACTA CRYSTALLOGR D, V67, P578, DOI 10.1107/S0907444911014818; Iwasaki W, 2013, FEBS OPEN BIO, V3, P363, DOI 10.1016/j.fob.2013.08.007; Doyen CM, 2006, EMBO J, V25, P4234, DOI 10.1038/sj.emboj.7601310; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Choy JS, 2010, J AM CHEM SOC, V132, P1782, DOI 10.1021/ja910264z; Tanaka Y, 2004, METHODS, V33, P3, DOI 10.1016/j.ymeth.2003.10.024; BINA M, 1980, P NATL ACAD SCI-BIOL, V77, P4044, DOI 10.1073/pnas.77.7.4044; CAVAZZA B, 1991, BIOCHEMISTRY-US, V30, P9060, DOI 10.1021/bi00101a022; Dechassa ML, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1320; Di Cerbo V, 2014, ELIFE, V3, DOI 10.7554/eLife.01632; DIMITROV SI, 1981, EUR J BIOCHEM, V115, P545; FULMER AW, 1979, BIOCHEMISTRY-US, V18, P659, DOI 10.1021/bi00571a017; Kelbauskas L, 2007, BIOCHEMISTRY-US, V46, P2239, DOI 10.1021/bi061289l; Kurumizaka H., 2013, CURR OPIN STRUC BIOL, V1, P109; Millar CB, 2013, BIOCHEM J, V449, P567, DOI 10.1042/BJ20121646; Moyle-Heyrman G, 2011, J MOL BIOL, V412, P634, DOI 10.1016/j.jmb.2011.07.032; Musselman CA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3969; NI XR, 1994, BIOCHEMISTRY-US, V33, P9276, DOI 10.1021/bi00197a031; Ong M.S., 2010, J NUCL ACIDS, V12; Siino JS, 2003, BIOCHEM BIOPH RES CO, V302, P885, DOI 10.1016/S0006-291X(03)00277-8; Sugiyama M, 2014, BIOPHYS J, V106, P2206, DOI 10.1016/j.bpj.2014.04.007; Talbert PB, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-7; Toth K, 2001, BIOCHEMISTRY-US, V40, P6921, DOI 10.1021/bi002695m; Toth K, 2006, BIOCHEMISTRY-US, V45, P1591, DOI 10.1021/bi052110u; Vardabasso C., 2013, CELL MOL LIFE SCI, V71, P379; Wolffe A, 1998, CHROMATIN STRUCTURE; Wunsch A, 2005, BIOCHEMISTRY-US, V44, P16351, DOI 10.1021/bi050876o	56	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	DEC	2014	70	2-3					119	126		10.1016/j.ymeth.2014.08.019		8	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AX4GG	WOS:000346891000006		
J	Maeshima, K; Imai, R; Hikima, T; Joti, Y				Maeshima, Kazuhiro; Imai, Ryosuke; Hikima, Takaaki; Joti, Yasumasa			Chromatin structure revealed by X-ray scattering analysis and computational modeling	METHODS			English	Article						Chromatin; Chromosomes; 30-nm chromatin fiber; Small-angle X-ray scattering; Cryo-electron microscopy; Computational modeling	METAPHASE CHROMOSOME STRUCTURE; NUCLEOSOME REPEAT LENGTH; HIGHER-ORDER STRUCTURE; FREE-ELECTRON LASER; IN-VIVO; CRYOELECTRON MICROSCOPY; MITOTIC CHROMOSOMES; CONDENSATION MECHANISM; LINKER HISTONE; FIBER	It remains unclear how the 2 m of human genomic DNA is organized in each cell. The textbook model has long assumed that the 11-nm-diameter nucleosome fiber (beads-on-a-string), in which DNA is wrapped around core histones, is folded into a 30-nm chromatin fiber. One of the classical models assumes that the 30-nm chromatin fiber is further folded helically to form a larger fiber. Small-angle X-ray scattering (SAXS) is a powerful method for investigating the bulk structure of interphase chromatin and mitotic chromosomes. SAXS can detect periodic structures in biological materials in solution. In our SAXS results, no structural feature larger than 11 nm was detected. Combining this with a computational analysis of "in silica condensed chromatin" made it possible to understand more about the X-ray scattering profiles and suggested that the chromatin in interphase nuclei and mitotic chromosomes essentially consists of irregularly folded nucleosome fibers lacking the 30-nm chromatin structure. In this article, we describe the experimental details of our SAXS and modeling systems. We also discuss other methods for investigating the chromatin structure in cells. (C) 2014 Elsevier Inc. All rights reserved.	[Maeshima, Kazuhiro; Imai, Ryosuke] Natl Inst Genet, Struct Biol Ctr, Biol Macromol Lab, Mishima, Shizuoka 4118540, Japan; [Maeshima, Kazuhiro; Imai, Ryosuke] Grad Univ Adv Studies Sokendai, Sch Life Sci, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Maeshima, Kazuhiro; Hikima, Takaaki; Joti, Yasumasa] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan; [Joti, Yasumasa] Japan Synchrotron Radiat Res Inst JASRI, XFEL Utilizat Div, Sayo Cho, Hyogo 6795198, Japan	Maeshima, K (reprint author), Natl Inst Genet, Struct Biol Ctr, Biol Macromol Lab, Mishima, Shizuoka 4118540, Japan.	kmaeshim@nig.ac.jp			CREST	We are grateful to Dr. Fujisawa and Dr. Hayakawa for technically supporting SAXS, and to all of our SAXS and USAXS collaborators at SPring-8, especially Dr. Nishino, Dr. Ito, Dr. Takahashi, and Dr. Eltsov. We thank Dr. Rhodes for providing the models of 30-nm fibers, and Dr. Ishikawa, Dr. Yamauchi and Dr. Imamoto for their strong support, Ms. Tamura for assistance and help of Figure preparation. This work was supported by a grant-in-aid from CREST.	Ahmed Kashif, 2009, Methods Mol Biol, V464, P415, DOI 10.1007/978-1-60327-461-6_23; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; LANGMORE JP, 1983, J CELL BIOL, V96, P1120, DOI 10.1083/jcb.96.4.1120; Scheffer MP, 2011, P NATL ACAD SCI USA, V108, P16992, DOI 10.1073/pnas.1108268108; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; FINCH JT, 1976, P NATL ACAD SCI USA, V73, P1897, DOI 10.1073/pnas.73.6.1897; Nishino Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.018101; Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105; OLINS AL, 1974, SCIENCE, V183, P330, DOI 10.1126/science.183.4122.330; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; Song F, 2014, SCIENCE, V344, P376, DOI 10.1126/science.1251413; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Quenet D, 2012, EMBO REP, V13, P943, DOI 10.1038/embor.2012.143; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Bazett-Jones DP, 2008, CHROMOSOME RES, V16, P397, DOI 10.1007/s10577-008-1237-3; Fussner E, 2012, EMBO REP, V13, P992, DOI 10.1038/embor.2012.139; Fussner E, 2011, EMBO J, V30, P1778, DOI 10.1038/emboj.2011.96; Fujisawa T, 2000, J APPL CRYSTALLOGR, V33, P797, DOI 10.1107/S002188980000131X; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Dubochet J, 2001, MICRON, V32, P91, DOI 10.1016/S0968-4328(00)00026-3; Ishikawa T, 2012, NAT PHOTONICS, V6, P540, DOI 10.1038/nphoton.2012.141; Albiez H, 2006, CHROMOSOME RES, V14, P707, DOI 10.1007/s10577-006-1086-x; WOODCOCK CLF, 1976, EXP CELL RES, V97, P101, DOI 10.1016/0014-4827(76)90659-5; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Seibert MM, 2011, NATURE, V470, P78, DOI 10.1038/nature09748; WOODCOCK CLF, 1984, J CELL BIOL, V99, P42, DOI 10.1083/jcb.99.1.42; Maeshima K, 2010, CURR OPIN CELL BIOL, V22, P291, DOI 10.1016/j.ceb.2010.03.001; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Nora EP, 2013, BIOESSAYS, V35, P818, DOI 10.1002/bies.201300040; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/nphoton.2010.176, 10.1038/NPHOTON.2010.176]; Maeshima K, 2014, CHROMOSOMA, V123, P225, DOI 10.1007/s00412-014-0460-2; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; WOODCOCK CL, 1994, J CELL BIOL, V125, P11, DOI 10.1083/jcb.125.1.11; Joti Y, 2012, NUCLEUS-AUSTIN, V3, P404, DOI 10.4161/nucl.21222; WIDOM J, 1985, CELL, V43, P207, DOI 10.1016/0092-8674(85)90025-X; Gan L, 2013, CHROMOSOMA, V122, P377, DOI 10.1007/s00412-013-0423-z; Miao JW, 2008, ANNU REV PHYS CHEM, V59, P387, DOI 10.1146/annurev.physchem.59.032607.093642; BELMONT AS, 1989, CHROMOSOMA, V98, P129, DOI 10.1007/BF00291049; Berezney R, 2005, ADV ENZYME REGUL, V45, P17, DOI 10.1016/j.advenzreg.2005.02.013; BORDAS J, 1986, EUR BIOPHYS J BIOPHY, V13, P157, DOI 10.1007/BF00542560; Bouchet-Marquis C, 2006, HISTOCHEM CELL BIOL, V125, P43, DOI 10.1007/s00418-005-0093-x; Debye P, 1915, ANN PHYS-BERLIN, V46, P809; DUBOCHET J, 1986, EMBO J, V5, P519; Fakan S, 2007, SEMIN CELL DEV BIOL, V18, P676, DOI 10.1016/j.semcdb.2007.08.010; Gaffney KJ, 2007, SCIENCE, V316, P1444, DOI 10.1126/science.1135923; HOLLANDT H, 1979, NUCLEIC ACIDS RES, V6, P2017, DOI 10.1093/nar/6.5.2017; Kimura T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4052; KOCH MHJ, 1987, EUR BIOPHYS J BIOPHY, V14, P307; Kowalski A, 2011, CHROMOSOME RES, V19, P579, DOI 10.1007/s10577-011-9218-3; Laemmli U.K., 1978, S QUANT BIOL, V42, P351; LANGMORE JP, 1980, NATURE, V288, P620, DOI 10.1038/288620a0; LEWIS CD, 1982, CELL, V29, P171, DOI 10.1016/0092-8674(82)90101-5; Maeshima K, 2005, CHROMOSOMA, V114, P365, DOI 10.1007/s00412-005-0023-7; Maeshima K, 2008, J BIOCHEM, V143, P145, DOI 10.1093/jb/mvm214; Maeshima K., 2010, S QUANT BIOL, V75, P439; MARSDEN MPF, 1979, CELL, V17, P849, DOI 10.1016/0092-8674(79)90325-8; PAULSON JR, 1983, J CELL BIOL, V96, P1132, DOI 10.1083/jcb.96.4.1132; PEREZGRAU L, 1984, NUCLEIC ACIDS RES, V12, P2987, DOI 10.1093/nar/12.6.2987; RATTNER JB, 1979, J CELL BIOL, V81, P453, DOI 10.1083/jcb.81.2.453; Roe R. J., 2000, METHODS XRAY NEUTRON; Schermelleh L, 2001, CHROMOSOME RES, V9, P77, DOI 10.1023/A:1026799818566; Sedat J., 1978, S QUANT BIOL, V42, P331; SPERLING L, 1976, FEBS LETT, V64, P89, DOI 10.1016/0014-5793(76)80256-6; Visvanathan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067689; Wachsmuth M, 2008, BBA-MOL CELL RES, V1783, P2061, DOI 10.1016/j.bbamcr.2008.07.022	72	2	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1046-2023	1095-9130		METHODS	Methods	DEC	2014	70	2-3					154	161		10.1016/j.ymeth.2014.08.008		8	Biochemical Research Methods; Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	AX4GG	WOS:000346891000010		
J	Honma, H; Takahashi, K; Fukuhara, M; Ishida, M; Sawada, K				Honma, Hiroaki; Takahashi, Kazuhiro; Fukuhara, Masashi; Ishida, Makoto; Sawada, Kazuaki			Free-standing aluminium nanowire arrays for high-transmission plasmonic color filters	MICRO & NANO LETTERS			English	Article							OPTICAL-TRANSMISSION; HOLE ARRAYS; RESONANCE	Presented is a fabrication process for the transmission of red-green-blue (RGB) colour filters based on surface plasmons (SPs) using aluminium (Al) nanowire arrays patterned through electron-beam lithography and the lift-off technique. An array of Al nanowires was deployed over a through hole formed by sacrificial silicon etching. The period of the Al nanowire arrays is the dominant structural parameter in determining the transmission peak position of SPs for a given material configuration. The Al nanowire arrays are designed with the same Al wire width under the assumption of operation using a microelectromechanical systems (MEMS) comb-drive actuator for the realisation of an RGB tunable colour filter. The peak wavelength of the transmitted light was red-shifted by increasing the period of the Al nanowire arrays from 450 to 600 nm, and RGB colours were demonstrated. A black pixel was produced using the 400 nm pitch Al nanowire array. The maximum measured transmittance of the peak wavelength was 56%. In addition, the number of nanowires sufficient for low-power operation by a MEMS comb-drive actuator was investigated and sufficient transmission light intensity was obtained from the pixel size of 10 mu m(2), including 20 Al nanowires.	[Honma, Hiroaki; Takahashi, Kazuhiro; Fukuhara, Masashi; Ishida, Makoto; Sawada, Kazuaki] Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Toyohashi, Aichi 4418580, Japan; [Fukuhara, Masashi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1028472, Japan; [Ishida, Makoto; Sawada, Kazuaki] Toyohashi Univ Technol, Elect Inspired Interdisciplinary Res Inst EIIRIS, Toyohashi, Aichi 4418580, Japan	Honma, H (reprint author), Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, 1-1 Hibarigaoka, Toyohashi, Aichi 4418580, Japan.	honma-h@int.ee.tut.ac.jp			Japan Society for the Promotion of Science;  [24710143]	The authors thank Professor M. Fukuda of the Toyohashi University of Technology for technical support for the optical measurement. This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and by a Grant-in-Aid for Young Scientists B (grant no. 24710143).	Chen Q, 2010, OPT EXPRESS, V18, P14056, DOI 10.1364/OE.18.014056; WANG SS, 1993, APPL OPTICS, V32, P2606, DOI 10.1364/AO.32.002606; Kanamori Y, 2006, IEEE PHOTONIC TECH L, V18, P2126, DOI 10.1109/LPT.2006.883208; Genet C, 2007, NATURE, V445, P39, DOI 10.1038/nature05350; Krishnan A, 2001, OPT COMMUN, V200, P1, DOI 10.1016/S0030-4018(01)01558-9; Inoue D, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3560467; Yamaguchi K, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.012201; Mizutani A, 2003, OPT REV, V10, P13, DOI 10.1007/s10043-003-0013-z; Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Ghaemi HF, 1998, PHYS REV B, V58, P6779, DOI 10.1103/PhysRevB.58.6779; Ikeda T, 2013, OPT EXPRESS, V21, P22034, DOI 10.1364/OE.21.022034; Ebbesen TW, 1998, NATURE, V391, P667, DOI 10.1038/35570; Lee HS, 2007, OPT EXPRESS, V15, P15457, DOI 10.1364/OE.15.015457; Hane K, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2193989; Honma H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.11PA01; Honma H., 2013, P INT C OPT MEMS NAN, P107; Huu N. N., 2011, P SOC PHOTO-OPT INS, V7934; Kanamori Y, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.06FH04; Kanamori Y, 2008, IEEE PHOTONIC TECH L, V20, P1136, DOI 10.1109/LPT.2008.924655; Lee T., 2010, NANOPHOTONICS, P107; Miyao H, 2011, ECS TRANSACTIONS, V35, P213, DOI 10.1149/1.3570798; Takahashi K, 2009, J MICROELECTROMECH S, V18, P818, DOI 10.1109/JMEMS.2009.2018371; Vincenti MA, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4718764; Xu T, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1058; Zeng BB, 2013, SCI REP-UK, V3, DOI 10.1038/srep02840	25	1	1	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1750-0443			MICRO NANO LETT	Micro Nano Lett.	DEC	2014	9	12					891	895		10.1049/mnl.2014.0423		5	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science & Technology - Other Topics; Materials Science	AX0IX	WOS:000346637200017		
J	Van, TTB; Yoshida, S; Miki, K; Kondo, A; Kamei, K				Truong Thi Bich Van; Yoshida, Shohei; Miki, Kaito; Kondo, Akihiro; Kamei, Kaeko			Genomic characterization of phi RS603, a filamentous bacteriophage that is infectious to the phytopathogen Ralstonia solanacearum	MICROBIOLOGY AND IMMUNOLOGY			English	Article						Bacteriophage; genome; Ralstonia solanacearum	PHI-RSM; SEQUENCE	A filamentous bacteriophage (phi), phi RS603, which is infectious to the phytopathogen Ralstonia solanacearum was isolated. phi RS603 was found to have a circular single-stranded DNA genome composed of 7679 nucleotides and to contain 13 putative open reading frames (ORFs). The phi RS603 genome showed strong similarity with those of Ralstonia phages phi RSM1 and phi RSM3, as reported by Askora et al. The phi RS603 genome had no ORFs corresponding to ORFs 2, 3, 13 and 14 (integrase) of phi RSM3. phi RS603 had an ORF that was homologous to other Ralstonia phages phi RSS0 and phi RSS1; however, phi RSM1 and phi RSM3 did not.	[Truong Thi Bich Van; Yoshida, Shohei; Miki, Kaito; Kamei, Kaeko] Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan	Kamei, K (reprint author), Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan.	kame@kit.ac.jp					Kawasaki T, 2007, J BACTERIOL, V189, P5792, DOI 10.1128/JB.00540-07; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Askora A, 2009, VIROLOGY, V384, P69, DOI 10.1016/j.virol.2008.11.007; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Rakonjac J, 2011, CURR ISSUES MOL BIOL, V13, P51; Yamada T, 2007, MICROBIOL-SGM, V153, P2630, DOI 10.1099/mic.0.2006/001453-0; Jones JB, 2007, ANNU REV PHYTOPATHOL, V45, P245, DOI 10.1146/annurev.phyto.45.062806.094411; Askora A, 2014, MOL GENET GENOMICS, V289, P589, DOI 10.1007/s00438-014-0835-3; Trun N., 2004, BACTERIOPHAGE FUNDAM, P105; Yamada T., 2012, BACTERIOPHAGES, P113	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0385-5600	1348-0421		MICROBIOL IMMUNOL	Microbiol. Immunol.	DEC	2014	58	12					697	700		10.1111/1348-0421.12203		4	Immunology; Microbiology	Immunology; Microbiology	AX2IN	WOS:000346767000005		
J	Sakuma, S; Kuroda, K; Arai, F; Taniguchi, T; Ohtani, T; Sakata, Y; Kaneko, M				Sakuma, Shinya; Kuroda, Keisuke; Arai, Fumihito; Taniguchi, Tatsunori; Ohtani, Tomohito; Sakata, Yasushi; Kaneko, Makoto			High Resolution Cell Positioning Based on a Flow Reduction Mechanism for Enhancing Deformability Mapping	MICROMACHINES			English	Article						flow reduction mechanism; cell positioning; high resolution; deformability; red blood cell	RED-BLOOD-CELLS; MICROFLUIDIC DEVICE; DEFORMATION; SYSTEM; MODEL	The dispersion of cell deformability mapping is a ffected not only by the resolution of the sensing system, but also by cell deformability itself. In order to extract the pure deformability characteristics of cells, it is necessary to improve the resolution of cell actuation in the sensing system, particularly in the case of active sensing, where an actuator is essential. This paper proposes a novel concept, a "flow reduction mechanism", where a flow is generated by a macroactuator placed outside of a microfluidic chip. The flow can be drastically reduced at the cell manipulation point in a microchannel due to the elasticity embedded into the fluid circuit of the microfluidic system. The great advantage of this approach is that we can easily construct a high resolution cell manipulation system by combining a macro-scale actuator and a macro- scale position sensor, even though the resolution of the actuator is larger than the desired resolution for cell manipulation. Focusing on this characteristic, we successfully achieved the cell positioning based on a visual feedback control with a resolution of 240 nm, corresponding to one pixel of the vision system. We show that the utilization of this positioning system contributes to reducing the dispersion coming from the positioning resolution in the cell deformability mapping.	[Sakuma, Shinya; Kuroda, Keisuke; Kaneko, Makoto] Osaka Univ, Dept Mech Engn, Suita, Osaka 5650871, Japan; [Arai, Fumihito] Nagoya Univ, Dept Micronano Syst Engn, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Taniguchi, Tatsunori; Ohtani, Tomohito; Sakata, Yasushi] Osaka Univ, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan	Sakuma, S (reprint author), Nagoya Univ, Dept Micronano Syst Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan.	sakuma@mech.nagoya-u.ac.jp; kuroda@hh.mech.eng.osaka-u.ac.jp; arai@mech.nagoya-u.ac.jp; t-taniguchi@outlook.com; ohtani@cardiology.med.osaka-u.ac.jp; yasushisk@cardiology.med.osaka-u.ac.jp; mk@mech.eng.osaka-u.ac.jp			Hyper Bio Assembler; Nanotechnology Platform Project (Nanotechnology Open Facilities in Osaka University); Ministry of Education, Culture, Sports, Science and Technology [26630098]; Creating Hybrid Organs of the Future at Osaka University; Japan Society for the Promotion of Science	A part of this work was supported by the "Hyper Bio Assembler", the " Nanotechnology Platform Project (Nanotechnology Open Facilities in Osaka University)", Grant-in-Aid for Challenging Exploratory Research (26630098) of the Ministry of Education, Culture, Sports, Science and Technology", Creating Hybrid Organs of the Future" at Osaka University and the Japan Society for the Promotion of Science.	Dao M, 2003, J MECH PHYS SOLIDS, V51, P2259, DOI 10.1016/j.jmps.2003.09.019; Shelby JP, 2003, P NATL ACAD SCI USA, V100, P14618, DOI 10.1073/pnas.2433968100; Tsukada K, 2001, MICROVASC RES, V61, P231, DOI 10.1006/mvre.2001.2307; Mahalanabis M, 2009, LAB CHIP, V9, P2811, DOI 10.1039/b905065p; Sun Y, 2003, IEEE T NANOBIOSCI, V2, P279, DOI 10.1109/TNB.2003.820273; Maruo S, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2358820; Pamme N, 2006, LAB CHIP, V6, P24, DOI 10.1039/b513005k; Kruger J, 2002, J MICROMECH MICROENG, V12, P486, DOI 10.1088/0960-1317/12/4/324; Adamo A, 2012, ANAL CHEM, V84, P6438, DOI 10.1021/ac300264v; Zheng Y, 2012, LAB CHIP, V12, P2560, DOI 10.1039/c2lc21210b; Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k; Bremmell KE, 2006, COLLOID SURFACE B, V50, P43, DOI 10.1016/j.colsurfb.2006.03.002; Tai CH, 2007, BIOMED MICRODEVICES, V9, P533, DOI 10.1007/s10544-007-9061-7; Braunmuller S, 2012, SOFT MATTER, V8, P11240, DOI 10.1039/c2sm26513c; Fukui W., 2012, P IEEE INT C ROB AUT, P4600; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; Hirose Y., 2010, P IEEE INT C ROB AUT, P4113; Ichikawa A., 2011, J ROBOT MECHATRON, V23, P13; Lee S.S., 2009, BIOMED MICRODEVICES, V11, P37; Lintel HV, 1988, SENSOR ACTUATOR, V15, P153; Sakuma S, 2014, LAB CHIP, V14, P1135, DOI 10.1039/c3lc51003d; Sakuma S., 2013, J ROBOT MECHATRON, V25, P277	22	3	3	MDPI AG	BASEL	POSTFACH, CH-4005 BASEL, SWITZERLAND	2072-666X			MICROMACHINES-BASEL	Micromachines	DEC	2014	5	4					1188	1201		10.3390/mi5041188		14	Nanoscience & Nanotechnology; Instruments & Instrumentation	Science & Technology - Other Topics; Instruments & Instrumentation	AX2TD	WOS:000346796400023		
J	Matsuda, T; Nagai, T				Matsuda, Tomoki; Nagai, Takeharu			Quantitative measurement of intracellular protein dynamics using photobleaching or photoactivation of fluorescent proteins	MICROSCOPY			English	Review						diffusion coefficient; fluorescent protein; photobleaching; photoactivation; FRAP; FDAP	LIVING CELLS; KINETICS; FRAP; MOBILITY	Unlike in vitro protein dynamics, intracellular protein dynamics are intricately regulated by protein-protein interactions or interactions between proteins and other cellular components, including nucleic acids, the plasma membrane and the cytoskeleton. Alteration of these dynamics plays a crucial role in physiological phenomena such as gene expression and cell division. Live-cell imaging via microscopy with the inherent properties of fluorescent proteins, i.e. photobleaching and photoconversion, or fluorescence correlation spectroscopy, provides insight into the movement of proteins and their interactions with cellular components. This article reviews techniques based on photo-induced changes in the physicochemical properties of fluorescent proteins to measure protein dynamics inside living cells, and it also discusses the strengths and weaknesses of these techniques.	[Matsuda, Tomoki; Nagai, Takeharu] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan	Nagai, T (reprint author), Osaka Univ, Inst Sci & Ind Res, 8-1 Mihogaoka, Osaka 5670047, Japan.	ng1@sanken.osaka-u.ac.jp			MEXT [23115003, 23111502]; JSPS [21687007]; JST CREST; JST PRESTO	This work was partly supported by MEXT Grant-in-Aid for Scientific Research on Innovative Areas (23115003, T.N. and 23111502, T.M.), and JSPS Grant-in-Aid for Young Scientists (A) 21687007 (T.M.), JST CREST (T.M.) and JST PRESTO (T.N.).	Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Carrero G, 2003, METHODS, V29, P14, DOI 10.1016/S1046-2023(02)00288-8; Matsuda T, 2008, NAT METHODS, V5, P339, DOI [10.1038/nmeth.1193, 10.1038/NMETH.1193]; Plachta N, 2011, NAT CELL BIOL, V13, P117, DOI 10.1038/ncb2154; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Patterson G, 2010, ANNU REV PHYS CHEM, V61, P345, DOI 10.1146/annurev.physchem.012809.103444; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Miyawaki A, 2011, NAT REV MOL CELL BIO, V12, P656, DOI 10.1038/nrm3199; Subach FV, 2010, CHEM BIOL, V17, P745, DOI 10.1016/j.chembiol.2010.05.022; AXELROD D, 1976, BIOPHYS J, V16, P1055; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Dundr M, 2003, CURR PROTOC CELL BIO, V13; Khun T, 2011, PLOS ONE, V6; Medina MA, 2002, BIOESSAYS, V24, P758, DOI 10.1002/bies.10118; Theis-Febvre N, 2005, MOL CELL BIOCHEM, V274, P15, DOI 10.1007/s11010-005-3115-z	16	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	DEC	2014	63	6					403	408		10.1093/jmicro/dfu033		6	Microscopy	Microscopy	AX0TJ	WOS:000346664800001		
J	Li, W; Tanji, T				Li, Wei; Tanji, Takayoshi			Restoration of singularities in reconstructed phase of crystal image in electron holography	MICROSCOPY			English	Article						electron holography; structure image; phase restoration; interference fringes; singularities; image processing	OFF-AXIS HOLOGRAPHY	Off-axis electron holography can be used to measure the inner potential of a specimen from its reconstructed phase image and is thus a powerful technique for materials scientists. However, abrupt reversals of contrast from white to black may sometimes occur in a digitally reconstructed phase image, which results in inaccurate information. Such phase distortion is mainly due to the digital reconstruction process and weak electron wave amplitude in some areas of the specimen. Therefore, digital image processing can be applied to the reconstruction and restoration of phase images. In this paper, fringe reconnection processing is applied to phase image restoration of a crystal structure image. The disconnection and wrong connection of interference fringes in the hologram that directly cause a 2p phase jump imperfection are correctly reconnected. Experimental results show that the phase distortion is significantly reduced after the processing. The quality of the reconstructed phase image was improved by the removal of imperfections in the final phase.	[Li, Wei] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan; [Li, Wei; Tanji, Takayoshi] Global Res Ctr Environm & Energy Based Nanomat Sc, Nagoya, Aichi 4648603, Japan; [Tanji, Takayoshi] Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648603, Japan	Li, W (reprint author), Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan.	liwei00jp@yahoo.co.jp			Global Research Center for Environment and Energy Based on Nanomaterials Science (GREEN) of the National Institute for Materials Science (NIMS), Japan	This study was supported in part by the Global Research Center for Environment and Energy Based on Nanomaterials Science (GREEN) of the National Institute for Materials Science (NIMS), Japan.	Amir H T, 2011, J ELECTRON MICROSC, V60, P307; LICHTE H, 1991, ULTRAMICROSCOPY, V38, P13, DOI 10.1016/0304-3991(91)90105-F; FRABBONI S, 1987, ULTRAMICROSCOPY, V23, P29, DOI 10.1016/0304-3991(87)90224-5; GABOR D, 1949, PROC R SOC LON SER-A, V197, P454, DOI 10.1098/rspa.1949.0075; Ghiglia D C, 1995, 2 DIMENSIONAL PHASE; ISHIZUKA K, 1993, ULTRAMICROSCOPY, V52, P1, DOI 10.1016/0304-3991(93)90017-R; ISHIZUKA K, 1994, ULTRAMICROSCOPY, V55, P197, DOI 10.1016/0304-3991(94)90170-8; Junginger F, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2709989; Lichte H, 2002, ADV IMAG ELECT PHYS, V123, P225; Rother A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.134116; Smith D J, 1998, INTRO ELECT HOLOGRAP, P107; TANJI T, 1982, J ELECTRON MICROSC, V31, P1; TANJI T, 1993, ULTRAMICROSCOPY, V49, P259, DOI 10.1016/0304-3991(93)90232-M; Tanji T, 2004, MICROSC MICROANAL, V10, P146, DOI 10.1017/S1431927604040358; Tanji T., 1995, Electron Holography. Proceedings of the International Workshop on Electron Holography, DOI 10.1016/B978-044482051-8/50006-3; Tonomura A, 1999, ELECT HOLOGRAPHY, P44; VOLKL E, 1990, ULTRAMICROSCOPY, V32, P177, DOI 10.1016/0304-3991(90)90035-K; Volkl E, 1998, INTRO ELECT HOLOGRAP, P125; Wei Li, 2013, Microscopy, V62, DOI 10.1093/jmicro/dft034; Yamamoto K, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2973675; Yuanming W, 2002, MICRON, V33, P15	21	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	DEC	2014	63	6					419	426		10.1093/jmicro/dfu031		8	Microscopy	Microscopy	AX0TJ	WOS:000346664800003		
J	Wang, YM; Wakasugi, T; Isobe, S; Hashimoto, N; Ohnuki, S				Wang, Yongming; Wakasugi, Takenobu; Isobe, Shigehito; Hashimoto, Naoyuki; Ohnuki, Somei			Interaction of electrons with light metal hydrides in the transmission electron microscope	MICROSCOPY			English	Article						transmission electron microscope; elastic scattering; inelastic scattering; light metal hydrides; electron irradiation	RADIATION-DAMAGE; HYDROGEN STORAGE; CARBON NANOTUBES; TEM; SPECTROSCOPY; TEMPERATURE; MGH2; SEM	Transmission electron microscope (TEM) observation of light metal hydrides is complicated by the instability of these materials under electron irradiation. In this study, the electron kinetic energy dependences of the interactions of incident electrons with lithium, sodium and magnesium hydrides, as well as the constituting element effect on the interactions, were theoretically discussed, and electron irradiation damage to these hydrides was examined using in situ TEM. The results indicate that high incident electron kinetic energy helps alleviate the irradiation damage resulting from inelastic or elastic scattering of the incident electrons in the TEM. Therefore, observations and characterizations of these materials would benefit from increased, instead decreased, TEM operating voltage.	[Wang, Yongming; Isobe, Shigehito] Hokkaido Univ, Creat Res Inst, North Ward, Sapporo, Hokkaido 0010021, Japan; [Wakasugi, Takenobu; Isobe, Shigehito; Hashimoto, Naoyuki; Ohnuki, Somei] Hokkaido Univ, Grad Sch Engn, North Ward, Sapporo, Hokkaido 0608628, Japan	Wang, YM (reprint author), Hokkaido Univ, Creat Res Inst, North Ward, N21W10, Sapporo, Hokkaido 0010021, Japan.	wang@eng.hokudai.ac.jp	Isobe, Shigehito/I-8292-2012		Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	A part of this work was conducted at Hokkaido University, partially supported by 'Nanotechnology Platform' Program of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Egerton RF, 2004, MICRON, V35, P399, DOI 10.1016/j.micron.2004.02.003; Danaie M, 2009, J ALLOY COMPD, V476, P590, DOI 10.1016/j.jallcom.2008.09.078; Sakintuna B, 2007, INT J HYDROGEN ENERG, V32, P1121, DOI 10.1016/j.ijhydene.2006.11.022; Banhart F, 1999, REP PROG PHYS, V62, P1181, DOI 10.1088/0034-4885/62/8/201; GLAESER RM, 1978, J MICROSC-OXFORD, V112, P127; Smith BW, 2001, J APPL PHYS, V90, P3509, DOI 10.1063/1.1383020; Yang J, 2010, CHEM SOC REV, V39, P656, DOI 10.1039/b802882f; [Anonymous], 2002, METALS CHEM CHANGE, V1; MCKINLEY WA, 1948, PHYS REV, V74, P1759, DOI 10.1103/PhysRev.74.1759; Banerjee AN, 2013, THIN SOLID FILMS, V537, P49, DOI 10.1016/j.tsf.2013.04.070; Bethe H, 1933, HDB PHYS, V24; Bethe H, 1930, ANN PHYS-BERLIN, V5, P325; COSSLETT VE, 1978, J MICROSC-OXFORD, V113, P113; Danaie M, 2010, ACTA MATER, V58, P3162, DOI 10.1016/j.actamat.2010.01.055; EGERTON RF, 1987, ULTRAMICROSCOPY, V23, P305, DOI 10.1016/0304-3991(87)90240-3; Hirsch P., 1965, ELECT MICROSCOPY THI; HOBBS LW, 1979, J AM CERAM SOC, V62, P267, DOI 10.1111/j.1151-2916.1979.tb09480.x; Hobbs L.W., 1987, INTRO ANAL ELECT MIC, P399; HUMPHREYS CJ, 1990, SCANNING MICROSCOP S, V4, P185; Jeon K J, 2011, NAT MATER, V10, P286; LIU M, 1994, SCANNING, V16, P1; Molhave K, 2007, ULTRAMICROSCOPY, V108, P52, DOI 10.1016/j.ultramic.2007.03.001; NIST, NIST STAND REF DAT; PANTANO CG, 1981, APPL SURF SCI, V7, P115, DOI 10.1016/0378-5963(81)90065-9; Porcu M, 2008, J ALLOY COMPD, V453, P341, DOI 10.1016/j.jallcom.2006.11.147; STERNHEIMER RM, 1982, PHYS REV B, V26, P6067, DOI 10.1103/PhysRevB.26.6067; Subert J, 1976, J THERM ANAL, V10, P5; TALMON Y, 1977, J MICROSC-OXFORD, V111, P151; Wakasugi T, 2013, J ALLOY COMPD, V580, pS127, DOI 10.1016/j.jallcom.2013.02.028; Wang HT, 2012, SCI REP-UK, V2, DOI 10.1038/srep00995; Yao H, 2010, MATER TRANS, V51, P1016, DOI 10.2320/matertrans.MBW200902; Yao H, 2011, J ELECTRON MICROSC, V60, P375, DOI 10.1093/jmicro/dfr072	32	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	DEC	2014	63	6					437	447		10.1093/jmicro/dfu034		11	Microscopy	Microscopy	AX0TJ	WOS:000346664800005		
J	Yamada, S; Sakai, T				Yamada, Susumu; Sakai, Takayuki			In situ transmission electron microscopy observation of dislocation motion in 9Cr steel at elevated temperatures: influence of shear stress on dislocation behavior	MICROSCOPY			English	Article						in situ transmission electron microscopy; 9Cr steel; shear stress; dislocation velocity; dislocation density	TEM STRAINING EXPERIMENTS; MICROSTRUCTURAL CHANGE; SINGLE-CRYSTALS; WELDED-JOINTS; CREEP; ALLOY; DEFORMATION; FILMS; CR; MECHANISMS	To elucidate high-temperature plastic deformation (creep) mechanism in materials, it is essential to observe dislocation motion under tensile loading. There are many reports on in situ transmission electron microscopy (TEM) observations in the literature; however, the relationship between the dislocation motion and shear stress in 9Cr steel is still not clear. In this study, in order to evaluate this relationship quantitatively, in situ TEM observations were carried out in conjunction with finite element method (FEM) analysis. A tensile test sample was strained at an elevated temperature (903 K) inside a transmission electron microscope, and the stress distribution in the strained sample was analyzed by FEM. The dislocation behavior was clearly found to depend on the shear stress. At a shear stress of 66 MPa, both the dislocation velocity and mobile dislocation density were low. However, a high shear stress level of 95 MPa caused a noticeable increase in the dislocation velocity and mobile dislocation density. Furthermore, in this article, we discuss the dependence of the dislocation behavior on stress. The results presented here also indicate that the relationship between the microstructure and the strength of materials can be revealed by the methods used in this work.	[Yamada, Susumu; Sakai, Takayuki] Cent Res Inst Elect Power Ind, Mat Sci Res Lab, Yokosuka, Kanagawa 2400196, Japan	Yamada, S (reprint author), Cent Res Inst Elect Power Ind, Mat Sci Res Lab, 2-6-1 Nagasaka, Yokosuka, Kanagawa 2400196, Japan.	susumu@criepi.denken.or.jp					Legros M, 2008, ACTA MATER, V56, P3380, DOI 10.1016/j.actamat.2008.03.032; Watanabe T, 2006, INT J PRES VES PIP, V83, P63, DOI 10.1016/j.ijpvp.2005.09.004; Chen YX, 2012, MAT SCI ENG A-STRUCT, V534, P649, DOI 10.1016/j.msea.2011.12.022; Caillard D, 2010, ACTA MATER, V58, P3493, DOI 10.1016/j.actamat.2010.02.023; Gilbert MR, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.174103; Chang JP, 2001, MAT SCI ENG A-STRUCT, V309, P160, DOI 10.1016/S0921-5093(00)01673-7; Nogiwa K, 2002, J NUCL MATER, V307, P946, DOI 10.1016/S0022-3115(02)01163-7; Oh SH, 2007, ACTA MATER, V55, P5558, DOI 10.1016/j.actamat.2007.06.015; Oh SH, 2009, NAT MATER, V8, P95, DOI [10.1038/nmat2370, 10.1038/NMAT2370]; Dehm G, 2006, J MATER SCI, V41, P4484, DOI 10.1007/s10853-006-0087-7; AONO Y, 1981, SCRIPTA METALL MATER, V15, P275, DOI 10.1016/0036-9748(81)90344-6; Caillard D, 2013, ACTA MATER, V61, P2793, DOI 10.1016/j.actamat.2013.01.048; Castany P, 2011, MAT SCI ENG A-STRUCT, V528, P1367, DOI 10.1016/j.msea.2010.10.025; Delmas F, 2003, MAT SCI ENG A-STRUCT, V340, P286, DOI 10.1016/S0921-5093(02)00184-3; Eisenlohr P, 2009, MAT SCI ENG A-STRUCT, V510-11, P393, DOI 10.1016/j.msea.2008.04.120; MORIKAWA T, 1995, J JPN I MET, V59, P8; Ogata T, 2011, ASME PVP PRESS VESS; Queyreau S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.064106; Sakai T, 2009, 2 ECCC INT C CREEP F, P681; Sawada K, 2010, MAT SCI ENG A-STRUCT, V527, P1417, DOI 10.1016/j.msea.2009.10.044; Terada D, 2002, ISIJ INT, V42, P1546, DOI 10.2355/isijinternational.42.1546; URABE N, 1975, MATER SCI ENG, V18, P41, DOI 10.1016/0025-5416(75)90071-3; Wang ZQ, 2004, ACTA MATER, V52, P1535, DOI 10.1016/j.actamat.2003.12.005; Yamada S, 2013, MAT SCI ENG A-STRUCT, V560, P450, DOI 10.1016/j.msea.2012.09.089; Yamada S, Q09011 CRIEPI; Yamada S, 2009, OPER MAINT MAT ISSUE, V6, P1; Yamada S, Q10028 CRIEPI	27	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	DEC	2014	63	6					449	461		10.1093/jmicro/dfu035		13	Microscopy	Microscopy	AX0TJ	WOS:000346664800006		
J	Watanabe, K; Kunisada, Y; Sakaguchi, N				Watanabe, Kei; Kunisada, Yuji; Sakaguchi, Norihito			Stability of {111}(Pd)/{0002}(ZnO) polar interface formed by internal oxidation of Pd-Zn alloys	MICROSCOPY			English	Article						internal oxidation; polar interface; interfacial structure; convergent-beam electron diffraction	OXYGEN; GROWTH; FE; CR	We investigated the stability of Pd/ZnO polar interfaces formed by internal oxidation of Pd-Zn alloys by using high-resolution transmission electron microscopy, electron energy-loss spectroscopy and convergent-beam electron diffraction. At 1273 K, a (111)(Pd)/(000 (2) over bar)(ZnO) polar interface defaceted and transformed into a curved interface, while another (111) Pd/ (0002)(ZnO) polar interface retained its flatness. The (111)(Pd)/(000 (2) over bar)(ZnO) polar interface lost some stability over non-polar interfaces at 1273 K, while the (111)(Pd)/(000 (2) over bar)(ZnO) polar interface remained stable.	[Watanabe, Kei; Kunisada, Yuji; Sakaguchi, Norihito] Hokkaido Univ, Fac Engn, Ctr Adv Res Energy & Mat, Sapporo, Hokkaido 0608628, Japan	Sakaguchi, N (reprint author), Hokkaido Univ, Fac Engn, Ctr Adv Res Energy & Mat, Sapporo, Hokkaido 0608628, Japan.	sakaguchi@eng.hokudai.ac.jp	Kunisada, Yuji/D-2639-2013				Pan TJ, 2011, CORROS SCI, V53, P2115, DOI 10.1016/j.corsci.2011.02.034; Brady MP, 2005, SCRIPTA MATER, V52, P809, DOI 10.1016/j.scriptamat.2005.01.019; Adachi Y, 2011, THIN SOLID FILMS, V519, P5875, DOI 10.1016/j.tsf.2011.02.087; HUANG XY, 1991, ACTA METALL MATER, V39, P893, DOI 10.1016/0956-7151(91)90289-D; Essuman E, 2007, SCRIPTA MATER, V57, P845, DOI 10.1016/j.scriptamat.2007.06.058; Bruncko M, 2007, CORROS SCI, V49, P1228, DOI 10.1016/j.corsci.2006.06.031; Dong YF, 2009, J VAC SCI TECHNOL B, V27, P1710, DOI 10.1116/1.3119681; Dubey M, 2013, SCRIPTA MATER, V68, P91, DOI 10.1016/j.scriptamat.2012.09.005; Miller CF, 2003, SCRIPTA MATER, V48, P103, DOI 10.1016/S1359-6462(02)00355-X; Murakami K, 2003, J ELECTRON MICROSC, V52, P27, DOI 10.1093/jmicro/52.1.27; Pippel E, 2000, ACTA MATER, V48, P2571, DOI 10.1016/S1359-6454(00)00058-6; Saito M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.134110; Sakaguchi N, 2013, KENBIKYO, V48, P195; Sakaguchi N, 2008, PHILOS MAG, V88, P1493, DOI 10.1080/14786430802203406	14	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	DEC	2014	63	6					463	467		10.1093/jmicro/dfu095		5	Microscopy	Microscopy	AX0TJ	WOS:000346664800007		
J	Tsuneta, R; Kashima, H; Iwane, T; Harada, K; Koguchi, M				Tsuneta, Ruriko; Kashima, Hideo; Iwane, Tomohiro; Harada, Ken; Koguchi, Masanari			Dual-axis 360 degrees rotation specimen holder for analysis of three-dimensional magnetic structures	MICROSCOPY			English	Article						holography; tomography; rotation specimen holder; magnetic field; three dimension; pillar-shaped specimen	ELECTRON-HOLOGRAPHIC INTERFEROMETRY; RECONSTRUCTION	A dual-axis 360 degrees rotation specimen holder was developed for use in reconstructing the three-dimensional (3D) distribution of a magnetic field using a combination of electron holography and tomography. Pillar-shaped specimens are used to obtain accurate reconstruction without a missing angle. The holder's rotation rod can be turned >360 degrees; the pillar is set +/- 45 degrees to the azimuth for both x- and y-axis rotation. Two rotation series of holograms in individual axes are recorded for vector field tomography. The two vector components of the magnetic field are reconstructed directly from the two series of holograms, and the remaining component is calculated using Maxwell's equation, div B = 0. As a result, all 3D magnetic fields are reconstructed.	[Tsuneta, Ruriko; Kashima, Hideo; Iwane, Tomohiro; Harada, Ken; Koguchi, Masanari] Hitachi Ltd, Cent Res Lab, Hatoyama, Saitama 3500395, Japan	Harada, K (reprint author), Hitachi Ltd, Cent Res Lab, Hatoyama, Saitama 3500395, Japan.	ken.harada.fz@hitachi.com					Harada K, 2004, APPL PHYS LETT, V84, P3229, DOI 10.1063/1.1715155; Phatak C, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.253901; Wolf D, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3604793; LAI GM, 1994, J APPL PHYS, V75, P4593, DOI 10.1063/1.355955; LAI GM, 1994, APPL OPTICS, V33, P829, DOI 10.1364/AO.33.000829; Koguchi M, 2001, J ELECTRON MICROSC, V50, P235, DOI 10.1093/jmicro/50.3.235; Frank J, 2005, ECOLOGI MANEJO BOSQU, P1; KAWASAKI T, 1990, JPN J APPL PHYS 2, V29, pL508, DOI 10.1143/JJAP.29.L508; Tanigaki T, 2012, J ELECTRON MICROSC, V61, P77, DOI 10.1093/jmicro/dfr097; Tonomura A, 1999, ELECT HOLOGRAPHY; Tsuneta R, 2014, MICROSC MICROANAL S3, V20, P268; Twitchett-Harrison AC, 2008, ULTRAMICROSCOPY, V108, P1401, DOI 10.1016/j.ultramic.2008.05.014	12	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	DEC	2014	63	6					469	473		10.1093/jmicro/dfu030		5	Microscopy	Microscopy	AX0TJ	WOS:000346664800008		
J	Vakhshouri, A; Hashimoto, K; Hirayama, Y				Vakhshouri, Amin; Hashimoto, Katsushi; Hirayama, Yoshiro			Atomic force microscope-assisted scanning tunneling spectroscopy under ambient conditions	MICROSCOPY			English	Article						combined atomic force/tunneling microscopy; room temperature tunneling spectroscopy; thermal drift suppression	CARBON NANOTUBES; GRAPHITE; SURFACE; AIR	We have developed a method of atomic force microscopy (AFM)-assisted scanning tunneling spectroscopy (STS) under ambient conditions. An AFM function is used for rapid access to a selected position prior to performing STS. The AFM feedback is further used to suppress vertical thermal drift of the tip-sample distance during spectroscopy, enabling flexible and stable spectroscopy measurements at room temperature.	[Vakhshouri, Amin; Hashimoto, Katsushi; Hirayama, Yoshiro] Tohoku Univ, Grad Sch Sci, Dept Phys, Sendai, Miyagi 9808578, Japan; [Hashimoto, Katsushi; Hirayama, Yoshiro] ERATO Nucl Spin Elect Project, JST, Sendai, Miyagi 9808578, Japan; [Hirayama, Yoshiro] Tohoku Univ, WPI AIMR, Sendai, Miyagi 9808577, Japan	Vakhshouri, A (reprint author), Tohoku Univ, Grad Sch Sci, Dept Phys, Sendai, Miyagi 9808578, Japan.	amin-v@s.tohoku.ac.jp					Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Radisavljevic B, 2011, NAT NANOTECHNOL, V6, P147, DOI [10.1038/nnano.2010.279, 10.1038/NNANO.2010.279]; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; BINNIG G, 1982, HELV PHYS ACTA, V55, P726; HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970; MARTIN Y, 1987, J APPL PHYS, V61, P4723, DOI 10.1063/1.338807; de Pablo PJ, 2000, ADV MATER, V12, P573, DOI 10.1002/(SICI)1521-4095(200004)12:8<573::AID-ADMA573>3.0.CO;2-3; Liscio A, 2008, J PHYS CHEM C, V112, P17368, DOI 10.1021/jp806657k; MAMIN HJ, 1986, PHYS REV B, V34, P9015, DOI 10.1103/PhysRevB.34.9015; MATE CM, 1989, SURF SCI, V208, P473, DOI 10.1016/0039-6028(89)90014-9; MEEPAGALA SC, 1991, J VAC SCI TECHNOL B, V9, P1340, DOI 10.1116/1.585192; Morita S., 2002, NONCONTACT ATOMIC FO; Niimi Y, 2006, PHYS REV B, V73, P8; Proksch R, 2006, patents: US, Patent No. [20060186876A1, 20060186876]; SALMERON M, 1991, J VAC SCI TECHNOL B, V9, P1347, DOI 10.1116/1.585194; Stroscio J.A., 1993, SCANNING TUNNELING M; Suganuma Y, 2003, REV SCI INSTRUM, V74, P4373, DOI 10.1063/1.1610784; SUGAWARA Y, 1991, J VAC SCI TECHNOL B, V9, P1092, DOI 10.1116/1.585267; SUGAWARA Y, 1990, JPN J APPL PHYS 1, V29, P1533, DOI 10.1143/JJAP.29.1533; Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139	22	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	DEC	2014	63	6					475	479		10.1093/jmicro/dfu028		5	Microscopy	Microscopy	AX0TJ	WOS:000346664800009		
J	Oshima, Y; Tsuda, T; Kuwabata, S; Yasuda, H; Takayanagi, K				Oshima, Yoshifumi; Tsuda, Tetsuya; Kuwabata, Susumu; Yasuda, Hidehito; Takayanagi, Kunio			Development of an electrochemical cell for in situ transmission electron microscopy observation	MICROSCOPY			English	Article						electrochemical cell; TEM; in situ; liquid	GROWTH; NANOSCALE; TEM	A new type of electrochemical cell was developed for in situ transmission electron microscopy observation that enables the electrode materials to be conveniently changed. The electrochemical cell was used to observe the electrochemical growth or dissolution of copper islands on a gold film with simultaneous cyclic voltammetry measurements. The copper islands could be explained by three-dimensional growing model.	[Oshima, Yoshifumi] JAIST, Sch Mat Sci, Nomi 9231292, Japan; [Oshima, Yoshifumi; Takayanagi, Kunio] JST CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Tsuda, Tetsuya; Kuwabata, Susumu] Osaka Univ, Grad Sch Engn, Suita, Osaka 5650871, Japan; [Yasuda, Hidehito] Osaka Univ, Res Ctr Ultra High Voltage Electron Microscopy, Osaka 5670047, Japan; [Takayanagi, Kunio] Tokyo Inst Technol, Dept Condensed Matter Phys, Meguro Ku, Tokyo 1528551, Japan	Oshima, Y (reprint author), JAIST, Sch Mat Sci, 1-1 Asahidai, Nomi 9231292, Japan.	oshima@jaist.ac.jp	Tsuda, Tetsuya/F-7234-2014	Tsuda, Tetsuya/0000-0001-9462-8066	Japan Science and Technology Agency (JST)	This work was supported by the Japan Science and Technology Agency (JST) under the CREST project.	Huang TW, 2013, SOFT MATTER, V9, P8856, DOI 10.1039/c3sm50906k; White ER, 2012, ACS NANO, V6, P6308, DOI 10.1021/nn3017469; Li DS, 2012, SCIENCE, V336, P1014, DOI 10.1126/science.1219643; Chen X, 2012, ACTA MATER, V60, P192, DOI 10.1016/j.actamat.2011.09.047; Gai PL, 2002, MICROSC MICROANAL, V8, P21, DOI 10.1017/S1431927601010054; Evans JE, 2011, NANO LETT, V11, P2809, DOI 10.1021/nl201166k; Parent LR, 2012, ACS NANO, V6, P3589, DOI 10.1021/nn300671g; Liu XH, 2011, ENERG ENVIRON SCI, V4, P3844, DOI 10.1039/c1ee01918j; Liao HG, 2012, SCIENCE, V336, P1011, DOI 10.1126/science.1219185; Zheng HM, 2009, SCIENCE, V324, P1309, DOI 10.1126/science.1172104; Williamson MJ, 2003, NAT MATER, V2, P532, DOI 10.1038/nmat944; de Jonge N, 2009, P NATL ACAD SCI USA, V106, P2159, DOI 10.1073/pnas.0809567106; Park J, 2012, ACS NANO, V6, P2078, DOI 10.1021/nn203837m; Zheng HM, 2009, NANO LETT, V9, P2460, DOI 10.1021/nl9012369; Jungjohann KL, 2013, NANO LETT, V13, P2964, DOI 10.1021/nl4014277; Liu XH, 2012, NAT NANOTECHNOL, V7, P749, DOI [10.1038/nnano.2012.170, 10.1038/NNANO.2012.170]; Lee S, 2013, J PHYS CHEM C, V117, P24236, DOI 10.1021/jp409032r; Noh KW, 2012, ULTRAMICROSCOPY, V116, P34, DOI 10.1016/j.ultramic.2012.03.012; Grogan JM, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.061405; Klein KL, 2011, J MICROSC-OXFORD, V242, P117, DOI 10.1111/j.1365-2818.2010.03484.x	20	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	DEC	2014	63	6					481	486		10.1093/jmicro/dfu096		6	Microscopy	Microscopy	AX0TJ	WOS:000346664800010		
J	Haraguchi, A; Fujishima, K; Ando, T; Mori, F; Imaizumi, M; Abiru, N; Yamasaki, H; Matsumoto, K; Takamura, N; Kawakami, A				Haraguchi, A.; Fujishima, K.; Ando, T.; Mori, F.; Imaizumi, M.; Abiru, N.; Yamasaki, H.; Matsumoto, K.; Takamura, N.; Kawakami, A.			Multiple drug combination of anti-diabetic agents as a predictor for poor clinical response to liraglutide	MINERVA ENDOCRINOLOGICA			English	Article						Hypoglycemic agents; Sulfonylurea compounds; Diabetes mellitus	TYPE-2 DIABETES-MELLITUS; GLP-1 RECEPTOR AGONISTS; PIOGLITAZONE; PHYSIOLOGY; EFFICACY; THERAPY	Aim. Aim of the study was to retrospectively analyze the clinical parameters that contribute to the therapeutic outcome of GLP-1 analogues. Methods. We enrolled 106 patients with type 2 diabetes mellitus (T2DM), treated with liraglutide (N.=69) or exenatide (N.=37) for longer than three months. The patients were divided into two groups: good responders and poor responders to GLP-1 analogues, based on pretreatment and post-treatment HbA1c levels. Good responders were those whose HbA1c level had decreased by 1% or more, or maintained at less than 7%. All other patients were categorized as poor responders. We used univariate and multivariate analyses to assess pretreatment parameters between the two groups. Results. Approximately 35% of the patients were poor responders. Our analysis of the pretreatment clinical parameters revealed that number of anti-diabetic agents and use of sulfonylurea were significantly associated with poor response to liraglutide (P=0.02 and P=0.03, respectively) in a multivariate analysis. We were not able to find any candidate related to clinical response to exenatide. Conclusion. Our study showed that the therapeutic effects of GLP-1 analogues on T2DM patients were heterogeneous. T2DM patients who require multiple anti-diabetic agents, especially sulfonylurea, do not benefit from liraglutide treatment.	[Haraguchi, A.; Ando, T.; Mori, F.; Imaizumi, M.; Abiru, N.; Kawakami, A.] Nagasaki Univ, Grad Sch Biomed Sci, Div Endocrinol & Metab, Nagasaki 8528501, Japan; [Fujishima, K.; Yamasaki, H.] Nagasaki Univ, Ctr Hlth & Community Med, Nagasaki 8528501, Japan; [Matsumoto, K.] Sasebo Chuo Hosp, Ctr Diabet, Sasebo, Japan; [Takamura, N.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Global Hlth Med & Welf, Nagasaki 8528501, Japan	Ando, T (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Div Endocrinol & Metab, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	takaoando@gmail.com			Astra Zeneca K.K. Science Promotion grant	Supported in part by Astra Zeneca K.K. Science Promotion grant (to TA).	Vilsboll T, 2007, EXPERT OPIN INV DRUG, V16, P231, DOI 10.1517/13543784.16.2.231; Takabe M, 2012, DIABETES RES CLIN PR, V98, pE32, DOI 10.1016/j.diabres.2012.09.036; Nauck MA, 2011, AM J MED, V124, pS19, DOI 10.1016/j.amjmed.2010.11.002; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Blonde L, 2009, DIABETES OBES METAB, V11, P26, DOI 10.1111/j.1463-1326.2009.01075.x; Kanoski SE, 2012, NEUROPHARMACOLOGY, V62, P1916, DOI 10.1016/j.neuropharm.2011.12.022; Solomon TPJ, 2012, J CLIN ENDOCR METAB, V97, P4682, DOI 10.1210/jc.2012-2097; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Wang G, 2007, INT J CLIN PRACT, V61, P552, DOI 10.1111/j.1742-1241.2006.01242.x; Meier JJ, 2010, DIABETES, V59, P1117, DOI 10.2337/db09-1899; Fadini GP, 2013, ACTA DIABETOL, V50, P943, DOI 10.1007/s00592-013-0489-3; Aroda VR, 2012, CLIN THER, V34, P1247, DOI 10.1016/j.clinthera.2012.04.013; Cho YM, 2013, ANN REV PHYSL; Igarashi M, 2007, DIABETES RES CLIN PR, V77, P389, DOI 10.1016/j.diabres.2006.12.022; NAUCK M, 1986, DIABETOLOGIA, V29, P46, DOI 10.1007/BF02427280; Opinto G, 2013, ARCH PHYSIOL BIOCHEM, V119, P170, DOI 10.3109/13813455.2013.812664; Perusicová J, 2013, Vnitr Lek, V59, P165; Shen XX, 2012, ENDOCR RES, V37, P12, DOI 10.3109/07435800.2011.610855; UK Prospective Diabetes Study Group, 1995, DIABETES, V44, P1249; van Bloemendaal L, 2013, J ENDOCRINOL	20	0	0	EDIZIONI MINERVA MEDICA	TURIN	CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY	0391-1977	1827-1634		MINERVA ENDOCRINOL	Minerva Endocrinol.	DEC	2014	39	4					289	297				9	Endocrinology & Metabolism	Endocrinology & Metabolism	AX4CE	WOS:000346880800005		
J	Nakajima, Y; Matsuki, Y; Lian, CL; Fortes, MD; Uy, WH; Campos, WL; Nakaoka, M; Nadaoka, K				Nakajima, Yuichi; Matsuki, Yu; Lian, Chunlan; Fortes, Miguel D.; Uy, Wilfredo H.; Campos, Wilfredo L.; Nakaoka, Masahiro; Nadaoka, Kazuo			The Kuroshio Current influences genetic diversity and population genetic structure of a tropical seagrass, Enhalus acoroides	MOLECULAR ECOLOGY			English	Article						microsatellite; migration pattern; peripheral population; population genetics	MULTILOCUS GENOTYPE DATA; ALLELE FREQUENCY DATA; ZOSTERA-MARINA; POSIDONIA-OCEANICA; MICROSATELLITE ANALYSIS; PHILIPPINE SEAGRASSES; UNSAMPLED POPULATIONS; PROPAGULE DISPERSAL; SCLERACTINIAN CORAL; SEXUAL REPRODUCTION	Information on genetic diversity and differentiation of seagrass populations is essential for the conservation of coastal ecosystems. However, little is known about the seagrasses in the Indo-West Pacific Ocean, where the world's highest diversity of seagrasses occurs. The influence of sea currents on these populations is also unknown. We estimated the genetic diversity and population genetic structure and identified reproductive features in Enhalus acoroides populations from the Yaeyama Islands, Hainan Island and the Philippines. The Philippines are situated at the centre of the E.acoroides range, Yaeyama and Hainan are peripheral populations, and the Yaeyama population is at the northern limit of the species range. The powerful Kuroshio Current flows from the Philippines to Yaeyama. Genetic analyses using nine microsatellite markers indicated that reproduction of E.acoroides is mostly sexual. Clonal diversity does not decrease in northern populations, although genetic diversity does. However, the genetic diversity of the Yaeyama populations is greater than that of the Hainan populations. Significant genetic differentiation among most populations was evident; however, the Yaeyama and north-east Philippines populations were genetically similar, despite being separated by similar to 1100km. An assignment test suggested that recruitment occurs from the north-east Philippines to Yaeyama. The strong current in this region is probably responsible for the extant genetic diversity and recruitment patterns.	[Nakajima, Yuichi; Matsuki, Yu; Lian, Chunlan] Univ Tokyo, Asian Nat Environm Sci Ctr, Tokyo 1880002, Japan; [Fortes, Miguel D.] Univ Philippines, Inst Marine Sci, Quezon City 1101, Philippines; [Uy, Wilfredo H.] Mindanao State Univ, Inst Fisheries Res & Dev, Naawan 9023, Misamis Orienta, Philippines; [Campos, Wilfredo L.] Univ Philippines, Div Biol Sci, Coll Arts & Sci, Iloilo 5023, Philippines; [Nakaoka, Masahiro] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Akkeshi Marine Stn, Akkeshi, Hokkaido 0881113, Japan; [Nadaoka, Kazuo] Tokyo Inst Technol, Grad Sch Informat Sci & Engn, Dept Mech & Environm Informat, Meguro Ku, Tokyo 1528552, Japan	Lian, CL (reprint author), Univ Tokyo, Asian Nat Environm Sci Ctr, 1-1-8 Midori Cho, Tokyo 1880002, Japan.	lian@anesc.u-tokyo.ac.jp	Nakajima, Yuichi/A-4330-2013; 悠, 松木/D-4526-2011	Nakajima, Yuichi/0000-0001-6558-5378; 	Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA); Science and Technology Research Partnership for Sustainable Development (SATREPS); coastal ecosystem conservation and adaptive management under local and global environmental impacts in the Philippines (CECAM project)	This research was funded by the Japan Science and Technology Agency (JST), the Japan International Cooperation Agency (JICA), Science and Technology Research Partnership for Sustainable Development (SATREPS) and the coastal ecosystem conservation and adaptive management under local and global environmental impacts in the Philippines (CECAM project: http://www.cecam-project.net/). We thank members of JST, JICA, SATREPS and CECAM project.	Agawin NSR, 2001, J EXP MAR BIOL ECOL, V260, P217, DOI 10.1016/S0022-0981(01)00253-2; MANTEL N, 1967, CANCER RES, V27, P209; Baums IB, 2005, MOL ECOL, V14, P1377, DOI 10.1111/j.1365-294X.2005.02489.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Cornuet JM, 1996, GENETICS, V144, P2001; Kendrick GA, 2012, BIOSCIENCE, V62, P56, DOI 10.1525/bio.2012.62.1.10; [Anonymous], 2006, MOL ECOL NOTES, DOI DOI 10.1111/J.1471-8286.2005.01155.X; Lian CL, 2001, HEREDITY, V87, P88, DOI 10.1046/j.1365-2540.2001.00913.x; Hardy TA, 1996, J GEOPHYS RES-OCEANS, V101, P14311, DOI 10.1029/96JC00202; Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Yasuda N, 2009, MOL ECOL, V18, P1574, DOI 10.1111/j.1365-294X.2009.04133.x; Rollon RN, 2003, AQUAT BOT, V76, P339, DOI 10.1016/S0304-3770(03)00070-6; Pineda J, 2007, OCEANOGRAPHY, V20, P22; Islam MS, 2006, MOL ECOL NOTES, V6, P30, DOI 10.1111/j.1471-8286.2005.01127.x; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.ecolsys.25.1.547; Hellberg ME, 2009, ANNU REV ECOL EVOL S, V40, P291, DOI 10.1146/annurev.ecolsys.110308.120223; Pritchard JK, 2000, GENETICS, V155, P945; Nakaoka M, 2005, POPUL ECOL, V47, P167, DOI 10.1007/s10144-005-0226-z; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; [Anonymous], 2012, CONSERV GENET RESOUR, DOI DOI 10.1007/S12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Hellberg ME, 2007, CORAL REEFS, V26, P463, DOI 10.1007/s00338-007-0205-2; Lian CL, 2003, MOL ECOL, V12, P609, DOI 10.1046/j.1365-294X.2003.01756.x; Goudet J, 1995, J HERED, V86, P485; Short F, 2007, J EXP MAR BIOL ECOL, V350, P3, DOI 10.1016/j.jembe.2007.06.012; Arnaud-Haond S, 2005, J HERED, V96, P434, DOI 10.1093/jhered/esi043; Serra IA, 2010, MOL ECOL, V19, P557, DOI 10.1111/j.1365-294X.2009.04462.x; Diekmann OE, 2012, MOL ECOL, V21, P1647, DOI 10.1111/j.1365-294X.2012.05500.x; Arnaud-Haond S, 2007, J BIOGEOGR, V34, P963, DOI 10.1111/j.1365-2699.2006.01671.x; Alberto F, 2005, MOL ECOL, V14, P2669, DOI 10.1111/j.1365-294X.2005.02640.x; Dorken ME, 2001, J ECOL, V89, P339, DOI 10.1046/j.1365-2745.2001.00558.x; Lacap CDA, 2002, MAR ECOL PROG SER, V235, P75, DOI 10.3354/meps235075; Migliaccio M, 2005, MAR ECOL PROG SER, V304, P55, DOI 10.3354/meps304055; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Nishikawa A, 2003, MAR ECOL PROG SER, V256, P87, DOI 10.3354/meps256087; Rousset F, 1997, GENETICS, V145, P1219; Arnaud-Haond S, 2006, MOL ECOL, V15, P3515, DOI 10.1111/j.1365-294X.2006.02997.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; ORTH RJ, 1994, ECOLOGY, V75, P1927, DOI 10.2307/1941597; Duffy JE, 2006, MAR ECOL PROG SER, V311, P233, DOI 10.3354/meps311233; Allen GR, 2002, ENVIRON BIOL FISH, V65, P209, DOI 10.1023/A:1020093012502; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Falush D, 2003, GENETICS, V164, P1567; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Arnaud-Haond S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030454; Becheler R, 2014, HEREDITY, V112, P114, DOI 10.1038/hdy.2013.82; BROUNS JJWM, 1986, AQUAT BOT, V25, P21, DOI 10.1016/0304-3770(86)90038-0; Duarte CM, 1997, BOT MAR, V40, P497, DOI 10.1515/botm.1997.40.1-6.497; EXCOFFIER L, 1992, GENETICS, V131, P479; Geng QF, 2009, CONSERV GENET, V10, P1133, DOI 10.1007/s10592-008-9727-6; Geng QF, 2008, MOL ECOL, V17, P4724, DOI 10.1111/j.1365-294X.2008.03948.x; GOWER JC, 1966, BIOMETRIKA, V53, P588, DOI 10.2307/2333664; Kawabe M, 2001, J OCEANOGR, V57, P189, DOI 10.1023/A:1011195224933; Kojima S, 1997, MAR ECOL PROG SER, V150, P149, DOI 10.3354/meps150149; DOUST LL, 1981, J ECOL, V69, P743, DOI 10.2307/2259633; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; MCROY CP, 1968, PAC SCI, V22, P507; Muniz-Salazar R, 2005, MOL ECOL, V14, P711, DOI 10.1111/j.1365-294X.2005.02454.x; Nakajima Y, 2012, CONSERV GENET RESOUR, V4, P515, DOI 10.1007/s12686-012-9614-9; Ohba T, 2007, SEAGRASSES JAPAN; Olsen JL, 2004, MOL ECOL, V13, P1923, DOI 10.1111/j.1365-294X.2004.02205.x; Procaccini G, 2007, J EXP MAR BIOL ECOL, V350, P234, DOI 10.1016/j.jembe.2007.05.035; R Development Core Team, 2013, R LANG ENV STAT COMP; Ravago-Gotanco RG, 2007, MAR ECOL PROG SER, V336, P161, DOI 10.3354/meps336161; Ravago-Gotanco RG, 2010, MOL ECOL, V19, P4520, DOI 10.1111/j.1365-294X.2010.04803.x; Reusch TBH, 2000, MOL ECOL, V9, P127, DOI 10.1046/j.1365-294x.2000.00839.x; Ridgway T, 2008, MAR ECOL PROG SER, V354, P161, DOI 10.3354/meps07245; Rodriguez-Lanetty M, 2002, MOL ECOL, V11, P1177, DOI 10.1046/j.1365-294X.2002.01511.x; Slatkin M, 2005, MOL ECOL, V14, P67, DOI 10.1111/j.1365-294X.2004.02393.x; vansDijk JK, 2010, AQUAT BOT, V92, P63; vansDijk JK, 2009, MARINE ECOLOGY PROGR, V390, P67; vansOosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI DOI 10.1111/J.1471-8286.2004.00684.X; WILSON KA, 1989, B MAR SCI, V44, P263; Yu JK, 1999, MAR BIOL, V133, P21, DOI 10.1007/s002270050438	75	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1083	1365-294X		MOL ECOL	Mol. Ecol.	DEC	2014	23	24					6029	6044		10.1111/mec.12996		16	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	AX2KH	WOS:000346771900010		
J	Takayama, K; Suzuki, T; Tsutsumi, S; Fujimura, T; Takahashi, S; Homma, Y; Urano, T; Aburatani, H; Inoue, S				Takayama, Ken-ichi; Suzuki, Takashi; Tsutsumi, Shuichi; Fujimura, Tetsuya; Takahashi, Satoru; Homma, Yukio; Urano, Tomohiko; Aburatani, Hiroyuki; Inoue, Satoshi			Integrative Analysis of FOXP1 Function Reveals a Tumor-Suppressive Effect in Prostate Cancer	MOLECULAR ENDOCRINOLOGY			English	Article							ANDROGEN RECEPTOR; TRANSCRIPTION FACTOR; GENE-EXPRESSION; PROGRESSION; CHROMATIN; NETWORK; BINDING; GROWTH; FOXA1; SURVIVAL	The transcriptional network of the androgen receptor (AR), a key molecule of prostate cancer, is frequently modulated by interactions with other transcriptional factors such as forkhead box protein A1 (FOXA1). However, global regulatory mechanisms of AR signaling mediated by such factors have not been well investigated. Here we conducted a chromatin immunoprecipitation sequence analysis, which revealed that another FOX family, FOXP1, is specifically regulated by both AR and FOXA1. We also found that FOXP1 acts as a tumor suppressor in prostate cancer through inhibiting cell proliferation and migration. We generated an extensive global map of FOXP1 binding sites and found that FOXP1 is directly involved in AR-mediated transcription. We demonstrated that FOXP1 has a repressive effect on AR-induced transcriptional activity or histone modification in enhancer regions. Moreover, by a global analysis of androgen-mediated transcriptional networks, we observed enrichment of FOXP1 binding genes in the gene cluster negatively regulated by FOXP1. Evaluation of FOXP1 expression in clinical samples indicated that the decreased expression of FOXP1 is another prognostic factor of prostate cancer. Taken together, our results suggest a novel mechanism in which AR-induced FOXP1 functions as a direct modulator of the AR and FOXA1 centric global transcriptional network.	[Takayama, Ken-ichi; Urano, Tomohiko; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Bunkyo Ku, Tokyo 1138655, Japan; [Takayama, Ken-ichi; Urano, Tomohiko; Inoue, Satoshi] Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Bunkyo Ku, Tokyo 1138655, Japan; [Fujimura, Tetsuya; Homma, Yukio] Univ Tokyo, Grad Sch Med, Dept Urol, Bunkyo Ku, Tokyo 1138655, Japan; [Suzuki, Takashi] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808575, Japan; [Tsutsumi, Shuichi; Aburatani, Hiroyuki] Univ Tokyo, Res Ctr Adv Sci & Technol, Genome Sci Div, Meguro Ku, Tokyo 1538904, Japan; [Takahashi, Satoru] Nihon Univ, Sch Med, Dept Urol, Itabashi Ku, Tokyo 1730032, Japan; [Inoue, Satoshi] Saitama Med Univ, Res Ctr Genom Med, Div Gene Regulat & Signal Transduct, Hidaka, Saitama 3501241, Japan	Inoue, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Antiaging Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	inoue-ger@h.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan; Japan Society for the Promotion of Science, Japan; Ministry of Health, Labour, and Welfare, Japan; Program for the Promotion of Fundamental Studies in Health Sciences; National Institute of Biomedical Innovation, Japan; Yamaguchi Endocrine Research Foundation, Japan	This work was supported by grants from the Cell Innovation Program (to S.I.) and P-DIRECT (to S.I.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; grants from the Japan Society for the Promotion of Science, Japan (to S.I. and K.T.); Grants-in-Aid from the Ministry of Health, Labour, and Welfare, Japan (to S.I.); the Program for the Promotion of Fundamental Studies in Health Sciences (to S.I.), National Institute of Biomedical Innovation, Japan; and grants from the Yamaguchi Endocrine Research Foundation, Japan (to K.T).	Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Katoh M, 2013, CANCER LETT, V328, P198, DOI 10.1016/j.canlet.2012.09.017; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Chng KR, 2012, EMBO J, V31, P2810, DOI 10.1038/emboj.2012.112; Takayama K, 2008, BIOCHEM BIOPH RES CO, V374, P388, DOI 10.1016/j.bbrc.2008.07.056; Takayama K, 2011, ONCOGENE, V30, P619, DOI 10.1038/onc.2010.436; Gerhardt J, 2012, AM J PATHOL, V180, P848, DOI 10.1016/j.ajpath.2011.10.021; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Wang B, 2003, J BIOL CHEM, V278, P24259, DOI 10.1074/jbc.M207174200; Murata T, 2012, CLIN CANCER RES, V18, P5617, DOI 10.1158/1078-0432.CCR-12-0281; Takayama K, 2013, EMBO J, V32, P1665, DOI 10.1038/emboj.2013.99; Krohn A, 2013, J PATHOL, V231, P130, DOI 10.1002/path.4223; Takayama K, 2013, INT J UROL, V20, P756, DOI 10.1111/iju.12146; Waltering KK, 2012, MOL CELL ENDOCRINOL, V360, P38, DOI 10.1016/j.mce.2011.12.019; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Tan PY, 2012, MOL CELL BIOL, V32, P399, DOI 10.1128/MCB.05958-11; Hermans KG, 2008, CANCER RES, V68, P7541, DOI 10.1158/0008-5472.CAN-07-5930; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Banham AH, 2001, CANCER RES, V61, P8820; Takayama KI, 2012, MOL ENDOCRINOL, V26, P748, DOI 10.1210/me.2011-1242; Takayama KI, 2009, CANCER RES, V69, P137, DOI 10.1158/0008-5472.CAN-08-3633; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Guseva NV, 2012, ONCOTARGET, V3, P183	27	2	2	ENDOCRINE SOC	WASHINGTON	2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA	0888-8809			MOL ENDOCRINOL	Mol. Endocrinol.	DEC	2014	28	12					2012	2024		10.1210/me.2014-1171		13	Endocrinology & Metabolism	Endocrinology & Metabolism	AX3KC	WOS:000346837200010		
J	Balogun, EO; Inaoka, DK; Shiba, T; Kido, Y; Tsuge, C; Nara, T; Aoki, T; Honma, T; Tanaka, A; Inoue, M; Matsuoka, S; Michels, PAM; Kita, K; Harada, S				Balogun, Emmanuel Oluwadare; Inaoka, Daniel Ken; Shiba, Tomoo; Kido, Yasutoshi; Tsuge, Chiaki; Nara, Takeshi; Aoki, Takashi; Honma, Teruki; Tanaka, Akiko; Inoue, Masayuki; Matsuoka, Shigeru; Michels, Paul A. M.; Kita, Kiyoshi; Harada, Shigeharu			Molecular basis for the reverse reaction of African human trypanosomes glycerol kinase	MOLECULAR MICROBIOLOGY			English	Article							INSENSITIVE ALTERNATIVE OXIDASE; CATION-PROMOTED ASSOCIATION; ESCHERICHIA-COLI; BLOOD-STREAM; PHOSPHORYL TRANSFER; SUBSTRATE-BINDING; BRUCEI; PROTEINS; TARGET; COMPARTMENTATION	The glycerol kinase (GK) of African human trypanosomes is compartmentalized in their glycosomes. Unlike the host GK, which under physiological conditions catalyzes only the forward reaction (ATP-dependent glycerol phosphorylation), trypanosome GK can additionally catalyze the reverse reaction. In fact, owing to this unique reverse catalysis, GK is potentially essential for the parasites survival in the human host, hence a promising drug target. The mechanism of its reverse catalysis was unknown; therefore, it was not clear if this ability was purely due to its localization in the organelles or whether structure-based catalytic differences also contribute. To investigate this lack of information, the X-ray crystal structure of this protein was determined up to 1.90 angstrom resolution, in its unligated form and in complex with three natural ligands. These data, in conjunction with results from structure-guided mutagenesis suggests that the trypanosome GK is possibly a transiently autophosphorylating threonine kinase, with the catalytic site formed by non-conserved residues. Our results provide a series of structural peculiarities of this enzyme, and gives unexpected insight into the reverse catalysis mechanism. Together, they provide an encouraging molecular framework for the development of trypanosome GK-specific inhibitors, which may lead to the design of new and safer trypanocidal drug(s).	[Balogun, Emmanuel Oluwadare; Shiba, Tomoo; Harada, Shigeharu] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Appl Biol, Sakyo Ku, Kyoto 6068585, Japan; [Balogun, Emmanuel Oluwadare; Inaoka, Daniel Ken; Kido, Yasutoshi; Tsuge, Chiaki; Kita, Kiyoshi] Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Bunkyo Ku, Tokyo 1130033, Japan; [Balogun, Emmanuel Oluwadare] Ahmadu Bello Univ, Dept Biochem, Zaria 2222, Nigeria; [Nara, Takeshi; Aoki, Takashi] Juntendo Univ, Dept Mol & Cellular Parasitol, Sch Med, Tokyo 1138421, Japan; [Honma, Teruki; Tanaka, Akiko] RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Inoue, Masayuki; Matsuoka, Shigeru] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo 1130033, Japan; [Michels, Paul A. M.] Univ Edinburgh, Inst Struct & Mol Biol, Sch Biol Sci, Edinburgh EH9 3BF, Midlothian, Scotland; [Michels, Paul A. M.] Univ Los Andes, Dept Biol, Lab Enzimol Parasitos, Merida 5101, Venezuela	Kita, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Biomed Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kitak@m.u-tokyo.ac.jp; harada@kit.ac.jp	Michels, Paul/A-5637-2009		Targeted Proteins Research Program (TPRP ); Creative Scientific Research Grant [18GS0314]; Japanese Society for the Promotion of Science [18073004]; Japanese Ministry of Education, Science, Culture, Sports and Technology (MEXT) [19036010]; Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry; JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development) [10000284]	We thank all staff members of beam lines BL32XU, BL41XU and BL44XU at SPring-8 and BL17A at Photon Factory for their help with X-ray diffraction data collection. Experiments using BL44XU were performed under the Cooperative Research Program of Institute for Protein Research, Osaka University. This work was supported by a grant from the Targeted Proteins Research Program (TPRP to KK and SH), and in part by a Creative Scientific Research Grant 18GS0314 (to KK), Grant-in-aid for Scientific Research on Priority Areas 18073004 (to KK) and 19036010 (to SH) from the Japanese Society for the Promotion of Science, and from the Japanese Ministry of Education, Science, Culture, Sports and Technology (MEXT) respectively. We also acknowledge support from the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry to KK and SH, and JST/JICA, SATREPS (Science and Technology Research Partnership for Sustainable Development) (10000284) to KK. EOB is a Fellow of the Japanese Society for the Promotion of Science (JSPS).	Schlichting I, 1997, BIOCHEMISTRY-US, V36, P9290, DOI 10.1021/bi970974c; Verlinde CLM, 2001, DRUG RESIST UPDATE, V4, P50, DOI 10.1054/drup.2000.0177; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Shiba T, 2013, P NATL ACAD SCI USA, V110, P4580, DOI 10.1073/pnas.1218386110; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Cockrell GM, 2013, BIOCHEMISTRY-US, V52, P8036, DOI 10.1021/bi401205n; Gualdron-Lopez M, 2013, PARASITOLOGY, V140, P1, DOI 10.1017/S0031182012001278; Zorba A, 2014, ELIFE, V3, DOI 10.7554/eLife.02667; Haanstra JR, 2008, P NATL ACAD SCI USA, V105, P17718, DOI 10.1073/pnas.0806664105; Bringaud F, 2006, MOL BIOCHEM PARASIT, V149, P1, DOI 10.1016/j.molbiopara.2006.03.017; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; JOHNSON LN, 1993, ANNU REV BIOPH BIOM, V22, P199, DOI 10.1146/annurev.bb.22.060193.001215; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; HURLEY JH, 1993, SCIENCE, V259, P673, DOI 10.1126/science.8430315; OPPERDOES FR, 1977, FEBS LETT, V80, P360, DOI 10.1016/0014-5793(77)80476-6; Balogun EO, 2010, ACTA CRYSTALLOGR F, V66, P304, DOI 10.1107/S1744309110000369; Balogun EO, 2013, J BIOCHEM, V154, P77, DOI 10.1093/jb/mvt037; Colasante C, 2006, PROTEOMICS, V6, P3275, DOI 10.1002/pmic.200500668; Dipple KM, 2001, HUM GENET, V109, P55, DOI 10.1007/s004390100545; FEESE M, 1994, P NATL ACAD SCI USA, V91, P3544, DOI 10.1073/pnas.91.9.3544; Guerra-Giraidez C, 2002, J CELL SCI, V115, P2651; Hannaert V., 2003, KINETOPLASTID BIOL D, V2, P11, DOI 10.1186/1475-9292-2-11; Holtman CK, 2001, BIOCHEMISTRY-US, V40, P14302, DOI 10.1021/bi011590w; Imada K., 2006, STRUCTURE GLYCEROL K; Koga Y, 2008, FEBS J, V275, P2632, DOI 10.1111/j.1742-4658.2008.06410.x; Kralova I, 2000, EUR J BIOCHEM, V267, P2323, DOI 10.1046/j.1432-1327.2000.01238.x; Lahiri SD, 2003, SCIENCE, V299, P2067, DOI 10.1126/science.1082710; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEFEBVRE RB, 1986, EXP PARASITOL, V62, P85, DOI 10.1016/0014-4894(86)90011-1; Li XQ, 2006, J BIOL CHEM, V281, P13837, DOI 10.1074/jbc.M602060200; Llinas P, 2005, J MOL BIOL, V350, P441, DOI 10.1016/j.jmb.2005.04.068; MARSHALL PB, 1948, BRIT J PHARM CHEMOTH, V3, P8; Migchelsen SJ, 2011, INT J INFECT DIS, V15, pE517, DOI 10.1016/j.ijid.2011.03.018; Minagawa N, 1997, MOL BIOCHEM PARASIT, V84, P271, DOI 10.1016/S0166-6851(96)02797-1; Minasov G., 2009, 2 7 ANGSTROM CRYSTAL; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nolan DP, 2000, EUR J BIOCHEM, V267, P4601, DOI 10.1046/j.1432-1327.2000.01476.x; Ohashi-Suzuki M, 2011, J VET MED SCI, V73, P615, DOI 10.1292/jvms.10-0481; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PETTIGREW DW, 1990, BIOCHEMISTRY-US, V29, P8620, DOI 10.1021/bi00489a018; Rahib L, 2007, EUR J HUM GENET, V15, P646, DOI 10.1038/sj.ejhg.5201801; Saimoto H, 2013, J BIOCHEM, V153, P267, DOI 10.1093/jb/mvs135; Schnick C, 2009, MOL MICROBIOL, V71, P533, DOI 10.1111/j.1365-2958.2008.06544.x; Stijlemans B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002072; Yeh JI, 2004, BIOCHEMISTRY-US, V43, P362, DOI 10.1021/bi034258o; Yu P, 2007, BIOCHEMISTRY-US, V46, P12355, DOI 10.1021/bi7010948; Yu P, 2003, BIOCHEMISTRY-US, V42, P4243, DOI 10.1021/bi0271421; ZWAIG N, 1966, SCIENCE, V153, P755, DOI 10.1126/science.153.3737.755	48	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0950-382X	1365-2958		MOL MICROBIOL	Mol. Microbiol.	DEC	2014	94	6					1315	1329		10.1111/mmi.12831		15	Biochemistry & Molecular Biology; Microbiology	Biochemistry & Molecular Biology; Microbiology	AX0QE	WOS:000346655900011		
J	Wang, Q; Kitaura, R; Yamamoto, Y; Arai, S; Shinohara, H				Wang, Qing; Kitaura, Ryo; Yamamoto, Yuta; Arai, Shigeo; Shinohara, Hisanori			Synthesis and TEM structural characterization of C-60-flattened carbon nanotube nanopeapods	NANO RESEARCH			English	Article						carbon nanotubes; nanopeapods; endohedral doping; electron microscopy	METAL NANOWIRES; FABRICATION; DIAMETER; C-60	A fully flattened carbon nanotube (FNT), a graphene nanoribbon (GNR) analogue, provides a hollow space at edges for endohedral doping. Due to the unique shape of the hollow space of FNTs, novel types of low-dimensional arrangements of atoms and molecules can be obtained through endohedral doping into FNTs, which provides a new type of nanopeapods. FNT-based nanopeapods have been synthesized through endohedral doping of C-60, and their structural characterization with transmission electron microscopy (TEM) performed. The doping of C-60 into the inner hollow space of FNTs has been carried out via the gas-phase filling method, where open-ended FNTs are sealed in a glass ampoule and heated at 723-773 K for two days. TEM observations show that most of the encapsulated C-60 molecules align as single molecular chains along the edges of FNTs and that some of the C-60 forms two-dimensional close-packed structures inside FNTs.	[Wang, Qing; Kitaura, Ryo; Shinohara, Hisanori] Nagoya Univ, Dept Chem, Nagoya, Aichi 4648602, Japan; [Wang, Qing; Kitaura, Ryo; Shinohara, Hisanori] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648602, Japan; [Yamamoto, Yuta; Arai, Shigeo] Nagoya Univ, High Voltage Electron Microscope Lab, Ecotopia Sci Inst, Nagoya, Aichi 4648602, Japan	Kitaura, R (reprint author), Nagoya Univ, Dept Chem, Nagoya, Aichi 4648602, Japan.	r.kitaura@nagoya-u.jp; noris@nagoya-u.jp	Kitaura, Ryo/B-8123-2008		MEXT of Japan [19084008, 22225001]	This work has been supported by the Grant-in-Aid for Specific Area Research (Grant No. 19084008) on Carbon Nanotube Nano-Electronics and for Scientific Research S (No. 22225001) of MEXT of Japan.	KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; Zhang CG, 2012, ACS NANO, V6, P6023, DOI 10.1021/nn301039v; Kitaura R, 2008, NANO LETT, V8, P693, DOI 10.1021/nl073070d; Kim K, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.245433; Hirahara K, 2000, PHYS REV LETT, V85, P5384, DOI 10.1103/PhysRevLett.85.5384; Smith BW, 1998, NATURE, V396, P323, DOI 10.1038/24521; Elliott JA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.095501; Wang ZY, 2011, J MATER CHEM, V21, P171, DOI 10.1039/c0jm02821e; Kitaura R, 2009, ANGEW CHEM INT EDIT, V48, P8298, DOI 10.1002/anie.200902615; AJAYAN PM, 1993, NATURE, V361, P333, DOI 10.1038/361333a0; Lee J, 2002, NATURE, V415, P1005, DOI 10.1038/4151005a; COWLEY JM, 1957, ACTA CRYSTALLOGR, V10, P609, DOI 10.1107/S0365110X57002194; Choi DH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01617; Hirahara K, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.115420; Kitaura R, 2006, CHEM-ASIAN J, V1, P646, DOI 10.1002/asia.200600162; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; Shimada T, 2002, APPL PHYS LETT, V81, P4067, DOI 10.1063/1.1522482; Suenaga K., 2001, PHYS REV B	18	1	1	TSINGHUA UNIV PRESS	BEIJING	TSINGHUA UNIV, RM A703, XUEYAN BLDG, BEIJING, 10084, PEOPLES R CHINA	1998-0124	1998-0000		NANO RES	Nano Res.	DEC	2014	7	12					1843	1848		10.1007/s12274-014-0544-6		6	Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	AX0KM	WOS:000346641400013		
J	Muntean, A; Aiki, T				Muntean, Adrian; Aiki, Toyohiko			PREFACE TO "THE MATHEMATICS OF CONCRETE"	NETWORKS AND HETEROGENEOUS MEDIA			English	Editorial Material									[Muntean, Adrian] Eindhoven Inst Technol, Inst Complex Mol Syst, Dept Math & Comp Sci, CASA Ctr Anal Sci Comp & Applicat, Eindhoven, Netherlands; [Aiki, Toyohiko] Japan Womens Univ, Fac Sci, Dept Math & Phys, Tokyo 112, Japan	Muntean, A (reprint author), Eindhoven Inst Technol, Inst Complex Mol Syst, Dept Math & Comp Sci, CASA Ctr Anal Sci Comp & Applicat, Eindhoven, Netherlands.							0	0	0	AMER INST MATHEMATICAL SCIENCES	SPRINGFIELD	PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA	1556-1801	1556-181X		NETW HETEROG MEDIA	Netw. Heterog. Media	DEC	2014	9	4			SI		I	II		10.3934/nhm.2014.9.4i		2	Mathematics, Interdisciplinary Applications	Mathematics	AX2SU	WOS:000346795500001		
J	Notsu, H; Kimura, M				Notsu, Hirofumi; Kimura, Masato			SYMMETRY AND POSITIVE DEFINITENESS OF THE TENSOR-VALUED SPRING CONSTANT DERIVED FROM P1-FEM FOR THE EQUATIONS OF LINEAR ELASTICITY	NETWORKS AND HETEROGENEOUS MEDIA			English	Article						Spring-block system; linear elasticity; finite element method; spring constant		We study spring-block systems which are equivalent to the P1-finite element methods for the linear elliptic partial differential equation of second order and for the equations of linear elasticity. Each derived spring-block system is consistent with the original partial differential equation, since it is discretized by P1-FEM. Symmetry and positive definiteness of the scalar and tensor-valued spring constants are studied in two dimensions. Under the acuteness condition of the triangular mesh, positive definiteness of the scalar spring constant is obtained. In case of homogeneous linear elasticity, we show the symmetry of the tensor-valued spring constant in the two dimensional case. For isotropic elastic materials, we give a necessary and sufficient condition for the positive definiteness of the tensor-valued spring constant. Consequently, if Poisson's ratio of the elastic material is small enough, like concrete, we can construct a consistent spring-block system with positive definite tensor-valued spring constant.	[Notsu, Hirofumi] Waseda Univ, Waseda Inst Adv Study, Shinjuku Ku, Tokyo 1698555, Japan; [Kimura, Masato] Kanazawa Univ, Inst Sci & Engn, Kanazawa, Ishikawa 9201192, Japan	Notsu, H (reprint author), Waseda Univ, Waseda Inst Adv Study, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	h.notsu@aoni.waseda.jp; mkimura@se.kanazawa-u.ac.jp			JSPS KAKENHI [26800091, 26400195, 25610031]; Japan-German Graduate Externship (Mathematical Fluid Dynamics); Waseda University	The first author was supported by JSPS KAKENHI Grant Number 26800091 and the Japan-German Graduate Externship (Mathematical Fluid Dynamics), and by Waseda University under Project research, Spectral analysis and its application to the stability theory of the Navier-Stokes equations of Research Institute for Science Engineering. The second author was supported by JSPS KAKENHI Grant Numbers 26400195 and 25610031.	Belytschko T, 1999, INT J NUMER METH ENG, V45, P601, DOI 10.1002/(SICI)1097-0207(19990620)45:5<601::AID-NME598>3.0.CO;2-S; Voronoi G, 1908, J REINE ANGEW MATH, V134, P198; Notsu H, 2009, J SCI COMPUT, V38, P1, DOI 10.1007/s10915-008-9217-5; Camborde F, 2000, COMPUT GEOTECH, V27, P225, DOI 10.1016/S0266-352X(00)00013-6; Hori M, 2005, J MECH PHYS SOLIDS, V53, P681, DOI 10.1016/j.jmps.2004.08.005; Brenner S. C., 2002, MATH THEORY FINITE E; Chen H., 2012, J JAPAN SOC CIVIL A, V68, P10; Ciarlet P.G., 1978, FINITE ELEMENT METHO; Gere J M, 2004, MECH MAT; Karatson J, 2009, SIAM J NUMER ANAL, V47, P2518, DOI 10.1137/080729566; Kimura M., 2013, KYOTO U RIMS KOKYURO, V1848, P171; Munjiza A., 2004, COMBINED FINITE DISC; Okabe A., 1992, SPATIAL TESSELLATION	13	0	0	AMER INST MATHEMATICAL SCIENCES	SPRINGFIELD	PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA	1556-1801	1556-181X		NETW HETEROG MEDIA	Netw. Heterog. Media	DEC	2014	9	4			SI		617	634		10.3934/nhm.2014.9.617		18	Mathematics, Interdisciplinary Applications	Mathematics	AX2SU	WOS:000346795500004		
J	Sato, N; Aiki, T; Murase, Y; Shirakawa, K				Sato, Naoki; Aiki, Toyohiko; Murase, Yusuke; Shirakawa, Ken			A ONE DIMENSIONAL FREE BOUNDARY PROBLEM FOR ADSORPTION PHENOMENA	NETWORKS AND HETEROGENEOUS MEDIA			English	Article						Free boundary problem; drying and wetting process	CONCRETE CARBONATION; LAW	In this paper we deal with a one-dimensional free boundary problem, which is a mathematical model for an adsorption phenomena appearing in concrete carbonation process. This model was proposed in line of previous studies of three dimensional concrete carbonation process. The main result in this paper is concerned with the existence and uniqueness of a time-local solution to the free boundary problem. This result will be obtained by means of the abstract theory of nonlinear evolution equations and Banach's fixed point theorem, and especially, the maximum principle applied to our problem will play a very important role to obtain the uniform estimate to approximate solutions.	[Sato, Naoki] Nagaoka Natl Coll Technol, Div Gen Educ, Nagaoka, Niigata 9408532, Japan; [Aiki, Toyohiko] Japan Womens Univ, Fac Sci, Dept Math & Phys Sci, Bunkyo Ku, Tokyo 1128681, Japan; [Murase, Yusuke] Meijo Univ, Fac Sci & Technol, Dept Math, Tenpaku Ku, Nagoya, Aichi 4688502, Japan; [Shirakawa, Ken] Chiba Univ, Fac Educ, Dept Math, Chiba 2638522, Japan	Sato, N (reprint author), Nagaoka Natl Coll Technol, Div Gen Educ, 888 Nishikatakai, Nagaoka, Niigata 9408532, Japan.	naoki@nagaoka-ct.ac.jp; aikit@fc.jwu.ac.jp; ymurase@meijo-u.ac.jp; sirakawa@faculty.chiba-u.jp					Aiki T., 2009, ADV MATH SCI APPL, V19, P109; Aiki T., 2011, ADV MATH SCI APPL, V21, P361; Aiki T., 2013, SURIKAISEKIKENKYUSHO, V1856, P1; Aiki T, 2012, PHYSICA B, V407, P1424, DOI 10.1016/j.physb.2011.10.016; Aiki T., 2012, SURIKAISEKIKENKYUSHO, V1792, P98; Aiki T, 2013, NONLINEAR ANAL-THEOR, V93, P3, DOI 10.1016/j.na.2013.07.002; Aiki T, 2010, COMMUN PUR APPL ANAL, V9, P1117, DOI 10.3934/cpaa.2010.9.1117; Aiki T, 2013, INTERFACE FREE BOUND, V15, P167, DOI 10.4171/IFB/299; FASANO A, 1979, J MATH ANAL APPL, V72, P247, DOI 10.1016/0022-247X(79)90287-7; Muntean A, 2009, J MATH ANAL APPL, V350, P234, DOI 10.1016/j.jmaa.2008.09.044; FASANO A, 1977, J MATH ANAL APPL, V58, P202, DOI 10.1016/0022-247X(77)90239-6; Kenmochis N., 1981, B FAC ED CHIBA U, V30, P1; Maekawa K., 2003, J ADV CONCR TECHNOL, V1, P91, DOI 10.3151/jact.1.91; Maekawa K., 1999, MODELING CONCRETE PE	14	0	0	AMER INST MATHEMATICAL SCIENCES	SPRINGFIELD	PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA	1556-1801	1556-181X		NETW HETEROG MEDIA	Netw. Heterog. Media	DEC	2014	9	4			SI		655	668		10.3934/nhm.2014.9.655		14	Mathematics, Interdisciplinary Applications	Mathematics	AX2SU	WOS:000346795500006		
J	Hilhorst, D; Murakawa, H				Hilhorst, Danielle; Murakawa, Hideki			SINGULAR LIMIT ANALYSIS OF A REACTION-DIFFUSION SYSTEM WITH PRECIPITATION AND DISSOLUTION IN A POROUS MEDIUM	NETWORKS AND HETEROGENEOUS MEDIA			English	Article						Reaction-diffusion system; precipitation; dissolution; singular limit analysis; fast reaction limit; Stefan problem; heat equation		In this paper we consider a three-component reaction-diffusion system with a fast precipitation and dissolution reaction term. We investigate its singular limit as the reaction rate tends to infinity. The limit problem is described by a combination of a Stefan problem and a linear heat equation. The rate of convergence with respect to the reaction rate is established in a specific case.	[Hilhorst, Danielle] CNRS, Math Lab, F-91405 Orsay, France; [Hilhorst, Danielle] Univ Paris 11, F-91405 Orsay, France; [Murakawa, Hideki] Kyushu Univ, Fac Math, Nishi Ku, Fukuoka 8190395, Japan	Hilhorst, D (reprint author), CNRS, Math Lab, F-91405 Orsay, France.	Danielle.Hilhorst@math.u-psud.fr; murakawa@math.kyushu-u.ac.jp			JSPS KAKENHI [23340023, 26287025, 26400205]	This work was supported by JSPS KAKENHI Grant Numbers 23340023, 26287025 and 26400205.	Eymard R, 2000, HDBK NUM AN, V7, P713; Bouillard N, 2009, NONLINEAR ANAL-REAL, V10, P629, DOI 10.1016/j.nonrwa.2007.10.019; Bouillard Nicolas, 2007, Mathematical Modelling and Numerical Analysis, V41, DOI 10.1051/m2an:2007047; Brezis H., 1983, ANAL FONCTIONNELLE; Pousin J, 2000, NONLINEAR ANAL-THEOR, V39, P261, DOI 10.1016/S0362-546X(98)00162-X	5	0	0	AMER INST MATHEMATICAL SCIENCES	SPRINGFIELD	PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA	1556-1801	1556-181X		NETW HETEROG MEDIA	Netw. Heterog. Media	DEC	2014	9	4			SI		669	682		10.3934/nhm.2014.9.669		14	Mathematics, Interdisciplinary Applications	Mathematics	AX2SU	WOS:000346795500007		
J	Aiki, T; Kumazaki, K				Aiki, Toyohiko; Kumazaki, Kota			UNIQUENESS OF SOLUTIONS TO A MATHEMATICAL MODEL DESCRIBING MOISTURE TRANSPORT IN CONCRETE MATERIALS	NETWORKS AND HETEROGENEOUS MEDIA			English	Article						Uniqueness of solutions; nonlinear parabolic equations; equations with hysteresis operator		When dealing with concrete materials it is always a big issue how to deal with the moisture transport. Here, we consider a mathematical model for moisture transport, which is given as a system consisting of the diffusion equation for moisture and of the ordinary differential equation which describes a hysteresis operator. In [3] we already proved the existence of a time global solution of an initial boundary value problem of this system, however, the uniqueness is obtained only for one dimensional domains. The main purpose of this paper is to establish the uniqueness of a solution of our problem in three dimensional domains under the assumption of the smooth boundary and initial data.	[Aiki, Toyohiko] Japan Womens Univ, Fac Sci, Dept Math, Tokyo 1128681, Japan; [Kumazaki, Kota] Tomakomai Natl Coll Technol, Dept Nat & Phys Sci, Tomakomai 0591275, Japan	Aiki, T (reprint author), Japan Womens Univ, Fac Sci, Dept Math, 2-8-1 Mejirodai, Tokyo 1128681, Japan.	aiki@fc.jwu.ac.jp; k.kumazaki@gt.tomakomai-ct.ac.jp					Aiki T., 2011, ADV MATH SCI APPL, V21, P361; Aiki T, 2012, PHYSICA B, V407, P1424, DOI 10.1016/j.physb.2011.10.016; Aiki T., 2012, RIMS KYOTO U SURIKAI, V1792, P99; Kenmochi N, 1998, NONLINEAR ANAL-THEOR, V34, P665, DOI 10.1016/S0362-546X(97)00592-0; Bary B, 2004, CEMENT CONCRETE RES, V34, P1859, DOI 10.1016/j.cemconres.20004.01.025; Besov O. V., 1979, SCRIPTA SERIES MATH, V2; Brokate M., 1996, HYSTERESIS PHASE TRA; Colli P, 2001, J MATH ANAL APPL, V256, P668, DOI 10.1006/jmaa.2000.7338; Derluyn H, 2012, CEMENT CONCRETE RES, V42, P1379, DOI 10.1016/j.cemconres.2012.06.010; Ladyzenskaja O. A., 1968, EQUATIONS DERIVEES P; Ladyzenskaja O A, 1967, TRANSLATIONS MATH MO, V23; Necas J., 1967, METHODES DIRECTES TH; Visintin A., 1994, DIFFERENTIAL MODELS	13	0	0	AMER INST MATHEMATICAL SCIENCES	SPRINGFIELD	PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA	1556-1801	1556-181X		NETW HETEROG MEDIA	Netw. Heterog. Media	DEC	2014	9	4			SI		683	707		10.3934/nhm.2014.9.683		25	Mathematics, Interdisciplinary Applications	Mathematics	AX2SU	WOS:000346795500008		
J	Fatima, T; Ijioma, E; Ogawa, T; Muntean, A				Fatima, Tasnim; Ijioma, Ekeoma; Ogawa, Toshiyuki; Muntean, Adrian			HOMOGENIZATION AND DIMENSION REDUCTION OF FILTRATION COMBUSTION IN HETEROGENEOUS THIN LAYERS	NETWORKS AND HETEROGENEOUS MEDIA			English	Article						Homogenization; dimension reduction; thin layers; filtration combustion; two-scale convergence; anisotropic singular perturbations	SMOLDERING COMBUSTION; POROUS-MEDIA; FINGERING INSTABILITY; 2-SCALE CONVERGENCE; PATTERN-FORMATION; HEAT; DIFFUSION; TRANSPORT; FLAMES	We study the homogenization of a reaction-diffusion-convection system posed in an epsilon-periodic delta-thin layer made of a two-component (solid-air) composite material. The microscopic system includes heat flow, diffusion and convection coupled with a nonlinear surface chemical reaction. We treat two distinct asymptotic scenarios: (1) For a fixed width delta > 0 of the thin layer, we homogenize the presence of the microstructures (the classical periodic homogenization limit epsilon --> 0); (2) In the homogenized problem, we pass to delta --> 0 (the vanishing limit of the layer's width). In this way, we are preparing the stage for the simultaneous homogenization (epsilon --> 0) and dimension reduction limit (delta --> 0) with delta = delta (epsilon). We recover the reduced macroscopic equations from [25] with precise formulas for the effective transport and reaction coefficients. We complement the analytical results with a few simulations of a case study in smoldering combustion. The chosen multiscale scenario is relevant for a large variety of practical applications ranging from the forecast of the response to fire of refractory concrete, the microstructure design of resistance-to-heat ceramic-based materials for engines, to the smoldering combustion of thin porous samples under microgravity conditions.	[Fatima, Tasnim] Eindhoven Univ Technol, CASA Ctr Anal Sci Comp & Applicat, Dept Math & Comp Sci, NL-5600 MB Eindhoven, Netherlands; [Ijioma, Ekeoma; Ogawa, Toshiyuki] Meiji Univ, Grad Sch Adv Math Sci, Nakano Ku, Tokyo 1648525, Japan; [Muntean, Adrian] Eindhoven Univ Technol, ICMS Inst Complex Mol Syst, CASA Ctr Anal Sci Comp & Applicat, Dept Math & Comp Sci, NL-5600 MB Eindhoven, Netherlands	Ijioma, E (reprint author), Meiji Univ, Grad Sch Adv Math Sci, Nakano Ku, 4-21-1 Nakano, Tokyo 1648525, Japan.	tasnimge@yahoo.com; e.r.ijioma@gmail.com; tshogw@gmail.com; a.muntean@tue.nl		Ijioma, Ekeoma/0000-0002-5631-2500	Meiji University Global Center of Excellence (GCOE) program "Formation and Development of Mathematical Sciences Based on Modeling and Analysis"; Japanese Government (Monbukagakusho: MEXT); EU ITN FIRST	This work is jointly supported by the Meiji University Global Center of Excellence (GCOE) program "Formation and Development of Mathematical Sciences Based on Modeling and Analysis" and the Japanese Government (Monbukagakusho: MEXT). AM thanks the Department of Mathematics of the University of Meiji, Tokyo, Japan for their kind hospitality, which facilitated the completion of this paper. Partial support from the EU ITN FIRST is also acknowledged. We thank I. S. Pop for showing us Ref. [48]. We are grateful to both referees for their careful reading of the manuscript.	Aganovic I., 2006, Glasnik Matematicki, Serija III, V41, DOI 10.3336/gm.41.1.08; Alberts B., 2002, MOL BIOL CELL; ALLAIRE G, 1992, SIAM J MATH ANAL, V23, P1482, DOI 10.1137/0523084; Amaziane B, 2010, ASYMPTOTIC ANAL, V70, P51, DOI 10.3233/ASY-2010-1005; Kagan L, 2008, COMBUST THEOR MODEL, V12, P269, DOI 10.1080/13647830701639462; van Duijn CJ, 2004, J REINE ANGEW MATH, V577, P171; Ijioma ER, 2013, COMBUST THEOR MODEL, V17, P185, DOI 10.1080/13647830.2012.734860; Zik O, 1998, PHYS REV LETT, V81, P3868, DOI 10.1103/PhysRevLett.81.3868; Kuwana K, 2014, COMBUST SCI TECHNOL, V186, P466, DOI 10.1080/00102202.2014.883220; Allaire G, 2013, SIAM J MATH ANAL, V45, P1136, DOI 10.1137/110849821; Ikeda K, 2008, HIROSHIMA MATH J, V38, P349; Oliveira AAM, 2001, PROG ENERG COMBUST, V27, P523, DOI 10.1016/S0360-1285(00)00030-7; CIORANESCU D, 1979, J MATH ANAL APPL, V71, P590, DOI 10.1016/0022-247X(79)90211-7; SAHRAOUI M, 1994, INT J HEAT MASS TRAN, V37, P2817, DOI 10.1016/0017-9310(94)90338-7; Barbu L., 2007, INT SERIES NUMERICAL, V156; Benes M, 2012, NONLINEAR ANAL-REAL, V13, P1562, DOI 10.1016/j.nonrwa.2011.11.015; Bourgeats A, 2003, APPL ANAL, V82, P103, DOI 10.1080/0003681031000063739; Chechkin G., 2007, TRANSLATIONS MATH MO, V234; Chen R.-H., 1992, S INT COMBUSTION, V24, P213, DOI 10.1016/S0082-0784(06)80030-5; Chipot M, 2011, APPL ANAL, V90, P1775, DOI 10.1080/00036811003627542; Chipot M., 2002, L GOES TO INFINITY; Cioranescu D., 1999, HOMOGENIZATION RETIC; Cioranescu D., 2008, REV ROUMAINE MATH PU, V53, P389; Constantin P, 2000, ARCH RATION MECH AN, V154, P53, DOI 10.1007/s002050000090; DENET B, 1992, COMBUST SCI TECHNOL, V86, P199, DOI 10.1080/00102209208947195; Donato P., 1999, INTRO HOMOGENIZATION; Fasano A, 2010, MATH METHOD APPL SCI, V33, P1211, DOI 10.1002/mma.1301; Fatima T, 2014, NONLINEAR ANAL-REAL, V15, P326, DOI 10.1016/j.nonrwa.2012.01.019; Gustafsson B, 2003, IMA J APPL MATH, V68, P269, DOI 10.1093/imamat/68.3.269; Habibi Z., 2011, THESIS ECOLE POLYTEC; Hornung U., 1997, HOMOGENIZATION POROU; HORNUNG U, 1991, J DIFFER EQUATIONS, V92, P199, DOI 10.1016/0022-0396(91)90047-D; Ijioma E.R., 2014, THESIS MEIJI U TOKYO; Neuss-Radu M, 2007, SIAM J MATH ANAL, V39, P687, DOI 10.1137/060665452; Kumar K., HOMOGENIZATION PORE; Kurdyumov VN, 2002, COMBUST FLAME, V128, P382, DOI 10.1016/S0010-2180(01)00358-3; Lions J. L., 1969, QUELQUES METHODES RE; Lu ZB, 2011, COMBUST THEOR MODEL, V15, P795, DOI 10.1080/13647830.2011.564658; Monsurro S., 2003, ADV MATH SCI APPL, V13, P43; Neukamm S, 2013, MATH MOD METH APPL S, V23, P2701, DOI 10.1142/S0218202513500449; NeussRadu M, 1996, CR ACAD SCI I-MATH, V322, P899; NGUETSENG G, 1989, SIAM J MATH ANAL, V20, P608, DOI 10.1137/0520043; Olson S., 1998, 27 S INT COMB, V27, P2525; Ozdemir I, 2008, INT J NUMER METH ENG, V73, P185, DOI 10.1002/nme.2068; Ronney P., 1992, COMBUST FLAME, V90, P71; Taylor HFW, 1990, CEMENT CHEM; Temam R.M., 2005, MATH MODELING CONTIN; Turns SR, 2000, MCGRAW HILL SERIES M; Vassal JP, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.011302; Yuan FP, 2013, APPL MATH MECH-ENGL, V34, P657, DOI 10.1007/s10483-013-1698-8	50	1	1	AMER INST MATHEMATICAL SCIENCES	SPRINGFIELD	PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA	1556-1801	1556-181X		NETW HETEROG MEDIA	Netw. Heterog. Media	DEC	2014	9	4			SI		709	737		10.3934/nhm.2014.9.709		29	Mathematics, Interdisciplinary Applications	Mathematics	AX2SU	WOS:000346795500009		
J	Krehel, O; Aiki, T; Muntean, A				Krehel, Oleh; Aiki, Toyohiko; Muntean, Adrian			HOMOGENIZATION OF A THERMO-DIFFUSION SYSTEM WITH SMOLUCHOWSKI INTERACTIONS	NETWORKS AND HETEROGENEOUS MEDIA			English	Article						Homogenization; well-posedness; colloids; thermal-diffusion; cross-diffusion; combustion	2-SCALE CONVERGENCE; POISSON SYSTEM; MODEL; RELEASE	We study the solvability and homogenization of a thermal-diffusion reaction problem posed in a periodically perforated domain. The system describes the motion of populations of hot colloidal particles interacting together via Smoluchowski production terms. The upscaled system, obtained via two-scale convergence techniques, allows the investigation of deposition effects in porous materials in the presence of thermal gradients.	[Krehel, Oleh] Eindhoven Univ Technol, CASA Ctr Anal Scient Comp & Engn, Dept Math & Comp Sci, NL-5600 MB Eindhoven, Netherlands; [Aiki, Toyohiko] Japan Womens Univ, Fac Sci, Dept Math & Phys Sci, Tokyo 112, Japan; [Muntean, Adrian] Eindhoven Univ Technol, CASA Ctr Anal Scient Comp & Engn, Dept Math & Comp Sci, ICMS Inst Complex Mol Syst, NL-5600 MB Eindhoven, Netherlands	Krehel, O (reprint author), Eindhoven Univ Technol, CASA Ctr Anal Scient Comp & Engn, Dept Math & Comp Sci, POB 513, NL-5600 MB Eindhoven, Netherlands.	o.krehel@tue.nl; a.muntean@tue.nl; aikit@fc.jwu.ac.jp			European Union [238702]	AM and OK gratefully acknowledge financial support by the European Union through the Initial Training Network Fronts and Interfaces in Science and Technology of the Seventh Framework Programme (grant agreement number 238702).	ALLAIRE G, 1992, SIAM J MATH ANAL, V23, P1482, DOI 10.1137/0523084; Andreianov B, 2011, MATH MOD METH APPL S, V21, P307, DOI 10.1142/S0218202511005064; Golestanian R, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.038303; Ray N, 2012, J MATH ANAL APPL, V390, P374, DOI 10.1016/j.jmaa.2012.01.052; Soares JS, 2010, BIOMATERIALS, V31, P3032, DOI 10.1016/j.biomaterials.2010.01.008; Benes M, 2013, APPL MATH COMPUT, V219, P7262, DOI 10.1016/j.amc.2011.02.064; Rothstein SN, 2009, BIOMATERIALS, V30, P1657, DOI 10.1016/j.biomaterials.2008.12.002; SHIGESADA N, 1979, J THEOR BIOL, V79, P83, DOI 10.1016/0022-5193(79)90258-3; Vanag VK, 2009, PHYS CHEM CHEM PHYS, V11, P897, DOI 10.1039/b813825g; Benes M, 2013, ZAMM-Z ANGEW MATH ME, V93, P233, DOI 10.1002/zamm.201200018; Bensoussan A., 2011, ASYMPTOTIC ANAL PERI, V374; de Groot S., 1962, SERIES IN PHYS; Elimelech M., 1998, PARTICLE DEPOSITION; Evans L. C., 1998, GRADUATE STUDIES MAT, V19; Fatima T, 2014, NONLINEAR ANAL-REAL, V15, P326, DOI 10.1016/j.nonrwa.2012.01.019; Funaki T, 2012, NETW HETEROG MEDIA, V7, P705, DOI 10.3934/nhm.2012.7.705; Gong ZX, 1996, J AM CERAM SOC, V79, P1649, DOI 10.1111/j.1151-2916.1996.tb08777.x; HORNUNG U, 1991, J DIFFER EQUATIONS, V92, P199, DOI 10.1016/0022-0396(91)90047-D; Krehel O., 2014, 1412 CASA; Kreliel O, 2012, P 19 INT C WAT RES C, P1; Lions J. L., 1969, QUELQUES METHODES RE; Marciniak-Czochra A, 2008, SIAM J MATH ANAL, V40, P215, DOI 10.1137/050645269; Masmoudi N, 2007, SIAM J MATH ANAL, V38, P1788, DOI 10.1137/050630763; Mei C. C., 2010, HOMOGENIZATION METHO; NeussRadu M, 1996, CR ACAD SCI I-MATH, V322, P899; NGUETSENG G, 1989, SIAM J MATH ANAL, V20, P608, DOI 10.1137/0520043; Ni Wei-Ming, 1998, NOT AM MATH SOC, V45, P9; NIRENBERG L., 1959, ANN SCUOLA NORM SUP, V13, P115; Smoluchowski M, 1917, Z PHYS CHEM, V92, P129	29	2	2	AMER INST MATHEMATICAL SCIENCES	SPRINGFIELD	PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA	1556-1801	1556-181X		NETW HETEROG MEDIA	Netw. Heterog. Media	DEC	2014	9	4			SI		739	762		10.3934/nhm.2014.9.739		24	Mathematics, Interdisciplinary Applications	Mathematics	AX2SU	WOS:000346795500010		
J	Fukuoka, H; Takahashi, Y				Fukuoka, Hidenori; Takahashi, Yutaka			The Role of Genetic and Epigenetic Changes in Pituitary Tumorigenesis	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						pituitary adenoma; tumorigenesis; cyclic adenosine monophosphate; cell cycle; growth factor	MULTIPLE ENDOCRINE NEOPLASIA; TUMOR-TRANSFORMING GENE; CELL-CYCLE REGULATION; SCHWANNOMAS CARNEY COMPLEX; INTERACTING PROTEIN GENE; SPOTTY SKIN PIGMENTATION; MCCUNE-ALBRIGHT SYNDROME; STIMULATORY G-PROTEIN; GERM-LINE MUTATIONS; TYPE-1 MEN1 GENE	Pituitary adenomas are one of the most common intracranial tumors. Despite their benign nature, dys-regulation of hormone secretion causes systemic metabolic deterioration, resulting in high mortality and an impaired quality of life. Tumorigenic pathogenesis of pituitary adenomas is mainly investigated by performing genetic analyses of somatic mutations in the tumor or germline mutations in patients. Genetically modified mouse models, which develop pituitary adenomas, are also used. Genetic analysis in rare familial pituitary adenomas, including multiple endocrine neoplasia type 1 and type 4, Carney complex, familial isolated pituitary adenomas, and succinate dehydrogenases (SDHs)-mediated paraganglioma syndrome, revealed several causal germline mutations and sporadic somatic mutations in these genes. The analysis of genetically modified mouse models exhibiting pituitary adenomas has revealed the underlying mechanisms, where cell cycle regulatory molecules, tumor suppressors, and growth factor signaling are involved in pituitary tumorigenesis. Furthermore, accumulating evidence suggests that epigenetic changes, including deoxyribonucleic acid (DNA) methylation, histone modification, micro ribonucleic acids (RNAs), and long noncoding RNAs play a pivotal role. The elucidation of precise mechanisms of pituitary tumorigenesis can contribute to the development of novel targeted therapy for pituitary adenomas.	[Fukuoka, Hidenori] Kobe Univ Hosp, Div Diabet & Endocrinol, Kobe, Hyogo 6500017, Japan; [Takahashi, Yutaka] Kobe Univ, Grad Sch Med, Div Diabet & Endocrinol, Kobe, Hyogo 657, Japan	Fukuoka, H (reprint author), Kobe Univ Hosp, Div Diabet & Endocrinol, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	fukuokah@med.kobe-u.ac.jp			Japanese Ministry of Education Science, Culture, Sports, Science, and Technology [24790945, 23659477, 23591354, 22591012]; Ministry of Health, Labor, and Welfare, Japan; Novo Nordisk; Daiichi-Sankyo Fundation of Life Science; Naito Foundation	This work was supported in part by a Grant-in-Aid for Scientific Research from Japanese Ministry of Education Science, Culture, Sports, Science, and Technology 24790945, 23659477, 23591354, and 22591012, Grants-in-Aid for Scientific Research (research on hypothalamic-hypophyseal disorders) from the Ministry of Health, Labor, and Welfare, Japan, Novo Nordisk, Daiichi-Sankyo Fundation of Life Science, and the Naito Foundation.	Abbud RA, 2005, MOL ENDOCRINOL, V19, P1383, DOI 10.1210/me.2004-0403; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Pellegata NS, 2006, P NATL ACAD SCI USA, V103, P15558, DOI 10.1073/pnas.0603877103; SCHEITHAUER BW, 1987, SEMIN DIAGN PATHOL, V4, P205; Igreja S, 2010, HUM MUTAT, V31, P950, DOI 10.1002/humu.21292; Palumbo T, 2013, ONCOGENE, V32, P1651, DOI 10.1038/onc.2012.190; Gentilin E, 2013, ENDOCRINOLOGY, V154, P1690, DOI 10.1210/en.2012-2070; Balogh K, 2006, TRENDS ENDOCRIN MET, V17, P357, DOI 10.1016/j.tem.2006.09.004; Trouillas J, 2008, AM J SURG PATHOL, V32, P534, DOI 10.1097/PAS.0b013e31815ade45; Chahal HS, 2010, TRENDS ENDOCRIN MET, V21, P419, DOI 10.1016/j.tem.2010.02.007; Fedele M, 2006, CANCER CELL, V9, P459, DOI 10.1016/j.ccr.2006.04.024; Zhou CQ, 2009, MOL ENDOCRINOL, V23, P2000, DOI 10.1210/me.2009-0161; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Daly AF, 2007, J CLIN ENDOCR METAB, V92, P1891, DOI 10.1210/jc.2006-2513; Veugelers M, 2004, P NATL ACAD SCI USA, V101, P14222, DOI 10.1073/pnas.0405535101; Fedele M, 2005, ONCOGENE, V24, P3427, DOI 10.1038/sj.onc.1208501; Clayton RN, 1999, BEST PRACT RES CL EN, V13, P451, DOI 10.1053/beem.1999.0036; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418; Agarwal SK, 2009, J CLIN ENDOCR METAB, V94, P1826, DOI 10.1210/jc.2008-2083; Yacqub-Usman K, 2012, NAT REV ENDOCRINOL, V8, P486, DOI 10.1038/nrendo.2012.54; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Thakker RV, 2014, MOL CELL ENDOCRINOL, V386, P2, DOI 10.1016/j.mce.2013.08.002; TERAMOTO A, 1994, RADIOLOGY, V193, P161; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Bilodeau S, 2009, MOL CELL BIOL, V29, P1895, DOI 10.1128/MCB.01885-08; Walisser JA, 2004, J BIOL CHEM, V279, P16326, DOI 10.1074/jbc.M400784200; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Asa SL, 1999, ENDOCRINOLOGY, V140, P5348, DOI 10.1210/en.140.11.5348; JACOBY LB, 1990, J NEUROSURG, V73, P731, DOI 10.3171/jns.1990.73.5.0731; Fukuoka H, 2011, J CLIN INVEST, V121, P4712, DOI 10.1172/JCI60417; Marx SJ, 2005, ENDOCR REV, V26, P615, DOI 10.1210/er.2003-0037; Chesnokova V, 2005, MOL ENDOCRINOL, V19, P2371, DOI 10.1210/me.2005-0137; HERMAN V, 1990, J CLIN ENDOCR METAB, V71, P1427; Bertherat J, 2009, J CLIN ENDOCR METAB, V94, P2085, DOI 10.1210/jc.2008-2333; Ezzat S, 2008, ENDOCR J, V55, P951; Lemos MC, 2008, HUM MUTAT, V29, P22, DOI 10.1002/humu.20605; Ben-Shlomo A, 2010, TRENDS ENDOCRIN MET, V21, P123, DOI 10.1016/j.tem.2009.12.003; Tenhagen M, 2012, ENDOCR-RELAT CANCER, V19, pR115, DOI 10.1530/ERC-12-0060; Butz H, 2010, J CLIN ENDOCR METAB, V95, pE181, DOI 10.1210/jc.2010-0581; Verges B, 2002, J CLIN ENDOCR METAB, V87, P457, DOI 10.1210/jc.87.2.457; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Ogino A, 2005, J NEUROPATH EXP NEUR, V64, P398; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Franklin DS, 1998, GENE DEV, V12, P2899, DOI 10.1101/gad.12.18.2899; Tritos NA, 2011, NAT REV ENDOCRINOL, V7, P279, DOI 10.1038/nrendo.2011.12; Beuschlein F, 2014, NEW ENGL J MED, V370, P1019, DOI 10.1056/NEJMoa1310359; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Melmed S, 2011, NAT REV ENDOCRINOL, V7, P257, DOI 10.1038/nrendo.2011.40; Casey M, 2000, J CLIN INVEST, V106, pR31, DOI 10.1172/JCI10841; Yasufuku-Takano J, 2006, CLIN ENDOCRINOL, V64, P91, DOI 10.1111/j.1365-2265.2005.02423.x; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; [Anonymous], 2009, NEUROL MED CHIR TO S, V49, pPS1; Vlotides G, 2007, ENDOCR REV, V28, P165, DOI 10.1210/er.2006-0042; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008; Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Lin Y, 2009, ENDOCR-RELAT CANCER, V16, P301, DOI 10.1677/ERC-08-0167; Palmieri D, 2012, ONCOGENE, V31, P3857, DOI 10.1038/onc.2011.557; Freda PU, 2007, PITUITARY, V10, P275, DOI 10.1007/s11102-007-0058-2; Yoshino A, 2007, J NEURO-ONCOL, V83, P153, DOI 10.1007/s11060-006-9316-9; Kirschner LS, 2000, NAT GENET, V26, P89; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Leontiou CA, 2008, J CLIN ENDOCR METAB, V93, P2390, DOI 10.1210/jc.2007-2611; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Kirschner LS, 2010, MOL CELL ENDOCRINOL, V326, P3, DOI 10.1016/j.mce.2010.04.027; Vierimaa O, 2006, SCIENCE, V312, P1228, DOI 10.1126/science.1126100; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Kirschner LS, 2005, CANCER RES, V65, P4506, DOI 10.1158/0008-5472.CAN-05-0580; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Yin ZR, 2011, MOL ENDOCRINOL, V25, P1786, DOI 10.1210/me.2011-1008; Beckers A, 2013, ENDOCR REV, V34, P239, DOI 10.1210/er.2012-1013; Brandi ML, 2001, J CLIN ENDOCR METAB, V86, P5658, DOI 10.1210/jc.86.12.5658; Okano M, 1998, NAT GENET, V19, P219; Liu NA, 2011, P NATL ACAD SCI USA, V108, P8414, DOI 10.1073/pnas.1018091108; Hatziapostolou M, 2013, TRENDS ENDOCRIN MET, V24, P361, DOI 10.1016/j.tem.2013.03.002; Fuks F, 2000, NAT GENET, V24, P88; Bottoni A, 2005, J CELL PHYSIOL, V204, P280, DOI 10.1002/jcp.20282; Buurman H, 2006, EUR J ENDOCRINOL, V154, P753, DOI 10.1530/eje.1.02107; D'Angelo D, 2012, J CLIN ENDOCR METAB, V97, pE1128, DOI 10.1210/jc.2011-3482; Tateno T, 2010, MOL CELL ENDOCRINOL, V326, P66, DOI 10.1016/j.mce.2009.12.028; Anthony L, 2009, CURR MED RES OPIN, V25, P2989, DOI 10.1185/03007990903328959; Kitagawa M, 2013, CELL MOL LIFE SCI, V70, P4785, DOI 10.1007/s00018-013-1423-0; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; LARSSON C, 1988, NATURE, V332, P85, DOI 10.1038/332085a0; Bottoni A, 2007, J CELL PHYSIOL, V210, P370, DOI 10.1002/jcp.20832; Zhu XG, 2008, J CLIN ENDOCR METAB, V93, P3610, DOI 10.1210/jc.2008-0578; JACKS T, 1992, NATURE, V359, P295, DOI 10.1038/359295a0; Raff SB, 2000, J PEDIATR ENDOCR MET, V13, P373; Vlotides G, 2009, CANCER RES, V69, P4209, DOI 10.1158/0008-5472.CAN-08-4934; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Zhang X, 2003, J CLIN ENDOCR METAB, V88, P5119, DOI 10.1210/jc.2003-030222; Butz Henriett, 2011, Pituitary, V14, P112, DOI 10.1007/s11102-010-0268-x; Thakker RV, 2012, J CLIN ENDOCR METAB, V97, P2990, DOI 10.1210/jc.2012-1230; Simpson DJ, 2000, CANCER RES, V60, P1211; CARNEY JA, 1985, MEDICINE, V64, P270; Melmed S, 2003, J CLIN INVEST, V112, P1603, DOI 10.1172/JCI20401; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Zhao HL, 2013, CANCER CELL, V24, P645, DOI 10.1016/j.ccr.2013.09.021; Marinoni I, 2011, NEUROENDOCRINOLOGY, V93, P19, DOI 10.1159/000320366; ALEXANDER JM, 1990, J CLIN INVEST, V86, P336, DOI 10.1172/JCI114705; Ben-Jonathan N, 2001, ENDOCR REV, V22, P724, DOI 10.1210/er.22.6.724; Zhou YL, 2014, MOL CELL ENDOCRINOL, V386, P16, DOI 10.1016/j.mce.2013.09.006; Kaji H, 1999, CANCER RES, V59, P5097; Armstrong DKB, 1997, BRIT J DERMATOL, V136, P578, DOI 10.1111/j.1365-2133.1997.tb02145.x; Asa S L, 1994, Neurosurg Clin N Am, V5, P71; Bossis I, 2004, J MED GENET, V41, P596, DOI 10.1136/jmg.2004.020214; Chien WM, 2006, P NATL ACAD SCI USA, V103, P4122, DOI 10.1073/pnas.0509514103; Cooper O, 2011, ENDOCR-RELAT CANCER, V18, pR197, DOI 10.1530/ERC-11-0066; Corbetta S, 1997, CLIN ENDOCRINOL, V47, P507, DOI 10.1046/j.1365-2265.1997.3311122.x; Cristina C, 2006, FRONT HORM RES, V35, P50, DOI 10.1159/000094308; CRYNS VL, 1993, J CLIN ENDOCR METAB, V77, P644, DOI 10.1210/jc.77.3.644; Elston MS, 2009, NAT REV ENDOCRINOL, V5, P453, DOI 10.1038/nrendo.2009.126; Ezzat S, 2006, MOL ENDOCRINOL, V20, P2976, DOI 10.1210/me.2006-0265; Ezzat S, 2002, J CLIN INVEST, V109, P69, DOI 10.1172/JCI14036; Fukuoka H, 2011, MOL ENDOCRINOL, V25, P92, DOI 10.1210/me.2010-0353; Gill AJ, 2014, AM J SURG PATHOL, V38, P560, DOI 10.1097/PAS.0000000000000149; Gillam MP, 2014, ONCOGENE; Guru SC, 1998, J INTERN MED, V243, P433; HORVATH E, 1986, SEMIN DIAGN PATHOL, V3, P4; Jiang Xiaobing, 2013, Endocrinol Metab (Seoul), V28, P245, DOI 10.3803/EnM.2013.28.4.245; Kohn D T, 2002, Minerva Endocrinol, V27, P287; KOVACS K, 1986, SEMIN DIAGN PATHOL, V3, P18; La P, 2004, J BIOL CHEM, V279, P49045, DOI 10.1074/jbc.M409358200; Lacerte A, 2004, MOL ENDOCRINOL, V18, P1558, DOI 10.1210/me.2003-0470; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; LANDIS CA, 1990, J CLIN ENDOCR METAB, V71, P1416; Lin BC, 2008, MOL PHARMACOL, V74, P1367, DOI 10.1124/mol.108.047068; Lin BC, 2007, J BIOL CHEM, V282, P35924, DOI 10.1074/jbc.M705471200; Mantovani G, 2010, MOL CELL ENDOCRINOL, V326, P15, DOI 10.1016/j.mce.2010.04.009; MCANDREW J, 1995, ENDOCRINOLOGY, V136, P4479, DOI 10.1210/en.136.10.4479; MICHELS VV, 1986, MAYO CLIN PROC, V61, P224; Morris D, 2002, ANN NY ACAD SCI, V970, P119; Namihira H, 2002, J MOL ENDOCRINOL, V29, P297, DOI 10.1677/jme.0.0290297; Occhi G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003350; Pack SD, 2000, J CLIN ENDOCR METAB, V85, P3860, DOI 10.1210/jc.85.10.3860; Pei L, 1997, MOL ENDOCRINOL, V11, P433, DOI 10.1210/me.11.4.433; Peng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059024; Peverelli E, 2014, J MOL ENDOCRINOL, V52, pR67, DOI 10.1530/JME-13-0172; Raitila A, 2010, AM J PATHOL, V177, P1969, DOI 10.2353/ajpath.2010.100138; Revill K, 2009, ENDOCR-RELAT CANCER, V16, P537, DOI 10.1677/ERC-09-0008; Roussel-Gervais A, 2010, MOL ENDOCRINOL, V24, P1835, DOI 10.1210/me.2010-0091; SANO T, 1992, MICROSC RES TECHNIQ, V20, P152, DOI 10.1002/jemt.1070200204; Schteingart DE, 2009, EXPERT OPIN EMERG DR, V14, P661, DOI 10.1517/14728210903413522; SCHWINDINGER WF, 1992, P NATL ACAD SCI USA, V89, P5152, DOI 10.1073/pnas.89.11.5152; Simpson DJ, 1999, GENE CHROMOSOME CANC, V24, P328, DOI 10.1002/(SICI)1098-2264(199904)24:4<328::AID-GCC6>3.0.CO;2-P; Sivapragasam M, 2011, ENDOCR PATHOL, V22, P134, DOI 10.1007/s12022-011-9167-6; Stratakis CA, 2001, ANN ENDOCRINOL-PARIS, V62, P180; Tanaka C, 1998, J CLIN ENDOCR METAB, V83, P960, DOI 10.1210/jc.83.3.960; Tichomirowa MA, 2012, ENDOCR-RELAT CANCER, V19, P233, DOI 10.1530/ERC-11-0362; Trivellin G, 2012, AM J PHYSIOL-ENDOC M, V303, pE708, DOI 10.1152/ajpendo.00546.2011; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Xekouki P, 2012, ENDOCR-RELAT CANCER, V19, pC33, DOI 10.1530/ERC-12-0118; Yin ZR, 2008, MOL ENDOCRINOL, V22, P380, DOI 10.1210/me.2006-0428; Yu SJ, 2003, J BIOL CHEM, V278, P19597, DOI 10.1074/jbc.M212432200; Zhang X, 2002, J CLIN ENDOCR METAB, V87, P1262, DOI 10.1210/jc.87.3.1262; Zhu XG, 2007, MOL ENDOCRINOL, V21, P1205, DOI 10.1210/me.2007-0053	161	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	DEC	2014	54	12					943	957		10.2176/nmc.ra.2014-0184		15	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX2FF	WOS:000346758300001		
J	Oki, Y				Oki, Yutaka			Medical Management of Functioning Pituitary Adenoma: An Update	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						prolactinoma; acromegaly; Cushing's disease; somatostatin analogue; dopamine agonist	HORMONE-RECEPTOR ANTAGONIST; ACROMEGALIC PATIENTS RESISTANT; DOPAMINE AGONIST CABERGOLINE; GAMMA-KNIFE RADIOSURGERY; LONG-TERM TREATMENT; GROWTH-HORMONE; SOMATOSTATIN ANALOGS; CUSHINGS-SYNDROME; FOLLOW-UP; PROLACTIN SECRETION	The treatment of functioning pituitary adenoma (FPA) must achieve endocrinological remission as well as tumor size reduction. The first-line treatment of FPA except prolactinoma is transsphenoidal surgery (TSS). Medical treatments and/or radiation will be applied as adjuvant therapies succeeding to TSS. In patients with prolactinoma, dopamine agonists, especially cabergoline, are quite efficient. Dopamine agonists decrease plasma prolactin levels and induce shrinkage in most patients and can be ceased in some of them. In patients with acromegaly, dopamine agonists, somatostatin analogues, and growth hormone receptor antagonist have been used as a monotherapy or the combination, and the high remission rate can be achieved. Pasireotide having high affinity to type 5 somatostatin receptors will be available for the patients presenting resistance against type 2 receptor agonists, such as octreotide and lanreotide. The preceding treatment with somatostatin analogues is beneficial for improving the success rate of TSS. The chimera compounds of somatostatin analogues and dopamine agonists have been investigated. The medical treatments of Cushing's disease are challenging, if TSS is not successful. To suppress ACTH secretion, dopamine agonists and somatostatin analogues have been examined, but neither came to show a sufficient effect. Pasireotide reduces urinary cortisol excretion with a high remission rate. Adrenal enzyme inhibitors (AEIs), such as metyrapone, can inhibit cortisol synthesis form adrenal glands promptly and sufficiently in most of patients. LCI699, a newly developed AEI, is more potent than metyrapone and will be available. We should use available medical treatments for improving the prognosis and quality of life.	[Oki, Yutaka] Hamamatsu Univ Sch Med, Dept Family & Community Med, Hamamatsu, Shizuoka 4313192, Japan; [Oki, Yutaka] Hamamatsu Univ Sch Med, Dept Endocrinol & Metab, Hamamatsu, Shizuoka 4313192, Japan	Oki, Y (reprint author), Hamamatsu Univ Sch Med, Dept Family & Community Med, Naka Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	okitaka@hama-med.ac.jp					Abs R, 1998, J CLIN ENDOCR METAB, V83, P374, DOI 10.1210/jc.83.2.374; Schade R, 2007, NEW ENGL J MED, V356, P29, DOI 10.1056/NEJMoa062222; Melmed S, 2009, J CLIN ENDOCR METAB, V94, P1509, DOI 10.1210/jc.2008-2421; Hammer GD, 2004, J CLIN ENDOCR METAB, V89, P6348, DOI 10.1210/jc.2003-032180; Biller BMK, 2008, J CLIN ENDOCR METAB, V93, P2454, DOI 10.1210/jc.2007-2734; Herman-Bonert VS, 2000, J CLIN ENDOCR METAB, V85, P2958, DOI 10.1210/jc.85.8.2958; Nomikos P, 2005, EUR J ENDOCRINOL, V152, P379, DOI 10.1530/eje.1.01863; Colao A, 2012, NEW ENGL J MED, V366, P914, DOI 10.1056/NEJMoa1105743; Roelfsema F, 2012, PITUITARY, V15, P71, DOI 10.1007/s11102-011-0347-7; Marazuela M, 2009, EUR J ENDOCRINOL, V160, P535, DOI 10.1530/EJE-08-0705; Dekkers OM, 2007, J CLIN ENDOCR METAB, V92, P976, DOI 10.1210/jc.2006-2112; Pollock BE, 2007, J NEUROSURG, V106, P833, DOI 10.3171/jns.2007.106.5.833; Barkan AL, 2005, J CLIN ENDOCR METAB, V90, P5684, DOI 10.1210/jc.2005-0331; Melmed S, 2013, PITUITARY, V16, P294, DOI 10.1007/s11102-012-0420-x; Pivonello R, 2009, J CLIN ENDOCR METAB, V94, P223, DOI 10.1210/jc.2008-1533; Ross RJM, 2001, J CLIN ENDOCR METAB, V86, P1716, DOI 10.1210/jc.86.4.1716; Kreutzer J, 2001, J CLIN ENDOCR METAB, V86, P4072, DOI 10.1210/jc.86.9.4072; Colao A, 2011, ENDOCR REV, V32, P247, DOI 10.1210/er.2010-0002; Batista DL, 2006, J CLIN ENDOCR METAB, V91, P4482, DOI 10.1210/jc.2006-1245; Carlsen SM, 2008, J CLIN ENDOCR METAB, V93, P2984, DOI 10.1210/jc.2008-0315; Castinetti F, 2005, J CLIN ENDOCR METAB, V90, P4483, DOI 10.1210/jc.2005-0311; Colao A, 2014, J CLIN ENDOCR METAB, V99, P791, DOI 10.1210/jc.2013-2480; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; Lindholm J, 2001, J CLIN ENDOCR METAB, V86, P117, DOI 10.1210/jc.86.1.117; Biller BMK, 1996, J CLIN ENDOCR METAB, V81, P2338, DOI 10.1210/jc.81.6.2338; Landolt AM, 2000, J CLIN ENDOCR METAB, V85, P1287, DOI 10.1210/jc.85.3.1287; BEVAN JS, 1992, ENDOCR REV, V13, P220, DOI 10.1210/er.13.2.220; Feelders RA, 2010, NEUROENDOCRINOLOGY, V92, P111, DOI 10.1159/000314292; Trainer PJ, 2000, NEW ENGL J MED, V342, P1171, DOI 10.1056/NEJM200004203421604; Colao A, 2003, NEW ENGL J MED, V349, P2023, DOI 10.1056/NEJMoa022657; Holdaway IM, 2004, J CLIN ENDOCR METAB, V89, P667, DOI 10.1210/jc.2003-031199; WEBSTER J, 1994, NEW ENGL J MED, V331, P904, DOI 10.1056/NEJM199410063311403; Maffei P, 2006, ANN INTERN MED, V145, P310; ALEXANDER L, 1980, CLIN ENDOCRINOL, V12, P71, DOI 10.1111/j.1365-2265.1980.tb03135.x; Neggers SJCMM, 2009, EUR J ENDOCRINOL, V160, P529, DOI 10.1530/EJE-08-0843; Bertagna X, 2014, J CLIN ENDOCR METAB, V99, P1375, DOI 10.1210/jc.2013-2117; Verhelst J, 1999, J CLIN ENDOCR METAB, V84, P2518, DOI 10.1210/jc.84.7.2518; van der Lely AJ, 2012, J CLIN ENDOCR METAB, V97, P1589, DOI 10.1210/jc.2011-2508; BARKAN AL, 1986, J CLIN ENDOCR METAB, V63, P1057; Beauregard C, 2003, CLIN ENDOCRINOL, V58, P86, DOI 10.1046/j.1365-2265.2003.01679.x; CHANSON P, 1993, ANN INTERN MED, V119, P236; Danila DC, 2001, J CLIN ENDOCR METAB, V86, P2976, DOI 10.1210/jc.86.7.2976; Delgrange E, 1996, EUR J ENDOCRINOL, V134, P454; ENGELHARDT D, 1994, J STEROID BIOCHEM, V49, P261, DOI 10.1016/0960-0760(94)90267-4; GANCEL A, 1994, CLIN ENDOCRINOL, V40, P421; Giustina A, 2011, PITUITARY, V14, P125, DOI 10.1007/s11102-010-0269-9; ISHIBASHI M, 1985, J CLIN ENDOCR METAB, V60, P599; Jaquet P, 2005, EUR J ENDOCRINOL, V153, P135, DOI 10.1530/eje.1.01950; Kars M, 2008, EUR J ENDOCRINOL, V159, P363, DOI 10.1530/EJE-08-0611; Kauppinen-Makelin R, 2005, J CLIN ENDOCR METAB, V90, P4081, DOI 10.1210/jc.2004-1381; Kelly Daniel F, 2007, Neurosurg Focus, V23, pE5, DOI 10.3171/foc.2007.23.3.7; KLIBANSKI A, 1991, NEW ENGL J MED, V324, P822; KOVACS K, 1991, VIRCHOWS ARCH A, V418, P439, DOI 10.1007/BF01605931; Nieman Lynnette K, 2002, Pituitary, V5, P77, DOI 10.1023/A:1022308429992; Oki Y, 2009, ENDOCR J, V56, P1095; Ono M, 2010, J CLIN ENDOCR METAB, V95, P2672, DOI 10.1210/jc.2009-2605; Ronchi CL, 2009, CLIN ENDOCRINOL, V71, P846, DOI 10.1111/j.1365-2265.2009.03589.x; Salgado LR, 1996, J ENDOCRINOL INVEST, V19, P433; Shimon I, 1997, J CLIN INVEST, V100, P2386, DOI 10.1172/JCI119779; THORNER MO, 1982, J CLIN INVEST, V70, P965, DOI 10.1172/JCI110708; van der Hoek Joost, 2004, Pituitary, V7, P257	61	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	DEC	2014	54	12					958	965		10.2176/nmc.ra.2014-0239		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX2FF	WOS:000346758300002		
J	Hirohata, T; Ishii, Y; Matsuno, A				Hirohata, Toshio; Ishii, Yudo; Matsuno, Akira			Treatment of Pituitary Carcinomas and Atypical Pituitary Adenomas: A Review	NEUROLOGIA MEDICO-CHIRURGICA			English	Review						atypical pituitary adenoma; pituitary carcinoma; temozolomide	DNA MISMATCH REPAIR; TEMOZOLOMIDE TREATMENT; NEUROENDOCRINE TUMORS; THERAPY; METASTASES; PROLACTINOMA; EXPERIENCE; EXPRESSION; MANAGEMENT; RESISTANT	Atypical pituitary adenomas (APAs) are aggressive tumors, harboring a Ki-67 (MIB-1) staining index of 3% or more, and positive immunohistochemical staining for p53 protein, according to the World Health Organization (WHO) classification in 2004. Pituitary carcinomas (PC) usually develop from progressive APAs and predominantly consist of hormone-generating tumors, defined by the presence of disseminations in the cerebrospinal system or systemic metastases. Most of the cases with these malignant pituitary adenomas underwent surgeries, irradiations and adjuvant medical treatments, nevertheless, the therapies are mainly palliative. Recently, the efficacy of temozolomide (TMZ), an orally administered alkylating agent, has been reported as an alternative medical treatment. However, some recent studies have demonstrated a significant recurrence rate after effective response to TMZ. Further clinical and pathological researches of malignant pituitary adenomas will be required to improve the outcome of patients with these tumors.	[Hirohata, Toshio; Ishii, Yudo; Matsuno, Akira] Teikyo Univ, Dept Neurosurg, Tokyo 173, Japan; [Hirohata, Toshio] Univ Tokyo, Dept Neurosurg, Tokyo 1138655, Japan	Hirohata, T (reprint author), Univ Tokyo, Dept Neurosurg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	hirohata-tky@umin.ac.jp					Annamalai AK, 2012, PITUITARY, V15, P276, DOI 10.1007/s11102-011-0363-7; McCormack AI, 2009, CLIN ENDOCRINOL, V71, P226, DOI 10.1111/j.1365-2265.2008.03487.x; Raverot G, 2010, J CLIN ENDOCR METAB, V95, P4592, DOI 10.1210/jc.2010-0644; Kinsella TJ, 2009, CLIN CANCER RES, V15, P1853, DOI 10.1158/1078-0432.CCR-08-1307; Saeger W, 2007, EUR J ENDOCRINOL, V156, P203, DOI 10.1530/eje.1.02326; Gorshtein A, 2009, ENDOCR-RELAT CANCER, V16, P1017, DOI 10.1677/ERC-08-0269; Syro LV, 2006, CLIN ENDOCRINOL, V65, P552, DOI 10.1111/j.1365-2265.2006.02653.x; Pernicone PJ, 1997, CANCER, V79, P804, DOI 10.1002/(SICI)1097-0142(19970215)79:4<804::AID-CNCR18>3.0.CO;2-3; Fukuoka H, 2011, J CLIN INVEST, V121, P4712, DOI 10.1172/JCI60417; Arnold PM, 2012, J SPINAL CORD MED, V35, P118, DOI 10.1179/2045772311Y.0000000055; Ekeblad S, 2007, CLIN CANCER RES, V13, P2986, DOI 10.1158/1078-0432.CCR-06-2053; Friedman HS, 1997, CANCER RES, V57, P2933; Mohammed S, 2009, NEUROSURGERY, V64, P773, DOI 10.1227/01.NEU.0000339115.12803.4E; Syro LV, 2011, CANCER-AM CANCER SOC, V117, P454, DOI 10.1002/cncr.25413; Kaltsas GA, 2004, ENDOCR REV, V25, P458, DOI 10.1210/er.2003-0014; Raverot G, 2012, CLIN ENDOCRINOL, V76, P769, DOI 10.1111/j.1365-2265.2012.04381.x; SCHEITHAUER BW, 1986, J NEUROSURG, V65, P733, DOI 10.3171/jns.1986.65.6.0733; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Takeshita A, 2009, EUR J ENDOCRINOL, V161, P553, DOI 10.1530/EJE-09-0414; Dworakowska D, 2009, ENDOCR-RELAT CANCER, V16, P1329, DOI 10.1677/ERC-09-0101; Scheithauer BW, 2005, NEUROSURGERY, V56, P1066, DOI 10.1227/01.NEU.0000157926.72826.DB; Bode H, 2010, EXP CLIN ENDOCR DIAB, V118, P760, DOI 10.1055/s-0030-1253419; Bush ZM, 2010, J CLIN ENDOCR METAB, V95, pE280, DOI 10.1210/jc.2010-0441; Byrne S, 2009, J CLIN NEUROSCI, V16, P1694, DOI 10.1016/j.jocn.2009.05.013; CARTWRIGHT DM, 1994, DIAGN CYTOPATHOL, V11, P68, DOI 10.1002/dc.2840110116; Cerovac V, 2010, CANCER RES, V70, P666, DOI 10.1158/0008-5472.CAN-09-2951; Curtò Lorenzo, 2010, ScientificWorldJournal, V10, P2132, DOI 10.1100/tsw.2010.210; Debono M, 2008, END ABSTR, V15, P188; Dillard TH, 2011, PITUITARY, V14, P80, DOI 10.1007/s11102-010-0264-1; Fadul CE, 2006, J NEUROSURG, V105, P621, DOI 10.3171/jns.2006.105.4.621; Gaffey TA, 2002, J NEUROSURG, V96, P352, DOI 10.3171/jns.2002.96.2.0352; Garrao AF, 1997, EUR J ENDOCRINOL, V137, P176, DOI 10.1530/eje.0.1370176; Guzel A, 2008, J CHILD NEUROL, V23, P1467, DOI 10.1177/0883073808319078; Hagen C, 2009, EUR J ENDOCRINOL, V161, P631, DOI 10.1530/EJE-09-0389; Hirohata T, 2013, J CLIN ENDOCR METAB, V98, P1130, DOI 10.1210/jc.2012-2924; Jouanneau E, 2012, PITUITARY, V15, P37, DOI 10.1007/s11102-011-0341-0; Kaltsas GA, 2005, J CLIN ENDOCR METAB, V90, P3089, DOI 10.1210/jc.2004-2231; Kaltsas GA, 1998, J CLIN ENDOCR METAB, V83, P4233, DOI 10.1210/jc.83.12.4233; Kaltsas G A, 1998, Pituitary, V1, P69, DOI 10.1023/A:1009975009924; Kovacs K, 2007, HUM PATHOL, V38, P185, DOI 10.1016/j.humpath.2006.07.014; Lim S, 2006, LANCET ONCOL, V7, P518, DOI 10.1016/S1470-2045(06)70728-8; Lloyd RV, 2004, INTRO WHO CLASSIFICA, P10; Losa M, 2010, EUR J ENDOCRINOL, V163, P843, DOI 10.1530/EJE-10-0629; Matsuno A, 2014, MED MOL MORPHOL, V47, P1, DOI 10.1007/s00795-013-0050-z; Morin E, 2012, PITUITARY, V15, P97, DOI 10.1007/s11102-010-0232-9; Moshkin O, 2011, HORM-INT J ENDOCRINO, V10, P162; Moyes VJ, 2009, EUR J ENDOCRINOL, V160, P115, DOI 10.1530/EJE-08-0557; Murakami M, 2011, NEUROSURGERY, V68, pE1761, DOI 10.1227/NEU.0b013e318217161a; Neff LM, 2007, PITUITARY, V10, P81, DOI 10.1007/s11102-007-0014-1; Ortiz LD, 2012, PITUITARY, V15, P445, DOI 10.1007/s11102-011-0346-8; Ortiz LD, 2012, CLINICS, V67, P119, DOI 10.6061/clinics/2012(Sup01)20; Ragel Brian T, 2004, Neurosurg Focus, V16, pE7; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Swords FM, 2003, J CLIN ENDOCR METAB, V88, P5334, DOI 10.1210/jc.2002-020356; Syro LV, 2009, HORM-INT J ENDOCRINO, V8, P303; Tamiya T, 2004, BRAIN TUMORS, P309; Thapar K., 1996, NEUROSURGERY, V38, P106; Thearle MS, 2011, PITUITARY, V14, P418, DOI 10.1007/s11102-009-0211-1; Vlotides G, 2008, CANCER RES, V68, P6377, DOI 10.1158/0008-5472.CAN-08-0508; WALKER JD, 1993, CLIN ENDOCRINOL, V38, P411, DOI 10.1111/j.1365-2265.1993.tb00523.x; WILSON DF, 1982, OTOLARYNG HEAD NECK, V90, P665; Yamada S, 2006, FOLIA ENDOCRINOGIC S, V82, P37; Zada G, 2011, J NEUROSURG, V114, P336, DOI 10.3171/2010.8.JNS10290	63	1	1	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	DEC	2014	54	12					966	973		10.2176/nmc.ra.2014-0178		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX2FF	WOS:000346758300003		
J	Matsuo, T; Kamada, K; Izumo, T; Nagata, I				Matsuo, Takayuki; Kamada, Kensaku; Izumo, Tsuyoshi; Nagata, Izumi			Indication and Limitations of Endoscopic Extended Transsphenoidal Surgery for Craniopharyngioma	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						craniopharyngioma; extended transsphenoidal surgery; basal interhemispheric approach	LAMINA TERMINALIS APPROACH; SUPRASELLAR CRANIOPHARYNGIOMAS; ENDONASAL RESECTION; SURGICAL-MANAGEMENT; OUTCOMES; CHILDREN; REMOVAL; NUANCES; SELLAE; GRAFT	The transsphenoidal approach has been utilized in intrasellar craniopharyngioma surgeries. However, the advent of endoscopic extended transsphenoidal approach (EETSA) has expanded its indication to suprasellar craniopharyngiomas. We compared the indication and limitations of EETSA to those of unilateral basal interhemispheric approach (UBIHA), which presents similar indications for surgery. We analyzed 30 patients with tumors located below the foramen of Monro and the lateral boundary extending slightly beyond the internal carotid artery (UBIHA: N = 18; EETSA: N = 12). Postoperative magnetic resonance imaging (MRI) revealed gross total resection in 10 patients in the EETSA group (83.3%) and 12 in the UBIHA group (66.7%). Postoperative MM in the EETSA group revealed residual tumor at the cavernous sinus in one patient, at the prepontine in one; in the UBIHA group, residual tumors were located in the retrochiasmatic area in two patients, infundibulum-hypothalamus in one, on the stalk in one, and in the intrasellar region in two. No intergroup differences were observed in the preservation of pituitary function and postoperative improvement of visual function. The extent of resection was better with EETSA than with UBIHA. EETSA is considered the first-line therapy because the distance between the optic chiasm and the superior border of the pituitary is large; the lateral extension does not go beyond the internal carotid artery; and the tumor does not extend inferiorly beyond the posterior clinoid process. However, in patients showing poorly developed sphenoid sinuses or pituitary stalks anterior to the tumor, surgery is difficult regardless of the selection criteria.	[Matsuo, Takayuki; Kamada, Kensaku; Izumo, Tsuyoshi; Nagata, Izumi] Nagasaki Univ, Sch Med, Dept Neurosurg, Nagasaki 8528501, Japan	Matsuo, T (reprint author), Nagasaki Univ, Sch Med, Dept Neurosurg, 1-7-1 Sakamoto, Nagasaki 8528501, Japan.	Takayuki@nagasaki-u.ac.jp					Elliott RE, 2011, NEUROSURGERY, V69, P630, DOI 10.1227/NEU.0b013e31821a872d; Mortini P, 2011, J NEUROSURG, V114, P1350, DOI 10.3171/2010.11.JNS10670; Kassam AB, 2008, J NEUROSURG, V108, P715, DOI 10.3171/JNS/2008/108/4/0715; Gardner PA, 2008, J NEUROSURG, V109, P6, DOI 10.3171/JNS/2008/109/7/0006; Wang KC, 2005, CHILD NERV SYST, V21, P628, DOI 10.1007/s00381-005-1203-8; Ahn JY, 2009, NEUROSURGERY, V65, P65, DOI 10.1227/01.NEU.0000327695.32775.BB; Kitano M, 2009, SURG NEUROL, V71, P290, DOI 10.1016/j.surneu.2007.11.014; FUJISAWA I, 1987, RADIOLOGY, V165, P487; Mortini P, 2013, CRIT REV ONCOL HEMAT, V88, P514, DOI 10.1016/j.critrevonc.2013.07.013; Ceylan S, 2009, NEUROSURG REV, V32, P309, DOI 10.1007/s10143-009-0201-9; Koutourousiou M, 2013, J NEUROSURG, V119, P1194, DOI 10.3171/2013.6.JNS122259; Komotar RJ, 2012, WORLD NEUROSURG, V77, P329, DOI 10.1016/j.wneu.2011.07.011; Kassam AB, 2008, NEUROSURGERY, V63, P44, DOI 10.1227/01.NEU.0000297074.13423.F5; Fernandez-Miranda JC, 2012, HEAD NECK-J SCI SPEC, V34, P1036, DOI 10.1002/hed.21771; Gardner PA, 2008, NEUROSURGERY, V63, P36, DOI [10.1227/01.NEU.0000335069.30319.1E, 10.1227/01.NEU.0000316852.01820.45]; Ikeda Hidetoshi, 2012, Front Endocrinol (Lausanne), V3, P25, DOI 10.3389/fendo.2012.00025; Jane JA, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.1.FOCUS09319; Kassam AB, 2008, NEUROSURGERY, V63, P57, DOI 10.1227/01.NEU.0000297013.35469.37; Kim EH, 2011, J NEUROSURG, V114, P1338, DOI 10.3171/2010.11.JNS10612; Kitano M, 2004, NEUROSURGERY, V54, P653, DOI 10.1227/01.NEU.0000108780.72365.DC; Liu JK, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.1.FOCUS09309; Liu JK, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.1.FOCUS10297; Maira G, 2000, NEUROSURGERY, V47, P857, DOI 10.1097/00006123-200010000-00014; Minamida Y, 2005, J NEUROSURG, V103, P224, DOI 10.3171/jns.2005.103.2.0224; Qi ST, 2011, ACTA NEUROCHIR, V153, P785, DOI 10.1007/s00701-010-0940-y; Samii Madjid, 1997, Neurologia Medico-Chirurgica, V37, P141, DOI 10.2176/nmc.37.141; Wang KC, 2002, SURG NEUROL, V57, P25, DOI 10.1016/S0090-3019(01)00657-7	27	0	0	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	DEC	2014	54	12					974	982		10.2176/nmc.oa.2014-0038		9	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX2FF	WOS:000346758300004		
J	Ishii, Y; Tahara, S; Teramoto, A; Morita, A				Ishii, Yudo; Tahara, Shigeyuki; Teramoto, Akira; Morita, Akio			Endoscopic Endonasal Skull Base Surgery: Advantages, Limitations, and Our Techniques to Overcome Cerebrospinal Fluid Leakage: Technical Note	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						cerebrospinal fluid leakage; endonasal; endoscope; skull base surgery	TUBERCULUM SELLAE MENINGIOMAS; TRANSPLANUM TRANSTUBERCULUM APPROACH; EXTENDED TRANSSPHENOIDAL APPROACH; NASOSEPTAL FLAP RECONSTRUCTION; ANTERIOR FOSSA; SUPRASELLAR CRANIOPHARYNGIOMAS; ORBITOPTERIONAL APPROACH; WATERTIGHT CLOSURE; SURGICAL TECHNIQUE; PITUITARY SURGERY	In recent years, resections of midline skull base tumors have been conducted using endoscopic endonasal skull base (EESB) approaches. Nevertheless, many surgeons reported that cerebrospinal fluid (CSF) leakage is still a major complication of these approaches. Here, we report the results of our 42 EESB surgeries and discuss the advantages and limits of this approach for resecting various types of tumors, and also report our technique to overcome CSF leakage. All 42 cases involved midline skull base tumors resected using the EESB technique. Dural incisions were closed using nasoseptal flaps and fascia patch inlay sutures. Total removal of the tumor was accomplished in seven pituitary adenomas (33.3%), five craniopharyngiomas (62.5%), five tuberculum sellae meningiomas (83.3%), three clival chordomas (100%), and one suprasellar ependymoma. Residual regions included the cavernous sinus, the outside of the intracranial part of the internal carotid artery, the lower lateral part of the posterior clivus, and the posterior pituitary stalk. Overall incidence of CSF leakage was 7.1%. Even though the versatility of the approach is limited, EESB surgery has many advantages compared to the transcranial approach for managing midline skull base lesions. To avoid CSF leakage, surgeons should have skills and techniques for complete closure, including use of the nasoseptal flap and fascia patch inlay techniques.	[Ishii, Yudo; Tahara, Shigeyuki; Morita, Akio] Nippon Med Sch, Dept Neurosurg, Tokyo 1138603, Japan; [Teramoto, Akira] Tokyo Rosai Occupat Dis & Injuries Hosp, Japan Labour Hlth & Welf Org, Tokyo, Japan	Ishii, Y (reprint author), Nippon Med Sch, Dept Neurosurg, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	yudo@nms.ac.jp					Aggarwal A, 2013, PITUITARY, V16, P26, DOI 10.1007/s11102-012-0429-1; Akutsu H, 2009, NEUROSURGERY, V65, P54, DOI 10.1227/01.NEU.0000348016.69726.A6; Andaluz N, 2003, SKULL BASE-INTERD AP, V13, P241, DOI 10.1055/s-2004-817701; Fortes FSG, 2007, LARYNGOSCOPE, V117, P1329, DOI 10.1097/mlg.0b013e318062111f; Ceylan S, 2011, ACTA NEUROCHIR, V153, P1, DOI 10.1007/s00701-010-0788-1; Gondim JA, 2010, PITUITARY, V13, P68, DOI 10.1007/s11102-009-0195-x; Han ZL, 2008, CLIN NEUROL NEUROSUR, V110, P570, DOI 10.1016/j.clineuro.2008.02.017; Jho HD, 2001, J NEURO-ONCOL, V54, P187, DOI 10.1023/A:1012969719503; Leng LZ, 2008, NEUROSURGERY, V62, P342, DOI 10.1227/01.NEU.0000312720.93685.17; Zanation AM, 2009, AMJ RHINOL ALLERGY, V23, P518, DOI 10.2500/ajra.2009.23.3378; Wang Q, 2010, WORLD NEUROSURG, V73, P694, DOI 10.1016/j.wneu.2010.04.007; Kassam AB, 2008, J NEUROSURG, V108, P715, DOI 10.3171/JNS/2008/108/4/0715; de Divitiis E, 2007, NEUROSURGERY, V61, P229, DOI [10.1227/01.neu.0000303221.63016.f2, 10.1227/01.NEU.0000280133.91420.10]; Mamelak AN, 2013, PITUITARY, V16, P393, DOI 10.1007/s11102-012-0437-1; Thaler ER, 1999, AM J RHINOL, V13, P303, DOI 10.2500/105065899782102827; Gardner PA, 2008, J NEUROSURG, V109, P6, DOI 10.3171/JNS/2008/109/7/0006; de Divitiis E, 2008, NEUROSURGERY, V62, P556, DOI [10.1227/01.neu.0000317303.93460.24, 10.1227/01.NEU.0000297113.72625.D1]; Casiano RR, 2001, AM J RHINOL, V15, P271; Cook SW, 2004, NEUROSURGERY, V55, P239, DOI 10.1227/01.NEU.0000126952.51782.4D; Cappabianca P, 2004, CHILD NERV SYST, V20, P796, DOI 10.1007/s00381-004-0933-3; Cappabianca P, 2002, MINIM INVAS NEUROSUR, V45, P193, DOI 10.1055/s-2002-36197; Shah RN, 2009, LARYNGOSCOPE, V119, P1067, DOI 10.1002/lary.20216; Harvey RJ, 2009, J NEUROSURG, V111, P371, DOI 10.3171/2008.8.JNS08236; Patel KS, 2013, J NEUROSURG, V119, P661, DOI 10.3171/2013.4.JNS13124; Liu XM, 2012, J NEUROSURG, V117, P45, DOI 10.3171/2012.7.GKS121019; Hadad G, 2006, LARYNGOSCOPE, V116, P1882, DOI 10.1097/01.mlg.0000234933.37779.c4; Kim SW, 2013, LARYNGOSCOPE, V123, P1602, DOI 10.1002/lary.24107; Kari E, 2012, INT FORUM ALLERGY RH, V2, P2, DOI 10.1002/alr.20036; Andaluz N, 2003, NEUROSURGERY, V52, P1140, DOI 10.1227/01.NEU.0000057834.83222.9F; Reisch R, 2003, SURG NEUROL, V59, P223, DOI 10.1016/S0090-3019(02)01037-6; Kitano M, 2007, J NEUROSURG, V107, P337, DOI 10.2171/JNS-07/08/0337; Jho HD, 2004, MINIM INVAS NEUROSUR, V47, P16, DOI 10.1088/s-2004-818347; Berker M, 2012, PITUITARY, V15, P288, DOI 10.1007/s11102-011-0368-2; Ogawa Y, 2012, ACTA NEUROCHIR, V154, P621, DOI 10.1007/s00701-011-1266-0; Gonzalez LF, 2002, NEUROSURGERY, V50, P550, DOI 10.1097/00006123-200203000-00023; Kassam AB, 2008, NEUROSURGERY, V63, P44, DOI 10.1227/01.NEU.0000297074.13423.F5; Couldwell WT, 2004, NEUROSURGERY, V55, P539, DOI 10.1227/01.NEU.0000134287.19377.A2; Reisch R, 2005, NEUROSURGERY, V57, P242, DOI 10.1227/01.NEU.0000178353.42777.2C; Fatemi N, 2009, NEUROSURGERY, V64, P269, DOI 10.1227/01.NEU.0000327857.22221.53; Clark AJ, 2012, J NEUROSURG-PEDIATR, V10, P293, DOI 10.3171/2012.7.PEDS11436; Zabramski JM, 1998, J NEUROSURG, V89, P336, DOI 10.3171/jns.1998.89.2.0336; Perneczky A, 1998, NEUROSURGERY, V42, P219, DOI 10.1097/00006123-199802000-00001; Arai H, 2000, ACTA NEUROCHIR, V142, P751, DOI 10.1007/s007010070089; Bowers CA, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.2.FOCUS1115; Cappabianca P, 2004, NEUROSURGERY, V55, P933, DOI 10.1227/01.NEU.0000137330.02549.0D; Choudhari KA, 2001, BRIT J NEUROSURG, V15, P533, DOI 10.1080/02688690120097660; Cukurova I, 2008, ACTA NEUROCHIR, V150, P897, DOI 10.1007/s00701-008-0005-7; Cunha AM, 2010, SKULL BASE-INTERD AP, V20, P261, DOI 10.1055/s-0030-1247628; Liu James K, 2012, J Neurosurg, V32 Suppl, pE3; Fraioli MF, 2009, MINIM INVAS NEUROSUR, V52, P267, DOI 10.1055/s-0028-1104612; Frank G, 2010, WORLD NEUROSURG, V73, P625, DOI 10.1016/j.wneu.2010.05.031; Gardner PA, 2008, J NEUROSURG, V108, P1043, DOI 10.3171/JNS/2008/108/5/1043; Gardner PA, 2008, NEUROSURGERY, V63, P36, DOI [10.1227/01.NEU.0000335069.30319.1E, 10.1227/01.NEU.0000316852.01820.45]; Hayhurst C, 2011, OTOLARYNG CLIN N AM, V44, P953, DOI 10.1016/j.otc.2011.06.012; Ishii Y, 2011, ACTA NEUROCHIR, V153, P1543, DOI 10.1007/s00701-011-0988-3; Jho HD, 2004, MINIM INVAS NEUROSUR, V47, P9, DOI 10.1055/s-2004-818346; Jho HD, 2004, MINIM INVAS NEUROSUR, V47, P1, DOI 10.1055/S-2003-812538; Kassam Amin, 2005, Neurosurg Focus, V19, pE3; Khamlichi Abdeslam El, 2013, Acta Neurochir Suppl, V116, P49, DOI 10.1007/978-3-7091-1376-9_8; Kinoshita M, 2012, WORLD NEUROSURG, V77, P342, DOI 10.1016/j.wneu.2011.03.040; Kitano M, 2004, NEUROSURGERY, V54, P653, DOI 10.1227/01.NEU.0000108780.72365.DC; Liu JK, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.3.FOCUS115; Liu JK, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.1.FOCUS10297; Mahmoud M, 2010, NEUROSURGERY, V67, P108, DOI 10.1227/01.NEU.0000383153.75695.24; Malik MU, 2012, J NEUROL SURG PART A, V73, P275, DOI 10.1055/s-0032-1304808; McCoul ED, 2014, WORLD NEUROSURG, V81, P136, DOI 10.1016/j.wneu.2012.08.011; McCutcheon IE, 1996, NEUROSURGERY, V38, P479; McCutcheon IE, 1996, NEUROSURGERY, V38, P471, DOI 10.1097/00006123-199603000-00009; Saleem M Abid, 2013, Acta Neurochir Suppl, V116, P55, DOI 10.1007/978-3-7091-1376-9_9; Scholz M, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-16; Shanno G, 2001, NEUROSURGERY, V48, P559, DOI 10.1097/00006123-200103000-00020; Shin M, 2012, NEUROL MED-CHIR, V52, P697; Van Gompel JJ, 2011, NEUROSURG FOCUS, V30, DOI 10.3171/2011.1.FOCUS118; Wang Q, 2009, J CLIN NEUROSCI, V16, P889, DOI 10.1016/j.jocn.2008.10.003; Yang Yu-ming, 2010, Zhonghua Yi Xue Za Zhi, V90, P2348; Zhang MZ, 2004, CHINESE MED J-PEKING, V117, P323	76	2	2	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	DEC	2014	54	12					983	990		10.2176/nmc.st.2014-0081		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX2FF	WOS:000346758300005		
J	Shidoh, S; Toda, M; Kawase, T; Nakajima, H; Tomita, T; Ogawa, K; Yoshida, K				Shidoh, Satoka; Toda, Masahiro; Kawase, Takeshi; Nakajima, Hideo; Tomita, Toshiki; Ogawa, Kaoru; Yoshida, Kazunari			Transoral vs. Endoscopic Endonasal Approach for Clival/Upper Cervical Chordoma	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						crania-vertebral junction; endoscopic endonasal approach; transoral approach; transpalatal approach	CRANIAL BASE CHORDOMAS; TRANSSPHENOIDAL APPROACH; CRANIOVERTEBRAL JUNCTION; CRANIOCERVICAL JUNCTION; SURGICAL EXPERIENCE; FOLLOW-UP; RESECTION; TRANSNASAL; LESIONS; SUPRASELLAR	The surgical results of 18 cases of clival/upper cervical chordoma treated in the last decade via the endoscopic endonasal approach (EEA, 9 cases) and the transoral-transpalatal approach (TO-TPA, 9 cases) were compared. Each group showed the same incidence of subdural invasion, with 5 cases each. The superior (frontal base) and lateral surgical fields were wider by EEA, but the inferior view lower than the cranio-vertebral junction (CVJ) was wider by TO-TPA. Gross total removal was achieved in 3 cases in the EEA group, but in only 1 case in the TO-TPA group. Differences in radicality might be due to the extent of the lateral and subdural overview. However for large tumors extending below the CVJ, TO-TPA was the only viable approach for surgical removal. Surgical complications were higher in the EEA (4 cases) than the TO-TPA group (1 case), and were mainly caused by aggressive management of subdural invasion in the EEA group. Post-operative oral intake was earlier and the operative time was shorter in the EEA group. The surgical results were more radical and less invasive in the EEA group than the TO-TPA group. However in tumors extending below the CVJ, the surgical field in EEA was limited, indicating the need to use the transoral route or a combination of routes. A higher complication rate following subdural management was a negative factor that requires improvement in the EEA group and two-staged EEA followed by a transcranial approach may be considered for the cases with subdural invasion.	[Shidoh, Satoka; Toda, Masahiro; Kawase, Takeshi; Yoshida, Kazunari] Keio Univ, Sch Med, Dept Neurosurg, Tokyo 1608582, Japan; [Nakajima, Hideo] Keio Univ, Sch Med, Dept Plast Surg, Tokyo 1608582, Japan; [Tomita, Toshiki; Ogawa, Kaoru] Keio Univ, Sch Med, Dept Otolaryngol, Tokyo 1608582, Japan	Shidoh, S (reprint author), Keio Univ, Sch Med, Dept Neurosurg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	blsk_sl_satok@z2.keio.jp					Aldana PR, 2012, NEUROSURGERY S, V71; Dusick JR, 2005, J NEUROSURG, V102, P832, DOI 10.3171/jns.2005.102.5.0832; Matsushima T, 2010, SKULL BASE-INTERD AP, V20, P83, DOI 10.1055/s-0029-1242193; Liu JK, 2008, SKULL BASE-INTERD AP, V18, P151, DOI 10.1055/s-2007-994288; Kassam AB, 2005, NEUROSURGERY, V57, P213, DOI 10.1227/01.NEU.0000163687.64774.E4; Koutourousiou M, 2012, NEUROSURGERY, V71, P614, DOI 10.1227/NEU.0b013e31825ea3e0; Seker A, 2010, WORLD NEUROSURG, V74, P583, DOI 10.1016/j.wneu.2010.06.033; Tzortzidis F, 2006, NEUROSURGERY, V59, P230, DOI 10.1227/01.NEU.0000223441.51012.9D; Choi D, 2013, NEUROSURGERY, V73, P296, DOI 10.1227/01.neu.0000430324.24623.10; de Almeida JR, 2009, LARYNGOSCOPE, V119, P239, DOI 10.1002/lary.20108; BERTALANFFY H, 1991, NEUROSURGERY, V29, P815; Kaptain GJ, 2001, NEUROSURGERY, V49, P94, DOI 10.1097/00006123-200107000-00014; Ogawa Y, 2012, ACTA NEUROCHIR, V154, P621, DOI 10.1007/s00701-011-1266-0; Crockard HA, 2001, J NEUROSURG, V95, P175, DOI 10.3171/jns.2001.95.2.0175; Couldwell WT, 2004, NEUROSURGERY, V55, P539, DOI 10.1227/01.NEU.0000134287.19377.A2; de Divitiis E, 2002, NEUROSURGERY, V51, P699, DOI 10.1227/01.NEU.0000023602.41408.CD; Saito K, 2012, ACTA NEUROCHIR, V154, P879, DOI 10.1007/s00701-012-1317-1; Kasemsiri P, 2013, LARYNGOSCOPE, V123, P811, DOI 10.1002/lary.23697; Colli BO, 2001, J NEUROSURG, V95, P933, DOI 10.3171/jns.2001.95.6.0933; Gay E, 1995, NEUROSURGERY, V36, P896; Kassam Amin, 2005, Neurosurg Focus, V19, pE4; Kassam Amin, 2005, Neurosurg Focus, V19, pE3; Kassam AB, 2008, NEUROSURGERY, V63, P57, DOI 10.1227/01.NEU.0000297013.35469.37; Kassam Amin B, 2005, Neurosurg Focus, V19, pE6; PR Aldana, 2012, NEUROSURGERY S, V71; Sen C, 2010, J NEUROSURG, V113, P1059, DOI 10.3171/2009.9.JNS08596; Trzcinski K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060520; Visocchi M, 2014, ACTA NEUROCHIR, V156, P285, DOI 10.1007/s00701-013-1910-y	28	1	1	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	DEC	2014	54	12					991	998		10.2176/nmc.st.2014-0135		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	AX2FF	WOS:000346758300006		
